{"questions":[{"documents":[{"golden":true,"id":"35198634"},{"golden":false,"id":"29637127"},{"golden":true,"id":"38595339"},{"golden":false,"id":"39430518"},{"golden":true,"id":"37115484"},{"golden":false,"id":"39397536"},{"golden":false,"id":"11788931"},{"golden":false,"id":"39029061"},{"golden":false,"id":"15050027"},{"golden":false,"id":"12623849"},{"golden":false,"id":"27568821"},{"golden":false,"id":"19695014"},{"golden":false,"id":"14692971"},{"golden":false,"id":"15373677"},{"golden":false,"id":"15327515"},{"golden":false,"id":"16533288"},{"golden":false,"id":"34127958"},{"golden":false,"id":"17580308"},{"golden":false,"id":"17898576"},{"golden":false,"id":"26024230"},{"golden":false,"id":"25359465"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":1452,"document":"35198634","golden":true,"offsetInEndSection":1609,"text":"A four-gene signature composed of ANXA3, CD177, GRAMD1C, and TIGD3 effectively distinguished patients with paediatric sepsis from those in the control group.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":757,"document":"38595339","golden":true,"offsetInEndSection":1134,"text":"Furthermore, we used qRT-PCR to detect the expression levels of pivotal genes and validate the diagnostic model\u0027s ability to diagnose pediatric sepsis in 65 actual clinical samples.Results: Among 294 overlapping genes of DEGs and modular sepsis genes, five pivotal genes (STOM, MS4A4A, CD177, MMP8, and MCEMP1) were screened to construct a diagnostic model of pediatric sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1028,"document":"39397536","golden":false,"offsetInEndSection":1454,"text":"Nineteen DE genes distinguished between levels of pneumonia severity, including four genes also identified in the viral-only vs. bacterial-only model (IGHGP, PI3, CD177, RAP1GAP1) and four genes from the typical vs atypical bacterial model (PRSS23, IFI27, OLFM4, and ABO).CONCLUSIONS: We identified transcriptomic biomarkers associated with microbial detections and phenotypic severity in children hospitalized with pneumonia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1927,"document":"37115484","golden":true,"offsetInEndSection":2167,"text":"Additionally, all diagnostic characteristics may correlate with immune cells to varying degrees.CONCLUSIONS: The candidate hub genes (CD177, CYSTM1, and MMP8) were identified, and the nomogram was constructed for pediatric sepsis diagnosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":343,"document":"35198634","golden":false,"offsetInEndSection":653,"text":"Therefore, in this study, we aimed to evaluate the diagnostic value of key genes involved in paediatric sepsis based on the data of the Gene Expression Omnibus database.METHODS: We used the GSE119217 dataset to identify differentially expressed genes (DEGs) between patients with and without paediatric sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1675,"document":"35198634","golden":false,"offsetInEndSection":1973,"text":"In addition, the meta-analysis results showed that the pooled sensitivity, specificity, and area under the curve values were 1.00, 0.98, and 1.00, respectively.CONCLUSION: The four-gene signature can be used as new biomarkers to distinguish patients with paediatric sepsis from healthy individuals.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1076,"document":"29637127","golden":false,"offsetInEndSection":1623,"text":"Pathway analysis was used to explore genes differentially expressed.RESULTS: Irrespective of underlying HIV infection, cases showed significant upregulation compared with controls of the following: S100 calcium-binding protein A12 (S100A12); vanin-1 (VNN1); arginase, liver (ARG1); matrix metallopeptidase 9 (MMP9); annexin A3 (ANXA3); interleukin 1 receptor, type II (IL1R2); CD177 molecule (CD177); endocytic adaptor protein (NUMB) and S100 calcium-binding protein A9 (S100A9), cytoskeleton-associated protein 4 (CKAP4); and glycogenin 1 (GYG1).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"29637127","golden":false,"offsetInEndSection":1075,"text":"INTRODUCTION: Invasive pneumococcal disease (IPD), caused by Streptococcus pneumoniae, is a leading cause of pneumonia, meningitis and septicaemia worldwide, with increased morbidity and mortality in HIV-infected children.OBJECTIVES: We aimed to compare peripheral blood expression profiles between HIV-infected and uninfected children with pneumococcal meningitis and controls, and between survivors and non-survivors, in order to provide insight into the host inflammatory response leading to poorer outcomes.DESIGN AND SETTING: Prospective case-control observational study in a tertiary hospital in Malawi.PARTICIPANTS: Children aged 2 months to 16 years with pneumococcal meningitis or pneumonia.METHODS: We used the human genome HGU133A Affymetrix array to explore differences in gene expression between cases with pneumococcal meningitis (n\u003d12) and controls, and between HIV-infected and uninfected cases, and validated gene expression profiles for 34 genes using real-time quantitative PCR (RT-qPCR) in an independent set of cases with IPD (n\u003d229) and controls (n\u003d13).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1245,"document":"35198634","golden":false,"offsetInEndSection":1451,"text":"Subsequently, a meta-analysis of the selected genes was performed to evaluate the value of these genes as biomarkers in paediatric sepsis.RESULTS: A total of 41 CGs were selected from the GSE119217 dataset.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":393,"document":"39029061","golden":false,"offsetInEndSection":526,"text":"Machine learning algorithms identify 3 diagnostic genes - CD177, LDHA, and MCEMP1 - consistently highly expressed in sepsis patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1527,"document":"37115484","golden":true,"offsetInEndSection":1766,"text":"ted 402 overlapping genes. As pediatric sepsis diagnostic indicators, CYSTM1 (AUC?\u003d?0.988), MMP8 (AUC?\u003d?0.973), and CD177 (AUC?\u003d?0.986) were investigated and demonstrated statistically significant differences (P?\u003c?0.05) and diagnostic effi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":920,"document":"38595339","golden":false,"offsetInEndSection":1107,"text":" clinical samples.Results: Among 294 overlapping genes of DEGs and modular sepsis genes, five pivotal genes (STOM, MS4A4A, CD177, MMP8, and MCEMP1) were screened to construct a diagnostic","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":339,"document":"35198634","golden":false,"offsetInEndSection":508,"text":"on. Therefore, in this study, we aimed to evaluate the diagnostic value of key genes involved in paediatric sepsis based on the data of the Gene Expression Omnibus datab","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":785,"document":"35198634","golden":false,"offsetInEndSection":838,"text":"Common genes (CGs) were found between DEGs and WGCNA.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"35198634","golden":false,"offsetInEndSection":73,"text":"Identification of a Four-Gene Signature for Diagnosing Paediatric Sepsis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":553,"document":"39430518","golden":false,"offsetInEndSection":606,"text":"Finally, two genes, CD177 and ANXA3, were identified.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35198634","golden":false,"offsetInEndSection":137,"text":"AIM: Early diagnosis of paediatric sepsis is crucial for the proper treatment of children and reduction of hospitalization and mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1557,"document":"37115484","golden":false,"offsetInEndSection":1796,"text":"pediatric sepsis diagnostic indicators, CYSTM1 (AUC?\u003d?0.988), MMP8 (AUC?\u003d?0.973), and CD177 (AUC?\u003d?0.986) were investigated and demonstrated statistically significant differences (P?\u003c?0.05) and diagnostic efficacy in the validation set. As","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2041,"document":"37115484","golden":false,"offsetInEndSection":2172,"text":"andidate hub genes (CD177, CYSTM1, and MMP8) were identified, and the nomogram was constructed for pediatric sepsis diagnosis. Our ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1852,"document":"35198634","golden":false,"offsetInEndSection":1978,"text":"our-gene signature can be used as new biomarkers to distinguish patients with paediatric sepsis from healthy individuals.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1249,"document":"17898576","golden":false,"offsetInEndSection":1500,"text":"s pulmonary transfusion reactions.SUMMARY: The expression of CD177 is an important biomarker of myeloproliferative diseases, NB1 glycoprotein is a ligand for PECAM-1 and it may have a role in Wegener\u0027s granulomatosis, and antibodies to HNA-2a frequent","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":105,"document":"26024230","golden":false,"offsetInEndSection":190,"text":"HNA-2 is coded by CD177 gene that associates with human myeloproliferative disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":437,"document":"15050027","golden":false,"offsetInEndSection":638,"text":"CD177 was first described as PRV-1, a gene that is overexpressed in neutrophils from approximately 95% of patients with polycythemia vera and from about half of patients with essential thrombocythemia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":557,"document":"25359465","golden":false,"offsetInEndSection":733,"text":"The high level of CD177 expression is also maintained in airspace neutrophils, suggesting a potential involvement of CD177 in neutrophil infiltration under infectious diseases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1303,"document":"16533288","golden":false,"offsetInEndSection":1473,"text":" are alleles of the same gene now referred to as CD177. Changes in CD177 expression may be a marker of increased or decreased myelopoiesis and are therefore an effect of,","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1150,"document":"15327515","golden":false,"offsetInEndSection":1288,"text":"These findings indicate that an elevated neutrophil CD177 mRNA level is not a specific marker for the diagnosis of PV nor for that of CMD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"12623849","golden":false,"offsetInEndSection":171,"text":"The human neutrophil NB1 glycoprotein (NB1 GP, HNA-2a, CD177) has gained clinical importance for being involved in pulmonary transfusion reactions and immune neutropenias.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":119,"document":"14692971","golden":false,"offsetInEndSection":216,"text":"eutrophils. PRV-1 is a gene that is over-expressed in neutrophils from patients with polycythemia","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":125,"document":"15373677","golden":false,"offsetInEndSection":278,"text":"Searches of human genome databases have revealed that a pseudogene highly homologous to exons 4-9 of CD177 is located adjacent to CD177 on chromosome 19.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":315,"document":"19695014","golden":false,"offsetInEndSection":584,"text":"disorders and after G-CSF. This study investigated the presence of polymorphisms in the gene encoding HNA-2 (CD177) in individuals presenting different patterns of antigen expression and determined the association of single nucleotide polymorphisms (SNPs) with the hete","beginSection":"abstract"}],"exact_answer":"","ideal_answer":[],"id":"677eda7e592fa4887300002f","type":"yesno","body":"Is CD177 gene associated with paediatric sepsis?"},{"documents":[{"golden":false,"id":"16458071"},{"golden":false,"id":"10997206"},{"golden":false,"id":"37189347"},{"golden":false,"id":"23777218"},{"golden":false,"id":"18684669"},{"golden":false,"id":"26671582"},{"golden":false,"id":"35025891"},{"golden":false,"id":"23025330"},{"golden":false,"id":"17227648"},{"golden":false,"id":"31309926"},{"golden":false,"id":"17352316"},{"golden":false,"id":"11227870"},{"golden":false,"id":"29337878"},{"golden":false,"id":"32326257"},{"golden":false,"id":"33645468"},{"golden":false,"id":"36582061"},{"golden":false,"id":"34910728"},{"golden":false,"id":"31956704"},{"golden":false,"id":"22022233"},{"golden":false,"id":"16727562"},{"golden":false,"id":"30470176"},{"golden":false,"id":"33194958"},{"golden":false,"id":"16397425"},{"golden":false,"id":"22335498"},{"golden":false,"id":"38038769"},{"golden":false,"id":"29783540"},{"golden":false,"id":"34576722"},{"golden":false,"id":"31771703"},{"golden":false,"id":"35673983"},{"golden":false,"id":"36244350"},{"golden":false,"id":"33337277"},{"golden":false,"id":"3174235"},{"golden":false,"id":"30817773"},{"golden":false,"id":"26458386"},{"golden":false,"id":"16735161"},{"golden":false,"id":"29624584"},{"golden":false,"id":"32012658"},{"golden":false,"id":"37873308"},{"golden":false,"id":"21886894"},{"golden":false,"id":"16866042"},{"golden":false,"id":"33960290"},{"golden":true,"id":"36342910"},{"golden":false,"id":"32418182"},{"golden":false,"id":"34751370"},{"golden":false,"id":"18564917"},{"golden":false,"id":"35053731"},{"golden":false,"id":"33667394"},{"golden":false,"id":"37797656"},{"golden":false,"id":"33676578"},{"golden":false,"id":"31061906"},{"golden":false,"id":"33036315"},{"golden":false,"id":"36194937"},{"golden":false,"id":"38152610"},{"golden":false,"id":"35133544"},{"golden":false,"id":"34529724"},{"golden":false,"id":"37150376"},{"golden":false,"id":"35616248"},{"golden":false,"id":"25917495"},{"golden":false,"id":"37570387"},{"golden":false,"id":"34657648"},{"golden":false,"id":"5307600"},{"golden":false,"id":"24066283"},{"golden":false,"id":"38257870"},{"golden":false,"id":"32034687"},{"golden":false,"id":"16753076"},{"golden":false,"id":"27755545"},{"golden":false,"id":"36586512"},{"golden":false,"id":"36038611"},{"golden":false,"id":"37103031"},{"golden":false,"id":"37117740"},{"golden":false,"id":"33030256"},{"golden":false,"id":"37375115"},{"golden":false,"id":"31952121"},{"golden":false,"id":"36341273"},{"golden":false,"id":"33724140"},{"golden":false,"id":"37529018"},{"golden":false,"id":"36298710"},{"golden":false,"id":"38065835"},{"golden":true,"id":"11731969"},{"golden":false,"id":"25650203"},{"golden":false,"id":"24552089"},{"golden":false,"id":"37467280"},{"golden":false,"id":"37756346"},{"golden":false,"id":"27212706"},{"golden":false,"id":"38072499"},{"golden":false,"id":"31217000"},{"golden":false,"id":"36139941"},{"golden":false,"id":"35192212"},{"golden":false,"id":"34646219"},{"golden":false,"id":"38287434"},{"golden":false,"id":"38283348"},{"golden":false,"id":"38283347"},{"golden":false,"id":"38279116"},{"golden":false,"id":"38277231"},{"golden":false,"id":"38267502"},{"golden":false,"id":"35023567"},{"golden":false,"id":"37246724"},{"golden":false,"id":"32815542"},{"golden":false,"id":"38004808"},{"golden":false,"id":"36976784"},{"golden":false,"id":"37673774"},{"golden":false,"id":"32918969"},{"golden":false,"id":"34882307"},{"golden":false,"id":"34302177"},{"golden":false,"id":"33747978"},{"golden":false,"id":"32334089"},{"golden":false,"id":"32244778"},{"golden":false,"id":"31973101"},{"golden":false,"id":"31477173"},{"golden":false,"id":"28820896"},{"golden":false,"id":"38346938"},{"golden":false,"id":"38324876"},{"golden":false,"id":"38300899"},{"golden":false,"id":"38256275"},{"golden":false,"id":"38252673"},{"golden":false,"id":"38241361"},{"golden":false,"id":"38236916"},{"golden":false,"id":"38228608"},{"golden":false,"id":"19467364"},{"golden":false,"id":"28942771"},{"golden":false,"id":"31411135"},{"golden":false,"id":"29621601"},{"golden":false,"id":"20961515"},{"golden":false,"id":"15334029"},{"golden":false,"id":"31469332"},{"golden":false,"id":"22590768"},{"golden":false,"id":"19120177"},{"golden":false,"id":"28410761"},{"golden":false,"id":"7974690"},{"golden":false,"id":"7043149"},{"golden":false,"id":"29253420"},{"golden":false,"id":"18022567"},{"golden":false,"id":"22039880"},{"golden":false,"id":"25719539"},{"golden":false,"id":"33237917"},{"golden":false,"id":"36817417"},{"golden":false,"id":"26306311"},{"golden":false,"id":"18366755"},{"golden":false,"id":"30414516"},{"golden":false,"id":"25307219"},{"golden":false,"id":"9830201"},{"golden":false,"id":"22221811"},{"golden":false,"id":"34115754"},{"golden":false,"id":"30169282"},{"golden":false,"id":"24153010"},{"golden":false,"id":"28502864"},{"golden":false,"id":"28428122"},{"golden":false,"id":"31983471"},{"golden":false,"id":"21944555"},{"golden":false,"id":"24626257"},{"golden":false,"id":"19646412"},{"golden":false,"id":"23989652"},{"golden":false,"id":"23082500"},{"golden":false,"id":"24719753"},{"golden":false,"id":"38330051"},{"golden":false,"id":"38326914"},{"golden":false,"id":"38324807"},{"golden":false,"id":"38310575"},{"golden":false,"id":"38308365"},{"golden":false,"id":"38306403"},{"golden":false,"id":"37199988"},{"golden":false,"id":"32772627"},{"golden":false,"id":"34055935"},{"golden":false,"id":"35025966"},{"golden":false,"id":"35748871"},{"golden":false,"id":"31964843"},{"golden":false,"id":"36678396"},{"golden":false,"id":"35677436"},{"golden":false,"id":"37427262"},{"golden":false,"id":"35249858"},{"golden":false,"id":"38338692"},{"golden":false,"id":"38329945"},{"golden":false,"id":"19104653"},{"golden":false,"id":"20450304"},{"golden":false,"id":"23260189"},{"golden":false,"id":"21072230"},{"golden":false,"id":"9695940"},{"golden":false,"id":"7477570"},{"golden":false,"id":"39009679"},{"golden":false,"id":"39522577"},{"golden":false,"id":"28239154"},{"golden":false,"id":"26504815"},{"golden":false,"id":"37443059"},{"golden":false,"id":"34414346"},{"golden":true,"id":"38133445"},{"golden":false,"id":"1503182"},{"golden":false,"id":"24918468"},{"golden":false,"id":"19254975"},{"golden":false,"id":"28838133"},{"golden":false,"id":"30680486"},{"golden":false,"id":"14602444"},{"golden":false,"id":"20229338"},{"golden":false,"id":"28612175"},{"golden":false,"id":"8880488"},{"golden":false,"id":"28889192"},{"golden":false,"id":"28963630"},{"golden":false,"id":"27060763"},{"golden":false,"id":"28360328"},{"golden":false,"id":"37272973"},{"golden":false,"id":"16050789"},{"golden":false,"id":"24592275"},{"golden":false,"id":"25680190"},{"golden":false,"id":"35215241"},{"golden":true,"id":"25917718"},{"golden":false,"id":"32492764"},{"golden":false,"id":"37645305"},{"golden":false,"id":"33565565"},{"golden":false,"id":"16150644"},{"golden":false,"id":"37532196"},{"golden":false,"id":"31002197"},{"golden":false,"id":"30597175"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":1047,"document":"31309926","golden":false,"offsetInEndSection":1138,"text":"In the studied period, the average yearly incidence was 0.01 cases per 100,000 inhabitants.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1277,"document":"31309926","golden":false,"offsetInEndSection":1416,"text":"These findings demonstrate the need to intensify the surveillance system for trichinellosis through the development of an Italian registry.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":832,"document":"31309926","golden":false,"offsetInEndSection":1046,"text":"Out of the 30 (29.4%) records with a correct diagnosis of trichinellosis, nine cases were reported by HDRs only, 21 cases were documented by both HDRs and the NRLT, whereas the NRLT documented 100 additional cases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1139,"document":"31309926","golden":false,"offsetInEndSection":1276,"text":"This study highlights the limitations of using HDRs to obtain a clear picture of the prevalence and incidence of trichinellosis in Italy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":897,"document":"28838133","golden":false,"offsetInEndSection":1019,"text":"ubtypes occurred each season. The average annual hospitalization rates in children \u003c5 years old with lower RTI were 1.9/10","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":599,"document":"30680486","golden":false,"offsetInEndSection":686,"text":"Our study confirmed a high annual number of HAI in healthcare facilities in the EU/EEA.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":401,"document":"31309926","golden":false,"offsetInEndSection":506,"text":"Hospital discharge records (HDRs) showing the code for trichinellosis (124) were registered and screened.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"31309926","golden":false,"offsetInEndSection":134,"text":"Retrospective analysis of hospital discharge records for cases of trichinellosis does not allow evaluation of disease burden in Italy.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":714,"document":"33645468","golden":false,"offsetInEndSection":840,"text":"More than half (56%) had severe or critical disease, 20% required ICU care (14% received invasive ventilation) and 10.7% died.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1417,"document":"31309926","golden":false,"offsetInEndSection":1673,"text":"This would allow the identification of patients with severe infections and pauci-symptomatic patients, and would avoid the need for clinical analyses and unnecessary treatments, reducing the resulting economic burden on the Italian National Health Service.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":85,"document":"31309926","golden":false,"offsetInEndSection":282,"text":"In Italy, as well as in most other European countries, notification of Trichinella infections in humans is mandatory; however, no information is available on the number of cases occurring annually.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":964,"document":"29783540","golden":false,"offsetInEndSection":1139,"text":"In the European Union, it is estimated that 5% of all hospital admissions are due to side effects related to pharmacotherapy, thus resulting in nearly 200,000 deaths per year.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":283,"document":"31309926","golden":false,"offsetInEndSection":400,"text":"The aim of the present study was to retrospectively evaluate the burden of trichinellosis in Italy from 2005 to 2016.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":737,"document":"31309926","golden":false,"offsetInEndSection":831,"text":"A total of 102 HDRs revealed that the 124 code was erroneously reported in 72 (70.6%) records.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1086,"document":"3174235","golden":false,"offsetInEndSection":1342,"text":"The model predicts equilibrium prevalences of Trypanosoma vivax, T. congolense and T. brucei of 47.0, 45.8 and 28.7% respectively in the animal hosts, 24.2, 3.4 and 0.15% in the tsetse vectors, and a 7.0% infection of humans with human-infective T. brucei.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1038,"document":"29624584","golden":false,"offsetInEndSection":1309,"text":"We further found that only a minority of prevalent cases in the first, haemo-lymphatic stage of the disease were detected passively (maximum likelihood estimate \u003c30% in all three settings), whereas around 50% of patients in the second, meningo-encephalitic were detected.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":288,"document":"38133445","golden":false,"offsetInEndSection":385,"text":"The index of underdiagnosis may be as high as 70%, affecting mainly females of child-bearing age.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"29624584","golden":false,"offsetInEndSection":161,"text":"Gambiense Human African Trypanosomiasis (HAT), or sleeping sickness, is a vector-borne disease affecting largely rural populations in Western and Central Africa.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":407,"document":"32012658","golden":false,"offsetInEndSection":534,"text":"Increased funding and awareness of HAT over the past two decades has led to a steady decline in reported cases (\u003c1000 in 2018).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1310,"document":"29624584","golden":false,"offsetInEndSection":1505,"text":"We estimated that passive case detection reduced transmission in affected areas by between 30 and 50%, suggesting that there is great potential value in improving rates of passive case detection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":875,"document":"29624584","golden":false,"offsetInEndSection":1037,"text":"We found heterogeneity in incidence across villages, with a small minority of villages found to have much higher transmission rates and burdens than the majority.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":639,"document":"36342910","golden":true,"offsetInEndSection":1201,"text":"During 2011-2020, 49 cases of HAT were diagnosed in 16 non-endemic countries across five continents: 35 cases were caused by Trypanosoma brucei rhodesiense, mainly in tourists visiting wildlife areas in eastern and southern Africa, and 14 cases were due to T. b. gambiense, mainly in African migrants originating from or visiting endemic areas in western and central Africa.CONCLUSIONS/SIGNIFICANCE: HAT diagnosis in non-endemic countries is rare and can be challenging, but alertness and surveillance must be maintained to contribute to WHO\u0027s elimination goals.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":162,"document":"29624584","golden":false,"offsetInEndSection":370,"text":"The main method for detecting and treating cases of gambiense HAT are active screening through mobile teams and passive detection through self-referral of patients to dedicated treatment centres or hospitals.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1506,"document":"29624584","golden":false,"offsetInEndSection":1778,"text":"As gambiense HAT is driven towards elimination, it will be important to establish good systems of passive screening, and estimates such as the ones here will be of value in assessing the expected impact of moving from a primarily active to a more passive screening regime.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":371,"document":"29624584","golden":false,"offsetInEndSection":506,"text":"Strategies based on active case finding and treatment have drastically reduced the global incidence of the disease over recent decades.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31061906","golden":false,"offsetInEndSection":120,"text":"BACKGROUND: Human and animal African trypanosomiases impose a large economic and health burden in their endemic regions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1379,"document":"31061906","golden":false,"offsetInEndSection":1622,"text":"Using these model parameters, our estimated R0 suggests humans cannot alone sustain the HAT epidemic in Uganda.CONCLUSIONS/SIGNIFICANCE: Even in the absence of zoonotic transmission, loss of a preferred tsetse host species can affect HAT risk.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1302,"document":"18564917","golden":false,"offsetInEndSection":1543,"text":"Differences were primarily attributable to organ space SSIs (n \u003d 76).CONCLUSIONS: In a European university hospital setting, SSIs are costly and constitute a heavy and potentially preventable burden on both patients and healthcare providers.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":285,"document":"31061906","golden":false,"offsetInEndSection":739,"text":"Using a mathematical model with a 10?year time horizon, we demonstrate the role of the cattle treatment with trypanocides in the epidemiology of zoonotic and non-zoonotic HAT in Uganda, and its potential implications on elimination and eradication of the disease.METHODOLOGY/PRINCIPAL FINDINGS: We created two compartmental, deterministic models, each comprised of three sub-models: humans, the tsetse fly vector (Glossina fuscipes fuscipes), and cattle.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1135,"document":"33676578","golden":false,"offsetInEndSection":1408,"text":"Significantly higher proportions of surgical patients were female, belonged to the 60-to-79 age group, and were less severely ill. Also, extrinsic factors (invasive devices, hospitalization at the ICU, and prior antibiotics therapy) were more frequent in surgical patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":982,"document":"31061906","golden":false,"offsetInEndSection":1275,"text":"In both foci we assumed G. fuscipes fuscipes expresses zoophilic biting behavior.With trypanocide treatment of cattle administered every 3?months, treatment in stage I (representing engagement in active or passive surveillance) had a larger impact on HAT burden than cattle treatment coverage.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1276,"document":"31061906","golden":false,"offsetInEndSection":1378,"text":"However increasing cattle treatment coverage allowed for further reduction in prevalence in both foci.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"31061906","golden":false,"offsetInEndSection":194,"text":"A mathematical model for evaluating the role of trypanocide treatment of cattle in the epidemiology and control of Trypanosoma brucei rhodesiense and T. b. gambiense sleeping sickness in Uganda.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1623,"document":"31061906","golden":false,"offsetInEndSection":1814,"text":"Thus One Health strategies which integrate HAT and animal African trypanosomiasis control may improve the timeliness and sustainability of gHAT and rHAT elimination and eradication in Uganda.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1094,"document":"34751370","golden":false,"offsetInEndSection":1164,"text":"TPR behaved better at predicting all-cause mortality in both analyses.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":667,"document":"33036315","golden":false,"offsetInEndSection":828,"text":"In vitro and in vivo experimental data show the therapeutic potential of these natural products for the treatment of infections caused by species of Trypanosoma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":98,"document":"33036315","golden":false,"offsetInEndSection":166,"text":"In humans, this includes Chagas disease and African trypanosomiasis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":591,"document":"33036315","golden":false,"offsetInEndSection":666,"text":"The main chemical constituents and mechanisms of action are also discussed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37873308","golden":false,"offsetInEndSection":110,"text":"Trypanosoma brucei is a protozoan parasite that causes human and animal African trypanosomiases (HAT and AAT).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":322,"document":"33036315","golden":false,"offsetInEndSection":484,"text":"This review describes studies of the trypanocidal properties of essential oils, an important group of natural products widely found in several tropical countries.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33036315","golden":false,"offsetInEndSection":97,"text":"Trypanosomiases are diseases caused by parasitic protozoan trypanosomes of the genus Trypanosoma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":167,"document":"33036315","golden":false,"offsetInEndSection":250,"text":"There are few therapeutic options, and there is low efficacy to clinical treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1017,"document":"38152610","golden":false,"offsetInEndSection":1162,"text":"Furthermore, these derivatives represent useful chemical probes to elucidate the molecular mechanism underlying I-BET151-induced differentiation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":251,"document":"33036315","golden":false,"offsetInEndSection":321,"text":"Therefore, the search for new drugs for the trypanosomiasis is urgent.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":485,"document":"33036315","golden":false,"offsetInEndSection":590,"text":"Seventy-seven plants were selected from literature for the trypanocidal activity of their essential oils.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1829,"document":"34657648","golden":false,"offsetInEndSection":2304,"text":"These estimates, alongside the prevalence of resistance, translated into direct hospitalization attributable costs per ICU-acquired infection of 5,224? (95% CI, 3,691-6,757) for Spain, 4,461? (95% CI, 1,948-6,974) for Portugal, and 4,320? (95% CI, 1,662-6,977) for Italy.CONCLUSIONS: ICU-acquired infections associated with antibiotic-resistant bacteria are substantially associated with a 15% increase in excess LOS and resource utilization in 3 southern European countries.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24066283","golden":false,"offsetInEndSection":183,"text":"African trypanosomes are unicellular flagellated parasites causing trypanosomiases in Africa, a group of severe diseases also known as sleeping sickness in human and nagana in cattle.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1860,"document":"32034687","golden":false,"offsetInEndSection":2509,"text":"In the first year of its introduction, dalbavancin significantly reduced the total economic burden in Italy and Spain (-??352,252 and -??233,991, respectively), while it increased the total economic burden in Austria (?80,769, 0.7% of the total expenditure for these patients); in the third year of its introduction, dalbavancin reduced the total economic burden in each Country (-??1.1 million, -??810,650, and -??70,269, respectively).CONCLUSIONS: The introduction of dalbavancin in a new patient pathway to treat non-severe ABSSSI could generate a significant reduction in hospitalized patients and the overall patient length of stay in hospital.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1604,"document":"36586512","golden":false,"offsetInEndSection":1895,"text":"Change escalation in CDI medication (OR 3.735) and treatment in an intensive care unit (OR 5.454) were found to be the most important variables associated with increased overall costs of patients with CDI.CONCLUSIONS: Treatment of patients with recurrent CDI results in a significant burden.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":266,"document":"24066283","golden":false,"offsetInEndSection":449,"text":"In this review, we describe and compare the three developmental programs of the main trypanosome species impacting human and animal health, with focus on the most recent observations.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"24066283","golden":false,"offsetInEndSection":78,"text":"Through the dark continent: African trypanosome development in the tsetse fly.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":184,"document":"24066283","golden":false,"offsetInEndSection":265,"text":"These parasites are almost exclusively transmitted by the bite of the tsetse fly.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":448,"document":"38257870","golden":false,"offsetInEndSection":597,"text":"Control of these infections is progressing and, in some cases (such as human African trypanomiasis (HAT)), significant reductions have been achieved.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":450,"document":"24066283","golden":false,"offsetInEndSection":608,"text":"From here, some reflections are made on research issues concerning trypanosome developmental biology in the tsetse fly that are to be addressed in the future.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":247,"document":"27755545","golden":false,"offsetInEndSection":907,"text":"Based on the methodology of the Burden of Communicable Diseases in Europe (BCoDE) project and 2011-2012 data from the European Centre for Disease Prevention and Control (ECDC) point prevalence survey (PPS) of HAIs and antimicrobial use in European acute care hospitals, we estimated the burden of six common HAIs.METHODS AND FINDINGS: The included HAIs were healthcare-associated pneumonia (HAP), healthcare-associated urinary tract infection (HA UTI), surgical site infection (SSI), healthcare-associated Clostridium difficile infection (HA CDI), healthcare-associated neonatal sepsis, and healthcare-associated primary bloodstream infection (HA primary BSI).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":145,"document":"37103031","golden":false,"offsetInEndSection":243,"text":"Moreover, HF is a great burden to overall healthcare, mainly because of frequent hospitalizations.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1178,"document":"38257870","golden":false,"offsetInEndSection":1411,"text":"These research contributions are complemented by an update revision of the current chemotherapy against African Trypanosoma species, and a critical review of the shortcomings of the prevailing model of drug discovery and development.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":953,"document":"36038611","golden":false,"offsetInEndSection":1121,"text":"Our results validate PEX5 as a target for small molecule inhibitors and provide scaffolds suitable for further pre-clinical development of novel trypanocidal compounds.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":114,"document":"38257870","golden":false,"offsetInEndSection":285,"text":"Diseases caused by Trypanosoma and Leishmania have variable clinical outcomes, ranging from self-healing to fatality, and are considered Neglected Tropical Diseases (NTD).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":598,"document":"38257870","golden":false,"offsetInEndSection":684,"text":"In the absence of effective vaccination, chemotherapy is the most used control method.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":685,"document":"38257870","golden":false,"offsetInEndSection":841,"text":"Unfortunately, the therapeutic arsenal is scarce, old, and of variable efficacy, and reports of resistance to most antiparasitic agents have been published.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38257870","golden":false,"offsetInEndSection":67,"text":"Antileishmanial and Antitrypanosomes Drugs for the Current Century.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37375115","golden":false,"offsetInEndSection":190,"text":"The physician Carlos Chagas (1879-1934) described the protozoan parasite Trypanosoma cruzi and discovered a new illness named American trypanosomiases or Chagas disease (Chagas, 1909) [...].","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":989,"document":"38257870","golden":false,"offsetInEndSection":1177,"text":"In this Special Issue, contributions regarding the identification and validation of drug targets, underlying mechanisms of action and resistance, and potential new molecules are presented.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":493,"document":"37529018","golden":false,"offsetInEndSection":698,"text":"The World Health Organization (WHO) has targeted the elimination of transmission of gambiense human African trypanosomiasis by 2030, defined as zero autochthonous cases for at least five consecutive years.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1438,"document":"37467280","golden":false,"offsetInEndSection":1786,"text":"However, according to hospital discharges, the estimated human leishmaniasis incidence was 0.70 in Italy and visceral leishmaniasis incidences were 0.67 in Spain and 0.41 in Portugal.CONCLUSIONS/SIGNIFICANCE: Overall, there was no evidence of widespread increased incidence of autochthonous human leishmaniasis by L. infantum in European countries.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2214,"document":"27212706","golden":false,"offsetInEndSection":2483,"text":"Over the period of this study the proportion of rHAT cases identified in early stage fell and by 2012 the majority of cases identified were diagnosed in the late stage.CONCLUSION: This study illustrates the critical role of the district health system in HAT management.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":325,"document":"37529018","golden":false,"offsetInEndSection":492,"text":"After over two decades of sustained efforts, the incidence of the disease is strongly declining, and some historically endemic countries are no longer detecting cases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":908,"document":"37529018","golden":false,"offsetInEndSection":1077,"text":"WHO has therefore developed a target product profile calling for development of a method for population-level cross-cutting surveillance of T. b. gambiense transmission.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37529018","golden":false,"offsetInEndSection":124,"text":"Human African trypanosomiasis is a life-threatening parasitic infection transmitted by the tsetse fly in sub-Saharan Africa.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":304,"document":"38065835","golden":false,"offsetInEndSection":500,"text":"Due to the concerted efforts of several bodies, including better identification and treatment of cases and improved tsetse fly vector control, the number of cases of HAT has declined dramatically.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"11731969","golden":true,"offsetInEndSection":269,"text":"A recent cluster of cases of African trypanosomiasis in humans (HAT) has been reported in tourists (most of whom were European) returning from Tanzania; we describe the first 2 patients (both of whom were Italian travelers) with HAT, who have been treated successfully.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1237,"document":"37529018","golden":false,"offsetInEndSection":1604,"text":"Among other characteristics the product profile specifies: (i)?a simple specimen collection procedure; (ii)?no cold-chain requirement to transfer specimens to reference laboratories; (iii)?high sensitivity and specificity; (iv)?high-throughput, substantially automatized; (v)?low cost per specimen, when analysed in large batches; and (vi)?applicable also in animals.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":861,"document":"24552089","golden":false,"offsetInEndSection":919,"text":"By 2012, the number of reported cases was fewer than 8000.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1173,"document":"35192212","golden":false,"offsetInEndSection":1501,"text":"Surgery for thyroid cancer being the cause of hypoPT was associated with lower odds in PF for patients and in PF and CF for patients with surgery for other thyroid-related diseases being the hypoPT cause.CONCLUSIONS: HypoPT needs to be recognised as a disease which might be associated with impaired QOL and affect daily living.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":749,"document":"37117740","golden":false,"offsetInEndSection":871,"text":"The TET2 PTV burden was associated with a lifespan through somatic mutation events presumably due to clonal hematopoiesis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":377,"document":"32034687","golden":false,"offsetInEndSection":808,"text":"This study aimed to evaluate the economic impact on the National Health System associated with the management of non-severe ABSSSIs treated in hospitals with innovative long-acting dalbavancin compared to standard antibiotic therapy in Italy, Spain, and Austria.METHODS: A budget impact analysis was developed to evaluate the direct costs associated with the management of ABSSSI from the national public health system perspective.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38287434","golden":false,"offsetInEndSection":52,"text":"BACKGROUND: Chagas disease is a neglected tropical d","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38283348","golden":false,"offsetInEndSection":131,"text":"Introduction: Chagas disease causes a cardiac illness characterized by immunoinflammatory reactions leading to myocardial fibrosis ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38283347","golden":false,"offsetInEndSection":56,"text":"Introduction: Chagas disease (CD) is caused by the proto","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38279116","golden":false,"offsetInEndSection":144,"text":"BACKGROUND: Trypanosoma brucei is the causative agent for trypanosomiasis in humans and livestock, which presents a growing challenge due to dru","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38277231","golden":false,"offsetInEndSection":288,"text":"Studies have shown that depending on the substitution pattern, microtubule (MT)-targeting 1,2,4-triazolo[1,5-a]pyrimidines (TPDs) can produce different cellular responses in mammalian cells that may be due to these compounds interacting with distinct binding sites within the MT structure","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38267502","golden":false,"offsetInEndSection":107,"text":"Chagas is an endemic disease in tropical regions of Latin America, caused by the parasite Trypanosoma cruzi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38257870","golden":false,"offsetInEndSection":112,"text":"Human infections by trypanosomatids are widely distributed and prevalent in the tropical and subtropical regions","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1491,"document":"35023567","golden":false,"offsetInEndSection":1814,"text":"The number of bed days for RSV-RTI was higher than that for RTIs associated with other pathogens in infants aged \u003c1 year, especially in those \u003c6 months.CONCLUSIONS: RSV disease prevention therapies (monoclonal antibodies and maternal vaccines) for infants could help prevent a substantial number of bed days due to RSV-RTI.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":123,"document":"35023567","golden":false,"offsetInEndSection":624,"text":"High-quality country-specific estimates of bed days and length of stay (LOS) show the population burden of RSV-RTI on secondary care services and the burden among patients, and can be used to inform RSV immunization implementation decisions.METHODS: We estimated the hospital burden of RSV-associated RTI (RSV-RTI) in children under 5 years in 7 European countries (Finland, Denmark, Norway, Scotland, England, the Netherlands, and Italy) using routinely collected hospital databases during 2001-2018.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":813,"document":"35023567","golden":false,"offsetInEndSection":1083,"text":"We estimated average annual numbers and rates of bed days for RSV-RTI and other-pathogen RTI, as well as the hospital LOS.RESULTS: We found that infants born 2 months before the peak month of RSV epidemics more frequently had the highest RSV-RTI hospital admission rate.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1299,"document":"35023567","golden":false,"offsetInEndSection":1490,"text":"Between 70% and 89% of these bed days were in infants aged \u003c1 year, representing 40.3 (95% confidence interval [CI], 40.1-40.4) to 91.2 (95% CI, 90.6-91.8) bed days per 1000 infants annually.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1080,"document":"37246724","golden":false,"offsetInEndSection":1414,"text":"Infants aged under 2 months represented the most affected group (71.6 per 1000 children; 95% CI, 66.6-76.6).CONCLUSIONS: Our findings will help support decisions regarding prevention efforts and represent an important benchmark to understand changes in the RSV burden following the introduction of RSV immunization programs in Europe.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1084,"document":"35023567","golden":false,"offsetInEndSection":1298,"text":"RSV-RTI hospital episodes accounted for 9.9-21.2 bed days per 1000 children aged \u003c5 years annually, with the median (interquartile range) LOS ranging from 2 days (0.5-4 days) to 4 days (2-6 days) between countries.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1132,"document":"32918969","golden":false,"offsetInEndSection":1727,"text":"Within European and North American healthcare settings, a meta-analysis of eight studies identified a pooled prevalence of ESBL-E on admission to hospital of 7.91% and an acquisition rate of 3.73%.DISCUSSION: Low prevalence at the point of hospital admission and insufficient evidence of patient-to-patient transmission suggests that infection prevention and control measures such as universal surveillance screening and single-room isolation are unlikely to be practical or effective interventions in reducing the overall burden of ESBL-E in hospitals, in line with current European guidelines.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35023567","golden":false,"offsetInEndSection":122,"text":"BACKGROUND: Respiratory syncytial virus (RSV) is a leading cause of respiratory tract infections (RTIs) in young children.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"35023567","golden":false,"offsetInEndSection":124,"text":"Respiratory Syncytial Virus-Associated Hospital Admissions and Bed Days in Children \u003c5 Years of Age in 7 European Countries.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1905,"document":"35023567","golden":false,"offsetInEndSection":1993,"text":"Variation in LOS between countries might reflect differences in hospital care practices.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35215241","golden":false,"offsetInEndSection":90,"text":"Human African trypanosomiasis (HAT or \u0027sleeping sickness\u0027) is a neglected tropical disease","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"34882307","golden":false,"offsetInEndSection":132,"text":"Human African trypanosomiasis, or sleeping sickness, is a severe disease affecting people in the poorest parts of Africa","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34302177","golden":false,"offsetInEndSection":98,"text":"Chagas disease is an infection caused by the parasite Trypanosoma cruzi, endemic in Latino America","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":17,"document":"33747978","golden":false,"offsetInEndSection":131,"text":", a zoonotic kinetoplastid protozoan parasite, is the causative agent of American trypanosomiasis (Chagas disease)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"32334089","golden":false,"offsetInEndSection":104,"text":"Spain is the European country with the highest number of Trypanosoma cruzi infected patients","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32244778","golden":false,"offsetInEndSection":173,"text":"To successfully eliminate human African trypanosomiasis (HAT), healthcare workers (HCWs) must maintain their diagnostic acuity to identify cases as the disease becomes rarer","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31973101","golden":false,"offsetInEndSection":86,"text":"The recent approval of fexinidazole for human African trypanosomiasis (HAT) caused by ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"31477173","golden":false,"offsetInEndSection":121,"text":"Tsetse flies (Glossina sp.) are the vectors of human and animal trypanosomiasis throughout sub-Saharan Africa","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"28820896","golden":false,"offsetInEndSection":174,"text":"Bolivia has the highest prevalence of Chagas disease (CD) in the world (6.1%), with more than 607,186 people with Trypanosoma cruzi infection, most of them adults","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":60,"document":"38346938","golden":false,"offsetInEndSection":116,"text":"However, most patients do not achieve long-term survival","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1101,"document":"38324876","golden":false,"offsetInEndSection":1143,"text":"From these patients, three had parasitemia","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":279,"document":"38300899","golden":false,"offsetInEndSection":379,"text":"Conventional diagnostic methods have limitations, and therapeutic response evaluation is challenging","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38256275","golden":false,"offsetInEndSection":41,"text":"Chagas disease is caused by the parasite ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":565,"document":"38252673","golden":false,"offsetInEndSection":717,"text":"Parasitemia (microhaematocrit and/or PCR) was performed at \u003c8 months of age, and serology (ELISA and IHA) at ?8 months to rule out congenital infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":485,"document":"38241361","golden":false,"offsetInEndSection":557,"text":"Mean age of the 109 patients was 43 years (range 19-76); 61% were female","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38236916","golden":false,"offsetInEndSection":137,"text":"An ?-Gal antigenic surrogate as a biomarker of treatment evaluation in Trypanosoma cruzi-infected children. A retrospective cohort study.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":388,"document":"38228608","golden":false,"offsetInEndSection":486,"text":"Here we present a subsequent investigation of triatomines collected around the case-patient\u0027s home","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"19467364","golden":false,"offsetInEndSection":120,"text":"UNLABELLED: Protozoan infections are very common among tropical countries and have an important impact on public health.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":375,"document":"19467364","golden":false,"offsetInEndSection":578,"text":"Toxoplasmosis and pneumocystosis (formerly thought to be caused by a protozoan) are worldwide parasitic infections with a very high incidence in immunocompromised patients but are not restricted to them.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":121,"document":"19467364","golden":false,"offsetInEndSection":275,"text":"Leishmaniasis is the most widely disseminated protozoan infection in the world, while the trypanosomiases are widespread in both Africa and South America.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1194,"document":"19467364","golden":false,"offsetInEndSection":1707,"text":"The recognition of the clinical symptoms and the dermatologic findings of these diseases, and a knowledge of the geographic distribution of the pathogen, can be critical in making the diagnosis of a protozoan infection.LEARNING OBJECTIVES: After completing this learning activity, participants should be able to recognize the significance of protozoan infections worldwide, identify the dermatologic manifestations of protozoan infections, and select the best treatment for the patient with a protozoan infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1089,"document":"19467364","golden":false,"offsetInEndSection":1193,"text":"Vertebrates also serve as vectors as in the case of toxoplasmosis and its transmission by domestic cats.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":139,"document":"29621601","golden":false,"offsetInEndSection":929,"text":"A robust and current evidence base that is specific to local, national and Europe-wide settings is necessary to inform the development of strategies to reduce HCAI and contain antimicrobial resistance.AIM: To measure the prevalence of HCAI and antimicrobial prescribing and identify key priority areas for interventions to reduce the burden of infection.METHODS: A national rolling point-prevalence survey (PPS) in National Health Service (NHS) acute, NHS non-acute, NHS paediatric, and independent hospitals was carried out between September and November 2016 using the European Centre for Disease Prevention and Control protocol designed for the European PPS.FINDINGS: The prevalence of HCAI was 4.6%, 2.7%, and 3.2% in acute adults, paediatric and non-acute patient groups, respectively.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":687,"document":"19467364","golden":false,"offsetInEndSection":784,"text":"There are cases in which people from other regions may have come in contact with these pathogens.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1282,"document":"28410761","golden":false,"offsetInEndSection":1571,"text":"Hospitalization reportedly constituted a substantial cost burden, with additional costs arising from medical staff, investigation, and treatment costs.CONCLUSION: Disparate reporting of SSIs makes direct cost comparisons difficult, but this review indicated that SSIs are extremely costly.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":129,"document":"20961515","golden":false,"offsetInEndSection":365,"text":"Within the healthcare setting alone, MRSA infections are estimated to affect more than 150,000 patients annually in the European Union (EU), resulting in attributable extra in-hospital costs of EUR 380 million for EU healthcare systems.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":276,"document":"19467364","golden":false,"offsetInEndSection":374,"text":"Amebiasis, a less common protozoal infection, is a cause of significant morbidity in some regions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":857,"document":"31411135","golden":false,"offsetInEndSection":914,"text":"The HAI incidence was estimated at 4.5 (95% CI: 4.0-5.0).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1429,"document":"31411135","golden":false,"offsetInEndSection":1562,"text":"The HAI prevalence was at European Union average (5.9% in 2016 and 2017), but higher than in some countries neighbouring Switzerland.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1083,"document":"31411135","golden":false,"offsetInEndSection":1428,"text":"The highest prevalence was identified in intensive care (20.6%), in large hospitals?\u003e?650 beds (7.8%), among elderly patients (7.4%), male patients (7.2%) and patients with an ultimately (9.3%) or rapidly (10.6%) fatal McCabe score.DiscussionThis is the first national PPS of Switzerland allowing direct comparison with other European countries.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1473,"document":"25719539","golden":false,"offsetInEndSection":1791,"text":"Malaria was significantly more common in patients under 18 years (45.5%; p\u003c 0.02), and was reported in 60% of the fatal cases in this age group.CONCLUSIONS: We show a wide spectrum of sleeping sickness clinical presentation and disease outcome that was apparently not significantly influenced by concurrent infections.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":327,"document":"18366755","golden":false,"offsetInEndSection":331,"text":"T.b.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25719539","golden":false,"offsetInEndSection":260,"text":"BACKGROUND: The acute form of Human African Trypanosomiasis (HAT, also known as Sleeping sickness) caused by Trypanosoma brucei rhodesiense has been shown to have a wide spectrum of focus specific clinical presentation and severity in East and Southern Africa.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":903,"document":"25719539","golden":false,"offsetInEndSection":1042,"text":"The case fatality rate was 10.5% with post treatment reactive encephalopathys reported in 7.9% of the cases, of whom 36.8% eventually died.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1373,"document":"25719539","golden":false,"offsetInEndSection":1472,"text":"Co-infections were present in 14.3% of in-hospital deaths, 38.5% of which were recorded as Malaria.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1243,"document":"25719539","golden":false,"offsetInEndSection":1372,"text":"Among the co-infections, malaria was significantly more prevalent (28.9%; p\u003c 0.0001) followed by urinary tract infections (4.2%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":836,"document":"25719539","golden":false,"offsetInEndSection":902,"text":"About 93.4% of the cases were diagnosed as late stage (p\u003c 0.0001).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1250,"document":"18366755","golden":false,"offsetInEndSection":1547,"text":"We also use a model of under-reporting of HAT to estimate the contribution of un-reported mortality to the overall disease burden in this community, and estimate the cost-effectiveness of hospital-based HAT control.RESULTS: Under-reporting accounts for 93% of the DALY estimate of rhodesiense HAT.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"22221811","golden":false,"offsetInEndSection":464,"text":"BACKGROUND: Human African trypanosomiasis (HAT) can affect travelers to sub-Saharan Africa, as well as migrants from disease endemic countries (DECs), posing diagnosis challenges to travel health services in non-disease endemic countries (non-DECs).METHODS: Cases reported in journals have been collected through a bibliographic research and complemented by cases reported to the World Health Organization (WHO) during the process to obtain anti-trypanosome drugs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":457,"document":"25719539","golden":false,"offsetInEndSection":736,"text":"We here describe the clinical presentation, presence of co-infections, and how the latter impact on HAT prognosis.METHODS AND FINDINGS: We carried out a retrospective analysis of clinical data from 258 sleeping sickness patients reporting to Lwala hospital between 2005 and 2012.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1425,"document":"15334029","golden":false,"offsetInEndSection":1653,"text":"30-day mortality for AMI patients did not change significantly.CONCLUSIONS: The new AMI definition had a dramatic impact on the CCU case load, case mix and length of stay and on the ability to provide early coronary angiography.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38330051","golden":false,"offsetInEndSection":164,"text":"Human African trypanosomiasis (HAT) still faces few therapeutic options and emerging drug resistance, stressing an urgency for novel antitrypanosomal drug discovery","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38326914","golden":false,"offsetInEndSection":166,"text":"Nagana and Human African Trypanosomiasis (HAT), caused by (sub)species of Trypanosoma, are diseases that impede human and animal health, and economic growth in Africa","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":507,"document":"38324807","golden":false,"offsetInEndSection":628,"text":"A total of 513 (7.1%) triatomines tested positive for the presence of trypomastigote forms, similar to Trypanosoma cruzi.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":178,"document":"38310575","golden":false,"offsetInEndSection":399,"text":"Among these, African Human Trypanosomiasis (HAT), known as sleeping sickness, shows alarming data, with treatment based on suramin and pentamidine in the initial phase and melarsoprol and eflornithine in the chronic phase","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":126,"document":"38308365","golden":false,"offsetInEndSection":217,"text":"Controlling this vector is the most promising method of preventing trypanosome transmission","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38306403","golden":false,"offsetInEndSection":216,"text":"Chagas disease, caused by the protozoan parasite Trypanosoma cruzi transmitted by blood-sucking insects of the subfamily Triatominae, is a major neglected tropical disease affecting 6 to 7 million of people worldwide","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25917718","golden":false,"offsetInEndSection":146,"text":"Although Spain is the European country with the highest Chagas disease burden, the country does not have a national control program of the disease","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1553,"document":"25680190","golden":false,"offsetInEndSection":1695,"text":"Our meta-analysis provides prevalence estimates of Chagas disease that should be used to estimate the burden of disease in European countries.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1175,"document":"37199988","golden":false,"offsetInEndSection":1658,"text":"DALYs per population were higher in the Latin part of Switzerland (98?DALYs per 100,000 population; 95%?UI:?83-115) compared with the German part (57?DALYs per 100,000 population; 95%?UI:?49-66) and in university hospitals (165?DALYs per 100,000 hospitalisation days; 95%?UI:?140-194) compared with non-university hospitals (62?DALYs per 100,000 hospitalisation days; 95%?UI:?53-72).ConclusionsThe AMR burden estimate in Switzerland has increased significantly between 2010 and 2019.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":419,"document":"37199988","golden":false,"offsetInEndSection":794,"text":"neighbouring Austria (77.2)).AimIn this study, the burden caused by the same infections due to antibiotic-resistant bacteria (\u0027AMR burden\u0027) in Switzerland from 2010 to 2019 was estimated and the effect of the factors \u0027linguistic region\u0027 and \u0027hospital type\u0027 on this estimate was examined.MethodsNumber of infections, DALYs and deaths were estimated according to Cassini et al.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":795,"document":"37199988","golden":false,"offsetInEndSection":1030,"text":"(2019) whereas separate models were built for each linguistic region/hospital type combination.ResultsDALYs increased significantly from 3,995 (95%?uncertainty interval (UI):?3;327-4,805) in 2010 to 6,805 (95%?UI:?5,820-7,949) in 2019.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":256,"document":"37199988","golden":false,"offsetInEndSection":418,"text":"The corresponding estimate for Switzerland was about half of this (87.8?DALYs per 100,000 population) but still higher than that of several EU/EEA countries (e.g.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":25,"document":"37199988","golden":false,"offsetInEndSection":255,"text":"(2019) estimated that, in 2015, infections with 16 different antibiotic-resistant bacteria resulted in ca 170?disability-adjusted life-years (DALYs) per 100,000 population in the European Union and European Economic area (EU/EEA).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1659,"document":"37199988","golden":false,"offsetInEndSection":1816,"text":"Considerable differences depending on the linguistic region and the hospital type were identified - a finding which affects the nationwide burden estimation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1031,"document":"37199988","golden":false,"offsetInEndSection":1174,"text":"Linguistic region and hospital type stratifications significantly affected the absolute values and the slope of the total AMR burden estimates.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1643,"document":"35748871","golden":false,"offsetInEndSection":2025,"text":"Adults older than 85 years had hospitalizations with respiratory infection associated to RSV in all 6 countries although incidence rates were low.CONCLUSIONS: Our findings highlight the substantial proportion of RSV infections among hospital admissions across different ages and may help public health professionals and policy makers when planning prevention and control strategies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":830,"document":"32772627","golden":false,"offsetInEndSection":907,"text":"In hospitals and nursing homes, they increase the overall case fatality rate.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37199988","golden":false,"offsetInEndSection":138,"text":"Associated deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in Switzerland, 2010 to 2019.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38338692","golden":false,"offsetInEndSection":50,"text":"The infectious agent for African trypanosomiasis, ","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38329945","golden":false,"offsetInEndSection":100,"text":"The importance of estimating the burden of disease from foodborne transmission of Trypanosoma cruzi.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":246,"document":"19104653","golden":false,"offsetInEndSection":496,"text":"We review current knowledge on the burden of HAT in sub-Saharan Africa, with an emphasis on the disability-adjusted life year (DALY), data sources, and methodological issues relating to the use of this metric for assessing the burden of this disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":215,"document":"19104653","golden":false,"offsetInEndSection":245,"text":"rhodesiense HAT is a zoonosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":497,"document":"19104653","golden":false,"offsetInEndSection":856,"text":"We highlight areas where data are lacking to properly quantify the impact of these diseases, mainly relating to quantifying under-reporting and disability associated with infection, and challenge the HAT research community to tackle the neglect in data gathering to enable better evidence-based assessments of burden using DALYs or other appropriate measures.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":167,"document":"19104653","golden":false,"offsetInEndSection":214,"text":"These are neglected tropical diseases, and T.b.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"19104653","golden":false,"offsetInEndSection":166,"text":"Human African trypanosomiasis (HAT, or sleeping sickness) is a protozoan parasitic infection caused by Trypanosoma brucei rhodesiense or Trypanosoma brucei gambiense.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"19104653","golden":false,"offsetInEndSection":44,"text":"The burden of human African trypanosomiasis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":689,"document":"21072230","golden":false,"offsetInEndSection":1067,"text":"DALYs were estimated using methods recommended by the Global Burden of Disease Project as well as those used in previous rhodesiense HAT estimates assuming HAT under reporting of 45%, a figure specific for Tanzania.RESULTS: The DALY estimate for HAT in Urambo District with and without age-weighting were 215.7 (95% CI: 155.3-287.5) and 281.6 (95% CI: 209.1-362.6) respectively.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":172,"document":"20450304","golden":false,"offsetInEndSection":228,"text":"Chagas disease is an independent risk factor for stroke.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1429,"document":"21072230","golden":false,"offsetInEndSection":1969,"text":"The burden in terms of indirect non-medical costs for the 143 patients was estimated at US$ 9,781.CONCLUSIONS: This study shows that HAT imposes a considerable burden on affected rural communities in Tanzania and stresses the urgent need for location- and disease-specific burden estimates tailored to particular rural settings in countries like Tanzania where a considerable number of infectious diseases are prevalent and, due to their focal nature, are often concentrated in certain locations where they impose an especially high burden.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1200,"document":"21072230","golden":false,"offsetInEndSection":1428,"text":"The costs of treating 143 patients in terms of admission costs, diagnosis, hospitalization and sleeping sickness drugs were estimated at US$ 15,514, of which patients themselves paid US$ 3,673 and the health services US$ 11,841.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39522577","golden":false,"offsetInEndSection":80,"text":"Chagas disease (CD), caused by the flagellate protozoan parasite Trypanosoma cru","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28239154","golden":false,"offsetInEndSection":119,"text":"The WHO recognizes human African trypanosomiasis, Chagas disease and the leishmaniases as neglected tropical diseases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"26504815","golden":false,"offsetInEndSection":160,"text":"Sleeping sickness is a parasitic infection caused by two species of trypanosomes (Trypanosoma brucei gambiense and rhodesiense), transmitted by the tsetse fly.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":634,"document":"38133445","golden":true,"offsetInEndSection":874,"text":"here is heterogeneity in Europe in terms of preventive strategies to avoid transfusion-related transmission of Chagas disease, not necessarily in line with the European directives, with some countries conducting systematic screening for T. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":793,"document":"1503182","golden":false,"offsetInEndSection":1133,"text":"These findings suggest that at the present time, HIV-1 infection is not having a significant impact on the incidence of T. brucei gambiense sleeping sickness in rural Zaire, but the possibility that incident cases of trypanosomiasis concurrently infected with HIV-1 may be at higher risk of treatment failure warrants further investigation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1240,"document":"37532196","golden":false,"offsetInEndSection":1528,"text":"Inpatients in acute hospitals were older and had higher risk of dying in 2016 compared with 2011; however, the proportion of inpatients with HCAIs or on antibiotics did not differ significantly.CONCLUSION: The burden of HCAIs in English hospitals increased slightly between 2011 and 2016.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1330,"document":"24918468","golden":false,"offsetInEndSection":1379,"text":"The prevalence of aHT is probably underestimated.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1574,"document":"19254975","golden":false,"offsetInEndSection":1937,"text":"All 1271 rotavirus-positive strains were genotyped (G1P[8]: 40.3%; G9P[8]: 31.2%; G4P[8]: 13.5%; G3P[8]: 7.1%).CONCLUSIONS: Rotavirus gastroenteritis places high demands on European health care systems, accounting for 56.2% of hospitalizations and 32.8% of emergency department visits because of community-acquired acute gastroenteritis in children aged \u003c5 years.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1050,"document":"28838133","golden":false,"offsetInEndSection":1317,"text":"Among children with RTI, the median HMPV shedding time by PCR was 13 days (range, 6-28 days), but all were culture negative (noninfectious) after 13 days.Conclusions: HMPV appears in epidemics in Norwegian children, with a hospitalization rate 5 times lower than RSV.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":855,"document":"37532196","golden":false,"offsetInEndSection":1006,"text":"The estimated prevalence of HCAIs was slightly higher in 2016 [6.89%, 95% confidence interval (CI) 6.21-7.57%] than in 2011 (6.41%, 95% CI 5.75-7.06%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":240,"document":"30680486","golden":false,"offsetInEndSection":427,"text":"After national validation, we estimated that 6.5% (cumulative 95% confidence interval (cCI): 5.4-7.8%) patients in acute care hospitals had at least one HAI (country-weighted prevalence).","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"14602444","golden":false,"offsetInEndSection":20,"text":"The trypanosomiases.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":663,"document":"20229338","golden":false,"offsetInEndSection":869,"text":"Results presented here, based on ITS-2 locus sequence analysis, suggest thatGlossina austeni can be placed into a separate subgenerus which forms a sister-group relationship with themorsitans group species.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":817,"document":"28612175","golden":false,"offsetInEndSection":1013,"text":"A coronary artery aneurysm was recorded in 2.2% of the patients younger than 5?years of age.CONCLUSION: This is the first epidemiologic study on Kawasaki disease incidence in the country of Italy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":543,"document":"20229338","golden":false,"offsetInEndSection":662,"text":"The placement ofGlossina austeni by both the traditional morphological and biochemical criteria has been controversial.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":806,"document":"28889192","golden":false,"offsetInEndSection":840,"text":"The incidence of BPD was of 34.9%.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":344,"document":"20229338","golden":false,"offsetInEndSection":542,"text":"Trees generated by parsimony confirmed the monophyletic taxonomic placement of genusGlossina wherefusca group species formed the deepest branch followed bymorsitans andpalpalis groups, respectively.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"20229338","golden":false,"offsetInEndSection":144,"text":"The flies of genusGlossina (Diptera: Glossinidae) are an important vector of African trypanosomiases which cause diseases in humans and animals.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":592,"document":"28612175","golden":false,"offsetInEndSection":698,"text":"The incidence rate was 5.7 per 100,000 children 0-14?years old and 14.7 for children younger than 5?years.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1036,"document":"28963630","golden":false,"offsetInEndSection":1257,"text":"Previous medical non-infectious conditions were recorded in 13%.CONCLUSION: The study revealed a high burden of infections in admitted patients mostly caused by well-known pathogens prevalent also in the local population.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1061,"document":"28889192","golden":false,"offsetInEndSection":1269,"text":"If the baby required home oxygen therapy or developed pulmonary hypertension, this cost could add up to 181,742.43 ?.CONCLUSION: Prematurity and BPD have an elevated cost, even for public health care systems.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":863,"document":"28963630","golden":false,"offsetInEndSection":911,"text":"The prevalence of tropical infections was 11.9%.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1232,"document":"25680190","golden":false,"offsetInEndSection":1472,"text":"alence of Chagas in LA migrants living in Europe is high, particularly in migrants from Bolivia and Paraguay. Data are highly heterogeneous dependent upon country of origin and within studies of migrants from the same country of origin. Cou","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1,"document":"35215241","golden":false,"offsetInEndSection":287,"text":"uman African trypanosomiasis (HAT or \u0027sleeping sickness\u0027) is a neglected tropical disease. If untreated, it is always fatal and leads to death. A few treatments are available for HAT, but most of them require a skilled professional, which increases the financial burden on the patient. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25917718","golden":true,"offsetInEndSection":250,"text":"Although Spain is the European country with the highest Chagas disease burden, the country does not have a national control program of the disease. The purpose of this study is to evaluate the efficiency of several strategies for Chagas disease scree","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":436,"document":"37645305","golden":false,"offsetInEndSection":688,"text":"Controlling and progressively minimizing the burden of animal trypanosomosis (COMBAT) is a four-year research and innovation project funded by the European Commission, whose ultimate goal is to reduce the burden of animal trypanosomosis (AT) in Africa.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":536,"document":"34414346","golden":false,"offsetInEndSection":1304,"text":"EXPANSE will address one of the most pertinent questions for urban planners, policy makers, and European citizens: \"How to maximize one\u0027s health in a modern urban environment?\" EXPANSE will take the next step in exposome research by (1) bringing together exposome and health data of more than 55 million adult Europeans and OMICS information for more than 2 million Europeans; (2) perform personalized exposome assessment for 5,000 individuals in five urban regions; (3) applying ultra-high-resolution mass-spectrometry to screen for chemicals in 10,000 blood samples; (4) evaluating the evolution of the exposome and health through the life course; and (5) evaluating the impact of changes in the urban exposome on the burden of cardiometabolic and pulmonary disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32492764","golden":false,"offsetInEndSection":237,"text":"In order to cope with the exponentially increasing number of patients infected with SARS-CoV-2, European countries made enormous efforts to reorganize medical assistance and several diseases, including stroke, were particularly impacted.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":33,"document":"33565565","golden":false,"offsetInEndSection":287,"text":"tional study.Background: Despite dysphagia large prevalence and the growing ageing phenomenon occurring in European countries, aspiration events among inpatients are often underestimated, given their frequent spontaneous resolution or silent contribution","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":285,"document":"16150644","golden":false,"offsetInEndSection":687,"text":"Apart from the introduction of eflornithine for the treatment of late-stage human African trypanosomiasis, with its serious limitations in terms of cost and difficulty of administration, no new drugs have been incorporated into the chemotherapeutic arsenal in the past 25 years, despite important advances in knowledge of the biology of the etiological agents and the pathophysiology of these diseases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1402,"document":"37532196","golden":false,"offsetInEndSection":1484,"text":"cs did not differ significantly.CONCLUSION: The burden of HCAIs in English hospita","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1038,"document":"37443059","golden":false,"offsetInEndSection":1449,"text":"With their predominantly publicly funded health systems and in the aftermath of COVID-19, countries of the European region appear to be now on the cusp of a multi-layered, slow-burning primary care crisis, with almost every country reporting long waiting lists for doctor appointments, shortages of physicians, unfilled vacancies, and consequently, added pressures on hospitals\u0027 Accident and Emergency services.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":454,"document":"31002197","golden":false,"offsetInEndSection":598,"text":"recognized.OBJECTIVES: With a large European study, we wanted to provide insights into the actual suffering and individual burden of disease in ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1489,"document":"30597175","golden":false,"offsetInEndSection":1734,"text":" to reduce prevalence over a 7-year period. Furthermore, it was able to keep hospital attention on HAIs and AU through the years and to guarantee a standardized and comparable evaluation of HAIs and AU burden in all RHS hospitals, as well as imp","beginSection":"abstract"}],"exact_answer":[],"ideal_answer":[],"id":"6593de2f06a2ea257c00001e","type":"factoid","body":"What is the burden of human trypanosomiases in European hospitals?"},{"documents":[{"golden":true,"id":"34078652"},{"golden":true,"id":"39375303"},{"golden":true,"id":"37272516"},{"golden":true,"id":"32071674"},{"golden":true,"id":"39557126"},{"golden":true,"id":"39723472"},{"golden":false,"id":"38425121"},{"golden":false,"id":"38760442"},{"golden":true,"id":"37276325"},{"golden":false,"id":"38931350"},{"golden":false,"id":"36823302"},{"golden":false,"id":"36453510"},{"golden":true,"id":"39215942"},{"golden":false,"id":"33982420"},{"golden":false,"id":"39253756"},{"golden":false,"id":"39302605"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":1463,"document":"34078652","golden":true,"offsetInEndSection":1744,"text":"Exploratory evaluation of tumor volumes in patients with nonenhancing glioma showed sustained tumor shrinkage in multiple patients.CONCLUSIONS: Vorasidenib was well tolerated and showed preliminary antitumor activity in patients with recurrent or progressive nonenhancing mIDH LGG.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":317,"document":"34078652","golden":true,"offsetInEndSection":693,"text":"Vorasidenib (AG-881) is a first-in-class, brain-penetrant, dual inhibitor of the mutant IDH1 and mutant IDH2 enzymes.PATIENTS AND METHODS: We conducted a multicenter, open-label, phase I, dose-escalation study of vorasidenib in 93 patients with mutant IDH1/2 (mIDH1/2) solid tumors, including 52 patients with glioma that had recurred or progressed following standard therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1717,"document":"37272516","golden":true,"offsetInEndSection":2044,"text":"An increased alanine aminotransferase level of grade 3 or higher occurred in 9.6% of the patients who received vorasidenib and in no patients who received placebo.CONCLUSIONS: In patients with grade 2 IDH-mutant glioma, vorasidenib significantly improved progression-free survival and delayed the time to the next intervention.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":804,"document":"34078652","golden":false,"offsetInEndSection":966,"text":"Enrollment is complete; this trial is registered with ClinicalTrials.gov, NCT02481154.RESULTS: Vorasidenib showed a favorable safety profile in the glioma cohort.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":228,"document":"39375303","golden":true,"offsetInEndSection":542,"text":"Vorasidenib received its first approval on 6 August 2024, in the USA, for the treatment of adult and pediatric patients aged 12 years and older with grade 2 astrocytoma or oligodendroglioma with a susceptible IDH1 or IDH2 mutation following surgery, including biopsy, sub-total resection, or gross total resection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":149,"document":"37272516","golden":true,"offsetInEndSection":554,"text":"Vorasidenib, an oral brain-penetrant inhibitor of mutant IDH1 and IDH2 enzymes, showed preliminary activity in IDH-mutant gliomas.METHODS: In a double-blind, phase 3 trial, we randomly assigned patients with residual or recurrent grade 2 IDH-mutant glioma who had undergone no previous treatment other than surgery to receive either oral vorasidenib (40 mg once daily) or matched placebo in 28-day cycles.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39557126","golden":true,"offsetInEndSection":149,"text":"The ARS brain committee recommends that vorasidenib may be appropriate for recurrent or residual IDH-mutant grade 2 oligodendroglioma or astrocytoma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34078652","golden":false,"offsetInEndSection":63,"text":"PURPOSE: Lower grade gliomas (LGGs) are malignant brain tumors.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34078652","golden":false,"offsetInEndSection":126,"text":"Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":702,"document":"32071674","golden":true,"offsetInEndSection":840,"text":"Vorasidenib represents a novel dual mIDH1/2 inhibitor and is currently in clinical development for the treatment of low-grade mIDH glioma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39375303","golden":true,"offsetInEndSection":228,"text":"Vorasidenib (VORANIGO?; Servier) is an orally administered, first-in-class, highly brain-penetrant dual inhibitor of mutant isocitrate dehydrogenase 1 and 2 (IDH1/2) enzymes being developed for use in IDH-mutant diffuse glioma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39215942","golden":true,"offsetInEndSection":155,"text":"Vorasidenib, an oral dual inhibitor targeting mutant enzymes isocitrate dehydrogenase 1 and 2, is utilized in the management of diffuse low-grade gliomas.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":138,"document":"37272516","golden":false,"offsetInEndSection":268,"text":"ure death. Vorasidenib, an oral brain-penetrant inhibitor of mutant IDH1 and IDH2 enzymes, showed preliminary activity in IDH-muta","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":894,"document":"39723472","golden":true,"offsetInEndSection":1047,"text":"n this review, we address the role of vorasidenib in the treatment of IDH-mutant gliomas, providing a roadmap for its incorporation into daily practice. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":368,"document":"38425121","golden":false,"offsetInEndSection":465,"text":"alignancies. Vorasidenib is a novel therapeutic agent targeting mutant IDH1/2, sparking interest ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":874,"document":"39375303","golden":true,"offsetInEndSection":989,"text":"This article summarizes the milestones in the development of vorasidenib leading to this first approval for glioma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":756,"document":"39375303","golden":true,"offsetInEndSection":873,"text":"In the EU and other countries worldwide, regulatory review of vorasidenib in IDH-mutant glioma is currently underway.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":11,"document":"37272516","golden":true,"offsetInEndSection":278,"text":" Isocitrate dehydrogenase (IDH)-mutant grade 2 gliomas are malignant brain tumors that cause considerable disability and premature death. Vorasidenib, an oral brain-penetrant inhibitor of mutant IDH1 and IDH2 enzymes, showed preliminary activity in IDH-mutant gliomas","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1898,"document":"37272516","golden":false,"offsetInEndSection":2049,"text":"tients with grade 2 IDH-mutant glioma, vorasidenib significantly improved progression-free survival and delayed the time to the next intervention. (Fun","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34078652","golden":false,"offsetInEndSection":212,"text":"PURPOSE: Lower grade gliomas (LGGs) are malignant brain tumors. Current therapy is associated with short- and long-term toxicity. Progression to higher tumor grade is associated with contrast enhancement on MRI. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1612,"document":"34078652","golden":false,"offsetInEndSection":1749,"text":"idenib was well tolerated and showed preliminary antitumor activity in patients with recurrent or progressive nonenhancing mIDH LGG.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33982420","golden":false,"offsetInEndSection":180,"text":"Recently, Vorasidenib (AG-881) has been reported as a therapeutic alternative that exerts potent dual inhibitory activity against mIDH1/2 towards the treatment of low-grade glioma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":367,"document":"38425121","golden":false,"offsetInEndSection":464,"text":"malignancies. Vorasidenib is a novel therapeutic agent targeting mutant IDH1/2, sparking interest","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":308,"document":"34078652","golden":false,"offsetInEndSection":425,"text":"1/IDH2). Vorasidenib (AG-881) is a first-in-class, brain-penetrant, dual inhibitor of the mutant IDH1 and mutant IDH2","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":291,"document":"36453510","golden":false,"offsetInEndSection":508,"text":"metabolite.OBJECTIVE: Vorasidenib (AG-881) has recently been reported as a promising dual inhibitor of mutant isocitrate dehydrogenase 1 and 2 with the ability to penetrate the blood-brain barrier towards the treatmen","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37276325","golden":true,"offsetInEndSection":214,"text":"According to the phase III INDIGO trial, vorasidenib, an IDH1/2 inhibitor, significantly benefited adults with IDH1/2-mutant low-grade gliomas, reducing progression risk and delaying the need for chemoradiotherapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":137,"document":"37272516","golden":false,"offsetInEndSection":267,"text":"ture death. Vorasidenib, an oral brain-penetrant inhibitor of mutant IDH1 and IDH2 enzymes, showed preliminary activity in IDH-mut","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":286,"document":"39253756","golden":false,"offsetInEndSection":407,"text":"n this population.RECENT FINDINGS: The IDH inhibitor vorasidenib recently demonstrated its efficacy after surgical resect","beginSection":"abstract"}],"exact_answer":[],"ideal_answer":[],"id":"677e8319592fa4887300001e","type":"factoid","body":"What disease can be treated with vorasidenib?"},{"documents":[{"golden":false,"id":"22348938"},{"golden":true,"id":"24057824"},{"golden":false,"id":"21694818"},{"golden":false,"id":"19629427"},{"golden":false,"id":"9065628"},{"golden":false,"id":"15601663"},{"golden":false,"id":"32285435"},{"golden":false,"id":"26017509"},{"golden":true,"id":"31586151"},{"golden":false,"id":"27638080"},{"golden":false,"id":"31094996"},{"golden":false,"id":"38635020"},{"golden":false,"id":"18852990"},{"golden":false,"id":"27083888"},{"golden":false,"id":"24711685"},{"golden":false,"id":"35015204"},{"golden":false,"id":"38018799"},{"golden":false,"id":"22379397"},{"golden":false,"id":"28375910"},{"golden":false,"id":"28965306"},{"golden":false,"id":"39206287"},{"golden":false,"id":"12712619"},{"golden":false,"id":"8470505"},{"golden":false,"id":"9082413"},{"golden":false,"id":"17160609"},{"golden":false,"id":"31054848"},{"golden":false,"id":"21832102"},{"golden":false,"id":"39384077"},{"golden":false,"id":"20352586"},{"golden":false,"id":"38137140"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":0,"document":"22348938","golden":false,"offsetInEndSection":97,"text":"Recent years have witnessed an upsurge of interest in migraine as a cause of vestibular symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":233,"document":"22348938","golden":false,"offsetInEndSection":398,"text":"Various syndromes of vestibular migraine (VM) have been described, diagnostic criteria proposed, epidemiologic data collected, and neurophysiologic models developed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":98,"document":"22348938","golden":false,"offsetInEndSection":232,"text":"Starting with 1970s case reports linking migraine to childhood vertigo, neurotologists worldwide have increasingly diagnosed migraine.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":399,"document":"22348938","golden":false,"offsetInEndSection":504,"text":"Yet, the concept that migraine causes vestibular symptoms rests on a surprisingly thin research database.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1071,"document":"31586151","golden":true,"offsetInEndSection":1363,"text":"These results support a pathogenic model where vestibular symptoms emanate from the vestibular nuclei, which are sensitized by migraine-related brainstem regions and simultaneously suppressed by inhibitory feedback from the cerebellar nodulus and uvula, the site of canal-otolith integration.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":980,"document":"24057824","golden":true,"offsetInEndSection":1156,"text":"The pathophysiology of vestibular migraine is unknown, but several mechanisms link the trigeminal system, which is activated during migraine attacks, and the vestibular system.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21694818","golden":false,"offsetInEndSection":138,"text":"Vestibular migraine is considered to be the second most common cause of vertigo and the most common cause of spontaneous episodic vertigo.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"26017509","golden":false,"offsetInEndSection":172,"text":"Vestibular migraine (VM) has been increasingly recognized as a frequent cause of episodic vertigo, affecting up to 1 % of the general population, with female preponderance.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":945,"document":"15601663","golden":false,"offsetInEndSection":1100,"text":"The findings during acute MV point to central-vestibular dysfunction in 10 patients (50%) and to peripheral vestibular dysfunction in three patients (15%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31094996","golden":false,"offsetInEndSection":761,"text":"BACKGROUND: Vestibular migraine (VM) is the most common neurologic cause of vertigo in adults and results in significant utilization of health care resources, but remains under-recognized and underdiagnosed.EVIDENCE ACQUISITION: Review of literature in PubMed using the following terms: vestibular migraine, migraine-associated vertigo, vertiginous migraine, benign recurrent vertigo, migraine-associated dizziness, migraine, migraine treatment, Meniere disease (MD), vertebrobasilar ischemia (VBI), posterior circulation stroke, benign paroxysmal positional vertigo, and episodic-ataxia Type 2 (EA2).RESULTS: VM can manifest with a variety of vestibular symptoms, including spontaneous vertigo, triggered vertigo, positional vertigo, and head-motion dizziness.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":769,"document":"22348938","golden":false,"offsetInEndSection":942,"text":"To stimulate more rigorous research, this paper poses three questions about clinical investigations into migraine and vestibular symptoms: What variables should be measured?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":672,"document":"18852990","golden":false,"offsetInEndSection":882,"text":"such disorder.FINAL REMARKS: There is a strong association between neurotological symptoms and migraine, and the auditory-vestibular dysfunction-associated migraine is the most common cause of spontaneous episo","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":787,"document":"38635020","golden":false,"offsetInEndSection":958,"text":"with another vestibular disorder. Recent experimental evidence suggests vestibular symptoms in vestibular migraine are linked to multisensory mechanisms that control body ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":99,"document":"38018799","golden":false,"offsetInEndSection":182,"text":" clinical entity. During this time, VM has emerged amongst the most common cause of","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27083888","golden":false,"offsetInEndSection":104,"text":"Vestibular migraine (VM) is the most common cause of episodic vertigo in adults as well as in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":453,"document":"24711685","golden":false,"offsetInEndSection":758,"text":"ased on such considerations, we proposed a classification of vertigo and other vestibular disorders related to migraine, and believe that a particular variant of migraine-related vertigo should be introduced, namely \"epigone migraine vertigo\" (EMV): this could be a kind of late migraine equivalent, i.e. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28965306","golden":false,"offsetInEndSection":164,"text":"OPINION STATEMENT: Vestibular migraine (VM) is a disorder with a spectrum of clinical presentations and among the most common causes of chronic vestibular symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35015204","golden":false,"offsetInEndSection":149,"text":"BACKGROUND: Vestibular migraine (VM) is considered the most common cause of spontaneous episodic vertigo and the second most common cause of vertigo.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"9082413","golden":false,"offsetInEndSection":179,"text":"BACKGROUND: Toxocariosis, the most frequent cause of visceral larva migrans, is usually a disease of children due to ingestion of eggs from the roundworm of dogs (Toxocara canis).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1243,"document":"17160609","golden":false,"offsetInEndSection":1603,"text":"The frequency of electrocardiographic abnormalities in patients with erythema migrans was not associated with the presence of systemic symptoms, or with the presence of meningitis or the isolation of Borrelia burgdorferi sensu lato from the blood.CONCLUSIONS: Electrocardiographic abnormalities in children with erythema migrans are mild, nonspecific and rare.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1234,"document":"22348938","golden":false,"offsetInEndSection":1321,"text":"Pilot data demonstrating pharmacologic and genetic dissection techniques are presented.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31054848","golden":false,"offsetInEndSection":209,"text":"OBJECTIVE: The aim of the present study was to evaluate complaints in people with M?ni?re\u0027s disease (MD) with and without migraine and headache to study the association between MD and Vestibular Migraine (VM).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"15601663","golden":false,"offsetInEndSection":80,"text":"Migrainous vertigo (MV) is an increasingly recognized cause of episodic vertigo.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":599,"document":"38018799","golden":false,"offsetInEndSection":825,"text":"Here we review experimental evidence that supports VM symptoms are linked to multisensory mechanisms that control body motion and position in space.SUMMARY: Multisensory integration is a key concept for understanding migraine.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35015204","golden":false,"offsetInEndSection":137,"text":"BACKGROUND: Vestibular migraine (VM) is considered the most common cause of spontaneous episodic vertigo and the second most common cause","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31094996","golden":false,"offsetInEndSection":195,"text":"BACKGROUND: Vestibular migraine (VM) is the most common neurologic cause of vertigo in adults and results in significant utilization of health care resources, but remains under-recognized and und","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":643,"document":"22379397","golden":false,"offsetInEndSection":825,"text":"Bilateral vestibular hypofunction is a heterogeneous clinical group defined by episodes of vertigo leading to progressive loss of vestibular function which also can include migraine.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"20352586","golden":false,"offsetInEndSection":271,"text":"Migraine-associated vertigo has become a well-recognized disease entity diagnosed based on a clinical history of recurrent vertigo attacks unexplained by other central or peripheral otologic abnormalities, which occurs in the patient with a history of migraine headaches.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":154,"document":"28375910","golden":false,"offsetInEndSection":444,"text":"iness and vertigo.RECENT FINDINGS: Improved methods of diagnosing patients with vertigo and dizziness have been evolving, including additional diagnostic criteria and characterization of some common conditions that cause dizziness (eg, vestibular migraine, benign paroxysmal positional vert","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":100,"document":"38018799","golden":false,"offsetInEndSection":183,"text":"clinical entity. During this time, VM has emerged amongst the most common cause of ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":270,"document":"39384077","golden":false,"offsetInEndSection":485,"text":"Peripheral causes, such as vestibular neuritis, benign paroxysmal positional vertigo, and M?ni?re\u0027s disease, are contrasted with central causes such as stroke, demyelinating diseases, and posterior fossa tumors. Dia","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":477,"document":"38137140","golden":false,"offsetInEndSection":873,"text":"Potential approaches to establish a diagnostic framework for CVM include (a) following the distinction between episodic and chronic migraine headaches, namely, frequent and/or prolonged episodes of VM (but not persistent vertigo or dizziness) in the context of chronic migraine headaches or (b) daily dizzy spells over more than 6 months that responded well to prophylactic anti-migraine therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"12712619","golden":false,"offsetInEndSection":188,"text":"Among varieties of migraine characteristic of liquidators of effects of the Chernobyl catastrophy and ChNPP personnel migraine with a manifest vestibular component holds a prominent place.","beginSection":"abstract"}],"ideal_answer":[],"id":"6772bdf0592fa48873000002","type":"summary","body":"What is the cause of vestibular migrane?"},{"documents":[{"golden":true,"id":"37337123"},{"golden":true,"id":"8483271"},{"golden":true,"id":"6803084"},{"golden":false,"id":"22419547"},{"golden":true,"id":"34945687"},{"golden":false,"id":"19675304"},{"golden":false,"id":"26913649"},{"golden":false,"id":"28403946"},{"golden":true,"id":"9350477"},{"golden":true,"id":"24138531"},{"golden":false,"id":"15018483"},{"golden":false,"id":"39057059"},{"golden":false,"id":"35807776"},{"golden":false,"id":"24489112"},{"golden":false,"id":"36083712"},{"golden":false,"id":"34472618"},{"golden":false,"id":"24936265"},{"golden":false,"id":"35057443"},{"golden":true,"id":"35053702"},{"golden":false,"id":"38245742"},{"golden":false,"id":"36515582"},{"golden":false,"id":"24292181"},{"golden":true,"id":"28065270"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":0,"document":"37337123","golden":true,"offsetInEndSection":220,"text":"Vitamin K is essential for several physiological processes, such as blood coagulation, in which it serves as a cofactor for the conversion of peptide-bound glutamate to ?-carboxyglutamate in vitamin K-dependent proteins.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"9350477","golden":true,"offsetInEndSection":216,"text":"Vitamin K is required for the biological activity of several coagulation factors, which is considered as the classical function of vitamin K. Recent research, however, suggests a role of vitamin K in bone metabolism.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"8483271","golden":true,"offsetInEndSection":217,"text":"Vitamin K has several biological functions in which the major role is a cofactor for gamma-carboxylation of glutamate residues in Gla proteins, such as, several coagulant and anticoagulant proteins for blood clotting.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34945687","golden":true,"offsetInEndSection":185,"text":"Vitamin K is involved many biological processes, such as the regulation of blood coagulation, prevention of vascular calcification, bone metabolism and modulation of cell proliferation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24138531","golden":true,"offsetInEndSection":158,"text":"Vitamin K plays an essential role in many biological processes including blood clotting, maintenance of bone health, and inhibition of arterial calcification.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"6803084","golden":true,"offsetInEndSection":216,"text":"Vitamin K is required for the posttranslational modification of liver precursors of prothrombin, blood coagulation Factors VII, IX, and X and additional proteins of undetermined functions in plasma and other tissues.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35807776","golden":false,"offsetInEndSection":177,"text":"Vitamin K and its derivatives represent a complex of fat-soluble vitamins, playing a major role in the regulation of a large number of physiologic processes required for optimal","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39057059","golden":false,"offsetInEndSection":81,"text":"Vitamin K (VK) is an essential micronutrient impacting many systems in the body.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36083712","golden":false,"offsetInEndSection":128,"text":"Vitamin K is one of the many health-promoting substances whose impact on the human body has been underestimated until recently.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1069,"document":"24489112","golden":false,"offsetInEndSection":1307,"text":"he mechanisms and functions of vitamin K recycling and MK-4 synthesis have dominated advances made in vitamin K biochemistry over the last five years and, after a brief overview of general metabolism, are the main focuses of this review. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34472618","golden":false,"offsetInEndSection":158,"text":"Vitamin K is traditionally connected with blood coagulation, since it is needed for the posttranslational modification of 7 proteins involved in this cascade.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":159,"document":"34472618","golden":false,"offsetInEndSection":347,"text":"However, it is also involved in the maturation of another 11 or 12 proteins that play different roles, encompassing in particular the modulation of the calcification of connective tissues.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35053702","golden":true,"offsetInEndSection":200,"text":"Vitamin K2 activates vitamin K-dependent proteins that support many biological functions, such as bone mineralization, the inhibition of vascular stiffness, the improvement of endothelial function, th","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":900,"document":"38245742","golden":false,"offsetInEndSection":1100,"text":"d to identify enriched GO terms in the biological process, molecular function, or cellular component categories. Non-parametric multivariate methods were used to classify samples from patients and eva","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36515582","golden":false,"offsetInEndSection":250,"text":"Background: Aging is a complex and gradual biological process that represents the major risk factor with respect to the development of chronic degenerative diseases, often associated with disability. Diet and nu-trition, coupled with proper physical ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":300,"document":"36515582","golden":false,"offsetInEndSection":450,"text":"tatus of the elderly with a decreased risk of disease being indicative of successful aging. Musculoskeletal conditions such as osteoporosis and sarcop","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":169,"document":"24936265","golden":false,"offsetInEndSection":394,"text":"Vitamin K is an essential micronutrient, present in plants and animal fermented products that plays an important role as a cofactor for the post-translational ?-carboxylation of glutamic acid residues in a number of proteins.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28065270","golden":true,"offsetInEndSection":290,"text":"Vitamin K-dependent carboxylation, an essential posttranslational modification catalyzed by gamma-glutamyl carboxylase, is required for the biological functions of proteins that control blood coagulation, vascular calcification, bone metabolism, and other important physiological processes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":691,"document":"35057443","golden":false,"offsetInEndSection":779,"text":"Vitamin K intake has been suggested to reduce VC and the associated cardiovascular risk.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"22419547","golden":false,"offsetInEndSection":151,"text":"Historically discovered for its role in blood coagulation, there is now convincing evidence that vitamin K has important actions in the nervous system.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":115,"document":"24292181","golden":false,"offsetInEndSection":248,"text":"PK is a major form of dietary vitamin K; however, the most prevalent form of vitamin K in animals and humans is menaquinone-4 (MK-4).","beginSection":"abstract"}],"exact_answer":[],"ideal_answer":[],"id":"6772c765592fa48873000009","type":"factoid","body":"What biological process is associated with Vitamin K?"},{"documents":[{"golden":true,"id":"17600610"},{"golden":true,"id":"31657489"},{"golden":false,"id":"31898926"},{"golden":false,"id":"21199976"},{"golden":false,"id":"38077225"},{"golden":false,"id":"38165837"},{"golden":false,"id":"20841374"},{"golden":false,"id":"28537476"},{"golden":false,"id":"19822588"},{"golden":false,"id":"29921276"},{"golden":false,"id":"32353037"},{"golden":false,"id":"36106806"},{"golden":false,"id":"28551446"},{"golden":true,"id":"33632170"},{"golden":false,"id":"24288192"},{"golden":false,"id":"27895065"},{"golden":false,"id":"34926844"},{"golden":false,"id":"22588551"},{"golden":true,"id":"15481481"},{"golden":true,"id":"33295844"},{"golden":false,"id":"29540421"},{"golden":false,"id":"26770687"},{"golden":false,"id":"32134836"},{"golden":false,"id":"33272941"},{"golden":false,"id":"36709257"},{"golden":false,"id":"37391852"},{"golden":false,"id":"21688110"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":1478,"document":"17600610","golden":true,"offsetInEndSection":1709,"text":"Emotional and physical abuse during pregnancy was associated with a 1.9-fold increased risk of preeclampsia (95% CI: 1.1-3.5).CONCLUSIONS: IPV among pregnant women is common and is associated with an increased risk of preeclampsia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1365,"document":"31657489","golden":true,"offsetInEndSection":1557,"text":"The perinatal mortality rate was higher in cases (9.3%) than in controls (1.8%).CONCLUSIONS: Intimate partner violence was associated with an increased risk of severe acute maternal morbidity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17600610","golden":false,"offsetInEndSection":128,"text":"OBJECTIVE: Mounting evidence supports the view that intimate partner violence (IPV) is an important cause of maternal mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":833,"document":"19822588","golden":false,"offsetInEndSection":1244,"text":"The associations between maternal IPV and death did not differ according to the child\u0027s gender.CONCLUSION: The robust association between exposure to household IPV and infant and child death could be attributable to the mother\u0027s inability to care for her child, psychological stress associated with witnessing violence, and the use of maternal violence victimization as a proxy for child violence victimization.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1345,"document":"17600610","golden":true,"offsetInEndSection":1477,"text":"Emotional abuse in the absence of physical violence was associated with a 3.2-fold (95% CI: 2.1-4.9) increased risk of preeclampsia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":129,"document":"17600610","golden":false,"offsetInEndSection":346,"text":"Some, but not all, prior studies suggest that IPV is associated with increased risks of maternal medical conditions such as hypertensive disorders of pregnancy which are leading causes of maternal mortality worldwide.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31657489","golden":true,"offsetInEndSection":118,"text":"BACKGROUND: Intimate partner violence is a prevalent public health issue associated with all-cause maternal mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21199976","golden":false,"offsetInEndSection":1091,"text":"OBJECTIVES: To examine associations between intimate partner violence (IPV) against Indian women and risk of death among their infants and children, as well as related gender-based disparities.DESIGN: Analyses of nationally representative data to estimate adjusted hazard ratios (aHRs) and attributable risks for infant and child mortality based on child gender and on IPV against mothers.SETTING: India.PARTICIPANTS: Women aged 15 to 49 years (n \u003d 59,467) across all 29 Indian states participating in the Indian National Family Health Survey 3 provided information about 158,439 births and about infant and child mortality occurring during the 20 years before the survey.MAIN OUTCOME MEASURES: Maternal IPV and infant and child (\u003c5 years) mortality among boy vs girl children.RESULTS: Infant mortality was greater among infants whose mothers experienced IPV (79.2 of 1000 births) vs those whose mothers did not experience IPV (59.1 of 1000 births) (aHR, 1.09; 95% confidence interval [CI], 1.03-1.15); this effect was significant only for girls (1.15; 1.07-1.24; for boys, 1.04; 0.97-1.11).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1035,"document":"17600610","golden":true,"offsetInEndSection":1206,"text":"Compared with those reporting never exposure to IPV during pregnancy, women reporting any exposure had a 2.4-fold increased risk of preeclampsia (OR\u003d2.4; 95% CI: 1.7-3.3).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":347,"document":"17600610","golden":false,"offsetInEndSection":515,"text":"We assessed the relation between IPV and risk of preeclampsia among Peruvian women.STUDY DESIGN: We conducted a case-control study at two large hospitals in Lima, Peru.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":548,"document":"28551446","golden":false,"offsetInEndSection":639,"text":"ntimate partner violence has a substantial impact on a woman\u0027s physical and mental health. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36106806","golden":false,"offsetInEndSection":129,"text":"AIM: The purpose of this study was to examine the effect of physical intimate partner violence on maternal pregnancy/ birth outco","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1419,"document":"31657489","golden":false,"offsetInEndSection":1518,"text":") than in controls (1.8%).CONCLUSIONS: Intimate partner violence was associated with an increased r","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1308,"document":"38165837","golden":false,"offsetInEndSection":1734,"text":"he associated factors of intimate partner violence were late initiation of antenatal care (AOR \u003d 3.81, 95% CI: 1.7, 6.04), non-autonomous women (AOR \u003d 1.8, 95% CI: 1.18, 3.14), inadequate antenatal utilization (AOR \u003d 3.41, 95% CI: 1.8, 6.2), and a husband with an extra wife (AOR \u003d 6.0, 95% CI: 4.2, 10.57).This study showed that more than one-third of pregnant women in this study area were facing intimate partner violence. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":624,"document":"31657489","golden":false,"offsetInEndSection":912,"text":"Multivariate logistic regression was used to model the association between intimate partner violence and severe acute maternal morbidity.RESULTS: There was a significantly higher rate of intimate partner violence both before and during pregnancy among cases (58.7%) than controls (27.5%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1465,"document":"15481481","golden":true,"offsetInEndSection":1689,"text":"Intimate partner violence is also responsible for increased fetal deaths in affected pregnancies (about 16.0 per 1000).CONCLUSION: Intimate partner violence is often a life-threatening event to both the mother and the fetus.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1272,"document":"31657489","golden":false,"offsetInEndSection":1364,"text":"The ICU admission rate was 18.8 (per 1000 live births), and ICU maternal mortality was 1.7%.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":913,"document":"31657489","golden":false,"offsetInEndSection":1271,"text":"In multivariate analysis, intimate partner violence both before and during pregnancy (aOR 3.83 (95% CI: 1.99-7.37)), being married (3.86 (1.27-11.73)), having \u003c8 antenatal care visits (2.78 (1.14-6.80)), and having previous abortions (miscarriage, therapeutic, or unsafe) (1.69 (1.13-2.51)) were significantly associated with severe acute maternal morbidity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":119,"document":"31657489","golden":false,"offsetInEndSection":466,"text":"This study investigated the relationship between intimate partner violence, severe acute maternal morbidity in the intensive care unit (ICU), and neonatal outcomes.METHODS: This was a prospective case-control study in a hospital in Lima, Peru, with 109 cases (maternal ICU admissions) and 109 controls (obstetric patients not admitted to the ICU).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":155,"document":"33295844","golden":true,"offsetInEndSection":282,"text":"Intimate partner violence during pregnancy has been shown to contribute to maternal mortality from pregnancy-associated deaths.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24288192","golden":false,"offsetInEndSection":125,"text":"It is well established that intimate partner violence (IPV) against women adversely affects maternal morbidity and mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1558,"document":"31657489","golden":false,"offsetInEndSection":1671,"text":"This suggests a more severe impact of intimate partner violence on pregnancy than has been previously identified.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":11,"document":"31657489","golden":true,"offsetInEndSection":117,"text":" Intimate partner violence is a prevalent public health issue associated with all-cause maternal mortality","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":179,"document":"38165837","golden":false,"offsetInEndSection":559,"text":"ven though the introduction of antenatal care has reduced maternal mortality by 34% since 2002, some atypical behaviors, such as intimate partner violence, have had a significant impact on how often women seek out expert medical treatment during pregnancy. Hence, early identification of such risk factors is very important to decrease maternal mortality from preventable causes. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":11,"document":"33272941","golden":false,"offsetInEndSection":335,"text":" Under-5 mortality remains a public health concern in low-income and middle-income countries. Africa contributes about one-fifth of the burden of global under-5 mortality; intimate partner violence (IPV) and polygyny, which are highly prevalent on the continent, have been linked to under-5 mortality at the individual level","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":140,"document":"37391852","golden":false,"offsetInEndSection":419,"text":" Intimate partner violence during pregnancy is associated with devastating maternal, perinatal, and neonatal health effects. We present the protocol for a systematic review and meta-analysis to estimate the global lifetime prevalence of intimate partner violence during pregnancy","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":11,"document":"36709257","golden":false,"offsetInEndSection":309,"text":" Mental health conditions are common during the perinatal period and associated with maternal, foetal, and neonatal morbidity and mortality. There is an established bidirectional relationship between mental health conditions and intimate partner violence (IPV), including during and after pregnancy","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32134836","golden":false,"offsetInEndSection":200,"text":"For decades, national paid maternity leave policies of 12 weeks or more have been established in every industrialized country except the United States. Despite women representing 47% of the current U.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1418,"document":"31657489","golden":false,"offsetInEndSection":1517,"text":"%) than in controls (1.8%).CONCLUSIONS: Intimate partner violence was associated with an increased ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1307,"document":"38165837","golden":false,"offsetInEndSection":1733,"text":"The associated factors of intimate partner violence were late initiation of antenatal care (AOR \u003d 3.81, 95% CI: 1.7, 6.04), non-autonomous women (AOR \u003d 1.8, 95% CI: 1.18, 3.14), inadequate antenatal utilization (AOR \u003d 3.41, 95% CI: 1.8, 6.2), and a husband with an extra wife (AOR \u003d 6.0, 95% CI: 4.2, 10.57).This study showed that more than one-third of pregnant women in this study area were facing intimate partner violence.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":352,"document":"27895065","golden":false,"offsetInEndSection":460,"text":"egnant women. Additionally, intimate partner violence has a great negative impact on women\u0027s health and preg","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1932,"document":"33632170","golden":true,"offsetInEndSection":2107,"text":"tilization is physical IPV.CONCLUSIONS: Women experiencing physical intimate partner violence show lower levels of utilization of maternal health services in a large sample of","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":780,"document":"22588551","golden":false,"offsetInEndSection":878,"text":"with under-five mortality.CONCLUSION: Maternal intimate partner violence victimization is strongly","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17600610","golden":false,"offsetInEndSection":117,"text":"OBJECTIVE: Mounting evidence supports the view that intimate partner violence (IPV) is an important cause of maternal","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1601,"document":"26770687","golden":false,"offsetInEndSection":1716,"text":"socioeconomic characteristics.CONCLUSION AND RECOMMENDATIONS: Intimate partner violence has an independent influenc","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1369,"document":"34926844","golden":false,"offsetInEndSection":1625,"text":"0.39 (95% CI: 0.21, 0.72)]. Women who experienced intimate partner violence [POR \u003d 2.52 (95% CI: 1.68, 3.78)], malnutrition during pregnancy [POR \u003d 2.00 (95% CI: 1.16, 3.46)], and previous preterm birth [POR \u003d 3.73 (95% CI: 2.37, 5.88)] had significantly h","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":415,"document":"21688110","golden":false,"offsetInEndSection":624,"text":"This analysis investigated whether women\u0027s status in the household, as measured by their experience of intimate partner violence (IPV), affected skilled attendance at most recent delivery among women in Kenya.","beginSection":"abstract"}],"ideal_answer":[],"id":"6777be0b592fa48873000014","type":"summary","body":"What is the impact of intimate partner violence on maternal mortality?"},{"documents":[{"golden":true,"id":"15801394"},{"golden":false,"id":"28648138"},{"golden":false,"id":"15521792"},{"golden":false,"id":"1071395"},{"golden":false,"id":"18981338"},{"golden":false,"id":"34850659"},{"golden":false,"id":"30439419"},{"golden":false,"id":"32894263"},{"golden":false,"id":"29265019"},{"golden":false,"id":"11584686"},{"golden":false,"id":"30869262"},{"golden":false,"id":"33716825"},{"golden":false,"id":"32314248"},{"golden":false,"id":"20529414"},{"golden":false,"id":"35926992"},{"golden":false,"id":"30526093"},{"golden":false,"id":"24085610"},{"golden":false,"id":"34925083"},{"golden":false,"id":"22907121"},{"golden":false,"id":"17073176"},{"golden":false,"id":"27567467"},{"golden":false,"id":"15804348"},{"golden":false,"id":"32546286"},{"golden":false,"id":"2368637"},{"golden":true,"id":"21206852"},{"golden":false,"id":"32714742"},{"golden":false,"id":"2892048"},{"golden":false,"id":"15052390"},{"golden":true,"id":"32877036"},{"golden":false,"id":"36639397"},{"golden":false,"id":"34384432"},{"golden":false,"id":"32772621"},{"golden":false,"id":"33464286"},{"golden":false,"id":"15381886"},{"golden":false,"id":"36051509"},{"golden":false,"id":"9684387"},{"golden":false,"id":"32433545"},{"golden":false,"id":"21462790"},{"golden":false,"id":"21592732"},{"golden":false,"id":"17712818"},{"golden":false,"id":"30442059"},{"golden":false,"id":"28858148"},{"golden":false,"id":"31073761"},{"golden":false,"id":"31656045"},{"golden":true,"id":"8075903"},{"golden":false,"id":"30276906"},{"golden":false,"id":"19698564"},{"golden":false,"id":"16319402"},{"golden":false,"id":"22897939"},{"golden":false,"id":"33656571"},{"golden":false,"id":"26427297"},{"golden":false,"id":"33530732"},{"golden":false,"id":"1845224"},{"golden":false,"id":"32781422"},{"golden":false,"id":"21557896"},{"golden":false,"id":"32653594"},{"golden":false,"id":"23886472"},{"golden":false,"id":"17596918"},{"golden":false,"id":"25133182"},{"golden":false,"id":"35772419"},{"golden":false,"id":"22682680"},{"golden":false,"id":"19932824"},{"golden":false,"id":"34895014"},{"golden":false,"id":"9171805"},{"golden":false,"id":"29125965"},{"golden":true,"id":"32487935"},{"golden":false,"id":"24133461"},{"golden":false,"id":"34360626"},{"golden":false,"id":"28635664"},{"golden":false,"id":"26636547"},{"golden":false,"id":"28219487"},{"golden":false,"id":"19586351"},{"golden":false,"id":"33017681"},{"golden":false,"id":"12492261"},{"golden":false,"id":"27745717"},{"golden":false,"id":"33884940"},{"golden":false,"id":"19818563"},{"golden":false,"id":"20512269"},{"golden":false,"id":"24878296"},{"golden":false,"id":"28314070"},{"golden":true,"id":"16506412"},{"golden":true,"id":"24001294"},{"golden":false,"id":"36618434"},{"golden":false,"id":"20680137"},{"golden":false,"id":"34282851"},{"golden":false,"id":"28112021"},{"golden":false,"id":"29513392"},{"golden":false,"id":"34937473"},{"golden":false,"id":"15458989"},{"golden":true,"id":"31408248"},{"golden":false,"id":"29655375"},{"golden":false,"id":"33324255"},{"golden":false,"id":"30567512"},{"golden":false,"id":"32197092"},{"golden":false,"id":"19693792"},{"golden":true,"id":"6324549"},{"golden":true,"id":"3000137"},{"golden":false,"id":"36068202"},{"golden":false,"id":"100034"},{"golden":false,"id":"36503404"},{"golden":false,"id":"33032307"},{"golden":true,"id":"20104292"},{"golden":false,"id":"35326345"},{"golden":false,"id":"31153010"},{"golden":false,"id":"32135391"},{"golden":false,"id":"28242263"},{"golden":false,"id":"30373388"},{"golden":false,"id":"19335936"},{"golden":false,"id":"33658953"},{"golden":false,"id":"8912803"},{"golden":false,"id":"37396699"},{"golden":false,"id":"32251385"},{"golden":true,"id":"38092565"},{"golden":false,"id":"23487279"},{"golden":false,"id":"37560074"},{"golden":false,"id":"20391271"},{"golden":false,"id":"17306720"},{"golden":false,"id":"24933652"},{"golden":false,"id":"37601084"},{"golden":false,"id":"22874079"},{"golden":false,"id":"15816011"},{"golden":false,"id":"31735534"},{"golden":false,"id":"20427249"},{"golden":false,"id":"28237318"},{"golden":false,"id":"19540408"},{"golden":false,"id":"34216995"},{"golden":false,"id":"35635442"},{"golden":false,"id":"24940853"},{"golden":false,"id":"15832587"},{"golden":false,"id":"12777342"},{"golden":false,"id":"9005035"},{"golden":false,"id":"24461737"},{"golden":false,"id":"35510826"},{"golden":true,"id":"29678279"},{"golden":false,"id":"37882050"},{"golden":false,"id":"33776815"},{"golden":true,"id":"34039454"},{"golden":true,"id":"37252542"},{"golden":false,"id":"33536109"},{"golden":false,"id":"32832129"},{"golden":true,"id":"36135314"},{"golden":false,"id":"37304435"},{"golden":false,"id":"37600902"},{"golden":false,"id":"32744296"},{"golden":false,"id":"38082004"},{"golden":false,"id":"34547353"},{"golden":true,"id":"37841549"},{"golden":true,"id":"23592072"},{"golden":true,"id":"32372364"},{"golden":false,"id":"21204913"},{"golden":true,"id":"37141480"},{"golden":false,"id":"32441004"},{"golden":false,"id":"37427882"},{"golden":false,"id":"37671673"},{"golden":false,"id":"37217977"},{"golden":false,"id":"37529155"},{"golden":false,"id":"38147055"},{"golden":false,"id":"38137146"},{"golden":false,"id":"33156704"},{"golden":false,"id":"32371364"},{"golden":false,"id":"34430163"},{"golden":false,"id":"27713377"},{"golden":false,"id":"36541815"},{"golden":false,"id":"32017680"},{"golden":false,"id":"38268564"},{"golden":false,"id":"36626471"},{"golden":false,"id":"38288007"},{"golden":false,"id":"36040711"},{"golden":true,"id":"36043688"},{"golden":false,"id":"35348056"},{"golden":false,"id":"38113810"},{"golden":false,"id":"38086211"},{"golden":false,"id":"38299647"},{"golden":false,"id":"32818918"},{"golden":true,"id":"37280059"},{"golden":false,"id":"32677690"},{"golden":false,"id":"37223912"},{"golden":false,"id":"37409875"},{"golden":false,"id":"35711159"},{"golden":false,"id":"34133967"},{"golden":false,"id":"32322678"},{"golden":false,"id":"38299652"},{"golden":false,"id":"38299044"},{"golden":false,"id":"36911236"},{"golden":false,"id":"35418857"},{"golden":false,"id":"33443326"},{"golden":false,"id":"35254241"},{"golden":false,"id":"36751116"},{"golden":false,"id":"32351740"},{"golden":false,"id":"18279244"},{"golden":false,"id":"25082422"},{"golden":false,"id":"25320613"},{"golden":false,"id":"24137134"},{"golden":false,"id":"18768298"},{"golden":true,"id":"22664772"},{"golden":false,"id":"16636640"},{"golden":true,"id":"36045802"},{"golden":false,"id":"21272280"},{"golden":false,"id":"38358665"},{"golden":false,"id":"38358657"},{"golden":false,"id":"38358656"},{"golden":false,"id":"38358335"},{"golden":false,"id":"38358093"},{"golden":false,"id":"38357583"},{"golden":false,"id":"38357179"},{"golden":false,"id":"38357050"},{"golden":false,"id":"38356586"},{"golden":false,"id":"38355787"},{"golden":false,"id":"38340534"},{"golden":false,"id":"38330353"},{"golden":false,"id":"38277146"},{"golden":false,"id":"38246028"},{"golden":true,"id":"38115193"},{"golden":false,"id":"38105651"},{"golden":true,"id":"38104420"},{"golden":false,"id":"38100655"},{"golden":false,"id":"19319174"},{"golden":false,"id":"30392700"},{"golden":false,"id":"28921405"},{"golden":true,"id":"22425410"},{"golden":false,"id":"30475257"},{"golden":false,"id":"29843260"},{"golden":false,"id":"30482948"},{"golden":true,"id":"27612527"},{"golden":false,"id":"27720453"},{"golden":false,"id":"23200103"},{"golden":false,"id":"24350211"},{"golden":false,"id":"28942289"},{"golden":false,"id":"31695525"},{"golden":false,"id":"27804883"},{"golden":true,"id":"35509728"},{"golden":false,"id":"38288087"},{"golden":false,"id":"36186500"},{"golden":false,"id":"37971872"},{"golden":false,"id":"32257665"},{"golden":false,"id":"15298320"},{"golden":false,"id":"33607919"},{"golden":false,"id":"33052273"},{"golden":false,"id":"37702087"},{"golden":false,"id":"1878628"},{"golden":false,"id":"27487697"},{"golden":false,"id":"38056532"},{"golden":false,"id":"31284404"},{"golden":false,"id":"20562767"},{"golden":false,"id":"18482435"},{"golden":false,"id":"33160291"},{"golden":false,"id":"21560079"},{"golden":false,"id":"20877748"},{"golden":false,"id":"21768160"},{"golden":false,"id":"16476127"},{"golden":false,"id":"36060373"},{"golden":false,"id":"34087766"},{"golden":false,"id":"38353645"},{"golden":false,"id":"38351841"},{"golden":false,"id":"38340400"},{"golden":false,"id":"38336263"},{"golden":false,"id":"38335780"},{"golden":false,"id":"35571129"},{"golden":false,"id":"34336561"},{"golden":false,"id":"33568074"},{"golden":false,"id":"35472157"},{"golden":true,"id":"36178356"},{"golden":false,"id":"35726408"},{"golden":false,"id":"31898125"},{"golden":false,"id":"34981958"},{"golden":false,"id":"37732960"},{"golden":false,"id":"34536871"},{"golden":true,"id":"24882185"},{"golden":false,"id":"31647377"},{"golden":false,"id":"24579344"},{"golden":false,"id":"36192621"},{"golden":true,"id":"28898309"},{"golden":true,"id":"21206788"},{"golden":true,"id":"36843769"},{"golden":false,"id":"38841675"},{"golden":false,"id":"38861239"},{"golden":false,"id":"22204498"},{"golden":false,"id":"39656577"},{"golden":false,"id":"33374666"},{"golden":false,"id":"32896111"},{"golden":false,"id":"26567470"},{"golden":false,"id":"7659985"},{"golden":false,"id":"11157424"},{"golden":false,"id":"32676242"},{"golden":true,"id":"39547825"},{"golden":false,"id":"34964921"},{"golden":false,"id":"26621349"},{"golden":false,"id":"22775447"},{"golden":false,"id":"39244500"},{"golden":false,"id":"34290290"},{"golden":false,"id":"19004601"},{"golden":false,"id":"27574527"},{"golden":false,"id":"18301941"},{"golden":false,"id":"17245678"},{"golden":false,"id":"35629112"},{"golden":false,"id":"28794966"},{"golden":false,"id":"29459327"},{"golden":false,"id":"28636769"},{"golden":false,"id":"36523702"},{"golden":false,"id":"38236224"},{"golden":false,"id":"29891008"},{"golden":false,"id":"18847572"},{"golden":false,"id":"23042939"},{"golden":false,"id":"34794704"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":400,"document":"15801394","golden":true,"offsetInEndSection":518,"text":"The psychiatric disorders related to cannabis use are anxiety disorders, depressive disorders and psychotic disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1435,"document":"21204913","golden":false,"offsetInEndSection":1571,"text":" since they lead to hospitalization. Beyond the well-known and widely investigated psychiatric events, serious cerebro and cardiovascula","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"15801394","golden":true,"offsetInEndSection":241,"text":"Cannabis disorders, according to the DSM-IV and the ICD-10 criteria, include cannabis intoxication, cannabis abuse, cannabis dependence, and cannabis-related disorders (anxiety disorders, psychotic disorders, cannabis intoxication delirium).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1122,"document":"21204913","golden":false,"offsetInEndSection":1434,"text":"cular disorders (9.5%). We estimated that in 2007 the incidence of cannabis-related AEs in the Midi-Pyrenees region ranged from 1.2 per 1000 regular cannabis users (95% confidence interval (CI) 0.7, 1.6) to 3.2 (95% CI 2.5, 3.9).CONCLUSIONS: Cannabis use is associated with complications, considered to be seriou","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":928,"document":"21204913","golden":false,"offsetInEndSection":1121,"text":"unted for 18.2% of AEs. Most frequent outcomes were central and peripheral nervous system disorders (15.8% of AEs), acute intoxication (12.1%), respiratory system disorders (11.1%) and cardiova","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":83,"document":"24579344","golden":false,"offsetInEndSection":212,"text":"Cannabis use is extremely commonplace and frequently comorbid with psychiatric disorders that raise questions about the etiology.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36523702","golden":false,"offsetInEndSection":197,"text":"Cannabis use has been associated with several psychiatric comorbidities and there appears to be a dose-response relationship between the intensity and duration of its use and the risk of psychosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":198,"document":"36523702","golden":false,"offsetInEndSection":466,"text":"More commonly, acute episodes of cannabis induced-psychosis manifest immediately following exposure, are precipitated after the use of large amounts of cannabis, resolve with abstinence, and are of shorter duration than those observed with primary psychotic disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":571,"document":"15521792","golden":false,"offsetInEndSection":863,"text":"From a clinical perspective, toxic or transient psychotic reactions to the administration of herbal cannabis preparations or specific cannabinoid compounds have to be differentiated from longer-lasting, persistent schizophrenia-like disorders associated with the use of cannabis/cannabinoids.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":194,"document":"21204913","golden":false,"offsetInEndSection":512,"text":"shed. The present study aimed to assess cannabis-related adverse events leading to hospitalization, and to estimate the corresponding annual risk for consumers.METHODS: Participants were patients admitted to the public hospitals in the Toulouse area (France) between January 2004 and December 2007 in relation to the u","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":498,"document":"32676242","golden":false,"offsetInEndSection":623,"text":"he legalization of marijuana, its use is on the rise leading to several mental health conditions, including catatonia. If lef","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1387,"document":"34850659","golden":false,"offsetInEndSection":1480,"text":"disorders.CONCLUSIONS: This study highlights the risk of intoxication by SCRAs when taking lo","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1282,"document":"30439419","golden":false,"offsetInEndSection":1467,"text":"s show that an interaction between cannabis exposure and stress during adolescence may lead to long-term anxiety disorders characterized by the presence of pathological fear.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":231,"document":"28794966","golden":false,"offsetInEndSection":423,"text":"imilar to natural cannabis, Synthetic Cannabinoid intoxication can present in several ways with the most common emergency room presentations to be of neurologic and psychiatric manifestation. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":946,"document":"32676242","golden":false,"offsetInEndSection":1103,"text":" present the case of two patients who presented with catatonia after cannabis consumption and discuss their treatment course and management.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34850659","golden":false,"offsetInEndSection":107,"text":"Involuntary MDMB-4en-PINACA intoxications following cannabis consumption: clinical and analytical findings.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1163,"document":"26567470","golden":false,"offsetInEndSection":1453,"text":"eaths. Major complications include cardiovascular events (myocardial infarction, ischemic stroke and emboli), acute kidney injury (AKI), generalized tonic-clonic seizures, psychiatric presentations (including first episode psychosis, paranoia, self-harm/suicide ideation) and hyperemesis. H","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30439419","golden":false,"offsetInEndSection":151,"text":"?9-tetrahydrocannabinol (THC) consumption during adolescence is reported to be a risk factor for the appearance of psychiatric disorders later in life.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1894,"document":"28794966","golden":false,"offsetInEndSection":2136,"text":"hetic Cannabinoids can cause respiratory depression in individuals without an underlying pulmonary disease and adds to the growing number of literature about the presentation and debilitating adverse events from its consumption. Although ther","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":174,"document":"34850659","golden":false,"offsetInEndSection":288,"text":"ication is scarce. This study presents MDMB-4en-PINACA identification in cannabis consumers with clinical and anal","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32894263","golden":false,"offsetInEndSection":224,"text":"Cannabis is the illicit drug most commonly used worldwide, and its consumption can both induce psychiatric symptoms in otherwise healthy subjects and unmask a florid psychotic picture in patients with a prior psychotic risk.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1232,"document":"29265019","golden":false,"offsetInEndSection":1491,"text":"ent-seeking population.INTERPRETATION \u0026 CONCLUSIONS: A review of Indian literature on cannabis use and its association with psychiatric disorders indicates a high co-prevalence of psychotic disorders, especially in vulnerable individuals as well as high rates","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":299,"document":"11584686","golden":false,"offsetInEndSection":449,"text":"main risk of cannabis use was especially the induction of \"madness\" or psychotic states in case of high dosage and high frequency of consumption. Neve","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":553,"document":"30869262","golden":false,"offsetInEndSection":730,"text":"ts with cannabis use disorder experience, on a daily basis, subthreshold withdrawal anxiety symptoms, characterized by irritability associated with craving for cannabis. By cont","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23042939","golden":false,"offsetInEndSection":182,"text":"OBJECTIVE: Whilst cannabis has been associated with an earlier age at onset in schizophrenia, the impact of amphetamine and/or cocaine plus cannabis consumption on age at onset remai","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":866,"document":"33716825","golden":false,"offsetInEndSection":1191,"text":"nxiety disorders are among the most common psychiatric illnesses affecting American adults, and anxiety relief is also the most commonly-reported reason for medicinal cannabis use, we focus particularly on applying human laboratory models to study cannabis effects in individuals with anxiety and related disorders. Finally, ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":140,"document":"32314248","golden":false,"offsetInEndSection":416,"text":"annabis. Recreational cannabis use may increase anxiety, depression, breathing problems, and weight in young adults in general and further result in poor control of sugar levels, increased consumption of carbohydrates, and poor self-management in young adults living with diab","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"20529414","golden":false,"offsetInEndSection":92,"text":"There is now compelling evidence that cannabis consumption might precipitate psychosis onset","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":919,"document":"35926992","golden":false,"offsetInEndSection":1178,"text":"igible studies that enrolled 12?143 adult patients with chronic pain. Very low certainty evidence suggests that adverse events are common (prevalence: 26.0%; 95%?CI 13.2% to 41.2%) among users of medical cannabis for chronic pain, particularly any psychiatric","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":862,"document":"30526093","golden":false,"offsetInEndSection":1118,"text":"association between several Single Nucleotide Polymorphism (SNP)s in main circadian genes SNPs, especially the gene locus HES7/PER1 on chromosome 17 and cannabis consumption as well as the development of neuropsychiatric and social disorders. This SNP\u0027s si","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1394,"document":"24882185","golden":false,"offsetInEndSection":1632,"text":" in definition of cannabis use/dependence. Lack of controlled studies limiting definite conclusions about a putative causal relationship between cannabis and onset of mania.CONCLUSIONS: Further investigations are needed to clarify the rel","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":838,"document":"24882185","golden":true,"offsetInEndSection":1006,"text":"cannabis abuse or dependence. Cannabis use is associated with younger age at onset of first mania and with more frequent depressive or manic episodes, although the evid","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":80,"document":"24882185","golden":false,"offsetInEndSection":203,"text":"r disorder. Available data has shown that the risk of psychotic disorders increases with the frequency and intensity of can","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":913,"document":"21206852","golden":true,"offsetInEndSection":1273,"text":"Whilst paranoid psychoses were more prevalent, a significant number of patients with affective psychoses, particularly mania, was also noted.Besides being known as either the causative agent or a potent risk factor in cases of paranoid psychoses, cannabis appears to have similar capabilities with regard to affective psychoses, particularly in cases of mania.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"15052390","golden":false,"offsetInEndSection":258,"text":"AIMS: The aim of this study was to estimate the prevalence of psychiatric disorders among 1439 heavy cannabis users seeking treatment for abuse problems in Denmark.DESIGN: Using two different registers, we compared cannabis users with 9122 abusers of other s","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32546286","golden":false,"offsetInEndSection":138,"text":"BACKGROUND: Posttraumatic stress disorder (PTSD) is the most highly co-occurring psychiatric disorder among veterans with cannabis use dis","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":715,"document":"32877036","golden":true,"offsetInEndSection":944,"text":"Effects of cannabis use include mood disorders, exacerbation of psychotic disorders in vulnerable people, cannabis use disorders, withdrawal syndrome, neurocognitive impairments, cardiovascular and respiratory and other diseases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":690,"document":"32714742","golden":false,"offsetInEndSection":830,"text":"s among youth in the United States. The primary psychiatric symptoms associated with cannabis use in youth are increased risk for addiction,","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":204,"document":"24882185","golden":false,"offsetInEndSection":536,"text":"abis abuse. The present purpose was to review relevant studies to investigate whether cannabis use can be linked to the onset of mania in bipolar disorder.METHODS: Articles published between 1972 and December 2013 were searched on Medline and PsychInfo using the following keywords: first manic episode, or onset mania, or bipolar d","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1239,"document":"24882185","golden":false,"offsetInEndSection":1393,"text":"with psychiatric comorbidity. While cannabis use often precedes first manic episodes, the causal direction remains to be determined.LIMITATIONS: Variation","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":362,"document":"32546286","golden":false,"offsetInEndSection":1276,"text":"is debated. The longitudinal relationship between PTSD diagnosis and traumatic intrusion symptoms with cannabis use and CUD was examined using cross-lagged panel model (CLPM) analysis.METHODS: Prospective data from a longitudinal observational study of 361 veterans deployed post-9/11/2001 included PTSD and CUD diagnoses, cannabis use, and PTSD-related traumatic intrusion symptoms from the Inventory of Depression and Anxiety Symptoms.RESULTS: A random intercept CLPM analysis that leveraged three waves (baseline, 6 months and 12 months) of cannabis use and PTSD-related intrusion symptoms to account for between-person differences found that baseline cannabis use was significantly positively associated with 6-month intrusion symptoms; the converse association was significant but reduced in magnitude (baseline use to 6-month intrusions: ? \u003d 0.46, 95% CI 0.155-0.765; baseline intrusions to 6-month use: ? \u003d ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":476,"document":"15381886","golden":false,"offsetInEndSection":679,"text":"nabis in the United States. There is growing evidence that early and regular marijuana use is associated with later increases in depression, suicidal behavior, and psychotic illness and may bring forward","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":139,"document":"32546286","golden":false,"offsetInEndSection":361,"text":"rder (CUD). Despite some evidence that cannabis use prospectively exacerbates the course of PTSD, which in turn increases the risk for CUD, the causal nature of the relationship between cannabis and psychiatric comorbidity","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":606,"document":"32772621","golden":false,"offsetInEndSection":1069,"text":" Plus, and EMBASE. Keywords were cannabis, medical cannabis, delta-9-tetrahydrocannabinaol, cannabidiol, and psychiatric disorders.RESULTS: The evidence that medical cannabis or cannabinoids is an effective treatment for the qualifying psychiatric disorders (e.g., posttraumatic stress disorder, agitation in Alzheimer\u0027s disease and other dementias, Tourette\u0027s syndrome, anxiety, and obsessive-compulsive disorder) is too weak and of low quality to recommend as a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1363,"document":"33464286","golden":false,"offsetInEndSection":2138,"text":"1 female participants [65.0%]; mean [SD] age at the time of mood disorder diagnosis, 17.2 [4.10] years). Cannabis use disorder was documented for 10.3% of youths with mood disorders (n?\u003d?21?040) and was significantly associated with older age (14-18 years vs 10-13 years: adjusted risk ratio [ARR], 9.35; 95% CI, 8.57-10.19; and 19-24 years vs 10-13 years: ARR, 11.22; 95% CI, 10.27-12.26), male sex (ARR, 1.79; 95% CI, 1.74-1.84), Black race (ARR, 1.39; 95% CI, 1.35-1.44), bipolar or other mood disorders (bipolar disorders: ARR, 1.24; 95% CI, 1.21-1.29; other mood disorders: ARR, 1.20; 95% CI, 1.15-1.25), prior history of self-harm (ARR, 1.66; 95% CI, 1.52-1.82), previous mental health outpatient visits (ARR, 1.26; 95% CI, 1.22-1.30), psychiatric hospitalizations (ARR","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36639397","golden":false,"offsetInEndSection":51,"text":"Cannabis use is a common risk factor for psychoses.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":136,"document":"34384432","golden":false,"offsetInEndSection":298,"text":"s globally. Cannabis use has several known physical, psychological, and social adverse events, such as altered judgement, poor educational outcomes, and respirato","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":147,"document":"32433545","golden":false,"offsetInEndSection":401,"text":"Though the relationship between cannabis use and psychiatric disorders remains controversial, consistent association between early adolescent cannabis use and the subsequent risk of psychosis suggested adolescence may be a particularly vulnerable period.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1730,"document":"32546286","golden":false,"offsetInEndSection":1848,"text":"ociation between PTSD and CUD was evident. Findings have significant clinical implications for the long-term effects o","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":966,"document":"21462790","golden":false,"offsetInEndSection":1138,"text":"The effects of cannabis are dosedependent.The most frequently report-ed adverse effects are mental slowness, impaired reaction times, and sometimes accentuation of anxiety.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2556,"document":"21462790","golden":false,"offsetInEndSection":2757,"text":"Withdrawal symptoms tend to occur within 48 hours following cessation of regular cannabis use, and include increased irritability, anxiety, nervousness, restlessness, sleep difficulties and aggression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21592732","golden":false,"offsetInEndSection":146,"text":"OBJECTIVE: Cannabis is associated with psychotic outcomes in numerous studies, an effect that is commonly attributed to ? (9)-tetrahydrocannabinol","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2329,"document":"21462790","golden":false,"offsetInEndSection":2471,"text":"It seems prudent to inform apparently vulnerable individuals that cannabis may cause acute psychotic decompensation, especially at high doses.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1499,"document":"21462790","golden":false,"offsetInEndSection":1694,"text":"There do not * About fifteen longitudinal cohort studies that examined the influence of cannabis on depressive thoughts or suicidal ideation have yielded conflicting results and are inconclusive.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2092,"document":"21462790","golden":false,"offsetInEndSection":2210,"text":"In Australia, the marked increase in cannabis use has not been accompanied by an increased incidence of schizophrenia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":417,"document":"28858148","golden":false,"offsetInEndSection":726,"text":"of past trauma.METHODS: The presence of alcohol and drugs (cannabis, cocaine, amphetamines, methamphetamines, benzodiazepines, opiates, methadone, barbiturates, and tricyclic antidepressants) was analyzed in 1,156 patients between 16 and 70 years old, hospitalized in a trauma hospital between November 2011 a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1592,"document":"28858148","golden":false,"offsetInEndSection":1857,"text":"ents who screened positive for alcohol, illicit drugs, and/or psychotropic medications had a higher frequency of past trauma history compared with patients with negative tests, independently of age, gender, or the presence of previous psychiatric disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":480,"document":"31073761","golden":false,"offsetInEndSection":832,"text":"were included. Clinical outcomes comprised efficacy (pain intensity, patient impression of improvement, combined responder, sleep problems, psychological distress, opioid maintenance and breakthrough dosage), tolerability (dropout rate due to adverse events) and safety (nervous system, psychiatric and gastrointestinal side effects; serious adverse ev","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1364,"document":"28858148","golden":false,"offsetInEndSection":1587,"text":"umption of alcohol, illicit drugs, and/or psychotropic medications was associated with increased recidivism in all substance groups; the adjusted odds ratio for multiple recidivism was 3.17 (95% CI [2.29, 4.39]).CONCLUSION:","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":544,"document":"31656045","golden":false,"offsetInEndSection":816,"text":"r 2018. Information regarding cannabis therapy, patient\u0027s demographic and clinical characteristics, concomitant medications, AE description according to the Medical Dictionary for Regulatory Activities (MedDRA) classification, AE seriousness and AE outcome, were collected","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":859,"document":"28858148","golden":false,"offsetInEndSection":1074,"text":"nce 1999. Multinomial logistic regression analysis was used to estimate the strength of the association between types of substances detected in current trauma patients and trauma recidivism (documented history of pa","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28858148","golden":false,"offsetInEndSection":96,"text":"BACKGROUND: Alcohol, illicit drugs, and psychotropic medications are well-known causes of trauma","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":223,"document":"31073761","golden":false,"offsetInEndSection":478,"text":"trial registers. Randomised controlled trials (RCTs) investigating medical cannabis and/or pharmaceutical cannabinoids for pain control in cancer patients with a?study duration of at least 2?weeks and a?sample size of at least 20?participants per study ar","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1450,"document":"31656045","golden":false,"offsetInEndSection":1535,"text":"Cannabis was generally well tolerated and the majority of AEs were mild and transient","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":192,"document":"28858148","golden":false,"offsetInEndSection":414,"text":"clear.OBJECTIVES: The purpose of this study was to quantify the strength of associations between the type of substance detected in patients admitted for traumatic injury and trauma recidivism, defined as a documented histo","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":866,"document":"30416428","golden":false,"offsetInEndSection":1024,"text":"The most frequent clinical manifestations described in these patients are febrile or afebrile seizures, status epilepticus, encephalopathies and encephalitis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":871,"document":"29302150","golden":false,"offsetInEndSection":989,"text":"Patients and their families experience depression, anxiety, trauma, suicidal ideation, panic and other manifestations.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":468,"document":"30858838","golden":false,"offsetInEndSection":721,"text":"Serious HFMD cases are associated with neurological complications, such as aseptic meningitis, acute flaccid paralysis, brainstem encephalitis, and have been associated with as many as 1000s of deaths in children and infants from 2008 to 2017, in China.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":366,"document":"27848998","golden":false,"offsetInEndSection":537,"text":"In this study, the clinical and epidemiological investigation showed that fever, cough, and sore throat were the three most common respiratory symptoms of HAdV infections.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":568,"document":"23242778","golden":false,"offsetInEndSection":617,"text":"Cough and wheezing were the most common symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1446,"document":"24610554","golden":false,"offsetInEndSection":1551,"text":"The most frequent symptoms associated with respiratory viruses were sore throat, rhinorrhea and headache.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"19698564","golden":false,"offsetInEndSection":135,"text":"Cannabis has been reported to produce acute psychiatric reactions, among these panic anxiety and derealization, which are self-limited.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":143,"document":"8075903","golden":true,"offsetInEndSection":255,"text":"These can be distinguished from adverse reactions to cannabis, the commonest of which is an acute anxiety state.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"8075903","golden":false,"offsetInEndSection":142,"text":"The usual phenomena of cannabis intoxication include experiences which in a non-intoxicated state would be considered as psychiatric symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":583,"document":"8075903","golden":false,"offsetInEndSection":768,"text":"The evidence that cannabis has a causative role in chronic psychotic or affective disorders is not convincing, although the drug may modify the course of an already established illness.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":877,"document":"22897939","golden":false,"offsetInEndSection":1152,"text":"r adjustment for confounders. There was a strong graded association between cannabis use and schizoaffective disorder, even after control for confounders, although the numbers were small (HR 7.4, 95% CI, 1.0-54.3).CONCLUSION: We did not find evidence for an increased risk of","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":256,"document":"8075903","golden":false,"offsetInEndSection":338,"text":"Acute psychotic episodes can also follow ingestion of the drug but are infrequent.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30276906","golden":false,"offsetInEndSection":169,"text":"AIMS: We tested the age-varying associations of cannabis use (CU) frequency and disorder (CUD) with psychotic, depressive and anxiety symptoms in adolescent and adult sa","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"8075903","golden":false,"offsetInEndSection":39,"text":"Psychiatric symptoms in cannabis users.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":314,"document":"33656571","golden":false,"offsetInEndSection":488,"text":"This is complicated by the fact that SIPDs associated with cannabis, hallucinogens and amphetamines have a?significant risk of transition to manifest psychotic disorder (e.g.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":438,"document":"8075903","golden":false,"offsetInEndSection":582,"text":"Neither presentation consistently shows enough specific features to warrant the diagnosis of \u0027cannabis psychosis\u0027 as a distinct clinical entity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":710,"document":"32714742","golden":false,"offsetInEndSection":851,"text":" United States. The primary psychiatric symptoms associated with cannabis use in youth are increased risk for addiction, depressive, and psyc","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":923,"document":"32781422","golden":false,"offsetInEndSection":1180,"text":" their 30\u0027s apparently bearing the brunt of this burden, cannabis consumption has been associated with an increase in ischemic stroke-a blockage in the cerebral or cerebellar vasculature-and almost a fivefold increase in myocardial infarction. THC containin","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1154,"document":"32372364","golden":false,"offsetInEndSection":1420,"text":", alcohol use disorder, tobacco smoking, parents\u0027 divorce, and history of physical assault and lower rates of lower rates of???40 weekly worked hours were identified as common associated factors for cannabis consumption and CUD. Hypnotic consumption, psychiatric fol","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":564,"document":"21557896","golden":false,"offsetInEndSection":840,"text":"007 (n\u003d7403).RESULTS: Findings suggested that cannabis consumption was predictive of psychosis diagnosis in a bivariate model; however, when estimated within a multivariate model that included childhood sexual abuse, the effect of cannabis use was attenuated and was not stati","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":242,"document":"21557896","golden":false,"offsetInEndSection":560,"text":"riences.METHOD: Using hierarchical multivariate logistic analyses the current study examined both the independent effect of cannabis consumption on psychosis diagnosis and the combined effect of cannabis consumption and childhood sexual abuse on psychosis diagnosis using data from the Adult Psychiatric Morbidity Surv","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1423,"document":"32372364","golden":false,"offsetInEndSection":1645,"text":"-up, and history of sexual assault were identified as factors associated specifically with CUD, suggesting that these factors were associated with more severe cannabis consumption. Only 17% of students identified with CUD ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1005,"document":"32653594","golden":false,"offsetInEndSection":1174,"text":"ported daily use. Compared to recreational users, medical users reported more problematic cannabis use in addition to greater psychiatric symptomatology (anxiety, depres","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1196,"document":"23886472","golden":false,"offsetInEndSection":1483,"text":"nt predictors of the first incidence of cannabis dependence included: living alone, coping motives for cannabis use, number and type of recent negative life events (major financial problems), and number and type of cannabis use disorder symptoms (impaired control over use). Cannabis exp","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":479,"document":"17596918","golden":false,"offsetInEndSection":814,"text":"asures.METHODS: The consumption of substances was investigated using biological measures (urine cotinine, cannabis, opiates, cocaine, amphetamines and barbiturates; blood carbohydrate-deficient transferrin [CDT] and gamma-glutamyl transferase [GGT]) in 486 consecutively admitted psychiatric patients, one day following their hospitali","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25133182","golden":false,"offsetInEndSection":151,"text":"OBJECTIVE: Comorbidities between psychiatric diseases and consumption of traditional substances of abuse (alcohol, cannabis, opioids, and cocaine) are ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":215,"document":"21206788","golden":false,"offsetInEndSection":476,"text":"Psychopathology and psychiatric syndromes associated with cannabis use that have received research attention in recent years include cannabis withdrawal, cannabis and psychotic disorders (especially schizophrenia), depression, anxiety, and cognitive impairment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1209,"document":"33530732","golden":false,"offsetInEndSection":1554,"text":"ed self-reported nightmares. Two small studies of THC for hospitalized patients with unipolar or bipolar depression found no improvement of depression; instead, anxiety and psychotic symptoms emerged in \u003e50% of patients.CONCLUSIONS: With only eight very small studies, insufficient evidence was found for efficacy of CBD and THC to manage affect","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1808,"document":"35772419","golden":false,"offsetInEndSection":1967,"text":"nt controls, through an additive effect. There was no evidence of an amplified vulnerability to cannabis-related increases in subclinical depression, anxiety o","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":339,"document":"8075903","golden":false,"offsetInEndSection":437,"text":"These can be classified as acute confusional states and episodes occurring in clear consciousness.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":152,"document":"29125965","golden":false,"offsetInEndSection":393,"text":"A 35-year-old man presented with behavioral disturbances of sudden onset after oral cannabis consumption and major self-mutilation (attempted amputation of the right arm, self-enucleation of both eyes and impalement) which resulted in death.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1021,"document":"32487935","golden":true,"offsetInEndSection":1235,"text":"Overall, this review found consistent evidence showing a cross-sectional association between recreational cannabis use and depression, anxiety, and suicide, despite some limitations and conflicts in the literature.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":727,"document":"19586351","golden":false,"offsetInEndSection":910,"text":"iated with chronic cannabis use. Cannabis has now been implicated in the etiology of many major long-term psychiatric conditions including depression, anxiety, psychosis, bipolar diso","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"29125965","golden":false,"offsetInEndSection":57,"text":"Death by self-mutilation after oral cannabis consumption.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":284,"document":"28635664","golden":false,"offsetInEndSection":435,"text":"Cocaine consumption and subsequent abstinence from it can cause psychiatric symptoms, such as psychosis, cognitive impairment, anxiety, and depression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"29125965","golden":false,"offsetInEndSection":151,"text":"Major self-mutilation (amputation, castration, self-inflicted eye injuries) is frequently associated with psychiatric disorders and/or substance abuse.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":209,"document":"26636547","golden":false,"offsetInEndSection":525,"text":"nnabis use. One group at risk for comorbid cannabis-use disorders and clinical depression is female emerging adults (those aged 18-25 years old) as cannabis use peaks during this period, depression is the most common psychiatric disorder among emerging adults, and females are at increased risk for depression relati","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1282,"document":"28219487","golden":false,"offsetInEndSection":1972,"text":"e these deficits in humans. The animal literature, however, clearly indicates that adolescent-onset exposure to cannabinoids can catalyze molecular processes that lead to persistent functional deficits in adulthood, deficits that are not found to follow adult-onset exposure and that model some of the adverse outcomes reported in humans among adult populations of early-onset cannabis users.CONCLUSION: Based on the data in the current literature, a strong association is found between early, frequent, and heavy adolescent cannabis exposure and poor cognitive and psychiatric outcomes in adulthood, yet definite conclusions?cannot yet be made as to whether cannabis use alone has a negati","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1146,"document":"29125965","golden":false,"offsetInEndSection":1235,"text":"We discuss the implications of oral consumption of cannabis with a very high THC content.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":586,"document":"29125965","golden":false,"offsetInEndSection":842,"text":"Toxicological findings showed cannabinoids in femoral blood (tetrahydrocannabinol (THC) 13.5?ng/mL, 11-hydroxy-tetrahydrocannabinol (11-OH-THC) 4.1?ng/mL, 11-nor-9-carboxy-THC (THC-COOH) 14.7?ng/mL, cannabidiol (CBD) 1.3?ng/mL, cannabinol (CBN) 0.7?ng/mL).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1109,"document":"20512269","golden":false,"offsetInEndSection":1603,"text":" a form of self-medication. In individuals with psychiatric disorders, the use of cannabis has been associated with increased positive symptoms, additional negative symptoms in the course of illness, impaired treatment compliance, and more hospitalizations.CONCLUSION: The abuse of cannabis by patients with psychiatric disorders such as schizophrenia and mood and anxious disorders has a negative impact both in the acute and advanced stages of these conditions, although further investigation","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":695,"document":"12492261","golden":false,"offsetInEndSection":865,"text":"Alcohol dependence, antisocial personality disorder, and conduct disorder had the strongest associations with cannabis dependence, followed by anxiety and mood disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":862,"document":"32896111","golden":false,"offsetInEndSection":1383,"text":"nabinol (THC) content. However, we found no association between diagnosis of residual and late-onset psychotic disorders and clinical genetic factors, presence of preceding psychiatric disorders, duration and frequency of cannabis use, starting age of cannabis use, or combined use of other psychoactive substances; an association was found only for the absence of use of cannabis products other than dried cannabis.CONCLUSION: The onset of cannabis dependence was related to long-term cannabis use and the use of cannabi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27745717","golden":false,"offsetInEndSection":163,"text":"INTRODUCTION: Cannabis use is very frequent in bipolar disorder and has been found to increase the duration and frequency of manic symptoms while decreasing those ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1323,"document":"19818563","golden":false,"offsetInEndSection":1712,"text":"These findings suggest that within this population that cannabis use and dependence, as well as individual cannabis dependence symptoms have a significant heritable component, that cannabis dependence is more likely to occur when use begins during adolescence, and that the cannabis dependence syndrome includes a number of heritable untoward psychiatric side effects including withdrawal.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1650,"document":"28314070","golden":false,"offsetInEndSection":1971,"text":"s seems to be associated with cannabinoid levels in hair. The continuation of persistent symptoms 3 months after the discontinuation of cannabis abuse, was a remarkable finding.SCIENTIFIC SIGNIFICANCE: We provide evidence that chronic and heavy cannabis abuse results in long-lasting brain dysfunction in all users and in","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":752,"document":"16506412","golden":true,"offsetInEndSection":958,"text":"Acute adverse effects of cannabis administration include tachycardia, orthostatic hypotension, pulmonary irritation (if smoked), motor incoordination, cognitive impairment, anxiety, paranoia, and psychosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":775,"document":"28314070","golden":false,"offsetInEndSection":1146,"text":"6) and non prisoners (n?\u003d?32), respectively. A total of 39.6% of the users experienced hallucinations (mostly auditory), 54.2% experienced delusions (mostly ideas of reference and persecution), 85.4% had organic brain dysfunction in a test addressing visual-motor functioning and visual perception skills, and all users (100%) were found to have organic brain dysfunction","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28314070","golden":false,"offsetInEndSection":390,"text":"BACKGROUND AND OBJECTIVES: The purpose of this study was to evaluate the extent of short-term memory impairment and schizophrenia-like symptoms in heavy and systematic cannabis users and the association between the severity of abuse and the longevity of its persistent symptoms after refraining from such use.METHODS: A complete psychiatric examination and a psychometric evaluation were pe","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1345,"document":"28314070","golden":false,"offsetInEndSection":1649,"text":" participants below 35 years old (p?\u003c?.001). Statistically elevated cannabinoids levels were observed in users with auditory hallucinations compared to users without any hallucinations (p?\u003d?.019).CONCLUSIONS: The existence of hallucinations, delusions, and organic brain dysfunction in heavy cannabis use","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1073,"document":"24001294","golden":true,"offsetInEndSection":1310,"text":"Chronic effects of cannabis use include mood disorders, exacerbation of psychotic disorders in vulnerable people, cannabis use disorders, withdrawal syndrome, neurocognitive impairments, cardiovascular and respiratory and other diseases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36618434","golden":false,"offsetInEndSection":115,"text":"Objectives: Cannabis is the most commonly used illicit substance and has been associated with mental health issues.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":762,"document":"16506412","golden":true,"offsetInEndSection":975,"text":"rse effects of cannabis administration include tachycardia, orthostatic hypotension, pulmonary irritation (if smoked), motor incoordination, cognitive impairment, anxiety, paranoia, and psychosis. Screening of res","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1192,"document":"34282851","golden":false,"offsetInEndSection":1515,"text":"hem (intracranial hypertension in the context of lung cancer, suicide, cerebral haematoma, neonatal death with concomitant chronic alcohol use), while in the other cases the toxicological analysis identified cannabis use (ruptured aneurysm and unknown aetiology).CONCLUSION: This study showed a multitude of AEs related to ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":902,"document":"28112021","golden":false,"offsetInEndSection":1072,"text":"rders. The level of evidence for cannabis withdrawal is B; cannabis addiction is C2; treatment of positive symptoms in schizophrenia and anxiety in social anxiety disorde","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":5108,"document":"29513392","golden":false,"offsetInEndSection":5337,"text":" cannabis-based medicines and in 5% using placebo (RD 0.10 (95% CI 0.06 to 0.15); NNTH 10 (95% CI 7 to 16); 1314 participants, nine studies, low-quality evidence).We found no information about long-term risks in the studies analy","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34937473","golden":false,"offsetInEndSection":121,"text":"OBJECTIVES: Anxiety disorders are one of the most common reasons for seeking treatment with cannabis-based medicinal prod","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":709,"document":"15458989","golden":false,"offsetInEndSection":909,"text":"items on the PSQ. Factors independently associated with psychotic symptoms were cannabis dependence, alcohol dependence, victimisation, recent stressful life events, lower intellectual ability and neu","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":385,"document":"31408248","golden":true,"offsetInEndSection":619,"text":"ed.RESULTS: Although causality is unclear, heavy and dependent cannabis use is consistently associated with a high prevalence of comorbid psychiatric disorders and learning and memory impairments that seem to recover after a period of","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1713,"document":"33324255","golden":false,"offsetInEndSection":1873,"text":"cine in patients with TS. Based on available data using different cannabis-based medicines, we expect not only a reduction of tics, but also an improvement of p","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1034,"document":"30567512","golden":false,"offsetInEndSection":1178,"text":"n other groups. Escape from home, cannabis abuse, psychological abuse, physical abuse and loneliness were more frequent in the SSD group than in","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":158,"document":"32197092","golden":false,"offsetInEndSection":325,"text":"tional use. The potential for increased cannabis use highlights the need to better understand its risks, including the acute induction of psychotic and other psychiatr","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"19693792","golden":false,"offsetInEndSection":104,"text":"BACKGROUND: Anxiety reactions and panic attacks are the acute symptoms most frequently associated with c","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":293,"document":"6324549","golden":false,"offsetInEndSection":498,"text":"The most frequently observed complication of cannabis inebriation, however, is a short-lasting acute psychological disturbance with symptoms of panic, paranoid apprehension and personality disorganization.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2367,"document":"32197092","golden":false,"offsetInEndSection":2631,"text":"[95% CI 0?59-0?97], p\u003c0?0001). In the systematic review, of the four studies evaluating CBD\u0027s effects on THC-induced symptoms, only one identified a significant reduction in symptoms.INTERPRETATION: A single THC administration induces psychotic, negative, and othe","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31647377","golden":false,"offsetInEndSection":149,"text":"Objective: This review discusses the relationship between cannabis use and psychotic, bipolar, depressive, and anxiety disorders, as well as suicide.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":333,"document":"3000137","golden":true,"offsetInEndSection":443,"text":"Anxiety reactions, flashbacks, dysphoric reactions and an abstinence syndrome are all sequels of cannabis use.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":736,"document":"32197092","golden":false,"offsetInEndSection":1270,"text":"n, crossover design. Inclusion criteria were studies reporting symptoms using psychiatric scales (the Brief Psychiatric Rating Scale [BPRS] and the Positive and Negative Syndrome Scale [PANSS]) following the acute administration of intravenous, oral, or nasal THC, CBD, and placebo in healthy participants, and presenting data that allowed calculation of standardised mean change (SMC) scores for positive (including delusions and hallucinations), negative (such as blunted affect and amotivation), and general (including depression a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":611,"document":"6324549","golden":true,"offsetInEndSection":1033,"text":"In addition to the acute effects of cannabis on mental performance and behaviour, this paper reviews the psychiatric consequences of chronic use and the accumulated evidence on organic toxicity associated with it: residual cognitive deficit, lethargic symptoms, cannabis psychosis, respiratory, gastro-intestinal and cardiovascular complications, as well as effects on immune response and gonadal functions, are discussed.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"32197092","golden":false,"offsetInEndSection":92,"text":"Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":127,"document":"20104292","golden":true,"offsetInEndSection":278,"text":"Clinicians agree that cannabis use can cause acute adverse mental effects that mimic psychiatric disorders, such as schizophrenia and bipolar disorder.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1136,"document":"20512269","golden":false,"offsetInEndSection":1368,"text":" In individuals with psychiatric disorders, the use of cannabis has been associated with increased positive symptoms, additional negative symptoms in the course of illness, impaired treatment compliance, and more hospitalizations.CO","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1502,"document":"33374666","golden":false,"offsetInEndSection":1719,"text":"CONCLUSIONS: Although the general population in the United States increasingly perceives cannabis to be a harmless substance, empirical evidence shows that cannabis use is associated both with CUD and comorbid psychia","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":156,"document":"29125965","golden":false,"offsetInEndSection":399,"text":"-year-old man presented with behavioral disturbances of sudden onset after oral cannabis consumption and major self-mutilation (attempted amputation of the right arm, self-enucleation of both eyes and impalement) which resulted in death. Durin","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":304,"document":"35326345","golden":false,"offsetInEndSection":488,"text":" present work analyses the literature to determine the existence of gender differences in the development of psychotic, depressive and anxious symptoms associated with cannabis use. Fi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":108,"document":"31153010","golden":false,"offsetInEndSection":369,"text":"le previous research indicates specific interactions between cannabis use and schizotypal PD associated with schizophrenia, research into cannabis use among individuals with other PDs and the development of several additional psychiatric disorders is scarce. We","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1281,"document":"32135391","golden":false,"offsetInEndSection":1532,"text":"nnabis substance use (ORs range: 13.7-36.1) and all psychiatric symptoms and traits (ORs in SD units range: 1.1-2.1) were positively associated with combustible, edible, and vaporized cannabis product use. The magnitude of comorbidity did not signific","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28242263","golden":false,"offsetInEndSection":104,"text":"Young adults with psychiatric illnesses are more likely to use cannabis and experience problems from use","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":599,"document":"35326345","golden":false,"offsetInEndSection":747,"text":" the main gender differences in psychiatric disorders, such as psychosis, depression, anxiety and cannabis use disorders, are enumerated. Subsequent","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1638,"document":"32135391","golden":false,"offsetInEndSection":1813,"text":"n poly-product than single-product cannabis use and greater for externalizing-type than internalizing-type psychiatric problems. Practitioners, policy makers, and scientists s","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":249,"document":"19693792","golden":false,"offsetInEndSection":648,"text":"of anxiety. Aims of the present study were to review the nature of the relationship between cannabis use and anxiety, as well as the possible clinical, diagnostic and causal implications.METHOD: Systematic review of the Medline, PsycLIT and EMBASE literature.RESULTS: Frequent cannabis users consistently have a high prevalence of anxiety disorders and patients with anxiety disorders have relativel","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":244,"document":"33658953","golden":false,"offsetInEndSection":515,"text":"Cannabis-related mental health adverse events precipitating Emergency Department (ED) or Emergency Medical Services presentations can include anxiety, suicidal thoughts, psychotic or attenuated psychotic symptoms, and can account for 25-30% of cannabis-related ED visits.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":459,"document":"8912803","golden":false,"offsetInEndSection":598,"text":"The most common physical or mental health problems, experienced by 22% of users were acute anxiety or panic attacks following cannabis use.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":753,"document":"19693792","golden":false,"offsetInEndSection":981,"text":"g-lasting anxiety disorders. Many hypotheses have been proposed in an attempt to explain these relationships, including neurobiological, environmental and social influences.CONCLUSIONS: The precise relationship between cannabis ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":649,"document":"19693792","golden":false,"offsetInEndSection":752,"text":" high rates of cannabis use. However, it is unclear if cannabis use increases the risk of developing lo","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":105,"document":"19693792","golden":false,"offsetInEndSection":248,"text":"nnabis use. Understanding the relationship between cannabis and anxiety may clarify the mechanism of action of cannabis and the pathophysiology","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":647,"document":"38092565","golden":false,"offsetInEndSection":745,"text":"dependent, and 2.1% cocaine/crack dependent. 37.8% have a current mood disorder, 47.6% have a curr","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1121,"document":"38092565","golden":false,"offsetInEndSection":1235,"text":"ifetime (odds ratio [OR]?\u003d?5.48; p?\u003c?10-3 ). The vast majority of women suffering from PTSD report having been sex","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1106,"document":"15816011","golden":false,"offsetInEndSection":1221,"text":"In conclusion, moderate cannabis use may help to ameliorate or mask MDMA-induced aggressivity and somatic symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":746,"document":"38092565","golden":false,"offsetInEndSection":961,"text":"nt anxiety disorder, and 8.8% are psychotic. Women suffer significantly more often than men from major depressive episodes, dysthymia, agoraphobia, social phobia, generalized anxiety disorder and posttraumatic stres","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":962,"document":"38092565","golden":false,"offsetInEndSection":1120,"text":" disorder (PTSD), both current and lifetime. Logistic regression shows that women have a significantly higher risk than men of suffering from PTSD over their ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1236,"document":"38092565","golden":true,"offsetInEndSection":1646,"text":"ally assaulted in the course of their lives. In addition, women are at greater risk of cannabis dependence (OR?\u003d?3.87; p?\u003c?.05) for lower cannabis consumption (grams smoked per week) (OR?\u003d?0.96; p?\u003c?.05).DISCUSSION AND CONCLUSIONS: French women heavy cannabis users are particularly at risk of PTSD?and are more likely than men to be dependent despite consuming fewer.SCIENTIFIC SIGNIFICANCE: Further studies a","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38092565","golden":false,"offsetInEndSection":84,"text":"Greater vulnerability to cannabis dependence among heavy cannabis user French women.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":589,"document":"23487279","golden":false,"offsetInEndSection":677,"text":"A younger age of initiation on alcohol use was associated with the presence of some SUD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":406,"document":"23487279","golden":false,"offsetInEndSection":547,"text":"Only 28% of the participants did not present any psychiatric disorder; while 65% had some SUD, the most common related to cannabis use (62%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1300,"document":"37601084","golden":false,"offsetInEndSection":1554,"text":"We use this case to provide the symptomatology and treatment of CIP secondary to cannabis pen use, as well as more broadly discuss the potential implications of cannabis vaping on adolescent neurodevelopment, substance use, and psychiatric comorbidities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1337,"document":"20427249","golden":false,"offsetInEndSection":1464,"text":"in the number of patients in specific time-periods. The medical consultations were mainly related to alterations in the level o","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1080,"document":"29678279","golden":true,"offsetInEndSection":1211,"text":"Studies report long-term cannabis exposure has been linked to psychiatric disorders, such as anxiety, psychotic and mood disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1395,"document":"37252542","golden":true,"offsetInEndSection":1712,"text":"Compared to patients presenting with other forms of cannabis toxicity, those with anxiety were likelier to be younger, ingested edible cannabis, had psychiatric comorbidities, or had a history of polysubstance abuse.CONCLUSIONS: Cannabis-induced anxiety occurred in 17.3% of ED patients in this community-based study.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":973,"document":"29678279","golden":true,"offsetInEndSection":1079,"text":"Cessation of cannabis use in individuals who are tolerant and dependent can lead to a withdrawal syndrome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1212,"document":"29678279","golden":true,"offsetInEndSection":1547,"text":"Limitations to the existing evidence notwithstanding, the plausibility of a causal relationship between cannabinoid exposure and persistent negative psychiatric outcomes, and the potential for long-term brain changes by regular exposure, especially for adolescents, are sufficient to warrant discussions with clinicians and the public.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":423,"document":"34039454","golden":true,"offsetInEndSection":726,"text":"We argue that while the biological mechanisms underlying individual susceptibility to develop a psychotic disorder following heavy cannabis use are still unknown, heavy cannabis use remains the most modifiable risk factor for the onset of psychotic disorders and for its clinical and functional outcome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":569,"document":"29678279","golden":false,"offsetInEndSection":766,"text":"Generally, in healthy individuals, the acute negative psychiatric effects of cannabinoids are rated as milder in severity compared with those in individuals with pre-existing psychiatric disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32832129","golden":false,"offsetInEndSection":171,"text":"BACKGROUND: Substance use disorders (SUDs) occur frequently in patients with psychotic disorders and have been associated with various demographic and clinical correlates.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":735,"document":"36135314","golden":true,"offsetInEndSection":939,"text":"Cannabis usage and CUD have also been linked to an increased risk of psychiatric disorders and Reward Deficiency Syndrome (RDS) subsets like schizophrenia, depression, anxiety, and substance use disorder.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":414,"document":"29678279","golden":true,"offsetInEndSection":568,"text":"Cannabinoids produce multiphasic and dose-dependent effects on anxiety, mood, and perception, in addition to impairing cognition and psychomotor function.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1692,"document":"37882050","golden":false,"offsetInEndSection":1885,"text":"Despite uncertainty surrounding cannabis\u0027 causal association with psychotic disorders, cautious attempts to reduce acute psychosis risk may benefit CHR-P individuals uninterested in abstinence.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1500,"document":"32744296","golden":false,"offsetInEndSection":1946,"text":"Cannabis consumption was associated with mental disorder admissions (OR: 3.16, p\u003c0.001), opioid consumption was associated with hepatic disorder admission (OR:2.16, p\u003c0.001) and cardiovascular admissions (OR: 1,78, p\u003c0.001), and cocaine was associated with cardiovascular admissions (OR:1,55, p:\u003c0.001).CONCLUSIONS: Mental disorders result to be the leading cause of hospitalization among drug-addicts, principally associated with cannabis abuse.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1574,"document":"37304435","golden":false,"offsetInEndSection":1763,"text":"This review outlines what the most common adverse events related to mental health with cannabis use are; as well as noting the most concerning but much rarer events that have been reported.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1462,"document":"37841549","golden":true,"offsetInEndSection":1707,"text":"The most commonly associated diagnosis was substance-induced psychosis.Conclusions: Cannabis use in individuals with mental illness is more common in males and an early age of initiation was linked to earlier age of onset of psychiatric illness.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37304435","golden":false,"offsetInEndSection":175,"text":"We have previously reviewed the types and numbers of cannabis-associated adverse events that have mental health presentations that are encountered in the Emergency Department.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23592072","golden":false,"offsetInEndSection":214,"text":"OBJECTIVES: Cannabis use has been associated to a wide variety of mental disorders, the possible causal role of this use in the etiology of severe mental disorders as schizophrenia or bipolar disorder standing out.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1633,"document":"23592072","golden":true,"offsetInEndSection":1823,"text":"The presence of these mental disorders was significantly associated to a lower age at initiation of cannabis use.CONCLUSIONS: Dual pathology is very high in cannabis addicts under treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1473,"document":"37304435","golden":false,"offsetInEndSection":1573,"text":"The evidence that cannabis use can adversely impact genders and sexes differently is also discussed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1383,"document":"32372364","golden":true,"offsetInEndSection":1603,"text":"Hypnotic consumption, psychiatric follow-up, and history of sexual assault were identified as factors associated specifically with CUD, suggesting that these factors were associated with more severe cannabis consumption.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1146,"document":"21204913","golden":false,"offsetInEndSection":1471,"text":"We estimated that in 2007 the incidence of cannabis-related AEs in the Midi-Pyrenees region ranged from 1.2 per 1000 regular cannabis users (95% confidence interval (CI) 0.7, 1.6) to 3.2 (95% CI 2.5, 3.9).CONCLUSIONS: Cannabis use is associated with complications, considered to be serious since they lead to hospitalization.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37141480","golden":false,"offsetInEndSection":383,"text":"INTRODUCTION: Catatonia is a syndrome of primarily psychomotor disturbances most common in psychiatric mood disorders but that also rarely has been described in association with cannabis use.CASE PRESENTATION: A 15-year-old White male presented with left leg weakness, altered mental status, and chest pain, which then progressed to global weakness, minimal speech, and a fixed gaze.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":384,"document":"37141480","golden":true,"offsetInEndSection":701,"text":"After ruling out organic causes of his symptoms, cannabis-induced catatonia was suspected, and the patient responded immediately and completely to lorazepam administration.DISCUSSION: Cannabis-induced catatonia has been described in several case reports worldwide, with a wide range and duration of symptoms reported.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":702,"document":"37141480","golden":true,"offsetInEndSection":1086,"text":"There is little known about the risk factors, treatment, and prognosis of cannabis-induced catatonia.CONCLUSIONS: This report emphasizes the importance of clinicians maintaining a high index of suspicion to accurately diagnose and treat cannabis-induced neuropsychiatric conditions, which is especially important as the use of high-potency cannabis products in young people increases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1625,"document":"37529155","golden":false,"offsetInEndSection":1807,"text":"Conclusions: Formulations of cannabis significantly improved anxiety, depression, fatigue, and the ability to participate in social activities in participants with anxiety disorders.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37141480","golden":false,"offsetInEndSection":64,"text":"Cannabis-Induced Catatonia in a 15-Year-Old Male: A Case Report.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1289,"document":"38147055","golden":false,"offsetInEndSection":1716,"text":"Covariate specification curve analyses indicated that within-pair effects on tobacco and illicit drug use, but not cannabis use disorder, attenuated substantially when covarying for lifetime alcohol and tobacco use.CONCLUSIONS: The cotwin control results suggest that more frequent cannabis use causes small increases in cannabis use disorder symptoms, approximately 1.3 symptoms when going from a once-a-year use to daily use.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":175,"document":"32441004","golden":false,"offsetInEndSection":481,"text":"This review examines the literature relating to pre-gestational and prenatal cannabinoid exposure and its effect on genes and molecular pathways related to the development of psychiatric disease.RECENT FINDINGS: Developmental cannabis exposure alters epigenetic processes with functional gene consequences.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1293,"document":"37427882","golden":false,"offsetInEndSection":1434,"text":"In conclusion, the literature supports the cannabis-suicidality association in recreational use but considers cannabidiol safe for treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1989,"document":"37217977","golden":false,"offsetInEndSection":2316,"text":"The overall prevalence of AEs reported for cannabis and delta-8-THC on FAERS were also similar when analyzed by system organ class (Pearson\u0027s r?\u003d?0.88).CONCLUSIONS: The findings of this case series suggest that most of the adverse events reported by delta-8-THC users are like those reported during acute cannabis intoxication.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1175,"document":"33156704","golden":false,"offsetInEndSection":1428,"text":"Where the compounds could be identified, the majority of events involved AB-FUBINACA (n?\u003d?18), 5?F-PB-22 (n?\u003d?17), and PB-22 (n?\u003d?6).CONCLUSIONS: This study found that young, male and European populations frequently were involved in SCRA adverse events.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":314,"document":"33156704","golden":false,"offsetInEndSection":497,"text":"The purpose of this study was to investigate adverse reactions associated with SCRA reported to the NZPhvC.METHODS: The NZPhvC database was searched for adverse events involving SCRA.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1492,"document":"33156704","golden":false,"offsetInEndSection":1631,"text":"Psychiatric reactions were of clinical significance, and possibly correlated to the high potency and efficacy of SCRA compared to cannabis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1666,"document":"36541815","golden":false,"offsetInEndSection":2044,"text":"Sleep complaints were associated with increased risk of incident psychiatric disorders, independent of sociodemographic and clinical characteristics.Conclusions: These findings suggest that sleep complaints should be clinically assessed in all psychiatric disorders, as these prodromal symptoms might constitute transdiagnostic biomarkers and therapeutic targets for prevention.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33156704","golden":false,"offsetInEndSection":122,"text":"INTRODUCTION: Synthetic Cannabinoid Receptor Agonists (SCRA) were legally available in New Zealand (NZ) prior to May 2014.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1253,"document":"32371364","golden":false,"offsetInEndSection":1324,"text":"SUD appears to be a significant predictor of NSSI in patients with SSD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":660,"document":"36541815","golden":false,"offsetInEndSection":1100,"text":"The analyses adjusted for sociodemographic and clinical characteristics, including sedative or tranquilizer use.Results: Among participants with MDE at Wave 1, 3-year incidence rates were dysthymia?\u003d?2.9%, general anxiety disorder?\u003d?8.2%, panic disorder?\u003d?3.4%, social anxiety disorder?\u003d?4.0%, specific phobia?\u003d?3.0%, alcohol use disorder?\u003d?8.1%, nicotine dependence?\u003d?6.2%, cannabis use disorder?\u003d?2.7%, and other drug use disorder?\u003d?4.9%.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":964,"document":"33156704","golden":false,"offsetInEndSection":1174,"text":"There were a total of 327 reactions recorded in these cases, and the majority were psychiatric (52%, n?\u003d?170), followed by nervous system (11%, n?\u003d?35), alimentary (7%, n?\u003d?24), and cardiovascular (7%, n?\u003d?23).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1429,"document":"33156704","golden":false,"offsetInEndSection":1491,"text":"A disproportionate number of M?ori were present in this group.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":660,"document":"32371364","golden":false,"offsetInEndSection":800,"text":"SUD was found to be related to NSSI in patients with SSD, and it was associated with an approximately fourfold increase in the risk of NSSI.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":958,"document":"36043688","golden":true,"offsetInEndSection":1520,"text":"After adjusting for parental psychiatric disorder, baseline emotional and behavioural problems, demographic factors and other substance use, using cannabis five or more times was associated with increased risk of anxiety disorders (hazard ratio 2.01, 95% CI 1.15-3.82), and using cannabis once (hazard ratio 1.93, 95% CI 1.30-2.87) or two to four times (hazard ratio 2.02, 95% CI 1.24-3.31) was associated with increased risk of depression.CONCLUSIONS: Cannabis use in adolescence was associated with an increased risk of future depression and anxiety disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1155,"document":"38086211","golden":false,"offsetInEndSection":1659,"text":"Participants with an ICD-10 cannabis code had a significantly greater risk of major depressive disorder (OR?\u003d?10.68, p?\u003c?0.0001) and any anxiety disorder (OR?\u003d?6.45, p?\u003c?0.0001), as well as specific anxiety or trauma-related disorders (e.g., generalized anxiety disorder, PTSD) and SUDs (ORs 2.72 - 16.00, p?\u003c?0.01 for all).CONCLUSIONS: Over a two-year period, diverse adults age 50?+?in Hawai\u0027i with ICD-10 cannabis codes experienced higher rates of subsequent psychiatric and SUDs compared to controls.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":763,"document":"38288007","golden":false,"offsetInEndSection":1016,"text":"Five randomized controlled trials examined the effects of therapeutic interventions in youth with common psychiatric disorders who used cannabis, including two studies on depression, one on bipolar disorder, one on anxiety and one on PTSD were reviewed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1051,"document":"38113810","golden":false,"offsetInEndSection":1294,"text":"In ARMS individuals, cannabis use was significantly related to disorganization symptoms.CONCLUSION: The results of this study suggest that cannabis plays a role in the psychopathology of ARMS individuals, leading to more severe symptomatology.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1351,"document":"38299647","golden":false,"offsetInEndSection":1532,"text":"Conversion rates to schizophrenia or bipolar disorder can be as high as one in three individuals, with cannabis users and those with early-onset substance abuse at the highest risk.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37280059","golden":true,"offsetInEndSection":290,"text":"AIM: Rates of cannabis use are elevated in early psychosis populations, rendering it difficult to determine if an episode of psychosis is related to cannabis use (e.g., cannabis-induced psychosis), or if substance use is co-occurring with a primary psychotic disorder (e.g., schizophrenia).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1412,"document":"32818918","golden":false,"offsetInEndSection":1511,"text":"Results suggest inflammatory alterations among psychotic individuals with comorbid cannabinoid use.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1482,"document":"37409875","golden":false,"offsetInEndSection":1887,"text":"Different conditions exacerbated by TND include acute alcoholic intoxication (OR?\u003d?11.4, p?\u003c?0.001), opioid use disorder (OR?\u003d?7.6, p?\u003c?0.001), schizoaffective disorder (OR?\u003d?7.4, p?\u003c?0.001), and cannabis use disorder (OR?\u003d?6.3, p?\u003c?0.001).CONCLUSIONS: Our findings reveal a strong association between TND and an increased risk of substance use disorder and mental health conditions among cancer patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":732,"document":"38299647","golden":false,"offsetInEndSection":882,"text":"Episodes of self-harm after substance-induced psychosis are strongly linked to an elevated likelihood of developing schizophrenia or bipolar disorder.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38299647","golden":false,"offsetInEndSection":137,"text":"Substance-induced psychosis is a secondary psychotic disorder resulting from drug abuse, characterized by one or more psychotic episodes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":536,"document":"38299647","golden":false,"offsetInEndSection":731,"text":"Substance-induced psychosis is strongly associated with the emergence of bipolar illness or schizophrenia spectrum disorder, with an increased chance of developing schizophrenia at a younger age.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":138,"document":"38299647","golden":false,"offsetInEndSection":309,"text":"Drug-induced psychosis is expected to resolve after a 30-day period of sobriety, however, individuals with this condition are more likely to develop severe drug addiction.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38299647","golden":false,"offsetInEndSection":32,"text":"Managing drug-induced psychosis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1496,"document":"37280059","golden":false,"offsetInEndSection":1833,"text":"There were no significant differences between groups on psychiatric symptoms, premorbid intellectual functioning, or problems related to cannabis use.CONCLUSIONS: In early stages of illness, reliance on traditional diagnostic tools or clinical interviews may be insufficient to distinguish between cannabis-induced and primary psychosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38299652","golden":false,"offsetInEndSection":108,"text":"Currently, few treatments are available for craving in general, and none of them have received approval for ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38299647","golden":false,"offsetInEndSection":136,"text":"Substance-induced psychosis is a secondary psychotic disorder resulting from drug abuse, characterized by one or more psychotic episodes","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38299044","golden":false,"offsetInEndSection":138,"text":"Background: Individual Placement and Support (IPS) is a specialist intervention to help people attain employment in the open competitive l","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":282,"document":"38288007","golden":false,"offsetInEndSection":470,"text":"This systematic review aimed to appraise the current evidence on integrated treatment for adolescents and young adults with common psychiatric disorders who engage in regular cannabis use.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":784,"document":"35254241","golden":false,"offsetInEndSection":1240,"text":"Relations between profile membership, cumulative ACEs, and demographic covariates were then evaluated.RESULTS: Results indicated four distinct profiles of psychiatric symptom comorbidity (PSC): (a) PTSD dominant with elevated illicit drug and cannabis use; (b) anxiety and depression dominant with elevated use across substances; (c) avoidance dominant with low severity of all other psychiatric symptoms and substance use; and (d) psychiatrically healthy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1066,"document":"38288007","golden":false,"offsetInEndSection":1262,"text":"Overall, there is a paucity of research on the treatment of comorbid adolescent mental health disorders and cannabis use, which limits the ability to draw evidence-based treatment recommendations.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1039,"document":"36040711","golden":false,"offsetInEndSection":1247,"text":"Our data reinforced the harmful effects of the HC diet\u0027s chronic consumption on compulsive and anxious behaviors and the potential of CBD as a drug treatment for psychiatric disorders associated with obesity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1386,"document":"32351740","golden":false,"offsetInEndSection":1760,"text":"Positive outcomes were more common among women, older respondents, those with higher levels of social support, and those who had never had major depressive disorder or generalized anxiety disorder.CONCLUSION: Although many Canadians with a history of cannabis dependence achieve remission and a large minority are truly resilient and achieve PMH, many are failing to thrive.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38288007","golden":false,"offsetInEndSection":281,"text":"Given the risks to mental health associated with cannabis use in youth and the increase in cannabis legalization worldwide and in the U.S., there is a need to understand existing evidence-based approaches to integrated management of psychiatric disorders in youth who use cannabis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1612,"document":"32322678","golden":false,"offsetInEndSection":1729,"text":"Conclusions: The perception of postoperative CDMP therapy was overwhelmingly positive in this West London population.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38288007","golden":false,"offsetInEndSection":108,"text":"A systematic review of evidence on integrated management of psychiatric disorders in youth who use cannabis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":904,"document":"36040711","golden":false,"offsetInEndSection":1038,"text":"The sub-chronic, but not acute, treatment with CBD attenuated the compulsive-like and anxiogenic-like behavior induced by the HC diet.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":906,"document":"18279244","golden":false,"offsetInEndSection":1226,"text":"The increases in average THC content and relative popularity of sinsemilla cannabis, combined with the absence of the anti-psychotic cannabinoid CBD, suggest that the current trends in cannabis use pose an increasing risk to those users susceptible to the harmful psychological effects associated with high doses of THC.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25082422","golden":false,"offsetInEndSection":115,"text":"INTRODUCTION: Regular cannabis use is associated with negative mental health impacts including psychosis, depressio","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1306,"document":"25320613","golden":false,"offsetInEndSection":1440,"text":"e adult and homeless youth.CONCLUSION: Homeless youth have high rates of physical and psychiatric comorbidity, similar to the adult ho","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":978,"document":"24137134","golden":false,"offsetInEndSection":1237,"text":"Most recreational users will never be faced with such persistent mental illness, but in some individuals cannabis use leads to undesirable effects: cognitive impairment, anxiety, paranoia, and increased risks of developing chronic psychosis or drug addiction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1384,"document":"18768298","golden":false,"offsetInEndSection":1554,"text":"in the ADHD group (p\u003d0.07).CONCLUSIONS: The findings support the view that young people at genetic high risk for schizophrenia are particularly vulnerable to mental healt","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":435,"document":"22664772","golden":true,"offsetInEndSection":648,"text":"Accounting for selection into cannabis use and shared frailties in mental and physical health, the results suggest that cannabis use reduces the mental wellbeing of men and women and the physical wellbeing of men.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":95,"document":"16636640","golden":false,"offsetInEndSection":267,"text":"zophrenia. We tested the hypothesis that cannabis use increases the likelihood of psychosis-like experiences in non-clinical participants who scored highly on a measure of ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1175,"document":"16636640","golden":false,"offsetInEndSection":1290,"text":"f use, and unpleasant after-effects. Our results are consistent with the hypothesis that cannabis use is a risk fac","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1185,"document":"36045802","golden":true,"offsetInEndSection":1385,"text":"he participants, p?\u003e?0.05.Conclusion: Due to the higher frequency of anxiety and depression disorders in cannabis users in this study compared to the general population, cannabis use is likely to be a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38358665","golden":false,"offsetInEndSection":231,"text":"Prenatal tobacco exposure (PTE) and tobacco-cannabis coexposure (PTCE) co-occur with negative maternal emotional functioning (termed prenatal risks) and together increase risk for child regulatory problems at early school age (ESA)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":805,"document":"38358657","golden":false,"offsetInEndSection":962,"text":" was associated with a greater likelihood of same-occasion co-use in the continuation phase but not the initiation phase, compared to no use (OR \u003d 1.48,95% C","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":276,"document":"38358656","golden":false,"offsetInEndSection":612,"text":"In the present preregistered study, we examined the associations among three different forms of resilience factors (i.e., general social support, lesbian, gay, bisexual, transgender, and queer (LGBTQ)-identity affirmation, LGBTQ community involvement) and alcohol, nicotine, and cannabis use, as well as on positive and negative affect.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":13,"document":"38358335","golden":false,"offsetInEndSection":110,"text":" Studies indicate that ?7% of pregnant individuals in North America consume cannabis in pregnancy","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":154,"document":"38358093","golden":false,"offsetInEndSection":267,"text":"Cannabidiol (CBD), a bioactive compound found in Cannabis sativa, is endowed with many pharmacological activities","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":11,"document":"38357583","golden":false,"offsetInEndSection":164,"text":"Synthetic cannabinoids (SCs), a class of psychoactive compounds emulating the effects of natural cannabis, have prompted addiction and psychosis concerns","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":841,"document":"38357179","golden":false,"offsetInEndSection":967,"text":"The commonly used substances were alcohol (90.5%; n\u003d172), cannabis/marijuana (43.7%; n\u003d83), prescription opioids (28.9%; n\u003d55)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38357050","golden":false,"offsetInEndSection":111,"text":"Blastomycosis is an endemic mycotic infection caused by inhalation of thermally dimorphic fungi from the genus ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38356586","golden":false,"offsetInEndSection":71,"text":"CBD is the primary noneuphorizing and nonaddictive compound of cannabis","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38355787","golden":false,"offsetInEndSection":101,"text":"Individuals suffering from chronic pain develop substance use disorders (SUDs) more often than others","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"38340534","golden":false,"offsetInEndSection":220,"text":"Few population-based data sources fully recognise the intersections between stressful events, social health issues, and cannabis use in pregnancy, and little is known about sequelae for women\u0027s mental health.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":568,"document":"38330353","golden":false,"offsetInEndSection":705,"text":"ompleted 60 days of EMA, consisting of four daily reports spanning 7 a.m.-11 p.m. assessing current negative affect and alcohol/cannabis ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2742,"document":"38277146","golden":false,"offsetInEndSection":2844,"text":"Higher use patterns were associated with symptoms of physical dependence (eg, withdrawal or tolerance)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":525,"document":"38246028","golden":false,"offsetInEndSection":723,"text":"Patients were further assessed via the Brief Psychiatric Rating Scale, Brief Negative Symptom Scale, Digit Symbol and Digit Substitution tasks, use of cannabis and tobacco, and stressful life events","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":353,"document":"38115193","golden":true,"offsetInEndSection":526,"text":"Leaders in psychiatry and other medical specialties have sounded the alarm about the marketing and sale of cannabis products for medical uses without prior review by the FDA","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":312,"document":"38105651","golden":false,"offsetInEndSection":435,"text":" drug. Participants received up to 3 mL of MediCabilis 5% CBD Oil (50 mg CBD/mL, \u003c2 mg delta-9-tetrahydrocannabinol (THC)/m","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1133,"document":"38104420","golden":true,"offsetInEndSection":1326,"text":"Many contextual aspects of cannabis use settings predicted an increased likelihood of alcohol and cannabis co-use, while few contextual aspects of drinking settings were associated with co-use.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1368,"document":"38100655","golden":false,"offsetInEndSection":1474,"text":"Three patients (4.5%) experienced minor, reversible adverse events potentially related to medical cannabis","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1615,"document":"30392700","golden":false,"offsetInEndSection":2009,"text":"Sixty-four per cent of the subjects were diagnosed \"disorders related to the use of PAS\", 14% as neurotic disorders, 9% as schizophrenia and 5% as of the mood disorders.CONCLUSION: This study identified a significant number of potentially reportable cases to the French Addictovigilance Network and demonstrated the interest of investigating cases of abuse/dependence in a psychiatric hospital.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"19319174","golden":false,"offsetInEndSection":61,"text":"Cannabinoid hyperemesis presenting to a New Zealand hospital.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":239,"document":"19319174","golden":false,"offsetInEndSection":416,"text":"Cannabinoid hyperemesis with abnormal bathing behaviour is a syndrome of episodic cyclic vomiting, often associated with relief being obtained by hot water bathing or showering.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":955,"document":"22425410","golden":false,"offsetInEndSection":1268,"text":"The cannabis and binge drinking groups did not show differences in the psychopathological symptoms evaluated.CONCLUSIONS: Our observations of this population of non-dependent drug users are consistent with the increased impulsivity traits and behaviors that have been described previously in chronic drug abusers.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":637,"document":"19319174","golden":false,"offsetInEndSection":875,"text":"Although there have been limited reports in the medical literature, it is likely that the syndrome is commoner than previously recognised and the presentation could easily be confused with psychiatric illness or cyclic vomiting syndromes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":128,"document":"22425410","golden":true,"offsetInEndSection":699,"text":"Impulsivity and several psychopathological signs are increased in chronic drug users, but the implications of recreational use are still poorly understood.METHODS: We evaluated impulsivity, sensation-seeking traits, impulsive decision-making, inhibitory control and possible symptoms of depression, anxiety and psychosis in three groups of young university adults: recreational cannabis users (N\u003d20), alcohol binge drinkers (N\u003d22) and non-drug users (N\u003d26).RESULTS: The cannabis and binge drinking groups had increased scores for impulsivity and sensation-seeking traits.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":137,"document":"19319174","golden":false,"offsetInEndSection":238,"text":"We report an unusual complication of chronic cannabis use which has recently been described overseas.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":473,"document":"19319174","golden":false,"offsetInEndSection":565,"text":"The proposed mechanism of the syndrome is accumulation of cannabis metabolites in the brain.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":117,"document":"27612527","golden":true,"offsetInEndSection":691,"text":"The consequences of cannabis use are not clearly understood and remain a concern.OBJECTIVES: To review the acute and persistent effects of cannabis use and associations with psychiatric disorders.METHODS: Using Pubmed and PsychInfo, we conducted a narrative review of the literature on cannabis and psychiatric comorbidity using the keywords cannab*, marijuana, schizo*, psychosis, mood, depression, mania, bipolar, and anxiety.RESULTS: There is substantial evidence of cannabis use leading to other illicit drug use and of an association between cannabis use and psychosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":417,"document":"19319174","golden":false,"offsetInEndSection":472,"text":"Underlying the disorder is the chronic use of cannabis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"22425410","golden":false,"offsetInEndSection":127,"text":"BACKGROUND: Recreational cannabis use and alcohol binge drinking are the most common drug consumption patterns in young adults.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1264,"document":"23200103","golden":false,"offsetInEndSection":1631,"text":"Of these risk factors, regular alcohol use, cigarette smoking, hard drug use, frequent truancy, an unfavourable school evaluation and frequent absence due to illness were also associated with cannabis use.CONCLUSIONS: The association between cannabis use and poor psychosocial functioning in adolescence is due, at least in part, to confounding by other risk factors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1509,"document":"22425410","golden":false,"offsetInEndSection":1650,"text":"These results suggest that impulsivity traits and behaviors are present not only in chronic drug abusers but also in recreational drug users.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23200103","golden":false,"offsetInEndSection":241,"text":"BACKGROUND: Although the association between cannabis use and a wide range of psychiatric symptoms is fairly well established, it is not clear whether cannabis use is also a risk factor for general mental health problems at secondary school.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1269,"document":"22425410","golden":true,"offsetInEndSection":1429,"text":"In this study, compared to no drug use, the recreational use of cannabis was associated with a major dysfunction of the different facets of impulsive behaviors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1430,"document":"22425410","golden":false,"offsetInEndSection":1508,"text":"However, alcohol binge drinking was related only to impulsive decision-making.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":303,"document":"27804883","golden":false,"offsetInEndSection":852,"text":"Cannabis is widely used to self-medicate by older people and people with brain disorders such as amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), Alzheimer\u0027s disease (AD), Parkinson\u0027s disease (PD), bipolar disorder, and schizophrenia.OBJECTIVE: This review provides an overview of the perceived benefits and adverse mental health effects of cannabis use in people with ALS, MS, AD, PD, bipolar disorder, and schizophrenia.RESULTS: The reviewed studies indicate that cannabis use diminishes some symptoms associated with these disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1268,"document":"37702087","golden":false,"offsetInEndSection":1613,"text":"Patients in the premorbid group initiated cannabis use at an earlier age, experienced the first comorbid psychiatric episode earlier, and were hospitalized earlier than those in the non- premorbid ACE-SEI-ND group.CONCLUSIONS: PreCUD-onset ACE, SEI, or ND conditions in individuals with CUDare linked to earlier onset of comorbid mental illness.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":212,"document":"35509728","golden":false,"offsetInEndSection":464,"text":"In this case of a young adult with a typical age of onset for psychotic symptoms also presenting with cannabis use, excessive vaping, history of COVID-19 illness, pineal cyst, and extreme elevation of blood pressure, the diagnostic certainty decreases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":465,"document":"35509728","golden":true,"offsetInEndSection":622,"text":"Increased risk of progression to schizophrenia in individuals with cannabis use disorder and genetic loading has been extensively reported in the literature.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35509728","golden":false,"offsetInEndSection":211,"text":"First break psychosis in young adults is sometimes presented as a dichotomous model of organic or substance-induced etiology?or a primary psychiatric disorder on the schizophrenia spectrum and related disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37971872","golden":false,"offsetInEndSection":184,"text":"Introduction: Cannabis use is common in people with psychotic disorders and is associated with the exacerbation of symptoms, poor treatment adherence, and an increased risk of relapse.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":747,"document":"35509728","golden":false,"offsetInEndSection":1015,"text":"For the clinicians acutely managing such patients facing these exact questions of unknown certainty in progression to full-blown schizophrenia, we highlight a case of severe acute psychosis and complete recovery on a first-generation antipsychotic and mood stabilizer.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":623,"document":"35509728","golden":false,"offsetInEndSection":746,"text":"Clinicians may face significant diagnostic and treatment challenges when managing a patient with severe psychotic symptoms.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"35509728","golden":false,"offsetInEndSection":118,"text":"Diagnostic Difficulties and Treatment Challenges of a Young Patient With Severe Acute Psychosis and Complete Recovery.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":2250,"document":"36186500","golden":false,"offsetInEndSection":2489,"text":"There was no significant impact of psychosis on the other parameters of course and outcome.CONCLUSION: Though psychotic symptoms are very common in BD, they are not always associated with an adverse impact on BD and its course and outcome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1385,"document":"38288087","golden":false,"offsetInEndSection":1552,"text":"Additionally, the implications of using CBD to manage psychiatric conditions such as psychosis, anxiety and fear, depression, and substance use disorders are explored.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1214,"document":"31284404","golden":false,"offsetInEndSection":1446,"text":"Cannabis use was seen significantly in adolescents (49.1%, 12-15 years), male (75.6%), and African Americans (45.6%).CONCLUSION: Conduct disorder inpatients have a higher risk of comorbid SUD compared to other psychiatric illnesses.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1033,"document":"30392700","golden":false,"offsetInEndSection":1380,"text":"Cases presenting the four criteria necessary for an addictovigilance notification: (1) identified notifier, (2) identified patient, (3) known consumed product (s) and (4) presence of an effect related to the abuse/dependence of PAS; were retained and analyzed.RESULTS: On an initial number of 252 cases, 82 cases of abuse/dependence were retained.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":491,"document":"30392700","golden":false,"offsetInEndSection":813,"text":"It aims, through a PMSI request, to identify the sociodemographic characteristics and psychiatric diagnoses of patients consuming psychoactive substances (PAS) and the PAS types consumed.METHODS: This is a retrospective observational study conducted over a nine-month period at the psychotherapeutic center of Nancy (CPN).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1495,"document":"30392700","golden":false,"offsetInEndSection":1614,"text":"Regarding drugs, the consumption of benzodiazepines, a predominantly female phenomenon, is observed in 34% of subjects.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1430,"document":"30392700","golden":false,"offsetInEndSection":1494,"text":"Cannabis (29%) and heroin (15%) are the most common illicit PAS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":769,"document":"30482948","golden":false,"offsetInEndSection":950,"text":"Significant genetic correlations were observed with 17 phenotypes, including schizophrenia, attention deficit-hyperactivity disorder, depression, and use of cigarettes and cannabis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":814,"document":"30392700","golden":false,"offsetInEndSection":1032,"text":"The codes used for the PMSI request are those of the international classification of diseases, tenth revision (ICD-10), codes F10 to F19 that characterize mental and behavioral disorders associated with the use of PAS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1987,"document":"38353645","golden":false,"offsetInEndSection":2093,"text":"experimental studies are needed to determine the causal effects of cannabis and cannabinoids in PTSD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38351841","golden":false,"offsetInEndSection":113,"text":"Use of both cannabis and synthetic cannabinoids has been regularly linked to the development of psychotic illness","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":954,"document":"38340400","golden":false,"offsetInEndSection":1159,"text":"The heavy cannabis and alcohol use class reported a significantly higher likelihood for any non-cannabis drug use at baseline and 24-months, as well as greater depression and physical ailments at 24-months","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1213,"document":"38336263","golden":false,"offsetInEndSection":1281,"text":"Opioid (27.9?%) and cannabis use disorders (29.6?%) were also common","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38335780","golden":false,"offsetInEndSection":117,"text":"Genetic contribution to the comorbidity between attention-deficit/hyperactivity disorder and substance use disorders.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1183,"document":"35571129","golden":false,"offsetInEndSection":1238,"text":"), underlining the importance of a medical supervision.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1099,"document":"34336561","golden":false,"offsetInEndSection":1362,"text":"Finally, most participants were not receiving evidence-based OCD treatment, and the odds of receiving treatment decreased with increased cannabis use.CONCLUSIONS: In this survey, participants with OCD reported both subjective benefits and harms from cannabis use.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36178356","golden":true,"offsetInEndSection":180,"text":"OBJECTIVE: Cannabis use disorder (CUD) is associated with an elevated risk for psychiatric disorders and symptoms, contributing to poor health outcomes and increased medical costs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33568074","golden":false,"offsetInEndSection":135,"text":"BACKGROUND: Cannabis is the most prevalent illegal drug used and the second most common cause of ED drug-related complaints in the USA.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":917,"document":"35571129","golden":false,"offsetInEndSection":1183,"text":"This anarchic use keeps questioning particularly in terms of risks: consumption of street cannabis, drug-drug interactions with usual medical treatment, consideration of medical history, and adverse reactions (psychiatric, respiratory, cardiovascular disorders, etc.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":107,"document":"35571129","golden":false,"offsetInEndSection":440,"text":"As we know that the endocannabinoid system is largely involved in neurological disorders, we focused on the scientific rationale of medical cannabis in three neurological disorders: amyotrophic lateral sclerosis, Parkinson\u0027s disease, and Alzheimer\u0027s disease through pharmacological plausibility, clinical studies, and patients\u0027 view.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":644,"document":"35571129","golden":false,"offsetInEndSection":734,"text":"Some show benefits on motor symptoms and others on non-motor symptoms and quality of life.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1239,"document":"35571129","golden":false,"offsetInEndSection":1341,"text":"To date, most scientific data support the therapeutic potential of cannabis in neurological disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":735,"document":"35571129","golden":false,"offsetInEndSection":916,"text":"Concerning patients\u0027 view, several web surveys were collected, highlighting the real use of cannabis to relieve symptoms of neurological disorders, mostly outside a medical pathway.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":937,"document":"33568074","golden":false,"offsetInEndSection":1669,"text":"Once the six topic areas were identified, we undertook an extensive narrative literature review for each section of this paper using New PubMed and Cochrane Central Register of Controlled Trials from the inception of the databases to September 30, 2020.RESULTS: The six subject areas that were most frequently reported in the medical literature relevant to cannabis-related ED care were acute intoxication/overdose, pediatric exposure, cannabinoid hyperemesis syndrome, cannabis withdrawal, e-cigarette or vaping product use-associated lung injury (EVALI), and synthetic cannabinoids.CONCLUSION: As cannabis becomes more widely available with the adoption of state medical cannabis laws, ED-related cannabis visits will likely rise.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1437,"document":"24882185","golden":false,"offsetInEndSection":1688,"text":"Lack of controlled studies limiting definite conclusions about a putative causal relationship between cannabis and onset of mania.CONCLUSIONS: Further investigations are needed to clarify the relationships between cannabis use and first manic episode.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24882185","golden":false,"offsetInEndSection":91,"text":"BACKGROUND: Cannabis is the most commonly abused drug among patients with bipolar disorder.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1726,"document":"31647377","golden":false,"offsetInEndSection":1893,"text":"Conclusions: The evidence that heavy use of high-THC/low-CBD types of cannabis increases the risk of psychosis is sufficiently strong to merit public health education.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1052,"document":"36523702","golden":false,"offsetInEndSection":1241,"text":"However, recently she experienced two brief psychotic episodes with disorganized behavior and persecutory delusions, both episodes happening a week after?discontinuing cannabis consumption.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":442,"document":"24579344","golden":false,"offsetInEndSection":491,"text":"The panic attack is the most common complication.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":586,"document":"36192621","golden":false,"offsetInEndSection":792,"text":"Among the 175 maternal AEs, the most commons were psychiatric AEs experienced by 96 (64.9%) women, in particular cannabis use disorders (n?\u003d?89, 60.1%), dependence (n?\u003d?54, 36.5%) and abuse (n?\u003d?21, 14.2%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":161,"document":"28898309","golden":true,"offsetInEndSection":326,"text":"those that start with intoxication but persist beyond the removal of the drug (cognitive, psychotic and anxiety disorders) and the development of addictive behavior.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":586,"document":"21206788","golden":true,"offsetInEndSection":779,"text":"Current evidence indicates that there is a clinically significant association between cannabis use disorders and psychotic syndromes, depression, anxiety and possibly mild cognitive impairment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2292,"document":"36843769","golden":false,"offsetInEndSection":2512,"text":"In conclusion, cannabis-induced anxiety or panic disorders should be considered in patients with no prior psychiatric history presenting with anxiety-like attacks following a period of cannabis dependence or current use.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":377,"document":"38841675","golden":false,"offsetInEndSection":737,"text":"nderstood.Methods: A sample of regular cannabis consumers completed self-reported assessments for depression (Patient Health Questionnaire-9), anxiety (General Anxiety Disorder-7), Attention-Deficit/Hyperactivity Disorder (ADHD; Adult ADHD Self-Report Scale V1.1), and psychosis (Early Recognition Inventory based on IRAOS) as well as previous black-market can","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":67,"document":"38861239","golden":false,"offsetInEndSection":178,"text":"annabis exposure involves in many cases negative mental emotions, which are unpleasant sensations or thoughts. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2238,"document":"39656577","golden":false,"offsetInEndSection":2542,"text":"onclusion Although further studies, ideally longitudinal, are needed to confirm the deleterious effect of cannabis on excitement symptoms, the present study reiterates the importance of screening and managing consumption habits of drugs, particularly cannabis, in people with serious mental disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":913,"document":"33374666","golden":false,"offsetInEndSection":1082,"text":"es were addressed.RESULTS: A strong body of literature shows associations between cannabis use and CUD with other drug use, psychosis, mood disorders, anxiety disorders,","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":144,"document":"32896111","golden":false,"offsetInEndSection":531,"text":"se.METHODS: We examined clinical genetic factors, psychiatric disorders prior to cannabis use, starting age of cannabis use, duration and frequency of cannabis use, types of cannabis products used, combined use of other psychoactive substances, and the psychiatric diagnosis of 71 patients with cannabis-related psychiatric disorders who underwent treatment at nine mental health hospita","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1452,"document":"26567470","golden":false,"offsetInEndSection":1753,"text":"However, most presentations were not serious, typically involved young males with tachycardia (? 37-77%), agitation (? 16-41%) and nausea (? 13-94%) requiring only symptomatic care with a length of stay of less than 8 hours.CONCLUSIONS: SCs most frequently result in tachycardia, agitation and nausea.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":545,"document":"11157424","golden":false,"offsetInEndSection":749,"text":"Results and conclusions An appreciable proportion of cannabis users report short-lived adverse effects, including psychotic states following heavy consumption, and regular users are at risk of dependence.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":506,"document":"7659985","golden":false,"offsetInEndSection":596,"text":"Chronic use of cannabis has mainly psychic effects, and may lead to the amotival syndrome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"11157424","golden":false,"offsetInEndSection":152,"text":"BACKGROUND: Cannabis is commonly regarded as an innocuous drug and the prevalence of lifetime and regular use has increased in most developed countries.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":492,"document":"32676242","golden":false,"offsetInEndSection":616,"text":"With the legalization of marijuana, its use is on the rise leading to several mental health conditions, including catatonia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1279,"document":"39547825","golden":true,"offsetInEndSection":1629,"text":"Some of the AEs reported in addictovigilance surveys on non-medical cannabis and CBD were observed during the experimentation of medical cannabis such as cardiovascular AEs (myocardial infarction, strokes, transient ischemic attack), psychiatric AEs (suicidal idea and attempt, depression), worsening of epilepsy, cognitive and/or sedative disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1275,"document":"26621349","golden":false,"offsetInEndSection":1607,"text":"Heavy cannabis consumption was associated with more commission errors in the continuous performance task (CPT) (p?\u003d?.008) and more time to complete trail making test A (TMT-A) (p?\u003d?.008), compared to the group of medium users.CONCLUSIONS: Heavy cannabis consumption seems to impair verbal memory in first psychotic episode patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1770,"document":"22775447","golden":false,"offsetInEndSection":2197,"text":"Among weekly+ adolescent cannabis users, those who continued to use cannabis use daily at 29 years remained at significantly increased odds of anxiety disorder (adjusted OR 3.2, 95% CI: 1.1-9.2).CONCLUSIONS: Regular (particularly daily) adolescent cannabis use is associated consistently with anxiety, but not depressive disorder, in adolescence and late young adulthood, even among regular users who then cease using the drug.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2237,"document":"39656577","golden":false,"offsetInEndSection":2539,"text":"Conclusion Although further studies, ideally longitudinal, are needed to confirm the deleterious effect of cannabis on excitement symptoms, the present study reiterates the importance of screening and managing consumption habits of drugs, particularly cannabis, in people with serious mental disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2283,"document":"39547825","golden":false,"offsetInEndSection":2558,"text":"Adverse effects of interest will need to be monitored in particular, including neurological disorders (epilepsy exacerbation, cognitive disorders), psychiatric disorders (substance use disorder, suicidal behaviour), and cardiovascular disorders as well as any unexpected AEs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2157,"document":"34964921","golden":false,"offsetInEndSection":2432,"text":"In the 42 remaining cases, it was unclear if the positive result was due to unreported methamphetamine use or cross-reactivity.CONCLUSIONS: Most patients with reported methamphetamine use were young and male, with signs of sympathomimetic arousal and/or psychiatric symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2027,"document":"39244500","golden":false,"offsetInEndSection":2551,"text":"After evaluation by the two authors of the 160 articles identified, seven studies investigating the impact of the legalization of cannabis for recreational use on the risk of psychosis were included in this systematic literature review.RESULTS: Four of the studies showed no increase in the use of health services for psychosis following the legalization of cannabis for recreational use whereas three other studies highlighted a negative impact of the legalization of cannabis for recreational use on the risk of psychosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":434,"document":"39547825","golden":false,"offsetInEndSection":743,"text":"Data from addictovigilance and international literature on the risks associated with non-medical cannabis use have helped establish exclusion criteria for patients at risk of complications when using medical cannabis (such as those with psychotic disorders, severe cardiovascular, renal, or liver conditions).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":925,"document":"39547825","golden":false,"offsetInEndSection":1174,"text":"We aimed to present the contribution of the addictovigilance data regarding cannabis-related reports to the ongoing French experimentation on cannabis used for medical purposes, to anticipate potential adverse drug reactions in the treated patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1175,"document":"39547825","golden":false,"offsetInEndSection":1278,"text":"Among the 3164 patients included in the French experimentation, 1186 of them presented at least one AE.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":100,"document":"17245678","golden":false,"offsetInEndSection":250,"text":"nce events or raves. MDMA - or more commonly ecstasy -, amphetamines, especially methamphetamine, ketamine and newly also GHB (and analoga) are freque","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":150,"document":"35629112","golden":false,"offsetInEndSection":300,"text":"was conducted as part of the Psychological and Genetic Factors of Addictions study (n \u003d 3003) and aimed to investigate genetic overlaps between differ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":231,"document":"28794966","golden":false,"offsetInEndSection":963,"text":"imilar to natural cannabis, Synthetic Cannabinoid intoxication can present in several ways with the most common emergency room presentations to be of neurologic and psychiatric manifestation. The respiratory depressive effect of Synthetic Cannabinoids has not been well documented in medical literature. We report four patients admitted in the Intensive Care Unit with acute respiratory failure necessitating endotracheal intubation after use of Synthetic Cannabinoid. All patients had a reversal of respiratory failure in less than 24?h, three patients had a complicated course due to aspiration pneumonia. All four patients exhibited aggressive behavior, with two of them diagnosed with Bipolar Disorder and Cocaine Use Disorder. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36523702","golden":false,"offsetInEndSection":466,"text":"Cannabis use has been associated with several psychiatric comorbidities and there appears to be a dose-response relationship between the intensity and duration of its use and the risk of psychosis.?More commonly, acute episodes of cannabis induced-psychosis manifest immediately following exposure, are precipitated after the use of large amounts of cannabis, resolve with abstinence, and are of shorter duration than those observed with primary psychotic disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1333,"document":"22204498","golden":false,"offsetInEndSection":1593,"text":"to endorse DLE probe items.CONCLUSIONS: While cannabis use disorders have been previously linked with DLE, our findings linking alcohol and tobacco use and DLE suggest that the influence of these substances on psychosis-related outcomes warrants closer scrutin","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":443,"document":"38236224","golden":false,"offsetInEndSection":674,"text":"The present study characterized cannabis use among adults with BE and tested between-group and within-group relationships between cannabis use and eating disorder symptoms, alcohol consumption and symptoms, and depression symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1629,"document":"29891008","golden":false,"offsetInEndSection":1871,"text":"annabis use may have an effect in men. The impact of cannabis use in psychiatric disorders needs ongoing examination in light of its common use, impending legalization with expected increased access and the uncertainty about cannabis\u0027 effects","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":401,"document":"18847572","golden":false,"offsetInEndSection":561,"text":"Cannabis breeds, in international classifications of mental disorders, intoxication charts, abuse and dependence, although this last could have been challenged.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1604,"document":"28636769","golden":false,"offsetInEndSection":1754,"text":"The effects of cannabis on healthy populations and clinical psychiatric samples will be discussed, focusing primarily on anxiety and mood disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"29459327","golden":false,"offsetInEndSection":103,"text":"BACKGROUND: Tobacco and cannabis are highly co-morbid in the general population and in patients with sc","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":400,"document":"34794704","golden":false,"offsetInEndSection":525,"text":"Older adults are at increased risk of developing cannabis use disorder alongside other medical and psychiatric comorbidities.","beginSection":"abstract"}],"exact_answer":[["panic attack psychotic states dependence abuse cognitive disorders amotival syndrome anxiety disorder suicidal idea and attempt Hallucinogenic effects Stimulant effects Aggressive behavior Addictive behaviors Bipolar Disorder"]],"ideal_answer":["The most common psychiatric events associated with the consumption of cannabis include anxiety disorders, depressive disorders, psychotic disorders, psychosis, paranoia, cognitive impairment, mood disorders, exacerbation of existing psychiatric disorders, withdrawal syndrome, and increased risk of developing chronic psychosis. These events can range from acute adverse mental effects to long-term negative psychiatric outcomes, especially in vulnerable individuals. Cannabis use has been consistently linked to a higher prevalence of comorbid psychiatric conditions, learning and memory impairments, and a range of mental health issues that can have significant impacts on an individual\u0027s well-being and quality of life.","The most common psychiatric events associated with the consumption of cannabis include anxiety disorders, depressive disorders, psychosis, and exacerbation of psychotic disorders -- particularly in vulnerable individuals. Cannabis use can lead to acute adverse effects such as anxiety, paranoia, and psychosis. Chronic use of cannabis may result in mood disorders, an increase in depressive or manic episodes, and the development of cannabis use disorders. Additionally, there is an association between cannabis use and the onset of first mania at a younger age, as well as an increase in impulsivity and sensation-seeking traits. Cannabis disorders are classified under the DSM-IV and ICD-10 criteria and include intoxication, abuse, dependence, as well as cannabis-induced psychotic and anxiety disorders.","The most common psychiatric events associated with the consumption of cannabis are anxiety, depression, and psychotic disorders, which include a range of symptoms such as paranoia, exacerbation of manic episodes in those with affective psychoses, particularly bipolar disorder, and an increased likelihood of developing schizophrenia in vulnerable populations. Cannabis use can also lead to cannabis use disorders, characterized by cannabis intoxication, abuse, and dependence as defined by DSM-IV and ICD-10 criteria. Acute adverse effects include anxiety states, cognitive impairments, tachycardia, and orthostatic hypotension, while chronic effects may involve mood disorders, neurocognitive impairments, and exacerbation of psychotic disorders. Impulsivity and sensation-seeking traits have been observed in recreational cannabis users, which are not only common in chronic drug abusers but also present in those who consume cannabis recreationally.","The most common psychiatric events associated with the consumption of cannabis include anxiety disorders, depressive disorders, and psychotic disorders. These conditions can range from acute reactions such as anxiety or paranoia during intoxication to more chronic effects like depression and exacerbation of pre-existing psychotic symptoms in vulnerable individuals. Cannabis use has also been linked to an increased risk of developing schizophrenia and other psychoses, particularly among those with a genetic predisposition or existing mental health conditions. Additionally, cannabis withdrawal can cause irritability, anxiety, sleep disturbances, and in some cases, more severe psychiatric symptoms.","The most common psychiatric events associated with the consumption of cannabis include an increased risk for the development and exacerbation of psychotic disorders, such as schizophrenia, particularly in individuals with a pre-existing genetic predisposition. Cannabis use is also linked to first-episode psychosis, characterized by severe symptoms that can sometimes be managed with antipsychotics and mood stabilizers. It may lead to poor treatment adherence and an increased risk of relapse in individuals with psychotic disorders. Moreover, cannabis use can be involved in the onset of comorbid mental illnesses at an earlier age. While not all experiencing psychosis from cannabis will have a negative outcome on their overall mental health trajectory, these symptoms are cause for clinical concern and require careful management to prevent progression to more severe mental health conditions.","The most common psychiatric events associated with cannabis consumption include anxiety disorders, depressive disorders, psychotic disorders such as schizophrenia, and substance use disorders. Acute adverse effects can consist of anxiety, paranoia, and psychosis, which can manifest as an acute anxiety state or even paranoid episodes. Cannabis use is also linked to exacerbation of psychotic disorders in vulnerable individuals and can affect mood, leading to disorders like depression. Additionally, there is a significant association between cannabis use and the development or worsening of psychiatric conditions such as attention deficit-hyperactivity disorder and conduct disorders, especially in adolescents and young adults. Chronic effects of cannabis can lead to cannabis use disorders, withdrawal syndrome, and neurocognitive impairments.","The most common psychiatric events associated with cannabis consumption include anxiety disorders, depressive disorders, psychotic disorders, and cannabis use disorders. Specifically, cannabis use has been linked to the exacerbation of psychotic disorders in vulnerable individuals, mood disorders, and an increased risk of psychiatric disorders such as schizophrenia, depression, anxiety, and substance use disorder. Acute adverse mental effects can mimic psychiatric disorders like schizophrenia and bipolar disorder. Additionally, cannabis use is associated with a withdrawal syndrome upon cessation in dependent individuals. Other psychiatric effects include paranoia, psychosis, and cannabis-induced anxiety, which has been observed in emergency department patients. There is also evidence suggesting a cross-sectional association between recreational cannabis use and depression, anxiety, and suicide."],"id":"63ac44c2c6c7d4d31b000011","type":"list","body":"Which are the most common psychiatric events associated with the consumption of cannabis?"},{"documents":[{"golden":true,"id":"2221744"},{"golden":true,"id":"10910312"},{"golden":false,"id":"1596433"},{"golden":true,"id":"9403872"},{"golden":false,"id":"17982329"},{"golden":false,"id":"11727172"},{"golden":true,"id":"6434735"},{"golden":false,"id":"25028259"},{"golden":false,"id":"1908716"},{"golden":false,"id":"11499345"},{"golden":false,"id":"39439736"},{"golden":true,"id":"39148498"},{"golden":true,"id":"38230942"},{"golden":true,"id":"38501516"},{"golden":false,"id":"26015115"},{"golden":false,"id":"24464000"},{"golden":false,"id":"25408302"},{"golden":true,"id":"7729330"},{"golden":false,"id":"146420"},{"golden":false,"id":"1336797"},{"golden":false,"id":"33434594"},{"golden":false,"id":"39121172"},{"golden":false,"id":"24654689"},{"golden":false,"id":"19566925"},{"golden":false,"id":"2213875"},{"golden":false,"id":"21267119"},{"golden":false,"id":"2606752"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":211,"document":"2221744","golden":true,"offsetInEndSection":483,"text":"The side effects of the pill on the skin do not pertain, in general, to those (like thrombo-embolism or, perhaps, breast cancer) which might be life-threatening, but they are probably more frequent and may have a potential to alter the quality of life of women who use it.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1128,"document":"2221744","golden":false,"offsetInEndSection":1337,"text":"on the one hand; on the other hand, one insists upon the fact that the pill in itself may have health benefits, general (reduction in the incidence of some cancers) or dermatological (e. g. an effect on acne).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":708,"document":"10910312","golden":true,"offsetInEndSection":855,"text":"Nausea and vomiting are the most troublesome adverse effects, but these can be controlled with antiemetic medication taken prior to the first dose.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":484,"document":"2221744","golden":false,"offsetInEndSection":674,"text":"The aim of this paper is to review the dermatological effects of hormonal contraceptives from the point of view of everyday prescribing, with the emphasis on the quality of life of patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":617,"document":"9403872","golden":true,"offsetInEndSection":712,"text":"Adverse effects include nausea, vomiting headache, and a change in menstrual bleeding patterns.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":858,"document":"2221744","golden":false,"offsetInEndSection":1127,"text":"As it would be unwise to speak of the risks without consideration for the benefits, an attempt is made to compare the dermatological safety profile of oral contraceptives to that of other birth control methods (barrier contraceptive methods, intrauterine devices, etc.)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":90,"document":"17982329","golden":false,"offsetInEndSection":279,"text":"Although there have been reports of rare adverse events, birth control pills do offer well-documented health benefits, including a decrease in the risk of ovarian and endometrial carcinoma.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"2221744","golden":false,"offsetInEndSection":44,"text":"[Evaluation of cutaneous risks of the Pill].","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":675,"document":"2221744","golden":false,"offsetInEndSection":857,"text":"The reported side effects of the pill are therefore classified according to their real or probable frequency, not to their severity or the theoretical importance of their mechanisms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"2221744","golden":false,"offsetInEndSection":210,"text":"Despite the fact that about 150 millions women must have taken hormonal contraceptives all over the world since the 1960s, the risk/benefit ratio of this birth control method has yet not been reliably assessed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":216,"document":"6434735","golden":true,"offsetInEndSection":356,"text":"The risks of four cardiovascular diseases increased: (1) hypertension, (2) venous thromboembolism, (3) stroke and (4) myocardial infarction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":4,"document":"39439736","golden":false,"offsetInEndSection":95,"text":"ctive: Over the decade, variety and effectiveness of contraception methods have greatly imp","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1232,"document":"39148498","golden":true,"offsetInEndSection":1313,"text":"hiatric disorders. Progestin-only pills may confer a higher psychiatric risk than","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":391,"document":"38230942","golden":true,"offsetInEndSection":587,"text":"owever, several thrombotic and vascular complications have been found to be associated with the usage of oral contraceptive pills, most notably being an increase in blood pressure and thrombosis. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":243,"document":"38501516","golden":true,"offsetInEndSection":432,"text":"ost studies describe a negative sleep profile among contraceptive users, including increased sleepiness, insomnia symptoms, decreased sleep efficiency, and a reduced overall sleep quality. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1181,"document":"25408302","golden":false,"offsetInEndSection":1384,"text":"Some of the reactions identified, such as miscarriage, febrile neutropenia, and porphyria, are not included in the Summary of Product Characteristics.CONCLUSIONS: Levonorgestrel as an ECP is mostly safe.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":604,"document":"25408302","golden":false,"offsetInEndSection":896,"text":"We completed the safety profile obtained with that coming from spontaneous reporting in Spain.RESULTS: Out of 139 women surveyed, 113 developed any adverse event--two considered as severe; the most frequently reported events were menstrual disturbances, which accounted for 21% of all events.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":164,"document":"7729330","golden":true,"offsetInEndSection":282,"text":"Breakthrough bleeding is the most significant adverse event associated with the low-dose combined oral contraceptives.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1014,"document":"25408302","golden":false,"offsetInEndSection":1058,"text":"Twenty-five cases were considered as severe.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":897,"document":"25408302","golden":false,"offsetInEndSection":1013,"text":"Through spontaneous reporting, 36 cases of whatever adverse events related to levonorgestrel as ECP were identified.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25408302","golden":false,"offsetInEndSection":133,"text":"BACKGROUND: The emergency contraceptive pill (ECP) containing levonorgestrel is dispensed without a prescription in Spain since 2009.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":274,"document":"25408302","golden":false,"offsetInEndSection":603,"text":"The aim of the present study is to further learn the adverse effects of this ECP.METHODS: An ad hoc follow-up study was carried out in three community pharmacies in a city of Central Spain; the sample was composed of those women asking for the ECP; they were interviewed by telephone after at least a month since the last menses.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"146420","golden":false,"offsetInEndSection":113,"text":"Most side effects of oral contraceptives can be attributed to an excess or a deficiency of estrogen or progestin.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":114,"document":"146420","golden":false,"offsetInEndSection":266,"text":"Knowledge of the relative amounts of estrogen and progestin in the available preparations permits a rational adjustment of dosage if side effects occur.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"146420","golden":false,"offsetInEndSection":36,"text":"When patients \u0027can\u0027t\u0027 take the pill.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":267,"document":"146420","golden":false,"offsetInEndSection":350,"text":"With this information, nearly every woman who wants to use birth control pills can.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":300,"document":"33434594","golden":false,"offsetInEndSection":793,"text":"performed a retrospective case series of 403 adult women treated for acne with spironolactone at an academic medical center between 2008 and 2019. Rates of objective, as assessed by Comprehensive Acne Severity Scale scores, and subjective acne clearance were evaluated, as well as rates of treatment discontinuation, dosage changes, and drug survival. Logistic regression was used to assess for association between incidence of menstrual adverse effects and combined oral contraceptive use.RES","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1618,"document":"39121172","golden":false,"offsetInEndSection":2124,"text":"results suggest that adult German women who experienced physical or psychological violence since the age of 16, including violence perpetrated by a parent or caregiver, were more likely to report miscarriage or stillbirth and abortion. Direct assessment of violence experiences against women should be conducted by healthcare professionals in clinical encounters, particularly by obstetrics and gynaecological specialists, for the prevention of women?s adverse sexual and reproductive health outcomes. Furt","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":150,"document":"24654689","golden":false,"offsetInEndSection":350,"text":" will cause severe competition for existing resources, not to mention the issue of overcrowding of the planet and additional greenhouse gases that will have an adverse effect on the ecological health ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"19566925","golden":false,"offsetInEndSection":250,"text":"BACKGROUND: For many women finding the right contraceptive method can be challenging and consistent and correct use over a lifetime is difficult. Even remembering to take a birth control pill every day can be a challenge. The primary objective of thi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":682,"document":"2606752","golden":false,"offsetInEndSection":838,"text":"Among the most common problems experienced were the side effects associated with oral contraceptive use and difficulty remembering to take a pill every day.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":217,"document":"11499345","golden":false,"offsetInEndSection":360,"text":"Because millions of healthy young women in industrialized societies use oral contraceptives, even rare side effects receive a lot of attention.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":791,"document":"1908716","golden":false,"offsetInEndSection":938,"text":"Despite this and other minor side effects, most users find the sustained-release systems acceptable alternatives to other methods of contraception.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":858,"document":"2221744","golden":false,"offsetInEndSection":1314,"text":"As it would be unwise to speak of the risks without consideration for the benefits, an attempt is made to compare the dermatological safety profile of oral contraceptives to that of other birth control methods (barrier contraceptive methods, intrauterine devices, etc.) on the one hand; on the other hand, one insists upon the fact that the pill in itself may have health benefits, general (reduction in the incidence of some cancers) or dermatological (e.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21267119","golden":false,"offsetInEndSection":117,"text":"Oral contraceptives provide the woman under 35 with the most effective and safest reversible method of birth control.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":156,"document":"25028259","golden":false,"offsetInEndSection":331,"text":"Over time, combined oral contraception (COC) formulations and pill-taking regimens have evolved with improved safety and tolerability while maintaining contraceptive efficacy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"26015115","golden":false,"offsetInEndSection":118,"text":"Essential facts Oral contraception remains the most popular method of birth control for a majority of women in the UK.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":123,"document":"2213875","golden":false,"offsetInEndSection":217,"text":"The first effective oral contraceptive pill was Enovid which was introduced by Searle in 1960.","beginSection":"abstract"}],"exact_answer":[],"ideal_answer":[],"id":"6777b9c5592fa4887300000f","type":"list","body":"What are the most severe adverse effects of the birth control pill?"},{"documents":[{"golden":false,"id":"30811157"},{"golden":false,"id":"20086657"},{"golden":false,"id":"17141009"},{"golden":false,"id":"30777592"},{"golden":false,"id":"11927065"},{"golden":true,"id":"37760901"},{"golden":true,"id":"15373308"},{"golden":false,"id":"29273079"},{"golden":true,"id":"38844748"},{"golden":false,"id":"6600390"},{"golden":false,"id":"38510216"},{"golden":true,"id":"39264535"},{"golden":false,"id":"26870652"},{"golden":false,"id":"36350319"},{"golden":false,"id":"37003663"},{"golden":false,"id":"18825364"},{"golden":true,"id":"25157702"},{"golden":false,"id":"29242941"},{"golden":false,"id":"23965651"},{"golden":true,"id":"39552666"},{"golden":true,"id":"39224580"},{"golden":false,"id":"39308811"},{"golden":true,"id":"38560338"},{"golden":false,"id":"38118247"},{"golden":false,"id":"39340648"},{"golden":true,"id":"38643086"},{"golden":false,"id":"36072175"},{"golden":false,"id":"19393928"},{"golden":false,"id":"17431846"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":1173,"document":"30811157","golden":false,"offsetInEndSection":1360,"text":"Surgical treatment options for patients who have minimal improvement after six to 12 weeks of nonsurgical treatment include manipulation under anesthesia and arthroscopic capsule release.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":669,"document":"15373308","golden":true,"offsetInEndSection":1112,"text":"All patients were treated with physical therapy and non-steroidal anti-inflammatory drugs.RESULTS: An increased statistically significant improvement (P \u003c 0.00001) was found between the first and last visits to the clinic in all measured movement directions: elevation and external and internal rotation.CONCLUSIONS: Conservative treatment (physical therapy and NSAIDs) is a good long-term treatment regimen for idiopathic adhesive capsulitis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1302,"document":"38844748","golden":true,"offsetInEndSection":1737,"text":"Pain and functionality scores improved significantly between baseline and follow-up visits.CONCLUSION: Ultrasound-assisted hydrodistention of the glenohumeral joint combined with targeted exercise has been successful in improving pain relief, reducing disability, and increasing range of motion in subjects with stage 1 and 2 adhesive capsulitis, especially if diagnosed before phase 2 (when the range of motion is completely reduced).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":868,"document":"30811157","golden":false,"offsetInEndSection":1061,"text":"Nonsurgical treatments include nonsteroidal anti-inflammatory drugs, short-term oral corticosteroids, intra-articular corticosteroid injections, physiotherapy, acupuncture, and hydrodilatation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":501,"document":"20086657","golden":false,"offsetInEndSection":635,"text":"Other treatments include corticosteroid injections, capsular distention, manipulation under anesthesia, and surgical capsular release.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":801,"document":"30811157","golden":false,"offsetInEndSection":867,"text":"The most effective treatment for adhesive capsulitis is uncertain.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":186,"document":"17141009","golden":false,"offsetInEndSection":395,"text":"Treatment methods include supervised benign neglect, physical therapy, intra-articular corticosteroid injections, closed manipulation under anesthesia, arthroscopic capsular release, and open surgical release.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1062,"document":"30811157","golden":false,"offsetInEndSection":1172,"text":"Physiotherapy and corticosteroid injections combined may provide greater improvement than physiotherapy alone.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":702,"document":"30811157","golden":false,"offsetInEndSection":800,"text":"Recent evidence of persistent functional limitations if left untreated has challenged this theory.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30811157","golden":false,"offsetInEndSection":170,"text":"Adhesive capsulitis, also known as \"frozen shoulder,\" is a common shoulder condition characterized by pain and decreased range of motion, especially in external rotation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":902,"document":"38510216","golden":false,"offsetInEndSection":1263,"text":"Results: Combining SSNB with physical therapy and/or IACS injection and combining IACS injection with physical therapy have support in the literature for improving shoulder pain, ROM, and function, while hydrodilatation and physical therapy seem to offer some additive benefits for improving shoulder ROM when used as adjunct treatments for adhesive capsulitis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38510216","golden":false,"offsetInEndSection":100,"text":"Background: Adhesive capsulitis, also known as frozen shoulder, is a challenge to treat clinically.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"26870652","golden":false,"offsetInEndSection":159,"text":"Idiopathic adhesive capsulitis, or primary frozen shoulder syndrome, is a fairly common orthopaedic problem characterized by shoulder pain and loss of motion.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25157702","golden":true,"offsetInEndSection":190,"text":"BACKGROUND: Adhesive capsulitis (also termed frozen shoulder) is commonly treated by manual therapy and exercise, usually delivered together as components of a physical therapy intervention.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":101,"document":"38510216","golden":false,"offsetInEndSection":262,"text":"ommon first-line treatment options are suprascapular nerve block (SSNB), intra-articular corticosteroid (IACS) injection, hydrodilatation, and physical therapy. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1,"document":"39552666","golden":true,"offsetInEndSection":422,"text":"e describe a new technique for hydrodilatation of the frozen shoulder, which we coined \u0027Sonographically-Navigated Frozen Shoulder Release (S-FSR)\u0027 or \u0027Dr Gonzalez\u0027s technique.\u0027 Traditional treatments include a combination of conservative and surgical modalities, such as non-steroidal anti-inflammatories, physical therapy, and open capsular release. We describe a modification to hydrodilatation of the frozen shoulder. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1,"document":"39224580","golden":true,"offsetInEndSection":600,"text":"ackground: Although several studies have reported the effectiveness of acupuncture treatment for adhesive capsulitis (AC), research on pharmacopuncture therapy for AC remains limited. We compared the effectiveness and safety of pharmacopuncture and physiotherapy for AC.Methods: This pragmatic, randomized, controlled, parallel-group pilot study enrolled patients with limitations of shoulder movement and a numeric rating scale (NRS) score for shoulder pain ?5 randomized (1:1) to the pharmacopuncture therapy (PPT) and physiotherapy (PT) groups. Treatment sessions were administered twice weekly f","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":681,"document":"39264535","golden":true,"offsetInEndSection":1221,"text":"fter excluding nine patients for other concomitant pathologies (five for calcific tendinopathy and four for rotator cuff injury), 36 patients were randomized into two groups: one group was treated with glenohumeral hydrodistension, the other with glenohumeral hydrodistension combined with bursal injection. Assessments were conducted at baseline and then 2, 4, and 6?months after treatment, focusing on changes in pain levels, functional scores, and range of motion in all planes. Each group followed a home-based rehabilitation protocol.R","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":11,"document":"39308811","golden":false,"offsetInEndSection":276,"text":" Moderate physical activity (MPA) has proven advantages for glycemic control, cardiovascular health, and functional independence. However, physical activity is not part of routine conventional physical therapy (CPT) in managing diabetic adhesive capsulitis patients","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":465,"document":"38560338","golden":true,"offsetInEndSection":601,"text":" As a result, pharmacoacupuncture (PA) is getting attention as an alternative therapy for patients with FS. PA is a new form of acupunct","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1681,"document":"38118247","golden":false,"offsetInEndSection":1925,"text":"xide gas associated with intensive physiotherapy for shoulder adhesive capsulitis did not improve function, pain or quality of life more than physiotherapy alone. zHowever, pain experienced during physiotherapy sessions appeared lower.TRIAL REG","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":503,"document":"39340648","golden":false,"offsetInEndSection":798,"text":" cohort of patients with symptoms suggestive of AC was assessed using the new scoring system, which integrates clinical, radiological, and patient history factors. Parameters included comorbidities like diabetes mellitus, recent immobility, rotator cuff tears, and specific ultrasound findings. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1599,"document":"38643086","golden":true,"offsetInEndSection":1832,"text":"f an at-home high-intensity stretching device for conservative treatment of idiopathic adhesive capsulitis improves outcomes in ROM and in ASES and SST scores both when used as an adjunct to physical therapy and when used alone.TRIAL","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36350319","golden":false,"offsetInEndSection":125,"text":"Adhesive capsulitis, also known as frozen shoulder, is a condition characterized by pain and stiffness of the shoulder joint.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17431846","golden":false,"offsetInEndSection":162,"text":"\"Frozen shoulder\" syndrome (adhesive capsulitis or pericapsulitis) refers to any kind of shoulder pain or to limited active or passive glenohumeral joint motions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36072175","golden":false,"offsetInEndSection":81,"text":"Adhesive capsulitis (frozen shoulder) may result from any injury to the shoulder.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30777592","golden":false,"offsetInEndSection":158,"text":"Frozen shoulder, or adhesive capsulitis, is a painful inflammatory disorder with an unknown pathogenesis characterised by progressive fibrosis of the capsule.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37003663","golden":false,"offsetInEndSection":154,"text":"Adhesive capsulitis, colloquially known as \"frozen shoulder,\" is a relatively common disorder, affecting approximately 2% to 5% of the general population.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":952,"document":"37760901","golden":true,"offsetInEndSection":1266,"text":"The application of extracorporeal shockwave therapy, stretching exercises, and corticosteroid injections combined with physical therapy modalities that enhance pain management, range of motion, and functional capacity is highly advisable for the treatment of adhesive capsulitis, commonly known as \"frozen joints\".","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"19393928","golden":false,"offsetInEndSection":73,"text":"BACKGROUND: The management of adhesive capsulitis (frozen shoulder) is co","beginSection":"abstract"}],"exact_answer":[],"ideal_answer":[],"id":"6772c6ae592fa48873000008","type":"list","body":"What are the treatments for Adhesive Capsulitis or \"Frozen Sholder\""},{"documents":[{"golden":false,"id":"9875023"},{"golden":false,"id":"36876200"},{"golden":false,"id":"8564118"},{"golden":false,"id":"26120004"},{"golden":true,"id":"28783810"},{"golden":false,"id":"31063297"},{"golden":false,"id":"32861227"},{"golden":true,"id":"16575137"},{"golden":false,"id":"17204963"},{"golden":false,"id":"29424065"},{"golden":false,"id":"28977260"},{"golden":false,"id":"33052510"},{"golden":false,"id":"31974673"},{"golden":false,"id":"29937192"},{"golden":false,"id":"16895511"},{"golden":false,"id":"34593484"},{"golden":false,"id":"31763206"},{"golden":true,"id":"37256281"},{"golden":true,"id":"36449658"},{"golden":false,"id":"32165955"},{"golden":false,"id":"35419955"},{"golden":false,"id":"35040080"},{"golden":false,"id":"32326684"},{"golden":true,"id":"33884211"},{"golden":false,"id":"34970683"},{"golden":false,"id":"36279244"},{"golden":false,"id":"35081239"},{"golden":false,"id":"29150856"},{"golden":false,"id":"32084099"},{"golden":false,"id":"38011018"},{"golden":true,"id":"29939978"},{"golden":false,"id":"34418011"},{"golden":false,"id":"37923813"},{"golden":false,"id":"37538442"},{"golden":false,"id":"35055359"},{"golden":false,"id":"30613455"},{"golden":true,"id":"34887229"},{"golden":true,"id":"12885479"},{"golden":false,"id":"34485201"},{"golden":false,"id":"34255639"},{"golden":false,"id":"1356457"},{"golden":false,"id":"33248372"},{"golden":false,"id":"32591242"},{"golden":false,"id":"38245889"},{"golden":true,"id":"34612847"},{"golden":false,"id":"36622781"},{"golden":false,"id":"26199699"},{"golden":false,"id":"37981801"},{"golden":false,"id":"32058370"},{"golden":false,"id":"32058369"},{"golden":false,"id":"36645795"},{"golden":false,"id":"37137815"},{"golden":false,"id":"37520007"},{"golden":false,"id":"34351432"},{"golden":false,"id":"35506809"},{"golden":false,"id":"22460770"},{"golden":true,"id":"30234742"},{"golden":false,"id":"21666537"},{"golden":false,"id":"32695992"},{"golden":true,"id":"15636651"},{"golden":false,"id":"15456585"},{"golden":false,"id":"28549024"},{"golden":true,"id":"30225636"},{"golden":false,"id":"20228689"},{"golden":false,"id":"35983521"},{"golden":false,"id":"31385882"},{"golden":false,"id":"25251517"},{"golden":false,"id":"29782390"},{"golden":false,"id":"8674325"},{"golden":false,"id":"12438671"},{"golden":false,"id":"31094887"},{"golden":false,"id":"28167245"},{"golden":false,"id":"27513354"},{"golden":false,"id":"31537228"},{"golden":false,"id":"38357132"},{"golden":false,"id":"38356035"},{"golden":false,"id":"38355207"},{"golden":false,"id":"38354362"},{"golden":false,"id":"38353591"},{"golden":false,"id":"38353586"},{"golden":false,"id":"38353160"},{"golden":false,"id":"38352942"},{"golden":false,"id":"38348451"},{"golden":false,"id":"16563181"},{"golden":false,"id":"15857546"},{"golden":false,"id":"23009115"},{"golden":false,"id":"15516535"},{"golden":false,"id":"28149888"},{"golden":false,"id":"3115677"},{"golden":false,"id":"28352704"},{"golden":false,"id":"30885453"},{"golden":false,"id":"31394566"},{"golden":false,"id":"31495868"},{"golden":false,"id":"32126571"},{"golden":false,"id":"30242298"},{"golden":false,"id":"35615605"},{"golden":false,"id":"34775116"},{"golden":false,"id":"33024378"},{"golden":false,"id":"35466350"},{"golden":false,"id":"37398718"},{"golden":false,"id":"37152345"},{"golden":false,"id":"37777757"},{"golden":false,"id":"37723295"},{"golden":false,"id":"23689050"},{"golden":false,"id":"27023591"},{"golden":false,"id":"17561989"},{"golden":false,"id":"37800309"},{"golden":false,"id":"35263468"},{"golden":false,"id":"35345613"},{"golden":false,"id":"27362850"},{"golden":false,"id":"32343114"},{"golden":false,"id":"30335688"},{"golden":false,"id":"38343680"},{"golden":false,"id":"38338654"},{"golden":false,"id":"38337815"},{"golden":false,"id":"38332633"},{"golden":false,"id":"38330817"},{"golden":false,"id":"38329114"},{"golden":false,"id":"38328327"},{"golden":false,"id":"38327418"},{"golden":false,"id":"38318959"},{"golden":false,"id":"38196017"},{"golden":false,"id":"38141118"},{"golden":false,"id":"38073164"},{"golden":false,"id":"38041208"},{"golden":false,"id":"33996681"},{"golden":true,"id":"39028682"},{"golden":true,"id":"37878412"},{"golden":false,"id":"38245897"},{"golden":false,"id":"39734076"},{"golden":true,"id":"39256242"},{"golden":false,"id":"28060151"},{"golden":false,"id":"11471256"},{"golden":false,"id":"38291524"},{"golden":false,"id":"21375090"},{"golden":false,"id":"10571765"},{"golden":false,"id":"38513681"},{"golden":false,"id":"31737894"},{"golden":false,"id":"31284692"},{"golden":false,"id":"32030529"},{"golden":false,"id":"33344390"},{"golden":false,"id":"34407568"},{"golden":false,"id":"35982172"},{"golden":true,"id":"37185949"},{"golden":false,"id":"36645762"},{"golden":false,"id":"35575803"},{"golden":false,"id":"27618276"},{"golden":false,"id":"28492402"},{"golden":false,"id":"19484951"},{"golden":true,"id":"31784324"},{"golden":false,"id":"15578805"},{"golden":true,"id":"29256116"},{"golden":false,"id":"24495564"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":0,"document":"28783810","golden":false,"offsetInEndSection":213,"text":"Importance: The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) uses the Sequential Organ Failure Assessment (SOFA) score to grade organ dysfunction in adult patients with suspecte","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2182,"document":"28783810","golden":false,"offsetInEndSection":2280,"text":"ellent discrimination for in-hospital mortality, with an area under the curve of 0.94 (95% CI, 0.9","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1527,"document":"28492402","golden":false,"offsetInEndSection":1716,"text":"ctatemia; calibration p value was 0.03, 0.36, and 0.49, respectively. A Pediatric Logistic Organ Dysfunction-2 score on day 1 greater than or equal to 8 reflected an overall risk of mortali","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"28783810","golden":false,"offsetInEndSection":153,"text":"Adaptation and Validation of a Pediatric Sequential Organ Failure Assessment Score and Evaluation of the Sepsis-3 Definitions in Critically Ill Children.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":2044,"document":"28783810","golden":false,"offsetInEndSection":2181,"text":"ivors, 127 (55.4%) were male with a median (IQR) age of 43 (8-144) months. In-hospital mortality was 2.6%. The maximum pSOFA score had ex","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":618,"document":"38011018","golden":false,"offsetInEndSection":796,"text":"butable mortality. Sensitivity analyses included recalculation of scores using worst preceding values for each variable, excluding hematologic parameters, and prediction of alter","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2833,"document":"28783810","golden":false,"offsetInEndSection":2945,"text":"r course.Conclusions and Relevance: The pSOFA score was adapted and validated with age-adjusted variables in cri","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":795,"document":"28783810","golden":false,"offsetInEndSection":1019,"text":"n were obtained from an electronic health record database. The pSOFA score was developed by adapting the original SOFA score with age-adjusted cutoffs for the cardiovascular and renal systems and by expanding the respiratory","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2357,"document":"28492402","golden":false,"offsetInEndSection":2499,"text":"g its use to standardize definitions and diagnostic criteria of pediatric sepsis. Further studies are needed to determine the usefulness of th","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1147,"document":"28783810","golden":false,"offsetInEndSection":1389,"text":"spitalization, discharge, or death (whichever came first). Three additional pediatric organ dysfunction scores were calculated for comparison.Exposures: Organ dysfunction measured by the pSOFA score, and sepsis and septic shock according to t","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1244,"document":"28977260","golden":false,"offsetInEndSection":1395,"text":"fections were the major causes of sepsis. PRISM III had a better calibration than the PELOD for prognosis of the patients, despite the high frequency o","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1018,"document":"31974673","golden":false,"offsetInEndSection":1234,"text":"Levels of MR-proADM were significantly higher in patients who required vasoactive drugs (p?\u003d?0.02) or presented renal dysfunction (p?\u003d?0.004).Conclusion: PCT appeared to be superior to MR-proADM in diagnosing sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33344390","golden":false,"offsetInEndSection":272,"text":"Objective: To evaluate serial ferritin levels measured in the initial 72 h of admission as a biomarker for new and progressive multi organ dysfunction syndrome (NPMODS) and mortality (unfavorable outcomes) in critically ill children with sepsis due to tropical infections.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":566,"document":"16895511","golden":false,"offsetInEndSection":690,"text":"russels score was developed. However, it, too, was suboptimal and was replaced by the sequential or sepsis-related organ fai","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":675,"document":"29937192","golden":false,"offsetInEndSection":770,"text":"This definition codifies organ dysfunction using the Sequential Organ Failure Assessment score.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1914,"document":"37256281","golden":false,"offsetInEndSection":2288,"text":"Among secondary outcomes, PELOD-2 performed significantly better than SIRS criteria and severe sepsis to predict prolonged duration of invasive MV, whereas better than severe sepsis to predict \"poor outcome\" (mortality or new disability).CONCLUSIONS: Day 1 organ dysfunction scores performed better in predicting mortality and morbidity outcomes than ICCPS-derived criteria.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36449658","golden":false,"offsetInEndSection":222,"text":"PURPOSE OF REVIEW: Organ dysfunction severity scores (sequential organ failure assessment or SOFA) are commonly used in the adult and pediatric populations when assessing risk of mortality and adverse outcomes from sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":240,"document":"32165955","golden":false,"offsetInEndSection":607,"text":"Pediatric Logistic Organ Dysfunction 2 (PELOD-2) score is recent scoring to assess organ dysfunction in sepsis children.AIM: To determine the correlation between troponin T, troponin I with PELOD-2 score in sepsis as a predictive factor of mortality.METHODS: A prospective cohort study was conducted on sepsis children in PICU Haji Adam Malik General Hospital, Medan.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2289,"document":"37256281","golden":false,"offsetInEndSection":2376,"text":"The PELOD-2 was the organ dysfunction score with the best performance for all outcomes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1500,"document":"37256281","golden":false,"offsetInEndSection":1913,"text":"The prognostic ability in mortality discrimination was significantly higher for organ dysfunction scores, with PELOD-2 showing the best performance (area under the receiver operating characteristic curve, 0.924; 95% confidence interval, 0.837-1.000), significantly better than SIRS 3 criteria (0.924 vs 0.509, P \u003d 0.009), SIRS 4 criteria (0.924 vs 0.509, P \u003c 0.001), and severe sepsis (0.924 vs 0.527, P \u003c 0.001).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":498,"document":"37256281","golden":false,"offsetInEndSection":1054,"text":"Sepsis organ dysfunction scores-pediatric Sequential Organ Failure Assessment (pSOFA) (Schlapbach, Matics, Shime), quickSOFA, quickSOFA-L, Pediatric Logistic Organ Dysfunction (PELOD)-2, quickPELOD-2, and Pediatric Multiple Organ Dysfunction score-were calculated during the first 24 hours of admission (day 1) and their performance compared with systemic inflammatory response syndrome (SIRS) and severe sepsis-International Consensus Conference on Pediatric Sepsis(ICCPS)-derived criteria-using the area under the receiver operating characteristic curve.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1453,"document":"35419955","golden":false,"offsetInEndSection":1824,"text":"Vital signs, blood tests and clinical sepsis scores, including Systemic Inflammatory Response Syndrome, quick Sequential Organ Failure Assessment and quick Paediatric Logistic Organ Dysfunction-2, performed poorly as predictors of these outcomes (area under the receiver operating characteristic curve?\u003c0.6).CONCLUSIONS: Very few patients with FN required ICU-level care.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":660,"document":"37878412","golden":false,"offsetInEndSection":1107,"text":"We excluded preterm infants and term infants younger than 7 days old.INTERVENTIONS: None.MEASUREMENTS AND MAIN RESULTS: We compared the 2005 International Pediatric Sepsis Consensus Conference (IPSCC), Pediatric Logistic Organ Dysfunction-2 (PELOD-2), pediatric Sequential Organ Failure Assessment (pSOFA), and Pediatric Organ Dysfunction Information Update Mandate (PODIUM) scores, measured at blood culture sampling, to predict 30-day mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37256281","golden":false,"offsetInEndSection":497,"text":"OBJECTIVE: To compare the performance of several prognostic scores calculated in the first 24 hours of admission (day 1) in predicting mortality and morbidity among critically ill children with sepsis presenting to the pediatric emergency department (PED) and then admitted to the pediatric intensive care unit (PICU).METHODS: Single-center, retrospective cohort study in children with a diagnosis of sepsis visiting the PED and then admitted to the PICU from January 1, 2010 to December 31, 2019.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1500,"document":"37878412","golden":false,"offsetInEndSection":1818,"text":"When restricting scores to neurologic, respiratory, and cardiovascular dysfunction, the adjusted AUC was 0.89 (0.84-0.94) for IPSCC, 0.85 (0.79-0.91) for PELOD-2, 0.87 (0.81-0.93) for pSOFA, and 0.88 (0.83-0.93) for PODIUM.CONCLUSIONS: IPSCC, PELOD-2, pSOFA, and PODIUM performed similarly to predict 30-day mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"29939978","golden":false,"offsetInEndSection":379,"text":"OBJECTIVES: We evaluated adapting the quick Sequential (Sepsis-Related) Organ Failure Assessment score (fast respiratory rate, altered mental status, low blood pressure) for pediatric use by selecting thresholds from three commonly used definitions: Pediatric Logistic Organ Dysfunction 2, Pediatric Advanced Life Support, and International Pediatric Sepsis Consensus Conference.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1655,"document":"29939978","golden":false,"offsetInEndSection":2510,"text":"When split by age group, the performance of Pediatric Logistic Organ Dysfunction 2 with mechanical ventilation was lowest in the youngest neonates (under 1?wk old), with an area under the receiver operating characteristics curve (95% CI) of 0.724 (0.656-0.791), and in the teenagers (13-18 yr), with an area under the receiver operating characteristics curve of 0.710 (0.682-0.738), yet it still outperformed Pediatric Advanced Life Support and International Pediatric Sepsis Consensus Conference in both groups.CONCLUSIONS: Among critically ill children who had a discharge diagnosis of infection in the PICU, quick Sequential (Sepsis-Related) Organ Failure Assessment score performs best when using the Pediatric Logistic Organ Dysfunction 2 age thresholds with mechanical ventilation, while all definitions performed worse at extremes of pediatric age.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1286,"document":"15578805","golden":false,"offsetInEndSection":1510,"text":"Neurological and cardiovascular dysfunctions were the independent risk factors for mortality.CONCLUSION: The SOFA scores showed high accuracy in describing the course of organ dysfunction for the patients with severe sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1356,"document":"29939978","golden":false,"offsetInEndSection":1654,"text":"Area under the receiver operating characteristics curve (95% CI) was 0.760 (0.749-0.771) for Pediatric Logistic Organ Dysfunction 2 with mechanical ventilation, 0.700 (0.689-0.712) for Pediatric Advanced Life Support, and 0.709 (0.696-0.721) for International Pediatric Sepsis Consensus Conference.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2511,"document":"29939978","golden":false,"offsetInEndSection":2718,"text":"Thus, mortality risk varies with vital sign thresholds, and although Pediatric Logistic Organ Dysfunction 2 with mechanical ventilation performed marginally better, it is unlikely to be of use to clinicians.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1863,"document":"36645762","golden":false,"offsetInEndSection":2141,"text":"The AUC for predicting death using VRI was 95% (95% CI 90% to 100%, p\u003c0.001) and PELOD-2 92.6% (95% CI 96.4% to 98.8%, p\u003c0.001).CONCLUSION: The VRI \u003c32.1?may potentially be used to predict mortality in children with septic shock and its predictive ability is as good as PELOD-2.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38011018","golden":false,"offsetInEndSection":499,"text":"OBJECTIVE: To evaluate the performance of existing sepsis scores for prediction of adverse outcomes in children with cancer admitted to the ICU with suspected sepsis.DESIGN: Retrospective chart review using data available at 1, 6, 12, and 24?h after ICU admission to calculate the Pediatric Risk of Mortality 3 (PRISM-3), Pediatric Sequential Organ Failure Assessment (pSOFA), Paediatric Logistic Organ Dysfunction 2 (PELOD-2), and Quick Pediatric Sequential Organ Failure Assessment (qSOFA) scores.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"29939978","golden":false,"offsetInEndSection":126,"text":"Mortality Risk Using a Pediatric Quick Sequential (Sepsis-Related) Organ Failure Assessment Varies With Vital Sign Thresholds.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1158,"document":"34418011","golden":false,"offsetInEndSection":1450,"text":"Paediatric risk of mortality score, need for inotropic support and mechanical ventilation were associated with mortality (p\u003c0.05).CONCLUSIONS: Packed red blood cell transfusion, which is frequently prescribed in intensive care settings, was not found to be associated with favourable outcome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35081239","golden":false,"offsetInEndSection":314,"text":"OBJECTIVE: To analyze the correlation between glycocalyx disruption measured via the serum syndecan-1 level and organ dysfunctions assessed by the PELOD-2 score and to evaluate its association with mortality in pediatric sepsis.METHODS: We performed a prospective observational study in a tertiary public hospital.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1217,"document":"34887229","golden":false,"offsetInEndSection":1472,"text":"Pooled sensitivity, specificity, and SROC were 80% (95% CI: 64%-90%), 36% (95% CI: 23%-51%), and 59% (95% CI: 55%-63%), respectively.CONCLUSION: This meta-analysis shows that SOFA was superior to SIRS for predicting mortality in PICU patients with sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1374,"document":"12885479","golden":false,"offsetInEndSection":1776,"text":"Calibration (p\u003d0.54) and discrimination (AUC\u003d0.91, SE\u003d0.01) of PELOD and dPELOD (p\u003e or \u003d0.39; AUC\u003e or \u003d0.79) scores were good.INTERPRETATION: PELOD and dPELOD scores are valid outcome measures of the severity of multiple organ dysfunction syndrome in paediatric intensive care units; their use should significantly reduce the sample size required to complete clinical trials in critically ill children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":701,"document":"34485201","golden":false,"offsetInEndSection":714,"text":"MOD criteria.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":66,"document":"34887229","golden":false,"offsetInEndSection":338,"text":"Several scoring systems are used to predict outcome and mortality for pediatric patients with sepsis, but how they compare to each other in terms of sensitivity and specificity is unclear.METHODS: The systematic literature review was performed following PRISMA guidelines.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34887229","golden":false,"offsetInEndSection":144,"text":"Accuracy of SIRS, age-adapted pSOFA, and quick SOFA scoring systems for predicting outcomes in paediatric patients with sepsis: a meta-analysis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":775,"document":"34887229","golden":false,"offsetInEndSection":1012,"text":"Heterogeneity was evaluated using I2, which estimates the percentage of variation between study results due to heterogeneity rather than sampling error.RESULTS: Eleven studies met inclusion criteria and evaluated the SOFA scoring system.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1259,"document":"33248372","golden":false,"offsetInEndSection":1580,"text":"The predictive power of our novel gene expression signature was then validated using independently published datasets.FINDING: None of the five demographic characteristics and 14 clinical features, including The Paediatric Logistic Organ Dysfunction (PELOD) score, could predict deterioration of MODS to ECMO at baseline.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1389,"document":"32591242","golden":false,"offsetInEndSection":1588,"text":"For high level of care admission, PIRO proved inferior to SOFA.CONCLUSIONS: We support the use of PIRO1, which combines ease of use and the best performance referred to mortality over the short term.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":221,"document":"34255639","golden":false,"offsetInEndSection":362,"text":"The Sequential Organ Failure Assessment (SOFA) score is widely utilized in clinical practice to assess septic patients for organ dysfunction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1179,"document":"34887229","golden":false,"offsetInEndSection":1216,"text":"Six studies examined the SIRS system.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":235,"document":"12885479","golden":false,"offsetInEndSection":591,"text":"We aimed to validate the paediatric logistic organ dysfunction (PELOD) score and estimate its validity when recorded daily (dPELOD).METHODS: We did a prospective, observational, multicentre cohort study in seven multidisciplinary, tertiary-care paediatric intensive care units of university-affiliated hospitals (two French, three Canadian, and two Swiss).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"26199699","golden":false,"offsetInEndSection":476,"text":"BACKGROUND: Procalcitonin (PCT) kinetics is a good prognosis marker in infectious diseases, but few studies of children sepsis have been performed.OBJECTIVES: The aim of our study was to examine kinetics of procalcitonin, to evaluate its relationship with severity and to analyze its usefulness in the prediction of multiorgan dysfunction syndrome (MODS).PATIENTS AND METHODS: Prospective observational study in an 8-bed pediatric intensive care unit of a university hospital.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"12885479","golden":false,"offsetInEndSection":111,"text":"BACKGROUND: Multiple organ dysfunction syndrome is more frequent than death in paediatric intensive care units.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"12885479","golden":false,"offsetInEndSection":117,"text":"Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1261,"document":"12885479","golden":false,"offsetInEndSection":1373,"text":"PELOD score was significantly higher in non-survivors (mean 31.0 [SE 1.2]) than survivors (9.4 [0.2]; p\u003c0.0001).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":749,"document":"12885479","golden":false,"offsetInEndSection":894,"text":"For each variable, the most abnormal value each day and during the whole stay were used in calculating the dPELOD and PELOD scores, respectively.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":664,"document":"12885479","golden":false,"offsetInEndSection":748,"text":"PELOD score includes six organ dysfunctions and 12 variables and was recorded daily.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1717,"document":"37981801","golden":false,"offsetInEndSection":1884,"text":"Conclusions: The predictive accuracies (AUC) of the PELOD-2 and PRISM III scores are limited in children with hemato-oncological diseases admitted to PICU with sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":679,"document":"37981801","golden":false,"offsetInEndSection":950,"text":"We collected and analyzed demographic, clinical, and laboratory data and outcomes for all patients, and evaluated the accuracy of two major prognostic scoring tools, the Pediatric Logistic Organ Dysfunction-2 (PELOD-2) and the Pediatric Risk of Mortality III (PRISM III).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1097,"document":"37185949","golden":false,"offsetInEndSection":1337,"text":"Prediction was inferior for admission PRISM and PELOD and for 6- and 12-month HRQL assessments.CONCLUSIONS: Illness severity scores have a good prediction of early functional morbidity but a more limited ability to predict longer-term HRQL.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1128,"document":"37981801","golden":false,"offsetInEndSection":1260,"text":"The predictive accuracies of PELOD-2 and PRISM III, as determined by the area under the curve (AUC), were 83% and 78%, respectively.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1825,"document":"32058369","golden":false,"offsetInEndSection":2500,"text":"In multivariable regression analysis (odds ratio [95% CI]), summation of daily Pediatric Logistic Organ Dysfunction scores, 1.01/per point (1.01-1.02), p \u003c 0.001; highest vasoactive-inotropic score, 1.02/per point (1.00-1.04), p \u003d 0.003; and any acute pathologic neurologic sign/event, 5.04 (2.15-12.01), p \u003c 0.001 were independently associated with death or persistent, serious deterioration of health-related quality of life at month 3.CONCLUSIONS AND RELEVANCE: Biologically plausible factors related to sepsis-associated critical illness organ dysfunction and its treatment were associated with poor outcomes at month 3 follow-up among children encountering septic shock.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":993,"document":"37137815","golden":false,"offsetInEndSection":1338,"text":"The pECMO mortality was 61.2% and the overall mortality was 53.0%, with the highest mortality rate in the bridge-to-transplant group (90.9%) because of lack of organ donation in our country.CONCLUSIONS: In our study, the PELOD two score, presence of sepsis, and use of CRRT were found to be in the predictors of in-hospital ECMO mortality model.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37981801","golden":false,"offsetInEndSection":263,"text":"Background: Children with hemato-oncological diseases or following stem cell transplantation (SCT) are at high risk for life-threatening infections; sepsis in this population constitutes a substantial proportion of pediatric intensive care unit (PICU) admissions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":92,"document":"37185949","golden":false,"offsetInEndSection":699,"text":"Given declining PICU mortality, we assessed the ability of the Pediatric Risk of Mortality-III (PRISM) and Pediatric Logistic Organ Dysfunction-2 (PELOD) scores to predict morbidity outcomes.METHODS: Among 359 survivors \u003c18 years in the Life After Pediatric Sepsis Evaluation multicenter prospective cohort study, we assessed functional morbidity at hospital discharge (Functional Status Scale increase ?3 points from baseline) and health-related quality of life (HRQL; Pediatric Quality of Life Inventory or Functional Status II-R) deterioration \u003e25% from baseline at 1, 3, 6, and 12 months post-admission.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1261,"document":"37981801","golden":false,"offsetInEndSection":1495,"text":"Nine new parameters were identified as clinically significant: age, SCT, viral infection, fungal infection, central venous line removal, vasoactive inotropic score, bilirubin level, C-reactive protein level, and prolonged neutropenia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1656,"document":"34485201","golden":false,"offsetInEndSection":1857,"text":"Conclusions: Early predictions from risk-based patient monitoring could provide more than 22 h of lead time for MOD onset, with ?0.93 positive predictive value for a high-risk group identified pre-MOD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34485201","golden":false,"offsetInEndSection":183,"text":"Objective: The objective of the study is to build models for early prediction of risk for developing multiple organ dysfunction (MOD) in pediatric intensive care unit (PICU) patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":938,"document":"34485201","golden":false,"offsetInEndSection":1092,"text":"The early prediction models from all methods achieved an area under the receiver operating characteristics curve ?0.91 for both IPSCC and Proulx criteria.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":496,"document":"34485201","golden":false,"offsetInEndSection":700,"text":"Measurements and main results: Organ dysfunction labels were generated every minute from preceding 24-h time windows using the International Pediatric Sepsis Consensus Conference (IPSCC) and Proulx et al.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1093,"document":"34485201","golden":false,"offsetInEndSection":1368,"text":"The best performance in terms of maximum F1-score was achieved with random forest (sensitivity: 0.72, positive predictive value: 0.70, F1-score: 0.71) and XGBoost (sensitivity: 0.8, positive predictive value: 0.81, F1-score: 0.81) for IPSCC and Proulx criteria, respectively.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1684,"document":"22460770","golden":false,"offsetInEndSection":1827,"text":"tine:free carnitine ratios did not differ between septic and control patients. Asymmetric dimethylarginine was inversely correlated with organ ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2055,"document":"22460770","golden":false,"offsetInEndSection":2185,"text":"rnitine:free carnitine were not associated with organ dysfunction or outcomes.CONCLUSIONS: Asymmetric dimethylarginine was decreas","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30234742","golden":false,"offsetInEndSection":300,"text":"OBJECTIVES: A quick Pediatric Logistic Organ Dysfunction 2 score on day 1, consisting of tachycardia, hypotension, and altered mentation, was shown to predict mortality with an area under the receiver operating characteristic curve of 82% (95% CI, 76-87%) in children admitted to a PICU with suspecte","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1583,"document":"30234742","golden":false,"offsetInEndSection":1864,"text":"n (17%) who died had a quick Pediatric Logistic Organ Dysfunction 2 score of 0. The area under the receiver operating characteristic curve was 72.6% (95% CI, 71.4-73.8%) for quick Pediatric Logistic Organ Dysfunction 2, compared with 85.0% (95% CI, 84.0-86.0%) for Pediatric Risk o","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1865,"document":"30234742","golden":false,"offsetInEndSection":2182,"text":" Mortality 3 and 81.5% (95% CI, 80.5-82.5%) for Pediatric Index of Mortality 2. Performance of quick Pediatric Logistic Organ Dysfunction 2 was worst in the greater than 12 years age group (area under the receiver operating characteristic curve, 67.8%; 95% CI, 65-70.5) and best in the less than 1 month age group (ar","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1305,"document":"38245889","golden":false,"offsetInEndSection":1593,"text":"nd included the redundant term, severe sepsis. The SCCM task force recommends that sepsis in children be identified by a Phoenix Sepsis Score of at least 2 points in children with suspected infection, which indicates potentially life-threatening dysfunction of the respiratory, cardiovasc","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1594,"document":"38245889","golden":false,"offsetInEndSection":1839,"text":"lar, coagulation, and/or neurological systems. Children with a Phoenix Sepsis Score of at least 2 points had in-hospital mortality of 7.1% in higher-resource settings and 28.5% in lower-resource settings, more than 8 times that of children with ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2038,"document":"38245889","golden":false,"offsetInEndSection":2308,"text":"ms that was not the primary site of infection. Septic shock was defined as children with sepsis who had cardiovascular dysfunction, indicated by at least 1 cardiovascular point in the Phoenix Sepsis Score, which included severe hypotension for age, blood lactate exceedi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2443,"document":"38245889","golden":false,"offsetInEndSection":2728,"text":"er- and lower-resource settings, respectively.Conclusions and Relevance: The Phoenix sepsis criteria for sepsis and septic shock in children were derived and validated by the international SCCM Pediatric Sepsis Definition Task Force using a large international database and survey, sys","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":736,"document":"21666537","golden":false,"offsetInEndSection":921,"text":"to quantitate the waveform. Severity of disease was assessed using the Glasgow Meningococcal Septicaemia Prognostic Score, Pediatric Risk of Mortality III score, and the Pediatric Logis","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1829,"document":"35983521","golden":false,"offsetInEndSection":2030,"text":"tatistically significant (P \u003c 0.05). The results of COX regression analysis indicated that the variables that were remarkably associated with death from sepsis in children were CK-MB, elevated cTnI lev","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1282,"document":"31385882","golden":false,"offsetInEndSection":1513,"text":"nts who had improving spare respiratory capacity over time (p \u003d 0.005). Mitochondrial respiration and content were not associated with day 1-2 Pediatric Logistic Organ Dysfunction score, but low spare respiratory capacity was assoc","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1811,"document":"31385882","golden":false,"offsetInEndSection":1962,"text":"lthough day 28 (? coefficient, -0.64; 95% CI, -1.35 to 0.06; p \u003d 0.08).CONCLUSIONS: Mitochondrial respiration was acutely decreased in peripheral blood","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2037,"document":"31385882","golden":false,"offsetInEndSection":2243,"text":" content. Over time, a rise in mitochondrial DNA tracked with improved respiration. Although initial mitochondrial alterations in peripheral blood mononuclear cells were unrelated to organ dysfunction, pers","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1986,"document":"25251517","golden":false,"offsetInEndSection":2152,"text":" 1-2 compared with patients with organ failure for more than 7 days (p \u003d 0.04).CONCLUSIONS: Mitochondrial dysfunction was present in peripheral blood mononuclear cell","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2153,"document":"25251517","golden":false,"offsetInEndSection":2253,"text":" in pediatric sepsis, evidenced by decreased bioenergetic reserve and increased uncoupling. Mitochon","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1196,"document":"29782390","golden":false,"offsetInEndSection":1357,"text":"80-1,820 ng/mL) in nonsurvivors, whereas 415 ng/mL (262-852 ng/mL) in survivors (p \u003d 0.11). Pediatric Logistic Organ Dysfunction score and C-reactive protein cor","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1792,"document":"29782390","golden":false,"offsetInEndSection":1949,"text":"ll significantly higher than that in sibling controls (19 ng/mL [10-54 ng/mL]) (p \u003d 0.003).CONCLUSIONS: Ferritin rises significantly in septic shock patients","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":685,"document":"38357132","golden":false,"offsetInEndSection":808,"text":"The odds of RDS among neonates with jaundice and sepsis are 4.33- and 1.92-times higher odds compared to their counterparts","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":699,"document":"38356035","golden":false,"offsetInEndSection":766,"text":"efficients (adj ?) 1.041; 95% confidence interval (CI): 0.01-0.08] ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":566,"document":"38355207","golden":false,"offsetInEndSection":652,"text":"Initial screenings for sepsis and blood group incompatibility yielded negative results","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":9,"document":"38354362","golden":false,"offsetInEndSection":207,"text":"Time to antibiotic administration (TTA) in \u003c60 minutes for children with neutropenic fever presenting to an emergency room is associated with reduced incidence of sepsis and intensive care admission","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1337,"document":"38353591","golden":false,"offsetInEndSection":1622,"text":"The outcomes of a multivariate logistic regression analysis suggested that a higher pediatric Sequential Organ Failure Assessment score, and the use of invasive mechanical ventilation and vasoactive medications were independently associated with PICU mortality in children with sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1916,"document":"38353586","golden":false,"offsetInEndSection":2073,"text":"The PCC-DOOR scale is a feasible, practical outcome for pediatric sepsis trials and demonstrates fair correlation with decrease in HRQL or death at 3 months.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1307,"document":"38353160","golden":false,"offsetInEndSection":1398,"text":"Further multicenter prospective data are needed, including infants with early-onset sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":151,"document":"38352942","golden":false,"offsetInEndSection":268,"text":"These mechanisms have been demonstrated in patients with sepsis, hemoglobinopathies, and those receiving transfusions","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":13,"document":"38348451","golden":false,"offsetInEndSection":184,"text":" Pediatric sepsis (PS) is a life-threatening infection associated with high mortality rates, necessitating a deeper understanding of its underlying pathological mechanisms","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":278,"document":"16563181","golden":false,"offsetInEndSection":543,"text":"Significant correlations were demonstrated between admission chemokine levels and the Paediatric Risk of Mortality score, the Disseminated Intravascular Coagulopathy score, the Sequential Organ Failure Assessment score and laboratory parameters of disease severity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1506,"document":"35982172","golden":false,"offsetInEndSection":1611,"text":"Conclusion: The nSOFA score was significantly associated with the risk of death from LOS in VLBW infants.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":544,"document":"16563181","golden":false,"offsetInEndSection":728,"text":"Additionally, nonsurvivors had much higher levels of chemokines compared with survivors, and the chemokine levels predicted mortality with a high degree of sensitivity and specificity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":595,"document":"15516535","golden":false,"offsetInEndSection":764,"text":"Hazard ratio of death significantly increased with the severity of organ dysfunction, as estimated by the PELOD score, and the worst diagnostic category of septic state.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":211,"document":"16563181","golden":false,"offsetInEndSection":277,"text":"The chemokine levels correlated with disease severity and outcome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":618,"document":"28149888","golden":false,"offsetInEndSection":904,"text":"The Quick (q) Sequential (Sepsis-related) Organ Failure Assessment (SOFA) score is proposed as a surrogate for organ dysfunction and may act as a risk predictor for patients with known or suspected infection, as well as being a prompt for clinicians to consider the diagnosis of sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":729,"document":"16563181","golden":false,"offsetInEndSection":909,"text":"The findings are important as they indicate a possible mechanism for risk stratification in future trials of novel therapies in human sepsis, which as yet have not been successful.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"16563181","golden":false,"offsetInEndSection":51,"text":"Meningococcal disease: identifying high-risk cases.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"16563181","golden":false,"offsetInEndSection":210,"text":"In the previous issue of Critical Care, Vermont and colleagues presented a simple but well-executed observational study describing the levels of chemokines in the serum of 58 children with meningococcal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23009115","golden":false,"offsetInEndSection":195,"text":"The human sequential organ failure assessment (SOFA) scoring system is used worldwide in intensive care units for assessing the extent of organ dysfunction/failure in patients with severe sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":198,"document":"15857546","golden":false,"offsetInEndSection":310,"text":"No neonatal organ dysfunction score has yet been validated as a reliable surrogate for disability-free survival.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":571,"document":"15857546","golden":false,"offsetInEndSection":700,"text":"Neonatal illness severity scores provide a convenient, but imperfect, tool to adjust for risk of sepsis in observational studies.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"15857546","golden":false,"offsetInEndSection":108,"text":"What is the role of neonatal organ dysfunction and illness severity scores in therapeutic studies in sepsis?","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":827,"document":"15857546","golden":false,"offsetInEndSection":989,"text":"However, they cannot circumvent the need for randomized trials of adequate size in neonatal sepsis, which address disability-free survival as the primary outcome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30242298","golden":false,"offsetInEndSection":142,"text":"INTRODUCTION: The Paediatric Index of ?Mortality 3 (PIM 3) and Paediatric Logistic Organ Dysfunction 2 (PELOD 2) scores were recently revised.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1586,"document":"31385882","golden":false,"offsetInEndSection":2046,"text":"Persistently low spare respiratory capacity was predictive of residual organ dysfunction on day 14 (area under the receiver operating characteristic, 0.72; 95% CI, 0.61-0.84) and trended toward fewer organ failure-free days although day 28 (? coefficient, -0.64; 95% CI, -1.35 to 0.06; p \u003d 0.08).CONCLUSIONS: Mitochondrial respiration was acutely decreased in peripheral blood mononuclear cells in pediatric sepsis despite an increase in mitochondrial content.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":146,"document":"31394566","golden":false,"offsetInEndSection":740,"text":"We determined the utility of an objective, electronic health record (EHR)-automated, neonatal sequential organ failure assessment (nSOFA) score to predict mortality from late-onset sepsis (LOS) in premature, very low birth weight (VLBW) infants.METHODS: Retrospective, single-center study of bacteremic preterm VLBW newborns admitted between 2012 and 2016. nSOFA scores were derived for patients with LOS at multiple time points surrounding the sepsis evaluation.RESULTS: nSOFA scores at evaluation and at all points measured after evaluation were different between survivors and non-survivors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":744,"document":"31385882","golden":false,"offsetInEndSection":899,"text":"Severity and duration of organ dysfunction were determined using the Pediatric Logistic Organ Dysfunction score and organ failure-free days through day 28.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33024378","golden":false,"offsetInEndSection":370,"text":"AIMS AND OBJECTIVES: Utility of pediatric logistic organ dysfunction-2 (PELOD-2) score on day 1 within 1 hour of admission in predicting mortality in children admitted in pediatric intensive care unit (PICU).BACKGROUND: Various scoring systems aid to evaluate the patient\u0027s mortality risk in the intensive care unit (ICU) by assigning a score and predicting the outcome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1910,"document":"34775116","golden":false,"offsetInEndSection":2127,"text":"Subgroup analyses showed similar results to the overall results.CONCLUSIONS: The discrimination for 28-day mortality with the SAPS?III and LODS models was superior to that of the SIRS, SOFA, OASIS, and SAPS?II models.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":102,"document":"15516535","golden":false,"offsetInEndSection":391,"text":"We analyzed by Cox regression models the cumulative influence of organ dysfunctions, using the pediatric logistic organ dysfunction (PELOD) score, and septic state (systemic inflammatory response syndrome or sepsis, severe sepsis, and septic shock) on mortality of critically ill children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1319,"document":"35615605","golden":false,"offsetInEndSection":1496,"text":"Recent studies have also underscored the applicability of the OEWS in intensive care unit (ICU) settings with results comparable to the more elaborate APACHE II and SOFA scores.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":765,"document":"15516535","golden":false,"offsetInEndSection":1051,"text":"Each increase of one unit in the PELOD score multiplied the hazard ratio by 1.096 (p \u003c 0.0001); hazard ratio of diagnostic category was 9.039 (p \u003d 0.031) for systemic inflammatory response syndrome or sepsis, 18.797 (p \u003d 0.007) for severe sepsis and 32.572 (p \u003c 0.001) for septic shock.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1158,"document":"15516535","golden":false,"offsetInEndSection":1350,"text":"We conclude that there is a cumulative accrual of the risk of death both with an increasing severity of organ dysfunction and an increasing severity of the diagnostic category of septic state.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1052,"document":"15516535","golden":false,"offsetInEndSection":1157,"text":"Cumulative hazard ratio of death \u003d (hazard ratio of PELOD score) x (hazard ratio of diagnostic category).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1164,"document":"35466350","golden":false,"offsetInEndSection":1723,"text":"Significant correlations were observed between IDo2 dose at 0 to 12 hours and day 2 maximum vasoactive inotropic score (? \u003d 0.27, P \u003d .006), day 1 Pediatric Logistic Organ Dysfunction (PELOD-2) score (? \u003d 0.41, P \u003c .001), day 2 PELOD-2 score (? \u003d 0.44, P \u003c .001), intensive care unit length of stay (? \u003d 0.35, P \u003c .001), days receiving invasive ventilation (? \u003d 0.42, P \u003c .001), and age (? \u003d -0.47, P \u003c .001).CONCLUSIONS: Routine IDo2 monitoring may identify critically ill children with sepsis who are at the highest risk of adverse events and poor outcomes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"15516535","golden":false,"offsetInEndSection":101,"text":"The interaction between sepsis and multiple organ dysfunction syndrome is poorly defined in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":696,"document":"30885453","golden":false,"offsetInEndSection":999,"text":"Risk factors associated with infection were female sex, admission SOFA score, Elixhauser score, and severe injury (P?\u003c?0.05).CONCLUSION: Patients with trauma often arrive with organ dysfunction, which adds complexity and inaccuracy to the operational definition of Sepsis-3 using changes in SOFA scores.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":238,"document":"37800309","golden":false,"offsetInEndSection":883,"text":"Here we compare liberal and restrictive transfusion in post-operative CHD patients in a cardiac intensive care unit.METHODS: Retrospective analysis was conducted on CHD patients who received liberal transfusion (2019-2021, n\u003d53) and restrictive transfusion (2021-2022, n\u003d43).RESULTS: The two groups were similar in terms of age, gender, Paediatric Risk of Mortality-3 score, Paediatric Logistic Organ Dysfunction-2 score, Risk Adjustment for Congenital Heart Surgery-1 score, cardiopulmonary bypass time, vasoactive inotropic score, total fluid balance, mechanical ventilation duration, length of cardiac intensive care unit stay, and mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":349,"document":"38343680","golden":false,"offsetInEndSection":453,"text":" patients.Methods: The databases (PubMed, Google Scholar, Web of Science, and Cochrane Library), along w","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":626,"document":"38338654","golden":false,"offsetInEndSection":766,"text":"M6229 was able to restore normal levels of both hepatic and renal parameters at 3 and 9 mg M6229/kg/h and prevented mortality of the animals","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38337815","golden":false,"offsetInEndSection":213,"text":"Although the diagnosis of sepsis requires the identification of the three components of infection, a systemic inflammation response, and organ dysfunction, there is currently no consensus on gold-standard criteria","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":441,"document":"38332633","golden":false,"offsetInEndSection":673,"text":"Identifying optimal treatment regimes that maximize residual life is especially desirable for patients with life-threatening diseases such as sepsis, a complex medical condition that involves severe infections with organ dysfunction","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":75,"document":"38330817","golden":false,"offsetInEndSection":264,"text":"Severe immune response to BSI can lead to sepsis, a systemic infection leading to multiple organ dysfunction, coupled with drug resistance, mortality, and limited clinical treatment options","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38329114","golden":false,"offsetInEndSection":165,"text":"Burns and burn sepsis, characterized by persistent and profound hypercatabolism, cause energy metabolism dysfunction that worsens organ injury and systemic disorders","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":745,"document":"38328327","golden":false,"offsetInEndSection":1127,"text":"The efficacy, safety (pancreatic fistula, intra-abdominal hemorrhage, sepsis, and organ dysfunction syndrome), abdominal bloating and pain relief time, bowel recovery time, hospital stay, inflammatory indicators (C-reactive protein, interleukin-6, and procalcitonin), and Acute Physiology and Chronic Health Evaluation (APACHE) II score of both groups were evaluated for comparison.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38327418","golden":false,"offsetInEndSection":97,"text":"Despite extensive investigations, urosepsis remains a life-threatening and high-mortality illness","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1706,"document":"38318959","golden":false,"offsetInEndSection":2014,"text":"Intra-abdominal hypertension was associated with greater inotropic support (p?\u003c?0.001), more gastrointestinal complications (p?\u003d?0.001), sepsis (p?\u003d?0.003), multiple organ dysfunction syndrome (p?\u003c?0.001), and prolonged intensive care unit stay (z\u003d-4.916, p?\u003c?0.001) and hospitalisation (z\u003d-4.710, p?\u003c?0.001)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"38196017","golden":false,"offsetInEndSection":126,"text":"Acute kidney injury (AKI) is common in children with sepsis, chronic kidney disease, poisoning or other conditions","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":666,"document":"38141118","golden":false,"offsetInEndSection":894,"text":"We identified 12,790 inpatients without infection (matched cohort 1), 12,789 inpatients with infection but without sepsis (matched cohort 2), and 10,536 inpatients with end-organ dysfunction but without sepsis (matched cohort 3)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":136,"document":"38073164","golden":false,"offsetInEndSection":356,"text":"In this prospective observational study carried out in a pediatric intensive care unit of a tertiary care center from 2020 to 2022, patients aged \u003c17 years with sepsis/septic shock and healthy children (HC) were enrolled","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1398,"document":"38041208","golden":false,"offsetInEndSection":1672,"text":"Secondary outcomes are mortality at 30 days, intensive care unit (ICU) length of stay, ICU readmission, Sequential Organ Failure Assessment (SOFA) scores recorded up to postoperative day 7, overall intraoperative fluid balance, vasopressors use, and the need for reoperation","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33996681","golden":false,"offsetInEndSection":230,"text":"Objective: The performances of the pediatric risk of mortality score III (PRISM III), pediatric logistic organ dysfunction score-2 (PELOD-2), and pediatric multiple organ dysfunction score (P-MODS) in Chinese patients are unclear.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":890,"document":"39028682","golden":false,"offsetInEndSection":1037,"text":"Elevated lactate levels were a risk factor for mortality.CONCLUSION: The pSOFA and PELOD2 scores had superior predictive performance for mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":326,"document":"39028682","golden":false,"offsetInEndSection":673,"text":"The six scores included the age-adapted pSOFA score, SIRS score, PELOD2 score, Sepsis-2 score, qSOFA score, and PMODS.RESULTS: Of the 5,356 children admitted to the PICU, 9.1% (488) died, and 25.1% (1,342) had basic disease with a mortality rate of 12.7% (171); 65.3% (3,499) of the patients were younger than 2 years, and 59.4% (3,183) were male.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1289,"document":"31784324","golden":true,"offsetInEndSection":1637,"text":"The diagnosis of sepsis applying a SOFA cutoff of 3 points predicted mortality better than both the SIRS and the SOFA cutoff of 2 points recommended by the Sepsis-3 consensus.CONCLUSIONS: The SOFA score at admission is useful for predicting outcomes in the general PICU population and is more accurate than SIRS for definition of paediatric sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1038,"document":"39028682","golden":false,"offsetInEndSection":1221,"text":"Given the relative unavailability of items and clinical operability, the pSOFA score should be recommended as an optimal tool for acute organ dysfunction in pediatric sepsis patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":674,"document":"39028682","golden":false,"offsetInEndSection":777,"text":"The discrimination abilities of the pSOFA and PELOD2 scores were superior to those of the other models.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":778,"document":"39028682","golden":false,"offsetInEndSection":889,"text":"The calibration curves of the pSOFA and PELOD2 scores were consistent between the predictions and observations.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39028682","golden":false,"offsetInEndSection":281,"text":"PURPOSE: We aimed to validate the performance of six available scoring models for predicting hospital mortality in children with suspected or confirmed infections.METHODS: This single-center retrospective cohort study included pediatric patients admitted to the PICU for infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1124,"document":"29256116","golden":true,"offsetInEndSection":1446,"text":"The discrimination of outcomes was significantly higher for SOFA (adjusted AUROC 0.829; 0.791-0.868) and PELOD-2 (0.816; 0.777-0.854) than for qSOFA (0.739; 0.695-0.784) and SIRS (0.710; 0.664-0.756).CONCLUSIONS: SIRS criteria lack specificity to identify children with infection at substantially higher risk of mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1222,"document":"39028682","golden":false,"offsetInEndSection":1324,"text":"Elevated lactate levels are related to a greater risk of death from infection in children in the PICU.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1800,"document":"38245897","golden":false,"offsetInEndSection":2198,"text":" and AUROCs of 0.71 to 0.92 (95% CI range, 0.70-0.92) to predict mortality in the validation sets. Using a Phoenix Sepsis Score of 2 points or higher in children with suspected infection as criteria for sepsis and sepsis plus 1 or more cardiovascular point as criteria for septic shock resulted in a higher positive predictive value and higher or similar sensitivity compared with the 2005 Internat","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":111,"document":"37878412","golden":false,"offsetInEndSection":332,"text":"U cohorts. We aimed to compare organ dysfunction criteria in children with blood culture-proven sepsis, including emergency department, PICU, and ward patients, and to assess relevance of organ dysfunctions for mortality ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1520,"document":"29256116","golden":false,"offsetInEndSection":1700,"text":"etter than Sepsis-2-based criteria. Our findings support the translation of Sepsis-3 into paediatric-specific sepsis definitions and highlight the importance of robust paediatric o","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39734076","golden":false,"offsetInEndSection":241,"text":"BACKGROUND: The neonatal Sequential Organ Failure Assessment (nSOFA) score is an organ dysfunction score developed for predicting mortality risk in preterm neonates with proven late-onset neonatal sepsis (LONS) and necrotising enterocolitis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1430,"document":"39734076","golden":false,"offsetInEndSection":1735,"text":"The nSOFA burden scores were positively associated with the risk for ROP (aOR 1.24; 95%?CI 1.09 to 1.41; p\u003d0.001) and BPD (aOR 1.30; 95%?CI 1.13 to 1.50; p\u003c0.001).CONCLUSION: Our findings show that the nSOFA score in preterm neonates suspected of LONS is associated with subsequent mortality, ROP and BPD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":242,"document":"39734076","golden":false,"offsetInEndSection":617,"text":"However, the utility of the nSOFA score in determining the risk of retinopathy of prematurity (ROP), bronchopulmonary dysplasia (BPD) or mortality in patients with suspected LONS is unknown.METHODS: We performed a dual-centre retrospective cohort study of preterm (gestational age \u003c32 weeks) neonates suspected of LONS, from 2016 to 2020 at two neonatal intensive care units.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1736,"document":"39734076","golden":false,"offsetInEndSection":1904,"text":"Incorporating nSOFA scores may help to identify sepsis survivors at the highest risk of adverse outcomes, who may require more intensive monitoring and adapted therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1068,"document":"39734076","golden":false,"offsetInEndSection":1152,"text":"The nSOFA was significantly associated with 10-day mortality at various time points.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"39734076","golden":false,"offsetInEndSection":163,"text":"Assessing neonatal Sequential Organ Failure (nSOFA) scores in suspected late-onset neonatal sepsis among preterm infants: implications for morbidity and mortality.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":901,"document":"39734076","golden":false,"offsetInEndSection":1067,"text":"The association with 10-day sepsis-related mortality and severe ROP and BPD was assessed.RESULTS: A total of 1157 episodes of suspected LONS in 706 neonates occurred.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1153,"document":"39734076","golden":false,"offsetInEndSection":1429,"text":"The nSOFA score 6?hours after drawing a blood culture (T6) was associated with 10-day sepsis-related mortality (adjusted OR (aOR) 1.31; 95%?CI (1.22 to 1.40; p\u003c0.001)), in a model corrected for gestational age, sex, age at evaluation and gestational age-adjusted birth weight.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1270,"document":"28060151","golden":false,"offsetInEndSection":1927,"text":"Survivors of new or progressive multiple organ dysfunction syndrome also had a higher frequency of moderate to severe disability defined as a Pediatric Overall Performance Category score of greater than or equal to 3 and an increase of greater than or equal to 1 from baseline: 22% versus 29% versus 11% for progressive, new, and no multiple organ dysfunction syndrome, respectively (p \u003c 0.001).CONCLUSIONS: Development of new or progressive multiple organ dysfunction syndrome is common (26%) in severe sepsis and is associated with a higher risk of morbidity and mortality than severe sepsis without new or progressive multiple organ dysfunction syndrome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":395,"document":"39256242","golden":false,"offsetInEndSection":674,"text":"This group recommends that sepsis in children be identified by a Phoenix Sepsis Score of at least 2 points in children with suspected infection, which indicates potentially life-threatening dysfunction of the respiratory, cardiovascular, coagulation, and/or neurological systems.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1064,"document":"39256242","golden":false,"offsetInEndSection":1664,"text":"These criteria have been shown to be independently associated with outcomes, and we recommend that in the future iterations of the criteria, renal and liver criteria should be defined according to latest definitions and the task force consider utilizing latest criteria for each organ system involved within the formulated criteria.CONCLUSION: ?In conclusion, Phoenix criteria are a step in the right direction to define life-threatening organ dysfunction in sepsis, but clinicians need to be mindful that diagnosis/treatment of less severe sepsis should not be delayed if these criteria are not met.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":830,"document":"11471256","golden":false,"offsetInEndSection":961,"text":"It is concluded that GMSPS and PRISM are useful methods for identifying and classifying children into low and high risk categories.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2163,"document":"32030529","golden":false,"offsetInEndSection":2681,"text":" cohort of international experts was able to achieve consensus regarding many recommendations for the best care of children with sepsis, acknowledging that most aspects of care had relatively low quality of evidence resulting in the frequent issuance of weak recommendations. Despite this challenge, these recommendations regarding the management of children with septic shock and other sepsis-associated organ dysfunction provide a foundation for consistent care to improve outcomes and inform future research.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2308,"document":"33344390","golden":false,"offsetInEndSection":2691,"text":"erial ferritin estimation predicted neither organ dysfunction nor mortality in pediatric sepsis with tropical infections. dPELOD-2 and PRISM-III predicted unfavorable outcomes better than ferritin. The current diagnostic criteria for MODS overestimated organ dysfunctions in tropical infections and hence may need modification with further validation in this epidemiological cohort.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":11,"document":"34407568","golden":false,"offsetInEndSection":156,"text":" In adults, sepsis-induced coagulopathy (SIC) is diagnosed by the SIC score, known as sepsis-3. There is no pediatric SIC (pSIC) score at present","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":69,"document":"35982172","golden":false,"offsetInEndSection":230,"text":"e aimed to evaluate if the Neonatal Sequential Organ Failure Assessment (nSOFA) is associated with mortality due to LOS in very low birth weight (VLBW) infants. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":865,"document":"37185949","golden":false,"offsetInEndSection":1099,"text":"ulative PELOD provided the best discrimination of discharge functional morbidity (area under the receive operating characteristics curve [AUROC] 0.81, 95% CI 0.76-0.87) and 3-month HRQL deterioration (AUROC 0.71, 95% CI 0.61-0.81). Pr","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":120,"document":"36645762","golden":false,"offsetInEndSection":263,"text":"es (31.7%). One of the most widely used scoring systems to assess mortality in sepsis or septic shock is Paediatric Logistic Organ Dysfunction ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35575803","golden":false,"offsetInEndSection":232,"text":"Importance: Pediatric sepsis definitions have evolved, and some have proposed using the measure used in adults to quantify organ dysfunction, a Sequential Organ Failure Assessment (SOFA) score of 2 or more in the setting of suspecte","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1280,"document":"27618276","golden":false,"offsetInEndSection":1688,"text":"cohort and 299 patients for the nonobstetric control cohort. The Sepsis in Obstetric Score, Acute Physiology and Chronic Health Evaluation II, Simplified Acute Physiology Score II, Sequential Organ Failure Assessment, and Multiple Organ Dysfunction Scores gave area under the receiver-operator characteristic curves of 0.67, 0.68, 0.72, 0.79, and 0.84 in the obstetric cohort, respectively, and 0.64, 0.72, 0","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2119,"document":"28492402","golden":false,"offsetInEndSection":2361,"text":"sure and greater than or equal to 15.9% with mean blood pressure.CONCLUSION: Among children admitted to PICU with suspected infection, Pediatric Logistic Organ Dysfunction-2 score on day 1 was highly predictive of PICU mortality suggesting it","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"19484951","golden":false,"offsetInEndSection":197,"text":"OBJECTIVE: To compare multiple organ dysfunction score (MODS), the sequential organ failure assessment (SOFA) and the logistic organ dysfunction score (LODS) in predicting hospital mortality in sev","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31784324","golden":false,"offsetInEndSection":288,"text":"OBJECTIVES: To assess performance of the age-adapted SOFA score in children admitted into Paediatric Intensive Care Units (PICUs) and whether the SOFA score can compete with the systemic inflammatory response syndrome (SIRS) in diagnosing sepsis, as recommended in the Sepsis-3 consensus ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1359,"document":"15578805","golden":false,"offsetInEndSection":1478,"text":"ctors for mortality.CONCLUSION: The SOFA scores showed high accuracy in describing the course of organ dysfunction for ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1519,"document":"29256116","golden":false,"offsetInEndSection":1699,"text":"better than Sepsis-2-based criteria. Our findings support the translation of Sepsis-3 into paediatric-specific sepsis definitions and highlight the importance of robust paediatric ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1327,"document":"24495564","golden":false,"offsetInEndSection":1607,"text":"ale or male, respectively. We hypothesize that n-score may be a simple and easy scoring system to estimate mortality of the patients with sepsis and severe sepsis/septic shock without requirement of special methods or special measuring equipment, and may be as reliable as the APA","beginSection":"abstract"}],"exact_answer":[],"ideal_answer":[],"id":"65844e9b06a2ea257c000004","type":"factoid","body":"Which organ dysfunction score is best for evaluating paediatric sepsis?"},{"documents":[{"golden":false,"id":"38231434"},{"golden":true,"id":"35748707"},{"golden":false,"id":"30552296"},{"golden":false,"id":"35596878"},{"golden":false,"id":"36325100"},{"golden":false,"id":"29453777"},{"golden":false,"id":"33724128"},{"golden":false,"id":"37977814"},{"golden":true,"id":"31603844"},{"golden":false,"id":"36959132"},{"golden":false,"id":"38895012"},{"golden":false,"id":"36004035"},{"golden":true,"id":"38606458"},{"golden":false,"id":"17199022"},{"golden":false,"id":"20172694"},{"golden":false,"id":"35520432"},{"golden":false,"id":"35943812"},{"golden":true,"id":"11139818"},{"golden":false,"id":"25147407"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":1827,"document":"35748707","golden":true,"offsetInEndSection":2081,"text":"Of the three deaths, none was considered related to ganaxolone; all occurred 9-22?days after completing ganaxolone.SIGNIFICANCE: IV ganaxolone achieved rapid and durable seizure control in patients with RSE, and showed acceptable safety and tolerability.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1512,"document":"38231434","golden":true,"offsetInEndSection":1667,"text":"Overall, ganaxolone was generally well tolerated at the doses studied and demonstrated pharmacokinetic and pharmacodynamic properties suitable to treat SE.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38231434","golden":false,"offsetInEndSection":393,"text":"Ganaxolone, a neuroactive steroid anticonvulsant that modulates both synaptic and extrasynaptic ?-aminobutyric acid type A (GABAA ) receptors, is in development for treatment of status epilepticus (SE) and rare epileptic disorders, and has been approved in the United States for treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder in patients ?2 years old.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":343,"document":"33724128","golden":false,"offsetInEndSection":1034,"text":"Ganaxolone (GNX) is a synthetic analog of the endogenous neurosteroid allopregnanolone and a member of a novel class of neuroactive steroids called epalons.Areas covered: The authors review the pharmacology of GNX, summarize the main clinical evidence about its antiseizure efficacy and tolerability, and suggest implications for clinical practice and future research.Expert opinion: The clinical development of GNX is mainly oriented to target unmet needs and focused on status epilepticus and rare genetic epilepsies that have few or no treatment options.The availability of oral and intravenous formulations allows reaching adult and pediatric patients in acute and chronic care settings.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":809,"document":"31603844","golden":true,"offsetInEndSection":950,"text":"Allopregnenolona and ganaxolone showed good efficacy in status epilepticus and could play an important future role in this clinical scenario.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":449,"document":"30552296","golden":false,"offsetInEndSection":653,"text":"administration in treatment-resistant models of status epilepticus (SE), to establish a pharmacokinetic (PK)/pharmacodynamic (PD) relationship, and to compare its PK and anticonvulsant activities to ALLO.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1086,"document":"38231434","golden":false,"offsetInEndSection":1325,"text":"Bolus doses above 10?mg of ganaxolone markedly influenced the bispectral index score with a rapid decline; smaller changes occurred on the Modified Observer\u0027s Assessment of Alertness/Sedation scale and in quantitative electroencephalogram.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1882,"document":"29453777","golden":false,"offsetInEndSection":2009,"text":"Allopregnanolone and ganaxolone are effective in the treatment of TETS-induced SE when administered by the intramuscular route.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":829,"document":"36325100","golden":false,"offsetInEndSection":949,"text":"Adjunctive ganaxolone was effective in terminating SRSE in both patients, safely permitting IV anesthetics to be weaned.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1436,"document":"38231434","golden":false,"offsetInEndSection":1511,"text":"No effects on systemic hemodynamics or respiratory functions were reported.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1326,"document":"38231434","golden":false,"offsetInEndSection":1435,"text":"Most adverse events were of mild severity, with 2 events of moderate severity; none were reported as serious.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":54,"document":"37977814","golden":false,"offsetInEndSection":156,"text":"eurosteroids as novel anticonvulsants for refractory status epilepticus (RSE) and as medical counterme","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38606458","golden":true,"offsetInEndSection":70,"text":"INTRODUCTION: Ganaxolone has exhibited potential in managing seizures ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":459,"document":"38895012","golden":false,"offsetInEndSection":628,"text":"mergency use authorization was obtained for intravenous ganaxolone, a neuroactive steroid that is a potent modulator of both synaptic and extrasynaptic GABAA receptors. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":462,"document":"17199022","golden":false,"offsetInEndSection":627,"text":"n early phase II studies, GNX has been shown to have activity in adult patients with partial-onset seizures and epileptic children with history of infantile spasms. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1,"document":"35520432","golden":false,"offsetInEndSection":805,"text":"he anionic carbosilane (CBS) dendrimer with sulfonate groups G2-S16 is a promising compound for the preparation of a microbicide gel to prevent HIV infection. However, until now its synthesis required aggressive conditions. Hence, a reliable synthetic procedure is very important to face GMP conditions and clinical trials. In this study, G2-S16 has been prepared by a new approach that involves the addition of an amine-terminated dendrimer to ethenesulfonyl fluoride (C2H3SO3F, ESF) and then transformation to the sulfonate dendrimer by treatment with a base. This strategy also makes feasible the synthesis of a labelled sulfonate dendrimer (G2-S16-FITC) to be used as a molecular probe for in vivo experiments. Interestingly, G2-S16-FITC enters into human peripheral blood mononuclear cells (PBMCs).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1,"document":"35943812","golden":false,"offsetInEndSection":1033,"text":"he immune factors associated with impaired SARS-CoV-2 vaccine response in elderly people are mostly unknown. We studied individuals older than 60 and younger than 60 years, who had been vaccinated with SARS-CoV-2 BNT162b2 mRNA, before and after the first and second dose. Aging was associated with a lower anti-RBD IgG levels and a decreased magnitude and polyfunctionality of SARS-CoV-2-specific T cell response. The dramatic decrease in thymic function in people \u003e 60 years, which fueled alteration in T cell homeostasis, and their lower CD161+ T cell levels were associated with decreased T cell response 2 months after vaccination. Additionally, deficient DC homing, activation, and TLR-mediated function, along with a proinflammatory functional profile in monocytes, were observed in the \u003e 60-year-old group, which was also related to lower specific T cell response after vaccination. These findings might be relevant for the improvement of the current vaccination strategies and for the development of new vaccine prototypes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":337,"document":"36325100","golden":false,"offsetInEndSection":456,"text":"Ganaxolone is currently in clinical trials to treat rare pediatric seizure disorders and established and refractory SE.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":729,"document":"11139818","golden":true,"offsetInEndSection":864,"text":"Open-label data in paediatric patients with intractable epilepsy suggest that ganaxolone may be effective in treating infantile spasms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":240,"document":"20172694","golden":false,"offsetInEndSection":500,"text":"Here we demonstrate that pretreatment with ganaxolone (1.25-20 mg/kg, s.c.) causes a dose-dependent suppression of behavioral and electrographic seizures in fully amygdala-kindled female mice, with nearly complete seizure protection at the highest dose tested.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":374,"document":"35748707","golden":false,"offsetInEndSection":460,"text":"esthetics. Ganaxolone is an investigational neuroactive steroid in development for RSE","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":856,"document":"29453777","golden":false,"offsetInEndSection":1116,"text":"Allopregnanolone and ganaxolone (each at 3?mg/kg) terminated SE in, respectively, 92% and 75% of animals, and prevented mortality in 85% and 50% of animals; the mean times to termination of behavioral seizures were, respectively, 172???16 and 447???52?seconds.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":419,"document":"25147407","golden":false,"offsetInEndSection":523,"text":"Neurosteroids and analogs such as ganaxolone show promise in the treatment of diverse forms of epilepsy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1079,"document":"30552296","golden":false,"offsetInEndSection":1302,"text":"Unlike other nonanesthetizing anticonvulsant agents indicated for SE, both GNX and ALLO produced anticonvulsant activity in models of pharmacoresistant SE with administration delay times of up to 1 hour after seizure onset.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":458,"document":"38895012","golden":false,"offsetInEndSection":627,"text":"Emergency use authorization was obtained for intravenous ganaxolone, a neuroactive steroid that is a potent modulator of both synaptic and extrasynaptic GABAA receptors.","beginSection":"abstract"}],"exact_answer":"","ideal_answer":[],"id":"677e816e592fa4887300001a","type":"yesno","body":"Should ganaxolone be used for treatment of status epilepticus?"},{"documents":[{"golden":false,"id":"34956320"},{"golden":true,"id":"17526521"},{"golden":false,"id":"21592396"},{"golden":false,"id":"20457745"},{"golden":false,"id":"28583129"},{"golden":false,"id":"36410105"},{"golden":false,"id":"18234563"},{"golden":false,"id":"38891019"},{"golden":false,"id":"39737401"},{"golden":false,"id":"23895370"},{"golden":false,"id":"39742833"},{"golden":false,"id":"39632911"},{"golden":false,"id":"39539946"},{"golden":false,"id":"38633435"},{"golden":false,"id":"28559929"},{"golden":false,"id":"26750448"},{"golden":false,"id":"19725948"},{"golden":false,"id":"37680201"},{"golden":false,"id":"39095347"},{"golden":false,"id":"36426870"},{"golden":false,"id":"28413437"},{"golden":false,"id":"37252189"},{"golden":false,"id":"38753612"},{"golden":false,"id":"17644558"},{"golden":false,"id":"24564564"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":1455,"document":"21592396","golden":false,"offsetInEndSection":1780,"text":"Over-Representation Analysis (ORA) of differentially regulated genes identified in pairwise comparisons revealed specific functional plant physiological categories as major targets upon Fe deficiency and in nas4x-1.CONCLUSION: Here, we obtained supporting evidence, that the nas4x-1 mutant was defective in metal homeostasis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":652,"document":"34956320","golden":false,"offsetInEndSection":1045,"text":"Matched normal and breast cancer samples from The Cancer Genome Atlas database were used to evaluate the performance of six GSA algorithms: Coincident Extreme Ranks in Numerical Observations (CERNO), Gene Set Enrichment Analysis (GSEA), GSEA-SNP, improved GSEA for GWAS (i-GSEA4GWAS), Meta-Analysis Gene-set Enrichment of variaNT Associations (MAGENTA), and Over-Representation Analysis (ORA).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":424,"document":"17526521","golden":true,"offsetInEndSection":642,"text":"Our web server provides two common statistical approaches, \u0027Over-Representation Analysis\u0027 (ORA) comparing a reference set of genes to a test set, and \u0027Gene Set Enrichment Analysis\u0027 (GSEA) scoring sorted lists of genes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1936,"document":"34956320","golden":false,"offsetInEndSection":2084,"text":"The correlation between GSA results from genomic and transcriptomic level was the highest when Stouffer integration was combined with LD correction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1822,"document":"34956320","golden":false,"offsetInEndSection":1935,"text":"Using any integration method was beneficial in comparison with a minimum p-value method in specific combinations.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1729,"document":"34956320","golden":false,"offsetInEndSection":1821,"text":"When Fisher or Stouffer were used with LD, sensitivity and reproducibility were also better.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1615,"document":"34956320","golden":false,"offsetInEndSection":1728,"text":"Applying LD correction increased prioritization and specificity of enrichment outcomes for all tested algorithms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":159,"document":"34956320","golden":false,"offsetInEndSection":255,"text":"To conduct gene set analysis (GSA), information from SNPs needs to be unified at the gene level.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1409,"document":"23895370","golden":false,"offsetInEndSection":1577,"text":").RESULTS: To address these challenges, we developed Confero, a contrast data and gene set platform for downstream analysis and biological interpretation of omics data.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2228,"document":"34956320","golden":false,"offsetInEndSection":2380,"text":"We showed that LD correction and Stouffer integration could increase the performance of enrichment analysis and encourage the usage of these techniques.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":946,"document":"20457745","golden":false,"offsetInEndSection":1136,"text":"MSEA offers three different enrichment analyses for metabolomic studies including overrepresentation analysis (ORA), single sample profiling (SSP) and quantitative enrichment analysis (QEA).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39539946","golden":false,"offsetInEndSection":145,"text":"Motivation: Overrepresentation analysis (ORA) is used widely to assess the enrichment of functional categories in a gene list compared to a backg","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":5,"document":"39632911","golden":false,"offsetInEndSection":165,"text":"set enrichment analysis (GSEA) tools can identify biological insights within gene expression-based studies. Although their statistical performance has been comp","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38633435","golden":false,"offsetInEndSection":165,"text":"Introduction: Gene set enrichment analysis (GSEA) subsequent to differential expression analysis is a standard step in transcriptomics and proteomics data analysis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":187,"document":"28559929","golden":false,"offsetInEndSection":437,"text":"phenotype. Gene Set Enrichment Analysis (GSEA) aims to address this by identifying sets of genes or biological pathways contributing to a phenotype, through gene-gene interactions or other mechanisms, which are not the focus of conventional associati","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36426870","golden":false,"offsetInEndSection":120,"text":"MOTIVATION: Gene set enrichment analysis (GSEA) is a commonly used algorithm for characterizing gene expression changes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28413437","golden":false,"offsetInEndSection":104,"text":"BACKGROUND: Over-representation analysis (ORA) detects enrichment of genes within biological categories.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":112,"document":"39095347","golden":false,"offsetInEndSection":608,"text":"ddressing this complexity, OmicScope emerges as an innovative solution for quantitative proteomics data analysis. Engineered to handle various data formats, it performs data pre-processing - including joining replicates, normalization, data imputation - and conducts differential proteomics analysis for both static and longitudinal experimental?designs. Empowered by Enrichr with over 224 databases, OmicScope performs Over Representation Analysis (ORA) and Gene Set Enrichment Analysis (GSEA). ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":256,"document":"39742833","golden":false,"offsetInEndSection":678,"text":"NAS genes have been reported in PMP, gene expression profiles of the tumors remain to be fully clarified because of its rarity and the difficulties in collecting pure cancerous cells scattered within the mucin. To disclose the molecular features of PMP cells, we performed RNA-seq analysis of ten PMPs and their matched non-tumorous colonic epithelium in combination with laser-microdissection. As a result, we identified ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":653,"document":"34956320","golden":false,"offsetInEndSection":1262,"text":"atched normal and breast cancer samples from The Cancer Genome Atlas database were used to evaluate the performance of six GSA algorithms: Coincident Extreme Ranks in Numerical Observations (CERNO), Gene Set Enrichment Analysis (GSEA), GSEA-SNP, improved GSEA for GWAS (i-GSEA4GWAS), Meta-Analysis Gene-set Enrichment of variaNT Associations (MAGENTA), and Over-Representation Analysis (ORA). Association of SNPs to phenotype was calculated using modified McNemar\u0027s test. Results for SNPs mapped to the same gene were integrated using Fisher and Stouffer methods and compared with the minimum p-value method. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17644558","golden":false,"offsetInEndSection":203,"text":"UNLABELLED: Gene Set Enrichment Analysis (GSEA) is a computational method that assesses whether an a priori defined set of genes shows statistically significant, concordant differences between two biolog","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36426870","golden":false,"offsetInEndSection":108,"text":"MOTIVATION: Gene set enrichment analysis (GSEA) is a commonly used algorithm for characterizing gene express","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":467,"document":"39095347","golden":false,"offsetInEndSection":607,"text":"Empowered by Enrichr with over 224 databases, OmicScope performs Over Representation Analysis (ORA) and Gene Set Enrichment Analysis (GSEA).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37680201","golden":false,"offsetInEndSection":169,"text":"Most high throughput genomic data analysis pipelines currently rely on over-representation or gene set enrichment analysis (ORA/GSEA) approaches for functional analysis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24564564","golden":false,"offsetInEndSection":129,"text":"BACKGROUND: Gene set enrichment analysis (GSEA) is an important approach to the analysis of coordinate expression changes at a pa","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28413437","golden":false,"offsetInEndSection":92,"text":"BACKGROUND: Over-representation analysis (ORA) detects enrichment of genes within biological","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"26750448","golden":false,"offsetInEndSection":112,"text":"Pathway or gene set over-representation analysis (ORA) has become a routine task in functional genomics studies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":324,"document":"38753612","golden":false,"offsetInEndSection":460,"text":"Among many tools developed so far, Gene Set Enrichment Analysis (GSEA) stands out as one of the pioneering and most widely used methods.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1662,"document":"19725948","golden":false,"offsetInEndSection":1756,"text":" small effect size. We find that the rank of gene set enrichment induced by GLAPA is more simi","beginSection":"abstract"}],"exact_answer":[],"ideal_answer":[],"id":"677ed900592fa4887300002c","type":"factoid","body":"What is the difference between Gene Set Enrichment Analysis (GSEA) and Over-Representation Analysis (ORA)?"},{"documents":[{"golden":false,"id":"38034215"},{"golden":true,"id":"30528161"},{"golden":false,"id":"34270469"},{"golden":false,"id":"37278674"},{"golden":false,"id":"29159310"},{"golden":false,"id":"37603883"},{"golden":false,"id":"35858806"},{"golden":false,"id":"34026813"},{"golden":false,"id":"30638830"},{"golden":false,"id":"22844815"},{"golden":false,"id":"31041616"},{"golden":false,"id":"28479132"},{"golden":false,"id":"37781442"},{"golden":false,"id":"34993519"},{"golden":false,"id":"34244072"},{"golden":false,"id":"36273487"},{"golden":false,"id":"36339880"},{"golden":false,"id":"29854744"},{"golden":false,"id":"30219984"},{"golden":false,"id":"31192877"},{"golden":false,"id":"37583948"},{"golden":false,"id":"37746299"},{"golden":false,"id":"36248210"},{"golden":false,"id":"31503150"},{"golden":false,"id":"38028733"},{"golden":false,"id":"37179471"},{"golden":false,"id":"36539066"},{"golden":false,"id":"38138197"},{"golden":false,"id":"37727344"},{"golden":false,"id":"36253559"},{"golden":false,"id":"33646126"},{"golden":false,"id":"36932000"},{"golden":false,"id":"34928859"},{"golden":false,"id":"28945902"},{"golden":false,"id":"36845860"},{"golden":false,"id":"34627657"},{"golden":false,"id":"38172957"},{"golden":false,"id":"32349613"},{"golden":false,"id":"35877120"},{"golden":false,"id":"38004352"},{"golden":false,"id":"34615399"},{"golden":false,"id":"34602167"},{"golden":false,"id":"36896073"},{"golden":false,"id":"35392681"},{"golden":false,"id":"36118304"},{"golden":false,"id":"37468033"},{"golden":false,"id":"37010957"},{"golden":false,"id":"37123806"},{"golden":false,"id":"37735028"},{"golden":false,"id":"35897291"},{"golden":false,"id":"37548048"},{"golden":false,"id":"35332854"},{"golden":false,"id":"37388627"},{"golden":false,"id":"32757514"},{"golden":false,"id":"36726039"},{"golden":false,"id":"36017406"},{"golden":false,"id":"33723376"},{"golden":false,"id":"37455781"},{"golden":false,"id":"38229964"},{"golden":false,"id":"33796924"},{"golden":false,"id":"32590639"},{"golden":false,"id":"36156703"},{"golden":false,"id":"38293963"},{"golden":false,"id":"36755659"},{"golden":false,"id":"37885491"},{"golden":false,"id":"34144898"},{"golden":false,"id":"35793109"},{"golden":false,"id":"36322979"},{"golden":false,"id":"32257862"},{"golden":false,"id":"37963404"},{"golden":false,"id":"34364678"},{"golden":false,"id":"34565902"},{"golden":false,"id":"35762947"},{"golden":false,"id":"30921151"},{"golden":false,"id":"35513312"},{"golden":false,"id":"37071372"},{"golden":false,"id":"32990485"},{"golden":false,"id":"37643142"},{"golden":false,"id":"33990998"},{"golden":false,"id":"35660072"},{"golden":false,"id":"36931571"},{"golden":false,"id":"37113210"},{"golden":false,"id":"34404544"},{"golden":false,"id":"35918245"},{"golden":false,"id":"36647306"},{"golden":false,"id":"36352808"},{"golden":false,"id":"35690947"},{"golden":false,"id":"36089115"},{"golden":false,"id":"27600715"},{"golden":false,"id":"38340965"},{"golden":false,"id":"38198631"},{"golden":false,"id":"38133914"},{"golden":false,"id":"37983814"},{"golden":false,"id":"37935961"},{"golden":false,"id":"37870257"},{"golden":false,"id":"37837637"},{"golden":false,"id":"37814700"},{"golden":true,"id":"31619510"},{"golden":false,"id":"31582020"},{"golden":false,"id":"31553137"},{"golden":false,"id":"31027547"},{"golden":false,"id":"33257402"},{"golden":false,"id":"26051304"},{"golden":false,"id":"36641249"},{"golden":false,"id":"35171629"},{"golden":false,"id":"36423305"},{"golden":false,"id":"33023854"},{"golden":false,"id":"36489201"},{"golden":false,"id":"37398606"},{"golden":false,"id":"38344787"},{"golden":false,"id":"37510824"},{"golden":false,"id":"31735692"},{"golden":false,"id":"37215272"},{"golden":false,"id":"34376826"},{"golden":false,"id":"36396559"},{"golden":false,"id":"33890884"},{"golden":false,"id":"38315125"},{"golden":false,"id":"32045294"},{"golden":false,"id":"36644120"},{"golden":false,"id":"35385859"},{"golden":false,"id":"34501809"},{"golden":false,"id":"9031580"},{"golden":false,"id":"32449665"},{"golden":false,"id":"33852937"},{"golden":false,"id":"33449463"},{"golden":false,"id":"25231782"},{"golden":false,"id":"37648589"},{"golden":false,"id":"37815328"},{"golden":false,"id":"37790660"},{"golden":false,"id":"37700562"},{"golden":false,"id":"37529407"},{"golden":false,"id":"37438971"},{"golden":false,"id":"37325930"},{"golden":false,"id":"37252769"},{"golden":false,"id":"34259985"},{"golden":false,"id":"37581925"},{"golden":false,"id":"34697689"},{"golden":false,"id":"36624821"},{"golden":false,"id":"36353692"},{"golden":false,"id":"34591101"},{"golden":false,"id":"37598885"},{"golden":false,"id":"37471638"},{"golden":false,"id":"33497725"},{"golden":true,"id":"28245038"},{"golden":false,"id":"38940898"},{"golden":false,"id":"38699117"},{"golden":false,"id":"38981783"},{"golden":false,"id":"38697058"},{"golden":false,"id":"38349521"},{"golden":false,"id":"38130983"},{"golden":false,"id":"38618736"},{"golden":false,"id":"39271026"},{"golden":false,"id":"38905554"},{"golden":false,"id":"39465092"},{"golden":false,"id":"39293270"},{"golden":false,"id":"39406866"},{"golden":false,"id":"30450345"},{"golden":false,"id":"37610753"},{"golden":false,"id":"34052163"},{"golden":false,"id":"39736610"},{"golden":true,"id":"24238576"},{"golden":true,"id":"35407551"},{"golden":false,"id":"37317409"},{"golden":false,"id":"36324882"},{"golden":false,"id":"38294149"},{"golden":false,"id":"36827481"},{"golden":false,"id":"37230432"},{"golden":false,"id":"37084532"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":1310,"document":"30528161","golden":false,"offsetInEndSection":1512,"text":"Evidence regarding surgical vaginoplasty in transgender females younger than age 18 years remains extremely scarce and conclusions cannot yet be drawn regarding its risks and benefits in this age group.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":357,"document":"24238576","golden":false,"offsetInEndSection":1138,"text":" individuals. Despite the minimum age of 18 as eligibility to undergo irreversible procedures, anecdotal reports show that vaginoplasties of female-affirmed patients under 18 have been performed by surgeons, thereby contravening the World Professional Association for Transgender Health Standards of Care.AIM: The purpose of this article is (i) to provide a review of salient factors regarding genital surgery in transgender adolescents; (ii) to review various ethical protocols for determining maturity in gender dysphoric individuals under 18; and (iii) to present a new systematic set of ethical principles largely derived from the surgical management of youths with disorders of sex development and adapted to the needs of transitioning adolescents.METHODS: A literature review","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":98,"document":"24238576","golden":true,"offsetInEndSection":356,"text":"adily fallen. Transgender adolescents are being treated with gonadotropin-releasing hormone analogues and subsequently cross-sex hormones at early or midpuberty, with genital surgery as the presumed final step in treatment for female-affirmed (male-to-female","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1139,"document":"24238576","golden":false,"offsetInEndSection":1572,"text":"of the topic was performed. Ethical guidelines derived from applied treatment protocols of children with disorders of sex development were written.MAIN OUTCOME MEASURE: Progressing from the current state of ethical standards and clinical assumptions, a new development of ethical guidelines for genital surgery in the female-affirmed transgender adolescent was created.RESULTS: There were no controlled studies of vaginoplasties perf","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24238576","golden":false,"offsetInEndSection":97,"text":"INTRODUCTION: During the last decade, the age of youths presenting for gender confirmation has st","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1573,"document":"24238576","golden":false,"offsetInEndSection":1914,"text":"rmed on female-affirmed adolescents under 18 years of age. A new set of ethical guidelines was created in order to support treatment professionals in their decision making process.CONCLUSIONS: Professionals across disciplines treating female-affirmed adolescents can utilize the proposed ethical guidelines to facilitate decision making on a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":199,"document":"22844815","golden":false,"offsetInEndSection":357,"text":"It is recommended that feminizing/masculinizing hormone therapy and genital surgery should not be carried out until 18 year old and 20 year old, respectively.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"24238576","golden":false,"offsetInEndSection":94,"text":"How young is too young: ethical concerns in genital surgery of the transgender MTF adolescent.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":231,"document":"31041616","golden":false,"offsetInEndSection":484,"text":"ate a neoclitoris. Masculinizing genitoplasty is more complex, typically is performed in multiple stages, and has more inherent urologic risks.RECENT FINDINGS: The most common urologic complications involve voiding dysfunction, specifically meatal steno","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1915,"document":"24238576","golden":false,"offsetInEndSection":2097,"text":"case-by-case basis in order to protect both patients and practitioners. These guidelines may also be used in support of more open discussions and disclosures of surgical results that","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1119,"document":"37610753","golden":false,"offsetInEndSection":1331,"text":"who underwent GAS were identified, including 25?099 (52.3%) who were aged 19 to 30 years. The most common procedures were breast and chest procedures, which occurred in 27?187 patients (56.6%), followed by genita","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1961,"document":"37610753","golden":false,"offsetInEndSection":2043,"text":"S has increased substantially in the US. Breast and chest surgery was the most com","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1602,"document":"37610753","golden":false,"offsetInEndSection":1884,"text":" to 30 years, 10?476 (21.8%) were aged 31 to 40, and 3678 (7.7%) were aged12 to 18 years. When stratified by the type of procedure performed, breast and chest procedures made up a greater percentage of the surgical interventions in younger patients, while genital surgical procedure","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":528,"document":"37610753","golden":false,"offsetInEndSection":1118,"text":"ulatory Surgery Sample and the National Inpatient Sample. Patients with diagnosis codes for gender identity disorder, transsexualism, or a personal history of sex reassignment were identified, and the performance of GAS, including breast and chest procedures, genital reconstructive procedures, and other facial and cosmetic surgical procedures, were identified.Main Outcome Measures: Weighted estimates of the annual number of inpatient and outpatient procedures performed and the distribution of each class of procedure overall and by age were analyzed.Results: A total of 48?019 patients","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1332,"document":"37610753","golden":false,"offsetInEndSection":1466,"text":" reconstruction (16?872 [35.1%]) and other facial and cosmetic procedures (6669 [13.9%]). The absolute number of GAS procedures rose f","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1467,"document":"37610753","golden":false,"offsetInEndSection":1601,"text":"om 4552 in 2016 to a peak of 13?011 in 2019 and then declined slightly to 12?818 in 2020. Overall, 25?099 patients (52.3%) were aged 1","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1885,"document":"37610753","golden":false,"offsetInEndSection":1960,"text":" were greater in older patients.Conclusions and Relevance: Performance of G","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30528161","golden":false,"offsetInEndSection":338,"text":"The Endocrine Society Clinical Practice Guidelines on the treatment of gender incongruent people recommend the use of gender-affirming cross-sex hormone (CSH) interventions in transgender children and adolescents who request this treatment, who have undergone psychiatric assessment, and have maintained a persistent transgender identity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1049,"document":"30528161","golden":true,"offsetInEndSection":1309,"text":"The small amount of available data suggest that when clearly indicated in accordance with international guidelines, gender-affirming CSHs and chest wall masculinisation in transgender males are associated with improvements in mental health and quality of life.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":786,"document":"30528161","golden":false,"offsetInEndSection":1048,"text":"This Review explores the available published evidence on gender-affirming CSH and surgical interventions in transgender children and adolescents, amalgamating findings on mental health outcomes, cognitive and physical effects, side-effects, and safety variables.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":577,"document":"30528161","golden":false,"offsetInEndSection":785,"text":"Some transgender individuals might also wish to access gender-affirming surgeries during adolescence; however, research to inform best clinical practice for surgeons and other medical professionals is scarce.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":683,"document":"34026813","golden":false,"offsetInEndSection":929,"text":"Results: Results demonstrate that the average age at the time of surgery was 32.2 years (range, 18-61 years); the average of operative time was 3.3 h (range 2-5 h); the average duration of hormone therapy before surgery was 12 years (range 1-39).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":339,"document":"30528161","golden":false,"offsetInEndSection":576,"text":"The intervention can help to affirm gender identity by inducing masculine or feminine physical characteristics that are congruent with an individual\u0027s gender expression, while aiming to improve mental health and quality-of-life outcomes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34026813","golden":false,"offsetInEndSection":222,"text":"Purpose: Gender dysphoria (GD) is an incompatibility between biological sex and personal gender identity; individuals harbor an unalterable conviction that they were born in the wrong body, which causes personal suffering.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1429,"document":"34026813","golden":false,"offsetInEndSection":1536,"text":"Conclusions: Findings confirm that it is a safety procedure, with a low incidence of serious complications.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1274,"document":"34026813","golden":false,"offsetInEndSection":1428,"text":"One hundred eighty-one (85 percent) patients in our series were able to have regular sexual intercourse, and no individual regretted having undergone GAS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1200,"document":"34026813","golden":false,"offsetInEndSection":1273,"text":"A total of 36 patients (16.8 percent) underwent some form of reoperation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":609,"document":"34026813","golden":false,"offsetInEndSection":682,"text":"During this period, 214 patients underwent penile inversion vaginoplasty.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":930,"document":"34026813","golden":false,"offsetInEndSection":1199,"text":"The most commons minor postoperative complications were granulation tissue (20.5 percent) and introital stricture of the neovagina (15.4 percent) and the major complications included urethral meatus stenosis (20.5 percent) and hematoma/excessive bleeding (8.9 percent).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":489,"document":"38028733","golden":false,"offsetInEndSection":958,"text":"While metoidioplasty has advantages such as limited scarring and preserved genital sensation and clitoral erection, it may not always guarantee the ability to void while standing or even penetrate a sexual partner.Aim: To describe our method of secondary phallic enhancement after metoidioplasty with a phallic prosthesis.Methods: Our case is based on a 39-year-old transgender male who underwent metoidioplasty with vaginectomy, scrotoplasty, and urethral lengthening.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1890,"document":"38028733","golden":false,"offsetInEndSection":2160,"text":"However, he remained dissatisfied with the amount of prepubic tissue and opted to undergo further liposuction.Conclusion: Phallic prosthesis implantation can be a procedure to improve the condition of multioperated cases of metoidioplasty with resistant phallic burying.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":477,"document":"37179471","golden":false,"offsetInEndSection":967,"text":"Hence, Adolescent Health Academy decided to release a statement on the care of transgender children, adolescents, and youth.OBJECTIVES: To review the existing international and national guidelines and recommendations to formulate a statement for the Pediatricians on (a) terminologies and definitions; (b) legal status in India; and (c) implications for pediatric practice.PROCESS: A task force was convened by the Adolescent Health Academy as the writing committee to draft the guidelines.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1624,"document":"38028733","golden":false,"offsetInEndSection":1889,"text":"Surgery was performed as a single procedure through a penoscrotal incision and greatly enhanced genital appearance.Results: Three months after surgery, the patient had good sensation of the phallus and was able to have satisfactory sexual activity with his partner.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1454,"document":"38028733","golden":false,"offsetInEndSection":1623,"text":"As a further step to improve the outcome, we proposed the implantation of a specific phallic prosthesis designed for metoidioplasty with testicular prosthesis placement.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2161,"document":"38028733","golden":false,"offsetInEndSection":2242,"text":"Reconstruction with a phallic prosthesis was performed successfully in this case.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2393,"document":"38028733","golden":false,"offsetInEndSection":2552,"text":"Further experience is needed to determine the efficacy and safety of using a phallic prosthesis as a secondary procedure in patients undergoing metoidioplasty.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36539066","golden":false,"offsetInEndSection":146,"text":"OBJECTIVE: Accumulating evidence demonstrates that gender affirming hormone therapy (GAHT) improves mental health outcomes in transgender persons.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38028733","golden":false,"offsetInEndSection":122,"text":"Secondary phallic prosthesis placement in transgender patients postmetoidioplasty: a case report on technique and outcome.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":2243,"document":"38028733","golden":false,"offsetInEndSection":2392,"text":"However, long-term complications and functional outcomes, such as the ability to void while standing or penetrate a sexual partner, remain uncertain.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1167,"document":"24238576","golden":false,"offsetInEndSection":1631,"text":"Ethical guidelines derived from applied treatment protocols of children with disorders of sex development were written.MAIN OUTCOME MEASURE: Progressing from the current state of ethical standards and clinical assumptions, a new development of ethical guidelines for genital surgery in the female-affirmed transgender adolescent was created.RESULTS: There were no controlled studies of vaginoplasties performed on female-affirmed adolescents under 18 years of age.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":371,"document":"24238576","golden":false,"offsetInEndSection":1166,"text":"Despite the minimum age of 18 as eligibility to undergo irreversible procedures, anecdotal reports show that vaginoplasties of female-affirmed patients under 18 have been performed by surgeons, thereby contravening the World Professional Association for Transgender Health Standards of Care.AIM: The purpose of this article is (i) to provide a review of salient factors regarding genital surgery in transgender adolescents; (ii) to review various ethical protocols for determining maturity in gender dysphoric individuals under 18; and (iii) to present a new systematic set of ethical principles largely derived from the surgical management of youths with disorders of sex development and adapted to the needs of transitioning adolescents.METHODS: A literature review of the topic was performed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1357,"document":"36845860","golden":false,"offsetInEndSection":1685,"text":"Apart from age, no other factors were found to potentially explain the different rates of complications between the age groups.Conclusion: Patients aged 18 or younger opting for chest masculinization surgery experience fewer complications and revision procedures while having higher satisfaction rates with the surgical outcome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1632,"document":"24238576","golden":false,"offsetInEndSection":1986,"text":"A new set of ethical guidelines was created in order to support treatment professionals in their decision making process.CONCLUSIONS: Professionals across disciplines treating female-affirmed adolescents can utilize the proposed ethical guidelines to facilitate decision making on a case-by-case basis in order to protect both patients and practitioners.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1300,"document":"35407551","golden":true,"offsetInEndSection":1483,"text":"These findings indicate gender-diverse individuals who underwent life-changing surgery at our institution had a median age of 18 years old, with many patients identifying as transmen.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24238576","golden":false,"offsetInEndSection":111,"text":"INTRODUCTION: During the last decade, the age of youths presenting for gender confirmation has steadily fallen.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":577,"document":"38172957","golden":false,"offsetInEndSection":1111,"text":"https://doi.org/10.1001/jamanetworkopen.2022.0978 ]..This study aims to analyze characteristics and to estimate relative frequencies of gender incongruence in a population of children and adolescents receiving gender-affirming care at a high-complexity university hospital located in the third largest city in Colombia.METHODS: This was a retrospective descriptive study of patients under 18 with gender incongruence that received gender-affirming care between January 2018 and June 2022 at Fundacion Valle del Lili in Cali, Colombia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":112,"document":"24238576","golden":true,"offsetInEndSection":370,"text":"Transgender adolescents are being treated with gonadotropin-releasing hormone analogues and subsequently cross-sex hormones at early or midpuberty, with genital surgery as the presumed final step in treatment for female-affirmed (male-to-female) individuals.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":357,"document":"38004352","golden":false,"offsetInEndSection":536,"text":"Between March 2021 and February 2023, penile microvascular dissection followed by gender-affirming vaginoplasty was performed in 41 patients aged 18 to 57 years (mean 30.5 years).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1987,"document":"24238576","golden":false,"offsetInEndSection":2169,"text":"These guidelines may also be used in support of more open discussions and disclosures of surgical results that could further the advancement of treatment in this emerging population.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":198,"document":"34615399","golden":false,"offsetInEndSection":437,"text":"HIV and sexually transmitted infections (STIs) disproportionately affect these populations, but there are limited epidemiologic and management data on STIs in people who have undergone gender-affirming genital surgery such as vaginoplasty.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":438,"document":"34615399","golden":false,"offsetInEndSection":753,"text":"This review will provide clinicians with anatomical details about the various vaginoplasty procedures currently being performed, complications associated with these procedures, and an overview of the current literature describing HIV/STI epidemiology among transfeminine individuals who have undergone vaginoplasty.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34615399","golden":false,"offsetInEndSection":197,"text":"As acceptance of transgender and gender diverse individuals continues to increase, gender-affirming surgery, a cornerstone in the management of gender dysphoria, is becoming more readily available.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34615399","golden":false,"offsetInEndSection":118,"text":"Anatomical and sexual health considerations among transfeminine individuals who have undergone vaginoplasty: A review.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":250,"document":"35392681","golden":false,"offsetInEndSection":516,"text":"Since the end of Medicare coverage exclusion for gender-affirming surgeries (GASs) and expansion in third-party coverage, patients seeking GAS have increased dramatically.Gender-affirming chest surgery (GACS) is performed at nearly twice the rate of genital surgery.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34602167","golden":false,"offsetInEndSection":145,"text":"Transgender people may choose to affirm their gender identity with gender-affirming hormone therapy (GAHT) and/or gender-affirming surgery (GAS).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":455,"document":"36896073","golden":false,"offsetInEndSection":673,"text":"An 18-year-old transgender male undergoing GAT reported to our centre in Mumbai, India with a complaint of masculine face with forwardly placed teeth in the upper arch and thick-set backwardly placed lower jaw and lip.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37468033","golden":false,"offsetInEndSection":366,"text":"OBJECTIVE: To describe choices of transgender and gender diverse (TGD) late adolescents assigned female at birth regarding gender-affirming surgery (GAS).METHODS: Participants aged 18-21 completed an online survey that included demographic characteristics, surgical history, desire for GAS, and barriers to care.RESULTS: Two hundred and sixty surveys were completed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":527,"document":"34602167","golden":false,"offsetInEndSection":580,"text":"GAHT and GAS may help to improve sexual satisfaction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":674,"document":"36896073","golden":false,"offsetInEndSection":795,"text":"Patient was taken up for ortho-surgical management to establish a feminine facial form and a stable functional occlusion.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":796,"document":"36896073","golden":false,"offsetInEndSection":1003,"text":"Mandibular advancement using the bilateral sagittal split ramus osteotomy, which is an uncommon protocol in GAT cases was found to be a viable option in the successful management of such a clinical scenario.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36896073","golden":false,"offsetInEndSection":171,"text":"Gender Affirmation Surgery/Therapy (GAS/GAT) constitutes an array of surgical and hormonal therapy performed on patients presenting with a diagnosis of \u0027Gender Dysphoria\u0027.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":296,"document":"37010957","golden":false,"offsetInEndSection":466,"text":"GAC facilitates the transition from the sex assigned at birth to the affirmed gender identity and is comprised of hormone therapy (HT) and gender-affirming surgery (GAS).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":172,"document":"36896073","golden":false,"offsetInEndSection":253,"text":"Facial Feminisation Surgery is a part of the overall gender reassignment process.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":951,"document":"35392681","golden":false,"offsetInEndSection":1036,"text":"This case highlights the importance of routine breast surveillance prior to FTM GACS.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36896073","golden":false,"offsetInEndSection":123,"text":"Atypical Orthognathic Surgical Protocol for Facial Feminisation as an Adjunct to Gender Affirmation Therapy: a Case Report.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":254,"document":"36896073","golden":false,"offsetInEndSection":454,"text":"It is a broad term used to describe the surgical alteration, generally performed on a male-to-female transsexual individual, in which, a masculine facial appearance is changed to a more feminine form.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36726039","golden":false,"offsetInEndSection":138,"text":"Vaginoplasty is the most frequently performed gender-affirming genital surgery for gender-diverse people with genital gender incongruence.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":331,"document":"36726039","golden":false,"offsetInEndSection":526,"text":"Penile inversion vaginoplasty (PIV) is a single surgical procedure involving anatomical component rearrangement of the penis and scrotum that enables many patients to meet these anatomical goals.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":922,"document":"36726039","golden":false,"offsetInEndSection":1080,"text":"However, major complications, such as rectal injury, rectovaginal fistula, and urethral or introital stenosis can substantially affect the patient experience.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":604,"document":"36726039","golden":false,"offsetInEndSection":751,"text":"Patient quality of life has been shown to improve drastically after vaginoplasty, but complication rates have been documented to be as high as 70%.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1081,"document":"36726039","golden":false,"offsetInEndSection":1260,"text":"Innovations in surgical approaches and techniques have demonstrated promising early results for reducing complications and augmenting vaginal depth, but long-term data are scarce.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":752,"document":"36726039","golden":false,"offsetInEndSection":921,"text":"Fortunately, most complications do not alter long-term postoperative clinical outcomes and can be managed without surgical intervention in the acute perioperative phase.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":139,"document":"36726039","golden":false,"offsetInEndSection":330,"text":"The procedure is performed to create an aesthetic and functional vulva and vaginal canal that enables receptive intercourse, erogenous clitoral sensation and a downward-directed urine stream.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":565,"document":"36017406","golden":false,"offsetInEndSection":742,"text":"Recent studies report a significant rise in prevalence of GI, which is similar to the experience of author and other large volume Gender identity clinics in India and worldwide.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36726039","golden":false,"offsetInEndSection":57,"text":"Principles and outcomes of gender-affirming vaginoplasty.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":527,"document":"36726039","golden":false,"offsetInEndSection":603,"text":"Other options include minimal-depth, peritoneal and intestinal vaginoplasty.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":233,"document":"37455781","golden":false,"offsetInEndSection":397,"text":"We present an unusual case of emergency penectomy required for a 57-year-old woman assigned-male-at-birth from rural Australia after a self-inflicted chemical burn.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":398,"document":"37455781","golden":false,"offsetInEndSection":692,"text":"This case report outlines the surgical challenges of partial penectomy and neo meatus formation to allow for future gender-affirming surgery and highlights the lack of infrastructure within the public healthcare system for management of gender dysphoria both in rural and metropolitan settings.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":130,"document":"37455781","golden":false,"offsetInEndSection":232,"text":"Currently, gender-affirming surgery is not offered under Australia\u0027s national public health insurance.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37455781","golden":false,"offsetInEndSection":72,"text":"Urology case report - Emergency penectomy for the transfeminine patient.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37455781","golden":false,"offsetInEndSection":129,"text":"Management of gender dysphoria and healthcare for transgender and non-binary patients is a growing field in Australia and abroad.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1420,"document":"34144898","golden":false,"offsetInEndSection":1732,"text":"None of them were treated with gonadotrophin-releasing hormone (GnRH) analogues.CONCLUSIONS: Parenthood strategies for transgender people have long been ignored, but this is an important issue to consider, especially because medical treatments and surgeries may be undertaken in adolescents or very young adults.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36156703","golden":false,"offsetInEndSection":190,"text":"Importance: Transgender and nonbinary (TGNB) adolescents and young adults (AYA) designated female at birth (DFAB) experience chest dysphoria, which is associated with depression and anxiety.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":432,"document":"33796924","golden":false,"offsetInEndSection":531,"text":"We review pre-, intra-, and postoperative care including the preoperative requirements for surgery.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33796924","golden":false,"offsetInEndSection":144,"text":"Gender dysphoria refers to the medical condition experienced by individuals whose physical anatomy is not consistent with their gender identity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":575,"document":"38229964","golden":false,"offsetInEndSection":903,"text":"However, there is a paucity of high-quality evidence reported in the literature about the management and breadth of complications regarding feminizing bottom surgery.Case: A healthy 37-year-old woman who was assigned male at birth underwent gender-affirming orchiectomy, penile inversion vaginoplasty, and vulvar reconstruction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":348,"document":"36322979","golden":false,"offsetInEndSection":453,"text":"Gender-affirming hormone therapy and/or surgery allows for some alignment of biology and gender identity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":585,"document":"36322979","golden":false,"offsetInEndSection":733,"text":"The Endocrine Society treatment guidelines were revised in 2017, and this article reviews recent data that might inform a future guideline revision.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":197,"document":"36322979","golden":false,"offsetInEndSection":347,"text":"Existing research on transgender health has focused heavily on mental health, HIV/AIDS, sexually transmitted diseases/infections, and substance abuse.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":454,"document":"36322979","golden":false,"offsetInEndSection":584,"text":"Gender-affirming care may offer quality-of-life benefits, which may outweigh modest concerns related to exogenous hormone therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":734,"document":"36322979","golden":false,"offsetInEndSection":840,"text":"Future longitudinal research is needed to close the gap in knowledge in the field of transgender medicine.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":977,"document":"35513312","golden":false,"offsetInEndSection":1446,"text":"Overall, 21 patients (6.6%) had some increased risk of breast cancer: 17 (5.3%) had proliferative lesions, mean age 38.2 ? 12.4 years; 2 had atypical ductal hyperplasia, ages 33.4 and 38.3 years; and 2 had invasive ductal carcinoma, ages 35.4 and 40.6 years.CONCLUSIONS: In this study, we found that 6.6% of FtM transgender patients undergoing top surgery had an elevated risk of breast cancer, with 1.2% of patients having a greater than 2 times risk of breast cancer.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36322979","golden":false,"offsetInEndSection":196,"text":"Transgender people often face barriers in health care due to lack of access to care, lack of knowledgeable healthcare professionals, discrimination, and gaps in medical and mental health research.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36322979","golden":false,"offsetInEndSection":37,"text":"Update in Adult Transgender Medicine.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37071372","golden":false,"offsetInEndSection":114,"text":"PURPOSE: Many issues still remain unresolved in the management of pubertal patients with gender incongruence (GI).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1009,"document":"32257862","golden":false,"offsetInEndSection":1132,"text":"Transmen before and after starting hormone therapy can pursue any assistive reproductive techniques available for ciswomen.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36017406","golden":false,"offsetInEndSection":216,"text":"A mismatch between the birth sex of a person and psychological recognition of self (gender) leads to a gender expression, which is at variance with the societal norms, and thus gives rise to gender incongruence (GI).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":374,"document":"36017406","golden":false,"offsetInEndSection":564,"text":"The authors, who have been performing gender affirmative surgeries (GAS) since the past 27 years, present their experience in gender affirmation together with the current state of knowledge.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":743,"document":"36017406","golden":false,"offsetInEndSection":926,"text":"This article endeavors to provide the medical professional with the current state of knowledge in the field of GI, so that they are better equipped to optimally manage these patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":217,"document":"36017406","golden":false,"offsetInEndSection":373,"text":"In the past few years, there has been a significant change in demographics, understanding of etiology, management, laws and legislations in the field of GI.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36017406","golden":false,"offsetInEndSection":104,"text":"Gender Affirmation in India-The Current State of Knowledge, Management, Legal and Legislative Situation.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":163,"document":"33990998","golden":false,"offsetInEndSection":641,"text":"The primary objective of this study was to evaluate the relationship between gender identity, gender affirming interventions such as gender affirming hormones (GAH) and gender affirming surgeries (GAS), and ED symptomatology.METHOD: Transgender patients at a primary care outpatient gender health program in the United States completed a survey consisting of demographics, medical history, and clinical variables, including the Eating Disorder Examination Questionnaire (EDE-Q).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":524,"document":"37963404","golden":false,"offsetInEndSection":713,"text":"Unique nuances exist in the considerations needed when preparing for hysterectomy, and patients should be thoroughly counseled with regard to concurrent vaginectomy or oophorectomy or both.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1468,"document":"36931571","golden":false,"offsetInEndSection":1791,"text":"Revision surgeries were performed for 38.9% of vaginoplasty patients during the study period, most commonly including urethral revision (29.6%), labia majoraplasty (20.4%), and labia minoraplasty (14.8%).CONCLUSION: Collaboration between urology and plastic surgery is a safe and effective means to establish a GAS program.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":905,"document":"37963404","golden":false,"offsetInEndSection":1085,"text":"Becoming familiar with the perioperative and delayed postoperative care needs of transfeminine patients undergoing vaginoplasty can help improve the care provided by gynecologists.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1001,"document":"35918245","golden":false,"offsetInEndSection":1466,"text":"Endometrial thickness was significantly lower in transmasculine people compared with cisgender women: median 3.9 mm (interquartile range [IQR] 2.8-5.1) and 4.9 mm (IQR 4.0-6.3), respectively (P \u003c 0.001), after correcting for confounding factor (current gonadotrophin releasing hormone agonist use).CONCLUSIONS: Endometrial thickness in transmasculine people exposed to testosterone is significantly lower compared with cisgender women without testosterone exposure.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":112,"document":"37963404","golden":false,"offsetInEndSection":189,"text":"Transmasculine individuals require routine gynecologic and preventative care.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":190,"document":"37963404","golden":false,"offsetInEndSection":434,"text":"Guidelines can be extrapolated from the cisgender female population, and using affirming language, acknowledging the challenges patients face with pelvic examination, and discussing individual gynecologic needs are important components of care.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1241,"document":"37963404","golden":false,"offsetInEndSection":1430,"text":"Gynecologists remain central to the care of TGD patients, the academic advancement of the field of transgender health, and the advocacy needed to support this vulnerable patient population.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":714,"document":"37963404","golden":false,"offsetInEndSection":904,"text":"Transfeminine patients often seek gynecologic care after gender-affirming surgery, and, unlike transmasculine patients, the gynecology visit is often very affirming and welcomed by patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":435,"document":"37963404","golden":false,"offsetInEndSection":523,"text":"Transmasculine patients may seek hysterectomy for gender affirmation from gynecologists.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1086,"document":"37963404","golden":false,"offsetInEndSection":1240,"text":"In general, prospective data on the outcomes of gender-affirming care in large cohorts of TGD patients are limited, but the body of literature is growing.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1608,"document":"36089115","golden":false,"offsetInEndSection":1826,"text":"eptible healing in patients on testosterone. As vaginal bleeding could worsen gender dysphoria, these findings support the need for patient counseling on postoperative bleeding expectations and identification of interv","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1281,"document":"36089115","golden":false,"offsetInEndSection":1607,"text":"eding identified (n?\u003d?4, 36.4%).CONCLUSIONS: Over half of transgender AYA on testosterone therapy in this cohort reported postoperative vaginal bleeding concerns that were most often secondary to atrophy and granulation tissue, suggesting possible susceptibility to vaginal tissue trauma at the time of GAH and granulation-sus","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":599,"document":"36089115","golden":false,"offsetInEndSection":695,"text":" ranged between 18 and 33 years. Among 25 patients who met the inclusion criteria, 13 (52.0%) re","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":696,"document":"36089115","golden":false,"offsetInEndSection":832,"text":"orted vaginal bleeding concerns. No modifiable patient or operative characteristics reached statistical significance in association with","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":3207,"document":"27600715","golden":false,"offsetInEndSection":3349,"text":" of the initial surgical intervention.RESULTS: In total, 14 of 103 (14%) patients treated for OCD in this study had an immediate and/or extend","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":4236,"document":"27600715","golden":false,"offsetInEndSection":4563,"text":"OCD in the general population according to prior research. Therefore, our data provide preliminary support for a familial inheritance pattern for OCD, suggesting that further clinical, biologic, and genomic investigation might help to improve our understanding of who is at highest risk for OCD and what moderating factors migh","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":4564,"document":"27600715","golden":false,"offsetInEndSection":4792,"text":" influence their disease severity and risk of progression. Furthermore, our data suggest that expanded patient education and screening regarding inheritance patterns might enhance identification of potential familial disease bur","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":886,"document":"38340965","golden":false,"offsetInEndSection":973,"text":"We identified 766 patients who underwent gender-affirming phalloplasty in 23 facilities","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38294149","golden":false,"offsetInEndSection":86,"text":"Gender-Affirming Mastectomy: Psychosocial and Surgical Outcomes in Transgender Adults.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":507,"document":"38198631","golden":false,"offsetInEndSection":715,"text":"Adolescent (18 years and older) and young adult (aged 19-25 years) transgender patients were analyzed for differences in demographics, comorbidities, surgical characteristics, and postoperative complications.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1215,"document":"38133914","golden":false,"offsetInEndSection":1351,"text":"This is a prospective pilot, open-label, randomized clinical trial conducted at an adult transgender clinic in a tertiary medical center","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":89,"document":"37983814","golden":false,"offsetInEndSection":284,"text":"However, the amount and timing of facial fat changes in response to feminizing hormone therapy are unknown, albeit relevant to counseling and surgical planning for facial gender-affirming surgery","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"37935961","golden":false,"offsetInEndSection":252,"text":"We designed a survey to evaluate preferences of facial appearance in transgender male (TM), transgender female (TF) and gender nonbinary patients to better inform goals of facial gender affirming surgery (FGAS) in gender nonbinary patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":384,"document":"37870257","golden":false,"offsetInEndSection":541,"text":"This single-center, cross-sectional study included individuals 18 years and older who underwent GM between 1990-2020 and were at least 2 years post-operative","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":378,"document":"37837637","golden":false,"offsetInEndSection":604,"text":"We conducted an institutional review board-approved retrospective study of all transmasculine individuals who had been taking testosterone for at least 1 year and had a uterus and ovaries at the time of testosterone initiation","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"37814700","golden":false,"offsetInEndSection":103,"text":"An increasing number of gender diverse individuals are presenting for gender affirming care","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1379,"document":"31619510","golden":true,"offsetInEndSection":1624,"text":"Eighty-nine patients underwent gender-affirming surgeries, mostly before age 18 and most frequently mastectomies (77%).CONCLUSIONS: The increase in referrals supports the need for expanded and accessible health care services for this population.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":138,"document":"31619510","golden":false,"offsetInEndSection":515,"text":"We identified the transition-related requests of pediatric transgender and gender-nonconforming patients and evaluated differences in referrals by age group.METHODS: Medical records were analyzed for all patients \u003c18 years of age in the Kaiser Permanente Northern California health system who were referred to a specialty transgender clinic between February 2015 and June 2018.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1191,"document":"33257402","golden":false,"offsetInEndSection":1517,"text":"In comparison with the general population, young transgender adults were less experienced with all types of sexual activities.CONCLUSIONS: Early GAT (including puberty suppression, affirmative hormones, and surgeries) may provide young transgender adults with the opportunity to increase their romantic and sexual experiences.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":382,"document":"38340965","golden":false,"offsetInEndSection":526,"text":"Adult patients 18 years or older undergoing gender-affirming phalloplasty in California from January 1, 2009 to December 31, 2019 were included.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":516,"document":"31619510","golden":false,"offsetInEndSection":772,"text":"Trends in treatment demand, demographic data, service requests, and surgical history were abstracted from medical charts and analyzed by using descriptive statistics.RESULTS: We identified 417 unique transgender and gender-nonconforming pediatric patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33257402","golden":false,"offsetInEndSection":164,"text":"OBJECTIVES: Early gender-affirmative treatment (GAT) of adolescents may consist of puberty suppression, use of affirming hormones, and gender-affirmative surgeries.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31619510","golden":false,"offsetInEndSection":137,"text":"OBJECTIVES: We characterized referral trends over time at a transgender clinic within an integrated health system in Northern California.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":773,"document":"31619510","golden":false,"offsetInEndSection":834,"text":"The median age at time of referral was 15 years (range 3-17).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":835,"document":"31619510","golden":false,"offsetInEndSection":883,"text":"Most (62%) identified on the masculine spectrum.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1266,"document":"38340965","golden":false,"offsetInEndSection":1641,"text":"Asian/Pacific Islander patients had lower risk of complications, and California residents had higher risk of complications.CONCLUSIONS: This population-based study confirms that gender-affirming phalloplasty has a high complication rate, and demonstrates for the first time an association with high rates of return to hospitals, emergency departments, and ambulatory centers.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1642,"document":"38340965","golden":false,"offsetInEndSection":1804,"text":"These findings provide additional higher-level evidence that may aid patient counseling, shared surgical decision making, and institutional and government policy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1175,"document":"38340965","golden":false,"offsetInEndSection":1265,"text":"Survival analysis indicated that 50% of patients re-presented by 1 year post-phalloplasty.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38340965","golden":false,"offsetInEndSection":381,"text":"OBJECTIVE: To evaluate the incidence of gender-affirming phalloplasty and complications in a large population-based dataset.METHODS: Retrospective cohort study was done using the California Department of Health Care Access and Information datasets which include patient-level data from all licensed hospitals, emergency departments, and ambulatory surgery facilities in California.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":778,"document":"38340965","golden":false,"offsetInEndSection":974,"text":"Statistical analysis included Kaplan-Meier survival analysis and Cox proportional hazards analysis.RESULTS: We identified 766 patients who underwent gender-affirming phalloplasty in 23 facilities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":975,"document":"38340965","golden":false,"offsetInEndSection":1174,"text":"Of 475 patients with record linkage numbers, 253 (55.3%) had subsequent re-presentations to the inpatient, emergency department, and ambulatory surgery settings related to phalloplasty complications.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":756,"document":"38344787","golden":false,"offsetInEndSection":1053,"text":"Further, the sex discrimination argument might force transgender individuals into making claims based on a binarized gender identity which may not conform with their lived experience.Claims based on the Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA) can address these shortcomings.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":115,"document":"38344787","golden":false,"offsetInEndSection":231,"text":"Most of these cases successfully advance equality claims by arguing that trans exclusions discriminate based on sex.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":366,"document":"38344787","golden":false,"offsetInEndSection":415,"text":"There are, however, limitations to this argument.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":567,"document":"38344787","golden":false,"offsetInEndSection":755,"text":"Second, a court that is hostile to the sex discrimination argument might hold that the denial does not arise from sex discrimination, but rather, because of the kind of diagnosis at issue.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1619,"document":"38344787","golden":false,"offsetInEndSection":1800,"text":"However, an MHPAEA claim would only appear in cases where a transgender individual is voluntarily submitting themselves to medical assistance in order to advance their own autonomy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1145,"document":"38315125","golden":false,"offsetInEndSection":1617,"text":"There was an absolute decrease of 8.8% in SSRI or SNRI prescription after gender-affirming plastic surgery (p\u003c0.001), and significant decreases in post-operative depression (7.7%), anxiety (1.6%), suicidal ideation (5.2%) and attempts (2.3%), alcohol abuse (2.1%), and drug abuse (1.9%).CONCLUSION: Gender-affirming surgery in appropriately selected gender dysphoric patients is associated with decreased postoperative rates of SSRI or SNRI use and improved mental health.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1342,"document":"38344787","golden":false,"offsetInEndSection":1488,"text":"Transgender individuals seeking gender affirming care arising from gender dysphoria can thus claim that exclusions of coverage violate the MHPAEA.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34376826","golden":false,"offsetInEndSection":351,"text":"An increasing number of transgender and gender-diverse (TGD) youth (early pubertal through to late adolescent, typically 9-10 through to 18 years of age) are seeking medical services to bring their physical sex characteristics into alignment with their gender identity - their inner sense of self as male or female or somewhere on the gender spectrum.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":915,"document":"37510824","golden":false,"offsetInEndSection":1111,"text":"On the other hand, internalizing problems, both in general and within the clinical range, were found to be more prevalent in assigned male at birth (AMAB) adolescents, as indicated by self-report.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1585,"document":"36396559","golden":false,"offsetInEndSection":1795,"text":"Transmasculine individuals may no longer require chest reconstruction for breast development.CONCLUSIONS: Offers of GnRHA treatment to TGNB adolescents should be balanced by careful preparation and counselling.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31553137","golden":false,"offsetInEndSection":209,"text":"BACKGROUND: In gender minority patients, electrolysis and laser hair removal may be necessary to reduce facial and body hair in individuals seeking a more feminine appearance and/or modified gender expression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1179,"document":"31553137","golden":false,"offsetInEndSection":1455,"text":"Cost was the most frequently cited barrier to care.CONCLUSION: As the majority of transwomen and nonbinary people on feminizing hormone therapy had persistent excess facial/body hair, routine use of gender-affirming hormones is not sufficient to fully eliminate unwanted hair.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":210,"document":"31553137","golden":false,"offsetInEndSection":605,"text":"These procedures may also be required preoperatively for some gender-affirming surgeries.AIMS: To identify (a) the frequency of unwanted facial and body hair, (b) the use of various hair removal methods, and (c) associated barriers to care in gender minority patients.METHODS: An online-based patient survey was distributed via social media on Facebook? , YouTube? , and Instagram? in fall 2018.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":606,"document":"31553137","golden":false,"offsetInEndSection":763,"text":"Respondents were at least 18?years old and self-identified as a gender minority.RESULTS: In total, 991 responses were recorded with a completion rate of 77%.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":986,"document":"31553137","golden":false,"offsetInEndSection":1178,"text":"Laser hair removal (18%) and electrolysis (17%) had similar rates of use in this cohort and were more commonly reported for nonsurgical gender-affirming purposes than preoperative preparation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1456,"document":"31553137","golden":false,"offsetInEndSection":1608,"text":"There remains a critical need to advocate for more comprehensive insurance coverage for laser hair removal and electrolysis in gender minority patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":764,"document":"31553137","golden":false,"offsetInEndSection":985,"text":"Considering excess hair, 84% of transwomen on feminizing hormone therapy (FHT: estrogen and anti-androgen therapy), 100% of transwomen not on FHT, and 100% of nonbinary individuals on FHT reported excess facial/body hair.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":885,"document":"37790660","golden":false,"offsetInEndSection":937,"text":"A total of 79% were taking gender-affirming hormones","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"37700562","golden":false,"offsetInEndSection":117,"text":"Vaginoplasty is a gender-affirming surgery that is medically necessary for some transfeminine individuals","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":641,"document":"37529407","golden":false,"offsetInEndSection":863,"text":"Among TGW, logistic regression with generalized estimating equations was used to estimate adjusted odds ratios (aORs) and 95% CIs for associations with taking hormones and having undergone gender affirmation surgery (GAS).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":14,"document":"37438971","golden":false,"offsetInEndSection":122,"text":"Assigned female at birth transgender people go through a gender-affirming hormone therapy using testosterone","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":577,"document":"37325930","golden":false,"offsetInEndSection":671,"text":"Majority of patients experienced gender incongruence (GI) since pre-pubertal age (median 11.0)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":273,"document":"37252769","golden":false,"offsetInEndSection":508,"text":" We used 2016 and 2017 cross-sectional data from the Nationwide Inpatient Sample to estimate the hysterectomy rate for individuals aged 18-54 years with a primary indication for gender-affirming care (GAC) compared to other indications","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":402,"document":"37398606","golden":false,"offsetInEndSection":1031,"text":"A total of 10,270 unique transgender and gender-diverse patients-aged 18 to 44 years (median age 24 years), with no prior use of gender-affirming hormone therapy-completed clinical intake forms between September 1, 2020, and January 1, 2022.Interventions: Patient sex assigned at birth, insurance status, age, and geographic location.Main Outcome Measures: Self-reported desire for children using own genetic material.Results: Transgender and gender-diverse patients seeking gender-affirming medical treatments who are open to having genetically related children are an important population to identify and appropriately counsel.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":712,"document":"34259985","golden":false,"offsetInEndSection":832,"text":"Results revealed that sex assigned at birth was significantly associated with almost all the sociodemographic variables.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1361,"document":"34259985","golden":false,"offsetInEndSection":1522,"text":"Results were discussed highlighting the heterogeneity found in terms of sociodemographic characteristics, gender identification, and gender affirmation pathways.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1100,"document":"34259985","golden":false,"offsetInEndSection":1244,"text":"These patterns indicated that the longer the gender affirmation pathway time, the greater the invasiveness level of the medical procedures used.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1245,"document":"34259985","golden":false,"offsetInEndSection":1360,"text":"Sex assigned at birth moderated the association between gender affirmation pathways and gender identity categories.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":918,"document":"34259985","golden":false,"offsetInEndSection":999,"text":"These gender identification categories varied according to sex assigned at birth.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":158,"document":"36353692","golden":false,"offsetInEndSection":845,"text":"We explored the influence of sex hormones on immune phenotype in the context of adolescent health and autoimmunity.Methods: In this cross-sectional study, healthy, post-pubertal cisgender individuals (aged 16-25 years); healthy, pre-pubertal cisgender individuals (aged 6-11 years); transgender individuals (aged 18-19 years) undergoing gender-affirming treatment (testosterone in individuals assigned female sex at birth and oestradiol in individuals assigned male sex at birth); and post-pubertal cisgender individuals (aged 14-25 years) with juvenile-onset systemic lupus erythematosus (SLE) age-matched to cisgender individuals without juvenile-onset SLE were eligible for inclusion.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1891,"document":"37398606","golden":false,"offsetInEndSection":2181,"text":"These results indicate that transgender and gender-diverse patients, particularly male-sex-assigned-at-birth individuals and patients with private insurance, could benefit from counseling regarding the impacts of gender-affirming hormone therapy and gender-affirming surgeries on fertility.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34259985","golden":false,"offsetInEndSection":142,"text":"Understanding the internal diversity of transgender communities is essential for developing optimal, inclusive policies and service provision.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37581925","golden":false,"offsetInEndSection":146,"text":"BACKGROUND: Of the 1.6 million transgender and gender-diverse (TGD) people in the United States, approximately 700,000 are youth aged 13-24 years.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"34052163","golden":false,"offsetInEndSection":132,"text":"Creating the neovaginal canal in transwomen is one of the most delicate steps of Genital Gender Affirming Surgery (GGAS)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":208,"document":"33497725","golden":false,"offsetInEndSection":320,"text":"Retrospective chart review of transgender men presenting for gender-affirming hysterectomy between 2010 and 2019","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":482,"document":"28245038","golden":true,"offsetInEndSection":631,"text":"Gender-confirming medical interventions are regulated by a special law that sets a minimum age for legal and surgical gender reassignment to 18 years","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":262,"document":"38940898","golden":false,"offsetInEndSection":694,"text":"This study aimed to estimate the prevalence of elevated breast cancer (BC) risk in TGD persons, compare self-perceived versus calculated risk, and determine how risk impacts the decision for GACMS versus RRM.METHODS: A prospective single-arm pilot educational intervention trial was conducted in individuals assigned female or intersex at birth, age ??18 years, considering GACMS, without a BC history or a known pathogenic variant.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38940898","golden":false,"offsetInEndSection":261,"text":"BACKGROUND: Persons assigned female or intersex at birth and identify as transgender and/or gender-diverse (TGD) may undergo gender-affirming chest masculinization surgery (GACMS); however, GACMS is not considered equivalent to risk-reducing mastectomies (RRM).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1308,"document":"38940898","golden":false,"offsetInEndSection":1561,"text":"Of the 13 with elevated risk, 5 (38.5%) underwent/are scheduled to undergo GACMS, 3 (23%) of whom underwent/are undergoing RRM.CONCLUSIONS: Over half of the cohort had elevated risk, and most of those who moved forward with surgery chose to undergo RRM.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1145,"document":"38940898","golden":false,"offsetInEndSection":1231,"text":"Thirteen (52%) had elevated risk (prevalence 95% confidence interval (CI) 31.3-72.2%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1562,"document":"38940898","golden":false,"offsetInEndSection":1637,"text":"A BC risk assessment should be performed for TGD persons considering GACMS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":948,"document":"38940898","golden":false,"offsetInEndSection":1144,"text":"All were assigned female sex at birth, most (84%) were Non-Hispanic (NH)-White, 48% identified as transgender and 40% as nonbinary, and 52% had a first- and/or second-degree family member with BC.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1788,"document":"38699117","golden":false,"offsetInEndSection":1968,"text":"Conclusion Gender-affirming surgery is significantly associated with elevated suicide attempt risks, underlining the necessity for comprehensive post-procedure psychiatric support.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":780,"document":"38940898","golden":false,"offsetInEndSection":947,"text":"Elevated risk was defined as ??17%.RESULTS: Twenty-five (N?\u003d?25) participants were enrolled with a median age of 24.0 years (interquartile range, IQR 20.0-30.0 years).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":112,"document":"38981783","golden":false,"offsetInEndSection":259,"text":"providers. Gender-affirming surgery is often delayed until after a patient reaches the age of majority; however, patients may desire surgery at a y","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":466,"document":"38349521","golden":false,"offsetInEndSection":728,"text":"ith the growth of TGD procedures as a field, more pediatric subspecialties are performing these procedures, and the approaches are informing the surgical care of the growing number of I/DSD individuals who are seeking surgery in adolescence and young adulthood. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":207,"document":"38130983","golden":false,"offsetInEndSection":341,"text":"urgeons are faced with the challenge of deciding whether a variation of gender-affirming surgery can be safely performed per request. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":262,"document":"38697058","golden":false,"offsetInEndSection":444,"text":"wellbeing.OBJECTIVE: This article provides an overview of genital gender affirmation surgeries, focusing on the available options and appropriate referral criteria for general practi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":549,"document":"38699117","golden":false,"offsetInEndSection":921,"text":"The study involved four cohorts: cohort A, adults aged 18-60 who had gender-affirming surgery and an emergency visit (N \u003d 1,501); cohort B, control group of adults with emergency visits but no gender-affirming surgery (N \u003d 15,608,363); and cohort C, control group of adults with emergency visits, tubal ligation or vasectomy, but no gender-affirming surgery (N \u003d 142,093).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1487,"document":"38699117","golden":false,"offsetInEndSection":1787,"text":"Compared to the tubal ligation/vasectomy controls, the risk was 5.03-fold higher before propensity matching and remained significant at 4.71-fold after matching (3.50% vs. 0.74%, RR 95% CI 2.46-9.024, p \u003c 0.0001) for the gender affirmation patients with similar results with the pharyngitis controls.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38699117","golden":false,"offsetInEndSection":126,"text":"Introduction With the growing acceptance of transgender individuals, the number of gender affirmation surgeries has increased.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":127,"document":"38699117","golden":false,"offsetInEndSection":239,"text":"Transgender individuals face elevated depression rates, leading to an increase in suicide ideation and attempts.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38699117","golden":false,"offsetInEndSection":67,"text":"Risk of Suicide and Self-Harm Following Gender-Affirmation Surgery.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38618736","golden":false,"offsetInEndSection":333,"text":"OBJECTIVE: To characterize the trends in and characteristics associated with the utilization and cost of gender-affirming surgery (GAS) in the United States from 2012-2019.SUMMARY BACKGROUND DATA: GAS is one option among gender-diverse (GD) people to transition from their biologic anatomy to the anatomy congruent with their gender.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":718,"document":"38618736","golden":false,"offsetInEndSection":901,"text":"Records from 2012-2019 that indicated ages 18 or older, GD diagnoses, and GAS procedures were identified using the International Classification of Diseases, Ninth and Tenth Revisions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1818,"document":"38618736","golden":false,"offsetInEndSection":2322,"text":"Lower costs were found in records that indicated hospital location in the Midwest (27% lower, 95% CI [0.61-0.87], P\u003c0.001), Northeast (34% lower, 95% CI [0.55-0.80], P\u003c0.001) and South (39% lower, 95% CI [0.53-0.71], P\u003c0.001) compared to the West.CONCLUSIONS: As demand for GAS increases with varying utilization and costs based on patient and hospital characteristics, there will likely be a need for more qualified surgeons, increased insurance coverage, and policies to ensure equitable access to GAS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":902,"document":"38618736","golden":false,"offsetInEndSection":1127,"text":"Within this cohort, demographics, utilization, and cost were collected and analyzed using descriptive statistics and multivariable regression models.RESULTS: 6,325 records with GD diagnoses and GAS procedures were identified.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1315,"document":"38618736","golden":false,"offsetInEndSection":1507,"text":"This cost trend was similar by type of surgery, and genital surgery had consistently higher costs than chest surgery from 2012 to 2019 (genital: $21,487 to $26,712, chest: $13,238 to $21,309).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1508,"document":"38618736","golden":false,"offsetInEndSection":1817,"text":"Lower odds of utilization were found in records with Medicaid (OR \u003d 0.27, 95% CI [0.22-0.35], P\u003c0.001) and Medicare (OR \u003d 0.15, 95% CI [0.11-0.23], P\u003c0.001) compared to private insurance, as well as those in the lowest income quartile (OR \u003d 0.68, 95% CI [0.54-0.85], P\u003c0.001) compared to the highest quartile.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38618736","golden":false,"offsetInEndSection":85,"text":"Utilization and Cost of Gender-affirming Surgery in the United States from 2012-2019.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1079,"document":"39293270","golden":false,"offsetInEndSection":1606,"text":"Multivariate logistic regression adjusted for common covariates (age, ethnicity, smoking status, asthma, autoimmune disorders, cardiovascular conditions, and mental health disorders) did not reveal any significant relationships between BMI and the likelihood of experiencing complications at any study point.CONCLUSIONS: Masculinizing chest reconstruction is safe and satisfactory for young adult patients across the range of BMI, with significant differences in outcomes found only for esthetic complications (i.e., dog ears).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39271026","golden":false,"offsetInEndSection":318,"text":"OBJECTIVE: To evaluate the outcomes of robot-assisted tubularized peritoneal vaginoplasty (RATPV) for trans-feminine patients desiring genital gender-affirming surgery (gGAS).METHODS: We retrospectively reviewed all patients (adults ?18 years old) who underwent RATPV for gGAS at our institution (July 2020-July 2022).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":982,"document":"39465092","golden":false,"offsetInEndSection":1540,"text":"Among several significant predictors, gender-affirming surgery (hysterectomy) (p-value \u003d \u003c0.0001) and telling others they are transgender at a younger age (\u003c 18) (p-value \u003d 0.0344) were associated with increased screening adherence, while having HIV was associated with decreased screening adherence (p-value \u003d 0.0045).Discussion: Our results suggest that interacting with the healthcare system to obtain comprehensive cancer screening can be difficult to navigate among the other healthcare needs of TGNB individuals both on an individual and systems level.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1216,"document":"37610753","golden":false,"offsetInEndSection":1926,"text":"t common procedures were breast and chest procedures, which occurred in 27?187 patients (56.6%), followed by genital reconstruction (16?872 [35.1%]) and other facial and cosmetic procedures (6669 [13.9%]). The absolute number of GAS procedures rose from 4552 in 2016 to a peak of 13?011 in 2019 and then declined slightly to 12?818 in 2020. Overall, 25?099 patients (52.3%) were aged 19 to 30 years, 10?476 (21.8%) were aged 31 to 40, and 3678 (7.7%) were aged12 to 18 years. When stratified by the type of procedure performed, breast and chest procedures made up a greater percentage of the surgical interventions in younger patients, while genital surgical procedures were greater in older patients.Conclusio","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":164,"document":"37084532","golden":false,"offsetInEndSection":482,"text":"o better understand the implication of testosterone therapy on female-to-male gender-affirming mastectomies, we conducted a retrospective cohort study based on the medical histories of 170 transgender males operated on by a single surgeon over 18 years. One hundred and one (59.4%) patients received hormonal therapy. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":13,"document":"38940898","golden":false,"offsetInEndSection":471,"text":"ersons assigned female or intersex at birth and identify as transgender and/or gender-diverse (TGD) may undergo gender-affirming chest masculinization surgery (GACMS); however, GACMS is not considered equivalent to risk-reducing mastectomies (RRM). This study aimed to estimate the prevalence of elevated breast cancer (BC) risk in TGD persons, compare self-perceived versus calculated risk, and determine how risk impacts the decision for GACMS versus RRM.M","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":100,"document":"34052163","golden":false,"offsetInEndSection":350,"text":" Gender Affirming Surgery (GGAS). Injury to the rectum is a rare but serious complication that can lead to further surgery and even creation of a colostomy.AIM: Implementation of a novel hydrospacing technique (HST) based on transrectal ultrasound (T","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":357,"document":"24238576","golden":false,"offsetInEndSection":648,"text":" individuals. Despite the minimum age of 18 as eligibility to undergo irreversible procedures, anecdotal reports show that vaginoplasties of female-affirmed patients under 18 have been performed by surgeons, thereby contravening the World Professional Association for Transgender Health Stan","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35407551","golden":false,"offsetInEndSection":174,"text":"Most minors and young transgender persons wishing to undergo gender-affirming surgery need to seek specialists affiliated with gender affirmation programs in adult hospitals.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1480,"document":"37317409","golden":false,"offsetInEndSection":1623,"text":"iscipline (OR 4.42, p\u003d0.032). Age 40 years or older predicted for belief that gender affirming surgery should not be covered by public insuranc","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":662,"document":"36324882","golden":false,"offsetInEndSection":778,"text":"The responses of individuals greater than 18?years of age who identified as transgender or non-binary were analyzed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1018,"document":"38294149","golden":false,"offsetInEndSection":1170,"text":"d psychosocial outcomes.RESULTS: A total of 111 transmasculine and nonbinary patients 18 to 63 years of age (mean ? SD 26.5???8) underwent mastectomy an","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":320,"document":"39736610","golden":false,"offsetInEndSection":499,"text":"le changes. For gender-affirming surgeries, patients undergoing assessments to discern whether they are ready to undergo the surgery, and to assist them in achieving preparedness ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":392,"document":"36827481","golden":false,"offsetInEndSection":538,"text":"e research.METHODS: A scoping review of recent literature was performed to assess evidence on gender-affirming surgery in individuals under the ag","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37230432","golden":false,"offsetInEndSection":266,"text":"Access to gender-affirming surgery is increasing for many transgender and nonbinary people in the United States, and radiation oncologists must be equipped to care for patients who have undergone such surgery in the region of their planned radiation treatment field.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":163,"document":"37084532","golden":false,"offsetInEndSection":417,"text":"To better understand the implication of testosterone therapy on female-to-male gender-affirming mastectomies, we conducted a retrospective cohort study based on the medical histories of 170 transgender males operated on by a single surgeon over 18 years.","beginSection":"abstract"}],"ideal_answer":[],"id":"6593d2e006a2ea257c000019","type":"summary","body":"Should gender-affirming surgery be performed in people under 18 years of age?"},{"documents":[{"golden":false,"id":"24239483"},{"golden":false,"id":"34248457"},{"golden":false,"id":"36483729"},{"golden":false,"id":"17050396"},{"golden":false,"id":"2441253"},{"golden":false,"id":"16570879"},{"golden":false,"id":"24414040"},{"golden":true,"id":"11450386"},{"golden":true,"id":"1783868"},{"golden":false,"id":"21345646"},{"golden":false,"id":"6503930"},{"golden":false,"id":"7227676"},{"golden":false,"id":"9009879"},{"golden":false,"id":"32231627"},{"golden":false,"id":"31182066"},{"golden":false,"id":"23257112"},{"golden":false,"id":"7751555"},{"golden":true,"id":"29404228"},{"golden":false,"id":"34232145"},{"golden":false,"id":"12087645"},{"golden":false,"id":"15505964"},{"golden":false,"id":"7751563"},{"golden":false,"id":"33158434"},{"golden":true,"id":"34784486"},{"golden":false,"id":"36511969"},{"golden":false,"id":"36360363"},{"golden":false,"id":"34513368"},{"golden":false,"id":"37018183"},{"golden":false,"id":"2270819"},{"golden":false,"id":"21807872"},{"golden":false,"id":"1273628"},{"golden":false,"id":"21887581"},{"golden":false,"id":"38131743"},{"golden":false,"id":"36141813"},{"golden":false,"id":"16324184"},{"golden":false,"id":"36979973"},{"golden":false,"id":"24008790"},{"golden":false,"id":"27992780"},{"golden":false,"id":"37448921"},{"golden":false,"id":"37299942"},{"golden":false,"id":"37975431"},{"golden":false,"id":"37171764"},{"golden":false,"id":"32419146"},{"golden":false,"id":"37528522"},{"golden":false,"id":"33892615"},{"golden":false,"id":"35318642"},{"golden":false,"id":"34099235"},{"golden":false,"id":"37901390"},{"golden":false,"id":"32297864"},{"golden":false,"id":"6786177"},{"golden":false,"id":"15736100"},{"golden":false,"id":"36511160"},{"golden":false,"id":"36733820"},{"golden":false,"id":"25894277"},{"golden":false,"id":"7777637"},{"golden":false,"id":"36381531"},{"golden":false,"id":"34132143"},{"golden":false,"id":"28833308"},{"golden":false,"id":"9738716"},{"golden":false,"id":"36902669"},{"golden":false,"id":"37269577"},{"golden":false,"id":"36850364"},{"golden":false,"id":"38186518"},{"golden":false,"id":"29379411"},{"golden":false,"id":"31730315"},{"golden":false,"id":"36909570"},{"golden":false,"id":"29651830"},{"golden":false,"id":"36584937"},{"golden":false,"id":"11530420"},{"golden":false,"id":"26336330"},{"golden":false,"id":"34501998"},{"golden":false,"id":"33192402"},{"golden":false,"id":"31374626"},{"golden":false,"id":"34085944"},{"golden":false,"id":"16401146"},{"golden":false,"id":"21103706"},{"golden":false,"id":"12664722"},{"golden":false,"id":"37270907"},{"golden":false,"id":"11767506"},{"golden":false,"id":"29213768"},{"golden":false,"id":"18562184"},{"golden":false,"id":"2299556"},{"golden":false,"id":"35590861"},{"golden":false,"id":"16083392"},{"golden":false,"id":"38297892"},{"golden":false,"id":"38294475"},{"golden":false,"id":"38294191"},{"golden":false,"id":"38291422"},{"golden":false,"id":"38288163"},{"golden":false,"id":"35763175"},{"golden":false,"id":"33641795"},{"golden":false,"id":"36248649"},{"golden":false,"id":"35429340"},{"golden":false,"id":"33761179"},{"golden":false,"id":"36465597"},{"golden":false,"id":"36571020"},{"golden":false,"id":"33767242"},{"golden":false,"id":"34115168"},{"golden":false,"id":"14959806"},{"golden":true,"id":"28368273"},{"golden":true,"id":"9736960"},{"golden":false,"id":"20211706"},{"golden":false,"id":"14676873"},{"golden":true,"id":"30556686"},{"golden":false,"id":"27644917"},{"golden":false,"id":"37480808"},{"golden":false,"id":"18605438"},{"golden":false,"id":"9006183"},{"golden":false,"id":"38350976"},{"golden":false,"id":"38350425"},{"golden":false,"id":"38340696"},{"golden":false,"id":"38332474"},{"golden":false,"id":"38330211"},{"golden":false,"id":"38329108"},{"golden":false,"id":"38324351"},{"golden":false,"id":"38323379"},{"golden":false,"id":"38322967"},{"golden":false,"id":"38317694"},{"golden":false,"id":"38357540"},{"golden":false,"id":"38356654"},{"golden":false,"id":"38356379"},{"golden":false,"id":"38352723"},{"golden":false,"id":"38347056"},{"golden":false,"id":"38343118"},{"golden":false,"id":"38340121"},{"golden":false,"id":"2745731"},{"golden":false,"id":"11460175"},{"golden":false,"id":"15490903"},{"golden":false,"id":"3216018"},{"golden":false,"id":"2583602"},{"golden":false,"id":"27541089"},{"golden":false,"id":"32847232"},{"golden":false,"id":"3501415"},{"golden":false,"id":"16392692"},{"golden":false,"id":"29097974"},{"golden":false,"id":"32540607"},{"golden":false,"id":"37233328"},{"golden":true,"id":"34331711"},{"golden":false,"id":"33655076"},{"golden":true,"id":"33977880"},{"golden":false,"id":"32206580"},{"golden":false,"id":"36063351"},{"golden":false,"id":"33235593"},{"golden":false,"id":"31978022"},{"golden":false,"id":"21177978"},{"golden":false,"id":"21106718"},{"golden":false,"id":"15495544"},{"golden":false,"id":"6728518"},{"golden":false,"id":"17849081"},{"golden":false,"id":"26113833"},{"golden":false,"id":"7251250"},{"golden":false,"id":"35309706"},{"golden":false,"id":"37079634"},{"golden":false,"id":"37416303"},{"golden":false,"id":"36138974"},{"golden":false,"id":"35002821"},{"golden":false,"id":"36745100"},{"golden":false,"id":"34395201"},{"golden":false,"id":"33125855"},{"golden":false,"id":"34652509"},{"golden":false,"id":"18781121"},{"golden":true,"id":"6827218"},{"golden":false,"id":"12585531"},{"golden":false,"id":"16392699"},{"golden":false,"id":"2279487"},{"golden":false,"id":"2034911"},{"golden":false,"id":"39630793"},{"golden":false,"id":"38952195"},{"golden":false,"id":"29284803"},{"golden":false,"id":"37671726"},{"golden":false,"id":"38574392"},{"golden":false,"id":"9354115"},{"golden":false,"id":"11320787"},{"golden":false,"id":"26545819"},{"golden":false,"id":"2925870"},{"golden":false,"id":"9666608"},{"golden":false,"id":"1266940"},{"golden":false,"id":"17166303"},{"golden":false,"id":"30305836"},{"golden":false,"id":"7298536"},{"golden":false,"id":"16917604"},{"golden":false,"id":"24958633"},{"golden":false,"id":"39267029"},{"golden":false,"id":"39046284"},{"golden":false,"id":"32788838"},{"golden":false,"id":"3820331"},{"golden":false,"id":"7079077"},{"golden":false,"id":"35940853"},{"golden":false,"id":"17182875"},{"golden":false,"id":"15284658"},{"golden":false,"id":"21357342"},{"golden":false,"id":"30556687"},{"golden":false,"id":"19651597"},{"golden":false,"id":"36760221"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":986,"document":"1783868","golden":true,"offsetInEndSection":1194,"text":"These results were interpreted as supporting the use of regression approaches to diagnose co-occurring learning disabilities, as that method is less likely to be biased by the child\u0027s intelligence test score.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1291,"document":"32788838","golden":false,"offsetInEndSection":1448,"text":"This article concludes with a discussion of recommendations for the best approaches to evaluating the movement and functional abilities of children with SLD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1093,"document":"32788838","golden":false,"offsetInEndSection":1290,"text":"The article presents the characteristics, strengths and limitations of five standardised assessment tools that are currently in use, which measure the movement and/or function of children with SLD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":93,"document":"32788838","golden":false,"offsetInEndSection":245,"text":"However, assessment tools that provide information on the movement and function of children with specific learning disabilities (SLD) are still limited.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":425,"document":"32788838","golden":false,"offsetInEndSection":679,"text":"Empirical studies on the assessment tools used are reviewed based on three criteria: (i) standardised tools; (ii) assessment of movement and/or function; (iii) applicability to children with SLD ranging from 4-17 years of age and widely used in practice.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":680,"document":"32788838","golden":false,"offsetInEndSection":1092,"text":"The following instruments have been included as they have been found to fulfil the criteria: (i) the Bruininks-Oseretsky test of motor proficiency-2 (BOT-2); (ii) the movement assessment battery for children-2 (MABC-2); (iii) the pediatric balance scale (PBS); (iv) the Vineland adaptive behaviour scale-II (VABS-II) and (v) the pediatric evaluation of disability inventory-computerised adaptive test (PEDI-CAT).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":246,"document":"32788838","golden":false,"offsetInEndSection":360,"text":"This article provides a narrative review of the characteristics of five movement and/or function assessment tools.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":933,"document":"11450386","golden":false,"offsetInEndSection":1072,"text":"With Individualized Remedial Education Plan (IEP) most children learn to cope up with disability and may get integrated in a regular steam.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"32788838","golden":false,"offsetInEndSection":139,"text":"An Assessment of the Movement and Function of Children with Specific Learning Disabilities: A Review of Five Standardised Assessment Tools.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32788838","golden":false,"offsetInEndSection":92,"text":"Various standardised assessment tools have been used to evaluate children with disabilities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1163,"document":"29404228","golden":true,"offsetInEndSection":1389,"text":"Conclusions The Eta/Mu model is effective in detecting the type of damage by quantifying the share of visuoperceptive and visuomotor coordination involvement in dyslexic children, allowing a customized rehabilitative approach.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":441,"document":"11450386","golden":false,"offsetInEndSection":611,"text":"Perinatal problems are certain neurological conditions, known to be associated with LD; however, genetic predisposition seems to be the most probable etiological factors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":612,"document":"11450386","golden":true,"offsetInEndSection":748,"text":"Evaluation of a child suspected to be having LD consists of medical examination, vision and hearing test analysis of school performance.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":749,"document":"11450386","golden":false,"offsetInEndSection":845,"text":"The psycho-behaviour assessment and education testing are essential in the process of diagnosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":340,"document":"11450386","golden":false,"offsetInEndSection":440,"text":"Dyslexia, dysgraphia and dyscalculia denote the problem related to reading, writing and mathematics.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":846,"document":"11450386","golden":false,"offsetInEndSection":932,"text":"The experienced persons in the field of LD should interpret the results of such tests.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"11450386","golden":false,"offsetInEndSection":112,"text":"Learning disabilities (LD) is one of the important causes of poor academic performance in school going children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33158434","golden":false,"offsetInEndSection":329,"text":"BACKGROUND: To develop and evaluate machine learning algorithms to ascertain attention-deficit/hyperactivity (ADHD) and learning disability (LD) using diagnostic codes in the medical record.METHOD: Diagnoses of ADHD and LD were confirmed in cohorts of children in Olmsted County of Minnesota based on validated research criteria.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":858,"document":"33158434","golden":false,"offsetInEndSection":1045,"text":"None of the models developed for LD performed well in the validation cohort.CONCLUSIONS: It is feasible to utilize diagnostic codes to ascertain cases of ADHD in a population of children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":330,"document":"33158434","golden":false,"offsetInEndSection":675,"text":"Models to predict ADHD and LD were developed using ICD-9 codes in a derivation cohort of 1057 children before evaluated in a validation cohort of 536 children.RESULTS: The ENET-MIN model using selected ICD-9 codes at prior probability of 0.25 has a sensitivity of 0.76, PPV of 0.85, specificity of 0.98, and NPV of 0.97 in the validation cohort.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34784486","golden":false,"offsetInEndSection":169,"text":"PURPOSE: Learning disabilities or learning disorders are umbrella terms used for wide variety of learning problems like Dyslexia, Dyscalculia, Dysgraphia, and Dyspraxia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":258,"document":"34784486","golden":true,"offsetInEndSection":578,"text":"Early diagnosis of these disabilities in kids from age 3 to 6 will help to start early medical treatments and get them back to the normal condition.MATERIAL AND METHOD: we developed a software-based Learning Disability Evaluation Kit called YALU with computer Game Modules for kids targeting their learning disabilities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1046,"document":"33158434","golden":false,"offsetInEndSection":1168,"text":"Machine learning approaches do not have advantage compared with simply using a single family of diagnostic codes for ADHD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1169,"document":"33158434","golden":false,"offsetInEndSection":1244,"text":"The use of medical record diagnostic codes is not feasible to ascertain LD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":587,"document":"21887581","golden":false,"offsetInEndSection":1019,"text":"In the final step, the remaining children were subjected to specific tests for reading, comprehension, writing and mathematical calculation.RESULTS: The prevalence of specific learning disabilities was 15.17% in sampled children, whereas 12.5%, 11.2% and 10.5% had dysgraphia, dyslexia and dyscalculia respectively.CONCLUSIONS: This study suggests that the prevalence of SpLDs is at the higher side of previous estimations in India.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"33158434","golden":false,"offsetInEndSection":150,"text":"Utility of medical record diagnostic codes to ascertain attention-deficit/hyperactivity disorder and learning disabilities in populations of children.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":676,"document":"33158434","golden":false,"offsetInEndSection":857,"text":"However, it does not offer significant advantage over a model using a single ICD-9 code of 314.X, which shows sensitivity of 0.81, PPV of 0.83, specificity of 0.98, and NPV of 0.97.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":438,"document":"37448921","golden":false,"offsetInEndSection":966,"text":"Children with learning disabilities have significant impairment in reading, writing, and mathematics in spite of normal intelligence and sensory abilities.Aim: The aim of the study was to evaluate the effectiveness of competency-based teacher education (CBTE) training module on knowledge, attitude, and practices (KAP) of school teachers regarding learning disabilities in children.Materials and Methods: This was a Quasi experimental study carried out in the month of December 2020 using one group pretest and posttest design.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1860,"document":"37448921","golden":false,"offsetInEndSection":2366,"text":"In terms of correlation between knowledge, attitude, and practices of school teachers on learning disabilities in children, it was found that there was a highly positive correlation between attitude and practice with r \u003d 0.884, and knowledge and practice with r \u003d 0.905.Conclusion: The CBTE training module is an effective method in enhancing the knowledge, changing the desirable attitude, and developing good skills of school teachers regarding the identification and management of learning disabilities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24008790","golden":false,"offsetInEndSection":909,"text":"CONTEXT: Children with learning disabilities might have difficulties to communicate effectively and give reliable responses as required in various visual function testing procedures.AIMS: The purpose of this study was to compare the testability of visual acuity using the modified Early Treatment Diabetic Retinopathy Study (ETDRS) and Cambridge Crowding Cards, stereo acuity using Lang Stereo test II and Butterfly stereo tests and colour perception using Colour Vision Test Made Easy (CVTME) and Ishihara\u0027s Test for Colour Deficiency (Ishihara Test) between children in mainstream classes and children with learning disabilities in special education classes in government primary schools.MATERIALS AND METHODS: A total of 100 primary school children (50 children from mainstream classes and 50 children from special education classes) matched in age were recruited in this cross-sectional comparative study.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1486,"document":"36979973","golden":false,"offsetInEndSection":2107,"text":"A task-oriented training program based on NTT principles, presented in small groups, has a positive effect on the motor performance in learners with neurodevelopmental disorders and this effect was larger than in the usual care group.CONCLUSION AND IMPLICATIONS: Although using a small group format in children with multiple neurodevelopmental disorders may be challenging for the therapists, it may be a way of delivering services to children in schools for special education.WHAT THIS PAPER ADDS: Children with DCD plus LSD show improvement in their motor skills by performing group-based NTT in the school environment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37448921","golden":false,"offsetInEndSection":182,"text":"Introduction: Inclusive education is a new approach towards a system of educating children with disabilities and learning difficulties with that of normal ones within the same crown.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1689,"document":"37448921","golden":false,"offsetInEndSection":1859,"text":"The effectiveness of CBTE training module was found to be statistically significant at P \u003c 0.05 in terms of mean scores enhancement in knowledge, attitude, and practices.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1022,"document":"27992780","golden":false,"offsetInEndSection":1462,"text":"The development of a logic model provided a structured way to explore how the program was implemented and achieved short, medium and long term outcomes within a complex community setting.DISCUSSION AND CONCLUSION: Kids Together was shown to be a highly effective and innovative model for supporting the inclusion of children with disabilities/additional needs in a range of environments central for early childhood learning and development.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":183,"document":"37448921","golden":false,"offsetInEndSection":437,"text":"Competency-based teacher education (CBTE) is a framework in which teachers demonstrate their learned knowledge, attitude, and skills in order to achieve specific predetermined \"competencies\" for a specific course or at a specific educational institution.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":482,"document":"27992780","golden":false,"offsetInEndSection":908,"text":"Using a key worker transdisciplinary team model, the program aligns with the individualised package approach of the National Disability Insurance Scheme (NDIS).AIM: This paper reports on the use of a logic model to underpin the process, outcomes and impact evaluation of the Kids Together program.METHODS: The research team worked across 15 Early Childhood Education and Care (ECEC) centres and in home and community settings.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37448921","golden":false,"offsetInEndSection":169,"text":"Competency-based teacher education (CBTE): A training module to improve knowledge, attitude, and practices (KAP) of school teachers on learning disabilities in children.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1414,"document":"34784486","golden":true,"offsetInEndSection":1504,"text":"Hence, the YALU Evaluation Kit to have an accuracy 85% in diagnosing the right disability.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1522,"document":"37528522","golden":false,"offsetInEndSection":1969,"text":"No further differences were found.CONCLUSIONS \u0026 IMPLICATIONS: These findings showed that the EP CSBS DP Infant-Toddler Checklist seems to be a reliable screening tool of communicative and symbolic behaviours for EP-learning children, which can be particularly relevant for decision-making in clinical practice.WHAT THIS PAPER ADDS: What is already known on the subject Early communication skills are known to be related to later language outcomes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1505,"document":"34784486","golden":true,"offsetInEndSection":2337,"text":"However, the accuracy could be increased with the accurate assessments of the parents about their kids.IMPLICATIONS FOR REHABILITATIONLearning disabilities are neurological disorders that affect the brain\u0027s ability to receive, process, store, respond to and communicate information; and there are four types (Dyslexia, Dyspraxia, Dysgraphia and Dyscalculia)In this paper, we present the extracted computational techniques targeting the Dyslexia, Dyspraxia, Dysgraphia and Dyscalculia and developed a software application (YALU Learning Disability Evaluation Kit) which consists of computer game modules for the kids for evaluation their learning disabilities.The developed game modules can screen the learning disabilities and these gamification modules (YALU) consists of tasks which are based on symptoms of the said disabilities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":579,"document":"34784486","golden":true,"offsetInEndSection":742,"text":"These Computer game-based modules of the YALU consist of different tasks for the different age levels to identify the symptoms of the disabilities mentioned above.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1341,"document":"34784486","golden":false,"offsetInEndSection":1413,"text":"Using YALU, twelve out of fourteen students had been clearly identified.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37975431","golden":false,"offsetInEndSection":88,"text":"BACKGROUND: Early intervention is recommended for pre-school children with low language.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":960,"document":"35318642","golden":false,"offsetInEndSection":1182,"text":"The children with epilepsy displayed the most impairment and least improvement.INTERPRETATION: This cross-diagnostic study of learning problems indicated the children with autism or ADHD received more structural education.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":789,"document":"6786177","golden":false,"offsetInEndSection":966,"text":"Preliminary work suggests that the natural conditions found universally in first language learning may be the best indicators of how to proceed with language-deficient children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":148,"document":"6786177","golden":false,"offsetInEndSection":412,"text":"In addition, this research has provided procedures that the determine what a child knows about language at a particular level of development and has established a sequence of linguistic development that maps the specific content and structure of training programs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":819,"document":"36381531","golden":false,"offsetInEndSection":1379,"text":"A BE diagnosis of ASD, by contrast, could not be predicted from children\u0027s early social communication problems nor the presence of restricted and repetitive behaviors and interests.Conclusions: Taken together, the results of this study suggest that language difficulties can be an early marker of a neurodevelopmental disorder which is often not identified at the age of first referral.Implications: Eligibility for treatment should, therefore, be based on biopsychosocial case formulation rather than DSM or ICD diagnostic classification.What this paper adds?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":698,"document":"36511160","golden":false,"offsetInEndSection":871,"text":"Findings highlight the effectiveness of CDM in identifying MLD subtypes and underscore the importance of understanding the specific deficits and antecedents of the subtypes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":357,"document":"15736100","golden":false,"offsetInEndSection":970,"text":"The goal of being able to offer an experience-based prognosis involves prior analysis of how learning dysfunctions are approached in the disabled population.DEVELOPMENT: Although we have an increasingly deeper understanding of the neurocognitive foundations of specific learning difficulties and the careful neuropsychological management of children with disorders affecting the acquisition of written language with a typical intellectual level, those with intellectual disability continue to be treated using a simplistic approach in which their intelligence quotient is still taken as the most relevant feature.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"6786177","golden":false,"offsetInEndSection":32,"text":"Language deficiency in children.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":262,"document":"36733820","golden":false,"offsetInEndSection":1184,"text":"\"Objective: This paper analyzes the role and functions of a neuropsychologist in primary schools and the possibilities of his/her collaboration with other specialists in diagnosing children\u0027s problems and organizing remediation for problematic kids.Design: We established four steps for launching neuropsychological work at primary schools: 1) setting up a screening group for neuropsychological assessment of all children entering the first year of school; 2) a comprehensive neuropsychological assessment of the children who showed poor results in the first step of the study; 3)ateam remediation program; and 4) evaluation of the remediation results by a new neuropsychological assessment at the end of the remediation program.Results: The results of the first step of our study showed a very high percentage of children with cognitive problems- 37% of 202 6-8 year-old schoolchildren entering the first year of school.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"6786177","golden":false,"offsetInEndSection":147,"text":"Research in cognition and language has provided useful constructs which suggests that specific deficits underlie language deficiencies in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"15736100","golden":false,"offsetInEndSection":233,"text":"AIMS: Following the diagnosis of intellectual disability, a prognosis can be offered concerning the degree of autonomy the child will be able to achieve based on prior experience, but which depends on the aetiology of the disability.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":498,"document":"6786177","golden":false,"offsetInEndSection":668,"text":"One approach focuses on the actual principles and strategies that normal children use to learn language, making it possible to determine which methods are most efficient.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1135,"document":"15736100","golden":false,"offsetInEndSection":1359,"text":"Yet, these are aspects that are submitted to thorough evaluation in children who are not disabled.CONCLUSIONS: The current concept of intellectual disability has gone beyond the definition based on the intelligence quotient.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25894277","golden":false,"offsetInEndSection":215,"text":"BACKGROUND: Investigation of patients, particularly children, with unexplained global developmental delay (GDD)/learning disability (LD) has been challenging due to a lack of clear guidance from specialised centres.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":216,"document":"25894277","golden":false,"offsetInEndSection":1109,"text":"Limited knowledge of rare diseases and a poor understanding of the purpose or limitations of appropriate investigations have been some of the principal reasons for this difficulty.AIMS: A guideline development group was formed to recommend on appropriate, first line metabolic, genetic and radiological investigations for children and adults with unexplained GDD/ID.METHODS AND RECOMMENDATIONS: A comprehensive literature search was conducted, evaluated and reviewed by the guideline committee and a best practice protocol for first line assessment and genetic, metabolic and radiological investigations was decided upon after considering diagnostic yield, practicality, treatability and costs.CONCLUSION: It is hoped that these recommendations will become national guidelines for the first line metabolic, genetic and radiological investigation of patients presenting with unexplained GDD/ID.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17182875","golden":false,"offsetInEndSection":497,"text":"PURPOSE: To determine whether children with a nonverbal learning disability (NVLD) have a higher incidence of auditory processing disorder (APD), especially in the tolerance-fading memory type of APD, and what associations could be found between performance on neuropsychological, intellectual, memory, and academic measures and APD.METHOD: Eighteen children with NVLD ranging in age from 6 to 18 years received a central auditory processing test battery to determine incidence and subtype of APD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1360,"document":"15736100","golden":false,"offsetInEndSection":1510,"text":"The wide variability in the reading function in children with intellectual disability cannot be explained only according to a psychometric assessment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":234,"document":"15736100","golden":false,"offsetInEndSection":356,"text":"It is still difficult to give a prospective answer regarding the capacity to reach an operative level of written language.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1138,"document":"36850364","golden":false,"offsetInEndSection":1253,"text":"These results are promising to suggest a new tool for dysgraphia early screening based on visual perception skills.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":502,"document":"36850364","golden":false,"offsetInEndSection":599,"text":"Then, we identified children at risk of dysgraphia through the means of a handwriting speed test.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":877,"document":"36850364","golden":false,"offsetInEndSection":1012,"text":"The machine learning models obtained good results, particularly with game performances as predictors (F1 score: 0.77 train, 0.71 test).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1644,"document":"26336330","golden":false,"offsetInEndSection":1906,"text":"Thus, results provide converging neurological and behavioral evidence, for dysgraphia, dyslexia, and OWL LD being different, diagnosable specific learning disabilities (SLDs) for persisting written language problems during middle childhood and early adolescence.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":837,"document":"38186518","golden":false,"offsetInEndSection":1138,"text":"Standardized methods, such as the Diagnostic and Statistical Manual, Fifth Edition (DSM-5), diagnostic instruments, a thorough medical history, multiple physical examinations, laboratory investigations, neuroimaging, and screening tests, play a pivotal role in early autism diagnosis and intervention.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1273,"document":"29651830","golden":false,"offsetInEndSection":1652,"text":"Going to investigate the actual use of the measures put in place by the school, it is evident a partial and incomplete application of Law 170.CONCLUSIONS: The most suitable measures for these children are pedagogical measures in order to make them integrate with the group class and strengthen their capacities through specific measures provided by a specific legislative decree.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1013,"document":"36850364","golden":false,"offsetInEndSection":1077,"text":"SHAP explainer was used to identify the most impactful features.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"29651830","golden":false,"offsetInEndSection":167,"text":"BACKGROUND: Specific learning disabilities are disorders that affect the instrumental skills of academic learning, leaving intact the general intellectual functioning.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":165,"document":"36850364","golden":false,"offsetInEndSection":309,"text":"To allow a preventive training program, abilities not directly related to handwriting should be evaluated, and one of them is visual perception.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36850364","golden":false,"offsetInEndSection":122,"text":"Investigating Visual Perception Impairments through Serious Games and Eye Tracking to Anticipate Handwriting Difficulties.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":669,"document":"6786177","golden":false,"offsetInEndSection":788,"text":"The second research approach looks at the contextual conditions adults and children provide the first language learner.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1400,"document":"36733820","golden":false,"offsetInEndSection":1825,"text":"In the third step, a team of school specialists, including a neuropsychologist, a teacher, a school psychologist, and a school social worker, implemented a remediation program which was created and supervised by a neuropsychologist.Conclusion: A comprehensive neuropsychological assessment of the pupils revealed a complex structure of cognitive disturbances which interfere with pupils\u0027 learning abilities in primary school.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":807,"document":"16401146","golden":false,"offsetInEndSection":969,"text":"A comprehensive evaluation also establishes a baseline of adaptive functioning and problematic behavior, which is essential for subsequent assessment of progress.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":970,"document":"16401146","golden":false,"offsetInEndSection":1085,"text":"This article discusses the differential diagnosis and evaluation of PDDs, focusing on the various assessment tools.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":639,"document":"16401146","golden":false,"offsetInEndSection":806,"text":"A wide variety of standardized diagnostic checklists, interviews, and observational measures are available to assist the clinician in making an accurate PDD diagnosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1086,"document":"16401146","golden":false,"offsetInEndSection":1179,"text":"The elements of a contemporary diagnostic evaluation and behavioral assessment are presented.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":502,"document":"16401146","golden":false,"offsetInEndSection":638,"text":"Increased awareness of PDDs and the availability of better assessment tools have improved the detection of these conditions in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":664,"document":"21103706","golden":false,"offsetInEndSection":797,"text":"ed of 20 good readers. All of the children were submitted to an assessment of the fine motor, sensorial and perceptive functions usin","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":321,"document":"12664722","golden":false,"offsetInEndSection":572,"text":"A number of gaps in service provision were identified. In particular, psychological and behavioural difficulties of children were of major concern to all those involved, but needs in relation to these areas were often unmet or inadequately dealt with.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":573,"document":"12664722","golden":false,"offsetInEndSection":775,"text":"Of greater concern was that some families in the area studied were paying privately for child learning disability clinical psychology services because they had such difficulty in accessing NHS services.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":142,"document":"37270907","golden":false,"offsetInEndSection":303,"text":"To start filling this gap, we examined changes in general cognitive functioning, visuo-constructive skills, and academic profiles in a group of children with NLD","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":403,"document":"37270907","golden":false,"offsetInEndSection":687,"text":"A total of 30 participants (24 boys) diagnosed with NLD were tested twice, with a three-year gap between the two assessments (T1: at age 8-13; T2: at 11-16), on their cognitive profile, visuospatial abilities, and academic performance (i.e., reading, writing and arithmetic abilities)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38297892","golden":false,"offsetInEndSection":152,"text":"BACKGROUND: The frequent prescribing of psychotropics and high prevalence of polypharmacy among older adults with intellectual disabilities require clos","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38294475","golden":false,"offsetInEndSection":32,"text":"MANAGEMENT OF AN AMNESIC PATIENT","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38294191","golden":false,"offsetInEndSection":17,"text":"Unequivocally, Pb","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38291422","golden":false,"offsetInEndSection":78,"text":"BACKGROUND: The aging population has caused assistive technology (AT) to recei","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38288163","golden":false,"offsetInEndSection":39,"text":"Case report: The evolving phenotype of ","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":434,"document":"35763175","golden":false,"offsetInEndSection":627,"text":"Mean depression levels increased from mid-childhood through adolescence before stabilizing in early adulthood and were most strongly predicted by academic achievement and learning disabilities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":138,"document":"35429340","golden":false,"offsetInEndSection":334,"text":"Dynamic assessments are a promising approach to identify and support children\u0027s language development.AIMS: We developed and studied a novel word learning task that is dynamic and language neutral.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1308,"document":"35429340","golden":false,"offsetInEndSection":1677,"text":"Finally, the scores on the dynamic task correlated to children\u0027s vocabulary scores on the standardized tests, but not parent report of language development, or the amount of exposure to the language of school.CONCLUSIONS \u0026 IMPLICATIONS: This novel dynamic assessment task taps into the process of vocabulary learning, but is less influenced by prior language knowledge.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":628,"document":"35763175","golden":false,"offsetInEndSection":825,"text":"Mean anxiety levels increased until adolescence before decreasing across early adulthood and were most strongly predicted by academic achievement, learning disabilities, and externalizing symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":826,"document":"35763175","golden":false,"offsetInEndSection":967,"text":"Quadratic models of growth fit best for both depression and anxiety, and depression and anxiety growth trajectories were strongly correlated.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":968,"document":"35763175","golden":false,"offsetInEndSection":1149,"text":"Though anxiety and depression trajectories differ in pattern and predictors, the two are highly interrelated and pathways to comorbid anxiety and depression should be characterized.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35763175","golden":false,"offsetInEndSection":361,"text":"This study aimed to (1) evaluate how population levels of anxiety and depression grow and correlate from middle childhood through early adulthood, and (2) determine whether sex, family socioeconomic status, parental education, academic achievement, learning disabilities, or externalizing symptoms predict anxiety and/or depression levels and growth trajectory.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1584,"document":"36248649","golden":false,"offsetInEndSection":1739,"text":"In sum, the results indicate that the brain morphology of the large-scale reading network at a preliterate age can predict how well children learn to read.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1507,"document":"36248649","golden":false,"offsetInEndSection":1583,"text":"Furthermore, phonological awareness significantly predicted future literacy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":944,"document":"33641795","golden":false,"offsetInEndSection":1088,"text":"We also highlight the gaps in the current literature and identify challenges in studying sleep-dependent memory in children with different IDDs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":218,"document":"14959806","golden":false,"offsetInEndSection":331,"text":"More consistent approaches to diagnosis and more rigorous assessment methods have significantly advanced research","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1002,"document":"28368273","golden":false,"offsetInEndSection":1301,"text":"ment of LD in children in India.RECOMMENDATIONS: A basic intervention approach should focus on: (i) interpretation of evaluation reports; (ii) description of specific skills that may be delayed (e.g., phoneme awareness and phonics; reading comprehension; spelling; number sense and organizational sk","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1302,"document":"28368273","golden":false,"offsetInEndSection":1381,"text":"lls) and (iii) identification of co-morbidities. The intervention should be int","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":327,"document":"9736960","golden":true,"offsetInEndSection":720,"text":"ntion factor.DEVELOPMENT: The neurological evaluation of learning disorders is based on clinical examination which includes the so-called minor signs of the noetic functions, specifically language, the praxes, gnosias, perceptive-motor function, laterality and the lexical, graphic and calculation functions together with the modulating element, mentioned above, of the level of attention with","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1168,"document":"9736960","golden":false,"offsetInEndSection":1367,"text":"l CT, MR, SPECT and PET).CONCLUSIONS: The contribution of neurological assessment is considered as part of the functions of a multi-disciplinary team which should deal with the diagnosis and treatmen","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":983,"document":"20211706","golden":false,"offsetInEndSection":1140,"text":"We conclude with ideas regarding future directions for the study of visual perception in children with developmental disorders using psychophysical measures.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":722,"document":"14676873","golden":false,"offsetInEndSection":932,"text":"Hearing, visual and mental deficiency, together with attention deficit hyperactive disorder and specific learning disorders should be part of the differential diagnosis of children with poor school achievement.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":183,"document":"30556686","golden":true,"offsetInEndSection":455,"text":"A comprehensive evaluation for ADHD gathers information across time and settings; considers common comorbid or alternative conditions, such as learning disabilities and disorders of mood or anxiety, vision, hearing, and sleep; and includes a thorough physical examination.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2685,"document":"27644917","golden":false,"offsetInEndSection":2859,"text":" to propose an MRI investigation. To our knowledge, this is the first report in the literature with a school age child of an unusual association between a temporal arachnoid ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1396,"document":"37480808","golden":false,"offsetInEndSection":1560,"text":" to be affected in children with SLD. A holistic evaluation including a multidisciplinary approach that includes suprathreshold auditory processing abilities is req","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"38350976","golden":false,"offsetInEndSection":144,"text":"Children with specific learning disabilities (SLDs) and their parents experience many problems that may influence their interactions","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38350425","golden":false,"offsetInEndSection":121,"text":"There has been an ongoing debate on how to diagnose learning disability (LD), with experts proposing different approaches","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1332,"document":"38340696","golden":false,"offsetInEndSection":1448,"text":"We recommend a careful monitoring to intercept learning disabilities and promptly start a multimodal rehabilitation.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38332474","golden":false,"offsetInEndSection":170,"text":"A systematic review of research on staff training as an intervention to develop communication in children and adults with profound intellectual and multiple disabilities.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":237,"document":"38330211","golden":false,"offsetInEndSection":433,"text":"Retrieval practice-a robust learning strategy-has been shown to improve children\u0027s retention of vocabulary, but it has not been investigated with DHH children who use listening and spoken language","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":622,"document":"38329108","golden":false,"offsetInEndSection":710,"text":"The children were aged 30-59 months and had moderate to severe intellectual disabilities","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2009,"document":"38324351","golden":false,"offsetInEndSection":2166,"text":"Future studies are needed to test the feasibility, acceptability, usability, use, and effectiveness of CONNECT among youth with childhood-onset disabilities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":840,"document":"38323379","golden":false,"offsetInEndSection":1007,"text":"Additionally, we examined differences in children\u0027s responses to different technological agents in teaching discrete skills to children with developmental disabilities","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38322967","golden":false,"offsetInEndSection":155,"text":"A systematic review of academic performance of Children with Disabilities (CWDs) in inclusive education schools in Low and Middle-Income Countries (LMICs).","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":312,"document":"38317694","golden":false,"offsetInEndSection":531,"text":"We used data from 2 cohorts enriched for likelihood of autism spectrum disorder (ASD): Early Autism Risk Longitudinal Investigation (EARLI) and the Markers of Autism Risk in Babies-Learning Early Signs (MARBLES) studies","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":191,"document":"38357540","golden":false,"offsetInEndSection":398,"text":"However, the offspring of patients with SLE still face the risks of preterm birth, low birth weight, learning disabilities, and neurological disorders, while the causes underlying these risks remain unclear.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":266,"document":"38356654","golden":false,"offsetInEndSection":485,"text":"Moreover, many frameworks for interventions for people with disabilities (PWDs) have been designed for resource-rich contexts, and little is known about their translatability to low- and middle-income countries (LMICs).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"38356379","golden":false,"offsetInEndSection":202,"text":"Almost no research has been published reporting on evaluations of the effectiveness of psychological interventions for people with severe to profound intellectual disabilities and depression","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":164,"document":"38352723","golden":false,"offsetInEndSection":372,"text":"Among the various research topics in BCIs, the classification of motor imagery using electroencephalography (EEG) signals has the potential to greatly improve the quality of life for people with disabilities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":118,"document":"38347056","golden":false,"offsetInEndSection":210,"text":"This study aimed to explore the potential impact of such changes on word-reading proficiency","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":722,"document":"38343118","golden":false,"offsetInEndSection":1138,"text":"Following a structured review of the literature, we sought to work with up to 10 people with learning disabilities and/or autistic people in three case-study sites (2021-22), supplementing this with interviews with family members and commissioners; interviews/focus groups with hospital staff, social workers, advocates and care providers; information from case files; and observations of multidisciplinary meetings.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1783,"document":"38340121","golden":false,"offsetInEndSection":1863,"text":"Findings can inform the development of interventions for TAYA with disabilities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":440,"document":"2745731","golden":false,"offsetInEndSection":575,"text":"An overall accuracy rate of 82.5% was obtained when the measures were used to predict the classification status of individual children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":846,"document":"28368273","golden":false,"offsetInEndSection":1350,"text":"Thereafter, a committee was established to review and finalize the points discussed in the meeting.OBJECTIVE: To provide guidelines on evaluation and management of LD in children in India.RECOMMENDATIONS: A basic intervention approach should focus on: (i) interpretation of evaluation reports; (ii) description of specific skills that may be delayed (e.g., phoneme awareness and phonics; reading comprehension; spelling; number sense and organizational skills) and (iii) identification of co-morbidities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":367,"document":"2745731","golden":false,"offsetInEndSection":439,"text":"The data from the two groups were analyzed with a discriminant analysis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":684,"document":"9006183","golden":false,"offsetInEndSection":828,"text":"The results indicate that brief intervention training in gentle teaching can have a positive impact upon the challenging behaviour of the child.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":576,"document":"2745731","golden":false,"offsetInEndSection":783,"text":"A stepwise discriminant analysis procedure revealed an experimental form of the TMT (part X), Tactual Performance Test total time, and Tactual Performance Test localization to be the most sensitive measures.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"2745731","golden":false,"offsetInEndSection":67,"text":"Screening for learning disabilities: a neuropsychological approach.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"2745731","golden":false,"offsetInEndSection":153,"text":"The ability of the Trail Making Test (TMT) and Tactual Performance Test (TPT) to discriminate between learning-disabled and normal children was examined.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":966,"document":"15490903","golden":false,"offsetInEndSection":1141,"text":"The results of the validation procedure showed that the SVS is a quick, reliable, and valid instrument that may be helpful in identifying children with VSLD in primary school.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28368273","golden":false,"offsetInEndSection":155,"text":"JUSTIFICATION: Learning Disability (LD) in children is a well-recognized developmental disorder, which has profound academic and psychosocial consequences.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":663,"document":"11460175","golden":false,"offsetInEndSection":750,"text":"The most frequent diagnosis was attention deficit and hyperactivity disorder, in 39,1%.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":309,"document":"28368273","golden":false,"offsetInEndSection":622,"text":"Given the paucity of evidence-based standardized treatment approaches, consensus guidelines for management of LD are needed.PROCESS: The meeting on formulation of national consensus guidelines on neurodevelopmental disorders was organized by Indian Academy of Pediatrics in Mumbai on 18th and 19th December, 2015.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":156,"document":"28368273","golden":true,"offsetInEndSection":308,"text":"Due to the complex nature of LD and multiple disadvantages posed to the child due to LD, a multidisciplinary approach towards intervention is warranted.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1168,"document":"29097974","golden":false,"offsetInEndSection":1366,"text":"The results indicated that the combination of the PRPP System of Intervention and the 4QM may improve the participants\u0027 ability to apply information processing strategies during academic activities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1431,"document":"28368273","golden":false,"offsetInEndSection":1680,"text":"Required services include: developmental pediatrics evaluation; neurological evaluation; ophthalmology and audiology evaluation; clinical psychology assessment; occupational therapy, remedial education, counseling for family, and career-counselling.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1351,"document":"28368273","golden":false,"offsetInEndSection":1430,"text":"The intervention should be inter-disciplinary and individualized to each child.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32847232","golden":false,"offsetInEndSection":157,"text":"BACKGROUND: ? There is a need for further development and evaluation of group-based parent- training interventions for parents of children with disabilities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":526,"document":"38350425","golden":false,"offsetInEndSection":615,"text":"The results showed that the IQ-Achievement Discrepancy approach is implemented in Turkey.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":720,"document":"34331711","golden":false,"offsetInEndSection":1417,"text":"Multivariate analysis revealed that cases exposed to antenatal smoking had higher odds ratio of abnormal emotional symptoms and abnormal total difficulties; cases with poor familial income and the presence of a history of antenatal smoking exposure showed considerably higher odds ratio of conduct problems; cases with younger age at the diagnosis of SLD, dyscalculia, extreme duration of preschool screen time (?4?h), and history of hospitalization had significantly higher odds ratio for hyperactivity-inattention problems; and cases having shorter breastfeeding duration had higher odds ratio of peer problems compared to counterparts.CONCLUSION: Children with SLD have a high score on the SDQ.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":616,"document":"38350425","golden":false,"offsetInEndSection":820,"text":"It was also revealed that the students\u0027 Wechsler Intelligence Scale for Children (WISC-R) average score was 80.31, and teachers mostly reported the weaknesses of the students during the diagnosis process.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34331711","golden":true,"offsetInEndSection":342,"text":"BACKGROUND: The study aims to investigate the social, emotional, and behavioral challenges in children with a specific learning disability (SLD) and to identify the factors that accompany these problems by screening with the Strengths and Difficulties Questionnaire (SDQ).METHODS: The descriptive study was conducted on 278 children with SLD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1089,"document":"38350425","golden":false,"offsetInEndSection":1153,"text":"The results are discussed on the basis of diagnostic approaches.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2071,"document":"33977880","golden":true,"offsetInEndSection":2163,"text":"The results support the usefulness of the SDQ for repeated assessments in clinical practice.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":821,"document":"38350425","golden":false,"offsetInEndSection":1088,"text":"Psychological counselors and psychiatrists pointed out the outdatedness of the tools used in the diagnosis, the limited number of measurement instruments to be used in the diagnosis, referral of too many students, and the lack of specialists to work in the diagnosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1330,"document":"36063351","golden":false,"offsetInEndSection":1438,"text":"The results show that the EOG signals-based approach gives successful results for the diagnosis of dyslexia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":192,"document":"38350425","golden":false,"offsetInEndSection":273,"text":"This study aims to analyze the problems related to the diagnosis of LD in Turkey.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":123,"document":"38350425","golden":false,"offsetInEndSection":191,"text":"Very limited research is available on the diagnosis of LD in Turkey.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"9006183","golden":false,"offsetInEndSection":277,"text":"This article outlines the initial stages of an ongoing experiment to evaluate the comparative efficacy of two different therapeutic interventions--behaviour modification and gentle teaching--in the management of challenging behaviour in children who have learning disabilities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":297,"document":"21106718","golden":false,"offsetInEndSection":741,"text":"Suggestions are offered from a curriculum-relevant/strategic-based language approach that places APD symptoms within a broader framework and takes into account the complex interaction among the language knowledge, skills, and strategies needed for academic success.METHOD: Using the metaphor of peeling an onion to get to its core, the author demonstrates how auditory perceptual processing is influenced by and dependent on language abilities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":278,"document":"9006183","golden":false,"offsetInEndSection":453,"text":"Using a workshop approach, parents are taught the principles and practice of one of these two interventions to enable better management of their child\u0027s challenging behaviour.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":536,"document":"9006183","golden":false,"offsetInEndSection":683,"text":"Preliminary analysis of data has been conducted on information gathered from those parents (n \u003d 24) who attended the gentle teaching workshop only.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":454,"document":"9006183","golden":false,"offsetInEndSection":535,"text":"A range of intervention outcomes are then compared with those of a control group.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"9006183","golden":false,"offsetInEndSection":61,"text":"Challenging behaviour in children with learning disabilities.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":442,"document":"3216018","golden":false,"offsetInEndSection":620,"text":"PPVT scores were found to load on a factor similar to what has been labeled verbal comprehension on the WISC-R with little secondary loadings on any of the remaining six factors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1130,"document":"33125855","golden":false,"offsetInEndSection":1402,"text":"Different technological tools are used to foster attention span and improve time management skills in children with attention deficit syndrome.CONCLUSION: It is important that therapists choose the instrument that will offer the best approach towards the goal that is set.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1138,"document":"35309706","golden":false,"offsetInEndSection":1369,"text":"Although generalisation beyond this course and setting is to be determined, the results suggest that parents of children with profound intellectual and multiple disabilities can appreciate a communication course and find it useful.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1063,"document":"35309706","golden":false,"offsetInEndSection":1137,"text":"The supportive social milieu offered by the course was highly appreciated.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1738,"document":"37079634","golden":false,"offsetInEndSection":1944,"text":"This indicates that school enrolment and quality are crucial for children\u0027s learning of numeracy skills, and that disabled children benefit equally from better school quality across these African countries.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":278,"document":"33125855","golden":false,"offsetInEndSection":625,"text":"This article presents a map of the technological devises applied as therapeutic instruments.METHODS: The research question of this review was which technological applications could be referred as an educational instrument for the management of children with autism spectrum disorders (ASDs), intellectual disability and attention deficit disorder.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":708,"document":"35309706","golden":false,"offsetInEndSection":833,"text":"Participants were slightly more satisfied with the course as compared with parents who had children with milder disabilities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":169,"document":"35309706","golden":false,"offsetInEndSection":269,"text":"The course curriculum included responsive strategies and augmentative and alternative communication.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1370,"document":"35309706","golden":false,"offsetInEndSection":1470,"text":"An individual approach within the group setting and practical learning opportunities seem important.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":918,"document":"35309706","golden":false,"offsetInEndSection":983,"text":"Perceptions of augmentative and alternative communication varied.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":984,"document":"35309706","golden":false,"offsetInEndSection":1062,"text":"It was unclear whether the course altered the children\u0027s communication or not.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":940,"document":"6827218","golden":true,"offsetInEndSection":1129,"text":"These findings suggest that the directed dichotic listening procedure and the WISC-R Verbal IQ measure are reasonably valuable clinical tools in the classification of learning disabilities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":602,"document":"6827218","golden":false,"offsetInEndSection":770,"text":"A stepwise discriminant function analysis revealed that both of the directed dichotic tasks contributed the most of all 13 measures to the significant group separation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":471,"document":"6827218","golden":false,"offsetInEndSection":601,"text":"A multivariate analysis of variance resulted in a significant separation between groups (p less than .001) using these procedures.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":771,"document":"6827218","golden":false,"offsetInEndSection":939,"text":"In addition, other cognitive tasks found to discriminate normal from learning disabled children include general verbal processes, concept formation, and tactile memory.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":166,"document":"6827218","golden":true,"offsetInEndSection":470,"text":"All children were administered the Wechsler Intelligence Scale for Children-Revised (WISC-R), a dichotic listening task involving both free and directed recall conditions, a handedness inventory, the Tactile Performance Test and the Category Test from the Halstead-Reitan Neuropsychological Test Battery.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"6827218","golden":false,"offsetInEndSection":165,"text":"The neuropsychological test scores of 23 learning disabled children were compared with those of a matched population of normal children in the 9-1 to 13-1 age range.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"6827218","golden":false,"offsetInEndSection":80,"text":"Neuropsychological assessment of learning disabilities: a discriminant analysis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":580,"document":"12585531","golden":false,"offsetInEndSection":812,"text":"The correlation between a global measure of memory and a global measure f intelligence was significant (r \u003d .59), indicating that memory should be viewed as an important component when evaluating children with learning disabilities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":470,"document":"16392699","golden":false,"offsetInEndSection":650,"text":"The response-to-intervention (RTI) perspective provides excellent support for the process in young children but is still developing the process for students above the second grade.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":294,"document":"2279487","golden":false,"offsetInEndSection":531,"text":"The impact of seizure activity, localization of epileptogenic foci, and antiepileptic treatment on cognitive functioning can be evaluated based upon the results of continuous assessment with a computerized neuropsychological test system.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":468,"document":"2034911","golden":false,"offsetInEndSection":631,"text":"All children with learning disabilities, whether or not they have accompanying neurologic problems, should be seen for psychological and/or educational evaluation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":231,"document":"39630793","golden":false,"offsetInEndSection":373,"text":"ent this. The objective of the study was the early detection and reference of children with learning disabilities as identified by their schoo","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":140,"document":"38952195","golden":false,"offsetInEndSection":307,"text":"e describe the essential components of language and literacy, universal screening, diagnostic assessments, curriculum-based measurement and eligibility determination. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":363,"document":"35940853","golden":false,"offsetInEndSection":492,"text":"e present a structured practical approach to assessing the school-aged child who presents with a possible learning disability.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37671726","golden":false,"offsetInEndSection":142,"text":"We review literature related to the assessment and identification of Specific Learning Disabilities (SLD) and Intellectual Disabilities (ID).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":843,"document":"29284803","golden":false,"offsetInEndSection":932,"text":"the predefined cutoff score ?10.RESULTS: ROC analysis showed AUC of 0.93 for differentiat","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"9354115","golden":false,"offsetInEndSection":230,"text":"Intervention-based assessment, a systematic form of prereferral intervention, represents a viable alternative to \"test and place\" models for identifying and teaching children with a variety of learning-related problems in schools.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1085,"document":"30556687","golden":false,"offsetInEndSection":1306,"text":"Interventions provided through an Individualized Education Program or Section 504 plan may include educational strategies, accommodations in test taking time or setting, speech or occupational therapy, and adaptive tools.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":514,"document":"9354115","golden":false,"offsetInEndSection":661,"text":"Of those children receiving intervention-based assessment, a slight decrease occurs in the percentage classified as specifically learning disabled.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"11320787","golden":false,"offsetInEndSection":148,"text":"[Multidisciplinary investigation is best for children with learning disabilities. Too critical attitude to diagnoses can keep the disorders hidden].","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":302,"document":"11320787","golden":false,"offsetInEndSection":552,"text":"A critical attitude toward diagnosing students with learning disabilities may result in exaggeration of psychosocial problems, thereby running the risk that genuine learning disabilities, neurological problems or other disorders are being overlooked.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":121,"document":"11320787","golden":false,"offsetInEndSection":301,"text":"Multidisciplinary collaboration between different professions provides a more complete picture of each person\u0027s unique requirements, thereby facilitating more appropriate teaching.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"11320787","golden":false,"offsetInEndSection":120,"text":"This article presents evidence of the importance of multidisciplinary assessment of students with learning disabilities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1974,"document":"26545819","golden":false,"offsetInEndSection":2140,"text":"These atypical neurophysiological activation patterns might provide a helpful guide for rehabilitation strategies to treat the deficiencies in these children with LD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":462,"document":"24958633","golden":false,"offsetInEndSection":587,"text":"Consequently, the structural validity of the WISC-IV for students with SLD was supported by the results of the present study.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1029,"document":"30305836","golden":false,"offsetInEndSection":1291,"text":"Using multi-factor analysis, three alternative factor models were compared.RESULTS: Analysis of factor structure models suggests a new bi-factorial model that more appropriately describes the areas of cognitive development of children with learning disabilities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":227,"document":"2925870","golden":false,"offsetInEndSection":336,"text":"The former index is sensitive to the test-specific cognitive effects of unilateral cerebral damage in adults.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1013,"document":"17166303","golden":false,"offsetInEndSection":1174,"text":"A high degree of correspondence between LCA classifications and those based on a more conventional algorithm provided evidence for the validity of this approach.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1292,"document":"30305836","golden":false,"offsetInEndSection":1758,"text":"The first factor includes Comprehension, Picture Arrangement, Coding, Block Design, and Object Assembly, whereas the second one combines Information, Similarities, Arithmetic, Vocabulary, and Picture Arrangement.CONCLUSIONS: The present study shows the existence of a factorial model with two factors: one aggregating the Comprehension verbal subtest with four performance subtests and the other the Picture Arrangement performance subtest with four verbal subtests.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32788838","golden":false,"offsetInEndSection":400,"text":"Various standardised assessment tools have been used to evaluate children with disabilities. However, assessment tools that provide information on the movement and function of children with specific learning disabilities (SLD) are still limited. This article provides a narrative review of the characteristics of five movement and/or function assessment tools. The strengths and limitations of the to","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":100,"document":"39267029","golden":false,"offsetInEndSection":300,"text":"ever for children and young people with intellectual disabilities, these programmes appear to be limited regarding information on relationships, informed choices and decision making. The purpose of th","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":200,"document":"39046284","golden":false,"offsetInEndSection":500,"text":"o conduct a meta-ethnography on the experiences and perceptions of children with chronic pain and their families of chronic pain, treatments and services. We investigated how children and their families conceptualise and live with chronic pain; what they think of and want from health and social care","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":362,"document":"35940853","golden":false,"offsetInEndSection":491,"text":"We present a structured practical approach to assessing the school-aged child who presents with a possible learning disability.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1606,"document":"17182875","golden":false,"offsetInEndSection":1754,"text":"ical assessment suggestive of APD. Collaborative, interdisciplinary evaluation of children with learning disorders is needed in order to provide eff","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":172,"document":"15284658","golden":false,"offsetInEndSection":813,"text":"Little research has been done into assessing and treating urinary continence difficulties of children with learning difficulties and many questions remain unanswered: what is the extent of the problem; what specific intervention do children with learning difficulties require to attain toileting skills; what expectation can the parent and clinician have that children with learning difficulties can be toilet trained and who is best placed to promote toileting skills? The main findings from the literature will support health and education professionals and carers who are involved in toilet training children with learning difficulties.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":530,"document":"7079077","golden":false,"offsetInEndSection":1156,"text":"The relationship of the locus of control construct to the field of learning disabilities is discussed in terms of four questions: (1) what is the relationship between locus of control and academic achievement?, (2) how is locus of control related to learned helplessness?, (3) is a change in locus of control orientation desirable?, and (4) what is the utility of locus of control for the education of learning disabled children? It is concluded that, in the course of remediation, attention should be devoted to the entire syndrome of characteristics associated with failure but within the context of academic intervention.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21357342","golden":false,"offsetInEndSection":190,"text":"Learning disabilities constitute a diverse group of disorders in which children who generally possess at least average intelligence have problems processing information or generating output.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":577,"document":"30556687","golden":false,"offsetInEndSection":762,"text":"The initial evaluation should include a thorough history and physical examination for medical conditions and mental disorders that may manifest as or coexist with learning disabilities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"19651597","golden":false,"offsetInEndSection":90,"text":"Learning disabilities, including reading disabilities, are commonly diagnosed in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":201,"document":"38574392","golden":false,"offsetInEndSection":365,"text":"ties vary.METHOD: We compared the performance of 59 children (mean age, 15?years) with learning disabilities (n?\u003d?18), Down syndrome (n?\u003d?21), and intellectual disa","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":73,"document":"36760221","golden":false,"offsetInEndSection":212,"text":"population. Currently, there is no consensus as to the most effective strategies for improving the learning skills of children and adolesce","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":154,"document":"3820331","golden":false,"offsetInEndSection":337,"text":"Nonretarded learning disabled children were 7.25 times (95%, confidence interval, 1.05 to 50.0) more likely than controls to have signs consistent with alcohol exposure in fetal life.","beginSection":"abstract"}],"ideal_answer":[],"id":"6593d9fe06a2ea257c00001c","type":"summary","body":"What is the best approach to evaluate learning disabilities in children?"},{"documents":[{"golden":false,"id":"37915075"},{"golden":false,"id":"37064029"},{"golden":false,"id":"25224898"},{"golden":false,"id":"18537652"},{"golden":false,"id":"38086949"},{"golden":true,"id":"23107555"},{"golden":false,"id":"11355149"},{"golden":false,"id":"31682277"},{"golden":false,"id":"9117377"},{"golden":true,"id":"31734845"},{"golden":false,"id":"31138052"},{"golden":false,"id":"17573453"},{"golden":false,"id":"19822097"},{"golden":false,"id":"35821534"},{"golden":false,"id":"23952563"},{"golden":false,"id":"20520784"},{"golden":false,"id":"35997389"},{"golden":false,"id":"37179299"},{"golden":false,"id":"19810920"},{"golden":false,"id":"25617880"},{"golden":false,"id":"20550693"},{"golden":false,"id":"34388595"},{"golden":false,"id":"37894116"},{"golden":false,"id":"37363482"},{"golden":false,"id":"21277567"},{"golden":false,"id":"16877121"},{"golden":false,"id":"32761353"},{"golden":false,"id":"32972442"},{"golden":false,"id":"24229326"},{"golden":false,"id":"37525488"},{"golden":true,"id":"15043967"},{"golden":false,"id":"37531610"},{"golden":false,"id":"38172662"},{"golden":false,"id":"35946099"},{"golden":false,"id":"34423297"},{"golden":false,"id":"22166468"},{"golden":false,"id":"34360831"},{"golden":false,"id":"34007311"},{"golden":false,"id":"37509603"},{"golden":true,"id":"26435495"},{"golden":false,"id":"37395951"},{"golden":true,"id":"35121410"},{"golden":false,"id":"29961146"},{"golden":false,"id":"34090138"},{"golden":true,"id":"33657474"},{"golden":true,"id":"36111418"},{"golden":false,"id":"26600111"},{"golden":false,"id":"38177128"},{"golden":false,"id":"35419061"},{"golden":true,"id":"34249008"},{"golden":false,"id":"32556004"},{"golden":false,"id":"36768705"},{"golden":true,"id":"36439056"},{"golden":true,"id":"37011956"},{"golden":true,"id":"26998359"},{"golden":false,"id":"33054899"},{"golden":false,"id":"36947108"},{"golden":false,"id":"37210459"},{"golden":true,"id":"38251542"},{"golden":false,"id":"37373402"},{"golden":false,"id":"35968278"},{"golden":false,"id":"32998680"},{"golden":true,"id":"33842886"},{"golden":false,"id":"35285272"},{"golden":false,"id":"15527505"},{"golden":true,"id":"33010585"},{"golden":false,"id":"37866021"},{"golden":false,"id":"32661288"},{"golden":true,"id":"37185821"},{"golden":false,"id":"38178091"},{"golden":true,"id":"25598355"},{"golden":false,"id":"21407167"},{"golden":false,"id":"38257114"},{"golden":false,"id":"24557875"},{"golden":false,"id":"31323874"},{"golden":false,"id":"19237251"},{"golden":false,"id":"35599774"},{"golden":false,"id":"38191373"},{"golden":false,"id":"38254650"},{"golden":false,"id":"38279728"},{"golden":false,"id":"32837036"},{"golden":true,"id":"25135658"},{"golden":false,"id":"21945535"},{"golden":false,"id":"22197082"},{"golden":false,"id":"26809839"},{"golden":false,"id":"19758204"},{"golden":false,"id":"37592949"},{"golden":false,"id":"35330475"},{"golden":false,"id":"16550262"},{"golden":true,"id":"37509005"},{"golden":false,"id":"30419269"},{"golden":false,"id":"37546944"},{"golden":false,"id":"34482194"},{"golden":false,"id":"36834970"},{"golden":false,"id":"34583577"},{"golden":false,"id":"32195878"},{"golden":true,"id":"36758522"},{"golden":true,"id":"30564562"},{"golden":false,"id":"23664637"},{"golden":false,"id":"16980837"},{"golden":false,"id":"36675440"},{"golden":false,"id":"26812920"},{"golden":false,"id":"35415848"},{"golden":false,"id":"33434563"},{"golden":false,"id":"37333619"},{"golden":false,"id":"38347175"},{"golden":false,"id":"38334253"},{"golden":false,"id":"38331459"},{"golden":false,"id":"38314594"},{"golden":false,"id":"38313087"},{"golden":false,"id":"38261628"},{"golden":false,"id":"38255163"},{"golden":false,"id":"38202282"},{"golden":false,"id":"38201291"},{"golden":false,"id":"38358794"},{"golden":false,"id":"38358423"},{"golden":false,"id":"38358334"},{"golden":false,"id":"38358141"},{"golden":false,"id":"38357801"},{"golden":false,"id":"38357797"},{"golden":false,"id":"22824349"},{"golden":false,"id":"27366343"},{"golden":false,"id":"12665396"},{"golden":false,"id":"26179434"},{"golden":false,"id":"21584188"},{"golden":false,"id":"26198889"},{"golden":false,"id":"25801843"},{"golden":false,"id":"15570154"},{"golden":false,"id":"27634186"},{"golden":true,"id":"29579369"},{"golden":false,"id":"25566171"},{"golden":false,"id":"16950834"},{"golden":false,"id":"28797855"},{"golden":false,"id":"20528076"},{"golden":false,"id":"35693009"},{"golden":false,"id":"33662501"},{"golden":false,"id":"36769022"},{"golden":false,"id":"38172332"},{"golden":false,"id":"24669210"},{"golden":false,"id":"35054876"},{"golden":false,"id":"38327880"},{"golden":false,"id":"27766535"},{"golden":false,"id":"22718491"},{"golden":false,"id":"24321163"},{"golden":false,"id":"18455685"},{"golden":false,"id":"30683707"},{"golden":false,"id":"18842520"},{"golden":false,"id":"16612182"},{"golden":false,"id":"1338059"},{"golden":false,"id":"24051268"},{"golden":false,"id":"27728987"},{"golden":false,"id":"27208412"},{"golden":false,"id":"33858827"},{"golden":false,"id":"6913474"},{"golden":false,"id":"37731525"},{"golden":false,"id":"37686834"},{"golden":false,"id":"37446047"},{"golden":false,"id":"37398656"},{"golden":false,"id":"37388814"},{"golden":false,"id":"37083270"},{"golden":false,"id":"35225228"},{"golden":true,"id":"33179588"},{"golden":false,"id":"36575839"},{"golden":false,"id":"35910262"},{"golden":true,"id":"35371364"},{"golden":false,"id":"33839028"},{"golden":false,"id":"36427058"},{"golden":false,"id":"16383212"},{"golden":false,"id":"35881416"},{"golden":false,"id":"32718868"},{"golden":false,"id":"17874343"},{"golden":true,"id":"21549189"},{"golden":true,"id":"15710856"},{"golden":true,"id":"16361589"},{"golden":false,"id":"26983770"},{"golden":false,"id":"33446049"},{"golden":false,"id":"30363584"},{"golden":false,"id":"12884756"},{"golden":false,"id":"20656623"},{"golden":false,"id":"38411371"},{"golden":false,"id":"21719591"},{"golden":false,"id":"17502633"},{"golden":false,"id":"9572086"},{"golden":false,"id":"21356304"},{"golden":false,"id":"23238467"},{"golden":false,"id":"34196306"},{"golden":false,"id":"15726642"},{"golden":true,"id":"25877847"},{"golden":false,"id":"20035260"},{"golden":false,"id":"28110208"},{"golden":false,"id":"28684277"},{"golden":false,"id":"31509764"},{"golden":false,"id":"35046929"},{"golden":false,"id":"35261628"},{"golden":false,"id":"36133318"},{"golden":false,"id":"36412084"},{"golden":false,"id":"38797848"},{"golden":false,"id":"28131211"},{"golden":false,"id":"21975140"},{"golden":false,"id":"28410877"},{"golden":false,"id":"18973731"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":1698,"document":"21975140","golden":false,"offsetInEndSection":1712,"text":" be caused by ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":269,"document":"23107555","golden":false,"offsetInEndSection":513,"text":"Neurophysiological observations suggest that motor mechanisms play a role in the pathophysiology of fatigue but there is no clear correlation between fatigue measured with clinical instruments and fatigue assessed with neurophysiological tests.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1407,"document":"31734845","golden":true,"offsetInEndSection":1642,"text":"These results suggest that aberrations in neuromuscular (NMJs) and myotendinous junctions play a role in MDD and that the aberrations in NMJs coupled with lowered CPK may play a role in chronic fatigue and fibromyalgia symptoms in MDD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":514,"document":"23107555","golden":true,"offsetInEndSection":646,"text":"Neuroimaging studies show that fatigue is associated with an involvement of non-dopaminergic or extrastriatal dopaminergic pathways.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":893,"document":"33657474","golden":false,"offsetInEndSection":985,"text":"elative to HC (p??? 0.05). Compared to HC, Glx levels in RRMS patients were significantly de","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23107555","golden":false,"offsetInEndSection":144,"text":"Fatigue is one of the most disabling symptoms in patients with Parkinson\u0027s disease (PD), with a significant impact on patients\u0027 quality of life.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":647,"document":"23107555","golden":false,"offsetInEndSection":746,"text":"It is conceivable that both motor and non-motor mechanisms underlie the pathophysiology of fatigue.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":834,"document":"19822097","golden":false,"offsetInEndSection":1004,"text":"Importantly, the expression of a gene encoding a component of the nicotinic cholinergic receptor binding site was reduced, suggesting impaired neuromuscular transmission.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":145,"document":"23107555","golden":false,"offsetInEndSection":268,"text":"Clinical studies using ad hoc questionnaires showed that in PD fatigue is associated with non-motor as well motor symptoms.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"23107555","golden":false,"offsetInEndSection":59,"text":"Fatigue in Parkinson\u0027s disease: motor or non-motor symptom?","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1819,"document":"9117377","golden":false,"offsetInEndSection":2008,"text":"We found no conclusive evidence that central fatigue is related to increased dysfunction in the primary central motor pathways and no evidence that FDCB is the pathophysiological mechanism.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":713,"document":"17573453","golden":false,"offsetInEndSection":970,"text":"Mechanisms proposed as underlying CRF include 5-HT neurotransmitter dysregulation, vagal afferent activation, alterations in muscle and ATP metabolism, hypothalamic-pituitary-adrenal axis dysfunction, circadian rhythm disruption, and cytokine dysregulation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":550,"document":"11355149","golden":false,"offsetInEndSection":768,"text":"Neurophysiological studies have shown that fatigue does not depend on involvement of the pyramidal tracts and implicate impairment of volitional drive of the descending motor pathways as a physiopathological mechanism.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":540,"document":"37525488","golden":false,"offsetInEndSection":901,"text":"Analogous pathophysiologic pathways in fibromyalgia (FM), myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and long COVID include host-microbial interactions in the absence of direct tissue invasion and absence of systemic autoimmunity, with?evidence for immune dysregulation as well as autonomic, peripheral, and central nervous system dysfunction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35946099","golden":false,"offsetInEndSection":1287,"text":"BACKGROUND: A meaningful part of schizophrenia patients suffer from physiosomatic symptoms (formerly named psychosomatic), which are reminiscent of chronic fatigue syndrome and fibromyalgia (FF) and are associated with signs of immune activation and increased levels of tryptophan catabolites (TRYCATs).AIMS: The study aims to examine whether FF symptoms in schizophrenia are associated with the breakdown of the paracellular pathway, zonulin, lowered natural IgM responses to oxidative specific epitopes (OSEs); and whether FF symptoms belong to the behavioral-cognitive-physical-psychosocial- (BCPS)-worsening index consisting of indices of a general cognitive decline (G-CoDe), symptomatome of schizophrenia, and quality of life (QoL)-phenomenome.METHODS: FF symptoms were assessed using the Fibromyalgia and Chronic Fatigue Rating scale in 80 schizophrenia patients and 40 healthy controls and serum cytokines/chemokines, IgA levels to TRYCATs, IgM to OSEs, zonulin and transcellular/paracellular (TRANS/PARA) molecules were assayed using ELISA methods.RESULTS: A large part (42.3%) of the variance in the total FF score was explained by the regression on the PARA/TRANS ratio, pro-inflammatory cytokines, IgM to zonulin, IgA to TRYCATs (all positively), and IgM to OSEs (inversely).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1302,"document":"37531610","golden":false,"offsetInEndSection":1672,"text":"In genome-wide studies in fibromyalgia syndrome, differential methylation in sites related to HDAC4 , TMEM44 , KCNQ1 , SLC17A9 , PRKG1 , ALPK3 , TFAP2A , and LY6G5C was found.CONCLUSIONS: Individuals with chronic fatigue syndrome and fibromyalgia syndrome seem to be characterized by altered DNA methylation of genes regulating cellular signaling and immune functioning.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":282,"document":"37525488","golden":false,"offsetInEndSection":539,"text":"Their persistent symptoms are strikingly similar to those of fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome, including fatigue, post-exertional malaise, myalgias/arthralgias, and sleep and cognitive disturbances in 50% to 100% of cases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":634,"document":"15043967","golden":true,"offsetInEndSection":879,"text":"Metabolic and structural lesions that disrupt the usual process of activation in pathways interconnecting the basal ganglia, thalamus, limbic system, and higher cortical centre are implicated in the pathophysiological process of central fatigue.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":880,"document":"15043967","golden":true,"offsetInEndSection":1045,"text":"A state of pre-existing relative hypocortisolaemia might sensitise the hypothalamic-pituitary-adrenal axis to development of persistent central fatigue after stress.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":902,"document":"37525488","golden":false,"offsetInEndSection":1106,"text":"Current treatment of long COVID has been based on multidisciplinary management recommended for FM and ME/CFS and has been formalized and made widely available by funding for nationwide long COVID clinics.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1204,"document":"37525488","golden":false,"offsetInEndSection":1386,"text":"The acknowledged role of patient engagement in research and open dialogue regarding work and disability noted in long COVID may have meaningful impact on patients with FM and ME/CFS.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37525488","golden":false,"offsetInEndSection":67,"text":"Applying Lessons From Rheumatology to Better Understand Long COVID.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1427,"document":"35946099","golden":false,"offsetInEndSection":1773,"text":"FF symptoms belong to a common core shared by G-CoDe, symtopmatome, and QoL phenomenome.CONCLUSION: The physio-somatic symptoms of schizophrenia are driven by various pathways, including increased zonulin, breakdown of the paracellular tight-junctions pathway, immune activation with induction of the TRYCAT pathway, and consequent neurotoxicity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":458,"document":"26435495","golden":true,"offsetInEndSection":782,"text":"Different pathways could be involved in fatigue and interact: the immune system with increased levels of pro-inflammatory cytokines (interleukin-1 and -6 and tumor necrosis factor alpha), dysregulation of the hypothalamic-pituitary-adrenal axis and neurological phenomena involving the central and autonomic nervous systems.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1147,"document":"33657474","golden":true,"offsetInEndSection":1528,"text":"Physical fatigue was negatively correlated with GABA+ in SMC and PFC (r \u003d -0.428 and -0.472 respectively, p??? 0.04) and positively with PFC Glx (r \u003d 0.480, p?\u003d? 0.028).CONCLUSION: The associations between fatigue and GABA?+?and Glx suggest that there might be dysregulation of GABAergic/glutamatergic neurotransmission in the pathophysiological mechanism of central fatigue in MS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":929,"document":"35121410","golden":true,"offsetInEndSection":1304,"text":"Two pathways were enriched for these metabolites, namely galactose metabolism and phenylalanine, tyrosine, and tryptophan biosynthesis.CONCLUSIONS: The results from this pilot study suggest that pathways involved in galactose metabolism and phenylalanine, tyrosine, and tryptophan biosynthesis are associated with cancer-related fatigue (CRF) in patients with CRC during CTX.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1615,"document":"37395951","golden":false,"offsetInEndSection":1877,"text":"Fatigue is frequently reported as an adverse event in patients treated by anti-amyloid agents in clinical trials.CONCLUSION: The literature is actually inconclusive about the main causes of fatigue in Alzheimer\u0027s disease individuals and its potential treatments.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":861,"document":"26435495","golden":true,"offsetInEndSection":935,"text":"Inflammation could be a common link between fatigue, pain, and depression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":783,"document":"26435495","golden":false,"offsetInEndSection":860,"text":"A pro-inflammatory process could be involved in pain and behavioral symptoms.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"26435495","golden":false,"offsetInEndSection":58,"text":"Fatigue in chronic inflammation - a link to pain pathways.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":313,"document":"26435495","golden":true,"offsetInEndSection":395,"text":"Indeed, biologic agents targeting inflammatory cytokines are effective in fatigue.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":243,"document":"26435495","golden":true,"offsetInEndSection":312,"text":"Fatigue could be associated with activity of inflammatory rheumatism.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"26435495","golden":false,"offsetInEndSection":99,"text":"Fatigue is a frequent symptom in several inflammatory diseases, particularly in rheumatic diseases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":297,"document":"26600111","golden":false,"offsetInEndSection":510,"text":"The pathophysiology of sleep disturbances in these patients involves alterations in immune and neuroendocrine function and shares common pathophysiologic pathways with comorbidities such as fatigue and depression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1224,"document":"32556004","golden":false,"offsetInEndSection":1774,"text":"Finally, cesium was positively correlated with neurocognitive probe results including the Tower of London, Symbol Coding, Controlled Word Association, Category Instances, Digit Sequencing Task, and List Learning tests.CONCLUSION: The results suggest that lowered serum cesium levels may play a role in the pathophysiology of SCZ, contributing to specific symptom domains including negative, depressive and fatigue symptoms, neurocognitive impairments (spatial working, episodic, and semantic memory and executive functions), and neuroimmune pathways.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":518,"document":"36111418","golden":true,"offsetInEndSection":646,"text":"Inflammation and mitochondrial dysfunction are among the most promising mechanisms through which malnutrition may cause fatigue.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":505,"document":"38177128","golden":false,"offsetInEndSection":835,"text":"We show that skeletal muscle structure is associated with a lower exercise capacity in patients, and local and systemic metabolic disturbances, severe exercise-induced myopathy and tissue infiltration of amyloid-containing deposits in skeletal muscles of patients with long COVID worsen after induction of post-exertional malaise.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":433,"document":"34249008","golden":true,"offsetInEndSection":636,"text":"The mechanisms involved with fatigue in SS are still poorly understood, but it appears fatigue signaling pathways are more associated with cell protection and defense than with pro-inflammatory pathways.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1311,"document":"33054899","golden":false,"offsetInEndSection":1495,"text":"These results suggested that inhibition of the Wnt/?-catenin signalling pathway and enhanced oxidative stress play an important role in abnormal placentation in pregnant mice with CFS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":959,"document":"36439056","golden":true,"offsetInEndSection":1140,"text":"The inflamed depression subtype has been associated with distinct clinical phenotypes, most robustly with physical symptoms such as sleep problems, changes in appetite, and fatigue.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37011956","golden":true,"offsetInEndSection":268,"text":"Central sensitization, a pathophysiologic process in which the central nervous system undergoes changes that alter its processing of pain and other sensory stimuli, may be the mechanism underlying various conditions in which patients have unexplained pain and fatigue.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1141,"document":"36439056","golden":false,"offsetInEndSection":1222,"text":"Neurofunctional changes are found in the dopaminergic reward processing pathways.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":101,"document":"36439056","golden":false,"offsetInEndSection":243,"text":"Existing data support the important role that inflammatory responses play in its pathophysiology, with new findings continuing to be reported.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":206,"document":"26998359","golden":true,"offsetInEndSection":547,"text":"Historically, there has been a tendency to draw psychological explanations for the origin of fatigue; however, this model is at odds with findings that fatigue and accompanying symptoms may be explained by central and peripheral pathophysiological mechanisms, including effects of the immune, oxidative, mitochondrial, and neuronal pathways.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":836,"document":"36439056","golden":false,"offsetInEndSection":958,"text":"Some risk factors heighten vulnerability to inflamed depression, including childhood adversity, old age, and being female.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36439056","golden":false,"offsetInEndSection":56,"text":"Towards a multidimensional model of inflamed depression.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1127,"document":"37373402","golden":false,"offsetInEndSection":1278,"text":"Meanwhile, female ME/CFS patients had significant alterations in gene networks related to cell stress, response to herpes viruses, and NF-?? signaling.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":628,"document":"36439056","golden":false,"offsetInEndSection":749,"text":"One important point that has emerged is the heterogeneous nature of the relationship between inflammation and depression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1621,"document":"35285272","golden":false,"offsetInEndSection":1796,"text":"Carnitine shuttle was associated with the PNS cluster (p \u003d .015).CONCLUSION: Fatty acids and amino acids pathways were associated with PNS in children undergoing chemotherapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1157,"document":"26998359","golden":false,"offsetInEndSection":1373,"text":"Bioenergetic muscle dysfunction is evident in CFS/ME, with a tendency towards an overutilisation of the lactate dehydrogenase pathway following low-level exercise, in addition to slowed acid clearance after exercise.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1466,"document":"33842886","golden":true,"offsetInEndSection":1679,"text":"Our findings support the idea that alterations in the catecholaminergic functional circuits underlie fatigue in multiple sclerosis and identify the NAT as a putative therapeutic target directed to pathophysiology.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":192,"document":"38251542","golden":true,"offsetInEndSection":374,"text":"Fatigue in these patients is not strongly linked with peripheral disease activity but is associated with CNS-derived symptoms such as chronic pain, sleep disturbance, and depression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":815,"document":"26998359","golden":false,"offsetInEndSection":823,"text":"Methods.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1145,"document":"26998359","golden":false,"offsetInEndSection":1156,"text":"Discussion.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1005,"document":"26998359","golden":false,"offsetInEndSection":1144,"text":"Studies show evidence for skeletal muscle biochemical abnormality in CFS/ME patients, particularly in relation to bioenergetic dysfunction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":14,"document":"26998359","golden":false,"offsetInEndSection":205,"text":"Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a debilitating disorder of unknown aetiology, characterised by severe disabling fatigue in the absence of alternative diagnosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1139,"document":"37185821","golden":false,"offsetInEndSection":1361,"text":"Our work highlights how male androgen hormone backgrounds and active autoimmunity reduce mitochondrial function and the ability to cope with stress and how pharmacological blockade of stress signal protects heart function.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1534,"document":"38178091","golden":false,"offsetInEndSection":1638,"text":"Collectively, our findings corroborate the central role of hypothalamic dysfunction in CNS autoimmunity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1362,"document":"37185821","golden":true,"offsetInEndSection":1478,"text":"These studies provide new insight into the diverse actions of IFN-? in fatigue, energy metabolism, and autoimmunity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":367,"document":"37185821","golden":true,"offsetInEndSection":508,"text":"Thus, we hypothesize that immune dysfunction-driven changes in myocyte mitochondria may play a critical role in fatigue-related pathogenesis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1730,"document":"35599774","golden":false,"offsetInEndSection":1991,"text":"In conclusion, CFAS-D may be triggered by a variety of stimuli and their effects are mediated by aberrations in the cross-talks between redox, NF-?B, and Wnt/?-catenin signaling pathways leading to dysfunctions in multicellular organismal homeostatic processes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1948,"document":"21407167","golden":false,"offsetInEndSection":2099,"text":"It is concluded that the activation of peripheral and / or central IO\u0026NS pathways may explain the co-occurrence of depression with the above disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":945,"document":"37185821","golden":true,"offsetInEndSection":1138,"text":"We report that inefficiencies and structural changes in mitochondria, with changes to expression of mitochondrial genes, are linked to male-biased fatigue and acute cardiomyopathy under stress.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":529,"document":"25598355","golden":true,"offsetInEndSection":794,"text":"A wide array of immune, inflammatory, oxidative and nitrosative stress (O\u0026NS), bioenergetic, and neurophysiological abnormalities are involved in the etiopathology of these disease states and may underpin the incapacitating fatigue that accompanies these disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":746,"document":"37185821","golden":false,"offsetInEndSection":944,"text":"Most notably, echocardiography unveiled that low ejection fraction in the left ventricle post-stress correlated with mitochondrial deficiencies, explaining how heart function decreases under stress.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":823,"document":"33010585","golden":true,"offsetInEndSection":1018,"text":"It seems likely that proinflammatory cytokines, tryptophan catabolites (the KYN pathway) and the gut-brain axis are involved in the mechanisms causing chronic fatigue and MDD-like symptoms in MS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38191373","golden":false,"offsetInEndSection":352,"text":"OBJECTIVES: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a significant medical challenge, with no indisputable pathophysiological mechanism identified to date.METHODS: Based on clinical clues, we hypothesized that 5-hydroxytryptamine (5-HT) hyperactivation is implicated in the pathogenic causes of ME/CFS and the associated symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":876,"document":"38191373","golden":false,"offsetInEndSection":1166,"text":"These ME/CFS-like features induced by excess serotonin were additionally verified using both a 5-HT synthesis inhibitor and viral vector for Htr1a (5-HT1A receptor) gene knockdown.CONCLUSIONS: Our findings support the involvement of 5-HTergic hyperactivity in the pathophysiology of ME/CFS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1657,"document":"25135658","golden":false,"offsetInEndSection":1862,"text":"vels; and higher serum IL-6 levels. The correlation analyses showed that the score of the SF-36 Vitality subscale was associated with age, dialytic age, TIRD, ADL, IADL, CCI, BDI, HARS, MMSE, serum urea, c","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2225,"document":"25135658","golden":false,"offsetInEndSection":2479,"text":"rrelation was 0.679 (R(2) \u003d 0.462). Fatigue, BDI, and IL-6 among biomarkers showed the strongest association with the underlying construct (standardized canonical coefficients \u003d -0.989, 0.015, and 0.852, respectively), thus explaining a correlation of IL","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2480,"document":"25135658","golden":false,"offsetInEndSection":2600,"text":"6 with both depression and fatigue.CONCLUSION: Fatigue was significantly associated with symptoms of depression and seru","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1163,"document":"25135658","golden":true,"offsetInEndSection":1350,"text":"igued than in nonfatigued patients. Serum IL-6 levels (pg/mL) were higher in the fatigued group (5.1 ? 3.4) than in the nonfatigued group (1.6 ? 1.5; P \u003c 0.001); serum albumin and creatin","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":949,"document":"21945535","golden":false,"offsetInEndSection":1042,"text":"evious depressive episodes. Neopterin and TNF? were associated with melancholia, while both P","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21945535","golden":false,"offsetInEndSection":307,"text":"BACKGROUND: Depression is characterized by activation of cell-mediated immunity (CMI), including increased neopterin levels, and increased pro-inflammatory cytokines (PICs), such as interleukin-1 (IL-1) and tumor necrosis factor-? (TNF?). These PICs may induce depressive, melancholic and chronic fatigue (C","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1174,"document":"21945535","golden":false,"offsetInEndSection":1384,"text":"he FF score and serum TNF?.DISCUSSION: Depression and melancholia are accompanied by CMI activation, suggesting that neopterin plays a role in their pathophysiology, e.g. through activation of oxidative and nit","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1385,"document":"21945535","golden":false,"offsetInEndSection":1543,"text":"osative stress and apoptosis pathways. The intertwined CMI and inflammatory responses are potentially associated with the onset of depression and with the mel","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":483,"document":"22197082","golden":false,"offsetInEndSection":849,"text":"Moreover, new pathways, i.e. concomitants and sequels of CMI activation and inflammation, were detected in depression: (1) Induction of indoleamine 2,3-dioxygenase (IDO) by IFN? and some PICs is associated with depleted plasma tryptophan, which may interfere with brain 5-HT synthesis, and increased production of anxiogenic and depressogenic tryptophan catabolites.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"26809839","golden":false,"offsetInEndSection":132,"text":"Converging sources of evidence point to a role for inflammation in the development of depression, fatigue and cognitive dysfunction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1153,"document":"37509005","golden":true,"offsetInEndSection":1623,"text":"Remitted RRMS patients showed increased chronic fatigue, depression, anxiety, physiosomatic, autonomic, and insomnia scores, which could partly be explained by M1 macrophage, Th1, Th-17, growth factor, and CIRS activation, as well as aberrations in the erythron including lowered hematocrit and hemoglobin levels.CONCLUSIONS: Around 50% of remitted RRMS patients show activation of immune-inflammatory pathways in association with mood and chronic-fatigue-like symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":615,"document":"38251542","golden":false,"offsetInEndSection":798,"text":"We then evaluate neuromodulation techniques that could affect these candidate brain regions and are potential treatment strategies for fatigue in patients with inflammatory arthritis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":632,"document":"37546944","golden":false,"offsetInEndSection":982,"text":"Based on genetic analysis, and computational theory and modeling we hypothesize that mucin protein dysfunction may contribute to ME/CFS symptoms due to the inability to form adequate mucosal layers throughout the body, especially in the ocular and otolaryngological pathways leading to low grade chronic inflammation and the exacerbation of symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":482,"document":"38251542","golden":false,"offsetInEndSection":614,"text":"In this Review, we focus on clinical imaging biomarkers that map candidate brain regions and are crucial in fatigue pathophysiology.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":266,"document":"37509005","golden":false,"offsetInEndSection":1152,"text":"Nonetheless, the pathophysiology of relapsing-remitting MS (RRMS)-related chronic fatigue, depression, anxiety, cognitive impairments, and autonomic disturbances is not well understood.OBJECTIVES: The current study aims to delineate whether the remitted phase of RRMS is accompanied by activated immune-inflammatory pathways and if the latter, coupled with erythron variables, explain the chronic fatigue and mood symptoms due to RRMS.MATERIAL AND METHODS: We recruited 63 MS patients, 55 in the remitted phase of RRMS and 8 with secondary progressive MS, and 30 healthy controls and assessed erythron variables, and used a bio-plex assay to measure 27 serum cytokines.RESULTS: A significant proportion of the MS patients (46%) displayed activation of the immune-inflammatory response (IRS) and compensatory immune response (CIRS) systems, and T helper (Th)1 and Th17 cytokine profiles.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38251542","golden":false,"offsetInEndSection":191,"text":"Despite developments in pharmacological treatments, chronic fatigue is an unresolved issue for most people with inflammatory arthritis that severely disrupts their personal and working lives.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38251542","golden":false,"offsetInEndSection":90,"text":"Brain mapping inflammatory-arthritis-related fatigue in the pursuit of novel therapeutics.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36758522","golden":false,"offsetInEndSection":196,"text":"Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is characterized by unexplained debilitating fatigue, cognitive dysfunction, gastrointestinal disturbances, and orthostatic intolerance.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":413,"document":"36758522","golden":true,"offsetInEndSection":583,"text":"Faecalibacterium prausnitzii and Eubacterium rectale, which are both recognized as abundant, health-promoting butyrate producers in the human gut, were reduced in ME/CFS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":584,"document":"36758522","golden":false,"offsetInEndSection":729,"text":"Functional metagenomics, qPCR, and metabolomics of fecal short-chain fatty acids confirmed a deficient microbial capacity for butyrate synthesis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":860,"document":"36758522","golden":true,"offsetInEndSection":953,"text":"The abundance of Faecalibacterium prausnitzii was inversely associated with fatigue severity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":581,"document":"30564562","golden":false,"offsetInEndSection":747,"text":"Pathobionts, and their associated proteins/metabolites, often control human metabolism and gene expression in a manner that pushes the body toward a state of illness.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":748,"document":"30564562","golden":true,"offsetInEndSection":927,"text":"Intracellular pathogens, including many associated with ME/CFS, drive microbiome dysbiosis by directly interfering with human transcription, translation, and DNA repair processes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1396,"document":"30564562","golden":false,"offsetInEndSection":1504,"text":"The metabolic dysfunction driven by these organisms can result in similar clusters of inflammatory symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23664637","golden":false,"offsetInEndSection":201,"text":"BACKGROUND: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is accompanied by activation of immuno-inflammatory pathways, increased bacterial translocation and autoimmune responses to serot","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1516,"document":"23664637","golden":false,"offsetInEndSection":1762,"text":"ess and a flu-like malaise.DISCUSSION: The results show that, in ME/CFS, increased 5-HT autoimmune activity is associated with activation of immuno-inflammatory pathways and increased bacterial translocation, factors which are known to play a rol","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1763,"document":"23664637","golden":false,"offsetInEndSection":1880,"text":" in the onset of autoimmune reactions. 5-HT autoimmune activity could play a role in the pathophysiology of ME/CFS an","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":742,"document":"38347175","golden":false,"offsetInEndSection":937,"text":"Notably, nearly all drugs currently under investigation for fatigue in post-COVID syndrome are rather addressing one single target instead of the several pathomechanisms underlying this condition","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1320,"document":"38334253","golden":false,"offsetInEndSection":1518,"text":"This study unveils a substantial occurrence (67.5%) of IIH in FMS patients, suggesting shared pathophysiological mechanisms contributing to symptoms like fatigue, headache, and cognitive dysfunction","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"38331459","golden":false,"offsetInEndSection":140,"text":"Long COVID impacts ?10% of people diagnosed with COVID-19, yet the pathophysiology driving ongoing symptoms is poorly understood","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":322,"document":"38314594","golden":false,"offsetInEndSection":543,"text":"Second, to assess whether detailed symptoms of pain and autonomic function, as well as measures of tinnitus, fatigue, daytime sleepiness and Mycoplasma pneumoniae infection are predictors of reaction time in fibromyalgia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":123,"document":"38313087","golden":false,"offsetInEndSection":295,"text":"Although widespread pain is the dominant feature, fibromyalgia incorporates a wide variety of symptoms, such as fatigue, unrefreshed sleep, and cognitive and mood disorders","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":746,"document":"38261628","golden":false,"offsetInEndSection":890,"text":"Patient burden (pain/morning stiffness/fatigue/functional disabilities/presenteeism) was assessed at baseline, 4/12/24?months and IA-development","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":200,"document":"38255163","golden":false,"offsetInEndSection":564,"text":"Based on the view that intermittent stress would be the most probable etiology for FM, intermittent cold- and intermittent psychological stress-induced generalized pain (ICGP and IPGP) models in mice have been developed and validated as FM-like pain models in terms of the patho-physiological and pharmacotherapeutic features that are shared with clinical versions","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38202282","golden":false,"offsetInEndSection":177,"text":"Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex disease characterized by profound fatigue, post-exertional malaise (PEM), and neurocognitive dysfunction","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":263,"document":"38201291","golden":false,"offsetInEndSection":346,"text":"However, a treatment targeting a novel pathophysiological mechanism is still needed","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1639,"document":"38358794","golden":false,"offsetInEndSection":1966,"text":"Changes from baseline to 6 months were significant only within the intervention group for weight (P\u003c.001), liver fat score (P\u003d.01), aspartate aminotransferase (P\u003d.03), alanine transferase (P\u003d.002), gamma-glutamyl transferase (P\u003d.04), self-management (P\u003c.001), fatigue (P\u003d.005), depression (P\u003d.003), and quality of life (P\u003c.001)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":168,"document":"38358423","golden":false,"offsetInEndSection":338,"text":"The purpose is to investigate the effect of photobiomodulation therapy on headache, fatigue, sinus opacification, and ostiomeatal complex obstruction in patients with CRS","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1432,"document":"38358334","golden":false,"offsetInEndSection":1511,"text":"The most common toxicities were fatigue (32%), anemia (26%), and anorexia (26%)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":785,"document":"38358141","golden":false,"offsetInEndSection":872,"text":"A pandemic fatigue was observed after nearly 7 to 10 months from the pandemic emergence","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":838,"document":"38357801","golden":false,"offsetInEndSection":944,"text":"binimetinib (called encorafenib plus binimetinib in this summary). Before starting the study, 59 people ha","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":948,"document":"38357797","golden":false,"offsetInEndSection":1060,"text":"?\u003d?0.0491). The most common treatment-emergent adverse events included somnolence, dizziness, fatigue, and balan","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":785,"document":"22824349","golden":false,"offsetInEndSection":928,"text":"In addition, challenge with pramipexole led to increased anger, fatigue, vigor and tension in healthy control subjects, but not in PD patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1143,"document":"22824349","golden":false,"offsetInEndSection":1358,"text":"The acute effects of a methylphenidate challenge on anhedonia and vigor in PD patients make this drug an interesting choice for further studies of the treatment of mood and motivational disorders in this population.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":182,"document":"27634186","golden":false,"offsetInEndSection":1190,"text":"This \"cross talk\" is enabled by the presence of highly adapted secretory cells, sampling cells and pattern recognition receptors in the gastric epithelium.METHODS: Herein we discuss the mechanisms involved in the breakdown of intestinal homeostasis and the development of systemic immune activation and neuroinflammation with a view to discussing the importance of these processes, in tandem with genetic and environmental factors, in the pathophysiology of (auto)immune diseases.Data is presented explaining how immune tolerance is maintained and how it may breakdown.CONCLUSION: The breakdown of immune homeostasis following the development of gut inflammation, caused for example by gut dysbiosis, and the consequent increased intestinal permeability, is increasingly considered to be the ultimate source of the systemic immune activation and T helper 17/T regulatory cell imbalances, and maybe neurological disturbances, seen in autoimmune diseases such as Type 1 diabetes and inflammatory bowel disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":601,"document":"12665396","golden":false,"offsetInEndSection":966,"text":"Proposed pathological mechanisms of fatigue in MS include neuronal factors such as dysfunction of premotor, limbic, basal ganglia or hypothalamic areas; disruption of the neuroendrocrine axis leading to low arousal; alteration in serotoninergic pathways; changes in neurotransmitter levels; and altered CNS functioning caused by a disruption of the immune response.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":929,"document":"22824349","golden":false,"offsetInEndSection":1020,"text":"Challenge with methylphenidate had a positive effect on anhedonia and vigor in PD patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":973,"document":"26179434","golden":false,"offsetInEndSection":1192,"text":"Thus, involvement of the corticobasal ganglia pathway and its interaction with motor, sensory, limbic, and executive networks in each of the components as well as their control by different neuromodulators is described.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"22824349","golden":false,"offsetInEndSection":197,"text":"In Parkinson\u0027s disease (PD) reduced dopaminergic activity in the mesocorticolimbic pathway is implied in the pathophysiology of several non-motor symptoms related to mood, motivation and cognition.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1379,"document":"25801843","golden":false,"offsetInEndSection":1612,"text":"It is concluded that secondary fatigue may be associated with activation of the TLR Radical Cycle pathway due to activated immune-inflammatory pathways, classical and redox-derived DAMPs and PAMPs plays a role in its pathophysiology.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":679,"document":"22824349","golden":false,"offsetInEndSection":784,"text":"Acute challenge with pramipexole had a negative effect on mood and fatigue in both patients and controls.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":687,"document":"15570154","golden":false,"offsetInEndSection":833,"text":"Therefore, an alteration of serotonergic system in the rostral anterior cingulate plays a key role in pathophysiology of chronic fatigue syndrome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1408,"document":"29579369","golden":true,"offsetInEndSection":1853,"text":"Results also replicated several specific genomic effects previously observed in fatigued cancer survivors, including upregulated expression of ?-synuclein (SNCA) and hemoglobin subunits (HBA and HBB).CONCLUSIONS: Cancer survivors\u0027 heightened fatigue levels may be partially explained by activation of specific immune cell subsets, thereby providing a potential molecular biomarker for clinical interventions targeting the remediation of fatigue.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1112,"document":"12665396","golden":false,"offsetInEndSection":1213,"text":"Amantadine and modafinil are among the most commonly used medications for fatigue associated with MS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"12665396","golden":false,"offsetInEndSection":65,"text":"Fatigue is a common disabling symptom of multiple sclerosis (MS).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":304,"document":"12665396","golden":false,"offsetInEndSection":351,"text":"Fatigue in MS frequently leads to unemployment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":145,"document":"28797855","golden":false,"offsetInEndSection":594,"text":"However, the dysregulation of a set of 35 genes was recently validated to predict development of fatigue in prostate cancer patients receiving radiotherapy.OBJECTIVES: To hypothesize novel pathways, and provide genetic targets for currently proposed pathways implicated in RIF development through analysis of the previously validated gene set.METHODS: The gene set was analyzed for all phenotypic attributions implicated in the phenotype of fatigue.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":854,"document":"25566171","golden":false,"offsetInEndSection":1168,"text":"We examine the hypothesis that the subjective feeling of MS-related fatigue may be a variant of inflammation-induced sickness behavior, resulting from cytokine-mediated activity changes within brain areas involved in interoception and homeostasis including the insula, the anterior cingulate, and the hypothalamus.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1214,"document":"12665396","golden":false,"offsetInEndSection":1301,"text":"Both medications have been studied with positive results in controlled clinical trials.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":352,"document":"12665396","golden":false,"offsetInEndSection":497,"text":"It is associated with a sense of loss of control over one\u0027s environment, low positive affect, psychological distress and neurological impairment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1043,"document":"27766535","golden":false,"offsetInEndSection":1259,"text":"Findings show that activation of immune-inflammatory and O\u0026NS pathways in ME/CFS are probably not secondary to HPA axis hypoactivity and that activation of these pathways may underpin HPA axis hypofunction in ME/CFS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1753,"document":"35693009","golden":false,"offsetInEndSection":1982,"text":"We believe the ME/CFS-like ongoing effects of Long COVID are arising by very similar mechanisms involving neuroinflammation, but likely with some unique signaling, resulting from the pathology of the initial SARS-CoV-2 infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1095,"document":"35693009","golden":false,"offsetInEndSection":1409,"text":"We propose the hypothesis that following the initial stressor event, the subsequent systemic pathology moves to the brain via neurovascular pathways or through a dysfunctional blood-brain barrier (BBB), resulting in chronic neuroinflammation and leading to a sustained illness with chronic relapse recovery cycles.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":964,"document":"33662501","golden":false,"offsetInEndSection":1136,"text":"Moreover, we discuss how the reduction/dysfunction of monoamines in MS may contribute to some clinical features typical of the disease, particularly fatigue and depression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":498,"document":"35054876","golden":false,"offsetInEndSection":746,"text":"Next, we summarize findings from the literature that suggest the involvement of HPA-axis dysfunction, the serotonergic system, cytokines and inflammation, metabolic insufficiency and mitochondrial dysfunction, and genetic changes in CRF and CFS/ME.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"12665396","golden":false,"offsetInEndSection":73,"text":"Fatigue in multiple sclerosis: definition, pathophysiology and treatment.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":211,"document":"27366343","golden":false,"offsetInEndSection":597,"text":"Intermediate and advanced PD stages are characterized by motor fluctuations and dyskinesia, which depend on complex mechanisms secondary to severe nigrostriatal loss and to the problems related to oral levodopa absorption, and motor and nonmotor symptoms and signs that are secondary to marked dopaminergic loss and multisystem neurodegeneration with damage to nondopaminergic pathways.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27366343","golden":false,"offsetInEndSection":210,"text":"Cardinal motor features of Parkinson\u0027s disease (PD) include bradykinesia, rest tremor, and rigidity, which appear in the early stages of the disease and largely depend on dopaminergic nigrostriatal denervation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":598,"document":"27366343","golden":false,"offsetInEndSection":846,"text":"Nondopaminergic dysfunction results in motor problems, including posture, balance and gait disturbances, and fatigue, and nonmotor problems, encompassing depression, apathy, cognitive impairment, sleep disturbances, pain, and autonomic dysfunction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1040,"document":"27366343","golden":false,"offsetInEndSection":1202,"text":"The present review will focus on classical notions and recent insights into the neuropathology, neuropharmacology, and neurophysiology of motor dysfunction of PD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1203,"document":"27366343","golden":false,"offsetInEndSection":1327,"text":"These pieces of information represent the basis for the pharmacological, neurosurgical, and rehabilitative approaches to PD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":542,"document":"26198889","golden":false,"offsetInEndSection":772,"text":"POTS is a \"final common pathway\" for a number of overlapping pathophysiologies, including an autonomic neuropathy in the lower body, hypovolemia, elevated sympathetic tone, mast cell activation, deconditioning, and autoantibodies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":526,"document":"37731525","golden":false,"offsetInEndSection":755,"text":"Iron deficiency may cause symptoms such as general fatigue, pica, and nerve deafness, while excessive iron plays a crucial role in the pathophysiological processes of the heart through ferroptosis triggered by the Fenton reaction","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1556,"document":"37686834","golden":false,"offsetInEndSection":1780,"text":"Here, we provide an up-to-date review of the potential mechanisms and pathophysiology of neuropsychiatric long COVID syndrome and the plausible neurological contributions of vitamin D in mitigating the effects of long COVID.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":450,"document":"37446047","golden":false,"offsetInEndSection":689,"text":"Referred to under the umbrella term LC, the onset of persistent and highly heterogeneous symptoms such as fatigue, post-exertion malaise, cognitive dysfunction, and others have a major impact on the child\u0027s daily quality of life for months","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":135,"document":"37398656","golden":false,"offsetInEndSection":275,"text":"The symptoms include inattention, short-term memory loss, and reduced mental acuity, which may undermine cognition, concentration, and sleep","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1017,"document":"37388814","golden":false,"offsetInEndSection":1379,"text":"ation can be persistent ant CoV-2-specific responses, new onset autoimmune responses, or a loss of normal immunoregulation resulting in widespread, sustained inflammatory pathologies that can affect both broad constitutional symptoms (such as fatigue, neurocognitive dysfunction, and anxiety/depression) and organ-specific dysfunction and/or failure.Conclusions:","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":721,"document":"37083270","golden":false,"offsetInEndSection":1092,"text":"Compared with cluster 1, cluster 2 included older patients with a higher burden of comorbidities (cardiovascular and RA related), more erosive and longer RA duration, more dyspnoea and fatigue, walking a shorter distance in the Six-Minute Walk Test, with more severe diastolic dysfunction, and a 4.5-fold higher risk of death or hospitalization for cardiovascular reasons","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":638,"document":"33179588","golden":true,"offsetInEndSection":1049,"text":"Here, we review recent neuroimaging and neuroimmunological findings, which indicate that dysfunctional reward processing might represent a shared functional mechanism fostering the symptom cluster of fatigue, depression, and pain in MS. We propose a framework that integrates these findings with a focus on monoaminergic neurotransmission and discuss its therapeutic implications, limitations, and perspectives.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35225228","golden":false,"offsetInEndSection":121,"text":"Fatigue is a common symptom in idiopathic inflammatory myopathies (IIMs), which greatly affects activities of daily life.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":277,"document":"35225228","golden":false,"offsetInEndSection":529,"text":"The aim of this review is to describe the different determinants of fatigue in IIMs, discuss their clinical implications and how to evaluate and manage the condition, which are all relevant issues for the treating physicians in their everyday practice.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1240,"document":"35910262","golden":false,"offsetInEndSection":1600,"text":"Altogether, a modulatory role of the cerebellum over multiple brain regions appears compelling, mainly by considering the complexity of its reciprocal connections to common neural networks involved in motor, vestibular, cognitive, affective, sensory, and autonomic processing-all functions affected at different phases and degrees across the migraine spectrum.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"35225228","golden":false,"offsetInEndSection":84,"text":"Fatigue as a common signature of inflammatory myopathies: clinical aspects and care.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":691,"document":"35371364","golden":true,"offsetInEndSection":860,"text":"The pathogenesis of fatigue in CLD is multifactorial and involves changes in the brain-liver axis resulting from changes in inflammatory cytokines or the gut microbiome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":134,"document":"36575839","golden":false,"offsetInEndSection":291,"text":"The pathophysiology which due to multisensory hypersensitivity of the central nervous system involves neuronal excitability leading to central sensitization.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":122,"document":"35225228","golden":false,"offsetInEndSection":276,"text":"Fatigue is a complex phenomenon that covers a range of dimensions from biological to behavioural, the pathophysiology of which is still poorly understood.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35881416","golden":false,"offsetInEndSection":176,"text":"INTRODUCTION: Fatigue is a common and debilitating symptom among multiple sclerosis (MS) patients with a prevalence up to 81% and with a considerable impact on quality of life.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":870,"document":"36427058","golden":false,"offsetInEndSection":1135,"text":"There is a dysregulation of multiple body organs and systems, involving the immune system, the coagulation cascade, endocrine organs, autonomic nervous system, microbiota-gut-brain axis, hypothalamic-pituitary-adrenal axis, hypothalamic-pituitary-thyroid axis, etc.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":989,"document":"15710856","golden":true,"offsetInEndSection":1379,"text":"Patients with fatigue had significantly elevated adrenocorticotropin (ACTH) levels in the combined Dex-CRH test.CONCLUSIONS: In contrast to results for chronic fatigue syndrome, where a hyporeactivity of the HPA axis has been shown, MS patients with fatigue exhibited a higher activity of the HPA axis than those without fatigue, as evidenced by significantly increased ACTH concentrations.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":296,"document":"17874343","golden":false,"offsetInEndSection":624,"text":"The role of various mechanisms has been suggested, including the effect of proinflammatory cytokines (TNF-alpha, IL-1beta and IL-6) on glutaminergic transmission, hypothalamo-pituitary-adrenal (HPA) axis dysfunction, disturbances of astroglia metabolism and decreased levels of the neurotransmitters noradrenaline and serotonin.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":991,"document":"21549189","golden":true,"offsetInEndSection":1085,"text":"These findings support the presence of HPA axis dysregulation in elderly individuals with CFS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1174,"document":"16361589","golden":true,"offsetInEndSection":1400,"text":"HPA axis activity was not related to fatigue but was modestly correlated with cognitive impairment.CONCLUSION: Our data suggest that fatigue in MS is at least partially mediated through activation of proinflammatory cytokines.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1137,"document":"17874343","golden":false,"offsetInEndSection":1206,"text":"Amantadine, modafinil and pemoline are administered to such patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17874343","golden":false,"offsetInEndSection":252,"text":"Fatigue without coincident depression may accompany many neurological disorders, including multiple sclerosis, Parkinson\u0027s disease, motor neuron disease, stroke and post-polio syndrome, and is frequently reported by patients as a predominant complaint.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":253,"document":"17874343","golden":false,"offsetInEndSection":295,"text":"The pathophysiology of fatigue is unknown.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1082,"document":"17874343","golden":false,"offsetInEndSection":1136,"text":"Pharmacological treatment leads to slight improvement.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":625,"document":"17874343","golden":false,"offsetInEndSection":800,"text":"The diagnosis of fatigue syndrome is based on exclusion of depression and additional organic conditions (anaemia, cardiovascular disorders, kidney diseases or hypothyroidism).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":847,"document":"17874343","golden":false,"offsetInEndSection":1081,"text":"Physical activity, rehabilitation, psychotherapy and avoidance of factors which may increase fatigue, such as fever, anxiety, depression, pain, sleep disturbances, as well as some drugs like opioids and benzodiazepines, are important.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30363584","golden":false,"offsetInEndSection":160,"text":"BACKGROUND: Fatigue is 1 of the most common and most disabling symptoms among patients with Parkinson\u0027s disease (PD) and has a significant impact on their quali","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33446049","golden":false,"offsetInEndSection":184,"text":"The last decade has seen the emergence of new theoretical frameworks to explain pathological fatigue, a much neglected, yet highly significant symptom across a wide range of diseases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":742,"document":"12884756","golden":false,"offsetInEndSection":900,"text":"he fatigue sensation is somehow related to hypofunction of the glutamatergic system through reduced uptake of acetyl-carnitine in the discrete brain regions. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"20656623","golden":false,"offsetInEndSection":118,"text":"Fatigue is a symptom whose causes are protean and whose phenotype includes physical, mood, and behavioral components.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":751,"document":"9572086","golden":false,"offsetInEndSection":933,"text":"The release of ACTH (but not cortisol) was significantly blunted in the CFS subjects compared with controls.CONCLUSIONS: Naloxone mediated activation of the HPA is attenuated in CFS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1792,"document":"21356304","golden":false,"offsetInEndSection":1976,"text":"Taken together, these findings indicate that sensitivity of p38 MAPK signaling pathways to immune stimulation is associated with depressive symptoms during chronic IFN-alpha treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1152,"document":"38411371","golden":false,"offsetInEndSection":1287,"text":"Patients differed from controls at baseline in tyrosine and purine pathways, and in the pyrimidine pathway after the stress challenges.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1528,"document":"38411371","golden":false,"offsetInEndSection":1764,"text":"Responses to metabolic and physical stresses result in a metabolic pattern that allows discrimination of fibromyalgia patients from controls and narrows the focus on key pathophysiological processes in fibromyalgia as treatment targets.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1047,"document":"38411371","golden":false,"offsetInEndSection":1151,"text":"In addition, 5-hydroxyindole-3-acetic acid and glutamine levels correlated with the severity of fatigue.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38411371","golden":false,"offsetInEndSection":141,"text":"Machine learning identifies fatigue as a key symptom of fibromyalgia reflected in tyrosine, purine, pyrimidine, and glutaminergic metabolism.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":683,"document":"38411371","golden":false,"offsetInEndSection":874,"text":"Algorithms trained with the FIQ information assigned the fibromyalgia diagnosis in new data with balanced accuracy of 88% while fatigue alone already provided the diagnosis with 86% accuracy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1357,"document":"38411371","golden":false,"offsetInEndSection":1435,"text":"This data-driven analysis highlights fatigue as a key symptom of fibromyalgia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":958,"document":"38411371","golden":false,"offsetInEndSection":1046,"text":"With these metabolites, fibromyalgia could be identified in new cases with 79% accuracy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1351,"document":"25877847","golden":true,"offsetInEndSection":1706,"text":"Juxtacortical and/or overlapping corticosubcortical lesion volume in frontal and temporal areas were significantly higher in the F-MS group compared to NF-MS patients.CONCLUSIONS: These results add new data suggesting that fatigue is associated with functional and structural changes of cerebral gray matter especially in frontal cortex and basal ganglia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1312,"document":"20035260","golden":false,"offsetInEndSection":1691,"text":"In the patient group, there were significant correlations between the urinary 8-OHdG and the total score on the FF scale and sadness and flu-like malaise.CONCLUSIONS: The findings show increased oxidatively generated DNA damage in patients with major depression and ME/CFS and, therefore, further extent the role played by IO\u0026NS pathways in the pathophysiology of both disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1415,"document":"15726642","golden":false,"offsetInEndSection":1734,"text":"In conclusion, 5-HT(1A) receptor agonist-induced amelioration of fatigue in cholestatic rats may be nonspecific and not linked to reversal of the pathophysiology of fatigue associated with cholestasis; however, these data do not exclude a potential role of the central serotoninergic system in the evolution of fatigue.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1209,"document":"23238467","golden":false,"offsetInEndSection":1795,"text":"Further, licofelone (5 and 10 mg/kg, po) and minocycline (50 and 100 mg/kg, po) drug treatments for 21 days significantly attenuated behavioral alterations, oxidative damage and restored mitochondrial enzyme complex activities (I, II, III and IV) as compared to control, whereas combination of licofelone (5 mg/kg) with minocycline (50 mg/kg) significantly potentiated their protective effect which was significant as compared to their effect per se.CONCLUSION: The present study highlights the therapeutic potential of licofelone, minocycline and their combination against CFS in mice.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35046929","golden":false,"offsetInEndSection":400,"text":"Myalgic encephalomyelitis (ME) or Chronic Fatigue Syndrome (CFS) is a neglected, debilitating multi-systemic disease without diagnostic marker or therapy. Despite evidence for neurological, immunological, infectious, muscular and endocrine pathophysiological abnormalities, the etiology and a clear pathophysiology remains unclear. The gut microbiome gained much attention in the last decade with man","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":100,"document":"38411371","golden":false,"offsetInEndSection":400,"text":"gy of fibromyalgia is incompletely understood but appears to involve metabolic changes at rest or in response to stress. We enrolled 54 fibromyalgia patients and 31 healthy controls to this prospective study. Symptoms were assessed using the Fibromyalgia Impact Questionnaire (FIQ) and blood samples ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":50,"document":"35261628","golden":false,"offsetInEndSection":350,"text":"hways between patients with and without cancer-related fatigue (CRF) were examined to identify metabolic serum biomarkers of CRF. In this preliminary study, metabolic profiling was applied to analyze the serum samples from 14 patients with CRF and 11 non-CRF individuals (non-fatigue cancer survivors","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":200,"document":"36133318","golden":false,"offsetInEndSection":500,"text":"elae of COVID-19 or part of the same syndrome.\"Methods: In this prospective multicentre study, frequency of post-COVID fatigue and cognitive impairment were assessed in n?\u003d?969 patients (535 [55%] female) ?6 months after SARS-CoV-2 infection with the FACIT-Fatigue scale (cut-off ?30) and Montreal Co","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36412084","golden":false,"offsetInEndSection":400,"text":"NEW FINDINGS: What is the topic of this review? The emerging condition of long COVID, its epidemiology, pathophysiological impacts on patients of different backgrounds, physiological mechanisms emerging as explanations of the condition, and treatment strategies being trialled. The review leads from a Physiological Society online conference on this topic. What advances does it highlight? Progress i","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1165,"document":"28131211","golden":false,"offsetInEndSection":1389,"text":"dies fulfilled the inclusion criteria. Primary MS fatigue mainly originated from a dysfunction of central nervous system neuronal circuits secondary to increased inflammation, reduced glucose metabolism, brain atrophy and di","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1535,"document":"21975140","golden":false,"offsetInEndSection":1700,"text":"ade inflammation and activation of CMI. The results suggest that characteristic symptoms of ME/CFS, such as fatigue, autonomic symptoms and a flu-like malaise, may b","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":83,"document":"38411371","golden":false,"offsetInEndSection":220,"text":"The pathophysiology of fibromyalgia is incompletely understood but appears to involve metabolic changes at rest or in response to stress.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":969,"document":"38797848","golden":false,"offsetInEndSection":1292,"text":"The potential role of S100 proteins in the pathophysiology of fibromyalgia could be mediated by RAGE and TLR4, which signal through JNK, ERK, and p38 to activate AP-1 and NF-?B and induce the release of proinflammatory cytokines, thereby producing the inflammation, fatigue, and chronic pain characteristic of fibromyalgia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28410877","golden":false,"offsetInEndSection":254,"text":"Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is characterised by multiple symptoms including fatigue, headaches and cognitive impairment, which have a significantly adverse effect on the normal functioning and well-being of the individual.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":188,"document":"18973731","golden":false,"offsetInEndSection":364,"text":"Research on the pathophysiology of FM has focused on dysregulation of sensory processing in the central nervous system, as well as genetic and sociobiologic background factors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17502633","golden":false,"offsetInEndSection":213,"text":"Primary fibromyalgia is a common yet poorly understood syndrome characterized by diffuse chronic pain accompanied by other somatic symptoms, including poor sleep, fatigue, and stiffness, in the absence of disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":293,"document":"21719591","golden":false,"offsetInEndSection":520,"text":"her among women. The diagnostic characteristics of fibromyalgia are chronic widespread pain, thought to arise from abnormalities of ascending pain and descending inhibitory sensory pathways, and allodynia on palpation of specif","beginSection":"abstract"}],"exact_answer":[["elevated adrenocorticotropin (ACTH) levels HPA axis dysfunction activation of proinflammatory cytokines (TNF-alpha, IL-1beta and IL-6) disturbances of astroglia metabolism decreased levels of noradrenaline decreased levels of serotonin proinflammatory cytokines (TNF-alpha, IL-1beta, IL-6) glutaminergic transmission astroglia metabolism disturbances decreased neurotransmitters noradrenaline and serotonin dysregulation of GABAergic/glutamatergic neurotransmission tyrosine metabolism purine metabolism pyrimidine metabolism glutaminergic metabolism aberrations in neuromuscular and myotendinous junctions tyrosine pathway purine pathway pyrimidine pathway p38 MAPK signaling pathway functional and structural changes of cerebral gray matter oxidative stress IO\u0026NS pathways central serotoninergic system","Gut dysbiosis, altered gut-brain axis activity, increased gut permeability, bacterial translocation, abnormal tryptophan metabolism, and reduced activity of the kynurenine pathway","Disrupted tyrosine, purine, and pyrimidine metabolism, and glutaminergic neurotransmission abnormalities in fibromyalgia","Disruptions in phospholipid metabolism, endocannabinoid system alterations, glycerophospholipid abnormalities, and anandamide level changes in cancer-related fatigue","Dysautonomia, micro-clotting, impaired oxygen delivery, and cellular energy metabolism changes in Long COVID-related fatigue"]],"ideal_answer":["Fatigue is a complex symptom with multiple pathophysiological pathways. Key mechanisms include alterations in gut-brain axis activity, gut dysbiosis, and increased gut permeability, as seen in conditions like chronic fatigue syndrome. In fibromyalgia, metabolic disruptions such as tyrosine, purine, and pyrimidine pathway changes, as well as glutaminergic neurotransmission abnormalities, play a role. Cancer-related fatigue involves phospholipid metabolism disturbances, endocannabinoid system changes, and glycerophospholipid imbalances. Post-COVID-19 fatigue is linked to dysautonomia, micro-clotting, impaired oxygen delivery, and disruptions in cellular energy metabolism. These pathways highlight the importance of tailored therapeutic strategies to address the underlying causes of fatigue."],"id":"6593dce006a2ea257c00001d","type":"list","body":"Which pathophysiological pathways are involved in the symptom FATIGUE?"},{"documents":[{"golden":true,"id":"34183713"},{"golden":true,"id":"35898301"},{"golden":false,"id":"10998175"},{"golden":false,"id":"35358332"},{"golden":false,"id":"33688234"},{"golden":false,"id":"38306913"},{"golden":false,"id":"29393415"},{"golden":false,"id":"33746973"},{"golden":false,"id":"26476786"},{"golden":false,"id":"25000179"},{"golden":false,"id":"36010061"},{"golden":false,"id":"39148395"},{"golden":false,"id":"38107458"},{"golden":false,"id":"24310803"},{"golden":false,"id":"36335405"},{"golden":false,"id":"36104331"},{"golden":false,"id":"25548220"},{"golden":false,"id":"16513739"},{"golden":false,"id":"12819089"},{"golden":false,"id":"34208220"},{"golden":false,"id":"38263289"},{"golden":false,"id":"36474749"},{"golden":false,"id":"33767373"},{"golden":false,"id":"29808244"},{"golden":false,"id":"38245687"},{"golden":false,"id":"36621204"},{"golden":false,"id":"37246430"},{"golden":false,"id":"25684123"},{"golden":false,"id":"8807086"},{"golden":false,"id":"22438436"},{"golden":false,"id":"16493078"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":1195,"document":"35898301","golden":true,"offsetInEndSection":1554,"text":"Cohorts with upregulated ANRIL (hazard ratio; HR \u003d 4.21, 95% CI \u003d 1.15-10.4, p\u003d0.030) and HOTAIR (HR \u003d 2.49, 95% CI \u003d 1.02-6.05, p\u003d0.044) were at a higher risk of mortality.Conclusion: Circulatory MALAT1, ANRIL, and HOTAIR were upregulated in neonatal sepsis, and the latter two may have the potential as prognostic biomarkers for survival in neonatal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1001,"document":"34183713","golden":false,"offsetInEndSection":1138,"text":"Furthermore, patients with high circulatory MYD88 levels were associated with poor survival, as revealed by Kaplan-Meier curves analysis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":994,"document":"35358332","golden":false,"offsetInEndSection":1436,"text":"The polymorphisms of VDR gene rs739837 and TREM-1?gene rs2234246 were not significantly correlated with the survival of patients with neonatal sepsis (p?\u003e?0.05).CONCLUSION: Vitamin D receptor gene rs739837?locus G\u003eT is associated with a reduction in the risk of neonatal sepsis, TREM-1 rs2234246 C\u003eT is associated with the increased risk of neonatal sepsis, but none of them was significantly associated with the prognosis of neonatal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1630,"document":"33688234","golden":false,"offsetInEndSection":1909,"text":"SLC2A6 was identified by STEM as associated with sepsis-associated mortality and showed the strongest positive correlation with infiltration levels of Th1 cells.CONCLUSION: In summary, our four key genes may have important implications for the early diagnosis of sepsis patients.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34183713","golden":true,"offsetInEndSection":121,"text":"MYD88, NFKB1, and IL6 transcripts overexpression are associated with poor outcomes and short survival in neonatal sepsis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1368,"document":"34183713","golden":true,"offsetInEndSection":1522,"text":"In conclusion, the study TLR pathway-related transcripts have a gender-specific signature, diagnostic, and prognostic clinical utility in neonatal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1139,"document":"34183713","golden":false,"offsetInEndSection":1235,"text":"MYD88, NFKB1, and IL6 transcripts showed association with different poor-outcome manifestations.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":917,"document":"34183713","golden":false,"offsetInEndSection":1000,"text":"ROC analysis revealed MYD88 and NFKB1 transcripts to be good biomarkers for sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":664,"document":"34183713","golden":false,"offsetInEndSection":763,"text":"MYD88, NFKB1, and IL6 relative expressions were significantly higher in sepsis cases than controls.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1592,"document":"29393415","golden":false,"offsetInEndSection":1703,"text":"These results indicated that upregulated IFN?I signaling may be a high-risk factor for mortality due to sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":464,"document":"39148395","golden":false,"offsetInEndSection":796,"text":"his article provides a review of gene polymorphisms related to neonatal sepsis, including interleukins, tumor necrosis factor, Toll-like receptors, NOD-like receptors, CD14, triggering receptor expressed on myeloid cells-1, mannose-binding lectin, and other immune proteins, aiming to promote precision medicine for this disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":215,"document":"38107458","golden":false,"offsetInEndSection":345,"text":"he impact of genetic background on susceptibility and clinical outcomes, particularly in neonatal sepsis, has gained recognition. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":14,"document":"24310803","golden":false,"offsetInEndSection":109,"text":"JECTIVE: Neonatal sepsis is associated with premature birth and maternal infection. Large-scale","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":167,"document":"36335405","golden":false,"offsetInEndSection":303,"text":"are units. Most genetic studies have identified gene variants associated with development and outcomes of sepsis focusing on biological ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1772,"document":"36474749","golden":false,"offsetInEndSection":1951,"text":"Only miR181b-5p, miR21-5p, and SNAP II were predictive factors of septic mortality.Conclusion: MiR181b-5p and miR21-5p are diagnostic and prognostic biomarkers of neonatal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":842,"document":"10998175","golden":false,"offsetInEndSection":1105,"text":"A significant proportion of the avirulent mutants had transposon insertions in genes encoding transport-associated or regulatory proteins or in genes involved in cell surface metabolism, emphasizing the significance of these functions for in vivo survival of GBS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38245687","golden":false,"offsetInEndSection":400,"text":"BACKGROUND: Neonatal sepsis, a perilous medical situation, is typified by the malfunction of organs and serves as the primary reason for neonatal mortality. Nevertheless, the mechanisms underlying newborn sepsis remain ambiguous. Programmed cell death (PCD) has a connection with numerous infectious illnesses and holds a significant function in newborn sepsis, potentially serving as a marker for di","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":100,"document":"36621204","golden":false,"offsetInEndSection":400,"text":"istan. We investigated common etiological patterns of neonatal sepsis at a tertiary care setup.METHODS: 90 pus and blood, gram negative and gram positive bacterial isolates were analyzed for virulence and antibiotic resistance gene profiling using PCR and disc diffusion methods.RESULTS: Staphylococc","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":50,"document":"37246430","golden":false,"offsetInEndSection":400,"text":" accompanied by severe sepsis, which is associated with high morbidity and mortality. 11?-hydroxysteroid dehydrogenase type 1 (11?-HSD1), encoded by Hsd11b1, is a reductase that can convert inactive cortisone into metabolically active cortisol, but the role of 11?-HSD1 in sepsis-induced myocardial dysfunction remains poorly understood. The current ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":87,"document":"25548220","golden":false,"offsetInEndSection":277,"text":"Although TLR signaling through the adaptor protein, MyD88, has been shown to be critical for survival to sepsis in adults, little is known about the role of MyD88 or TRIF in neonatal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":217,"document":"10998175","golden":false,"offsetInEndSection":386,"text":"In this study, signature-tagged transposon mutagenesis (STM) was used to identify genes required for growth and survival of GBS in a neonatal rat sepsis infection model.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1092,"document":"16493078","golden":false,"offsetInEndSection":1199,"text":"In a neonatal mouse model of GBS sepsis SP600125 inhibited the inflammatory response and improved survival.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":87,"document":"34183713","golden":false,"offsetInEndSection":427,"text":"We aimed to evaluate the genetic profile of TLR pathway-related key genes; the myeloid differentiation protein 88 (MYD88), IL1 receptor-associated kinase 1 (IRAK1), the nuclear factor kappa-B1 (NFKB1), and interleukin 6 (IL6) in the blood of neonates with sepsis at the time of admission and post-treatment for the available paired-samples.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"22438436","golden":false,"offsetInEndSection":247,"text":"OBJECTIVES: Vancomycin use for neonatal coagulase-negative staphylococci (CoNS) sepsis is based on a high CoNS carriage rate of mecA, encoding penicillin-binding protein (PBP)-2a, with low affinity for, and associated with resistance to, ?-lactam ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1733,"document":"25684123","golden":false,"offsetInEndSection":2036,"text":"These findings suggest that endogenous caspase-1/11 activity, independent of the NLRP3 inflammasome, not only promotes the magnitude of the inflammatory response, but also suppresses protective immunity in the neonate, so contributing to innate immune dysfunction and poor survival in neonatal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36104331","golden":false,"offsetInEndSection":149,"text":"Perinatal infection with Streptococcus agalactiae, or Group B Streptococcus (GBS), is associated with preterm birth, neonatal sepsis, and stillbirth.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":274,"document":"12819089","golden":false,"offsetInEndSection":467,"text":"Using signature-tagged transposon mutagenesis to screen for novel virulence factors, we identified the rpoE gene as essential for development of sepsis in a neonatal rat model of GBS infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1451,"document":"8807086","golden":false,"offsetInEndSection":1598,"text":"These results suggest that endogenous IL-11 gene expression may be upregulated during acute thrombocytopenia and associated bacterial sepsis in NR.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":336,"document":"16513739","golden":false,"offsetInEndSection":502,"text":"We previously reported that a transposon insertion disrupting rpoE resulted in the decreased survival of the mutant in the neonatal rat sepsis model of GBS infection.","beginSection":"abstract"}],"exact_answer":[],"ideal_answer":[],"id":"677ecab2592fa48873000026","type":"list","body":"Which genes are associated with neonatal sepsis survival?"},{"documents":[{"golden":false,"id":"21165659"},{"golden":false,"id":"25781076"},{"golden":false,"id":"31533229"},{"golden":false,"id":"30117045"},{"golden":false,"id":"25943368"},{"golden":false,"id":"27033472"},{"golden":false,"id":"29644751"},{"golden":false,"id":"25005181"},{"golden":false,"id":"24896322"},{"golden":false,"id":"33143428"},{"golden":false,"id":"35697900"},{"golden":false,"id":"23370589"},{"golden":false,"id":"28659169"},{"golden":false,"id":"35172141"},{"golden":false,"id":"24427136"},{"golden":false,"id":"18331585"},{"golden":false,"id":"26658949"},{"golden":false,"id":"30030679"},{"golden":false,"id":"31369907"},{"golden":false,"id":"35964686"},{"golden":false,"id":"32574378"},{"golden":false,"id":"28108264"},{"golden":false,"id":"35996824"},{"golden":false,"id":"21791473"},{"golden":false,"id":"35275026"},{"golden":false,"id":"29619158"},{"golden":false,"id":"34537326"},{"golden":false,"id":"18474731"},{"golden":false,"id":"11222787"},{"golden":false,"id":"32928263"},{"golden":false,"id":"27108605"},{"golden":false,"id":"21895884"},{"golden":false,"id":"12658373"},{"golden":false,"id":"29843254"},{"golden":false,"id":"22329867"},{"golden":false,"id":"27029487"},{"golden":false,"id":"25112865"},{"golden":false,"id":"21807124"},{"golden":false,"id":"24814618"},{"golden":false,"id":"17967839"},{"golden":false,"id":"34664101"},{"golden":false,"id":"33536413"},{"golden":false,"id":"35922689"},{"golden":false,"id":"33685343"},{"golden":false,"id":"32629061"},{"golden":false,"id":"29748743"},{"golden":false,"id":"22034002"},{"golden":false,"id":"29285884"},{"golden":false,"id":"36102035"},{"golden":false,"id":"9763218"},{"golden":false,"id":"36544626"},{"golden":false,"id":"34224251"},{"golden":false,"id":"25559767"},{"golden":false,"id":"31644927"},{"golden":false,"id":"31285534"},{"golden":false,"id":"24661465"},{"golden":false,"id":"29287521"},{"golden":false,"id":"34958045"},{"golden":false,"id":"31594253"},{"golden":false,"id":"25962410"},{"golden":false,"id":"23424961"},{"golden":false,"id":"28370340"},{"golden":false,"id":"24055014"},{"golden":false,"id":"22821063"},{"golden":false,"id":"30811439"},{"golden":false,"id":"20921906"},{"golden":false,"id":"22406440"},{"golden":false,"id":"11603411"},{"golden":false,"id":"20607038"},{"golden":false,"id":"12064916"},{"golden":false,"id":"12783095"},{"golden":false,"id":"29200160"},{"golden":false,"id":"24782365"},{"golden":false,"id":"30868263"},{"golden":false,"id":"28394491"},{"golden":false,"id":"26165407"},{"golden":false,"id":"9414297"},{"golden":false,"id":"10051057"},{"golden":false,"id":"18318774"},{"golden":false,"id":"26133718"},{"golden":false,"id":"7834865"},{"golden":false,"id":"10554823"},{"golden":false,"id":"16339662"},{"golden":false,"id":"36755516"},{"golden":false,"id":"15809885"},{"golden":false,"id":"9057792"},{"golden":false,"id":"10493280"},{"golden":false,"id":"12127956"},{"golden":false,"id":"35861925"},{"golden":false,"id":"16305464"},{"golden":false,"id":"33410108"},{"golden":false,"id":"18274979"},{"golden":false,"id":"8959943"},{"golden":false,"id":"19482634"},{"golden":false,"id":"25671931"},{"golden":false,"id":"34981144"},{"golden":false,"id":"25643967"},{"golden":false,"id":"18558000"},{"golden":false,"id":"9029756"},{"golden":false,"id":"14521486"},{"golden":false,"id":"20865357"},{"golden":false,"id":"35007919"},{"golden":false,"id":"28096656"},{"golden":false,"id":"15595934"},{"golden":false,"id":"33399276"},{"golden":false,"id":"11921113"},{"golden":false,"id":"32342325"},{"golden":false,"id":"32894625"},{"golden":false,"id":"32568111"},{"golden":false,"id":"23688265"},{"golden":false,"id":"23937987"},{"golden":false,"id":"28448199"},{"golden":false,"id":"10674529"},{"golden":false,"id":"30344970"},{"golden":false,"id":"33444337"},{"golden":false,"id":"23940095"},{"golden":false,"id":"38334258"},{"golden":false,"id":"28623611"},{"golden":false,"id":"24251381"},{"golden":false,"id":"39495531"},{"golden":false,"id":"37721280"},{"golden":false,"id":"31202468"},{"golden":true,"id":"38002094"},{"golden":false,"id":"39275060"},{"golden":false,"id":"31912279"},{"golden":false,"id":"33963933"},{"golden":false,"id":"35147617"},{"golden":false,"id":"39317669"},{"golden":false,"id":"32100150"},{"golden":true,"id":"36449420"},{"golden":true,"id":"28469157"},{"golden":false,"id":"32726602"},{"golden":false,"id":"32741833"},{"golden":false,"id":"29381045"},{"golden":false,"id":"23859349"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":145,"document":"36449420","golden":false,"offsetInEndSection":494,"text":"e disorder. Early research suggests that the iron chelator deferiprone can reduce nigrostriatal iron content in persons with Parkinson\u0027s disease, but its effects on disease progression are unclear.METHODS: We conducted a multicenter, phase 2, randomized, double-blind trial involving participants with newly diagnosed Parkinson\u0027s disease who had nev","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":305,"document":"31533229","golden":false,"offsetInEndSection":568,"text":"More recently, the use of deferiprone to chelate iron from various brain regions in Parkinson\u0027s Disease and Friederich\u0027s Ataxia has yielded encouraging results, although the side effects, in \u003c2% of Parkinson\u0027s Disease(PD) patients, have limited its long-term use.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":521,"document":"30117045","golden":false,"offsetInEndSection":677,"text":"Deferiprone (DFP) is an oral iron chelator used for the treatment of systemic iron overload disorders, and has recently been tested for Parkinson\u0027s disease.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36449420","golden":false,"offsetInEndSection":44,"text":"Trial of Deferiprone in Parkinson\u0027s Disease.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":979,"document":"28469157","golden":true,"offsetInEndSection":1132,"text":"Although 30?mg/kg deferiprone treated patients showed a trend for improvement in motor-UPDRS scores and quality of life, this did not reach significance.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1824,"document":"36449420","golden":true,"offsetInEndSection":2217,"text":"up than in the placebo group. The main serious adverse events with deferiprone were agranulocytosis in 2 participants and neutropenia in 3 participants.CONCLUSIONS: In participants with early Parkinson\u0027s disease who had never received levodopa and in whom treatment with dopaminergic medications was not planned, deferiprone was associated with worse scores in measures of parkinsonism than th","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1058,"document":"27033472","golden":false,"offsetInEndSection":1266,"text":"However, several studies indicate that it may prevent or slow down disease progression of several disorders such as aceruloplasminemia, pantothenate kinase-associated neurodegeneration or Parkinson\u0027s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":97,"document":"28469157","golden":false,"offsetInEndSection":253,"text":"This study evaluated whether the iron chelator, deferiprone, is well tolerated, able to chelate iron from various brain regions and improve PD symptomology.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1516,"document":"21165659","golden":false,"offsetInEndSection":1693,"text":"Our results confirm that the administration of these chelators show therapeutic efficacy and should be considered as therapeutic agents for the treatment of Parkinson\u0027s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":895,"document":"25005181","golden":false,"offsetInEndSection":962,"text":"Deferiprone is also used in clinical trials in Parkinson\u0027s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1239,"document":"32726602","golden":false,"offsetInEndSection":1457,"text":"ecules are neuroprotective in PD animal models and the anti-ferroptotic iron chelator, deferiprone, slowed disease progression and improved motor function in two independent clinical trials for PD. An ongoing larger mu","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":653,"document":"24896322","golden":false,"offsetInEndSection":848,"text":"e, other chelators and their combinations could be used as main, adjuvant and alternative therapies in untreated conditions eg forms of cancer, Alzheimer\u0027s and Parkinson\u0027s diseases. Therapeutic t","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"33143428","golden":false,"offsetInEndSection":155,"text":"Effectiveness of the Iron Chelator CN128 in Mitigating the Formation of Dopamine Oxidation Products Associated with the Progression of Parkinson\u0027s Disease.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1460,"document":"32726602","golden":false,"offsetInEndSection":1606,"text":"-centre phase 2 clinical trial will confirm the therapeutic potential of deferiprone and the relevance of ferroptosis in PD. This review addresses","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1011,"document":"35697900","golden":false,"offsetInEndSection":1294,"text":"hilic chelator desferrioxamine exerted protection only at high and clinically unachievable concentrations, deferiprone and deferasirox significantly reduced the catecholamine neurotoxicity at concentrations that are within their plasma levels following standard dosage. SIH was the m","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":407,"document":"33143428","golden":false,"offsetInEndSection":655,"text":"xygen species (ROS). As such, one of the proposed therapeutic strategies has been the use of iron chelators such as deferiprone (DFP) (which is recognized to have limitations related to its rapid degradation in the liver) to reduce the concentratio","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":359,"document":"24896322","golden":false,"offsetInEndSection":653,"text":"te that many chelators inhibit FRD in vitro and in vivo, only Deferiprone (L1) has been shown to be effective and safe in the reversal of oxidative stress related tissue damage in iron overload and other conditions such as cardiomyopathy, acute kidney disease, Friedreich ataxia etc. Deferipron","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"31912279","golden":false,"offsetInEndSection":121,"text":"Conservative iron chelation for neurodegenerative diseases such as Parkinson\u0027s disease and amyotrophic lateral sclerosis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":135,"document":"35697900","golden":false,"offsetInEndSection":492,"text":" chelation has been successfully used in clinical practice to manage iron overload in diseases such as thalassemia major; however, the use of conventional iron chelators in pathological states without systemic iron overload remains at the preclinical investigative level and is complicated by the risk of adverse outcomes due to systemic iron depletion. In ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":603,"document":"31912279","golden":false,"offsetInEndSection":858,"text":"ve degeneration of the substantia nigra pars compacta (SNc) is associated with the appearance of siderotic foci, largely caused by increased labile iron levels resulting from an imbalance between cell iron import, storage and export. At a molecular level,","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1984,"document":"36449420","golden":true,"offsetInEndSection":2256,"text":"ONS: In participants with early Parkinson\u0027s disease who had never received levodopa and in whom treatment with dopaminergic medications was not planned, deferiprone was associated with worse scores in measures of parkinsonism than those with placebo over a period of 36 we","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"29381045","golden":false,"offsetInEndSection":98,"text":"Mechanism Underlying the Effectiveness of Deferiprone in Alleviating Parkinson\u0027s Disease Symptoms.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":461,"document":"32100150","golden":false,"offsetInEndSection":634,"text":"riprone (DFP) is a brain penetrating iron chelator that has demonstrated effectiveness in preventing neurological deterioration in Parkinson\u0027s disease clinical trials. There","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":147,"document":"36449420","golden":false,"offsetInEndSection":333,"text":"disorder. Early research suggests that the iron chelator deferiprone can reduce nigrostriatal iron content in persons with Parkinson\u0027s disease, but its effects on disease progression are","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":314,"document":"31533229","golden":false,"offsetInEndSection":587,"text":"ntly, the use of deferiprone to chelate iron from various brain regions in Parkinson\u0027s Disease and Friederich\u0027s Ataxia has yielded encouraging results, although the side effects, in \u003c2% of Parkinson\u0027s Disease(PD) patients, have limited its long-term use. A new class of hyd","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1023,"document":"21165659","golden":false,"offsetInEndSection":1270,"text":"tration of deferasirox (20 mg/kg), deferiprone (10 mg/kg) or deferrioxamine (30 mg/kg), to the 6-OHDA rat model of Parkinson\u0027s disease, significantly attenuated the loss of dopaminergic neurons and striatal dopamine content. Further studies to com","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1124,"document":"33963933","golden":false,"offsetInEndSection":1299,"text":"ults indicated that N-hydroxyalkyl substituted deferiprone has potential application prospects as chelating agents for Parkinson\u0027s disease chelation therapy strategy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":637,"document":"23370589","golden":false,"offsetInEndSection":832,"text":", an iron chelator, has been shown to be safe and tolerable in patients with PKAN as well as effective in reducing brain iron accumulation, as measured by magnetic resonance imaging. This case re","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"28469157","golden":false,"offsetInEndSection":132,"text":"Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson\u0027s disease.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":653,"document":"35172141","golden":false,"offsetInEndSection":796,"text":"Genetic deletion of IL-6, or treatment with the iron chelator deferiprone, reduces pathological ?-syn toxicity in a mouse model of sporadic PD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1139,"document":"24427136","golden":false,"offsetInEndSection":1483,"text":"We first examine cell models that recapitulate iron maldistribution and associated dysfunctions identified with Friedreich ataxia and Parkinson\u0027s disease and use them to explore the ability of the double-acting agent deferiprone, an orally active chelator, to mediate iron scavenging and redeployment and thereby causing functional improvement.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1099,"document":"31369907","golden":false,"offsetInEndSection":1243,"text":"Recent research indicates that treatment with exogenous chelators, such as deferiprone, apomorphine, and hinokitiol, can inhibit PD progression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":195,"document":"24427136","golden":false,"offsetInEndSection":565,"text":"In their present use for hemosiderosis, chelation regimens might not be suitable for treating disorders of iron maldistribution, as those are characterized by toxic islands of siderosis appearing in a background of normal or subnormal iron levels (e.g., sideroblastic anemias, neuro- and cardio-siderosis in Friedreich ataxia- and neurosiderosis in Parkinson\u0027s disease).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":797,"document":"35172141","golden":false,"offsetInEndSection":934,"text":"These data suggest that IL-6-induced CISR leads to toxic neuronal iron accumulation, contributing to synuclein-induced neurodegeneration.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1391,"document":"26658949","golden":false,"offsetInEndSection":1584,"text":"Our results support a role for oral iron chelators as good candidates for the early treatment of PD, at stages of the disease where there is axodendritic tree retraction without neuronal death.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":496,"document":"30030679","golden":false,"offsetInEndSection":641,"text":"Recent research indicates that the substantia nigra degeneration can be decelerated by treatment with iron binding compounds such as deferiprone.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":102,"document":"35172141","golden":false,"offsetInEndSection":243,"text":"The substantia nigra of patients with PD contains excess iron, yet the underlying mechanism accounting for this iron accumulation is unclear.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35172141","golden":false,"offsetInEndSection":101,"text":"?-synuclein (?-syn) aggregation and accumulation drive neurodegeneration in Parkinson\u0027s disease (PD).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1825,"document":"18331585","golden":false,"offsetInEndSection":2106,"text":"The present study demonstrates that deferiprone protects against FeNTA, hydrogen peroxide, MPP(+) and Abeta1-40-induced neuronal cell death in vitro, which is consistent with previous in vitro and in vivo studies that have demonstrated similar protection with other iron chelators.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":990,"document":"21791473","golden":false,"offsetInEndSection":1189,"text":"These results underline the safety and tolerability of deferiprone, and suggest that chelating treatment might be effective in improving neurological manifestations associated with iron accumulation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":177,"document":"35996824","golden":false,"offsetInEndSection":618,"text":" disorders. No treatment is currently available.OBJECTIVE: We assessed conservative iron chelation with deferiprone at 30?mg/kg/day on the disease progression with controlled periods of discontinuation.METHODS: Four patients with confirmed molecular diagnosis of neuroferritinopathy were given deferiprone at different stages of disease progression and with clinical and biological monitoring to control benefit and risk.RESULTS: The four pa","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":783,"document":"35996824","golden":false,"offsetInEndSection":950,"text":"ymptoms after a few months of treatment. The earliest the treatment was started, the most efficient it was on disease progression.CONCLUSIONS: Conservative iron chelat","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":700,"document":"35996824","golden":false,"offsetInEndSection":782,"text":"ease progression for more than 11?years. In another case, we were able to reverse ","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"35996824","golden":false,"offsetInEndSection":52,"text":"Conservative Iron Chelation for Neuroferritinopathy.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":990,"document":"29619158","golden":false,"offsetInEndSection":1080,"text":"The results of our paper show that deferiprone can prevent the progression of the disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":733,"document":"29619158","golden":false,"offsetInEndSection":989,"text":"In our study qualitative evaluation of MRI showed that deferiprone was able to reduce the iron load in globus pallidus of all the patients and the results of clinical rating scales show that in four patients, there is an improvement in the first 12 months.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1527,"document":"34537326","golden":false,"offsetInEndSection":1738,"text":"and ceruloplasmin prevented decline in motor performance in aged PLP-?syn mice and were associated with higher neuronal survival and reduced density of ?-synuclein aggregates in substantia nigra. This is the fir","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":504,"document":"30030679","golden":false,"offsetInEndSection":648,"text":"esearch indicates that the substantia nigra degeneration can be decelerated by treatment with iron binding compounds such as deferiprone. Intere","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1135,"document":"18331585","golden":false,"offsetInEndSection":1358,"text":"le neuroprotective action of deferiprone against Parkinson\u0027s disease relevant insults another group of experiments were performed in the human neuroblastoma catecholaminergic SHSY-5Y cell line. SHSY-5Y cells were treated wi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1155,"document":"24427136","golden":false,"offsetInEndSection":1501,"text":" cell models that recapitulate iron maldistribution and associated dysfunctions identified with Friedreich ataxia and Parkinson\u0027s disease and use them to explore the ability of the double-acting agent deferiprone, an orally active chelator, to mediate iron scavenging and redeployment and thereby causing functional improvement. We subsequently e","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1867,"document":"18331585","golden":false,"offsetInEndSection":2150,"text":"prone protects against FeNTA, hydrogen peroxide, MPP(+) and Abeta1-40-induced neuronal cell death in vitro, which is consistent with previous in vitro and in vivo studies that have demonstrated similar protection with other iron chelators.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1120,"document":"31369907","golden":false,"offsetInEndSection":1267,"text":"ates that treatment with exogenous chelators, such as deferiprone, apomorphine, and hinokitiol, can inhibit PD progression. The endogenous chelator","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":873,"document":"35275026","golden":false,"offsetInEndSection":1132,"text":" offer new insight into the mechanisms underlying mitophagy upon iron chelation, and have relevance to the therapeutic potential of DFP in a number of disorders, including Parkinson disease. Abbreviations DFP: deferiprone; OMM: outer mitochondrial membrane. P","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1360,"document":"18331585","golden":false,"offsetInEndSection":1522,"text":" MPP(+) iodide, the active metabolite of the dopaminergic neurotoxin MPTP and the neuroprotective actions of deferiprone evaluated. Cytotoxicity was assessed at 2","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":360,"document":"35996824","golden":false,"offsetInEndSection":569,"text":"of discontinuation.METHODS: Four patients with confirmed molecular diagnosis of neuroferritinopathy were given deferiprone at different stages of disease progression and with clinical and biological monitoring","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":162,"document":"34537326","golden":false,"offsetInEndSection":408,"text":"ere is compelling evidence suggesting that biological trace metals like iron and copper play an important role in synucleinopathies like Parkinson\u0027s disease and removing excess brain iron using chelators could slow down the disease progression. I","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"18474731","golden":false,"offsetInEndSection":140,"text":"Tesofensine (NS 2330), a monoamine reuptake inhibitor, in patients with advanced Parkinson disease and motor fluctuations: the ADVANS Study.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1751,"document":"12658373","golden":false,"offsetInEndSection":2098,"text":"In conclusion, although the primary efficacy variable did not reach statistical significance, the present results demonstrate that entacapone provides additional antiparkinsonian benefits to levodopa therapy and is well tolerated in levodopa-treated PD patients experiencing wearing-off motor fluctuations despite adjunct dopamine agonist therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1388,"document":"18474731","golden":false,"offsetInEndSection":1885,"text":" no clear dose-response relationship was observed. Gastrointestinal tract and neuropsychiatric adverse events were more frequent with tesofensine than with placebo, especially at the higher dosages.CONCLUSIONS: Patients with PD in advanced stages showed modest improvements in UPDRS subscale II plus subscale III total score and in off time when treated with tesofensine, but a dose-response relationship could not be established for efficacy, while adverse drug reactions tended to be more freque","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"18474731","golden":false,"offsetInEndSection":222,"text":"OBJECTIVE: To assess the safety and efficacy of tesofensine, a triple monoamine reuptake inhibitor, in patients with advanced Parkinson disease (PD).DESIGN: A pilot phase 2, randomized, double-blind, placebo-controlled, pa","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":765,"document":"18474731","golden":false,"offsetInEndSection":1281,"text":"\"off\" time noted in self-scoring diaries. Secondary end points were safety, pharmacokinetics, responder analysis (\u003e or \u003d20% reduction in UPDRS score and in off time), and changes in percentage of waking hours spent in \"on\" time with and without troublesome dyskinesia.RESULTS: The adjusted mean differences (relative to placebo) were -4.7 points in UPDRS subscale II plus subscale III total score (P \u003d.005) with tesofensine, 0.5 mg, and -7.1% in off time (-68 minutes, P \u003d.02) with tesofensine, 0.25 mg. Other dosage","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":389,"document":"18474731","golden":false,"offsetInEndSection":764,"text":"ons were enrolled. Tesofensine (0.125, 0.25, 0.5, or 1 mg) or placebo tablets were administered once daily for 14 weeks.MAIN OUTCOME MEASURES: Coprimary end points were the changes from baseline in Unified Parkinson Disease Rating Scale (UPDRS) subscale II (activities of daily living) plus subscale III (motor function) total score and in percentage of waking hours spent in","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1311,"document":"22329867","golden":false,"offsetInEndSection":1413,"text":"se of the risk of orthostatic hypotension. Our results indicate that DLI improves both motor and non-m","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":939,"document":"11222787","golden":false,"offsetInEndSection":1274,"text":"evious studies of remacemide. The percent \"on\" time and motor UPDRS scores showed trends toward improvement in the patients treated with 150 and 300 mg/d remacemide compared with placebo-treated patients, although these improvements were not significant.CONCLUSION: Remacemide is a safe and tolerable adjunct to dopaminergic therapy fo","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":286,"document":"27029487","golden":false,"offsetInEndSection":395,"text":"riprone, an oral iron chelator, has been shown effective in cell and animal models of Friedreich ataxia. The ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1147,"document":"25112865","golden":false,"offsetInEndSection":1345,"text":"ients receiving 20mg/kg/day of deferiprone had no significant change in FARS, similar to the placebo-treated patients, whereas those receiving 40mg/kg/day had worsening in FARS and ICARS scores. The","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":111,"document":"21807124","golden":false,"offsetInEndSection":318,"text":"evious studies found that deferiprone, an iron chelator, suppressed disease activity in a mouse model of multiple sclerosis, and inhibition of T cell proliferation was implicated as a putative mechanism. The","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1047,"document":"24814618","golden":false,"offsetInEndSection":1184,"text":"e, during 5-years of study, suggests that Deferiprone does not alter survival in comparison with Deferoxamine (p\u003d0.38). In conclusion, lo","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":310,"document":"24814618","golden":false,"offsetInEndSection":608,"text":"he results of this study show that Deferiprone has the same effectiveness as Deferoxamine in decreasing body iron burden, measured as repeated measurements of serum ferritin concentrations on the same patient over 5-years and analyzed according to the linear mixed-effects model (LMM) (p\u003d0.822). Bo","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"17967839","golden":false,"offsetInEndSection":105,"text":"Deferiprone, an orally deliverable iron chelator, ameliorates experimental autoimmune encephalomyelitis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":267,"document":"21791473","golden":false,"offsetInEndSection":470,"text":"patients with genetically-confirmed pantothenate kinase-associated neurodegeneration, and 2 with parkinsonism and focal dystonia, but inconclusive genetic tests, received 15 mg/kg deferiprone bid. Magnet","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21791473","golden":false,"offsetInEndSection":72,"text":"Deferiprone was shown to reverse iron deposition in Friedreich\u0027s ataxia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1420,"document":"34664101","golden":false,"offsetInEndSection":1580,"text":"xia scores. Early deferiprone administration after disease onset and long-term administration were correlated with greater signal improvements on magnetic reson","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"30030679","golden":false,"offsetInEndSection":49,"text":"Prevention of progression in Parkinson\u0027s disease.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":642,"document":"30030679","golden":false,"offsetInEndSection":781,"text":"Interestingly compounds known to decrease PD risk including caffeine, niacin, nicotine and salbutamol also possess iron binding properties.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1124,"document":"30030679","golden":false,"offsetInEndSection":1320,"text":"Further research is recommended to identify therapeutic targets of the proposed interventions, in particular protection of the DA biosynthesis by oxygen radical scavengers and iron binding agents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":588,"document":"33536413","golden":false,"offsetInEndSection":896,"text":"We have further discussed the contribution of ferroptosis to the pathogenesis of several diseases such as cancer, ischemia/reperfusion, and various neurodegenerative diseases (e.g., Alzheimer\u0027s disease and Parkinson\u0027s disease), and evaluated the therapeutic applications of ferroptosis inhibitors in clinics.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"22034002","golden":false,"offsetInEndSection":518,"text":"BACKGROUND AND PURPOSE: Superficial siderosis is a neurodegenerative disease caused by toxic accumulation of hemosiderin on the surface of the brain and spinal cord for which there is no known effective treatment.METHODS: Oral deferiprone, a lipid-soluble iron chelator with ability to cross the blood-brain barrier, at a dose of 30 mg/kg per day was tested for safety in an open pilot study in 10 subjects with superficial siderosis.RESULTS: Over a 90-day period, deferiprone had no significant adverse effects on hem","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":778,"document":"33685343","golden":false,"offsetInEndSection":1222,"text":"These findings suggest that mito-QC\u0027s poor sensitivity may account for conflicting reports of PINK1-PRKN mitophagy in vivo and caution against using mito-QC as a reporter for PINK1-PRKN mitophagy.Abbreviations: DFP: deferiprone; EE: exhaustive exercise; FBS: fetal bovine serum; OAQ: oligomycin, antimycin, and Q-VD-OPH; OMM: outer mitochondrial membrane; PBS: phosphate-buffered saline; PD: Parkinson disease; UPS: ubiquitin-proteasome system.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":132,"document":"33536413","golden":false,"offsetInEndSection":409,"text":"The process of ferroptotic cell death is defined by the accumulation of lethal lipid species derived from the peroxidation of lipids, which can be prevented by iron chelators (e.g., deferiprone, deferoxamine) and small lipophilic antioxidants (e.g., ferrostatin, liproxstatin).","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"23859349","golden":false,"offsetInEndSection":53,"text":"Deferiprone for the treatment of Friedreich\u0027s ataxia.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":918,"document":"35922689","golden":false,"offsetInEndSection":1074,"text":"LUHMES neurons were protected from RSL3 by three of the chelators, 2,3-dimercapto-1-propanesulfonic acid (DMPS), deferoxiprone (DFX), and deferiprone (DFP).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1152,"document":"32629061","golden":false,"offsetInEndSection":1275,"text":"Notably, these deleterious effects were ameliorated by two clinically used chelators, triethylenetetramine and deferiprone.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1113,"document":"36102035","golden":false,"offsetInEndSection":1297,"text":"and/or 1?month post-TBI in mice receiving oral deferiprone. Deferiprone treatment showed significant improvements in neurological severity scores, locomotor/gait performance and cognit","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"33536413","golden":false,"offsetInEndSection":48,"text":"Ferroptosis: mechanisms and links with diseases.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":410,"document":"33536413","golden":false,"offsetInEndSection":587,"text":"This review summarizes current knowledge about the regulatory mechanism of ferroptosis and its association with several pathways, including iron, lipid, and cysteine metabolism.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1502,"document":"34224251","golden":false,"offsetInEndSection":1744,"text":"However, further clinical studies are needed to define the most effective treatment.RESEARCH HIGHLIGHTS Deferiprone is an optimized method for treating iron storage disease.The essential metals homeostasis is impaired in iron storage disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1263,"document":"31644927","golden":false,"offsetInEndSection":1457,"text":"Therefore, this study suggests neuroprotective and memory enhancing effects for Deferiprone in SCOP-treated rats which might be attributed to its iron chelating action and anti-oxidative effect.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":715,"document":"29748743","golden":false,"offsetInEndSection":1009,"text":"Therefore, we tried rhLF as a protector against the severe neurologic disorders developed in rats, such as the rotenone-induced model of Parkinson\u0027s disease and experimental autoimmune encephalomyelitis as a model of multiple sclerosis, and observed its capacity to mitigate the grave symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1440,"document":"31285534","golden":false,"offsetInEndSection":1763,"text":"eveal a novel mitophagic mechanism in lung cancer, suggesting that lung cancer-linked mutations in PARK2 are associated with impaired mitophagy and identifying DFP as a novel therapeutic agent for PARK2-linked lung cancer and possibly other types of cancers driven by mitophagic dysregulation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2015,"document":"29748743","golden":false,"offsetInEndSection":2090,"text":"ator) had the similar effect. Upon iron binding (in DMEM/F12) rhLF did not ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1171,"document":"32629061","golden":false,"offsetInEndSection":1295,"text":"terious effects were ameliorated by two clinically used chelators, triethylenetetramine and deferiprone. Together, our resul","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1275,"document":"31285534","golden":false,"offsetInEndSection":1437,"text":"deferiprone (DFP), an iron chelator that can induce mitophagy, greatly increased the death of A46T Parkin-expressing lung cancer cells. Taken together, our result","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":946,"document":"32629061","golden":false,"offsetInEndSection":1116,"text":"brils formed in the presence of copper/iron ions were more cytotoxic, causing increased ROS production, cell apoptosis, and shortened the lifespan of a C. elegans PD mode","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":606,"document":"33536413","golden":false,"offsetInEndSection":920,"text":"scussed the contribution of ferroptosis to the pathogenesis of several diseases such as cancer, ischemia/reperfusion, and various neurodegenerative diseases (e.g., Alzheimer\u0027s disease and Parkinson\u0027s disease), and evaluated the therapeutic applications of ferroptosis inhibitors in clinics.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1297,"document":"32629061","golden":false,"offsetInEndSection":1477,"text":" suggest a new role for heavy metal ions, e.g. copper and iron, in the pathogenesis of PD through accelerating prion-like propagation of ?-synuclein fibrils.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":137,"document":"33536413","golden":false,"offsetInEndSection":420,"text":"rocess of ferroptotic cell death is defined by the accumulation of lethal lipid species derived from the peroxidation of lipids, which can be prevented by iron chelators (e.g., deferiprone, deferoxamine) and small lipophilic antioxidants (e.g., ferrostatin, liproxstatin). This revie","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":930,"document":"35922689","golden":false,"offsetInEndSection":1090,"text":"ns were protected from RSL3 by three of the chelators, 2,3-dimercapto-1-propanesulfonic acid (DMPS), deferoxiprone (DFX), and deferiprone (DFP). Collectively, t","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":478,"document":"32629061","golden":false,"offsetInEndSection":778,"text":" reported that copper/iron ions accelerate prion-like propagation of ?-synuclein fibrils by promoting cellular internalization of ?-synuclein fibrils, intracellular ?-synuclein aggregation and the subsequent release of mature fibrils to the extracellular space to induce further propagation. Mechanis","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1445,"document":"25957460","golden":false,"offsetInEndSection":1513,"text":"m these drugs, no antiviral has been shown to be effective. Preventi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":359,"document":"32041232","golden":false,"offsetInEndSection":469,"text":"Despite much effort, no clinically approved antiviral treatment is available for children suffering from HFMD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1229,"document":"31882748","golden":false,"offsetInEndSection":1413,"text":"While amodiaquine on its own failed to demonstrate efficacy, we cannot exclude potential therapeutic value of amodiaquine when used in combination with artesunate or another antiviral.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":404,"document":"30940462","golden":false,"offsetInEndSection":535,"text":"Most respiratory virus infections are managed with supportive therapy, although there is effective antiviral therapy for influenza.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":128,"document":"10775620","golden":false,"offsetInEndSection":284,"text":"a). However, systemic delivery of r-hIFN-alpha is associated with severe side effects, but more importantly, it is effective in only a small percentage of p","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":248,"document":"25988934","golden":false,"offsetInEndSection":299,"text":"Chloroquine is not a promising treatment for Ebola.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":67,"document":"18279075","golden":false,"offsetInEndSection":145,"text":"However, there is no effective antiviral drug available for infected patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":509,"document":"15031783","golden":false,"offsetInEndSection":624,"text":"00 IU/mL. In conclusion, ribavirin alone is unlikely to be beneficial in the prophylaxis or treatment of SARS CoV i","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":191,"document":"16530274","golden":false,"offsetInEndSection":428,"text":"a combination therapy using interferon and inosiplex or ribavirin appears to prolong survival time to some extent, there is currently no effective treatment to completely cure SSPE and a new treatment strategy is greatly needed. In this ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1009,"document":"24661465","golden":false,"offsetInEndSection":1290,"text":" a chelator agent for iron accumulation. The clinical stabilization observed in 5/6 of our patients suggests that DFP may be a reasonable therapeutic option for the treatment of the neurological manifestations linked with iron accumulation and neurodegeneration, especially in adul","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"24661465","golden":false,"offsetInEndSection":207,"text":"Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): results from a four years follow-up.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":338,"document":"31594253","golden":false,"offsetInEndSection":1338,"text":"ic systems. Previous results from two six months, double-blind, placebo-controlled studies demonstrated that safinamide has positive effects on both motor functions and quality of life in PD patients.OBJECTIVE: To investigate the effects of safinamide 100?mg/day over two-year treatment on PD symptoms severity and quality of life, using data from the study 018.METHODS: Data from 352 patients were analyzed to evaluate the effects of safinamide on OFF time and ON time (with no or non-troublesome dyskinesia) in the overall population and in subgroups of patients (receiving levodopa monotherapy or with other anti-Parkinson therapies), and the effects of safinamide on motor symptoms/clinical fluctuations (by means of UPDRS III and IV) and on health-related quality of life (using UPDRS II and PDQ-39 summary index score).RESULTS: Safinamide, administered as add-on to standard therapy in fluctuating PD patients, significantly improved motor symptoms and clinical fluctuations in the overall popu","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24661465","golden":false,"offsetInEndSection":244,"text":"OBJECTIVE: To evaluate the long-term effect of Deferiprone (DFP) in reducing brain iron overload and improving neurological manifestations in patients with NBIA.METHODS: 6 NBIA patients (5 with genetically confirmed PKAN), received DFP solution","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34958045","golden":false,"offsetInEndSection":131,"text":"BACKGROUND: Recent randomized clinical trials using hydrophobic statins reported no influence on Parkinson\u0027s disease (PD) clinical ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":678,"document":"24661465","golden":false,"offsetInEndSection":1008,"text":"n motor symptoms in 5/6 Pts. In the same subjects MRI evaluation showed reduced hypointensity in the globus pallidus (GP); quantitative assessment confirmed a significant increment in the T2* value, and hence reduction of the iron content of the GP.CONCLUSION: The data from our 4-years follow-up study confirm the safety of DFP a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":430,"document":"24661465","golden":false,"offsetInEndSection":677,"text":"d during follow up. Quantitative assessment of brain iron was performed with T2* relaxometry, using a gradient multi-echo T2* sequence.RESULTS: After 48 months of treatment clinical rating scales and blinded video rating indicated a stabilization ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1246,"document":"28370340","golden":false,"offsetInEndSection":1536,"text":"0.3/0.75?mg group (P?\u003d?.003). Significant benefits were also observed for both doses in the responder analysis (P?\u003d?.0002 and P?\u003d?.0001), Parkinson Disease Quality of Life Scale-39 scores (P?\u003d?.05 and P?\u003d?.01), and the UPDRS motor (P?\u003d?.02 and P?\u003d?.006) and activities of daily living (P?\u003d?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1291,"document":"24661465","golden":false,"offsetInEndSection":1336,"text":" patients at early stage of the disease. (Cli","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"31644927","golden":false,"offsetInEndSection":136,"text":"Deferiprone ameliorates memory impairment in Scopolamine-treated rats: The impact of its iron-chelating effect on ?-amyloid disposition.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":2829,"document":"30811439","golden":false,"offsetInEndSection":2905,"text":"owed ineffectiveness and significant toxicity in most patients. Combination ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1011,"document":"20921906","golden":false,"offsetInEndSection":1158,"text":"s associated with a significant decline in mean serum ferritin level from 2532?1463 ?g/L at baseline to 2176?1144 ?g/L (P\u003c0.0005). The results of t","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"22406440","golden":false,"offsetInEndSection":161,"text":"Deferiprone reduces amyloid-? and tau phosphorylation levels but not reactive oxygen species generation in hippocampus of rabbits fed a cholesterol-enriched diet","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"11603411","golden":false,"offsetInEndSection":243,"text":"Deferiprone, an oral iron chelator, has been licensed in Europe for the treatment of iron overload in patients with beta thalassaemia who cannot be treated with deferoxamine because of adverse effects or the difficult administration schedule. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1588,"document":"20607038","golden":false,"offsetInEndSection":1774,"text":" 4 hours UIE is cost effective and non-invasive test rather than serum ferritin for monitoring iron overload in Hepatitis\u0027 positive BTM patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"12064916","golden":false,"offsetInEndSection":91,"text":"Deferiprone has been suggested as an effective oral chelation therapy for thalassemia major","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":696,"document":"12783095","golden":false,"offsetInEndSection":844,"text":"ne has been used by over 6000 patients in 40 countries worldwide, in some cases daily for more than 10 years, with very promising results. Doses of ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1063,"document":"29200160","golden":false,"offsetInEndSection":1245,"text":"ely). Patients on deferiprone alone significantly improved glucose homeostasis on follow-up than those on desferrioxamine or combination therapy of desferrioxamine and deferiprone (P","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":463,"document":"30868263","golden":false,"offsetInEndSection":634,"text":"Deferiprone has high affinity for copper binding and can be considered for the potential treatment of copper toxicity and overloading conditions, such as Wilson\u0027s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1450,"document":"24782365","golden":false,"offsetInEndSection":1543,"text":"rmination of deferiprone in cell lysate. Deferiprone can significantly inhibit hOCT1 and hOCT","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2331,"document":"10051057","golden":false,"offsetInEndSection":2505,"text":"This study confirmed the effectiveness of deferiprone in heavily iron-loaded patients and provided evidence that its effectiveness decreases in proportion to liver iron load.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24782365","golden":false,"offsetInEndSection":387,"text":"OBJECTIVE: To develop a LC-MS/MS method for determination of deferiprone in cell lysate and to study the potential interaction between deferiprone and hOCTs or hOAT1 transporters in vitro.METHODS: The determination was performed on an Agilent Eclipse Plus C18 column(3.5 ?m, 2.1 mm?50 mm).The gradient mobile phase was composed of solvent A:0.1% formic acid in water, and B:0.1% formic a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1301,"document":"28394491","golden":false,"offsetInEndSection":1444,"text":"In conclusion, there was no clinically meaningful effect on QTc interval following single therapeutic or supratherapeutic doses of deferiprone.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"24782365","golden":false,"offsetInEndSection":93,"text":"[In vitro interaction of deferiprone with cellular membrane transporters of hOCTs and hOAT1].","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1259,"document":"24782365","golden":false,"offsetInEndSection":1449,"text":"show significant difference. Deferiprone of 100 ?mol/L did not significantly affect the accumulation of 6-CF in MDCK-hOAT1 cell.CONCLUSION: The method is sensitivity and suitable for the det","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1544,"document":"24782365","golden":false,"offsetInEndSection":1608,"text":", but has no effects on hOCT2 and hOAT1. hOCTs may not play a ma","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":608,"document":"24782365","golden":false,"offsetInEndSection":759,"text":"tin at m/z 180?110. The effects of deferiprone on the accumulation of typical substrates of hOCTs and hOAT1 were evaluated by MDCK-hOCTs and MDCK-hOAT1","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1167,"document":"24782365","golden":false,"offsetInEndSection":1258,"text":".1% and 70.4%, respectively. The uptake of deferiprone in MDCK-hOCTs and mock cells did not","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":880,"document":"16339662","golden":false,"offsetInEndSection":1036,"text":"After many years of controversy, deferiprone is emerging as a useful oral iron chelator that enhances the chances for the patient to have optimal treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1270,"document":"10493280","golden":false,"offsetInEndSection":1514,"text":" instances. Although few long term comparative data are available, deferiprone at the recommended dosage of 75 mg/kg/day appears to be less effective than deferoxamine; however, compliance is superior with deferiprone, which may partly compensa","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1362,"document":"15809885","golden":false,"offsetInEndSection":1594,"text":"These results suggest that deferiprone may effectively decrease the iron deposition in patients with SCD; moreover, T2 MRI proves to be a reliable and rapid, noninvasive method for assessing the liver iron load in patients with SCD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"16339662","golden":false,"offsetInEndSection":108,"text":"Recent results from independent studies suggest that deferiprone is more cardioprotective than deferoxamine.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":109,"document":"16339662","golden":false,"offsetInEndSection":293,"text":"Patients on long-term treatment with deferiprone have a better myocardial magnetic resonance imaging pattern and less chance to develop a new cardiac disease or worsen an existing one.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":455,"document":"12127956","golden":false,"offsetInEndSection":858,"text":"Unfortunately, studies emerging over the last five years have confirmed that the most widely administered orally active agent, deferiprone (L1; 1,2-dimethyl-3-hydropyrid-4-one) may be harmfully ineffective in many patients: 18-65% of patients in six studies which obtained hepatic irons after long term deferiprone treatment had body iron exceeding the threshold for cardiac disease and premature death.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":655,"document":"16339662","golden":false,"offsetInEndSection":879,"text":"Again, these data require confirmation, as they were mostly obtained on individual cases or small groups of patients treated with a wide range of combinations of the two chelators, but the univocity of results is impressive.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":473,"document":"16339662","golden":false,"offsetInEndSection":654,"text":"Most results indicate an additional effect on iron excretion and a significant reduction of the time required to mitigate severe iron overload and to reverse clinical heart disease.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"16339662","golden":false,"offsetInEndSection":25,"text":"Deferiprone: New insight.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":516,"document":"33410108","golden":false,"offsetInEndSection":727,"text":"ne (DFP) is a clinically available iron chelator, which has demonstrated potential therapeutic advantages of chelating iron in neurodegenerative disorders, and is currently in clinical trials for AD. However, it","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1418,"document":"18274979","golden":false,"offsetInEndSection":1670,"text":" appears to be effective in the rapid clearance of cardiac iron, in the reversal of iron overload related cardiomyopathy, in the maintenance of normal iron stores and the overall long-term survival of thalassemia patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1039,"document":"8959943","golden":false,"offsetInEndSection":1145,"text":"arly not effective in three patients (two with myelofibrosis, one with myelodysplasia). One patient with m","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":488,"document":"19482634","golden":false,"offsetInEndSection":749,"text":"rone (L1) has been shown to be effective and safe in the reversal of accelerating oxidative stress related tissue damage in iron loading and non iron loading conditions such as cardiomyopathy in thalassaemia, acute kidney disease and Friedreich ataxia. The sele","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1578,"document":"25671931","golden":false,"offsetInEndSection":1716,"text":"ONCLUSION: Deferiprone is a highly efficacious and safe chelation therapy for patients with thalassemia major who are non-compliant to Def","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":111,"document":"34981144","golden":false,"offsetInEndSection":374,"text":"feriprone (Ferriprox?) is an oral iron chelator indicated for the treatment of transfusional iron overload due to thalassemia syndromes and has been recently approved as a treatment for iron overload in adult and pediatric patients with SCD and other anemias. The","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":640,"document":"25643967","golden":false,"offsetInEndSection":812,"text":"ost effective in combination therapy with DFO rather than monotherapy; however, DFX is very expensive and the cost is a significant new burden for patients. Recently, resea","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"18558000","golden":false,"offsetInEndSection":78,"text":"Deferiprone targets aconitase: implication for Friedreich\u0027s ataxia treatment.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"9029756","golden":false,"offsetInEndSection":183,"text":"Deferiprone (L1) is the first clinically available oral iron chelator and it has been proven to be effective for the treatment of transfusional iron overload in thalassemic patients. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":627,"document":"14521486","golden":false,"offsetInEndSection":836,"text":"e is indicated as second-line treatment in patients with thalassaemia major, for whom deferoxamine therapy is contraindicated or in patients who present with serious toxicity to deferoxamine therapy. This pape","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1594,"document":"20865357","golden":false,"offsetInEndSection":1814,"text":"Combined therapy with idebenone and deferiprone in patients with FDRA indicates a stabilizing effect in neurologic dysfunctions due to an improvement in the kinetic functions, with a worsening of gait and posture scores.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":220,"document":"20865357","golden":false,"offsetInEndSection":404,"text":"The objective of the study was to evaluate the effects of the combined therapy of idebenone and low oral doses of deferiprone on the neurological signs and cardiac function parameters.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1175,"document":"35007919","golden":false,"offsetInEndSection":1471,"text":"nly with 100?mg/day (p?\u003d?0.01). At both doses, safinamide significantly improved cardinal motor symptom scores (bradykinesia, rigidity, tremor, axial symptoms, and gait disturbances).CONCLUSIONS: The observed response profile to the 50-mg/day dose may be related to baseline non-motor symptoms, b","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28096656","golden":false,"offsetInEndSection":113,"text":"BACKGROUND: Pramipexole (PPX), a non-ergot dopamine receptor agonist, is a first-line treatment for Parkinson\u0027s d","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"20865357","golden":false,"offsetInEndSection":219,"text":"Iron chelators are a new therapeutical approach for patients with Friedreich\u0027s ataxia, on the basis that oxidative cell damage that occurs in these patients is due to the increasing deposits of mitochondrial iron pools.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":475,"document":"20865357","golden":false,"offsetInEndSection":599,"text":"Twenty Friedreich\u0027s ataxia patients were treated with idebenone (20 mg/kg/day) and deferiprone (20 mg/kg/day) for 11 months.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1472,"document":"35007919","golden":false,"offsetInEndSection":1561,"text":"t this was not true for the 100-mg/day dose. Both safinamide doses improved major motor s","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"20865357","golden":false,"offsetInEndSection":85,"text":"Combined therapy with idebenone and deferiprone in patients with Friedreich\u0027s ataxia.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1197,"document":"20865357","golden":false,"offsetInEndSection":1418,"text":"Echocardiography data showed a significant reduction of the interventricular septum thickness (Wilcoxon\u0027s test, p \u003d 0.04) and in the left ventricular mass index (Wilcoxon\u0027s test, p \u003d 0.038) after the start of the therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1020,"document":"20865357","golden":false,"offsetInEndSection":1196,"text":"Posture and gait scores increased significantly after 11 months of therapy (Wilcoxon\u0027s test, p \u003d 0.04) and kinetic function improved significantly (Wilcoxon\u0027s test, p \u003d 0.015).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":973,"document":"23937987","golden":false,"offsetInEndSection":1228,"text":"ed the usefulness of deferasirox as an effective and safe iron chelator in MDS patients and indication of deferiprone as an alternative treatment only in patients with mild or moderate iron overload clearly not indicated for deferasirox.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":568,"document":"28448199","golden":false,"offsetInEndSection":866,"text":"mens. Expert commentary: Extensive data support that deferiprone is particularly efficacious at cardiac iron removal and therefore, a chelator regimen that contains deferiprone is generally recommended when there is significant cardiac iron loading and/or in the setting of iron-related cardiac dis","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1215,"document":"36755516","golden":false,"offsetInEndSection":1472,"text":" chelation. Deferiprone\u0027s ability to significantly decrease cardiac and liver iron content can be utilized in other transfusion-dependent hematologic conditions, as evidenced by its recent approval for use in the US for sickle cell disease or other anemias.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":997,"document":"10493280","golden":false,"offsetInEndSection":1155,"text":"ated. Deferiprone is not effective in all patients (some of whom show increases in serum ferritin and/or liver iron content, particularly during long term the","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":183,"document":"10674529","golden":false,"offsetInEndSection":306,"text":"eferiprone is the first oral iron chelator to be shown to be effective in chronically iron overloaded thalassemia patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":880,"document":"30344970","golden":false,"offsetInEndSection":1055,"text":"rone was given as adjunctive treatment with a median dose and duration of 100 mg/kd/day (range: 86.2-100 mg/kg/day) and 25 days (range: 15-215 days), respectively. Overall, de","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":340,"document":"33444337","golden":false,"offsetInEndSection":545,"text":"ention. This study demonstrates the safety and efficacy of Chitogel with Deferiprone and/or antibacterial Gallium Protoporphyrin in different concentrations in preventing adhesion formation after abdominal","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":467,"document":"30868263","golden":false,"offsetInEndSection":639,"text":"riprone has high affinity for copper binding and can be considered for the potential treatment of copper toxicity and overloading conditions, such as Wilson\u0027s disease. In t","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":102,"document":"23940095","golden":false,"offsetInEndSection":194,"text":"alassemia. Deferiprone is an effective oral iron chelator but is known to cause significant ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1291,"document":"24782365","golden":false,"offsetInEndSection":1389,"text":"eriprone of 100 ?mol/L did not significantly affect the accumulation of 6-CF in MDCK-hOAT1 cell.CO","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":964,"document":"38334258","golden":false,"offsetInEndSection":1201,"text":"However, it significantly reduced iron accumulation in the substantia nigra, putamen, and caudate as measured by T2*-weighted MRI (with high certainty evidence).CONCLUSION: Current evidence does not support the use of DFP in PD patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1854,"document":"36449420","golden":true,"offsetInEndSection":2260,"text":"The main serious adverse events with deferiprone were agranulocytosis in 2 participants and neutropenia in 3 participants.CONCLUSIONS: In participants with early Parkinson\u0027s disease who had never received levodopa and in whom treatment with dopaminergic medications was not planned, deferiprone was associated with worse scores in measures of parkinsonism than those with placebo over a period of 36 weeks.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":274,"document":"38334258","golden":false,"offsetInEndSection":545,"text":"We conducted this meta-analysis to summarize and synthesize evidence from published randomized controlled trials about the efficacy of DFP for PD patients.METHODS: A comprehensive literature search of four electronic databases was performed, spanning until February 2023.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":645,"document":"38334258","golden":false,"offsetInEndSection":809,"text":"The primary outcome was the change in the Unified Parkinson\u0027s Disease Rating Scale (UPDRS-III).RESULTS: Three RCTs with 431 patients were included in this analysis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38334258","golden":false,"offsetInEndSection":149,"text":"INTRODUCTION: Several studies have reported iron accumulation in the basal ganglia to be associated with the development of Parkinson\u0027s Disease (PD).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":810,"document":"38334258","golden":false,"offsetInEndSection":963,"text":"DFP did not significantly improve UPDRS-III score compared to placebo (Standardized mean difference?-0.06, 95% CI [-0.69, 0.58], low certainty evidence).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":150,"document":"38334258","golden":false,"offsetInEndSection":273,"text":"Recently, a few trials have examined the efficacy of using the iron-chelating agent Deferiprone (DFP) for patients with PD.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38334258","golden":false,"offsetInEndSection":127,"text":"Efficacy of the iron-chelating agent, deferiprone, in patients with Parkinson\u0027s disease: A systematic review and meta-analysis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":938,"document":"28623611","golden":false,"offsetInEndSection":1005,"text":"DFP treatment significantly improved the performance in both tasks.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1506,"document":"24251381","golden":false,"offsetInEndSection":1972,"text":"Apart from three rapidly resolved neutropenia cases, safety was maintained throughout the trial.INNOVATION: A moderate iron chelation regimen that avoids changes in systemic iron levels may constitute a novel therapeutic modality for PD.CONCLUSIONS: The therapeutic features of a chelation modality established in translational models and in pilot clinical trials warrant comprehensive evaluation of symptomatic and/or disease-modifying potential of chelation in PD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1202,"document":"38334258","golden":false,"offsetInEndSection":1351,"text":"Future disease-modification trials with better population selection, adjustment for concomitant medications, and long-term follow up are recommended.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2741,"document":"39495531","golden":false,"offsetInEndSection":2992,"text":"openia (4 participants [7.5%] in the deferiprone group) was higher than in similar studies (1.6%-4.4%).Conclusions: These trial findings show that deferiprone 15 mg/kg twice a day decreased hippocampal QSM and accelerated cognitive decline in patients","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":146,"document":"36449420","golden":false,"offsetInEndSection":331,"text":" disorder. Early research suggests that the iron chelator deferiprone can reduce nigrostriatal iron content in persons with Parkinson\u0027s disease, but its effects on disease progression a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":4001,"document":"31202468","golden":false,"offsetInEndSection":4220,"text":"related to deferiprone use.INTERPRETATION: Deferiprone was well tolerated, achieved target engagement (lowering of iron in the basal ganglia), and seemed to somewhat slow disease progression at 18 months, although not s","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":858,"document":"38002094","golden":true,"offsetInEndSection":1025,"text":"However, a clinical study with the iron chelator deferiprone in patients with Parkinson\u0027s disease has not shown positive effects but rather worsened clinical symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":546,"document":"38334258","golden":false,"offsetInEndSection":644,"text":"Relevant RCTs were selected, and their data were extracted and analyzed using the RevMan software.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":800,"document":"32726602","golden":false,"offsetInEndSection":1063,"text":" accumulation of lipid peroxides, shares several features with PD pathophysiology. Interestingly, ?-syn has been functionally linked with the metabolism of both iron and lipid, suggesting a possible interplay between dysregulated ?-syn and other PD pathological h","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36449420","golden":false,"offsetInEndSection":700,"text":"BACKGROUND: Iron content is increased in the substantia nigra of persons with Parkinson\u0027s disease and may contribute to the pathophysiology of the disorder. Early research suggests that the iron chelator deferiprone can reduce nigrostriatal iron content in persons with Parkinson\u0027s disease, but its effects on disease progression are unclear.METHODS: We conducted a multicenter, phase 2, randomized, double-blind trial involving participants with newly diagnosed Parkinson\u0027s disease who had never received levodopa. Participants were assigned (in a 1:1 ratio) to receive oral deferiprone at a dose of 15 mg per kilogram of body weight twice daily or matched placebo for 36 weeks. Dopaminergic therapy","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":400,"document":"38334258","golden":false,"offsetInEndSection":1007,"text":"icacy of DFP for PD patients.METHODS: A comprehensive literature search of four electronic databases was performed, spanning until February 2023. Relevant RCTs were selected, and their data were extracted and analyzed using the RevMan software. The primary outcome was the change in the Unified Parkinson\u0027s Disease Rating Scale (UPDRS-III).RESULTS: Three RCTs with 431 patients were included in this analysis. DFP did not significantly improve UPDRS-III score compared to placebo (Standardized mean difference?-0.06, 95% CI [-0.69, 0.58], low certainty evidence). However, it significantly reduced iron accu","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":800,"document":"31912279","golden":false,"offsetInEndSection":1027,"text":"ell iron import, storage and export. At a molecular level, ?-synuclein regulates dopamine and iron transport with PD-associated mutations in this protein causing functional disruption to these processes. Equally, in ALS, an ear","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33963933","golden":false,"offsetInEndSection":813,"text":"The blood-brain barrier (BBB) permeability of molecules needs to meet stringent requirements of Lipinski\u0027s rule, which pose a difficulty for the rational design of efficient chelating agents for Parkinson\u0027s disease chelation therapy. Therefore, the iron chelators employed N-aliphatic alcohols modification of deferiprone were reasonably designed in this work. The chelators not only meet Lipinski\u0027s rule for BBB permeability, but also ensure the iron affinity. The results of solution thermodynamics demonstrated that the pFe3+ value of N-hydroxyalkyl substituted deferiprone is between 19.20 and 19.36, which is comparable to that of clinical deferiprone. The results of 2,2-diphenyl-1-picrylhydrazyl radical scavenging assays indicated that the N-hydroxyalkyl substituted deferiprone also possesses similar rad","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":300,"document":"35147617","golden":false,"offsetInEndSection":906,"text":"ng therapies for its treatment. In this study, novel 1-hydroxypyrazin-2(1H)-one iron chelators were synthesized and their physicochemical properties, iron chelation abilities, antioxidant capacities and neuroprotective effects in a cell culture model of Parkinson\u0027s disease were evaluated. Physicochemical properties (log??, log?D7.4, pL0.5) suggest that these ligands have a poorer ability to penetrate cell membranes and form weaker iron complexes than the closely related 1-hydroxypyridin-2(1H)-ones. Despite this, we show that levels of neuroprotection provided by these ligands against the catecholami","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":457,"document":"32100150","golden":false,"offsetInEndSection":628,"text":"Deferiprone (DFP) is a brain penetrating iron chelator that has demonstrated effectiveness in preventing neurological deterioration in Parkinson\u0027s disease clinical trials.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":145,"document":"36449420","golden":false,"offsetInEndSection":330,"text":"e disorder. Early research suggests that the iron chelator deferiprone can reduce nigrostriatal iron content in persons with Parkinson\u0027s disease, but its effects on disease progression ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37721280","golden":false,"offsetInEndSection":321,"text":"The positive effect of levodopa in the treatment of Parkinson\u0027s disease, although it is limited in time and has severe side effects, has encouraged the scientific community to look for new drugs that can stop the neurodegenerative process or even regenerate the neuromelanin-containing dopaminergic nigrostriatal neurons.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":254,"document":"28469157","golden":false,"offsetInEndSection":413,"text":"In a randomised double-blind, placebo controlled trial, 22 early onset PD patients, were administered deferiprone, 10 or 15?mg/kg BID or placebo, for 6 months.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1219,"document":"32726602","golden":false,"offsetInEndSection":1436,"text":"Anti-ferroptosis molecules are neuroprotective in PD animal models and the anti-ferroptotic iron chelator, deferiprone, slowed disease progression and improved motor function in two independent clinical trials for PD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":254,"document":"32741833","golden":false,"offsetInEndSection":391,"text":"conditions. The metal chelator deferiprone (DFP), which has a high affinity for iron, is currently in clinical trials for AD and Parkinso","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":682,"document":"29381045","golden":false,"offsetInEndSection":831,"text":"The DFP related scavenging of dopamine semiquinone (DA?-) and superoxide (O2?-) may also contribute to its positive effects in the treatment of PD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":176,"document":"39317669","golden":false,"offsetInEndSection":340,"text":"There are no clinically approved medications targeting excess Fe2+ associated with FA or the neurological disorders Parkinson\u0027s disease and Multiple System Atrophy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":619,"document":"23859349","golden":false,"offsetInEndSection":796,"text":"Here, clinical studies on Deferiprone are reviewed in the context of alternative agents such as desferoxamine, with specific regard to its mechanistic and clinical implications.","beginSection":"abstract"}],"exact_answer":"no","ideal_answer":[],"id":"63adc949c6c7d4d31b000019","type":"yesno","body":"Is Deferiprone effective for Parkinson?s Disease?"},{"documents":[{"golden":true,"id":"38039751"},{"golden":false,"id":"38588614"},{"golden":false,"id":"26376757"},{"golden":false,"id":"39617276"},{"golden":false,"id":"24978886"},{"golden":false,"id":"28793286"},{"golden":false,"id":"21501163"},{"golden":true,"id":"32617294"},{"golden":false,"id":"32008037"},{"golden":false,"id":"36567558"},{"golden":false,"id":"39044690"},{"golden":false,"id":"37607110"},{"golden":false,"id":"39106371"},{"golden":false,"id":"22026963"},{"golden":false,"id":"37935545"},{"golden":false,"id":"19895991"},{"golden":false,"id":"39433604"},{"golden":false,"id":"20207161"},{"golden":false,"id":"37169553"},{"golden":false,"id":"21859896"},{"golden":false,"id":"38727856"},{"golden":false,"id":"34080641"},{"golden":false,"id":"33413595"},{"golden":false,"id":"32163900"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":1340,"document":"38039751","golden":true,"offsetInEndSection":1626,"text":"Finally, GSE100159 and GSE133822 confirmed IL-17 signaling pathway-associated genes including IL-17R, TRAF6, RELB, TRAF5, CEBPB, JUNB, CXCL1, CXCL3, CXCL8, CXCR1, and CXCR2 were significantly up-regulated in sepsis blood samples compared with the age-matched healthy control population.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1451,"document":"32617294","golden":false,"offsetInEndSection":1895,"text":"Moreover, the release of IL-1? and IL-18 and the levels of the molecules (NLRP3, NLRC4, Cleaved caspase-1, and Cleaved GSDMD) associated with caspase-1-dependent pyroptosis were up-regulated in pneumonia-induced sepsis.CONCLUSIONS: As NK-?B activation can promote the development of caspase-1-dependent pyroptosis, these findings suggested that the activation of the IL-17 signaling pathway could promote pyroptosis in pneumonia-induced sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2657,"document":"38588614","golden":false,"offsetInEndSection":2981,"text":"S100A9 knockdown decreases transcription of apoptosis-related markers Bax, Bcl and caspase-3, alleviating LPS-induced apoptosis.CONCLUSIONS: S100A9 as a key biomarker of sepsis-induced acute lung injury, and exacerbates lung damage and epithelial cell apoptosis induced by LPS via the IL-17-NF?B-caspase-3 signaling pathway.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1096,"document":"38039751","golden":false,"offsetInEndSection":1339,"text":"Subsequently, GO and KEGG enrichment analysis of differential expression genes in each cluster found that DEGs between healthy control and sepsis patients were significantly enriched in the IL-17 signaling pathway in monocyte, NK, and T cells.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1723,"document":"26376757","golden":false,"offsetInEndSection":1990,"text":"Conversely, mfge8(-/-) mice showed increased phosphorylated STAT3 compared with wild-type mice after sepsis.CONCLUSION: Our findings demonstrate MFG-E8-mediated downregulation of IL-17 expression, implicating its potential as a novel therapeutic agent against sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1279,"document":"38588614","golden":false,"offsetInEndSection":1550,"text":"The expression of interleukin (IL)-17-nuclear factor kappa B (NF?B)-caspase-3 signaling components was identified using western blotting.RESULTS: Six common DEGs (S100A9, S100A8, IFITM6, SAA3, CD177, and MMP9) were identified in the six datasets related to ALI in sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1270,"document":"39617276","golden":false,"offsetInEndSection":1565,"text":"Experimental validation confirmed that the expression levels of TBX21, CSF3, IL-6, CXCR3, and CXCL9 matched the sequencing results.CONCLUSION: TBX21, CSF3, IL-6,CXCR3, and CXCL9 may be potential biological markers for the diagnosis and treatment the sepsis-associated intestinal mucosal barrier.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1627,"document":"38039751","golden":false,"offsetInEndSection":1808,"text":"Taken together, we concluded that the IL-17 signaling pathway serves as a significant potential mechanism of sepsis and provides a promising therapeutic target for sepsis treatment.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38039751","golden":false,"offsetInEndSection":116,"text":"Single-cell transcriptional gene signature analysis identifies IL-17 signaling pathway as the key pathway in sepsis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1097,"document":"28793286","golden":false,"offsetInEndSection":1373,"text":"Finally, IL-33 was shown to inhibit the IL-17 pathway via activating suppressor of cytokine signaling (SOCS)-3.CONCLUSION: Collectively, the results suggest that IL-33 plays a negative regulatory role in sepsis progression by inhibiting IL-17 pathway through activating SOCS3.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1080,"document":"21501163","golden":false,"offsetInEndSection":1257,"text":"These results demonstrate that C5a acts directly on the C5aR expressed on ??T cells, resulting in cell activation, and subsequently enhances their capacity for IL-17 production.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":517,"document":"37607110","golden":false,"offsetInEndSection":634,"text":"he amounts of Th17 cells, IL-17A, IL-1?, IL-18, and lipopolysaccharide is significantly elevated in sepsis patients. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":840,"document":"39106371","golden":false,"offsetInEndSection":955,"text":"I, 3.51-10.31; p \u003c 0.00001; I2 \u003d 92%).CONCLUSION: Conclusions: IL-17 levels were significantly elevated in non-surv","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1609,"document":"22026963","golden":false,"offsetInEndSection":1742,"text":"5%CI 1.17-2.40, P \u003d 0.0052).CONCLUSIONS: IL17A genetic variation is associated with altered susceptibility to Gram-positive infection","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1604,"document":"24978886","golden":false,"offsetInEndSection":1867,"text":"Altogether, these results suggest that increased activation of the IL-23/IL-17 pathway has detrimental effects on sepsis-induced lung inflammation, whereas activation of the IL-12/interferon-? pathway may lead, in contrast, to less pronounced inflammatory events.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1460,"document":"37169553","golden":false,"offsetInEndSection":1740,"text":"IFN-? and IL-12 levels were elevated in PBMC of septic patients after IL2RB transfection, but IL-4, IL-10, and IL-17A levels were lowered.CONCLUSION: Sepsis-induced immunological dysfunction is improved by IL2RB, which also balances Th1/Th2 responses and prevents Th17 activation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":621,"document":"20207161","golden":false,"offsetInEndSection":1042,"text":"Patients (59) with severe sepsis; 15 patients with gram-negative bacteraemia but without critical illness and 10 healthy controls were assayed for TGFbeta-1, IL-17a, IL-17f, IL-6 and IL-1beta mRNA in peripheral blood mononuclear cells (PBMC) by quantitative real-time PCR and serum protein levels by ELISA.RESULTS: TGFbeta-1 mRNA levels are reduced in patients with bacteraemia and sepsis compared with controls (p\u003d0.02).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1468,"document":"20207161","golden":false,"offsetInEndSection":1664,"text":"IL-1beta protein was not detectable in the majority of patients.CONCLUSIONS: Down regulation of TGFbeta-1 gene transcription was related to the occurrence of infection but not the onset of sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":900,"document":"38039751","golden":false,"offsetInEndSection":1300,"text":"sion reduction analysis. Meanwhile, the main cell types including B, NK, T, and monocyte cells were identified via the cell maker website and the \"Single R\" package cell-type annotation analysis. Subsequently, GO and KEGG enrichment analysis of differential expression genes in each cluster found that DEGs between healthy control and sepsis patients were significantly enriched in the IL-17 signalin","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":800,"document":"36567558","golden":false,"offsetInEndSection":1200,"text":" |log2 (fold change, FC)| ? 3 and P \u003c 0.001. Gene ontology (GO) function enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were performed on DEG. STRING and CytoScape software were used to construct a protein-protein interaction (PPI) network and screen key genes. The peripheral blood mononuclear cell (PBMC) of 20 septic patients admitted to the eme","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1100,"document":"38588614","golden":false,"offsetInEndSection":1500,"text":"to mimic ALI and were modulated by S100A9 lentiviral transfection. The impact of S100A9 on cell apoptosis and inflammatory responses were identified using flow cytometry and PCR. The expression of interleukin (IL)-17-nuclear factor kappa B (NF?B)-caspase-3 signaling components was identified using western blotting.RESULTS: Six common DEGs (S100A9, S100A8, IFITM6, SAA3, CD177, and MMP9) were identi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1571,"document":"32163900","golden":false,"offsetInEndSection":1722,"text":"In short, our study proposes that ITK signaling plays a significant role in sepsis-induced ALI through upregulation of Th17 cells and oxidative stress.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2758,"document":"38588614","golden":false,"offsetInEndSection":2943,"text":"ting LPS-induced apoptosis.CONCLUSIONS: S100A9 as a key biomarker of sepsis-induced acute lung injury, and exacerbates lung damage and epithelial cell apoptosis induced by LPS via the I","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":770,"document":"32617294","golden":false,"offsetInEndSection":875,"text":"sis were evaluated.RESULTS: IL-17 signaling pathway was significantly related to pneumonia-induced sepsis","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1502,"document":"33413595","golden":false,"offsetInEndSection":1673,"text":"oduced by in vivo findings.CONCLUSION: These data demonstrated that exosomal miR-27b derived from MSCs inhibited the development of sepsis by downregulating JMJD3 and inac","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37935545","golden":false,"offsetInEndSection":340,"text":"Objective: To investigate the mechanism of interleukin-6 (IL-6) /signal transducers and activators of transcriptional 3 (STAT3) /helper T cell 17 (Th17) signaling pathway in lung injury of rats with sepsis intervened by forsythia, with a view to provide experimental basis for the role and mechanism of forsythia in the treatment of sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1247,"document":"19895991","golden":false,"offsetInEndSection":1462,"text":"tion genes CD1c and CD207 (langerin). Comparison of responders and nonresponders revealed rapid downmodulation of innate IL-1beta and IL-8 sepsis cascade cytokines in both groups, but only responders downregulated I","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34080641","golden":false,"offsetInEndSection":207,"text":"Excessive inflammatory response and apoptosis play key roles in the pathogenic mechanisms of sepsis?induced acute lung injury (ALI); however, the molecular pathways linked to ALI pathogenesis remain unclear.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39433604","golden":false,"offsetInEndSection":158,"text":"As an indispensable inflammatory mediator during sepsis, granulocyte colony-stimulating factor (G-CSF) facilitates neutrophil production by activating G-CSFR.","beginSection":"abstract"}],"exact_answer":[],"ideal_answer":[],"id":"677eab59592fa48873000023","type":"list","body":"Which genes of IL-17 signalling pathway are upregulated in sepsis?"},{"documents":[{"golden":true,"id":"16199517"},{"golden":true,"id":"17644558"},{"golden":true,"id":"15941488"},{"golden":false,"id":"37125646"},{"golden":true,"id":"31307154"},{"golden":true,"id":"20457745"},{"golden":false,"id":"36865134"},{"golden":false,"id":"20048385"},{"golden":true,"id":"21427759"},{"golden":true,"id":"17683603"},{"golden":true,"id":"39632911"},{"golden":false,"id":"38950178"},{"golden":false,"id":"28559929"},{"golden":true,"id":"32692836"},{"golden":true,"id":"17127676"},{"golden":false,"id":"38753612"},{"golden":true,"id":"23632162"},{"golden":false,"id":"17130162"},{"golden":true,"id":"27663265"},{"golden":false,"id":"38294221"},{"golden":false,"id":"38537674"},{"golden":false,"id":"38293536"},{"golden":false,"id":"38726127"},{"golden":false,"id":"18854360"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":0,"document":"37125646","golden":false,"offsetInEndSection":231,"text":"Gene set enrichment analysis (GSEA) plays an important role in large-scale data analysis, helping scientists discover the underlying biological patterns over-represented in a gene list resulting from, for example, an \u0027omics\u0027 study.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":173,"document":"16199517","golden":false,"offsetInEndSection":301,"text":"Here, we describe a powerful analytical method called Gene Set Enrichment Analysis (GSEA) for interpreting gene expression data.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17644558","golden":true,"offsetInEndSection":215,"text":"UNLABELLED: Gene Set Enrichment Analysis (GSEA) is a computational method that assesses whether an a priori defined set of genes shows statistically significant, concordant differences between two biological states.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":991,"document":"15941488","golden":false,"offsetInEndSection":1460,"text":"Comparison of two aged muscle microarray data sets at gene set level using PAGE revealed common biological themes better than comparison at individual gene level.CONCLUSION: PAGE was statistically more sensitive and required much less computational effort than GSEA, it could identify significantly changed biological themes from microarray data irrespective of analysis methods or microarray platforms, and it was useful in comparison of multiple microarray data sets.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"15941488","golden":true,"offsetInEndSection":202,"text":"BACKGROUND: Gene set enrichment analysis (GSEA) is a microarray data analysis method that uses predefined gene sets and ranks of genes to identify significant biological changes in microarray data sets.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":458,"document":"16199517","golden":false,"offsetInEndSection":572,"text":"We demonstrate how GSEA yields insights into several cancer-related data sets, including leukemia and lung cancer.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":302,"document":"16199517","golden":false,"offsetInEndSection":457,"text":"The method derives its power by focusing on gene sets, that is, groups of genes that share common biological function, chromosomal location, or regulation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":573,"document":"16199517","golden":false,"offsetInEndSection":749,"text":"Notably, where single-gene analysis finds little similarity between two independent studies of patient survival in lung cancer, GSEA reveals many biological pathways in common.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":462,"document":"17683603","golden":false,"offsetInEndSection":772,"text":"Usually, significance scores (p-values) of GSEA are computed by nonparametric permutation tests, a time consuming procedure that yields only estimates of the p-values.RESULTS: We present a novel dynamic programming algorithm for calculating exact significance values of unweighted Gene Set Enrichment Analyses.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"16199517","golden":false,"offsetInEndSection":106,"text":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":5,"document":"39632911","golden":false,"offsetInEndSection":165,"text":"set enrichment analysis (GSEA) tools can identify biological insights within gene expression-based studies. Although their statistical performance has been comp","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38950178","golden":false,"offsetInEndSection":184,"text":"MOTIVATION: Gene set enrichment (GSE) analysis allows for an interpretation of gene expression through pre-defined gene set databases and is a critical step in understanding different ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31307154","golden":true,"offsetInEndSection":158,"text":"Gene set enrichment analysis (GSEA) is a popular tool to identify underlying biological processes in clinical samples using their gene expression phenotypes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":187,"document":"28559929","golden":false,"offsetInEndSection":437,"text":"phenotype. Gene Set Enrichment Analysis (GSEA) aims to address this by identifying sets of genes or biological pathways contributing to a phenotype, through gene-gene interactions or other mechanisms, which are not the focus of conventional associati","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":325,"document":"38753612","golden":false,"offsetInEndSection":461,"text":"mong many tools developed so far, Gene Set Enrichment Analysis (GSEA) stands out as one of the pioneering and most widely used methods. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27663265","golden":true,"offsetInEndSection":248,"text":"BACKGROUND: Gene Set Enrichment Analysis (GSEA) is a popular method to reveal significant dependencies between predefined sets of gene symbols and observed phenotypes by evaluating the deviation of gene expression values between cases and controls.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17130162","golden":false,"offsetInEndSection":116,"text":"The Gene Set Enrichment Analysis (GSEA) identifies sets of genes that are differentially regulated in one direction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":380,"document":"21427759","golden":true,"offsetInEndSection":536,"text":"The gene-set-enrichment analysis (GSEA) is a pathway-based approach that tests for such aggregated effects of genes that are linked by biological functions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":100,"document":"38294221","golden":false,"offsetInEndSection":600,"text":"ulated by the same regulator, i.e., regulons. Unfortunately, current gene set enrichment analysis (GSEA) tools do not consider whether a gene is activated or repressed by a regulator. This distinction is crucial when analyzing regulons since a regulator can work as an activator of certain genes and as a repressor of other genes, yet both sets of genes belong to the same regulon. Therefore, simply averaging expression differences of the genes of such a regulon will not properly reflect the activi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":50,"document":"38753612","golden":false,"offsetInEndSection":300,"text":"ational biology method to interpret a list of genes (typically derived from the association of large-scale omics data with phenotypes of interest) in terms of higher-level, predefined gene sets that share biological function, chromosomal location, or","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":800,"document":"38537674","golden":false,"offsetInEndSection":1200,"text":"GSEA) and CIBERSORT were used to investigate molecular pathways and immune cell distributions related to GADD45G and NUPR1.RESULTS: This study identified 14 genes that are common to NAFLD and AD. Machine learning identified six biomarkers for NAFLD, four for AD, and two crucial shared biomarkers: GADD45G and NUPR1. Validation confirmed their expression patterns and robust predictive abilities. GSE","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":700,"document":"38293536","golden":false,"offsetInEndSection":1000,"text":"SEA, CIBERSORTx, and ImmuCellAI algorithms were used to identify immune infiltration in plaque samples. GAS5 and ANXA2 expression levels in RAW264.7?cells treated with oxidized low-density lipoprotein (ox-LDL) were measured by qRT-PCR and Western blot. Small interfering and short hairpin RNA were us","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":600,"document":"38726127","golden":false,"offsetInEndSection":900,"text":"lysis (GSEA) revealed their molecular mechanisms. The diagnostic biomarkers were selected via receiver operating characteristic (ROC) analysis. Moreover, an analysis of immune elements infiltration degree was carried out. Authentication of pivotal gene expression at the mRNA level was investigated i","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17644558","golden":false,"offsetInEndSection":203,"text":"UNLABELLED: Gene Set Enrichment Analysis (GSEA) is a computational method that assesses whether an a priori defined set of genes shows statistically significant, concordant differences between two biolog","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32692836","golden":false,"offsetInEndSection":132,"text":"MOTIVATION: Gene Set Enrichment Analysis (GSEA) is an algorithm widely used to identify statistically enriched gene sets in transcri","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17127676","golden":false,"offsetInEndSection":130,"text":"MOTIVATION: Gene Set Enrichment Analysis (GSEA) has been developed recently to capture changes in the expression of pre-defined se","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36865134","golden":false,"offsetInEndSection":231,"text":"Gene set enrichment analysis (GSEA) plays an important role in large-scale data analysis, helping scientists discover the underlying biological patterns over-represented in a gene list resulting from, for example, an \u0027omics\u0027 study.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":324,"document":"38753612","golden":false,"offsetInEndSection":460,"text":"Among many tools developed so far, Gene Set Enrichment Analysis (GSEA) stands out as one of the pioneering and most widely used methods.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":561,"document":"20048385","golden":false,"offsetInEndSection":657,"text":"However, the most popular method, gene set enrichment analysis (GSEA), seems overly complicated.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":127,"document":"18854360","golden":false,"offsetInEndSection":324,"text":"To provide a remedy, we combined SNP association analysis with the pathway-driven gene set enrichment analysis (GSEA), recently developed to facilitate handling of genome-wide gene expression data.","beginSection":"abstract"}],"ideal_answer":[],"id":"677ecc12592fa48873000028","type":"summary","body":"How does Gene Set Enrichment Analysis (GSEA) work?"},{"documents":[{"golden":false,"id":"32613752"},{"golden":false,"id":"34042040"},{"golden":false,"id":"2029154"},{"golden":false,"id":"22768177"},{"golden":false,"id":"11790513"},{"golden":false,"id":"17260344"},{"golden":false,"id":"21684335"},{"golden":false,"id":"28672806"},{"golden":false,"id":"15341508"},{"golden":false,"id":"18072817"},{"golden":false,"id":"10929932"},{"golden":false,"id":"16274338"},{"golden":false,"id":"12184472"},{"golden":false,"id":"24469940"},{"golden":false,"id":"15096406"},{"golden":false,"id":"1358615"},{"golden":false,"id":"16142989"},{"golden":false,"id":"19753135"},{"golden":false,"id":"25420207"},{"golden":false,"id":"23767969"},{"golden":false,"id":"22950594"},{"golden":false,"id":"35341012"},{"golden":false,"id":"10451759"},{"golden":false,"id":"72132"},{"golden":false,"id":"25322951"},{"golden":false,"id":"17683172"},{"golden":false,"id":"22133327"},{"golden":false,"id":"27190009"},{"golden":false,"id":"18516813"},{"golden":false,"id":"36587195"},{"golden":false,"id":"26965692"},{"golden":false,"id":"29217303"},{"golden":false,"id":"11593450"},{"golden":false,"id":"32016321"},{"golden":false,"id":"25859801"},{"golden":false,"id":"12150769"},{"golden":false,"id":"18695057"},{"golden":false,"id":"30925619"},{"golden":false,"id":"30144250"},{"golden":false,"id":"15254792"},{"golden":false,"id":"35921451"},{"golden":false,"id":"17110281"},{"golden":false,"id":"15908232"},{"golden":false,"id":"20061077"},{"golden":false,"id":"11921116"},{"golden":false,"id":"19252795"},{"golden":false,"id":"34407293"},{"golden":false,"id":"32062624"},{"golden":false,"id":"23634791"},{"golden":false,"id":"15180133"},{"golden":false,"id":"15965307"},{"golden":false,"id":"20297857"},{"golden":false,"id":"10223406"},{"golden":false,"id":"9638397"},{"golden":false,"id":"20839895"},{"golden":false,"id":"28789629"},{"golden":false,"id":"15180135"},{"golden":false,"id":"28749580"},{"golden":false,"id":"15725358"},{"golden":false,"id":"8533059"},{"golden":false,"id":"21482191"},{"golden":false,"id":"20502722"},{"golden":false,"id":"30248222"},{"golden":false,"id":"34442442"},{"golden":false,"id":"36253105"},{"golden":false,"id":"26048686"},{"golden":false,"id":"8140562"},{"golden":false,"id":"25177294"},{"golden":false,"id":"24090949"},{"golden":false,"id":"23978853"},{"golden":false,"id":"35953517"},{"golden":false,"id":"11785037"},{"golden":false,"id":"28622283"},{"golden":false,"id":"10812945"},{"golden":false,"id":"18788836"},{"golden":false,"id":"23380027"},{"golden":false,"id":"26563663"},{"golden":false,"id":"10837922"},{"golden":false,"id":"16028004"},{"golden":false,"id":"34561166"},{"golden":false,"id":"7565821"},{"golden":false,"id":"22383696"},{"golden":false,"id":"34724257"},{"golden":false,"id":"17045989"},{"golden":false,"id":"25668262"},{"golden":false,"id":"36732514"},{"golden":false,"id":"23726851"},{"golden":false,"id":"36449420"},{"golden":false,"id":"32201505"},{"golden":false,"id":"15190232"},{"golden":false,"id":"22976926"},{"golden":false,"id":"30564614"},{"golden":false,"id":"21551108"},{"golden":false,"id":"19412491"},{"golden":false,"id":"9270567"},{"golden":false,"id":"19810883"},{"golden":false,"id":"24490799"},{"golden":false,"id":"12470183"},{"golden":false,"id":"2276120"},{"golden":false,"id":"32171387"},{"golden":false,"id":"17009915"},{"golden":false,"id":"26295349"},{"golden":false,"id":"8629572"},{"golden":false,"id":"10830413"},{"golden":false,"id":"27592010"},{"golden":false,"id":"19946270"},{"golden":false,"id":"17962848"},{"golden":false,"id":"31580415"},{"golden":false,"id":"19290777"},{"golden":false,"id":"24185369"},{"golden":false,"id":"26164633"},{"golden":false,"id":"17224935"},{"golden":false,"id":"34245502"},{"golden":false,"id":"26646536"},{"golden":false,"id":"19129703"},{"golden":false,"id":"8569250"},{"golden":false,"id":"12080520"},{"golden":false,"id":"11590151"},{"golden":false,"id":"36182642"},{"golden":false,"id":"22703631"},{"golden":false,"id":"33693397"},{"golden":false,"id":"17117171"},{"golden":false,"id":"20073162"},{"golden":false,"id":"15157851"},{"golden":false,"id":"19724249"},{"golden":false,"id":"16198279"},{"golden":false,"id":"2553232"},{"golden":false,"id":"23963470"},{"golden":false,"id":"28370340"},{"golden":false,"id":"33321002"},{"golden":false,"id":"34910248"},{"golden":false,"id":"30884365"},{"golden":false,"id":"12588911"},{"golden":false,"id":"31678032"},{"golden":false,"id":"22382608"},{"golden":false,"id":"1955897"},{"golden":false,"id":"35128728"},{"golden":false,"id":"36507343"},{"golden":false,"id":"23250679"},{"golden":false,"id":"21542016"},{"golden":false,"id":"9452324"},{"golden":false,"id":"22298943"},{"golden":false,"id":"1362394"},{"golden":false,"id":"27593744"},{"golden":false,"id":"19811035"},{"golden":false,"id":"14676046"},{"golden":true,"id":"38315945"},{"golden":false,"id":"39666171"},{"golden":false,"id":"38936981"},{"golden":false,"id":"37721280"},{"golden":false,"id":"39313800"},{"golden":false,"id":"37658103"},{"golden":false,"id":"34814867"},{"golden":false,"id":"38622249"},{"golden":false,"id":"22651796"},{"golden":false,"id":"37037069"},{"golden":false,"id":"21244307"},{"golden":false,"id":"38139032"},{"golden":false,"id":"26600626"},{"golden":false,"id":"11562835"},{"golden":false,"id":"35005605"},{"golden":false,"id":"23180276"},{"golden":true,"id":"35921450"},{"golden":false,"id":"18591143"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":2193,"document":"35921450","golden":true,"offsetInEndSection":2492,"text":"oup and any cinpanemab group. The most common adverse events with cinpanemab were headache, nasopharyngitis, and falls.CONCLUSIONS: In participants with early Parkinson\u0027s disease, the effects of cinpanemab on clinical measures of disease progression and changes in DaT-SPECT imaging did not differ f","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"35921450","golden":false,"offsetInEndSection":49,"text":"Trial of Cinpanemab in Early Parkinson\u0027s Disease.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":752,"document":"34042040","golden":false,"offsetInEndSection":1040,"text":"In this review, an overview of how alpha-synuclein contributes to Parkinson\u0027s disease and the effects of a few new immunotherapeutic treatments, including BIIB054 (cinpanemab), MEDI1341, AFFITOPE, and PRX002 (prasinezumab) that are currently under clinical development, will be discussed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32613752","golden":false,"offsetInEndSection":197,"text":"This modeling and simulation analysis was aimed at selecting doses of cinpanemab (BIIB054), a monoclonal antibody targeting aggregated ?-synuclein, for a phase II study in Parkinson\u0027s disease (PD).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":84,"document":"35921450","golden":false,"offsetInEndSection":583,"text":"thogenesis. Cinpanemab, a human-derived monoclonal antibody that binds to ?-synuclein, is being evaluated as a disease-modifying treatment for Parkinson\u0027s disease.METHODS: In a 52-week, multicenter, double-blind, phase 2 trial, we randomly assigned, in a 2:1:2:2 ratio, participants with early Parkinson\u0027s disease to receive intravenous infusions of placebo (control) or cinpanemab at a dose of 250 mg, 1250 mg, or 3500 mg every 4 weeks, followed by an active-treatment dose-blinded extension period","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":261,"document":"2029154","golden":false,"offsetInEndSection":388,"text":"Monoamine oxidase B inhibitors have been shown to delay disease progression in early Parkinson\u0027s Disease and improve mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":447,"document":"34814867","golden":false,"offsetInEndSection":768,"text":"T patterns. However, the utility of DaT-SPECT in enhancing early PD participant selection in a global, multicenter clinical trial of a potentially disease-modifying therapy is not well understood.METHODS: The SPARK clinical trial was a phase 2 trial of cinpanemab, a monoclonal antibody against alpha-synuclein, in partic","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1182,"document":"35921450","golden":false,"offsetInEndSection":1265,"text":"and 100 to the 3500-mg group. The trial was stopped after the week 72 interim analy","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":850,"document":"11790513","golden":false,"offsetInEndSection":957,"text":"These results indicate that S 17092 has cognition-enhancing properties in this model of early parkinsonism.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1266,"document":"35921450","golden":false,"offsetInEndSection":1664,"text":"is owing to lack of efficacy. The change to week 52 in the MDS-UPDRS score was 10.8 points in the control group, 10.5 points in the 250-mg group, 11.3 points in the 1250-mg group, and 10.9 points in the 3500-mg group (adjusted mean difference vs. control, -0.3 points [95% confidence interval {CI}, -4.9 to 4.3], P?\u003d?0.90; 0.5 points [95% CI, -3.3 to 4.3], P?\u003d?0.80; and 0.1 point [95% CI, -3.8 to ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2357,"document":"35921450","golden":false,"offsetInEndSection":2568,"text":"nson\u0027s disease, the effects of cinpanemab on clinical measures of disease progression and changes in DaT-SPECT imaging did not differ from those of placebo over a 52-week period. (Funded by Biogen; SPARK Clinica","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":642,"document":"34814867","golden":false,"offsetInEndSection":780,"text":".METHODS: The SPARK clinical trial was a phase 2 trial of cinpanemab, a monoclonal antibody against alpha-synuclein, in participants with ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":86,"document":"35921450","golden":false,"offsetInEndSection":239,"text":"ogenesis. Cinpanemab, a human-derived monoclonal antibody that binds to ?-synuclein, is being evaluated as a disease-modifying treatment for Parkinson\u0027s ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2160,"document":"35921450","golden":false,"offsetInEndSection":2261,"text":"ifferences between the control group and any cinpanemab group. The most common adverse events with ci","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1047,"document":"35921450","golden":false,"offsetInEndSection":1214,"text":"Of the 357 enrolled participants, 100 were assigned to the control group, 55 to the 250-mg cinpanemab group, 102 to the 1250-mg group, and 100 to the 3500-mg group. Th","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":455,"document":"34814867","golden":false,"offsetInEndSection":640,"text":"ns. However, the utility of DaT-SPECT in enhancing early PD participant selection in a global, multicenter clinical trial of a potentially disease-modifying therapy is not well understo","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1658,"document":"34814867","golden":false,"offsetInEndSection":1832,"text":"ure studies. If supported, the radiation risks, imaging costs, and operational burden of DaT-SPECT for enrichment may be mitigated by clinical assessment and other study desi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2264,"document":"35921450","golden":false,"offsetInEndSection":2354,"text":"nemab were headache, nasopharyngitis, and falls.CONCLUSIONS: In participants with early Pa","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1115,"document":"34814867","golden":false,"offsetInEndSection":1353,"text":"is.RESULTS: In total, 482 unique participants were screened between January 2018 and May 2019; 3.8% (15/398) of imaged participants were excluded owing to negative DaT-SPECT findings (i.e., scans without evidence of dopaminergic deficit [","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":653,"document":"15341508","golden":false,"offsetInEndSection":897,"text":" two pharmacoeconomic analyses suggest that cabergoline may be a cost-effective treatment option versus levodopa in patients with early Parkinson\u0027s disease, and highlight the need for further evaluation of the drug in this indication.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":427,"document":"15341508","golden":false,"offsetInEndSection":650,"text":"patients with early Parkinson\u0027s disease, cabergoline (with or without levodopa) is well tolerated and effective in controlling disease symptoms, and may reduce the risk of developing drug-induced motor complications. Data f","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"32613752","golden":false,"offsetInEndSection":137,"text":"Phase II Dose Selection for Alpha Synuclein-Targeting Antibody Cinpanemab (BIIB054) Based on Target Protein Binding Levels in the Brain.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":884,"document":"18072817","golden":false,"offsetInEndSection":1134,"text":"nistered as a simple and convenient dosage regimen, is a well tolerated and effective option for monotherapy in patients with early Parkinson\u0027s disease and for adjunctive therapy in patients with moderate to advanced disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":405,"document":"10929932","golden":false,"offsetInEndSection":760,"text":"ase. In the symptomatic treatment of early Parkinson\u0027s disease ropinirole monotherapy was significantly more effective than placebo in 2 multicentre, randomised, double-blind trials of 3 to 12 months duration as assessed by the Unified Parkinson\u0027s Disease Rating Scale (UPDRS) motor scores and Clinical Global Impression/Clinical Global Evaluation Scales.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":317,"document":"18072817","golden":false,"offsetInEndSection":504,"text":" well designed clinical studies indicate that rasagiline is effective as initial monotherapy and improves Parkinson\u0027s symptomatology in patients with early Parkinson\u0027s disease. In additio","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1104,"document":"16274338","golden":false,"offsetInEndSection":1267,"text":"al trials, rasagiline proves effective as monotherapy in early Parkinson\u0027s disease, as well as adjunctive therapy to levodopa in advanced disease. Clinical data su","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"12184472","golden":false,"offsetInEndSection":267,"text":"Levodopa should generally be avoided early in the course of Parkinson disease; dopamine agonists, particularly second-generation agents such as ropinirole (Requip) and pramipexole (Mirapex), carry a smaller long-term risk of dyskinesia and should be used instead. Dee","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":103,"document":"19753135","golden":false,"offsetInEndSection":587,"text":"It has demonstrated efficacy in monotherapy for early Parkinson\u0027s disease (PD) patients in one large randomized, placebo-controlled trial (TVP-1012 in Early Monotherapy for Parkinson\u0027s Disease Outpatients), and has shown ability to reduce off time in more advanced PD patients with motor fluctuations in two large placebo-controlled trials (Parkinson\u0027s Rasagiline: Efficacy and Safety in the Treatment of \"Off\", and Lasting Effect in Adjunct Therapy With Rasagiline Given Once Daily).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"15096406","golden":false,"offsetInEndSection":138,"text":"BACKGROUND: Treatment with rasagiline mesylate, an irreversible monoamine oxidase type B inhibitor, improves symptoms of early Parkinson d","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":139,"document":"15096406","golden":false,"offsetInEndSection":854,"text":"sease (PD). Preclinical studies suggest that this compound may also modify the progression of PD.OBJECTIVE: To compare the effects of early and later initiation of rasagiline on progression of disability in patients with PD.DESIGN: Double-blind, parallel-group, randomized, delayed-start clinical trial.SETTINGS AND PATIENTS: Four hundred four subjects with early PD, not requiring dopaminergic therapy, enrolled at 32 sites in the United States and Canada.INTERVENTIONS: Subjects were randomized to receive rasagiline, 1 or 2 mg/d, for 1 year or placebo for 6 months followed by rasagiline, 2 mg/d, for 6 months.MAIN OUTCOME MEASURE: Change in total Unified Parkinson\u0027s Disease Rating Scale score from baseline to ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":855,"document":"15096406","golden":false,"offsetInEndSection":1122,"text":"2 months.RESULTS: Three hundred seventy-one subjects were included in the 1-year efficacy analysis. Subjects treated with rasagiline, 2 mg/d, for 1 year had a 2.29-unit smaller increase in mean adjusted total Unified Parkinson\u0027s Disease Rating Scale score compared wi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"1358615","golden":false,"offsetInEndSection":440,"text":"The management of patients with early Parkinson\u0027s disease should now take into account the possibility that MAO-B inhibitors may provide neuroprotective therapy, that dopamine undergoes oxidative metabolism and has the potential to generate cytotoxic free radicals, and that the early employment of drugs which provide sustained central dopamine agonism may delay the development of adverse effects associated with chronic levodopa therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1811,"document":"16142989","golden":false,"offsetInEndSection":1947,"text":"However, a recently published study in advanced Parkinson\u0027s disease showed no therapeutic benefit of NS-2330 in this patient population.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1123,"document":"15096406","golden":false,"offsetInEndSection":1475,"text":"h subjects treated with placebo for 6 months followed by rasagiline, 2 mg/d, for 6 months (P \u003d.01). The mean adjusted difference between the placebo/rasagiline, 2 mg/d, group and those receiving rasagiline, 1 mg/d, for 1 year was -1.82 unit on the Unified Parkinson\u0027s Disease Rating Scale score (P \u003d.05).CONCLUSION: Subjects treated with rasagiline, 2 ","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"15096406","golden":false,"offsetInEndSection":87,"text":"A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":966,"document":"35341012","golden":false,"offsetInEndSection":1060,"text":"This shows that, in the early stage of medication, it has certain benefits in disease control.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":790,"document":"23767969","golden":false,"offsetInEndSection":930,"text":"Our observations support an earlier age of onset for homozygous cases and possible beneficial effects of DBS in Parkin-related parkinsonism.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"1358615","golden":false,"offsetInEndSection":38,"text":"Early therapy for Parkinson\u0027s disease.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":178,"document":"25322951","golden":false,"offsetInEndSection":385,"text":"In randomized, controlled trials, oral rasagiline 1 mg once daily was superior to placebo in the symptomatic treatment of early Parkinson\u0027s disease, both as monotherapy or as an adjunct to dopamine agonists.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":862,"document":"17683172","golden":false,"offsetInEndSection":1109,"text":"Thus, rasagiline, administered as a simple and convenient dosage regimen, is a well tolerated and effective option for monotherapy in patients with early Parkinson\u0027s disease and for adjunctive therapy in patients with moderate to advanced disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":441,"document":"1358615","golden":false,"offsetInEndSection":602,"text":"The aim of treatment for patients with early Parkinson\u0027s disease is to utilize strategies designed to address these issues without compromising clinical control.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1549,"document":"22133327","golden":false,"offsetInEndSection":1785,"text":"Rasagiline 1?mg/day has been shown to provide improved motor control in terms of Unified Parkinson\u0027s Disease Rating Scale (UPDRS) score at 18 months in those patients with early disease who began the drug 9 months before a second group.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":603,"document":"1358615","golden":false,"offsetInEndSection":633,"text":"These approaches are reviewed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":855,"document":"19753135","golden":false,"offsetInEndSection":1109,"text":"One large trial has investigated the potential for disease modification in PD patients (Attenuation of Disease progression with Azilect Given Once-daily) and preliminary results maintain some possible advantage to earlier initiation of the 1 mg/day dose.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":108,"document":"26965692","golden":false,"offsetInEndSection":266,"text":"he frequency of Gaucher disease patients and heterozygote carriers that developed Parkinson disease has been found to be above that of the control population.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":900,"document":"29217303","golden":false,"offsetInEndSection":1109,"text":"ase is a histiocytic proliferative disorder diagnosed by the presence of tissue infiltration by S100-positive CD1a-negative histiocytes and plasma cell aggregates, often with Russell bodies. A typical, though ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"11593450","golden":false,"offsetInEndSection":138,"text":"Huntington disease (HD) is a common autosomal dominant neurodegenerative disease with early adult-onset motor abnormalities and dementia. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":803,"document":"32016321","golden":false,"offsetInEndSection":1065,"text":" neurites/bodies were not present in the 50-year-old individual or in controls, severe neuronal loss in the substantia nigra pars compacta and LP corresponding to neuropathological stage 4 of Parkinson disease was seen in the 58-year-old FD patient. Major cerebr","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1481,"document":"25859801","golden":false,"offsetInEndSection":1709,"text":" progression occurred in both unilateral MMD and bilateral MMD, but the interval before disease progression in patients with unilateral disease was significantly longer than in patients with bilateral disease (p \u003d 0.021). The in","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"12150769","golden":false,"offsetInEndSection":232,"text":"Although Alzheimer\u0027s disease, Parkinson\u0027s disease, and motor neurone disease are distinct disorders, there could be a common neurodegenerative mechanism that characterises the death of selective neurone populations in each case. We ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"18695057","golden":false,"offsetInEndSection":164,"text":"BACKGROUND: The significance of Lewy bodies detected at autopsy in the brains of clinically normal individuals is uncertain but may represent preclinical Parkinson ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"29217303","golden":false,"offsetInEndSection":125,"text":"This chapter describes the main features of two different diseases, Castleman Disease (CD) and Rosai-Dorfman Disease (RDD). C","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":491,"document":"30925619","golden":false,"offsetInEndSection":757,"text":"ferentiation between DLB and PD-D is based on an arbitrary distinction between the time of onset of parkinsonism and cognitive symptoms; extrapyramidal symptoms precede dementia in PD-D, whereas it coincides with or follows dementia within 1?year in DLB. When the cl","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":502,"document":"30144250","golden":false,"offsetInEndSection":598,"text":"D in older patients is normal, of little concern, and does not require treatment. However, studi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1278,"document":"15254792","golden":false,"offsetInEndSection":1486,"text":"The results of this pilot study suggest that as compared to levodopa monotherapy DEC may have beneficial effects on decline of dopamine transporter binding similar to those recently described for pramipexole.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":227,"document":"23634791","golden":false,"offsetInEndSection":520,"text":"nd cognition. Oral rasagiline, as monotherapy or as adjunctive therapy to levodopa, was effective in the symptomatic treatment of adult patients with Parkinson\u0027s disease participating in double-blind, placebo-controlled, international studies.AREAS COVERED: This article reviews the reported a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"15254792","golden":false,"offsetInEndSection":223,"text":"Putative neurotoxic actions of levodopa and neuroprotective effects of dopamine agonists, as indicated by laboratory and animal studies, provide the rationale to study their effect on the progression of Parkinson\u0027s disease.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"17110281","golden":false,"offsetInEndSection":102,"text":"TCH346 as a neuroprotective drug in Parkinson\u0027s disease: a double-blind, randomised, controlled trial.","beginSection":"title"},{"endSection":"title","offsetInBeginSection":0,"document":"35921451","golden":false,"offsetInEndSection":57,"text":"Trial of Prasinezumab in Early-Stage Parkinson\u0027s Disease.","beginSection":"title"},{"endSection":"title","offsetInBeginSection":0,"document":"15254792","golden":false,"offsetInEndSection":147,"text":"Comparison of alpha-dihydroergocryptine and levodopa monotherapy in Parkinson\u0027s disease: assessment of changes in DAT binding with [123I]IPT SPECT.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":470,"document":"15254792","golden":false,"offsetInEndSection":635,"text":"25 PD patients (H\u0026Y stages 1 to 2.5) entered this study and were treated in a randomized fashion either with DEC (101+/-39 mg) or levodopa (369+/-51 mg) monotherapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":224,"document":"15254792","golden":false,"offsetInEndSection":469,"text":"Aim of this pilot study was to compare the effects of monotherapy with the dopamine agonist alpha-dihydroergocryptine (DEC) versus monotherapy with levodopa on nigrostriatal dopaminergic neurons as measured with dopamine transporter (DAT) SPECT.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":91,"document":"35921451","golden":false,"offsetInEndSection":437,"text":"\u0027s disease. The monoclonal antibody prasinezumab, directed at aggregated ?-synuclein, is being studied for its effect on Parkinson\u0027s disease.METHODS: In this phase 2 trial, we randomly assigned participants with early-stage Parkinson\u0027s disease in a 1:1:1 ratio to receive intravenous placebo or prasinezumab at a dose of 1500 mg or 4500 mg every ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1130,"document":"15254792","golden":false,"offsetInEndSection":1277,"text":"Due to the small sample size and the relatively short observation period, however, group differences did not reach a statistical significant level.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":236,"document":"15180133","golden":false,"offsetInEndSection":527,"text":"direct comparisons of dopamine agonists show that ergot derivatives, such as pergolide and cabergoline, are as effective as non-ergot derivatives, such as ropinirole and pramipexole, in ameliorating Parkinson\u0027s disease symptoms in patients in early or advanced stages of the condition. As fa","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1130,"document":"36587195","golden":false,"offsetInEndSection":1396,"text":"\u0027s disease mice. Early treatment with CD28SA attenuated dopaminergic neurodegeneration in the SN of h?Syn Parkinson\u0027s disease mice accompanied with reduced brain numbers of activated CD4+, CD8+ T cells and CD11b+ microglia observed at the late disease-stage 10?weeks","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":317,"document":"17683172","golden":false,"offsetInEndSection":504,"text":" well designed clinical studies indicate that rasagiline is effective as initial monotherapy and improves Parkinson\u0027s symptomatology in patients with early Parkinson\u0027s disease. In additio","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":884,"document":"17683172","golden":false,"offsetInEndSection":1134,"text":"nistered as a simple and convenient dosage regimen, is a well tolerated and effective option for monotherapy in patients with early Parkinson\u0027s disease and for adjunctive therapy in patients with moderate to advanced disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"15965307","golden":false,"offsetInEndSection":110,"text":"Rotigotine is a new dopamine agonist with transdermal patch formulation for the treatment of Parkinson disease","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":447,"document":"20297857","golden":false,"offsetInEndSection":720,"text":"exole ER improved the symptoms of Parkinson\u0027s disease in three well designed trials in adults with early or advanced disease, as measured by changes from baseline in the sum of the Unified Parkinson\u0027s Disease Rating Scale (UPDRS) parts II and III subtotal scores. In a 9-we","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"15965307","golden":false,"offsetInEndSection":153,"text":"Safety, tolerability, and efficacy of continuous transdermal dopaminergic stimulation with rotigotine patch in early-stage idiopathic Parkinson disease.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":965,"document":"10223406","golden":false,"offsetInEndSection":1222,"text":"ave demonstrated that pramipexole has excellent pharmacokinetic properties and that it is an effective monotherapy in treating early Parkinson\u0027s disease and an effective adjunctive therapy with L-DOPA in treating late Parkinson\u0027s disease. In addition, prami","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":548,"document":"9638397","golden":false,"offsetInEndSection":769,"text":"ies. Data from relatively long term (10- or 31-week) studies suggest that pramipexole monotherapy (0.375 to 6.0 mg/day) can improve activities of daily living and motor symptoms in patients with early Parkinson\u0027s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":843,"document":"20839895","golden":false,"offsetInEndSection":982,"text":"ave shown that pramipexole is effective as monotherapy in early Parkinson\u0027s disease and as adjunctive therapy in advanced disease. Trials f","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1122,"document":"16142989","golden":false,"offsetInEndSection":1333,"text":"In 2003, the results from two studies using istradefylline in patients with Parkinson\u0027s disease were published, with both showing a positive benefit of the study drug when used as adjunctive therapy to levodopa.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2458,"document":"16142989","golden":false,"offsetInEndSection":2582,"text":"The PRECEPT study is currently in progress to assess the neuroprotective role of CEP-1347 in the early phase of the disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1725,"document":"16142989","golden":false,"offsetInEndSection":1810,"text":"A phase II proof-of-concept study is currently underway in early Parkinson\u0027s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1334,"document":"16142989","golden":false,"offsetInEndSection":1547,"text":"In non-human primate models of Parkinson\u0027s disease, talampanel has been found to have antiparkinsonian effects when administered as high-dose monotherapy and antidyskinetic effects on levodopa-induced dyskinesias.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1548,"document":"16142989","golden":false,"offsetInEndSection":1724,"text":"NS-2330, another drug currently undergoing clinical trials, is a triple monoamine reuptake inhibitor that has therapeutic potential in both Parkinson\u0027s and Alzheimer\u0027s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2341,"document":"16142989","golden":false,"offsetInEndSection":2457,"text":"Studies in patients with Parkinson\u0027s disease with coenzyme Q10 have suggested that it slows down functional decline.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":420,"document":"15180135","golden":false,"offsetInEndSection":596,"text":"Ergot derivatives, such as pergolide, induce minor side-effects and provide significant and sustained improvements in motor function in patients with early Parkinson\u0027s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":248,"document":"20502722","golden":false,"offsetInEndSection":419,"text":"The addition of zonisamide at 25-50 mg/day to currently used antiparkinsonian drugs significantly improved cardinal symptoms in patients with advanced Parkinson\u0027s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2406,"document":"21482191","golden":false,"offsetInEndSection":2842,"text":"ion to about 6 units per year. In the placebo group, patients with the lowest quartile of baseline UPDRS scores (?14; n\u003d160) progressed more slowly than did those with highest scores (\u003e25?5; n\u003d145; mean difference -3?46 [SE 0?77]; p\u003c0?0001).INTERPRETATION: These findings show that rasagiline delayed the need for symptomatic antiparkinsonian drugs and emphasise the contribution of the UPDRS ADL in the response of the rasagiline 1 mg ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1298,"document":"21482191","golden":false,"offsetInEndSection":1698,"text":"bo 0?41, 0?26-0?64, p\u003d0?0001). At week 36, both doses significantly improved UPDRS motor subscores compared with placebo (1 mg rasagiline mean difference -1?88 [SE 0?35]; 2 mg rasagiline -2?18 [0?35]; both p\u003c0?0001) and activities of daily living subscores (ADL; 1 mg rasagiline -0?86 [0?18]; 2 mg rasagiline -0?88 [0?18]; both p\u003c0?0001), and 1 mg rasagiline significantly improved UPDRS mentation su","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1853,"document":"21482191","golden":false,"offsetInEndSection":2241,"text":" dose (-0?62 [0?29]; p\u003d0?035). When assessed for the effect on non-motor symptoms at week 36, both doses showed benefits on the Parkinson fatigue scale versus placebo (1 mg rasagiline mean difference -0?14 [SE 0?05], p\u003d0?0032; 2 mg rasagiline -0?19 [0?05], p\u003c0?0001), and the 1 mg dose showed benefits on the scale for non-motor experiences of daily living compared with placebo (mean dif","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":203,"document":"21482191","golden":false,"offsetInEndSection":631,"text":"y analysis. Here, we report additional secondary and post-hoc analyses of the ADAGIO study.METHODS: ADAGIO was a placebo-controlled, double-blind, multicentre, delayed-start study, in which 1176 patients with untreated early Parkinson\u0027s disease were randomly assigned to receive rasagiline 1 mg or 2 mg per day for 72 weeks (early-start groups) or placebo for 36 weeks followed by rasagiline 1 mg or 2 mg per day for 36 weeks (d","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":632,"document":"21482191","golden":false,"offsetInEndSection":923,"text":"layed-start groups). We assessed the need for additional antiparkinsonian therapy and changes in non-motor experiences of daily living and fatigue scales (prespecified outcomes) and changes in unified Parkinson\u0027s disease rating scale (UPDRS) scores and subscores in placebo and active groups","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"21482191","golden":false,"offsetInEndSection":214,"text":"A double-blind, delayed-start trial of rasagiline in Parkinson\u0027s disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21482191","golden":false,"offsetInEndSection":102,"text":"BACKGROUND: The ADAGIO study investigated whether rasagiline has disease-modifying effects in Parkinso","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":283,"document":"30248222","golden":false,"offsetInEndSection":541,"text":"As most of the PD-related mutations occurred in the kinase domain and impaired PINK1\u0027s catalytic activity, it was suggested that small molecules that activated PINK1 would maintain mitochondrial quality control and, as a result, have neuroprotective effects.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":103,"document":"21482191","golden":false,"offsetInEndSection":202,"text":"\u0027s disease. Rasagiline 1 mg per day, but not 2 mg per day, was shown to be efficacious in the prima","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36253105","golden":false,"offsetInEndSection":513,"text":"BACKGROUND AND OBJECTIVES: The Levodopa in EArly Parkinson\u0027s Disease (LEAP) study enabled us to conduct post hoc analyses concerning the effects of levodopa in patients with early Parkinson disease.METHODS: The LEAP study was a double-blind, placebo-controlled, randomized, delayed-start trial in which patients with early Parkinson disease were randomized to receive levodopa/carbidopa 300/75 mg daily for 80 weeks (early-start group) or to placebo for 40 weeks followed by levodopa/carbidopa 300/75 mg daily for","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":406,"document":"23978853","golden":false,"offsetInEndSection":629,"text":"In this evidence-based review, emphasis is put on the clinical efficacy of dopamine agonists in early and advanced Parkinsons disease, and where possible comparative evidence regarding their efficacy and safety is provided.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1384,"document":"36253105","golden":false,"offsetInEndSection":1696,"text":"ively, -0.32, -0.19, and -0.27 (small effect). At 80 weeks, fewer patients in the early-start group (46 of 205 patients, 23%) experienced motor response fluctuations than patients in the delayed-start group (81 of 211, 38%; p \u003c 0.01).DISCUSSION: In patients with early Parkinson disease, levodopa improves bradyk","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":305,"document":"11785037","golden":false,"offsetInEndSection":547,"text":"Recent studies indicate that the use of dopamine agonists in monotherapy from the early stages of the disease can be as effective as levodopa for clinical improvement with the added advantage of a significant less presentation of diskinesias.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":454,"document":"18788836","golden":false,"offsetInEndSection":847,"text":"The introduction of dopamine agonists early in the treatment of Parkinson\u0027s disease leads to a delay of these motor complications, but the treatment is associated with higher costs.In this review we evaluate available cost-effectiveness analyses of the dopamine agonists pramipexole, pergolide, bromocriptine, ropinirole, cabergoline and levodopa in the treatment of early Parkinson\u0027s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1468,"document":"35953517","golden":false,"offsetInEndSection":1583,"text":"In conclusion, we argue that targeting RNS may be of therapeutic benefit for people in early clinical stages of PD.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36253105","golden":false,"offsetInEndSection":99,"text":"Levodopa Response in Patients With Early Parkinson Disease: Further Observations of the LEAP Study.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":929,"document":"36253105","golden":false,"offsetInEndSection":1383,"text":"age at baseline 65.5 ? 8.8 years; 69% male). The difference between the early- and delayed-start groups in mean change from baseline to week 4, expressed as Hedges g effect size, was -0.33 for bradykinesia, -0.29 for rigidity, and -0.25 for tremor (for all symptoms indicating a small effect in favor of the early-start group); from baseline to week 22, respectively, -0.49, -0.36, and -0.44 (small to medium effect); and from baseline to week 40, respec","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":700,"document":"28622283","golden":false,"offsetInEndSection":891,"text":"We concluded cannabinoids probably do not decrease symptoms in Parkinson?s disease or dyskinesia, and probably are associated to frequent adverse effects in patients with Parkinson?s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1124,"document":"23380027","golden":false,"offsetInEndSection":1460,"text":"tified in rare familial forms of PD encode proteins whose functions overlap widely with the known molecular pathways in sporadic disease and these have again expanded our knowledge of the neurodegenerative process but again have so far failed to yield effective models of sporadic disease when translated into animals. We seem to be mis","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":820,"document":"26563663","golden":false,"offsetInEndSection":1135,"text":"riggering factor causing the misfolding and aggregation of the target protein is unknown, Parkinson\u0027s disease is a highly relevant model for the study of these mechanisms and also to test specific treatments targeting the assemblies of ?-synuclein and propagation from pre-motor phase of the disease. Despite this p","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23380027","golden":false,"offsetInEndSection":161,"text":"Parkinson disease (PD) is a complex neurodegenerative disorder with both motor and nonmotor symptoms owing to a spreading process of neuronal loss in the brain. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"10837922","golden":false,"offsetInEndSection":276,"text":"The present study examines N-myc and c-myc protein expression with Western blotting and single and double-labeling immunohistochemistry in the hippocampus in Alzheimer disease (AD), the striatum in Huntington disease (HD) and the substantia nigra in Parkinson disease (PD). No","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"16028004","golden":false,"offsetInEndSection":222,"text":"PURPOSE: To describe the disease status of degenerative diseases (i.e., type 2 diabetes mellitus, Parkinson\u0027s disease) as function of disease process and treatment effects, a family of disease progression models is introdu","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34561166","golden":false,"offsetInEndSection":130,"text":"OBJECTIVE: Disease modification in Parkinson disease (PD) has remained an elusive goal, in spite of large investments over several","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1059,"document":"34561166","golden":false,"offsetInEndSection":1226,"text":"olders.CONCLUSIONS: We identify potential barriers to progress in disease modification for Parkinson\u0027s and propose a set of research priorities that may improve the li","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1172,"document":"16028004","golden":false,"offsetInEndSection":1441,"text":"t point.CONCLUSION: Disease system analysis constitutes a scientific basis for the distinction between symptomatic versus protective drug effects in relation to specific disease processes as well as the identification of the exposure-response relationship during the ti","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"7565821","golden":false,"offsetInEndSection":96,"text":"Hypokinesia in Parkinson\u0027s disease: influence of age, disease severity, and disease duration.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":421,"document":"22383696","golden":false,"offsetInEndSection":760,"text":"kers of cardiomyopathy, such as left ventricular hypertrophy and dysfunction, and early markers of atherosclerosis, such as increased carotid artery intima-media thickness, carotid arterial wall stiffness, and coronary artery calcification, are frequently present in these children, especially those on maintenance dialysis. As a populatio","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1445,"document":"25957460","golden":false,"offsetInEndSection":1513,"text":"m these drugs, no antiviral has been shown to be effective. Preventi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":359,"document":"32041232","golden":false,"offsetInEndSection":469,"text":"Despite much effort, no clinically approved antiviral treatment is available for children suffering from HFMD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1229,"document":"31882748","golden":false,"offsetInEndSection":1413,"text":"While amodiaquine on its own failed to demonstrate efficacy, we cannot exclude potential therapeutic value of amodiaquine when used in combination with artesunate or another antiviral.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1186,"document":"24051429","golden":false,"offsetInEndSection":1294,"text":"However, HCMV alone was not effective in eliciting strong T cell immune responses when used in a mouse host.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":171,"document":"4597726","golden":false,"offsetInEndSection":302,"text":"Isoprinosine, which had demonstrable antiviral activity in animal models, did not appear to protect humans from clinical influenza.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":509,"document":"15031783","golden":false,"offsetInEndSection":624,"text":"00 IU/mL. In conclusion, ribavirin alone is unlikely to be beneficial in the prophylaxis or treatment of SARS CoV i","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":67,"document":"18279075","golden":false,"offsetInEndSection":145,"text":"However, there is no effective antiviral drug available for infected patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":757,"document":"17928345","golden":false,"offsetInEndSection":960,"text":"Despite its favorable activity in cell culture, mitoxantrone administered intraperitoneally at the maximum tolerated dose failed to protect mice against a lethal intranasal infection with vaccinia virus.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":128,"document":"10775620","golden":false,"offsetInEndSection":284,"text":"a). However, systemic delivery of r-hIFN-alpha is associated with severe side effects, but more importantly, it is effective in only a small percentage of p","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1248,"document":"34724257","golden":false,"offsetInEndSection":1734,"text":"d significantly over 1 year (P?\u003d?0.025). Movement Disorder Society Unified Parkinson\u0027s Disease Rating Scale testing of motor function, Part III increased significantly over 1 year (P?\u003d?0.009), and baseline free-water in the pSN correlated with the 1-year change in Movement Disorder Society Unified Parkinson\u0027s Disease Rating Scale testing of motor function, Part III (P?\u003d?0.004) and 1-year change in bradykinesia score (P?\u003d?0.044).CONCLUSIONS: We found no evidence that 1?mg/day rasagi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":105,"document":"34724257","golden":false,"offsetInEndSection":282,"text":"sease (PD). Whether rasagiline is disease modifying remains in question.OBJECTIVE: The main objective of this study was to determine whether rasagiline has disease-modifying eff","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34724257","golden":false,"offsetInEndSection":104,"text":"BACKGROUND: Rasagiline has received attention as a potential disease-modifying therapy for Parkinson\u0027s d","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1058,"document":"34724257","golden":false,"offsetInEndSection":1146,"text":"hort TR: P?\u003d?0.346; long TR: P?\u003d?0.228). No significant differences were found in any se","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"17045989","golden":false,"offsetInEndSection":113,"text":"Rotigotine treatment partially protects from MPTP toxicity in a progressive macaque model of Parkinson\u0027s disease.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":2027,"document":"25668262","golden":false,"offsetInEndSection":2343,"text":"tine was 2414 (95% CI, 2304-2524). The global statistical test yielded t1865.8?\u003d?-0.75 (2-sided P?\u003d?.45). There were no detectable differences (P?\u003c?.01 to partially adjust for multiple comparisons) in adverse and serious adverse events by body system.CONCLUSIONS AND RELEVANCE: Among patients with early and treated ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":283,"document":"34724257","golden":false,"offsetInEndSection":589,"text":"cts in PD over 1 year. Secondarily we evaluated two diffusion magnetic resonance imaging pulse sequences to determine the best sequence to measure disease progression.METHODS: This prospective, randomized, double-blind, placebo-controlled trial assessed the effects of rasagiline administered at 1?mg/day o","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34724257","golden":false,"offsetInEndSection":122,"text":"Diffusion Magnetic Resonance Imaging Detects Progression in Parkinson\u0027s Disease: A Placebo-Controlled Trial of Rasagiline.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":631,"document":"32201505","golden":false,"offsetInEndSection":914,"text":"06649751?\u003d?25; placebo?\u003d?22). Despite early termination, the study met its primary endpoint with the PF-06649751 group showing statistically significant improvement from baseline in the Movement Disorder Society-Unified Parkinson\u0027s Disease Rating Scale (MDS-UPDRS) Part?III score at ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17045989","golden":false,"offsetInEndSection":227,"text":"Clinical DA agonist monotherapy trials, which used in vivo imaging of the DA transporter (DAT) to assess the rate of progression of nigrostriatal degeneration, have failed to demonstrate consistent evidence for neuroprotection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":276,"document":"21551108","golden":false,"offsetInEndSection":529,"text":"evodopa remains the most effective and best tolerated Parkinson\u0027s drug to date, and should have an important role in all therapeutic strategies, both as monotherapy in early Parkinson\u0027s disease and as part of combination therapy in advanced disease. Reg","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":120,"document":"19412491","golden":false,"offsetInEndSection":352,"text":"te, it is approved for the treatment of early Parkinson\u0027s disease as monotherapy and has been shown to be effective in the treatment of advanced-stage Parkinson\u0027s disease and restless legs syndrome in several clinical trials. This r","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1017,"document":"9270567","golden":false,"offsetInEndSection":1137,"text":"ective and well-tolerated therapeutic option for treatment of early Parkinson\u0027s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":268,"document":"19810883","golden":false,"offsetInEndSection":425,"text":"pamine agonists are effective as monotherapy in early Parkinson\u0027s disease and as an adjunctive treatment to levodopa in the advanced stages of the disease. D","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1131,"document":"24490799","golden":false,"offsetInEndSection":1327,"text":"ished articles.EXPERT OPINION: RPR is effective in the treatment of patients with early Parkinson\u0027s disease; in advanced Parkinsonian patients, the amount of daily off-time significantly decreases","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"12470183","golden":false,"offsetInEndSection":82,"text":"CONTEXT: Monotherapy with rasagiline mesylate may be useful in early Parkinson dis","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":286,"document":"2276120","golden":false,"offsetInEndSection":490,"text":"was seen in 94% of idiopathic Parkinson\u0027s disease cases as well as in all cases in which the pathology was characterized by neuronal loss in the substantia nigra without Lewy body inclusions. Improvement ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":103,"document":"32171387","golden":false,"offsetInEndSection":214,"text":"ly initiation of dopaminergic therapies does not convey disease-modifying effects but does reduce disability. C","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":637,"document":"17009915","golden":false,"offsetInEndSection":774,"text":"and clinical trials have shown rotigotine to be a well-tolerated and effective treatment for early-stage Parkinson\u0027s disease. Rotigotine ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1052,"document":"26295349","golden":false,"offsetInEndSection":1231,"text":"hinese family. We found that the patient exhibited progressive deteriorated parkinsonism with Parkinson disease-like neuropathology and also had a good response to the initial lev","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":437,"document":"8629572","golden":false,"offsetInEndSection":616,"text":"Other therapies in the early stages of Parkinson\u0027s disease may include neuroprotective agents, dopamine agonists, dopamine reuptake inhibitors, anticholinergics and/or amantadine.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":969,"document":"10830413","golden":false,"offsetInEndSection":1149,"text":"We conclude that a wash-out of at least 2 weeks is required to eliminate the symptomatic effects of levodopa/carbidopa and bromocriptine in patients with early Parkinson\u0027s disease.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"8629572","golden":false,"offsetInEndSection":48,"text":"Treatment options for early Parkinson\u0027s disease.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":310,"document":"8629572","golden":false,"offsetInEndSection":436,"text":"Parkinson\u0027s disease is treated with a number of medications, but levodopa, a dopamine precursor, is considered most effective.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":730,"document":"10830413","golden":false,"offsetInEndSection":968,"text":"Mean total Unified Parkinson\u0027s Disease Rating Scale scores (+/- standard error) increased (worsened) by 7.4+/-1.5 from day 1 to day 15 (p \u003c0.0001), 4.5+/-1.2 from day 1 to day 8 (p \u003d 0.0009), and 2.9+/-1.0 from day 8 to day 15 (p \u003d 0.01).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":181,"document":"8629572","golden":false,"offsetInEndSection":309,"text":"Parkinson\u0027s disease tremor occurs at rest, involves the jaw and limbs and is associated with bradykinesia, rigidity and falling.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"27592010","golden":false,"offsetInEndSection":70,"text":"Early Onset Parkinson\u0027s disease due to DJ1 mutations: An Indian study.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"8629572","golden":false,"offsetInEndSection":80,"text":"Proper treatment of tremor in any clinical setting depends on correct diagnosis.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"10830413","golden":false,"offsetInEndSection":131,"text":"Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson\u0027 s disease.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":167,"document":"17962848","golden":false,"offsetInEndSection":399,"text":"Blood morphine levels should be studied in patients suffering from Parkinson\u0027s disease before treatment as well as in depressive patients (being the group most affected by Parkinson s disease) to achieve early preclinical diagnosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":106,"document":"26646536","golden":false,"offsetInEndSection":367,"text":"on\u0027s disease. These drugs have rapidly gained popularity as a monotherapy in the early stages of Parkinson\u0027s disease for patients less than 65-70?years old since they are about as effective as levodopa but patients demonstrate a lower tendency to develop motor ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":921,"document":"34245502","golden":false,"offsetInEndSection":1097,"text":"It was concluded, that the tenuigenin deserves further study and possibly will be used as augmentation of Alzheimer`s, Parkinson`s and other neurodegenerative diseases therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":301,"document":"34245502","golden":false,"offsetInEndSection":732,"text":"It was noted, that the capacities of the tenuigenin to decrease the secretion of beta amyloid and to protect of neurons from damage by already made beta ameloids, to inhibit the processes of the tau proteins` hyperphosphorylation and inflammations in microglia, as well as increase the main synaptic transmission can be used by the development of effective therapeutic drugs aimed to reduce the pathogenesis of Alzheimer`s disease.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34245502","golden":false,"offsetInEndSection":149,"text":"[Neurobiological effects of tenuigenin and the opportunity of it\u0027s using in the therapy of Alzheimer\u0027s and Parkinson\u0027s diseases (literature review).]","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":733,"document":"34245502","golden":false,"offsetInEndSection":920,"text":"The effects of dopaminergic neurons and mitochondrial membrane potential protection as well as reduction of ?-synuclein phosphorylation can influence the processes by Parkinson`s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":186,"document":"34245502","golden":false,"offsetInEndSection":211,"text":"in this review was given.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":903,"document":"19129703","golden":false,"offsetInEndSection":1133,"text":"No differences were found between the 2 groups with regard to symptoms at PD onset, disease duration, Hoehn-Yahr stage, hallucination, dementia, wearing-off, orthostatic hypotension, cerebral blood flow and antiparkinsonism drugs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34245502","golden":false,"offsetInEndSection":185,"text":"The analysis of experimental and partially clinical data about researches of neurobiological effects of tenuigenin - the most important bioactive substance of Polygala tenuifolia Willd.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":277,"document":"36182642","golden":false,"offsetInEndSection":481,"text":"the advent of metagenomic sequencing and metabolomic analysis, a plethora of evidence has revealed different gut microbiomes and gut metabolites in patients with PD compared with unaffected controls. Curr","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":976,"document":"22703631","golden":false,"offsetInEndSection":1256,"text":"naemia. Evidence consistently suggests that a lower risk of PD is associated with hyperuricaemia, tobacco and coffee use, while a lower risk of AD is associated with moderate alcohol consumption, physical exercise, perimenopausal hormone replacement therapy and good cognitive res","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":475,"document":"33693397","golden":false,"offsetInEndSection":696,"text":". Patients with high pre-disease cognitive capabilities tend to score better on cognitive tests that are sensitive early in disease relative to patients with low pre-disease cognitive capabilities at a similar disease sta","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17117171","golden":false,"offsetInEndSection":318,"text":"The term neurodegenerative disease refers to the principal pathology associated with disorders such as amyotrophic lateral sclerosis, Alzheimer\u0027s disease, Huntington\u0027s disease and Parkinson\u0027s disease, and it is presumed that neurodegeneration results in the clinical findings seen in patients with these diseases. Deca","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":446,"document":"20073162","golden":false,"offsetInEndSection":667,"text":"ers of CVD such as microalbuminuria and uric acid levels need to be added to the routine annual evaluation, particularly among high-risk individuals such as diabetics, hypertensives, smokers, and the elderly. Likewise, th","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"15157851","golden":false,"offsetInEndSection":209,"text":"Several separate gene mutations have now been identified in familial Parkinson\u0027s disease and important environmental influences modulating risk for the idiopathic form of the disease have also been recognised.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":181,"document":"19724249","golden":false,"offsetInEndSection":336,"text":" this article, we illustrate this two-pronged approach for two common age-related disorders: Parkinson disease (PD) and cerebrovascular disease (CVD). We f","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":341,"document":"16198279","golden":false,"offsetInEndSection":661,"text":"rkers of cardiomyopathy, such as left ventricular hypertrophy (LVH) and left ventricular dysfunction (LV dysfunction), and early markers of atherosclerosis, such as increased carotid artery intima-media thickness (IMT) and carotid arterial wall stiffness, are frequently found in this patient population. Early identific","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":623,"document":"2553232","golden":false,"offsetInEndSection":804,"text":"s disease and ALS; they are all characterized by the deposition of cytoskeletal debris in tissue, so they may perhaps be collectively termed the \"Cytoskeletal Disorders\".","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":136,"document":"23963470","golden":false,"offsetInEndSection":418,"text":"tless legs syndrome, or Willis-Ekbom Disease (RLS/WED), is a common sensorimotor disorder with a circadian rhythmicity defined by an uncontrollable urge to move the legs that worsens during periods of inactivity or at rest in the evening, often resulting in sleep disruptions. Sleep","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1246,"document":"28370340","golden":false,"offsetInEndSection":1536,"text":"0.3/0.75?mg group (P?\u003d?.003). Significant benefits were also observed for both doses in the responder analysis (P?\u003d?.0002 and P?\u003d?.0001), Parkinson Disease Quality of Life Scale-39 scores (P?\u003d?.05 and P?\u003d?.01), and the UPDRS motor (P?\u003d?.02 and P?\u003d?.006) and activities of daily living (P?\u003d?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1537,"document":"28370340","golden":false,"offsetInEndSection":1809,"text":"005 and P?\u003d?.0004) subscores. Adverse events of P2B001 were comparable to placebo apart from transient nausea and somnolence, which were more common with P2B001 treatment.CONCLUSIONS: P2B001 offers a promising treatment option for patients with early PD with good clinical","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":136,"document":"28370340","golden":false,"offsetInEndSection":638,"text":"mechanisms. We performed a placebo-controlled study to determine whether 2 doses of a novel slow-release, low-dose combination of rasagiline and pramipexole (P2B001) are effective and have a good safety profile in patients with early untreated PD.METHODS: Previously untreated patients with early PD were randomized (1:1:1) to once-daily treatment with P2B001 (0.3?mg pramipexole/0.75?mg rasagiline), P2B001 (0.6?mg pramipexole/0.75?mg rasagiline) or placebo in a 12-week multicenter double-blind, plac","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"28370340","golden":false,"offsetInEndSection":110,"text":"A randomized trial of a low-dose Rasagiline and Pramipexole combination (P2B001) in early Parkinson\u0027s disease.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":322,"document":"22382608","golden":false,"offsetInEndSection":617,"text":"rkinsonism. Ioflupane, N-u-fluoropropyl-2a-carbomethoxy-3a-(4-iodophenyl) nortropane, also called FP-CIT, labelled with (123)I (commercially known as DaTSCAN) has been proven to be useful in the differential diagnosis between PD and ET and to confirm dopaminergic degeneration in patients with p","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28370340","golden":false,"offsetInEndSection":135,"text":"BACKGROUND: Rasagiline and pramipexole act to improve striatal dopaminergic transmission in PD via distinct and potentially synergistic","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":329,"document":"33321002","golden":false,"offsetInEndSection":685,"text":"osis in iRBD. Our primary objective was to identify a quantitative measure of DAT imaging that predicts diagnosis of clinically-defined aSN in iRBD.METHODS: The sample included individuals with iRBD, early Parkinson\u0027s Disease (PD), and healthy controls (HC) enrolled in the Parkinson Progression Marker Initiative, a longitudinal, observational, internatio","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1029,"document":"28370340","golden":false,"offsetInEndSection":1245,"text":" (91.3%) completed the study. Adjusted mean change from baseline to final visit versus placebo in Total-UPDRS score was -4.67???1.28 points for the P2B001 0.6/0.75?mg group (P?\u003d?.0004) and -3.84???1.25 points for the","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":433,"document":"34910248","golden":false,"offsetInEndSection":640,"text":"Finally the clinical research using DAT-SPECT as a biomarker for the progression of PD, for the detection of a preclinical dopaminergic lesion and its correlation with neuropathological findings is outlined.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":741,"document":"28370340","golden":false,"offsetInEndSection":1028,"text":"core versus placebo. Secondary measures included responder analyses of patients achieving ?4 UPDRS point reduction, and changes in Parkinson Disease Quality of Life Scale-39 and UPDRS activities of daily living and motor scores.RESULTS: A total of 149 participants were randomized and 13","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":773,"document":"23250679","golden":false,"offsetInEndSection":1095,"text":" new evidences have shown that the earlier introduction of rasagiline is associated with a delay in introducing other dopaminergic drugs, thus indicating that the symptomatic benefit of rasagiline on daily motor function is not only present in the early Parkinson\u0027s disease stages, but is maintained over time.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21542016","golden":false,"offsetInEndSection":163,"text":"This report presents the results of 2 randomized trials-Rembrandt and Vermeer-on the efficacy and safety of pardoprunox in patients with early Parkinson\u0027s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"9452324","golden":false,"offsetInEndSection":248,"text":"The efficacies of ropinirole and levodopa were compared after 6 months of treatment in a planned interim analysis of a 5-year, double-blind, randomized, multicenter study of patients with early Parkinson\u0027s disease requiring dopaminergic therapy. Th","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":755,"document":"22298943","golden":false,"offsetInEndSection":927,"text":"ial affinity for the D(3) receptor subtype could contribute to its efficacy in the treatment of both the motor and psychiatric symptoms of Parkinson\u0027s disease. The best app","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":115,"document":"1362394","golden":false,"offsetInEndSection":349,"text":"find out whether early treatment of PD with levodopa, dopaminoagonists or l-deprenyl is associated with any difference in motor fluctuations occurrence, the Italian Parkinson Study Group initiated a multicenter, randomized study. Sinc","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"9452324","golden":false,"offsetInEndSection":122,"text":"Ropinirole in the treatment of early Parkinson\u0027s disease: a 6-month interim report of a 5-year levodopa-controlled study. ","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1050,"document":"27593744","golden":false,"offsetInEndSection":1221,"text":" 10%.CONCLUSION: Unilateral STN stimulation is a safe and effective procedure for selected patients with marked asymmetry Parkinson\"s disease motor symptoms and early moto","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"1362394","golden":false,"offsetInEndSection":135,"text":"A multicenter Italian randomised study on early treatment of Parkinson disease: comparison of L-dopa, l-deprenyl and dopaminoagonists. ","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"19811035","golden":false,"offsetInEndSection":167,"text":"Clinicians now have an extensive and effective pharmacopeia to treat the symptoms of Parkinson\u0027s disease - especially in the early and moderate stages of the disorder.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"14676046","golden":false,"offsetInEndSection":81,"text":"BACKGROUND: Oral dopamine agonists are effective for treating early Parkinson\u0027s d","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":154,"document":"38315945","golden":false,"offsetInEndSection":415,"text":"In this study, we evaluate the biomarkers of early PD diagnosis, disease progression, and treatment effect collected in the SPARK.METHODS: Cinpanemab is a human-derived monoclonal antibody binding preferentially to aggregated forms of extracellular ?-synuclein.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2113,"document":"38315945","golden":true,"offsetInEndSection":2544,"text":"Broadly, there was minimal annual change with high interindividual variability across biomarkers-with striatal binding ratios of the ipsilateral putamen showing the greatest mean change/SD over time.DISCUSSION: Biomarker results indicated enrollment of the intended population with early PD, but there was no significant correlation with disease progression or clear evidence of a cinpanemab treatment effect on biomarker measures.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2223,"document":"35921450","golden":true,"offsetInEndSection":2535,"text":"The most common adverse events with cinpanemab were headache, nasopharyngitis, and falls.CONCLUSIONS: In participants with early Parkinson\u0027s disease, the effects of cinpanemab on clinical measures of disease progression and changes in DaT-SPECT imaging did not differ from those of placebo over a 52-week period.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1739,"document":"38315945","golden":false,"offsetInEndSection":1878,"text":"Clinical disease progression was observed, with no statistically significant difference in cinpanemab groups compared with that in placebo.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1366,"document":"38315945","golden":false,"offsetInEndSection":1592,"text":"SPARK was conducted from January 2018 to April 2021 and terminated due to lack of efficacy.RESULTS: Approximately 3.8% (15/398) of SPECT-imaged participants did not have evidence of dopaminergic deficit and were screen-failed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":595,"document":"39666171","golden":false,"offsetInEndSection":863,"text":"Specifically, UB-312, AFFITOPE PD01A, PD03A and ACI-7104.056 are designed to provoke an immune response against ?-syn (active immunisation), while Prasinezumab and Cinpanemab, MEDI1341 and Lu AF82422 focus on directly targeting ?-syn aggregates (passive immunisation).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1113,"document":"39313800","golden":false,"offsetInEndSection":1286,"text":"Similarly, in Parkinson\u0027s disease (PD), DMTs utilizing anti-?Syn (MAbs) (e.g., prasinezumab, cinpanemab,) are progressively being developed and evaluated in clinical trials.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":459,"document":"34814867","golden":false,"offsetInEndSection":789,"text":"However, the utility of DaT-SPECT in enhancing early PD participant selection in a global, multicenter clinical trial of a potentially disease-modifying therapy is not well understood.METHODS: The SPARK clinical trial was a phase 2 trial of cinpanemab, a monoclonal antibody against alpha-synuclein, in participants with early PD.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38315945","golden":false,"offsetInEndSection":109,"text":"Cinpanemab in Early Parkinson Disease: Evaluation of Biomarker Results From the Phase 2 SPARK Clinical Trial.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1984,"document":"38315945","golden":false,"offsetInEndSection":2112,"text":"No statistically significant changes from baseline were observed between treatment groups and placebo across biomarker measures.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39666171","golden":false,"offsetInEndSection":187,"text":"Parkinson\u0027s disease (PD) is a prevalent, chronic neurodegenerative disorder characterised by the progressive loss of dopaminergic neurons in the substantia nigra and other brain regions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38622249","golden":false,"offsetInEndSection":170,"text":"Prasinezumab, a monoclonal antibody that binds aggregated ?-synuclein, is being investigated as a potential disease-modifying therapy in early-stage Parkinson\u0027s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38315945","golden":false,"offsetInEndSection":127,"text":"BACKGROUND AND OBJECTIVES: Sensitive, reliable, and scalable biomarkers are needed to accelerate the development of therapies f","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"26600626","golden":false,"offsetInEndSection":935,"text":"INTRODUCTION: Mutations in the leucine-rich repeat kinase 2 gene (LRRK2 or Dardarin) are considered to be a common cause of autosomal dominant and sporadic Parkinson?s disease, but the prevalence of these mutations varies among populations.OBJECTIVE: to analyzed the frequency of the LRRK2 p.G2019S mutation (c.6055 G\u003eA transition) in a sample of Colombian patients.METHODS: In the present study we have analyzed the frequency of the LRRK2 p.G2019S mutation in 154 patients with familial or sporadic Parkinson Disease, including early and late onset patients, and 162 normal controls.RESULTS: Our results show occurrence of this mutation in two cases (2/154, 1.3%) with classical Parkinson?s signs, and one completely asymptomatic control (1/162, 0.6%).CONCLUSION: The p.G2019S mutation is not an important causal factor of Parkinson Disease in Colombia having similar frequencies to those reported in other Latin American populations.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38315945","golden":false,"offsetInEndSection":153,"text":"BACKGROUND AND OBJECTIVES: Sensitive, reliable, and scalable biomarkers are needed to accelerate the development of therapies for Parkinson disease (PD).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35921450","golden":false,"offsetInEndSection":800,"text":"BACKGROUND: Aggregated ?-synuclein plays an important role in Parkinson\u0027s disease pathogenesis. Cinpanemab, a human-derived monoclonal antibody that binds to ?-synuclein, is being evaluated as a disease-modifying treatment for Parkinson\u0027s disease.METHODS: In a 52-week, multicenter, double-blind, phase 2 trial, we randomly assigned, in a 2:1:2:2 ratio, participants with early Parkinson\u0027s disease to receive intravenous infusions of placebo (control) or cinpanemab at a dose of 250 mg, 1250 mg, or 3500 mg every 4 weeks, followed by an active-treatment dose-blinded extension period for up to 112 weeks. The primary end points were the changes from baseline in the Movement Disorder Society-sponsored revision of the Unified Parkinson\u0027s Disease Rating Scale (MDS-UPDRS) total score (range, 0 to 236,","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38315945","golden":false,"offsetInEndSection":600,"text":"BACKGROUND AND OBJECTIVES: Sensitive, reliable, and scalable biomarkers are needed to accelerate the development of therapies for Parkinson disease (PD). In this study, we evaluate the biomarkers of early PD diagnosis, disease progression, and treatment effect collected in the SPARK.METHODS: Cinpanemab is a human-derived monoclonal antibody binding preferentially to aggregated forms of extracellular ?-synuclein. SPARK was a randomized, double-blind, placebo-controlled, phase 2 multicenter trial evaluating 3 cinpanemab doses administered intravenously every 4 weeks for 52 weeks with an active t","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":300,"document":"38936981","golden":false,"offsetInEndSection":800,"text":"ereas published studies from some immunotherapy trials have demonstrated engagement in plasma, none have shown direct drug-antigen interactions in the disease-relevant compartment, the central nervous system (CNS). Cinpanemab (BIIB054) selectively targets pathological aggregated ?-syn with low affinity binding to monomeric forms. The avidity-driven binding, low drug concentration, and the very low ?-syn levels plus its heterogeneous nature in cerebrospinal fluid (CSF) made it not possible to mea","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":84,"document":"35921450","golden":false,"offsetInEndSection":235,"text":"thogenesis. Cinpanemab, a human-derived monoclonal antibody that binds to ?-synuclein, is being evaluated as a disease-modifying treatment for Parkinso","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"22651796","golden":false,"offsetInEndSection":154,"text":"BACKGROUND: The search for biomarkers in Parkinson\u0027s disease (PD) is crucial to identify the disease early and monitor the effectiveness of neuroprotectiv","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":515,"document":"38936981","golden":false,"offsetInEndSection":631,"text":"Cinpanemab (BIIB054) selectively targets pathological aggregated ?-syn with low affinity binding to monomeric forms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35005605","golden":false,"offsetInEndSection":127,"text":"INTRODUCTION: Parkinson\u0027s disease (PD) patients usually start treatment with apomorphine infusion (APO) in later stages of adva","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37721280","golden":false,"offsetInEndSection":321,"text":"The positive effect of levodopa in the treatment of Parkinson\u0027s disease, although it is limited in time and has severe side effects, has encouraged the scientific community to look for new drugs that can stop the neurodegenerative process or even regenerate the neuromelanin-containing dopaminergic nigrostriatal neurons.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38315945","golden":false,"offsetInEndSection":126,"text":"BACKGROUND AND OBJECTIVES: Sensitive, reliable, and scalable biomarkers are needed to accelerate the development of therapies ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1818,"document":"23180276","golden":false,"offsetInEndSection":2117,"text":"It is clear that the disease process in Parkinson\u0027s disease, as in other neurodegenerative disorders, is very complicated; there can be several different molecular pathways which are responsible for diverse and possibly also unrelated functions inside the neuron, playing roles in PD pathogenesis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"11562835","golden":false,"offsetInEndSection":146,"text":"INTRODUCTION: Parkinson s disease (PD) is caused by an abnormal degeneration of the dopamine producing cells in the substantia nigra and ventral t","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"18591143","golden":false,"offsetInEndSection":95,"text":"Parkinson\u0027s disease (PD) is an age-related, inexorably progressive, neurodegenerative disorder.","beginSection":"abstract"}],"exact_answer":"no","ideal_answer":[],"id":"63adca9ec6c7d4d31b00001d","type":"yesno","body":"Is Cinpanemab effective for Early Parkinson?s Disease?"},{"documents":[{"golden":false,"id":"15451490"},{"golden":false,"id":"23205841"},{"golden":false,"id":"36427274"},{"golden":false,"id":"10530582"},{"golden":false,"id":"16622651"},{"golden":false,"id":"30280095"},{"golden":true,"id":"30319615"},{"golden":false,"id":"7082191"},{"golden":false,"id":"24857169"},{"golden":false,"id":"30575697"},{"golden":false,"id":"33214628"},{"golden":false,"id":"11181198"},{"golden":false,"id":"27468879"},{"golden":false,"id":"37173760"},{"golden":true,"id":"30169202"},{"golden":false,"id":"16492989"},{"golden":false,"id":"35475418"},{"golden":false,"id":"3954416"},{"golden":false,"id":"24841497"},{"golden":false,"id":"30192397"},{"golden":false,"id":"30868774"},{"golden":false,"id":"30836976"},{"golden":false,"id":"31694565"},{"golden":false,"id":"34912024"},{"golden":false,"id":"16537670"},{"golden":false,"id":"36449079"},{"golden":false,"id":"17515672"},{"golden":false,"id":"33830803"},{"golden":false,"id":"34446092"},{"golden":false,"id":"32753048"},{"golden":false,"id":"32333286"},{"golden":false,"id":"36090526"},{"golden":false,"id":"34590796"},{"golden":false,"id":"32201899"},{"golden":false,"id":"31983492"},{"golden":false,"id":"35630492"},{"golden":true,"id":"33962589"},{"golden":false,"id":"34858905"},{"golden":false,"id":"34627055"},{"golden":false,"id":"35699701"},{"golden":false,"id":"15675497"},{"golden":false,"id":"34939034"},{"golden":false,"id":"32998967"},{"golden":false,"id":"36801697"},{"golden":false,"id":"33045237"},{"golden":false,"id":"38102316"},{"golden":false,"id":"37371198"},{"golden":false,"id":"38254697"},{"golden":false,"id":"23997450"},{"golden":false,"id":"10164058"},{"golden":false,"id":"17331270"},{"golden":false,"id":"36943823"},{"golden":false,"id":"36142813"},{"golden":false,"id":"2561089"},{"golden":false,"id":"37605134"},{"golden":false,"id":"35192447"},{"golden":false,"id":"22068147"},{"golden":false,"id":"38276162"},{"golden":false,"id":"2549231"},{"golden":false,"id":"31094887"},{"golden":false,"id":"38071208"},{"golden":false,"id":"32898875"},{"golden":false,"id":"35327510"},{"golden":false,"id":"37439553"},{"golden":false,"id":"37562521"},{"golden":false,"id":"36337758"},{"golden":false,"id":"30086729"},{"golden":false,"id":"37063937"},{"golden":false,"id":"36629234"},{"golden":false,"id":"35839362"},{"golden":false,"id":"38050541"},{"golden":false,"id":"7667058"},{"golden":false,"id":"31303335"},{"golden":false,"id":"36362702"},{"golden":false,"id":"9386664"},{"golden":false,"id":"20009784"},{"golden":false,"id":"15857567"},{"golden":false,"id":"37501504"},{"golden":false,"id":"36670711"},{"golden":false,"id":"37810514"},{"golden":false,"id":"36529894"},{"golden":false,"id":"36472648"},{"golden":false,"id":"35196995"},{"golden":true,"id":"34827296"},{"golden":false,"id":"36982221"},{"golden":false,"id":"32253866"},{"golden":false,"id":"25652198"},{"golden":false,"id":"28794881"},{"golden":false,"id":"22440053"},{"golden":false,"id":"26989885"},{"golden":false,"id":"15788823"},{"golden":false,"id":"16544299"},{"golden":false,"id":"35582414"},{"golden":false,"id":"12656537"},{"golden":false,"id":"18534225"},{"golden":false,"id":"22561321"},{"golden":false,"id":"37890901"},{"golden":false,"id":"37872349"},{"golden":false,"id":"37509478"},{"golden":false,"id":"37154081"},{"golden":false,"id":"35459180"},{"golden":false,"id":"35137684"},{"golden":false,"id":"34888744"},{"golden":false,"id":"38357132"},{"golden":false,"id":"38356035"},{"golden":false,"id":"38355207"},{"golden":false,"id":"38354362"},{"golden":false,"id":"38353591"},{"golden":false,"id":"38353586"},{"golden":false,"id":"38353160"},{"golden":false,"id":"38352942"},{"golden":false,"id":"38348451"},{"golden":false,"id":"29376570"},{"golden":false,"id":"2510121"},{"golden":false,"id":"25621006"},{"golden":false,"id":"16414864"},{"golden":false,"id":"15069401"},{"golden":false,"id":"8156232"},{"golden":false,"id":"36375105"},{"golden":false,"id":"27833059"},{"golden":false,"id":"21355513"},{"golden":false,"id":"9350892"},{"golden":false,"id":"31729791"},{"golden":false,"id":"24253109"},{"golden":false,"id":"17968200"},{"golden":false,"id":"31194750"},{"golden":false,"id":"24064563"},{"golden":false,"id":"38259971"},{"golden":false,"id":"37739226"},{"golden":false,"id":"37891594"},{"golden":false,"id":"32898878"},{"golden":false,"id":"34479076"},{"golden":false,"id":"37627950"},{"golden":false,"id":"12940634"},{"golden":false,"id":"34732550"},{"golden":false,"id":"36322631"},{"golden":false,"id":"32132525"},{"golden":false,"id":"30507610"},{"golden":false,"id":"1882827"},{"golden":false,"id":"34704033"},{"golden":false,"id":"38358334"},{"golden":false,"id":"38357933"},{"golden":false,"id":"38357644"},{"golden":false,"id":"38357643"},{"golden":false,"id":"38357545"},{"golden":false,"id":"38357510"},{"golden":false,"id":"38357174"},{"golden":false,"id":"38259485"},{"golden":false,"id":"38190645"},{"golden":false,"id":"38110534"},{"golden":false,"id":"37985552"},{"golden":false,"id":"37843118"},{"golden":false,"id":"37778538"},{"golden":false,"id":"35149567"},{"golden":false,"id":"35657183"},{"golden":false,"id":"38291524"},{"golden":false,"id":"36972964"},{"golden":false,"id":"37076330"},{"golden":false,"id":"34189083"},{"golden":true,"id":"32699026"},{"golden":false,"id":"35796793"},{"golden":false,"id":"33569493"},{"golden":false,"id":"38513681"},{"golden":false,"id":"39313063"},{"golden":false,"id":"19762956"},{"golden":true,"id":"39429081"},{"golden":false,"id":"39142742"},{"golden":false,"id":"27014507"},{"golden":false,"id":"25596126"},{"golden":false,"id":"12390408"},{"golden":false,"id":"15720891"},{"golden":false,"id":"38790589"},{"golden":false,"id":"9131715"},{"golden":false,"id":"21659882"},{"golden":false,"id":"25573462"},{"golden":false,"id":"3020718"},{"golden":false,"id":"1662355"},{"golden":false,"id":"3956962"},{"golden":false,"id":"38530103"},{"golden":false,"id":"39143644"},{"golden":false,"id":"38732074"},{"golden":false,"id":"15166819"},{"golden":false,"id":"31607572"},{"golden":false,"id":"25877546"},{"golden":true,"id":"1883188"},{"golden":false,"id":"27608345"},{"golden":false,"id":"32336983"},{"golden":false,"id":"33632088"},{"golden":false,"id":"1588581"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":0,"document":"30280095","golden":false,"offsetInEndSection":152,"text":"Sepsis in children is typically presumed to be bacterial in origin until proven otherwise, but frequently bacterial cultures ultimately return negative.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":153,"document":"30280095","golden":false,"offsetInEndSection":331,"text":"Although viruses may be important causative agents of culture-negative sepsis worldwide, the incidence, disease burden and mortality of viral-induced sepsis is poorly elucidated.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"30280095","golden":false,"offsetInEndSection":25,"text":"Viral Sepsis in Children.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":69,"document":"33632088","golden":false,"offsetInEndSection":127,"text":"Bacterial sepsis in dengue fever is not widely recognised.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":100,"document":"30319615","golden":true,"offsetInEndSection":221,"text":"Sepsis can be caused by a broad range of pathogens; however, bacterial infections represent the majority of sepsis cases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":332,"document":"30280095","golden":false,"offsetInEndSection":551,"text":"Consideration of viral sepsis is critical as its recognition carries implications on appropriate use of antibacterial agents, infection control measures, and, in some cases, specific, time-sensitive antiviral therapies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":552,"document":"30280095","golden":false,"offsetInEndSection":739,"text":"This review outlines our current understanding of viral sepsis in children and addresses its epidemiology and pathophysiology, including pathogen-host interaction during active infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":308,"document":"24857169","golden":false,"offsetInEndSection":414,"text":"Amongst 401 children, those with bacterial pneumonia were older than those with viral pneumonia (P\u003c0.001).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":740,"document":"30280095","golden":false,"offsetInEndSection":851,"text":"Clinical manifestation, diagnostic testing, and management options unique to viral infections will be outlined.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1009,"document":"19762956","golden":false,"offsetInEndSection":1305,"text":"nfection (83 pg/ml vs.52 pg/ml). The geometric mean TNF-alpha concentrations in patients with severe sepsis and those with late septic shock were 47 pg/ml (range 5-2720) and 59 pg/ml (range 5-3310) respectively.CONCLUSION: TNF-alpha was significantly raised in culture-positive cases in general a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1934,"document":"30868774","golden":false,"offsetInEndSection":2274,"text":" bacterial and fungal 3(17%). Remaining 3 (14%) patients death causes include, neutropenic colitis was observed in first patient, second patient died of infection without any identifiable focus, and third patient died due to chemotherapy related toxicity..CONCLUSIONS: Our study concludes that the fungal infection was the most common cause","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1741,"document":"30868774","golden":false,"offsetInEndSection":1933,"text":"organism in 5 (28%) patients. Death was observed in 21 (13%) patients and causes were sepsis due to infections in 18 (86%) out of which fungal infections were 11(61%), bacterial 4(22%), combin","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"33632088","golden":false,"offsetInEndSection":60,"text":"Bacterial sepsis in dengue fever - A paediatric perspective.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33830803","golden":false,"offsetInEndSection":103,"text":"Neonatal sepsis results from acute bacterial or viral infection occurring in the first 28 days of life.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35630492","golden":false,"offsetInEndSection":261,"text":"A considerable proportion of patients with severe COVID-19 meet Sepsis-3 criteria and share common pathophysiological mechanisms of multiorgan injury with bacterial sepsis, in absence of secondary bacterial infections, a process characterized as \"viral sepsis\".","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":331,"document":"34446092","golden":false,"offsetInEndSection":454,"text":"Gram-negative sepsis is more common than gram-positive infection, but sepsis can also be due to fungal and viral pathogens.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":255,"document":"33830803","golden":false,"offsetInEndSection":379,"text":"This article describes the most common causes of sepsis, and explains why neonates are particularly vulnerable to infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":380,"document":"33830803","golden":false,"offsetInEndSection":655,"text":"It highlights the non-specific way in which an infant with a serious infection may present, indicating the crucial features to elicit during history taking and examination, and emphasising the \u0027red-flag\u0027 signs and symptoms that should increase suspicion of a serious illness.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"33830803","golden":false,"offsetInEndSection":46,"text":"Recognition and management of neonatal sepsis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":104,"document":"33830803","golden":false,"offsetInEndSection":254,"text":"It causes significant morbidity and mortality, although the outcome can be improved by early recognition and prompt treatment by health professionals.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"32753048","golden":false,"offsetInEndSection":104,"text":"Comparison of clinical laboratory tests between bacterial sepsis and SARS-CoV-2-associated viral sepsis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":656,"document":"33830803","golden":false,"offsetInEndSection":934,"text":"The authors have adapted National Institute for Health and Care Excellence guidelines to produce an evidence-based approach to the management of an infant with suspected sepsis, and describe the roles of nurses in ensuring effective treatment and best outcomes for these babies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32201899","golden":false,"offsetInEndSection":154,"text":"BACKGROUND: Parechovirus (PeV)-A3 and enteroviruses (EV) are the most common viruses causing sepsis and meningoencephalitis in neonates and young infants.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1124,"document":"34627055","golden":false,"offsetInEndSection":1501,"text":"Multiorgan dysfunction syndrome (MODS) at the onset of sepsis (time zero) was found to be more prevalent in NTG than in TG (P \u003d 0.001), while the progression of MODS over the three days remained the same in both groups.CONCLUSION: Thrombocytopenia was more associated with non-bacterial sepsis/septic shock, and it may indicate a better outcome of sepsis in pediatric patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":857,"document":"34858905","golden":false,"offsetInEndSection":966,"text":"Viral agent such as dengue, malaria are common in LMIC and initial approach differ from bacterial infections.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1789,"document":"34939034","golden":false,"offsetInEndSection":2100,"text":"Respiratory failure and coma were the most common causes of in-hospital death.CONCLUSIONS: In addition to suspected bacterial, viral, and fungal infections, malaria and other parasitic infections are common and important causes of sepsis in adults and children admitted to a rural hospital in sub-Sahara Africa.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":967,"document":"34858905","golden":false,"offsetInEndSection":1254,"text":"Some authors found increased or no impact in mortality or increased length of stay associated with the implementation of the SCC sepsis bundle which reinforces the importance of adapting it to most frequent diseases, disposable resources, and characteristics of healthcare professionals.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1787,"document":"15675497","golden":false,"offsetInEndSection":2010,"text":"Streptococcus pneumoniae (10, 30.3%) was the most common invasive bacterial pathogen causing sepsis and Escherichia coli (14, 34.2%) was the most common bacterial pathogen causing urinary tract infections, among the cohort.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2295,"document":"35699701","golden":false,"offsetInEndSection":2903,"text":"Mucopurulent ocular discharge (sensitivity, 0.76 [95% CI, 0.60-0.87); specificity, 0.66 [95% CI, 0.58-0.73]; positive LR, 2.1 [95% CI, 1.7-2.6]) and otitis media (sensitivity, 0.24 [95% CI, 0.20-0.29]; specificity, 0.91 [95% CI, 0.85-0.94]; positive LR, 2.5 [95% CI, 1.5-4.4]) were associated with the presence of bacterial conjunctivitis.Conclusions and Relevance: In this review, bacterial conjunctivitis was more common than viral conjunctivitis in children and viral conjunctivitis was more common than bacterial conjunctivitis in adults, although the prevalence estimates were based on limited evidence.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1038,"document":"34627055","golden":false,"offsetInEndSection":1123,"text":"NTG was associated with a higher mortality rate (29%) than the TG (12.2%, P \u003d 0.005).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":215,"document":"34858905","golden":false,"offsetInEndSection":488,"text":"Advantages to the adoption of a pediatric sepsis recognition and treatment protocol include: a reduction in time to start fluid and antibiotic administration, decreased kidney dysfunction and organ dysfunction, reduction in length of stay, and even a decrease on mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1167,"document":"33962589","golden":true,"offsetInEndSection":1291,"text":"Bacterial and viral infections were the most common infectious etiology with reported rates of 29.2 and 21.2%, respectively.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1503,"document":"33045237","golden":false,"offsetInEndSection":1765,"text":"Four infants had bacterial coinfections diagnosed within 24?hours of admission; 40 infants had viral coinfections.CONCLUSIONS: Although most frequent in summer and fall, PeV-A infections were encountered in every calendar month within the 3-year period of study.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1105,"document":"38102316","golden":false,"offsetInEndSection":1308,"text":"In conclusion, endocan levels are associated with the occurrence of cardiovascular failure in COVID-19 and depend on the etiology of the infection, with higher values for bacterial than for viral sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34446092","golden":false,"offsetInEndSection":84,"text":"Sepsis is a common consequence of infection, associated with a mortality rate?\u003e?25%.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":85,"document":"34446092","golden":false,"offsetInEndSection":179,"text":"Although community-acquired sepsis is more common, hospital-acquired infection is more lethal.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":180,"document":"34446092","golden":false,"offsetInEndSection":330,"text":"The most common site of infection is the lung, followed by abdominal infection, catheter-associated blood steam infection and urinary tract infection.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34446092","golden":false,"offsetInEndSection":43,"text":"Initial antimicrobial management of sepsis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":455,"document":"34446092","golden":false,"offsetInEndSection":739,"text":"To reduce mortality, it is necessary to give immediate, empiric, broad-spectrum therapy to those with severe sepsis and/or shock, but this approach can drive antimicrobial overuse and resistance and should be accompanied by a commitment to de-escalation and antimicrobial stewardship.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":100,"document":"38254697","golden":false,"offsetInEndSection":224,"text":"While viral infections are usually self-limiting, sometimes bacterial illnesses may lead to sepsis and severe complications.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":573,"document":"38254697","golden":false,"offsetInEndSection":764,"text":"The aim of this narrative review is to provide the most recent evidence on biomarkers and predictor models, combining them for serious bacterial infection (SBI) diagnosis in febrile children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1396,"document":"37605134","golden":false,"offsetInEndSection":1726,"text":"The observation group had a higher proportion of patients treated in the paediatric intensive care unit and a longer hospital stay, and the differences were statistically significant (P?\u003c?0.05).CONCLUSION: Severe influenza virus-associated pneumonia complicated with bacterial infection was more common in children aged???5 years.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1013,"document":"36943823","golden":false,"offsetInEndSection":1211,"text":"A SARS-CoV-2 infection has frequently been considered as a form of viral sepsis (owing to common features with bacterial sepsis) but is also associated with an array of specific and unique symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1245,"document":"10164058","golden":false,"offsetInEndSection":1519,"text":"Finally, rational antimicrobial treatment of common paediatric bacterial infections, such as streptococcal tonsillopharyngitis, acute otitis media, acute sinusitis, bacterial pneumonia, pertussis, Lyme borreliosis (early stage) and lower urinary tract infection is reviewed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38254697","golden":false,"offsetInEndSection":99,"text":"Febrile infections in children are a common cause of presentation to the emergency department (ED).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":225,"document":"38254697","golden":false,"offsetInEndSection":572,"text":"Inflammatory biomarkers such as C reactive protein (CRP) and procalcitonin are usually the first blood exams performed in the ED to differentiate bacterial and viral infections; nowadays, a better understanding of immunochemical pathways has led to the discovery of new and more specific biomarkers that could play a role in the emergency setting.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":933,"document":"38254697","golden":false,"offsetInEndSection":1041,"text":"CRP and procalcitonin still represent the most used biomarkers in the pediatric ED for the diagnosis of SBI.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":460,"document":"35192447","golden":false,"offsetInEndSection":561,"text":"At the same time, the incidence of acute bacterial pneumonia and sepsis has fallen steeply worldwide.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38254697","golden":false,"offsetInEndSection":64,"text":"Biomarkers for Serious Bacterial Infections in Febrile Children.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1514,"document":"31094887","golden":false,"offsetInEndSection":1896,"text":"Overall mortality was 5.5% (n \u003d 2 patients), with both deaths occurring in multidrug-resistant organism episodes.CONCLUSIONS: We report that multidrug-resistant organisms are increasingly being identified as causative pathogens for sepsis in pediatric liver transplant recipients and are associated with significantly higher odds for mechanical ventilation and higher organ failure.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2045,"document":"32898875","golden":false,"offsetInEndSection":2260,"text":"KEY POINTS: ? Neonatal sepsis remains a leading cause of mortality.. ? Challenges include bacterial resistance and newer viruses.. ? Future treatments may include newer antibiotics/antivirals and stem cell therapy..","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1543,"document":"38071208","golden":false,"offsetInEndSection":1745,"text":"Patients with viral-bacterial infections are more likely to be admitted to ICU and die at the hospital than bacterial or viral infections (60% and 20% vs. 31.8% and 1.9% vs. 12.5% and 12.5%, p?\u003c?0.001).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1298,"document":"38071208","golden":false,"offsetInEndSection":1374,"text":"Bacteria caused 3.5% of cases and 4.4% had mixed viral-bacterial infections.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1746,"document":"38071208","golden":false,"offsetInEndSection":1871,"text":"Viruses particularly RSV are the leading cause of SARI causing significant health problem among children?\u003c?16 years in Egypt.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1872,"document":"38071208","golden":false,"offsetInEndSection":1948,"text":"Bacterial on top of viral infection can worsen disease courses and outcomes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1375,"document":"38071208","golden":false,"offsetInEndSection":1542,"text":"Rhinovirus was the most common cause of death among children with SARI, followed by RSV (8.7% and 1.4%), whereas influenza and Adenovirus did not result in any deaths.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":663,"document":"36337758","golden":false,"offsetInEndSection":943,"text":"Those with documented bacterial co-infections had initially elevated PCT levels that decreased by more than 50% with antimicrobial therapy.Conclusion: These cases are the first to report serial PCT measurements in confirmed cases of WNV-NID and support a low serum PCT in WNV-NID.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1949,"document":"38071208","golden":false,"offsetInEndSection":2114,"text":"Studies are required to estimate the SARI burden accurately among Egyptian children and a comprehensive approach tailored to Egypt is necessary to reduce its burden.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":887,"document":"38276162","golden":false,"offsetInEndSection":1042,"text":"Retinoic acid-inducible gene I-like receptors and Toll-like receptors play pivotal roles, and the cytokine storm in COVID-19 differs from bacterial sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":173,"document":"36142813","golden":false,"offsetInEndSection":322,"text":"Sepsis is commonly caused by an exaggerated immune response to bacterial, viral, and fungal infections, and leads to severe thrombotic complications.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1008,"document":"36629234","golden":false,"offsetInEndSection":1273,"text":"On multi-variate analysis, sepsis, septic shock, and the need for mechanical ventilation independently predicted mortality.Conclusion: Bacterial aetiology was the most common cause; though the fungal aetiology was seen less, it was associated with higher mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":323,"document":"36142813","golden":false,"offsetInEndSection":467,"text":"Among others, the endotoxin lipopolysaccharide (LPS) found in the outer membrane of Gram-negative bacteria is the most common trigger of sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1229,"document":"36142813","golden":false,"offsetInEndSection":1438,"text":"The ability of various sources of LPS to elicit platelet activation in terms of aggregation, granule secretion, cytokine release, ROS production, and interaction with leukocytes and NET formation is discussed.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36142813","golden":false,"offsetInEndSection":62,"text":"The Controversial Role of LPS in Platelet Activation In Vitro.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":994,"document":"36142813","golden":false,"offsetInEndSection":1117,"text":"This review summarizes and critically analyzes past and recent publications about LPS-induced platelet activation in vitro.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":468,"document":"36142813","golden":false,"offsetInEndSection":744,"text":"Since the discovery of the expression of the LPS receptor TLR4 in platelets, several studies have investigated the ability of LPS to induce platelet activation and to contribute to a prothrombotic phenotype, per se or in combination with plasma proteins and platelet agonists.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":858,"document":"38050541","golden":false,"offsetInEndSection":1136,"text":"Importantly, we emphasize the importance of group distinction of infectious agents in sepsis patients for biomarker identification, because the host response to infection of bacteria, virus, or fungus could be substantially different and thus the results of biomarker screening.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1138,"document":"31094887","golden":false,"offsetInEndSection":1433,"text":"se producers were the most frequently identified multidrug-resistant organisms. Patients with multidrug-resistant organism sepsis demonstrated higher admission Pediatric Logistic Organ Dysfunction scores (p \u003d 0.043) and were noted to have an odds ratio of 3.8 and 3.6 for mechanical ventilation ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":482,"document":"31094887","golden":false,"offsetInEndSection":598,"text":"isodes total). Median age at admission was 2 years (1-6.5 yr), 47.2% were male. Bacterial infections were the most c","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":452,"document":"7667058","golden":false,"offsetInEndSection":724,"text":"The most common organisms recovered were: nontyphoidal Salmonella, 10 cases (23%); Streptococcus pneumoniae, 9 cases (21%); Staphylococcus epidermidis, 6 cases (14%); Escherichia coli, 5 cases (12%); Enterococcus faecalis, 4 cases (9%); Campylobacter jejuni, 2 cases (5%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1061,"document":"31303335","golden":false,"offsetInEndSection":1160,"text":" 2.6, 95% CI 1.1-6.3, P \u003c .05).CONCLUSIONS: Viral DNAemia was associated with hyperferritinemia and","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1593,"document":"36362702","golden":false,"offsetInEndSection":1691,"text":"Together with tachypnoe and SpO2 \u003c 94%, it improved the prediction value of sepsis as well as SBI.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":527,"document":"9386664","golden":false,"offsetInEndSection":609,"text":"sk of mortality score was 16.1. Bacterial and viral sepsis was confirmed in five a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1157,"document":"36362702","golden":false,"offsetInEndSection":1292,"text":"Our analysis revealed statistically significant differences between leucocyte, neutrophil, and CRP levels between SBI and other groups.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":725,"document":"7667058","golden":false,"offsetInEndSection":935,"text":"In 28 episodes of bacteremia there were other sites of associated infection: pneumonia, 6 cases; urinary tract infection (UTI), 5 cases; gastrointestinal disease, 4 cases; catheter-related bacteremia, 12 cases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1866,"document":"20009784","golden":false,"offsetInEndSection":2092,"text":"ever, the same may not be true for other systemic viral infections, such as influenza. In patients with acute bacterial meningitis, maintenance fluids-instead of restricted fluids-and use of glycerol may improve the outcomes; ","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37810514","golden":false,"offsetInEndSection":177,"text":"Retracted: Analysis of the Relevant Vital Signs and Infection of Sepsis Patients and to Explore the Influencing Factors of Acute Lung Injury/Acute Respiratory Distress Syndrome.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":629,"document":"30086729","golden":false,"offsetInEndSection":1171,"text":"Here we present the study details of the TAILORED-Treatment study, an observational, prospective, multi-centre study aiming to generate a multi-parametric model, combining host and pathogen data, for distinguishing between bacterial and viral aetiologies in children and adults with LRTI and/or sepsis.METHODS: A total number of 1200 paediatric and adult patients aged 1?month and older with LRTI and/or sepsis or a non-infectious disease are recruited from Emergency Departments and hospital wards of seven Dutch and Israeli medical centres.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1361,"document":"36362702","golden":false,"offsetInEndSection":1429,"text":"A higher PNLR value was observed in a bacterial group, PNR-in viral.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1572,"document":"35196995","golden":false,"offsetInEndSection":1788,"text":"On the 13th day of hospitalization, the patient died.CONCLUSIONS: Co-infections with bacterial pathogens appear to be not common among COVID-19 patients, but may cause a sudden deterioration of the general condition.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1223,"document":"36472648","golden":false,"offsetInEndSection":1368,"text":"Conclusion: Beyond malodorous urine, A. urinae detection is associated with more severe presentations including UTI in the paediatric population.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":765,"document":"38254697","golden":false,"offsetInEndSection":932,"text":"Literature analysis shows that inflammatory response is a complex mechanism in which many biochemical and immunological factors contribute to the host response in SBI.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":357,"document":"25652198","golden":false,"offsetInEndSection":460,"text":"ometric assay.RESULTS: (a) Patients with bacterial meningitis had significantly higher serum PCT than t","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":835,"document":"25652198","golden":false,"offsetInEndSection":921,"text":"d than those who survived.CONCLUSIONS: Serum PCT is related to the severity of disease","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":830,"document":"28794881","golden":false,"offsetInEndSection":1037,"text":"tonin alone may not be effective. Rapid elevation in the concentration of procalcitonin and other newly emerging biomarkers during an infection and its correlation with severity of illness makes it an ideal ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1135,"document":"22440053","golden":false,"offsetInEndSection":1250,"text":"0.919; P 0.0046), respectively.CONCLUSION: PCT levels were significantly higher in bacterial and fungal infection i","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1251,"document":"22440053","golden":false,"offsetInEndSection":1380,"text":" comparison to other inflammatory markers. PCT proved to be the most specific parameter in differentiating bacterial infection fr","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":750,"document":"26989885","golden":false,"offsetInEndSection":885,"text":"l infections were reported. Bacterial infections were most frequent during the first year post transplantation with ascending cholangit","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1206,"document":"26989885","golden":false,"offsetInEndSection":1368,"text":"senting with severe sepsis. Compared with the white blood cell count and absolute neutrophil count, C-reactive protein level was found to be a more sensitive biom","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1447,"document":"26989885","golden":false,"offsetInEndSection":1637,"text":"or for bacterial infection.CONCLUSION: Febrile hospitalized pediatric LTR are immunocompromised hosts at high risk for bacterial infections, and usually warrant prompt evaluation and empiric","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":752,"document":"15788823","golden":false,"offsetInEndSection":978,"text":"epsis evaluations.RESULTS: A total of 69 febrile neonates met the inclusion criteria. The number of neonates in each group was as follows: 8 with bacterial infections, 10 with viral infections, 3 with pneumonias, and 48 with n","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1170,"document":"16544299","golden":false,"offsetInEndSection":1212,"text":"and diarrhea to septic shock. Four patient","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"37890901","golden":false,"offsetInEndSection":217,"text":"Differentiating between self-resolving viral infections and bacterial infections in children who are febrile is a common challenge, causing difficulties in identifying which individuals require antibiotics","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1670,"document":"37872349","golden":false,"offsetInEndSection":1845,"text":"What is Known: ? Febrile infants with laboratory-confirmed viral infections have a significantly lower risk of serious bacterial infections when compared to those without them","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":213,"document":"37509478","golden":false,"offsetInEndSection":552,"text":"In 40-50% of ACLF cases, the trigger is not recognized; for many of these patients, bacterial translocation associated with systemic inflammation is thought to be the determining factor; in the other 50% of patients, sepsis, alcohol consumption, and reactivation of chronic viral hepatitis are the most frequently described trigger factors","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":11,"document":"37154081","golden":false,"offsetInEndSection":132,"text":"Respiratory infections in children are one of the most common causes of hospital attendances and a common cause of sepsis","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":601,"document":"35459180","golden":false,"offsetInEndSection":672,"text":"She experienced viral sepsis and multiorgan dysfunction after admission","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"35137684","golden":false,"offsetInEndSection":115,"text":"Diarrheal illness is a leading cause of antibiotic use for children in low- and middle-income countries","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34888744","golden":false,"offsetInEndSection":71,"text":"Clinical profile of children with parechovirus meningitis in Singapore.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":685,"document":"38357132","golden":false,"offsetInEndSection":808,"text":"The odds of RDS among neonates with jaundice and sepsis are 4.33- and 1.92-times higher odds compared to their counterparts","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"38356035","golden":false,"offsetInEndSection":223,"text":"Longer hospitalizations for preterm infants with bronchopulmonary dysplasia (BPD) delay developmental outcomes, increase the risk for hospital-acquired complications, and exert a substantial socioeconomic burden","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":566,"document":"38355207","golden":false,"offsetInEndSection":652,"text":"Initial screenings for sepsis and blood group incompatibility yielded negative results","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":9,"document":"38354362","golden":false,"offsetInEndSection":207,"text":"Time to antibiotic administration (TTA) in \u003c60 minutes for children with neutropenic fever presenting to an emergency room is associated with reduced incidence of sepsis and intensive care admission","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1729,"document":"38353591","golden":false,"offsetInEndSection":1784,"text":"Sepsis is still a life-threatening disease in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":234,"document":"38353586","golden":false,"offsetInEndSection":317,"text":"Secondary analysis of the Life After Pediatric Sepsis Evaluation prospective study.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1307,"document":"38353160","golden":false,"offsetInEndSection":1398,"text":"Further multicenter prospective data are needed, including infants with early-onset sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":151,"document":"38352942","golden":false,"offsetInEndSection":268,"text":"These mechanisms have been demonstrated in patients with sepsis, hemoglobinopathies, and those receiving transfusions","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":13,"document":"38348451","golden":false,"offsetInEndSection":184,"text":" Pediatric sepsis (PS) is a life-threatening infection associated with high mortality rates, necessitating a deeper understanding of its underlying pathological mechanisms","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"29376570","golden":false,"offsetInEndSection":98,"text":"New prediction model for diagnosis of bacterial infection in febrile infants younger than 90 days.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":935,"document":"29376570","golden":false,"offsetInEndSection":1090,"text":"Most common diagnosis was urinary tract infection (68.6%), followed by pneumonia (12.9%), sepsis (11.4%), gastroenterocolitis (5.7%) and meningitis (1.4%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1545,"document":"21355513","golden":false,"offsetInEndSection":1755,"text":"There were 79.7% (n \u003d 51) of infectious episodes with a cotrimoxazole-resistant organism occurring among those on cotrimoxazole prophylaxis.CONCLUSIONS: Escherichia coli was the most frequent bacterial isolate.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":164,"document":"29376570","golden":false,"offsetInEndSection":351,"text":"Due to non-specific clinical presentation in febrile infants, extensive laboratory testing is often carried out to distinguish simple viral disease from serious bacterial infection (SBI).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":916,"document":"27833059","golden":false,"offsetInEndSection":1082,"text":"In all cases, the virus identified in CSF was EV.CONCLUSIONS: Bacterial infections were frequent in young infants with viral neurological infections associated to EV.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1184,"document":"15069401","golden":false,"offsetInEndSection":1520,"text":"No patient had Pneumocystis jerovici pneumonia or a complication of live viral vaccine.CONCLUSIONS: In spite of the high prevalence of laboratory immunologic abnormalities, systemic bacterial, severe viral, and opportunistic infections are uncommon in A-T. Cross-sectional analysis suggests that the immune defect is rarely progressive.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1012,"document":"2510121","golden":false,"offsetInEndSection":1171,"text":"The results indicate that mixed bacterial and viral infections occur more frequently in children than one could anticipate on the basis of the earlier reports.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1091,"document":"29376570","golden":false,"offsetInEndSection":1170,"text":"Male gender was shown to be a risk factor for SBI in this population (p\u003d0.008).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":618,"document":"29376570","golden":false,"offsetInEndSection":796,"text":"Febrile \u003c 90-day-old infants hospitalized in 2-year-period at Department of Pediatrics, University Hospital Centre Split with suspicion of having SBI were included in this study.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":352,"document":"29376570","golden":false,"offsetInEndSection":475,"text":"Objective of this study was to compare efficacy of different biomarkers in early diagnosis of SBI in infants \u003c 90 days old.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":443,"document":"2510121","golden":false,"offsetInEndSection":517,"text":"A mixed bacterial and viral infection was documented in 19 patients (37%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":518,"document":"2510121","golden":false,"offsetInEndSection":761,"text":"Seven patients (14%) showed a diagnostic rise in antibodies to H. influenzae and 8 patients (16%) showed an antibody elevation to B. catarrhalis in their paired sera; pneumococcal antigen was detected in acute phase serum from 4 patients (8%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1172,"document":"2510121","golden":false,"offsetInEndSection":1386,"text":"Mixed bacterial and viral etiology is highly probable in a child who has a defined viral infection with high C-reactive protein and white blood cell count values, especially in the presence of respiratory symptoms.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"2510121","golden":false,"offsetInEndSection":60,"text":"Mixed bacterial and viral infections are common in children.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"2510121","golden":false,"offsetInEndSection":442,"text":"Acute phase and convalescent sera from 51 pediatric patients who had a documented viral infection and no obvious culture-confirmed bacterial infection such as meningitis, otitis media or urinary tract infection were tested by enzyme immunoassay for antibodies to Haemophilus influenzae and Branhamella catarrhalis and by the latex agglutination test for pneumococcal antigens to evaluate the frequency of mixed bacterial and viral infections.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":762,"document":"2510121","golden":false,"offsetInEndSection":839,"text":"The rate of mixed infections in patients having respiratory symptoms was 52%.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"9350892","golden":false,"offsetInEndSection":480,"text":"Clinical diagnosis of sepsis in newborn infants is not easy and there is no laboratory test with 100% specificity and sensitivity, with the exception of blood culture, the results of which are not available for at least 48-72 h. Polymerase chain reaction methodology has been used to diagnose different bacterial, viral and protozoal infections, and the possibility of amplifying the DNA region common to all bacteria could represent an optimal method for the diagnosis of sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1525,"document":"32898878","golden":false,"offsetInEndSection":1871,"text":"KEY POINTS: ? Blood cultures are the gold standard diagnosis of neonatal sepsis but sometimes may be negative.. ? Other bacterial, viral, and noninfectious conditions may mimic sepsis, prompting initiation of empiric antibiotic treatments.. ? Since a definition of neonatal sepsis is lacking, recognizing real septic episodes may be challenging..","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":197,"document":"38259971","golden":false,"offsetInEndSection":308,"text":"Sepsis can develop from bacterial (gram negative or gram positive), fungal or viral (such as COVID) infections.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37891594","golden":false,"offsetInEndSection":564,"text":"BACKGROUND: Sepsis is a systemic inflammatory response syndrome caused by severe infection in children, but cases of sepsis associated with human parainfluenza virus (HPIV) have been rarely reported in newborns.CASE PRESENTATION: We report a case of HPIV-3 positive full-term newborn admitted to the Neonatal Intensive Care Unit of Beijing Children\u0027s Hospital due to hematuria, gloomy spirit, inactivity and loss of appetite for 6?h. He had septic shock when he arrived the Accident \u0026 Emergency Department requiring immediate intubation and mechanical ventilation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":972,"document":"34732550","golden":false,"offsetInEndSection":1206,"text":"Among the cohort, 63 patients (62.4%) had an infection-attributed mortality, of which 43 (68.3%) were bacterial, 14 (22.2%) were viral, and 10 (15.9%) were fungal.CONCLUSION: Infections remain a significant cause of death in the PICU.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":553,"document":"38259971","golden":false,"offsetInEndSection":722,"text":"The current understanding is that the host response to sepsis is highly diverse among patients, and this heterogeneity impacts immune function and response to infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1312,"document":"38259971","golden":false,"offsetInEndSection":1652,"text":"In this review, we will discuss the latest research exploring how in silico modeling of a synergistic combination of new organ-on-chip models incorporating human cells/tissue, omics analysis and clinical data from sepsis patients will allow us to identify relevant signaling pathways and characterize specific immune phenotypes in patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":84,"document":"38259971","golden":false,"offsetInEndSection":196,"text":"Sepsis is now defined as life-threatening organ dysfunction caused by a dysregulated host response to infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38259971","golden":false,"offsetInEndSection":83,"text":"Sepsis is a global health concern accounting for more than 1 in 5 deaths worldwide.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1835,"document":"38259971","golden":false,"offsetInEndSection":2005,"text":"This synergistic approach can lead to the development of new therapeutics and the identification of FDA approved drugs that can be repurposed for the treatment of sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":752,"document":"36322631","golden":false,"offsetInEndSection":1067,"text":"Last, we built a machine learning framework, SepstratifieR, to deploy SRSq in adult and pediatric bacterial and viral sepsis, H1N1 influenza, and COVID-19, demonstrating clinically relevant stratification across diseases and revealing some of the physiological alterations linking immune dysregulation to mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25621006","golden":false,"offsetInEndSection":217,"text":"After an initial febrile viral syndrome, infection with Ebola virus often induces an explosive late \"Ebola sepsis-like syndrome\" which appears very similar to some phenotypes of bacterial sepsis and is commonly fatal.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":659,"document":"1882827","golden":false,"offsetInEndSection":808,"text":"Infection rate and severity were markedly worse in the cocaine group: bacterial cellulitis, sepsis, and abscess each increased greater than fourfold.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1596,"document":"38358334","golden":false,"offsetInEndSection":1671,"text":"There was 1 possibly related death (sepsis with attendant hepatic failure).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38357933","golden":false,"offsetInEndSection":127,"text":"Understanding the kinetics of dengue viruses in the bloodstream can provide insights into the clinical outcomes of the disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"38357644","golden":false,"offsetInEndSection":131,"text":"Sepsis, affecting over 30 million people worldwide each year, is a key mortality risk factor in critically ill patients","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":804,"document":"38357643","golden":false,"offsetInEndSection":908,"text":"In the studied cohort of 32,971 sepsis patients, 2,327 were identified as meeting the inclusion criteria","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":68,"document":"38357545","golden":false,"offsetInEndSection":262,"text":" that is almost solely transmitted by Culicoides biting midges and causes a globally important haemorrhagic disease, bluetongue (BT), in susceptible ruminants. Infection with BTV is characterise","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1525,"document":"38357510","golden":false,"offsetInEndSection":1639,"text":"Pulmonary hemorrhage, tension pneumothorax and early onset sepsis were independent risk factors for high-grade IVH","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":212,"document":"38357174","golden":false,"offsetInEndSection":393,"text":"In retrospective observational study, during October 2019 to December 2021, 145 patients with septic shock treated in our hospital were enrolled by the method of observational study","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38259485","golden":false,"offsetInEndSection":84,"text":"DNases improve effectiveness of antibiotic treatment in murine polymicrobial sepsis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":505,"document":"38190645","golden":false,"offsetInEndSection":701,"text":"Children who had lumbar punctures performed as part of a septic screen were identified retrospectively through clinical discharge coding and microbiology databases from April 2017 to December 2018","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":859,"document":"38110534","golden":false,"offsetInEndSection":1002,"text":"The GF-B/V model discriminated bacterial from viral infection in the discovery cohort an area under the receiver operator curve (AUROC) of 0.93","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":216,"document":"37985552","golden":false,"offsetInEndSection":328,"text":"However, data on its prevalence and burden on mortality in patients with bloodstream infection (BSI) are lacking","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"37891594","golden":false,"offsetInEndSection":211,"text":"Sepsis is a systemic inflammatory response syndrome caused by severe infection in children, but cases of sepsis associated with human parainfluenza virus (HPIV) have been rarely reported in newborns.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1382,"document":"37843118","golden":false,"offsetInEndSection":1706,"text":"Thus, the focus of investigation in the ARLG has evolved from improving understanding of drug-resistant gram-negative bacterial infections to positively affecting clinical care for affected patients through a combination of interventional pharmacokinetic and clinical studies, a focus that will be maintained moving forward.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":473,"document":"37778538","golden":false,"offsetInEndSection":585,"text":"Unfortunately, early signs and symptoms of disseminated viral infections may be misdiagnosed as bacterial sepsis","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":980,"document":"35149567","golden":false,"offsetInEndSection":1074,"text":"Pneumonia was the most common bacterial infection (28.6%) followed by clinical sepsis (17.8%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1436,"document":"35796793","golden":false,"offsetInEndSection":2179,"text":"Children most at risk for sepsis/meningitis were children with malignancy/immunodeficiency (aOR 14.5, 8.5-24.8), while children with psychomotor delay/neurological disease were most at risk for life-saving interventions (aOR 5.3, 4.1-6.9) or PICU admission (aOR 9.7, 6.1-15.5).CONCLUSIONS: Our data show how children with comorbidities are a population at risk, as they more often are diagnosed with bacterial infections and more often require PICU admission and life-saving interventions.WHAT IS KNOWN: ? While children with comorbidity constitute a large part of ED frequent flyers, they are often excluded from studies.WHAT IS NEW: ? Children with comorbidities in general are more ill upon presentation than children without comorbidities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":919,"document":"35149567","golden":false,"offsetInEndSection":979,"text":"The common indication for antibiotics was for HCAIs (40.3%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1861,"document":"35149567","golden":false,"offsetInEndSection":2200,"text":"Patients treated at secondary-level hospitals had 0.34 times lower odds of being on antibiotics compared with those in tertiary hospitals.CONCLUSIONS: Antibiotic use across the surveyed hospitals was common and most were empiric which has both practical and policy implications for strengthening ASP and promoting rational antibiotics use.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":248,"document":"35657183","golden":false,"offsetInEndSection":380,"text":"The most critical patients present with acute respiratory distress syndrome and multiple organ failure, resembling bacterial sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":376,"document":"32699026","golden":false,"offsetInEndSection":541,"text":"Bacteria have been shown to be the predominant pathogen of sepsis among patients with pathogens detected, while sepsis caused by viruses is underdiagnosed worldwide.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":184,"document":"35149567","golden":false,"offsetInEndSection":867,"text":"This study sought to assess antibiotics use and healthcare-associated infections (HCAIs) in Ethiopian public hospitals.DESIGN: We conducted a cross-sectional study using the WHO point-prevalence survey protocol for systemic antibiotics use and HCAIs for low/middle-income countries.SETTING: The study was conducted among 10 public hospitals in 2021.PARTICIPANTS: All patients admitted to adult and paediatric inpatient and emergency wards before or at 08:00 on the survey date were enrolled.OUTCOME MEASURE: The primary outcome measures were the prevalence of antibiotic use, HCAIs and the hospitals\u0027 readiness to implement ASP.RESULTS: Data were collected from 1820 patient records.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1323,"document":"35149567","golden":false,"offsetInEndSection":1466,"text":"Age, having HIV infection, ward type, type of hospital, catheterisation and intubation history had significant association with antibiotic use.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1021,"document":"34189083","golden":false,"offsetInEndSection":1393,"text":"CRP was altered in 88.9% of HAdV infected children and in 87% infected with bacteria, although the percentage was greater than in cases where other respiratory viruses were present (61.3% P\u003c0.05).CONCLUSIONS: Results demonstrate a clear relationship between HAdV infection and alterations in PCT and CRP which should be taken into account in paediatric patient management.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":935,"document":"35459180","golden":false,"offsetInEndSection":1294,"text":"We identified a rarely reported rhinovirus A45 in her oropharyngeal and anal swabs by metagenomic next-generation sequencing, and bacterial culture of blood specimens yielded negative results.CONCLUSIONS: This case presents a patient with severe rhinovirus infection, which was very likely responsible for her central nervous system symptoms and viral sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2592,"document":"38513681","golden":false,"offsetInEndSection":3456,"text":"In the external EUCLIDS validation dataset (n\u003d362), the disease class and disease severity predicted organ dysfunction at time of sampling with an AUC of 70?1% (95% CI 44?1-96?2) for patients with predicted bacterial infection and 69?6% (53?1-86?0) for patients with predicted viral infection.INTERPRETATION: In children evaluated for sepsis, novel host transcriptomic signatures specific for bacterial and viral infection can identify dysregulated host response leading to organ dysfunction.FUNDING: Australian Government Medical Research Future Fund Genomic Health Futures Mission, Children\u0027s Hospital Foundation Queensland, Brisbane Diamantina Health Partners, Emergency Medicine Foundation, Gold Coast Hospital Foundation, Far North Queensland Foundation, Townsville Hospital and Health Services SERTA Grant, and Australian Infectious Diseases Research Centre.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":203,"document":"38513681","golden":false,"offsetInEndSection":605,"text":"We aimed to develop host gene expression signatures to predict organ dysfunction in children with bacterial or viral infection.METHODS: This cohort study was done in emergency departments and intensive care units of four hospitals in Queensland, Australia, and recruited children aged 1 month to 17 years who, upon admission, underwent a diagnostic test, including blood cultures, for suspected sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1042,"document":"19762956","golden":false,"offsetInEndSection":1350,"text":"The geometric mean TNF-alpha concentrations in patients with severe sepsis and those with late septic shock were 47 pg/ml (range 5-2720) and 59 pg/ml (range 5-3310) respectively.CONCLUSION: TNF-alpha was significantly raised in culture-positive cases in general and in gram-negative infections in particular.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38513681","golden":false,"offsetInEndSection":122,"text":"BACKGROUND: Sepsis is defined as dysregulated host response to infection that leads to life-threatening organ dysfunction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39313063","golden":false,"offsetInEndSection":91,"text":"Differentiating bacterial from viral infections in children is a common clinical challenge.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2318,"document":"38513681","golden":false,"offsetInEndSection":2591,"text":"Used in tandem, the disease class and disease severity signatures predicted organ dysfunction within 24 h of sampling with an AUC of 90?5% (95% CI 83?3-97?6) for patients with predicted bacterial infection and 94?7% (87?8-100?0) for patients with predicted viral infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1478,"document":"38513681","golden":false,"offsetInEndSection":1625,"text":"The primary endpoint was the presence of organ dysfunction 24 h after blood sampling in the presence of confirmed bacterial versus viral infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1969,"document":"38513681","golden":false,"offsetInEndSection":2146,"text":"We derived a ten-gene disease class signature that achieved an AUC of 94?1% (95% CI 90?6-97?7) in distinguishing bacterial from viral infections in the RAPIDS validation cohort.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1271,"document":"38513681","golden":false,"offsetInEndSection":1477,"text":"Feature selection approaches were applied to derive novel gene signatures for disease class (bacterial vs viral infection) and disease severity (presence vs absence of organ dysfunction 24 h post-sampling).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2147,"document":"38513681","golden":false,"offsetInEndSection":2317,"text":"A ten-gene disease severity signature achieved an AUC of 82?2% (95% CI 76?3-88?1) in predicting organ dysfunction within 24 h of sampling in the RAPIDS validation cohort.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2733,"document":"39429081","golden":true,"offsetInEndSection":2850,"text":"onclusions: Bacterial infection are predominant in pediatric septic shock, but viral infection are also significant. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39142742","golden":false,"offsetInEndSection":173,"text":"Sepsis disproportionally affects children across all health-care settings and is one of the leading causes of morbidity and mortality in neonatal and paediatric age groups.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27014507","golden":false,"offsetInEndSection":95,"text":"Severe sepsis and septic shock remains a leading cause of mortality and morbidity in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":393,"document":"15720891","golden":false,"offsetInEndSection":532,"text":"A pathogen was identified in 115 of the 147 children, 72 of whom had a bacterial pathogen (bacterial group) and 43 rotavirus (viral group).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1008,"document":"15720891","golden":false,"offsetInEndSection":1154,"text":"Despite the small sample size, our data suggest that serum IL-6, IL-8 and CRP are significantly elevated in children with bacterial enterocolitis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"15720891","golden":false,"offsetInEndSection":94,"text":"It is difficult to distinguish clinically between bacterial and viral causes of enterocolitis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1247,"document":"15720891","golden":false,"offsetInEndSection":1359,"text":"Determination of serum cytokines might be a useful way of differentiating viral from bacterial gastro-enteritis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":533,"document":"15720891","golden":false,"offsetInEndSection":634,"text":"Mean values of the serum markers IL-6, IL-8 and CRP were significantly higher in the bacterial group.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"15720891","golden":false,"offsetInEndSection":77,"text":"Serum cytokines in differentiating between viral and bacterial enterocolitis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":95,"document":"15720891","golden":false,"offsetInEndSection":205,"text":"The aim of the study was to investigate if serum cytokines can distinguish bacterial from viral enterocolitis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1346,"document":"21659882","golden":false,"offsetInEndSection":1463,"text":"No patient died but two had sequelae.CONCLUSION: In the era of PCV7, pneumococcus is the leading cause of IBI in PED.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":701,"document":"9131715","golden":false,"offsetInEndSection":860,"text":"Also, patients with Gram-positive infections (77%) were more likely to survive their ECMO course than those with Gram-negative (60%) or viral infections (40%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":913,"document":"38790589","golden":false,"offsetInEndSection":1164,"text":"The difference in P-SEP levels in viral versus bacterial infections was found to be statistically significant; therefore, P-SEP may have a central role in the evaluation of febrile children, helping clinicians distinguish between these two etiologies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":136,"document":"1662355","golden":false,"offsetInEndSection":224,"text":"Final diagnosis was bacterial sepsis in 15, viral infection in 13 and no infection in 3.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38530103","golden":false,"offsetInEndSection":800,"text":"OBJECTIVES: To determine the prevalence of respiratory bacterial codetection in children younger than 2 years intubated for acute lower respiratory tract infection (LRTI), primarily viral bronchiolitis, and identify the association of codetection with mechanical ventilation duration.DESIGN: Prospective observational study evaluating the prevalence of bacterial codetection (moderate/heavy growth of pathogenic bacterial plus moderate/many polymorphonuclear neutrophils) and the impact of codetection on invasive mechanical ventilation (IMV) duration.SETTING: PICUs in 12 high and low/middle-income countries.PATIENTS: Children younger than 2 years old requiring intubation and ICU admission for LRTI and who had a lower respiratory tract culture obtained at the time of intubation between December ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39143644","golden":false,"offsetInEndSection":700,"text":"BACKGROUND: Fever in children represents one of the most common causes of medical evaluation. Infants younger than 90?days of age are at higher risk of severe and invasive bacterial infections (SBI and IBI). However, clinical signs and symptoms of viral and bacterial infections in young infants are frequently similar, and several studies have shown that the risk of SBIs remains non-negligible even in the presence of a positive point-of-care viral test. Our study aims to evaluate whether the proportion of SBIs and IBIs in febrile infants younger than 90?days during the COVID-19 pandemic was higher than that in the pre-pandemic period, and to describe the proportion of SBIs and IBIs in infants","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38732074","golden":false,"offsetInEndSection":700,"text":"Early diagnosis of infections in young infants remains a clinical challenge. Young infants are particularly vulnerable to infection, and it is often difficult to clinically distinguish between bacterial and viral infections. Urinary tract infection (UTI) is the most common bacterial infection in young infants, and the incidence of associated bacteremia has decreased in the recent decades. Host RNA expression signatures have shown great promise for distinguishing bacterial from viral infections in young infants. This prospective study included 121 young infants admitted to four pediatric emergency care departments in the capital region of Denmark due to symptoms of infection. We collected who","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":654,"document":"12390408","golden":false,"offsetInEndSection":880,"text":"Mixed viral-bacterial infections have been especially common in young children under 2 years of age, reflecting the high frequency of respiratory syncytial virus infections and their tendency to induce bacterial co-infections.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":685,"document":"31607572","golden":false,"offsetInEndSection":788,"text":"Echoviruses and coxsackievirus B viruses are most common serotypes associated with the neonatal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":116,"document":"15166819","golden":false,"offsetInEndSection":256,"text":"talities annually. Approximately half of bacterial sepsis cases occur following acute respiratory infections, and the lungs are the most com","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":526,"document":"25877546","golden":false,"offsetInEndSection":874,"text":"Although assessing the overall contribution of bacteria to disease severity is complicated by the presence of many confounding factors in clinical studies, understanding the role of viral/bacterial co-infections in defining the outcome of paediatric ARI will potentially reveal novel treatment and prevention strategies, improving patient outcomes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":938,"document":"1883188","golden":true,"offsetInEndSection":987,"text":"Bacterial infections were more common in infancy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":828,"document":"27608345","golden":false,"offsetInEndSection":1030,"text":"In 866 episodes of suspected sepsis where paired PCT and ITR were performed, the median ITR in children with bacteraemia was 0.19 ng/ml (IQR 0.04-0.35), and the median PCT was 6.5 ng/ml (IQR 0.71-61.8).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":144,"document":"32336983","golden":false,"offsetInEndSection":291,"text":"Bacterial bloodstream infection is the most commonly diagnosed cause of febrile neutropenia, with Gram-positive organisms most frequently isolated.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":373,"document":"33632088","golden":false,"offsetInEndSection":429,"text":"Thirteen children had concurrent sepsis (13/124, 10.4%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1588,"document":"25596126","golden":false,"offsetInEndSection":1904,"text":"The results demonstrated high morbidity associated with viral infections and that rotavirus and norovirus remain the most common pathogens associated with severe gastroenteritis during summer months in Bulgaria, a country with a temperate climate, and significant molecular diversity among circulating virus strains.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":315,"document":"1588581","golden":false,"offsetInEndSection":535,"text":"Neutropenia was common in association with the presence of viruses in stool or sputum, and was significantly more common in these groups than in patients with bacterial gastroenteritis and cow\u0027s milk protein intolerance.","beginSection":"abstract"}],"exact_answer":"","ideal_answer":[],"id":"6584542106a2ea257c000006","type":"yesno","body":"Is bacterial more common than viral paediatric sepsis?"},{"documents":[{"golden":true,"id":"19225009"},{"golden":false,"id":"37113274"},{"golden":false,"id":"11157839"},{"golden":false,"id":"11679538"},{"golden":false,"id":"35562615"},{"golden":true,"id":"31850340"},{"golden":false,"id":"14532867"},{"golden":false,"id":"9663781"},{"golden":false,"id":"32312123"},{"golden":true,"id":"22924252"},{"golden":false,"id":"36936144"},{"golden":false,"id":"37953342"},{"golden":false,"id":"27652839"},{"golden":false,"id":"32641062"},{"golden":false,"id":"36940434"},{"golden":false,"id":"37078589"},{"golden":false,"id":"3686599"},{"golden":false,"id":"33336089"},{"golden":false,"id":"7021189"},{"golden":false,"id":"36085268"},{"golden":false,"id":"31667820"},{"golden":false,"id":"36316218"},{"golden":false,"id":"33448004"},{"golden":false,"id":"34203117"},{"golden":false,"id":"30811549"},{"golden":false,"id":"34056138"},{"golden":false,"id":"34291195"},{"golden":false,"id":"33501382"},{"golden":false,"id":"36031703"},{"golden":false,"id":"31725880"},{"golden":false,"id":"16709216"},{"golden":true,"id":"22369001"},{"golden":false,"id":"32603474"},{"golden":false,"id":"15016781"},{"golden":false,"id":"32172637"},{"golden":false,"id":"16802186"},{"golden":false,"id":"26740578"},{"golden":true,"id":"20570973"},{"golden":false,"id":"23842560"},{"golden":false,"id":"32123753"},{"golden":false,"id":"36384906"},{"golden":false,"id":"34035929"},{"golden":false,"id":"6633270"},{"golden":false,"id":"35251982"},{"golden":false,"id":"26493012"},{"golden":false,"id":"26917474"},{"golden":false,"id":"31598568"},{"golden":false,"id":"26083621"},{"golden":false,"id":"36539233"},{"golden":false,"id":"31286144"},{"golden":false,"id":"28114299"},{"golden":false,"id":"36029522"},{"golden":false,"id":"38113762"},{"golden":false,"id":"32474592"},{"golden":false,"id":"36746507"},{"golden":false,"id":"32151288"},{"golden":false,"id":"37968233"},{"golden":false,"id":"24067621"},{"golden":false,"id":"37840754"},{"golden":false,"id":"38336757"},{"golden":false,"id":"38319332"},{"golden":false,"id":"38289310"},{"golden":false,"id":"38183116"},{"golden":false,"id":"38133445"},{"golden":false,"id":"38132370"},{"golden":false,"id":"38127973"},{"golden":false,"id":"38113196"},{"golden":false,"id":"38096116"},{"golden":false,"id":"38070921"},{"golden":false,"id":"38353086"},{"golden":false,"id":"27378767"},{"golden":false,"id":"29040579"},{"golden":false,"id":"20667406"},{"golden":false,"id":"27189043"},{"golden":false,"id":"27666276"},{"golden":false,"id":"26485833"},{"golden":false,"id":"27979919"},{"golden":false,"id":"26965431"},{"golden":false,"id":"27543212"},{"golden":false,"id":"18954861"},{"golden":false,"id":"18566567"},{"golden":false,"id":"32142582"},{"golden":false,"id":"36998947"},{"golden":false,"id":"32329514"},{"golden":false,"id":"30614237"},{"golden":true,"id":"36029062"},{"golden":false,"id":"33709345"},{"golden":false,"id":"35768691"},{"golden":false,"id":"35367015"},{"golden":false,"id":"14656408"},{"golden":false,"id":"21401447"},{"golden":false,"id":"31593582"},{"golden":false,"id":"38337248"},{"golden":false,"id":"38203658"},{"golden":false,"id":"38199042"},{"golden":false,"id":"38142472"},{"golden":false,"id":"38139165"},{"golden":false,"id":"38110741"},{"golden":false,"id":"38079178"},{"golden":false,"id":"38052102"},{"golden":false,"id":"38050118"},{"golden":false,"id":"38002013"},{"golden":false,"id":"35005162"},{"golden":false,"id":"31910163"},{"golden":false,"id":"37010330"},{"golden":false,"id":"34364312"},{"golden":false,"id":"35371371"},{"golden":false,"id":"36739613"},{"golden":false,"id":"38323524"},{"golden":false,"id":"35265993"},{"golden":false,"id":"38283622"},{"golden":false,"id":"38273527"},{"golden":false,"id":"38249068"},{"golden":false,"id":"22585630"},{"golden":false,"id":"22040135"},{"golden":false,"id":"25729824"},{"golden":false,"id":"19646742"},{"golden":false,"id":"39366583"},{"golden":false,"id":"32760812"},{"golden":false,"id":"34377841"},{"golden":false,"id":"22343707"},{"golden":false,"id":"26645803"},{"golden":false,"id":"36112009"},{"golden":false,"id":"38806697"},{"golden":false,"id":"16402663"},{"golden":false,"id":"22767463"},{"golden":false,"id":"32521764"},{"golden":false,"id":"7491857"},{"golden":false,"id":"38743990"},{"golden":false,"id":"22010447"},{"golden":false,"id":"24626802"},{"golden":false,"id":"26099440"},{"golden":false,"id":"16409135"},{"golden":false,"id":"25791968"},{"golden":false,"id":"33043154"},{"golden":false,"id":"32161952"},{"golden":false,"id":"36210721"},{"golden":false,"id":"35328944"},{"golden":false,"id":"33744927"},{"golden":false,"id":"11547268"},{"golden":false,"id":"32377787"},{"golden":false,"id":"30682152"},{"golden":false,"id":"20121657"},{"golden":false,"id":"24885428"},{"golden":false,"id":"31252241"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":572,"document":"19225009","golden":false,"offsetInEndSection":884,"text":"European data on intrauterine insemination using husband/partner\u0027s semen (IUI-H) and donor semen (IUI-D) were reported from 21 countries and included 128 908 IUI-H and 20 568 IUI-D cycles.RESULTS: In 16 countries where all clinics reported to the IVF register, 1115 cycles were performed per million inhabitants.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1529,"document":"19225009","golden":true,"offsetInEndSection":1759,"text":"In women \u003c40 years of age, IUI-H was associated with a twin and triplet pregnancy rate of 11.0% and 1.1%, respectively.CONCLUSIONS: Compared with earlier years, there was an increase in the reported number of ART cycles in Europe.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1614,"document":"20121657","golden":false,"offsetInEndSection":1904,"text":"A higher cumulative pregnancy rate was observed with the use of follitropin alfa FbM than follitropin alfa FbIU (41.3% vs 37.8%, respectively; p \u003d 0.02).CONCLUSIONS: This study represents the most comprehensive audit of individualized ART in clinical practice in Central and Eastern Europe.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":451,"document":"35562615","golden":false,"offsetInEndSection":645,"text":"Data from PPCM patients were compared to those from postpartum women in the German general population.RESULTS: The prevalence of reported subfertility was high among PPCM patients (30%; 33/111).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":991,"document":"19225009","golden":false,"offsetInEndSection":1046,"text":"For ICSI, the corresponding rates were 28.5% and 30.9%.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1312,"document":"19225009","golden":false,"offsetInEndSection":1430,"text":"The distribution of singleton, twin and triplet deliveries after IVF and ICSI was 78.2%, 21.0% and 0.8%, respectively.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1431,"document":"19225009","golden":false,"offsetInEndSection":1528,"text":"This gives a total multiple delivery rate of 21.8% compared with 22.7% in 2004 and 23.1% in 2003.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1047,"document":"19225009","golden":false,"offsetInEndSection":1128,"text":"After IUI-H, the clinical pregnancy rate was 12.6% per insemination in women \u003c40.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":885,"document":"19225009","golden":false,"offsetInEndSection":990,"text":"For IVF, the clinical pregnancy rates per aspiration and per transfer were 26.9% and 30.3%, respectively.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":318,"document":"31850340","golden":true,"offsetInEndSection":589,"text":"According to the latest reports of the European Society of Human Reproduction and Embryology (ESHRE) and the Centers for Disease Control and Prevention of the United States (CDC), the percentages of deliveries per ART cycle in 2014 and 2016 were 21 and 22%, respectively.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35328944","golden":false,"offsetInEndSection":230,"text":"Around 20% of couples worldwide are affected by infertility issues, with numbers in the European Union reaching as high as 25%, while access to reproductive care varies significantly by geopolitical and country-specific variables.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":847,"document":"35328944","golden":false,"offsetInEndSection":1057,"text":"We observed that high stress exposure leads to a substantially higher duration to conceive using ART, although the proportions of successful pregnancies did not differ between low-stress and high-stress groups.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1234,"document":"22924252","golden":true,"offsetInEndSection":1603,"text":"The clinical pregnancy rate per ermbryo transfer was 35.44%; while the live birth rate per embryo transfer was 26.53%.DISCUSSION AND CONCLUSION: Our success rates are comparable with those in other European countries, where for in vitro fertilization the clinical pregnancy rates per aspiration and per transfer were 29.0 and 32.4%, respectively in the observed period.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1374,"document":"35328944","golden":false,"offsetInEndSection":1637,"text":"The findings indicated that Romanian couples experiencing infertility must contend with significant expenses for specialist infertility treatments, as well as treatment-related stress, both of which have a detrimental effect on their odds of attaining conception.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1058,"document":"35328944","golden":false,"offsetInEndSection":1220,"text":"A significantly higher number of couples achieved pregnancy when their monthly household income was higher than EUR 1000 and if the ART method was more expensive.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32312123","golden":false,"offsetInEndSection":171,"text":"Introduction: An estimated of 500,000 women and girls in the European Union (EU) have undergone female genital mutilation (FGM), with a further 180,000 at risk every year.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1221,"document":"35328944","golden":false,"offsetInEndSection":1373,"text":"Additionally, we observed that advanced age, high stress levels, and the high cost of ART had a negative association with achieving pregnancy using ART.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":231,"document":"35328944","golden":false,"offsetInEndSection":421,"text":"The purpose of this research is to shed light on the unique social, psychological, and financial difficulties faced by Romanian couples seeking access to assisted reproductive therapy (ART).","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"35328944","golden":false,"offsetInEndSection":102,"text":"Impact of Stress and Financials on Romanian Infertile Women Accessing Assisted Reproductive Treatment.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"22924252","golden":false,"offsetInEndSection":84,"text":"INTRODUCTION: Infertility affects 15-17% of reproductive age couples in our country.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":694,"document":"7021189","golden":false,"offsetInEndSection":779,"text":"Forty-five subjects (5%) became pregnant during the average 3.1-cycle teaching phase.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":594,"document":"22924252","golden":false,"offsetInEndSection":1141,"text":"The main outcome measures were demographic features, cause of infertility, duration of stimulation, average gonadothropine consumption, number of oocytes per aspiration and embryos transferred, mode of conception as well as clinical pregnancy and aspiration rate.RESULTS: The two main factors were the male infertility and tubal factor inferitily, being 51.61% and 48.39%, respectively The classical method of in vitro fertilization constituted 72.40% of all cycles, while intra cytoplasmic sperm injection method was used in 27.60% of all cycles.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1279,"document":"36085268","golden":false,"offsetInEndSection":1552,"text":"Only nine patients (8.0%) underwent ovarian tissue transplantation for fertility restoration and six of them became pregnant and delivered at least once.CONCLUSION: Young adult women expressed a good satisfaction rate with OTC and that their experience had been beneficial.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1604,"document":"31667820","golden":false,"offsetInEndSection":1834,"text":"Twenty percent (n?\u003d?15) of the women who underwent social egg freezing have successfully had a baby or are currently pregnant, half (n?\u003d?8; 53%) of whom conceived spontaneously and a quarter (n?\u003d?4; 26%) used their stored oocytes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1835,"document":"31667820","golden":false,"offsetInEndSection":2092,"text":"In all, 91% (n?\u003d?73) had no regrets over their decision to undergo social egg freezing.CONCLUSIONS: We demonstrate herein important and novel insights into the motivations and perceptions of women from a UK population who have undergone social egg freezing.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31667820","golden":false,"offsetInEndSection":229,"text":"INTRODUCTION: Social egg freezing enhances reproductive autonomy by empowering women with the capacity to delay their childbearing years, while preserving the opportunity to maintain biological relation with subsequent offspring.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1216,"document":"31667820","golden":false,"offsetInEndSection":1357,"text":"The majority of women (83%; n?\u003d?68) knew there was a chance of treatment failure in the future and that a live birth could not be guaranteed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":531,"document":"31667820","golden":false,"offsetInEndSection":1074,"text":"The aim of this study was to investigate the motivations of women who have undergone social egg freezing, identify their perceptions following treatment, and assess potential feelings of regret.MATERIAL AND METHODS: This cross-sectional survey, based at a fertility clinic in the UK, used an electronic questionnaire to assess the motivations and perceptions of women who underwent social egg freezing between 1 January 2008 and 31 December 2018.RESULTS: One hundred questionnaires were distributed, and 85 women responded (85% response rate).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":914,"document":"36316218","golden":false,"offsetInEndSection":1130,"text":"Thanks to progress in treatment, up to 80% of pediatric oncology patients survive into adulthood, but chemotherapy, especially highly effective alkylating agents, is associated with a high risk of impaired fertility.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2093,"document":"31667820","golden":false,"offsetInEndSection":2234,"text":"Despite potential physical, psychological, and financial burdens, only a small minority of women experience regret after social egg freezing.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1076,"document":"34291195","golden":false,"offsetInEndSection":1203,"text":"In the BT trial, the percentage of responders was 21.4% versus 4.5% (P \u003c 0.0001) for luspatercept versus placebo, respectively.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1075,"document":"31667820","golden":false,"offsetInEndSection":1215,"text":"The most frequent reason for freezing oocytes was not having a partner with 56 (70%) women saying it \"definitely\" influenced their decision.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":687,"document":"33448004","golden":false,"offsetInEndSection":1105,"text":"The report presents the availability and structure of infertility treatment services, the number of procedures, their effectiveness and complications.RESULTS: Between 2013 and 2016, a total of 106,718 treatment cycles using ART [64,413 classical in vitro fertilization and in vitro fertilization with intracytoplasmic sperm injection (IVF + ICSI), 36,041 frozen embryo replacements (FER)] and 51,405 IUI were recorded.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1431,"document":"22369001","golden":true,"offsetInEndSection":1658,"text":"Our success rates are comparable with those in other European countries where the clinical pregnancy rates per aspiration and per transfer for in vitro fertilization were 29 and 32.4%, respectively in the period of observation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1080,"document":"22369001","golden":true,"offsetInEndSection":1430,"text":"The clinical pregnancy and live birth rate were 33.41% and 26.78% per embryo transfer respectively.DISCUSSION AND CONCLUSION: The results in our study showed that in our setting there are far less intracytoplasmic sperm injection cycles compared with the European average of 66.5% of all fresh cycles, and that we transferred more embryos on average.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"22369001","golden":false,"offsetInEndSection":117,"text":"INTRODUCTION: Infertility affects 15-17% of reproductive age couples in our country, and 10-15% of couples worldwide.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1005,"document":"22369001","golden":false,"offsetInEndSection":1079,"text":"The cycle cancellation rate was 14.10% and the aspiration rate was 94.40%.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":118,"document":"22369001","golden":false,"offsetInEndSection":700,"text":"The aim of this paper was to present results and experience gained after the first 1000 cycles of the national In Vitro Fertilization (IVF) program, to offer professional standard of work in our country and to compare it with results obtained in Europe and worldwide.MATERIAL AND METHODS: The study prospectively included 1000 women who had undergone national In Vitro Fertilization program from October 2006 until November 2009 at the Department of Gynecology and Obstetrics, Clinical Center of Vojvodina, Novi Sad.RESULTS: The analysis included 1000 in vitro fertilization cycles.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":789,"document":"22369001","golden":false,"offsetInEndSection":952,"text":"The classic method of in vitro fertilization constituted 72.3% of all cycles, while intracytoplasmic sperm injection (ICSI) method was used in 27.7% of all cycles.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1835,"document":"20570973","golden":true,"offsetInEndSection":2158,"text":"IUI-H in women below 40 years of age resulted in 10.6% twin and 0.6% triplet pregnancies.CONCLUSIONS: Compared with previous years, the reported number of ART cycles in Europe has increased, pregnancy rates have increased marginally, even though fewer embryos were transferred and the multiple delivery rates have declined.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1659,"document":"22369001","golden":false,"offsetInEndSection":1739,"text":"For intracytoplasmic sperm injection, the corresponding rates were 29.9 and 33%.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":953,"document":"22369001","golden":false,"offsetInEndSection":1004,"text":"The average number of embryos transferred was 2.67.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":684,"document":"15016781","golden":false,"offsetInEndSection":752,"text":"Mandatory eSET would result in 42%-70% fewer births compared to DET.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1157,"document":"35251982","golden":false,"offsetInEndSection":1483,"text":"Of the patients with CR, 57 women attempted to get pregnant and 16 (28.1%) patients became pregnant, 7 (12.3%) of them successfully delivered and 4 (7.0%) were in pregnancy, while 5 (8.8%) of them miscarried.CONCLUSION: For obese patients with EC and AEH, fertility-preserving treatment can still achieve a promising response.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":994,"document":"26493012","golden":false,"offsetInEndSection":1076,"text":"ree survival rate was 71%. Among the 33 patients who retained a desire to conceive","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2093,"document":"26917474","golden":false,"offsetInEndSection":2258,"text":"ssel rupture was observed. The effect on menstrual cycle and fertility were followed in 25 patients. 17 (68%, 17/25) reported resumption of normal menses and 8 (32%,","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1077,"document":"26493012","golden":false,"offsetInEndSection":1139,"text":" 17 (52%) became pregnant.CONCLUSION: Fertility-sparing manage","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1112,"document":"31598568","golden":false,"offsetInEndSection":1298,"text":"r this study was 104.0 males per 100 female births (binomial exact 95% CI: 103.1-105.0) for all IVF and ICSI cycles performed in the UK recorded through the HFEA. This was comparable to ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":445,"document":"26083621","golden":false,"offsetInEndSection":707,"text":"Data from the Human Fertilisation and Embryology Authority suggests live birth rates after in vitro fertilisation for lesbians is comparable to estimates for natural attempt at pregnancy for heterosexuals, whereas success rates with donor insemination are lower.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1299,"document":"31598568","golden":false,"offsetInEndSection":1519,"text":"he overall SSR for England and Wales at 105.3 males per 100 female births (95% CI: 105.2-105.4) from 1991 to 2016 obtained from the Office of National Statistics database. Male predominance was seen with conventional ins","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":708,"document":"26083621","golden":false,"offsetInEndSection":874,"text":"Unsurprisingly, live birth rates for lesbians after in vitro fertilisation are higher compared with heterosexual couples (the latter attending with fertility issues).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":875,"document":"26083621","golden":false,"offsetInEndSection":991,"text":"However, outcomes for lesbians after donor insemination are slightly lower, potentially due to increased female age.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":538,"document":"30811549","golden":false,"offsetInEndSection":722,"text":"pregnancy rate was equivalent.WHAT IS KNOWN ALREADY: Vitrification and blastocyst transfer have considerably improved success rates after FET with ongoing pregnancy rates in frozen cyc","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2259,"document":"26917474","golden":false,"offsetInEndSection":2301,"text":"8/25) reported amenorrhea. Three pregnanci","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1244,"document":"38113762","golden":false,"offsetInEndSection":1604,"text":"Practices of European specialists were also guided by sperm parameter results; 44-67% of specialists responding that they would propose sperm cryopreservation in cases of moderate to severe sperm parameter alterations.CONCLUSION: Post-treatment semen analysis could be widely proposed to CCS who have not benefitted from pre-therapeutic fertility preservation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1486,"document":"24067621","golden":false,"offsetInEndSection":1864,"text":"No statistically significant difference in the outcome of in vitro fertilization or intracytoplasmic sperm injection was observed between women with normal hysteroscopic findings and patients with hysteroscopically corrected endometrial disease.CONCLUSION: Sensitivity of diagnostic hysteroscopy is significantly higher than TVS and HSG in the diagnosis of intrauterine lesions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":658,"document":"38113762","golden":false,"offsetInEndSection":1001,"text":"Demographic characteristics of the responding practitioner were also collected.RESULTS: Post-treatment sperm cryopreservation was proposed by 100% of fertility specialists in cases of severe oligoasthenoteratozoospermia, 77-88% in cases of moderate oligoasthenoteratozoospermia and in 65-77% in cases of sperm motility and vitality impairment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":433,"document":"35251982","golden":false,"offsetInEndSection":695,"text":"Clinical characteristics, treatment outcomes, adverse events, and reproductive outcomes were collected and analyzed.RESULTS: A total of 88 (86.3%) patients achieved complete response (CR), 92.5% in AEH and 82.3% in EC, with 6 months (3-12 months) median CR time.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38336757","golden":false,"offsetInEndSection":95,"text":"Perceptions and experiences of fertility preservation in female patients with cancer in Greece.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":932,"document":"38319332","golden":false,"offsetInEndSection":1090,"text":"Statistical methods included logistic regression adjusted for characteristics of the pregnant individuals, with additional restricted and stratified analyses.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":59,"document":"38289310","golden":false,"offsetInEndSection":199,"text":"In Russia, the proportion of infertile marriages ranges from 8 to 17.5%, with half of all forms of female infertility being the uterine form","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38183116","golden":false,"offsetInEndSection":114,"text":"In Italy the fertility rate is very low, and an increasing number of patients are infertile and require treatments","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":386,"document":"38133445","golden":false,"offsetInEndSection":631,"text":"Standardized screening of fertile, non-pregnant, women from endemic countries and subsequent treatment is considered an essential strategy to control transmission and prevent new cases, yet no uniform legislation for screening risk groups exists","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":154,"document":"38132370","golden":false,"offsetInEndSection":260,"text":"The regulation of reproductive medicine procedures is stricter in Switzerland than in some other countries","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":385,"document":"38127973","golden":false,"offsetInEndSection":661,"text":"The analysis, specifically, tests our prior model using a third time point, The following positive constructs were examined in relation to later positive mental health: resilience, social support, social rhythm, family affluence, physical health and expectations for fertility","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2260,"document":"38113196","golden":false,"offsetInEndSection":2391,"text":"The associations between fertility treatments and BMI were only modestly different in subgroups defined by the cause of infertility","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38096116","golden":false,"offsetInEndSection":157,"text":"First 15 Years of Assisted Reproductive Technology Using Washed Sperm in HIV-Positive Individuals Under Antiretroviral Therapy: Sweden\u0027s Nationwide Outcomes.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1019,"document":"38070921","golden":false,"offsetInEndSection":1143,"text":"63% (n\u003d132) of the cohort had previously considered adoption, 5% (n\u003d11) had attempted it and 2 (1%) had successfully adopted","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":937,"document":"38353086","golden":false,"offsetInEndSection":1080,"text":"A random-effects meta-analysis was performed.RESULTS: The overall pregnancy rate after anastomosis was found to be 65.3?% (95?% CI: 61.0-69.6).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38353086","golden":false,"offsetInEndSection":96,"text":"OBJECTIVE: Between 20% and 30% of women who have undergone tubal ligation regret their decision.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1081,"document":"38353086","golden":false,"offsetInEndSection":1195,"text":"The percentage of women who had at least one live birth, known as the birth rate, was 42.6?% (95?% CI: 34.9-51.4).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1654,"document":"38353086","golden":false,"offsetInEndSection":2145,"text":"Finally, when comparing the results of tubal reversal with in vitro fertilization, reversal procedures appear more favorable for patients over 35?years old, while the results are similar for patients under 35?years old, but more data is needed to evaluate this finding.CONCLUSION: Therefore, the available literature review demonstrates that surgical anastomosis following tubal ligation is a reproducible technique with relevant success rates, performed by multiple expert groups worldwide.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1103,"document":"27378767","golden":false,"offsetInEndSection":1233,"text":"More women in the FETO group attempted a subsequent pregnancy: 70% (62/89) when compared with 47% (27/58) in controls (P \u003d 0.009).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1196,"document":"38353086","golden":false,"offsetInEndSection":1407,"text":"Adverse outcomes after surgery were also examined: the observed abortion rate among women who underwent surgery was 9.4?% (95?% CI: 7.0-11.7), and the overall ectopic pregnancy rate was 6.8?% (95?% CI: 4.6-9.0).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":119,"document":"27666276","golden":false,"offsetInEndSection":249,"text":"The fertility rate was 1.65 in 2011, and the average age of women at first child birth was 4?years higher than in the early 1990s.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":76,"document":"20667406","golden":false,"offsetInEndSection":296,"text":"Our experience with five patients suggests that IVF is a safe and effective fertility treatment for these women, although special considerations should be made when treating patients who have undergone bariatric surgery.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1234,"document":"27378767","golden":false,"offsetInEndSection":1400,"text":"This coincided with a longer follow-up in the FETO group (76 versus 59 months; P \u003c 0.001) and a lower survival rate in the index pregnancy (53 versus 72%; P \u003d 0.028).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":643,"document":"27543212","golden":false,"offsetInEndSection":960,"text":"The proposed fertility risk category system is analogous to the FDA\u0027s A/B/C/D/X/N pregnancy-risk categories.RESULTS: For female patients, 58% of treatments represent a fertility risk (Category C and D), 33% have unknown risk (Category N), and 1 therapy (vemurafenib) did not show animal ovarian toxicity (Category B).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"18954861","golden":false,"offsetInEndSection":107,"text":"The number of infertile couples to be cared for in infertility centres is estimated to be between 1 to 6 %.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2588,"document":"18566567","golden":false,"offsetInEndSection":2857,"text":"Similarly, 15% of ART singletons, 66% of ART twins, and 97% of ART triplets or higher-order multiples were born preterm.INTERPRETATION: Whether an ART procedure resulted in a pregnancy and live-birth delivery varied according to different patient and treatment factors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1692,"document":"18566567","golden":false,"offsetInEndSection":1815,"text":"The highest live-birth rates were observed among ART procedures that used freshly fertilized embryos from donor eggs (52%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1540,"document":"18566567","golden":false,"offsetInEndSection":1691,"text":"Overall, 42% of ART transfer procedures resulted in a pregnancy, and 35% resulted in a live-birth delivery (delivery of one or more live-born infants).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1484,"document":"36029062","golden":false,"offsetInEndSection":1839,"text":"In total, 82 recipients were granted donated cryo-embryos, twenty had an ongoing pregnancy\u003cbr /\u003e(24.4%), nineteen of whom have given birth to a healthy child (23%).\u003cbr /\u003eConclusion: Altruistic embryo donation of embryos appears to be satisfying for the donors, as they are not obliged to destroy\u003cbr /\u003etheir embryos, but instead help others build a family.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36998947","golden":false,"offsetInEndSection":160,"text":"BACKGROUND: The prevalence of female infertility between the ages of 25 and 44 is 3.5% to 16.7% in developed countries and 6.9% to 9.3% in developing countries.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":685,"document":"36029062","golden":true,"offsetInEndSection":1200,"text":"We perform a\u003cbr /\u003ethorough medical and psychological screening of donor couples and recipients, according to the protocol drawn up in\u003cbr /\u003eclose collaboration with the Dutch Ministry of Health.\u003cbr /\u003eResults: Up to June 2021, 54 women have received embryos from our embryo bank, all single embryo transfers.\u003cbr /\u003eWhile the clinical pregnancy rate in \u0027unknown\u0027 embryo donations was relatively high (25.3%), the live birth rate\u003cbr /\u003eshows limited success (12.6%), partly due to high pregnancy loss through miscarriage.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2150,"document":"18566567","golden":false,"offsetInEndSection":2324,"text":"The multiple-birth risk was highest for women who underwent ART transfer procedures that used freshly fertilized embryos from either donor eggs (41%) or their own eggs (32%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1226,"document":"18566567","golden":false,"offsetInEndSection":1303,"text":"These procedures resulted in 38,910 live-birth deliveries and 52,041 infants.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1731,"document":"32142582","golden":false,"offsetInEndSection":1821,"text":"Among the 1745 embryo transfer cycles, 856 of the cycles resulted in a live birth (49.1%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2399,"document":"18566567","golden":false,"offsetInEndSection":2461,"text":"Those infants accounted for 17% of multiple births nationwide.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":207,"document":"38353086","golden":false,"offsetInEndSection":617,"text":"This article presents a systematic review with meta-analysis to assess the current evidence on the efficacy of tubal recanalization surgery in patients who have previously undergone tubal ligation.STUDY DESIGN: The search was conducted in the World of Science (WOS) database, The Cochrane Library and ClinicalTrials.gov record using the keywords \"tubal reversal\", \"tubal reanastomosis\" and \"tubal anastomosis\".","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1551,"document":"38353086","golden":false,"offsetInEndSection":1653,"text":"The patient\u0027s age was identified as the most significant determining factor for fertility restoration.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1633,"document":"38337248","golden":false,"offsetInEndSection":1930,"text":"Furthermore, the overall efficiency of the plastic degradation of pre-treatments should be studied using a multicriteria approach, since FTIR assessments, in some cases, only consider oxidation processes on the plastic surface and do not show the potential integrity changes on the plastic probes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38203658","golden":false,"offsetInEndSection":84,"text":"Infertility affects millions worldwide, posing a significant global health challenge","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":554,"document":"38199042","golden":false,"offsetInEndSection":655,"text":"We also evaluated the interaction of current smoking with sex or diet (fibre, folate, and vitamin C).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":345,"document":"38142472","golden":false,"offsetInEndSection":531,"text":"Each sample was classified into two groups according to pregnancy rates (PR) achieved with this semen: \"good fertility\" (GF; n?\u003d?17; PR???30?%) or \"poor fertility\" (PF; n?\u003d?12; PR \u003c20?%)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1260,"document":"38139165","golden":false,"offsetInEndSection":1463,"text":"Although we are far from a complete understanding of the regulatory processes, the results of PARS research and the therapeutic application of aspirin and PRP during in vitro fertilization are promising.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":863,"document":"38110741","golden":false,"offsetInEndSection":1065,"text":"We apply the method to the case of Namibia (2019) using estimates of fertility and survival from the United Nations World Population Prospects along with nationally representative data on the MNM ratio.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":416,"document":"38079178","golden":false,"offsetInEndSection":612,"text":"This observational population-based cohort study used data from 4 Nordic countries (2009-2020), the US MarketScan Database (2012-2021), and the Israeli Maccabi Health Services database (2009-2020)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":3048,"document":"38052102","golden":false,"offsetInEndSection":3177,"text":"We hope our results will inform investigations of ovarian response in new and existing ARTs and the causes of female infertility.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1382,"document":"38050118","golden":false,"offsetInEndSection":1689,"text":"Such legislation and guidelines should guarantee the consistency of values throughout diverse reproductive contexts and mandate that fertility clinics and medical professionals provide individuals with comprehensive information regarding the potential risks associated with assisted reproductive treatments.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1080,"document":"38002013","golden":false,"offsetInEndSection":1229,"text":"Data were collected from 100 men who underwent IVF/ICSI at the University Hospital of Ioannina\u0027s IVF Unit in the Obstetrics and Gynecology Department","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":550,"document":"37010330","golden":false,"offsetInEndSection":1136,"text":"While also addressing work-up for fertility preservation treatments and the management and follow-up for fertility preservation, it was considered relevant to further extend the guidance on fertility sparing treatment.Objectives: To define recommendations for fertility-sparing treatment of patients with endometrial carcinoma.Materials and Methods: ESGO/ESHRE/ESGE nominated an international multidisciplinary development group consisting of practicing clinicians and researchers who have demonstrated leadership and expertise in the care and research of EC (11 experts across Europe).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":724,"document":"35005162","golden":false,"offsetInEndSection":841,"text":"The patient achieved union and the initially planned limb lengthening regime was achieved with minimal complications.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37010330","golden":false,"offsetInEndSection":235,"text":"Background: The standard surgical treatment of endometrial carcinoma (EC) consisting of total hysterectomy with bilateral salpingo-oophorectomy drastically affects the quality of life of patients and creates a challenge for clinicians.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":449,"document":"38323524","golden":false,"offsetInEndSection":687,"text":"We conducted a retrospective cohort study including 67?613 pregnant women, participating in the Norwegian Mother, Father and Child Cohort Study between 1999 and 2008, with self-reported information on age at menarche and time to pregnancy","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":599,"document":"38283622","golden":false,"offsetInEndSection":871,"text":"A cross-sectional analysis was conducted using data from 200 healthy men (mean age 28.4???5.5?years) enrolled in the Led-Fertyl (Lifestyle and Environmental Determinants of Seminogram and Other Male Fertility-Related Parameters) study between February 2021 and April 2023.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1406,"document":"38273527","golden":false,"offsetInEndSection":1698,"text":"A review of the latest advances in agronomy shows that some of the practices suggested to promote synchrony (e.g., reduced tillage, rotation with perennial plant cover, crop diversification) have already been tested and shown to be effective in reducing nutrient losses, fertilizer use, and N","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38249068","golden":false,"offsetInEndSection":28,"text":"The African citrus psyllid, ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":938,"document":"19646742","golden":false,"offsetInEndSection":1392,"text":"The cumulative pregnancy rate among the women who attempted to conceive was 13.8% (4/29).CONCLUSION: Among selected women with early-stage cervical cancer, especially those with a tumor diameter of \u003c20 mm, abdominal radical trachelectomy and pelvic lymphadenectomy is a fertility-sparing treatment option, even though the cumulative conception rate was not particularly high compared with that for women who had undergone a vaginal radical trachelectomy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":615,"document":"22585630","golden":false,"offsetInEndSection":990,"text":"Although the current European Union (EU) Directive can be considered a step in the right direction to improve patient safety, questions remain as to whether the implementation of this EU Directive, requiring extra time and money, has resulted in higher quality with respect to the quality dimensions of effectiveness, efficiency, timeliness, equity, and patient centeredness.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":275,"document":"22585630","golden":false,"offsetInEndSection":614,"text":"This article presents a case study of the implementation of the Tissues and Cells Directive in the Leuven University Fertility Center (LUFC) with a focus on the assisted reproductive technologies laboratory with respect to laboratory facilities, quality management system, traceability, storage conditions as well as serological screening.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"22585630","golden":false,"offsetInEndSection":133,"text":"Since 2004, assisted conception is encompassed by the European Directive on the Quality and Safety of Tissues and Cells (2004/23/EC).","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"22585630","golden":false,"offsetInEndSection":153,"text":"Does the European Union Tissues and Cells Directive improve quality in the in vitro fertilization laboratory? A case study in a tertiary referral center.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":191,"document":"22040135","golden":false,"offsetInEndSection":721,"text":"The idea of artificially conceived child protection, present in the Italian provision, is substituted, partially in French law, and totally in Spanish law, by an exclusively individualistic outlook, configuring a true ?right to maternity? for married women and for those not living with a male partner (single women, divorced or widowed) or with a female partner (lesbians), and for women inseminated artificially by the semen of the husband before or after their death, and for women already having culminated their fertile life.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":134,"document":"22585630","golden":false,"offsetInEndSection":274,"text":"The aim of a standard for quality and safety is to minimize risks of errors, contamination, and accidents and to maximize efficiency of use.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"22040135","golden":false,"offsetInEndSection":190,"text":"The paper undertakes the determination of parentage and users of assisted reproduction techniques in comparative law, particularly in three European Union countries: Italy, France and Spain.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1079,"document":"39366583","golden":false,"offsetInEndSection":1224,"text":"The model shows a reduction in yield per crop at the EU level up to 2.1, 6.4 and 11.2?% with the 5, 15 and 25?% reduction scenario, respectively.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2239,"document":"32760812","golden":false,"offsetInEndSection":2444,"text":"total of 461?401 treatment cycles were performed, corresponding to a mean of 1410 cycles per million inhabitants (range 82-3088 per million inhabitants). In the 40 reporting countries, after IVF the clinic","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34377841","golden":false,"offsetInEndSection":635,"text":"STUDY QUESTION: What are the data on ART and IUI cycles, and fertility preservation (FP) interventions reported in 2017 as compared to previous years, as well as the main trends over the years?SUMMARY ANSWER: The 21st ESHRE report on ART and IUI shows the continual increase in reported treatment cycle numbers in Europe, with a decrease in the proportion of transfers with more than one embryo causing an additional slight reduction of multiple delivery rates (DR) as well as higher pregnancy rates (PR) and DR after frozen embryo replacement (FER) compared to fresh IVF and ICSI cycles, while the number of IUI cycles increased and t","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":945,"document":"22343707","golden":false,"offsetInEndSection":1006,"text":"d 28.6 and 33.0% for ICSI. Delivery rate after IUI-H was 10.2","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1498,"document":"26645803","golden":false,"offsetInEndSection":1697,"text":"with age in all countries. ART outcomes varied by country, with the highest implantation, pregnancy, and live birth rates reported by fertility specialists in the US and China and the lowest rates re","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":122,"document":"22767463","golden":false,"offsetInEndSection":373,"text":"The demographic picture in the EU-27 is clearer: population growth is mainly the result of immigration, fertility is far below the replacement ratio, and the population is growing older, which will be a key demographic challenge in many Member States.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38806697","golden":false,"offsetInEndSection":287,"text":"PURPOSE: This study assesses fertility treatment outcomes in female patients who had undergone successful oocyte retrieval following cancer therapy.METHODS: Between January 2020 and December 2022, we collected fertility treatment data from six participating centres in Spain and Germany.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":288,"document":"38806697","golden":false,"offsetInEndSection":649,"text":"All patients associated with this data had undergone successful oocyte retrieval following cancer treatment.RESULTS: Women had most frequently been diagnosed with a haematological (41.9%), breast (22.6%) or gynaecological malignancy (12.9%); two thirds (67.7%) had previously received a chemotherapy, half a radiotherapy (53.3%) and 45.2% had undergone surgery.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1618,"document":"38806697","golden":false,"offsetInEndSection":1810,"text":"On average, children were carried to term.CONCLUSION: In this small cohort, oocytes were successfully collected after chemotherapy and radiotherapy, despite-in individual cases-low AMH values.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1165,"document":"38806697","golden":false,"offsetInEndSection":1270,"text":"Live birth rate per fresh transfer was 45% (9/20); no births were reported following cryotransfer (0/10).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":778,"document":"32521764","golden":false,"offsetInEndSection":1170,"text":"Chernobyl-exposed women were more likely to be nulliparous and have fewer children (2.1 + 0.8 vs. 3.1 + 1.8, p \u003c 0.001), were more likely to undergo fertility treatments (8.8% vs. 5.8%, adjusted OR \u003d 1.8, 95%CI 1.04-3.2, p \u003d 0.036), and were also more likely to have anemia after delivery (49.4% vs. 36.6%, OR \u003d 1.7, 95%CI 1.2-2.3, p \u003d 0.001), compared to women in the combined comparison gro","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1038,"document":"38806697","golden":false,"offsetInEndSection":1164,"text":"Out of the 190 oocytes collected for immediate use of artificial reproductive technique, 139 were fertilised at a rate of 73%.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1171,"document":"32521764","golden":false,"offsetInEndSection":1333,"text":"ps. The overall fertility of Chernobyl-exposed women seems to be reduced as reflected by the lower number of children and their greater need for fertility treatme","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1554,"document":"38806697","golden":false,"offsetInEndSection":1617,"text":"Two twin and 5 single pregnancies resulted in nine live births.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1497,"document":"38806697","golden":false,"offsetInEndSection":1553,"text":"Ten pregnancies were documented; 3 ended in miscarriage.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":756,"document":"38806697","golden":false,"offsetInEndSection":929,"text":"Forty-nine ovarian stimulation cycles had been conducted on these 31 women between 2004 and 2021 (mean age at first oocyte collection following treatment: 34.8 ? 5.7 years).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33043154","golden":false,"offsetInEndSection":600,"text":"STUDY QUESTION: What are women\u0027s perceptions and experience of fertility assessment and counselling 6 years after attending a Fertility Assessment and Counselling (FAC) clinic in Denmark?SUMMARY ANSWER: Women viewed the personalized fertility knowledge and advice they received as important aids to decision-making and they felt the benefits outweighed the risks of receiving personalized fertility information.WHAT IS KNOWN ALREADY: Many young people wish to become parents in the future. However, research demonstrates there is a gap in women\u0027s and men\u0027s knowledge of fertility and suggests they ma","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36210721","golden":false,"offsetInEndSection":500,"text":"STUDY QUESTION: What are women\u0027s views on having children, including the age they want to have them and other influences such as the coronavirus disease 2019 (COVID-19) pandemic?SUMMARY ANSWER: Women\u0027s views on having children, at their preferred age of 30?years, included their maternal urge and concerns about their biological clock and stability, while 19% said COVID-19 had affected their views.WHAT IS KNOWN ALREADY: Women globally are delaying the birth of their first child, with the average a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35328944","golden":false,"offsetInEndSection":700,"text":"Around 20% of couples worldwide are affected by infertility issues, with numbers in the European Union reaching as high as 25%, while access to reproductive care varies significantly by geopolitical and country-specific variables. The purpose of this research is to shed light on the unique social, psychological, and financial difficulties faced by Romanian couples seeking access to assisted reproductive therapy (ART). A cross-sectional study was conducted between 2017 and 2019 to involve women who accessed ART at fertility clinics in Romania by completing two infertility surveys. We analyzed the data in terms of all facets of infertility and ART, including the effect of personal background a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32161952","golden":false,"offsetInEndSection":600,"text":"STUDY QUESTION: Does the method of fertilisation improve reproductive outcomes in poor ovarian response (POR) cycles when compared to all other ovarian response categories in the absence of male factor subfertility?SUMMARY ANSWER: ICSI does not confer any benefit in improving the clinical pregnancy or live birth (LB) outcome in autologous ovarian response cycles in the absence of male factor subfertility when compared to IVF.WHAT IS KNOWN ALREADY: ICSI is associated with an improved outcome when compared to IVF in patients with severe male factor subfertility.STUDY DESIGN, SIZE, DURATION: A re","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1104,"document":"30682152","golden":false,"offsetInEndSection":1227,"text":" total) men and women responded. Among all respondents, 10% had undergone IVF treatment and 48% had considered or would con","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1835,"document":"20121657","golden":false,"offsetInEndSection":1937,"text":"ndividualized ART in clinical practice in Central and Eastern Europe. Overall, clinical pregnancy was ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":324,"document":"11547268","golden":false,"offsetInEndSection":427,"text":" clinic in Canada.RESULTS: The women had been in fertility treatment for 2.3 +/- 2.6 years; 67.8% repor","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2365,"document":"36112009","golden":false,"offsetInEndSection":2633,"text":"cations) to the closest fertility clinic after adjusting for SES, childbearing delay, remoteness area, and marital status.MAIN RESULTS AND THE ROLE OF CHANCE: On average, 19.1 women per 1000 women of reproductive age underwent at least one fresh or frozen ART cycle, w","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":855,"document":"32377787","golden":false,"offsetInEndSection":986,"text":"to cryopreserve oocytes. About 3?years after treatment, 37 women of 72 women (51%) of the women with a mean age of 29.9?years had a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":813,"document":"24885428","golden":false,"offsetInEndSection":961,"text":"Embryology (ESHRE).RESULTS: Most countries with a higher total fertility rate (TFR) also registered a higher number of treatment cycles per 1 millio","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":216,"document":"31252241","golden":false,"offsetInEndSection":585,"text":"How do Spanish fertility clinics manage to match the increasing domestic and foreign demand for female oocytes? Adopting a weak performativity approach and drawing insights from interviews carried out with 20 fertility clinic representatives, this study suggests that Spanish clinics are successful thanks to an egg provision system designed as a (quasi) social market.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1616,"document":"33744927","golden":false,"offsetInEndSection":1898,"text":" alkylating agent exposure, and (ii) dose categories for individual chemotherapeutic agents and for RT-exposed body sites.MAIN RESULTS AND THE ROLE OF CHANCE: A positive dose-effect relationship between cyclophosphamide equivalent dose (CED) score and fertility impairment was found","beginSection":"abstract"}],"exact_answer":[],"ideal_answer":[],"id":"6593d3ab06a2ea257c00001a","type":"factoid","body":"What is the percentage of women that have successfully undergone fertility treatment in the European Union?"},{"documents":[{"golden":true,"id":"36527479"},{"golden":false,"id":"39472236"},{"golden":false,"id":"33688234"},{"golden":false,"id":"26484146"},{"golden":false,"id":"24135723"},{"golden":false,"id":"28419265"},{"golden":false,"id":"11433091"},{"golden":false,"id":"11861933"},{"golden":false,"id":"25661089"},{"golden":false,"id":"14751053"},{"golden":false,"id":"38467246"},{"golden":false,"id":"38549978"},{"golden":false,"id":"35198634"},{"golden":false,"id":"22547779"},{"golden":false,"id":"22507868"},{"golden":false,"id":"9350892"},{"golden":false,"id":"29563816"},{"golden":false,"id":"36411922"},{"golden":false,"id":"17211148"},{"golden":false,"id":"37448783"},{"golden":false,"id":"23297182"},{"golden":false,"id":"38517573"},{"golden":false,"id":"11181212"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":1202,"document":"36527479","golden":true,"offsetInEndSection":1844,"text":"Through bioinformatics analysis, a diagnostic four-gene model that can accurately distinguish neonatal EOS in newborns with bacterial infection was constructed, which can be used as an auxiliary test for diagnosing neonatal EOS with bacterial infection in the future.CONCLUSION: In the current study, we analyzed gene expression profiles of neonatal EOS patients from public databases to develop a genetic model for predicting sepsis, which could provide insight into early molecular changes and biological mechanisms of neonatal EOS.WHAT IS KNOWN: ??Infants with suspected EOS usually receive empiric antibiotic therapy directly after birth.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1554,"document":"39472236","golden":false,"offsetInEndSection":1952,"text":"Additionally, during the first week of life, EOS disrupted expression of \u003e1800 genes including those influencing immune and metabolic transitions observed in healthy controls.INTERPRETATION: Despite appearing healthy at birth, neonates who later developed EOS already had distinct whole blood gene expression changes at birth, which enabled the development of a 4-gene predictive signature for EOS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1630,"document":"33688234","golden":false,"offsetInEndSection":1909,"text":"SLC2A6 was identified by STEM as associated with sepsis-associated mortality and showed the strongest positive correlation with infiltration levels of Th1 cells.CONCLUSION: In summary, our four key genes may have important implications for the early diagnosis of sepsis patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":755,"document":"36527479","golden":false,"offsetInEndSection":918,"text":"Four genes (CST7, CD3G, CD247, and ANKRD22) were identified that most accurately predicted neonatal EOS and were subsequently used to construct a diagnostic model.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36527479","golden":true,"offsetInEndSection":125,"text":"Identification and validation of a novel four-gene diagnostic model for neonatal early-onset sepsis with bacterial infection.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":934,"document":"26484146","golden":false,"offsetInEndSection":1177,"text":"Our data set has allowed identification of a patient invariant 52-gene classifier that predicts bacterial infection with high accuracy and lays the foundation for advancing diagnostic, prognostic and therapeutic strategies for neonatal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1993,"document":"36527479","golden":false,"offsetInEndSection":2319,"text":"Additionally, because of the concern for inadequate clinical sepsis production and the limited sensitivity of blood cultures, the duration of antibiotic therapy for the kid is typically extended.WHAT IS NEW: ??We established a 4-gene diagnostic model of neonatal EOS with bacterial infection by bioinformatics analysis method.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1945,"document":"14751053","golden":false,"offsetInEndSection":2251,"text":"The positive rate of CD(11b) detection was 86.3%, which was higher than the blood culture test (17.6%, chi(m)(2) \u003d 31.2, P \u003c 0.05).CONCLUSION: The expression of CD(11b) in neonatal sepsis presented with a down-regulation and, the decreased CD(11b) expression might be related to the severity of infections.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":994,"document":"28419265","golden":false,"offsetInEndSection":1284,"text":"We recently reported an 11-gene diagnostic test for sepsis (Sepsis MetaScore) based on host whole-blood gene expression in children and adults, but this test has not been evaluated in neonates.METHODS: We identified existing gene expression microarray-based cohorts of neonates with sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":919,"document":"36527479","golden":false,"offsetInEndSection":1095,"text":"ROC analysis revealed that this diagnostic model performed well in differentiating between neonatal EOS and normal infants in both the GSE25504 dataset and our clinical cohort.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":182,"document":"39472236","golden":false,"offsetInEndSection":322,"text":"ervention. Our objective was to identify neonatal sepsis gene expression biomarkers that could predict sepsis at birth, prior to clinical pr","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1487,"document":"38467246","golden":false,"offsetInEndSection":1942,"text":"le types, because of a lack of a uniform EOS case definition, small sample sizes, and large heterogeneity between studies. Interesting markers were procalcitonin (pooled sensitivity 79%, 95% CI 71-84%; specificity 91%, 95% CI 83-96%, n?\u003d?11) and interleukin (IL)-6 (pooled sensitivity 83%, 95% CI 71-90%; specificity 87%, 95% CI 78-93%, n?\u003d?8) in umbilical cord blood and presepsin (pooled sensitivity 82%, 95% CI 62-93%; specificity 86%, 95% CI 73-93%, n","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":29,"document":"38549978","golden":false,"offsetInEndSection":84,"text":"I: 10.1155/2022/5217885.].","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1816,"document":"35198634","golden":false,"offsetInEndSection":1944,"text":"1.00, respectively.CONCLUSION: The four-gene signature can be used as new biomarkers to distinguish patients with paediatric sep","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1665,"document":"36411922","golden":false,"offsetInEndSection":1954,"text":"Finally, three genes SLC2A3, OSCAR, and CD3G were identified as key biomarkers for NS.Conclusions: Our findings will provide novel insights into the pathogenesis of NS, and the potential biomarkers may have promising application values for its early detection and therapeutic intervention.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":894,"document":"17211148","golden":false,"offsetInEndSection":1450,"text":"Concentrations of all studied inflammatory mediators (except IL-1beta and RANTES) were significantly higher in the infected than in the noninfected group at 0 h, but the levels decreased precipitously by 24 h. IP-10 with a plasma cutoff concentration \u003e or \u003d 1250 pg/mL could identify all septicemic and NEC cases and had the highest overall sensitivity (93%) and specificity (89%) at 0 h. We conclude that preterm infants have the ability to induce a robust chemokine and cytokine response during sepsis, and IP-10 is a sensitive early marker of infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1675,"document":"35198634","golden":false,"offsetInEndSection":1973,"text":"In addition, the meta-analysis results showed that the pooled sensitivity, specificity, and area under the curve values were 1.00, 0.98, and 1.00, respectively.CONCLUSION: The four-gene signature can be used as new biomarkers to distinguish patients with paediatric sepsis from healthy individuals.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36527479","golden":false,"offsetInEndSection":1043,"text":"Neonatal early-onset sepsis (EOS) has unfortunately been the third leading cause of neonatal death worldwide. The current study is aimed at discovering reliable biomarkers for the diagnosis of neonatal EOS through transcriptomic analysis of publicly available datasets. Whole blood mRNA expression profiling of neonatal EOS patients in the GSE25504 dataset was downloaded and analyzed. The binomial LASSO model was constructed to select genes that most accurately predicted neonatal EOS. Then, ROC curves were generated to assess the performance of the predictive features in differentiating between neonatal EOS and normal infants. Finally, the miRNA-mRNA network was established to explore the potential biological mechanisms of genes within the model. Four genes (CST7, CD3G, CD247, and ANKRD22) were identified that most accurately predicted neonatal EOS and were subsequently used to construct a diagnostic model. ROC analysis revealed that this diagnostic model performed well in differentiating between neonatal EOS and normal infants i","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37448783","golden":false,"offsetInEndSection":1018,"text":"Objectives: Neonatal early onset sepsis (EOS), bacterial infection during the first seven days of life, is difficult to diagnose because presenting signs are non-specific, but early diagnosis before birth can direct life-saving treatment for mother and baby. Specifically, maternal fever during labor from placental infection is the strongest predictor of EOS. Alterations in maternal heart rate variability (HRV) may precede development of intrapartum fever, enabling incipient EOS detection. The objective of this work was to build a predictive model for intrapartum fever.Methods: Continuously measured temperature, heart rate, and beat-to-beat RR intervals were obtained from wireless sensors on women (n?\u003d?141) in labor; traditional manual vital signs were taken every 3-6?hours. Validated measures of HRV were calculated in moving 5-minute windows of RR intervals: standard deviation of normal-to-normal intervals (SDNN) and root mean square of successive differences (RMSSD) between normal heartbeats.Results: F","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":181,"document":"39472236","golden":false,"offsetInEndSection":321,"text":"tervention. Our objective was to identify neonatal sepsis gene expression biomarkers that could predict sepsis at birth, prior to clinical p","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"29563816","golden":false,"offsetInEndSection":158,"text":"INTRODUCTION: A key challenge in identifying serious bacterial infection in new born infants is the nonspecific clinical presentation of early-onset neonatal ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1202,"document":"36527479","golden":true,"offsetInEndSection":1469,"text":"Through bioinformatics analysis, a diagnostic four-gene model that can accurately distinguish neonatal EOS in newborns with bacterial infection was constructed, which can be used as an auxiliary test for diagnosing neonatal EOS with bacterial infection in the future.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":426,"document":"23297182","golden":false,"offsetInEndSection":636,"text":"Late-onset sepsis (LOS) attributable to gram-positive organisms including coagulase-negative Staphylococci and Staphylococcus aureus is associated with increased morbidity and mortality among premature infants.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":282,"document":"22547779","golden":false,"offsetInEndSection":449,"text":"The identification of neonates at risk for early-onset sepsis is frequently based on a constellation of perinatal risk factors that are neither sensitive nor specific.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"9350892","golden":false,"offsetInEndSection":228,"text":"Clinical diagnosis of sepsis in newborn infants is not easy and there is no laboratory test with 100% specificity and sensitivity, with the exception of blood culture, the results of which are not available for at least 48-72 h.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":636,"document":"38517573","golden":false,"offsetInEndSection":909,"text":"7/1000 live births (LB). Group B streptococcus (GBS) was the most common pathogen causing BSI in full-term infants and early-onset sepsis (EOS) (0.20/1000 LB), while coagulase-negative staphylococci (CoNS) were predominant in infants born very preterm and in late-onset sep","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"11181212","golden":false,"offsetInEndSection":148,"text":"OBJECTIVE: To analyze the incidence, etiology and management of infants born in 1977 with vertically transmitted bacteremia or suspected early neona","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"22507868","golden":false,"offsetInEndSection":103,"text":"C-reactive protein (CRP) is one of the most studied and most used laboratory tests for neonatal sepsis.","beginSection":"abstract"}],"exact_answer":"","ideal_answer":[],"id":"677ecc65592fa48873000029","type":"yesno","body":"Is there a four-gene diagnostic signature for neonatal early-onset sepsis with bacterial infection?"},{"documents":[{"golden":true,"id":"34642494"},{"golden":true,"id":"35971951"},{"golden":false,"id":"19043521"},{"golden":false,"id":"27519544"},{"golden":false,"id":"21521474"},{"golden":false,"id":"16301645"},{"golden":false,"id":"11772249"},{"golden":false,"id":"1344652"},{"golden":false,"id":"25686119"},{"golden":false,"id":"22550982"},{"golden":false,"id":"28579387"},{"golden":false,"id":"34878645"},{"golden":false,"id":"1596594"},{"golden":false,"id":"35602078"},{"golden":false,"id":"27262680"},{"golden":false,"id":"7191635"},{"golden":false,"id":"18762157"},{"golden":false,"id":"19737851"},{"golden":false,"id":"26831796"},{"golden":false,"id":"36043797"},{"golden":false,"id":"35453582"},{"golden":false,"id":"26750723"},{"golden":false,"id":"35046674"},{"golden":false,"id":"24882720"},{"golden":false,"id":"26576222"},{"golden":false,"id":"36146675"},{"golden":false,"id":"16127621"},{"golden":false,"id":"16610769"},{"golden":false,"id":"24357084"},{"golden":false,"id":"23480335"},{"golden":false,"id":"12090559"},{"golden":false,"id":"34826506"},{"golden":false,"id":"33242518"},{"golden":false,"id":"36396043"},{"golden":false,"id":"17709147"},{"golden":false,"id":"31756766"},{"golden":false,"id":"30403127"},{"golden":false,"id":"12076749"},{"golden":false,"id":"16844238"},{"golden":false,"id":"31981244"},{"golden":false,"id":"32094138"},{"golden":false,"id":"35487605"},{"golden":false,"id":"16396876"},{"golden":false,"id":"10935278"},{"golden":false,"id":"15028793"},{"golden":false,"id":"2259879"},{"golden":false,"id":"34643361"},{"golden":false,"id":"29539797"},{"golden":false,"id":"18998478"},{"golden":false,"id":"33804430"},{"golden":false,"id":"25779752"},{"golden":false,"id":"15206058"},{"golden":false,"id":"23340064"},{"golden":false,"id":"18609679"},{"golden":false,"id":"23672175"},{"golden":false,"id":"20402598"},{"golden":true,"id":"36712949"},{"golden":false,"id":"23379765"},{"golden":false,"id":"20421366"},{"golden":false,"id":"32160283"},{"golden":false,"id":"16483845"},{"golden":false,"id":"15049596"},{"golden":false,"id":"28097052"},{"golden":false,"id":"20299465"},{"golden":false,"id":"32638706"},{"golden":false,"id":"27144735"},{"golden":false,"id":"19750192"},{"golden":false,"id":"25986720"},{"golden":false,"id":"35426935"},{"golden":false,"id":"35215241"},{"golden":false,"id":"32517446"},{"golden":false,"id":"23172094"},{"golden":false,"id":"12831638"},{"golden":false,"id":"34641339"},{"golden":false,"id":"17135510"},{"golden":false,"id":"25616524"},{"golden":false,"id":"23631257"},{"golden":false,"id":"19048070"},{"golden":false,"id":"35972595"},{"golden":false,"id":"31824367"},{"golden":false,"id":"22144849"},{"golden":false,"id":"32939691"},{"golden":false,"id":"17696230"},{"golden":false,"id":"35697332"},{"golden":false,"id":"36477212"},{"golden":false,"id":"22131901"},{"golden":false,"id":"11857520"},{"golden":false,"id":"24995515"},{"golden":false,"id":"20955704"},{"golden":false,"id":"32594100"},{"golden":false,"id":"28039902"},{"golden":false,"id":"10916855"},{"golden":false,"id":"8752457"},{"golden":false,"id":"11677782"},{"golden":false,"id":"23448451"},{"golden":false,"id":"8910831"},{"golden":false,"id":"28799516"},{"golden":false,"id":"22925316"},{"golden":false,"id":"17557672"},{"golden":false,"id":"23433060"},{"golden":false,"id":"35818944"},{"golden":false,"id":"15496127"},{"golden":false,"id":"14611139"},{"golden":false,"id":"10713663"},{"golden":false,"id":"9421706"},{"golden":false,"id":"24283970"},{"golden":false,"id":"24116962"},{"golden":false,"id":"30090969"},{"golden":false,"id":"32244936"},{"golden":false,"id":"23043900"},{"golden":false,"id":"24786290"},{"golden":false,"id":"33557131"},{"golden":false,"id":"34955635"},{"golden":false,"id":"27354902"},{"golden":false,"id":"27072904"},{"golden":false,"id":"30180522"},{"golden":false,"id":"32840112"},{"golden":false,"id":"34823578"},{"golden":false,"id":"34725684"},{"golden":false,"id":"25419692"},{"golden":false,"id":"26379556"},{"golden":false,"id":"9403401"},{"golden":false,"id":"31208308"},{"golden":false,"id":"14974368"},{"golden":false,"id":"36065536"},{"golden":false,"id":"15850471"},{"golden":false,"id":"19370775"},{"golden":false,"id":"16677367"},{"golden":false,"id":"25243955"},{"golden":false,"id":"25096404"},{"golden":false,"id":"29184389"},{"golden":false,"id":"29689122"},{"golden":false,"id":"27506549"},{"golden":false,"id":"18060195"},{"golden":false,"id":"12928038"},{"golden":false,"id":"16028004"},{"golden":false,"id":"34643362"},{"golden":false,"id":"28546865"},{"golden":false,"id":"12441039"},{"golden":false,"id":"23196574"},{"golden":false,"id":"29217303"},{"golden":false,"id":"37902953"},{"golden":true,"id":"37393402"},{"golden":false,"id":"39268699"},{"golden":true,"id":"38796564"},{"golden":true,"id":"38547374"},{"golden":false,"id":"37095713"},{"golden":false,"id":"37137837"},{"golden":false,"id":"39214467"},{"golden":false,"id":"37460153"},{"golden":false,"id":"37253400"},{"golden":false,"id":"37163255"},{"golden":true,"id":"36346079"},{"golden":true,"id":"35714812"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":246,"document":"34642494","golden":true,"offsetInEndSection":441,"text":"Bepirovirsen is an antisense oligonucleotide targeting all HBV messenger RNAs; in cell culture and animal models, bepirovirsen leads to reductions in HBV-derived RNAs, HBV DNA and viral proteins.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":696,"document":"34642494","golden":true,"offsetInEndSection":836,"text":"The primary objective was to assess the safety and tolerability of bepirovirsen in individuals with chronic hepatitis B (CHB) (NCT02981602).","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34642494","golden":true,"offsetInEndSection":166,"text":"Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35714812","golden":true,"offsetInEndSection":183,"text":"BACKGROUND \u0026 AIMS: Bepirovirsen, an antisense oligonucleotide targeting pregenomic and mRNA transcripts of HBV, has been conjugated to N-acetyl galactosamine (GSK3389404) to enhance h","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36346079","golden":true,"offsetInEndSection":69,"text":"Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1225,"document":"35971951","golden":true,"offsetInEndSection":1437,"text":"In conclusion, bepirovirsen showed an acceptable safety profile in humans with observed pharmacokinetics consistent with the chemical class, warranting further evaluation of bepirovirsen in chronic HBV infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36346079","golden":true,"offsetInEndSection":346,"text":"BACKGROUND: Bepirovirsen is an antisense oligonucleotide that targets all hepatitis B virus (HBV) messenger RNAs and acts to decrease levels of viral proteins.METHODS: We conducted a phase 2b, randomized, investigator-unblinded trial involving participants with chronic HBV infection who were receiving or not receiving nucleoside or nucleotide a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2541,"document":"34642494","golden":true,"offsetInEndSection":2680,"text":"These preliminary observations warrant further investigation of the safety and activity of bepirovirsen in a larger CHB patient population.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1000,"document":"34642494","golden":true,"offsetInEndSection":1363,"text":"Participants with CHB infection ?6 months and serum HBsAg ?50 IU?ml-1 were enrolled from seven centers across Hong Kong and the Republic of Korea and randomized (3:1 within each dose cohort) to receive bepirovirsen or placebo via subcutaneous injection twice weekly during weeks 1 and 2 (days 1, 4, 8 and 11) and once weekly during weeks 3 and 4 (days 15 and 22).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2094,"document":"34642494","golden":false,"offsetInEndSection":2347,"text":"HBsAg reductions were observed and were significant versus placebo for treatment-na?ve participants receiving bepirovirsen 300?mg (P?\u003d?0.001), but not for the bepirovirsen 150?mg group (P?\u003d?0.245) or participants receiving stable NA therapy (P?\u003d?0.762).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35714812","golden":true,"offsetInEndSection":186,"text":"BACKGROUND \u0026 AIMS: Bepirovirsen, an antisense oligonucleotide targeting pregenomic and mRNA transcripts of HBV, has been conjugated to N-acetyl galactosamine (GSK3389404) to enhance hepa","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2106,"document":"35714812","golden":false,"offsetInEndSection":2213,"text":" controlling the virus. GSK3389404 is an investigational agent that targets HBV RNA, resulting in reduced v","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"35714812","golden":false,"offsetInEndSection":126,"text":"Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":2347,"document":"35714812","golden":false,"offsetInEndSection":2456,"text":"ronic HBV infection. GSK3389404 showed dose-dependent reduction in hepatitis B surface antigen, with an accep","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":470,"document":"35714812","golden":false,"offsetInEndSection":656,"text":"art 2 dosing. In Part 2, patients with chronic hepatitis B on nucleos(t)ide analogue therapy were randomised 11:2 to GSK3389404 (30, 60, 120?mg weekly or 120?mg bi-weekly) or placebo unt","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2216,"document":"35714812","golden":false,"offsetInEndSection":2344,"text":"l protein production. This study assessed the safety of GSK3389404 and its ability to reduce the viral proteins in patients with","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":189,"document":"35714812","golden":false,"offsetInEndSection":273,"text":"yte delivery. This dose-finding study was the first to assess GSK3389404 for chronic","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1689,"document":"35714812","golden":false,"offsetInEndSection":1799,"text":"SK3389404 showed an acceptable safety profile and target engagement, with dose-dependent reductions in HBsAg. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1018,"document":"35714812","golden":false,"offsetInEndSection":1198,"text":"onse. HBsAg reductions were dose-dependent (Day 85: mean 0.34 [60?mg weekly] to 0.75 log10 IU/ml [120?mg weekly]) and occurred in hepatitis B e antigen-positive and -negative patie","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1872,"document":"35714812","golden":false,"offsetInEndSection":2103,"text":"ER: NCT03020745.LAY SUMMARY: Hepatitis B virus (HBV) can result in chronic HBV infection, which may ultimately lead to chronic liver disease, primary liver cancer and death; HBV proteins may prevent the immune system from successfu","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36346079","golden":true,"offsetInEndSection":148,"text":"BACKGROUND: Bepirovirsen is an antisense oligonucleotide that targets all hepatitis B virus (HBV) messenger RNAs and acts to decrease levels of vira","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36346079","golden":true,"offsetInEndSection":68,"text":"Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection","beginSection":"title"},{"endSection":"title","offsetInBeginSection":0,"document":"35971951","golden":true,"offsetInEndSection":272,"text":"Preclinical and Phase 1 Assessment of Antisense Oligonucleotide Bepirovirsen in Hepatitis B Virus-Transgenic Mice and Healthy Human Volunteers: Support for Clinical Dose Selection and Evaluation of Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":709,"document":"34642494","golden":true,"offsetInEndSection":850,"text":"bjective was to assess the safety and tolerability of bepirovirsen in individuals with chronic hepatitis B (CHB) (NCT02981602). The secondary","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35971951","golden":true,"offsetInEndSection":157,"text":"Dose-dependent reductions in hepatitis B virus (HBV) RNA, DNA, and viral proteins following bepirovirsen administration were observed in HepG2.2.15 cells. In","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":838,"document":"36346079","golden":true,"offsetInEndSection":1120,"text":"he composite primary outcome was a hepatitis B surface antigen (HBsAg) level below the limit of detection and an HBV DNA level below the limit of quantification maintained for 24 weeks after the planned end of bepirovirsen treatment, without newly initiated antiviral medication.RES","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27262680","golden":false,"offsetInEndSection":290,"text":"Pimavanserin (Nuplazid?) is a selective and potent serotonin 2A (5-HT2A) receptor inverse agonist and antagonist developed by ACADIA Pharmaceuticals that has been approved in the US as a treatment for patients with hallucinations and delusions associated with Parkinson\u0027s disease psychosis.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"25686119","golden":false,"offsetInEndSection":68,"text":"Shifting paradigms in the treatment of chronic lymphocytic leukemia.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25686119","golden":false,"offsetInEndSection":72,"text":"The treatment of chronic lymphocytic leukemia (CLL) is evolving rapidly.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":73,"document":"25686119","golden":false,"offsetInEndSection":385,"text":"Insight into the genetics and biology of the disease, including the importance of intracellular signaling pathways and interactions with the microenvironment has led to the development of rational targeted therapies which are having a major impact on the survival of patients with relapsed and high-risk disease.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"22550982","golden":false,"offsetInEndSection":52,"text":"New and emerging treatments for Alzheimer\u0027s disease.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":503,"document":"25686119","golden":false,"offsetInEndSection":803,"text":"We review the current understanding of CLL genetics and biology, current treatment strategies in specific patient groups and opportunities for future treatment combinations which will bring the goal of cure or long-term disease control with minimal toxicity within reach for the majority of patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":472,"document":"27262680","golden":false,"offsetInEndSection":674,"text":"This article summarizes the milestones in the development of pimavanserin leading to this first approval for the treatment of hallucinations and delusions in patients with Parkinson\u0027s disease psychosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":386,"document":"25686119","golden":false,"offsetInEndSection":502,"text":"In addition, an exciting array of cellular therapies and immunotherapy options are in various stages of development.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":220,"document":"18762157","golden":false,"offsetInEndSection":537,"text":"Demonstration of clinical efficacy in drug-sensitive tuberculosis is challenging, given high success rates for existing regimens, concerns about substituting an investigational agent for the most effective agents in a regimen and difficulties in determining the effect size of the components of a combination regimen.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"28579387","golden":false,"offsetInEndSection":52,"text":"Treatment advances in small cell lung cancer (SCLC).","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":934,"document":"34878645","golden":false,"offsetInEndSection":1147,"text":"Anti-angiogenesis treatments are widely used for cancer and eye disease and there are clinical reports of patients treated with VEGF-A inhibitors who have experienced Psoriasis Area and Severity Index improvement.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34878645","golden":false,"offsetInEndSection":104,"text":"Antivascular endothelial growth factor-A therapy: a novel personalized treatment approach for psoriasis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":558,"document":"26831796","golden":false,"offsetInEndSection":928,"text":"DNDi has promoted overall drug discovery research including the screening of drug candidates, hit to lead, lead optimization, pre-clinical and clinical studies in the area of infectious diseases with a focus on malaria, sleeping sickness (human African trypanosomiasis; HAT), Chagas disease, leishmaniasis, filarial diseases and pediatric formulations for HIV treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1675,"document":"34878645","golden":false,"offsetInEndSection":1833,"text":"Anti-VEGF-A therapies may offer an alternative to existing anticytokine strategies or be complementary to standard treatments for the management of psoriasis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1148,"document":"34878645","golden":false,"offsetInEndSection":1251,"text":"Existing psoriasis treatments downregulate VEGF-A and angiogenesis as part of their therapeutic effect.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1440,"document":"34878645","golden":false,"offsetInEndSection":1674,"text":"There is a subset of patients with psoriasis with an increased predisposition to produce high levels of VEGF-A, who may be most likely to benefit from anti-VEGF-A therapy, offering an opportunity to personalize treatment in psoriasis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34878645","golden":false,"offsetInEndSection":282,"text":"Chronic plaque psoriasis is an inflammatory skin disease in which genetic predisposition along with environmental factors lead to the development of the disease, which affects 2% of the UK\u0027s population and is associated with extracutaneous morbidities and a reduced quality of life.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1252,"document":"34878645","golden":false,"offsetInEndSection":1439,"text":"Pharmacogenetics studies suggest the existence of different genetic signatures within patients with psoriasis that correspond with different treatment responsiveness and disease severity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":837,"document":"34878645","golden":false,"offsetInEndSection":933,"text":"Targeting VEGF-A in in?vivo models of psoriasis-like inflammation resulted in disease clearance.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36146675","golden":false,"offsetInEndSection":125,"text":"A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":768,"document":"36146675","golden":false,"offsetInEndSection":885,"text":" Canada have also recently approved Tecovirimat to treat smallpox in 2018 and 2021, respectively. The efficacy of Tec","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":715,"document":"28579387","golden":false,"offsetInEndSection":938,"text":"ntly, a new understanding of the biology of SCLC has led to the development of novel drugs, of which the most promising are the immune checkpoint inhibitors and the antibody drug conjugate rovalpituzumab tesirine.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1736,"document":"36146675","golden":false,"offsetInEndSection":1889,"text":"urrent MPX outbreak and is a new hope of biosecurity against smallpox or orthopoxvirus-related bioterrorism attack.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":83,"document":"36146675","golden":false,"offsetInEndSection":218,"text":"opean Medicines Agency (EMA) approved Tecovirimat in capsule dosage form (200 mg) as the first treatment for MPX in January 2022. This ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"16127621","golden":false,"offsetInEndSection":244,"text":"Alfa Wassermann, in collaboration with Opocrin, is developing Desmin 370, an antithrombotic agent which is in phase III clinical trials for the treatment of deep vein thrombosis, and may have potential in the treatment of pulmonary embolism. Th","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":410,"document":"16610769","golden":false,"offsetInEndSection":615,"text":"I trial of HuCNS-SC for infantile and late-infantile NCL has been initiated, following the March 2006 U.S. Food and Drug Administration approval of StemCells\u0027 investigational new drug application.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":957,"document":"24357084","golden":false,"offsetInEndSection":1181,"text":"imidazolone derivatives imepitoin (ELB138) and ELB139 were shown to act as low-affinity partial agonists at the BZD site of the GABAA receptor, and imepitoin was developed for the treatment of epilepsy. Imepitoin displayed a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":606,"document":"23480335","golden":false,"offsetInEndSection":780,"text":"BL and BCR-ABL-T315I. Two benzotriazine based compounds, tirapazamine for the treatment of cancer and TG100801 for the treatment of age-related macular degeneration, have ent","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":155,"document":"12090559","golden":false,"offsetInEndSection":376,"text":"By November 1998, phase II trials had commenced for biricodar, in combination with chemotherapy, for five common cancer indications: breast, ovarian, soft-tissue sarcomas, small cell lung cancer and prostate cancer. Phase","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1068,"document":"34826506","golden":false,"offsetInEndSection":1258,"text":"AB-506 exhibits good oral bioavailability, systemic exposure, and higher liver to plasma ratios in rodents, a pharmacokinetic profile supporting clinical development for chronic hepatitis B.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34826506","golden":false,"offsetInEndSection":253,"text":"AB-506, a small-molecule inhibitor targeting the HBV core protein, inhibits viral replication in vitro (HepAD38?cells: EC50 of 0.077??M, CC50?\u003e?25??M) and in vivo (HBV mouse model: ?3.0 log10 reductions in serum HBV DNA compared to the vehicle control).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1548,"document":"32094138","golden":false,"offsetInEndSection":1665,"text":"JNJ-6379 is in development for chronic hepatitis B treatment and may translate into higher HBV functional cure rates.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":570,"document":"34826506","golden":false,"offsetInEndSection":714,"text":"AB-506 demonstrated activity across HBV genotypes A-H and maintains antiviral activity against nucleos(t)ide analog-resistant variants in vitro.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17709147","golden":false,"offsetInEndSection":181,"text":"Nucleos(t)ide analogue antiviral therapy for chronic hepatitis B has proven to be effective in the short term but the frequent development of resistance limits its clinical utility.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34826506","golden":false,"offsetInEndSection":105,"text":"Preclinical characterization of AB-506, an inhibitor of HBV replication targeting the viral core protein.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":282,"document":"33242518","golden":false,"offsetInEndSection":392,"text":"DHQ, is a first in class investigational agent and could represent an entirely new category of HBV antivirals.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"30403127","golden":false,"offsetInEndSection":75,"text":"ARB-1740, a RNA Interference Therapeutic for Chronic Hepatitis B Infection.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":358,"document":"34826506","golden":false,"offsetInEndSection":569,"text":"Furthermore, AB-506 blocks cccDNA establishment in HBV-infected HepG2-hNTCP-C4 cells and primary human hepatocytes, leading to inhibition of viral RNA, HBsAg, and HBeAg production (EC50 from 0.64??M to 1.92??M).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":254,"document":"34826506","golden":false,"offsetInEndSection":357,"text":"Binding of AB-506 to HBV core protein accelerates capsid assembly and inhibits HBV pgRNA encapsidation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":93,"document":"35487605","golden":false,"offsetInEndSection":419,"text":"Although kidney involvement due to tubular or vascular disease is more common, glomerular diseases became more prevalent as hepatitis infections increased and then subsequently decreased with the widespread availability of hepatitis A and B vaccines and the development of effective antiviral treatments for hepatitis B and C.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1121,"document":"16396876","golden":false,"offsetInEndSection":1307,"text":" form of agammaglobulinemia (X-linked) never get Epstein-Barr virus infection, and patients with another form (common variable) are seemingly cured by HIV infection. HIV/AIDS is prevente","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1310,"document":"16396876","golden":false,"offsetInEndSection":1447,"text":"r modified by co-receptor mutations (notably the CCRDelta32 chemokine mutation), HIV-2, or GB virus C infection. Additional exploration o","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":628,"document":"10935278","golden":false,"offsetInEndSection":981,"text":" of expanding international trade, the authors provide an overview of existing knowledge on the subject to enhance available information on the epidemiology of IBD, the identification of reliable viral markers for diagnosis, and the implementation of specific control measures to ensure a global and co-ordinated approach to the disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":204,"document":"15028793","golden":false,"offsetInEndSection":299,"text":"eumonia, an infectious process within the lung, is the sixth-leading overall cause of death. An","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":178,"document":"2259879","golden":false,"offsetInEndSection":504,"text":"n general, B27-positive disease has an earlier onset, a more severe and prolonged clinical course and is more often complicated by acute anterior uveitis and peripheral arthritis, whereas B27-negative disease is accompanied by psoriasis, inflammatory bowel disease and erythema nodosum in a higher percentage of the cases. Des","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"10935278","golden":false,"offsetInEndSection":173,"text":"Infectious bursal disease (IBD) (Gumboro disease) has been described throughout the world, and the socio-economic significance of the disease is considerable world-wide. Var","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":755,"document":"34643361","golden":false,"offsetInEndSection":921,"text":"s a GFR less than 60 mL/min/1.73 m2 or persistent evidence of kidney damage on imaging, biopsy, or urinalysis that persists for longer than 3 months. CKD is classifie","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"29539797","golden":false,"offsetInEndSection":194,"text":"It is our central hypothesis that periodontal diseases, which are chronic Gramnegative infections, represent a previously unrecognized risk factor for atherosclerosis and thromboembolic events. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"18998478","golden":false,"offsetInEndSection":143,"text":"Creutzfeldt-Jakob disease (CJD) is the most common form of the human transmissible spongiform encephalopathies, also known as prion diseases. T","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1053,"document":"23340064","golden":false,"offsetInEndSection":1457,"text":"When considering the importance of the rifamycins in the treatment of serious human diseases, the large number of patients affected by IBS, and the lack of scientific evidence available on the development of antibiotic resistance to rifaximin over the long-term when used in the gut, it is advisable that the use of rifaximin as a therapy for IBS should be limited to single, acute, short-term treatment.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"33804430","golden":false,"offsetInEndSection":91,"text":"Microvascular Dysfunction in Peripheral Artery Disease: Is Heat Therapy a Viable Treatment?","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1633,"document":"33804430","golden":false,"offsetInEndSection":1798,"text":"Heat therapies may emerge as a conservative treatment option capable of attenuating the progression of PAD and ultimately impeding the development of plantar ulcers.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":284,"document":"33804430","golden":false,"offsetInEndSection":448,"text":"Understanding the mechanisms underlying the development of plantar ulcers is a critical step in the development of adequate treatment options for patients with PAD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33804430","golden":false,"offsetInEndSection":130,"text":"Peripheral artery disease (PAD) is characterized by the development of atherosclerotic plaques in the lower-body conduit arteries.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":131,"document":"33804430","golden":false,"offsetInEndSection":283,"text":"PAD is commonly accompanied by microvascular disease, which may result in poor wound healing, plantar ulcer development, and subsequent limb amputation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1210,"document":"33804430","golden":false,"offsetInEndSection":1377,"text":"Heat therapies are capable of stimulating the cardiovascular system, which may lead to beneficial adaptations that may ultimately reduce fatigue during walking in PAD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1017,"document":"35602078","golden":false,"offsetInEndSection":1200,"text":"The severity of HTLV-1-associated diseases (ATL, HAM/TSP) and limited treatment options highlights the need for development of a preventative vaccine or new therapeutic interventions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1616,"document":"36712949","golden":true,"offsetInEndSection":1757,"text":"Another path for HDV cure will derive from achieving HBsAg clearance, the goal of new promising anti-HBV gene therapies (bepirovirsen, etc.).","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36712949","golden":false,"offsetInEndSection":107,"text":"Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":824,"document":"36712949","golden":false,"offsetInEndSection":985,"text":"BLV is administered subcutaneously once daily at doses between 2 and 10 mg. BLV received conditional approval in Europe in 2020 to treat chronic hepatitis delta.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":600,"document":"23379765","golden":false,"offsetInEndSection":1489,"text":"minal region. Therefore, development of therapeutic agents that specifically target kinases and kinase-domain-containing proteins affecting PTEN would lead to the treatment of PTEN-related diseases.AREAS COVERED: With increasing evidence on the role of PTEN in many human diseases, the present review focuses on the clinical relevance of PTEN with a comprehensive list of currently identified modulators of PTEN, and proposes potentially novel molecular targets which could aid in the development of drug candidates for the treatment of PTEN-related diseases such as cardiovascular diseases, diabetes, obesity, cancer, autism, Parkinson\u0027s and Alzheimer\u0027s diseases.EXPERT OPINION: This review describes several target sites that could help in the development of novel drug candidates to regulate or restore the normal physiological functions of PTEN and are essential in the treatment of hu","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1758,"document":"36712949","golden":false,"offsetInEndSection":1864,"text":"In summary, the advent of BLV has triggered a renovated interest for antiviral therapy in hepatitis delta.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":913,"document":"32160283","golden":false,"offsetInEndSection":1220,"text":"Nonimmunogenic oral small molecule therapies, including Janus kinase inhibitors, are currently being developed and have demonstrated efficacy in early phase clinical trials, which has already led to regulatory approval of tofacitinib for the treatment of patients with moderate-to-severe ulcerative colitis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":986,"document":"36712949","golden":false,"offsetInEndSection":1075,"text":"The advent of peginterferon lambda or new specific anti-HDV antivirals (lonafarnib, etc.)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":460,"document":"36712949","golden":false,"offsetInEndSection":574,"text":"As monotherapy or in combination with peginterferon, BLV is well tolerated and exhibits potent antiviral activity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":124,"document":"36712949","golden":false,"offsetInEndSection":230,"text":"The search for molecules interfering with the binding of NTCP and HBV/HDV led to design bulevirtide (BLV).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":637,"document":"16483845","golden":false,"offsetInEndSection":915,"text":"It is hoped that some of these developments might contribute to effective treatment not only of systemic amyloidosis, which is relatively rare, but also of the much more common type II diabetes and Alzheimer\u0027s disease, in which local amyloid formation is thought to play a role.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"19750192","golden":false,"offsetInEndSection":79,"text":"Targeted treatment in COPD: a multi-system approach for a multi-system disease.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25986720","golden":false,"offsetInEndSection":213,"text":"Siltuximab is a chimeric monoclonal antibody targeting interleukin-6 (IL-6), which in the fall of 2014 became the first FDA-approved treatment of the rare disease idiopathic multicentric Castleman\u0027s disease (MCD).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":516,"document":"34641339","golden":false,"offsetInEndSection":610,"text":"r was originally developed for the treatment of influenza at Emory University, USA. However, t","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":223,"document":"17135510","golden":false,"offsetInEndSection":404,"text":" H5N2 inactivated vaccine was produced from a low pathogenic virus, A/turkey/England/N-28/73, and was used for the buffer zone vaccination in the H5N1 outbreaks in 2004 in China. We","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25616524","golden":false,"offsetInEndSection":191,"text":"The management of the recent Ebola virus disease (EVD) epidemic continues to pose currently insuperable challenges to health care providers in the resource-deprived countries of West Africa. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2255,"document":"23631257","golden":false,"offsetInEndSection":2504,"text":"pies in the EAON model, considered to be a model of optic neuritis associated with multiple sclerosis, suggest that optic neuritis may be suppressed by inducing anterior chamber-associated immune deviation (ACAID). Applying this phenomenon, cell the","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"19048070","golden":false,"offsetInEndSection":269,"text":"Necrotizing enterocolitis (NEC) is the leading cause of death and long-term disability from gastrointestinal disease in preterm infants, and is characterized by acute and chronic intestinal inflammation that may lead to systemic sepsis and multi-system organ failure. N","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":831,"document":"35972595","golden":false,"offsetInEndSection":1039,"text":"at ANE administration through the intraoral droplet method exhibited significantly higher fibrosis than the intrabuccal injections, as evidenced by the H\u0026E and Masson\u0027s trichrome staining. Furthermore, intrao","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":795,"document":"31824367","golden":false,"offsetInEndSection":1133,"text":"tlines the role of predisposing, precipitating, and perpetuating factors in disease states and conditions (the 3Ps) and provides examples of how this model may be adapted and applied to a number of health-related diseases or disorders including chronic pain, gastrointestinal disorders, oral disease, and heart disease. The 3P framework c","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":330,"document":"22144849","golden":false,"offsetInEndSection":495,"text":"ial PID cases were identified among women aged 15-44 years at Group Health (GH) and Kaiser Permanente Colorado (KPCO) and verified by medical record review. A classi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":327,"document":"32939691","golden":false,"offsetInEndSection":573,"text":"Russia.METHODS: This retrospective analysis assessed the frequency of NAFLD in the population of patients in the DIREG_L_06725 study, an epidemiological, observational, cross-sectional, multicenter study performed in 50,145 outpatients from 16 Ru","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":174,"document":"29642580","golden":false,"offsetInEndSection":306,"text":"Arbidol (umifenovir) is a broad-spectrum antiviral compound approved in Russia and China for prophylaxis and treatment of influenza.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27095301","golden":false,"offsetInEndSection":155,"text":"Nitazoxanide is a broad-spectrum antiviral agent undergoing clinical development for treatment of influenza and other viral respiratory infections. Nitazox","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":488,"document":"27095301","golden":false,"offsetInEndSection":665,"text":"een used extensively in clinical trials and in post-marketing experience, nitazoxanide is an attractive drug candidate for treatment of Middle East respiratory syndrome. Future ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":294,"document":"31589999","golden":false,"offsetInEndSection":423,"text":"en shown that S1P1 receptor agonists such as fingolimod can be suitable candidates for treatment of autoimmune diseases. The curr","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":848,"document":"23943849","golden":false,"offsetInEndSection":978,"text":"Induction or inhibition of autophagy using small molecule compounds has shown promise in the treatment of diseases such as cancer.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17696230","golden":false,"offsetInEndSection":257,"text":"AIM: To investigate the safety and efficacy of the formulation HD-03/ES capsules in the management of patients with chronic hepatitis B infection.METHODS: A total of 25 patients were recruited to the study and were given HD-03/ES, two capsules twice daily f","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24995515","golden":false,"offsetInEndSection":416,"text":"BACKGROUND AND AIMS: Albinterferon is a fusion of albumin and interferon-?2b developed to improve the pharmacokinetics, convenience, and potential efficacy of interferon-? for the treatment of chronic hepatitis infections.METHODS: This open-label, randomized, active-controlled, multicenter study investigated the safety and efficacy of albinterferon in patients with chronic hepatitis B virus (HBV) infection who we","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"20955704","golden":false,"offsetInEndSection":219,"text":"BACKGROUND \u0026 AIMS: Tenofovir disoproxil fumarate (TDF), a nucleotide analogue and potent inhibitor of hepatitis B virus (HBV) polymerase, showed superior efficacy to adefovir dipivoxil in treatment of chronic hepatitis ","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"17696230","golden":false,"offsetInEndSection":111,"text":"Safety and efficacy of oral HD-03/ES given for six months in patients with chronic hepatitis B virus infection.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1305,"document":"36712949","golden":false,"offsetInEndSection":1419,"text":"n hepatitis C combining several antivirals, curing nearly all patients treated for 3 months. Clearance of HDV-RNA ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":916,"document":"36712949","golden":false,"offsetInEndSection":1000,"text":"ditional approval in Europe in 2020 to treat chronic hepatitis delta. The advent of ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":399,"document":"10916855","golden":false,"offsetInEndSection":547,"text":"anagement of KD, with intravenous gamma globulin (IVGG) and aspirin (ASA) is highly effective, but was not known or available in 1965.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1788,"document":"36712949","golden":false,"offsetInEndSection":1894,"text":"has triggered a renovated interest for antiviral therapy in hepatitis delta. We envision combination thera","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"8752457","golden":false,"offsetInEndSection":83,"text":"Huntington\u0027s disease (HD) is associated with expansion of an unstable CAG repeat. U","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":261,"document":"11677782","golden":false,"offsetInEndSection":374,"text":"are important genetic influences on susceptibility to CJD and on the resulting clinico-pathological picture. The ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2857,"document":"23448451","golden":false,"offsetInEndSection":2967,"text":"to cerebrovasculopathy, with an increased incidence of stroke. The abnormal neuronal accumulation of glycosphi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"8910831","golden":false,"offsetInEndSection":195,"text":"It is our central hypothesis that periodontal diseases, which are chronic Gram-negative infections, represent a previously unrecognized risk factor for atherosclerosis and thromboembolic events. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1270,"document":"8910831","golden":false,"offsetInEndSection":1437,"text":" adjusted for established cardiovascular risk factors were 1.5, 1.9, and 2.8 for bone loss and total CHD, fatal CHD, and stroke, respectively. Levels of bone loss and ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":131,"document":"28799516","golden":false,"offsetInEndSection":834,"text":"t strategy. However, research of new compounds for patients with drugresistant epilepsies is still based on animal experiments, mostly in rodents, which are far from being a model of chronic human epilepsy and have failed to differentiate the efficacy of new compounds versus standard drug treatment.OBJECTIVE: The objective was identification and description of compounds in clinical development in 2016.METHOD: Search was conducted from the website of the U.S. National Institutes of Health and from literature.RESULTS: Identified compounds have been divided in two groups: 1) compounds initially developed for the treatment of diseases other than epilepsy: biperiden, bumetanide, everolimus, fenflura","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":835,"document":"28799516","golden":false,"offsetInEndSection":1009,"text":"ine, melatonin, minocycline, verapamil. 2) Compounds specifically developed for the treatment of epilepsy: allopregnanolone, cannabidiol, cannabidivarin, ganaxolone, nalutoza","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1010,"document":"28799516","golden":false,"offsetInEndSection":1161,"text":", PF-06372865, UCB0942, and cenobamate. Everolimus, and perhaps, fenfluramine are effective in specific epileptic diseases and may be considered as tru","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":193,"document":"22925316","golden":false,"offsetInEndSection":509,"text":"Subsequent clinical trials showed benefits of macrolides as long-term adjuncts in the treatment of a spectrum of chronic inflammatory respiratory diseases, particularly diffuse panbronchiolitis, cystic fibrosis, post-transplant bronchiolitis obliterans and more recently chronic obstructive pulmonary disease (COPD).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1162,"document":"28799516","golden":false,"offsetInEndSection":1251,"text":" disease modifying antiepileptic drugs. These are tuberous sclerosis complex for everolim","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":357,"document":"15496127","golden":false,"offsetInEndSection":457,"text":"The aim of this work is to evaluate the efficacy of the Apimicos-B, a treatment against chalk brood.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1252,"document":"28799516","golden":false,"offsetInEndSection":1647,"text":"s and Dravet syndrome for fenfluramine. With the exception of a few other compounds such as cannabinidiol, cannabidivarin and minocycline, the vast majority of other compounds had mechanisms of action which are similar to the mechanism of action of the anti-seizure drugs already in the market.CONCLUSION: Substantial improvements in the efficacy, specifically as pharmacological treatment of dr","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":996,"document":"17557672","golden":false,"offsetInEndSection":1129,"text":"Sunitinib has been approved for the treatment of advanced renal-cell cancer and imatinib-resistant gastro-intestinal stromal tumours.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":529,"document":"23433060","golden":false,"offsetInEndSection":705,"text":"evelopment. Artesunate and mefloquine are well-established drugs for the treatment of uncomplicated malaria, with a strong safety record based on many years of field-based stud","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"28799516","golden":false,"offsetInEndSection":66,"text":"Antiepileptic Drugs in Clinical Development: Differentiate or Die?","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":507,"document":"36271424","golden":false,"offsetInEndSection":653,"text":"II (MPS III). For type 1 Gaucher and Fabry disease several therapies are available, resulting in a near normal or improved, but individually varyi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36271424","golden":false,"offsetInEndSection":116,"text":"INTRODUCTION: Several new treatment modalities are being developed for lysosomal storage disorders (LSDs), including","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":892,"document":"24786290","golden":false,"offsetInEndSection":1268,"text":"Currently, two new protease inhibitors for HCV treatment are expected (deleobuvir, faldaprevir) and together with the promising drug, daclatasvir (NS5A-inhibitor, currently in clinical trials), adequate therapy is to be expected in due course (circumventing the requirement of interferon with its side-effects), while in contrast, efficient HBV therapeutics are still lacking.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"24116962","golden":false,"offsetInEndSection":70,"text":"Development of pharmacological strategies for mitochondrial disorders.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1637,"document":"36271424","golden":false,"offsetInEndSection":1705,"text":" willingness to choose gene therapy. Gaucher and Fabry patients deem","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36271424","golden":false,"offsetInEndSection":96,"text":"Patients\u0027 view on gene therapy development for lysosomal storage disorders: a qualitative study.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":627,"document":"24786290","golden":false,"offsetInEndSection":891,"text":"The current treatment of choice for HBV/HCV infection is an interferon-based combination therapy with oral antiviral drugs, like nucleos(t)ide analogues, which is associated with improving the therapeutic success and also preventing the development of resistances.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":341,"document":"23043900","golden":false,"offsetInEndSection":624,"text":"The close association of some forms of FTD with neuropathological accumulation of tau protein or increased neuroinflammation due to progranulin protein deficiency suggests that a drug\u0027s success in treating FTD may predict efficacy in more common diseases such as Alzheimer\u0027s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":323,"document":"27072904","golden":false,"offsetInEndSection":512,"text":"octanol-water value for the (99m)Tc-labled PFDH was -2.19 and the radiotracer was stable in phosphate-buffered saline and human serum for 2h (\u003e95% in PBS or ?90% in human serum). To investi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":166,"document":"30180522","golden":false,"offsetInEndSection":424,"text":"lesion.METHODS: With permission from Giacino, the developer of the Coma Recovery Scale Revised (CRSR), the scale was translated into Korean and back-translated into English by a Korean physiatrist highly proficient in English, and then verified by the origin","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":981,"document":"32840112","golden":false,"offsetInEndSection":1096,"text":"stance. The quantification ranges of our method were 0.2-200 ?g/L for BPA and 0.2-20 ?g/L for BPA-G, BPS, D-8, and ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":475,"document":"32840112","golden":false,"offsetInEndSection":623,"text":" develop and validate a method to quantify BPA, its glucuronide metabolite (BPA-G), BPS, D-8, and PF201 in in vitro skin absorption samples. After s","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":178,"document":"34823578","golden":false,"offsetInEndSection":489,"text":"k engine. This study was conducted to develop a prediction equation suitable for the current diabetes treatment policy using patient data from Kitasato University Kitasato Institute Hospital (Hospital A) and to externally validate the developed equation using patient data from Kitasato University Hospital (Hos","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1221,"document":"34725684","golden":false,"offsetInEndSection":1448,"text":" use of the vaccine. To reduce those risks and ensure equitable access to a GBS vaccine, the role of donors or financers can prove very important, as can a coordinated operational research agenda that aims at clarifying those a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":488,"document":"25419692","golden":false,"offsetInEndSection":748,"text":"s were administered three HRQL survey tools (SF-36, European Organization for Research and Treatment of Cancer QLQ-c30 and St George Respiratory Questionnaire (SGRQ)) before transplant and then again at 6 months, 1 year and 2 years after transplant. Patients w","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":126,"document":"26379556","golden":false,"offsetInEndSection":348,"text":"n order to examine the effect of decreasing Ca(2+) sensitivity of cTnC on cardiac function, we generated knock-in mice carrying a D73N mutation (not known to be associated with heart disease in human patients) in cTnC. The","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":640,"document":"9403401","golden":false,"offsetInEndSection":893,"text":"n was gathered to assist in the development of key messages and strategies for the NHLBI Latino Community Cardiovascular Disease Prevention and Outreach Initiative, Salud para su Coraz?n--a heart disease prevention and education campaign. Findings from ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":304,"document":"31208308","golden":false,"offsetInEndSection":380,"text":"le Calmette-Guerin (BCG) is the vaccine commonly available against TB. BCG d","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"14974368","golden":false,"offsetInEndSection":145,"text":"The aim of this study was to evaluate efficacy and safety of lamivudine therapy in renal allograft recipients with chronic hepatitis B infection.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"14974368","golden":false,"offsetInEndSection":105,"text":"[The influence of lamivudine therapy on the course of chronic hepatitis B in renal allograft recipients].","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":66,"document":"36065536","golden":false,"offsetInEndSection":569,"text":"na is high. The safety and efficacy of secukinumab in psoriasis patients with HBV infection have not been fully elucidated.Objectives: To investigate the safety and efficacy of secukinumab in psoriasis patients with HBV infection in China.Materials \u0026 Methods: In this retrospective study, 20 psoriasis patients with HBV infection were identified, all of whom had been treated with secukinumab for ?24 weeksResults: Four patients had chronic inactive HBV infection, two patients had occult HBV infection,","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":235,"document":"14974368","golden":false,"offsetInEndSection":344,"text":"We obtained HBV replication blockage in 95% of patients, in half of them also ALT normalisation was observed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":345,"document":"14974368","golden":false,"offsetInEndSection":560,"text":"Delayed HBV replication blockage was observed in patients with prolonged duration of haemodialysotherapy or HBV infection and HCV coinfection, although listed parameters did not influence overall treatment efficacy.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"27506549","golden":false,"offsetInEndSection":265,"text":"Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":669,"document":"14974368","golden":false,"offsetInEndSection":744,"text":"We did not observed any serious adverse reactions under lamivudine therapy.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36065536","golden":false,"offsetInEndSection":111,"text":"Safety and efficacy of secukinumab in psoriasis patients infected with hepatitis B virus: a retrospective study","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":158,"document":"15850471","golden":false,"offsetInEndSection":383,"text":"The objective of this study was to evaluate the long-term, dose-related efficacy and safety of Talpha1 treatment in chronic hepatitis B patients with positive HBV-DNA and abnormally high alanine aminotransferase (ALT) levels.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":850,"document":"25096404","golden":false,"offsetInEndSection":979,"text":"In conclusion, GS-9669 is a good candidate to be used in interferon-free combinations for the treatment of chronic HCV infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"18060195","golden":false,"offsetInEndSection":166,"text":"Darier disease (DD) and Hailey-Hailey disease (HHD) are autosomal dominantly inherited genodermatosis, caused by mutations in ATP2A2 gene and ATP2C1 respectively. We ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":601,"document":"12928038","golden":false,"offsetInEndSection":702,"text":"iew, we summarize the available in vivo and in vitro models of PD and discuss their value.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"16028004","golden":false,"offsetInEndSection":222,"text":"PURPOSE: To describe the disease status of degenerative diseases (i.e., type 2 diabetes mellitus, Parkinson\u0027s disease) as function of disease process and treatment effects, a family of disease progression models is introdu","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1120,"document":"34643362","golden":false,"offsetInEndSection":1364,"text":"h advanced chronic kidney disease or ESRD, treatment includes management of complications, including hyperkalemia, hypervolemia, metabolic acidosis, anemia, mineral and bone disorders, and protein-calorie malnutrition.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":309,"document":"28546865","golden":false,"offsetInEndSection":464,"text":"fferent disease stages.CONCLUSION: We reviewed the literature on the coexistence of PD and GD and speculate that the severity of symptoms may be related to","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":183,"document":"12441039","golden":false,"offsetInEndSection":346,"text":"s article reviews the major components and operating characteristics of clinical activity indices commonly used in randomized, controlled trials of IBD therapy. In","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":179,"document":"23196574","golden":false,"offsetInEndSection":318,"text":"thological findings in the encephalitis are chiefly perivascular cuffing of small venules by neutrophils, T lymphocytes, and macrphages. De","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":179,"document":"12928038","golden":false,"offsetInEndSection":309,"text":"pathology of PD is typified by the presence of cytoplasmic inclusions (Lewy bodies) containing alpha-synuclein and ubiquitin. The ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":312,"document":"12928038","golden":false,"offsetInEndSection":437,"text":"hogenesis of PD is not completely understood but environmental and genetic factors are thought to play important roles. To un","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":129,"document":"29217303","golden":false,"offsetInEndSection":414,"text":"eman disease (CD) is a clinical and histopathologically heterogeneous lymphoproliferative disorder that encompasses at least three distinct entities with some common overlapping morphological features: Hyaline Vascular CD (HVCD), Unicentric Plasma Cell CD and Multicentric CD. The most","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37902953","golden":false,"offsetInEndSection":95,"text":"Bepirovirsen (GSK3228836) in chronic hepatitis B infection: an evaluation of phase II progress.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1440,"document":"38547374","golden":true,"offsetInEndSection":1753,"text":"Bepirovirsen, a modified antisense oligonucleotide, shows promising results and a good safety profile, but requires further exploration in larger number of patients to determine whether a functional cure is possible.CONCLUSIONS: Eradication of HBV infection with currently available therapies is not yet possible.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37393402","golden":true,"offsetInEndSection":277,"text":"INTRODUCTION: Bepirovirsen (GSK3228836) is an antisense oligonucleotide that induced rapid and prolonged hepatitis?B surface antigen (HBsAg) reduction with a favorable safety profile following 4?weeks of treatment in participants with chronic hepatitis?B virus (HBV) infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36346079","golden":false,"offsetInEndSection":367,"text":"BACKGROUND: Bepirovirsen is an antisense oligonucleotide that targets all hepatitis B virus (HBV) messenger RNAs and acts to decrease levels of viral proteins.METHODS: We conducted a phase 2b, randomized, investigator-unblinded trial involving participants with chronic HBV infection who were receiving or not receiving nucleoside or nucleotide analogue (NA) therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38796564","golden":true,"offsetInEndSection":133,"text":"INTRODUCTION: Bepirovirsen is a novel antisense oligonucleotide in development for chronic hepatitis B virus (HBV) infection therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39268699","golden":false,"offsetInEndSection":117,"text":"Bepirovirsen is a developmental antisense oligonucleotide (ASO) for treatment of chronic hepatitis B virus infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1221,"document":"37902953","golden":false,"offsetInEndSection":1311,"text":"In the long run, Bepirovirsen has the potential to facilitate viral hepatitis elimination.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":317,"document":"37902953","golden":false,"offsetInEndSection":602,"text":"Currently, numerous novel compounds are being developed, including bepirovirsen, an antisense oligonucleotide (ASO).AREAS COVERED: This review summarizes the mechanism of action, pharmacokinetics, clinical efficacy and safety data collected from phase I and II studies of bepirovirsen.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":603,"document":"37902953","golden":false,"offsetInEndSection":1029,"text":"The data were extracted from publications relevant to the pivotal trials of bepirovirsen, in either full manuscript or conference abstracts.EXPERTOPINION: Bepirovirsen, a 20-mer ASO, has already entered phase III clinical evaluation using the optimal dosing regimen of 300?mg subcutaneous injection weekly for 24?weeks in nucleoside analogue-treated HBeAg-negative non-cirrhotic patients with low (\u003c3000 IU/mL) baseline HBsAg.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37902953","golden":false,"offsetInEndSection":141,"text":"INTRODUCTION: Chronic hepatitis B infection is a major global health issue associated with significant liver-related morbidity and mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38796564","golden":false,"offsetInEndSection":120,"text":"INTRODUCTION: Bepirovirsen is a novel antisense oligonucleotide in development for chronic hepatitis B virus (HBV) infec","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1754,"document":"39214467","golden":false,"offsetInEndSection":2046,"text":"esponses to bepirovirsen by reducing relapse.IMPACT AND IMPLICATIONS: This phase IIb study investigated whether sequential therapy with bepirovirsen?followed by Peg-IFN could improve off-treatment response rates to bepirovirsen alone by converting partial bepirovirsen responders to full resp","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37095713","golden":false,"offsetInEndSection":243,"text":"Bersiporocin, a novel first-in-class prolyl-tRNA synthetase (PRS) inhibitor currently under clinical development, was shown to exert an antifibrotic effect through the downregulation of collagen synthesis in various pulmonary fibrosis models.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1368,"document":"39214467","golden":false,"offsetInEndSection":1680,"text":"The proportions of participants with adverse events and treatment-related adverse events in both treatment windows were similar between treatment arms.CONCLUSIONS: Sequential therapy with bepirovirsen followed by Peg-IFN is tolerable and effective in participants with chronic HBV infection on stable NA therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38796564","golden":true,"offsetInEndSection":128,"text":"INTRODUCTION: Bepirovirsen is a novel antisense oligonucleotide in development for chronic hepatitis B virus (HBV) infection the","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":724,"document":"37253400","golden":false,"offsetInEndSection":826,"text":"ining drinking water for two days, the animals generate rcccDNA in hepatocytes, and the rcccDNA suppor","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37393402","golden":true,"offsetInEndSection":263,"text":"INTRODUCTION: Bepirovirsen (GSK3228836) is an antisense oligonucleotide that induced rapid and prolonged hepatitis?B surface antigen (HBsAg) reduction with a favorable safety profile following 4?weeks of treatment in participants with chronic hepatitis?B virus (H","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38796564","golden":false,"offsetInEndSection":119,"text":"INTRODUCTION: Bepirovirsen is a novel antisense oligonucleotide in development for chronic hepatitis B virus (HBV) infe","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":204,"document":"37137837","golden":false,"offsetInEndSection":445,"text":"Particularly in the report of phase IIb clinical trial of Bepirovirsen (GSK3228836), approximately 9-10% patients with low baseline serum HBsAg (\u003e 100 IU/ml \u0026 \u003c 3 000 IU/ml) achieved functional cure after 24 weeks\u0027 of Bepirovirsen treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":716,"document":"37902953","golden":false,"offsetInEndSection":987,"text":"pt or conference abstracts.EXPERTOPINION: Bepirovirsen, a 20-mer ASO, has already entered phase III clinical evaluation using the optimal dosing regimen of 300?mg subcutaneous injection weekly for 24?weeks in nucleoside analogue-treated HBeAg-negative non-cirrhotic patie","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36346079","golden":false,"offsetInEndSection":147,"text":"BACKGROUND: Bepirovirsen is an antisense oligonucleotide that targets all hepatitis B virus (HBV) messenger RNAs and acts to decrease levels of vir","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1753,"document":"39214467","golden":false,"offsetInEndSection":2045,"text":"responses to bepirovirsen by reducing relapse.IMPACT AND IMPLICATIONS: This phase IIb study investigated whether sequential therapy with bepirovirsen?followed by Peg-IFN could improve off-treatment response rates to bepirovirsen alone by converting partial bepirovirsen responders to full res","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1039,"document":"37460153","golden":false,"offsetInEndSection":1133,"text":"Bepirovirsen was localized primarily in nonparenchymal liver cells and proximal renal tubules.","beginSection":"abstract"}],"exact_answer":[["hepatitis b"]],"ideal_answer":[],"id":"63adc82ec6c7d4d31b000016","type":"factoid","body":"Bepirovirsen was developed for treatment of which disease?"},{"documents":[{"golden":true,"id":"33334840"},{"golden":false,"id":"22521141"},{"golden":false,"id":"21668860"},{"golden":false,"id":"16451112"},{"golden":false,"id":"18324889"},{"golden":false,"id":"12100056"},{"golden":false,"id":"19216626"},{"golden":false,"id":"31843845"},{"golden":false,"id":"26418475"},{"golden":false,"id":"24152153"},{"golden":false,"id":"39004434"},{"golden":false,"id":"39244712"},{"golden":false,"id":"39598421"},{"golden":false,"id":"31866435"},{"golden":false,"id":"23095872"},{"golden":false,"id":"5297557"},{"golden":false,"id":"27343438"},{"golden":false,"id":"31443989"},{"golden":false,"id":"38857311"},{"golden":false,"id":"21829748"},{"golden":false,"id":"31157592"},{"golden":false,"id":"30586557"},{"golden":false,"id":"32155619"},{"golden":false,"id":"19667059"},{"golden":false,"id":"16229996"},{"golden":false,"id":"34310889"},{"golden":false,"id":"37182566"},{"golden":false,"id":"37670552"},{"golden":false,"id":"23735680"},{"golden":false,"id":"10732430"},{"golden":false,"id":"17594874"},{"golden":false,"id":"20347059"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":521,"document":"33334840","golden":true,"offsetInEndSection":835,"text":"We hypothesise that a single dose of whole-cell vaccine in early infancy is protective against IgE-mediated food allergy.METHODS AND ANALYSIS: This adaptive double-blind randomised controlled trial is investigating whether a mixed whole-cell/aP vaccine schedule prevents allergic disease in the first year of life.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21668860","golden":false,"offsetInEndSection":194,"text":": The use of specific immunotherapy (SIT) for allergic disorders has recently been extended by introduction of a convenient, tablet-based, disease-modifying vaccine against grass pollen allergy.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"33334840","golden":false,"offsetInEndSection":123,"text":"OPTIMUM study protocol: an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1329,"document":"12100056","golden":false,"offsetInEndSection":1446,"text":"The vaccine was safe.CONCLUSIONS: The KLH-conjugated decapeptide vaccine was not effective in cypress pollen allergy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33334840","golden":false,"offsetInEndSection":237,"text":"INTRODUCTION: Combination vaccines containing whole-cell pertussis antigens were phased out from the Australian national immunisation programme between 1997 and 1999 and replaced by the less reactogenic acellular pertussis (aP) antigens.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":433,"document":"26418475","golden":false,"offsetInEndSection":572,"text":")RECENT FINDINGS: To date, two allergy vaccine-containing TLR agonists have been investigated in clinical trials; Pollinex Quattro and AIC.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":238,"document":"33334840","golden":false,"offsetInEndSection":520,"text":"In a large case-control study of Australian children born during the transition period, those with allergist diagnosed IgE-mediated food allergy were less likely to have received whole-cell vaccine in early infancy than matched population controls (OR: 0.77 (95% CI, 0.62 to 0.95)).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":906,"document":"33334840","golden":false,"offsetInEndSection":1261,"text":"Secondary outcomes include new onset of atopic dermatitis by 6 or 12 months of age; sensitisation to at least one allergen by 12 months of age; seroconversion in anti-pertussis toxin IgG titres after vaccination with aP booster at 18 months of age; and solicited systemic and local adverse events following immunisation with pertussis-containing vaccines.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1229,"document":"16451112","golden":false,"offsetInEndSection":1459,"text":"Vaccination with the Bet v 1-derivatives improved symptoms of birch pollen allergy, induced a healthy allergen-specific immunoglobulin G response and led to a significant reduction of seasonally induced boosts of immunoglobulin E.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":814,"document":"22521141","golden":false,"offsetInEndSection":976,"text":"Successful clinical trials performed with the new vaccines indicate that broad allergy vaccination is on the horizon and may help to control the allergy pandemic.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39004434","golden":false,"offsetInEndSection":437,"text":"BACKGROUND: The beneficial off-target effects of Bacille Calmette-Gu?rin (BCG) vaccination potentially include protection against allergy.OBJECTIVE: In the MIS BAIR trial, we aimed to determine whether neonatal BCG vaccination reduces atopic sensitisation and clinical food allergy in infants.METHODS: In this randomised controlled trial, 1272 neonates were allocated to BCG-Denmark vaccine (0.05?mL intradermal dose) or no BCG at birth.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":369,"document":"39598421","golden":false,"offsetInEndSection":494,"text":"ypoallergenic T-cell peptide vaccines and recombinant allergens require further research to confirm their clinical benefits. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":129,"document":"39244712","golden":false,"offsetInEndSection":497,"text":"he majority of hypersensitivity reactions after vaccination are mild, and anaphylaxis is reported to be rare, although it remains challenging to estimate the frequency attributed to each single vaccine, either because of the lower number of administered doses of less common vaccines, or the administration of simultaneous vaccine in most of the vaccination programs. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1596,"document":"31866435","golden":false,"offsetInEndSection":1767,"text":"sting of a complex allergen mixture.CONCLUSIONS: Our data suggest that vaccination using single peanut allergens displayed on CuMVtt may represent a novel therapy against ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23095872","golden":false,"offsetInEndSection":157,"text":"Allergen-specific immunotherapy is currently performed via either the subcutaneous or sublingual routes as a treatment for type I (IgE dependent) allergies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1499,"document":"33334840","golden":false,"offsetInEndSection":1716,"text":"The investigators will ensure that this trial is conducted in accordance with the principles of the Declaration of Helsinki and with the International Conference on Harmonisation Guidelines for Good Clinical Practice.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1442,"document":"19667059","golden":false,"offsetInEndSection":1550,"text":"These data suggest that vaccination with Qbeta-Fel d1 may be a safe and effective treatment for cat allergy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":910,"document":"32155619","golden":false,"offsetInEndSection":1230,"text":"We confirm in vitro binding of the mAb to the inhibitory low-affinity Fc?RIIb receptor using a sensitive biosensor and demonstrate in vivo that protection was dependent on Fc?RIIb.CONCLUSION: A single mAb specific for Ara h 2 is able to improve local and systemic allergic symptoms induced by the whole allergen mixture.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1846,"document":"33334840","golden":false,"offsetInEndSection":2032,"text":"The dissemination of these research findings will follow the National Health and Medical Research Council of Australia Open Access Policy.TRIAL REGISTRATION NUMBER: ACTRN12617000065392p.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":836,"document":"33334840","golden":false,"offsetInEndSection":905,"text":"The primary outcome is IgE-mediated food allergy by 12 months of age.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37182566","golden":false,"offsetInEndSection":242,"text":"Immediate hypersensitivity reactions to vaccines, the most severe of which is anaphylaxis, are uncommon events occurring in fewer than 1 in a million doses administered. These reactions are infrequently immunoglobulin E-mediated. Because they","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":837,"document":"37670552","golden":false,"offsetInEndSection":1014,"text":"re were 479 children vaccinated between 2018 and 2021 for reasons such as post- chemotherapy, after hematopoietic stem cell transplantation, before/after solid organ trans- plan","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":507,"document":"33334840","golden":false,"offsetInEndSection":628,"text":"62 to 0.95)). We hypothesise that a single dose of whole-cell vaccine in early infancy is protective against IgE-mediated","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":451,"document":"17594874","golden":false,"offsetInEndSection":741,"text":"ble in Spain. The aim of this study was to evaluate the clinical safety of a conventional MMR vaccine in a population of egg allergic patients and to determine the presence of egg allergens in a conventional MMR vaccine and if IgE antibodies from egg allergic can recognize egg allergens in","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":349,"document":"23735680","golden":false,"offsetInEndSection":491,"text":"Two doses (10PFU and 1000PFU) of three monovalent vaccines were tested in human clinical trials to compare safety and immunogenicity profiles.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":150,"document":"38857311","golden":false,"offsetInEndSection":355,"text":") vaccines. Based on immunological and epidemiological evidence, we hypothesised that substituting the first aP dose in the routine vaccination schedule with wP vaccine might protect against IgE-mediated f","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":844,"document":"31443989","golden":false,"offsetInEndSection":1200,"text":"While some vaccines, such as the smallpox vaccine approach the gold standard of life-long protection in everyone following a single immunization, other vaccines are less effective, often requiring multiple immunizations, being less effective to populations most susceptible to disease such as infants, the elderly, and those living in the developing world.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1013,"document":"27343438","golden":false,"offsetInEndSection":1154,"text":"The NIAID vaccine is promising as a travel vaccine as a single dose fully protected susceptible adults against live dengue 2 virus challenge.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1644,"document":"10732430","golden":false,"offsetInEndSection":1826,"text":"Live recombinant vaccines against rabies and rinderpest have proven to be highly effective for controlling these infections in the field, and those for AIDS are under clinical trial.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":695,"document":"20347059","golden":false,"offsetInEndSection":850,"text":"After a single dose in hamsters and macaques, neutralizing antibody titers were similar to those elicited by the live 17D vaccine (YF-VAX, Sanofi Pasteur).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":331,"document":"5297557","golden":false,"offsetInEndSection":441,"text":"The preliminary results of a blind comparative trial, in newborn children, of BCG vaccine from Czechoslovakia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":239,"document":"21829748","golden":false,"offsetInEndSection":433,"text":"rDEN1?30 is a live attenuated investigational vaccine for the prevention of DENV-1 illness and is also a component of an investigational tetravalent DENV vaccine currently in Phase I evaluation.","beginSection":"abstract"}],"exact_answer":"","ideal_answer":[],"id":"6777bcec592fa48873000013","type":"yesno","body":"Are there any trials for a single vaccine against most allergies?"},{"documents":[{"golden":true,"id":"9382105"},{"golden":true,"id":"8341298"},{"golden":false,"id":"30363942"},{"golden":false,"id":"16602105"},{"golden":false,"id":"8987231"},{"golden":false,"id":"21193116"},{"golden":false,"id":"9560330"},{"golden":false,"id":"31725139"},{"golden":false,"id":"31862781"},{"golden":false,"id":"20301981"},{"golden":false,"id":"11952718"},{"golden":false,"id":"10277820"},{"golden":false,"id":"16572631"},{"golden":false,"id":"31011621"},{"golden":false,"id":"18087227"},{"golden":false,"id":"29392341"},{"golden":false,"id":"7608996"},{"golden":false,"id":"35637057"},{"golden":false,"id":"3728126"},{"golden":false,"id":"32004362"},{"golden":false,"id":"12007911"},{"golden":false,"id":"32038419"},{"golden":false,"id":"32605487"},{"golden":false,"id":"14587357"},{"golden":false,"id":"11668435"},{"golden":false,"id":"21496604"},{"golden":false,"id":"15073521"},{"golden":false,"id":"28204270"},{"golden":false,"id":"12940653"},{"golden":false,"id":"22466675"},{"golden":false,"id":"18846146"},{"golden":false,"id":"20589866"},{"golden":false,"id":"8505478"},{"golden":false,"id":"19562760"},{"golden":false,"id":"21786433"},{"golden":false,"id":"10153513"},{"golden":false,"id":"25025576"},{"golden":false,"id":"11994689"},{"golden":false,"id":"27800720"},{"golden":false,"id":"6502645"},{"golden":false,"id":"27219255"},{"golden":false,"id":"27432003"},{"golden":false,"id":"34269630"},{"golden":false,"id":"9415926"},{"golden":false,"id":"34780239"},{"golden":false,"id":"22258735"},{"golden":false,"id":"23368804"},{"golden":false,"id":"24757013"},{"golden":false,"id":"3112825"},{"golden":false,"id":"24290997"},{"golden":false,"id":"3319557"},{"golden":false,"id":"24377432"},{"golden":false,"id":"28384991"},{"golden":false,"id":"25874730"},{"golden":false,"id":"29753395"},{"golden":false,"id":"25102581"},{"golden":false,"id":"10164976"},{"golden":false,"id":"31178258"},{"golden":false,"id":"1486076"},{"golden":false,"id":"15992320"},{"golden":false,"id":"15264677"},{"golden":false,"id":"21323806"},{"golden":false,"id":"22031392"},{"golden":false,"id":"25791778"},{"golden":false,"id":"19769836"},{"golden":false,"id":"34297908"},{"golden":false,"id":"26495087"},{"golden":false,"id":"23547414"},{"golden":false,"id":"22787248"},{"golden":false,"id":"24008991"},{"golden":false,"id":"27634470"},{"golden":false,"id":"30121245"},{"golden":false,"id":"25090812"},{"golden":false,"id":"18789959"},{"golden":false,"id":"15853550"},{"golden":false,"id":"16299966"},{"golden":false,"id":"33251679"},{"golden":false,"id":"26176354"},{"golden":false,"id":"33829568"},{"golden":false,"id":"32229270"},{"golden":false,"id":"21240951"},{"golden":false,"id":"20875164"},{"golden":false,"id":"19906675"},{"golden":false,"id":"30946646"},{"golden":false,"id":"19038671"},{"golden":false,"id":"22414772"},{"golden":false,"id":"11079218"},{"golden":false,"id":"17779277"},{"golden":false,"id":"24757582"},{"golden":false,"id":"12440098"},{"golden":false,"id":"35356032"},{"golden":false,"id":"24297501"},{"golden":false,"id":"32789270"},{"golden":false,"id":"28041759"},{"golden":false,"id":"19293491"},{"golden":false,"id":"1773532"},{"golden":false,"id":"9340151"},{"golden":false,"id":"15246489"},{"golden":false,"id":"26598493"},{"golden":false,"id":"38152859"},{"golden":false,"id":"11785009"},{"golden":false,"id":"23338739"},{"golden":false,"id":"17618046"},{"golden":false,"id":"38276052"},{"golden":false,"id":"11483404"},{"golden":false,"id":"24868416"},{"golden":false,"id":"17370757"},{"golden":false,"id":"23826191"},{"golden":false,"id":"39717301"},{"golden":false,"id":"39484307"},{"golden":false,"id":"36631170"},{"golden":false,"id":"38629011"},{"golden":false,"id":"24766155"},{"golden":false,"id":"33155298"},{"golden":false,"id":"21434900"},{"golden":false,"id":"33900895"},{"golden":false,"id":"11640941"},{"golden":false,"id":"8997170"},{"golden":false,"id":"33355474"},{"golden":false,"id":"38528803"},{"golden":false,"id":"11218356"},{"golden":false,"id":"11831430"},{"golden":false,"id":"248090"},{"golden":false,"id":"33854777"},{"golden":false,"id":"16251949"},{"golden":true,"id":"32874771"},{"golden":true,"id":"35672188"},{"golden":false,"id":"25325595"},{"golden":false,"id":"18023028"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":0,"document":"9382105","golden":true,"offsetInEndSection":123,"text":"Hereditary geniospasm is an unusual movement disorder causing episodes of involuntary tremor of the chin and the lower lip.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"8341298","golden":true,"offsetInEndSection":120,"text":"Geniospasm is a hereditary disorder characterized by episodic, usually stress-induced involuntary trembling of the chin.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32874771","golden":true,"offsetInEndSection":178,"text":"Background: Geniospasm is a rare genetic disorder characterized by paroxysmal rhythmic or irregular movements of the chin and lower lip due to repetitive contractions of the ment","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":231,"document":"9382105","golden":false,"offsetInEndSection":325,"text":"Hereditary geniospasm is inherited as an autosomal dominant trait, and its cause is not known.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":108,"document":"25325595","golden":false,"offsetInEndSection":348,"text":"e injury. Causes for tongue biting during sleep in children include seizures, bruxism, faciomandibular myoclonia, hypnic myoclonia, and rarely geniospasm, which has been described as a rare inherited movement disorder accompanied with chin ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35672188","golden":true,"offsetInEndSection":120,"text":"BACKGROUND: Geniospasm is a rare and generally benign movement disorder of the chin yet with potentially debilitating co","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33854777","golden":false,"offsetInEndSection":113,"text":"Hereditary geniospasm is a rare and benign disorder that can cause distress and social embarrassment to patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"16602105","golden":false,"offsetInEndSection":310,"text":"Jaw tremor can be seen as a component of various neurological disorders such as essential tremor, Parkinson\u0027s disease, dystonia, branchial myoclonus, hereditary geniospasm, task-specific tremor, and Whipple\u0027s disease, as well as in normal situations such as shivering, and subclinical physiological jaw tremor.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"9382105","golden":false,"offsetInEndSection":93,"text":"Hereditary geniospasm: linkage to chromosome 9q13-q21 and evidence for genetic heterogeneity.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":662,"document":"9382105","golden":false,"offsetInEndSection":867,"text":"Construction of haplotypes defined an interval of 2.1 cM between the flanking markers D9S1806 and D9S175, thus assigning one locus for hereditary geniospasm to the proximal long arm of chromosome 9q13-q21.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32874771","golden":true,"offsetInEndSection":179,"text":"Background: Geniospasm is a rare genetic disorder characterized by paroxysmal rhythmic or irregular movements of the chin and lower lip due to repetitive contractions of the menta","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"9382105","golden":true,"offsetInEndSection":125,"text":"Hereditary geniospasm is an unusual movement disorder causing episodes of involuntary tremor of the chin and the lower lip. E","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"8341298","golden":true,"offsetInEndSection":123,"text":"Geniospasm is a hereditary disorder characterized by episodic, usually stress-induced involuntary trembling of the chin. Ni","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35672188","golden":true,"offsetInEndSection":122,"text":"BACKGROUND: Geniospasm is a rare and generally benign movement disorder of the chin yet with potentially debilitating comp","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33854777","golden":false,"offsetInEndSection":115,"text":"Hereditary geniospasm is a rare and benign disorder that can cause distress and social embarrassment to patients. T","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"9382105","golden":true,"offsetInEndSection":122,"text":"Hereditary geniospasm is an unusual movement disorder causing episodes of involuntary tremor of the chin and the lower lip","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32874771","golden":true,"offsetInEndSection":177,"text":"Background: Geniospasm is a rare genetic disorder characterized by paroxysmal rhythmic or irregular movements of the chin and lower lip due to repetitive contractions of the men","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33854777","golden":false,"offsetInEndSection":112,"text":"Hereditary geniospasm is a rare and benign disorder that can cause distress and social embarrassment to patients","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35672188","golden":true,"offsetInEndSection":119,"text":"BACKGROUND: Geniospasm is a rare and generally benign movement disorder of the chin yet with potentially debilitating c","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"9560330","golden":false,"offsetInEndSection":51,"text":"Visual memory: what do you know about what you saw?","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"9560330","golden":false,"offsetInEndSection":145,"text":"Recent studies of visual perception are bringing us closer to an understanding of what we remember - and what we forget - when we recall a scene.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"29392341","golden":false,"offsetInEndSection":328,"text":"BACKGROUND: Hyperacusis is a?troublesome symptom that can have a?marked negative impact on quality of life.OBJECTIVES: To identify major research questions in hyperacusis.MATERIALS AND METHODS: Review of gaps in knowledge regarding hyperacusis, and where opportunities may lie to address these.RESULTS: Eight major research ques","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":112,"document":"20301981","golden":false,"offsetInEndSection":510,"text":"The limits of psychoanalytically inclined political theory are read for what they can tell us about the lasting eclipse of the political, and so, inversely, for what they can tell us about what a viable political culture requires, just as the limits of the political efficacy of psychoanalytic practice are read for what they can tell us about what would be required for its successful realization.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":944,"document":"31862781","golden":false,"offsetInEndSection":1509,"text":"QUESTIONS: What are the differential diagnoses and what investigations should be considered?What type of imaging modality has been used for figures 1 and 2 and what do they show?What type of imaging is used in figures 3 and 4 and what do they show?What is the difference between moyamoya disease and moyamoya syndrome?Histologically in what way does MMD affect the cerebral vasculature?What are the different types of MMD?What are the management strategies used in MMD?edpract;106/6/341/F1F1F1Figure 1MRI angiogram (MRA) showing the internal carotid arteries (ICA).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":116,"document":"31725139","golden":false,"offsetInEndSection":145,"text":"Here\u0027s what you need to know.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"31862781","golden":false,"offsetInEndSection":36,"text":"Something hazy drifting in the air?.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31725139","golden":false,"offsetInEndSection":51,"text":"What physical findings should raise your suspicion?","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"31725139","golden":false,"offsetInEndSection":53,"text":"Head \u0026 neck cancers: What you\u0027ll see, how to proceed.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":157,"document":"18087227","golden":false,"offsetInEndSection":411,"text":"Based on an analysis of 146 patients diagnosed with CIDP at the Centre de R?f?rence de Pathologie Neuromusculaire Paris Est between January 2005 and August 2006, our study seeks to answer the following questions: What is the frequency of this neuropathy?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":173,"document":"7608996","golden":false,"offsetInEndSection":459,"text":"As much can be learned from unsuccessful as from successful patients as sex therapy tries to answer the question \"What type of therapeutic intervention, with what type of sexual problems, what type of patients, and what type of therapist is most likely to result in a positive outcome?\"","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":323,"document":"32038419","golden":false,"offsetInEndSection":803,"text":"On minimalist assumptions the evolution of the language faculty must have involved at least three major developments: (i) the evolution of computational atoms, lexical items, understood as bundles of features, (ii) the evolution of a single, simple recursive operation that glues together lexical items and complexes of lexical items, and (iii) externalization linking the syntactic component of the language faculty to the cognitive systems that humans use for sound and gesture.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"7608996","golden":false,"offsetInEndSection":48,"text":"Learning from unsuccessful sex therapy patients.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":101,"document":"7608996","golden":false,"offsetInEndSection":172,"text":"It is especially important to be aware of potential iatrogenic effects.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"7608996","golden":false,"offsetInEndSection":100,"text":"This paper examines what can be learned from evaluating work with unsuccessful sex therapy patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"3728126","golden":false,"offsetInEndSection":337,"text":"Using data gathered from a sixty-three item dating and mate-selection questionnaire completed by two hundred and eighty student and nonstudent respondents, this study investigates the differences between what people believe is proper premarital sexual behavior, what they do and what they think others are doing at five stages of dating.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":577,"document":"14587357","golden":false,"offsetInEndSection":970,"text":"Rather than pursue \"the psychology of the individual characters; what they are like, what makes them what they are, what intentions, often apparently not conscious, seem to motivate their actions and attitudes\" (Silberger 1973), I would look instead at what characters do (what they say, what they appear to emote and think) in response to each others\u0027 speech and imputed feelings and designs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":261,"document":"32605487","golden":false,"offsetInEndSection":499,"text":"The inquiry uncovered the discerning extant moment of deliberating what is important as follows: Deliberating what is important is arduous deciphering amid discordant proposals surfacing in untangled resolve with cultivating affiliations.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":529,"document":"35637057","golden":false,"offsetInEndSection":671,"text":"This investigation explored what people were told about the effects of pregnancy on the voice in comparison to what they actually experienced.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":173,"document":"35637057","golden":false,"offsetInEndSection":394,"text":"Assumptions exist about what can happen to a person\u0027s voice during pregnancy, but these assumptions are based on theoretical predictions leaving little knowledge of the lived experiences of voice changes during pregnancy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":511,"document":"21496604","golden":false,"offsetInEndSection":742,"text":"The forms most commonly seen in neurological practice include cranial dystonia (blepharospasm, oromandibular and lingual dystonia and spasmodic dysphonia), cervical dystonia (also known as spasmodic torticollis) and writer\u0027s cramp.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":178,"document":"11785009","golden":false,"offsetInEndSection":238,"text":"ed by stress. It was first described by Massaro in 1894 like","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"15073521","golden":false,"offsetInEndSection":151,"text":"Embouchure dystonia is a focal task-specific disorder involving abnormal non-coordinated movements and involuntary muscle contraction around the mouth.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21496604","golden":false,"offsetInEndSection":129,"text":"Dystonia is defined as involuntary sustained muscle contractions producing twisting or squeezing movements and abnormal postures.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"22466675","golden":false,"offsetInEndSection":252,"text":"Drug-induced tardive motor syndromes (TMS) is a group of disorders, characterized by involuntary movements of the tongue, face, lips, trunk and extremities, occurring after long-term exposure to a variety of pharmacological agents, mostly neuroleptics.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"21496604","golden":false,"offsetInEndSection":21,"text":"Adult-onset dystonia.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":148,"document":"18846146","golden":false,"offsetInEndSection":585,"text":"l postures. The aim of this brief review is to summarize the current state of knowledge as to the clinical, genetic, diagnostic and therapeutic aspects of dystonia.MATERIAL AND METHODS: This article is based on own research, clinical experience and recent medical literature found by searching Medline.RESULTS AND INTERPRETATIONS: Dystonia is the third most prevalent movement disorder in humans and is a common term for a group of prima","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1773,"document":"21496604","golden":false,"offsetInEndSection":1891,"text":"This chapter focuses on adult-onset focal dystonias including cranial dystonia, cervical dystonia, and writer\u0027s cramp.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":818,"document":"21496604","golden":false,"offsetInEndSection":999,"text":"A general characteristic of dystonia is that the movements or postures may occur in relation to specific voluntary actions by the involved muscle groups (such as in writer\u0027s cramp).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1555,"document":"21496604","golden":false,"offsetInEndSection":1703,"text":"Patients often discover maneuvers that reduce the dystonia and which involve sensory stimuli such as touching the chin lightly in cervical dystonia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":234,"document":"21786433","golden":false,"offsetInEndSection":428,"text":"Specifically, the following questions have been addressed: 1) What criteria should be used to determine whether a scientific discovery or invention is worthy of translation to human application?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":304,"document":"27800720","golden":false,"offsetInEndSection":306,"text":"\u0027.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":135,"document":"21786433","golden":false,"offsetInEndSection":233,"text":"Some of the background for why human studies have evolved to their current state is also included.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":591,"document":"21786433","golden":false,"offsetInEndSection":789,"text":"4) What characteristics of a human disorder should be noted, tracked, or stratified for a clinical trial and what inclusion /exclusion criteria are important to enrolling appropriate trial subjects?","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"21786433","golden":false,"offsetInEndSection":69,"text":"Are you \"tilting at windmills\" or undertaking a valid clinical trial?","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21786433","golden":false,"offsetInEndSection":134,"text":"In this review, several aspects surrounding the choice of a therapeutic intervention and the conduct of clinical trials are discussed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":970,"document":"21786433","golden":false,"offsetInEndSection":1071,"text":"7) What are the success rates of clinical trials and what can we learn from previous clinical trials?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":527,"document":"21786433","golden":false,"offsetInEndSection":590,"text":"3) What are the different types and phases of a clinical trial?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":876,"document":"21786433","golden":false,"offsetInEndSection":969,"text":"6) What confounding factors can alter the accurate interpretation of clinical trial outcomes?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1072,"document":"21786433","golden":false,"offsetInEndSection":1150,"text":"8) What are the essential principles for the conduct of valid clinical trials?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":146,"document":"24290997","golden":false,"offsetInEndSection":150,"text":"tran","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":561,"document":"9415926","golden":false,"offsetInEndSection":992,"text":"Both accurate and inaccurate source attributions result from heuristic processes and more reflectively complex processes that evaluate a mental experience for various qualities such as amount and type of perceptual, contextual, affective, semantic and cognitive detail, that retrieve additional supporting or disconfirming evidence, and that evaluate plausibility and consistency given general knowledge, schemes, biases and goals.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"9415926","golden":false,"offsetInEndSection":137,"text":"Memory distortion reflects failures to identify the sources of mental experience (reality monitoring failures or source misattributions).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":138,"document":"9415926","golden":false,"offsetInEndSection":384,"text":"For example, people sometimes confuse what they inferred or imagined and what actually happened, what they saw and what was suggested to them, one person\u0027s actions and another\u0027s what they heard and what they previously knew, and fiction and fact.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"9415926","golden":false,"offsetInEndSection":40,"text":"Source monitoring and memory distortion.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":385,"document":"9415926","golden":false,"offsetInEndSection":560,"text":"Source confusions arise because activated information is incomplete or ambiguous and the evaluative processes responsible for attributing information to sources are imperfect.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":143,"document":"34780239","golden":false,"offsetInEndSection":329,"text":"In three experiments, we asked adults and children between the ages of 3 and 12 to report what is \"disgusting,\" what is \"gross,\" or what might have caused someone to make a disgust face.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":993,"document":"9415926","golden":false,"offsetInEndSection":1126,"text":"Experimental and clinical evidence regarding cognitive mechanisms and underlying brain structures of source monitoring are discussed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":643,"document":"22258735","golden":false,"offsetInEndSection":668,"text":"Related to the \"So what?\"","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":330,"document":"34780239","golden":false,"offsetInEndSection":618,"text":"In Study 1, parents of 3- to 12-year-old children (n \u003d 120) were asked what they thought was disgusting and what they thought their children would find disgusting and completed a picky eating questionnaire to examine the extent to which children\u0027s eating habits may be related to disgust.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":133,"document":"25874730","golden":false,"offsetInEndSection":356,"text":"MS is a disease of the central nervous system that is associated with heterogeneous symptoms and functional consequences, and the current first-line disease-modifying therapies often become ineffective later in the disease.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"29753395","golden":false,"offsetInEndSection":311,"text":"Quantitative Extent of Atherosclerotic Plaque in the Major Epicardial Coronary Arteries in Patients with Fatal Coronary Heart Disease, in Coronary Endarterectomy Specimens, in Aorta-Coronary Saphenous Venous Conduits, and Means to Prevent the Plaques: A Review after Studying the Coronary Arteries for 50 Years.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":516,"document":"25874730","golden":false,"offsetInEndSection":632,"text":"We proposed 10 research questions to guide future research on PA and MS: (1) Is PA an MS disease-modifying behavior?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":357,"document":"25874730","golden":false,"offsetInEndSection":515,"text":"There is increasing evidence for the benefits of physical activity (PA) in people with MS, but this population is generally physically inactive and sedentary.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1060,"document":"29753395","golden":false,"offsetInEndSection":1142,"text":"What is the mechanism of luminal widening by angioplasty in the coronary arteries?","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"1486076","golden":false,"offsetInEndSection":91,"text":"A method for assessing the accuracy of surgical technique in the correction of astigmatism.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1143,"document":"29753395","golden":false,"offsetInEndSection":1257,"text":"What observations suggest that atherosclerotic plaques are the result at least in part of organization of thrombi?","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"25874730","golden":false,"offsetInEndSection":78,"text":"Top 10 research questions related to physical activity and multiple sclerosis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25874730","golden":false,"offsetInEndSection":132,"text":"An estimated 2.5 million people worldwide are living with multiple sclerosis (MS), and this disease may be increasing in prevalence.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":560,"document":"22031392","golden":false,"offsetInEndSection":577,"text":"What is evidence?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":123,"document":"29636878","golden":false,"offsetInEndSection":263,"text":"Ubiquitination, a way of protein modification, plays a key role in regulating various biological functions including inflammation responses.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27774293","golden":false,"offsetInEndSection":141,"text":"Recombination is a process that unlinks neighboring loci allowing for independent evolutionary trajectories within genomes of many organisms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1125,"document":"22566909","golden":false,"offsetInEndSection":1293,"text":"Host switching - the acquisition of new host species by parasites - is a major mechanism that drives parasite diversity and is frequently involved in disease emergence.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31216043","golden":false,"offsetInEndSection":286,"text":"ADP-ribosylation is a reversible chemical modification catalysed by ADP-ribosyltransferases such as PARPs that utilize nicotinamide adenine dinucleotide (NAD+) as a cofactor to transfer monomer or polymers of ADP-ribose nucleotide onto macromolecular targets such as proteins and DNA. A","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":629,"document":"28473450","golden":false,"offsetInEndSection":778,"text":"It is reminiscent of paraptosis, a caspase-independent, non-apoptotic form of cell death associated with the formation of large cytoplasmic vacuoles.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25541518","golden":false,"offsetInEndSection":83,"text":"Recombination is a pervasive process generating diversity in most viruses. It joins","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":90,"document":"29712969","golden":false,"offsetInEndSection":199,"text":"ADP-ribosylation is a posttranslational modification catalyzed primarily by ARTD (aka PARP) enzymes in cells.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23474712","golden":false,"offsetInEndSection":128,"text":"ADP-ribosylation is a reversible post-translational modification with wide-ranging biological functions in all kingdoms of life.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"22766145","golden":false,"offsetInEndSection":220,"text":"Poly(ADP-ribosyl)ation (PARylation), a protein post-translational modification that was originally connected to the DNA damage response, is now known to engage in a continuously increasing number of biological processes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25791778","golden":false,"offsetInEndSection":146,"text":"Chins, which are unique to humans, have generated considerable debate concerning their evolutionary origins, yet a consensus has remained elusive.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":115,"document":"19769836","golden":false,"offsetInEndSection":332,"text":"of rosacea. The most common phyma is rhinophyma, yet similar swellings may occur on the chin (gnatophyma), forehead (metophyma), one or both ears (otophyma), and eyelids (blepharophyma).OBJECTIVE: Unlike rhinophyma, o","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":147,"document":"25791778","golden":false,"offsetInEndSection":243,"text":"Many have argued that chins are adaptations for chewing stress, speech, or sexual ornamentation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":244,"document":"25791778","golden":false,"offsetInEndSection":372,"text":"Alternatively, some have suggested that chins are spandrels-byproducts of selection operating elsewhere in the mandible or face.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24008991","golden":false,"offsetInEndSection":112,"text":"Malouf syndrome is a rare congenital disorder involving the heart, genitalia, skin and skeletal characteristics.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":619,"document":"25791778","golden":false,"offsetInEndSection":736,"text":"These questions are important since the chin is one of the features used to define Homo sapiens in the fossil record.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":426,"document":"25791778","golden":false,"offsetInEndSection":618,"text":"The questions addressed by this study are: [1] whether chins represent an exceptionally derived morphological condition, and [2] if this can be interpreted as the product of natural selection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1164,"document":"25791778","golden":false,"offsetInEndSection":1335,"text":"These results suggest that human symphyseal morphology is exceptionally derived relative to other primates, and selection has been operational in producing the human chin.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23547414","golden":false,"offsetInEndSection":140,"text":"Poland syndrome is a rare congenital anomaly typically characterized by unilateral chest wall hypoplasia and ipsilateral hand abnormalities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":163,"document":"34297908","golden":false,"offsetInEndSection":366,"text":"The potential of DNAm signatures (also known as \"episignatures\") is just beginning to emerge as there are \u003e300 known epigenetic regulatory genes, ?100 of which are linked to neurodevelopmental disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33251679","golden":false,"offsetInEndSection":675,"text":"BACKGROUND: Information is available about what predicts Lidcombe Program treatment time, but nothing is known about what predicts treatment prognosis.AIMS: To investigate the predictors of treatment dropout and treatment outcome for children who were treated for early stuttering with the Lidcombe Program (N \u003d 277).METHODS \u0026 PROCEDURES: A total of 32 variables were used as predictors in regression analyses of short- and medium-term Lidcombe Program outcome, and of treatment dropout.OUTCOMES \u0026 RESULTS: Regression analyses associated children who have better language skills and easy temperament with better treatment outcome, although only a small portion of the varianc","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"18789959","golden":false,"offsetInEndSection":180,"text":"The mean age of the human population is steadily increasing in many areas around the globe, a phenomenon with large social, political, economic and biological/medical implications.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":311,"document":"18789959","golden":false,"offsetInEndSection":624,"text":"To foster interactions and collaboration between diverse scientists interested in the biochemical, physiological, epidemiological and psychosocial aspects of aging, The University of Copenhagen Faculty of Health Sciences recently organized and co-sponsored a workshop entitled Aging-From Molecules to Populations.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1000,"document":"18789959","golden":false,"offsetInEndSection":1101,"text":"Are human progeriod diseases, characterized by premature aging, good models for \"normal\" human aging?","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"18789959","golden":false,"offsetInEndSection":36,"text":"Aging-from molecules to populations.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"11640941","golden":false,"offsetInEndSection":238,"text":"Patients with visual form agnosia exhibit a profound impairment in shape perception (what an object is) coupled with intact visuomotor functions (how to act on an object), demonstrating a dissociation between visual perception and action.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":181,"document":"18789959","golden":false,"offsetInEndSection":310,"text":"Inevitably, this phenomenon is stimulating great interest in understanding and potentially modulating the process of human aging.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":828,"document":"18789959","golden":false,"offsetInEndSection":880,"text":"Which genes have the greatest impact on human aging?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1170,"document":"18789959","golden":false,"offsetInEndSection":1302,"text":"To what extent and by what mechanisms do early life environmental factors influence aging-associated physical and cognitive decline?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1102,"document":"18789959","golden":false,"offsetInEndSection":1169,"text":"Is delayed or \"elite\" aging informative about \"normal\" human aging?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24757582","golden":false,"offsetInEndSection":350,"text":"BACKGROUND: Hemimasticatory spasm is a very rare movement disorder characterized by unilateral, involuntary, paroxysmal contractions of the jaw-closing muscles, causing clinically brief twitches and/or spasms.CASE REPORT: A 62-year-old female consulted us with a 30-year history of unusual involuntary twitches in the preauricular region and spasms t","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":152,"document":"19906675","golden":false,"offsetInEndSection":521,"text":"Here we review and evaluate (i) what is known about these candidate magnetoreceptor molecules, (ii) what characteristics cryptochrome molecules must fulfil to possibly underlie light-dependent, radical pair based magnetoreception, (iii) what evidence supports the involvement of cryptochromes in magnetoreception, and (iv) what needs to be addressed in future research.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"19906675","golden":false,"offsetInEndSection":88,"text":"Cryptochromes--a potential magnetoreceptor: what do we know and what do we want to know?","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"19906675","golden":false,"offsetInEndSection":151,"text":"Cryptochromes have been suggested to be the primary magnetoreceptor molecules underlying light-dependent magnetic compass detection in migratory birds.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":522,"document":"19906675","golden":false,"offsetInEndSection":620,"text":"The review focuses primarily on our knowledge of cryptochromes in the context of magnetoreception.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":129,"document":"33900895","golden":false,"offsetInEndSection":701,"text":"l outcomes. We used a communication tool called \"What Matters to Me\" (WMTM) to provide insight into what seriously ill children want to tell their healthcare providers about what is important to them.RESEARCH APPROACH: Content analysis of completed tools.PARTICIPANTS: 21 pediatric patients hospitalized on a stem cell transplant unit.METHODOLOGICAL APPLICATION: Direct content analysis.FINDINGS: Three themes were identified: importance of personal identity, preferences for communication, and preferences for care delivery.INTERPRETATIONS: Children and adolescents with ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":220,"document":"19038671","golden":false,"offsetInEndSection":248,"text":"What works and what doesn\u0027t?","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"11640941","golden":false,"offsetInEndSection":84,"text":"Dissociating \u0027what\u0027 and \u0027how\u0027 in visual form agnosia: a computational investigation.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":499,"document":"30946646","golden":false,"offsetInEndSection":556,"text":"What bars should be set, at what height, and to what end?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"12440098","golden":false,"offsetInEndSection":103,"text":"Paroxysmal kinesigenic choreoathetosis (PKC) is a rare and benign disorder with its onset in childhood.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35356032","golden":false,"offsetInEndSection":169,"text":"Laryngeal dystonia is a debilitating disorder of voicing in which the laryngeal muscles are intermittently in spasm resulting in involuntary interruptions during speech.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":753,"document":"32789270","golden":false,"offsetInEndSection":1210,"text":"d pyriform sinus. Analysis of the mechanism of these improvements revealed that combined head and neck flexion, compared with neck flexion, decreased the distance between the origin and insertion (DOI) of the sternohyoid muscle (SM) and increased the muscle contraction rate and the maximum contraction duration of the geniohyoid muscle (GM) during swallowing.DISCUSSION: In the present case, the patient had restrictions in extension of the SM that applied","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28041759","golden":false,"offsetInEndSection":238,"text":"Numb chin syndrome (NCS) is a rare yet potentially ominous sensory neuropathy in the distribution of the mental or inferior alveolar nerve characterized by unilateral hypoesthesia over the lower lip, chin and occasionally gingival mucosa.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24297501","golden":false,"offsetInEndSection":194,"text":"The ubiquitous human polyomavirus JC virus (JCV) is the established etiological agent of the debilitating and often fatal demyelinating disease, progressive multifocal leukoencephalopathy (PML).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":642,"document":"12440098","golden":false,"offsetInEndSection":798,"text":"These results suggest dysfunction or immaturity of the indirect pathway of basal ganglia in PKC, as well as the hyperexcitability of the descending pathway.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":104,"document":"12440098","golden":false,"offsetInEndSection":183,"text":"PKC generally improves with age, and its pathophysiology has not been revealed.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"12440098","golden":false,"offsetInEndSection":113,"text":"[Ictal SPECT and paired stimulation SEP recovery curve in a patient with paroxysmal kinesigenic choreoathetosis].","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":260,"document":"12440098","golden":false,"offsetInEndSection":397,"text":"Ictal SPECT showed a significant decrease in blood flow in the caudate nucleus contralateral to the limb showing an involuntary movement.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":184,"document":"12440098","golden":false,"offsetInEndSection":259,"text":"We recorded both ictal and interictal SPECT in a 14-year-old girl with PKC.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":171,"document":"38152859","golden":false,"offsetInEndSection":400,"text":"Although highly suggestive of epilepsy, a differential diagnosis should be made with sleep-related movement disorders such as bruxism, hypnic myoclonus, facio-mandibular myoclonus, and geniospasm when this hypothesis is excluded.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32874771","golden":true,"offsetInEndSection":190,"text":"Background: Geniospasm is a rare genetic disorder characterized by paroxysmal rhythmic or irregular movements of the chin and lower lip due to repetitive contractions of the mentalis muscle.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38152859","golden":false,"offsetInEndSection":170,"text":"Bleeding tongue-biting episodes during sleep are a rare and alarming situation that can negatively impact the child\u0027s and parents\u0027 sleep, affecting their quality of life.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35672188","golden":true,"offsetInEndSection":132,"text":"BACKGROUND: Geniospasm is a rare and generally benign movement disorder of the chin yet with potentially debilitating complications.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":648,"document":"38152859","golden":false,"offsetInEndSection":1053,"text":"This study reports the challenging case of managing and diagnosing a 2-year-old boy with recurrent tongue biting during sleep since he was 12 months old, causing bleeding lacerations, frequent awakenings, and significant sleep impairment with daytime consequences for him and his family.CITATION: Cascais I, Ashworth J, Ribeiro L, Freitas J, Rios M. A rare case of tongue biting during sleep in childhood.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":512,"document":"38152859","golden":false,"offsetInEndSection":647,"text":"Treatment with clonazepam can be necessary in the presence of frequent tongue biting that causes severe injuries and sleep disturbance.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38152859","golden":false,"offsetInEndSection":55,"text":"A rare case of tongue biting during sleep in childhood.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"11785009","golden":false,"offsetInEndSection":191,"text":"INTRODUCTION: Chin tremor is an uncommon hereditary autosomic dominant disorder, characterized by involuntary, episodic, and repetitive movements involving chin muscles, stimulated by stress.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":567,"document":"23338739","golden":false,"offsetInEndSection":797,"text":"We discuss the hypothesis that the anatomopathological abnormality may lie at the level of the higher cortical centers or midbrain.CONCLUSIONS: Further studies are needed in order to gain greater comprehension of neonatal tremors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24868416","golden":false,"offsetInEndSection":162,"text":"Essential palatal tremor (EPT) is a rare disorder which shows rhythmic involuntary movement of the muscles of soft palate, especially tensor veli palatini muscle.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":754,"document":"17370757","golden":false,"offsetInEndSection":936,"text":"Excellent control of post-stroke movement disorders was achieved by conventional DBS and/or MCS in 20 of 28 patients with hemichoreoathetosis, hemiballism tremor, and motor weakness.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1054,"document":"38152859","golden":false,"offsetInEndSection":1071,"text":"J Clin Sleep Med.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39484307","golden":false,"offsetInEndSection":195,"text":"We present a case of coronary vasospasm that presented as an acute ST-segment elevation myocardial infarction following a syncopal event, which was preceded by an episode of crushing chest pain.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39717301","golden":false,"offsetInEndSection":90,"text":"This case report describes a 15-year-old boy who presented with vasospastic angina (VSA).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38629011","golden":false,"offsetInEndSection":223,"text":"Coronary vasospasm is defined as the abnormal contraction of an epicardial coronary artery.?Variant angina is a severe form of coronary vasospasm, reflecting transmural ischemia with ST-T elevation on an electrocardiogram.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36631170","golden":false,"offsetInEndSection":312,"text":"We present a case of recurrent vasospasm as an uncommon cause of ventricular fibrillation in a young female patient who was found to have a genetic mutation of unknown significance in the desmoplakin (DSP) gene and ultimately required an implantable cardiac defibrillator and percutaneous coronary intervention.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":499,"document":"24766155","golden":false,"offsetInEndSection":711,"text":"The composite results suggest considerable convergence in what is considered discredited and offer a first step in identifying discredited procedures in modern mental health practice for children and adolescents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":287,"document":"33155298","golden":false,"offsetInEndSection":375,"text":"in the presence of colored objects (e.g., a yellow cat) with 3 preschoolers with autism.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":141,"document":"33900895","golden":false,"offsetInEndSection":801,"text":"We used a communication tool called \"What Matters to Me\" (WMTM) to provide insight into what seriously ill children want to tell their healthcare providers about what is important to them.RESEARCH APPROACH: Content analysis of completed tools.PARTICIPANTS: 21 pediatric patients hospitalized on a stem cell transplant unit.METHODOLOGICAL APPLICATION: Direct content analysis.FINDINGS: Three themes were identified: importance of personal identity, preferences for communication, and preferences for care delivery.INTERPRETATIONS: Children and adolescents with serious medical illnesses are willing to share what matters to them with members of their care team.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33900895","golden":false,"offsetInEndSection":140,"text":"OBJECTIVES: Engagement of pediatric patients in conversations about their healthcare can lead to better psychological and physical outcomes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24766155","golden":false,"offsetInEndSection":223,"text":"In the context of intense interest in identifying what works in mental health, we sought to establish a consensus on what doesnot work-discredited psychological assessments and treatments used with children and adolescents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":245,"document":"21434900","golden":false,"offsetInEndSection":337,"text":"Meaning what we say refers to the authenticity of our response, that what we say is sincere.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1071,"document":"11640941","golden":false,"offsetInEndSection":1202,"text":"The simulation results are discussed in terms of their implications for visual form agnosia and other neuropsychological syndromes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1229,"document":"8997170","golden":false,"offsetInEndSection":1415,"text":"These data lend support to theories of utterance interpretation in cognitive science that pragmatics strongly influences people\u0027s understanding of what speakers both say and communicate.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":827,"document":"38528803","golden":false,"offsetInEndSection":1073,"text":"These results favor counterfactual theories of causal reasoning, demonstrate how eye movements can reflect simulation during this reasoning and provide a novel approach for investigating retrospective causal reasoning and counterfactual thinking.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1072,"document":"38152859","golden":false,"offsetInEndSection":1091,"text":"2024;20(4):653-656.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35672188","golden":true,"offsetInEndSection":340,"text":"BACKGROUND: Geniospasm is a rare and generally benign movement disorder of the chin yet with potentially debilitating complications. Due to its rarity, previous literature was limited to only case reports or series with critical knowledge gap on its natural history, prognosis, and management. We aimed to establish the natural history, pro","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33854777","golden":false,"offsetInEndSection":300,"text":"Hereditary geniospasm is a rare and benign disorder that can cause distress and social embarrassment to patients. There are only a handful of possible treatment options available. Due to the rarity of the condition, practices differ across the world and the results are varied. These include beta-blo","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32874771","golden":true,"offsetInEndSection":270,"text":"Background: Geniospasm is a rare genetic disorder characterized by paroxysmal rhythmic or irregular movements of the chin and lower lip due to repetitive contractions of the mentalis muscle. Pathophysiology is poorly understood, and optimal treatment has not been establ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":502,"document":"25325595","golden":false,"offsetInEndSection":615,"text":"onazepam. Geniospasm should be considered in the differential diagnosis of cases with unexplained tongue injury i","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":210,"document":"18023028","golden":false,"offsetInEndSection":285,"text":"In one subject we documented a paroxysm of geniospasm during sleep phase 2.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"16251949","golden":false,"offsetInEndSection":120,"text":"Sleep is a widespread biological phenomenon, and its scientific study is proceeding at multiple levels at the same time.","beginSection":"abstract"}],"ideal_answer":[],"id":"63adc90bc6c7d4d31b000018","type":"summary","body":"What is geniospasm?"},{"documents":[{"golden":true,"id":"16001560"},{"golden":false,"id":"1693300"},{"golden":false,"id":"34067874"},{"golden":false,"id":"24550549"},{"golden":false,"id":"11474856"},{"golden":true,"id":"34784486"},{"golden":false,"id":"32533257"},{"golden":false,"id":"19904474"},{"golden":false,"id":"10229905"},{"golden":false,"id":"708096"},{"golden":false,"id":"26226112"},{"golden":false,"id":"39630793"},{"golden":false,"id":"31262202"},{"golden":false,"id":"29284803"},{"golden":false,"id":"34584341"},{"golden":false,"id":"18021459"},{"golden":false,"id":"32711819"},{"golden":false,"id":"29660967"},{"golden":false,"id":"36726225"},{"golden":false,"id":"34584304"},{"golden":false,"id":"34790476"},{"golden":false,"id":"9535422"},{"golden":false,"id":"6728519"},{"golden":false,"id":"36267415"},{"golden":false,"id":"34493755"},{"golden":false,"id":"10761545"},{"golden":false,"id":"39532186"},{"golden":false,"id":"33314050"},{"golden":false,"id":"11993293"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":1106,"document":"16001560","golden":false,"offsetInEndSection":1131,"text":"Mean age was 5; 10 years.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":157,"document":"16001560","golden":true,"offsetInEndSection":259,"text":"Six years old--the age at which children start the elementary school--is a key age for this screening.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1147,"document":"32533257","golden":false,"offsetInEndSection":1364,"text":"The items covered the increasing language development for the ages from 1 to 6.Conclusion: The ELS is a valid instrument to identify children with DLD covering an age range of 1 to 6 years in community-based settings.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":702,"document":"16001560","golden":false,"offsetInEndSection":856,"text":"Those children, aged from 5 to 6, were screened with ERTLA6 by the school practitioner during a medical visit (score from 0 [the best] to 18 [the worse]).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":690,"document":"1693300","golden":false,"offsetInEndSection":933,"text":"Intervention was started at a mean age of 1 year 5 months (range 2 months to 3 years) for children with severe learning difficulties, and 3 years 9 months (2 years 3 months to 6 years 6 months) for children with moderate learning difficulties.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"16001560","golden":false,"offsetInEndSection":122,"text":"[Validation of a screening test of language and learning disorders for 6-year old children (ERTLA6)--a prospective study].","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"10229905","golden":false,"offsetInEndSection":384,"text":"OBJECTIVE: Evaluation of school attainments in children with congenital hypothyroidism (CH) detected by neonatal screening and treated early in life.PATIENTS AND METHODS: Text comprehension, mathematics, reading, writing and verbal and spatial memory, as indices of school learning, were evaluated in nineteen 5- to 10-year-old children with CH attending nursery or elementary school.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":619,"document":"34067874","golden":false,"offsetInEndSection":1050,"text":"We identified 37 studies, consisting of 10 systematic reviews and 27 primary studies.RESULTS: Delay in gesture production, receptive and/or expressive vocabulary, syntactic comprehension, or word combination up to 30 months emerged as early predictors of DLD, a family history of DLD appeared to be a major risk factor, and low socioeconomic status and environmental input were reported as risk factors with lower predictive power.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":611,"document":"708096","golden":false,"offsetInEndSection":862,"text":"These neurological findings were equally common in patients in whom treatment started between 4 and 10 weeks of age and patients treated after 10 weeks, suggesting that early detection of hypothyroidism by neonatal screening may be of limited benefit.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1335,"document":"16001560","golden":false,"offsetInEndSection":1394,"text":"The percentage of well classified children was 84% [69-99].","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1142,"document":"24550549","golden":false,"offsetInEndSection":1493,"text":"This study demonstrates an efficient means to identify infants at risk for autism spectrum disorder by 9 months of age and serves to alert primary care providers of infants who are vulnerable for autism spectrum disorder before symptoms are discernible by clinical judgment of primary care providers, parental concerns, or by screening questionnaires.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31262202","golden":false,"offsetInEndSection":337,"text":"Purpose: To evaluate the feasibility, preliminary diagnostic accuracy and reliability of a screening tool for developmental language disorder (DLD) in early school-age children seen in a paediatric primary care setting.Method: Sixty-six children aged 6-8years attending well-child visits at a large urban paediatric clinic participated.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":231,"document":"39630793","golden":false,"offsetInEndSection":373,"text":"ent this. The objective of the study was the early detection and reference of children with learning disabilities as identified by their schoo","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1278,"document":"34584341","golden":false,"offsetInEndSection":1483,"text":"he results of this approach to development are applicable to other screening methods, especially those that attempt to predict those children at risk of dyslexia prior to the onset of reading instruction. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"29284803","golden":false,"offsetInEndSection":94,"text":"BACKGROUND: Learning disorder (LD) is a common cause for poor academic performance among schoo","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":258,"document":"34784486","golden":true,"offsetInEndSection":578,"text":"Early diagnosis of these disabilities in kids from age 3 to 6 will help to start early medical treatments and get them back to the normal condition.MATERIAL AND METHOD: we developed a software-based Learning Disability Evaluation Kit called YALU with computer Game Modules for kids targeting their learning disabilities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1132,"document":"16001560","golden":false,"offsetInEndSection":1334,"text":"With a threshold \u003e or \u003d 7, ERTLA6 sensibility and specificity were respectively 79% [63-94] and 87% [81-93]; the positive predictive value was 58% [42-74], the negative predictive value was 95% [90-99].","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32533257","golden":false,"offsetInEndSection":450,"text":"The aim of this study was to assess the criterion validity of a new screening instrument, the Early Language Scale (ELS), for the identification of young children at risk for developmental language disorder (DLD), and to determine optimal age-adjusted cut-off scores. We recruited a community-based sample of 265 children aged 1 to 6 years of age. Parents of these children responded on the ELS, a 26-item \"yes-no\" questionnaire. The children were as","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34493755","golden":false,"offsetInEndSection":300,"text":"The prevalence of colorectal adenoma and advanced adenoma (AA) differs between sexes. Also, the optimal age for the first screening colonoscopy is under debate. We, therefore, performed a sex-specific and age-adjusted comparison of adenoma, AA and advanced neoplasia (AN) rates in a real-world screen","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1708,"document":"18021459","golden":false,"offsetInEndSection":1853,"text":"ts to learn more about ASD.CONCLUSION: The average age of ASD diagnosis (4 years, 10 months) was later than optimal if children are to receive th","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":3392,"document":"11993293","golden":false,"offsetInEndSection":3589,"text":"Because substance use at age 14 or 15 years can be predicted by academic and social behavior at ages 7 to 9 years, early detection of poor social skills and learning difficulties is essential [43].","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":125,"document":"33314050","golden":false,"offsetInEndSection":524,"text":"ers.METHOD: Using a screening test designed and validated to measure dorsal EVSP ability, 168 children (122 males, 46 females; mean age 10y [SD 1y 10mo], range 4y 8mo-16y 4mo) diagnosed with developmental coordination disorder (DCD), specific learning disorder (SLD), attention-deficit/hyperactivity disorder (ADHD), and/or oral language disorder were compared with a group of 184 typically developi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32533257","golden":false,"offsetInEndSection":267,"text":"The aim of this study was to assess the criterion validity of a new screening instrument, the Early Language Scale (ELS), for the identification of young children at risk for developmental language disorder (DLD), and to determine optimal age-adjusted cut-off scores.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1541,"document":"29660967","golden":false,"offsetInEndSection":1862,"text":"t can be attained from using the tool.CONCLUSION: Recommendations are made for procedures for systematically implementing ABI screening in pediatric settings including schools, primary care providers, mental health, and juvenile justice systems to improve the access to brain injury services and affording more successful","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":654,"document":"10761545","golden":false,"offsetInEndSection":864,"text":"The ultimate goal of the implementation of neonatal hearing screening is: identification of bilateral hearing losses before the age of 3 months and start of therapy and counselling before the age of 6 months.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":101,"document":"32711819","golden":false,"offsetInEndSection":191,"text":"Detection in an earlier age enables early intervention, which is typically more effective.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1809,"document":"39532186","golden":false,"offsetInEndSection":2096,"text":"In conclusion, the proposed approach provides a two-phase strategy for identifying ASD children and offering a suitable teaching strategy with respect to the severity of the ASD, thereby potentially contributing to the development of tailored solutions for children with varying needs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36726225","golden":false,"offsetInEndSection":207,"text":"INTRODUCTION: Developmental and Epileptic Encephalopathies (DEEs) encompass a group of neurological disorders caused by either abnormal neuronal development and white matter maturation or even by weak synapt","beginSection":"abstract"}],"exact_answer":[],"ideal_answer":[],"id":"6777bb95592fa48873000010","type":"factoid","body":"What is the optimal age to start screening for learning disorders?"},{"documents":[{"golden":true,"id":"33388093"},{"golden":false,"id":"17166282"},{"golden":false,"id":"33419394"},{"golden":false,"id":"33574121"},{"golden":false,"id":"10501371"},{"golden":false,"id":"38348152"},{"golden":false,"id":"23656644"},{"golden":false,"id":"21905783"},{"golden":false,"id":"32499597"},{"golden":false,"id":"29168012"},{"golden":false,"id":"23554987"},{"golden":false,"id":"36200173"},{"golden":false,"id":"31199303"},{"golden":false,"id":"38399546"},{"golden":false,"id":"19901700"},{"golden":false,"id":"17326757"},{"golden":false,"id":"21276672"},{"golden":false,"id":"20695756"},{"golden":false,"id":"38773455"},{"golden":false,"id":"21827668"},{"golden":false,"id":"23607943"},{"golden":false,"id":"38192587"},{"golden":false,"id":"10592925"},{"golden":false,"id":"26457970"},{"golden":false,"id":"22633511"},{"golden":false,"id":"10906017"},{"golden":false,"id":"22262986"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":2130,"document":"33388093","golden":true,"offsetInEndSection":2477,"text":"Moreover, high-expression IFI27 was associated with more severe cases (p?\u003d?0.041), more requirements of mechanical ventilation (p?\u003d?0.034), more frequent hospitalization (p?\u003c?0.001) and longer cumulative hospital stay (p?\u003d?0.012).CONCLUSION: IFI27 might serve to predict RSV infection and evaluate the severity of RSV infection in preterm infants.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1113,"document":"17166282","golden":false,"offsetInEndSection":1459,"text":"When performing QRT-PCR on these genes IFI27 was upregulated in all but one infant, and CLC was downregulated in all 18 infants, and similar to that given by microarray.CONCLUSION: The gene IFI27 is upregulated and the gene CLC is downregulated in whole blood of infants hospitalised with RSV, subtype B, bronchiolitis and is not reported before.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"33388093","golden":true,"offsetInEndSection":104,"text":"IFI27 may predict and evaluate the severity of respiratory syncytial virus infection in preterm infants.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":980,"document":"33419394","golden":false,"offsetInEndSection":1185,"text":"The expression of IFI27, IFI44, IFITM3, FCER1A, and ISG15 were shown to be involved in the pathogenesis of RSV.CONCLUSIONS: We concluded that IFI27, IFI44, IFITM3, FCER1A, and ISG15 may play a role in RSV.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1254,"document":"33388093","golden":false,"offsetInEndSection":1421,"text":"Further, the RSV infected infants with high-expression IFI27 and those with low-expression IFI27 were compared (defined as higher or lower than the median mRNA level).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1422,"document":"33388093","golden":false,"offsetInEndSection":1608,"text":"Finally, the gene set enrichment analysis (GSEA) focusing on IFI27 was carried out.RESULTS: Totally, 4028 DEGs were screened out and among which, 131 most significant DEGs were selected.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1837,"document":"33388093","golden":false,"offsetInEndSection":1934,"text":"Furthermore, IFI27 was confirmed to be the most significantly expressed in clinical verification.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33388093","golden":false,"offsetInEndSection":221,"text":"BACKGROUND: Preterm infants are a special population that vulnerable to respiratory syncytial virus (RSV) infection and the lower respiratory tract infections (LRTIs) caused by RSV could be severe and even life-threating.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1053,"document":"33388093","golden":false,"offsetInEndSection":1253,"text":"Clinical verification was employed to verify the expression level of top five hub genes among 72 infants including 50 RSV infected patients and 22 non-RSV-infected patients hospitalized in our center.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":222,"document":"33388093","golden":false,"offsetInEndSection":685,"text":"The purpose of the present study was to identify candidate genes of preterm infants who are susceptible to RSV infection and provide a new insight into the pathogenesis of RSV infection.METHODS: Three datasets (GSE77087, GSE69606 and GSE41374) containing 183 blood samples of RSV infected patients and 33 blood samples of healthy controls from Gene Expression Omnibus (GEO) database were downloaded and the differentially expressed genes (DEGs) were screened out.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":144,"document":"31199303","golden":false,"offsetInEndSection":367,"text":"e disease.OBJECTIVE: The aim of this study (Assessing Predictors of Infant RSV Effects and Severity, AsPIRES) was to identify factors associated with severe disease in full-term healthy infants younger than 10 months with p","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1353,"document":"36200173","golden":false,"offsetInEndSection":1568,"text":"-.98) irrespective of age.CONCLUSIONS: Children with milder RSV infection and those aged \u003e6 months had higher concentrations of mucosal IFNs, suggesting that maturation of mucosal IFN responses are associated with p","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23554987","golden":false,"offsetInEndSection":166,"text":"OBJECTIVES: This study aimed to update and validate a prediction rule for respiratory syncytial virus (RSV) hospitalization in preterm infants 33-35 weeks gestational","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":921,"document":"38773455","golden":false,"offsetInEndSection":1048,"text":"nd prior exposure. We account for the differential risk of RSV-hospitalisation in full-term and preterm infants (defined as \u003c?3","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1045,"document":"38399546","golden":false,"offsetInEndSection":1449,"text":"onclusions: our study shows for the first time that type II IFN score was significant reduced in peripheral blood of infants with bronchiolitis by RSV compared to age-matched healthy controls; in the NPS swab this resulted downregulation was not statistically significant and the type II IFN score in the NPS swab can be used as marker of resolution of infection or improvement of clinical conditions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1143,"document":"23656644","golden":false,"offsetInEndSection":1488,"text":"During this time, the proportion of infants with recurrent wheeze was 10 percentage points lower in patients treated with palivizumab (11% vs. 21%, P\u003d0.01).CONCLUSIONS: In otherwise healthy preterm infants, palivizumab treatment resulted in a significant reduction in wheezing days during the first year of life, even after the end of treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33388093","golden":false,"offsetInEndSection":450,"text":"BACKGROUND: Preterm infants are a special population that vulnerable to respiratory syncytial virus (RSV) infection and the lower respiratory tract infections (LRTIs) caused by RSV could be severe and even life-threating. The purpose of the present study was to identify candidate genes of preterm infants who are susceptible to RSV infection and provide a new insight into the pathogenesis of RSV infection.METHODS: Three datasets (GSE77087, GSE6960","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2333,"document":"33388093","golden":false,"offsetInEndSection":2440,"text":" hospital stay (p?\u003d?0.012).CONCLUSION: IFI27 might serve to predict RSV infection and evaluate the severity","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21276672","golden":false,"offsetInEndSection":231,"text":"Preterm infants are at increased risk of being rehospitalised during the first few months of life with severe respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) that usually manifests as apnea and hypoxemia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17326757","golden":false,"offsetInEndSection":136,"text":"OBJECTIVE: To evaluate the risk of concurrent bacterial infection in preterm infants hospitalized due to respiratory syncytial virus (RS","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":439,"document":"19901700","golden":false,"offsetInEndSection":587,"text":"This article describes the risk and incidence of RSV infection in late preterm infants and the necessary subsequent hospital, home, and clinic care.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":390,"document":"20695756","golden":false,"offsetInEndSection":561,"text":"As a consequence, similar risks of serious RSV illness have been observed in late preterm and preterm (born ? 32 wGA) infants, higher when compared with full-term infants.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":920,"document":"38773455","golden":false,"offsetInEndSection":1047,"text":"and prior exposure. We account for the differential risk of RSV-hospitalisation in full-term and preterm infants (defined as \u003c?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"10906017","golden":false,"offsetInEndSection":135,"text":"BACKGROUND: Respiratory syncytial virus (RSV) specific immune globulin is now being marketed for prevention of RSV infection in ex-pret","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":710,"document":"22262986","golden":false,"offsetInEndSection":971,"text":"The typical clinical picture of lower respiratory tract infection is not different in term and preterm infants, but rates of apnoeas are significantly increased in preterms, ranging from 4.9 to 37.5 percent with decreasing rates observed in more recent studies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1377,"document":"22633511","golden":false,"offsetInEndSection":1693,"text":"The authors believe that qualification criteria will enable caregivers to target RSV prophylaxis more effectively in children with rare conditions and the proposed approach provides direction for future epidemiological studies on the risk of severe RSV infection in children with these uncommon, medical illnesses.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":704,"document":"26457970","golden":false,"offsetInEndSection":882,"text":"Risk factors that determine RSV-disease severity and hospitalization and the impact on healthcare resource utilization and potential long-term respiratory sequelae are discussed.","beginSection":"abstract"}],"exact_answer":"","ideal_answer":[],"id":"677ecb2e592fa48873000027","type":"yesno","body":"Can IFI27 predict RSV infection in preterm infants?"},{"documents":[{"golden":true,"id":"11124998"},{"golden":true,"id":"15258850"},{"golden":false,"id":"11948617"},{"golden":false,"id":"18453001"},{"golden":true,"id":"30740124"},{"golden":true,"id":"17242039"},{"golden":false,"id":"21269927"},{"golden":false,"id":"25295052"},{"golden":true,"id":"23331754"},{"golden":false,"id":"22331545"},{"golden":false,"id":"1620342"},{"golden":false,"id":"28418778"},{"golden":false,"id":"32121433"},{"golden":false,"id":"36526213"},{"golden":true,"id":"16451848"},{"golden":false,"id":"7347910"},{"golden":false,"id":"16773614"},{"golden":false,"id":"9452222"},{"golden":false,"id":"2192787"},{"golden":true,"id":"35605864"},{"golden":false,"id":"9311542"},{"golden":true,"id":"22024235"},{"golden":false,"id":"33991619"},{"golden":false,"id":"21658306"},{"golden":false,"id":"38517806"},{"golden":false,"id":"32585290"},{"golden":true,"id":"24376148"},{"golden":false,"id":"8139607"},{"golden":false,"id":"32721662"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":1576,"document":"11124998","golden":false,"offsetInEndSection":1747,"text":"These synergistic effects of combined PQ + MB, preferentially expressed in the nigrostriatal DA system, suggest that such mixtures could play a role in the etiology of PD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17242039","golden":true,"offsetInEndSection":511,"text":"INTRODUCTION: Idiopathic Parkinson\u0027s disease (PD) is a neurodegenerative disorder in which loss of dopaminergic neurons in the basal ganglia leads to tremor, bradykinesia, rigidity and postural instability.METHODS: Literature search using Medline with keywords \u0027Parkinson\u0027s disease\u0027 and \u0027pesticides\u0027, limited to English, was undertaken, supplemented by articles from the author\u0027s files.RESULTS: Many studies have found an association between pesticides and PD, but no one agent has been consistently identified.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":828,"document":"15258850","golden":true,"offsetInEndSection":1091,"text":"In addition to a brief historical overview of the toxin-induced PD models, this study provides a detailed description of exiting models in which Parkinsonism is initiated via the exposure of animals to such agricultural chemicals as rotenone, paraquat, and maneb.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":665,"document":"21269927","golden":false,"offsetInEndSection":1462,"text":"Controls were a stratified random sample of all AHS participants frequency-matched to cases by age, sex, and state at approximately three controls:one case.RESULTS: In 110 PD cases and 358 controls, PD was associated with use of a group of pesticides that inhibit mitochondrial complex I [odds ratio (OR)\u003d1.7; 95% confidence interval (CI), 1.0-2.8] including rotenone (OR\u003d2.5; 95% CI, 1.3-4.7) and with use of a group of pesticides that cause oxidative stress (OR \u003d 2.0; 95% CI, 1.2-3.6), including paraquat (OR\u003d2.5; 95% CI, 1.4-4.7).CONCLUSIONS: PD was positively associated with two groups of pesticides defined by mechanisms implicated experimentally-those that impair mitochondrial function and those that increase oxidative stress-supporting a role for these mechanisms in PD pathophysiology.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1240,"document":"11124998","golden":false,"offsetInEndSection":1344,"text":"Correspondingly, striatal TH protein levels were decreased only by combined PQ + MB 5 d after injection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":680,"document":"11948617","golden":false,"offsetInEndSection":882,"text":"Recently, it has been found that agricultural chemicals, such as rotenone and paraquat, when administered systemically, can reproduce specific features of PD in rodents, apparently via oxidative damage.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"11124998","golden":true,"offsetInEndSection":140,"text":"Experimental evidence supporting 1,1\u0027-dimethyl-4,4\u0027-bipyridinium [paraquat (PQ)] as a risk factor for Parkinson\u0027s disease (PD) is equivocal.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":206,"document":"30740124","golden":true,"offsetInEndSection":413,"text":"Epidemiological evidence suggests that occupational exposure to pesticides (e.g., dieldrin, paraquat, rotenone, maneb, and ziram) is associated with a higher risk of developing PD in susceptible populations.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1069,"document":"1620342","golden":false,"offsetInEndSection":1190,"text":"These results support the hypothesis that the occupational use of herbicides is associated with an increased risk for PD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32121433","golden":false,"offsetInEndSection":164,"text":"The two major causes of Parkinson\u0027s disease (PD) are genetic susceptibility and exposure to agricultural pesticides. Access to 23,224 individuals\u0027 hospital primary ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28418778","golden":false,"offsetInEndSection":87,"text":"OBJECTIVES: Examine associations between pesticide exposure and signs or symptoms of pa","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36526213","golden":false,"offsetInEndSection":89,"text":"BACKGROUND: Pesticide exposure has consistently been associated with Parkinson\u0027s disease ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":719,"document":"16451848","golden":true,"offsetInEndSection":893,"text":"oxicologic data suggest that paraquat and rotenone may have neurotoxic actions that potentially play a role in the development of PD, with limited data for other pesticides. ","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"15258850","golden":true,"offsetInEndSection":136,"text":"Neurotoxicant-induced animal models of Parkinson\u0027s disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":386,"document":"2192787","golden":false,"offsetInEndSection":571,"text":"These are methanol, lithium, methyldopa, antimetabolites, antidepressants, sympathomimetic anorexiants, some types of antihistamines, and various combinations of agricultural chemicals.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":696,"document":"22024235","golden":true,"offsetInEndSection":897,"text":"The results across the studies are inconsistent.CONCLUSIONS: The inherent difficulties of studying Parkinson\u0027s disease in relation to paraquat or other pesticides are well illustrated by these studies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36526213","golden":false,"offsetInEndSection":100,"text":"BACKGROUND: Pesticide exposure has consistently been associated with Parkinson\u0027s disease (PD) onset.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"2192787","golden":false,"offsetInEndSection":126,"text":"This is a review of reserpine, haloperidol, and various phenothiazines that produce parkinsonism and other movement disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":127,"document":"2192787","golden":false,"offsetInEndSection":238,"text":"The by-products of illicit meperidine synthesis, MPTP and its more sinister companion, MPP, are also discussed.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"2192787","golden":false,"offsetInEndSection":55,"text":"Drug-induced parkinsonism and other movement disorders.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35605864","golden":true,"offsetInEndSection":450,"text":"Exposure to pyrethroids, a significant class of the most widely used agricultural chemicals, has been associated with an increased risk of Parkinson\u0027s disease (PD). However, although many different pyrethroids induce roughly the same symptoms of Parkinsonism, the underlying mechanisms remain unknown. To find the shared key features among these mechanisms, we focused on 3-phenoxybenzoic acid (3-PBA), a common and prominent metabolite of most pyret","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38517806","golden":false,"offsetInEndSection":400,"text":"Long-term exposure to pesticides used in agriculture is increasingly being identified as a risk factor for developing Parkinson\u0027s disease. How chronic pesticide exposure might contribute to the growth of Parkinson\u0027s disease in the mainly agricultural communities of Sub-Saharan Africa has thus far received limited attention. There are specific concerns in this area of the world: aging of the popula","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32585290","golden":false,"offsetInEndSection":450,"text":"Indiscriminate overuse or occupational exposure to agricultural chemicals can lead to neurotoxicity. Many pesticides act to impair mitochondrial function which can lead to exacerbation of neurodegeneration. Triazole fungicides are applied to grain, fruit, and vegetable crops to combat mold and fungi and their use is increasing worldwide. Here, we assessed the in vitro toxicity of two widely used triazole fungicides, propiconazole and tebuconazole","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35605864","golden":true,"offsetInEndSection":164,"text":"Exposure to pyrethroids, a significant class of the most widely used agricultural chemicals, has been associated with an increased risk of Parkinson\u0027s disease (PD).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"7347910","golden":false,"offsetInEndSection":176,"text":"Parkinson\u0027s disease has been associated with heavy occupational exposure to carbon disulfide, and this solvent, as well as other organic solvents, may cause neurotoxic effects.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"16773614","golden":false,"offsetInEndSection":104,"text":"The putative association between pesticide exposures and Parkinson\u0027s disease (PD) remains controversial.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1465,"document":"24376148","golden":true,"offsetInEndSection":1843,"text":"These data further confirm that paraquat and maneb toxicity can modulate gene expression of the nociceptin/orphanin-NOP receptor and prodynorphin-KOP receptor systems in the substantia nigra and caudate putamen, offering further support to the hypothesis that chronic exposure to these agrochemicals might be implicated in the mechanisms underlying sporadic Parkinson\u0027s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"9452222","golden":false,"offsetInEndSection":225,"text":"While unproved, environmental toxins of industrial and or agricultural origin represent an attractive theory to explain the increasing incidence of degenerative diseases of the nervous system such as Parkinson\u0027s disease (PD).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"1620342","golden":false,"offsetInEndSection":335,"text":"This population-based case-control study of 130 Calgary residents with neurologist-confirmed idiopathic Parkinson\u0027s disease (PD) and 260 randomly selected age- and sex-matched community controls attempted to determine whether agricultural work or the occupational use of pesticide chemicals is associated with an increased risk for PD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":730,"document":"8139607","golden":false,"offsetInEndSection":951,"text":"We conclude that although occupations involving the use of agricultural chemicals may predispose to the development of IP, it seems likely that the pathogenesis is multifactorial rather than related to a specific agent.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":382,"document":"23331754","golden":true,"offsetInEndSection":526,"text":"It has been documented in epidemiological and experimental studies the association of occupational exposure to paraquat and Parkinson\u0027s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32721662","golden":false,"offsetInEndSection":135,"text":"Parkinson\u0027s disease (PD) is a common neurodegenerative disorder that leads to significant morbidity and decline in the quality of life.","beginSection":"abstract"}],"exact_answer":[],"ideal_answer":[],"id":"6772c43b592fa48873000006","type":"list","body":"Please list the agricultural chemicals related to Parkinson\u0027s Disease."},{"documents":[{"golden":true,"id":"35469060"},{"golden":false,"id":"35971310"},{"golden":false,"id":"36165093"},{"golden":false,"id":"35718854"},{"golden":false,"id":"35489824"},{"golden":false,"id":"36253511"},{"golden":false,"id":"35929392"},{"golden":false,"id":"35841240"},{"golden":false,"id":"36336488"},{"golden":false,"id":"34091073"},{"golden":true,"id":"36586644"},{"golden":false,"id":"35290498"},{"golden":false,"id":"34198582"},{"golden":false,"id":"35542992"},{"golden":false,"id":"35320578"},{"golden":false,"id":"36457865"},{"golden":false,"id":"35401412"},{"golden":false,"id":"34579778"},{"golden":false,"id":"36184326"},{"golden":false,"id":"34708251"},{"golden":false,"id":"34110536"},{"golden":false,"id":"36632701"},{"golden":false,"id":"35493943"},{"golden":false,"id":"36388611"},{"golden":false,"id":"34443678"},{"golden":false,"id":"35289363"},{"golden":false,"id":"25459121"},{"golden":false,"id":"22665688"},{"golden":false,"id":"26993513"},{"golden":false,"id":"27582220"},{"golden":false,"id":"24849360"},{"golden":false,"id":"21592055"},{"golden":false,"id":"34697913"},{"golden":false,"id":"35815585"},{"golden":false,"id":"35177833"},{"golden":false,"id":"20946660"},{"golden":false,"id":"21091109"},{"golden":false,"id":"25031633"},{"golden":false,"id":"33836798"},{"golden":false,"id":"16332141"},{"golden":false,"id":"9660108"},{"golden":false,"id":"21316359"},{"golden":false,"id":"20926738"},{"golden":false,"id":"28890916"},{"golden":false,"id":"27392670"},{"golden":false,"id":"31705489"},{"golden":false,"id":"25016785"},{"golden":false,"id":"36725282"},{"golden":false,"id":"27767993"},{"golden":false,"id":"23859546"},{"golden":false,"id":"35306512"},{"golden":false,"id":"27103040"},{"golden":false,"id":"18210830"},{"golden":false,"id":"20562785"},{"golden":false,"id":"23251208"},{"golden":false,"id":"18769671"},{"golden":false,"id":"31173890"},{"golden":false,"id":"11299482"},{"golden":false,"id":"36708988"},{"golden":false,"id":"10469261"},{"golden":false,"id":"22475799"},{"golden":false,"id":"26425394"},{"golden":false,"id":"27035958"},{"golden":false,"id":"31356828"},{"golden":false,"id":"31099321"},{"golden":false,"id":"34426940"},{"golden":false,"id":"29854935"},{"golden":false,"id":"16306154"},{"golden":false,"id":"18044984"},{"golden":false,"id":"36210219"},{"golden":false,"id":"33368017"},{"golden":false,"id":"16990077"},{"golden":false,"id":"36537965"},{"golden":false,"id":"27239541"},{"golden":false,"id":"20930301"},{"golden":false,"id":"30336989"},{"golden":false,"id":"17466645"},{"golden":false,"id":"11934339"},{"golden":false,"id":"31984570"},{"golden":false,"id":"12086563"},{"golden":false,"id":"19810980"},{"golden":false,"id":"11528541"},{"golden":false,"id":"36766796"},{"golden":false,"id":"36749830"},{"golden":false,"id":"17458476"},{"golden":false,"id":"17302278"},{"golden":false,"id":"35436382"},{"golden":false,"id":"33233678"},{"golden":false,"id":"24640977"},{"golden":false,"id":"36481386"},{"golden":false,"id":"9720482"},{"golden":false,"id":"31676377"},{"golden":false,"id":"8314040"},{"golden":false,"id":"36611492"},{"golden":false,"id":"29264389"},{"golden":false,"id":"17675917"},{"golden":false,"id":"35814256"},{"golden":false,"id":"22902196"},{"golden":false,"id":"28879701"},{"golden":false,"id":"11279122"},{"golden":false,"id":"16437436"},{"golden":false,"id":"27263933"},{"golden":false,"id":"35513767"},{"golden":false,"id":"35440022"},{"golden":false,"id":"22303443"},{"golden":false,"id":"27246255"},{"golden":false,"id":"36738268"},{"golden":false,"id":"14505582"},{"golden":false,"id":"36186498"},{"golden":false,"id":"17401657"},{"golden":true,"id":"38692883"},{"golden":true,"id":"38779110"},{"golden":false,"id":"38095619"},{"golden":false,"id":"37676096"},{"golden":false,"id":"37955845"},{"golden":false,"id":"38730496"},{"golden":true,"id":"38867460"},{"golden":false,"id":"39638097"},{"golden":false,"id":"38095822"},{"golden":true,"id":"37009976"},{"golden":true,"id":"38414336"},{"golden":false,"id":"36949897"},{"golden":true,"id":"39034660"},{"golden":true,"id":"38484190"},{"golden":false,"id":"37874099"},{"golden":false,"id":"36482412"},{"golden":true,"id":"36449413"},{"golden":true,"id":"36544184"},{"golden":false,"id":"33865446"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":421,"document":"36586644","golden":true,"offsetInEndSection":698,"text":"In June 2021, the FDA approved aducanumab, an anti-A? monoclonal antibody for early AD based on its ability to reduce brain amyloid plaques, while two other amyloid-clearing antibodies (lecanemab and donanemab) have recently produced encouraging cognitive and clinical results.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36482412","golden":false,"offsetInEndSection":338,"text":"BACKGROUND: Lecanemab (BAN2401) is a humanized IgG1 monoclonal antibody that preferentially targets soluble aggregated A? species (protofibrils) with activity at insoluble fibrils and slowed clinical decline in an 18-month phase 2 proof-of-concept study (Study 201; ClinicalTrials.gov NCT01767311) in 856 subjects with early Alzheimer\u0027s d","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":440,"document":"36165093","golden":false,"offsetInEndSection":511,"text":"administration of lecanemab in subjects with early Alzheimer\u0027s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36544184","golden":true,"offsetInEndSection":209,"text":"BACKGROUND: Lecanemab, a humanized IgG1 monoclonal antibody that targets soluble aggregated A? species (protofibrils), has demonstrated robust brain fibrillar amyloid reduction and slowing of clinical decline ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1501,"document":"36544184","golden":false,"offsetInEndSection":1786,"text":"cross 3 clinical assessments. In the OLE, lecanemab 10 mg/kg biweekly treatment produced dose-dependent reductions in amyloid PET SUVr, improvements in plasma A?42/40 ratio, and reductions in plasma p-tau181.CONCLUSIONS: Lecanemab treatment resulted in significant reduction in amyloid","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":143,"document":"36449413","golden":false,"offsetInEndSection":614,"text":"\u0027s disease. Lecanemab, a humanized IgG1 monoclonal antibody that binds with high affinity to A? soluble protofibrils, is being tested in persons with early Alzheimer\u0027s disease.METHODS: We conducted an 18-month, multicenter, double-blind, phase 3 trial involving persons 50 to 90 years of age with early Alzheimer\u0027s disease (mild cognitive impairment or mild dementia due to Alzheimer\u0027s disease) with evidence of amyloid on positron-emission tomography (PET) or by cerebro","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1864,"document":"36449413","golden":false,"offsetInEndSection":2048,"text":"I], -0.67 to -0.23; P\u003c0.001). In a substudy involving 698 participants, there were greater reductions in brain amyloid burden with lecanemab than with placebo (difference, -59.1 centil","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36449413","golden":false,"offsetInEndSection":39,"text":"Lecanemab in Early Alzheimer\u0027s Disease.","beginSection":"title"},{"endSection":"title","offsetInBeginSection":0,"document":"33865446","golden":false,"offsetInEndSection":149,"text":"A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer\u0027s disease with lecanemab, an anti-A? protofibril antibody.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33865446","golden":false,"offsetInEndSection":185,"text":"BACKGROUND: Lecanemab (BAN2401), an IgG1 monoclonal antibody, preferentially targets soluble aggregated amyloid beta (A?), with activity across oligomers, protofibrils, and insoluble fi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1929,"document":"33865446","golden":false,"offsetInEndSection":2055,"text":"th 9.9% incidence of amyloid-related imaging abnormalities-edema/effusion at 10?mg/kg biweekly.CONCLUSIONS: BAN2401-G000-201 d","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":244,"document":"35290498","golden":false,"offsetInEndSection":436,"text":"o date. The monoclonal anti-amyloid beta antibody aducanumab was recently approved for the treatment of AD in the USA but was rejected in Europe in December 2021 by the European Medicines Agen","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36253511","golden":false,"offsetInEndSection":179,"text":"Lecanemab, Aducanumab, and Gantenerumab - Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer\u0027s Disease.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1083,"document":"34198582","golden":false,"offsetInEndSection":1349,"text":"ents with positive clinical or biomarker data include four antibodies that engage A? oligomers (aducanumab, lecanemab, gantenerumab, and donanemab) and ALZ-801, an oral agent that fully blocks the formation of A? oligomers at the clinical dose.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":188,"document":"33865446","golden":false,"offsetInEndSection":491,"text":"ls. BAN2401-G000-201, a randomized double-blind clinical trial, utilized a Bayesian design with response-adaptive randomization to assess 3 doses across 2 regimens of lecanemab versus placebo in early Alzheimer\u0027s disease, mild cognitive impairment due to Alzheimer\u0027s disease (AD) and mild AD dementia.ME","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":943,"document":"35290498","golden":false,"offsetInEndSection":1149,"text":"ug Administration (FDA). In the USA donanemab, gantenerumab and lecanemab have received the status of a?so-called breakthrough therapy and are expected to go through an accelerated approval process by the F","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":724,"document":"36253511","golden":false,"offsetInEndSection":820,"text":"ctive as it had tenfold stronger binding to protofibrils compared to fibrils. Aducanumab and gan","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":146,"document":"35542992","golden":false,"offsetInEndSection":358,"text":"eview summarizes the existing literature on ARIA, including bapineuzumab, gantenerumab, donanemab, lecanemab, and aducanumab studies, with regard to potential risk factors, detection, and management. The pathophy","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":116,"document":"35469060","golden":false,"offsetInEndSection":221,"text":"ementia. Lecanemab is a humanized monoclonal antibody targeting amyloid protofibrils for the treatment of","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36544184","golden":true,"offsetInEndSection":211,"text":"BACKGROUND: Lecanemab, a humanized IgG1 monoclonal antibody that targets soluble aggregated A? species (protofibrils), has demonstrated robust brain fibrillar amyloid reduction and slowing of clinical decline in","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":429,"document":"36586644","golden":true,"offsetInEndSection":710,"text":"2021, the FDA approved aducanumab, an anti-A? monoclonal antibody for early AD based on its ability to reduce brain amyloid plaques, while two other amyloid-clearing antibodies (lecanemab and donanemab) have recently produced encouraging cognitive and clinical results. We reviewed","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1714,"document":"35469060","golden":false,"offsetInEndSection":1927,"text":"ON: The model results demonstrate the potential clinical value of lecanemab for patients with early AD and how it can slow the rate of disease progression and reduce the lifetime probability for institutionalized ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":965,"document":"35469060","golden":true,"offsetInEndSection":1170,"text":"ne.RESULTS: Lecanemab treatment was estimated to slow the rate of disease progression, resulting in an extended duration of MCI due to AD and mild AD dementia and shortened duration in moderate and severe ","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36482412","golden":false,"offsetInEndSection":149,"text":"Consistency of efficacy results across various clinical measures and statistical methods in the lecanemab phase 2 trial of early Alzheimer\u0027s disease.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1711,"document":"36544184","golden":false,"offsetInEndSection":1817,"text":"NCLUSIONS: Lecanemab treatment resulted in significant reduction in amyloid plaques and a slowing of clini","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36482412","golden":false,"offsetInEndSection":273,"text":"BACKGROUND: Lecanemab (BAN2401) is a humanized IgG1 monoclonal antibody that preferentially targets soluble aggregated A? species (protofibrils) with activity at insoluble fibrils and slowed clinical decline in an 18-month phase 2 proof-of-concept study (Study 201; Clinica","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36544184","golden":false,"offsetInEndSection":203,"text":"Lecanemab in patients with early Alzheimer\u0027s disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":879,"document":"25459121","golden":false,"offsetInEndSection":1251,"text":"Results from amyloid-based immunotherapy studies in clinical trials indicate that intervention appears to be more effective in early stages of amyloid accumulation in particular solanezumab with a potential impact at mild Alzheimer\u0027s disease, highlighting the importance of diagnosing Alzheimer\u0027s disease as early as possible and undertaking clinical trials at this stage.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1324,"document":"34708251","golden":false,"offsetInEndSection":1470,"text":"Passive immunisation is providing efficiency in clearing A? and slowing cognitive decline, such as aducanumab, donanemab, and lecanemab (ban2401).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36184326","golden":false,"offsetInEndSection":209,"text":"In 2021, aducanumab, an immunotherapy targeting amyloid-?, was approved for Alzheimer\u0027s disease (AD) by the US Food and Drug Administration thanks to positive results on a putative biological surrogate marker.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1113,"document":"34443678","golden":false,"offsetInEndSection":1350,"text":"Aducanumab, a human monoclonal antibody against the aggregated form of A?, was recently approved for Alzheimer\u0027s disease, and other monoclonal antibodies, including gantenerumab, solanezumab, and lecanemab, could also be up for approval.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1332,"document":"36184326","golden":false,"offsetInEndSection":1767,"text":"When pooled together, the data from high-clearance anti-amyloid immunotherapies trials confirm a statistically significant clinical effect of these drugs on cognitive decline after 18 months (difference in cognitive decline measured with CDR-SB after 18 months between the high dose immunotherapy groups vs. placebo?\u003d?-0.24 points; P\u003d0.04, frequentist random-effect model), with results on ADAS-Cog being the most statistically robust.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36388611","golden":false,"offsetInEndSection":331,"text":"Patients with Alzheimer\u0027s disease who have been given monoclonal antibodies targeting amyloid-? (A?) (eg, gantenerumab, donanemab, lecanemab, and aducanumab) for scientific purposes may have a spectrum of imaging findings known as amyloid-related imaging abnormalities (ARIA), shown on brain magnetic resonance imaging (MRI) scans.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":681,"document":"36184326","golden":false,"offsetInEndSection":973,"text":"Compared to those tested in previous trials of the 2010s, the common feature and novelty of these anti-amyloid immunotherapies is their ability to induce a high clearance of amyloid load, as measured with positron emission tomography, in the brain of early-stage biomarker-proven AD patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":624,"document":"35493943","golden":false,"offsetInEndSection":1025,"text":"Recently, disease-modifying therapies (DMTs) that can change the underlying pathophysiology of AD, with anti-A? monoclonal antibodies (mabs) (e.g., aducanumab, bapineuzumab, gantenerumab, solanezumab, and lecanemab) have been developed successively and conducted in clinical trials based on the theory that a systemic failure of cell-mediated A? clearance contributes to AD occurrence and progression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2192,"document":"36184326","golden":false,"offsetInEndSection":2300,"text":"The risk/benefit ratio of high-clearance immunotherapies in early AD is so far questionable after 18 months.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1091,"document":"22665688","golden":false,"offsetInEndSection":1203,"text":"It has a small beneficial effect on cognition, activity of daily living, behaviour, and overall clinical rating.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36184326","golden":false,"offsetInEndSection":160,"text":"High-clearance anti-amyloid immunotherapies in Alzheimer\u0027s disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1126,"document":"34443678","golden":false,"offsetInEndSection":1370,"text":" human monoclonal antibody against the aggregated form of A?, was recently approved for Alzheimer\u0027s disease, and other monoclonal antibodies, including gantenerumab, solanezumab, and lecanemab, could also be up for approval. As many other agent","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1363,"document":"34708251","golden":false,"offsetInEndSection":1511,"text":"iency in clearing A? and slowing cognitive decline, such as aducanumab, donanemab, and lecanemab (ban2401). Causation of AD by impairment of the inn","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36184326","golden":false,"offsetInEndSection":214,"text":"In 2021, aducanumab, an immunotherapy targeting amyloid-?, was approved for Alzheimer\u0027s disease (AD) by the US Food and Drug Administration thanks to positive results on a putative biological surrogate marker. This","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1167,"document":"36632701","golden":false,"offsetInEndSection":1494,"text":"is calibrated with pharmacological and clinical information on aducanumab, bapineuzumab, crenezumab, gantenerumab, lecanemab and solanezumab, predicting adequately the change in PET imaging measured amyloid load and the changes in plasma A?42 /A?40 ratio, while slightly overestimating the change in CSF A?42 . ARIA-E is well p","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1146,"document":"36184326","golden":false,"offsetInEndSection":1349,"text":"quentist and Bayesian meta-analyses of the clinical efficacy and safety of the highest dose groups from the two aducanumab phase 3 trials and the donanemab and lecanemab phase 2 trials. When pooled toget","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2492,"document":"36184326","golden":false,"offsetInEndSection":2680,"text":"medico-economical analyses seems to indicate that the current cost of aducanumab in the US is not in reasonable alignment with its clinical benefits.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1497,"document":"36632701","golden":false,"offsetInEndSection":1560,"text":"icted for all antibodies except bapineuzumab. This QSP model co","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1188,"document":"35493943","golden":false,"offsetInEndSection":1311,"text":"he discussion of the impact of aducanumab and lecanemab on AD pathology and clinical profiles. The review provides a possib","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":810,"document":"34110536","golden":false,"offsetInEndSection":942,"text":"ive development. Targeting A? with mAbs has the potential to treat various stages of AD: prodromal, prodromal to mild, mild, and mil","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"35493943","golden":false,"offsetInEndSection":146,"text":"Impact of Anti-amyloid-? Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer\u0027s Disease: A Focus on Aducanumab and Lecanemab.","beginSection":"title"},{"endSection":"title","offsetInBeginSection":0,"document":"27582220","golden":false,"offsetInEndSection":66,"text":"The antibody aducanumab reduces A? plaques in Alzheimer\u0027s disease.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":581,"document":"27582220","golden":false,"offsetInEndSection":730,"text":"In patients with prodromal or mild AD, one year of monthly intravenous infusions of aducanumab reduces brain A? in a dose- and time-dependent manner.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33836798","golden":false,"offsetInEndSection":291,"text":"BACKGROUND: Aducanumab is an anti-amyloid-? (A?) antibody that achieved reduced amyloid pathology in Alzheimer\u0027s disease (AD) trials; however, it is controversial whether it also improved cognition, which has been suggested would require a sufficiently high cumulative dose of the antibody i","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":961,"document":"27582220","golden":false,"offsetInEndSection":1041,"text":"These results justify further development of aducanumab for the treatment of AD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34697913","golden":false,"offsetInEndSection":165,"text":"Aducanumab is a human immunoglobulin G1 anti-amyloid beta (A?) antibody currently being evaluated for potential treatment of patients with early Alzheimer\u0027s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35815585","golden":false,"offsetInEndSection":154,"text":"In early June 2021, the U.S. Food and Drug Administration (\"FDA\") granted Accelerated Approval to Aducanumab (\"Aduhelm\") for treating Alzheimer\u0027s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":110,"document":"35177833","golden":false,"offsetInEndSection":375,"text":"However, four anti-A? antibodies have been shown to mediate the removal of amyloid plaque from brains of patients with AD, and the FDA has recently granted accelerated approval to one of these, aducanumab, using reduction of amyloid plaque as a surrogate end point.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":731,"document":"27582220","golden":false,"offsetInEndSection":875,"text":"This is accompanied by a slowing of clinical decline measured by Clinical Dementia Rating-Sum of Boxes and Mini Mental State Examination scores.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":680,"document":"24849360","golden":false,"offsetInEndSection":840,"text":"HJ6.3 mildly improved spatial learning performance in the water maze, restored resting-state functional connectivity, and modestly reduced brain A? plaque load.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1042,"document":"27582220","golden":false,"offsetInEndSection":1193,"text":"Should the slowing of clinical decline be confirmed in ongoing phase 3 clinical trials, it would provide compelling support for the amyloid hypothesis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":999,"document":"16332141","golden":false,"offsetInEndSection":1216,"text":"ing drug, tramiprosate (3-amino-1-propanesulfonic acid; Alzhemed), which is effective in reducing polymerisation in vitro and plaque deposition in animals, has now reached phase III clinical trials. Thus, it is plausi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":138,"document":"9660108","golden":false,"offsetInEndSection":316,"text":"amotrigine (LTG) inhibits presynaptic glutamate release and is considered to be effective in treatment of other neurodegenerative disorders by its cerebroprotective properties. W","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"9660108","golden":false,"offsetInEndSection":73,"text":"Antiglutamatergic therapy in Alzheimer\u0027s disease--effects of lamotrigine.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1298,"document":"21316359","golden":false,"offsetInEndSection":1505,"text":"rate that stemazole is effective in the treatment of A?1-40 aggregates injection rat model, suggesting that this compound may be used as a therapeutic agent against Alzheimer\u0027s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1013,"document":"20926738","golden":false,"offsetInEndSection":1224,"text":"es using panels of biomarkers for diagnosis of Alzheimer disease or mild cognitive impairment have been promising, though no such studies have been cross-validated in independent samples of subjects. The ideal b","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":791,"document":"34110536","golden":false,"offsetInEndSection":920,"text":"s for AD are in active development. Targeting A? with mAbs has the potential to treat various stages of AD: prodromal, prodromal ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":921,"document":"34110536","golden":false,"offsetInEndSection":1042,"text":"o mild, mild, and mild to moderate. Monoclonal antibodies discussed here include aducanumab, lecanemab, solanezumab, cren","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1043,"document":"34110536","golden":false,"offsetInEndSection":1230,"text":"zumab, donanemab, and gantenerumab. The final decision by the FDA regarding the approval of aducanumab will offer valuable insight into the trajectory of drug development for mAbs in AD a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1150,"document":"36632701","golden":false,"offsetInEndSection":1477,"text":"The QSP platform is calibrated with pharmacological and clinical information on aducanumab, bapineuzumab, crenezumab, gantenerumab, lecanemab and solanezumab, predicting adequately the change in PET imaging measured amyloid load and the changes in plasma A?42 /A?40 ratio, while slightly overestimating the change in CSF A?42 .","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36632701","golden":false,"offsetInEndSection":171,"text":"Antibody-mediated removal of aggregated ?-amyloid (A?) is the current most clinically advanced potential disease-modifying treatment approach for Alzheimer\u0027s disease (AD).","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34110536","golden":false,"offsetInEndSection":52,"text":"Critical Appraisal of Amyloid Lowering Agents in AD.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34110536","golden":false,"offsetInEndSection":109,"text":"PURPOSE OF REVIEW: According to the amyloid cascade hypothesis, removing amyloid beta (A?) should cure Alzhei","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36725282","golden":false,"offsetInEndSection":52,"text":"Evidence for lecanemab in early Alzheimer\u0027s disease.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36725282","golden":false,"offsetInEndSection":92,"text":"Overview of: van Dyck CH, Swanson CJ, Aisen P, et al Lecanemab in Early Alzheimer\u0027s Disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1236,"document":"27767993","golden":false,"offsetInEndSection":1653,"text":"ts with mild-to-moderate AD (S-Connect). The number needed to treat (6 and 21 for Souvenir I and II, respectively) and high number needed to harm values indicate a favorable harm:benefit ratio for Souvenaid versus control in patients with mild AD.CONCLUSIONS: The favorable safety profile and impact on outcome measures converge to corroborate the putative mode of action and demonstrate that Souvenaid can achieve cl","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":93,"document":"36725282","golden":false,"offsetInEndSection":120,"text":"N Engl J Med 2023;388:9-21.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1153,"document":"27767993","golden":false,"offsetInEndSection":1235,"text":" (Wechsler memory scale delayed recall). No effect was shown on cognition in patie","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":814,"document":"18769671","golden":false,"offsetInEndSection":1197,"text":"2 proteins, or by AChE inhibition or silencing. Moreover, inherent N-AChE-S was upregulated by stressors inducing protein misfolding and calcium imbalances, both characteristic of AD; and in cortical tissues from AD patients, N-AChE-S overexpression coincides with Tau hyper-phosphorylation.CONCLUSIONS: Together, these findings attribute an apoptogenic role to N-AChE-S and outline ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1471,"document":"20562785","golden":false,"offsetInEndSection":1811,"text":"share the same mechanism as traditional AD. The responsiveness to Galantamine in this patient may suggest an alternative mechanism of Early Onset Alzheimer\u0027s Disease to typical Alzheimer\u0027s Disease in the over 65\u0027s.CONCLUSION: The case raises interesting questions as to whether EOAD should be considered distinct to typical (over 65\u0027s) AD, ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1307,"document":"23859546","golden":false,"offsetInEndSection":1589,"text":"In light of the low efficiency of AD therapies based on the amyloid cascade hypothesis, a novel framework, the aging factor cascade hypothesis, is proposed in an attempt to integrate the new data and concepts that emerged from recent research to develop disease modifying therapies.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"23859546","golden":false,"offsetInEndSection":80,"text":"The effects of soluble A? oligomers on neurodegeneration in Alzheimer\u0027s disease.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27767993","golden":false,"offsetInEndSection":643,"text":"BACKGROUND: Souvenaid? (uridine monophosphate, docosahexaenoic acid, eicosapentaenoic acid, choline, phospholipids, folic acid, vitamins B12, B6, C, and E, and selenium), was developed to support the formation and function of neuronal membranes.OBJECTIVE: To determine effect sizes observed in clinical trials of Souvenaid and to calculate the number needed to treat to show benefit or harm.METHODS: Data from all three reported randomized controlled trials of Souvenaid in Alzheimer\u0027s disease (AD) dementia (Souvenir I, Souvenir II, and S-Connect) and an open-label extension study were included in analyses of effect size for cognitive, func","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1062,"document":"11299482","golden":false,"offsetInEndSection":1073,"text":"CONCLUSION.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1242,"document":"36708988","golden":false,"offsetInEndSection":1608,"text":"ing from the early to late stage. Furthermore, treatment with neohesperidin, but not N-acetylcysteine (NAC), improved PDI S-nitrosylation level in GSH-depleted SH-SY5Y cells because nitrosylated compound of NAC induces PDI S-nitrosylation.SIGNIFICANCE: The results of our study provide a new insight into the mechanisms of neurodegeneration, and may be useful for th","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":519,"document":"11299482","golden":false,"offsetInEndSection":592,"text":"There is slight clinical improvement with a definite therapeutic ceiling.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"31356828","golden":false,"offsetInEndSection":134,"text":"Early intervention with ABA prevents neuroinflammation and memory impairment in a triple transgenic mice model of Alzheimer?s disease.","beginSection":"title"},{"endSection":"title","offsetInBeginSection":0,"document":"27035958","golden":false,"offsetInEndSection":99,"text":"S-nitrosation of proteins relevant to Alzheimer\u0027s disease during early stages of neurodegeneration.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":405,"document":"10469261","golden":false,"offsetInEndSection":750,"text":"Here, we review a number of current findings indicating that disregulated ectopic re-activation of cell cycle-mediated events, akin to neoplasia, represent an important early pathway associated with neuronal death and, more importantly, one that involves virtually the entire spectrum of the pathological events described in Alzheimer\u0027s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":195,"document":"31173890","golden":false,"offsetInEndSection":370,"text":"Interestingly, an enhancement of glucose uptake, glycolysis and pentose phosphate pathway occurs in both cancer cells and amyloid-?-resistant neurons in the early phase of AD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36725282","golden":false,"offsetInEndSection":90,"text":"Overview of: van Dyck CH, Swanson CJ, Aisen P, et al Lecanemab in Early Alzheimer\u0027s Diseas","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1445,"document":"25957460","golden":false,"offsetInEndSection":1513,"text":"m these drugs, no antiviral has been shown to be effective. Preventi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":359,"document":"32041232","golden":false,"offsetInEndSection":469,"text":"Despite much effort, no clinically approved antiviral treatment is available for children suffering from HFMD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1229,"document":"31882748","golden":false,"offsetInEndSection":1413,"text":"While amodiaquine on its own failed to demonstrate efficacy, we cannot exclude potential therapeutic value of amodiaquine when used in combination with artesunate or another antiviral.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":171,"document":"4597726","golden":false,"offsetInEndSection":302,"text":"Isoprinosine, which had demonstrable antiviral activity in animal models, did not appear to protect humans from clinical influenza.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1186,"document":"24051429","golden":false,"offsetInEndSection":1294,"text":"However, HCMV alone was not effective in eliciting strong T cell immune responses when used in a mouse host.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":67,"document":"18279075","golden":false,"offsetInEndSection":145,"text":"However, there is no effective antiviral drug available for infected patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":509,"document":"15031783","golden":false,"offsetInEndSection":624,"text":"00 IU/mL. In conclusion, ribavirin alone is unlikely to be beneficial in the prophylaxis or treatment of SARS CoV i","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":757,"document":"17928345","golden":false,"offsetInEndSection":960,"text":"Despite its favorable activity in cell culture, mitoxantrone administered intraperitoneally at the maximum tolerated dose failed to protect mice against a lethal intranasal infection with vaccinia virus.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":408,"document":"30464745","golden":false,"offsetInEndSection":569,"text":"However, even though rhinoviral infections are likely to be one of the factors initiating the onset of CF lung disease, there is no effective targeted treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":311,"document":"34426940","golden":false,"offsetInEndSection":660,"text":"loid plaques. In the phase 3 clinical trial EMERGE (NCT02484547), aducanumab reduced clinical decline in patients with mild cognitive impairment (MCI) due to AD and mild AD dementia and confirmed amyloid pathology.METHODS: We used a Markov modeling approach to predict the long-term clinical benefits of aducanumab for patients with early AD based o","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":141,"document":"34426940","golden":false,"offsetInEndSection":310,"text":"d caregivers. Aducanumab is the first AD therapy approved by the US Food and Drug Administration to reduce a defining pathophysiological feature of the disease, brain am","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":749,"document":"27239541","golden":false,"offsetInEndSection":958,"text":"anezumab relative to cognition. An increasing effect of solanezumab over 18?months was shown for cognition and function.DISCUSSION: Function as the sole measure to demonstrate clinical meaningfulness of cognit","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34426940","golden":false,"offsetInEndSection":93,"text":"Predicted Lifetime Health Outcomes for Aducanumab in Patients with Early Alzheimer\u0027s Disease.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1323,"document":"34426940","golden":false,"offsetInEndSection":1845,"text":"with patients treated with SOC. Aducanumab treatment translated to a lower lifetime probability of transitioning to AD dementia, a lower lifetime probability of transitioning to institutionalization (25.2% vs. 29.4%), delays in the median time to transition to AD dementia (7.50 vs. 4.92?years from MCI to moderate AD dementia or worse), and an incremental median time in the community of 1.32?years compared with SOC.CONCLUSION: The model predicted long-term benefits of aducanumab treatment in patients with MCI due to A","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":953,"document":"34426940","golden":false,"offsetInEndSection":1322,"text":"parator was SOC alone. Data sources for base-case and scenario analyses included EMERGE, published National Alzheimer\u0027s Coordinating Center analyses, and other published literature.RESULTS: Per patient over a lifetime horizon, aducanumab treatment corresponded to 0.65 incremental patient quality-adjusted life-years (QALYs) and 0.09 fewer caregiver QALYs lost compared","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"29854935","golden":false,"offsetInEndSection":721,"text":"INTRODUCTION: The objective of this study was to estimate longitudinal changes in disease progression (measured by Alzheimer\u0027s disease assessment scale-cognitive 11-item [ADAS-cog/11] scale) after bapineuzumab treatment and to identify covariates (demographics or baseline characteristics) contributing to the variability in disease progression rate and baseline disease status.METHODS: A population-based disease progression model was developed using pooled placebo and bapineuzumab data from two phase-3 studies in APOE ?4 noncarrier and carrier Alzheimer\u0027s disease (AD) patients.RESULTS: A beta regression model with the Richard\u0027s function as the structural component best described ADAS-cog/11 disease progression for","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1189,"document":"36537965","golden":false,"offsetInEndSection":1343,"text":" in MCI due to AD (ADCOMS). The AMBAR results (active vs control) demonstrated 59% slowing of progression over 14 months in Mild-to-Moderate AD (ADAS-cog,","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1355,"document":"16990077","golden":false,"offsetInEndSection":1708,"text":"n to AD would be particularly beneficial. In a 3-year, randomized, double-blind, placebo-controlled study in 769 patients with a-MCI, treatment with the cholinesterase inhibitor donepezil was associated with a significantly lower rate of progression to AD compared with placebo during the first 12 months of treatment (hazard ratio\u003d0.42; 95% CI, 0.24-0.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":722,"document":"29854935","golden":false,"offsetInEndSection":933,"text":"mild-to-moderate AD population. This analysis confirmed no effect of bapineuzumab exposure on ADAS-cog/11 progression rate, consistent with the lack of clinical efficacy observed in the statistical analysis of A","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":222,"document":"30336989","golden":false,"offsetInEndSection":319,"text":"nitive stimulation therapy is an effective therapy for persons with moderate Alzheimer disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":674,"document":"17466645","golden":false,"offsetInEndSection":851,"text":"esterase inhibitor therapy with rivastigmine, donepezil, or galantamine is endorsed as standard first-line therapy in patients with mild-to-moderate Alzheimer\u0027s disease. The N-m","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":654,"document":"11934339","golden":false,"offsetInEndSection":902,"text":" that nonsteroidal anti-inflammatory drugs and oestrogen replacement therapies may be effective in preventing Alzheimer\u0027s disease only if taken during the latent phase of the disease several years prior to the appearance of disturbances. Antioxidan","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":745,"document":"31984570","golden":false,"offsetInEndSection":920,"text":" mild-to-moderate Alzheimer\u0027s disease are most likely to benefit with the use of photographs, videos, and music that are associated with their past experiences. This review hi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":653,"document":"12086563","golden":false,"offsetInEndSection":790,"text":"treatment of Alzheimer disease.CONCLUSIONS: Clinical trials indicate that oral conjugated equine estrogen is not an effective treatment f","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":617,"document":"19810980","golden":false,"offsetInEndSection":794,"text":"al trials of acetyl-l-carnitine indicate that it is well-tolerated and may be effective in younger Alzheimer\u0027s disease patients and may be an effective adjuvant treatment. Acety","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"11934339","golden":false,"offsetInEndSection":155,"text":"A growing body of evidence suggests that several classes of drugs marketed for other indications may be effective in the prevention of Alzheimer\u0027s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":125,"document":"11528541","golden":false,"offsetInEndSection":364,"text":"he current study evaluated the clinical utility of the Mini-Mental Status Exam (MMSE) and the Fuld Object Memory Evaluation (FOME) in detecting Alzheimer\u0027s disease (AD) among both African American and European American older adults. One hu","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36749830","golden":false,"offsetInEndSection":101,"text":"Lecanemab (BAN2401): an anti-beta-amyloid monoclonal antibody for the treatment of Alzheimer disease.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36766796","golden":false,"offsetInEndSection":150,"text":"Aducanumab, co-developed by Eisai (Japan) and Biogen (U.S.), has received Food and Drug Administration approval for treating Alzheimer\u0027s disease (AD).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":151,"document":"36766796","golden":false,"offsetInEndSection":217,"text":"In addition, its successor antibody, lecanemab, has been approved.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":126,"document":"35436382","golden":false,"offsetInEndSection":851,"text":" pathology. One of the drivers of Alzheimer?s pathogenesis is the production of soluble oligomeric A?, which could potentially serve as a biomarker of AD.METHODS: Given that the diphenylalanine (FF) at the C-terminus of A? fragments plays a key role in inducing the AD pathology, based on the hydrophobic structure of FF, we synthesized a near-infrared BF2-dipyrrolmethane fluorescent imaging probe (NB) to detect both soluble and insoluble A?.RESULTS: We found that NB not only binds A?, particularly oligomeric A?, but also interposes self-assembly of A? through ?-? interaction between NB and FF.CONCLUSION: This work holds great promise in the early detection of AD and may also provide an innovative approach to decelera","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36766796","golden":false,"offsetInEndSection":116,"text":"The Pursuit of the \"Inside\" of the Amyloid Hypothesis-Is C99 a Promising Therapeutic Target for Alzheimer\u0027s Disease?","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":850,"document":"24640977","golden":false,"offsetInEndSection":1162,"text":"Fortunately, the US FDA-approved antidiabetics exenatide (Byetta; Amylin Pharmaceuticals, Inc., CA, USA) and liraglutide (Victoza; Novo Nordisk A/S, Bagsvaerd, Denmark) are showing much promise in reducing Alzheimer\u0027s disease pathology and in restoring normal brain insulin responsiveness and cognitive function.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":550,"document":"17302278","golden":false,"offsetInEndSection":794,"text":"Although validation remains required as to whether retention of these agents in the neocortex truly reflects the level of amyloid deposition, such findings suggest the potential usefulness of amyloid imaging technique for early diagnosis of AD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1189,"document":"36766796","golden":false,"offsetInEndSection":1369,"text":"This review aimed to outline the nature, metabolism, and impact of C99 on AD pathogenesis and discuss whether it could be a therapeutic target complementing the amyloid hypothesis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":481,"document":"36766796","golden":false,"offsetInEndSection":588,"text":"However, the effects of immunotherapy are still limited, suggesting the need to reconsider this hypothesis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":487,"document":"36749830","golden":false,"offsetInEndSection":830,"text":"ties (ARIAs). Lecanemab is currently being studied in phase III trials.AREAS COVERED: This article briefly reviews mAbs that target A? in AD and discusses the biology, mechanism of action, and targets of lecanemab.EXPERT OPINION: mAbs that target A? are an important focus of therapeutic development for AD, with several soon to be considered ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1408,"document":"36611492","golden":false,"offsetInEndSection":1537,"text":"There is preliminary support for delayed cognitive and functional decline with Donanemab among patients with mild-to-moderate AD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":496,"document":"35814256","golden":false,"offsetInEndSection":698,"text":"Objective: This study was designed to determine whether LY01 delays the cognitive and memory decline in the early stage of AD and whether this effect of LY01 is related to promoting neural regeneration.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"8314040","golden":false,"offsetInEndSection":174,"text":"The present findings for familial Alzheimer\u0027s disease suggest a possible linkage to gene(s) on chromosome 21 for the early onset form and to chromosome 19 for the late onset.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":218,"document":"36766796","golden":false,"offsetInEndSection":339,"text":"These antibodies target the aggregated form of the small peptide, amyloid-? (A?), which accumulates in the patient brain.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":557,"document":"36749830","golden":false,"offsetInEndSection":686,"text":".AREAS COVERED: This article briefly reviews mAbs that target A? in AD and discusses the biology, mechanism of action, and target","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36766796","golden":false,"offsetInEndSection":155,"text":"Aducanumab, co-developed by Eisai (Japan) and Biogen (U.S.), has received Food and Drug Administration approval for treating Alzheimer\u0027s disease (AD). In a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":159,"document":"36766796","golden":false,"offsetInEndSection":227,"text":"ion, its successor antibody, lecanemab, has been approved. These ant","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":256,"document":"36749830","golden":false,"offsetInEndSection":329,"text":"ypes. Lecanemab Eisai has a high affinity for large and soluble A? protof","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":849,"document":"36749830","golden":false,"offsetInEndSection":935,"text":"g Administration approval. The experience of aducanumab informs the development of oth","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":332,"document":"36749830","golden":false,"offsetInEndSection":494,"text":"ils. Data from phase II clinical trials have suggested the possibility of a robust efficacy signal and manageable risk of amyloid-related imaging abnormalities (A","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":992,"document":"36749830","golden":false,"offsetInEndSection":1188,"text":"ormation of A? targets. Targeting monomeric species has not resulted in robust clinical efficacy, whereas targeting A? in the form of oligomers, protofibrils, and plaques has shown evidence of slo","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":498,"document":"36749830","golden":false,"offsetInEndSection":554,"text":"). Lecanemab is currently being studied in phase III tri","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":692,"document":"36766796","golden":false,"offsetInEndSection":900,"text":"tes, the 99-amino acids C-terminal fragment (C99, also called ?CTF), is a direct precursor of A? and accumulates in the AD patient\u0027s brain to demonstrate toxicity independent of A?. Conventional drug discover","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2907,"document":"16437436","golden":false,"offsetInEndSection":3168,"text":" 24mg/d was found to have similar efficacy and side-effect profile as the equivalent twice-daily regime. Data from the two MCI trials suggest marginal clinical benefit, but a yet unexplained excess in death rate.AUTHORS\u0027 CONCLUSIONS: Subjects in these trials we","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":323,"document":"36749830","golden":false,"offsetInEndSection":486,"text":"protofibrils. Data from phase II clinical trials have suggested the possibility of a robust efficacy signal and manageable risk of amyloid-related imaging abnormal","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"22303443","golden":false,"offsetInEndSection":102,"text":"CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer\u0027s disease.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"14505582","golden":false,"offsetInEndSection":360,"text":"Early diagnosis of Alzheimer\u0027s disease (AD) is needed to initiate symptomatic treatment with acetylcholinesterase inhibitors, and will be of even greater significance if drugs aimed at slowing down the degenerative process, such as vaccination regimes and beta-secretase and gamma-secretase inhibitors, prove to affect AD pathology and to have clinical effect.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":248,"document":"36749830","golden":false,"offsetInEndSection":322,"text":"fic A? types. Lecanemab Eisai has a high affinity for large and soluble A?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":831,"document":"36749830","golden":false,"offsetInEndSection":917,"text":"or US Food and Drug Administration approval. The experience of aducanumab informs the ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36749830","golden":false,"offsetInEndSection":198,"text":"INTRODUCTION: Nearly a dozen monoclonal antibodies (mAbs) directed against beta-amyloid (A?) have been developed for the treatment of Alzheimer disease (AD), and most of these mAbs are undergoing cl","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":971,"document":"36749830","golden":false,"offsetInEndSection":1165,"text":"ideration is the conformation of A? targets. Targeting monomeric species has not resulted in robust clinical efficacy, whereas targeting A? in the form of oligomers, protofibrils, and plaques ha","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":319,"document":"36186498","golden":false,"offsetInEndSection":385,"text":"ndeniable that magnesium may be an effective therapy for AD.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36186498","golden":false,"offsetInEndSection":62,"text":"Magnesium may be an effective therapy for Alzheimer\u0027s disease.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":393,"document":"17401657","golden":false,"offsetInEndSection":513,"text":", there is currently no effective treatment to halt the progression or prevent the onset of Alzheimer\u0027s disease. This is","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38692883","golden":true,"offsetInEndSection":158,"text":"[Mechanism of action and clinical trial results of Lecanemab (Leqembi? 200??mg, 500??mg for Intravenous Infusion), a novel treatment for Alzheimer\u0027s disease].","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":2383,"document":"36449413","golden":true,"offsetInEndSection":2758,"text":"Lecanemab resulted in infusion-related reactions in 26.4% of the participants and amyloid-related imaging abnormalities with edema or effusions in 12.6%.CONCLUSIONS: Lecanemab reduced markers of amyloid in early Alzheimer\u0027s disease and resulted in moderately less decline on measures of cognition and function than placebo at 18 months but was associated with adverse events.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":839,"document":"38692883","golden":false,"offsetInEndSection":1050,"text":"In Japan, it was approved for \"control of the progression of mild cognitive impairment or mild dementia stage of Alzheimer\u0027s disease\" in September 2023, and was added to the NHI drug price list in December 2023.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36544184","golden":false,"offsetInEndSection":221,"text":"BACKGROUND: Lecanemab, a humanized IgG1 monoclonal antibody that targets soluble aggregated A? species (protofibrils), has demonstrated robust brain fibrillar amyloid reduction and slowing of clinical decline in early AD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":98,"document":"38692883","golden":false,"offsetInEndSection":236,"text":"It was developed for the treatment of early Alzheimer\u0027s disease (mild cognitive impairment or mild dementia stage of Alzheimer\u0027s disease).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":453,"document":"38692883","golden":false,"offsetInEndSection":671,"text":"The efficacy and safety of Lecanemab in early Alzheimer\u0027s disease were investigated in an international Phase II placebo-controlled study (Study 201) and an international Phase III placebo-controlled study (Study 301).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":237,"document":"38692883","golden":false,"offsetInEndSection":452,"text":"Among the amyloid-? (A?) involved in Alzheimer\u0027s disease, Lecanemab selectively binds to the highly neurotoxic A? protofibrils, and is thought to reduce A? protofibrils and amyloid plaques (A? plaques) in the brain.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1531,"document":"36544184","golden":true,"offsetInEndSection":1829,"text":"In the OLE, lecanemab 10 mg/kg biweekly treatment produced dose-dependent reductions in amyloid PET SUVr, improvements in plasma A?42/40 ratio, and reductions in plasma p-tau181.CONCLUSIONS: Lecanemab treatment resulted in significant reduction in amyloid plaques and a slowing of clinical decline.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":504,"document":"38779110","golden":false,"offsetInEndSection":656,"text":"The difference in mean CDR-SOB score improvement between the treatment and placebo groups was -0.45, of which the clinical significance could be argued.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38779110","golden":true,"offsetInEndSection":121,"text":"The Food and Drug Administration granted traditional approval of lecanemab for the treatment of Alzheimer\u0027s disease (AD).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1286,"document":"39638097","golden":false,"offsetInEndSection":1433,"text":"ecanemab has demonstrated efficacy in slowing cognitive impairment progression in Alzheimer\u0027s disease as measured by ADCOMS, ADAS-Cog, and CDR-SB. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38867460","golden":true,"offsetInEndSection":126,"text":"PURPOSE: The US Food and Drug Administration authorized lecanemab for the therapeutic use of Alzheimer\u0027s disease (AD) in Janua","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":181,"document":"33865446","golden":false,"offsetInEndSection":478,"text":"e fibrils. BAN2401-G000-201, a randomized double-blind clinical trial, utilized a Bayesian design with response-adaptive randomization to assess 3 doses across 2 regimens of lecanemab versus placebo in early Alzheimer\u0027s disease, mild cognitive impairment due to Alzheimer\u0027s disease (AD) and mild A","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":144,"document":"38095822","golden":false,"offsetInEndSection":338,"text":"ecanemab, an anti-amyloid beta monoclonal antibody, is the first Alzheimer\u0027s disease drug targeting amyloid beta that has shown statistically significant cognitive benefits in phase III trials. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":899,"document":"37009976","golden":true,"offsetInEndSection":1318,"text":"The disease progression is described by changes in the underlying biomarkers of AD, including measures of amyloid and tau, and their connection to the clinical presentation of the disease assessed through various patient-level scales of cognition and function.RESULTS: Lecanemab treatment was estimated to slow the progression of AD to moderate and severe stages and reduce the time spent in these more advanced states.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":485,"document":"39034660","golden":true,"offsetInEndSection":760,"text":"Furthermore, lecanemab has been shown to effectively reduce A? accumulation in patients with early Alzheimer\u0027s disease, which might contribute not only to delaying the progression of cognitive decline, but also to improving the quality of life of patients and their families.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38484190","golden":true,"offsetInEndSection":286,"text":"BACKGROUND AND OBJECTIVES: Little is known regarding the cost-effectiveness of lecanemab (Leqembi), a monoclonal antibody approved by the US Food and Drug Administration in January 2023 for the treatment of mild cognitive impairment (MCI) or mild dementia due to Alzheimer disease (AD).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33865446","golden":false,"offsetInEndSection":450,"text":"BACKGROUND: Lecanemab (BAN2401), an IgG1 monoclonal antibody, preferentially targets soluble aggregated amyloid beta (A?), with activity across oligomers, protofibrils, and insoluble fibrils. BAN2401-G000-201, a randomized double-blind clinical trial, utilized a Bayesian design with response-adaptive randomization to assess 3 doses across 2 regimens of lecanemab versus placebo in early Alzheimer\u0027s disease, mild cognitive impairment due to Alzheim","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38414336","golden":false,"offsetInEndSection":400,"text":"INTRODUCTION: There is no cure for Alzheimer\u0027s disease, which is the sixth leading cause of death in the USA. Lecanemab is anti-A? monoclonal antibody approved for the treatment of early Alzheimer\u0027s disease but is only marginally effective. Other antibodies are being developed including solanezumab.AREAS COVERED: A phase 3 clinical trial of solanezumab in preclinical Alzheimer\u0027s disease. In the A4","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39034660","golden":true,"offsetInEndSection":450,"text":"The introduction of lecanemab has dramatically changed the field of dementia medicine. Lecanemab, defined as an anti-amyloid-? (A?) drug, comprises an antibody against A?, a protein structure believed to cause Alzheimer\u0027s disease. This drug represents a new direction in dementia treatment. In a phase?III study, lecanemab was found to significantly slow cognitive decline, while showing manageable levels of amyloid-related imaging abnormalities, wh","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":99,"document":"38414336","golden":true,"offsetInEndSection":229,"text":"n the USA. Lecanemab is anti-A? monoclonal antibody approved for the treatment of early Alzheimer\u0027s disease but is only marginally","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":167,"document":"37009976","golden":false,"offsetInEndSection":338,"text":"e in the USA. Lecanemab is a humanized IgG1 monoclonal antibody targeting amyloid protofibrils for the treatment of early AD [i.e., mild cognitive impairment (MCI) or mild","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2509,"document":"36449413","golden":true,"offsetInEndSection":2718,"text":"dema or effusions in 12.6%.CONCLUSIONS: Lecanemab reduced markers of amyloid in early Alzheimer\u0027s disease and resulted in moderately less decline on measures of cognition and function than placebo at 18 months","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":301,"document":"37676096","golden":false,"offsetInEndSection":427,"text":"(2023) entitled \"Lecanemab in early Alzheimer\u0027s disease\", published in The New England Journal of Medicine on January 5, 2023.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":115,"document":"37874099","golden":false,"offsetInEndSection":302,"text":"otofibrils. In phase 3 development, lecanemab has been shown to reduce markers of amyloid in early Alzheimer\u0027s disease and reduce decline on clinical endpoints of cognition and function a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36949897","golden":false,"offsetInEndSection":176,"text":"INTRODUCTION: Lecanemab is a humanized immunoglobulin G1 (IgG1) monoclonal antibody that preferentially targets soluble aggregated A? species (protofibrils) with activity at am","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":180,"document":"33865446","golden":false,"offsetInEndSection":477,"text":"le fibrils. BAN2401-G000-201, a randomized double-blind clinical trial, utilized a Bayesian design with response-adaptive randomization to assess 3 doses across 2 regimens of lecanemab versus placebo in early Alzheimer\u0027s disease, mild cognitive impairment due to Alzheimer\u0027s disease (AD) and mild ","beginSection":"abstract"}],"exact_answer":"yes","ideal_answer":[],"id":"63adc8d8c6c7d4d31b000017","type":"yesno","body":"Is Lecanemab effective for early Alzheimer?s Disease?"},{"documents":[{"golden":false,"id":"35140533"},{"golden":false,"id":"27993224"},{"golden":false,"id":"678732"},{"golden":false,"id":"35418919"},{"golden":false,"id":"34560850"},{"golden":false,"id":"23160701"},{"golden":false,"id":"10969422"},{"golden":false,"id":"22325631"},{"golden":false,"id":"17066222"},{"golden":false,"id":"7100356"},{"golden":true,"id":"4020613"},{"golden":false,"id":"11480955"},{"golden":false,"id":"24183875"},{"golden":false,"id":"32677241"},{"golden":false,"id":"21942993"},{"golden":true,"id":"11885086"},{"golden":true,"id":"7400467"},{"golden":false,"id":"35731302"},{"golden":false,"id":"36450437"},{"golden":false,"id":"16628130"},{"golden":false,"id":"6737952"},{"golden":false,"id":"7295373"},{"golden":false,"id":"24665327"},{"golden":false,"id":"36213567"},{"golden":false,"id":"22813655"},{"golden":false,"id":"8567595"},{"golden":false,"id":"23549791"},{"golden":false,"id":"22940454"},{"golden":false,"id":"7896673"},{"golden":false,"id":"32082948"},{"golden":false,"id":"32956964"},{"golden":false,"id":"21836759"},{"golden":false,"id":"28365479"},{"golden":false,"id":"14678313"},{"golden":false,"id":"15972068"},{"golden":true,"id":"7794207"},{"golden":false,"id":"36115626"},{"golden":false,"id":"27824311"},{"golden":false,"id":"15666935"},{"golden":false,"id":"15899315"},{"golden":false,"id":"10808035"},{"golden":false,"id":"26303558"},{"golden":false,"id":"28803506"},{"golden":true,"id":"22863172"},{"golden":false,"id":"17728901"},{"golden":true,"id":"10668054"},{"golden":false,"id":"8585824"},{"golden":false,"id":"19918674"},{"golden":false,"id":"17854906"},{"golden":false,"id":"11766870"},{"golden":false,"id":"4599484"},{"golden":false,"id":"21474570"},{"golden":false,"id":"9168568"},{"golden":false,"id":"24892732"},{"golden":false,"id":"32210463"},{"golden":false,"id":"16844356"},{"golden":false,"id":"21041282"},{"golden":false,"id":"12563066"},{"golden":false,"id":"16251012"},{"golden":false,"id":"30181470"},{"golden":false,"id":"27297012"},{"golden":false,"id":"18381506"},{"golden":false,"id":"35798530"},{"golden":false,"id":"18020820"},{"golden":false,"id":"34078876"},{"golden":false,"id":"11693583"},{"golden":false,"id":"25050602"},{"golden":false,"id":"34354040"},{"golden":false,"id":"26569537"},{"golden":false,"id":"18344050"},{"golden":false,"id":"16274933"},{"golden":false,"id":"23398755"},{"golden":false,"id":"11068893"},{"golden":false,"id":"9586773"},{"golden":true,"id":"34788300"},{"golden":false,"id":"34982305"},{"golden":false,"id":"30903988"},{"golden":false,"id":"17075232"},{"golden":false,"id":"21727235"},{"golden":false,"id":"11913568"},{"golden":false,"id":"17217665"},{"golden":false,"id":"26107805"},{"golden":false,"id":"9132733"},{"golden":true,"id":"25364062"},{"golden":false,"id":"31140060"},{"golden":false,"id":"22744292"},{"golden":false,"id":"19564226"},{"golden":false,"id":"1893470"},{"golden":true,"id":"25838782"},{"golden":true,"id":"7942065"},{"golden":false,"id":"31382113"},{"golden":false,"id":"35271511"},{"golden":false,"id":"29369038"},{"golden":false,"id":"7651249"},{"golden":false,"id":"17913993"},{"golden":false,"id":"22018419"},{"golden":false,"id":"31299968"},{"golden":true,"id":"17175406"},{"golden":false,"id":"27254891"},{"golden":false,"id":"24977773"},{"golden":false,"id":"26883756"},{"golden":false,"id":"21804846"},{"golden":false,"id":"6529932"},{"golden":true,"id":"12091784"},{"golden":false,"id":"25583656"},{"golden":false,"id":"36619667"},{"golden":false,"id":"35768872"},{"golden":false,"id":"26667158"},{"golden":false,"id":"9867430"},{"golden":false,"id":"8408365"},{"golden":true,"id":"19863784"},{"golden":false,"id":"3782623"},{"golden":true,"id":"34621342"},{"golden":false,"id":"8961408"},{"golden":false,"id":"34999973"},{"golden":false,"id":"29413138"},{"golden":false,"id":"16719635"},{"golden":false,"id":"18281410"},{"golden":false,"id":"24359862"},{"golden":false,"id":"25933173"},{"golden":false,"id":"22977304"},{"golden":false,"id":"21969769"},{"golden":false,"id":"33358009"},{"golden":true,"id":"10680851"},{"golden":false,"id":"25581241"},{"golden":false,"id":"32833883"},{"golden":false,"id":"25712380"},{"golden":true,"id":"24292965"},{"golden":false,"id":"23561039"},{"golden":false,"id":"36331294"},{"golden":false,"id":"25412352"},{"golden":false,"id":"12707562"},{"golden":false,"id":"26618860"},{"golden":false,"id":"22388476"},{"golden":false,"id":"33495200"},{"golden":false,"id":"11068892"},{"golden":false,"id":"16551710"},{"golden":false,"id":"31469175"},{"golden":false,"id":"20454820"},{"golden":false,"id":"22565039"},{"golden":false,"id":"7568605"},{"golden":false,"id":"29510354"},{"golden":false,"id":"36645004"},{"golden":false,"id":"2173343"},{"golden":false,"id":"35087645"},{"golden":false,"id":"30293307"},{"golden":false,"id":"30702385"},{"golden":false,"id":"25433518"},{"golden":false,"id":"37181428"},{"golden":false,"id":"23152255"},{"golden":false,"id":"19686874"},{"golden":false,"id":"35289047"},{"golden":false,"id":"32433786"},{"golden":false,"id":"19445770"},{"golden":false,"id":"33928055"},{"golden":false,"id":"11261405"},{"golden":false,"id":"4015172"},{"golden":false,"id":"30410921"},{"golden":false,"id":"23990388"},{"golden":false,"id":"15688079"},{"golden":false,"id":"24597565"},{"golden":false,"id":"26205740"},{"golden":false,"id":"23880496"},{"golden":false,"id":"31391190"},{"golden":false,"id":"32950957"},{"golden":false,"id":"29239637"},{"golden":false,"id":"33228749"},{"golden":false,"id":"2027167"},{"golden":false,"id":"33720406"},{"golden":false,"id":"26769979"},{"golden":false,"id":"28343321"},{"golden":false,"id":"33994159"},{"golden":true,"id":"36715031"},{"golden":false,"id":"37982248"},{"golden":false,"id":"36928863"},{"golden":false,"id":"36170705"},{"golden":false,"id":"33646416"},{"golden":true,"id":"33284065"},{"golden":false,"id":"36233683"},{"golden":true,"id":"33030459"},{"golden":false,"id":"34629841"},{"golden":false,"id":"35763409"},{"golden":false,"id":"36324445"},{"golden":false,"id":"36940922"},{"golden":false,"id":"32383428"},{"golden":false,"id":"36219440"},{"golden":false,"id":"33028438"},{"golden":false,"id":"32766456"},{"golden":false,"id":"32290876"},{"golden":false,"id":"35656347"},{"golden":false,"id":"33418360"},{"golden":false,"id":"32861591"},{"golden":false,"id":"32563266"},{"golden":false,"id":"33731441"},{"golden":false,"id":"37252287"},{"golden":false,"id":"34246951"},{"golden":false,"id":"37743609"},{"golden":true,"id":"38278245"},{"golden":false,"id":"34925078"},{"golden":false,"id":"22574894"},{"golden":false,"id":"33582311"},{"golden":false,"id":"34132034"},{"golden":false,"id":"33398688"},{"golden":false,"id":"35188556"},{"golden":false,"id":"33227064"},{"golden":false,"id":"3213255"},{"golden":false,"id":"33431142"},{"golden":false,"id":"33776389"},{"golden":false,"id":"33099654"},{"golden":false,"id":"36396698"},{"golden":false,"id":"38190253"},{"golden":false,"id":"36420245"},{"golden":true,"id":"35940184"},{"golden":false,"id":"32283536"},{"golden":false,"id":"34598737"},{"golden":false,"id":"35971178"},{"golden":false,"id":"37982311"},{"golden":false,"id":"36786936"},{"golden":false,"id":"32382407"},{"golden":false,"id":"34565543"},{"golden":false,"id":"34408674"},{"golden":false,"id":"34434441"},{"golden":false,"id":"35052560"},{"golden":false,"id":"35772281"},{"golden":false,"id":"36281540"},{"golden":false,"id":"33606120"},{"golden":false,"id":"26898199"},{"golden":false,"id":"16534438"},{"golden":false,"id":"36273673"},{"golden":true,"id":"17986682"},{"golden":false,"id":"25345238"},{"golden":false,"id":"35303038"},{"golden":false,"id":"18714913"},{"golden":false,"id":"30806443"},{"golden":false,"id":"15385011"},{"golden":false,"id":"38070866"},{"golden":false,"id":"36041571"},{"golden":false,"id":"33357165"},{"golden":false,"id":"36282484"},{"golden":false,"id":"32162065"},{"golden":false,"id":"33147746"},{"golden":false,"id":"34773141"},{"golden":false,"id":"33223344"},{"golden":true,"id":"26353868"},{"golden":true,"id":"9384941"},{"golden":false,"id":"29119823"},{"golden":false,"id":"24047040"},{"golden":false,"id":"29959767"},{"golden":false,"id":"36901574"},{"golden":false,"id":"17649676"},{"golden":false,"id":"24254851"},{"golden":false,"id":"15565897"},{"golden":false,"id":"10955928"},{"golden":false,"id":"38358670"},{"golden":false,"id":"38358536"},{"golden":false,"id":"38358241"},{"golden":false,"id":"38358236"},{"golden":false,"id":"38358187"},{"golden":false,"id":"38358078"},{"golden":false,"id":"11821566"},{"golden":false,"id":"14685437"},{"golden":false,"id":"1519143"},{"golden":false,"id":"12143923"},{"golden":false,"id":"9760380"},{"golden":false,"id":"26842307"},{"golden":false,"id":"18485930"},{"golden":false,"id":"17552129"},{"golden":false,"id":"16034762"},{"golden":false,"id":"16285840"},{"golden":false,"id":"1101924"},{"golden":false,"id":"37371243"},{"golden":false,"id":"29627597"},{"golden":true,"id":"36381869"},{"golden":true,"id":"31967198"},{"golden":false,"id":"27697136"},{"golden":false,"id":"38125276"},{"golden":false,"id":"33791438"},{"golden":false,"id":"38076886"},{"golden":false,"id":"37949626"},{"golden":false,"id":"34285655"},{"golden":false,"id":"36090243"},{"golden":false,"id":"36245865"},{"golden":false,"id":"30071985"},{"golden":false,"id":"9005505"},{"golden":false,"id":"20377929"},{"golden":false,"id":"38275441"},{"golden":false,"id":"38247704"},{"golden":false,"id":"38245017"},{"golden":false,"id":"38222135"},{"golden":false,"id":"38197473"},{"golden":false,"id":"38195450"},{"golden":false,"id":"38180636"},{"golden":false,"id":"38178016"},{"golden":true,"id":"38146536"},{"golden":true,"id":"38358664"},{"golden":true,"id":"36857050"},{"golden":true,"id":"37929632"},{"golden":false,"id":"35507217"},{"golden":true,"id":"33192681"},{"golden":false,"id":"35648742"},{"golden":false,"id":"37294680"},{"golden":false,"id":"2914002"},{"golden":false,"id":"36922452"},{"golden":false,"id":"32252139"},{"golden":false,"id":"16434782"},{"golden":false,"id":"12455925"},{"golden":false,"id":"38630744"},{"golden":false,"id":"39145898"},{"golden":false,"id":"9232475"},{"golden":false,"id":"30949092"},{"golden":false,"id":"23390431"},{"golden":false,"id":"19344385"},{"golden":false,"id":"26649557"},{"golden":false,"id":"1629998"},{"golden":true,"id":"25174703"},{"golden":false,"id":"15312818"},{"golden":false,"id":"1573336"},{"golden":false,"id":"26515470"},{"golden":false,"id":"38913227"},{"golden":false,"id":"24011977"},{"golden":false,"id":"14584986"},{"golden":false,"id":"39540216"},{"golden":false,"id":"34158147"},{"golden":false,"id":"38466416"},{"golden":false,"id":"26130384"},{"golden":false,"id":"3283505"},{"golden":false,"id":"39713865"},{"golden":false,"id":"33477503"},{"golden":false,"id":"34239334"},{"golden":false,"id":"31238296"},{"golden":false,"id":"1891391"},{"golden":false,"id":"16195952"},{"golden":false,"id":"18308337"},{"golden":false,"id":"22299011"},{"golden":false,"id":"8630499"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":132,"document":"4020613","golden":false,"offsetInEndSection":419,"text":"The results indicated that the depressed children were like depressed adults in that they reported experiencing a pattern of emotions including sadness, anger, self-directed hostility, and shame, and they tended to explain negative events in terms of internal, stable, and global causes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":209,"document":"11480955","golden":false,"offsetInEndSection":319,"text":"The childhood depression can be wholly chemical, wholly due to psychological factors of a combination of both.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":124,"document":"11885086","golden":true,"offsetInEndSection":292,"text":"Children under stress, those who experience loss, or children who have attention, learning, conduct, or anxiety disorders are at a higher risk for depressive disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"678732","golden":false,"offsetInEndSection":315,"text":"A matched controlled study of 84 depressed women confirms the findings of Browm et al, that loss of mother before 11, three or more children at home under 14 years of age, lack of a confiding marital relationship and lack of employment may be vulnerability factors predisposing to depression in working-class women.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"4020613","golden":false,"offsetInEndSection":86,"text":"Affective and cognitive characteristics of depression in 10- and 11-year-old children.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":125,"document":"7400467","golden":true,"offsetInEndSection":416,"text":"Children rated as depressed by their parents on the Personality Inventory for Children evidenced significantly more conduct problems, anxiety, impulsive hyperactivity, learning problems, psychosomatic problems, perfectionism, and muscular tension at home than children rated as nondepressed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":440,"document":"11480955","golden":false,"offsetInEndSection":648,"text":"Some children display the classical symptoms of sadness, anxiety, restlessness, eating and sleeping problems while others present with physical problems like aches and pains which do not respond to treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"4020613","golden":true,"offsetInEndSection":131,"text":"Indices of emotion experiences, attribution style, and intellectual performance were regressed on an index of childhood depression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":682,"document":"4020613","golden":false,"offsetInEndSection":889,"text":"The measures of emotion experiences accounted for 78.1% and 46.1% of the variance in girls\u0027 and boys\u0027 depression scores, respectively, after the variance accounted for by attribution style was partialed out.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":538,"document":"4020613","golden":false,"offsetInEndSection":681,"text":"Depression was not related to performance on a verbal task, but depressed girls performed worse than nondepressed girls on a block design task.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1406,"document":"35731302","golden":false,"offsetInEndSection":1528,"text":"s of maternal depression on adolescents\u0027 emotion regulation are partly mediated by child maltreatment at age 11.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":564,"document":"36450437","golden":false,"offsetInEndSection":868,"text":" years with psychiatric symptoms at age 18 years. In an association analysis, we examined the relationship between presence of symptomatic joint hypermobility syndrome (JHS) and International Classification of Diseases-10 indication of depression and anxiety (Clinical Interview Schedule Revised (CIS-R),","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":195,"document":"16628130","golden":false,"offsetInEndSection":458,"text":"is study explored such associations in 8 boys and 8 girls, age 11 to 17 years, all prescribed bupropion sustained release (SR) for major depression (n \u003d 6) or depressive disorder not otherwise specified (n \u003d 10) as part of a pharmacokinetic (PK) study. All were s","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1593,"document":"6737952","golden":false,"offsetInEndSection":1870,"text":"catecholamines may be involved in the hyperkinetic child syndrome, but because of the heterogenity of this syndrome the depression of the plasma catecholamines as observed under methylphenidate could not differentiate between drug-responders and non-responders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1228,"document":"7295373","golden":false,"offsetInEndSection":1413,"text":"nd immunologic depression from therapy are important factors to be evaluated when laparotomy is performed in children with Hodgkin\u0027s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":77,"document":"24665327","golden":false,"offsetInEndSection":199,"text":"s occur. For example, in children with cancer or renal failure, prolonged hospitalization and chemotherapy can lead to dep","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":178,"document":"1629998","golden":false,"offsetInEndSection":435,"text":"oss of mother before age 11 years and lack of confiding relationship was found to act as a vulnerability factor whereas employment status and having three or more children aged 14 or under were not found to have an increased vulnerability in these patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":185,"document":"36213567","golden":false,"offsetInEndSection":372,"text":"his study aimed to examine how anxiety and depression are uniquely related to spelling and math achievement beyond attention and hyperactivity deficits in children in underserved schools.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":219,"document":"22813655","golden":false,"offsetInEndSection":403,"text":"is study explored associations between sibling caretaking, school performance, and depression among 1943 students randomly selected from 11 junior high and high schools in Cambodia. Th","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":90,"document":"25174703","golden":false,"offsetInEndSection":237,"text":"en. We examined the risk factors for symptoms of depression in 11-year-old children, including the interaction between birthweight and other variab","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1083,"document":"25174703","golden":false,"offsetInEndSection":1220,"text":"nths. There was also a significant interaction between maternal stress in pregnancy and symptoms of depression in 11-year-old children bo","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":728,"document":"8567595","golden":false,"offsetInEndSection":920,"text":"t that, as in the general population, significant life events, particularly those with a negative impact, may contribute to the occurrence of depression in children with PDD. Future studies sh","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23549791","golden":false,"offsetInEndSection":320,"text":"OBJECTIVE: The paper aims to study the prevalence of depression in epileptic children and adolescents by reviewing the existing literature, looking for any association between depression in these children and their demographic or seizure related factors to highlight the potential risk factors for depression in epilepti","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"25174703","golden":false,"offsetInEndSection":105,"text":"Maternal stress during pregnancy is associated with moderate to severe depression in 11-year-old children","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":604,"document":"22940454","golden":false,"offsetInEndSection":727,"text":"al depression occurring when the child was 2 to 3 years of age, was a risk factor for anxiety in 10 and 11 year olds. Timin","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1014,"document":"7896673","golden":false,"offsetInEndSection":1259,"text":"ed (externalizing) children. The lack of a mediating role of family variables suggests that anger expression styles may be more related to the characteristics of depression in children, a finding that has clinical implications for addressing tre","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"7794207","golden":false,"offsetInEndSection":56,"text":"Childhood depression, stressors and parental depression.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":325,"document":"36219440","golden":false,"offsetInEndSection":555,"text":"cted youth. Major depressive disorder (MDD) in children and adolescents is strongly associated with recurrent depression in adulthood; other mental disorders; and increased risk for suicidal ideation, suicide attempts, and suicide","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":153,"document":"7794207","golden":false,"offsetInEndSection":286,"text":"Depressed children aged 7-11 years (n \u003d 20) were compared with clinical non-depressed children (n \u003d 88) and normal children (n \u003d 55).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":907,"document":"36115626","golden":false,"offsetInEndSection":1331,"text":"14.4% (95% CI:13.4-15.3)). Males, children 5-11 years, non-Hispanic children, children living in families in large metropolitan areas, incomes at or below the federal poverty level, and whose highest educated parent had more than a HS education, also showed statistically significant increases in anxiety and depression symptoms.CONCLUSIONS: NHIS data may be used to monitor this increase in mental health symptomatology and","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"7794207","golden":false,"offsetInEndSection":152,"text":"The relationship between depression and stressors and the relationship between depression in children and depression in their parents were investigated.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":477,"document":"7794207","golden":true,"offsetInEndSection":687,"text":"The findings showed that children and mothers in the depressed group reported more stressors than other children and other mothers while fathers of children in the depressed group did not report more stressors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":558,"document":"15666935","golden":false,"offsetInEndSection":660,"text":"These results indicate an association between smoking and depression among children in this age group.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":153,"document":"31238296","golden":false,"offsetInEndSection":304,"text":"The aim of this study was to evaluate the relationship between Toxoplasma gondii (T. gondii) seropositivity and depression in children and adolescents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":350,"document":"7794207","golden":false,"offsetInEndSection":476,"text":"Measures included the Children\u0027s Depression Inventory, Recent Life Events Scale, Stressor Scale and Beck Depression Inventory.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":688,"document":"7794207","golden":false,"offsetInEndSection":882,"text":"The findings also showed that mothers of depressed children were more depressed than mothers of normal children while there were no differences between the scores of fathers in the three groups.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"28803506","golden":false,"offsetInEndSection":136,"text":"Parental stress and depressive symptoms increase the risk of separation among parents with children less than 11 years of age in Sweden.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":287,"document":"10668054","golden":true,"offsetInEndSection":510,"text":"Children whose parents died from suicide, compared with those whose parents died from cancer, reported significantly more depressive symptoms, involving negative mood, interpersonal problems, ineffectiveness, and anhedonia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1152,"document":"28803506","golden":false,"offsetInEndSection":1494,"text":"ciated with separation. In multivariable regression analyses of the parents\u0027 separation rate 9 to 11 years after childbirth, the only significant predictor was mothers\u0027 Spouse relationship problems ( p \u003c .001).CONCLUSIONS: The knowledge that parental stress and depressive symptoms are risk factors for separation may simplify professional su","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":147,"document":"22863172","golden":false,"offsetInEndSection":570,"text":"onflicting. Our aim was to estimate the prevalence and perinatal and early life factors associated with symptoms of depression in children aged 7 to 11 years from two Brazilian birth cohorts.METHODS: The study was conducted on 1444 children whose data were collected at birth and at school age, in 1994 and 2004/2005 in Ribeirao Preto, where they were aged 10-11 years and in 1997/98 and 2005/06 in S?o Lu?s, where children","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":781,"document":"28803506","golden":false,"offsetInEndSection":974,"text":"years after childbirth. Separation was associated with depressive symptoms at 3 months (mothers p \u003d .002, fathers p \u003d .025) and total parental stress at 18 months after childbirth (mothers p \u003d ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":549,"document":"19918674","golden":false,"offsetInEndSection":912,"text":"uicidal ideation was 14.1%. Factors associated to suicidal ideation: female gender, current alcohol consumption, use of illicit drugs, symptoms indicating conduct disorders and high Children\u0027s Depression Inventory scores for depressive symptoms.CONCLUSION: Prevention strategies should focus on female adolescents, especially those sexually active with probable m","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2261,"document":"11766870","golden":false,"offsetInEndSection":2948,"text":"ed to perception of child health and the parents\u0027 own MUPS. Parents of higher attenders were more likely to be depressed (HAD depression scale \u003d 0-7, 8-10, 11+ respectively; adjusted ORs (95% CIs) \u003d 1, 2.04 (1.27-3.27), 1.60 (0.75-3.42)) or anxious (anxiety scale 0-7, 8-10, 11+, respectively; adjusted ORs [95% CIs] \u003d 1, 1.60 [0.99-2.58], 1.97 [1.20-3.26]).CONCLUSION: Important parental factors are council house tenancy, the parents\u0027 perception of and willingness to tolerate, somatic symptoms in the child, and the parents\u0027 own attendance history, health anxiety, and perception of somatic symptoms Doctors should be sensitive to the parental and family factors that underlie the dec","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":240,"document":"28803506","golden":false,"offsetInEndSection":544,"text":"hood. The objective of the present study was to examine parental stress and depressive symptoms during early parenthood and their association with parental separation.METHODS: Four hundred and seven couples completed questionnaires on depressive symptoms for 3 months and parental stress for 18 months af","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":975,"document":"28803506","golden":false,"offsetInEndSection":1151,"text":"010, fathers p \u003d .005). The sub-areas of parental stress, Spouse relationship problems (mothers p \u003d \u003c.001, fathers p \u003d .001) and fathers\u0027 Social isolation ( p \u003d .005), were ass","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1798,"document":"22863172","golden":true,"offsetInEndSection":2005,"text":" with depressive symptoms in both cohorts. Low paternal age was a risk factor for depressive symptoms in the less developed city, S?o Lu?s, whereas low birth weight was a risk factor for depressive symptoms ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":65,"document":"4599484","golden":false,"offsetInEndSection":242,"text":"The true incidence of suicide in the pediatric population is not known because of under-reporting; suicide is, however, considered as a leading cause of death in this age group.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21474570","golden":false,"offsetInEndSection":74,"text":"BACKGROUND: Asthma may increase the risk of comorbid depressive disorders ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":243,"document":"4599484","golden":false,"offsetInEndSection":451,"text":"Suicide in young children often reflects an immature comprehension of the state of death, combined with a wish to alter an intolerable living situation or to punish individuals significant in his environment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":452,"document":"4599484","golden":false,"offsetInEndSection":506,"text":"At age 14 the incidence of suicide increases markedly.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"4599484","golden":false,"offsetInEndSection":64,"text":"Suicide and depression in children and adolescents are reviewed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24892732","golden":false,"offsetInEndSection":650,"text":"OBJECTIVE: This study examines experiences of depressive symptoms among a group of 32 low-income, African-American and White mothers of young children who resided in rural Eastern North Carolina, USA.DESIGN: Women\u0027s experiences of depressive symptoms were elicited through a series of longitudinal ethnographic interviews, including an explanatory models interview specifically designed to elicit their beliefs about the causes, symptomatology and help-seeking behavior and management of depressive symptoms.RESULTS: A content analysis of interview data indicated that most women (11 African-Americans and 15 Whites) reported having depressive sympto","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"4599484","golden":false,"offsetInEndSection":52,"text":"Suicide and depression in childhood and adolescence.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":75,"document":"21474570","golden":false,"offsetInEndSection":146,"text":"n children. Children suffering from asthma or depression are more often","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1286,"document":"32210463","golden":false,"offsetInEndSection":1431,"text":"n in children below age 13 could not be discriminated by MFQ or SMFQ whether filled in by child and mostly also when filled in by parent. Favouri","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1531,"document":"16844356","golden":false,"offsetInEndSection":1759,"text":"nteraction between cytokines, depression and anxiety in children and adolescents undergoing hematopoietic stem cell transplantation merits further long-term studies under natural conditions and on laboratory models.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":758,"document":"21041282","golden":false,"offsetInEndSection":989,"text":"mptoms.RESULTS: A PHQ-9 score of 11 or more had a sensitivity of 89.5% and a specificity of 77.5% for detecting youth who met the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria for major depression o","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":922,"document":"12563066","golden":false,"offsetInEndSection":1185,"text":"(67% vs 36%). Child psychiatrists were more likely than pediatricians to report prescribing SSRIs (93% vs 75%) and mood stabilizers (45% vs 11%) for depression, and SSRIs (74% vs 50%) and tricyclic antidepressants (37% vs 12%) for obsessive compulsive disorder. O","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"16251012","golden":false,"offsetInEndSection":227,"text":"This validation study assessed the degree of confidence that can be placed on inferences from depressive symptoms among adolescents, based on a 12-item version of the Centre for Epidemiological Studies Depression scale (CES-D).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21041282","golden":false,"offsetInEndSection":191,"text":"OBJECTIVE: The purpose of this study was to examine the performance characteristics and validity of the Patient Health Questionnaire-9 Item (PHQ-9) as a screening tool for depression among ad","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":952,"document":"30181470","golden":false,"offsetInEndSection":1133,"text":"come families. These children have an about eleven times higher odds of comorbid psychosis (OR \u003d 11.810) and seven times higher odds of depression (OR \u003d 7.093) compared to the compa","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":302,"document":"27297012","golden":false,"offsetInEndSection":608,"text":"services. The National Institute for Health and Care Excellence (NICE) recommends 2 \u0027ultra-brief\u0027 case-finding questions (the Whooley questions) to aid identification of depression during the perinatal period, but this recommendation was made in the absence of any validation studies in a perinatal populat","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":688,"document":"18381506","golden":false,"offsetInEndSection":932,"text":"nclusion criteria. In the 54 children who developed toxicity, the clinical effects included drowsiness or lethargy (55%), vomiting (21%), miosis (21%), respiratory depression (7%), agitation or irritability (5%), pallor (3%), and coma (2%). The","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1752,"document":"35798530","golden":false,"offsetInEndSection":2046,"text":"ression levels.CONCLUSION: A large proportion of children had elevated anxiety and depressive symptoms during the pandemic relative to before the pandemic, suggesting a need for measures to engage children in healthy habits to protect children\u0027s mental health and continuous monitoring of child","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1105,"document":"28018433","golden":false,"offsetInEndSection":1174,"text":"Viruses constitute a significant cause of ARI in children under five.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30118916","golden":false,"offsetInEndSection":125,"text":"BACKGROUND: Acute respiratory infections (ARIs) are the most common causes of death in children under 5 years of age. While t","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"22834653","golden":false,"offsetInEndSection":107,"text":"BACKGROUND: Rotaviruses are the single most important cause of severe diarrhea in young children worldwide.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28673837","golden":false,"offsetInEndSection":142,"text":"BACKGROUND: Acute respiratory infections are the leading cause of mortality in children worldwide, especially in developing countries. Pneumon","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"15472321","golden":false,"offsetInEndSection":130,"text":"Most lower respiratory tract infections (LRTIs) in children under the age of 3 years are due to respiratory syncytial virus (RSV).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"20728404","golden":false,"offsetInEndSection":129,"text":"BACKGROUND: Human rhinoviruses (HRVs) are among the most common causes of community-acquired pneumonia (CAP) in children. However","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":300,"document":"26594615","golden":false,"offsetInEndSection":413,"text":"The most common cause of non-malarial febrile illness (NMFI) in African children is respiratory tract infection. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"24133181","golden":false,"offsetInEndSection":125,"text":"Human parainfluenza viruses (HPIVs) are among the most common causes of respiratory tract infections in children.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"18020820","golden":false,"offsetInEndSection":99,"text":"Pathways to childhood depressive symptoms: the role of social, cognitive, and genetic risk factors.","beginSection":"title"},{"endSection":"title","offsetInBeginSection":0,"document":"25050602","golden":false,"offsetInEndSection":94,"text":"Depressive symptoms in young, urban schoolchildren: environmental, social, and cognitive risk.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":681,"document":"11693583","golden":false,"offsetInEndSection":905,"text":"The links between postnatal depression and the children\u0027s intellectual problems were not mediated by parental IQ and were not accounted for by measures of social disadvantage nor by the mother\u0027s later mental health problems.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":937,"document":"25050602","golden":false,"offsetInEndSection":1172,"text":"Together, findings suggest that significant relations exist among stressful life events, social and cognitive processes, and depressive symptoms in young urban children and that these relations are influenced by gender and development.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":900,"document":"26569537","golden":false,"offsetInEndSection":1079,"text":"t cases of CHD had occurred. Poor emotional control increased the risk of CHD (HR \u003d 1.31, 95% CI \u003d 1.18-1.45), adjusting for childhood socioeconomic position, anxiety, depression,","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":752,"document":"11068893","golden":false,"offsetInEndSection":981,"text":"3.RESULTS: Only 5 and 8 of 220 parent-reported preschool problem items were significantly related to later child-reported depression and anxiety, respectively, and only 3 of 120 teacher-reported problem items were related to late","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1206,"document":"9586773","golden":false,"offsetInEndSection":1469,"text":"ort to the validity of depression as a distinct condition in some children with autism/PDD and suggest that, as in the normal population, autistic children who suffer from depression are more likely to have a family history of depression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1522,"document":"34788300","golden":true,"offsetInEndSection":1818,"text":"TERPRETATION: Children who live with a parent who has depression are more likely to develop depression and not achieve educational milestones, compared to children who live with a parent who has a history of depression (but no active depression in child\u0027s lifetime) and compared to those with no ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":180,"document":"34982305","golden":false,"offsetInEndSection":426,"text":"e present study comprehensively investigated the associations between the three constructs of empathy and depression in children, as well as the potential moderating effect of peer relationships (i.e., social preference) on this association. A to","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1478,"document":"30903988","golden":false,"offsetInEndSection":1818,"text":"sity of the sample.CONCLUSIONS: Taken together, the current results suggest that the relationship between hormones and internalizing and externalizing symptoms in children may vary as a function of parental depression and child sex, knowledge that may inform intervention efforts aimed at preventing psychopathology in children whose parent","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":759,"document":"34982305","golden":false,"offsetInEndSection":1037,"text":"with a low social preference, all three empathy constructs were positively quadratically correlated with depression, extremely high and low empathy were associated with increased depression, and moderate empathy was associated with the lowest level of depression. For children w","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":866,"document":"17075232","golden":false,"offsetInEndSection":1085,"text":"s study was that certain aspects of depression (i.e., interpersonal problems and feelings of ineffectiveness) were correlated with higher levels of sedentary behavior in children aged 11 to 13. A factor analysis of the ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":629,"document":"21727235","golden":false,"offsetInEndSection":940,"text":" by almost four times. Children exposed only to antenatal depression or only to childhood maltreatment were no more at risk of developing psychopathology; however, children exposed to both antenatal depression and childhood maltreatment were at almost 12 times greater risk of developing psychopathology than of","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":108,"document":"11913568","golden":false,"offsetInEndSection":342,"text":"n this study, we evaluated the anxiety and depression in epileptic children to compare their results with that of a healthy control group and to determine the relationship of anxiety and depression scores to epilepsy-related factors. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":178,"document":"30903988","golden":false,"offsetInEndSection":365,"text":"mstances. Having a parent with a history of depression may be one circumstance under which dysregulated hormone patterns are especially associated with emotional and behavioral symptoms i","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":464,"document":"25364062","golden":true,"offsetInEndSection":789,"text":"Results indicated that high rates of community poverty and unemployment, children\u0027s depressive attributional style, and low levels of self-perceived competence predict children\u0027s depressive symptoms, even after accounting for demographic and familial risk factors, such as parental education and negative parenting behaviors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1351,"document":"31140060","golden":false,"offsetInEndSection":1675,"text":"The key finding is that socioeconomic inequality in maternal postnatal depression is a significant contributor to inequalities in special educational needs, emotional problems, and low self-assessed health for children at age 11?years, even after accounting for a range of other factors that might explain such associations.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25050602","golden":false,"offsetInEndSection":151,"text":"This study examined relations among stressors, perceived social competence, attributional style, and depressive symptoms in young urban schoolchildren.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":534,"document":"25050602","golden":false,"offsetInEndSection":651,"text":"For older children and girls, main effects were found for stressful life events as predictors of depressive symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34354040","golden":false,"offsetInEndSection":156,"text":"Dysregulated hypothalamic-pituitary-adrenal (HPA)-axis function might underlie the relationship between adverse childhood experiences (ACEs) and depression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1812,"document":"9132733","golden":false,"offsetInEndSection":2015,"text":"Subjects with Impulsive cognitive style had significantly higher scores than subjects with Reflective cognitive style on a self-rating scale for childhood depression, the Children\u0027s Depression Inventory.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":932,"document":"34354040","golden":false,"offsetInEndSection":1131,"text":"The results showed that ACEs cumulative exposure (b?\u003d?-0.20, p?\u003d?0.03), bullying (b?\u003d?-0.61, p?\u003d?0.01), and emotional abuse (b?\u003d?-0.84, p?\u003d?0.02) were associated with lower cortisol levels at age 11.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":652,"document":"25050602","golden":false,"offsetInEndSection":815,"text":"Mediational analyses indicated that perceived peer acceptance served as a mediator of the relation between stressful life events and depressive symptoms for girls.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":329,"document":"1893470","golden":false,"offsetInEndSection":524,"text":"The author presents als the results of an investigated group of 120 depressive child patients and discusses different clinical symptoms, their frequency, interrelationship, age-related character.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":476,"document":"25838782","golden":false,"offsetInEndSection":657,"text":"In addition, nutrient deficiencies, such as iron deficiency, are known to impair learning and cause decreased productivity in school-age children, and maternal depressive disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":127,"document":"1893470","golden":false,"offsetInEndSection":236,"text":"She mentions basic aetiopathogenetic factors participating in the development of depression during childhood.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"35271511","golden":false,"offsetInEndSection":154,"text":"Accidental Flibanserin Ingestion in Children Causing Acute Respiratory and Central Nervous System Depression: What Health Care Professionals Need to Know.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":659,"document":"1893470","golden":false,"offsetInEndSection":803,"text":"Based on an analysis of the results the author describes the changes and development of the clinical picture in depressive syndrome in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":751,"document":"7942065","golden":true,"offsetInEndSection":870,"text":"Children and adolescents with depressive illnesses have higher rates of scholastic failure and school-related problems.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":267,"document":"25838782","golden":true,"offsetInEndSection":475,"text":"Longitudinal studies in Canada indicate that hunger is related to poor health outcomes, including a higher risk of depression and suicidal ideation in adolescents, and chronic conditions, particularly asthma.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"1893470","golden":false,"offsetInEndSection":62,"text":"[Development of symptoms of depressive syndrome in childhood].","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":804,"document":"1893470","golden":false,"offsetInEndSection":928,"text":"Finally she emphasizes that it is useful to collaborate with paediatricians when treating children with depressive syndrome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":557,"document":"7942065","golden":false,"offsetInEndSection":750,"text":"Approximately 3.1% of the population have dysthymia including children and adolescents who, like adults, exhibit a higher risk for new episodes of depressive illness if they have this disorder.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":399,"document":"17175406","golden":true,"offsetInEndSection":809,"text":"Basic epidemiologic and clinical research indicates that increased risk for depression is associated with being female; a family history of depression, particularly in a parent; subclinical depressive symptoms; anxiety; stressful life events; neurobiological dysregulation; temperament/personality (e.g., neuroticism); negative cognitions; problems in self-regulation and coping; and interpersonal dysfunction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":211,"document":"17175406","golden":false,"offsetInEndSection":398,"text":"This paper highlights research about risk factors for depression in children and adolescents and links it to current knowledge about interventions aimed at preventing depression in youth.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":878,"document":"27254891","golden":false,"offsetInEndSection":1045,"text":"Low mood is the predominant feature and depressed children might also have various unexplained physical symptoms, eating disorders, school refusal or substance misuse.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"12091784","golden":true,"offsetInEndSection":175,"text":"Depression in children and adolescents is associated with poor psychosocial functioning, high psychiatric comorbidity, risk of recurrent episodes or onset of bipolar disorder.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":957,"document":"17175406","golden":false,"offsetInEndSection":1205,"text":"Although several existing depression-prevention studies have targeted one or more of these risk factors, the efficacy of these various prevention programs for youth with different combinations of these risk factors needs to be investigated further.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"17175406","golden":false,"offsetInEndSection":77,"text":"Depression in children and adolescents: linking risk research and prevention.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":89,"document":"24977773","golden":false,"offsetInEndSection":291,"text":"n children. Previous studies have demonstrated that depressed skull fractures (SFs) represent approximately one quarter of all SFs in children and approximately 10% percent of hospital admissions after ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":452,"document":"22299011","golden":false,"offsetInEndSection":670,"text":" has repeated a school year. About 60% of depressed boys aged 6-11 years are referred to child psychiatry services for behavioral difficulties and 71% of boys in this age group have a depressive disorder comorbid with ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1046,"document":"27254891","golden":false,"offsetInEndSection":1261,"text":"Two thirds of adolescents with depression are thought to have at least one comorbid psychiatric disorder, most commonly the range of anxiety disorders, disruptive behavioural disorders and substance misuse problems.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":356,"document":"21804846","golden":false,"offsetInEndSection":1030,"text":"he original sample. Multiple linear regression analyses were performed using children\u0027s internalizing symptoms and child, family and socioeconomic characteristics.RESULTS: Four variables interacted significantly with mothers\u0027 lifetime depressive/anxiety disorders to predict 6 to 11 year-old children\u0027s internalizing symptoms: child age (t\u003d2.415, P\u003d0.016), mother\u0027s caring behaviours (t\u003d2.950, P\u003d0.003), mother\u0027s punitive behaviours (t\u003d2.629, P\u003d0.009) and parental social support (t\u003d2.272, P\u003d0.023).CONCLUSION: Results highlight the important contribution of the family context to the intergenerational transmission of internalizing symptoms and the relevance of taking into","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":279,"document":"36619667","golden":false,"offsetInEndSection":393,"text":"One possible reason for these delayed effects is the neuroinflammation caused by neonatal immune activation (NIA).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36619667","golden":false,"offsetInEndSection":278,"text":"Adverse factors such as stress or inflammation in the neonatal period can affect the development of certain brain structures and have negative delayed effects throughout the lifespan of an individual, by reducing cognitive abilities and increasing the risk of psychopathologies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":572,"document":"8408365","golden":false,"offsetInEndSection":693,"text":"1.8% of children met the criteria for major depression, with a further 6.4% being diagnosed as having dysthymic disorder.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"19863784","golden":true,"offsetInEndSection":106,"text":"BACKGROUND: Physical disorders are commonly comorbid with depression in children attending general medical","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"35768872","golden":false,"offsetInEndSection":155,"text":"A prospective study of peer victimization and depressive symptoms among left-behind children in rural China: the mediating effect of stressful life events.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1249,"document":"36619667","golden":false,"offsetInEndSection":1642,"text":"Analyses of molecular changes have shown that NIA leads to an increase in the amount of activated microglia and astroglia in the frontal cortex and hippocampus, an increase in oxidative-stress parameters, a change in stress reactivity of the HPA axis, and an imbalance of cytokines in various regions of the brain, but not in blood plasma, thus confirming the local nature of the inflammation.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36619667","golden":false,"offsetInEndSection":154,"text":"Once induced, it lasts for a long time: the structural and molecular signatures associated with depressive-like behavior after neonatal immune activation.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1643,"document":"36619667","golden":false,"offsetInEndSection":1823,"text":"Therefore, NIA causes depressive-like behavior in adult males under aversive testing conditions, which are accompanied by local inflammation and have sex- and age-specific effects.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":631,"document":"36619667","golden":false,"offsetInEndSection":800,"text":"In addition, neuroinflammation may affect the hypothalamic-pituitary-adrenal (HPA) axis and processes of oxidative stress, thereby resulting in higher stress reactivity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34621342","golden":true,"offsetInEndSection":162,"text":"Background: The depressive syndrome is commonly found in children suffering from chronic diseases, which is also present in patients with juvenile idiopathic arth","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1310,"document":"8961408","golden":false,"offsetInEndSection":1541,"text":"ns and behavioural problems were significantly associated with depression and these were three times as frequent amongst depressed women with no children aged under one compared with women in their post-natal year. Depressed women ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":287,"document":"8961408","golden":false,"offsetInEndSection":666,"text":" study focuses on clinical facets of this work, including the rate and content of depression amongst health visitor attenders, the capacity of health visitors to identify accurately the presence of depression, the relationship between depression and child abuse and child behavioural issues, variations in the practice of health visitors and work with other professionals. In a c","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2062,"document":"34999973","golden":false,"offsetInEndSection":2249,"text":"he treatment of mood disorders in child and adolescent populations, and should be considered in severe and treatment-refractory cases. Controlled studies with objective measures and long-","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"29413138","golden":false,"offsetInEndSection":122,"text":"BACKGROUND: Maternal postnatal depression occurs following 10-15% of births and is associated with a range of negative chi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":484,"document":"16719635","golden":false,"offsetInEndSection":666,"text":"s of parental helpseeking for children\u0027s services included the emergence of new fears in children since 9/11, parent symptoms of depression, and parents\u0027 own helpseeking. The stronge","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1531,"document":"18281410","golden":false,"offsetInEndSection":1699,"text":"S: Continuation treatment with fluoxetine was superior to placebo in preventing relapse and in increasing time to relapse in children and adolescents with major depress","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":317,"document":"34999973","golden":false,"offsetInEndSection":615,"text":"e need for effective treatments for severe mood disorders in adolescents and the low use rate of ECT, this systematic review examines the existing literature on the effectiveness and adverse effect profile of ECT when used for treatment-resistant mood disorders in children and adolescents. Searche","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":587,"document":"24359862","golden":false,"offsetInEndSection":769,"text":"importance.RESULTS: One-hundred and ninety parenting strategies were endorsed as important or essential in reducing adolescents\u0027 risk of developing depression or anxiety disorders by","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1558,"document":"25933173","golden":false,"offsetInEndSection":1822,"text":"have demonstrated promise in terms of efficacy, but no depression prevention program for children or adolescents as yet has garnered sufficient evidence of effectiveness under real-world conditions to warrant widespread dissemination at this time.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"22977304","golden":false,"offsetInEndSection":55,"text":"Depressive symptoms and childhood sleep apnea syndrome.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":531,"document":"21969769","golden":false,"offsetInEndSection":690,"text":"Preschool depression is characterized by typical symptoms of depression such as anhedonia; changes in sleep, appetite, and activity level; and excessive guilt.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":902,"document":"22977304","golden":false,"offsetInEndSection":1060,"text":"en desaturation index values. Logistic regression showed that an apnea-hypopnea index ? 3 and an oxygen desaturation index ? 1 could be risk factors for devel","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":577,"document":"22977304","golden":false,"offsetInEndSection":901,"text":"ation was performed. All subjects filled out the Italian version of the Children Depression Inventory (CDI) to screen for the presence of depressive symptoms.RESULTS: The group with SRBD showed higher CDI scores than the group without SRBD, with a positive correlation found between CDI scores, apnea-hypopnea index, and oxy","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21969769","golden":false,"offsetInEndSection":208,"text":"The empirical finding that school-aged children could suffer clinical depression refuted the widely held assumption that this age group would be too developmentally immature to experience depressive symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":276,"document":"22977304","golden":false,"offsetInEndSection":491,"text":"literature. The aim of this study was to assess the relationship between SRBD and depressive symptoms in a population of school-aged children.METHODS: The study population comprised 94 children affected by SRBD and ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1501,"document":"33358009","golden":false,"offsetInEndSection":2010,"text":"score increase, respectively. For depression and anxiety, aggressive behavior, and attention-deficit/hyperactivity disorder symptoms, a one-unit increase in E-DII scores (a more proinflammatory diet) was associated with a 7% increased risk of all three analyzed emotional and behavioral symptoms: OR 1.07, 95% CI, 1.03-1.11; OR 1.07, 95% CI, 1.02-1.13; OR 1.07, 95% CI, 1.01-1.13, respectively.CONCLUSIONS: Our findings suggest that a maternal low-quality and proinflammatory diet may increase the risk of emo","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1294,"document":"22977304","golden":false,"offsetInEndSection":1578,"text":" desaturation index was \u003e4.2. The limitations of this study are that our data are derived from one single psychometric test and not from a complete psychiatric evaluation, and our subjects came from a small group in southern Italy.CONCLUSION: Our results suggest the importance of moo","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"22977304","golden":false,"offsetInEndSection":275,"text":"BACKGROUND: The relationship between sleep and mood regulation is well known, and some reports suggest a key role of sleep-related breathing disorders (SRBD) in the development of the symptomatology of depression, even if no conclusive data are actually found in the clinical","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":419,"document":"25581241","golden":false,"offsetInEndSection":870,"text":"More broadly, we describe research by Susan and her colleagues on the predictors of depression in childhood and adolescence; gender differences in depression and rumination in adolescence and adulthood; roots, correlates, and adverse consequences of ruminative response styles; and rumination as a transdiagnostic risk factor for not only depression but also a host of psychological disorders, including anxiety, substance abuse, and eating disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1541,"document":"25412352","golden":false,"offsetInEndSection":1693,"text":"the WJ-III-COG and CHC theory in identifying cognitive problems associated with depression in children and adolescents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":639,"document":"12707562","golden":false,"offsetInEndSection":935,"text":"s in adolescents. For children of mothers with no or less chronic depression, higher IQ was associated with a lower likelihood of depression; in contrast, for children of mothers with a history of more chronic depression, higher levels of IQ were significantly associated with a greater likelihoo","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":122,"document":"26618860","golden":false,"offsetInEndSection":259,"text":"velopment. However, some children exposed to postnatal depression have outcomes similar to unexposed children, and can be referred to as ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":121,"document":"25412352","golden":false,"offsetInEndSection":308,"text":"ost commonly discussed in relation to the adult population, growing evidence has supported the idea that children and adolescents experience cognitive problems in relation to depression. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1012,"document":"22388476","golden":false,"offsetInEndSection":1247,"text":"ve skills. However, at both the six- and the 12-month follow-ups, children of mothers whose depression had remitted, regardless of treatment assignment, had significantly fewer behavior problems than children whose mothers remained dep","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1853,"document":"33495200","golden":false,"offsetInEndSection":1995,"text":"ON: Treatment of maternal depression was associated with higher prevalence of daily health complaints and low SAH in the offspring at age 11 y","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1073,"document":"11068892","golden":false,"offsetInEndSection":1245,"text":"ONCLUSIONS: Teachers are more likely than parents to notice internalizing problems and related problems such as social and academic problems in children reporting depressio","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1555,"document":"16551710","golden":false,"offsetInEndSection":1772,"text":"ith reductions in the children\u0027s diagnoses and symptoms. There was an overall 11% decrease in rates of diagnoses in children of mothers whose depression remitted compared with an approximate 8% increase in rates of di","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1220,"document":"31469175","golden":false,"offsetInEndSection":1486,"text":" small proportion (7.7%) evidenced moderate and increasing INT and high stable EXT symptoms: this pattern was strongly predictive of adolescent psychopathology (e.g. depression at 11?years: unadjusted odds ratio?\u003d?5.62; 95% confidence intervals?\u003d?3.82, 8.27). The ot","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"20454820","golden":false,"offsetInEndSection":196,"text":"In adult-onset multiple sclerosis (MS) cases, major depression, fatigue and psychological distress are common, whereas there is little information on these issues in children with the disease. The","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":384,"document":"10680851","golden":false,"offsetInEndSection":476,"text":"Genetic factors are associated more strongly with depression among pubertal girls than boys.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1842,"document":"30293307","golden":false,"offsetInEndSection":1955,"text":"Conclusion: Childhood physical and emotional abuse might increase the risk of depressive symptoms in adolescence.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":148,"document":"10680851","golden":false,"offsetInEndSection":303,"text":"The emerging gender difference (more girls depressed than boys) in depressed mood and depressive disorders appears after the age of 13 years or midpuberty.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"10680851","golden":false,"offsetInEndSection":147,"text":"This article reviews the description and possible explanations for the development of gender differences in depression in children and adolescents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":909,"document":"10680851","golden":false,"offsetInEndSection":1134,"text":"Girls identify more strongly with a feminine stereotype of needing to appear thin and consequently become more dissatisfied with their body shape and physical appearance, which in turn is associated with increased depression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":761,"document":"10680851","golden":true,"offsetInEndSection":908,"text":"Girls are more likely to experience negative events in the family than boys, and these adversities are in turn associated with elevated depression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24292965","golden":false,"offsetInEndSection":204,"text":"This study tested whether childhood parental emotional abuse and peer emotional bullying serve as antecedents of depression in adolescence and identified the cognitive mechanisms involved in this process.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":727,"document":"24292965","golden":true,"offsetInEndSection":986,"text":"Thus, findings suggest that the experiences of childhood emotional abuse by parents and peers serve as antecedents to develop a negative cognitive style, vulnerability that, once developed, is a risk factor for the onset of depressive symptoms in adolescence.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":638,"document":"10680851","golden":false,"offsetInEndSection":760,"text":"Studies on childhood adversities and gender role have provided evidence explaining why more girls are depressed than boys.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":32,"document":"1891391","golden":false,"offsetInEndSection":33,"text":".","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":92,"document":"32433786","golden":false,"offsetInEndSection":201,"text":"What genetic and environmental risk factors result in some children developing autism, and others depression?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":416,"document":"32433786","golden":false,"offsetInEndSection":497,"text":"My prediction is nicely borne out by studies in the current issue of the journal.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":202,"document":"32433786","golden":false,"offsetInEndSection":415,"text":"I discussed the issue of causation in an earlier editorial (Lerv?g, 2019) and anticipated that \u0027we will see many more studies in the Journal of Child Psychology and Psychiatry (JCPP) testing causal relationships\u0027.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":451,"document":"4015172","golden":false,"offsetInEndSection":619,"text":"There was considerable behavioural deviance in children attending the outpatient clinics; 44% of the 7 to 11 year olds who were surgical outpatients had deviant scores.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"32433786","golden":false,"offsetInEndSection":107,"text":"Editorial: Some roads less travelled-different routes to understanding the causes of child psychopathology.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32433786","golden":false,"offsetInEndSection":91,"text":"The most critical issue in our field is to understand the causes of the disorders we study.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1088,"document":"19445770","golden":false,"offsetInEndSection":1849,"text":"nal studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: citalopram, cognitive behavioural therapy (CBT) (individual or group, to prevent relapse), escitalopram, electroconvulsive therapy, family therapy, fluoxetine (alone or with cognitive therapy or CBT), fluvoxamine, group therapeutic support (other than CBT), guided self-help, individual psychodynamic psychotherapy, interpersonal therapy, lithium, mirtazapine, monoamine oxidase inhibitors (MAOIs), omega-3 polyunsaturated fatty acids, paroxetine, sertraline (alone or with CBT), St John\u0027s Wort (Hypericu","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":848,"document":"11261405","golden":false,"offsetInEndSection":975,"text":"Finally, the CCC model accounted for much more variance in depression than conduct problems, suggesting diagnostic specificity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":922,"document":"33928055","golden":false,"offsetInEndSection":1171,"text":"ce rate of 4.5% over 12-months. This study confirms that girls report a higher range of point prevalence, 12- month-prevalence, and 12-month incidence compared to boys.CONCLUSIONS: The results indicate that depressive symptoms among children and you","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1323,"document":"32950957","golden":false,"offsetInEndSection":1446,"text":"The classes with symptomatology and irritability (2 and 3) clearly differed from class 1 (low) at baseline and in outcomes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1180,"document":"29239637","golden":false,"offsetInEndSection":1433,"text":"In contrast, the link between RSA and anxiety was qualified by both strategy repertoire for fear and age, such that higher resting RSA was most strongly associated with fewer anxiety symptoms for older children with larger strategy repertoires for fear.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":492,"document":"2027167","golden":false,"offsetInEndSection":557,"text":"Of these 14 children, seven developed acute bacterial infections.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":838,"document":"2027167","golden":false,"offsetInEndSection":1039,"text":"These results confirm previous reports of depressed phagocytic and bactericial capacities of PMN in measles, and further document that peripheral blood monocyte functions are also depressed in measles.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":156,"document":"30410921","golden":false,"offsetInEndSection":289,"text":"institutions. These children and adolescents living as orphans or in stigmatized environments are vulnerable because of the loss of p","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1001,"document":"29239637","golden":false,"offsetInEndSection":1179,"text":"Children\u0027s resting RSA interacted with age to predict externalizing symptoms, such that low resting RSA was associated with more externalizing symptoms for younger children only.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1257,"document":"36715031","golden":false,"offsetInEndSection":1423,"text":"Conclusion Overzealous online education, lack of adequate sleep and failure to spend quality time with the family can negatively impact the mental health of children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1556,"document":"36928863","golden":false,"offsetInEndSection":1878,"text":"The most frequently identified barriers to maintaining optimal mental wellbeing were lack of routine, lack of social interaction and social supports, and uncertainty and fear.CONCLUSIONS: Findings underscore areas of need during times of large-scale social isolation, specifically for families with children who have ADHD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1092,"document":"33284065","golden":true,"offsetInEndSection":1440,"text":"Moreover, we found some characteristic biological and cognitive-emotional characteristics of children with depressive disorders, such as low stress-related cortisol, low evaluation of own performance, and more negative cognitions in dealing with stressful situations, low self-esteem and a general impairment of emotional processing of human faces.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":552,"document":"36715031","golden":false,"offsetInEndSection":601,"text":"The prevalence of childhood depression was 13.7%.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":821,"document":"36715031","golden":false,"offsetInEndSection":957,"text":"Those who used a cell phone for online classes had a higher likelihood of depression compared to other devices, such as tabs or laptops.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":958,"document":"36715031","golden":true,"offsetInEndSection":1156,"text":"Children who slept less than 8 hours a day had a higher likelihood of depression while those who either did not sleep in the afternoon or slept less than 1 hour had a lower likelihood of depression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1419,"document":"33646416","golden":false,"offsetInEndSection":1558,"text":"While some parents coped well, a particularly negative pattern was observed in a subgroup of families that experienced an increase in ACEs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":730,"document":"36715031","golden":true,"offsetInEndSection":820,"text":"Children who had more than 4 hours online education had a higher likelihood of depression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":602,"document":"36715031","golden":true,"offsetInEndSection":729,"text":"Girls were more likely to be depressed than boys; 11-16-year-olds were more likely to be depressed than 5-10-year-old children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":365,"document":"36928863","golden":false,"offsetInEndSection":708,"text":"These trends are particularly concerning for families raising neuroatypical children such as those with Attention-Deficit Hyperactivity Disorder (ADHD), as these children are already more likely than their typically developing peers to experience comorbid mental health issues, and to experience greater distress when required to stay indoors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":646,"document":"36219440","golden":false,"offsetInEndSection":1384,"text":"Psychiatric disorders and previous suicide attempts increase suicide risk.Objective: To update its 2014 and 2016 recommendations, the US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening, accuracy of screening, and benefits and harms of treatment of MDD and suicide risk in children and adolescents that would be applicable to primary care settings.Population: Children and adolescents who do not have a diagnosed mental health condition or are not showing recognized signs or symptoms of depression or suicide risk.Evidence Assessment: The USPSTF concludes with moderate certainty that screening for MDD in adolescents aged 12 to 18 years has a moderate net benefit.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1352,"document":"32383428","golden":false,"offsetInEndSection":1717,"text":"Adjusted analyses showed that sustained or transitory maternal depressive symptoms during childhood had no effect on the offspring\u0027s body composition indices at 11 years of age.CONCLUSION: Children raised by chronically depressed mothers have body composition indices at 11 years of age that are similar to those of children whose mothers have never been depressed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1494,"document":"36219440","golden":false,"offsetInEndSection":1751,"text":"The USPSTF concludes that the evidence is insufficient on the benefit and harms of screening for suicide risk in children and adolescents owing to a lack of evidence.Recommendation: The USPSTF recommends screening for MDD in adolescents aged 12 to 18 years.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":337,"document":"36219440","golden":false,"offsetInEndSection":567,"text":"Major depressive disorder (MDD) in children and adolescents is strongly associated with recurrent depression in adulthood; other mental disorders; and increased risk for suicidal ideation, suicide attempts, and suicide completion.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36219440","golden":false,"offsetInEndSection":66,"text":"Importance: Depression is a leading cause of disability in the US.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1752,"document":"36219440","golden":false,"offsetInEndSection":1931,"text":"(B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for MDD in children 11 years or younger.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":568,"document":"36219440","golden":false,"offsetInEndSection":645,"text":"Suicide is the second-leading cause of death among youth aged 10 to 19 years.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33028438","golden":false,"offsetInEndSection":565,"text":"BACKGROUND: Depression is associated with lower educational attainment, but there has been little investigation of long-term educational trajectories in large cohorts with diagnosed depression.AIMS: To describe the educational attainment trajectories of children with a depression diagnosis in secondary care, and to investigate whether these trajectories vary by sociodemographic characteristics.METHOD: We identified new referrals to South London and Maudsley\u0027s NHS Foundation Trust between 2007 and 2013 who received a depression diagnosis at under 18 years old.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1671,"document":"36940922","golden":false,"offsetInEndSection":1780,"text":"In conclusion, parasomnias were more prevalent among children of mothers with chronic symptoms of depression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2098,"document":"35656347","golden":false,"offsetInEndSection":2327,"text":"Prosocial behavior alone was not associated with depressive symptoms.Conclusions: Being praised for prosocial behavior rather than objective prosocial behavior at 10 years of age predicted lower depressive symptoms 2 years later.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1729,"document":"32563266","golden":false,"offsetInEndSection":2099,"text":"However, there was no discernable correlation between mothers\u0027 CESD-11 scores and the proportion of private education cost (moderate: ??\u003d?-?0.078, S. E?\u003d?0.250, p?\u003d?0.7555; high: ??\u003d?0.003, S. E?\u003d?0.215, p?\u003d?0.9882).CONCLUSIONS: These results may be explained by the tendency for fathers to experience greater economic burdens than mothers in patriarchal Korean society.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1478,"document":"32290876","golden":false,"offsetInEndSection":1767,"text":"Suicide death of schoolmate/acquaintance increased risks of an adulthood trajectory as compared to never-attempted and adolescence-limited [RR 8.41 (3.04-23.27) and 6.63 (1.29-34.06), respectively].CONCLUSION: In half the participants attempting suicide, attempts continued into adulthood.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1445,"document":"33030459","golden":true,"offsetInEndSection":1645,"text":"The rates of depressive and anxiety disorders usually increase over time, and poor mental health is associated with poor socioeconomic conditions - particularly with social isolation and unemployment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32766456","golden":false,"offsetInEndSection":132,"text":"Depression is a leading cause of disability and is associated with a number of adverse offspring outcomes when it occurs in parents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":420,"document":"32766456","golden":false,"offsetInEndSection":710,"text":"The Avon Longitudinal Study of Parents and Children (ALSPAC) is a large birth cohort study in England which administered one of the most commonly used depression instruments, the Edinburgh Postnatal Depression Scale (EPDS) at 11 timepoints in mothers and at 10 timepoints in their partners.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":711,"document":"32766456","golden":false,"offsetInEndSection":859,"text":"In addition to repeated measurements of the EPDS, ALSPAC has a wealth of participant data on biological, social, demographic, and lifestyle factors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1230,"document":"34246951","golden":false,"offsetInEndSection":1559,"text":"Maternal self-harm thoughts remained associated with both offspring outcomes independent of maternal depression, and no evidence was found for an interaction between the two exposures.DISCUSSION: Clinicians collecting data on maternal depression may consider paying attention to questions about self-harm ideation in assessments.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"32766456","golden":false,"offsetInEndSection":133,"text":"Depressive symptoms measured using the Edinburgh Postnatal Depression Scale in mothers and partners in the ALSPAC Study: A data note.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":860,"document":"32766456","golden":false,"offsetInEndSection":1035,"text":"The purpose of this data note is to introduce potential users of the data to the characteristics of the EPDS in ALSPAC, as well as some key considerations when using the data.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1315,"document":"33731441","golden":false,"offsetInEndSection":1608,"text":"For young children under 5 years of age, congenital anomalies, protein-energy malnutrition and diarrhoeal diseases were important causes of YLDs, while childhood behavioural disorders, asthma, anxiety disorders and depressive disorders were important causes for older children and adolescents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1162,"document":"35656347","golden":false,"offsetInEndSection":1681,"text":"Multiple linear regression analysis was performed using the SMFQ score at age 12 as the objective variable and being praised for prosocial behavior as the main explanatory variable, and the SMFQ score at age 10 and the objective prosocial behavior at age 10 were included as confounders.Results: Depressive symptoms (SMFQ scores) in the \"prosocial praise group\" were significantly lower than those in the other group both at age 10 (4.3 ? 4.4 vs. 4.9 ? 4.6, p \u003c 0.001) and at age 12 (3.4 ? 4.2 vs. 4.0 ? 4.6, p \u003c 0.01).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1736,"document":"38278245","golden":false,"offsetInEndSection":2197,"text":"All combinations of cliques (two-, three-, and four-components) were significantly associated with increased log-transformed t-scored CDI (??\u003d?0.14, 95%CI?\u003d?[0.05,0.23], P?\u003c?0.01 for the four-component clique).SIGNIFICANCE: This study offers a new approach to chemical-microbial analysis and a novel demonstration that children with specific gut microbiome cliques and metal exposures during pregnancy may have a higher likelihood of elevated depression scores.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1264,"document":"38278245","golden":false,"offsetInEndSection":1532,"text":"Analyses were adjusted for relevant covariates.RESULTS: We identified a subgroup of children (11.6?% of the sample) characterized by a four-component metal-microbial clique that had a significantly high depression score (15.4?% higher than the rest) in late childhood.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":184,"document":"38278245","golden":false,"offsetInEndSection":716,"text":"However, few, if any, have studied their interacting effect in specific subgroups of children.OBJECTIVES: Using an interpretable machine-learning method, this study investigates whether children with specific combinations of prenatal metals and childhood microbial signatures (cliques or groups of metals and microbes) were more likely to have higher depression scores at 9-11?years of age.METHODS: We leveraged data from a well-characterized pediatric longitudinal birth cohort in Mexico City and its microbiome substudy (n?\u003d?112).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1106,"document":"22574894","golden":false,"offsetInEndSection":1615,"text":"We found evidence for both between- and within-class mediation, suggesting multiple pathways by which SES can affect BMI development.CONCLUSIONS: These findings add to the research that suggests that being in a family with a low SES is associated with falling into patterns of development characterized by early and lasting increases in BMI relative to one\u0027s peers, and that this association is partly accounted for by maternal depression and parenting styles.STATEMENT OF CONTRIBUTION: What is already known?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1533,"document":"38278245","golden":false,"offsetInEndSection":1735,"text":"This metal-microbial clique consisted of high Zinc in the second trimester, low Cobalt in the third trimester, a high abundance of Bacteroides fragilis, a high abundance of Faecalibacterium prausnitzii.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":4114,"document":"35188556","golden":false,"offsetInEndSection":4767,"text":"Among all children in the multiethnic cohort, the integrated model also outperformed the baseline model in estimating the risk of overall suicidal thoughts and behaviors (AUROC, 0.71; 95% CI, 0.67-0.75; accuracy, 0.68) and suicidal ideation (AUROC, 0.75; 95% CI, 0.71-0.78; accuracy, 0.67).Conclusions and Relevance: In this cohort study of preadolescent youths in the US, higher genome-wide polygenic scores for psychiatric disorders, such as attention-deficit/hyperactivity disorder, autism spectrum disorder, posttraumatic stress disorder, and schizophrenia, were significantly associated with a greater risk of suicidal ideation and suicide attempt.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35188556","golden":false,"offsetInEndSection":732,"text":"Importance: Suicide is the second leading cause of death among youths worldwide, but no available means exist to identify the risk of suicide in this population.Objective: To assess whether genome-wide polygenic scores for psychiatric and common traits are associated with the risk of suicide among preadolescent children and to investigate whether and to what extent the interaction between early life stress (a major environmental risk factor) and polygenic factors is associated with suicidal thoughts and behaviors among youths.Design, Setting, and Participants: This cohort study analyzed the genotype-phenotype data of 11?869 preadolescent children aged 9 to 10 years from the Adolescent Brain and Cognitive Development study.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38278245","golden":true,"offsetInEndSection":119,"text":"Prenatal metal exposures and childhood gut microbial signatures are associated with depression score in late childhood.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38278245","golden":false,"offsetInEndSection":74,"text":"BACKGROUND: Childhood depression is a major public health issue worldwide.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":75,"document":"38278245","golden":false,"offsetInEndSection":183,"text":"Previous studies have linked both prenatal metal exposures and the gut microbiome to depression in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1498,"document":"33776389","golden":false,"offsetInEndSection":1681,"text":"Findings also demonstrate that the lower cognitive abilities among children of severely depressed mothers persist beyond childhood and pertain to a broad range of cognitive abilities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1054,"document":"37982311","golden":false,"offsetInEndSection":1715,"text":"Three main findings emerged: (1) parental mental health problems, especially depressive symptoms in mothers, were associated with child developmental delays and mental health problems; (2) better parenting practices and cohesive home environment were positively associated with child development, and (3) Vulnerable social environments (e.g., poverty and housing insecurity) may be linked to child mental health problems.CONCLUSIONS: Studies reviewed show that promoting better family dynamics and increasing family cohesion, as well as parenting abilities, are beneficial to a child\u0027s socio-emotional development and prevention of child mental health problems.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1308,"document":"36420245","golden":false,"offsetInEndSection":1471,"text":"Due to the high level of hostile parenting and low level of positive parenting, they experience stress, peer pressure, and social and family relationship problems.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":733,"document":"36420245","golden":false,"offsetInEndSection":849,"text":"Children exhibit internalizing and externalizing symptoms as a result of harsh, aggressive, and intrusive parenting.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":938,"document":"36420245","golden":false,"offsetInEndSection":1051,"text":"The main reason for the rise in depression in children is the non-cooperation and support of mothers and fathers.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1620,"document":"36786936","golden":false,"offsetInEndSection":1940,"text":"Mothers of infants with a prenatal diagnosis of CHD reported significantly lower rates of life stress despite higher severity of heart defects (p?\u003d?0.02).CONCLUSIONS FOR PRACTICE: Mothers of infants with CHD have similar proportions of resolution to diagnosis compared to mothers of children with other chronic diseases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1155,"document":"36420245","golden":false,"offsetInEndSection":1307,"text":"While family and social stress increase the chances of depression in children, a negative parenting style means children face family and social anxiety.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":675,"document":"35940184","golden":true,"offsetInEndSection":974,"text":"Young people who have a family history of depression, exposure to social stressors (eg, bullying, discordant relationships, or stressful life events), and belong to certain subgroups (eg, having a chronic physical health problem or being a sexual minority) are at especially high risk of depression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35971178","golden":false,"offsetInEndSection":220,"text":"BACKGROUND: Adolescent depression can place a young person at high risk of recurrence and a range of psychosocial and vocational impairments in adult life, highlighting the importance of early recognition and prevention.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1685,"document":"34408674","golden":false,"offsetInEndSection":2079,"text":"Conclusions: This study suggests that among behavioral, environmental, developmental, parent-infant relationship, and mental health variables, a mother\u0027s higher self-efficacy, psychological distress symptoms particularly depression and anger symptoms, symptoms in the child particularly fussing/crying symptoms, and age-inappropriate physical development are associated with higher maternal PS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":88,"document":"34598737","golden":false,"offsetInEndSection":594,"text":"This parallel randomized controlled trial evaluates the effectiveness of the German version of the family-group-cognitive-behavioral (FGCB) preventive intervention for children of depressed parents.METHODS: Families with (i) a parent who has experienced depression and (ii) a healthy child aged 8-17?years (mean?\u003d?11.63; 53% female) were randomly allocated (blockwise; stratified by child age and parental depression) to the 12-session intervention (EG; n?\u003d?50) or no intervention (CG; usual care; n?\u003d?50).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":844,"document":"33431142","golden":false,"offsetInEndSection":1148,"text":"Influenza virus infection was found to be the predominant cause of ILI-related GP visits in all age groups except children under 5, in which respiratory syncytial virus (RSV) infection was found to be the main contributor.CONCLUSIONS: The burden of influenza in terms of GP consultations is considerable.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":233,"document":"33582311","golden":false,"offsetInEndSection":451,"text":"Reestablishing the parent-child relationship can be hindered by the anger, distress, vulnerability, and abuse the child may have experienced during the separation leading to behavioral concerns and depressive symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":479,"document":"33398688","golden":false,"offsetInEndSection":599,"text":"There was no evidence of group differences in AB; neither between the HR and LR children, nor between HD and ND parents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1308,"document":"33227064","golden":false,"offsetInEndSection":1480,"text":"The feeling of stress was positively correlated with anxiety and depression, but there was no significant correlation between psychological elasticity and various symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":609,"document":"26898199","golden":false,"offsetInEndSection":703,"text":"study participants.RESULTS: Twenty-five percent of children had a diagnosis of depression base","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":618,"document":"16534438","golden":false,"offsetInEndSection":810,"text":"Childhood correlates that were particularly relevant for exposure to bullying were parental overcontrol, illness or disability, and the tendency to have an inhibited temperament early in life.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":811,"document":"16534438","golden":false,"offsetInEndSection":1016,"text":"The experience of childhood bullying was strongly related to high levels of comorbid anxiety, both in terms of greater levels of state anxiety and a higher prevalence of both social phobia and agoraphobia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1017,"document":"16534438","golden":false,"offsetInEndSection":1234,"text":"Independent of other childhood risk factors, exposure to bullying was especially predictive of subjects\u0027 higher levels of general state anxiety and the tendency to express anxious arousal externally when under stress.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1881,"document":"36273673","golden":false,"offsetInEndSection":2109,"text":"based treatment outcomes.CONCLUSION: Disproportionate to the magnitude of the problem, there are significant limitations in the quality and quantity of rigorous empirical support for the etiology, assessment, and treatment of de","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17986682","golden":true,"offsetInEndSection":147,"text":"OBJECTIVE: Offspring of parents with major depressive disorder face a threefold higher risk for major depression than offspring without such family","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1504,"document":"17986682","golden":false,"offsetInEndSection":1613,"text":"an in the low-risk group.CONCLUSIONS: Amygdala and nucleus accumbens responses to affective stimuli may refle","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25345238","golden":false,"offsetInEndSection":95,"text":"Suicide is one of the major causes of morbidity and mortality amongst children and adolescents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1804,"document":"35303038","golden":false,"offsetInEndSection":1961,"text":", job presence, and drug use.CONCLUSION: This study identified the factors that drove street children to live on the streets, such as the inability to find w","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":622,"document":"18714913","golden":false,"offsetInEndSection":681,"text":"\"Family conflicts\" was the main stressor reported by 66.7%.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1236,"document":"38190253","golden":false,"offsetInEndSection":1745,"text":"Post-hoc exploratory analyses documented that, relative to maternal PTSD and depression, CPTSD and depression comorbidity was marginally significantly but strongly associated with child internalizing (SMD?\u003d?.67), but not externalizing symptoms (SMD?\u003d?.35).Conclusions: Findings implicate maternal CPTSD and comorbid depression in child socio-emotional development and inform clinical assessment, prevention, and intervention to attenuate poor development among children in unstable post-displacement settings.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38190253","golden":false,"offsetInEndSection":580,"text":"Background: Traumatic stress among forcibly displaced people has a variety of adverse consequences beyond individual mental health, including implications for poor socioemotional developmental outcomes for their children post-displacement.Objective: This study explored the intergenerational transmission of maternal ICD-11 Complex Posttraumatic Stress Disorder (CPTSD) and depression among asylum-seeking mothers for their children\u0027s internalizing and externalizing difficulties.Method: Participants were 127 trauma-affected Eritrean mothers of preschool-aged children in Israel.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":581,"document":"38190253","golden":false,"offsetInEndSection":1000,"text":"The severity of child difficulties was compared between mothers with probable ICD-11 CPTSD (94.5% comorbid depression), ICD-11 PTSD (48.5% comorbid depression), unimorbid depression, and healthy mothers, using multivariate analyses of variance, while controlling for children\u0027s direct exposure to adverse life experiences.Results: Probable ICD-11 CPTSD and PTSD were present in 23.6% and 26.0% of mothers, respectively.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38070866","golden":false,"offsetInEndSection":349,"text":"In recent years, preadolescents have been shown to have higher rates of suicidal thoughts and behaviors (STBs).1 Importantly, children 5 to 11 years old account for 43% of emergency department visits for STBs in the United States.2 Despite the public health implications of STBs, limited research has focused on the longitudinal development of STBs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1001,"document":"38190253","golden":false,"offsetInEndSection":1235,"text":"Relative to maternal PTSD, CPTSD was significantly and strongly associated with elevated child internalizing symptoms (d?\u003d?2.44) and marginally significantly, although strongly, associated with child externalizing symptoms (d?\u003d?1.30).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":136,"document":"36282484","golden":false,"offsetInEndSection":902,"text":"These exceptional measures may have an impact on the mental health of the population.OBJECTIVES: We hypothesize that children with the rheumatological chronic disease might be a population at higher risk of psychological distress.DESIGN: This study evaluated the psychological effect of social distancing in pediatric rheumatological patients and its possible correlation with disease relapse.SETTING: Pediatric patients diagnosed with juvenile idiopathic arthritis (JIA) were included in the study.SUBJECTS AND METHODS: They completed the Multidimensional Anxiety Scale for Children (MASC-2) to assess anxious symptoms, the Children Depression Inventory Self Report (CDI-2 SR) for depression symptoms and a semi-structured questionnaire to collect their activities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":350,"document":"38070866","golden":false,"offsetInEndSection":583,"text":"In this issue of the Journal, Hennefield et?al.3 provide valuable insight into the persistence of preschool-onset major depressive disorder (PO-MDD) and STBs in preadolescents, highlighting opportunities for clinical systems of care.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38190253","golden":false,"offsetInEndSection":128,"text":"Complex posttraumatic stress disorder in intergenerational trauma transmission among Eritrean asylum-seeking mother-child dyads.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":993,"document":"32162065","golden":false,"offsetInEndSection":1265,"text":"Among others, they described an emotional burden (11/37, 30%), and restrictions in school performance (8/37, 22%) and favorite leisure activities (4/37, 11%).Conclusion: School-aged children are well able to describe adverse drug events of their anticonvulsant medication.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1575,"document":"33147746","golden":false,"offsetInEndSection":1732,"text":"From the results, it can be observed that each SCFA which comprises of the SFCAs profile, has a relationship with SIDS and could help in risk identification.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"26353868","golden":true,"offsetInEndSection":157,"text":"INTRODUCTION: Depressive disorders are among the most common psychiatric disorders in children and adolescents, and have adverse effects on their psychosocia","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":207,"document":"9384941","golden":true,"offsetInEndSection":446,"text":"Depression is an important psychiatric disorder in children and adolescents that increases in frequency with age, often coexists with anxiety disorders and behavior disorders, and is associated with long-term morbidity and risk of suicide.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":602,"document":"9384941","golden":false,"offsetInEndSection":836,"text":"Given the significant duration, relapse rate, morbidity, and impaired psychosocial functioning associated with depressive disorders in childhood, further exploration of the natural history and treatment of this condition is warranted.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1075,"document":"29119823","golden":false,"offsetInEndSection":1340,"text":"Mothers with depressive symptoms were more than three times likely to have stunted (odds ratio (OR) 3.15, 95% confidence interval (CI) 1.91-5.18, p value \u003c .001) and underweight (OR 3.26, 95% CI 1.99-5.34, p value \u003c .001) children compared to non-depressed mothers.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":971,"document":"29119823","golden":false,"offsetInEndSection":1074,"text":"Maternal depressive symptoms were significantly associated with children being stunted and underweight.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":545,"document":"24047040","golden":false,"offsetInEndSection":725,"text":"Data were collected on maternal-child interactions, child development, social support, difficult life circumstances, family functioning, child temperament, and parental depression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":390,"document":"29959767","golden":false,"offsetInEndSection":507,"text":"child temperament, depression symptoms, serious life events, family functioning, parental sensitivity and structuring","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":569,"document":"29959767","golden":false,"offsetInEndSection":713,"text":"Results revealed that low (temperamental) soothability and less parental structuring at age 6 predicted increased emotional overeating at age 10","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":656,"document":"36901574","golden":false,"offsetInEndSection":700,"text":"rehabilitation services in the inpatient war","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1437,"document":"36901574","golden":false,"offsetInEndSection":1635,"text":"day preceding the completion of the survey were analyzed based on statistical analysis methods.RESULTS: 73 of the surveyed caregivers (16.08%) suffered from severe anxiety disorders, and 21 (4.63%) ","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38358670","golden":false,"offsetInEndSection":162,"text":"Biological and behavioral pathways from prenatal depression to offspring cardiometabolic risk: Testing the developmental origins of health and disease hypothesis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1132,"document":"38358536","golden":false,"offsetInEndSection":1264,"text":"Traumatic early childhood experiences predispose people to a stress-response system that is more prone to inactivity and impulsivity","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1088,"document":"38358241","golden":false,"offsetInEndSection":1244,"text":"After the management, SG had lower noise decibel values in daytime and nighttime and significantly lower scores of anxiety and depression than CG (P \u003c 0.01)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":801,"document":"38358236","golden":false,"offsetInEndSection":909,"text":"Patients\u0027 anxiety and depression, quality of life and satisfaction degree in the three groups were compared.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1561,"document":"38358187","golden":false,"offsetInEndSection":1605,"text":"Depression and burnout were reported in 42%.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":960,"document":"38358078","golden":false,"offsetInEndSection":1093,"text":"The BPD group also reported more severe depression and anxiety, a higher incidence of childhood trauma, and more negative self-schema","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"11821566","golden":false,"offsetInEndSection":195,"text":"Postnatal depression is one of the most common forms of psychiatric morbidity of child-bearing and causes a host of adverse psychosocial complications to the mother, the children, and the family.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":853,"document":"16034762","golden":false,"offsetInEndSection":1187,"text":"Significant correlations between the CDI score of the children and the STAI or SDS score of the mothers were observed only among children aged 7 to 11 years.CONCLUSIONS: The frequency of depression and anxiety among children with congenital anorectal malformation and that among their mothers was associated with the age of the child.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":196,"document":"11821566","golden":false,"offsetInEndSection":329,"text":"Recent studies have shown that 12% of local women have postnatal depression and most of them receive no meaningful medical attention.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":330,"document":"11821566","golden":false,"offsetInEndSection":472,"text":"The validation of a local version of the Edinburgh Postnatal Depression Scale has made systematic screening for postnatal depression feasible.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2415,"document":"26842307","golden":false,"offsetInEndSection":2765,"text":"Child sex modified the associations of maternal depression with school performance such that maternal depression had a larger negative influence on child school performance for girls compared with boys.CONCLUSIONS AND RELEVANCE: Diagnoses of parental depression throughout a child\u0027s life were associated with worse school performance at age 16 years.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1138,"document":"14685437","golden":false,"offsetInEndSection":1467,"text":"The quality and pattern of the feeding was adequate in only 4 patients.CONCLUSIONS: We conclude that chronic malnutrition is common in childhood CLD and that weight/height values underestimate the degree of acute malnutrition compared with TSF thickness, most likely because of the inflated patient weight caused by organomegaly.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":585,"document":"11821566","golden":false,"offsetInEndSection":683,"text":"Much remains to be done if a reasonable level of post-partum psychological care is to be provided.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":473,"document":"11821566","golden":false,"offsetInEndSection":584,"text":"However, such a screening programme should be backed up by well-resourced counselling and psychiatric services.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"14685437","golden":false,"offsetInEndSection":272,"text":"OBJECTIVE: To characterize the type of malnutrition and to determine the usefulness of anthropometric indices in children with chronic liver disease (CLD).METHODS: 11 children (aged 5 - 105 mo) with CLD underwent anthropometric evaluation when they were clinically stable.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":582,"document":"14685437","golden":false,"offsetInEndSection":844,"text":"The analysis of the 24-hour recall was used to evaluate the quality and pattern of the feeding.RESULTS: The mean weight / age (W/A \u003d -1.18) and height / age (H/A \u003d - 1.26) Z scores were depressed under 1 SD, whereas mean weight / height (W/H) Z score was normal.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":437,"document":"16034762","golden":false,"offsetInEndSection":704,"text":"The psychology of their mothers was assessed by Spielberger\u0027s State-Trait Anxiety Index (STAI) and Zung\u0027s Self-rating Depression Scale (SDS).RESULTS: Depression was more marked in the children aged 12 to 16 years than in those aged 7 to 11 years according to the CDI.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":684,"document":"11821566","golden":false,"offsetInEndSection":818,"text":"Additional funding is required to train nurse counsellors and set up postnatal mental health teams, as well as mother and child units.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":3,"document":"9760380","golden":false,"offsetInEndSection":224,"text":"Despite an 80% increase in prescriptions written for antidepressants for the treatment of pediatric depression, little empirical research has been done on the effects of antidepressant therapy on children and adolescents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1191,"document":"31967198","golden":true,"offsetInEndSection":1514,"text":"The main methods used in suicide attempts were injury by sharp or blunt objects and intentional self-poisoning.CONCLUSIONS: Psychiatric comorbidities and a previous history of disturbances in the family and at school are important factors to consider with relation to suicidal behavior by children with depressive episodes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":457,"document":"31967198","golden":true,"offsetInEndSection":774,"text":"All participants had a history of suicide attempt and were in a depressive episode at the time of assessment.RESULTS: Vulnerabilities related to the children themselves were self-harm, aggression, loss of an important family figure, sexual abuse, sexuality disorders, use of alcohol or other drugs, and ill-treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":620,"document":"36381869","golden":true,"offsetInEndSection":836,"text":"The psychological health effects comprise suicidal tendencies and symptoms of depression which are associated with digital device dependency, screen-time-induced poor sleep quality, and content-influenced negativity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31967198","golden":false,"offsetInEndSection":456,"text":"INTRODUCTION: Child suicidal behavior is related to specific childhood variations, constituting risk factors, including predisposing factors, internal factors, and environmental factors.OBJECTIVE: To characterize suicidal behavior among children aged 5 to 12 years diagnosed with a depressive episode.METHODS: Fifteen participants, aged 5 to 12, were assessed at a child and adolescent mental health center in Belo Horizonte, state of Minas Gerais, Brazil.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1476,"document":"38125276","golden":false,"offsetInEndSection":1767,"text":"These were: parental psychopathology, exposure to parental physical and verbal violence and social and neighbourhood disadvantage.Conclusions: Very young children are exposed to a complex mix of risk factors, which operate at different levels and influence children at different time points.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":192,"document":"36381869","golden":true,"offsetInEndSection":417,"text":"Constant exposure to devices like smartphones, personal computers, and television can severely affect mental health- increase stress and anxiety, for example, and cause various sleep issues in both children as well as adults.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36381869","golden":false,"offsetInEndSection":191,"text":"Dependency on digital devices resulting in an ever-increasing daily screen time has subsequently also been the cause of several adverse effects on physical and mental or psychological health.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":837,"document":"36381869","golden":false,"offsetInEndSection":1056,"text":"Oftentimes it can cause the induction of a state of hyper-arousal, increase stress hormones, desynchronize the body clock or the circadian cycle, alter brain chemistry and create a drag on mental energy and development.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2463,"document":"27697136","golden":false,"offsetInEndSection":2621,"text":"DNBC children with SD and MDD had comorbid anxiety or conduct/oppositional disorders just as frequently, and the degree of functional impairment was the same.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1057,"document":"36381869","golden":false,"offsetInEndSection":1267,"text":"With a focus on brain development in children and detrimental effects in both adults and children, this research article goes on to explore the various aspects of screen addiction and excessive screen exposure.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":620,"document":"1519143","golden":false,"offsetInEndSection":836,"text":"Sixty-one per cent (892) of all cases were of poisoning associated with medication (treatment) and 8% (113) were accidental poisonings, while suicides and parasuicides accounted for 0.2% (3) and 2% (30) respectively.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":837,"document":"1519143","golden":false,"offsetInEndSection":919,"text":"The mortality rate was 6% (2% of deaths were accidental and/or treatment-related).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1083,"document":"1519143","golden":false,"offsetInEndSection":1200,"text":"Treatment consisted mainly of supportive therapy and involved the induction of vomiting with ipecacuanha in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":920,"document":"1519143","golden":false,"offsetInEndSection":1082,"text":"The main reasons for seeking treatment with traditional medicines were for depressed fontanelles and fever in children and diarrhoea and abdominal pain in adults.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":375,"document":"1519143","golden":false,"offsetInEndSection":576,"text":"The majority of patients (53%; 776) were under 5 years of age; 18% (264) were 21-30 years old; the 31-40-year age group accounted for 9.1% (132) of patients, and the 11-20-year age group for 6.7% (97).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1201,"document":"1519143","golden":false,"offsetInEndSection":1282,"text":"This study indicates that the use of traditional medicines is common in Zimbabwe.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":182,"document":"1519143","golden":false,"offsetInEndSection":294,"text":"A total of 1456 cases were recorded, and this represented 23% (the biggest single group) of all poisoning cases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":940,"document":"38275441","golden":false,"offsetInEndSection":999,"text":"Depressed adolescents display reduced cognitive flexibility","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":925,"document":"38247704","golden":false,"offsetInEndSection":1048,"text":"These findings carry significant implications for directing prevention efforts and interventions for adolescent depression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":555,"document":"38245017","golden":false,"offsetInEndSection":965,"text":"We assessed eight interventions for children and young people (aged ?25 years) with low, moderate, and high-to-very-high psychological distress: technology-enabled integrated care, emergency department-based suicide prevention, crisis response service, family education programme, online parenting programme, school-based suicide prevention programme, trauma service for youths, and multicultural-informed care","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38222135","golden":false,"offsetInEndSection":81,"text":"Introduction Young children experiencing head trauma are prone to skull fractures","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":951,"document":"38197473","golden":false,"offsetInEndSection":1068,"text":"This can have a cyclical effect, exacerbating child behavioural difficulties and further increasing parental distress","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1107,"document":"38195450","golden":false,"offsetInEndSection":1226,"text":"The prevalence of pregnant women exhibiting stress, anxiety, and depression symptoms was 11%, 40%, and 16% respectively","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":72,"document":"38180636","golden":false,"offsetInEndSection":165,"text":"It is unknown if social determinants of health (SDOH) influence postpartum symptom typologies","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":239,"document":"38178016","golden":false,"offsetInEndSection":356,"text":"Esketamine, an N-methyl-d-aspartate (NMDA) receptor antagonist, causes less cardiorespiratory depression than opioids","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"38146536","golden":true,"offsetInEndSection":154,"text":"The COVID-19 pandemic was associated with increases in the prevalence of depression, anxiety and behavioural problems among children and youth","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":959,"document":"38358664","golden":true,"offsetInEndSection":1389,"text":"Results suggested that time-specific fluctuations of AP1 (mostly mothers) anxiety/depressive symptoms in infancy (9 months) were indirectly associated with offspring anxiety/depressive symptoms at 11 years via offspring anxiety/depressive symptoms at 4.5 years; time-specific fluctuations of AP1 anxiety/depressive symptoms at child age 11 years were concurrently associated with offspring anxiety/depressive symptoms at 11 years.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1599,"document":"38358664","golden":false,"offsetInEndSection":1758,"text":"Results suggested infancy and early adolescence as developmental periods when children are susceptible to influences of parent anxiety and depressive symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36857050","golden":true,"offsetInEndSection":162,"text":"Importance: Parental intimate partner violence (IPV) and maternal depression are associated with increased risk of depression in children at the population level.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2122,"document":"33192681","golden":true,"offsetInEndSection":2490,"text":"Although paternal concurrent affective symptoms were positively related to more child emotional problems in early adolescence, they did not moderate the association between maternal symptoms and child emotional problems.CONCLUSIONS: Our results indicate that fathers and children seem to be affected only to a small extent by maternal postpartum anxiety or depression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1484,"document":"38358664","golden":false,"offsetInEndSection":1598,"text":"Genetic and prenatal influences measured by BP internalizing problems were not associated with offspring symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1390,"document":"38358664","golden":false,"offsetInEndSection":1483,"text":"AP2 (mostly fathers) anxiety/depressive symptoms were not associated with offspring symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":79,"document":"37294680","golden":false,"offsetInEndSection":1326,"text":"Interventions targeting maternal mental health need to be developed.OBJECTIVE: To determine the feasibility and preliminary effectiveness of the Healthy Mothers Healthy Families-Health Promoting Activities Coaching (HMHF-HPAC) intervention for mothers to improve participation in healthy activities and mental health and to evaluate outcome measures.DESIGN: Nonrandomized controlled pilot feasibility study with one group who received HMHF-HPAC and a control group.SETTING: Pediatric occupational therapy service; on site or telehealth.PARTICIPANTS: Twenty-three mothers completed prequestionnaires; of those, 11 mothers participated in the intervention, and 5 did not (7 withdrew).INTERVENTION: Eleven pediatric occupational therapists were trained to deliver six 10-min sessions of HMHF-HPAC to mothers, integrated into their child\u0027s therapy session or separately via telehealth.OUTCOMES AND MEASURES: Mixed-design analysis of variance explored changes in scores on the Depression Anxiety Stress Scale-21 Items and the Health Promoting Activities Scale.RESULTS: The intervention group reported, on average, significant reductions in depressive symptoms and stress symptoms and significant increases in participation in health-promoting activity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2018,"document":"36857050","golden":false,"offsetInEndSection":2602,"text":"At the individual level, the area under the receiver operating characteristic curve was 0.58 (95% CI, 0.55-0.60) for depression according to the SMFQ and 0.59 (95% CI, 0.55-0.62) for the CIS-R, indicating a 58% to 59% probability (ie, 8%-9% above chance) that a random participant with depression at age 18 years had been exposed to IPV and/or maternal depression compared with a random participant who did not have depression.Conclusions and Relevance: In this cohort study, parental IPV and maternal depression were associated with depression in adolescence at the population level.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":753,"document":"37929632","golden":true,"offsetInEndSection":841,"text":"Reciprocal parental depression was associated with greater psychopathology at age 10-11.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":608,"document":"38358664","golden":false,"offsetInEndSection":835,"text":"Using a trait-state-occasion model with eight assessments from child ages 9 months to 11 years, we partitioned trait-like AP anxiety and depressive symptoms from time-specific fluctuations of AP anxiety and depressive symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1396,"document":"16434782","golden":false,"offsetInEndSection":1729,"text":"Behavioral activation, aggression, worsening depression, anxiety, insomnia, or impulsivity can herald a switch to mania or suicidality.CONCLUSION: Depression in youth is common and treatable and responds best to multimodal treatment combining patient and family education, cognitive behavioral therapy, and antidepressant medication.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1593,"document":"12455925","golden":false,"offsetInEndSection":2022,"text":"Adolescents who scored highly on self-rated depression questionnaires experienced significantly more shared life events and their mothers had significantly higher internalising symptoms than adolescents who scoredwithin the normal range.CONCLUSIONS: The results of this study add to the evidence that the aetiology of depressive symptoms differs by age, with genetic factors becoming more important from childhood to adolescence.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"16434782","golden":false,"offsetInEndSection":314,"text":"PURPOSE: The clinical presentation and neurobiology of depression in youth and its appropriate treatment, as well as strategies for improving therapeutic benefit and preventing adverse outcomes, including suicide, are reviewed.SUMMARY: Functionally impairing depression occurs in 2-10% of children and adolescents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1089,"document":"25174703","golden":true,"offsetInEndSection":1423,"text":"There was also a significant interaction between maternal stress in pregnancy and symptoms of depression in 11-year-old children born SGA.CONCLUSION: Increasing maternal stress during pregnancy was associated with increased risk of symptoms of moderate to severe depression in 11-year-old children, especially those who were born SGA.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1075,"document":"38630744","golden":false,"offsetInEndSection":1504,"text":"In the final regression analysis, female gender [OR \u003d 4.3, p \u003d 0.046], the experience of bullying [OR \u003d 7.96, p \u003d 0.004], difficulty getting along with friends, [OR \u003d 7.5, p \u003d 0.004], history of sexual abuse [OR \u003d 8.1, p \u003d 0.01], and perceived family dysfunction [OR \u003d 4.9, p \u003d 0,023] were found to be independent predictors of depressive disorders.CONCLUSION: Depressive syndromes are a significant health burden in adolescents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":537,"document":"16434782","golden":false,"offsetInEndSection":643,"text":"Risk factors for depression include childhood trauma, genetic susceptibility, and environmental stressors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38630744","golden":false,"offsetInEndSection":484,"text":"BACKGROUND: Depressive disorders, with a prevalence of 15-21%, are among the most common disorders in children and adolescents, and increases the risk of suicide, the second leading cause of death in children aged 10 to 19.AIM: To determine the prevalence and correlates of depressive disorders among senior students attending secondary schools in Abeokuta.METHOD: The study was conducted in five schools randomly selected from a representative sample and was carried out in 2 phases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":760,"document":"16434782","golden":false,"offsetInEndSection":945,"text":"Youth are at risk for the same adverse effects as adults but have an increased risk of behavioral activation, or switch, to mania and suicidal thoughts and behaviors early in treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":315,"document":"16434782","golden":false,"offsetInEndSection":536,"text":"A diagnosis of depression should be considered when a physically healthy child exhibits depressed mood or anhedonia, multiple somatic complaints, or behavioral changes, such as bullying, aggression, and social withdrawal.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1291,"document":"39145898","golden":false,"offsetInEndSection":1590,"text":"There was a significant relationship between MDD score, age, sex, current residency status, and traumatic event exposure, with P values less than 0.001 for all variables.CONCLUSION: Major depressive disorder was highly prevalent among Sudanese children and adolescents included in the present study.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":550,"document":"9232475","golden":false,"offsetInEndSection":683,"text":"implications for the management of clinically depressed children, as well as the prevention of very early-onset depressive disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1777,"document":"30949092","golden":false,"offsetInEndSection":2063,"text":"iven that initial manifestations of depression may occur from a very early age, further and more in-depth research is required into the biological, psychological and social factors that, in an interrelated manner, may explain the appearance, development, and treatment of depression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":161,"document":"19344385","golden":false,"offsetInEndSection":238,"text":"om groups. It is possible that childhood anxiety typically precedes depressio","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23390431","golden":false,"offsetInEndSection":62,"text":"OBJECTIVE: To review recent evidence on child and adolescent d","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":783,"document":"15312818","golden":false,"offsetInEndSection":1143,"text":"The family-based results suggested that the S-allele was preferentially transmitted to depressed children (haplotype-based haplotype relative risk: chi(2) \u003d 7.231 df \u003d 1, p \u003d.007; transmission disequilibrium test: chi(2) \u003d 5.233, df \u003d 1, p \u003d.022).CONCLUSIONS: A role for the 5-HTTLPR locus that needs replication in larger samples is suggested in childhood DD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":177,"document":"1629998","golden":false,"offsetInEndSection":435,"text":"Loss of mother before age 11 years and lack of confiding relationship was found to act as a vulnerability factor whereas employment status and having three or more children aged 14 or under were not found to have an increased vulnerability in these patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":681,"document":"25174703","golden":true,"offsetInEndSection":1088,"text":"Multivariable logistic regression analysis examined the relationship between self-reported symptoms of moderate to severe depression at the age of 11 and explanatory variables.RESULTS: Symptoms of moderate to severe depression were related to increasing maternal stress during pregnancy, young maternal age, lower intelligence test scores at 7-years-old and being bullied at school in the previous 6 months.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":518,"document":"15312818","golden":false,"offsetInEndSection":782,"text":"The same patients were included in the family-based study, which consisted of 41 triads and 11 dyads.RESULTS: An excess of the SS-genotype (p \u003d.025) and of the S-allele (p \u003d.021) was found among DD children (odds ratio \u003d 1.81; 95% confidence interval \u003d 1.12-2.94).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":633,"document":"1573336","golden":false,"offsetInEndSection":798,"text":"Implications of the results are discussed relative to the role of school personnel and the assessment process in recognizing depressive symptoms in students with LD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1362,"document":"26515470","golden":false,"offsetInEndSection":1859,"text":"For example, children whose mothers had low-level depressive symptoms were twice as likely to have clinically elevated internalizing problems compared with children whose mothers never had symptoms of depression.CONCLUSIONS: Children whose mothers experience low-level depressive symptoms early in their development have increased risk for later behavioral problems, suggesting a possible need for new screening and intervention strategies for mothers with lower than clinically elevated symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39145898","golden":false,"offsetInEndSection":188,"text":"BACKGROUND: Tiredness, poor concentration, disturbed sleep and poor appetite can all be caused by depression, which is a common mental disorder and a leading cause of disability worldwide.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1621,"document":"38466416","golden":false,"offsetInEndSection":1978,"text":"What is Known: ? Virtual reality (VR) is increasingly being applied in paediatrics, with benefits in terms of anxiety reduction, improved pain management associated with procedures, as an adjunct to physiotherapy and supporting treatments in autistic spectrum disorder.. ??Safety guidance in relation to VR use, particularly in younger children, is limited.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1979,"document":"38466416","golden":false,"offsetInEndSection":2322,"text":"What is New: ? A systematic review of available literature regarding the safety of VR use via head-mounted display in children under 14 years of age demonstrated limited evidence regarding any potential harms from short exposure to VR.. ? Studies rarely report safety data and adverse side effects are poorly defined, measured and/or reported.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":189,"document":"39145898","golden":false,"offsetInEndSection":633,"text":"This study aimed to assess the prevalence of major depressive disorder, suicidal ideation, and risk factors in Sudanese children and adolescents during the Sudanese army conflict.METHODS: A descriptive cross-sectional community-based study was carried out among Sudanese children between 11 and 17?years old who living in Sudan at the start of the conflict by using a self-administered questionnaire under the guidance of parents, if necessary.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1591,"document":"39145898","golden":false,"offsetInEndSection":1692,"text":"Additionally, suicidal ideation, which requires immediate intervention, was reported to be very high.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":981,"document":"39145898","golden":false,"offsetInEndSection":1290,"text":"Data analysis was performed using Statistical Package for the Social Sciences version 25 software, and descriptive analysis and any appropriate statistical tests were performed.RESULTS: Among the 963 participants, the mean age was 15.18???2.1?years, 65.5% were female, and 67.7% had major depressive disorder.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":332,"document":"14584986","golden":false,"offsetInEndSection":574,"text":"Structural equation modeling revealed that the child\u0027s violence was predicted by the mother\u0027s postnatal depression even when her depression during pregnancy, her later history of depression, and family characteristics were taken into account.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"26515470","golden":false,"offsetInEndSection":312,"text":"OBJECTIVES: Examine the association between mothers\u0027 low- and high-level depressive symptoms in early childhood and children\u0027s behavior problems in middle childhood.METHODS: We used data from 1844 families in a multi-site, longitudinal study beginning when children were 14 months and continuing to age 11 years.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39713865","golden":false,"offsetInEndSection":450,"text":"BACKGROUND: To date, most large surveys on the mental health of children under 11?years old have relied exclusively on data collected from parents and teachers, with no information from children themselves. However, these children are valuable informants despite their young age.OBJECTIVE: To evaluate the effects of adding young children\u0027s self-evaluation of internalizing disorders to a combined teacher/parent-based algorithm using data from a Eur","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33477503","golden":false,"offsetInEndSection":500,"text":"Background. This cross-sectional study aimed to evaluate stress and immune biomarkers in saliva samples of attention-deficit/hyperactivity disorder ADHD compared to healthy non-ADHD children. Material and methods. A total of 132 children under 11 years old (8.5 ? 1.1) enrolled in a cross-sectional study: with confirmed ADHD (n \u003d 60) and healthy controls (n \u003d 72). The clinical evaluation included physical measurements (height, waist, hip circumference, body weight, body mass index BMI, BMI z-scor","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34239334","golden":false,"offsetInEndSection":480,"text":"PURPOSE: This study assessed the psychological distress, life satisfaction, and perceived stress of Ecuadorian teachers who adopted online learning in response to the COVID-19 pandemic. It also aimed to qualitatively report the coping strategies used to maintain their mental health and well-being.METHODS: A web-based cross-sectional survey was conducted from June to mid-August 2020.RESULTS: In total, 394 teachers completed the questionnaire, and from those, 320 also completed","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":238,"document":"31238296","golden":false,"offsetInEndSection":304,"text":"gondii) seropositivity and depression in children and adolescents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":98,"document":"26649557","golden":false,"offsetInEndSection":195,"text":" adolescents. Depression may affect 2% to 8% of children and adolescents, with a peak incidence a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"1891391","golden":false,"offsetInEndSection":474,"text":"Recent years have witnessed accumulating evidence that the disorders subsumed under the heading of childhood depression are much more prevalent than used to be believed; that these conditions in prepubertal youngsters are more similar to those disorders occurring in adolescents and adults than was previously believed; that childhood depression can co-exist with many other childhood conditions; and that, although a rare occurrence, suicide is committed by older children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":430,"document":"16195952","golden":false,"offsetInEndSection":981,"text":"Based on a sample of 414 early adolescents (197 girls), four groups were identified with distinct longitudinal profiles of depressed mood between ages 11 and 14: One group with consistently low levels of depressed mood, another with consistently moderate levels of depressed mood, a third group whose depressed mood increased sharply from late childhood through early adolescence, and a fourth group who already showed clinical-range levels of depressed mood during late childhood and whose depressive feelings increased even slightly more thereafter.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1236,"document":"18308337","golden":false,"offsetInEndSection":1433,"text":"The family environment, including parental divorce or separation and perceived parental support, appears to explain most of the relation between low family income and childhood depressive symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":454,"document":"22299011","golden":false,"offsetInEndSection":672,"text":"as repeated a school year. About 60% of depressed boys aged 6-11 years are referred to child psychiatry services for behavioral difficulties and 71% of boys in this age group have a depressive disorder comorbid with di","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39145898","golden":false,"offsetInEndSection":176,"text":"BACKGROUND: Tiredness, poor concentration, disturbed sleep and poor appetite can all be caused by depression, which is a common mental disorder and a leading cause of disabilit","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":102,"document":"8630499","golden":false,"offsetInEndSection":239,"text":"Unipolar disorder, also termed major depressive disorder, describes the occurrence of depression alone without episodes of elevated mood.","beginSection":"abstract"}],"exact_answer":[],"ideal_answer":[],"id":"63ac45e4c6c7d4d31b000015","type":"list","body":"What are the causes of depression in children under 11?"},{"documents":[{"golden":false,"id":"16967063"},{"golden":false,"id":"17914266"},{"golden":false,"id":"33260979"},{"golden":false,"id":"1573221"},{"golden":false,"id":"4049984"},{"golden":false,"id":"11142392"},{"golden":false,"id":"20824872"},{"golden":false,"id":"18054175"},{"golden":false,"id":"29998801"},{"golden":false,"id":"10642976"},{"golden":false,"id":"25595543"},{"golden":false,"id":"38848614"},{"golden":false,"id":"36789312"},{"golden":false,"id":"26251611"},{"golden":false,"id":"38575221"},{"golden":false,"id":"2255717"},{"golden":false,"id":"37072198"},{"golden":false,"id":"17940743"},{"golden":false,"id":"30466670"},{"golden":false,"id":"21068471"},{"golden":false,"id":"23418727"},{"golden":false,"id":"17028466"},{"golden":false,"id":"11323019"},{"golden":false,"id":"15539813"},{"golden":false,"id":"36330504"},{"golden":false,"id":"30076469"},{"golden":false,"id":"20027710"},{"golden":false,"id":"11387701"},{"golden":false,"id":"3856914"},{"golden":false,"id":"28303389"},{"golden":false,"id":"14633782"},{"golden":false,"id":"17206644"},{"golden":false,"id":"25936488"},{"golden":false,"id":"39561927"},{"golden":false,"id":"39411366"},{"golden":false,"id":"38887767"},{"golden":false,"id":"38486681"},{"golden":false,"id":"39687960"},{"golden":false,"id":"37287118"},{"golden":false,"id":"18322884"},{"golden":false,"id":"19412191"},{"golden":false,"id":"39652376"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":0,"document":"16967063","golden":false,"offsetInEndSection":115,"text":"BACKGROUND: Haemolysis, elevated liver enzymes, and low platelet (HELLP) syndrome is a severe form of preeclampsia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":536,"document":"16967063","golden":false,"offsetInEndSection":745,"text":"Several studies have shown benefits to HELLP patients after administration of corticosteroids.MATERIAL AND METHODS: We have reviewed the literature for this treatment and present a case report as illustration.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":840,"document":"16967063","golden":false,"offsetInEndSection":1095,"text":"We have chosen to review the prospective and randomised studies.RESULTS AND INTERPRETATION: None of the studies show statistically significant differences in maternal morbidity or mortality by administering corticosteroids to patients with HELLP syndrome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1096,"document":"16967063","golden":false,"offsetInEndSection":1298,"text":"Treatment can give a faster increase in the platelet count for patients with platelets \u003c 50 (10(9)/L), but larger trials are needed to support the use of corticosteroids for treatment of HELLP-syndrome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":327,"document":"16967063","golden":false,"offsetInEndSection":461,"text":"There is however a small group of patients in which no arrest or reversal of the HELLP process can be seen after 72 hours post partum.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":422,"document":"17914266","golden":false,"offsetInEndSection":508,"text":"Magnesium sulfate is the drug of choice for the prevention and treatment of eclampsia.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"16967063","golden":false,"offsetInEndSection":54,"text":"[Corticosteroids in the treatment of HELLP-syndrome?].","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":349,"document":"1573221","golden":false,"offsetInEndSection":410,"text":"Six patients were helped by prophylactic Caesarean operation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":509,"document":"17914266","golden":false,"offsetInEndSection":641,"text":"Volume expansion as well as the use of steroids in preeclamptic patients without HELLP syndrome have failed to show any improvement.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":210,"document":"16967063","golden":false,"offsetInEndSection":326,"text":"Women diagnosed with the HELLP-syndrome normally show evidence of recovery within the first 48 hours after delivery.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1427,"document":"38848614","golden":false,"offsetInEndSection":1529,"text":"d eight treated with ASMs.CONCLUSION: ACTH therapy shows the best efficacy and rapid action in patient","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36789312","golden":false,"offsetInEndSection":155,"text":"A man diagnosed as TAFRO syndrome was successfully responded to a novel immunosuppressive regimen containing methylprednisolone and mycophenolate mofetil.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"26251611","golden":false,"offsetInEndSection":119,"text":"This review describes and summarizes the available evidence related to the treatment and management of Barth syndrome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38575221","golden":false,"offsetInEndSection":165,"text":"Proton pump inhibitors (PPIs), swallowed topical corticosteroids (STSs), and dupilumab are highly effective therapies for the treatment of eosinophilic esophagitis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1570,"document":"11323019","golden":false,"offsetInEndSection":1772,"text":"The results of our investigation suggest that the use of dexamethasone in patients with HELLP syndrome is associated with faster regression and lower incidence of complications in comparison to heparin.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1639,"document":"18054175","golden":false,"offsetInEndSection":1889,"text":"For the main outcome of preeclampsia, there was no evidence that women in any of subgroups as preexisting renal disease, preexisting diabetes or hypertension benefited more or less from the use of antiplatelet agents than those in any other subgroup.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":955,"document":"33260979","golden":false,"offsetInEndSection":1161,"text":"Due to the rarity of the disease, the treatment of ES is mostly extrapolated from what is recommended for isolated AIC and mostly relies on corticosteroids, rituximab, splenectomy, and supportive therapies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":933,"document":"28303389","golden":false,"offsetInEndSection":1392,"text":"The definition of steroid resistance was variable in the European centers, but strikingly, the first-line treatment was uniform throughout the centers and included the combination of prednisone plus calcineurin antagonists.CONCLUSION: The variability in the approach of idiopathic nephrotic syndrome is unexpectedly large and affects treatment of the first flare, strategies in the case of steroid dependency, as well as the definitions of steroid resistance.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":232,"document":"30466670","golden":false,"offsetInEndSection":385,"text":"Low-FODMAP diets have been helpful in providing symptom relief, as have cognitive behavioral and mind-body techniques that help patients manage symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":547,"document":"30466670","golden":false,"offsetInEndSection":684,"text":"Newer treatments for IBS-D, such as eluxadoline, and IBS-C, with linaclotide, lubiprostone, plecanatide, also can provide durable relief.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1399,"document":"30076469","golden":false,"offsetInEndSection":1819,"text":"For hospital intervention, IV fluids with 10% dextrose, antiemetics, and analgesics can lessen symptoms while effective sedation in some instances can truncate severe episodes.CONCLUSION: Although management of CVS remains challenging to the clinician, approaches based upon recent literature and accumulated experience with subgroups of patients has led to improved treatment of the refractory and hospitalized patient.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":386,"document":"30466670","golden":false,"offsetInEndSection":546,"text":"Targeted symptomatic relief for the patient\u0027s predominant symptoms provides relief in addition to effective older medications that are inexpensive and reliable.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36330504","golden":false,"offsetInEndSection":125,"text":"Red Breast Syndrome: Complete Resolution Following Replacement of Acellular Dermal Matrices With Acellular Collagen Matrices.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30466670","golden":false,"offsetInEndSection":156,"text":"Irritable bowel syndrome (IBS) is present in patients with symptoms of chronic abdominal pain and altered bowel habits but no identifiable organic etiology.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":195,"document":"15539813","golden":false,"offsetInEndSection":301,"text":"This occurs even though GH deficiency per se is an unlikely explanation for their lack of catch-up growth.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"30466670","golden":false,"offsetInEndSection":54,"text":"Irritable Bowel Syndrome: What Treatments Really Work.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":157,"document":"30466670","golden":false,"offsetInEndSection":231,"text":"Rome IV classification groups patients based on predominant stool pattern.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"15539813","golden":false,"offsetInEndSection":194,"text":"Research during the last decade shows clearly that growth hormone (GH) therapy causes a sustained increase in growth velocity when applied to short children born small for gestational age (SGA).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1194,"document":"15539813","golden":false,"offsetInEndSection":1388,"text":"Future efforts should include studies that better define how GH should be used in the short child born SGA and address more broadly the medical, social and psychological needs of these patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1055,"document":"15539813","golden":false,"offsetInEndSection":1193,"text":"While GH therapy provides a means by which one aspect of the SGA syndrome can be helped, there are other issues for SGA apart from height.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":640,"document":"15539813","golden":false,"offsetInEndSection":779,"text":"Intrauterine growth retardation reflects a variety of etiologies, some of which merit special consideration and may respond variably to GH.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":780,"document":"15539813","golden":false,"offsetInEndSection":937,"text":"The dose of GH used exceeds physiologic replacement and is higher than that commonly used to treat other non-GH-deficient conditions such as Turner syndrome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2731,"document":"39561927","golden":false,"offsetInEndSection":2946,"text":"These results indicate that people with APDS are able to start treatment with leniolisib during adolescence, which may slow the build-up of symptoms and may also have a positive impact on the quality of their lives.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":302,"document":"15539813","golden":false,"offsetInEndSection":550,"text":"In the United States, children born weighing less than -2 SD for gestational age and who show no growth recovery (usually defined as stature persisting below -2 SD at age 2 years) are eligible for GH treatment using doses up to 0.48 mg/kg per week.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1399,"document":"30076469","golden":false,"offsetInEndSection":1575,"text":"For hospital intervention, IV fluids with 10% dextrose, antiemetics, and analgesics can lessen symptoms while effective sedation in some instances can truncate severe episodes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2169,"document":"23418727","golden":false,"offsetInEndSection":2455,"text":" within general health care facilities. For people suffering from local syndromes characterized by loss or sadness, the primary aim for public mental health interventions would be to empower existing social support systems already in place at local levels, and to strengthen social cohe","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":133,"document":"2255717","golden":false,"offsetInEndSection":241,"text":"The syndrome should, however, be explained in clinical terms, its aetiology defined and treatment offered.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":306,"document":"37072198","golden":false,"offsetInEndSection":596,"text":" (ACNES). How is this condition diagnosed? What is the recommended treatment?ANSWER: Anterior cutaneous nerve entrapment syndrome, first described almost 100 years ago, is caused by entrapment of the anterior branch of the abdominal cutaneous nerve as it pierces the anterior rectus abdomin","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":715,"document":"39652376","golden":false,"offsetInEndSection":959,"text":"The findings emphasize the all-encompassing effects of Guillain-Barr? syndrome, illustrating the need for rehabilitation professionals to alleviate uncertainty and foster practices that could facilitate patients\u0027 navigation through the illness.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":613,"document":"19412191","golden":false,"offsetInEndSection":808,"text":"NSAIDs, colchicine and corticosteroids have roles in the treatment of some of these disorders, but biologic drugs that target interleukin-1beta are emerging as consistently effective therapies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":78,"document":"21068471","golden":false,"offsetInEndSection":241,"text":"The syndrome has been given several names such as insulin resistance (IR) syndrome, plurimetabolic syndrome, Reaven\u0027s syndrome, Syndrome X, and the deadly quartet.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":255,"document":"17940743","golden":false,"offsetInEndSection":526,"text":"Elderly and old patients with acute coronary syndrome are still less frequently being referred to percutaneous coronary intervention (PCI) than younger patients, although statistically even octogenarians profit from PCI more than from thrombolysis or purely drug therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":680,"document":"18322884","golden":false,"offsetInEndSection":862,"text":"Despite numerous reviews on this subject, it is very difficult to give general dietary advice to IBS patients, but dietary experts may have a positive role in managing such patients.","beginSection":"abstract"}],"exact_answer":[],"ideal_answer":[],"id":"677e81be592fa4887300001b","type":"factoid","body":"What is the treatment of the helps syndrome?"},{"documents":[{"golden":false,"id":"33763058"},{"golden":false,"id":"34375680"},{"golden":false,"id":"28049484"},{"golden":false,"id":"33781320"},{"golden":false,"id":"34094824"},{"golden":true,"id":"30941303"},{"golden":true,"id":"34113750"},{"golden":false,"id":"31195686"},{"golden":true,"id":"31610841"},{"golden":false,"id":"33673696"},{"golden":true,"id":"31789308"},{"golden":false,"id":"32486160"},{"golden":false,"id":"29861325"},{"golden":false,"id":"31139410"},{"golden":false,"id":"32997278"},{"golden":false,"id":"31578576"},{"golden":false,"id":"37981695"},{"golden":false,"id":"34412685"},{"golden":false,"id":"28659689"},{"golden":false,"id":"28843422"},{"golden":false,"id":"31229353"},{"golden":false,"id":"37256141"},{"golden":false,"id":"34858726"},{"golden":true,"id":"36937957"},{"golden":false,"id":"33239386"},{"golden":false,"id":"36983330"},{"golden":false,"id":"33573914"},{"golden":false,"id":"37154980"},{"golden":false,"id":"32849662"},{"golden":true,"id":"33256900"},{"golden":true,"id":"34097135"},{"golden":false,"id":"27930631"},{"golden":false,"id":"33341289"},{"golden":false,"id":"37528237"},{"golden":true,"id":"34198713"},{"golden":false,"id":"35456250"},{"golden":false,"id":"32671999"},{"golden":false,"id":"32813253"},{"golden":false,"id":"37968136"},{"golden":false,"id":"36384203"},{"golden":false,"id":"38035829"},{"golden":false,"id":"32801727"},{"golden":false,"id":"31951421"},{"golden":false,"id":"31947775"},{"golden":false,"id":"35151842"},{"golden":false,"id":"34830003"},{"golden":false,"id":"35008832"},{"golden":false,"id":"37190280"},{"golden":false,"id":"35848695"},{"golden":false,"id":"35468841"},{"golden":false,"id":"37705357"},{"golden":true,"id":"34935501"},{"golden":false,"id":"36993279"},{"golden":false,"id":"35565307"},{"golden":false,"id":"34840026"},{"golden":false,"id":"36077853"},{"golden":false,"id":"33047234"},{"golden":false,"id":"35919494"},{"golden":false,"id":"37147740"},{"golden":false,"id":"35618140"},{"golden":false,"id":"38099466"},{"golden":true,"id":"29662203"},{"golden":true,"id":"33275678"},{"golden":false,"id":"34777381"},{"golden":false,"id":"38027932"},{"golden":false,"id":"37142568"},{"golden":true,"id":"36599192"},{"golden":false,"id":"37564196"},{"golden":false,"id":"38090582"},{"golden":false,"id":"34687790"},{"golden":false,"id":"32446888"},{"golden":false,"id":"37073129"},{"golden":false,"id":"33031009"},{"golden":false,"id":"17575166"},{"golden":false,"id":"23169344"},{"golden":false,"id":"28624542"},{"golden":false,"id":"28684168"},{"golden":false,"id":"23838315"},{"golden":false,"id":"31649672"},{"golden":false,"id":"37025994"},{"golden":false,"id":"33925883"},{"golden":false,"id":"33746981"},{"golden":false,"id":"37337518"},{"golden":false,"id":"34446084"},{"golden":false,"id":"34253582"},{"golden":false,"id":"34628995"},{"golden":false,"id":"34114161"},{"golden":false,"id":"37958672"},{"golden":false,"id":"38249856"},{"golden":false,"id":"34028069"},{"golden":true,"id":"33992682"},{"golden":false,"id":"36056858"},{"golden":false,"id":"32973759"},{"golden":true,"id":"26349422"},{"golden":false,"id":"27531808"},{"golden":false,"id":"35705114"},{"golden":false,"id":"30126755"},{"golden":false,"id":"31811551"},{"golden":false,"id":"31790025"},{"golden":false,"id":"38217445"},{"golden":false,"id":"38081778"},{"golden":false,"id":"37880478"},{"golden":false,"id":"37868996"},{"golden":false,"id":"37863355"},{"golden":false,"id":"37863088"},{"golden":false,"id":"37821078"},{"golden":false,"id":"37816472"},{"golden":false,"id":"27030986"},{"golden":false,"id":"31244578"},{"golden":false,"id":"30686353"},{"golden":true,"id":"30559740"},{"golden":false,"id":"26562471"},{"golden":false,"id":"28771104"},{"golden":false,"id":"30109179"},{"golden":false,"id":"38168186"},{"golden":false,"id":"29540509"},{"golden":true,"id":"30603741"},{"golden":false,"id":"33815972"},{"golden":false,"id":"32860590"},{"golden":true,"id":"34625231"},{"golden":true,"id":"33062462"},{"golden":true,"id":"38023730"},{"golden":false,"id":"35155252"},{"golden":false,"id":"36185807"},{"golden":false,"id":"33355997"},{"golden":false,"id":"34760690"},{"golden":false,"id":"27860544"},{"golden":false,"id":"31804974"},{"golden":false,"id":"24338745"},{"golden":false,"id":"29451276"},{"golden":false,"id":"32025828"},{"golden":false,"id":"38149027"},{"golden":false,"id":"30181421"},{"golden":false,"id":"33689570"},{"golden":false,"id":"36605213"},{"golden":false,"id":"30701179"},{"golden":false,"id":"25696911"},{"golden":false,"id":"38053567"},{"golden":false,"id":"34990326"},{"golden":false,"id":"32899932"},{"golden":false,"id":"33717171"},{"golden":false,"id":"38201467"},{"golden":false,"id":"34858843"},{"golden":false,"id":"36101937"},{"golden":false,"id":"34145792"},{"golden":false,"id":"34207884"},{"golden":false,"id":"35445870"},{"golden":false,"id":"32731404"},{"golden":false,"id":"38357463"},{"golden":false,"id":"38357207"},{"golden":false,"id":"38356491"},{"golden":false,"id":"38356460"},{"golden":false,"id":"38356024"},{"golden":false,"id":"38355973"},{"golden":false,"id":"38354315"},{"golden":false,"id":"38353855"},{"golden":false,"id":"30629377"},{"golden":false,"id":"32368181"},{"golden":false,"id":"38832424"},{"golden":false,"id":"36714936"},{"golden":false,"id":"39495525"},{"golden":false,"id":"30231350"},{"golden":false,"id":"38588880"},{"golden":false,"id":"24959420"},{"golden":false,"id":"32975147"},{"golden":false,"id":"38669002"},{"golden":false,"id":"31779968"},{"golden":false,"id":"34978693"},{"golden":false,"id":"36466893"},{"golden":false,"id":"35705177"},{"golden":false,"id":"26065479"},{"golden":false,"id":"29312333"},{"golden":false,"id":"24724418"},{"golden":false,"id":"39695851"},{"golden":false,"id":"38551501"},{"golden":true,"id":"39133891"},{"golden":false,"id":"39043633"},{"golden":true,"id":"34572932"},{"golden":true,"id":"36396552"},{"golden":true,"id":"37152812"},{"golden":false,"id":"26587548"},{"golden":true,"id":"29132473"},{"golden":false,"id":"29764159"},{"golden":false,"id":"31502008"},{"golden":false,"id":"38304036"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":0,"document":"34375680","golden":false,"offsetInEndSection":184,"text":"Chimeric antigen receptor (CAR)-T-cell therapy is a promising approach for the treatment of childhood cancers, particularly high-risk tumors that fail to respond to standard therapies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31789308","golden":true,"offsetInEndSection":201,"text":"Chimeric antigen receptor (CAR) T-cell therapy for cancer has achieved significant clinical benefit for resistant and refractory hematological malignancies such as childhood acute lymphocytic leukemia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34113750","golden":true,"offsetInEndSection":346,"text":"Immune-based therapies have now been credentialed for pediatric cancers with the robust efficacy of chimeric antigen receptor (CAR) T cells for pediatric B cell acute lymphocytic leukemia (ALL), offering a chance of a cure for children with previously lethal disease and a potentially more targeted therapy to limit treatment-related morbidities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":489,"document":"29132473","golden":true,"offsetInEndSection":663,"text":"The complete remission rate of pediatric patients with relapse and refractory acute lymphoblastic leukemia can be as high as 90% when treated with CD19-targeting CAR-T cells.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1098,"document":"34375680","golden":false,"offsetInEndSection":1310,"text":"Here, we summarize the different strategies used to maintain CAR-T cells in an early phenotypic stage and present evidence suggesting that this approach may be particularly relevant to treating childhood cancers.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34375680","golden":false,"offsetInEndSection":67,"text":"Early-phenotype CAR-T cells for the treatment of pediatric cancers.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30941303","golden":true,"offsetInEndSection":164,"text":"Chimeric antigen receptor (CAR)-T cell therapy has transformed pediatric oncology by producing high remission rates and potent effects in CD19+ B-cell malignancies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":185,"document":"34375680","golden":false,"offsetInEndSection":278,"text":"CAR-T cells have been highly successful in treating some types of hematological malignancies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":435,"document":"31610841","golden":true,"offsetInEndSection":652,"text":"A commercial CD19 CAR T-cell product has recently been approved as treatment for acute lympho-blastic leukaemia in children and young adults in Denmark, and a non-commercial CAR T-cell production is being established.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":856,"document":"29132473","golden":true,"offsetInEndSection":971,"text":"As to solid tumors, only patients with neuroblastoma present good response to the GD2-targeting CAR-T cell therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2175,"document":"36937957","golden":false,"offsetInEndSection":2552,"text":"The patient remains in remission 3 years after receiving tisagenlecleucel.Conclusion: As conventional chemotherapy and radiation can potentially increase the risk of DNA damage and development of secondary malignancies, CD19 CAR-T therapy (tisagenlecleucel) can be used as a substitute for intensive re-induction chemotherapy and HCT in patients with a germline CHEK2 mutation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32975147","golden":false,"offsetInEndSection":185,"text":"INTRODUCTION: Though 85% of children and young adults with acute lymphoblastic leukemia (ALL) are cured, until recently, the prognosis of relapsed or refractory disease has been dismal.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":522,"document":"36937957","golden":true,"offsetInEndSection":859,"text":"The use of tisagenlecleucel has not been described in patients with CHEK2 mutation.Case Presentation: We describe a case of a pediatric patient with a heterozygous pathogenic germline CHEK2 mutation (c.1100delC; p.Thr367Metfs*15) successfully treated with tisagenlecleucel for relapsed B-ALL to avoid hematopoietic cell transplant (HCT).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34097135","golden":true,"offsetInEndSection":292,"text":"OPINION STATEMENT: Chimeric antigen receptor (CAR) T-cell therapy has become the standard of care for children and young adults with relapsed and refractory B-cell acute lymphoblastic leukemia (B-ALL), and it is a highly promising therapy under investigation for adults with relapsed disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1999,"document":"36937957","golden":false,"offsetInEndSection":2174,"text":"Fifteen months after diagnosis the patient had a relapse of B-ALL (both medullary and extramedullary with blasts in CSF), which was successfully treated with tisagenlecleucel.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1167,"document":"36937957","golden":false,"offsetInEndSection":1272,"text":"He was treated as per Children\u0027s Oncology Group (COG) AALL1131 therapy and achieved a complete remission.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1273,"document":"36937957","golden":false,"offsetInEndSection":1391,"text":"Seven months after diagnosis, he was found to have papillary thyroid carcinoma with no evidence of metastatic disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":346,"document":"36937957","golden":false,"offsetInEndSection":521,"text":"Chimeric antigen receptor-T (CAR-T) cell therapy directed against CD19 antigen (tisagenlecleucel) is a novel cellular therapy for treatment of relapsed/refractory (R/R) B-ALL.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33256900","golden":true,"offsetInEndSection":207,"text":"The introduction of chimeric antigen receptor (CAR) T-cell therapy in acute lymphoblastic leukemia (ALL) has dramatically altered the landscape of treatment options available to children and adults with ALL.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36937957","golden":false,"offsetInEndSection":121,"text":"Case report: Tisagenlecleucel for treatment of relapsed B- acute lymphoblastic leukemia in a patient with CHEK2 mutation.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1044,"document":"37152812","golden":true,"offsetInEndSection":1255,"text":"Furthermore, HER2 CAR T cells provided a significant regression in intracranial DIPG xenograft tumors.Conclusions: HER2 CAR T cells are already in clinic development and are well tolerated in pediatric patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":285,"document":"37152812","golden":false,"offsetInEndSection":747,"text":"Chimeric antigen receptor (CAR) T cell therapy has been identified as a promising new approach in the treatment of DMG tumors; however, additional targets are urgently required given known tumor heterogeneity and the prospect of antigen escape of this cancer.Methods: Using cell surface mass spectrometry, we detected high HER2 cell surface protein across a panel of patient-derived DIPG cells, thereby identifying an existing CAR T cell therapy for use in DIPG.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1174,"document":"36396552","golden":true,"offsetInEndSection":1443,"text":"The co-CAR approach successfully demonstrated the ability to avoid targeting single-antigen-positive targets as a strategy for mitigating on-target off-tumor toxicity.CONCLUSIONS: These data provide further proof of concept for ALK as a neuroblastoma CAR T-cell target.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1256,"document":"37152812","golden":true,"offsetInEndSection":1397,"text":"Here we provide strong preclinical evidence for the inclusion of DIPG patients in future pediatric CNS tumor HER2 CAR T cell clinical trials.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37152812","golden":false,"offsetInEndSection":213,"text":"Background: Diffuse intrinsic pontine glioma (DIPG) and other diffuse midline gliomas (DMG) of the thalamus and spinal cord are rare but devastating high-grade glial tumors of childhood with no curative treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":748,"document":"37152812","golden":false,"offsetInEndSection":1043,"text":"Primary human T cells were transduced to express a second-generation HER2 CAR and interrogated for efficacy against patient-derived DIPG cells.Results: HER2 CAR T cells demonstrated potent and antigen-specific cytotoxicity and cytokine secretion when co-cultured with patient-derived DIPG cells.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37152812","golden":false,"offsetInEndSection":115,"text":"HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine glioma.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35456250","golden":false,"offsetInEndSection":263,"text":"CAR T cell therapy has revolutionized immunotherapy in the last decade with the successful establishment of chimeric antigen receptor (CAR)-expressing cellular therapies as an alternative treatment in relapsed and refractory CD19-positive leukemias and lymphomas.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":340,"document":"36396552","golden":true,"offsetInEndSection":936,"text":"Anaplastic lymphoma kinase (ALK) is expressed in a majority of neuroblastomas at low antigen density but is largely absent from healthy tissues.METHODS: To explore an alternate target antigen for neuroblastoma CAR T-cell therapy, the authors generated and screened a single-chain variable fragment library targeting ALK extracellular domain to make a panel of new anti-ALK CAR T-cell constructs.RESULTS: A lead novel CAR T-cell construct was capable of specific cytotoxicity against neuroblastoma cells expressing low levels of ALK, but with only weak cytokine and proliferative T-cell responses.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":344,"document":"32671999","golden":false,"offsetInEndSection":693,"text":"Chronic myeloid leukemia (CML) is an indolent disease which requires lifelong treatment, is associated with significant side effects, and carries a risk of progression to potentially lethal blast crises.RECENT FINDINGS: Recent advances in molecular biology, virology, and immunology have enabled researchers to grow and modify T lymphocytes ex-vivo.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32671999","golden":false,"offsetInEndSection":171,"text":"BACKGROUND: Myeloid leukemia represents a heterogeneous group of cancers of blood and bone marrow which arise from clonal expansion of hematopoietic myeloid lineage cells.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1217,"document":"32671999","golden":false,"offsetInEndSection":1453,"text":"In this review, we present the recent advances in this field and discuss strategies for future development of myeloid targeting CAR T-cell therapy.CONCLUSIONS: The field of CAR T-cell therapy has rapidly evolved over the past few years.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":694,"document":"32671999","golden":false,"offsetInEndSection":873,"text":"Chimeric antigen receptor (CAR) T-cell therapy has been shown to specifically target cells of lymphoid lineage and induce remission in acute lymphoblastic leukemia (ALL) patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34198713","golden":true,"offsetInEndSection":165,"text":"Chimeric Antigen Receptor (CAR) T-cell therapy has demonstrated high rates of response in recurrent B-cell Acute Lymphoblastic Leukemia in children and young adults.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":274,"document":"32813253","golden":false,"offsetInEndSection":388,"text":"The use of chimeric antigen receptor T cells has been a very successful strategy in some hematologic malignancies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":224,"document":"38035829","golden":false,"offsetInEndSection":429,"text":"Since 2017, several CD19-CAR-T cell therapies have been approved for some CD19-positive B-cell lymphomas/leukemias, as well as CAR-T therapies targeting B-cell maturation antigen(BCMA)for multiple myeloma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":874,"document":"32671999","golden":false,"offsetInEndSection":1035,"text":"While the success of CAR T-cells against ALL is considered a defining moment in modern oncology, similar efficacy against myeloid leukemia cells remains elusive.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"32671999","golden":false,"offsetInEndSection":80,"text":"Finding new lanes: Chimeric antigen receptor (CAR) T-cells for myeloid leukemia.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":271,"document":"37968136","golden":false,"offsetInEndSection":365,"text":"CAR-T therapy has yielded significant improvements in relapsed/refractory B-cell malignancies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":393,"document":"34830003","golden":false,"offsetInEndSection":661,"text":"CAR-T cells have been very effective in hematologic malignancies, such as diffuse large B cell lymphoma (DLBCL), B cell acute lymphoblastic leukemia (B-ALL), and multiple myeloma (MM); however, its effectiveness in treating solid tumors has not been evaluated clearly.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1216,"document":"36384203","golden":false,"offsetInEndSection":1359,"text":"The?in vivo study showed that KDR-CAR-T cells dramatically inhibited the growth of lung cancer KDR-A549 xenografts in BALB/c-nu mice at day 10.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1544,"document":"35848695","golden":false,"offsetInEndSection":1667,"text":"CAR-T cell therapy is approved for management of Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukaemia and lymphoma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37705357","golden":false,"offsetInEndSection":161,"text":"Chimeric Antigen Receptor T-cell (CAR-T cell) therapy has emerged as a groundbreaking immunotherapeutic approach for treating various hematological malignancies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36993279","golden":false,"offsetInEndSection":217,"text":"Chimeric antigen receptor (CAR) T-cell therapy shows unprecedented efficacy for cancer treatment, particularly in treating patients with various blood cancers, most notably B-cell acute lymphoblastic leukemia (B-ALL).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":289,"document":"36077853","golden":false,"offsetInEndSection":629,"text":"The success of CAR-T therapy in the treatment of acute lymphoblastic leukemia (ALL) and other types of blood cancers proved that the immunotherapy is an effective approach in fighting against cancers, yet adverse effects, such as graft versus host disease (GvHD) and cytokine release syndrome (CRS), cannot be ignored for the CAR-T therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34935501","golden":true,"offsetInEndSection":135,"text":"Chimeric antigen receptor T (CAR-T) is a relatively new treatment for pediatric leukemia and has been the focus of recent advancements.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":773,"document":"37705357","golden":false,"offsetInEndSection":891,"text":"This phenomenon poses a significant clinical concern, as it can lead to disease relapse and limited treatment options.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":892,"document":"37705357","golden":false,"offsetInEndSection":1071,"text":"This review explores the mechanisms underlying antigen loss following CAR-T cell therapy, its implications on treatment outcomes, and potential strategies to overcome the problem.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":297,"document":"37705357","golden":false,"offsetInEndSection":476,"text":"While the therapy has shown remarkable efficacy, a significant challenge that has been observed in 30%-70% of patients showing recurrent disease is antigen loss or downregulation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":477,"document":"37705357","golden":false,"offsetInEndSection":635,"text":"We searched PubMed/MEDLINE, EMBASE, and Google scholar for articles on antigen loss/escape following Chimeric antigen receptor T-cell therapy in malignancies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":162,"document":"37705357","golden":false,"offsetInEndSection":296,"text":"CAR-T cells are engineered to express synthetic receptors that target specific antigens on cancer cells, leading to their eradication.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1896,"document":"34840026","golden":false,"offsetInEndSection":2113,"text":"In view of the very small patient numbers with relapsed lymphoma, careful prioritisation is needed to evaluate CAR T-cells in children with Burkitt lymphoma, primary mediastinal B cell lymphoma?and other NHL subtypes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":858,"document":"34840026","golden":false,"offsetInEndSection":1079,"text":"Although the effect is of limited duration in about half of the patients, anti-CD19 CAR T-cells produce high response rates in relapsed/refractory BCP-ALL and this has highlighted previously unknown mechanisms of relapse.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1416,"document":"29662203","golden":true,"offsetInEndSection":1626,"text":"With a cautious multidisciplinary clinical approach, GD2-targeted CAR T cell therapy for H3-K27M+ diffuse gliomas of pons, thalamus and spinal cord could prove transformative for these lethal childhood cancers.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"29662203","golden":false,"offsetInEndSection":86,"text":"Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":102,"document":"36599192","golden":true,"offsetInEndSection":415,"text":"Based on adoptive cellular therapy\u0027s clinical success against childhood leukemia and the preclinical efficacy against pediatric CNS tumors, chimeric antigen receptor (CAR) T cells offer hope of improving outcomes for recurrent tumors and universally fatal diseases such as diffuse intrinsic pontine glioma (DIPG).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"29662203","golden":false,"offsetInEndSection":187,"text":"Diffuse intrinsic pontine glioma (DIPG) and other diffuse midline gliomas (DMGs) with mutated histone H3 K27M (H3-K27M)1-5 are aggressive and universally fatal pediatric brain cancers 6 .","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33275678","golden":true,"offsetInEndSection":196,"text":"As CAR T-cell therapy has advanced in B-cell acute lymphoblastic leukemia, research is now underway to develop similar therapies for other lymphoid and myeloid malignancies for pediatric patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":562,"document":"38027932","golden":false,"offsetInEndSection":667,"text":"In 2017, the FDA approved the first CAR-T for the treatment of B-cell acute lymphoblastic leukemia (ALL).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":527,"document":"29662203","golden":false,"offsetInEndSection":687,"text":"Anti-GD2 CAR T cells incorporating a 4-1BBz costimulatory domain 14 demonstrated robust antigen-dependent cytokine generation and killing of DMG cells in vitro.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":688,"document":"29662203","golden":false,"offsetInEndSection":900,"text":"In five independent patient-derived H3-K27M+ DMG orthotopic xenograft models, systemic administration of GD2-targeted CAR T cells cleared engrafted tumors except for a small number of residual GD2lo glioma cells.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34777381","golden":false,"offsetInEndSection":241,"text":"Chimeric antigen receptor T-cell (CAR-T) therapy has been successful in creating extraordinary clinical outcomes in the treatment of hematologic malignancies including relapsed or refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":486,"document":"34687790","golden":false,"offsetInEndSection":591,"text":"Furthermore, IKZF3 KO had similar effects on the CD133-specific CAR T cells targeting glioblastoma cells.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"33047234","golden":false,"offsetInEndSection":106,"text":"Strategies for having a more effective and less toxic CAR T-cell therapy for acute lymphoblastic leukemia.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":862,"document":"32446888","golden":false,"offsetInEndSection":1243,"text":"In this review we will highlight recent clinical developments of the B cell maturation antigen (BCMA) CAR-T therapy for multiple myeloma (MM) to showcase how innovative CAR designs, coupled with careful selection of tumor-associated antigens, used in combination with other therapeutic agents, could help overcome some of the current limitations experienced in CAR-T immunotherapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":223,"document":"33031009","golden":false,"offsetInEndSection":272,"text":"It treats childhood blood and bone marrow cancer.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":367,"document":"17575166","golden":false,"offsetInEndSection":529,"text":"We determined if T cells grafted with a HER2-specific chimeric antigen receptor (CAR; HER2-specific T cells) recognized and killed HER2-positive medulloblastomas.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23169344","golden":false,"offsetInEndSection":110,"text":"Neuroblastoma is the most common extracranial solid cancer in childhood and the most common cancer in infancy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1505,"document":"23169344","golden":false,"offsetInEndSection":1745,"text":"These results indicated that YB-1 immunization combined with Treg depletion could induce specific T-cell responses against neuroblastoma and could be a potential strategy for the prevention and treatment of neuroblastoma in the early stage.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28624542","golden":false,"offsetInEndSection":84,"text":"BACKGROUND: T-cell acute lymphoblastic leukemia (T-ALL) accounts for about 15% of pe","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":833,"document":"28684168","golden":false,"offsetInEndSection":1009,"text":"In this study we aimed to investigate the potential of siRNNs as therapeutic tools in T-acute lymphoblastic leukemia (T-ALL) using T-ALL cell lines and patient-derived samples.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1010,"document":"28684168","golden":false,"offsetInEndSection":1256,"text":"We demonstrate for the first time that RNAi prodrugs (siRNNs) targeting Plk1, can enter pediatric T-ALL patient cells without a transfection reagent and induce Plk1 knockdown on both protein and mRNA levels resulting in G2/M-arrest and apoptosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":329,"document":"23838315","golden":false,"offsetInEndSection":563,"text":"equired. Immunotherapy with antigen-specific T cells can have antileukemic activity without the toxicities seen with intensive chemotherapy, and therefore represents an attractive strategy to improve the outcome of high-risk patients ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":564,"document":"23838315","golden":false,"offsetInEndSection":793,"text":"ith ALL. We explored the feasibility of generating tumor antigen-specific T cells ex vivo from the peripheral blood of 50 patients with ALL [26 National Cancer Institute (NCI) high-risk and 24 standard-risk] receiving maintenance","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1494,"document":"23838315","golden":false,"offsetInEndSection":1685,"text":"and long-term coculture experiments.CONCLUSION: This study supports the use of immunotherapy with adoptively transferred autologous tumor antigen-specific T cells to prevent relapse and impro","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1581,"document":"38249856","golden":false,"offsetInEndSection":1783,"text":"CAR-T, stem cells, CIKs, and TILs exert antitumor activity and can recognize and could be used to treat lung cancer.Conclusions: Cell therapy represents a novel solution in the treatment of lung cancer.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1479,"document":"33746981","golden":false,"offsetInEndSection":1718,"text":"Here, we will discuss how allogeneic CAR T cells could allow for multivalent approaches and alteration of the tumor microenvironment, potentially allowing the development of next generation therapies for the treatment of patients with GBM.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":125,"document":"37337518","golden":false,"offsetInEndSection":332,"text":"Although CAR T cell therapy has demonstrated therapeutic effects in some subtypes of B cell leukemia or lymphoma, there are many challenges that limit the therapeutic efficacy of CAR T cells in solid tumors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":350,"document":"33746981","golden":false,"offsetInEndSection":523,"text":"CAR T cell therapy is currently being investigated in solid tumors including glioblastoma (GBM), a tumor for which survival has only modestly improved over the past decades.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1078,"document":"34446084","golden":false,"offsetInEndSection":1222,"text":"In addition, we investigate the latest ongoing clinical trials that are applying CRISPR-associated TCR/CAR T-cells for the treatment of cancers.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":127,"document":"33992682","golden":true,"offsetInEndSection":309,"text":"Chimeric antigen receptor T-cell therapy and bispecific antibodies targeting CD19 have shown success for the treatment of pediatric patients with B-cell acute lymphoblastic leukemia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1344,"document":"36056858","golden":false,"offsetInEndSection":1458,"text":"CAR T-cell therapy (chimeric antigen receptors T-cell therapy) is under research and requires further development.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":128,"document":"32973759","golden":false,"offsetInEndSection":208,"text":"Immunotherapy is emerging as an important therapeutic tool for childhood cancer.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":597,"document":"31502008","golden":false,"offsetInEndSection":765,"text":"less likelihood of cytokine storm. Cytotoxicity to solid tumors (rhabdomyosarcoma, Ewing\u0027s sarcoma, neuroblastoma) is seen with graft versus tumor effect in transplant ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1027,"document":"33992682","golden":true,"offsetInEndSection":1262,"text":"Glypican 2 (GPC2) and B7-H3 (CD276) are two cell surface antigens that are expressed by a variety of pediatric tumors such as neuroblastoma and potentially can have a positive impact on the treatment of pediatric cancers in the clinic.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":673,"document":"26349422","golden":true,"offsetInEndSection":980,"text":"In pediatric cancer, monoclonal antibodies have demonstrated efficacy in hematologic malignancies, and neuroblastoma and bispecific antibodies that activate resident T cells, as well as adoptive cell therapy, have shown recent exciting results for the treatment of acute lymphoblastic leukemia in childhood.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":503,"document":"27531808","golden":false,"offsetInEndSection":564,"text":"T lymphocytes are the most potent effective anti-tumor cells.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1119,"document":"35705114","golden":false,"offsetInEndSection":1322,"text":"Among cell-based strategies, the clinically most advanced approach is chimeric-antigen receptor (CAR) T therapy for both pathologies, which is currently under investigation in phase I/II clinical trials.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1180,"document":"30126755","golden":false,"offsetInEndSection":1386,"text":"Immunotherapies, including chimeric antigen receptor-modified T-cells (CAR T-cells) and immune checkpoint inhibitors, are emerging as potentially effective strategies to treat some types of childhood cancer","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":299,"document":"31502008","golden":false,"offsetInEndSection":596,"text":"L15) can enhance NK cell function. NK cell-CAR therapy has advantages of shorter life span that lessens chronic toxicities, lower risk of graft versus host disease when using allogeneic cells, ability of NK cells to recognize tumor cells that have downregulated MHC to escape T cells, and possibly","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38304036","golden":false,"offsetInEndSection":80,"text":"Childhood leukemias in Mexico: towards implementing CAR-T cell therapy programs.","beginSection":"title"},{"endSection":"title","offsetInBeginSection":0,"document":"38217445","golden":false,"offsetInEndSection":191,"text":"Healthcare cost and utilization for chimeric antigen receptor (CAR) T-cell therapy in the treatment of pediatric acute lymphoblastic leukemia: A commercial insurance claims database analysis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1161,"document":"38081778","golden":false,"offsetInEndSection":1263,"text":"expanded NK cells. Phenotypic and transcriptomic properties of TIGIT KO and wild-type (WT) NK cells we","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37880478","golden":false,"offsetInEndSection":157,"text":"Tisagenlecleucel vs. historical standard of care in children and young adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":408,"document":"37868996","golden":false,"offsetInEndSection":569,"text":"We hypothesized that intracellular delivery of an exogenous immunization antigen would activate antigen-specific CD8 T cells and reduce tumors in immunized mice.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":280,"document":"37863355","golden":false,"offsetInEndSection":574,"text":"In March 2023, a group of experts in CAR T cell therapy assembled at the National Institutes of Health in Bethesda, Maryland at the Insights in Pediatric CAR T Cell Immunotherapy: Recent Advances and Future Directions (INSPIRED) Symposium to identify key areas for research for the coming years","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":186,"document":"37863088","golden":false,"offsetInEndSection":297,"text":"We aimed to assess the activity and safety of sequential CD19-directed and CD22-directed CAR T-cell treatments.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37821078","golden":false,"offsetInEndSection":120,"text":"INSPIRED Symposium Part 4A: Access to CAR T Cell Therapy in Unique Populations with B Cell Acute Lymphoblastic Leukemia.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1181,"document":"37816472","golden":false,"offsetInEndSection":1268,"text":"The clinical focus of respondents was HSCT in 71%, followed by leukemia/lymphoma in 24%","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27030986","golden":false,"offsetInEndSection":71,"text":"Neuroblastoma is the commonest extra cranial solid cancer of childhood.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":625,"document":"27030986","golden":false,"offsetInEndSection":724,"text":"Clinical data with early CAR designs directed against GD2 have shown some promise in Neuroblastoma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"29540509","golden":false,"offsetInEndSection":214,"text":"Chimeric antigen receptor (CAR)-T cell therapy has been clinically validated as a curative treatment for the difficult to treat malignancies of relapsed/refractory B-cell acute lymphoblastic leukaemia and lymphoma.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"27030986","golden":false,"offsetInEndSection":125,"text":"An Optimized GD2-Targeting Retroviral Cassette for More Potent and Safer Cellular Therapy of Neuroblastoma and Other Cancers.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":310,"document":"30559740","golden":true,"offsetInEndSection":660,"text":"As a result of complete and durable responses in individuals who are refractory to standard of care therapy, CAR T cells directed against the CD19 protein have been granted United States Food and Drug Administration (FDA) approval as a therapy for treatment of pediatric and young adult acute lymphoblastic leukemia and diffuse large B cell lymphoma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":256,"document":"30686353","golden":false,"offsetInEndSection":507,"text":"A new class of immunotherapy based on a chimeric antigen receptor \"CAR\" targeting the CD19 on the B leukemic cells and that is transduced in an autologous or allogenic T lymphocyte will allow to transform the prognosis of refractory or relapsed B-ALL.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":255,"document":"31244578","golden":false,"offsetInEndSection":417,"text":"This type of adoptive cell immunotherapy has been a breakthrough in the treatment of aggressive B-cell lymphoma and B-cell precursor acute lymphoblastic leukemia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":171,"document":"27030986","golden":false,"offsetInEndSection":345,"text":"Disialoganglioside (GD2) is consistently expressed at high-levels in neuroblastoma tumors, which have been targeted with some success using therapeutic monoclonal antibodies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30686353","golden":false,"offsetInEndSection":139,"text":"CAR T CELLS: CURRENT INDICATIONS IN CHILDREN AND PERSPECTIVES: Acute lymphoblastic leukemia (ALL) is the first cause of cancer in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":141,"document":"30603741","golden":true,"offsetInEndSection":385,"text":"The anti-cluster of differentiation (CD)19 CAR-T cell therapy has been remarkably successful against refractory/relapsed acute lymphoblastic leukemia (ALL), and a complete remission rate as high as 90% was observed, in both children and adults.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":913,"document":"38304036","golden":false,"offsetInEndSection":1121,"text":"In Mexico, leukemias represent around 50% of total cancer diagnosed in pediatric patients, and the rate of relapsed or refractory disease is higher than reported in other countries, a multi-factorial problem.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38304036","golden":false,"offsetInEndSection":72,"text":"Leukemias are the most common type of pediatric cancer around the world.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":410,"document":"30109179","golden":false,"offsetInEndSection":602,"text":"The CAR-T cell has been used predominantly in the treatment of hematological malignancies, including acute lymphoblastic leukemia, chronic lymphocytic leukemia, lymphoma, and multiple myeloma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34625231","golden":true,"offsetInEndSection":193,"text":"Chimeric antigen receptor (CAR) T cell therapy has transformed the treatment for both pediatric and adult patients with relapsed or refractory (R/R) B cell acute lymphoblastic leukemia (B-ALL).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38023730","golden":true,"offsetInEndSection":261,"text":"The treatment landscape for pediatric cancers over the last 11 years has undergone a dramatic change, especially with relapsed and refractory B-cell acute lymphoblastic leukemia (ALL), due to the introduction of chimeric antigen receptor-T (CAR-T) cell therapy.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"32860590","golden":false,"offsetInEndSection":96,"text":"Immunotherapy in Pediatric B-Cell Acute Lymphoblastic Leukemia: Advances and Ongoing Challenges.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32860590","golden":false,"offsetInEndSection":122,"text":"Leukemia, most commonly B-cell acute lymphoblastic leukemia (B-ALL), accounts for about 30% of childhood cancer diagnoses.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1029,"document":"32860590","golden":false,"offsetInEndSection":1210,"text":"In this article, we discuss the clinical biology and treatment of B-ALL with an emphasis on the role of immunotherapy in overcoming the challenges of conventional cytotoxic therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":123,"document":"32860590","golden":false,"offsetInEndSection":255,"text":"While there have been dramatic improvements in childhood ALL outcomes, certain subgroups-particularly those who relapse-fare poorly.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":617,"document":"33355997","golden":false,"offsetInEndSection":704,"text":"This is the first reported case of safe and effective delivery of cardiac BRT in B-ALL.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1211,"document":"32860590","golden":false,"offsetInEndSection":1446,"text":"As immunotherapy continues to move into the frontline of pediatric B-ALL therapy, we also discuss strategies to address unique side effects associated with these agents and efforts to overcome mechanisms of resistance to immunotherapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":862,"document":"36185807","golden":false,"offsetInEndSection":1145,"text":"We explore the use of cell-based therapies, oncolytic virotherapy or immunovirotherapy, immune checkpoint inhibition, and immunomodulatory vaccination strategies, and highlight the recent clinical success of anti-GD2 CAR-T therapy in diffuse intrinsic pontine glioma (DIPG) patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33062462","golden":true,"offsetInEndSection":258,"text":"Chimeric antigen receptor T-lymphocytes (CAR T) targeting the CD19 surface antigen have achieved a breakthrough in the treatment of multiply relapsed and refractory bone marrow (BM) disease in childhood B-cell precursor acute lymphoblastic leukaemia (B-ALL).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1031,"document":"31804974","golden":false,"offsetInEndSection":1169,"text":"These results suggest that EGFR-specific CAR-T cells might be a promising therapeutic strategy in patients with high-EGFR-expressing TNBC.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28771104","golden":false,"offsetInEndSection":182,"text":"Chimeric antigen receptor (CAR) T-cell therapy has recently been recommended for approval for certain B-cell malignancies bringing the approach closer to mainstream cancer treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":346,"document":"27030986","golden":false,"offsetInEndSection":491,"text":"GD2 is also expressed in a range of other cancer but with the exception of some peripheral nerves is largely absent from non-transformed tissues.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":894,"document":"32899932","golden":false,"offsetInEndSection":1107,"text":"In vitro and in vivo studies demonstrated the therapeutic ability of mRNA-engineered T cells in solid tumors, including melanoma, neuroblastoma and ovarian cancer; however, very few clinical trials are registered.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1430,"document":"35445870","golden":false,"offsetInEndSection":1701,"text":"Moreover, disease-free survival was efficiently prolonged.CONCLUSION: These results show that Trop2-targeted CAR T cells equipped with a fully human anti-Trop2 scFv could be a potential treatment strategy for pancreatic cancer and could be useful for clinical evaluation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1122,"document":"38304036","golden":false,"offsetInEndSection":1340,"text":"Although significant progress has been made during the last decades in leukemia diagnosis and treatment, making new therapies available to Mexican patients is a priority, and cell and gene therapies are on the horizon.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1423,"document":"38304036","golden":false,"offsetInEndSection":1654,"text":"This article summarizes a general landscape of childhood leukemias in Mexico, and we give a perspective about the current strategies, advances, and challenges ahead to make gene and cell therapies for leukemia clinically available.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32731404","golden":false,"offsetInEndSection":280,"text":"Novel engineered T cells containing chimeric antigen receptors (CAR-T cells) that combine the benefits of antigen recognition and T cell response have been developed, and their effect in the anti-tumor immunotherapy of patients with relapsed/refractory leukemia has been dramatic.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":73,"document":"38304036","golden":false,"offsetInEndSection":340,"text":"Prognosis has improved during the last decades, and many patients are cured with conventional treatment as chemotherapy; however, many patients still present with a refractory disease requiring additional treatments, including hematopoietic stem cell transplantation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":341,"document":"38304036","golden":false,"offsetInEndSection":489,"text":"Immunotherapy with monoclonal antibodies or cellular therapy is a promising strategy for treating refractory or relapsed hematological malignancies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":66,"document":"38357463","golden":false,"offsetInEndSection":278,"text":"Still, cancer and its therapies are associated with a myriad of long-term complications such that childhood cancer survivors (CCS) endure excess disease burden, morbidity, and mortality throughout their lifetimes","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"38357207","golden":false,"offsetInEndSection":99,"text":"Advances in treatment of childhood malignancies have improved overall cure rates to 80%","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":991,"document":"38356491","golden":false,"offsetInEndSection":1298,"text":"After adjusting for maternal obesity, gestational diabetes, and cigarette smoking, African American women with higher oxidative status were more likely to report higher maternal adverse childhood experience scores (??\u003d?0.16, se?\u003d?1.07, p-value?\u003d?0.024) and depression scores (??\u003d?0.05, se?\u003d?0.02, p?\u003d?0.014)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":342,"document":"38356460","golden":false,"offsetInEndSection":520,"text":"Here, we performed multi-omics analyses of primary leukemia cells and patient-derived xenografts from an acute lymphoblastic leukemia (ALL) patient with ETV6::ACSL6 translocation","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1124,"document":"38356024","golden":false,"offsetInEndSection":1358,"text":"Especially childhood overweight that did not persist into adulthood was associated with an increased risk of disabilities (OR?\u003d?1.82, 95% CI?\u003d?1.26-2.63) and early retirement (OR?\u003d?2.05, 95% CI?\u003d?1.38-3.03) in the postmenopausal group","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":87,"document":"38355973","golden":false,"offsetInEndSection":139,"text":"Previous clinical trials showed that autologous CD34","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":139,"document":"38354315","golden":false,"offsetInEndSection":225,"text":"Here, we applied a life-course approach to analyze the health risks associated with PM","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":488,"document":"38353855","golden":false,"offsetInEndSection":665,"text":"The Swiss Childhood Cancer Survivor Study sent questionnaires to all???5-year LCH survivors registered in the Swiss Childhood Cancer Registry and diagnosed between 1976 and 2015","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":643,"document":"30629377","golden":false,"offsetInEndSection":895,"text":"In this review article, we describe the therapeutic strategies, clinical trial results, side effects and future direction of CAR T cell therapy in B cell acute lymphoblastic leukemia and other pediatric cancers and its future role in the Swiss setting.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32368181","golden":false,"offsetInEndSection":438,"text":"Adoptive cellular therapy with chimeric antigen receptor T cells (car-ts) has recently received approval from Health Canada and the U.S. Food and Drug Administration after remarkable and durable remissions were seen in children with recurrent or refractory leukemia and adults with non-Hodgkin lymphoma-responses that were so impressive that a shift in the paradigm of care has now occurred for children with acute lymphoblastic leukemia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36714936","golden":false,"offsetInEndSection":122,"text":"INTRODUCTION: Acute lymphoblastic leukemia (ALL) is the most common malignancy in childhood, arising from the bone marrow.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2017,"document":"39495525","golden":false,"offsetInEndSection":2557,"text":"A common adverse effect occurring with these T lymphocyte-based therapies is capillary leak syndrome, which is characterized by fluid retention, pulmonary edema, and kidney dysfunction.Conclusions and Relevance: CAR T-cell therapy is an FDA-approved therapy that has improved progression-free survival for multiple myeloma, improved overall survival for large B-cell lymphoma, and attained high rates of cancer remission for other hematologic malignancies such as acute lymphoblastic leukemia, follicular lymphoma, and mantle cell lymphoma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":472,"document":"30629377","golden":false,"offsetInEndSection":642,"text":"Autologous T cells engineered to express a CAR targeting CD19 have shown unprecedented efficacy in clinical trials for relapsed/refractory B-cell leukemias and lymphomas.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38832424","golden":false,"offsetInEndSection":129,"text":"Allogeneic chimeric antigen receptor T cells for children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30629377","golden":false,"offsetInEndSection":159,"text":"Fighting leukemia using the immune system (antibodies, lymphocytes) is an old idea, which has already been fulfilled in allogeneic bone marrow transplantation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":160,"document":"30629377","golden":false,"offsetInEndSection":251,"text":"Indeed, the effectiveness of the transplant depends on the action of the donor lymphocytes.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"30629377","golden":false,"offsetInEndSection":84,"text":"[Recent advances and future directions in CAR-T cell therapy in pediatric oncology].","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":252,"document":"30629377","golden":false,"offsetInEndSection":471,"text":"To limit the adverse effects on bystander organs (graft-versus-host disease), autologous T cells can be engineered to express synthetic chimeric antigen receptors (CARs) with artificially redirected antigen specificity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38588880","golden":false,"offsetInEndSection":207,"text":"Chimeric antigen receptor (CAR) T cell therapy has demonstrated remarkable efficacy in relapsed/refractory (r/r) B cell malignancies, including in pediatric patients with acute lymphoblastic leukemia (ALL).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":756,"document":"30231350","golden":false,"offsetInEndSection":884,"text":"n this review, we summarize the clinical experience with CAR T-cell therapy for pediatric solid tumors, including brain tumors. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":836,"document":"32975147","golden":false,"offsetInEndSection":979,"text":"R T in pediatric patients.EXPERT OPINION: CD19-targeted CARs have demonstrated remarkable response rates and produced durable remissions in ver","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":491,"document":"38304036","golden":false,"offsetInEndSection":664,"text":"articularly, CAR-T cells have shown clinical efficacy in clinical trials, and different products are now commercially approved by regulatory agencies in the USA and Europe. ","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38669002","golden":false,"offsetInEndSection":81,"text":"CAR T-cell therapy: a potential treatment strategy for pediatric midline gliomas.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1294,"document":"38669002","golden":false,"offsetInEndSection":1499,"text":"In vivo research on CAR T-cell therapy for DIPG has yielded encouraging results, but in human trials, the early results have shown potentially fatal side effects and very modest, but fleeting improvements.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":79,"document":"38669002","golden":false,"offsetInEndSection":262,"text":"Diffuse midline glioma (DMG) and diffuse intrinsic pontine glioma (DIPG) are frequently unresectable due to their difficult access location, and 5-year survival remains less than 20%.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":543,"document":"38669002","golden":false,"offsetInEndSection":649,"text":"High levels of expression were detected for both disialoganglioside (GD2) and B7-H3 in pediatric DMG/DIPG.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1168,"document":"38669002","golden":false,"offsetInEndSection":1293,"text":"The initial results of clinical trials show that the outcomes are not highly encouraging as B cell malignancies and myelomas.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38669002","golden":false,"offsetInEndSection":78,"text":"Pediatric brain tumors are the primary cause of death in children with cancer.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":373,"document":"38669002","golden":false,"offsetInEndSection":542,"text":"Immunotherapy using T cells with a chimeric antigen receptor (CAR) that has been genetically engineered is quickly emerging as a new treatment option for these patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34978693","golden":false,"offsetInEndSection":127,"text":"Recently, chimeric antigen receptor (CAR) T-cell therapy has begun to be used for solid tumors such as glioblastoma multiforme.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":225,"document":"39495525","golden":false,"offsetInEndSection":654,"text":"CAR T treatments improve overall survival for patients with large B-cell lymphoma and progression-free survival for patients with multiple myeloma.Observations: Six CAR T-cell products are approved by the US Food and Drug Administration (FDA) for 6 hematologic malignancies: B-cell acute lymphoblastic leukemia, large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, chronic lymphocytic leukemia, and multiple myeloma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":761,"document":"31779968","golden":false,"offsetInEndSection":870,"text":"UCART7 for CD7+ T-cell malignancies is in development for treatment of relapsed T-ALL in children and adults.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39695851","golden":false,"offsetInEndSection":800,"text":"Sarcomas are rare, mesenchymal tumors, representing about 10-15% of all childhood cancers. GD2 is a suitable target for chimeric antigen receptor (CAR) T-cell therapy due to its overexpression in several solid tumors. In this preclinical study, we investigated the potential use of iCasp9.2A.GD2.CAR-CD28.4-1BB? (CAR.GD2) T-cells as a treatment option for patients who have GD2-positive sarcomas and we sought to identify factors shaping hostile tumor microenvironment in this setting. GD2 expression was evaluated by flow-cytometry on primary tumor biopsies of pediatric sarcoma patients. GD2 expression in sarcoma cells was also evaluated in response to an enhancer of zeste homolog 2 (EZH2) inhibitor (Tazemetostat). The antitumor activity of CAR.GD2 T-cells was evaluated both in vitro and in viv","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38551501","golden":false,"offsetInEndSection":900,"text":"PURPOSE: Medulloblastoma (MB), the most common childhood malignant brain tumor, has a poor prognosis in about 30% of patients. The current standard of care, which includes surgery, radiation, and chemotherapy, is often responsible for cognitive, neurologic, and endocrine side effects. We investigated whether chimeric antigen receptor (CAR) T cells directed toward the disialoganglioside GD2 can represent a potentially more effective treatment with reduced long-term side effects.EXPERIMENTAL DESIGN: GD2 expression was evaluated on primary tumor biopsies of MB children by flow cytometry. GD2 expression in MB cells was also evaluated in response to an EZH2 inhibitor (tazemetostat). In in vitro and in vivo models, GD2+ MB cells were targeted by a CAR-GD2.CD28.4-1BB? (CAR.GD2)-T construct, including the suicide gene inducible caspase-9.RESULTS: GD2 was expressed in 82.68% of MB tumors. The SHH","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39133891","golden":true,"offsetInEndSection":850,"text":"Infants with B-cell acute lymphoblastic leukemia (B-ALL) continue to have significantly worse outcomes compared to older children with B-ALL, and those with relapsed or refractory (R/R) infant ALL have especially dismal outcomes with conventional treatment. CD19-targeting chimeric antigen receptor (CAR) T-cell therapy has demonstrated remarkable success in the treatment of R/R childhood B-ALL, though the majority of reports have been in non-infant patients. Barriers to the successful implementation of CAR T-cell therapy in infant B-ALL include challenges related to apheresis, product manufacturing and disease-specific considerations such as lineage switch. We describe our experience utilizing two experimental CD19-CAR T-cell products, SCRI-CAR19 or SCRI-CAR19x22, for 19 patients with R/R infant B-ALL enrolled on three clinical trials. CAR","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39043633","golden":false,"offsetInEndSection":850,"text":"Chimeric antigen receptor (CAR) T-cells targeting Fibroblast Growth Factor Receptor 4 (FGFR4), a highly expressed surface tyrosine receptor in rhabdomyosarcoma (RMS), are already in the clinical phase of development, but tumour heterogeneity and suboptimal activation might hamper their potency. Here we report an optimization strategy of the co-stimulatory and targeting properties of a FGFR4 CAR. We replace the CD8 hinge and transmembrane domain and the 4-1BB co-stimulatory domain with those of CD28. The resulting CARs display enhanced anti-tumor activity in several RMS xenograft models except for an aggressive tumour cell line, RMS559. By searching for a direct target of the RMS core-regulatory transcription factor MYOD1, we identify another surface protein, CD276, as a potential target. Bicistronic CARs (BiCisCAR) targeting both FGFR4 an","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":681,"document":"34572932","golden":true,"offsetInEndSection":912,"text":"In this review, we provide an update of the CAR T cell therapies that are currently being tested in pediatric sarcoma clinical trials, including those targeting tumors that express HER2, NY-ESO, GD2, EGFR, GPC3, B7-H3, and MAGE-A4.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":158,"document":"36396552","golden":false,"offsetInEndSection":322,"text":"target antigens. Promising pre-clinical and clinical data of CAR T-cell activity have emerged from targeting surface antigens such as GD2 and B7H3 in childhood canc","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1119,"document":"37152812","golden":false,"offsetInEndSection":1215,"text":"nial DIPG xenograft tumors.Conclusions: HER2 CAR T cells are already in clinic development and a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":229,"document":"26587548","golden":false,"offsetInEndSection":341,"text":"As a result, cellular and humoral immunotherapy approaches have been investigated for several childhood cancers.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1119,"document":"29132473","golden":false,"offsetInEndSection":1284,"text":"Although the CD19-targeting CAR-T cell therapy for childhood cancer can result in a high remission rate, the relapse rate is high, including CD19+ and CD19- relapse.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":284,"document":"29764159","golden":false,"offsetInEndSection":548,"text":"Moreover, cellular therapeutic approaches including chimeric antigen receptor (CAR) T-cells as well as natural killer (NK) cells have the potential to cure patients with so far incurable malignancies and are the basis for future new therapies for pediatric cancer.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":460,"document":"24959420","golden":false,"offsetInEndSection":592,"text":"T-cell ALL accounts for up to 20% of childhood leukemia but has yet to see a set of high-value immunotherapeutic targets identified.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":840,"document":"31502008","golden":false,"offsetInEndSection":942,"text":"which is suppressive for NK cells. NK cell immunotherapy in childhood cancers is promising and recent ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":490,"document":"38304036","golden":false,"offsetInEndSection":663,"text":"Particularly, CAR-T cells have shown clinical efficacy in clinical trials, and different products are now commercially approved by regulatory agencies in the USA and Europe.","beginSection":"abstract"}],"exact_answer":[["B-cell acute lymphoblastic leukemia B cell acute lymphoblastic leukemia acute lymphoblastic leukemia pediatric midline gliomas diffuse midline glioma (DMG) diffuse intrinsic pontine glioma (DIPG) diffuse midline glioma diffuse intrinsic pontine glioma pediatric sarcomas including osteosarcoma and alveolar rhabdomyosarcomas medulloblastoma childhood B-cell acute lymphoblastic leukemia (B-ALL) rhabdomyosarcoma"]],"ideal_answer":["CAR-T cell therapy has been used in treating childhood cancers such as acute lymphoblastic leukemia (ALL), diffuse midline glioma (DMG), and diffuse intrinsic pontine glioma (DIPG). These therapies have shown promise, particularly in pediatric hematologic malignancies like ALL, where they have achieved high remission rates. However, the application in solid tumors like DMG and DIPG is still in the experimental stages and has shown limited success with significant challenges."],"id":"6593d1f206a2ea257c000018","type":"list","body":"In which childhood cancers has CAR-T cell therapy been used?"},{"documents":[{"golden":true,"id":"28118320"},{"golden":false,"id":"20212937"},{"golden":true,"id":"28845129"},{"golden":false,"id":"36449079"},{"golden":false,"id":"17127789"},{"golden":true,"id":"22527068"},{"golden":false,"id":"19762956"},{"golden":true,"id":"31789702"},{"golden":true,"id":"34150343"},{"golden":true,"id":"30996609"},{"golden":true,"id":"23056769"},{"golden":true,"id":"21659882"},{"golden":false,"id":"9711515"},{"golden":true,"id":"31893041"},{"golden":false,"id":"2456717"},{"golden":false,"id":"30868774"},{"golden":false,"id":"2819581"},{"golden":false,"id":"34038340"},{"golden":true,"id":"26060088"},{"golden":false,"id":"33607856"},{"golden":false,"id":"30759805"},{"golden":false,"id":"31969351"},{"golden":false,"id":"38203566"},{"golden":false,"id":"36591712"},{"golden":false,"id":"34446092"},{"golden":false,"id":"35191410"},{"golden":false,"id":"37424549"},{"golden":false,"id":"14984170"},{"golden":false,"id":"38220445"},{"golden":false,"id":"15675497"},{"golden":false,"id":"37523584"},{"golden":false,"id":"34412948"},{"golden":false,"id":"36352436"},{"golden":false,"id":"36536860"},{"golden":false,"id":"33475605"},{"golden":false,"id":"33287861"},{"golden":false,"id":"31900849"},{"golden":false,"id":"33538544"},{"golden":false,"id":"21355513"},{"golden":true,"id":"35968045"},{"golden":false,"id":"37660388"},{"golden":false,"id":"36302268"},{"golden":false,"id":"34886592"},{"golden":false,"id":"33044242"},{"golden":false,"id":"19579754"},{"golden":false,"id":"36691803"},{"golden":false,"id":"35999433"},{"golden":false,"id":"35019748"},{"golden":false,"id":"37429320"},{"golden":false,"id":"35800816"},{"golden":false,"id":"34623496"},{"golden":false,"id":"36728654"},{"golden":false,"id":"11885408"},{"golden":false,"id":"34706677"},{"golden":false,"id":"34556127"},{"golden":false,"id":"21046397"},{"golden":false,"id":"29536341"},{"golden":false,"id":"32471377"},{"golden":false,"id":"31787739"},{"golden":false,"id":"32364598"},{"golden":false,"id":"36849349"},{"golden":false,"id":"9785746"},{"golden":false,"id":"35177175"},{"golden":false,"id":"33178633"},{"golden":false,"id":"36773942"},{"golden":false,"id":"37810514"},{"golden":false,"id":"33043260"},{"golden":false,"id":"32415489"},{"golden":false,"id":"35920879"},{"golden":false,"id":"35381607"},{"golden":false,"id":"38345975"},{"golden":false,"id":"38333085"},{"golden":false,"id":"38330522"},{"golden":false,"id":"38327256"},{"golden":false,"id":"38304439"},{"golden":false,"id":"38280438"},{"golden":false,"id":"38275320"},{"golden":false,"id":"38257953"},{"golden":false,"id":"38252054"},{"golden":true,"id":"38241655"},{"golden":true,"id":"38241304"},{"golden":false,"id":"38218193"},{"golden":false,"id":"38193658"},{"golden":false,"id":"38150416"},{"golden":false,"id":"38134373"},{"golden":false,"id":"38103692"},{"golden":false,"id":"38079094"},{"golden":false,"id":"17957758"},{"golden":false,"id":"20172274"},{"golden":false,"id":"17250501"},{"golden":false,"id":"29201229"},{"golden":false,"id":"22942104"},{"golden":false,"id":"12560192"},{"golden":false,"id":"10530575"},{"golden":false,"id":"22169780"},{"golden":false,"id":"1021049"},{"golden":true,"id":"1867074"},{"golden":true,"id":"31819560"},{"golden":false,"id":"28143490"},{"golden":true,"id":"22964280"},{"golden":false,"id":"1762591"},{"golden":false,"id":"34215207"},{"golden":false,"id":"20876594"},{"golden":false,"id":"35213629"},{"golden":false,"id":"36190133"},{"golden":true,"id":"11028154"},{"golden":false,"id":"34758222"},{"golden":false,"id":"33816402"},{"golden":false,"id":"37063937"},{"golden":false,"id":"10481961"},{"golden":false,"id":"23318793"},{"golden":false,"id":"3895874"},{"golden":false,"id":"32956076"},{"golden":false,"id":"26118325"},{"golden":false,"id":"11211542"},{"golden":false,"id":"35404292"},{"golden":false,"id":"26984074"},{"golden":false,"id":"38001444"},{"golden":false,"id":"30992228"},{"golden":false,"id":"35094903"},{"golden":false,"id":"38358334"},{"golden":false,"id":"38357933"},{"golden":false,"id":"38357644"},{"golden":false,"id":"38357643"},{"golden":false,"id":"38357545"},{"golden":false,"id":"38357510"},{"golden":false,"id":"38357174"},{"golden":false,"id":"35902218"},{"golden":false,"id":"24168984"},{"golden":false,"id":"14510320"},{"golden":false,"id":"32093381"},{"golden":false,"id":"11099593"},{"golden":false,"id":"37048786"},{"golden":false,"id":"38357132"},{"golden":false,"id":"38356035"},{"golden":false,"id":"38355207"},{"golden":false,"id":"38354362"},{"golden":false,"id":"38353591"},{"golden":false,"id":"38353586"},{"golden":false,"id":"38353160"},{"golden":false,"id":"38352942"},{"golden":false,"id":"38348451"},{"golden":true,"id":"27005713"},{"golden":true,"id":"23419199"},{"golden":true,"id":"30169202"},{"golden":false,"id":"39429081"},{"golden":true,"id":"39090628"},{"golden":true,"id":"38163773"},{"golden":false,"id":"28104185"},{"golden":false,"id":"23034322"},{"golden":false,"id":"25884449"},{"golden":true,"id":"38517573"},{"golden":true,"id":"24003995"},{"golden":false,"id":"16542604"},{"golden":true,"id":"39542423"},{"golden":false,"id":"17515647"},{"golden":false,"id":"30109836"},{"golden":false,"id":"38726020"},{"golden":true,"id":"15497012"},{"golden":false,"id":"30192397"},{"golden":false,"id":"27468879"},{"golden":false,"id":"36999339"},{"golden":true,"id":"37252038"},{"golden":false,"id":"36529894"},{"golden":true,"id":"34852884"},{"golden":false,"id":"36472648"},{"golden":false,"id":"35475418"},{"golden":false,"id":"9294341"},{"golden":true,"id":"31756213"},{"golden":false,"id":"37223064"},{"golden":false,"id":"33632088"},{"golden":false,"id":"34711945"},{"golden":false,"id":"32803355"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":1394,"document":"30169202","golden":false,"offsetInEndSection":1657,"text":"in 455 (39%) of 1181 episodes. Escherichia coli (242 of 1181 [20%]), Staphylococcus aureus (177 of 1181 [15%]), coagulase-negative staphylococci (135 of 1181 [11%]), and Streptococcus pneumoniae (118 of 1181 [10%]) were the most prevalent pathogens in our study, ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":560,"document":"19762956","golden":false,"offsetInEndSection":610,"text":"la pneumoniae. Enterobacter spp. Serratia marscece","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":720,"document":"24003995","golden":false,"offsetInEndSection":810,"text":"and 42 infants, respectively. Coagulase-negative staphylococci (CONS) was the most common ","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"23056769","golden":true,"offsetInEndSection":76,"text":"Entrobacter, the most common pathogen of neonatal septicemia in rasht, iran.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":2500,"document":"30169202","golden":false,"offsetInEndSection":2847,"text":"thy children, and children with comorbidities. Although for most episodes of blood culture-proven bacterial sepsis, no organ dysfunction was seen, presence of organ dysfunction was strongly associated with mortality.FUNDING: Swiss National Science Foundation, Swiss Society of Intensive Care, Bangerter Foundation, Vinetum and Borer Foundation, an","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34150343","golden":true,"offsetInEndSection":154,"text":"Staphylococcus aureus is known to be one of the most common gram-positive microorganisms and an important pathogen associated with sepsis and toxic shock.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1205,"document":"30169202","golden":false,"offsetInEndSection":1393,"text":"000 (133?2-159?6) in neonates. Central line-associated bloodstream infections and primary bloodstream infections accounted for 569 (48%) of 1181 episodes, and organ dysfunction was present","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1696,"document":"31789702","golden":false,"offsetInEndSection":1892,"text":"most common identified pathogen was S. aureus in previously healthy and chronically ill children. In addition, a high proportion of children with sepsis and select chronic diseases had infections ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":891,"document":"30169202","golden":false,"offsetInEndSection":1081,"text":"ed 1096 children to our study. Of 1181 episodes of blood culture-proven bacterial sepsis, 382 (32%) occurred in 379 previously healthy children, 402 (34%) in 391 neonates, and 397 (34%) in 3","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":611,"document":"21659882","golden":true,"offsetInEndSection":840,"text":".4%) were stable on arrival. The most common diagnoses were sepsis with/without meningitis (23, 38.9%) and bacteraemia (14, 23.7%), while the pathogens most frequently isolated were Streptococcus pneumoniae (23, 38.9%) and Neisse","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"30169202","golden":false,"offsetInEndSection":114,"text":"Epidemiology of blood culture-proven bacterial sepsis in children in Switzerland: a population-based cohort study.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1934,"document":"30868774","golden":false,"offsetInEndSection":2274,"text":" bacterial and fungal 3(17%). Remaining 3 (14%) patients death causes include, neutropenic colitis was observed in first patient, second patient died of infection without any identifiable focus, and third patient died due to chemotherapy related toxicity..CONCLUSIONS: Our study concludes that the fungal infection was the most common cause","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34038340","golden":false,"offsetInEndSection":528,"text":"Introduction: Staphylococcus lugdunensis (SL), a tube coagulase negative Staphylococcus, is known to be pathogenic in adults, causing mainly skin infections.Gap Statement: Previous studies assessing SL\u0027s role in paediatric populations are sparse and are mainly limited to case reports.Aim: Present the clinical characteristics consistent with SL infections and its putative role as a pathogen in the paediatric population.Methodology: A retrospective multicentre study was conducted in four paediatric medical centres in Israel.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1361,"document":"34038340","golden":false,"offsetInEndSection":1608,"text":"Two cases of SL growth in blood culture were found in children presenting with signs and symptoms consistent with invasive blood stream infection.Conclusions: In the paediatric population, studied infections caused by SL are increasingly observed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1418,"document":"37252038","golden":false,"offsetInEndSection":1533,"text":"Escherichia coli, Coagulase-negative staphylococci (CoNS) and Staphylococcus aureus were the most common pathogens.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":367,"document":"30759805","golden":false,"offsetInEndSection":457,"text":"Streptococcus pneumoniae (Pneumococcus) remains the most common causative pathogen in CAP.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2414,"document":"38220445","golden":false,"offsetInEndSection":2510,"text":"Conclusions: The common pathogen of BSI-induced severe sepsis in PICU is Gram-negative bacteria.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1634,"document":"31969351","golden":false,"offsetInEndSection":1998,"text":"Overall susceptibility to ampicillin/gentamicin and third-generation cephalosporin were 40% and 37%, respectively, in middle-income countries versus 93% and 91%, respectively, in high-income countries.CONCLUSIONS: EOS in middle-income countries was more likely to be due to Gram-negative pathogens and less likely to be susceptible to empirical antibiotic therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":201,"document":"37424549","golden":false,"offsetInEndSection":324,"text":"As per the associated microbiology, Staphylococcus aureus is the most common microorganism responsible for the cause of IE.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1696,"document":"37252038","golden":false,"offsetInEndSection":1835,"text":"Coverage was improved when vancomycin was included in the regimen, reflecting uncertainty about the empirically targeted pathogen spectrum.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1181,"document":"37252038","golden":false,"offsetInEndSection":1291,"text":"Preterm neonates were the most commonly represented group, and half of infants and children had a comorbidity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1534,"document":"37252038","golden":false,"offsetInEndSection":1695,"text":"At all hospitals, ceftazidime plus amikacin regimen had the lowest coverage, and coverage of amoxicillin plus gentamicin and meropenem were generally comparable.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":331,"document":"34446092","golden":false,"offsetInEndSection":454,"text":"Gram-negative sepsis is more common than gram-positive infection, but sepsis can also be due to fungal and viral pathogens.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37252038","golden":false,"offsetInEndSection":164,"text":"Estimating antibiotic coverage from linked microbiological and clinical data from the Swiss Paediatric Sepsis Study to support empiric antibiotic regimen selection.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1976,"document":"33287861","golden":false,"offsetInEndSection":2148,"text":"Gram positive organisms were the most common pathogens (47%) in septic children supported with ECMO.CONCLUSION: Survival rates of children with sepsis needing ECMO was 59%.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1787,"document":"15675497","golden":false,"offsetInEndSection":2010,"text":"Streptococcus pneumoniae (10, 30.3%) was the most common invasive bacterial pathogen causing sepsis and Escherichia coli (14, 34.2%) was the most common bacterial pathogen causing urinary tract infections, among the cohort.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36352436","golden":false,"offsetInEndSection":148,"text":"BACKGROUND: Among hospitalized children suffering from community-acquired pneumonia, Mycoplasma pneumoniae (MP) is one of the most common pathogens.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1454,"document":"37523584","golden":false,"offsetInEndSection":1517,"text":"(25/30, 83%) and coagulase-negative staphylococci (54/66, 82%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":415,"document":"36536860","golden":false,"offsetInEndSection":687,"text":"Cluster and classification analysis, KEGG pathway enrichment analysis, multidimensional OPLS-DA, Z scores, correlation analysis were used to analyze the metabolites.Results: Escherichia coli (E. coli) was the pathogen that caused the most infection (about 21%) and sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1545,"document":"21355513","golden":false,"offsetInEndSection":1755,"text":"There were 79.7% (n \u003d 51) of infectious episodes with a cotrimoxazole-resistant organism occurring among those on cotrimoxazole prophylaxis.CONCLUSIONS: Escherichia coli was the most frequent bacterial isolate.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1532,"document":"34886592","golden":false,"offsetInEndSection":1757,"text":"In addition, the mortality rate of neonatal sepsis caused by gram-negative bacteria was significantly higher than that caused by gram-positive bacteria (P\u003c0.001).CONCLUSIONS: CoNS was the most common pathogen for EOS and LOS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1174,"document":"33538544","golden":false,"offsetInEndSection":1492,"text":"Both EOS and LOS were independently associated with adverse neonatal outcome.CONCLUSIONS: These data from a large German neonatal cohort confirm neonatal sepsis as the most common cause of morbidity and mortality in VLBW infants, as well as E. coli and coagulase-negative staphylococci as the most prevalent pathogens.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":77,"document":"31900849","golden":false,"offsetInEndSection":265,"text":"Pathogens encountered in neonatal sepsis vary worldwide; reports from developing countries more commonly show Gram negative organisms, most common being Acinetobacter spp., Klebsiella spp.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1292,"document":"37252038","golden":false,"offsetInEndSection":1417,"text":"67% of neonatal sepsis cases were hospital-acquired late-onset whereas in children 76% of infections were community-acquired.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":266,"document":"31900849","golden":false,"offsetInEndSection":287,"text":"and Escherichia coli.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":804,"document":"33475605","golden":false,"offsetInEndSection":869,"text":"Escherichia coli (n\u003d10) was found to be the most common pathogen.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1274,"document":"37429320","golden":false,"offsetInEndSection":1508,"text":"Neonatal clinicians should consider obtaining urine culture in the setting of late-onset sepsis evaluations in VLBW infants.KEY POINTS: ? UTI is a common cause of LOS in VLBW infants.. ? The most common pathogens are Enterococcus spp.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1408,"document":"19579754","golden":false,"offsetInEndSection":1648,"text":"The sepsis-related mortality rates were higher in early-onset sepsis (10%) than in late-onset sepsis (7%).CONCLUSION: Unlike previous reports from Taiwan, in the present study, GBS was found to be the leading pathogen in early-onset sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1051,"document":"33044242","golden":false,"offsetInEndSection":1066,"text":"Klebsiella spp.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":208,"document":"33044242","golden":false,"offsetInEndSection":225,"text":"Enterobacter spp.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":139,"document":"33044242","golden":false,"offsetInEndSection":278,"text":"The major pathogens include Klebsiella pneumoniae, Escherichia coli, Enterobacter spp., Pseudomonas aeruginosa and Acinetobacter baumannii.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":836,"document":"33044242","golden":false,"offsetInEndSection":922,"text":"E. coli is a common infection in immune-competent children, including neonatal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1024,"document":"34623496","golden":false,"offsetInEndSection":1629,"text":"No statistically significant differences were found between patients treated with antibiotics covering streptococci (n?\u003d?60) versus antibiotics covering streptococci and S. aureus (n?\u003d?25) in terms of duration of hospitalisation (median 4 vs 4?days, p?\u003d?0.26), altered antibiotic treatment because of insufficient clinical or biochemical progress (7% vs 12%, p?\u003d?0.41), and abscess recurrence (8% vs 12%, p?\u003d?0.69).CONCLUSION: S. aureus was the predominant pathogen in paediatric CSL at all cervical levels, and even in cases with evidence of primary site infection not normally associated with S. aureus.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1413,"document":"35800816","golden":false,"offsetInEndSection":1540,"text":"Mortality?due to sepsis was 8%.CONCLUSION: ?S. aureus?followed by CONS was found to be the most common cause of sepsis in SNCU.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":823,"document":"37429320","golden":false,"offsetInEndSection":835,"text":"Candida spp.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1484,"document":"33044242","golden":false,"offsetInEndSection":1700,"text":"and A. baumannii largely cause hospital-acquired infections with experimental vaccines limited to phase 1 research.SUMMARY: The current immunization pipelines for the most prevalent GNB are years away from licensure.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2041,"document":"34706677","golden":false,"offsetInEndSection":2340,"text":"A significant number of gram-positive bacteria showed resistance to vancomycin.CONCLUSION: The study findings show a high proportion of neonatal sepsis among neonates admitted to hospitals in Sana\u0027a city with antibiotic-resistant B. cepacia being the single most common pathogen causing EOS and LOS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1257,"document":"33044242","golden":false,"offsetInEndSection":1325,"text":"P. aeruginosa is a common pathogen in patients with cystic fibrosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"29536341","golden":false,"offsetInEndSection":183,"text":"BACKGROUND: Coagulase-negative staphylococci (CoNS) are the most common cause of late-onset sepsis in the neonatal intensive care unit (NICU) and usually require vancomycin treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21046397","golden":false,"offsetInEndSection":135,"text":"Coagulase-negative staphylococci (CoNS) are the most common cause of biofilm-associated sepsis in very low birth weight infants (VLBW).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":797,"document":"32471377","golden":false,"offsetInEndSection":1092,"text":"Multivariable logistic regression showed that significant predictors of mortality were birth weight?\u003c?1500?g, respiratory distress and convulsions.CONCLUSIONS: Gram-negative organisms have an important role in LOS in our region, with high levels of resistance to third-generation cephalosporins.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":139,"document":"35019748","golden":false,"offsetInEndSection":369,"text":"The most frequently encountered paediatric oncological emergencies include neutropenic sepsis, hyperleukocytosis, brain tumours presenting with raised intracranial pressure, tumour lysis syndrome and superior mediastinal syndrome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1509,"document":"37429320","golden":false,"offsetInEndSection":1648,"text":"and E. coli.. ? UTI risk varies among different VLBW infant populations.. ? Next steps should include evaluation of preventative measures..","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37810514","golden":false,"offsetInEndSection":177,"text":"Retracted: Analysis of the Relevant Vital Signs and Infection of Sepsis Patients and to Explore the Influencing Factors of Acute Lung Injury/Acute Respiratory Distress Syndrome.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1217,"document":"35381607","golden":false,"offsetInEndSection":1774,"text":"No clinical variables were associated with true bacteremia on multivariable analysis.CONCLUSION: ?Diagnosis should definitely be based on at least two positive BCs, despite objective difficulties in obtaining BCs in neonates.KEY POINTS: ? CoNS is a frequent pathogen causing LOS in neonates.. ? Due to technical difficulties, often only one culture is collected prior to antibiotic therapy.. ? No clinical/laboratory variables were associated with the diagnosis of true CoNS bacteremia.. ? Diagnosis should definitely be based on at least two positive BCs..","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"38345975","golden":false,"offsetInEndSection":101,"text":"Bloodstream infections (BSI) represent a common cause of sepsis and mortality in children","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1348,"document":"38333085","golden":false,"offsetInEndSection":1407,"text":"The most common pathogens identified in urine culture were ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"38330522","golden":false,"offsetInEndSection":92,"text":"Neonatal sepsis is responsible for significant morbidity and mortality worldwide","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":420,"document":"38327256","golden":false,"offsetInEndSection":590,"text":"A working group comprised of infection specialists, hepatologists and histopathologists met virtually to review the cases, presentation, investigations and histopathology","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38304439","golden":false,"offsetInEndSection":190,"text":"We describe the case of an infant who presented with simple rhinovirus/enterovirus bronchiolitis whose condition worsened with rapid progression to multiple organ dysfunction syndrome (MODS)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"38280438","golden":false,"offsetInEndSection":210,"text":"Implementation of water-less care, including removal of sinks from patient care areas, is an emerging approach to reduce water-borne infections in high-risk areas such as intensive care units (ICUs)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38275320","golden":false,"offsetInEndSection":54,"text":"The frequently multidrug-resistant bacterial pathogen ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38257953","golden":false,"offsetInEndSection":191,"text":"Coagulase-negative staphylococci (CoNS) are commensal on human body surfaces and, for years, they were not considered a cause of bloodstream infection and were often regarded as contamination","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":558,"document":"38252054","golden":false,"offsetInEndSection":627,"text":"Herein, we report the first case of bloodstream infection caused by C","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38241655","golden":false,"offsetInEndSection":132,"text":"High Incidence Rates of Early-onset Bacterial Sepsis in Infants Born in Two Brazilian Maternities: A 15-year Retrospective Analysis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":2325,"document":"38241304","golden":false,"offsetInEndSection":2450,"text":"Research into hospital based novel treatment and prevention interventions for neonatal sepsis should be urgently prioritized.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1965,"document":"38218193","golden":false,"offsetInEndSection":2219,"text":"The most common clinical syndromes among deaths with K pneumoniae in the causal chain were sepsis (44%, 95% CI 40-49; 221 of 2352 deaths), sepsis in conjunction with pneumonia (19%, 16-23; 94 of 2352 deaths), and pneumonia (16%, 13-20; 80 of 2352 deaths)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":200,"document":"38193658","golden":false,"offsetInEndSection":287,"text":"from blood cultures, may offer clinical benefit. We assessed this approach in compariso","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":14,"document":"38150416","golden":false,"offsetInEndSection":189,"text":"Greater than half of in-hospital maternal deaths are caused by sepsis, a condition that occurs when infection exceeds local tissue containment and results in organ dysfunction","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":756,"document":"38134373","golden":false,"offsetInEndSection":935,"text":"Gram-positive bacteria were the predominant pathogens (54.5%), with coagulase-negative Staphylococci accounting for 45.3% of the cases, followed by gram-negative organisms (37.3%)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":860,"document":"38103692","golden":false,"offsetInEndSection":969,"text":"Coagulase-negative staphylococci were the most common infecting organisms of all CLABSI episodes (N\u003d100, 63%)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1270,"document":"38079094","golden":false,"offsetInEndSection":1347,"text":"Paediatric cases frequently reported issues with sepsis screening tools (26%)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17957758","golden":false,"offsetInEndSection":222,"text":"A paediatric oncology patient presented with central line sepsis caused by Vibrio harveyi, a gram negative bioluminescent marine bacterium known to be pathogenic to fish and marine invertebrates, after swimming in the sea.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1220,"document":"17250501","golden":false,"offsetInEndSection":1542,"text":"Sepsis as a result of Gram-negative pathogens (especially K. pneumoniae) were involved in outbreaks that occurred for a few years during the study interval.CONCLUSIONS: The major outcome of this review was the emergence of CONS in the NICU during a relatively short period of time (10 years) as a common neonatal pathogen.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"17957758","golden":false,"offsetInEndSection":45,"text":"Vibrio harveyi sepsis in a child with cancer.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1318,"document":"20172274","golden":false,"offsetInEndSection":1461,"text":"The most common pathogens were Staphylococcus spp and Enterococcus spp, similar to etiologies of sepsis among children in intensive care units.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1266,"document":"22942104","golden":false,"offsetInEndSection":1529,"text":"Of all Gram-negative organisms, 47%, 37% and 32% were resistant to third-generation cephalosporins, gentamicin or both, respectively.CONCLUSIONS: The pattern of EOS in Asian settings is similar to that in industrialised countries with low incidence of GBS sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":575,"document":"1021049","golden":false,"offsetInEndSection":633,"text":"The main pathogene of sepsis at present is staphylococcus.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":574,"document":"1867074","golden":false,"offsetInEndSection":701,"text":"Klebsiella was the most common organism causing NC sepsis, others being Staphylococcus aureus (15%) and Serratia species (15%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"29201229","golden":false,"offsetInEndSection":132,"text":"Staphylococcus aureus (S. aureus) is one of the most frequently isolated pathogens in neonatal cases of early and late-onset sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1129,"document":"17250501","golden":false,"offsetInEndSection":1219,"text":"The pathogen associated with the highest mortality was Klebsiella pneumoniae (25%, 10/39).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"12560192","golden":false,"offsetInEndSection":120,"text":"Adenovirus is increasingly being recognised as a significant pathogen in children following bone marrow transplantation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1240,"document":"22964280","golden":false,"offsetInEndSection":1533,"text":"Overall, apnea and/or bradycardia and/or cyanosis (65.8%), poor activity (48.7%), and increased respiratory effort (43.0%) were the most common presenting features of sepsis.CONCLUSION: Unlike term infants, Gram-negative organism and E coli were the leading pathogen of EOS among VLBW infants.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":921,"document":"20172274","golden":false,"offsetInEndSection":1096,"text":"The most common Gram-positive pathogens were Staphylococcus spp and Enterococcus spp; the Gram-negative pathogens were Klebsiella spp followed by Enterobacter spp and E. coli.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1580,"document":"31819560","golden":false,"offsetInEndSection":1865,"text":"An extended-spectrum ?-lactamase producer was identified in 37.3% of E. coli and 50.4% of K. pneumoniae.CONCLUSION: K. pneumoniae was the most frequent pathogen in culture-proven NS in South China, primarily associated with LOS in preterm, whereas GBS was the dominant pathogen in EOS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":557,"document":"28143490","golden":false,"offsetInEndSection":1174,"text":"Gram-positive cocci exhibited a higher penicillin resistance rate and full vancomycin sensitivity, whereas Gram-negative bacilli exhibited a higher cephalosporin resistance rate, low meropenem resistance rate (6.7%), and no resistance to amikacin.CONCLUSIONS: The main causative pathogens of NS in our hospital were Gram-positive cocci, among which coagulase-negative Staphylococcus spp such as S. epidermidis and S. haemolyticus were the main conditional pathogens; among Gram-negative pathogens, Klebsiella pneumoniae were most frequently isolated and showed widespread resistance to penicillins and cephalosporins.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":851,"document":"20172274","golden":false,"offsetInEndSection":920,"text":"Also, 19% of children displayed polymicrobial bloodstream infections.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1187,"document":"20172274","golden":false,"offsetInEndSection":1317,"text":"There was no difference in the incidence of catheter-related blood stream infection according to the primary underlying diagnosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":323,"document":"20172274","golden":false,"offsetInEndSection":551,"text":"The aim of this retrospective analysis was to investigate the rate and the epidemiologic profile of septicemia in the patient group at greatest risk, namely, children less than 1 year of age with IF on parenteral nutrition (PN).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":949,"document":"34215207","golden":false,"offsetInEndSection":1005,"text":"(82/262, 31%) and Klebsiella pneumoniae (38/262, 14.5%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1973,"document":"34215207","golden":false,"offsetInEndSection":2179,"text":"Early (7-day mortality) and late mortality rate (30-day mortality) were 10 and 3.4%, respectively.CONCLUSIONS: The emergence of MDR gram-negative BSI is a significant healthcare problem in oncology centers.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1695,"document":"38345975","golden":false,"offsetInEndSection":2180,"text":"The lower volume of blood inoculated into culture bottles hardly affected the growth of most bacteria, but optimized PF Plus resin-bottles accelerated the detection of infectious agents, especially S. aureus, Streptococcus pneumoniae, and C. glabrata.CONCLUSIONS: It is possible to enhance recovery from antibiotic-containing pediatric bottles and shorten TTD for the identification of pathogens by using the BacT/Alert blood culture system combination with new resin-containing media.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1441,"document":"35213629","golden":false,"offsetInEndSection":1964,"text":"Mortality was associated with low body temperature, tachycardia, respiratory symptoms, convulsions, history of difficult feeding, movement only when stimulated or reduced level of consciousness, diarrhea and/or vomiting.CONCLUSION: While Klebsiella pneumonia and Staphylococcus aureus, as well as Escherichia coli were pathogens most frequently identified in infants with clinical suspicion of serious invasive infections, most cases remain without definite diagnosis, making more accurate diagnostic tools urgently needed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2180,"document":"34215207","golden":false,"offsetInEndSection":2306,"text":"The high proportion of the most frequently isolated pathogens were CR and ESBL-producing Enterobacterales and Pseudomonas spp.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1691,"document":"34758222","golden":false,"offsetInEndSection":2017,"text":"Gram-negative bacteria had a high level of resistance to 3rd generation cephalosporins, but both Gram-positive and negative bacteria were susceptible to ciprofloxacin.CONCLUSIONS: S. aureus, CoNS, S. pneumoniae, Klebsiella spp and E. coli remain the most important bacteria responsible for bloodstream infection in this study.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1289,"document":"37063937","golden":false,"offsetInEndSection":1672,"text":"Antepartum exposure to cephalosporins (OR\u003d25.191, 95% CI: 3.184-199.326, P\u003c0.01) and parenteral nutrition for more than 1 week (OR\u003d4.495, 95% CI: 2.009-10.055, P\u003c0.01) were independent risk factors for neonatal infection with ESBL-producing stains among infants with E. coli sepsis.Conclusion: E. coli remains the most common Gram-negative bacterial pathogen causing neonatal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1941,"document":"33816402","golden":false,"offsetInEndSection":2056,"text":"Conclusion: GBS was the most common causative pathogens in EOS, but E. coli dominated in infants with GA \u003c28 weeks.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":946,"document":"38345975","golden":false,"offsetInEndSection":1378,"text":"The usefulness of a diagnosis to confirm or exclude BSI was evaluated by lower than recommended blood culture sampling (102 CFU/mL, 0.3 mL).RESULTS: Staphylococcus aureus (S. aureus), and Candida glabrata (C. glabrata) were recovered from 100% of two types of resin-containing bottles in the presence of a sufficient antibiotic dose, while Escherichia coli (E. coli) was not restored to 100% in BD FX400 peds plus pediatric bottles.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1142,"document":"10481961","golden":false,"offsetInEndSection":1178,"text":"and Proteus mirabilis, respectively.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":431,"document":"10530575","golden":false,"offsetInEndSection":625,"text":"The study showed that the traditionally known acute respiratory infection pathogen Streptococcus pneumoniae was most common in this extended neonatal age group, found in 10 of 41 blood isolates.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":718,"document":"23318793","golden":false,"offsetInEndSection":915,"text":"Furthermore, we show that Pep19-2.5 can bind and neutralize not only endotoxins but also other bacterial pathogenicity factors, such as those from the Gram-positive bacterium Staphylococcus aureus.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1479,"document":"22169780","golden":false,"offsetInEndSection":1611,"text":"12 (2%).CONCLUSIONS: A high burden of omphalitis can be associated with sepsis among newborns in low-income communities in Pakistan.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1596,"document":"38358334","golden":false,"offsetInEndSection":1671,"text":"There was 1 possibly related death (sepsis with attendant hepatic failure).","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38357933","golden":false,"offsetInEndSection":20,"text":"Race against dengue.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1205,"document":"38357644","golden":false,"offsetInEndSection":1254,"text":"The data analysis involved 22,633 sepsis patients","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":804,"document":"38357643","golden":false,"offsetInEndSection":908,"text":"In the studied cohort of 32,971 sepsis patients, 2,327 were identified as meeting the inclusion criteria","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":271,"document":"38357545","golden":false,"offsetInEndSection":299,"text":"nosuppression and substantia","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1525,"document":"38357510","golden":false,"offsetInEndSection":1639,"text":"Pulmonary hemorrhage, tension pneumothorax and early onset sepsis were independent risk factors for high-grade IVH","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":212,"document":"38357174","golden":false,"offsetInEndSection":393,"text":"In retrospective observational study, during October 2019 to December 2021, 145 patients with septic shock treated in our hospital were enrolled by the method of observational study","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1099,"document":"35902218","golden":false,"offsetInEndSection":1286,"text":"Two deaths were reported, both in term infants (Proteus mirabilis and E. coli).CONCLUSION: In neonates ?34 WG born in the Paris area, GBS was twice as frequent as E. coli in term infants.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":884,"document":"11099593","golden":false,"offsetInEndSection":1427,"text":"The very low frequency of fulminant sepsis caused by coagulase-negative staphylococci did not increase during the period when oxacillin was used instead of vancomycin as the empiric antibiotic for Gram-positive organisms.CONCLUSIONS: These data suggest that empiric antibiotics selected for treatment of suspected sepsis in infants \u003e3 days old need to effectively treat Gram-negative pathogens, particularly Pseudomonas sp., because these organisms, although less frequent, are strongly associated with fulminant late-onset sepsis in the NICU.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1436,"document":"24168984","golden":false,"offsetInEndSection":1664,"text":"Morbidity and mortality rates of infants with EOS caused by CoNS were similar to those of infants with EOS caused by other pathogens.CONCLUSIONS: VLBW infants with EOS are at an increased risk of mortality and major morbidities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":881,"document":"26984074","golden":false,"offsetInEndSection":1090,"text":"Additionally, 87.5% of the isolated K. pneumoniae strains were resistant to third generation cephalosporins.CONCLUSION: Coagulase-negative staphylococci were the most common pathogens found in neonatal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1287,"document":"35902218","golden":false,"offsetInEndSection":1395,"text":"EOS was six times more frequent in late preterm than in term infants and was due to E. coli in 60% of cases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35902218","golden":false,"offsetInEndSection":234,"text":"BACKGROUND: Early-onset neonatal sepsis (EOS) is a rare condition but an important cause of severe morbidity and mortality in neonates.METHODS: This is a prospective observational study in neonates born at ?34 weeks of gestation (WG).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":593,"document":"35902218","golden":false,"offsetInEndSection":794,"text":"In term infants, the most frequent pathogens were group B Streptococcus (GBS) (n\u003d47) and Escherichia coli (n\u003d20); in late preterm infants, the most frequent pathogens were E. coli (n\u003d15) and GBS (n\u003d7).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":511,"document":"14510320","golden":false,"offsetInEndSection":776,"text":"A change in pathogens causing early-onset sepsis among Network patients has been observed over the past decade, with a significant reduction in early-onset group B streptococcal infections, but also a significant increase in early-onset Escherichia coli infections.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":836,"document":"35902218","golden":false,"offsetInEndSection":952,"text":"Five E. coli strains (14%) were resistant to both amoxicillin and gentamicin, which is an empiric treatment for EOS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":391,"document":"35902218","golden":false,"offsetInEndSection":592,"text":"Data on EOS were collected exhaustively from all maternity wards in Paris area (April 2019-March 2021).RESULTS: 108 EOS were recorded (annual incidence, 0.32 per 1000 live births; 95%?CI 0.26 to 0.38).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":685,"document":"38357132","golden":false,"offsetInEndSection":808,"text":"The odds of RDS among neonates with jaundice and sepsis are 4.33- and 1.92-times higher odds compared to their counterparts","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":535,"document":"38356035","golden":false,"offsetInEndSection":582,"text":"A total of 4263 infants were diagnosed with BPD","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":566,"document":"38355207","golden":false,"offsetInEndSection":652,"text":"Initial screenings for sepsis and blood group incompatibility yielded negative results","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":9,"document":"38354362","golden":false,"offsetInEndSection":207,"text":"Time to antibiotic administration (TTA) in \u003c60 minutes for children with neutropenic fever presenting to an emergency room is associated with reduced incidence of sepsis and intensive care admission","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1729,"document":"38353591","golden":false,"offsetInEndSection":1784,"text":"Sepsis is still a life-threatening disease in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":365,"document":"38353586","golden":false,"offsetInEndSection":405,"text":"Children (1 mo-18 yr) with septic shock.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1307,"document":"38353160","golden":false,"offsetInEndSection":1398,"text":"Further multicenter prospective data are needed, including infants with early-onset sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":151,"document":"38352942","golden":false,"offsetInEndSection":268,"text":"These mechanisms have been demonstrated in patients with sepsis, hemoglobinopathies, and those receiving transfusions","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":13,"document":"38348451","golden":false,"offsetInEndSection":184,"text":" Pediatric sepsis (PS) is a life-threatening infection associated with high mortality rates, necessitating a deeper understanding of its underlying pathological mechanisms","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1187,"document":"27005713","golden":false,"offsetInEndSection":1415,"text":"Most of the isolated organisms showed sensitivity to amikacin, cloxacillin, ciprofloxacin and vancomycin.CONCLUSIONS: This study has indicated possible emergence of Staphylococcus aureus as the dominant cause of neonatal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":792,"document":"27005713","golden":true,"offsetInEndSection":1186,"text":"Proportions of late and early onset were 25 (83.3%) and 5(17.7%) respectively.In blood culture Staphylococcus aureus was the most common organism(80%),followed by Coagulase negative Staphylococcus (6.66%), Acinetobacter (6.66%), Enterobacter species(3.33%) and Morgonellamorgoni (3.33.5%).Gram positive organisms were isolated in all cases of early onset sepsis and in 84% of late onset sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1959,"document":"23419199","golden":false,"offsetInEndSection":2289,"text":"Coagulase negative Staphylococci was susceptible to Gentamicin (72.0%) but Coagulase positive Staphylococci showed intermediate sensitivity to Gentamicin (42.9%).CONCLUSION: Coagulase Negative, Coagulase Positive Staphylococci, Salmonella and Klebsiella were the aetiological agents of bloodstream infection among children at TTH.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1416,"document":"27005713","golden":false,"offsetInEndSection":1544,"text":"Cloxacillin, amikacin, ciprofloxacin have high proportion of efficacy against the commonly isolated bacteria in neonatal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":488,"document":"27005713","golden":false,"offsetInEndSection":728,"text":"The data was collected from medical records of neonatal intermediate care unit and microbiology department and analyzed using SPSS version 20.RESULTS: There were 644 admissions, among which 210 (32%)were suspected of having neonatal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27005713","golden":false,"offsetInEndSection":84,"text":"BACKGROUND: Sepsis is one of the leading causes of neonatal morbidity and mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":729,"document":"27005713","golden":false,"offsetInEndSection":791,"text":"Thirty(14%) of the suspected cases had positive blood culture.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"27005713","golden":false,"offsetInEndSection":127,"text":"Bacteriological Profile of Neonatal Sepsis in Neonatal Intermediate Care Unit of Central Paediatric Referral Hospital in Nepal.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1425,"document":"30169202","golden":false,"offsetInEndSection":1688,"text":"Escherichia coli (242 of 1181 [20%]), Staphylococcus aureus (177 of 1181 [15%]), coagulase-negative staphylococci (135 of 1181 [11%]), and Streptococcus pneumoniae (118 of 1181 [10%]) were the most prevalent pathogens in our study, accounting for 57% of episodes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2236,"document":"39090628","golden":false,"offsetInEndSection":2364,"text":"of the bacterial isolates.CONCLUSION: Gram positive bacteria were the predominant isolates among pediatric sepsis cases and most","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2030,"document":"28104185","golden":false,"offsetInEndSection":2159,"text":" 95% CI 2?7-10?4; p\u003c0?001).INTERPRETATION: Sepsis in southeast Asia is caused by a wide range of known and emerging pathogens, an","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2733,"document":"39429081","golden":false,"offsetInEndSection":2850,"text":"onclusions: Bacterial infection are predominant in pediatric septic shock, but viral infection are also significant. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":164,"document":"38163773","golden":false,"offsetInEndSection":292,"text":"eonates and children are among the most vulnerable population groups of developing sepsis because of their weak immune barrier. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1987,"document":"25884449","golden":false,"offsetInEndSection":2281,"text":"S. pneumoniae BSI declined significantly over time (58/465 [12.5%] to 33/399 [8.3%]; p \u003d0.04).CONCLUSION: Although BSI rates declined over time, children with BSI had high mortality and pathogens exhibited substantial antimicrobial resistance in both community and hospital-acquired infections.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1277,"document":"38517573","golden":false,"offsetInEndSection":1465,"text":"The antimicrobial resistance (AMR) rate was highest in CoNS isolates.CONCLUSION: GPB-BSI was four times more common than Gram-negative BSI in neonates but resulted in lower mortality rate.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1109,"document":"24003995","golden":true,"offsetInEndSection":1366,"text":"Although mortality rate due to Gram-negative bacteria and fungi was higher, CONS was an important cause of mortality in infants with LOS and VLOS.CONCLUSIONS: CONS was found to be the most common causative organism in three sepsis types in preterm neonates.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38517573","golden":false,"offsetInEndSection":398,"text":"PURPOSE: To assess Gram-positive bacterial (GPB) bloodstream infection (BSI) in neonates, covering incidence, morbidity, mortality, antimicrobial resistance patterns and biomarkers in Region Stockholm, Sweden between 2006 and 2016.METHODS: A population-based retrospective epidemiological study including infants with GPB-BSI, admitted to the neonatal units at Karolinska University Hospital (KUH).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1532,"document":"38517573","golden":true,"offsetInEndSection":1648,"text":"CoNS was the most common pathogen in LOS and infants born very preterm, and the AMR rate was high in these isolates.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1141,"document":"38517573","golden":false,"offsetInEndSection":1276,"text":"Staphylococcus aureus (S. aureus) BSI increased during the study period, but no methicillin or vancomycin resistant strains were found.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":661,"document":"38517573","golden":true,"offsetInEndSection":934,"text":"Group B streptococcus (GBS) was the most common pathogen causing BSI in full-term infants and early-onset sepsis (EOS) (0.20/1000 LB), while coagulase-negative staphylococci (CoNS) were predominant in infants born very preterm and in late-onset sepsis (LOS) (0.79/1000 LB).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":399,"document":"38517573","golden":false,"offsetInEndSection":660,"text":"Data were collected from patient records, the Swedish Neonatal Quality Register, the microbiological laboratory at KUH and the Swedish Public Health Agency.RESULTS: We identified 357 infants with GPB-BSI, representing an incidence of 1.47/1000 live births (LB).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1466,"document":"38517573","golden":true,"offsetInEndSection":1531,"text":"GBS was the most common pathogen in full-term infants and in EOS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1649,"document":"38517573","golden":false,"offsetInEndSection":1729,"text":"The increasing trend of S. aureus BSI indicates a need of further investigation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":935,"document":"38517573","golden":false,"offsetInEndSection":1001,"text":"There were no fatal GBS BSI cases, but 10.2% developed meningitis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39542423","golden":true,"offsetInEndSection":176,"text":"INTRODUCTION: Staphylococcus aureus bacteraemia (SAB) is the most common cause of sepsis, contributing to paediatric intensive care unit admission in Australia and New Zealand.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1299,"document":"16542604","golden":false,"offsetInEndSection":1476,"text":"Staphylococcus aureus were more sensitive to ciprofloxacin (85%), meropenem (87%), imipenem (82%) as compared to cephalosporins and aminoglycosides.CONCLUSION: E.coli and Staph.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38726020","golden":false,"offsetInEndSection":589,"text":"Background: Viridans Group Streptococci (VGS) are often considered organisms of low virulence; however, infection can result in clinically significant sepsis and life-threatening complications in paediatric patients.Objectives: This study aimed to describe the spectrum of clinical presentation of VGS bacteraemia in paediatric patients, to analyse risk factors, and to describe the antibiotics resistance patterns of VGS.Method: Cultures of VGS in paediatric patients admitted to Chris Hani Baragwanath Academic Hospital in 2019 were identified through National Health Laboratory Service.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37252038","golden":false,"offsetInEndSection":450,"text":"In light of rising antibiotic resistance, better methods for selection of empiric antibiotic treatment based on clinical and microbiological data are needed. Most guidelines target specific clinical infections, and variably adjust empiric antibiotic selection by certain patient characteristics. Coverage estimates reflect the probability that an antibiotic regimen will be active against the causative pathogen once confirmed and can provide an obje","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37223064","golden":false,"offsetInEndSection":450,"text":"A delay in detecting sepsis pathogens is a problematic issue for determining definitive antibiotic therapy for the causative pathogens. The gold standard method for sepsis is blood culture but this requires 3?days to detect the definitive pathogen. Molecular methods offer rapid identification of pathogens. We evaluated the use of sepsis flow chip (SFC) assay for identifying pathogens from children with sepsis. Blood samples from children with sep","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36529894","golden":false,"offsetInEndSection":450,"text":"Emerging mobile colistin resistance (mcr) genes pose a significant threat to public health for colistin was used as the last resort to treat multidrug-resistant (MDR) pathogenic bacterial infections. Hypervirulent Klebsiella pneumoniae (hvKP) is a clinically significant pathogen resulting in highly invasive infections, often complicated by devastating dissemination. Worryingly, the untreatable and severe infections caused by mcr-harbouring hvKP l","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36999339","golden":false,"offsetInEndSection":450,"text":"AIM: To assess whether febrile neonates from the community received their first dose of intravenous antibiotics within 1?h from time of arrival, as per the regional paediatric sepsis pathway, at a tertiary combined adult/child emergency department in New Zealand.METHOD: Retrospective data were collected from January 2018 to December 2019 with 28 patients included.RESULTS: Mean time to first antibiotic dose for all neonates and those with serious ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":934,"document":"34852884","golden":false,"offsetInEndSection":1045,"text":"with culture-negative neonatal sepsis. The commonest pathogens causing culture-confirmed neonatal sepsis were S","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1593,"document":"36472648","golden":false,"offsetInEndSection":1761,"text":"urinae) is known to be a common pathogen in the geriatric population, causing urinary tract infection (UTI), sepsis, and endocarditis, predominantly in female patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35475418","golden":false,"offsetInEndSection":171,"text":"Owing to an increasing number of infections in adults, Lactococcus (L.) garvieae has gained recognition as an emerging human pathogen, causing bacteraemia and septicaemia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":463,"document":"9294341","golden":false,"offsetInEndSection":626,"text":"We report a paediatric case of documented Chromobacterium sepsis in Singapore who presented like septicaemic melioidosis associated with diminished T-cell numbers.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1553,"document":"31756213","golden":false,"offsetInEndSection":1758,"text":" curve 0.81, H-L p \u003d 0.41). Commonly identified pathogens included coagulase-negative staphylococci (CoNS n \u003d 71, 21.4%), Escherichia coli (n \u003d 50, 15.1%), Staphylococcus aureus (n \u003d 41, 12.4%) and Enterob","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23034322","golden":false,"offsetInEndSection":61,"text":"Sepsis is among the most common causes of death in hospitals.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":965,"document":"37223064","golden":false,"offsetInEndSection":1146,"text":"SFC assay offers promise to identify pathogens from positive blood culture in paediatric patients with sepsis and may support the antimicrobial stewardship programme in hospitals.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":430,"document":"33632088","golden":false,"offsetInEndSection":673,"text":"Children between 0 and five years (7/13, 53.8%, p?\u003d?0.019), having longer hospital stay (7/13, 53.8%, p?\u003d?0.00029), shock (10/13, 76.9%, p?\u003d?0.00001), and increased PCT (13/13, 100%, p?\u003c?0.001) were some indicators of sepsis in these patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34711945","golden":false,"offsetInEndSection":103,"text":"Sepsis, a dysregulated host response to infection, has been difficult to accurately define in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":781,"document":"32803355","golden":false,"offsetInEndSection":925,"text":" a male predominance (64%). Traditional laboratory culture method isolated an organism in 66% of cases: Staphylococcus aureus was the most commo","beginSection":"abstract"}],"exact_answer":[[]],"ideal_answer":["The most common pathogen in paediatric sepsis may vary depending on the geographic location and the population studied. However, Staphylococcus aureus is commonly reported as a leading cause of sepsis. Other pathogens such as Group B Streptococcus (GBS), Klebsiella species, Enterobacter, Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii have also been identified in various studies as common causative agents of sepsis in children.","The most common pathogen in pediatric sepsis varies depending on the geographic area and the patient\u0027s age and health conditions, but Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus are frequently reported. GBS (Group B streptococcus) is considered the leading pathogen in early-onset sepsis in neonates.","The most common pathogen in pediatric sepsis is Streptococcus pneumoniae.","Neisseria meningitidis, Streptococcus pneumoniae, Escherichia coli, Klebsiella spp., Salmonella typhi, Staphylococcus aureus, Entrobacter, Acinetobacter spp., Enterobacter, Salmonella paratyphi A\n","Staphylococcus aureus (S. aureus) is one of the most frequently isolated pathogens in pediatric cases of sepsis, including both early and late-onset sepsis. It is a common gram-positive microorganism and plays a significant role as a pathogen associated with sepsis and toxic shock. In addition to Staphylococcus aureus, other common pathogens that can cause sepsis in pediatric patients are various species of Streptococcus, Enterococcus, and Gram-negative organisms like Klebsiella pneumoniae, the latter being associated with the highest mortality in the context of sepsis as per the provided snippets. The prevalence of specific pathogens may vary by region and by specific patient populations such as neonates in intensive care units, where CONS (coagulase-negative staphylococci) has emerged as a common pathogen. This suggests that while Staphylococcus aureus is commonly implicated, the etiology of pediatric sepsis can be broad and influenced by various factors including geography and healthcare settings.","The most common pathogens involved in pediatric sepsis vary depending on the patient population and the geographical location, but generally, Gram-positive bacteria like Staphylococcus spp (including Staphylococcus aureus and coagulase-negative Staphylococci such as S. epidermidis and S. haemolyticus), and Enterococcus spp are among the leading causes of sepsis in children. In neonates, particularly very low birth weight (VLBW) infants, Gram-negative bacteria such as E. coli can be prevalent causes of early-onset sepsis (EOS). Other Gram-negative bacteria like Klebsiella pneumoniae are also significant, and often associated with late-onset sepsis (LOS) in preterm infants. The presence of antibiotic-resistant strains, such as extended-spectrum ?-lactamase (ESBL) producing E. coli and K. pneumoniae, adds to the complexity of treating pediatric sepsis.","The most common pathogen in pediatric sepsis can vary depending on the age group and region, but overall, Escherichia coli (E. coli) and Staphylococcus aureus are frequently identified as significant causative agents in infants with clinical suspicion of serious invasive infections. In very low birth weight (VLBW) infants, Gram-negative organisms, particularly E. coli, are documented as leading pathogens of early onset sepsis (EOS), whereas Group B Streptococcus (GBS) is the most common pathogen in EOS, especially in infants with a gestational age of less than 28 weeks. Additionally, Klebsiella pneumoniae is also notable as a common pathogen in pediatric sepsis cases. These findings stress the need for accurate diagnostic tools and effective management strategies to address pediatric sepsis.","The most common pathogens associated with pediatric sepsis are staphylococci, particularly Staphylococcus aureus, and Streptococcus pneumoniae. Staphylococcus aureus is frequently isolated in neonatal cases of early and late-onset sepsis, and studies have highlighted its significance as a major pathogen in the neonatal intensive care setting. Streptococcus pneumoniae has traditionally been recognized as a common acute respiratory infection pathogen and also frequently found in blood isolates in neonatal sepsis. The prevalence of these pathogens underscores their importance in pediatric sepsis and the need for ongoing surveillance and targeted antimicrobial therapy.","The most common pathogens in pediatric sepsis vary by region and study, but based on the provided excerpts, Streptococcus pneumoniae is highlighted as a frequently isolated pathogen in cases of sepsis with or without meningitis and bacteraemia in children. Additionally, Staphylococcus aureus is noted as an important gram-positive microorganism associated with sepsis and toxic shock in general, which may also be relevant in pediatric cases. Entrobacter is mentioned as the most common pathogen of neonatal septicemia in a specific region (Rasht, Iran), indicating that the prevalence of pathogens can be geographically specific. Therefore, while Streptococcus pneumoniae is identified as a common pathogen in the provided data, it\u0027s important to consider regional differences and the age group of the pediatric population when identifying the most common pathogen in pediatric sepsis.","50?60% of the sepsis cases in children are caused by gram-positive bacteria and 40?50% of the cases are caused by gram-negative bacteria. 20% of the sepsis cases in children are due to viral infection, and 3?4% are due to fungi.\n","The most common pathogen in pediatric sepsis is Staphylococcus aureus, a gram-positive microorganism that is frequently isolated in cases of neonatal and pediatric sepsis.","Escherichia coli, Coagulase-negative staphylococci, Staphylococcus aureus, and Klebsiella pneumoniae are the most common pathogens in paediatric sepsis."],"id":"6584593f06a2ea257c000008","type":"factoid","body":"Which is the most common pathogen in paediatric sepsis?"},{"documents":[{"golden":false,"id":"33767739"},{"golden":false,"id":"18688037"},{"golden":false,"id":"32542149"},{"golden":false,"id":"19591008"},{"golden":false,"id":"8829695"},{"golden":false,"id":"9629235"},{"golden":false,"id":"39286970"},{"golden":false,"id":"27364395"},{"golden":true,"id":"17261360"},{"golden":false,"id":"22079680"},{"golden":false,"id":"35966636"},{"golden":false,"id":"30394940"},{"golden":false,"id":"20853323"},{"golden":false,"id":"18443225"},{"golden":false,"id":"14673233"},{"golden":false,"id":"12379999"},{"golden":false,"id":"19863777"},{"golden":false,"id":"30996136"},{"golden":false,"id":"39477067"},{"golden":false,"id":"38370992"},{"golden":false,"id":"37758506"},{"golden":false,"id":"9209805"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":1441,"document":"33767739","golden":false,"offsetInEndSection":1612,"text":"Overall, this evolutionary paradigm can help explain why the phenomenon of autoimmunity occurs preferentially in women and raises the possibility of new treatment options.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":693,"document":"33767739","golden":false,"offsetInEndSection":803,"text":"Several facts suggest differences in antibodies may cause increased prevalence of autoimmune disease in women.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":293,"document":"33767739","golden":false,"offsetInEndSection":554,"text":"In this manuscript, we evaluate the hypothesis that qualitative or quantitative differences in circulating antibodies may explain, at least in part, the pathogenesis of autoimmune disease and its sex bias-especially when considering an evolutionary perspective.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":841,"document":"17261360","golden":true,"offsetInEndSection":1323,"text":"Since, in analogy to allogeneic organ transplantation, fetal-maternal (and maternal-fetal) microchimerism may play an important role in the immunologic tolerance of the fetal semi-allograft, female preponderance for autoimmune diseases may be understood as a consequence of increased allogeneic cell traffic in females (in comparison to males), increased risk for long-term microchimerism and, therefore, as a consequence of the former two, the development of abnormal autoimmunity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":555,"document":"33767739","golden":false,"offsetInEndSection":692,"text":"Indeed, women have higher absolute levels of antibodies than men, and (auto)antibodies are also associated with most autoimmune diseases.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"33767739","golden":false,"offsetInEndSection":78,"text":"Why women have more autoimmune diseases than men: An evolutionary perspective.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1050,"document":"18688037","golden":false,"offsetInEndSection":1207,"text":"Autoimmune diseases with an increased incidence in females that appear clinically past age 50 are associated with a chronic, fibrotic Th2-mediated pathology.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":847,"document":"18688037","golden":false,"offsetInEndSection":1049,"text":"In contrast, female-predominant autoimmune diseases that manifest during the acute phase, such as Graves\u0027 disease and systemic lupus erythematosus, are diseases with a known antibody-mediated pathology.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1006,"document":"32542149","golden":false,"offsetInEndSection":1154,"text":"Throughout this review, various hypotheses are explored that provide?insight into the increased?susceptibility of autoimmune disorders within women.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1072,"document":"33767739","golden":false,"offsetInEndSection":1187,"text":"Third, a dose-response effect exists between parity and both serum antibodies and prevalence of autoimmune disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":66,"document":"39286970","golden":false,"offsetInEndSection":211,"text":"ost autoimmune diseases occur more often in women than men, with rheumatic autoimmune diseases being among those most highly expressed in women. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":292,"document":"35966636","golden":false,"offsetInEndSection":521,"text":"n general women have stronger innate and adaptive immune responses than men, explaining their ability to clear viral and bacterial infections faster, but also contributing to their increased susceptibility to autoimmune disease. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":830,"document":"30394940","golden":false,"offsetInEndSection":1015,"text":"f the gut, and the immune system.SUMMARY: Sex bias in autoimmune disease is the manifestation of a complex interplay of the sex chromosomes, sex hormones, the microbiota, and additional","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1112,"document":"30996136","golden":false,"offsetInEndSection":1201,"text":"This work strongly implicates VGLL3 as a pivotal orchestrator of sex-biased autoimmunity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":630,"document":"18688037","golden":false,"offsetInEndSection":846,"text":"Autoimmune diseases that are more prevalent in males usually manifest clinically before age 50 and are characterized by acute inflammation, the appearance of autoantibodies, and a proinflammatory Th1 immune response.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":369,"document":"18688037","golden":false,"offsetInEndSection":629,"text":"This review discusses the distribution of autoimmune diseases based on sex and age, showing that autoimmune diseases progress from an acute pathology associated with an inflammatory immune response to a chronic pathology associated with fibrosis in both sexes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1208,"document":"18688037","golden":false,"offsetInEndSection":1277,"text":"Th17 responses increase neutrophil inflammation and chronic fibrosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":142,"document":"18688037","golden":false,"offsetInEndSection":368,"text":"Women are known to respond to infection, vaccination, and trauma with increased antibody production and a more T helper (Th)2-predominant immune response, whereas a Th1 response and inflammation are usually more severe in men.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"19591008","golden":false,"offsetInEndSection":114,"text":"Autoimmune diseases are generally more common in women than men; however, there is no simple explanation for this.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39286970","golden":false,"offsetInEndSection":450,"text":"Autoimmune diseases are a leading cause of disability worldwide. Most autoimmune diseases occur more often in women than men, with rheumatic autoimmune diseases being among those most highly expressed in women. Several key factors, identified mainly in animal models and cell culture experiments, are important in increasing autoimmune disease in females. These include sex hormones, immune genes including those found on the X chromosome, sex-specif","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39477067","golden":false,"offsetInEndSection":450,"text":"Sex is a key variable in the regulation of human physiology and pathology. Many diseases disproportionately affect one sex: autoimmune diseases, such as systemic lupus erythematosus, are more common in women but more severe in men, whereas the incidence of other disorders such as gouty arthritis and malignant cancers is higher in men. Besides the pathophysiology, sex may also influence the efficacy of therapeutics; participants in clinical trials","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37758506","golden":false,"offsetInEndSection":450,"text":"CONTEXT: Turner syndrome (TS) is the most common chromosomal aberration in women; it is the result of structural or numeric abnormalities in the X chromosome. Autoimmune hypothyroidism has been recognized as one of the more prominent disorders associated with TS.OBJECTIVE: This work aimed to study the prevalence of autoimmune diseases in TS.METHODS: A cross-sectional, longitudinal, 25-year follow-up study was conducted of patients from adult Turn","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38370992","golden":false,"offsetInEndSection":450,"text":"Background The coronavirus disease 2019 (COVID-19) pandemic has raised significant concerns about the effects of the virus on patients with autoimmune diseases. Therefore, understanding the COVID-19 outcomes in this population is crucial for effective prevention and management. Objective This study aimed to investigate the association between autoimmune diseases and the severity of COVID-19 in terms of mortality and morbidity. Despite substantial","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"8829695","golden":false,"offsetInEndSection":58,"text":"The autoimmune diseases are more common in women than men.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"18443225","golden":false,"offsetInEndSection":62,"text":"Most autoimmune diseases are more common in women than in men.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"22079680","golden":false,"offsetInEndSection":72,"text":"A large number of autoimmune diseases (ADs) are more prevalent in women.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":65,"document":"39286970","golden":false,"offsetInEndSection":210,"text":"Most autoimmune diseases occur more often in women than men, with rheumatic autoimmune diseases being among those most highly expressed in women.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"9209805","golden":false,"offsetInEndSection":69,"text":"Autoimmune diseases occur most commonly in women of childbearing age.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"20853323","golden":false,"offsetInEndSection":180,"text":"Autoimmune disorders are more frequent in women, whereas most non-Hodgkin lymphomas (NHLs) are common in men; yet, sexspecific autoimmune?lymphoma associations are rarely reported.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"19863777","golden":false,"offsetInEndSection":59,"text":"The majority of autoimmune diseases predominate in females.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"12379999","golden":false,"offsetInEndSection":402,"text":"The thyroid diseases are more frequent in women, which is probably related to the fact that many thyroid diseases are of the autoimmune type, secondary to the effects of sexual steroids in the immunological system; although it had never been completely cleared up, it seems that estrogens and progestogens may modulate the lymphocyte differentiation as well as the induction of the autoimmune response.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":121,"document":"14673233","golden":false,"offsetInEndSection":361,"text":"While most dermal antigens and autoantibodies in these diseases have been identified, the etiology and clinical characteristics of the autoimmunity remain obscure, such as why more than 70% of autoimmune diseases are more frequent in women.","beginSection":"abstract"}],"ideal_answer":[],"id":"6777bc37592fa48873000012","type":"summary","body":"Why are autoimmune diseases more common in women?"},{"documents":[{"golden":true,"id":"35585374"},{"golden":false,"id":"34704267"},{"golden":false,"id":"33991294"},{"golden":false,"id":"35942672"},{"golden":true,"id":"32840332"},{"golden":false,"id":"34324040"},{"golden":false,"id":"36518658"},{"golden":true,"id":"35727341"},{"golden":false,"id":"36470990"},{"golden":false,"id":"35691950"},{"golden":false,"id":"15765886"},{"golden":false,"id":"15025769"},{"golden":false,"id":"15340390"},{"golden":false,"id":"21539725"},{"golden":false,"id":"36383062"},{"golden":false,"id":"27797957"},{"golden":false,"id":"2848776"},{"golden":false,"id":"12391935"},{"golden":false,"id":"21763207"},{"golden":false,"id":"6388495"},{"golden":false,"id":"2894665"},{"golden":false,"id":"32197623"},{"golden":false,"id":"28540057"},{"golden":false,"id":"20350658"},{"golden":false,"id":"17403543"},{"golden":false,"id":"15968260"},{"golden":false,"id":"25947283"},{"golden":false,"id":"15275567"},{"golden":false,"id":"34838486"},{"golden":false,"id":"218186"},{"golden":false,"id":"12690408"},{"golden":false,"id":"2082259"},{"golden":false,"id":"1599409"},{"golden":false,"id":"1371038"},{"golden":false,"id":"13867755"},{"golden":false,"id":"16880924"},{"golden":false,"id":"24195524"},{"golden":false,"id":"23147550"},{"golden":false,"id":"35978820"},{"golden":false,"id":"15030390"},{"golden":false,"id":"26878886"},{"golden":false,"id":"36370693"},{"golden":false,"id":"17384667"},{"golden":false,"id":"15663483"},{"golden":false,"id":"17503505"},{"golden":false,"id":"16878173"},{"golden":false,"id":"18682740"},{"golden":false,"id":"10710492"},{"golden":false,"id":"27667859"},{"golden":false,"id":"18083518"},{"golden":false,"id":"17935771"},{"golden":false,"id":"33873250"},{"golden":false,"id":"22681697"},{"golden":false,"id":"23095902"},{"golden":false,"id":"1114952"},{"golden":false,"id":"23789973"},{"golden":false,"id":"35384866"},{"golden":false,"id":"7689439"},{"golden":false,"id":"23089283"},{"golden":false,"id":"17458649"},{"golden":false,"id":"20012482"},{"golden":false,"id":"24628581"},{"golden":false,"id":"24274737"},{"golden":false,"id":"17762320"},{"golden":false,"id":"17229773"},{"golden":false,"id":"26143936"},{"golden":false,"id":"9123943"},{"golden":false,"id":"23625971"},{"golden":false,"id":"20704677"},{"golden":false,"id":"23423598"},{"golden":false,"id":"7514332"},{"golden":false,"id":"6096847"},{"golden":false,"id":"11068911"},{"golden":false,"id":"1337388"},{"golden":false,"id":"25052484"},{"golden":false,"id":"11916069"},{"golden":false,"id":"6296885"},{"golden":false,"id":"1218263"},{"golden":false,"id":"6994806"},{"golden":false,"id":"25698840"},{"golden":false,"id":"33847313"},{"golden":false,"id":"12238801"},{"golden":false,"id":"2936372"},{"golden":false,"id":"1562510"},{"golden":false,"id":"1326934"},{"golden":false,"id":"22369784"},{"golden":false,"id":"23541756"},{"golden":false,"id":"36228827"},{"golden":false,"id":"31093018"},{"golden":false,"id":"29669851"},{"golden":false,"id":"14763129"},{"golden":false,"id":"33762737"},{"golden":false,"id":"30805745"},{"golden":false,"id":"28444446"},{"golden":false,"id":"10497304"},{"golden":false,"id":"17983317"},{"golden":false,"id":"16942861"},{"golden":false,"id":"14758473"},{"golden":false,"id":"33615007"},{"golden":false,"id":"20526978"},{"golden":false,"id":"19929763"},{"golden":false,"id":"35507019"},{"golden":true,"id":"36751779"},{"golden":false,"id":"11897887"},{"golden":false,"id":"15570014"},{"golden":false,"id":"18406313"},{"golden":false,"id":"18806702"},{"golden":false,"id":"23667117"},{"golden":false,"id":"29049083"},{"golden":false,"id":"3066876"},{"golden":false,"id":"34935228"},{"golden":false,"id":"33853851"},{"golden":false,"id":"36622328"},{"golden":false,"id":"25404049"},{"golden":false,"id":"1759608"},{"golden":false,"id":"19129788"},{"golden":false,"id":"21653637"},{"golden":false,"id":"34973057"},{"golden":false,"id":"12690410"},{"golden":false,"id":"26683668"},{"golden":false,"id":"7608321"},{"golden":false,"id":"18729096"},{"golden":false,"id":"9859690"},{"golden":false,"id":"3010823"},{"golden":false,"id":"12323126"},{"golden":false,"id":"7449994"},{"golden":false,"id":"2483141"},{"golden":false,"id":"31268366"},{"golden":false,"id":"25134731"},{"golden":false,"id":"28524214"},{"golden":false,"id":"29270111"},{"golden":false,"id":"32865783"},{"golden":false,"id":"35592494"},{"golden":false,"id":"28480639"},{"golden":false,"id":"35653060"},{"golden":false,"id":"17078389"},{"golden":false,"id":"26366588"},{"golden":false,"id":"19352696"},{"golden":false,"id":"25089880"},{"golden":true,"id":"39330700"},{"golden":false,"id":"38914784"},{"golden":false,"id":"39054363"},{"golden":false,"id":"37316681"},{"golden":true,"id":"39473221"},{"golden":false,"id":"39457466"},{"golden":false,"id":"38979291"},{"golden":true,"id":"38666665"},{"golden":true,"id":"38758193"},{"golden":true,"id":"37975798"},{"golden":false,"id":"16262900"},{"golden":false,"id":"38855716"},{"golden":false,"id":"39017978"},{"golden":false,"id":"38022476"},{"golden":false,"id":"39490682"},{"golden":true,"id":"32640130"},{"golden":true,"id":"36129998"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":0,"document":"32640130","golden":true,"offsetInEndSection":151,"text":"BACKGROUND: Tofersen is an antisense oligonucleotide that mediates the degradation of superoxide dismutase 1 (SOD1) messenger RNA to reduce SOD1 protei","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2169,"document":"32640130","golden":false,"offsetInEndSection":2171,"text":"CT","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":961,"document":"35585374","golden":true,"offsetInEndSection":1121,"text":"Tofersen is an investigational antisense oligonucleotide designed to reduce synthesis of superoxide dismutase 1 (SOD1) protein through degradation of SOD1 mRNA.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"32640130","golden":false,"offsetInEndSection":67,"text":"Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":756,"document":"32840332","golden":true,"offsetInEndSection":1099,"text":"This article highlights the oral tyrosine kinase inhibitor masitinib; the antisense drug tofersen; the humanized monoclonal antibody C5 complement inhibitor ravulizumab-cwvz; and mesenchymal stem cell (MSC)-neurotrophic factor (NTF) cells, a proprietary platform that induces autologous bone marrow-derived MSCs to secrete high levels of NTFs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":911,"document":"35727341","golden":true,"offsetInEndSection":1052,"text":"Similarly, tofersen, an antisense oligonucleotide, is now undergoing clinical trial phase for use in ALS patients carrying the SOD1 mutation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":152,"document":"32640130","golden":false,"offsetInEndSection":394,"text":" synthesis. Intrathecal administration of tofersen is being studied for the treatment of amyotrophic lateral sclerosis (ALS) due to SOD1 mutations.METHODS: We conducted a phase 1-2 ascending-dose trial evaluating tofersen in adults with ALS d","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1363,"document":"36129998","golden":false,"offsetInEndSection":1488,"text":" to have faster progression). Tofersen led to greater reductions in concentrations of SOD1 in CSF and of neurofilament light ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":302,"document":"34704267","golden":false,"offsetInEndSection":496,"text":"Recently, the results of a phase I/II study using the antisense oligonucleotides Tofersen to treat familial amyotrophic lateral sclerosis with superoxide dismutase 1 mutation have been reported.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1358,"document":"32640130","golden":false,"offsetInEndSection":1937,"text":"espiratory failure on day 52. The difference at day 85 in the change from baseline in the CSF SOD1 concentration between the tofersen groups and the placebo group was 2 percentage points (95% confidence interval [CI], -18 to 27) for the 20-mg dose, -25 percentage points (95% CI, -40 to -5) for the 40-mg dose, -19 percentage points (95% CI, -35 to 2) for the 60-mg dose, and -33 percentage points (95% CI, -47 to -16) for the 100-mg dose.CONCLUSIONS: In adults with ALS due to SOD1 mutations, CSF SOD1 concentrations decreased at the highest concentration of tofersen administer","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":945,"document":"33991294","golden":false,"offsetInEndSection":1062,"text":"vance fundamental understanding of whole-body distribution of IT-administered ASOs. We propose a physiologically-base","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33991294","golden":false,"offsetInEndSection":339,"text":"Antisense oligonucleotides (ASOs) are promising therapeutic agents for a variety of neurodegenerative and neuromuscular disorders, e.g., Alzheimer\u0027s, Parkinson\u0027s and Huntington\u0027s diseases, spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS), caused by genetic abnormalities or increased protein accumulation. The blood-br","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1340,"document":"33991294","golden":false,"offsetInEndSection":1522,"text":"eter identifiability and physiological plausibility of the model, several alternative model structures were chosen and fitted to the NHP data. The model analysis of the NHP data led ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":666,"document":"33991294","golden":false,"offsetInEndSection":795,"text":"O therapeutics have already demonstrated clinical effect, e.g., nusinersen (SMA) and tofersen (ALS). Due to novelty of IT dosing ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1241,"document":"33991294","golden":false,"offsetInEndSection":1337,"text":"that drive and limit ASO access to the CNS target tissues. To elucidate the trade-off between pa","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2170,"document":"33991294","golden":false,"offsetInEndSection":2269,"text":"concentration emerging along the spinal CSF canal. These local concentrations need to be taken into","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1639,"document":"33991294","golden":false,"offsetInEndSection":1909,"text":"maximum total exposure in the CNS tissues, including the spinal cord and brain, is achieved within two days after the IT injection, and the maximum amount absorbed by the CNS tissues is about 4% of the administered IT dose. This amount greatly exceeds the CNS exposures ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1525,"document":"33991294","golden":false,"offsetInEndSection":1636,"text":"important qualitative conclusions that can inform projection to human. In particular, the model predicts that t","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1911,"document":"33991294","golden":false,"offsetInEndSection":2001,"text":"livered by systemic administration of ASOs. Clearance from the CNS is controlled by the ra","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2004,"document":"33991294","golden":false,"offsetInEndSection":2168,"text":"of transfer from the CNS tissues back to CSF, whereas ASO degradation in tissues is very slow and can be neglected. The model also describes local differences in AS","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":974,"document":"35585374","golden":false,"offsetInEndSection":1135,"text":"n investigational antisense oligonucleotide designed to reduce synthesis of superoxide dismutase 1 (SOD1) protein through degradation of SOD1 mRNA. Informed by P","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32640130","golden":true,"offsetInEndSection":152,"text":"BACKGROUND: Tofersen is an antisense oligonucleotide that mediates the degradation of superoxide dismutase 1 (SOD1) messenger RNA to reduce SOD1 protein","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36129998","golden":true,"offsetInEndSection":241,"text":"BACKGROUND: The intrathecally administered antisense oligonucleotide tofersen reduces synthesis of the superoxide dismutase 1 (SOD1) protein and is being studied in patients with amyotrophic lateral sclerosis (ALS) associated with mutations ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":305,"document":"34704267","golden":false,"offsetInEndSection":499,"text":"ently, the results of a phase I/II study using the antisense oligonucleotides Tofersen to treat familial amyotrophic lateral sclerosis with superoxide dismutase 1 mutation have been reported. In","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":768,"document":"32840332","golden":false,"offsetInEndSection":1114,"text":" highlights the oral tyrosine kinase inhibitor masitinib; the antisense drug tofersen; the humanized monoclonal antibody C5 complement inhibitor ravulizumab-cwvz; and mesenchymal stem cell (MSC)-neurotrophic factor (NTF) cells, a proprietary platform that induces autologous bone marrow-derived MSCs to secrete high levels of NTFs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":930,"document":"35727341","golden":false,"offsetInEndSection":1073,"text":", an antisense oligonucleotide, is now undergoing clinical trial phase for use in ALS patients carrying the SOD1 mutation. However, these thera","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"32640130","golden":false,"offsetInEndSection":60,"text":"Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SO","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":608,"document":"35691950","golden":false,"offsetInEndSection":692,"text":"eroxide dismutase 1 (SOD1) was a pioneer in developing ASO for ALS. Improving protoc","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":501,"document":"34704267","golden":false,"offsetInEndSection":624,"text":"athecal Tofersen administration resulted in a 36% reduction in superoxide dismutase 1 level in the cerebrospinal fluid. Ano","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36129998","golden":false,"offsetInEndSection":50,"text":"Trial of Antisense Oligonucleotide Tofersen for SO","beginSection":"title"},{"endSection":"title","offsetInBeginSection":0,"document":"15340390","golden":false,"offsetInEndSection":69,"text":"Biochemical mechanisms of drug action: what does it take for success?","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":131,"document":"36383062","golden":false,"offsetInEndSection":301,"text":"Their classical mechanisms of action are associated with binding to the sodium channel of insect neurons, disrupting its inactivation, ensuring their use as insecticides.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":313,"document":"15340390","golden":false,"offsetInEndSection":491,"text":"This article addresses potential drug discovery and development risks associated with the biochemical mechanism of drug action, and proposes simple rules to minimize these risks.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":543,"document":"21539725","golden":false,"offsetInEndSection":659,"text":"This article reviews a set of molecules with a range of mechanisms that have been trialed but with negative results.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":147,"document":"15340390","golden":false,"offsetInEndSection":312,"text":"It is important to increase our understanding of the fundamental properties of effective drugs so that we can anticipate potential problems in developing new agents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"15340390","golden":false,"offsetInEndSection":38,"text":"Drug discovery is extremely difficult.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":39,"document":"15340390","golden":false,"offsetInEndSection":146,"text":"There are many unanticipated scientific, medical and business challenges to every drug discovery programme.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27797957","golden":false,"offsetInEndSection":124,"text":"Poly(ADP-ribose) polymerase (PARP) inhibitors are the first DNA damage response targeted agents approved for cancer therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":425,"document":"2894665","golden":false,"offsetInEndSection":471,"text":"What is the mechanism of the favorable action?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":454,"document":"36383062","golden":false,"offsetInEndSection":629,"text":"Acute exposure to a high dose of PY causes enhancement of the late sodium current (INaL), which impairs the action potential waveform and can cause severe cardiac arrhythmias.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":768,"document":"36383062","golden":false,"offsetInEndSection":944,"text":"Isolated and preliminary evidence supports that, for acute exposure to PY, an antiarrhythmic therapy with ranolazine (an INaL blocker), can be a promising therapeutic approach.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":123,"document":"25947283","golden":false,"offsetInEndSection":362,"text":"Based upon the findings of in vitro experiments, its mode of action against MM occurs through a combination of direct tumoricidal effects on myeloma cells, modulatory effects on tumor immunity and tumor microenvironment-regulatory effects.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28540057","golden":false,"offsetInEndSection":129,"text":"Treatment with rituximab, a monoclonal antibody against the B-lymphocyte surface protein CD20, leads to the depletion of B cells.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":231,"document":"20350658","golden":false,"offsetInEndSection":389,"text":"Direct signaling, complement-mediated cytotoxicity (CMC), and antibody-dependent cellular cytotoxicity (ADCC) all appear to play a role in rituximab efficacy.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"2848776","golden":false,"offsetInEndSection":30,"text":"Neuromuscular blocking agents.","beginSection":"title"},{"endSection":"title","offsetInBeginSection":0,"document":"36383062","golden":false,"offsetInEndSection":109,"text":"Cardiotoxicity of pyrethroids: molecular mechanisms and therapeutic options for acute and long-term toxicity.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36383062","golden":false,"offsetInEndSection":130,"text":"Pyrethroids (PY) are synthetic pesticides used in many applications ranging from large-scale agriculture to household maintenance.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":630,"document":"36383062","golden":false,"offsetInEndSection":767,"text":"Moreover, long-term, low-dose exposure to PY displays oxidative stress in the heart, which could induce tissue remodeling and impairment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":332,"document":"34838486","golden":false,"offsetInEndSection":691,"text":"lar Endothelial Growth Factor inhibitors have different mechanisms of action, targeting either the ligand (e.g. bevacizumab, anti-Vascular Endothelial Growth Factor monoclonal antibody; aflibercept, recombinant anti-Vascular Endothelial Growth Factor fusion protein), or its receptors such as tyrosine kinase inhibitors (e.g. sunitinib or sorafenib). These tr","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":459,"document":"218186","golden":false,"offsetInEndSection":732,"text":"sion was drawn that the mechanism of the diuretic action of the epiphysis extracts consisted in the competitive suppression of the ADH action at the renal tubules level on account of excitation of the alpha-adrenoceptors and inhibition of the adenylcyclase activity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":172,"document":"12690408","golden":false,"offsetInEndSection":488,"text":"t is a generally accepted fact that the antipyschotic action of neuroleptics depends upon blockade of D2 receptors, in part because all of currently used neuroleptics share that action, and in part because for all typical neuroleptics there is a tight correlation between D2 receptor affinity and clinical potency. T","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":320,"document":"2082259","golden":false,"offsetInEndSection":457,"text":"esults allow the antianaphylactic effect of Saventol to be linked with its antimediator effect realized through beta 2-adrenoceptors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1197,"document":"1599409","golden":false,"offsetInEndSection":1345,"text":"teria the primary target of purpuromycin is on ribosomes and that its action precedes the elongation step of protein synthesis. The effect on nuclei","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":146,"document":"1371038","golden":false,"offsetInEndSection":364,"text":"arnet and its analogues achieve their antiviral effects via inhibition of viral polymerases, with such inhibition not being dependent on activation or phosphorylation of the compounds by viral or cellular proteins. Cur","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":352,"document":"13867755","golden":false,"offsetInEndSection":497,"text":"sults suggest a rapid change of the permeability of the cell membrane as the mechanism of all the diversified biological actions of Colisan.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":143,"document":"13867755","golden":false,"offsetInEndSection":186,"text":"isan liberates histamine from mast cells. I","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"16880924","golden":false,"offsetInEndSection":226,"text":"The lipoglycodepsipeptide antibiotic ramoplanin is proposed to inhibit bacterial cell wall biosynthesis by binding to intermediates along the pathway to mature peptidoglycan, which interferes with further enzymatic processing.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"24195524","golden":false,"offsetInEndSection":45,"text":"Trabectedin mechanism of action: what\u0027s new?","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1529,"document":"23147550","golden":false,"offsetInEndSection":2058,"text":"he healthy controls (mean [SE] level, 134 [4] ng/mL). Elevated CSF SOD1 levels did not correlate with disease characteristics in participants with ALS or controls with dementia of the Alzheimer type, but they did correlate with tau, phosphorylated tau, VILIP-1 and YKL-40 levels in controls with dementia of the Alzheimer type.CONCLUSIONS: SOD1 in CSF may be an excellent pharmacodynamic marker for SOD1-lowering therapies because antisense oligonucleotide therapy lowers protein levels in the rat brain and rat CSF samples and b","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23147550","golden":false,"offsetInEndSection":443,"text":"BACKGROUND: Therapies designed to decrease the level of SOD1 are currently in a clinical trial for patients with superoxide dismutase (SOD1)-linked familial amyotrophic lateral sclerosis (ALS).OBJECTIVE: To determine whether the SOD1 protein in cerebral spinal fluid (CSF) may be a pharmacodynamic marker for antisense oligonucleotide therapy and a disease marker for ALS.DESIGN: Antisense oligonucleotides targeting human SOD1 were administer","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":629,"document":"35978820","golden":false,"offsetInEndSection":747,"text":"LCS-1, an inhibitor of SOD1, increased the expression SOD1 at both mRNA and protein levels slightly but significantly.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"15030390","golden":false,"offsetInEndSection":126,"text":"Abstract Dorfin is a RING-finger type ubiquitin ligase for mutant superoxide dismutase 1 (SOD1) that enhances its degradation.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"23147550","golden":false,"offsetInEndSection":96,"text":"SOD1 in cerebral spinal fluid as a pharmacodynamic marker for antisense oligonucleotide therapy.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":605,"document":"15030390","golden":false,"offsetInEndSection":858,"text":"We showed that Dorfin significantly reduced the amount of mutant SOD1 in the mitochondria, the release of cytochrome c and the activation of the following caspase cascade, thereby preventing eventual neuronal cell death in a neuronal cell model of FALS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":133,"document":"36370693","golden":false,"offsetInEndSection":353,"text":"presented phase 3 data for the RNase-H-recruiting antisense oligonucleotide (ASO) targeting superoxide dismutase 1 (SOD1) in ALS, which represents a step forward in the deployment of ASO therapeutics against CNS targets.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":524,"document":"23147550","golden":false,"offsetInEndSection":1043,"text":"e rats\u0027 brain and CSF samples. In human CSF samples, the following proteins were measured: SOD1, tau, phosphorylated tau, VILIP-1, and YKL-40.PARTICIPANTS: Ninety-three participants with ALS, 88 healthy controls, and 89 controls with a neurological disease (55 with dementia of the Alzheimer type, 19 with multiple sclerosis, and 15 with peripheral neuropathy).RESULTS: Antisense oligonucleotide-treated SOD1G93A rats had decreased human SOD1 messenger RNA levels (mean [SD] decrease of 69% [4%]) and decreased protein ","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"35978820","golden":false,"offsetInEndSection":117,"text":"LCS-1 inhibition of superoxide dismutase 1 induces ROS-dependent death of glioma cells and degradates PARP and BRCA1.","beginSection":"title"},{"endSection":"title","offsetInBeginSection":0,"document":"15030390","golden":false,"offsetInEndSection":161,"text":"Dorfin prevents cell death by reducing mitochondrial localizing mutant superoxide dismutase 1 in a neuronal cell model of familial amyotrophic lateral sclerosis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1628,"document":"10710492","golden":false,"offsetInEndSection":1842,"text":"hepatic galanin acts directly on the liver to selectively modulate norepinephrine\u0027s metabolic action, whereas endogenous hepatic NPY acts independently of NE to cause vasoconstriction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":691,"document":"27667859","golden":false,"offsetInEndSection":997,"text":"this account, the experience of acting is (at the very least) a temporally extended, co-conscious collection of agentive and perceptual experiences, functionally integrated and structured both by multimodal perceptual processing as well as by what an agent is, at the time, trying to do.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1388,"document":"18083518","golden":false,"offsetInEndSection":1559,"text":"port the assumption that action understanding in novel situations is primarily mediated by an inferential interpretive system rather than the mirror system.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":196,"document":"17935771","golden":false,"offsetInEndSection":395,"text":"dies have found that the motor processes for manual rotation are engaged in a direction-specific manner when a verb disambiguates the direction of rotation [e.g. \"unscrewed;\" Zwaan, R. A., \u0026 Taylor, ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":388,"document":"27667859","golden":false,"offsetInEndSection":618,"text":"I assess recent zombie action arguments regarding conscious visual experience, and I argue that contrary to what some have claimed, conscious visual experience plays a causal role for action control in some circumstances. Second, ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":339,"document":"33873250","golden":false,"offsetInEndSection":640,"text":"d computer animations to simulate actions in social groups initiated by visual action cues or category labels, and we measured differences in response times between identifying actions that were and were not consistent with group members, without explicit requirements regarding generalization. It was","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":540,"document":"22681697","golden":false,"offsetInEndSection":751,"text":" of neural activity showed that the representation of the selected action was stronger in lateral prefrontal cortex (lPFC), and occurred earlier in the lPFC than it did in the dorsal striatum (dSTR). In contrast","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1082,"document":"18083518","golden":false,"offsetInEndSection":1314,"text":"brain areas that are part of a network involved in inferential interpretive processes of rationalization and mentalization but that lack mirror properties are more active when the action occurs in an implausible context. However, no","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23095902","golden":false,"offsetInEndSection":117,"text":"BACKGROUND AND PURPOSE: Both action observation (AO) and action imagery have been proposed as therapeutic options for","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":239,"document":"35384866","golden":false,"offsetInEndSection":429,"text":"Numerous studies have demonstrated a multidirectional mechanism of action involving the effect of the drug on the adrenergic and cholinergic systems and the intracellular calcium metabolism.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"1114952","golden":false,"offsetInEndSection":298,"text":"Studies on the electrophysiologic mechanisms responsible for disturbances of cardiac rate, rhythm, and conduction, and studies on the actions and mechanisms of action of antiarrhythmic and other drugs, permit the development of an apparently reasonable approach to treatment of cardiac arrhythmias.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"1114952","golden":false,"offsetInEndSection":120,"text":"Electrophysiology and pharmacology of cardiac arrhythmias. III. The causes and treatment of cardiac arrhythmias. Part B.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":728,"document":"1114952","golden":false,"offsetInEndSection":851,"text":"It is likely, also, that disease modifies the response of cardiac cells to drugs in ways that have not yet been discovered.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":578,"document":"1114952","golden":false,"offsetInEndSection":727,"text":"It is likely that cardiac disease in humans has effects on the electrical activity of cardiac cells which have not been reproduced in the laboratory.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":244,"document":"7689439","golden":false,"offsetInEndSection":404,"text":"The molecular mechanism of action of these compounds provides the potential for use in clinical medicine in areas other than their role as antibacterial agents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":199,"document":"12391935","golden":false,"offsetInEndSection":327,"text":"Ideas about the mechanism of therapeutic action, in contrast, are hypothetical constructs, and cannot be completely spelled out.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":293,"document":"23789973","golden":false,"offsetInEndSection":407,"text":"The extension of such mechanisms to language may occur only in sensorimotor circuits devoted to the action domain.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":299,"document":"1114952","golden":false,"offsetInEndSection":400,"text":"Some of the rules derived from an appreciation of cardiac electrophysiology are generally applicable.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":852,"document":"1114952","golden":false,"offsetInEndSection":1005,"text":"Nevertheless, some progress has been made and further experiment and thought may provide both better understanding and new and better therapeutic agents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":216,"document":"24628581","golden":false,"offsetInEndSection":356,"text":"It also prevents cell death by a known mechanism dependant on astrocytes and the secretion of the plasminogen activator inhibitor 1 (PAI-1).","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"20012482","golden":false,"offsetInEndSection":78,"text":"Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":394,"document":"20012482","golden":false,"offsetInEndSection":697,"text":"Three anti-angiogenic tyrosine kinase inhibitors (TKIs), sunitinib, sorafenib and pazopanib, with differential binding capacities to angiogenic kinases were recently approved for treatment of patients with advanced cancer (renal cell cancer, gastro-intestinal stromal tumors, and hepatocellular cancer).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1011,"document":"20012482","golden":false,"offsetInEndSection":1169,"text":"We describe their molecular structure and classification, their mechanism of action, and their inhibitory activity against specific kinase signaling pathways.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17229773","golden":false,"offsetInEndSection":110,"text":"Trastuzumab is a humanized mAb directed against the extracellular domain of the tyrosine kinase receptor HER2.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":713,"document":"17762320","golden":false,"offsetInEndSection":851,"text":"Zonisamide also inhibits low-threshold T-type calcium channels in neurons, which may prevent the spread of seizure discharge across cells.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"20012482","golden":false,"offsetInEndSection":147,"text":"Tyrosine kinases are important cellular signaling proteins that have a variety of biological activities including cell proliferation and migration.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":366,"document":"23423598","golden":false,"offsetInEndSection":428,"text":"Indomethacin has a clear action as a cyclooxygenase inhibitor.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":288,"document":"20012482","golden":false,"offsetInEndSection":393,"text":"Inhibition of angiogenic tyrosine kinases has been developed as a systemic treatment strategy for cancer.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1170,"document":"20012482","golden":false,"offsetInEndSection":1357,"text":"In addition, we provide insight into what extent selective targeting of angiogenic kinases by TKIs may contribute to the clinically observed anti-tumor activity, resistance, and toxicity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"7514332","golden":false,"offsetInEndSection":161,"text":"Experimental results suggest that protein kinase C (PK-C) may play a substantial role in the action of IFNs, but the precise biochemical pathway remains unknown.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":135,"document":"11068911","golden":false,"offsetInEndSection":500,"text":"The aims of this paper are to examine what is currently known about its mechanism of action, to compare the action with that of a widely investigated aliphatic dialdehyde, glutaraldehyde (GTA), and to put forward a hypothesis that would, in the light of current knowledge, explain how OPA inactivates micro-organisms, including GTA-resistant Mycobacterium chelonae.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":162,"document":"7514332","golden":false,"offsetInEndSection":311,"text":"Recent evidences reveal the complexity of the mechanism of IFN-action and show that the IFN-alpha, -beta and -gamma induced pathways are overlapping.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"7514332","golden":false,"offsetInEndSection":68,"text":"Signal transducing mechanisms in interferon action (a brief review).","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1010,"document":"9123943","golden":false,"offsetInEndSection":1117,"text":"They can bind to the genomic DNA in the nucleus and thus block transcription (Hoogsten-type base triplets).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"6096847","golden":false,"offsetInEndSection":103,"text":"The action of a drug is mediated by the attainment of an appropriate concentration at an effector site.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":312,"document":"7514332","golden":false,"offsetInEndSection":428,"text":"We briefly discuss what is known in this field and suggest a way in which the contrasting views might be reconciled.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":104,"document":"6096847","golden":false,"offsetInEndSection":216,"text":"However, the mechanisms of action of TCA\u0027s are complex, with multiple effector sites mediating multiple actions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"11068911","golden":false,"offsetInEndSection":134,"text":"Ortho-phthalaldehyde (OPA) is a new aromatic dialdehyde antimicrobial agent, the mechanism of action of which has been little studied.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"6296885","golden":false,"offsetInEndSection":74,"text":"Antithrombotic activity and the mechanism of action of trapidil (Rocornal)","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":240,"document":"1218263","golden":false,"offsetInEndSection":464,"text":"study of endogenous creatinine and of osmotic-free water clearance showed the diuretic action of chloracizine to be mainly due to the increase of glomerular filtration and to reduction of the relative proximal reabsorption.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1014,"document":"6994806","golden":false,"offsetInEndSection":1211,"text":"a-dehydrobiotin would be partly due to the fact that it compete with biotin for the fixation on the apocarboxylases, producing irreversibly inactive enzymes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"1218263","golden":false,"offsetInEndSection":237,"text":"Diuretic and natriuretic action of chloracizine in rats was not associated with its direct influence on the kidney and was accompanied by increase in the plasma volume, by a fall of the hematocrite index and of the total plasma proteins.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":184,"document":"25698840","golden":false,"offsetInEndSection":405,"text":"nents of LNG-EC have argued that they have moral certitude that LNG-EC works via a non-abortifacient mechanism of action, and claim that all the major scientific and medical data consistently support this hypothesis. Howe","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":217,"document":"33847313","golden":false,"offsetInEndSection":387,"text":"ic acid is a prodrug rapidly converted in the liver to a coenzyme A derivate, ETC-1200-CoA, by an endogenous liver very long-chain acyl-CoA synthetase-1 (ACSVL1). Since A","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":475,"document":"12238801","golden":false,"offsetInEndSection":840,"text":"um hypochlorite is the most used irrigating solution in endodontics, because its mechanism of action causes biosynthetic alterations in cellular metabolism and phospholipid destruction, formation of chloramines that interfere in cellular metabolism, oxidative action with irreversible enzymatic inactivation in bacteria, and lipid and fatty acid degradation. The ai","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":229,"document":"2936372","golden":false,"offsetInEndSection":388,"text":"tronidazole had anti-oxidant action which was not exerted by the scavenging of reactive oxygen species, but by having an effect on neutrophil cell functions. B","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1024,"document":"1562510","golden":false,"offsetInEndSection":1316,"text":"erequisites for their antiproliferative potency are an affinity to the progesterone receptor as well as a sufficient number of available receptors in the tumors, the strong tumor inhibiting potential of the antiprogestins cannot be explained by a classical anti-hormonal mechanism. Surprising","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":393,"document":"1326934","golden":false,"offsetInEndSection":607,"text":" cyclic GMP activates a kinase protein which in turn activates a number of other protein enzymes involved in the recaptation of calcium by the sarcoplasmic reticulum and in the extrusion of calcium from the cell. I","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":877,"document":"31633330","golden":false,"offsetInEndSection":1171,"text":"f action of these CQDs was revealed to be inhibition of HCoV-229E entry that could be due to interaction of the functional groups of the CQDs with HCoV-229E entry receptors; surprisingly, an equally large inhibition activity was observed at the viral replication step.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":726,"document":"7543588","golden":false,"offsetInEndSection":939,"text":"We therefore conclude that a major mechanism of action of NB-DNJ as an inhibitor of HIV replication is the impairment of viral entry at the level of post-CD4 binding, due to an effect on viral envelope components.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":359,"document":"25515946","golden":false,"offsetInEndSection":700,"text":"This broad range of anti-infective activities is due to one common mode of action, i.e., the inhibition of type II topoisomerases or inhibition of viral helicases, thus maintaining the selective toxicity of fluoroquinolones inhibiting microbial topoisomerases at low concentrations but mammalian topoisomerases at much higher concentrations.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1541,"document":"16188329","golden":false,"offsetInEndSection":1760,"text":" The data suggested that the primary mechanism of action for baicalein may be to block HCMV infection at entry while the primary mechanism of action for genistein may be to block HCMV immediate-early protein functioning","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":458,"document":"30637608","golden":false,"offsetInEndSection":689,"text":"The mechanism of Griffithsin\u0027s action against PEDV involved both preventing viral attachment to host cells and disrupting cell-to-cell transmission; its dual mode of action distinguished Griffithsin from most other antiviral drugs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":558,"document":"26989425","golden":false,"offsetInEndSection":650,"text":"The primary mode of action of PEP and PEP + ALK + OA is the inhibition of virus replication.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":495,"document":"27865960","golden":false,"offsetInEndSection":681,"text":"tion of the mechanism of action of the compound revealed that IOP treatment induces its inhibitory actions directly on virus particles through blocking viral binding/absorpting. The inhi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":187,"document":"18567519","golden":false,"offsetInEndSection":444,"text":"hanism of action involves nucleophilic attack by Cys145 present in the active site on the carbonyl carbon of the scissile amide bond of the substrate and the intermediate product is stabilized by hydrogen bonds with the residues of the oxyanion hole. Based ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":96,"document":"23870416","golden":false,"offsetInEndSection":189,"text":"molecule, 4EGI-1 has been reported to selectively block the initiation factor eIF4E. We have ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":710,"document":"28049552","golden":false,"offsetInEndSection":855,"text":" this study suggested that targeting multiple tumor metabolic regulators might be one anti-glioma mechanism of streptodepsipeptide P11A. A possib","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":190,"document":"22369784","golden":false,"offsetInEndSection":420,"text":"Olesoxime (TRO19622), a novel neuroprotective and reparative compound identified in a high-throughput screen based on motoneuron (MN) survival, delays disease onset and improves survival in mutant SOD1(G93A) mice, a model for ALS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1252,"document":"22369784","golden":false,"offsetInEndSection":1477,"text":"These studies suggest that olesoxime exerts its protective effect on multiple cell types implicated in the disease process in SOD1(G93A) mice, slowing down muscle denervation, astrogliosis, microglial activation and MN death.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36228827","golden":false,"offsetInEndSection":155,"text":"Inotersen is an antisense oligonucleotide inhibitor licensed for the treatment of polyneuropathy complicating hereditary transthyretin amyloidosis (ATTRv).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":280,"document":"30805745","golden":false,"offsetInEndSection":426,"text":"Nusinersen, an SMN2 mRNA splicing modifier, was approved as first-ever therapy of spinal muscular atrophy (SMA) by FDA in 2016 and by EMA in 2017.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":100,"document":"33762737","golden":false,"offsetInEndSection":376,"text":"Nine single-stranded antisense oligonucleotide (ASO) drugs representing four chemical classes, two mechanisms of action and four routes of administration have been approved for commercial use, including the first RNA-targeted drug to be a major commercial success, nusinersen.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":421,"document":"22369784","golden":false,"offsetInEndSection":573,"text":"The present study further analyses the cellular basis for the protection provided by olesoxime at the neuromuscular junctions (NMJ) and the spinal cord.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":71,"document":"23541756","golden":false,"offsetInEndSection":287,"text":" sclerosis. In the SOD1 Gly93Ala rat model of amyotrophic lateral sclerosis, the antisense oligonucleotide ISIS 333611 delivered to CSF decreased SOD1 mRNA and protein concentrations in spinal cord tissue and prolong","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":530,"document":"14763129","golden":false,"offsetInEndSection":733,"text":"These inhibitors block the expression of Raf protein, block Ras/Raf interaction, block its kinase activity, or block the kinase activity of the Raf target protein mitogen-activated protein kinase kinase.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"22369784","golden":false,"offsetInEndSection":116,"text":"Olesoxime delays muscle denervation, astrogliosis, microglial activation and motoneuron death in an ALS mouse model.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1010,"document":"22369784","golden":false,"offsetInEndSection":1251,"text":"Immunostaining of cryostat sections of the lumbar spinal cord with VAChT to visualize MNs, GFAP for astrocytes and Iba1 for microglial cells showed that olesoxime strongly reduced astrogliosis and microglial activation and prevented MN loss.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":887,"document":"17983317","golden":false,"offsetInEndSection":1100,"text":"ng effects for repeating the target-to-movement mapping (i.e., the action rule) of a tool-use action and suggest that a rather abstract action schema is activated during action observation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":475,"document":"16942861","golden":false,"offsetInEndSection":638,"text":"ial prefrontal cortex is involved in implementing the goal-based action selection and the striatum is involved in implementing the utility-based action bias. Goal-","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":579,"document":"14758473","golden":false,"offsetInEndSection":720,"text":"ndicate that in both modes ideomotor movements are governed by two basic principles: Perceptual induction and intentional induction. In the p","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":202,"document":"33615007","golden":false,"offsetInEndSection":316,"text":"is study seeks to disclose the interference of an implicit motor prediction effect during actions reconstruction. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":140,"document":"20526978","golden":false,"offsetInEndSection":362,"text":"he present study replicates and extends these findings by indicating a real-time simulation process (Graf et al., 2007), which can be differentiated from a similarity-based evaluation of internal action representations. Mo","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1028,"document":"14758473","golden":false,"offsetInEndSection":1144,"text":"on through observation can pertain to both the action\u0027s physical surface and underlying intentions. Furthermore, our","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":641,"document":"19929763","golden":false,"offsetInEndSection":863,"text":"lowed by an attenuation of processing for both spatially and action type compatible stimuli, likely to be driven by efference copy signals that attenuate processing of predicted sensory consequences of actions. Attenuation","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":866,"document":"19929763","golden":false,"offsetInEndSection":1077,"text":"s not response-modality specific; it was found for manual stimuli when participants prepared manual and vocal responses, in line with the hypothesis that action control is hierarchically organized. These results","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1077,"document":"35507019","golden":false,"offsetInEndSection":1193,"text":"s an effective agency cue modulating the amount of self-other integration in joint action.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1142,"document":"36751779","golden":true,"offsetInEndSection":1504,"text":"A 28-week trial of tofersen, an antisense oligonucleotide for superoxide dismutase 1 in patients with amyotrophic lateral sclerosis with superoxide dismutase 1 gene mutations failed to show significant beneficial effects but the 1-year open label extension of this study indicated better clinical and functional outcomes in the group with early tofersen therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":847,"document":"36751779","golden":false,"offsetInEndSection":1141,"text":"A major trial on tominersen, an antisense oligonucleotide designed to reduce the production of the huntingtin protein in subjects with Huntington\u0027s disease, was prematurely interrupted because the drug failed to show higher efficacy than placebo and, at highest doses, led to worsened outcomes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1505,"document":"36751779","golden":false,"offsetInEndSection":1787,"text":"A trial of venglustat, a potent and brain-penetrant glucosylceramide synthase inhibitor, in Parkinson\u0027s disease subjects with heterozygous glucocerebrosidase gene mutations revealed worsened clinical and cognitive performance of patients on the enzyme inhibitor compared to placebo.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":543,"document":"36751779","golden":false,"offsetInEndSection":846,"text":"Two long-term, controlled trials on three anti-?-amyloid monoclonal antibodies (solanezumab, gantenerumab and crenezumab) in subjects carrying Alzheimer\u0027s disease-linked mutated genes encoding for amyloid precursor protein or presenilin 1 or presenilin 2 failed to show cognitive or functional benefits.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":635,"document":"11897887","golden":false,"offsetInEndSection":827,"text":"It is likely that theophylline (a related methylxanthine) has similar actions and it has been suggested that the combination of caffeine and sympathomimetics may be a more potent erogenic aid.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1331,"document":"23667117","golden":false,"offsetInEndSection":1460,"text":"Some drugs function as sodium or calcium channel blockers, others enhance GABAergic function or modulate neuro-plastic functions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1788,"document":"36751779","golden":false,"offsetInEndSection":2076,"text":"We concluded that clinical trials in neurodegenerative diseases with a genetic basis should test monoclonal antibodies, antisense oligonucleotides or gene editing directed against the mutated enzyme or the mutated substrate without dramatically affecting physiological wild-type variants.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":211,"document":"36751779","golden":false,"offsetInEndSection":447,"text":"Specifically, we discussed randomized clinical trials in subjects with Alzheimer\u0027s disease, Huntington\u0027s disease and amyotrophic lateral sclerosis bearing pathogenic gene mutations, and glucocerebrosidase-associated Parkinson\u0027s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":414,"document":"18806702","golden":false,"offsetInEndSection":541,"text":"What are the potential mechanisms of action of probiotics in IBS: immune function, motor, secretory, sensory, and fermentation?","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36751779","golden":false,"offsetInEndSection":135,"text":"Investigational treatments for neurodegenerative diseases caused by inheritance of gene mutations: lessons from recent clinical trials.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":155,"document":"25404049","golden":false,"offsetInEndSection":360,"text":"Recent studies have shown that Withaferin A (WA), an inhibitor of nuclear factor-kappa B activity, was efficient in reducing disease phenotype in a TAR DNA binding protein 43 transgenic mouse model of ALS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":164,"document":"19129788","golden":false,"offsetInEndSection":372,"text":"The essence of this \u0027mirror\u0027 mechanism is as follows: whenever individuals observe an action being done by someone else, a set of neurons that code for that action is activated in the observers\u0027 motor system.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":723,"document":"36622328","golden":false,"offsetInEndSection":845,"text":"Expression of SOD1LUTI is induced by the Unfolded Protein Response, and it acts to repress canonical SOD1 mRNA expression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":861,"document":"36751779","golden":false,"offsetInEndSection":1159,"text":"on tominersen, an antisense oligonucleotide designed to reduce the production of the huntingtin protein in subjects with Huntington\u0027s disease, was prematurely interrupted because the drug failed to show higher efficacy than placebo and, at highest doses, led to worsened outcomes. A 28-week trial o","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"12690410","golden":false,"offsetInEndSection":224,"text":"Antiepileptic drugs (DAEs) act through different mechanisms of action: increase in central inhibition, inhibition of excitatorios mechanisms and modification of the excitability through their action on the ionic channels. Ep","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":611,"document":"26683668","golden":false,"offsetInEndSection":839,"text":"te its ability to bind precursors from different pathways, lysobactin\u0027s cellular mechanism of killing is due exclusively to Lipid II binding, which causes septal defects and catastrophic cell envelope damage.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"7608321","golden":false,"offsetInEndSection":276,"text":"The mechanism of antiinflammatory action of cordiachromene A, isolated from the chloromethylenic extract of the ascidian Aplidium antillense or chemically synthesized, was studied using different in vivo and in vitro inhibition tests on enzymes of the cyclooxygenase cascade. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":547,"document":"18729096","golden":false,"offsetInEndSection":806,"text":"icle, we review the possible action mechanism of insulin-mimetic and antidiabetic vanadyl complexes, focusing on a recently proposed complex, bis(allixinato)oxovanadium(IV), with respect to the insulin-signaling pathway in cultured adipocytes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"9859690","golden":false,"offsetInEndSection":130,"text":"Zolmitriptan is a new serotonergic agonist with excellent oral bioavailability exhibiting a potent symptomatic antimigraine effect","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":240,"document":"3010823","golden":false,"offsetInEndSection":415,"text":"croaggregation of the GnRH receptor mimics all known actions of the releasing hormone, and therefore is viewed as an early step in the molecular mechanism of hormone action. I","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"12323126","golden":false,"offsetInEndSection":52,"text":"Inhaled furosemide: a whole new mechanism of action.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"7449994","golden":false,"offsetInEndSection":174,"text":"The mechanism of antiherpetic action of bonaphthon was studied in experimental herpetic keratitis of rabbits infected with herpes simplex type I virus (Koptev and IC strains)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":219,"document":"2483141","golden":false,"offsetInEndSection":414,"text":"boxin was found to stimulate anaerobic glycolysis with the hyperproduction of lactate and the formation of glucose deficiency and also to increase the rate of protein synthesis on polyribosomes. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":349,"document":"31268366","golden":false,"offsetInEndSection":597,"text":"Areas covered: Inotersen, an antisense oligonucleotide inhibitor, was recently approved in the United States and Europe for the treatment of the polyneuropathy of ATTRv based on the positive results obtained in the pivotal phase 3 trial, NEURO-TTR.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":931,"document":"25134731","golden":false,"offsetInEndSection":1110,"text":"Guanabenz, a centrally acting oral drug approved for the treatment of hypertension, enhances the PERK pathway by selectively inhibiting GADD34-mediated dephosphorylation of eIF2?.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":725,"document":"28524214","golden":false,"offsetInEndSection":916,"text":"Nusinersen, a methoxi-ethyl phosphotioate antisense oligonucleotide has recently approved for treatment of patients with SMA type 1 after having proved its efficacy in clinical trial phase 3.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17078389","golden":false,"offsetInEndSection":184,"text":"ISIS-301012 is an antisense oligonucleotide inhibitor of apolipoprotein B-100, which is being developed by Isis Pharmaceuticals Inc for the potential treatment of hypercholesterolemia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":341,"document":"29270111","golden":false,"offsetInEndSection":489,"text":"While there are currently no clinical ALS gene therapies, the splice-switching antisense oligonucleotide, nusinersen, was recently approved for SMA.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1136,"document":"31268366","golden":false,"offsetInEndSection":1333,"text":"Expert opinion: Inotersen targets the disease-forming protein, TTR, and has been shown to improve quality of life and neuropathy progression in patients with stage 1 or 2 ATTRv with polyneuropathy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1162,"document":"36751779","golden":false,"offsetInEndSection":1524,"text":"ofersen, an antisense oligonucleotide for superoxide dismutase 1 in patients with amyotrophic lateral sclerosis with superoxide dismutase 1 gene mutations failed to show significant beneficial effects but the 1-year open label extension of this study indicated better clinical and functional outcomes in the group with early tofersen therapy. A trial of venglust","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":551,"document":"36751779","golden":false,"offsetInEndSection":858,"text":"-term, controlled trials on three anti-?-amyloid monoclonal antibodies (solanezumab, gantenerumab and crenezumab) in subjects carrying Alzheimer\u0027s disease-linked mutated genes encoding for amyloid precursor protein or presenilin 1 or presenilin 2 failed to show cognitive or functional benefits. A major tri","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1527,"document":"36751779","golden":false,"offsetInEndSection":1811,"text":" a potent and brain-penetrant glucosylceramide synthase inhibitor, in Parkinson\u0027s disease subjects with heterozygous glucocerebrosidase gene mutations revealed worsened clinical and cognitive performance of patients on the enzyme inhibitor compared to placebo. We concluded that clini","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":986,"document":"26366588","golden":false,"offsetInEndSection":1158,"text":"eriments, we apply the mined part detectors as a visual vocabulary to the task of action recognition on four datasets: KTH, Olympic Sports, UCF50, and HMDB51. The experimen","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1093,"document":"19352696","golden":false,"offsetInEndSection":1298,"text":"g was observed when both action choice and action timing were internally generated or externally specified, compared to conditions where the two parameters were selected by different routes. Our result sug","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":862,"document":"25089880","golden":false,"offsetInEndSection":1101,"text":"f skilled handball goalkeepers anticipated the direction of penalty throws performed by opponents before and after a training intervention that provided situational probability information in the form of action preferences (AP). During the","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":354,"document":"26366588","golden":false,"offsetInEndSection":500,"text":"address this problem by learning and selecting a collection of discriminative and representative action part detectors directly from video data. W","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1379,"document":"25089880","golden":false,"offsetInEndSection":1639,"text":"nents who did have an action preference during the training phase resulted in improved anticipatory performance if the opponent continued to bias their throws towards their preferred direction, but decreased performance if the opponent did not. These findings ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":367,"document":"39330700","golden":true,"offsetInEndSection":527,"text":"Tofersen, an antisense oligonucleotide that reduces expression of SOD1 via RNAase mediated degradation of SOD1 mRNA, has shown robust effects on ALS biomarkers.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36129998","golden":true,"offsetInEndSection":430,"text":"BACKGROUND: The intrathecally administered antisense oligonucleotide tofersen reduces synthesis of the superoxide dismutase 1 (SOD1) protein and is being studied in patients with amyotrophic lateral sclerosis (ALS) associated with mutations in SOD1 (SOD1 ALS).METHODS: In this phase 3 trial, we randomly assigned adults with SOD1 ALS in a 2:1 ratio to receive eight doses of tofersen (100 mg) or placebo over a period of 24 weeks.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":718,"document":"38914784","golden":false,"offsetInEndSection":980,"text":"RNase H-dependent ASOs include inotersen and eplontersen (for hereditary transthyretin amyloidosis), fomiversen (for opportunistic cytomegalovirus infection), mipomersen (for familial hypercholesterolemia), and tofersen [for amyotrophic lateral sclerosis (ALS)].","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"39330700","golden":false,"offsetInEndSection":22,"text":"Tofersen for SOD1 ALS.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32640130","golden":true,"offsetInEndSection":163,"text":"BACKGROUND: Tofersen is an antisense oligonucleotide that mediates the degradation of superoxide dismutase 1 (SOD1) messenger RNA to reduce SOD1 protein synthesis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":247,"document":"39330700","golden":false,"offsetInEndSection":366,"text":"ALS associated with gain of function mutations in SOD1 make \u0027knock-down\u0027 strategies an attractive therapeutic approach.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":324,"document":"39473221","golden":true,"offsetInEndSection":575,"text":"The results from a Phase III trial of the antisense oligonucleotide, that is, tofersen, which targets SOD1 mRNA, showed decreased levels of cerebrospinal fluid SOD1 and plasma neurofilament light chain but no improvements in primary clinical endpoint.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37316681","golden":false,"offsetInEndSection":135,"text":"Tofersen (Qalsody?) is an antisense oligonucleotide being developed by Biogen for the treatment of amyotrophic lateral sclerosis (ALS).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":367,"document":"38666665","golden":true,"offsetInEndSection":610,"text":"In the four years following enrollment, the patient received monthly intrathecal treatment with tofersen, an antisense oligonucleotide compound that inhibits SOD1 protein expression and hence lowers the synthesis of toxic SOD1 protein species.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39330700","golden":false,"offsetInEndSection":96,"text":"Amyotrophic lateral sclerosis (ALS) is a neurodegenerative condition affecting the motor system.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":981,"document":"38914784","golden":false,"offsetInEndSection":1165,"text":"Splice modulating ASOs include nursinersen (for spinal muscular atrophy) and eteplirsen, golodirsen, viltolarsen, and casimersen (all for the treatment of Duchenne muscular dystrophy).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":341,"document":"38914784","golden":false,"offsetInEndSection":472,"text":"The second MOA is triggered by ASOs that occlude splice acceptor sites in pre-mRNAs leading to skipping of a mutation-bearing exon.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":213,"document":"38914784","golden":false,"offsetInEndSection":340,"text":"The first MOA is initiated by base-pairing between the ASO and its target mRNA, followed by RNase H-dependent mRNA degradation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":947,"document":"39054363","golden":false,"offsetInEndSection":1246,"text":"The results indicate that both mono- and bi-allelic SOD1D91A are causally relevant targets, with a possibly reduced effect size of SOD1D91Ahet.CONCLUSIONS: The finding is relevant for decision making regarding tofersen treatment, patient counseling and inclusion of SOD1D91A patients in drug trials.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":248,"document":"38758193","golden":false,"offsetInEndSection":349,"text":"ll patients. Tofersen is a novel oligonucleotide antisense drug specifically developed to treat SOD1-","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1244,"document":"37975798","golden":true,"offsetInEndSection":1477,"text":" able to better monitor and treat ALS.CONCLUSIONS: Although treatment of ALS is difficult, the newly approved drug tofersen has emerged as a potential therapy to slow down the progression of ALS by targeting SOD1 mRNA, representing a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1186,"document":"39017978","golden":false,"offsetInEndSection":1413,"text":"verall, these findings suggest that tofersen treatment markedly alters selenium status and probably the redox status within the central nervous system, possibly due to a direct effect on neurons and/or the blood-brain barrier. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2090,"document":"16262900","golden":false,"offsetInEndSection":2173,"text":"ation of the tolafentrine. When assessed in vitro, tolafentrine blocked the enhance","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":528,"document":"39330700","golden":false,"offsetInEndSection":681,"text":"While a Phase III trial of tofersen failed to meet its primary end point, open label extension data suggests that tofersen slows progression of SOD1 ALS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39054363","golden":false,"offsetInEndSection":260,"text":"BACKGROUND: Since the antisense oligonucleotide tofersen has recently become available for the treatment of amyotrophic lateral sclerosis (ALS) caused by mutations in SOD1, determining the causality of the over 230 SOD1 variants has become even more important.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":391,"document":"39054363","golden":false,"offsetInEndSection":858,"text":"The reason is the high allele frequency of SOD1D91A in Europe, exceeding 1% in Finno-Scandinavia.METHODS: We present the clinical disease course and serum neurofilament light chain (NfL) results of treating 11 patients either homo- or heterozygous for the SOD1D91A allele for up to 16 months with tofersen.RESULTS: Tofersen decreases serum neurofilament levels (sNFL), which are associated with the ALS progression rate, in the 6 ALS patients homozygous for SOD1D91A.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":247,"document":"38758193","golden":true,"offsetInEndSection":348,"text":"all patients. Tofersen is a novel oligonucleotide antisense drug specifically developed to treat SOD1","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1365,"document":"36129998","golden":false,"offsetInEndSection":1490,"text":"o have faster progression). Tofersen led to greater reductions in concentrations of SOD1 in CSF and of neurofilament light ch","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":678,"document":"39054363","golden":false,"offsetInEndSection":830,"text":"nths with tofersen.RESULTS: Tofersen decreases serum neurofilament levels (sNFL), which are associated with the ALS progression rate, in the 6 ALS patie","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":373,"document":"38022476","golden":false,"offsetInEndSection":498,"text":"Tofersen, an antisense oligonucleotide, in SOD1 related ALS, has joined the bandwagon of FDA-approved drugs for ALS recently.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1185,"document":"39017978","golden":false,"offsetInEndSection":1412,"text":"Overall, these findings suggest that tofersen treatment markedly alters selenium status and probably the redox status within the central nervous system, possibly due to a direct effect on neurons and/or the blood-brain barrier.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38855716","golden":false,"offsetInEndSection":239,"text":"Background: Qalsody (tofersen), an intrathecal therapy (IT) antisense oligonucleotide (ASO), was granted accelerated approval by the Food and Drug Administration for the treatment of SOD1-mediated amyotrophic lateral sclerosis (ALS) on Apr","beginSection":"abstract"}],"ideal_answer":[],"id":"63adc9e7c6c7d4d31b00001a","type":"summary","body":"What is the mechanism of action of Tofersen?"},{"documents":[{"golden":false,"id":"36230843"},{"golden":false,"id":"33346092"},{"golden":false,"id":"33753753"},{"golden":false,"id":"32617293"},{"golden":true,"id":"33547073"},{"golden":false,"id":"30537486"},{"golden":true,"id":"27306666"},{"golden":false,"id":"36873300"},{"golden":false,"id":"35337938"},{"golden":true,"id":"36297663"},{"golden":false,"id":"37626360"},{"golden":false,"id":"35267132"},{"golden":false,"id":"39207625"},{"golden":false,"id":"38000663"},{"golden":false,"id":"30214628"},{"golden":false,"id":"39624326"},{"golden":false,"id":"37142373"},{"golden":false,"id":"30674905"},{"golden":false,"id":"37672093"},{"golden":false,"id":"23527068"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":1470,"document":"33346092","golden":false,"offsetInEndSection":1868,"text":"The FUS-mediated BBB opening increased the brain tumor-to-serum ratio of etoposide by 3.5-fold and increased the etoposide concentration in brain tumor tissue by 8-fold compared with treatment without ultrasound.CONCLUSIONS: The current study demonstrates that BBB opening with FUS increases intratumoral delivery of etoposide in the brain, resulting in local control and overall survival benefits.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1174,"document":"32617293","golden":false,"offsetInEndSection":1468,"text":"We anticipate that there will be minimal side effects associated with NaviFUS-mediated transient BBB opening.CONCLUSIONS: Obtained results will support a planned phase 2 trial to evaluate whether NaviFUS can effectively enhance the delivery of chemotherapeutic agents and improve tumor control.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":349,"document":"36230843","golden":false,"offsetInEndSection":532,"text":"Focused ultrasound (FUS) has shown promising results in preclinical and clinical trials for treatment of GBM and has received regulatory approval for the treatment of other neoplasms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":696,"document":"36230843","golden":false,"offsetInEndSection":864,"text":"Low-intensity FUS can be used to transiently open the blood-brain barrier (BBB), which restricts diffusion of most macromolecules and therapeutic agents into the brain.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":225,"document":"36230843","golden":false,"offsetInEndSection":348,"text":"Nonetheless, recurrence and tumor progression is the norm, driven by tumor stem cell activity and a high mutational burden.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36230843","golden":false,"offsetInEndSection":95,"text":"Glioblastoma (GBM) is an aggressive primary astrocytoma associated with short overall survival.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1192,"document":"27306666","golden":true,"offsetInEndSection":1474,"text":"Our preliminary findings indicate that repeated opening of the BBB using our pulsed ultrasound system, in combination with systemic microbubble injection, is safe and well tolerated in patients with recurrent GBM and has the potential to optimize chemotherapy delivery in the brain.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1500,"document":"36230843","golden":false,"offsetInEndSection":1646,"text":"Finally, another mechanism under investigation, known as histotripsy, produces tumor ablation via acoustic cavitation rather than thermal effects.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1311,"document":"36230843","golden":false,"offsetInEndSection":1499,"text":"Additionally, FUS can stimulate immunological attack of tumor cells, can activate sonosensitizers to exert cytotoxic effects on tumor tissue, and can sensitize tumors to radiation therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1070,"document":"36230843","golden":false,"offsetInEndSection":1239,"text":"BBB opening can also be used to improve detection of cell-free tumor DNA with liquid biopsies, allowing non-invasive diagnosis and identification of molecular mutations.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1207,"document":"37626360","golden":false,"offsetInEndSection":1404,"text":"In conclusion, FeDOX@cellMBs successfully penetrated the blood-brain barrier and effectively inhibited glioblastoma growth under the combined effects of focused ultrasound and magnetic stimulation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1102,"document":"35267132","golden":false,"offsetInEndSection":1307,"text":"support clinical needs.CONCLUSION: This article reviews the key preclinical and clinical updates from the workshop, outlines next steps to research, and provides relevant references for focused ultrasound ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":279,"document":"39207625","golden":false,"offsetInEndSection":480,"text":" (BBB). Focused ultrasound (FUS) combined with systemically administered microbubbles has emerged as a non-invasive, targeted, and reversible approach to transiently open the BBB, thus enhancing drug d","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":427,"document":"38000663","golden":false,"offsetInEndSection":624,"text":"ocused ultrasound (FUS) with microbubbles has recently emerged as an innovative and exciting technology that non-invasively permeabilizes the BBB in a small focal region with millimeter precision. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30214628","golden":false,"offsetInEndSection":247,"text":"Focused ultrasound with microbubbles promises unprecedented advantages for blood-brain barrier disruption over existing intracranial drug delivery methods, as well as a significant number of tunable parameters that affect its safety and efficacy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":533,"document":"36230843","golden":false,"offsetInEndSection":695,"text":"Here, we review the range of applications for FUS in the treatment of GBM, which depend on parameters, including frequency, power, pulse duration, and duty cycle.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33346092","golden":false,"offsetInEndSection":450,"text":"PURPOSE: Glioblastoma (GBM) is a devastating disease. With the current treatment of surgery followed by chemoradiation, outcomes remain poor, with median survival of only 15 months and a 5-year survival rate of 6.8%. A challenge in treating GBM is the heterogeneous integrity of the blood-brain barrier (BBB), which limits the bioavailability of systemic therapies to the brain. There is a growing interest in enhancing drug delivery by opening the B","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33547073","golden":true,"offsetInEndSection":450,"text":"Focused ultrasound (FUS) in the presence of microbubbles can transiently open the blood-brain barrier (BBB) to increase therapeutic agent penetration at the targeted brain site to benefit recurrent glioblastoma (rGBM) treatment. This study is a dose-escalating pilot trial using a device combining neuronavigation and a manually operated frameless FUS system to treat rGBM patients. The safety and feasibility were established, while a dose-dependent","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36297663","golden":true,"offsetInEndSection":450,"text":"Glioblastoma (GBM) is an aggressive and malignant primary brain tumor. The blood-brain barrier (BBB) limits the therapeutic options available to tackle this incurable tumor. Transient disruption of the BBB by focused ultrasound (FUS) is a promising and safe approach to increase the brain and tumor concentration of drugs administered systemically. Non-invasive, sensitive, and reliable imaging approaches are required to better understand the impact","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37626360","golden":false,"offsetInEndSection":450,"text":"Glioblastoma is the most common type of brain tumor. Due to the presence of the blood-brain barrier, the effects of chemotherapy have been unsatisfactory. The combination of focused ultrasound and microbubbles to reversibly open the blood-brain barrier is now considered a key factor in improving treatment outcomes of glioblastoma. In this study, we developed bionic drug delivery microbubbles, which in combination with focused ultrasound had an ob","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37672093","golden":false,"offsetInEndSection":450,"text":"BACKGROUND: Focused ultrasound (FUS) shows promise for enhancing drug delivery to the brain by temporarily opening the blood-brain barrier (BBB), and it is increasingly used in the clinical setting to treat brain tumours. It remains however unclear whether FUS is being introduced in an ethically and methodologically sound manner. The IDEAL-D framework for the introduction of surgical innovations and the SYRCLE and ROBINS-I tools for assessing the","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39624326","golden":false,"offsetInEndSection":450,"text":"Focused ultrasound-mediated opening of the blood-brain barrier offers a great opportunity to deliver therapeutics into hard-to-treat brain tumors such as glioblastoma multiforme or diffuse midline glioma. However, the potential of the technique to offer a time window for efficient nanomedicine delivery has not been thoroughly studied. Non-invasive and targeted delivery of large drug-loaded nanocarriers, such as liposomes, could offer a safe and s","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39624326","golden":false,"offsetInEndSection":204,"text":"Focused ultrasound-mediated opening of the blood-brain barrier offers a great opportunity to deliver therapeutics into hard-to-treat brain tumors such as glioblastoma multiforme or diffuse midline glioma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33547073","golden":false,"offsetInEndSection":228,"text":"Focused ultrasound (FUS) in the presence of microbubbles can transiently open the blood-brain barrier (BBB) to increase therapeutic agent penetration at the targeted brain site to benefit recurrent glioblastoma (rGBM) treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23527068","golden":false,"offsetInEndSection":285,"text":"The purpose of this study is to assess the preclinical therapeutic efficacy of magnetic resonance imaging (MRI)-monitored focused ultrasound (FUS)-induced blood-brain barrier (BBB) disruption to enhance Temozolomide (TMZ) delivery for improving Glioblastoma Multiforme (GBM) treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":155,"document":"37626360","golden":false,"offsetInEndSection":332,"text":"The combination of focused ultrasound and microbubbles to reversibly open the blood-brain barrier is now considered a key factor in improving treatment outcomes of glioblastoma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":148,"document":"32617293","golden":false,"offsetInEndSection":286,"text":"ioblastoma. Transient BBB opening in glioblastoma (GBM) is feasible by combining focused ultrasound (FUS) with systemic infusion of microb","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":455,"document":"36873300","golden":false,"offsetInEndSection":639,"text":"To address this limitation, focused ultrasound (FUS) has been safely utilized to create transient openings in the BBB, allowing various high molecular weight drugs access to the brain.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":231,"document":"30537486","golden":false,"offsetInEndSection":575,"text":"In order to allow more patients to benefit from this treatment, we explored magnetic resonance image-guided microbubble-enhanced low-intensity pulsed focused ultrasound (LIFU) to transiently open the blood-brain barrier and deliver a first-in-class liposome-loaded small molecule MGMT inactivator in mice bearing temozolomide-resistant gliomas.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37142373","golden":false,"offsetInEndSection":146,"text":"BACKGROUND: Low-intensity pulsed ultrasound with concomitant administration of intravenous microbubbles (LIPU-MB) can be used to open the blood-br","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1101,"document":"35267132","golden":false,"offsetInEndSection":1306,"text":" support clinical needs.CONCLUSION: This article reviews the key preclinical and clinical updates from the workshop, outlines next steps to research, and provides relevant references for focused ultrasound","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":447,"document":"35337938","golden":false,"offsetInEndSection":693,"text":"Focused ultrasound (FUS) - a technique that uses low-frequency ultrasound waves to induce targeted temporary disruption of the BBB - promises to improve survival outcomes by enhancing drug delivery and accumulation to infiltrating tumour regions.","beginSection":"abstract"}],"exact_answer":"","ideal_answer":[],"id":"677e80fd592fa48873000018","type":"yesno","body":"Is focused ultrasound safe for blood brain barrier opening in treatment of glioblastoma?"},{"documents":[{"golden":true,"id":"39282907"},{"golden":true,"id":"38500292"},{"golden":true,"id":"37982848"},{"golden":true,"id":"36995115"},{"golden":false,"id":"20012482"},{"golden":false,"id":"32661391"},{"golden":false,"id":"39172988"},{"golden":false,"id":"33846641"},{"golden":false,"id":"28761757"},{"golden":false,"id":"11521720"},{"golden":false,"id":"21424359"},{"golden":false,"id":"38880548"},{"golden":false,"id":"37961860"},{"golden":false,"id":"1337388"},{"golden":false,"id":"6106495"},{"golden":false,"id":"23317282"},{"golden":false,"id":"21777192"},{"golden":false,"id":"17403543"},{"golden":false,"id":"35384866"},{"golden":false,"id":"27805502"},{"golden":false,"id":"25947283"},{"golden":false,"id":"26143936"},{"golden":false,"id":"20350658"},{"golden":false,"id":"11916069"},{"golden":false,"id":"33024310"},{"golden":false,"id":"22985411"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":1691,"document":"39282907","golden":true,"offsetInEndSection":2100,"text":"Adverse events of any cause were reported in 70% of the patients in the ponsegromab group and in 80% of those in the placebo group.CONCLUSIONS: Among patients with cancer cachexia and elevated GDF-15 levels, the inhibition of GDF-15 with ponsegromab resulted in increased weight gain and overall activity level and reduced cachexia symptoms, findings that confirmed the role of GDF-15 as a driver of cachexia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":219,"document":"39282907","golden":true,"offsetInEndSection":807,"text":"In a small, open-label, phase 1b study involving patients with cancer cachexia, ponsegromab, a humanized monoclonal antibody inhibiting GDF-15, was associated with improved weight, appetite, and physical activity, along with suppressed serum GDF-15 levels.METHODS: In this phase 2, randomized, double-blind, 12-week trial, we assigned patients with cancer cachexia and an elevated serum GDF-15 level (?1500 pg per milliliter) in a 1:1:1:1 ratio to receive ponsegromab at a dose of 100 mg, 200 mg, or 400 mg or to receive placebo, administered subcutaneously every 4 weeks for three doses.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":491,"document":"38500292","golden":true,"offsetInEndSection":600,"text":"Ponsegromab is a potent and selective humanized monoclonal antibody that inhibits GDF-15-mediated signalling.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":157,"document":"37982848","golden":true,"offsetInEndSection":514,"text":"This first-in-patient (phase Ib), 24-week study assessed use of ponsegromab, a mAb against GDF-15, in adults with advanced cancer, cachexia, and elevated GDF-15 serum concentration.PATIENTS AND METHODS: Participants (n \u003d 10) received open-label ponsegromab subcutaneous 200 mg every 3 weeks for 12 weeks in addition to standard-of-care anticancer treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1385,"document":"37982848","golden":true,"offsetInEndSection":1762,"text":"Ponsegromab-mediated improvements in actigraphy-based assessments of physical activity and in quality of life, including appetite as assessed by Functional Assessment of Anorexia-Cachexia Therapy total and subscale scores, were also observed.CONCLUSIONS: Ponsegromab was well tolerated, suppressed serum GDF-15 concentrations, and demonstrated preliminary evidence of efficacy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1206,"document":"36995115","golden":true,"offsetInEndSection":1425,"text":"Ponsegromab (GDF15 inhibitor), a new compound that has just entered a phase II clinical trial, is a promising candidate to treat cancer cachexia and may produce exciting results if the study can be conducted as planned.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39282907","golden":false,"offsetInEndSection":106,"text":"BACKGROUND: Cachexia is a common complication of cancer and is associated with an increased risk of death.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":107,"document":"39282907","golden":false,"offsetInEndSection":218,"text":"The level of growth differentiation factor 15 (GDF-15), a circulating cytokine, is elevated in cancer cachexia.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"39282907","golden":false,"offsetInEndSection":49,"text":"Ponsegromab for the Treatment of Cancer Cachexia.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":887,"document":"39282907","golden":false,"offsetInEndSection":1056,"text":"Key secondary end points were appetite and cachexia symptoms, digital measures of physical activity, and safety.RESULTS: A total of 187 patients underwent randomization.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":208,"document":"39282907","golden":true,"offsetInEndSection":464,"text":" cachexia. In a small, open-label, phase 1b study involving patients with cancer cachexia, ponsegromab, a humanized monoclonal antibody inhibiting GDF-15, was associated with improved weight, appetite, and physical activity, along with suppressed serum GDF","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":394,"document":"37961860","golden":false,"offsetInEndSection":558,"text":"denosumab.OBJECTIVE: The study aimed to investigate if the mechanism by which denosumab inhibits GCTB neoplastic stromal cells growth is via p62 modulation and othe","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1445,"document":"38880548","golden":false,"offsetInEndSection":1583,"text":"ata also suggest that PUF60 is one of its target molecules responsible for the suppression of calcineurin/NFAT signaling by pyrogallol.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1348,"document":"37982848","golden":false,"offsetInEndSection":1590,"text":"oximately 6.6% relative to baseline. Ponsegromab-mediated improvements in actigraphy-based assessments of physical activity and in quality of life, including appetite as assessed by Functional Assessment of Anorexia-Cachexia Therapy total and","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1530,"document":"39282907","golden":false,"offsetInEndSection":1690,"text":"Improvements were observed across measures of appetite and cachexia symptoms, along with physical activity, in the 400-mg ponsegromab group relative to placebo.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39282907","golden":true,"offsetInEndSection":450,"text":"BACKGROUND: Cachexia is a common complication of cancer and is associated with an increased risk of death. The level of growth differentiation factor 15 (GDF-15), a circulating cytokine, is elevated in cancer cachexia. In a small, open-label, phase 1b study involving patients with cancer cachexia, ponsegromab, a humanized monoclonal antibody inhibiting GDF-15, was associated with improved weight, appetite, and physical activity, along with suppre","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37982848","golden":true,"offsetInEndSection":450,"text":"PURPOSE: Cachexia is common in patients with advanced cancer and is associated with elevated serum growth differentiation factor 15 (GDF-15) concentrations. This first-in-patient (phase Ib), 24-week study assessed use of ponsegromab, a mAb against GDF-15, in adults with advanced cancer, cachexia, and elevated GDF-15 serum concentration.PATIENTS AND METHODS: Participants (n \u003d 10) received open-label ponsegromab subcutaneous 200 mg every 3 weeks fo","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38500292","golden":false,"offsetInEndSection":450,"text":"BACKGROUND: Cancer cachexia is a multifactorial metabolic wasting syndrome characterized by anorexia, unintentional loss of weight involving both skeletal muscle and adipose tissues, progressive functional impairment and reduced survival. Therapeutic strategies for this serious condition are very limited. Growth differentiation factor 15 (GDF-15) is a cytokine that is implicated in cancer cachexia and may represent both a biomarker of cancer cach","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":207,"document":"39282907","golden":true,"offsetInEndSection":463,"text":"r cachexia. In a small, open-label, phase 1b study involving patients with cancer cachexia, ponsegromab, a humanized monoclonal antibody inhibiting GDF-15, was associated with improved weight, appetite, and physical activity, along with suppressed serum GD","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":346,"document":"37982848","golden":false,"offsetInEndSection":649,"text":" AND METHODS: Participants (n \u003d 10) received open-label ponsegromab subcutaneous 200 mg every 3 weeks for 12 weeks in addition to standard-of-care anticancer treatment. Ponsegromab safety, tolerability, and pharmacokinetics were assessed in addition to serum GDF-15 concentrations and exploratory measur","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":556,"document":"23317282","golden":false,"offsetInEndSection":699,"text":"A better understanding of the fundamental mechanisms of trastuzumab action is required so that new therapies directed at HER2 can be developed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1358,"document":"20012482","golden":false,"offsetInEndSection":1544,"text":"We feel that it is of crucial importance to increase our understanding of the clinical mechanism of action of anti-angiogenic TKIs in order to further optimize their clinical efficacy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":690,"document":"38752576","golden":false,"offsetInEndSection":767,"text":"s on the role of the hypothalamus. Melanocortin receptor antagonists are show","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":504,"document":"22985411","golden":false,"offsetInEndSection":761,"text":"Our review provides an update in the development of several novel agents targeting the AR signalling pathway now in clinical testing, as well as review novel therapies in development with distinct mechanisms of action showing promising preclinical activity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":392,"document":"33024310","golden":false,"offsetInEndSection":642,"text":"What we do not know is the ultimate mechanism of action; that is, how these drugs irreversibly terminate the \u0027individuality\u0027 of bacterial cells by removing barriers to the external world (cell envelopes) or by destroying their genetic identity (DNA).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":199,"document":"1337388","golden":false,"offsetInEndSection":983,"text":"To date, only the antidepressants and the anticonvulsants have shown any effectiveness, albeit incomplete and inconsistent, and many questions remain unanswered: What are the exact indications for the antidepressants? What component of neuropathic pain do they relieve, and through which mechanisms? Which type of antidepressants should be prescribed? A first-generation tricyclic? Or a new compound with a selective action on serotonin reuptake? What are the effective dosage and duration of the treatment? What is it mechanism of action? What other antalgic effects do carbamazepine and baclofen possess apart from their action on trigeminal neuralgia? The opiates are generally considered to be without effect, but recent clinical and experimental findings seem to point otherwise.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":737,"document":"6106495","golden":false,"offsetInEndSection":1522,"text":"The hypothesis that the anticonvulsant actions of these drugs may be due to their ability to enhance the actions of GABA at CNS synapses is an attractive one, but many questions remain: Do all CNS benzodiazepine receptors interact with GABA sites, and are all GABA receptors linked to benzodiazepine sites? What is the endogenous ligand for the benzodiazepine receptors? Can the anxiolytic and sedative effects of the benzodiazepines be explained by their interaction with GABA mechanisms, or are other interactions more important? Is there more than one sub-type of benzodiazepine receptor in brain? Although these questions cannot be unequivocally answered, the benzodiazepines currently represent one of the most active and exciting areas for basic psychopharmacological research.","beginSection":"abstract"}],"ideal_answer":[],"id":"677e8514592fa48873000020","type":"summary","body":"What is the mechanism of action of Ponsegromab?"},{"documents":[{"golden":true,"id":"11594585"},{"golden":true,"id":"38149950"},{"golden":false,"id":"7726642"},{"golden":false,"id":"39412302"},{"golden":false,"id":"11594563"},{"golden":false,"id":"27982549"},{"golden":true,"id":"26192916"},{"golden":false,"id":"36210659"},{"golden":false,"id":"27501224"},{"golden":false,"id":"27622024"},{"golden":false,"id":"32226341"},{"golden":false,"id":"39079789"},{"golden":false,"id":"39545505"},{"golden":false,"id":"32301713"},{"golden":false,"id":"38015484"},{"golden":false,"id":"19169210"},{"golden":true,"id":"6083835"},{"golden":false,"id":"27540476"},{"golden":true,"id":"15841167"},{"golden":false,"id":"21344783"},{"golden":false,"id":"34232982"},{"golden":false,"id":"34927279"},{"golden":false,"id":"2942033"},{"golden":false,"id":"11678256"},{"golden":false,"id":"10348073"},{"golden":false,"id":"2064417"},{"golden":false,"id":"33270606"},{"golden":false,"id":"9747220"},{"golden":false,"id":"38170178"},{"golden":false,"id":"37971624"},{"golden":false,"id":"33158772"},{"golden":false,"id":"35673767"},{"golden":false,"id":"37555911"},{"golden":false,"id":"35026392"},{"golden":false,"id":"21083462"},{"golden":false,"id":"15202525"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":0,"document":"11594585","golden":true,"offsetInEndSection":310,"text":"Although it has been well established that the human T cell lymphotropic virus type I (HTLV-I) causes adult T cell leukemia/lymphoma (ATLL) in regions of the world where this virus is endemic, its role in the pathogenesis of cutaneous T cell lymphoma (CTCL) in the Western world has been less well established.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":202,"document":"26192916","golden":true,"offsetInEndSection":391,"text":"The results implicate mutations in 17 genes in CTCL pathogenesis, including genes involved in T cell activation and apoptosis, NF-?B signaling, chromatin remodeling and DNA damage response.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":426,"document":"38149950","golden":true,"offsetInEndSection":661,"text":"This review covers current evidence supporting chemical and microbial stimuli that may act as antigenic triggers of CTCL and summarizes novel areas of investigation, in which the potential antigenicity of the exposure is still unknown.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39412302","golden":false,"offsetInEndSection":162,"text":"ABSTRACT: Primary cutaneous gamma delta T-cell lymphoma (PCGDTCL) is a rare type of non-Hodgkin lymphoma accounting for \u003c1% of primary cutaneous T-cell lymphomas.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34232982","golden":false,"offsetInEndSection":165,"text":"Cutaneous T-cell lymphoma (CTCL) is a heterogeneous group of mature T-cell neoplasms characterized by the accumulation of clonal malignant CD4+ T cells in the skin.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39079789","golden":false,"offsetInEndSection":149,"text":"Cutaneous T-cell lymphoma is a group of non-Hodgkin T-cell lymphomas that develop in and affect the skin but can potentially spread to other organs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39545505","golden":false,"offsetInEndSection":137,"text":"Cutaneous T-cell lymphomas (CTCLs) are a heterogeneous group of diseases characterised by abnormal neoplastic T-cell growth in the skin.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32301713","golden":false,"offsetInEndSection":145,"text":"Cutaneous T-cell lymphoma is a heterogeneous group of non-Hodgkin\u0027s lymphoma, characterized by an infiltration of malignant T?cells in the skin.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38015484","golden":false,"offsetInEndSection":83,"text":"INTRODUCTION: Cutaneous T-cell lymphoma (CTCL) is a heterogenous group of non-Hodgk","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1453,"document":"34927279","golden":false,"offsetInEndSection":1552,"text":"Therefore, S.?aureus may be a novel target for the treatment of advanced-stage MF/SS in the future.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34927279","golden":false,"offsetInEndSection":80,"text":"Pathogenesis of cutaneous T cell lymphoma: Involvement of Staphylococcus aureus.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":747,"document":"34927279","golden":false,"offsetInEndSection":907,"text":"In recent years, skin-colonizing S.?aureus has been identified to not only cause severe infections but also play an important role in the pathogenesis of MF/SS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":618,"document":"34927279","golden":false,"offsetInEndSection":746,"text":"The susceptibility to infection is associated with barrier dysfunction and immunosuppression, which are the main symptoms of MF.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1275,"document":"34927279","golden":false,"offsetInEndSection":1452,"text":"Antibiotic therapy for S.?aureus eradication has been reported to cause considerable clinical improvement in the majority of individuals with advanced cutaneous T-cell lymphoma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":485,"document":"34927279","golden":false,"offsetInEndSection":617,"text":"Advanced MF/SS is known to be highly sensitive to Staphylococcus aureus, and the majority of deaths are caused by severe infections.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1197,"document":"34927279","golden":false,"offsetInEndSection":1274,"text":"Lipoprotein may also be associated with the induction of Th2-dominant milieu.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":226,"document":"34927279","golden":false,"offsetInEndSection":378,"text":"Increase in malignant T cells is accompanied by a decrease in CD8-positive T cells, with a shift toward a Th2-dominant milieu in advanced-stage lesions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34927279","golden":false,"offsetInEndSection":87,"text":"Mycosis fungoides (MF) and S?zary syndrome (SS) are representative cutaneous lymphomas.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38149950","golden":true,"offsetInEndSection":450,"text":"Cutaneous T-cell lymphoma (CTCL) involves a clonal expansion of malignant cells accumulating in the skin, a primary barrier site. CTCL has long been hypothesized to be caused or perpetuated by chronic antigen stimulation due to unknown exposures. These antigenic triggers, defined as any element that may cause activation of malignant T cells through TCR signaling, have been hypothesized to range from chemicals to microbes. This review covers curre","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38170178","golden":false,"offsetInEndSection":450,"text":"ABSTRACT: Patients with S?zary syndrome (SS), a leukemic variant of cutaneous T-cell lymphoma (CTCL), are prone to Staphylococcus aureus infections and have a poor prognosis due to treatment resistance. Here, we report that S aureus and staphylococcal enterotoxins (SE) induce drug resistance in malignant T cells against therapeutics commonly used in CTCL. Supernatant from patient-derived, SE-producing S aureus and recombinant SE significantly inh","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39079789","golden":false,"offsetInEndSection":450,"text":"Cutaneous T-cell lymphoma is a group of non-Hodgkin T-cell lymphomas that develop in and affect the skin but can potentially spread to other organs. There are many subtypes, the most common of which are mycosis fungoides, Sezary syndrome, lymphomatoid papulosis, and primary cutaneous anaplastic large cell lymphoma. Cutaneous lymphoma is a common cause of recalcitrant chronic skin rash and notoriously mimics other dermatologic and hematologic cond","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37971624","golden":false,"offsetInEndSection":450,"text":"Cutaneous T-cell lymphomas are a heterogenous group of lymphomas that cause various skin manifestations. Severe pruritus occurs frequently in cutaneous T-cell lymphoma and negatively impacts patients\u0027 quality of life. The pathophysiology of cutaneous T-cell lymphoma-associated itch is complex and involves various immune cells, inflammatory cytokines, and neuroimmune interactions. Treating cutaneous T-cell lymphoma pruritus can be challenging, and","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35673767","golden":false,"offsetInEndSection":450,"text":"Infections originating in the skin/soft tissue are a major cause of mortality in cutaneous T-cell lymphoma (CTCL). We performed a retrospective analysis to characterize cutaneous cultures and assess risk factors for bacteremia among 69 patients with CTCL. Cutaneous infections and antimicrobial resistance were common. Black race and lymph node involvement were associated with bacteremia. Mitigating strategies for invasive infections in CTCL remain","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33158772","golden":false,"offsetInEndSection":450,"text":"BACKGROUND: S?zary syndrome (SS) and mycosis fungoides (MF), 2 types of cutaneous T-cell lymphoma, cause significant morbidity and adversely affect patients\u0027 quality of life (QoL). The present study assessed the QoL measurement changes in patients receiving mogamulizumab versus vorinostat.PATIENTS AND METHODS: A multicenter phase III trial was conducted of patients with stage IB-IV MF/SS with?? 1 failed systemic therapy. The QoL measures included","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"15841167","golden":true,"offsetInEndSection":143,"text":"Cutaneous T cell lymphomas (CTCLs) are a heterogenous group of lymphoproliferative disorders caused by clonally derived, skin-invasive T cells.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"6083835","golden":true,"offsetInEndSection":186,"text":"Cutaneous T-cell lymphomas define a spectrum of disorders associated with T-lymphocytic proliferation with clinical manifestations occurring in the skin during the course of the disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27540476","golden":false,"offsetInEndSection":188,"text":"Cutaneous T cell lymphomas (CTCLs) are a heterogeneous group of extranodal non-Hodgkin\u0027s lymphomas that are characterized by a cutaneous infiltration of malignant monoclonal T lymphocytes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21083462","golden":false,"offsetInEndSection":155,"text":"Cutaneous T-cell lymphomas (CTCLs) are rare lymphomas that arise primarily in the skin and are treated with skin-directed therapies in early-stage disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37555911","golden":false,"offsetInEndSection":228,"text":"Primary cutaneous T-cell lymphomas (CTCL), which include mycosis fungoides (MF) and S?zary syndrome (SS), are a group of lymphoproliferative disorders characterized by clonal accumulation of neoplastic T-lymphocytes in the skin.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"15202525","golden":false,"offsetInEndSection":213,"text":"The term cutaneous T-cell lymphoma (CTCL) describes a heterogeneous group of neoplasms of skin-homing T-cells that vary considerably in clinical presentation, histologic appearance, immunophenotype, and prognosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":68,"document":"21344783","golden":false,"offsetInEndSection":393,"text":"The variety of T-cell lymphomas can be grouped into 2 broad clinical categories: the usually aggressive systemic T-cell lymphomas can be included under the term peripheral T-cell lymphoma (PTCL), and the usually indolent T-cell lymphomas presenting in the skin can be included under the term cutaneous T-cell lymphoma (CTCL).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35026392","golden":false,"offsetInEndSection":84,"text":"BACKGROUND: Primary cutaneous lymphomas are a group of T- (CTCL) and B-cell (CBCL) m","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":450,"document":"19169210","golden":false,"offsetInEndSection":556,"text":"Mycosis fungoides (MF) is a cutaneous T cell lymphoma (CTCL) that preferentially travels to the epidermis.","beginSection":"abstract"}],"ideal_answer":[],"id":"6772e4ed592fa4887300000a","type":"summary","body":"Please summarize what is known about the cause of Cutaneous T cell lymphoma"},{"documents":[{"golden":false,"id":"27126581"},{"golden":false,"id":"7580307"},{"golden":false,"id":"3934848"},{"golden":false,"id":"23440788"},{"golden":false,"id":"26558801"},{"golden":false,"id":"15748095"},{"golden":false,"id":"9459276"},{"golden":true,"id":"20933120"},{"golden":false,"id":"20839093"},{"golden":false,"id":"11570312"},{"golden":false,"id":"22419294"},{"golden":false,"id":"34153318"},{"golden":false,"id":"28550023"},{"golden":false,"id":"31169952"},{"golden":false,"id":"18425943"},{"golden":false,"id":"17636607"},{"golden":false,"id":"28118681"},{"golden":false,"id":"32469052"},{"golden":false,"id":"29096046"},{"golden":false,"id":"23235628"},{"golden":false,"id":"17443545"},{"golden":false,"id":"16580772"},{"golden":false,"id":"21563131"},{"golden":false,"id":"21860304"},{"golden":false,"id":"26608695"},{"golden":false,"id":"22592687"},{"golden":false,"id":"17443569"},{"golden":false,"id":"27042398"},{"golden":false,"id":"20933121"},{"golden":true,"id":"33005125"},{"golden":false,"id":"11232016"},{"golden":false,"id":"15867009"},{"golden":false,"id":"26949570"},{"golden":false,"id":"14723979"},{"golden":false,"id":"14667989"},{"golden":false,"id":"17380214"},{"golden":false,"id":"14513653"},{"golden":true,"id":"12161475"},{"golden":false,"id":"33900134"},{"golden":false,"id":"32082579"},{"golden":false,"id":"36347310"},{"golden":true,"id":"37940863"},{"golden":false,"id":"38124194"},{"golden":false,"id":"32284159"},{"golden":false,"id":"2445210"},{"golden":false,"id":"34020554"},{"golden":false,"id":"37799231"},{"golden":false,"id":"35249804"},{"golden":false,"id":"34559358"},{"golden":false,"id":"35650700"},{"golden":false,"id":"23970458"},{"golden":false,"id":"36807147"},{"golden":false,"id":"20021654"},{"golden":true,"id":"32298717"},{"golden":false,"id":"38174816"},{"golden":false,"id":"36325880"},{"golden":false,"id":"31526281"},{"golden":false,"id":"37698459"},{"golden":false,"id":"38156687"},{"golden":false,"id":"33507722"},{"golden":false,"id":"36944952"},{"golden":false,"id":"37747064"},{"golden":false,"id":"32032641"},{"golden":false,"id":"34706964"},{"golden":false,"id":"12242850"},{"golden":false,"id":"22995540"},{"golden":false,"id":"11225976"},{"golden":true,"id":"19293262"},{"golden":false,"id":"16230226"},{"golden":false,"id":"15799215"},{"golden":false,"id":"15330744"},{"golden":false,"id":"16626799"},{"golden":false,"id":"26633041"},{"golden":false,"id":"15105800"},{"golden":false,"id":"35721718"},{"golden":false,"id":"22950651"},{"golden":false,"id":"34660758"},{"golden":false,"id":"35168313"},{"golden":false,"id":"36930168"},{"golden":false,"id":"21530305"},{"golden":false,"id":"11024222"},{"golden":false,"id":"16300697"},{"golden":false,"id":"18646185"},{"golden":false,"id":"32173633"},{"golden":false,"id":"34374108"},{"golden":false,"id":"37591656"},{"golden":false,"id":"34223253"},{"golden":false,"id":"34733238"},{"golden":false,"id":"33796856"},{"golden":false,"id":"36809499"},{"golden":false,"id":"32211953"},{"golden":false,"id":"38012910"},{"golden":false,"id":"38212837"},{"golden":false,"id":"37837609"},{"golden":false,"id":"37210024"},{"golden":false,"id":"37141450"},{"golden":false,"id":"37071891"},{"golden":false,"id":"36864016"},{"golden":false,"id":"36779325"},{"golden":false,"id":"36759181"},{"golden":false,"id":"38348645"},{"golden":false,"id":"38338771"},{"golden":false,"id":"38332521"},{"golden":false,"id":"38318101"},{"golden":false,"id":"38246518"},{"golden":false,"id":"38219543"},{"golden":false,"id":"38071334"},{"golden":false,"id":"38063965"},{"golden":false,"id":"38060679"},{"golden":false,"id":"16034694"},{"golden":false,"id":"2426053"},{"golden":false,"id":"25291334"},{"golden":false,"id":"16205090"},{"golden":false,"id":"7945771"},{"golden":false,"id":"21547529"},{"golden":false,"id":"15707556"},{"golden":false,"id":"21069701"},{"golden":false,"id":"28101363"},{"golden":true,"id":"15266528"},{"golden":false,"id":"17364710"},{"golden":false,"id":"17611956"},{"golden":false,"id":"17542267"},{"golden":false,"id":"24981149"},{"golden":false,"id":"11097787"},{"golden":false,"id":"34656768"},{"golden":false,"id":"14557437"},{"golden":false,"id":"14686803"},{"golden":false,"id":"27591451"},{"golden":false,"id":"17458182"},{"golden":false,"id":"29928620"},{"golden":false,"id":"16854679"},{"golden":false,"id":"17110396"},{"golden":false,"id":"21249699"},{"golden":false,"id":"10199762"},{"golden":false,"id":"19469045"},{"golden":false,"id":"18436704"},{"golden":false,"id":"33931201"},{"golden":false,"id":"20933122"},{"golden":false,"id":"28189123"},{"golden":false,"id":"31537614"},{"golden":false,"id":"36499313"},{"golden":false,"id":"36409333"},{"golden":false,"id":"36336005"},{"golden":false,"id":"37450195"},{"golden":false,"id":"38357937"},{"golden":false,"id":"38079168"},{"golden":false,"id":"31915452"},{"golden":false,"id":"37581383"},{"golden":false,"id":"36755659"},{"golden":false,"id":"35136878"},{"golden":false,"id":"36617207"},{"golden":false,"id":"38001791"},{"golden":false,"id":"36213273"},{"golden":false,"id":"36195924"},{"golden":true,"id":"487815"},{"golden":true,"id":"39016284"},{"golden":false,"id":"39341709"},{"golden":false,"id":"32197832"},{"golden":false,"id":"39030853"},{"golden":false,"id":"33814126"},{"golden":true,"id":"31754066"},{"golden":false,"id":"16622804"},{"golden":false,"id":"37348787"},{"golden":false,"id":"27090863"},{"golden":false,"id":"24579923"},{"golden":false,"id":"26171903"},{"golden":false,"id":"33617839"},{"golden":false,"id":"30602479"},{"golden":false,"id":"33481994"},{"golden":true,"id":"20808223"},{"golden":true,"id":"32019712"},{"golden":false,"id":"36909934"},{"golden":true,"id":"25620227"},{"golden":true,"id":"12041962"},{"golden":true,"id":"35550379"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":525,"document":"20933120","golden":true,"offsetInEndSection":760,"text":"The first randomized, placebo-controlled clinical trial performed by the pharmaceutical industry demonstrated the effectiveness of a combination of testosterone undecanoate and etonogestrel in suppressing spermatogenesis in volunteers.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":729,"document":"12041962","golden":true,"offsetInEndSection":846,"text":"The contraceptive efficacy after treatment with testosterone alone was comparable to that of female hormonal methods.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":197,"document":"20808223","golden":true,"offsetInEndSection":489,"text":"ire other options. Hormonal male contraceptive methods have undergone extensive clinical trials in healthy men and shown to be efficacious, reversible and appear to be well tolerated.RECENT FINDINGS: The success rate of male hormonal contraception using injectable testosterone alone is high ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1634,"document":"34153318","golden":false,"offsetInEndSection":1705,"text":" men desiring reversible hormonal male contraception (HMC). These data ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":525,"document":"12041962","golden":false,"offsetInEndSection":728,"text":"Studies published in the 1990s demonstrated that a testosterone-containing hormonal contraceptive method suppressed spermatogenesis to azoospermia in most men and severe oligozoospermia in the remaining.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":308,"document":"20933120","golden":false,"offsetInEndSection":386,"text":"In Caucasians, additional agents are required of which progestins are favored.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":90,"document":"12041962","golden":false,"offsetInEndSection":159,"text":"Vas occlusion is very effective but is intended to be non-reversible.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":129,"document":"20933120","golden":true,"offsetInEndSection":307,"text":"All hormonal male contraceptives use testosterone, but only in East Asian men can testosterone alone suppress spermatogenesis to a level compatible with contraceptive protection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":289,"document":"12041962","golden":true,"offsetInEndSection":524,"text":"The only other male-oriented methods in clinical trials utilize the administration of testosterone alone or its combination with another gonadotropin-suppressing agent such as a progestin or a gonadotropin-releasing hormone antagonist.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":462,"document":"11570312","golden":false,"offsetInEndSection":683,"text":"The results from the European study are consistent with clinical trials conducted elsewhere and support the conclusion that the monthly combination injectable contraceptive represents a desirable new birth control method.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"20933120","golden":false,"offsetInEndSection":47,"text":"Clinical trials in male hormonal contraception.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":387,"document":"20933120","golden":false,"offsetInEndSection":524,"text":"Clinical trials concentrate on testosterone combined with norethisterone, desogestrel, etonogestrel or depot-medroxyprogesterone acetate.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"20933120","golden":false,"offsetInEndSection":128,"text":"Research has established the principle of hormonal male contraception based on suppression of gonadotropins and spermatogenesis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":847,"document":"12041962","golden":true,"offsetInEndSection":1045,"text":"Having proven that reversible male contraception is a reality, present trials are attempting to identify the best androgen delivery system and the most effective androgen plus progestin preparation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":142,"document":"20933121","golden":false,"offsetInEndSection":295,"text":"Considerable progress has been made particularly in the last 5 years, establishing for the first time the reversibility of MHC and its short-term safety.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"20933121","golden":false,"offsetInEndSection":141,"text":"Landmark WHO-sponsored trials showed decades ago that male hormonal contraception (MHC) is an effective male-directed contraceptive approach.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":957,"document":"20933121","golden":false,"offsetInEndSection":1160,"text":"These are the best data available and will provide guidance and reassurance for the larger-scale Phase III specific regimen efficacy studies that will be required to bring MHC to the population (market).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":944,"document":"33005125","golden":false,"offsetInEndSection":1068,"text":"Efficacy trials of hormonal male contraceptives have demonstrated contraceptive efficacy rates greater than that of condoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":790,"document":"20933121","golden":false,"offsetInEndSection":956,"text":"We report integrated analyses of factors that are important in predicting suppression and recovery of spermatogenesis after MHC clinical trials for the past 15 years.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2042,"document":"11232016","golden":false,"offsetInEndSection":2301,"text":"In conclusion, combination treatment with NETE showed suppression of spermatogenesis comparable with results using testosterone esters in combination with GnRH antagonists or cyproterone acetate, but had more favorable injection intervals and better efficacy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1264,"document":"14667989","golden":false,"offsetInEndSection":1395,"text":"MENT) are combined with injections of DMPA or noresthisterone enanthate or with implants containing levonorgestrel or etonogestrel.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":3511,"document":"12161475","golden":true,"offsetInEndSection":3667,"text":"We conclude that Norplant II implants plus TE 100 mg/wk were very efficient in suppressing spermatogenesis to a level acceptable for contraceptive efficacy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":194,"document":"14723979","golden":false,"offsetInEndSection":353,"text":"Although clinical trials have proven the concept of hormonal male contraception, their modalities have been unacceptable for practical use for several reasons.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":523,"document":"33005125","golden":true,"offsetInEndSection":741,"text":"Investigators have tested androgen plus progestin approaches using oral, transdermal, subdermal, and injectable drug formulations and demonstrated the short-term safety and reversibility of hormonal male contraception.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":577,"document":"37940863","golden":false,"offsetInEndSection":869,"text":"We include a cautiously optimistic discussion of benefits and potential drawbacks, highlighting several methods in preclinical and clinical stages of development.RESULTS: As of June 2023, two hormonal male contraceptive methods are undergoing phase II clinical trials for safety and efficacy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1311,"document":"37940863","golden":false,"offsetInEndSection":1483,"text":"There are also several non-hormonal methods with strong potential in preclinical stages of development.CONCLUSIONS: There exist several hurdles to novel male contraception.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37940863","golden":false,"offsetInEndSection":149,"text":"BACKGROUND: Since the release of the combined oral contraceptive pill in 1960, women have shouldered the burden of contraception and family planning.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1512,"document":"35550379","golden":false,"offsetInEndSection":2113,"text":"Older and higher educated participants more often preferred specialists over regular doctors and pharmacists (p?\u003d?0.02 and p?\u003d?0.01).CONCLUSIONS: Despite receiving contraceptive steroid hormones and care from endocrinologists and family planning specialists in a clinical trial, participants would prefer to obtain contraception from their regular doctor.IMPLICATIONS: As most men expect to obtain hormonal male contraceptives from their regular doctor when commercially available, primary care physicians should become familiar with HMCs and be prepared to provide counseling and options accordingly.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":870,"document":"37940863","golden":true,"offsetInEndSection":1077,"text":"A large-scale, international phase IIb trial investigating efficacy of transdermal segesterone acetate (Nestorone) plus testosterone gel has enrolled over 460 couples with completion estimated for late 2024.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35550379","golden":false,"offsetInEndSection":764,"text":"OBJECTIVE: To assess men\u0027s preferences for healthcare provider from whom they would obtain hormonal male contraceptive (HMC) methods.STUDY DESIGN: We asked participants from 3 clinical trials of investigational HMC methods-an oral pill (11?-Methyl-19-nortestosterone-17?-dodecylcarbonate, 11?-MNTDC), intramuscular or subcutaneous injection (Dimethandrolone undecanoate), and transdermal gel (Nestorone and testosterone)-to rank their top 3 preferred HMC providers from a list including: men\u0027s health doctor (urologist/andrologist), hormonal doctor (endocrinologist), reproductive health doctor (OB/GYN), family planning clinician (community health worker, midwife, nurse practitioner), regular doctor (family medicine/internal medicine), and community pharmacist.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1078,"document":"37940863","golden":true,"offsetInEndSection":1310,"text":"A second hormonal method, dimethandrolone undecanoate, is in two clinical trials focusing on safety, pharmacodynamics, suppression of spermatogenesis and hormones; the first of these two is estimated for completion in December 2024.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":293,"document":"37940863","golden":false,"offsetInEndSection":406,"text":"However, there are now a variety of promising hormonal and non-hormonal male contraceptive options being studied.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":361,"document":"36347310","golden":false,"offsetInEndSection":931,"text":"\"SETTING: Research institute at an academic medical center.PARTICIPANT(S): Couples participating in the male contraceptive clinical trial.INTERVENTIONS: None.MAIN OUTCOME MEASURE(S): The ability by participants to monitor sperm suppression to a threshold compatible with contraceptive efficacy utilizing a user-controlled test verified by sperm concentration determined by standard laboratory methods.RESULT(S): Thirty-eight men participating in a hormonal male contraceptive clinical trial provided multiple samples during spermatogenesis suppression for this substudy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38124194","golden":false,"offsetInEndSection":149,"text":"BACKGROUND: Feminizing gender-affirming hormone therapy (GAHT) for transgender individuals traditionally includes estradiol and androgen deprivation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34020554","golden":false,"offsetInEndSection":477,"text":": Objective: The aim of the study CERES (CzEch REkovelle real life Study) was to gather experience with the use of a?novel gonadotrophine, to evaluate the efficacy of follitropin delta in Czech clinical settings and to compare our results with the clinical trial ESTHER-1.METHODS: Individualized follitropin delta daily dose in ?g based on the patient?s anti-M?llerian hormone (AMH) level and body weight (AMH \u003c 15 pmol/?L: 12 ?g/?d; AMH \u003e 15 pmol/?L: 0.10?0.19 ?g/?kg/?d; max.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1069,"document":"33005125","golden":false,"offsetInEndSection":1262,"text":"Although there has been less progression in the development of nonhormonal male contraceptives, potentially reversible vaso-occlusive methods are currently in clinical trials in some countries.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":330,"document":"33005125","golden":false,"offsetInEndSection":522,"text":"Hormonal methods have progressed the furthest in clinical development and androgen plus progestin formulations hold promise as a marketable, reversible male contraceptive over the next decade.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":56,"document":"33005125","golden":false,"offsetInEndSection":174,"text":"Despite a variety of female contraceptive options, male contraceptive options are limited to the condom and vasectomy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":450,"document":"33481994","golden":false,"offsetInEndSection":588,"text":"Nonhormonal methods are in earlier stages of development.CONTENT: Several hormonal male contraceptive agents have entered clinical trials.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1603,"document":"33005125","golden":false,"offsetInEndSection":1852,"text":"The ultimate availability of male contraceptives could have an important impact on decreasing global unintended pregnancy rates (currently 40% of all pregnancies) and will be a step towards reproductive justice and greater equity in family planning.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1353,"document":"33005125","golden":false,"offsetInEndSection":1602,"text":"Barriers to development include an absence of investment from pharmaceutical companies, concerns regarding side effects and spermatogenic rebound with hormonal methods, and lack of clear reversibility and proven effectiveness of nonhormonal methods.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":254,"document":"35650700","golden":false,"offsetInEndSection":890,"text":"Studies in rodents identified the testis as a target organ of concern, which led to monitoring of reproductive hormones in \u003e800 male patients enrolled in four clinical trials of Pa-containing regimens and the HRZE (isoniazid+rifampin+pyrazinamide+ethambutol) control regimen.METHODS: Serum hormone levels relevant to male reproductive health - follicle stimulating hormone (FSH), luteinizing hormone (LH), inhibin B (InhB) and total testosterone (T) - from the four clinical trials were summarized numerically and analyzed by repeated-measures modeling.RESULTS: Hormone levels generally behaved similarly in Pa-containing and HRZE arms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1090,"document":"35650700","golden":false,"offsetInEndSection":1437,"text":"Before treatment, many patients were borderline hypogonadal, with T levels near the lower limits of the normal range.CONCLUSION: Changes in male hormones in four clinical trials studying patients with TB indicate that Pa-containing treatment was not associated with testicular toxicity but rather led to improvement in the underlying hypogonadism.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":249,"document":"33507722","golden":false,"offsetInEndSection":1242,"text":"We aimed to investigate a new strategy (daily GnRH agonist for LPS following GnRH agonist trigger) as an alternative for the conventional approach to the patients undergoing intracytoplasmic sperm injection (ICSI).METHODS: In this randomized controlled trial study, 44 ICSI patients were randomly assigned into two groups: group 1, patients received standard strategy (hCG trigger [10000 IU] and progesterone bid [400 mg/BD] for LPS); group 2, patients received a dose of GnRHa (0.2 mg) for ovulation trigger and subcutaneous injection of GnRHa bid (0.2 mg) for LPS.RESULTS: The pregnancy, miscarriage, and live birth rates for the patients undergoing LPS following the GnRHa trigger were similar to those of patients undergoing the standard strategy.CONCLUSIONS: We showed that a daily subcutaneous injection of GnRHa for LPS following the GnRHa trigger can be successfully performed as an alternative to the standard strategy, with comparable pregnancy and live birth rates in ICSI patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1902,"document":"20021654","golden":false,"offsetInEndSection":2257,"text":"As we accept a 12.5% loss in pregnancy rate in one of the two IVF arms to prevent multiple pregnancies, we need 200 couples per arm (600 couples in total).DISCUSSION: Determining the safest and most cost-effective treatment will ensure optimal chances of pregnancy for subfertile couples with substantially diminished perinatal and maternal complications.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":856,"document":"20021654","golden":false,"offsetInEndSection":1451,"text":"Secondly, the aim is to perform a cost effective analyses and assess treatment preference of these couples.METHODS/DESIGN: We plan a multicentre randomised controlled clinical trial in the Netherlands comparing six cycles of intra-uterine insemination with controlled ovarian hyperstimulation or six cycles of Modified Natural Cycle (MNC) IVF or three cycles with IVF-elective Single Embryo Transfer (eSET) plus cryo-cycles within a time frame of 12 months.Couples with unexplained subfertility or mild male subfertility and a poor prognosis for treatment independent pregnancy will be included.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":478,"document":"20021654","golden":false,"offsetInEndSection":855,"text":"The cumulative pregnancy rate is 40%, with a 10% multiple pregnancy rate.This study aims to reveal whether alternative treatments such as IVF elective Single Embryo Transfer (IVF e SET) or Modified Natural Cycle IVF (MNC IVF) can reduce the number of multiple pregnancy rates, but uphold similar pregnancy rates as IUI COH in couples with mild male or unexplained subfertility.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"20021654","golden":false,"offsetInEndSection":186,"text":"The INeS study: prevention of multiple pregnancies: a randomised controlled trial comparing IUI COH versus IVF e SET versus MNC IVF in couples with unexplained or mild male subfertility.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32298717","golden":false,"offsetInEndSection":402,"text":"OBJECTIVE: To determine men\u0027s satisfaction with and acceptability of a once-daily, oral regimen of dimethandrolone undecanoate (DMAU) versus placebo when used for 28?days.STUDY DESIGN: After a Phase I double-blind, randomized, placebo-controlled, dose-escalating trial of oral DMAU for 28-days, 57 healthy male volunteers completed a survey assessing their experience and satisfaction with the regimen.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":147,"document":"38156687","golden":false,"offsetInEndSection":687,"text":"Preparations based on testicular regulatory polypeptides are the most physiological and universal, owing to a complex effect on the self-regulation of testicular tissue.AIM: To study the delayed efficiency and safety of therapy with Fertiwell in patients with pathospermia and to assess the frequency of conception and pregnancy outcome in their partners based on the collection, analysis and interpretation of medical data.MATERIALS AND METHODS: A telephone survey of patients participating in the phase III clinical trial was carried out.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38174816","golden":false,"offsetInEndSection":242,"text":"BACKGROUND: During a stimulated cycle of in vitro fertilisation or intracytoplasmic sperm injection (IVF/ICSI), women receive daily doses of gonadotropin follicle-stimulating hormone (FSH) to induce multifollicular development in the ovaries.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1471,"document":"37698459","golden":false,"offsetInEndSection":1794,"text":"Serum LH levels 12 hours post trigger were high in the dual trigger group (46.23mIU/ml vs. 0.93mIU/ml, p\u003c0.0001).CONCLUSIONS: This study found that the addition of GnRHa to hCG trigger leads to improved embryological outcomes and the possibility of cryopreserving surplus embryos, thereby increasing cumulative live births.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":199,"document":"20021654","golden":false,"offsetInEndSection":477,"text":"This trend is partly due to the fact that women start family planning at an increased age, but also due to the increased use of ART.Couples with unexplained or mild male subfertility generally receive intrauterine insemination IUI with controlled hormonal stimulation (IUI COH).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"12242850","golden":false,"offsetInEndSection":531,"text":"PURPOSE: To review the efficacy, safety, and patient acceptance of the Lunelle monthly contraceptive injection and to raise awareness of this new contraceptive in the United States.DATA SOURCES: Worldwide scientific literature, reports of clinical trials, and manufacturers\u0027 product information and guidelines.CONCLUSIONS: Lunelle is a combined hormonal method with a safety/tolerability profile comparable to that of oral contraceptives (OC) and a high efficacy rate and provides a rapid return of fertility after discontinuation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1397,"document":"32298717","golden":false,"offsetInEndSection":1586,"text":"Having to take the drug after a high-fat meal did not detract from acceptability.IMPLICATIONS: Most participants in a 4-week trial of daily DMAU capsules would recommend and use the method.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1587,"document":"32298717","golden":true,"offsetInEndSection":1731,"text":"High satisfaction among DMAU and placebo groups affirms acceptability of a daily male contraceptive pill, warranting further study of oral DMAU.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":817,"document":"34706964","golden":false,"offsetInEndSection":1284,"text":"This double-blinded randomised controlled trial (RCT) aims to test the hypothesis whether transient targeted supplementation of DHEA as an adjuvant to progesterone in frozen embryo transfer (FET) cycles, for women with low serum testosterone, helps in improving live birth rate.METHODS AND ANALYSIS: This study is planned as a double-blinded, placebo-controlled randomised trial and the sample size, calculated for the primary outcome measure-live birth rate, is 140.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1143,"document":"32298717","golden":false,"offsetInEndSection":1396,"text":"Most respondents, 91% (52/57), reported no difficulty with having to take up to 4 pills within 30?min of ingesting a high-fat meal.CONCLUSION: Most participants reported that the study method, daily oral DMAU or placebo, was satisfactory and acceptable.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":672,"document":"32298717","golden":false,"offsetInEndSection":846,"text":"Participants were counseled that they could not rely on the drug for contraception.RESULTS: Fifty-seven participants were offered acceptability surveys (39 DMAU, 18 placebo).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"19293262","golden":true,"offsetInEndSection":598,"text":"CONTEXT: Hormonal male contraceptive regimens effectively and reversibly suppress sperm production, but there are few large-scale efficacy studies.OBJECTIVE: The safety, contraceptive efficacy, reversibility, and feasibility of injectable testosterone undecanoate (TU) in tea seed oil as a hormonal male contraceptive was assessed.DESIGN: This was a multicenter, phase III, contraceptive efficacy clinical trial.PARTICIPANTS: A total of 1045 healthy fertile Chinese men were recruited throughout China into the study.INTERVENTION(S): Injections of 500 mg TU were administered monthly for 30 months.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":377,"document":"22995540","golden":false,"offsetInEndSection":642,"text":"Novel products such as new implants, contraceptive vaginal rings, transdermal patches and newer combinations of oral contraceptives have recently been introduced in family planning programs, and hormonal contraception is widely used for spacing and limiting births.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":794,"document":"22995540","golden":false,"offsetInEndSection":1071,"text":"Recent developments include use of natural compounds such as estradiol and estradiol valerate with the hope to decrease thrombotic risk, in combination with newer progestins derived from the progesterone structure or from spirolactone, in order to avoid the androgenic effects.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1313,"document":"22995540","golden":false,"offsetInEndSection":1586,"text":"Future developments also include the combination of a contraceptive with an antiretroviral agent for dual contraception and protection against sexually transmitted diseases, to be used before intercourse or on demand, as well as for continuous use in dual-protection rings.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1587,"document":"22995540","golden":false,"offsetInEndSection":1810,"text":"Although clinical trials of male contraception have reflected promising results, limited involvement of industry in that area of research has decreased the likelihood of having a male method available in the current decade.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1566,"document":"19293262","golden":true,"offsetInEndSection":1818,"text":"Spermatogenesis returned to the normal fertile reference range in all but two participants.CONCLUSIONS: Monthly injection of 500 mg TU provides safe, effective, reversible, and reliable contraception in a high proportion of healthy fertile Chinese men.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"16230226","golden":false,"offsetInEndSection":143,"text":"OBJECTIVE: Male, non-barrier, contraceptive options are limited to vasectomy and inadequate methods such as withdrawal and periodic abstinence.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":84,"document":"22995540","golden":false,"offsetInEndSection":242,"text":"Hormonal and nonhormonal modern contraceptives have improved women\u0027s lives by reducing different health conditions that contributed to considerable morbidity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":566,"document":"11225976","golden":false,"offsetInEndSection":708,"text":"A number of clinical trials substantiate that it is indeed possible to have a reversible, effective and safe hormonal method of contraception.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1072,"document":"22995540","golden":false,"offsetInEndSection":1312,"text":"Progesterone antagonists and progesterone receptor modulators are highly effective in blocking ovulation and preventing follicular rupture and are undergoing investigations in the form of oral pills and in semi-long-acting delivery systems.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36325880","golden":false,"offsetInEndSection":187,"text":"PURPOSE OF REVIEW: Medical therapy for idiopathic male infertility has historically been empiric and based on small observational studies rather than larger well designed clinical trials.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":527,"document":"36325880","golden":false,"offsetInEndSection":734,"text":"The Males, Antioxidants, and Infertility (MOXI) trial is of particular interest, being a large multicenter RCT, which demonstrated no improvement in semen parameters or live-birth rates with antioxidant use.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":188,"document":"36325880","golden":false,"offsetInEndSection":526,"text":"This review is timely and relevant because of the recent publication of several studies that are less susceptible to bias because of being placebo-controlled and more highly powered.RECENT FINDINGS: The largest proportion of recent publications covered antioxidants, with eight randomized controlled trials (RCTs) included in this review.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":907,"document":"36325880","golden":false,"offsetInEndSection":1323,"text":"Progress was also made in the realm of regenerative medicine, with the realization of the first successful primate model of sperm production from pluripotent stem cells.SUMMARY: It may be time to stop recommending antioxidants for idiopathic male infertility given recent studies suggesting lack of efficacy, but given their relative safety, it is reasonable to continue their use until the evidence is overwhelming.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35168313","golden":false,"offsetInEndSection":547,"text":"PURPOSE: Nonobstructive azoospermia (NOA) associated with primary spermatogenic failure is a common cause of male infertility usually considered untreatable; however, some reports have suggested that hormonal stimulation to boost the intra-testicular testosterone level and spermatogenesis might increase the chance of achieving pregnancy using homologous sperm.MATERIALS AND METHODS: We report a series of eight NOA males who received long-term treatment with recombinant human chorionic gonadotropin twice a week for spermatogenesis stimulation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":735,"document":"36325880","golden":false,"offsetInEndSection":906,"text":"In addition, phosphodiesterase-5 inhibitors (PDE5i) have been shown to improve semen parameters, while duloxetine use was not associated with any adverse effects on sperm.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":949,"document":"35168313","golden":false,"offsetInEndSection":1309,"text":"Two live births were obtained after intracytoplasmic sperm injection with ejaculated spermatozoa and one live birth and an ongoing pregnancy using thawed spermatozoa from TESA.CONCLUSION: Our proof-of-concept study indicates that hormonal therapy with recombinant gonadotropins could be considered in infertile men with NOA as an alternative to sperm donation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1343,"document":"38156687","golden":false,"offsetInEndSection":1595,"text":"There were no significant differences in anthropometric parameters of newborns between the two groups (p\u003e0.05).CONCLUSION: When using the drug Fertiwell, pregnancy and live birth rate was significantly higher (2.23 times) compared to the control group.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1494,"document":"36930168","golden":false,"offsetInEndSection":1601,"text":" medical graduates (IMGs) and 70% practiced in a state that had expanded Medicaid in 2016. Of the total phy","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":888,"document":"21530305","golden":false,"offsetInEndSection":1096,"text":"Among women with normal Nugent score (n\u003d92), IL-8 and IL-1? were lowest in those using abstinence as compared to hormonal contraceptives or male/female sterilization as their primary method for birth control.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":542,"document":"11024222","golden":false,"offsetInEndSection":676,"text":"Women who adopted user-independent methods (tubal ligation, implants, injectable hormones) appear to have completed their family plan.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2161,"document":"36930168","golden":false,"offsetInEndSection":2446,"text":" years (OR, 0.51; 95% CI, 0.39-0.65), and 65 years or older (OR, 0.29; 95% CI, 0.19-0.44). Except for those specializing in OBGYN, being an IMG was associated with lower odds of providing hormonal contraceptive service (family medicine IMGs: OR, 0.80 [95% CI, 0.73-0.88]; internal medi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2729,"document":"36930168","golden":false,"offsetInEndSection":3003,"text":"ne (OR, 1.71; 95% CI, 1.18-2.48) physicians but not for physicians from other specialties.Conclusions and Relevance: In this cross-sectional study of primary care physicians, physician- and community-level factors, such as specialty, age, and the Medicaid expansion status o","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2019,"document":"16300697","golden":false,"offsetInEndSection":2185,"text":"0.05) while no correlation was observed with LH and FSH in all the groups.CONCLUSION: In this study, there was significant decrease in serum and seminal plasma zinc l","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2186,"document":"16300697","golden":false,"offsetInEndSection":2264,"text":"vels in oligospermic and azoospermic infertile males with significantly low an","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2265,"document":"16300697","golden":false,"offsetInEndSection":2429,"text":"rogen. It indicates zinc has a possible role for spermatogenesis and steroidogenesis. Therefore, zinc concentration in seminal plasma should be considered as one of","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":908,"document":"11024222","golden":false,"offsetInEndSection":1011,"text":"Barrier method users were more likely than other women to use condoms and spermicides during the study.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1195,"document":"11024222","golden":false,"offsetInEndSection":1358,"text":"The synergism between the intention to prevent pregnancy and the intention to prevent STD should be considered in the design of interventions promoting condom use.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":548,"document":"35168313","golden":false,"offsetInEndSection":849,"text":"Six males received additional recombinant follicle-stimulating hormone (FSH) supplementation 150-225 IU twice weekly.RESULTS: After recombinant gonadotropin therapy, viable spermatozoa were retrieved from the ejaculate in two patients and by testicular sperm aspiration (TESA) in another two subjects.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34223253","golden":false,"offsetInEndSection":1193,"text":"OBJECTIVE: To determine the cost of achieving a live birth after first transfer using highly purified human menotropin (HP-hMG) or recombinant follicle-stimulating hormone (FSH) for controlled ovarian stimulation in predicted high-responder patients in the Menopur in Gonadotropin-releasing hormone Antagonist Single Embryo Transfer-High Responder (MEGASET-HR) trial.DESIGN: Cost minimization analysis of trial results.SETTING: Thirty-one fertility centers.PATIENTS: Six hundred and nineteen women with serum antim?llerian hormone ?5 ng/mL.INTERVENTIONS: Controlled ovarian stimulation with HP-hMG or recombinant FSH in a gonadotropin-releasing hormone (GnRH) antagonist assisted reproduction cycle where fresh transfer of a single blastocyst was performed unless ovarian response was excessive whereupon all embryos were cryopreserved and patients could undergo subsequent frozen blastocyst transfer within 6 months of randomization.MAIN OUTCOME MEASURES: Mean cost of achieving live birth after first transfer (fresh or frozen).RESULTS: First-transfer efficacy, defined as live birth after first fresh or frozen transfer, was 54.5% for HP-hMG and 48.0% for recombinant FSH (difference 6.5%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32173633","golden":false,"offsetInEndSection":498,"text":"OBJECTIVES: To evaluate the effectiveness of dual trigger using gonadotropin-releasing hormone (GnRH) agonist and recombinant human chorionic gonadotropin (rHCG) versus rHCG alone for normal responders in GnRH antagonist intracytoplasmic sperm injection (ICSI) cycles.PATIENTS AND METHODS: The current study was a registered open-labeled randomized controlled trial (clinical trial.gov: NCT02916173) conducted in the ART Unit of a tertiary University hospital between October 2016 and October 2018.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38012910","golden":false,"offsetInEndSection":739,"text":"BACKGROUND: Treatments to stimulate spermatogenesis and antioxidant food supplements are often offered to infertile patients either before sperm extraction surgery to improve results, or as part of medically assisted reproduction or spontaneous fertility to increase the likelihood of a live birth.METHODS: A bibliographic search limited to English-language literature on men published before 5/2023 was carried out, including clinical trials, literature reviews and meta-analyses on spermatogenesis-stimulating molecules and antioxidant treatments.RESULTS: Several medical treatments seem capable of improving male fertility: they act mainly by stimulating spermatogenesis through hormones, or by reducing the effects of oxidative stress.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1084,"document":"32173633","golden":false,"offsetInEndSection":1389,"text":"Dual trigger group was significantly higher in the clinical pregnancy rate and live birth rate after frozen embryo transfer (p \u003d 0.04, 0.03, respectively).CONCLUSION: Dual trigger by GnRH agonist and rHCG improve the oocyte maturity and embryo grading for normal responders in GnRH antagonist ICSI cycles.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1913,"document":"36809499","golden":false,"offsetInEndSection":2231,"text":"The expressions of BMP15 and GDF9 in the ZYPs group were significantly up-regulated compared with the control group (both P\u003c0.05).CONCLUSIONS: ZYPs exhibited beneficial effects in DOR patients undergoing IVF-ET, resulting in increments of oocytes and embryos, and up-regulation of BMP15 and GDF9 expressions in the FF.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1310,"document":"35168313","golden":false,"offsetInEndSection":1486,"text":"Large-scale studies are needed to substantiate hormone stimulation therapy with recombinant gonadotropins in routine clinical practice for this severe form of male infertility.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37591656","golden":false,"offsetInEndSection":192,"text":"INTRODUCTION: Hormone replacement treatment (HRT) is the most commonly used endometrial preparation protocol for frozen embryo transfer (FET) in patients with polycystic ovary syndrome (PCOS).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":881,"document":"38212837","golden":false,"offsetInEndSection":1041,"text":"This study will be performed in 236 first cycle in vitro fertilization (IVF) and/or ICSI (intracytoplasmic sperm injection) patients, randomized 1:1 in two arms","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37837609","golden":false,"offsetInEndSection":165,"text":"Hormonal control during infancy and testicular adrenal rest tumor development in males with congenital adrenal hyperplasia: a retrospective multicenter cohort study.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37210024","golden":false,"offsetInEndSection":169,"text":"Injectable male hormonal contraceptives are effective for preventing pregnancy in clinical trials; however, users may prefer to avoid medical appointments and injections","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":162,"document":"37141450","golden":false,"offsetInEndSection":272,"text":"Expanding contraceptive options, including male methods, are urgently needed to tackle these global challenges","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":3187,"document":"37071891","golden":false,"offsetInEndSection":3386,"text":"In addition, the dosages and durations of exogenous estrogen used by postmenopausal women varied from study to study, and combined progestogen administration may have had some effect on the outcomes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":230,"document":"36864016","golden":false,"offsetInEndSection":452,"text":"The aims were to measure (i) how women with MUD independently and compared with men respond to treatment versus placebo and (ii) among women, how the hormonal method of contraception (HMC) affects treatment responsiveness.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":3173,"document":"36779325","golden":false,"offsetInEndSection":3330,"text":"The current level of evidence is insufficient and additional trials on the effects of HL and (current) treatment regimens on reproductive function are needed","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":183,"document":"36759181","golden":false,"offsetInEndSection":297,"text":"Hormonal contraceptive (HC) use is common among collegiate female athletes and may modify baseline SRC performance","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1976,"document":"38348645","golden":false,"offsetInEndSection":2132,"text":"These results suggest that Se supplementation could be a promising strategy to alleviate chemotherapy-induced testicular damage and preserve male fertility.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":112,"document":"38338771","golden":false,"offsetInEndSection":210,"text":"Prenatal exposure to low doses of DDT has been shown to affect adrenal medulla growth and function","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1922,"document":"38332521","golden":false,"offsetInEndSection":2062,"text":"Participants preferred programmes that offered PrEP services without cost-sharing and bundled with gender-affirming hormone therapy services","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1188,"document":"38318101","golden":false,"offsetInEndSection":1374,"text":"This study suggests that progesterone treatment in neonatal mice does not cause any structural changes in the male reproductive tracts at puberty, unlike the neonatal estrogen treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1442,"document":"38246518","golden":false,"offsetInEndSection":1523,"text":"Prenatal THC had dose-dependent effects on maternal weight gain and birth weight.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1044,"document":"38219543","golden":false,"offsetInEndSection":1231,"text":"In women of relatively high socioeconomic status, several EDC biomarkers were associated with select hormones, without cumulative or non-linear associations with progesterone, FT4, or TT4","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38071334","golden":false,"offsetInEndSection":123,"text":"Antidepressant use is two-fold greater in women compared to men; however, most studies have been performed in male subjects","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38063965","golden":false,"offsetInEndSection":67,"text":"Excessive fluoride exposure can disturb the balance of sex hormones","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38060679","golden":false,"offsetInEndSection":63,"text":"Gestational hyperandrogenism adversely impacts offspring health","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1360,"document":"16034694","golden":false,"offsetInEndSection":1513,"text":"Finally, laparoscopic adnexectomy with complete robotic assistance was reported as an important technical addition in the field of reproductive medicine.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":345,"document":"21069701","golden":false,"offsetInEndSection":725,"text":"The effectiveness of triggering with a GnRH agonist compared to HCG measured as pregnancy and ovarian hyperstimulation(OHSS) rates are unknown.OBJECTIVES: To compare the effectiveness of a GnRH agonist with HCG for triggering final oocyte maturation in IVF and ICSI patients undergoing controlled ovarian hyperstimulation in a GnRH antagonist protocol followed by embryo transfer.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1202,"document":"16034694","golden":false,"offsetInEndSection":1359,"text":"Successful egg retrieval from autotransplanted ovarian tissue was reported following successful radiotherapy in a patient with advanced cancer of the cervix.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":605,"document":"16034694","golden":false,"offsetInEndSection":861,"text":"Many prospective randomized multicenter clinical trials illustrated the advantages of using gonadotrophin-releasing hormone antagonist instead of the agonist for controlled ovarian hyperstimulation, for patients undergoing assisted reproductive techniques.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1040,"document":"16034694","golden":false,"offsetInEndSection":1201,"text":"Aromatase inhibitors that have been extensively used for post-menopausal breast cancer therapy were tried successfully for the first time in ovulation induction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":862,"document":"16034694","golden":false,"offsetInEndSection":1039,"text":"Antiprogestin medicated intrauterine device and combined hormonal contraceptive patches were introduced to improve the efficacy and reduce side effects of birth control methods.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21069701","golden":false,"offsetInEndSection":247,"text":"BACKGROUND: Gonadotropin-releasing hormone (GnRH) antagonist protocols for pituitary down regulation in in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI) allow the use of GnRH agonists for triggering final oocyte maturation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":313,"document":"25291334","golden":false,"offsetInEndSection":584,"text":"In this article Vernon Stevens describes the background of the research in this field, outlines the clinical trials planned or underway to test early hCG vaccine formulations, and gives a personal view of the research still needed to achieve a safe and effective vaccine.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":426,"document":"16034694","golden":false,"offsetInEndSection":604,"text":"Among the new discoveries, the characterization of two subtypes of progesterone receptors remains an outstanding addition that will impact on the future of breast cancer therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":249,"document":"16034694","golden":false,"offsetInEndSection":425,"text":"The meeting was characterized by many clinical updates, new discoveries in clinical and basic research and significant societal issues in the practice of reproductive medicine.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":876,"document":"16205090","golden":false,"offsetInEndSection":961,"text":"Previous clinical trials have validated the concept of hormonal contraception in men.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":239,"document":"16205090","golden":false,"offsetInEndSection":385,"text":"Apart from earlier sexual maturation, the absence of contraceptive use or the use of inefficient methods contributes mainly towards this increase.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1361,"document":"15266528","golden":false,"offsetInEndSection":1415,"text":"Few significant differences emerged from these trials.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1278,"document":"24981149","golden":false,"offsetInEndSection":1606,"text":"However, men with concerns about sexually transmitted disease were significantly less satisfied than men without such concerns (p\u003d0.03).CONCLUSIONS: A majority of the men who volunteered to participate in this trial of an experimental male hormonal contraceptive were satisfied with this transdermal male hormonal contraceptive.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1452,"document":"16205090","golden":false,"offsetInEndSection":1624,"text":"Of these, testosterone with either depot medroxyprogesterone acetate, norethisterone, desogestrel or etonogestrel have shown promising efficacy in phase II clinical trials.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":962,"document":"16205090","golden":false,"offsetInEndSection":1110,"text":"However, the application modalities and the ineffectiveness of all self-administered androgen preparations have been unacceptable for practical use.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1910,"document":"15266528","golden":true,"offsetInEndSection":2099,"text":"Several regimens, including testosterone alone and GnRH agonists and antagonists, had disappointing results.REVIEWERS\u0027 CONCLUSIONS: No male hormonal contraceptive is ready for clinical use.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"15266528","golden":false,"offsetInEndSection":65,"text":"BACKGROUND: Male hormonal contraception has been an elusive goal.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":233,"document":"28101363","golden":false,"offsetInEndSection":378,"text":"The results showed that it was possible to develop methods of male contraception that inhibited spermatogenesis with good contraceptive efficacy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1301,"document":"16205090","golden":false,"offsetInEndSection":1451,"text":"Over the last decades various combinations of androgen preparations with different progestins or GnRH antagonists have been tested in clinical trials.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34656768","golden":false,"offsetInEndSection":300,"text":"OBJECTIVES: To evaluate the spermicidal efficacy of non-hormonal vaginal gel in vitro and in a post-coital test, and to evaluate its contraceptive efficacy in Canadian women of childbearing age.METHODS: We conducted single-centre trial to assess spermicidal and contraceptive efficacy of vaginal gel.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1139,"document":"34656768","golden":false,"offsetInEndSection":1405,"text":"Four women became pregnant during the study period; 2 during unprotected vaginal intercourse around the time of ovulation, and 2 attributed to user failure.CONCLUSION: Based on our results, the vaginal gel demonstrated important spermicidal and contraceptive effect.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":189,"document":"11097787","golden":false,"offsetInEndSection":359,"text":"Following the earlier contraceptive efficacy trials using testosterone alone, synergistic combination regimes using newer androgens and other agents are now being tested.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":360,"document":"11097787","golden":false,"offsetInEndSection":569,"text":"The combination of a long-acting testosterone preparation with a progestogen appears to be the most promising, and will hopefully lead to an accepted product for clinical application early in the 21st century.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"11097787","golden":false,"offsetInEndSection":188,"text":"Male hormonal contraceptive methods are based on the principle of pituitary gonadotrophin suppression and intratesticular testosterone depletion, leading to suppression of spermatogenesis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1452,"document":"14686803","golden":false,"offsetInEndSection":1593,"text":"These results demonstrated that long-term supraphysiological TU injection did not obviously affect the examined rat immunological parameters.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":420,"document":"34656768","golden":false,"offsetInEndSection":762,"text":"Measured outcomes included effect of vaginal gel on sperm motility in vitro, its effect on sperm in a post-coital test, and its effect on pregnancy prevention over 3 months.RESULTS: For in vitro spermicidal effect, 98% and 67% of sperm were immotile in the presence of the gel with sodium lauryl sulfate (gel-SLS) and gel alone, respectively.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17458182","golden":false,"offsetInEndSection":99,"text":"Efficacy trials have shown that male hormonal contraceptives can be effective, safe and reversible.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1803,"document":"37210024","golden":false,"offsetInEndSection":1968,"text":"IMPLICATIONS: The development of a safe, effective, reversible male contraceptive would improve contraceptive options and may decrease rates of unintended pregnancy.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"11097787","golden":false,"offsetInEndSection":28,"text":"Male hormonal contraception.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":238,"document":"17110396","golden":false,"offsetInEndSection":511,"text":"This randomized multicentre trial using a parallel design compares the efficacy of clomiphene citrate (CC) with that of recombinant FSH (rFSH).METHODS: Couples with primary unexplained or male subfertility were randomized to receive CC or rFSH for ovarian hyperstimulation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17110396","golden":false,"offsetInEndSection":154,"text":"BACKGROUND: Controlled ovarian hyperstimulation with intrauterine insemination (IUI) is a widely accepted treatment for unexplained and male subfertility.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1220,"document":"36499313","golden":false,"offsetInEndSection":1345,"text":"Therefore, COC can be selected as method of contraception during and after cenerimod therapy without the risk of interaction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1466,"document":"36409333","golden":false,"offsetInEndSection":1552,"text":"A DRSP-only pill is a good OC option for women with contraindications to oestrogen use","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":214,"document":"36336005","golden":false,"offsetInEndSection":393,"text":"In this single-center trial, women at risk of preterm birth at 24 to less than 37?weeks of gestation?were randomized to receive 2 doses of betamethasone or placebo, 24?hours apart","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1465,"document":"37450195","golden":false,"offsetInEndSection":1771,"text":"Fat Mass Index (FMI) was correlated with lumbar and femur BMD both in transgender individuals, while no correlations were found between lean mass parameters and BMD in AMAB transgender people.CONCLUSIONS: Body composition and lifestyle factors could contribute to low BMD in transgender adults before GAHT.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37450195","golden":false,"offsetInEndSection":193,"text":"PURPOSE: Preliminary data suggested that bone mineral density (BMD) in transgender adults before initiating gender-affirming hormone therapy (GAHT) is lower when compared to cisgender controls.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":194,"document":"37450195","golden":false,"offsetInEndSection":774,"text":"In this study, we analyzed bone metabolism in a sample of transgender adults before GAHT, and its possible correlation with biochemical profile, body composition and lifestyle habits (i.e., tobacco smoke and physical activity).METHODS: Medical data, smoking habits, phospho-calcic and hormonal blood tests and densitometric parameters were collected in a sample of 125 transgender adults, 78 Assigned Females At Birth (AFAB) and 47 Assigned Males At Birth (AMAB) before GAHT initiation and 146 cisgender controls (57 females and 89 males) matched by sex assigned at birth and age.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1109,"document":"36213273","golden":false,"offsetInEndSection":1436,"text":"The GnRHa-HRT group had significantly higher rates of biochemical pregnancy, clinical pregnancy, multiple pregnancy, and term birth.Conclusion: The endometrial preparation protocol of HRT with GnRH-a pre-treatment could obviously increase the live birth rate for women with male-factor infertility undergoing the FET programme.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1418,"document":"35136878","golden":false,"offsetInEndSection":1594,"text":"Conclusions: The increased conception rate observed following the use of the Clearblue Connected Ovulation Test System was found to translate into an increased live birth rate.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":775,"document":"37450195","golden":false,"offsetInEndSection":1078,"text":"55 transgender and 46 cisgender controls also underwent a complete body composition evaluation and assessment of physical activity using the International Physical Activity Questionnaire (IPAQ).RESULTS: 14.3% of transgender and 6.2% of cisgender sample, respectively, had z-score values?\u003c?-2 (p?\u003d?0.04).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":634,"document":"38357937","golden":false,"offsetInEndSection":732,"text":"The cLBR between the PPOS group and GnRH-ant group were comparable (55.75% vs. 52.87%, p?\u003d?0.591).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2129,"document":"38079168","golden":false,"offsetInEndSection":2504,"text":"More newborns assigned to the oropharyngeal surfactant group were diagnosed with and treated for pneumothorax (21 [16.6%] vs 8 [6.4%]; P \u003d .04).Conclusions and Relevance: This randomized clinical trial found that administration of prophylactic oropharyngeal surfactant to newborns born before 29 weeks\u0027 GA did not reduce the rate of intubation in the first 120 hours of life.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37450195","golden":false,"offsetInEndSection":123,"text":"Bone health and body composition in transgender adults before gender-affirming hormonal therapy: data from the COMET study.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":585,"document":"37581383","golden":false,"offsetInEndSection":1511,"text":"This review is an update of the review, first published in 1999, comparing ICSI with c-IVF for couples with males presenting with normal total sperm count and motility.OBJECTIVES: To evaluate the effectiveness and safety of ICSI relative to c-IVF in couples with males presenting with normal total sperm count and motility.SEARCH METHODS: We searched the following databases and trial registers: Cochrane Central Register of Controlled Trials (CENTRAL), Embase (excerpta Medica Database), MEDLINE (Medical Literature Analysis and Retrieval System Online) and PsycINFO (Psychological literature database) for articles between January 2010 and 22 February 2023.SELECTION CRITERIA: We included randomised controlled trials (RCTs) that compared ICSI with c-IVF in couples with males presenting with normal total sperm count and motility.DATA COLLECTION AND ANALYSIS: We used standard methodical procedures recommended by Cochrane.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":414,"document":"36195924","golden":false,"offsetInEndSection":668,"text":"Women were randomized in a 1:1 ratio to be treated with either follitropin delta dose based on anti-M?llerian hormone (AMH) and body weight or conventional dosing with follitropin alfa following a gonadotropin-releasing hormone (GnRH) antagonist protocol","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":697,"document":"39016284","golden":true,"offsetInEndSection":1047,"text":"In contraceptive efficacy studies, testosterone alone or combined with a progestin are as effective in preventing pregnancies as female contraceptive methods.CONCLUSION: Hormone combinations for male contraception are in late-phase clinical trials and hold the promise of being the new, reversible contraception method for men in over half a century.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"487815","golden":false,"offsetInEndSection":197,"text":"Pregnancies associated with sperm concentrations below 10 million/ml in clinical studies of a potential male contraceptive method, monthly depot medroxyprogesterone acetate and testosterone esters.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":216,"document":"20808223","golden":true,"offsetInEndSection":525,"text":"Hormonal male contraceptive methods have undergone extensive clinical trials in healthy men and shown to be efficacious, reversible and appear to be well tolerated.RECENT FINDINGS: The success rate of male hormonal contraception using injectable testosterone alone is high and comparable to methods for women.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":645,"document":"487815","golden":false,"offsetInEndSection":681,"text":"There were no spontaneous abortions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"487815","golden":true,"offsetInEndSection":244,"text":"A potential male contraceptive approach was evaluated in clinical trials involving monthly injections of depot medroxyprogesterone acetate and either subdermal implants of testosterone propionate or monthly injections of testosterone enanthate.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":682,"document":"487815","golden":false,"offsetInEndSection":810,"text":"6 pregnancies were carried to term, and all progeny were normal, based on physical examination at birth or 3 months after birth.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":339,"document":"487815","golden":false,"offsetInEndSection":409,"text":"In 5 of the 9 instances, the sperm counts were less than 1 million/ml.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":410,"document":"487815","golden":false,"offsetInEndSection":543,"text":"It appears that male contraceptive methods involving spermatogenic suppression may require attainment and maintenance of azoospermia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":829,"document":"39016284","golden":false,"offsetInEndSection":1009,"text":"ale contraceptive methods.CONCLUSION: Hormone combinations for male contraception are in late-phase clinical trials and hold the promise of being the new, reversible contraception ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1224,"document":"36909934","golden":false,"offsetInEndSection":1349,"text":"espite multiple human trials, no male birth control agents have garnered regulatory approval in the United States or abroad. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1045,"document":"39030853","golden":false,"offsetInEndSection":1160,"text":"verall, by developing non-hormonal male contraceptives, men will have more control over their reproductive health. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":697,"document":"32197832","golden":false,"offsetInEndSection":909,"text":"ewer hormonal male contraceptive formulations and the alternative routes of administration are discussed, along with potential barriers, challenges, and opportunities for hormonal male contraceptive development. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":458,"document":"39341709","golden":false,"offsetInEndSection":676,"text":" range of both long-acting and self-administered combination methods are effective, including injection, implant and gel methods of administration, with up to 95% of men achieving sufficient spermatogenic suppression. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35550379","golden":false,"offsetInEndSection":123,"text":"OBJECTIVE: To assess men\u0027s preferences for healthcare provider from whom they would obtain hormonal male contraceptive (HMC","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":245,"document":"487815","golden":false,"offsetInEndSection":338,"text":"Pregnancies occurred in partners of 9 men with recent sperm counts of 10 million/ml or below.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39016284","golden":true,"offsetInEndSection":199,"text":"INTRODUCTION: Male contraception with exogenously administered hormones suppresses both luteinizing hormone and follicle stimulating hormone leading to low intratesticular testosterone concentration.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":200,"document":"39016284","golden":true,"offsetInEndSection":696,"text":"This results in reversible suppression of spermatogenesis and marked decrease in sperm output in the ejaculate and preventing pregnancy in the female partner.PRIOR STUDIES: Studies of testosterone administered alone or in combination of another gonadotropin suppressive agent such as a progestin or gonadotropin releasing hormone (GnRH) analog showed decisively that the exogenous hormone administrations are effective in suppressing sperm output with few adverse events that are not anticipated.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31754066","golden":true,"offsetInEndSection":361,"text":"INTRODUCTION: There is unmet need for male contraceptive options, but a recent injectable combination male contraceptive trial was terminated early due to adverse events (AEs).METHODS: We examined the frequency of reported AEs by male research participants compared with AEs reported in prescribing information of approved female hormonal contraceptive methods.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27090863","golden":false,"offsetInEndSection":1007,"text":"OBJECTIVE: To examine the efficacy and safety of frozen-thawed embryo transfer (FTET) cycles with supernumerary embryos cryopreserved during a randomized clinical trial (PURSUE).DESIGN: Follow-up clinical study.SETTING: In?vitro fertilization (IVF) centers.PATIENT(S): Infertile women 35 to 42 years of age.INTERVENTION(S): In PURSUE, women were randomized to a single injection of 150??g of corifollitropin alfa (n \u003d 694) or daily 300 IU of recombinant follicle-stimulating hormone (recombinant FSH; n \u003d 696) for the first 7?days of controlled ovarian stimulation (COS) in a gonadotropin-releasing hormone (GnRH) antagonist protocol.MAIN OUTCOME MEASURE(S): Cumulative vital pregnancy rate per-patient by treatment group, cumulative live-birth rate per-patient by treatment group, and occurrence of adverse events in (pregnant) women and their fetuses/infants and the incidence of congenital malformations in the infants.RESULT(S): Of the 1,390 treated women in PURSUE, 307 were enrolled in the FTET study.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1048,"document":"39016284","golden":false,"offsetInEndSection":1181,"text":"Lessons learned from the male hormonal contraceptive development pave the way for new targeted approached to regulate male fertility.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"39016284","golden":false,"offsetInEndSection":28,"text":"Hormonal male contraception.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1017,"document":"31754066","golden":false,"offsetInEndSection":1296,"text":"Men discontinued participation due to AEs at a lower frequency than women.CONCLUSIONS: Female hormonal methods generally have similar frequencies of AEs to those reported in a recent male hormonal contraceptive trial, and male users had lower rates of discontinuation due to AEs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2412,"document":"33814126","golden":false,"offsetInEndSection":3103,"text":"No statistically significant differences with respect to implantation rate (68.1% in the MPA group vs. 62% in the antagonist group), clinical pregnancy rate (64.5% in the MPA group vs. 57.8 in the antagonist group), ongoing pregnancy rate (55.4% in the MPA group vs. 48.5% in the antagonist group), live birth rate (55.1% in the MPA group vs. 48.5% in the antagonist group), or cumulative live birth rate (73.8% in the MPA group vs. 70.7% in the antagonist group) were observed between the groups.CONCLUSION(S): The administration of MPA resulted in oocyte retrieval rates, endocrine profiles, viable embryo numbers, and pregnancy outcomes similar to those achieved with the GnRH antagonist.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24579923","golden":false,"offsetInEndSection":575,"text":"BACKGROUND: The cause of infertility is unexplained or poorly explained in 30-40% of couples undergoing standard investigations, and treatment ranges from expectant management to IUI and IVF.AIMS: The aim of this study was to compare the clinical pregnancy rates and costs of intra-uterine insemination (IUI) and in vitro fertilisation (IVF) in women where the same ovarian stimulation led to the development of two or three mature follicles.METHODS: A randomised controlled clinical trial compared the efficacy of IUI and IVF in a tertiary fertility centre (ISRCTN28780587).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35550379","golden":true,"offsetInEndSection":450,"text":"OBJECTIVE: To assess men\u0027s preferences for healthcare provider from whom they would obtain hormonal male contraceptive (HMC) methods.STUDY DESIGN: We asked participants from 3 clinical trials of investigational HMC methods-an oral pill (11?-Methyl-19-nortestosterone-17?-dodecylcarbonate, 11?-MNTDC), intramuscular or subcutaneous injection (Dimethandrolone undecanoate), and transdermal gel (Nestorone and testosterone)-to rank their top 3 preferred","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33617839","golden":false,"offsetInEndSection":450,"text":"OBJECTIVE: Reddit is one of the most popular websites in the United States because of its user-driven aggregation and community-based curation of online content. We describe the use and impact of Reddit\u0027s Ask Me Anything platform, for public engagement and education about developments in hormonal male contraception (HMC).METHODS: We analyzed the content from and user engagement with 2 Reddit Ask Me Anything events that answered user queries about","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":579,"document":"30602479","golden":false,"offsetInEndSection":651,"text":"ier stages.CONTENT: Several hormonal male contraceptive agents have ente","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":496,"document":"33481994","golden":false,"offsetInEndSection":568,"text":"evelopment.CONTENT: Several hormonal male contraceptive agents have ente","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":197,"document":"20808223","golden":false,"offsetInEndSection":361,"text":"ire other options. Hormonal male contraceptive methods have undergone extensive clinical trials in healthy men and shown to be efficacious, reversible and appear to","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":291,"document":"32019712","golden":true,"offsetInEndSection":426,"text":"Non-hormonal male contraceptives and vas occlusion have also been explored, but to date no method has progressed past clinical testing.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1223,"document":"36909934","golden":false,"offsetInEndSection":1348,"text":"Despite multiple human trials, no male birth control agents have garnered regulatory approval in the United States or abroad.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":400,"document":"25620227","golden":true,"offsetInEndSection":533,"text":"Testosterone (T) alone, or in combination with a progestin currently provides the most promising lead to male hormonal contraception.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1046,"document":"12041962","golden":false,"offsetInEndSection":1208,"text":"It is likely that the first marketed male hormonal contraceptive method will be a long-acting (injectable or implant) combination of an androgen plus a progestin.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1044,"document":"39030853","golden":false,"offsetInEndSection":1159,"text":"Overall, by developing non-hormonal male contraceptives, men will have more control over their reproductive health.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35550379","golden":false,"offsetInEndSection":122,"text":"OBJECTIVE: To assess men\u0027s preferences for healthcare provider from whom they would obtain hormonal male contraceptive (HM","beginSection":"abstract"}],"exact_answer":"yes","ideal_answer":["Yes, there are clinical trials on hormonal male birth control methods. These trials have evaluated combinations such as testosterone undecanoate and etonogestrel, as well as monthly depot medroxyprogesterone acetate with testosterone esters, showing effectiveness in suppressing spermatogenesis and promising potential as reversible contraception methods for men."],"id":"6593d46c06a2ea257c00001b","type":"yesno","body":"Are there clinical trials on hormonal male birth control methods?"},{"documents":[{"golden":true,"id":"19595920"},{"golden":true,"id":"24650059"},{"golden":true,"id":"17453265"},{"golden":false,"id":"28932605"},{"golden":false,"id":"35799435"},{"golden":false,"id":"11342677"},{"golden":false,"id":"35930282"},{"golden":false,"id":"18537198"},{"golden":false,"id":"11454121"},{"golden":false,"id":"32903556"},{"golden":false,"id":"38627686"},{"golden":false,"id":"39031361"},{"golden":false,"id":"39220280"},{"golden":false,"id":"20818471"},{"golden":false,"id":"23936862"},{"golden":false,"id":"9539404"},{"golden":false,"id":"20845398"},{"golden":false,"id":"32609745"},{"golden":false,"id":"15683958"},{"golden":false,"id":"17078433"},{"golden":false,"id":"2414676"},{"golden":false,"id":"2053451"},{"golden":false,"id":"30842996"},{"golden":false,"id":"28122474"},{"golden":false,"id":"37379733"},{"golden":false,"id":"37850919"},{"golden":false,"id":"38274411"},{"golden":false,"id":"38746636"},{"golden":false,"id":"33336226"},{"golden":false,"id":"32848703"},{"golden":false,"id":"16050849"},{"golden":false,"id":"33015310"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":1204,"document":"17453265","golden":true,"offsetInEndSection":1483,"text":"Further cognitive testing could not detect 9 dementia cases without memory complaints and with MMSE scores \u003e or \u003d 22.CONCLUSIONS: In older primary care patients with memory complaints, cognitive screening does not help identify those who require further examination for dementia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":240,"document":"19595920","golden":true,"offsetInEndSection":413,"text":"By distinction, the problems of defining, diagnosing, and treating mild cognitive impairment (MCI) are not yet resolved, and MCI is not ready for a screening recommendation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":414,"document":"19595920","golden":false,"offsetInEndSection":644,"text":"Dementia screening approaches, including cognitive testing and functional assessment, must be evaluated on their scientific merits, including sensitivity and specificity for recognizing affected individuals in at-risk populations.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":83,"document":"19595920","golden":false,"offsetInEndSection":139,"text":"Furthermore, dementia diagnoses are widely unrecognized.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":140,"document":"19595920","golden":false,"offsetInEndSection":239,"text":"As a result, persons with dementia are missing important clinical care and treatment interventions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"19595920","golden":false,"offsetInEndSection":82,"text":"Multiple arguments for considering routine dementia screening have been presented.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":645,"document":"19595920","golden":false,"offsetInEndSection":876,"text":"Screening tests must be \"cost-worthy\", with the benefits of true-positive test results justifying the costs of testing and resolving false-positive cases, with due consideration for proper diagnostic evaluation and potential harms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1219,"document":"11454121","golden":false,"offsetInEndSection":1611,"text":"Adding two or more risk factors for AD improved sensitivity and specificity to 71% and 89% and, in the physician assessment subgroup, to 75% and 87%, primarily by halving the false-positive rate.CONCLUSION: The combination of the simple, self-administered CCT and two or more AD risk factors is a more effective screening instrument for DAT and potentially preclinical DAT than the CCT alone.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":877,"document":"19595920","golden":false,"offsetInEndSection":1079,"text":"With the tremendous number of new cases projected in the near future and the expected emergence of beneficial therapies, considerably more research is needed to develop more efficient screening systems.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"19595920","golden":false,"offsetInEndSection":97,"text":"Should older adults be screened for dementia? It is important to screen for evidence of dementia!","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1478,"document":"35799435","golden":false,"offsetInEndSection":1727,"text":"Chair stand speed was not associated with plasma markers; A?42 was not associated with function.CONCLUSION: Grip strength and fast walk speed are associated with plasma markers of neurodegeneration in dementia-free middle aged and older individuals.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":986,"document":"39031361","golden":false,"offsetInEndSection":1244,"text":"entered into five databases. Articles were included if they focused on population or risk screening for dementia via primary/community care-based assessments, and which included majority ethnic minority or low socio-economic groups or discretely considered t","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1014,"document":"39220280","golden":false,"offsetInEndSection":1207,"text":"overnment policies on dementia prevention and health care, along with early and regular dementia screening programs, can enhance the early identification and management of individuals at risk. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1391,"document":"20818471","golden":false,"offsetInEndSection":1738,"text":"espite the majority of IMPACT respondents being in favour of screening for AD, the evidence to support the introduction of population screening for cognitive impairment is not available; however, the importance of optimal identification of AD and other dementias in primary care should be a priority for community health professionals and payors. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":195,"document":"23936862","golden":false,"offsetInEndSection":636,"text":"n the western world, the recognition of the impact on patients, families, health care systems, and societies that dementia poses has led to great efforts to help define the indicators for current and future dementia with the intention to treat those already afflicted even with the primarily symptomatic medications that exist and to recognize those at future risk with the hope of providing counselling to forestall its future development. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":351,"document":"24650059","golden":true,"offsetInEndSection":484,"text":"The disadvantages include psychological damage related to anxiety and depression, and risk of stigmatization and/or social exclusion.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":735,"document":"24650059","golden":false,"offsetInEndSection":899,"text":"Thus, these screening tools are recommended for assessment of the severity of functional decline after sufficient information has been gathered to suspect dementia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24650059","golden":false,"offsetInEndSection":140,"text":"Early detection of dementia is recommended in the stages from mild cognitive impairment to early dementia, excluding the asymptomatic stage.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":485,"document":"24650059","golden":false,"offsetInEndSection":549,"text":"The possibility of false positive diagnoses is also problematic.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17453265","golden":false,"offsetInEndSection":442,"text":"BACKGROUND: Dementia screening is currently recommended only for symptomatic patients.OBJECTIVE: To evaluate memory complaints, a mental status test, and several cognitive tests as dementia screens in primary care.DESIGN: Cross-sectional clinical epidemiologic study.PARTICIPANTS: Three hundred thirty-nine comprehensively assessed, primary care patients aged \u003e or \u003d 65 years.MEASUREMENTS: Memory complaints were abstracted from chart review.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":141,"document":"24650059","golden":false,"offsetInEndSection":350,"text":"The advantages of early detection for patients and their caregivers include early receipt of pharmacological and non-pharmacological therapies, and early access to appropriate agencies and/or support networks.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1447,"document":"24650059","golden":false,"offsetInEndSection":1613,"text":"Under a community-based integrated care system, each community will create a \"tailored\" system that meets the health needs, health status and values of the community.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1420,"document":"11342677","golden":false,"offsetInEndSection":1762,"text":"These subjects were at increased risk for developing dementia or AD when compared with similarly aged individuals in the general population.RECOMMENDATIONS: There were sufficient data to recommend the evaluation and clinical monitoring of persons with mild cognitive impairment due to their increased risk for developing dementia (Guideline).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32903556","golden":false,"offsetInEndSection":450,"text":"Background: Cognitive impairment is a common condition in older people, and age-related cognitive symptoms may progress to Mild Cognitive Impairment and Dementia. Physical exercise and cognitive training may be useful in maintaining cognitive function, and those developing impaired cognitive function should be advised to plan for the future. The MoCA test is a useful cognitive screening instrument, but the Russian version of this test has not yet","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37379733","golden":false,"offsetInEndSection":450,"text":"BACKGROUND AND OBJECTIVES: Sleep and physical activity have gained traction as modifiable risk factors for Alzheimer\u0027s disease. Sleep duration is linked to amyloid-? clearance while physical activity is associated with brain volume maintenance. We investigate how sleep duration and physical activity are associated with cognition by testing if the associations between sleep duration or physical activity to cognition are explained by amyloid-? burd","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37850919","golden":false,"offsetInEndSection":450,"text":"OBJECTIVE: With our aging population, an increasing number of older adults with hearing loss have cognitive decline. Hearing care practitioners have an important role in supporting healthy aging and should be knowledgeable about cognitive decline and associated management strategies to maximize successful hearing intervention.METHODS: A review of current research and expert opinion.RESULTS: This article outlines the association between hearing lo","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38274411","golden":false,"offsetInEndSection":450,"text":"INTRODUCTION: Low-cost simple tests for preclinical Alzheimer\u0027s disease are a research priority. We evaluated whether remote unsupervised?webcam recordings of finger-tapping were associated with cognitive performance in older adults.METHODS: A total of 404 cognitively-asymptomatic participants (64.6 [6.77] years; 70.8% female) completed 10-second finger-tapping tests (Tasmanian [TAS] Test) and cognitive tests (Cambridge Neuropsychological Test Au","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38746636","golden":false,"offsetInEndSection":450,"text":"Background: In recent years, studies have examined the acceptability and attitudes that influence the intention to early screen for Alzheimer\u0027s disease (AD) in the general population, older people, carers, and asymptomatic individuals who report a family history of AD. However, it remains unclear what specific factors promote or reduce the acceptability of pre-symptomatic screening.Objective: The aim of this study is to explore the attitudes of f","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33336226","golden":false,"offsetInEndSection":450,"text":"BACKGROUND: Computerized cognitive assessments may improve Alzheimer\u0027s disease (AD) secondary prevention trial efficiency and accuracy. However, they require validation against standard outcomes and relevant biomarkers.OBJECTIVE: To assess the feasibility and validity of the tablet-based Computerized Cognitive Composite (C3).DESIGN: Cross-sectional analysis of cognitive screening data from the A4 study (Anti-Amyloid in Asymptomatic AD).SETTING: M","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32848703","golden":false,"offsetInEndSection":450,"text":"Background: The pathogenesis of dementia often starts several years prior to clinical onset during which the individual is asymptomatic. Existing strategies for the accurate diagnosis of early dementia are limited by high cost and the invasive nature of the procedures. Eye movement parameters associated with cognitive functions may be helpful in the early identification of dementia and in the development and evaluation of preventive and therapeut","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":272,"document":"9539404","golden":false,"offsetInEndSection":458,"text":"The efficacy of and benefits from unselective use of cognitive testing and informant questionnaires for detecting early dementia in older patients attending general practice are limited.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":337,"document":"32609745","golden":false,"offsetInEndSection":425,"text":" benefits vs. harms of dementia screening or whether a dementia screening program could ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1269,"document":"16050849","golden":false,"offsetInEndSection":1508,"text":"common and undiagnosed in primary care. Screening instruments alone have insufficient specificity to establish a valid diagnosis of dementia when used in a comprehensive screening program; these results may not be generalized to older adul","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"20845398","golden":false,"offsetInEndSection":123,"text":"OBJECTIVES: To determine the acceptability of dementia screening in two populations of older adults in different primary ca","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"11342677","golden":false,"offsetInEndSection":177,"text":"OBJECTIVE: The goal of this project was to determine whether screening different groups of elderly individuals in a general or specialty practice would be beneficial in detectin","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1273,"document":"18537198","golden":false,"offsetInEndSection":1444,"text":"eing excluded from MCI classifications. More broadly defined criteria would be better for selection of individuals at risk of dementia in population settings, but at the p","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":163,"document":"15683958","golden":false,"offsetInEndSection":379,"text":"On the other hand, the usefulness of screening cases, which have no repercussion on daily life, is not proven considering the difficulty to discriminate early stages from age-related intellectual performance decline.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33015310","golden":false,"offsetInEndSection":204,"text":"INTRODUCTION: Understanding the associations among depression, subjective cognitive decline, and prodromal Alzheimer\u0027s disease (AD) has important implications for both depression and dementia screening in","beginSection":"abstract"}],"ideal_answer":[],"id":"6777bfbe592fa48873000016","type":"summary","body":"What would be the main disadvantages of screening for dementia in asymptomatic older populations?"},{"documents":[{"golden":false,"id":"35779372"},{"golden":false,"id":"31558467"},{"golden":false,"id":"34364105"},{"golden":false,"id":"36001711"},{"golden":true,"id":"35378683"},{"golden":false,"id":"31044580"},{"golden":true,"id":"26307241"},{"golden":false,"id":"35237397"},{"golden":false,"id":"33406479"},{"golden":false,"id":"35030985"},{"golden":true,"id":"35869335"},{"golden":true,"id":"35570581"},{"golden":true,"id":"32933335"},{"golden":false,"id":"34599723"},{"golden":true,"id":"33880738"},{"golden":false,"id":"28288710"},{"golden":false,"id":"31077854"},{"golden":false,"id":"33516134"},{"golden":false,"id":"31994023"},{"golden":false,"id":"30516432"},{"golden":true,"id":"35185862"},{"golden":true,"id":"28810856"},{"golden":true,"id":"34370283"},{"golden":true,"id":"33551958"},{"golden":true,"id":"30573759"},{"golden":false,"id":"28499646"},{"golden":true,"id":"34382120"},{"golden":true,"id":"31027436"},{"golden":false,"id":"34418815"},{"golden":false,"id":"12867058"},{"golden":false,"id":"26015261"},{"golden":false,"id":"28004361"},{"golden":false,"id":"24731302"},{"golden":false,"id":"25014645"},{"golden":false,"id":"16814387"},{"golden":false,"id":"27890931"},{"golden":false,"id":"22150234"},{"golden":false,"id":"25877943"},{"golden":false,"id":"36057010"},{"golden":false,"id":"35341428"},{"golden":false,"id":"10170423"},{"golden":false,"id":"18253702"},{"golden":false,"id":"24689530"},{"golden":false,"id":"28719092"},{"golden":false,"id":"11206201"},{"golden":false,"id":"34067669"},{"golden":false,"id":"3407332"},{"golden":false,"id":"1933672"},{"golden":false,"id":"35852793"},{"golden":false,"id":"32300434"},{"golden":false,"id":"29300693"},{"golden":false,"id":"33459118"},{"golden":false,"id":"30709431"},{"golden":false,"id":"31847708"},{"golden":false,"id":"36143259"},{"golden":false,"id":"27960628"},{"golden":false,"id":"36303796"},{"golden":false,"id":"20451549"},{"golden":false,"id":"20384574"},{"golden":false,"id":"28276536"},{"golden":false,"id":"26285615"},{"golden":false,"id":"20109133"},{"golden":false,"id":"18045070"},{"golden":false,"id":"24724406"},{"golden":false,"id":"11226006"},{"golden":false,"id":"10322362"},{"golden":false,"id":"21196171"},{"golden":false,"id":"24555705"},{"golden":false,"id":"15925559"},{"golden":false,"id":"16195797"},{"golden":false,"id":"24674882"},{"golden":false,"id":"19584004"},{"golden":false,"id":"17492926"},{"golden":false,"id":"12962009"},{"golden":false,"id":"24564508"},{"golden":false,"id":"32324354"},{"golden":false,"id":"30850038"},{"golden":false,"id":"25406944"},{"golden":false,"id":"36534148"},{"golden":false,"id":"27480113"},{"golden":false,"id":"36756069"},{"golden":false,"id":"27902473"},{"golden":false,"id":"29254981"},{"golden":false,"id":"35500041"},{"golden":false,"id":"18502830"},{"golden":false,"id":"2771603"},{"golden":false,"id":"25012065"},{"golden":false,"id":"23438039"},{"golden":false,"id":"20432075"},{"golden":false,"id":"21592000"},{"golden":false,"id":"12871122"},{"golden":false,"id":"12864941"},{"golden":false,"id":"15134822"},{"golden":false,"id":"30532015"},{"golden":false,"id":"16305491"},{"golden":false,"id":"32503913"},{"golden":false,"id":"35999405"},{"golden":false,"id":"23040543"},{"golden":false,"id":"32223334"},{"golden":false,"id":"19687518"},{"golden":false,"id":"28592762"},{"golden":false,"id":"35651781"},{"golden":false,"id":"11815272"},{"golden":false,"id":"29358322"},{"golden":false,"id":"17168674"},{"golden":false,"id":"26277232"},{"golden":false,"id":"23988437"},{"golden":false,"id":"19123390"},{"golden":false,"id":"31513015"},{"golden":false,"id":"10067158"},{"golden":false,"id":"37811115"},{"golden":true,"id":"37156035"},{"golden":true,"id":"36920653"},{"golden":true,"id":"38480630"},{"golden":false,"id":"29609506"},{"golden":false,"id":"39050801"},{"golden":true,"id":"39512280"},{"golden":true,"id":"37842819"},{"golden":false,"id":"33722905"},{"golden":false,"id":"37033984"},{"golden":true,"id":"37906325"},{"golden":false,"id":"36999373"},{"golden":false,"id":"33411674"},{"golden":true,"id":"27982425"},{"golden":true,"id":"36317532"},{"golden":true,"id":"32351164"},{"golden":true,"id":"28220479"},{"golden":true,"id":"23611989"},{"golden":false,"id":"33631112"},{"golden":false,"id":"31232925"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":0,"document":"32351164","golden":true,"offsetInEndSection":200,"text":"BACKGROUND: Ublituximab, a novel monoclonal antibody (mAb) targeting a unique epitope on the CD20 antigen, is glycoengineered for enhanced B-cell targeting through antibody-dependent cellular cytotoxi","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"27982425","golden":true,"offsetInEndSection":225,"text":"Ublituximab (TG-1101), a novel glycoengineered anti-CD20 antibody, in combination with ibrutinib is safe and highly active in patients with relapsed and/or refractory chronic lymphocytic leukaemia: results of a phase 2 trial.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":126,"document":"27982425","golden":true,"offsetInEndSection":239,"text":"Ublituximab is a novel, glycoengineered anti-CD20 monoclonal antibody with single-agent activity in relapsed CLL.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":76,"document":"36317532","golden":true,"offsetInEndSection":379,"text":"ntly emerged. Ublituximab is a monoclonal antibody that binds to the B-cell antigen CD20 with enhanced B-cell targeting.AREAS COVERED: This evaluation is of the identical ULTIMATE (UbLiTuximab In Multiple Sclerosis Treatment Effects) I and II trials comparing ublituximab (TG-1101) and teriflunomide in ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":822,"document":"29609506","golden":false,"offsetInEndSection":1010,"text":"ng CD20 (e.g. obinituzumab, ofatumumab), and includes ublituximab (Ub), with higher complement-dependent cytotoxicity (CDC) and antibody-dependent cellular cytotoxicity (ADCC) against mali","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":3910,"document":"33631112","golden":false,"offsetInEndSection":4062,"text":"ctory high-risk chronic lymphocytic leukaemia. These findings provide support for the addition of ublituximab to Bruton tyrosine kinase inhibitors for t","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":189,"document":"31558467","golden":false,"offsetInEndSection":470,"text":"The safety of the next-generation compounds umbralisib, a PI3K-? inhibitor, plus ublituximab, an anti-CD20 monoclonal antibody (combination referred to as U2), was evaluated in patients with chronic lymphocytic lymphoma (CLL) or non-Hodgkin lymphoma (NHL) in this phase 1/1b study.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"23611989","golden":true,"offsetInEndSection":148,"text":"Preclinical study of Ublituximab, a Glycoengineered anti-human CD20 antibody, in murine models of primary cerebral and intraocular B-cell lymphomas.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":240,"document":"27982425","golden":false,"offsetInEndSection":387,"text":"We report the results of a phase 2 study evaluating combination therapy with ibrutinib and ublituximab in patients with relapsed or refractory CLL.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1153,"document":"27982425","golden":false,"offsetInEndSection":1237,"text":"Ublituximab in combination with ibrutinib resulted in rapid and high response rates.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":729,"document":"29609506","golden":false,"offsetInEndSection":1037,"text":"mergence of resistance to RTX prompted the development of the next-generation of mAbs targeting CD20 (e.g. obinituzumab, ofatumumab), and includes ublituximab (Ub), with higher complement-dependent cytotoxicity (CDC) and antibody-dependent cellular cytotoxicity (ADCC) against malignant B-cells. Areas covere","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"29609506","golden":false,"offsetInEndSection":66,"text":"Ublituximab for the treatment of CD20 positive B-cell malignancies","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":719,"document":"35378683","golden":true,"offsetInEndSection":937,"text":" hand, the anti-CD52 monoclonal antibody alemtuzumab and the anti-CD20 monoclonal antibodies rituximab, ocrelizumab, ofatumumab, and ublituximab work via eliminating selected pathogenic cell populations. However, poten","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1171,"document":"31044580","golden":false,"offsetInEndSection":1336,"text":"approach is the inhibition of Bruton\u0027s tyrosine kinase, a key enzyme that mediates B cell activation and survival, by agents such as evobrutinib. On the other hand, ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":527,"document":"26307241","golden":true,"offsetInEndSection":750,"text":"tion anti-CD20 mAbs (ofatumumab, ublituximab, obinutuzumab, ocaratuzumab) were significantly more effective at inducing ADP compared to rituximab, but none were as effective as the anti-CD52 mAb alemtuzumab. Ofatumumab (10 ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":969,"document":"35237397","golden":false,"offsetInEndSection":1300,"text":"igenetic agents (e.g. cladribine and vorinostat), mammalian target of rapamycin (mTOR) inhibitors (e.g. temsirolimus and everolimus), and monoclonal antibodies and/or antibody-drug conjugates (e.g. obinutuzumab, polatuzumab, and ublituximab) are promising therapeutic agents currently under clinical trial investigation. Most recen","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33406479","golden":false,"offsetInEndSection":147,"text":"Ocrelizumab, rituximab, ofatumumab, ublituximab, inebilizumab, and evobrutinib are immunotherapies that target various B cell-related proteins. Mos","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":625,"document":"33406479","golden":false,"offsetInEndSection":859,"text":"he significance of this breakthrough in the context of the current MS therapeutic armamentarium, this review more closely examines the clinical development of CD20 depletion and the pioneering contribution of rituximab. Phase 3 and th","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":507,"document":"35030985","golden":false,"offsetInEndSection":815,"text":"mber 1, a total of 11 antibody therapeutics had been granted first approvals in either the United States or European Union in 2021 (evinacumab, dostarlimab loncastuximab tesirine, amivantamab, aducanumab, tralokinumab, anifrolumab, bimekizumab, tisotumab vedotin, regdanvimab, REGEN-COV2). The first global a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":341,"document":"33411674","golden":false,"offsetInEndSection":439,"text":", ocrelizumab and inebilizumab are licensed for treatment of MS and NMOSD, respectively. This part","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":832,"document":"35869335","golden":true,"offsetInEndSection":923,"text":"ed antibody ublituximab is the next anti-CD20 therapy about to be approved. Within the next","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1063,"document":"35570581","golden":true,"offsetInEndSection":1385,"text":"tegies include the targeting of surface molecules such as CD20 (rituximab, ocrelizumab, ofatumumab, ublituximab) and CD19 (inebilizumab), and molecules necessary for B-cell activation such as B cell activating factor (BAFF) (belimumab) and Bruton\u0027s Tyrosine Kinase (BTK) (evobrutinib). We finally discuss the use of B-cell","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":359,"document":"32933335","golden":true,"offsetInEndSection":525,"text":" therapies.AREAS COVERED: The novel anti-CD20 antibodies of atumumab, ublituximab, and obinutuzumab were developed to be differentiated via structural and mechanistic","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":904,"document":"34599723","golden":false,"offsetInEndSection":1204,"text":"labrutinib in CLL. Ongoing and future studies focus on either combining BTK inhibitors with other novel agents (e.g., venetoclax, obinutuzumab, or ublituximab) or developing next-generation non-covalent reversible BTK inhibitors that may be effective in treating patients with CLL harboring BTK-resis","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":951,"document":"33880738","golden":true,"offsetInEndSection":1132,"text":"we provide an overview of the current anti-CD20 mabs used or tested for the treatment of MS-namely rituximab (RTX), OCR, ofatumumab (OFA), and ublituximab (UB). Besides their effect","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":360,"document":"28288710","golden":false,"offsetInEndSection":642,"text":"e role of targeted agents, such as obinutuzumab, ibrutinib and idelalisib, and of some very new drugs (venetoclax, copanlisib, ublituximab and TGR-1202) is also discussed, taking into account the most relevant experiences in patients with indolent non-Hodgkin\u0027s lymphomas. A glance ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":194,"document":"33516134","golden":false,"offsetInEndSection":281,"text":"These monoclonal antibodies deplete B cells by targeting the cell surface protein CD20.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":635,"document":"34370283","golden":true,"offsetInEndSection":865,"text":"In this review, we focus on four anti-CD20 monoclonal antibodies-rituximab, ocrelizumab, ofatumumab, and ublituximab-that are currently used, approved, or in late-stage clinical development for the treatment of multiple sclerosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33516134","golden":false,"offsetInEndSection":193,"text":"Rituximab, ocrelizumab, ofatumumab and ublituximab are disease modifying therapies (DMT) currently used in the treatment of multiple sclerosis (MS) or are in advanced stages of clinical trials.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":367,"document":"28810856","golden":true,"offsetInEndSection":690,"text":"At the 2017 ASCO Meeting, results of the GENUINE phase III trial showed that, by adding ublituximab, a glycoengineered, anti-CD20 type 1 monoclonal antibody, to ibrutinib, the overall response rate (ORR), complete response rate (CRR), and minimal residual disease (MRD) negativity may be improved in high-risk CLL patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":230,"document":"35185862","golden":true,"offsetInEndSection":431,"text":"body (mAb). Following rituximab, second- and third-generation anti-CD20 mAbs have been developed and tried in immune-mediated diseases, including obinutuzumab, ocrelizumab, ofatumumab, ublituximab, and","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":750,"document":"31994023","golden":false,"offsetInEndSection":1022,"text":"Furthermore, we provide an overview of the characteristics and clinical data for the four monoclonal antibodies (ocrelizumab, ofatumumab, rituximab, and ublituximab) that have been approved, are currently been used off-label or are being investigated as treatments for MS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":877,"document":"30573759","golden":true,"offsetInEndSection":1018,"text":"Whether the newer anti-CD20 agents ocrelizumab, ofatumumab, obinutuzumab, ublituximab or inebilizumab will be more effective remains unclear.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":380,"document":"33551958","golden":true,"offsetInEndSection":568,"text":"In this mini review, we will critically review previous and ongoing clinical trials of anti-CD20 monoclonal antibodies in MS, including rituximab, ocrelizumab, ofatumumab, and ublituximab.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"33516134","golden":false,"offsetInEndSection":97,"text":"Comparison of the Efficacy and Safety of Anti-CD20 B Cells Depleting Drugs in Multiple Sclerosis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1027,"document":"34382120","golden":true,"offsetInEndSection":1400,"text":"This review provides an updated overview of the involvement of B?cells in the immune pathophysiology and pathology of MS. We summarize the rationale regarding the use of anti-CD20 therapies and the results of the main randomized controlled trials and observational studies investigating the efficacy and safety profile of rituximab, ocrelizumab, ofatumumab and ublituximab.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1023,"document":"31994023","golden":false,"offsetInEndSection":1197,"text":"These antibodies all target the cluster of differentiation (CD)-20 molecule and bind to distinct or overlapping epitopes on B cells and a subset of T cells that express CD20.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":252,"document":"31994023","golden":false,"offsetInEndSection":507,"text":"However, these therapies do also target B cells, and a B-cell-depleting monoclonal antibody (ocrelizumab) has recently been approved for MS therapy and is efficacious not only in relapsing forms of MS but also in some patients with primary progressive MS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":197,"document":"31027436","golden":true,"offsetInEndSection":776,"text":"young adults. The recently established therapeutic targeting of B cells in MS patients using CD20 monoclonal antibodies (CD20-mAbs) not only profoundly suppresses inflammatory disease activity but also materializes as the first treatment approach against disability accumulation in a subset of patients with primary progressive MS.AREAS COVERED: We will review current concepts regarding the immunopathology of B cells as well as results of clinical trials with CD20-mAbs in MS, from the murine-human chimeras rituximab and ublituximab to their increasingly humanized counterpart","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"31994023","golden":false,"offsetInEndSection":81,"text":"Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple Sclerosis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":381,"document":"34382120","golden":false,"offsetInEndSection":680,"text":"monstration of the strong efficacy and good safety profile of selective B-cell-depleting therapies (such as anti-CD20 monoclonal antibodies) has significantly expanded the therapeutic scenario for both relapsing and progressive MS patients with the identification of a new therapeutic target. The ke","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1040,"document":"34382120","golden":true,"offsetInEndSection":1414,"text":"rovides an updated overview of the involvement of B?cells in the immune pathophysiology and pathology of MS. We summarize the rationale regarding the use of anti-CD20 therapies and the results of the main randomized controlled trials and observational studies investigating the efficacy and safety profile of rituximab, ocrelizumab, ofatumumab and ublituximab. Suggestions r","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1552,"document":"34382120","golden":false,"offsetInEndSection":1667,"text":"es under investigation and future perspectives of anti-CD20 therapies are taken into consideration.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"31994023","golden":false,"offsetInEndSection":80,"text":"Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple Sclerosis","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":231,"document":"34382120","golden":false,"offsetInEndSection":379,"text":"g last years, there has been a dramatic evolution in several key concepts of immune pathophysiology of MS and in the treatment of this disease. The ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34382120","golden":false,"offsetInEndSection":229,"text":"Multiple sclerosis (MS) is a chronic inflammatory, demyelinating and neurodegenerative disease affecting the central nervous system (CNS), often characterized by the accumulation of irreversible clinical disability over time. Dur","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34382120","golden":false,"offsetInEndSection":83,"text":"Anti-CD20 therapies for multiple sclerosis: current status and future perspectives.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31994023","golden":false,"offsetInEndSection":126,"text":"Multiple sclerosis (MS) was previously thought to be a T-cell-mediated, demyelinating disease of the central nervous system. D","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1306,"document":"31994023","golden":false,"offsetInEndSection":1464,"text":"g suppression of clinical and radiological disease activity as well as slowing of the development of persisting neurological impairment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1417,"document":"34382120","golden":false,"offsetInEndSection":1550,"text":"rding vaccinations and management of MS patients during COVID-19 pandemic with anti-CD20 therapies are also discussed. Finally, thera","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":299,"document":"26015261","golden":false,"offsetInEndSection":549,"text":"Elotuzumab (HuLuc63), an anti-CS1 monoclonal IgG1 antibody, is believed to induce anti-tumor activity and MM cytotoxicity through antibody dependent cellular cytotoxicity (ADCC) and inhibition of MM cell adhesion to bone marrow stromal cells (BMSCs).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28004361","golden":false,"offsetInEndSection":255,"text":"Obinutuzumab (GA101) is a novel, type II, glycoengineered, humanized anti-CD20 monoclonal antibody that has been developed to address the need for new therapeutics with improved efficacy in patients with lymphocytic leukemia and lymphoma of B-cell origin.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":219,"document":"27890931","golden":false,"offsetInEndSection":469,"text":"The glycoengineered anti-CD20 mAb obinutuzumab was developed to induce enhanced antibody-dependent cellular cytotoxicity, antibody-dependent phagocytosis and direct cell death and was shown to lead to improved outcomes in a randomized study in B-CLL.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1355,"document":"26015261","golden":false,"offsetInEndSection":1626,"text":"Our results indicate that Fc glycosylation is critical for in vivo efficacy and afucosylated anti-CS1 mAb expressed in glycoengineered Pichia pastoris shows a better in vivo efficacy in tumor regression when compared to fucosylated anti-CS1 mAb expressed in HEK293 cells.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"26015261","golden":false,"offsetInEndSection":117,"text":"In vivo anti-tumor efficacy of afucosylated anti-CS1 monoclonal antibody produced in glycoengineered Pichia pastoris.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25014645","golden":false,"offsetInEndSection":144,"text":"PURPOSE OF REVIEW: Obinutuzumab is a new anti-CD20 monoclonal antibody which demonstrated clinical superiority compared with rituximab in a rece","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1118,"document":"26015261","golden":false,"offsetInEndSection":1354,"text":"The purpose of this study was to compare afucosylated anti-CS1 mAb expressed in glycoengineered Pichia pastoris with fucosylated anti-CS1 mAb expressed in mammalian HEK293 cells through in vitro ADCC and in vivo tumor inhibition models.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":550,"document":"26015261","golden":false,"offsetInEndSection":744,"text":"Modulations of the Fc glycan composition at the N297 site by selective mutations or afucosylation have been explored as strategies to develop bio-better therapeutics with enhanced ADCC activity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":235,"document":"35185862","golden":true,"offsetInEndSection":442,"text":"(mAb). Following rituximab, second- and third-generation anti-CD20 mAbs have been developed and tried in immune-mediated diseases, including obinutuzumab, ocrelizumab, ofatumumab, ublituximab, and veltuzumab","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":383,"document":"33551958","golden":true,"offsetInEndSection":575,"text":"this mini review, we will critically review previous and ongoing clinical trials of anti-CD20 monoclonal antibodies in MS, including rituximab, ocrelizumab, ofatumumab, and ublituximab. Side e","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":889,"document":"30573759","golden":true,"offsetInEndSection":1032,"text":"newer anti-CD20 agents ocrelizumab, ofatumumab, obinutuzumab, ublituximab or inebilizumab will be more effective remains unclear. Belimumab, an","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1419,"document":"36057010","golden":false,"offsetInEndSection":1707,"text":"ients with MCL. Moreover, combining ibrutinib with other agents such as rituximab, venetoclax, and ublituximab can increase its efficacy and reduce chemotherapy-induced resistance in most cases; however, in the case of combination therapy, patients need to be monitored more strictly in t","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":704,"document":"30573759","golden":false,"offsetInEndSection":887,"text":", an anti-CD20 monoclonal antibody that depletes peripheral B cells, has also been effective in many large uncontrolled series, although was not in a small phase III trial. Whether th","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33516134","golden":false,"offsetInEndSection":198,"text":"Rituximab, ocrelizumab, ofatumumab and ublituximab are disease modifying therapies (DMT) currently used in the treatment of multiple sclerosis (MS) or are in advanced stages of clinical trials. Thes","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":54,"document":"35185862","golden":false,"offsetInEndSection":231,"text":"disorders. Targeting CD20 has proved to be efficacious in several B cell-mediated immunopathologies, as illustrated by the use of rituximab, the first anti-CD20 monoclonal antib","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":796,"document":"35341428","golden":false,"offsetInEndSection":858,"text":"D during a relapse. These treatments include bevacizumab, ubli","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":519,"document":"35185862","golden":false,"offsetInEndSection":735,"text":"ective: To evaluate safety and efficacy of obinutuzumab, ocrelizumab, ofatumumab, ublituximab, and veltuzumab for the treatment of immune-mediated disorders compared to placebo, conventional treatment or other biolog","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":547,"document":"30573759","golden":false,"offsetInEndSection":702,"text":"ticular, eculizumab, a monoclonal antibody against complement C5, has been approved by the FDA for refractory MG on the basis of a phase III trial. Rituxim","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1940,"document":"30516432","golden":false,"offsetInEndSection":2307,"text":"In addition, our data show that 3 product candidates (leronlimab, brolucizumab, polatuzumab vedotin) may enter regulatory review by the end of 2018, and at least 12 (eptinezumab, teprotumumab, crizanlizumab, satralizumab, tanezumab, isatuximab, spartalizumab, MOR208, oportuzumab monatox, TSR-042, enfortumab vedotin, ublituximab) may enter regulatory review in 2019.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2486,"document":"30516432","golden":false,"offsetInEndSection":2762,"text":"Of these, 7 (tremelimumab, spartalizumab, BCD-100, omburtamab, mirvetuximab soravtansine, trastuzumab duocarmazine, and depatuxizumab mafodotin) are being evaluated in clinical studies with primary completion dates in late 2018 and in 2019, and are thus \u0027antibodies to watch\u0027.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1137,"document":"30516432","golden":false,"offsetInEndSection":1606,"text":"In 2018, a record number (12) of antibodies (erenumab (Aimovig), fremanezumab (Ajovy), galcanezumab (Emgality), burosumab (Crysvita), lanadelumab (Takhzyro), caplacizumab (Cablivi), mogamulizumab (Poteligeo), moxetumomab pasudodox (Lumoxiti), cemiplimab (Libtayo), ibalizumab (Trogarzo), tildrakizumab (Ilumetri, Ilumya), emapalumab (Gamifant)) that treat a wide variety of diseases were granted a first approval in either the European Union (EU) or United States (US).","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"12867058","golden":false,"offsetInEndSection":105,"text":"Understanding the mechanisms of action of EGFR inhibitors in NSCLC: what we know and what we do not know.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":2308,"document":"30516432","golden":false,"offsetInEndSection":2485,"text":"Finally, we found that approximately half (18 of 33) of the late-stage pipeline of antibody therapeutics for cancer are immune checkpoint modulators or antibody-drug conjugates.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1607,"document":"30516432","golden":false,"offsetInEndSection":1939,"text":"As of November 2018, 4 antibody therapeutics (sacituzumab govitecan, ravulizumab, risankizumab, romosozumab) were being considered for their first marketing approval in the EU or US, and an additional 3 antibody therapeutics developed by Chinese companies (tislelizumab, sintilimab, camrelizumab) were in regulatory review in China.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"10170423","golden":false,"offsetInEndSection":40,"text":"Targeted searches: a double-edged sword.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":246,"document":"18253702","golden":false,"offsetInEndSection":308,"text":"Is the interest in a particular type of target or all targets?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":737,"document":"30516432","golden":false,"offsetInEndSection":1136,"text":"Our data indicate that: 1) antibody therapeutics are entering clinical study, and being approved, in record numbers; 2) the commercial pipeline is robust, with over 570 antibody therapeutics at various clinical phases, including 62 in late-stage clinical studies; and 3) Phase 1 to approval success rates are favorable, ranging from 17-25%, depending on the therapeutic area (cancer vs. non-cancer).","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"30516432","golden":false,"offsetInEndSection":28,"text":"Antibodies to watch in 2019.","beginSection":"title"},{"endSection":"title","offsetInBeginSection":0,"document":"35852793","golden":false,"offsetInEndSection":117,"text":"Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Patients with CLL: A Phase II Study of an MRD-Driven Approach.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":438,"document":"36143259","golden":false,"offsetInEndSection":699,"text":"cal Trials Register. Only randomized clinical trials (RCTs) enrolling patients with Multiple Sclerosis comparing B-cell targeted therapies (Rituximab, Ocrelizumab, Ofatumumab, Ublituximab or Cladribine) with placebo were selected for the systematic review and f","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1153,"document":"29300693","golden":false,"offsetInEndSection":1406,"text":"Of the 12 candidates, 8 are for non-cancer indications (lanadelumab, crizanlizumab, ravulizumab, eptinezumab, risankizumab, satralizumab, brolucizumab, PRO140) and 4 are for cancer (sacituzumab govitecan, moxetumomab pasudotox, cemiplimab, ublituximab).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1607,"document":"27960628","golden":false,"offsetInEndSection":1951,"text":"Of these, 5 mAbs are for cancer (durvalumab, JNJ-56022473, ublituximab, anetumab ravtansine, glembatumumab vedotin) and 15 mAbs are for non-cancer indications (caplacizumab, lanadelumab, roledumab, tralokinumab, risankizumab, SA237, emapalumab, suptavumab, erenumab, eptinezumab, fremanezumab, fasinumab, tanezumab, lampalizumab, brolucizumab).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":302,"document":"35852793","golden":false,"offsetInEndSection":662,"text":"ble MRD. Umbralisib and ublituximab (U2) were added on to ibrutinib, patients were treated until achieving undetectable-MRD (U-MRD), and then they entered a period of treatment-free observation (TFO).PATIENTS AND METHODS: Patients were eligible if they received ibrutinib in any line of therapy for at least 6 months and had detectable MRD (flow cytometry, \u003c1 ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35852793","golden":false,"offsetInEndSection":133,"text":"PURPOSE: Ibrutinib has transformed the management of chronic lymphocytic leukemia (CLL), though its use is limited by toxicity and re","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":663,"document":"35852793","golden":false,"offsetInEndSection":735,"text":"ell in 10-4 cutoff for U-MRD). U2 was added to ibrutinib, and patients w","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":267,"document":"32300434","golden":false,"offsetInEndSection":483,"text":"Seven databases were searched in accordance with PRISMA statement guidelines using the following keywords: chronic lymphocytic leukemia, CLL, Bruton tyrosine kinase inhibitor, BTK inhibitor, ibrutinib, and PCI-32765.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1923,"document":"33459118","golden":false,"offsetInEndSection":2175,"text":"*Note added in proof on key events announced during December 1-21, 2020: margetuximab-cmkb and ansuvimab-zykl were approved by FDA on December 16 and 21, 2020, respectively; biologics license applications were submitted for ublituximab and amivantamab.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":134,"document":"35852793","golden":false,"offsetInEndSection":301,"text":"istance. In this study, we utilized an \"add on\" approach for patients who had been treated with ibrutinib in the front-line or relapsed/refractory settings with detect","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1204,"document":"32300434","golden":false,"offsetInEndSection":1299,"text":"Combination of ibrutinib and ublituximab (n \u003d 64) had an ORR of 78% (CR 7%) in a phase 3 study.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32300434","golden":false,"offsetInEndSection":198,"text":"Ibrutinib has shown to have better efficacy than standard chemoimmunotherapy in del17 positive chronic lymphocytic leukemia (CLL) patients; however its role in del17 negative patients is less clear.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1907,"document":"32300434","golden":false,"offsetInEndSection":1987,"text":"Ibrutinib is being evaluated in combination with rituximab for del17p mutations.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1300,"document":"32300434","golden":false,"offsetInEndSection":1465,"text":"In del17p negative R/R patients, combination of bendamustine/rituximab (BR) and ibrutinib (n \u003d 289) achieved an ORR of 83% (CR/CRi 10%) and the 18 month PFS was 79%.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"32300434","golden":false,"offsetInEndSection":89,"text":"Efficacy of Ibrutinib-Based Regimen in Chronic Lymphocytic Leukemia: A Systematic Review.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":447,"document":"36143259","golden":false,"offsetInEndSection":714,"text":"s Register. Only randomized clinical trials (RCTs) enrolling patients with Multiple Sclerosis comparing B-cell targeted therapies (Rituximab, Ocrelizumab, Ofatumumab, Ublituximab or Cladribine) with placebo were selected for the systematic review and further meta-ana","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":3555,"document":"30709431","golden":false,"offsetInEndSection":3754,"text":" chronic lymphocytic leukaemia and B-cell non-Hodgkin lymphoma. This triplet combination will require further investigation in future studies to improve understanding of this novel, chemotherapy-free","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":119,"document":"30709431","golden":false,"offsetInEndSection":256,"text":"proaches. We assessed the safety and efficacy of the triplet ublituximab, umbralisib, and ibrutinib in patients with advanced B-cell mali","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"30709431","golden":false,"offsetInEndSection":189,"text":"Tolerability and activity of ublituximab, umbralisib, and ibrutinib in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: a phase 1 dose escalation and expansion trial.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1385,"document":"31847708","golden":false,"offsetInEndSection":1733,"text":" were undergoing evaluation as treatments for cancer, and potentially 9 of these (belantamab mafodotin, oportuzumab monatox, margetuximab, dostarlimab, spartalizumab, 131I-omburtamab, loncastuximab tesirine, balstilimab, and zalifrelimab) may enter regulatory review in late 2019 or in 2020. Overall, the biopharmaceutical industry\u0027s clinical pipel","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":953,"document":"31847708","golden":false,"offsetInEndSection":1152,"text":"ndergoing evaluation in late-stage studies for non-cancer indications, with 2 of these (ublituximab, pamrevlumab) also in late-stage studies for cancer indications. Companies developing 7 (tanezumab,","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":334,"document":"29300693","golden":false,"offsetInEndSection":516,"text":"ibodies granted approvals are: brodalumab, dupilumab, sarilumab, guselkumab, benralizumab, ocrelizumab, inotuzumab ozogamicin, avelumab, duvalumab, and emicizumab. Brodalumab, howeve","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":587,"document":"29300693","golden":false,"offsetInEndSection":899,"text":"nine antibody therapeutics (ibalizumab, burosumab, tildrakizumab, caplacizumab, erenumab, fremanezumab, galcanezumab, romosozumab, mogamulizumab) were in regulatory review in the EU or US, and regulatory actions on their marketing applications are expected by the end of 2018. Based on company announcements and ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":799,"document":"27960628","golden":false,"offsetInEndSection":1041,"text":"US approvals may also be granted for at least nine mAbs (ocrelizumab, avelumab, Xilonix, inotuzumab ozogamicin, dupilumab, sirukumab, sarilumab, guselkumab, romosozumab) that are not yet approved in any country. Based on announcements of comp","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1030,"document":"25843424","golden":false,"offsetInEndSection":1149,"text":"step targeted by BRACO-19 was viral DNA replication, while no effect on virus entry in the cells was observed. This wor","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":129,"document":"16352551","golden":false,"offsetInEndSection":326,"text":"This study sought to isolate and characterize the receptor protein used by the virus to gain entry into Penaeus monodon Oka (lymphoid) organ cells, a primary target of yellow head virus infections.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":110,"document":"1655802","golden":false,"offsetInEndSection":274,"text":"In animal cells expressing the protein from cDNA, the E1 protein is targeted to cis Golgi cisternae (Machamer, C. E., S. A. Mentone, J. K. Rose, and M. G. Farquhar.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":241,"document":"23133793","golden":false,"offsetInEndSection":342,"text":"The Asn-Gly-Arg (NGR) tripeptide selected by phage display can specifically target tumor vasculature.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":94,"document":"28276536","golden":false,"offsetInEndSection":388,"text":"Obinutuzumab is part of a new generation of anti-CD20 monoclonal antibodies, which are synthesized using molecular engineering technology, resulting in novel target epitopes and unprecedented optimization of antibody-dependent cellular cytotoxicity and antibody-dependent cellular phagocytosis.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"20109133","golden":false,"offsetInEndSection":50,"text":"Ofatumumab, a human anti-CD20 monoclonal antibody.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":997,"document":"28276536","golden":false,"offsetInEndSection":1223,"text":"Additional phase III trials are underway to test obinutuzumab as a first-line anti-CD20 agent in FL with good preliminary results (GALLIUM trial); thus, it is likely that obinutuzumab will soon achieve a first-line indication.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"26285615","golden":false,"offsetInEndSection":151,"text":"Obinutuzumab is the second next-generation monoclonal anti-CD20 antibody (after ofatumumab) to enter clinical practice in chronic lymphocytic leukemia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":289,"document":"24555705","golden":false,"offsetInEndSection":737,"text":" CLL therapy. More recently, CD37, a member of the tetraspanin superfamily of cell surface antigens, has been considered as a target for B-cell malignancies.AREAS COVERED: The results of preclinical and early clinical studies suggest that in patients with CLL, newer anti-CD37 agents, otlertuzumab (formerly known as TRU-016), BI 836826, IMGN529 and (177)Lu-tetulomab can be useful in the treatment of this disease.EXPERT OPINION: CD37 may offer ad","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":575,"document":"28276536","golden":false,"offsetInEndSection":660,"text":"Obinutuzumab is slowly positioning itself in the treatment of CD20+ B-cell neoplasms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":156,"document":"10322362","golden":false,"offsetInEndSection":447,"text":"The unconjugated, chimeric anti-CD20 antibody, Rituximab (MabThera(R), Rituxan(R)), has recently been approved in the USA for patients with relapsed or refractory, low-grade or follicular, B-cell non-Hodgkin\u0027s lymphoma, and in Europe for therapy of relapsed stage III/IV follicular lymphoma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28276536","golden":false,"offsetInEndSection":93,"text":"The CD20 marker continues to be exploited as a therapeutic target for non-Hodgkin\u0027s lymphoma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":661,"document":"28276536","golden":false,"offsetInEndSection":996,"text":"On the basis of favorable results from the phase III GADOLIN trial, obinutuzumab was recently approved by the U.S. Food and Drug Administration in combination with bendamustine followed by obinutuzumab maintenance, for the treatment of follicular lymphoma (FL) patients who relapsed or are refractory to a rituximab-containing regimen.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":960,"document":"33459118","golden":false,"offsetInEndSection":1104,"text":"olimab and olokizumab had been granted first approvals in Russia and cetuximab saratolacan sodium was first approved in Japan. The number of app","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":142,"document":"15925559","golden":false,"offsetInEndSection":458,"text":"The growing appreciation of the pathophysiologic consequences of sustained expression of proinflammatory mediators in preclinical and clinical CHF models culminated in a series of multicenter clinical trials that used targeted approaches to neutralize tumor necrosis factor in patients with moderate-to-advanced CHF.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"15925559","golden":false,"offsetInEndSection":52,"text":"Targeted anticytokine therapy and the failing heart.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":252,"document":"25406944","golden":false,"offsetInEndSection":456,"text":"Because it plays an important role in cancer by silencing certain genes, such as tumor suppressor genes, and by reactivating other regions, such as repeated elements, it is a promising therapeutic target.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"12962009","golden":false,"offsetInEndSection":36,"text":"Molecular targets in cancer therapy.","beginSection":"title"},{"endSection":"title","offsetInBeginSection":0,"document":"24674882","golden":false,"offsetInEndSection":72,"text":"B cell transcription factors: Potential new therapeutic targets for SLE.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":459,"document":"15925559","golden":false,"offsetInEndSection":657,"text":"However, these targeted approaches have resulted in worsening CHF, thereby raising a number of important questions about what role, if any, proinflammatory cytokines play in the pathogenesis of CHF.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"15925559","golden":false,"offsetInEndSection":141,"text":"Recent studies have identified the importance of proinflammatory mediators in the development and progression of chronic heart failure (CHF).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":658,"document":"15925559","golden":false,"offsetInEndSection":805,"text":"This review summarizes what has been learned from the negative clinical trials, as well as the potential direction of future research in this area.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":318,"document":"32324354","golden":false,"offsetInEndSection":444,"text":"Nowadays a growing number of drugs are designed to aim at a specific molecular target, an example being monoclonal antibodies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1015,"document":"16195797","golden":false,"offsetInEndSection":1367,"text":"This review will discuss what angiogenesis is, how pediatric brain tumors regulate angiogenesis to obtain a vascular supply, what types of inhibitors are available, how different classes of inhibitors work, the types of resistance possible, how rapidly these inhibitors may work, and what surrogate markers of activity are available to follow response.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36534148","golden":false,"offsetInEndSection":290,"text":"Obinutuzumab is a therapeutic antibody for B cell non-Hodgkin\u0027s Lymphoma (BNHL), which is a glyco-engineered anti-CD20 antibody with enhanced antibody-dependent cellular cytotoxicity (ADCC) and causes binding-induced direct cell death (DCD) through lysosome membrane permeabilization (LMP).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27480113","golden":false,"offsetInEndSection":431,"text":"Agents targeting B-cell receptor (BCR) signaling-associated kinases such as Bruton tyrosine kinase (BTK) or phosphatidylinositol 3-kinase can induce mobilization of neoplastic B cells from the lymphoid tissues into the blood, which makes them potentially ideal to combine with anti-CD20 monoclonal antibodies (such as rituximab, obinutuzumab, or ofatumumab) for treatment of B-cell lymphomas and chronic lymphocytic leukemia (CLL).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":427,"document":"36534148","golden":false,"offsetInEndSection":790,"text":"As both obinutuzumab- and TNFR1-induced cell deaths are mediated by LMP and combining TNFR1 and obinutuzumab can amplify LMP-mediated cell death, we made dual-targeting antibody for CD20 and TNFR1 to enhance DCD of obinutuzumab.Obinutuzumab treatment-induced CD20 and TNFR1 colocalisation, and TNFR1-overexpressing cells showed increased obinutuzumab-induced DCD.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36534148","golden":false,"offsetInEndSection":100,"text":"CD20/TNFR1 dual-targeting antibody enhances lysosome rupture-mediated cell death in B cell lymphoma.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":791,"document":"36534148","golden":false,"offsetInEndSection":990,"text":"Two targeting modes, anti-CD20/TNFR1 bispecific antibodies (bsAbs), and obinutuzumab-TNF? fusion proteins (OBI-TNF?WT and OBI-TNF?MUT), were designed to cluster CD20 and TNFR1 on the plasma membrane.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"27480113","golden":false,"offsetInEndSection":85,"text":"Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1111,"document":"36534148","golden":false,"offsetInEndSection":1301,"text":"TNFR1 expression is upregulated in many BNHL subtypes compared to that in normal B cells; OBI-TNF?MUT specifically increased DCD and ADCC in a B cell lymphoma cell line overexpressing TNFR1.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1302,"document":"36534148","golden":false,"offsetInEndSection":1569,"text":"Further, OBI-TNF?MUT blocked NF-?B activation in the presence of TNF-?, implying that it can antagonise the proliferative role of TNF-? in cancers.Our study suggests that dual targeting of CD20 and TNFR1 can be a new therapeutic strategy for improving BNHL treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":222,"document":"27902473","golden":false,"offsetInEndSection":325,"text":"Rituximab, a monoclonal CD20 antibody, was attached to the surfaces of doxorubicin-loaded microbubbles.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":396,"document":"23438039","golden":false,"offsetInEndSection":484,"text":"viously approved drug is belimumab, which antagonizes the B-cell stimulator BLyS. Atacic","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":171,"document":"20432075","golden":false,"offsetInEndSection":356,"text":"tumumab is a new, fully human anti-EGFR monoclonal antibody, what is well-tolerated, effective as a single agent in chemotherapy refractory patients and in different combinations. The c","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":936,"document":"21592000","golden":false,"offsetInEndSection":1067,"text":"ction against melanoma. The NK-1 receptor antagonist aprepitant is used in clinical practice and exerts an antitumor action against","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":825,"document":"12871122","golden":false,"offsetInEndSection":955,"text":" (CYP A) and other cyclophilin family members, CYP D is targeted by the immunosuppressant cyclosporin A (CsA). CsA is cytoprotecti","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":440,"document":"12864941","golden":false,"offsetInEndSection":613,"text":"cin and novel rapamycin analogues with more favorable pharmaceutical properties, such as CCI-779, RAD 001, and AP23573, are highly specific inhibitors of mTOR. In essence, t","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":527,"document":"15134822","golden":false,"offsetInEndSection":712,"text":"lective aldosterone blocker, eplerenone (Inspra), is under development for human therapeutic use for treatment of hypertension and heart failure post-myocardial infarction (MI). Clinica","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30532015","golden":false,"offsetInEndSection":337,"text":"Rapamycin and FK506 are macrocyclic natural products with an extraordinary mode of action, in which they form binary complexes with FK506-binding protein (FKBP) through a shared FKBP-binding domain before forming ternary complexes with their respective targets, mechanistic target of rapamycin (mTOR) and calcineurin, respectively. Inspi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":881,"document":"16305491","golden":false,"offsetInEndSection":1018,"text":"ncluding CCI-779, RAD001, and AP23573, are entering clinical studies for patients with hematologic malignancies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":728,"document":"32503913","golden":false,"offsetInEndSection":853,"text":" action. Furthermore, we were able to rule out inhibition of FabI, a confirmed target of the diaryl ether antibiotic triclosa","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":271,"document":"12864941","golden":false,"offsetInEndSection":437,"text":"eting mTOR, the immunosuppressant and antiproliferative agent rapamycin inhibits signals required for cell cycle progression, cell growth, and proliferation. Both rap","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":66,"document":"35999405","golden":false,"offsetInEndSection":209,"text":"The receptor is the target of some food and drug administration (FDA) approved monoclonal antibodies (mAb), such as Rituximab and Obinutuzumab.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"32223334","golden":false,"offsetInEndSection":140,"text":"Phase II trial evaluating the efficacy and safety of the anti-CD20 monoclonal antibody obinutuzumab in patients with marginal zone lymphoma.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1248,"document":"35999405","golden":false,"offsetInEndSection":1339,"text":"Detecting CD20 in western blot showed that G7 binds to a linear epitope on CD20 large loop.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"19687518","golden":false,"offsetInEndSection":153,"text":"Targeting the CD20 antigen on B lymphocytes with the monoclonal antibody rituximab has greatly improved the outcome of patients with B-cell malignancies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":404,"document":"28592762","golden":false,"offsetInEndSection":696,"text":"Strategies for treating CLL are rapidly evolving, with targeted agents such as the B-cell receptor signaling pathway inhibitors (ibrutinib, idelalisib), novel anti-CD20 monoclonal antibody (obinutuzumab), and Bcl-2 inhibitor (venetoclax) being approved by the US Food and Drug Administration.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":210,"document":"35999405","golden":false,"offsetInEndSection":302,"text":"Blocking CD20 using the aforementioned mAbs has improved Non-Hodgkin Lymphoma (NHL) therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":436,"document":"29358322","golden":false,"offsetInEndSection":731,"text":"Ocrelizumab, a humanized anti-CD20 monoclonal antibody, was approved by the Food and Drug Administration (FDA) in March 2017 after pivotal trials showed dramatic reductions in inflammatory disease activity in relapsing MS as well as lessening of disability progression in primary progressive MS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":671,"document":"35999405","golden":false,"offsetInEndSection":844,"text":"Herein, we report the isolation and characterization of a fully human single-chain variable fragment (scFv) against the large loop of CD20 from na?ve human antibody library.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35999405","golden":false,"offsetInEndSection":65,"text":"CD20 is a receptor expressed on B cells with anonymous functions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":785,"document":"23040543","golden":false,"offsetInEndSection":918,"text":"In vitro, HB22.7-SAP effectively bound to CD22 on the surface of pre-B ALL cell lines and exhibited potent and specific cytotoxicity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23988437","golden":false,"offsetInEndSection":271,"text":"The aim of this study was to carry out a review of margins that should be used for the delineation of target volumes in lung cancer, with a focus on margins from gross tumour volume (GTV) to clinical target volume (CTV) and internal target volume (ITV) delineation. Our r","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1679,"document":"19123390","golden":false,"offsetInEndSection":1736,"text":"s detectable distance was less than 0.3 m.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31513015","golden":false,"offsetInEndSection":132,"text":"Cells rely on prolyl hydroxylase enzymes to sense low levels of oxygen, but they might act on fewer targets than previously thought.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":312,"document":"10067158","golden":false,"offsetInEndSection":449,"text":"the setbacks, exposing health care\u0027s complexities and contradictions--and reminding us that nothing escapes market discipline.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1628,"document":"19123390","golden":false,"offsetInEndSection":1676,"text":"ange was tunable within 0.1-0.5 m. The least tar","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":572,"document":"37811115","golden":false,"offsetInEndSection":996,"text":"Briumvi, the fourth type of anti-CD20 antibody was approved by FDA in December 2022, for the treatment of relapsing types of MS, including relapsing-remitting multiple sclerosis, active secondary progressive multiple sclerosis, and clinically isolated syndromes after the drug was tested in two randomized, double-blind, phase III, ULTIMATE I, and II trials which compared Briumvi (ublituximab) with Aubiago (teriflunomide).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32351164","golden":true,"offsetInEndSection":212,"text":"BACKGROUND: Ublituximab, a novel monoclonal antibody (mAb) targeting a unique epitope on the CD20 antigen, is glycoengineered for enhanced B-cell targeting through antibody-dependent cellular cytotoxicity (ADCC).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36920653","golden":true,"offsetInEndSection":172,"text":"Ublituximab (ublituximab-xiiy; BRIUMVI?) is a glycoengineered anti-CD20 monoclonal antibody developed by TG Therapeutics, Inc. for the treatment of multiple sclerosis (MS).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38480630","golden":true,"offsetInEndSection":211,"text":"Currently, there are four monoclonal antibodies (mAbs) that target the cluster of differentiation (CD) 20 receptor available to treat multiple sclerosis (MS): rituximab, ocrelizumab, ofatumumab, and ublituximab.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1106,"document":"37811115","golden":false,"offsetInEndSection":1232,"text":"Briumvi is a chimeric recombinant IgG1 monoclonal antibody directed against human CD20 with potential antineoplastic activity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":90,"document":"36317532","golden":true,"offsetInEndSection":408,"text":"Ublituximab is a monoclonal antibody that binds to the B-cell antigen CD20 with enhanced B-cell targeting.AREAS COVERED: This evaluation is of the identical ULTIMATE (UbLiTuximab In Multiple Sclerosis Treatment Effects) I and II trials comparing ublituximab (TG-1101) and teriflunomide in relapsing multiple sclerosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37156035","golden":true,"offsetInEndSection":174,"text":"Ublituximab, an intravenous glycoengineered chimeric anti-CD20 IgG1 monoclonal antibody (mAb), is a new FDA-approved treatment for relapsing forms of Multiple Sclerosis (MS).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":490,"document":"37811115","golden":false,"offsetInEndSection":571,"text":"Rituximab, ocrelizumab, and ofatumumab are anti-CD20 antibodies already approved.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":836,"document":"29609506","golden":false,"offsetInEndSection":1024,"text":"obinituzumab, ofatumumab), and includes ublituximab (Ub), with higher complement-dependent cytotoxicity (CDC) and antibody-dependent cellular cytotoxicity (ADCC) against malignant B-cells.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":313,"document":"37811115","golden":false,"offsetInEndSection":489,"text":"Therefore, researchers have been exploring B cell therapy as an alternative treatment option for MS. B cell therapy is based on the targeted depletion of CD20-positive B cells.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39512280","golden":true,"offsetInEndSection":124,"text":"Background: Ublituximab is a novel anti-CD20 monoclonal antibody glycoengineered for enhanced antibody-dependent cellular cy","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":346,"document":"39050801","golden":false,"offsetInEndSection":463,"text":"everal anti-CD20 mAbs are now licensed for use in MS, with ublituximab being the latest to gain regulatory approval. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":142,"document":"37842819","golden":true,"offsetInEndSection":300,"text":"erosis (MS). Ublituximab (ublituximab-xiiy) is the latest approved chimeric glycoengineered anti-CD20 monoclonal antibody (mAb) for the treatment of relapsing","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":459,"document":"33722905","golden":false,"offsetInEndSection":578,"text":"BC growth. We therefore hypothesized that the anti-GD2 antibody dinutuximab (ch14.18) targets GD2+ BCSCs and inhibits T","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1459,"document":"23611989","golden":true,"offsetInEndSection":1754,"text":"This efficacy was observed only against lymphoma B cells expressing hCD20.CONCLUSIONS: These in vivo results confirm the potential of the glycoengineered anti-hCD20 mAb ublituximab as an innovative therapeutic approach to treat primary central nervous system lymphoma and other B-cell lymphomas.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":997,"document":"37811115","golden":false,"offsetInEndSection":1105,"text":"Ublituximab was found to have a much lower annual relapse rate in the ULTIMATE II trials than teriflunomide.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39512280","golden":true,"offsetInEndSection":135,"text":"Background: Ublituximab is a novel anti-CD20 monoclonal antibody glycoengineered for enhanced antibody-dependent cellular cytotoxicity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":429,"document":"37906325","golden":true,"offsetInEndSection":609,"text":"Rituximab, ocrelizumab, ofatumumab, ublituximab and BCD-132 are anti-CD20 therapies that are either undergoing clinical development, or have been approved, for the treatment of MS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33411674","golden":false,"offsetInEndSection":180,"text":"Ocrelizumab, rituximab, ofatumumab, ublituximab, inebilizumab, and evobrutinib are immunotherapies that target various B cell-related proteins. Most of these treatments have proven","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27982425","golden":false,"offsetInEndSection":155,"text":"Ibrutinib is effective in patients with chronic lymphocytic leukaemia (CLL); however, treatment resistance remains a problem. Ublituximab is a novel, glyco","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":76,"document":"36317532","golden":true,"offsetInEndSection":182,"text":"ntly emerged. Ublituximab is a monoclonal antibody that binds to the B-cell antigen CD20 with enhanced B-c","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36920653","golden":true,"offsetInEndSection":126,"text":"Ublituximab (ublituximab-xiiy; BRIUMVI?) is a glycoengineered anti-CD20 monoclonal antibody developed by TG Therapeutics, Inc.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":141,"document":"37842819","golden":true,"offsetInEndSection":299,"text":"lerosis (MS). Ublituximab (ublituximab-xiiy) is the latest approved chimeric glycoengineered anti-CD20 monoclonal antibody (mAb) for the treatment of relapsin","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28220479","golden":true,"offsetInEndSection":309,"text":"This phase 1/2 study evaluated the safety, pharmacokinetic behavior and anti-tumour activity of ublituximab, a unique type I, chimeric, glycoengineered anti-CD20 monoclonal antibody, in rituximab-relapsed or -refractory patients with B-cell non-Hodgkin lymphoma (B-NHL) or chronic lymphocytic leukaemia (CLL).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1509,"document":"23611989","golden":true,"offsetInEndSection":1719,"text":" cells expressing hCD20.CONCLUSIONS: These in vivo results confirm the potential of the glycoengineered anti-hCD20 mAb ublituximab as an innovative therapeutic approach to treat primary central nervous system l","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33631112","golden":false,"offsetInEndSection":195,"text":"BACKGROUND: Patients with chronic lymphocytic leukaemia and high-risk features have poorer outcomes on ibrutinib than those without high-risk features. The aim of this study was to assess the ben","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1248,"document":"31232925","golden":false,"offsetInEndSection":1365,"text":" relapsed within 3 months.CONCLUSIONS: Ublituximab is a safe add-on therapy for NMOSD patients presenting with acute ","beginSection":"abstract"}],"exact_answer":[["CD20"]],"ideal_answer":[],"id":"63adca12c6c7d4d31b00001b","type":"factoid","body":"What is the target of Ublituximab?"},{"documents":[{"golden":true,"id":"25183485"},{"golden":false,"id":"28413437"},{"golden":false,"id":"19429895"},{"golden":false,"id":"34492007"},{"golden":false,"id":"26750448"},{"golden":false,"id":"24587272"},{"golden":true,"id":"39539946"},{"golden":false,"id":"25887539"},{"golden":false,"id":"33456621"},{"golden":false,"id":"19653913"},{"golden":false,"id":"39498334"},{"golden":false,"id":"30136978"},{"golden":true,"id":"17526521"},{"golden":false,"id":"15176478"},{"golden":false,"id":"32652319"},{"golden":false,"id":"33260034"},{"golden":false,"id":"36568378"},{"golden":false,"id":"36410105"},{"golden":false,"id":"39742833"},{"golden":false,"id":"39660256"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":807,"document":"25183485","golden":false,"offsetInEndSection":1194,"text":"However, ORA is usually applied to a set of variables differentiating a single experimental variable and does not take into account correlations.RESULTS: Over-representation of correlation analysis (ORCA) is a novel combination of ORA and correlation analysis that provides a means to test whether more associations exist between two specific groups of variables than expected by chance.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28413437","golden":false,"offsetInEndSection":104,"text":"BACKGROUND: Over-representation analysis (ORA) detects enrichment of genes within biological categories.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39539946","golden":true,"offsetInEndSection":156,"text":"Motivation: Overrepresentation analysis (ORA) is used widely to assess the enrichment of functional categories in a gene list compared to a background list.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":548,"document":"25183485","golden":true,"offsetInEndSection":806,"text":"Over-representation analysis (ORA) is a simple method for objectively deciding whether a set of variables of known or suspected biological relevance, such as a gene set or pathway, is more prevalent in a set of variables of interest than we expect by chance.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":94,"document":"19429895","golden":false,"offsetInEndSection":352,"text":"A common approach to address this is over-representation analysis (ORA), which uses the hypergeometric test (or its variants) to evaluate whether a particular functionally defined group of genes is represented more than expected by chance within a gene list.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1801,"document":"28413437","golden":false,"offsetInEndSection":2137,"text":"However, nucleoside triphosphate catabolic process was the GO BP labeled exclusively at 6?h after treatment with topotecan followed by control.CONCLUSIONS: goSTAG converts gene lists from genomic analyses into biological themes by enriching biological categories and constructing GO subtrees from over-represented terms in the clusters.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25887539","golden":false,"offsetInEndSection":145,"text":"BACKGROUND: In genome-wide studies, over-representation analysis (ORA) against a set of genes is an essential step for biological interpretation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25183485","golden":false,"offsetInEndSection":147,"text":"MOTIVATION: Often during the analysis of biological data, it is of importance to interpret the correlation structure that exists between variables.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1550,"document":"25183485","golden":false,"offsetInEndSection":1812,"text":"These observations suggest that ORCA has the potential to reveal novel insights from these data, which are not readily apparent using classical ORA.AVAILABILITY AND IMPLEMENTATION: The R code of the method is available at https://github.com/ORCABioinfo/ORCAcode.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34492007","golden":false,"offsetInEndSection":151,"text":"Over-representation analysis (ORA) is one of the commonest pathway analysis approaches used for the functional interpretation of metabolomics datasets.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39539946","golden":false,"offsetInEndSection":145,"text":"Motivation: Overrepresentation analysis (ORA) is used widely to assess the enrichment of functional categories in a gene list compared to a backg","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39498334","golden":false,"offsetInEndSection":165,"text":"Use of machine learning to perform database operations, such as indexing, cardinality estimation, and sorting, is shown to provide substantial performance benefits.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":727,"document":"30136978","golden":false,"offsetInEndSection":923,"text":"o address this, we define SIRIUS (Symmetric Interactive Representations In a Unified System), a symmetric, dual projection technique to support exploratory data analysis of high-dimensional data. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":600,"document":"19653913","golden":false,"offsetInEndSection":942,"text":"Here we present a novel ORA, protein interaction permutation analysis (PIPA), that takes advantage of canonical pathways and established protein interactions to identify pathways enriched for protein interactions connecting RNAi hits.RESULTS: We use PIPA to analyze genome-scale siRNA cell growth screens performed in HeLa and TOV cell lines.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":800,"document":"32652319","golden":false,"offsetInEndSection":950,"text":"nt of four KEGG signaling pathways, including amphetamine addiction, extracellular matrix (ECM) receptor interaction, neuroactive ligand-receptor inte","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":300,"document":"33260034","golden":false,"offsetInEndSection":500,"text":" coronaviruses (SARS-CoV, MERS-CoV) that caused outbreaks previously can help in the identification of potential drugs for the treatment of COVID-19. Hence, we used time point meta-analysis to investi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":800,"document":"36568378","golden":false,"offsetInEndSection":950,"text":"acted from whole genome sequencing (WGS) data of 100 sALS patients. The secondary pre-miRNA structures were predicted using MiRVas to evaluate the imp","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":700,"document":"36410105","golden":false,"offsetInEndSection":900,"text":" are more frequently mutated in White (W50) than in Black or African American patients (BAA50), while HUWE1, HYDIN, and FBXW7 mutations are more frequent in BAA50. Over-representation analysis (ORA) a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":700,"document":"39742833","golden":false,"offsetInEndSection":850,"text":"tly expressed genes (DEGs) between the tumors and non-tumorous colonic epithelium. A cell-of-origin subtype analysis with the nearest template predict","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":348,"document":"15176478","golden":false,"offsetInEndSection":569,"text":"The first method, \"overrepresentation analysis\" (ORA), is based on statistically evaluating the fraction of genes in a particular gene ontology class found among the set of genes showing age-related changes in expression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":169,"document":"19653913","golden":false,"offsetInEndSection":380,"text":"robustness. Over representation approaches (ORA), such as the Hypergeometric or z-score, are an established statistical framework used to associate RNA interference effectors to biologically annotated gene sets ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25887539","golden":false,"offsetInEndSection":133,"text":"BACKGROUND: In genome-wide studies, over-representation analysis (ORA) against a set of genes is an essential step for biological int","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39660256","golden":false,"offsetInEndSection":220,"text":"Gene Ontology overrepresentation analysis (GO-ORA) is a standard approach towards characterizing salient functional characteristics of sets of differentially expressed genes (DGE) in RNA sequencing (RNA-seq) experiments.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"26750448","golden":false,"offsetInEndSection":112,"text":"Pathway or gene set over-representation analysis (ORA) has become a routine task in functional genomics studies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":152,"document":"24587272","golden":false,"offsetInEndSection":291,"text":"To understand their functions, the sets are usually mapped to Gene Ontology knowledge bases by means of over-representation analysis (ORA).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":424,"document":"17526521","golden":false,"offsetInEndSection":642,"text":"Our web server provides two common statistical approaches, \u0027Over-Representation Analysis\u0027 (ORA) comparing a reference set of genes to a test set, and \u0027Gene Set Enrichment Analysis\u0027 (GSEA) scoring sorted lists of genes.","beginSection":"abstract"}],"ideal_answer":[],"id":"677ed8b8592fa4887300002b","type":"summary","body":"How does Over-Representation Analysis (ORA) work?"},{"documents":[{"golden":false,"id":"4190040"},{"golden":false,"id":"33009955"},{"golden":false,"id":"18557889"},{"golden":false,"id":"33800765"},{"golden":false,"id":"27060849"},{"golden":false,"id":"19705189"},{"golden":false,"id":"6465018"},{"golden":false,"id":"30278272"},{"golden":false,"id":"30451723"},{"golden":false,"id":"31720783"},{"golden":false,"id":"38975546"},{"golden":false,"id":"38246713"},{"golden":false,"id":"39656569"},{"golden":false,"id":"24369458"},{"golden":false,"id":"17252034"},{"golden":true,"id":"31786948"},{"golden":false,"id":"3690440"},{"golden":false,"id":"7206030"},{"golden":false,"id":"10829554"},{"golden":false,"id":"1330261"},{"golden":false,"id":"12354534"},{"golden":false,"id":"34438522"},{"golden":false,"id":"21068023"},{"golden":false,"id":"37092805"},{"golden":false,"id":"26976205"},{"golden":false,"id":"6026343"},{"golden":false,"id":"3995447"},{"golden":false,"id":"20468781"},{"golden":false,"id":"3463386"},{"golden":false,"id":"16494736"},{"golden":false,"id":"27086495"},{"golden":false,"id":"34079943"},{"golden":false,"id":"32278265"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":362,"document":"4190040","golden":false,"offsetInEndSection":973,"text":"The most common cardiovascular defects were patent ductus arteriosus (36 patients), ventricular septal defect (22 patients) and pulmonary valvular stenosis (17 patients).Ninety-three per cent of the mothers had a history of exposure to rubella during their first trimester.The administration of gamma globulin to mothers exposed to rubella did not prevent fetal damage.Although this group of patients accounted for only 6% of children requiring open-heart surgery, it did account for 27% of the children having closed-heart surgical procedures and 10% of the case load of the cardiac catheterization laboratory.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"4190040","golden":false,"offsetInEndSection":361,"text":"A retrospective study is reported of 75 children with rubella embryopathy syndrome, admitted to the Health Centre for Children, Vancouver General Hospital, during the four-year period from July 1, 1964 to July 1, 1968.Sixty-four of the 75 had cardiovascular malformations, 37 had ophthalmological defects, 31 had nerve deafness and three were mentally retarded.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":357,"document":"33009955","golden":false,"offsetInEndSection":649,"text":"This work will review these two entities with emphasis on current treatment.RECENT FINDINGS: Greater emphasis on understanding and addressing the mechanism of restenosis for congenital PVS has led to the use of drug-eluting stents (DES) and systemic drug therapy to target neo-intimal growth.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33009955","golden":false,"offsetInEndSection":139,"text":"PURPOSE OF REVIEW: Pulmonary vein stenosis (PVS) is a rare entity that until the last 2 decades was seen primarily in infants and children.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"4190040","golden":false,"offsetInEndSection":118,"text":"The hospital incidence and clinical significance of congenital heart malformations resulting from rubella embryopathy.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33800765","golden":false,"offsetInEndSection":204,"text":"Pulmonary vein stenosis (PVS) is a rare, but high mortality and resource intensive disease caused by mechanical obstruction or intraluminal myofibroproliferation, which can be post-surgical or idiopathic.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"18557889","golden":false,"offsetInEndSection":119,"text":"Congenital pulmonary venous stenosis is a rare condition leads to progressive pulmonary hypertension and heart failure.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27060849","golden":false,"offsetInEndSection":234,"text":"INTRODUCTION: To determine the usefulness of mortality risk scores for the endovascular treatment of ruptured abdominal aortic aneurysms.METHODS: Retrospective study of 61 patients undergoing endovascular repair between 2009 and 2014.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":207,"document":"31720783","golden":false,"offsetInEndSection":276,"text":"There is a high incidence of ISS following stent implantation in PVS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":292,"document":"19705189","golden":false,"offsetInEndSection":453,"text":"A case is presented involving single-ventricle physiology associated with extensive and recurrent congenital PVS despite multiple attempts with surgical therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38975546","golden":false,"offsetInEndSection":134,"text":"Scimitar syndrome is a congenital disorder characterized by partial anomalous pulmonary venous return to the inferior vena cava (IVC).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1924,"document":"39656569","golden":false,"offsetInEndSection":2039,"text":"he so-called Montreal syndrome allows us to think about the link between mental health and the identity of a city. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38246713","golden":false,"offsetInEndSection":207,"text":"Fraser syndrome or cryptophthalmos-syndactyly syndrome is a rare genetic disease, the diagnosis of which is based on a series of major and minor clinical criteria and that can be supported by genetic tests.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24369458","golden":false,"offsetInEndSection":228,"text":"Cronkhite-Canada syndrome is a rare disease characterised by diffuse polyposis of the gastrointestinal tract, diarrhoea, weight loss, abdominal pain, cutaneous hyperpigmentation, dystrophic changes of fingernails, and alopecia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17252034","golden":false,"offsetInEndSection":107,"text":"Cronkhite-Canada syndrome (CCS), first described in 1955, is a rare clinical syndrome of unknown etiology.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34438522","golden":false,"offsetInEndSection":103,"text":"Pulmonary vein stenosis (PVS) is an extremely challenging clinical problem in congenital heart disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":466,"document":"31786948","golden":true,"offsetInEndSection":968,"text":"We introduce the concept of Vagus Associated Neurogenic Cough Occurring due to Unilateral Vascular Encroachment of its Root (VANCOUVER syndrome) and present the salient features of this condition.METHODS: A case review is presented with details of the patient\u0027s history, examination, imaging, laryngoscopy, intraoperative findings, and long-term clinical outcome.RESULTS: A 60-year-old man presented with a 15-year history of non-productive cough refractory to antibiotics, and anti-reflux medications.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"26976205","golden":false,"offsetInEndSection":429,"text":"PURPOSE: We sought to establish the reliability and validity of the Dutch version of the Vancouver Symptom Score for Dysfunctional Elimination Syndrome for children with dysfunctional voiding and their parents.MATERIALS AND METHODS: For this cross-sectional multicenter study the Vancouver Symptom Score for Dysfunctional Elimination Syndrome was translated and?cross-culturally adapted to Dutch following a standardized process.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1231,"document":"31786948","golden":false,"offsetInEndSection":1466,"text":"There were no surgical complications and the patient remains asymptomatic at 1?year.CONCLUSIONS: Neurogenic cough has been likened to a vagus nerve neuropathy in a similar way that trigeminal neuralgia is a trigeminal nerve neuropathy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31786948","golden":false,"offsetInEndSection":226,"text":"OBJECTIVES: A patient is presented with neurogenic cough due to a unilateral vascular compression of a vagus nerve rootlet at the brainstem with complete resolution of cough following microvascular decompression of that nerve.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"6026343","golden":false,"offsetInEndSection":443,"text":"Of a series of 130 patients undergoing operation for peptic ulcer disease at the Vancouver General Hospital, seven patients with personality defects had a disastrous outcome after operation.THE MAIN FEATURES OF THIS POSTGASTRECTOMY SYNDROME WERE REMARKABLY SIMILAR: persistent abdominal pain without demonstrable cause, intermittent and inexplicable nausea and vomiting, continued analgesic drug dependence and marked nutritional deficiencies.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"31786948","golden":true,"offsetInEndSection":154,"text":"Vagus Associated Neurogenic Cough Occurring Due to Unilateral Vascular Encroachment of Its Root: A Case Report and Proof of Concept of VANCOUVER Syndrome.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37092805","golden":false,"offsetInEndSection":130,"text":"BACKGROUND: Bladder and bowel dysfunction (BBD) is a common problem in school-aged children and is evaluated using questionnaires.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1584,"document":"31786948","golden":false,"offsetInEndSection":1707,"text":"We demonstrate that neurogenic cough, like trigeminal neuralgia, may be caused by a vascular compression of its nerve root.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1098,"document":"31786948","golden":false,"offsetInEndSection":1230,"text":"MRI demonstrated a vascular compression of his left vagus nerve and microvascular decompression of that nerve resolved his symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"7206030","golden":false,"offsetInEndSection":144,"text":"Four patients with sleep apnea syndrome were seen at the Vancouver General Hospital within the last three years and are discussed in this paper.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1603,"document":"26976205","golden":false,"offsetInEndSection":1881,"text":"Cutoff scores for dysfunctional voiding were 11 and 9 for patients and parents, respectively.CONCLUSIONS: The Dutch Vancouver Symptom Score for Dysfunctional Elimination Syndrome displayed moderate to good reliability and validity properties for the patient and parent versions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31786948","golden":false,"offsetInEndSection":450,"text":"OBJECTIVES: A patient is presented with neurogenic cough due to a unilateral vascular compression of a vagus nerve rootlet at the brainstem with complete resolution of cough following microvascular decompression of that nerve. This etiology of a neurogenic cough has not been previously reported to our knowledge. The proportion of patients with neurogenic cough refractory to all current therapies and suffering with this treatable condition remains","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":451,"document":"31786948","golden":true,"offsetInEndSection":900,"text":"to be defined. We introduce the concept of Vagus Associated Neurogenic Cough Occurring due to Unilateral Vascular Encroachment of its Root (VANCOUVER syndrome) and present the salient features of this condition.METHODS: A case review is presented with details of the patient\u0027s history, examination, imaging, laryngoscopy, intraoperative findings, and long-term clinical outcome.RESULTS: A 60-year-old man presented with a 15-year history of non-prod","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":49,"document":"1330261","golden":false,"offsetInEndSection":122,"text":"e deficiency syndrome (AIDS) autopsies of primarily neurologically sympto","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":454,"document":"31786948","golden":false,"offsetInEndSection":650,"text":"be defined. We introduce the concept of Vagus Associated Neurogenic Cough Occurring due to Unilateral Vascular Encroachment of its Root (VANCOUVER syndrome) and present the salient features of thi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"10829554","golden":false,"offsetInEndSection":96,"text":"The \"Vancouver experience\" engendered great interest, generating palpable energy and enthusiasm.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":124,"document":"34079943","golden":false,"offsetInEndSection":179,"text":"monitoring.DATA SOURCES: ICU, Vancouver General Hospita","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":145,"document":"16494736","golden":false,"offsetInEndSection":260,"text":"By July 2003, Vancouver had identified 5 cases (4 imported); Toronto reported 247 cases (3 imported) and 43 deaths.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1519,"document":"32278265","golden":false,"offsetInEndSection":1769,"text":"h extended use of opioids. The problem with this is that many of these \"symptoms\" of drug use are, in the case of SNAP participants, tied to contextual issues of living in the DTES, experiencing structural vulnerability, and being the target of punit","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":433,"document":"27086495","golden":false,"offsetInEndSection":623,"text":"t survival.METHODS: A retrospective chart review was conducted on 64 patients admitted to Vancouver General Hospital with a diagnosis of Stevens-Johnson syndrome or toxic epidermal necrolysi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":259,"document":"12354534","golden":false,"offsetInEndSection":439,"text":"Recently, market place downgrading of the fish has occurred due to a syndrome referred to as \"black-mould\", characterized by linear black disfigurations, and erosions, of the skin.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"3690440","golden":false,"offsetInEndSection":136,"text":"The ALS symposium in Vancouver was the first of its kind in Canada and was a contribution from both American and Canadian investigators.","beginSection":"abstract"}],"ideal_answer":[],"id":"677e8136592fa48873000019","type":"summary","body":"What is VANCOUVER syndrome."},{"documents":[{"golden":false,"id":"33127742"},{"golden":false,"id":"34756191"},{"golden":false,"id":"22527068"},{"golden":false,"id":"28991832"},{"golden":true,"id":"11471256"},{"golden":true,"id":"16575137"},{"golden":false,"id":"24383711"},{"golden":false,"id":"31723040"},{"golden":false,"id":"31441900"},{"golden":false,"id":"32481464"},{"golden":false,"id":"29424065"},{"golden":false,"id":"29312910"},{"golden":false,"id":"31910037"},{"golden":true,"id":"33947731"},{"golden":false,"id":"26246167"},{"golden":false,"id":"36862700"},{"golden":false,"id":"28271449"},{"golden":false,"id":"36604132"},{"golden":false,"id":"31888705"},{"golden":false,"id":"36823611"},{"golden":false,"id":"33884211"},{"golden":false,"id":"36908280"},{"golden":false,"id":"36562614"},{"golden":false,"id":"33083117"},{"golden":false,"id":"37185949"},{"golden":false,"id":"34504815"},{"golden":false,"id":"37878412"},{"golden":false,"id":"37917869"},{"golden":false,"id":"38074971"},{"golden":false,"id":"37210541"},{"golden":false,"id":"36513805"},{"golden":false,"id":"38082381"},{"golden":false,"id":"36082720"},{"golden":false,"id":"38129945"},{"golden":false,"id":"37545445"},{"golden":false,"id":"35902704"},{"golden":true,"id":"36645762"},{"golden":false,"id":"38214173"},{"golden":false,"id":"35186813"},{"golden":false,"id":"35308977"},{"golden":false,"id":"37809490"},{"golden":false,"id":"37641388"},{"golden":false,"id":"31974673"},{"golden":false,"id":"36715271"},{"golden":false,"id":"32984583"},{"golden":false,"id":"33178370"},{"golden":false,"id":"33223466"},{"golden":false,"id":"19131419"},{"golden":false,"id":"33043053"},{"golden":false,"id":"29700315"},{"golden":false,"id":"37572145"},{"golden":false,"id":"33003178"},{"golden":false,"id":"36399355"},{"golden":false,"id":"38245897"},{"golden":false,"id":"35751423"},{"golden":false,"id":"34325720"},{"golden":false,"id":"31284692"},{"golden":false,"id":"35575803"},{"golden":false,"id":"36980042"},{"golden":false,"id":"37979776"},{"golden":false,"id":"38234587"},{"golden":false,"id":"34760657"},{"golden":false,"id":"35818064"},{"golden":false,"id":"36670566"},{"golden":false,"id":"36449658"},{"golden":false,"id":"18183720"},{"golden":false,"id":"36747744"},{"golden":false,"id":"38222192"},{"golden":false,"id":"33465096"},{"golden":false,"id":"33052510"},{"golden":false,"id":"32637121"},{"golden":false,"id":"37711478"},{"golden":false,"id":"35710638"},{"golden":false,"id":"20925939"},{"golden":false,"id":"33248372"},{"golden":false,"id":"34824136"},{"golden":false,"id":"37810514"},{"golden":false,"id":"37452625"},{"golden":false,"id":"38002822"},{"golden":false,"id":"32116318"},{"golden":false,"id":"37398718"},{"golden":false,"id":"35837567"},{"golden":false,"id":"32278589"},{"golden":false,"id":"34970683"},{"golden":false,"id":"31506150"},{"golden":false,"id":"38357132"},{"golden":false,"id":"38356035"},{"golden":false,"id":"38355207"},{"golden":false,"id":"38354362"},{"golden":true,"id":"38353591"},{"golden":false,"id":"38353586"},{"golden":false,"id":"38353160"},{"golden":false,"id":"38352942"},{"golden":false,"id":"38348451"},{"golden":false,"id":"38216206"},{"golden":false,"id":"38136745"},{"golden":false,"id":"37918940"},{"golden":false,"id":"37854668"},{"golden":false,"id":"37700586"},{"golden":false,"id":"37697654"},{"golden":false,"id":"37659119"},{"golden":false,"id":"37478801"},{"golden":false,"id":"9875023"},{"golden":false,"id":"29447109"},{"golden":false,"id":"31063297"},{"golden":true,"id":"23025259"},{"golden":false,"id":"9846250"},{"golden":false,"id":"16563181"},{"golden":false,"id":"18976355"},{"golden":true,"id":"30613455"},{"golden":true,"id":"31703390"},{"golden":false,"id":"15791874"},{"golden":false,"id":"27922344"},{"golden":true,"id":"28977260"},{"golden":false,"id":"27043996"},{"golden":true,"id":"32166273"},{"golden":false,"id":"25088380"},{"golden":false,"id":"34650938"},{"golden":false,"id":"34427572"},{"golden":false,"id":"30270118"},{"golden":false,"id":"29746311"},{"golden":false,"id":"33965991"},{"golden":false,"id":"29308758"},{"golden":false,"id":"36067988"},{"golden":false,"id":"37577648"},{"golden":false,"id":"25875250"},{"golden":true,"id":"37256281"},{"golden":false,"id":"36755189"},{"golden":false,"id":"30234742"},{"golden":false,"id":"28220227"},{"golden":false,"id":"26711848"},{"golden":false,"id":"23823254"},{"golden":false,"id":"29678851"},{"golden":false,"id":"35836633"},{"golden":false,"id":"33242147"},{"golden":false,"id":"30084442"},{"golden":false,"id":"38358334"},{"golden":false,"id":"38357933"},{"golden":false,"id":"38357644"},{"golden":false,"id":"38357643"},{"golden":false,"id":"38357545"},{"golden":false,"id":"38357510"},{"golden":false,"id":"38357174"},{"golden":false,"id":"38348209"},{"golden":false,"id":"38345975"},{"golden":false,"id":"38343480"},{"golden":false,"id":"38343439"},{"golden":false,"id":"38341181"},{"golden":false,"id":"38335761"},{"golden":false,"id":"38331694"},{"golden":true,"id":"38330522"},{"golden":false,"id":"37313382"},{"golden":false,"id":"36190217"},{"golden":false,"id":"34441017"},{"golden":false,"id":"36476893"},{"golden":false,"id":"37810960"},{"golden":false,"id":"36937966"},{"golden":false,"id":"37538442"},{"golden":true,"id":"26320678"},{"golden":true,"id":"15636652"},{"golden":true,"id":"38011018"},{"golden":false,"id":"39735042"},{"golden":false,"id":"38754894"},{"golden":false,"id":"39709376"},{"golden":false,"id":"36053116"},{"golden":true,"id":"29256116"},{"golden":true,"id":"39205818"},{"golden":false,"id":"33077558"},{"golden":false,"id":"38632681"},{"golden":false,"id":"32724864"},{"golden":false,"id":"31641836"},{"golden":false,"id":"30682104"},{"golden":false,"id":"38760748"},{"golden":false,"id":"27468879"},{"golden":false,"id":"32271186"},{"golden":false,"id":"33096256"},{"golden":false,"id":"35970677"},{"golden":false,"id":"38454423"},{"golden":false,"id":"35311061"},{"golden":false,"id":"37981801"},{"golden":false,"id":"39138095"},{"golden":true,"id":"34887229"},{"golden":true,"id":"31784324"},{"golden":true,"id":"23577792"},{"golden":true,"id":"32861227"},{"golden":true,"id":"9255650"},{"golden":false,"id":"12660055"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":830,"document":"11471256","golden":false,"offsetInEndSection":961,"text":"It is concluded that GMSPS and PRISM are useful methods for identifying and classifying children into low and high risk categories.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1120,"document":"23577792","golden":false,"offsetInEndSection":1259,"text":" higher lactate than survivors. Paediatric risk of mortality (PRISM) score, Glasgow meningococcal septicaemia prognosis score (GMSPS) and R","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"23577792","golden":false,"offsetInEndSection":135,"text":"A new scoring system derived from base excess and platelet count at presentation predicts mortality in paediatric meningococcal sepsis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":618,"document":"38011018","golden":false,"offsetInEndSection":796,"text":"butable mortality. Sensitivity analyses included recalculation of scores using worst preceding values for each variable, excluding hematologic parameters, and prediction of alter","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1260,"document":"23577792","golden":false,"offsetInEndSection":1426,"text":"tterdam score were also higher. Using the consortium set, a new scoring system using base excess and platelet count at presentation, termed the BEP score, was mathema","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":928,"document":"23577792","golden":false,"offsetInEndSection":1119,"text":"en in the replication set died. Children dying in the consortium set had significantly lower base excess, C-reactive protein (CRP), platelet and white cell count, more deranged coagulation an","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1427,"document":"23577792","golden":false,"offsetInEndSection":1584,"text":"ically developed and validated. BEP predicted mortality with high sensitivity and specificity scores (area under the curve (AUC) in the validation set\u003d0.86 a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":963,"document":"31784324","golden":false,"offsetInEndSection":1042,"text":"nd PIM2 scores, respectively. The AUC of the SOFA score for predicting a prolon","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":359,"document":"32861227","golden":false,"offsetInEndSection":478,"text":"participants, 45 died. Plasma lactate at 0 h and 6 h was significantly higher, and lactate clearance was significantly ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1585,"document":"23577792","golden":false,"offsetInEndSection":2037,"text":"d in the replication set\u003d0.96). In the validation set, BEP score performance (AUC\u003d0.86, confidence interval (CI): 0.80 to 0.91) was better than GMSPS (AUC\u003d0.77, CI: 0.68, 0.85), similar to Rotterdam (AUC\u003d0.87, CI: 0.81 to 0.93) and not as good as PRISM (AUC\u003d0.93, CI: 0.85 to 0.97).CONCLUSIONS: The BEP score, relying on only two variables that are quickly and objectively measurable and readily available at presentation, is highly sensitive and speci","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31910037","golden":false,"offsetInEndSection":439,"text":"Rationale: Although proposed as a clinical prompt to sepsis based on predictive validity for mortality, the Quick Sepsis-related Organ Failure Assessment (qSOFA) score is often used as a screening tool, which requires high sensitivity.Objectives: To assess the predictive accuracy of qSOFA for mortality in Brazil, focusing on sensitivity.Methods: We prospectively collected data from two cohorts of emergency department and ward patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":895,"document":"31723040","golden":false,"offsetInEndSection":1119,"text":"We demonstrate that the PERSEVERE biomarkers are reliably associated with mortality in mice challenged with experimental sepsis, thus providing an opportunity to test precision medicine strategies in the preclinical setting.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1380,"document":"33884211","golden":false,"offsetInEndSection":1452,"text":"The PRISM III, PELOD-2, and pSOFA scores correlated well with mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1597,"document":"36562614","golden":false,"offsetInEndSection":1860,"text":"Corticosteroid exposure was associated with fewer ICU-free days ( p \u003c 0.0001).CONCLUSIONS: In our multicenter observational study, corticosteroid administration was associated with increased mortality in a subgroup of children with a high PERSEVERE-II risk score.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2751,"document":"33884211","golden":false,"offsetInEndSection":3004,"text":"Among children admitted to the PICU with septic shock, SOFA scores on both days 1 and 3, have a greater discriminative power for predicting in-hospital mortality than either PRISM III score (within 24?hours of admission) or PELOD-2 score (days 1 and 3).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1646,"document":"36908280","golden":false,"offsetInEndSection":1933,"text":"Measurement using more straightforward methods, such as mid-upper arm circumference, was feasible in numerous health care facilities.Conclusion: Leveraging prognostic models to predict mortality among pediatric patients with sepsis remains an important and well-recognized area of study.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":131,"document":"33884211","golden":false,"offsetInEndSection":310,"text":"The aim of the study is to determine the application of SOFA scores as a predictor of outcome in children admitted to the pediatric intensive care unit with a diagnosis of sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2576,"document":"33884211","golden":false,"offsetInEndSection":2750,"text":"Similar association was-observed between ?SOFA of ?2 and-longer duration of inotropic support ( p ?\u003d?0.0006) with correlation co-efficient 0.2 (95% CI: 0.15-0.35; p ?\u003d?0.01).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1040,"document":"34504815","golden":false,"offsetInEndSection":1186,"text":"Conclusion: PRISM-III/IV, PIM-3, and PELOD-2 had good performance for mortality prediction in PICU but with low to moderate certainty of evidence.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":3005,"document":"33884211","golden":false,"offsetInEndSection":3154,"text":"An increase in ?SOFA of \u003e2 adds additional prognostic accuracy in determining not only mortality risk but also duration of inotropic support as well.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33884211","golden":false,"offsetInEndSection":130,"text":"Sequential organ failure assessment (SOFA) score is used as a predictor of outcome of sepsis in the pediatric intensive care unit.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1563,"document":"33884211","golden":false,"offsetInEndSection":1833,"text":"pSOFA scores on both day 1 (area under the curve or AUC 0.84) and day 3 (AUC 0.87) demonstrated significantly higher discriminative power for in-hospital mortality as compared with PRISM III (AUC, 0.7), and PELOD-2 (day 1, [AUC, 0.73]), and PELOD-2 (day 3, [AUC, 0.81]).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1863,"document":"36645762","golden":false,"offsetInEndSection":2141,"text":"The AUC for predicting death using VRI was 95% (95% CI 90% to 100%, p\u003c0.001) and PELOD-2 92.6% (95% CI 96.4% to 98.8%, p\u003c0.001).CONCLUSION: The VRI \u003c32.1?may potentially be used to predict mortality in children with septic shock and its predictive ability is as good as PELOD-2.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":449,"document":"36645762","golden":false,"offsetInEndSection":892,"text":"Therefore, this study aims to evaluate the ability of Vascular Reactivity Index (VRI) compared with PELOD-2 score as a predictor of mortality in children with septic shock based on vascular response to vasoactive agents.METHODS: A retrospective cohort study was conducted using data from children aged 1?month to 18 years with septic shock treated in the ER and paediatric intensive care unit (PICU) of the tertiary hospital from 2017 to 2021.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1798,"document":"38082381","golden":false,"offsetInEndSection":2051,"text":"This study found that lactate was the most frequent predictor but was seriously ignored by current clinical scoring tools.CONCLUSION: Machine learning methods demonstrate relatively favorable accuracy in predicting the mortality risk in sepsis patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":828,"document":"36513805","golden":false,"offsetInEndSection":1146,"text":"We derived a new decision tree that is neonate specific (nPERSEVERE) with improved performance compared to IL-8 (sensitivity 100%, specificity 86%, negative predictive value 100%, AUC 0.95, p?\u003c?0.0001).CONCLUSIONS: IL-8 and nPERSEVERE demonstrated good prognostic performance in a small cohort of neonates with sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32861227","golden":false,"offsetInEndSection":381,"text":"AIM: We compared the performance of plasma lactate with high-sensitivity C-reactive protein (hs-CRP), and paediatric sepsis-related organ failure assessment (pSOFA) score for predicting mortality in septic children.METHODS: Serial plasma lactate and hs-CRP levels and pSOFA score was assessed during early hospital stay in septic children.RESULTS: Out of 149 participants, 45 died.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2142,"document":"36645762","golden":false,"offsetInEndSection":2198,"text":"The assessment of VRI is faster and easier than PELOD-2.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2825,"document":"37545445","golden":false,"offsetInEndSection":3151,"text":"DCA curve showed that the RF model exhibited greater net benefit as well as threshold probability compared to other models, indicating that the RF model was the best model with good clinical utility.CONCLUSIONS: The machine learning model can be used as a reliable tool for predicting in-hospital mortality in sepsis patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1612,"document":"36645762","golden":false,"offsetInEndSection":1714,"text":"The majority of the patients who died were found in the high cardiac index and low SVRI group (17.6%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":132,"document":"36645762","golden":false,"offsetInEndSection":275,"text":"One of the most widely used scoring systems to assess mortality in sepsis or septic shock is Paediatric Logistic Organ Dysfunction 2 (PELOD-2).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":70,"document":"36513805","golden":false,"offsetInEndSection":380,"text":"We assessed the utility of a validated pediatric prognostic tool called PERSEVERE II that uses decision tree methodology to predict mortality at discharge in neonates who experienced sepsis.METHODS: Prospective study in a dual-center cohort of neonates with sepsis admitted between June 2020 and December 2021.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35902704","golden":false,"offsetInEndSection":183,"text":"BACKGROUND: Age-adjusted Sequential Organ Failure Assessment (SOFA) and age-adjusted quick SOFA (qSOFA) scores have been developed to predict poor outcomes in children with infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":381,"document":"36513805","golden":false,"offsetInEndSection":613,"text":"Biomarker analysis was done on serum samples obtained at the time of evaluation for the event.RESULTS: In a cohort of 59 neonates with a mortality rate of 15.3%, PERSEVERE II was 67% sensitive and 59% specific for mortality, p 0.27.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1168,"document":"35902704","golden":false,"offsetInEndSection":1734,"text":"Different baseline populations, different SOFA adaptation methods and different cut-offs used for age-adjusted SOFA may be potential sources of heterogeneity.CONCLUSIONS: Age adjusted SOFA score is a useful tool for predicting mortality in children with sepsis/suspected sepsis.IMPACT: First study to investigate the prognostic performance of age-adjusted sequential organ failure assessment (SOFA) and age adjusted quick SOFA (qSOFA) scores in comparison to the systemic inflammatory response criteria (SIRS) for the prediction of mortality in children with sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1018,"document":"31974673","golden":false,"offsetInEndSection":1234,"text":"Levels of MR-proADM were significantly higher in patients who required vasoactive drugs (p?\u003d?0.02) or presented renal dysfunction (p?\u003d?0.004).Conclusion: PCT appeared to be superior to MR-proADM in diagnosing sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1147,"document":"36513805","golden":false,"offsetInEndSection":1413,"text":"Moving toward precision medicine in sepsis, our study proposes an important tool for clinical trial prognostic enrichment that needs to be validated in larger studies.IMPACT: Prognostic and predictive biomarker research is lacking in the newborn intensive care unit.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":614,"document":"36513805","golden":false,"offsetInEndSection":827,"text":"Amongst PERSEVERE II biomarkers, IL-8 showed good prognostic performance for mortality prediction with a cutoff of 300?pg/mL (sensitivity 100%, specificity 65%, negative predictive value 100%, AUC 0.87, p 0.0003).","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36513805","golden":false,"offsetInEndSection":124,"text":"Biomarkers estimating baseline mortality risk for neonatal sepsis: nPERSEVERE: neonate-specific sepsis biomarker risk model.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1301,"document":"33223466","golden":false,"offsetInEndSection":1605,"text":"The ability of Tregs PD-1 in predicting 28-day mortality was validated in stage II (AUC?\u003d?0.792).CONCLUSION: PD-1 overexpression in Tregs was associated with poor outcomes, and PD-1 in Tregs is considered to be a valuable tool for the prediction of prognosis in septic patients using sepsis-3.0 criteria.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":808,"document":"38214173","golden":false,"offsetInEndSection":912,"text":"Conclusion: Sepsis screening tools have limited predictive accuracy for infections and mortality in DKA.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1717,"document":"37981801","golden":false,"offsetInEndSection":1884,"text":"Conclusions: The predictive accuracies (AUC) of the PELOD-2 and PRISM III scores are limited in children with hemato-oncological diseases admitted to PICU with sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1228,"document":"37572145","golden":false,"offsetInEndSection":1409,"text":"Conclusion: Neonatal SOFA score showed greater discriminatory capacity for mortality than SIRS criteria and might be helpful to plan management for patients at higher risk of death.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"19131419","golden":false,"offsetInEndSection":861,"text":"OBJECTIVE: To audit current UK practice of the management of severe sepsis in children against the 2002 American College of Critical Care Medicine/Pediatric Advanced Life Support (ACCM-PALS) guideline.DESIGN: Prospective observational study.SETTING: 17 UK paediatric intensive care units (PICUs) and two UK PICU transport services.PARTICIPANTS: 200 children accepted for PICU admission within 12 h of arrival in hospital, whether or not successfully transported to a PICU, with a discharge diagnosis of sepsis or suspected sepsis.MAIN OUTCOME MEASURES: Medical interventions, physiological and laboratory data to determine the presence or absence of shock, inter-hospital transfer times, predicted mortality (using the Paediatric Index of Mortality, version 2 (PIM2) scoring system) and observed mortality.RESULTS: 34/200 (17%) children died following referral.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1740,"document":"33003178","golden":false,"offsetInEndSection":2233,"text":"A new decision tree using the Pediatric Sepsis Biomarker Risk Model biomarkers had an area under the receiver operating characteristic curve of 0.87 (95% CI, 0.80-0.95) for estimating the risk of persistent, serious deterioration health-related quality of life at 3 months among children who survived septic shock.CONCLUSIONS: Pediatric Sepsis Biomarker Risk Model had modest performance for estimating hospital mortality in an external cohort of children with community-acquired septic shock.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":679,"document":"37981801","golden":false,"offsetInEndSection":950,"text":"We collected and analyzed demographic, clinical, and laboratory data and outcomes for all patients, and evaluated the accuracy of two major prognostic scoring tools, the Pediatric Logistic Organ Dysfunction-2 (PELOD-2) and the Pediatric Risk of Mortality III (PRISM III).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1441,"document":"33043053","golden":false,"offsetInEndSection":1653,"text":"In addition, differences were found in eosinophil count and C-reactive protein concentrations among the three subgroups.CONCLUSIONS: In children, RDW stands out as a biomarker associated with the severity of OSA.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":929,"document":"35751423","golden":false,"offsetInEndSection":1360,"text":"The predictive performance for mortality of the combination of PaO2/FiO2, SOFA score and D-dimer (area under the receiver operating characteristic curve of 0.926) was higher than the values for the individual factors (0.761, 0.745 and 0.878, respectively).CONCLUSION: The combination of PaO2/FiO2, SOFA score and D-dimer represents a promising tool and biomarker for predicting 28-day mortality of the elderly patients with sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1109,"document":"19131419","golden":false,"offsetInEndSection":1368,"text":"Binary logistic regression analysis demonstrated that the odds ratio for death, if shock was present at PICU admission, was 3.8 (95% CI 1.4 to 10.2, p \u003d 0.008).CONCLUSIONS: The presence of shock at PICU admission is associated with an increased risk of death.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1128,"document":"37981801","golden":false,"offsetInEndSection":1260,"text":"The predictive accuracies of PELOD-2 and PRISM III, as determined by the area under the curve (AUC), were 83% and 78%, respectively.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1769,"document":"34325720","golden":false,"offsetInEndSection":2035,"text":"With regard to clinical usefulness, the decision curve analysis (DCA) of POSMI showed a higher net benefit than SOFA and APACHE IV in the development cohort.CONCLUSION: POSMI was validated to be an effective tool for predicting mortality in ICU patients with sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1261,"document":"37981801","golden":false,"offsetInEndSection":1495,"text":"Nine new parameters were identified as clinically significant: age, SCT, viral infection, fungal infection, central venous line removal, vasoactive inotropic score, bilirubin level, C-reactive protein level, and prolonged neutropenia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":734,"document":"36980042","golden":false,"offsetInEndSection":998,"text":"Along with the PIM-2, PRISM III, and PELOD-2 scores, the highest value of the pSOFA score was recorded.RESULTS: According to the pRIFLE and AKIN classifications, 62 (8.7%) patients developed kidney injury, which had a statistically significant effect on mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1743,"document":"36980042","golden":false,"offsetInEndSection":2124,"text":"According to the PIM-2 ratio and pRIFLE criteria, there was a statistically significant difference between patients in the injury and failure plus loss stages and those who did not develop AKI.CONCLUSIONS: Our study is the first pediatric study to show a substantial correlation between the variables associated with the PICU scoring modalities in critically ill children with AKI.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1360,"document":"35818064","golden":false,"offsetInEndSection":1685,"text":"Model performance varied when estimating risk of individual organ dysfunctions with AUROCS ranging from 0.91 to 0.97 and 0.68 to 0.89 in training and test sets, respectively.CONCLUSIONS: The newly derived PERSEVEREnce biomarker model reliably estimates risk of death or persistent organ dysfunctions on day 7 of septic shock.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1640,"document":"38234587","golden":false,"offsetInEndSection":1846,"text":"However, this association was not causally mediated by PERSEVERE-II biomarkers.CONCLUSIONS: Our data demonstrate the influence of cumulative %PFB on the risk of complicated course in pediatric septic shock.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":264,"document":"37981801","golden":false,"offsetInEndSection":467,"text":"The current pediatric prognostic scoring tools to evaluate illness severity and mortality risk are designed for the general pediatric population and may not be adequate for this vulnerable subpopulation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1077,"document":"37981801","golden":false,"offsetInEndSection":1127,"text":"Results: The survival rate for the cohort was 83%.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1452,"document":"33052510","golden":false,"offsetInEndSection":1688,"text":"Stage 3 AKI assessed with KDIGO classification was significantly associated with 28-day mortality.CONCLUSIONS: Half of critically ill cirrhotic children admitted to PICU either died or were transplanted within the initial 28-day period.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1600,"document":"33465096","golden":false,"offsetInEndSection":1946,"text":"The model had higher diagnostic accuracy with an area-under-the-ROC curve of 0.85 (95%CI: 0.78-0.92) compared to abbMEDS (0.63,0.54-0.73), mREMS (0.63,0.54-0.72) and internal medicine physicians (0.74,0.65-0.82).CONCLUSION: Machine learning models outperformed internal medicine physicians and clinical risk scores in predicting 31-day mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1113,"document":"29700315","golden":false,"offsetInEndSection":1213,"text":"Overall, the findings suggest that high DNI values are associated with mortality in septic patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1496,"document":"37981801","golden":false,"offsetInEndSection":1716,"text":"Unique scoring systems were established by the integration of these new parameters into the algorithm; the new systems significantly improved their predictive accuracy to 91% (p?\u003d?0.01) and 89% (p?\u003c?0.001), respectively.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":809,"document":"12660055","golden":false,"offsetInEndSection":905,"text":"ality was 39.4% (13 of 30). When all variables were integrated into our final model, we predicte","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2045,"document":"20925939","golden":false,"offsetInEndSection":2304,"text":" the highest case fatality. A combination of six indicators: irregular respiration, oxygen saturation of \u003c90%, pallor, neck stiffness, weight \u003c 1.5 kg, and abnormally elevated blood glucose \u003e 7 mmol/l predicted inpatient neonatal death with a sensitivity of 8","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2270,"document":"33248372","golden":false,"offsetInEndSection":2425,"text":"igenetic-related processes. Further univariate analysis of these 30 genes suggested a signature of seven DE genes associated with ECMO (OR \u003e 3.0, P-value ?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1553,"document":"33248372","golden":false,"offsetInEndSection":1813,"text":"f MODS to ECMO at baseline. From previously published sepsis signatures, only the signatures positively associated with patient\u0027s mortality could differentiate ECMO patients from MODS patients, when applied to our transcriptomic dataset (P-value ranges from 0.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2030,"document":"33248372","golden":false,"offsetInEndSection":2269,"text":".82 [95% CI 0.63 - 12.45]). A total of 30 genes were differentially expressed between ECMO and MODS patients at baseline (log2 fold change ? 1 or ? -1 with false discovery rate ? 0.01). These genes are involved in protein maintenance and e","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":231,"document":"12660055","golden":false,"offsetInEndSection":311,"text":"tal course. We aimed to prospectively validate our model for accuracy of outcome","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":595,"document":"12660055","golden":false,"offsetInEndSection":642,"text":"tilator dependency. We entered these data into ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1825,"document":"34824136","golden":false,"offsetInEndSection":2028,"text":"dies addressed this important question. In LMICs, pulse oximetry may assist clinicians in diagnosing and managing paediatric pneumonia, but for the greatest impact on patient outcomes should be implement","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1518,"document":"20925939","golden":false,"offsetInEndSection":1706,"text":"so increased significantly. Clinical diagnoses of neonatal sepsis, prematurity, neonatal jaundice, neonatal encephalopathy, tetanus and neonatal meningitis accounted for over 75% of the in","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37810514","golden":false,"offsetInEndSection":177,"text":"Retracted: Analysis of the Relevant Vital Signs and Infection of Sepsis Patients and to Explore the Influencing Factors of Acute Lung Injury/Acute Respiratory Distress Syndrome.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1239,"document":"35837567","golden":false,"offsetInEndSection":1505,"text":"The AUROC analysis confirmed that the spSOFA provided good predictive capability in sepsis-related pediatric deaths, relative to the 24 h-pSOFA and SIRS.CONCLUSIONS: The pSOFA score performed better than SIRS in diagnosing infected children with high mortality risk.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":237,"document":"36980042","golden":false,"offsetInEndSection":601,"text":"We compared the AKIN (Acute Kidney Injury Network) and pRIFLE (pediatric risk, injury, failure, loss, and end stage) AKI classifications and PICU scoring modalities in this study.METHODS: A total of 716 children, whose serum creatinine levels were within the normal limits at the time of admission to the PICU between January 2018 and December 2020, were included.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32278589","golden":false,"offsetInEndSection":499,"text":"BACKGROUND: Plasma lactate has been used to predict the prognosis of critically ill children, but mortality risk scores appear to be more appealing, particularly in resource-limited countries.OBJECTIVE: To assess the prognostic utility of lactate compared with the pediatric Sequential Organ Failure Assessment (pSOFA) score among the general pediatric intensive care unit (PICU) population.METHODS: This was a prospective observational study including 78 children admitted to a tertiary-level PICU.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":999,"document":"36980042","golden":false,"offsetInEndSection":1145,"text":"The occurrence of renal injury was found to be statistically strongly and significantly correlated with high PRISM III, PELOD-2, and pSOFA scores.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1420,"document":"36980042","golden":false,"offsetInEndSection":1554,"text":"For the PRISM III, PELOD 2, and pSOFA scores, there were no significant differences between the stages according to the AKIN criteria.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1555,"document":"36980042","golden":false,"offsetInEndSection":1742,"text":"A substantial difference was discovered between the patients who did not develop AKI and those who were in the risk, injury, and failure plus loss stages according to the pRIFLE criteria.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1769,"document":"32278589","golden":false,"offsetInEndSection":1939,"text":"Combining 24-h lactate level with pSOFA demonstrated superior performance (AUC\u003d0.88).CONCLUSION: Both 24-h lactate level and pSOAF are useful for prediction of mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":685,"document":"38357132","golden":false,"offsetInEndSection":808,"text":"The odds of RDS among neonates with jaundice and sepsis are 4.33- and 1.92-times higher odds compared to their counterparts","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":359,"document":"38356035","golden":false,"offsetInEndSection":526,"text":"A cohort study was conducted using the Korean Neonatal Network registry of very low birth weight infants with BPD between 2013 and 2017 through retrospective analysis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":566,"document":"38355207","golden":false,"offsetInEndSection":652,"text":"Initial screenings for sepsis and blood group incompatibility yielded negative results","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":9,"document":"38354362","golden":false,"offsetInEndSection":207,"text":"Time to antibiotic administration (TTA) in \u003c60 minutes for children with neutropenic fever presenting to an emergency room is associated with reduced incidence of sepsis and intensive care admission","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1729,"document":"38353591","golden":false,"offsetInEndSection":1784,"text":"Sepsis is still a life-threatening disease in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":234,"document":"38353586","golden":false,"offsetInEndSection":317,"text":"Secondary analysis of the Life After Pediatric Sepsis Evaluation prospective study.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1307,"document":"38353160","golden":false,"offsetInEndSection":1398,"text":"Further multicenter prospective data are needed, including infants with early-onset sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":151,"document":"38352942","golden":false,"offsetInEndSection":268,"text":"These mechanisms have been demonstrated in patients with sepsis, hemoglobinopathies, and those receiving transfusions","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":13,"document":"38348451","golden":false,"offsetInEndSection":184,"text":" Pediatric sepsis (PS) is a life-threatening infection associated with high mortality rates, necessitating a deeper understanding of its underlying pathological mechanisms","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1822,"document":"38216206","golden":false,"offsetInEndSection":1925,"text":"We will use these data to determine sepsis epidemiology based on existing and novel diagnostic criteria","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":432,"document":"38136745","golden":false,"offsetInEndSection":605,"text":"NP, one of the most prevalent causes of sepsis in surgical Intensive Care Units (ICUs), is often associated with multi-drug resistant (MDR) bacteria and high mortality rates","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":920,"document":"37918940","golden":false,"offsetInEndSection":1166,"text":"Of 1336 neonates, 68 (5%) had adverse outcomes, that is, sepsis (n\u003d40, 59%), critical congenital heart disease (n\u003d2, 3%), severe persistent pulmonary hypertension (n\u003d1), hospitalisation (n\u003d8, 12%) and death (n\u003d17, 25%) assessed at 4 weeks of life","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":704,"document":"37854668","golden":false,"offsetInEndSection":927,"text":" An ACORN pilot was implemented in three hospitals in Southeast Asia (1 paediatric, 2 general) to collect clinical and microbiological data from patients with community- or hospital-acquired pneumonia, sepsis, or meningitis","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":485,"document":"37700586","golden":false,"offsetInEndSection":646,"text":"Despite updating of pediatric sepsis definition and implementation of screening tools to facilitate early recognition, mortality from sepsis continues to be high","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":311,"document":"37697654","golden":false,"offsetInEndSection":414,"text":"The mortality rate of pediatric sepsis in our study was 76.1% among 176 records with outcome identified","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37659119","golden":false,"offsetInEndSection":91,"text":"miRNAs: novel noninvasive biomarkers as diagnostic and prognostic tools in neonatal sepsis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":518,"document":"37478801","golden":false,"offsetInEndSection":812,"text":"While engagement of pyroptosis during sepsis-induced cardiomyopathy and septic shock is expected and well documented, we are just beginning to understand pyroptosis involvement in the pathogenesis of cardiovascular diseases with less defined inflammatory components, such as atrial fibrillation","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":704,"document":"9875023","golden":false,"offsetInEndSection":945,"text":"Factors predicting death were a high admission paediatric risk of mortality (PRISM) score (30.38 v 18.75) and the presence of multiple organ dysfunction syndrome (92% v 25%).CONCLUSION: Both definitions identified similar groups of patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1723,"document":"23025259","golden":false,"offsetInEndSection":2141,"text":"False positive subjects in the updated model had greater illness severity compared to the true negative subjects, as measured by persistence of organ failure, length of stay, and intensive care unit free days.CONCLUSIONS: The pediatric sepsis biomarker risk model (PERSEVERE; PEdiatRic SEpsis biomarkEr Risk modEl) reliably identifies children at risk of death and greater illness severity from pediatric septic shock.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"9875023","golden":false,"offsetInEndSection":233,"text":"OBJECTIVES: To determine the incidence and outcome of acute respiratory distress syndrome (ARDS) in children by comparing two commonly used definitions: the lung injury score and the American-European Consensus Conference definition.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":909,"document":"18976355","golden":false,"offsetInEndSection":1183,"text":"There was a positive correlation between the baseline TnI levels and the predicted mortality using the paediatric index of mortality (PIM2) scores at admission (r \u003d 0.51, p \u003d 0.03).CONCLUSION: A majority of children with septic shock have evidence of myocardial cell injury.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1090,"document":"9875023","golden":false,"offsetInEndSection":1216,"text":"Poor outcome was associated with sepsis, a high admission PRISM score, and simultaneous occurrence of other organ dysfunction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":427,"document":"29447109","golden":false,"offsetInEndSection":650,"text":"A new screening tool for sepsis (quick Sequential Organ Failure Assessment [qSOFA]) has been proposed to predict the likelihood of poor outcome in out-of-intensive care unit (ICU) patients with clinical suspicion of sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":234,"document":"9875023","golden":false,"offsetInEndSection":479,"text":"The causes and risk for developing ARDS were also studied.METHODS: Part prospective and retrospective analysis of 8100 consecutive hospital admissions from 1 June 1995 to 1 April 1997.RESULTS: Twenty one patients fulfilled the criteria for ARDS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":111,"document":"29447109","golden":false,"offsetInEndSection":426,"text":"Early recognition and diagnosis of sepsis is required to prevent the transition into septic shock, which is associated with a mortality rate of 40% or more.DISCUSSION: New definitions for sepsis and septic shock (Third International Consensus Definitions for Sepsis and Septic Shock [Sepsis-3]) have been developed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":680,"document":"9875023","golden":false,"offsetInEndSection":703,"text":"Mortality was 13 of 21.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":637,"document":"9875023","golden":false,"offsetInEndSection":679,"text":"The main causes were sepsis and pneumonia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1155,"document":"9846250","golden":false,"offsetInEndSection":1279,"text":"Overall, the GMSPS score, the NESI score and the Algren criteria predicted death in respectively 10, nine and five patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1422,"document":"9846250","golden":false,"offsetInEndSection":1540,"text":"The Algren criteria predicted the severity of the clinical process more accurately than did the GMSPS and NESI scores.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1280,"document":"9846250","golden":false,"offsetInEndSection":1421,"text":"Death was falsely predicted in six patients by the GMSPS score, in five patients by the NESI score and in one patient by the Algren criteria.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1021,"document":"28977260","golden":false,"offsetInEndSection":1166,"text":"The area under the curve was 0.723 for PRISM III and 0.78 for PELOD.CONCLUSION: A multiple organ dysfunctions was associated with high mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1472,"document":"27922344","golden":false,"offsetInEndSection":1788,"text":"On multivariate analysis, only the use of vasoactive drugs [odds ratio (OR) 12.24, 95% confidence interval (CI) 4.4-35.4, p?\u003c?0.001] and MP score???5 (OR 16.1, CI 6.3-40.8, p?\u003c?0.001) were associated with mortality.CONCLUSION: The observed mortality rate was in the range reported in other resource-limited settings.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1422,"document":"32166273","golden":false,"offsetInEndSection":1939,"text":"The tool was validated in 28 nonseptic patients from the same ICUs who became septic later and was subject to 10-fold cross-validation, achieving similarly high area under the curve.CONCLUSIONS: Using a novel version of the Cox model, we created a prognostic tool for septic patients that yields not only a predicted probability of dying but also a mortality risk profile that reveals how six time-varying biological indicators differentially and longitudinally account for the patient\u0027s overall daily mortality risk.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1089,"document":"9846250","golden":false,"offsetInEndSection":1154,"text":"The three scoring systems in these four patients predicted death.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":157,"document":"27922344","golden":false,"offsetInEndSection":657,"text":"However, published data on the practice of critical care and patient outcomes in these settings are scant.OBJECTIVE: This study sought to identify risk factors associated with mortality in the newly established Paediatric Intensive Care Unit (PICU) at Kigali University Teaching Hospital (KUTH) in Rwanda and test the predictive ability of a newly devised mortality risk score, the modified PRISM (MP) score.METHODS: All admissions to the PICU at KUTH from October 2012 to October 2014 were included.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":263,"document":"34650938","golden":false,"offsetInEndSection":494,"text":"We aimed to determine the association of Pediatric Index of Mortality 2 (PIM2), Pediatric Risk of Mortality Score III (PRISM III) and Pediatric Logistic Organ Dysfunction (PELOD) scores with mortality in pediatric patients on ECMO.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":989,"document":"34650938","golden":false,"offsetInEndSection":1103,"text":"PIM2, PRISM III, and PELOD scores are not associated with odds of mortality for pediatric patients receiving ECMO.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":892,"document":"34650938","golden":false,"offsetInEndSection":988,"text":"AUCs for PIM2, PRISM III, and PELOD predicting mortality were 0.52, 0.52, and 0.51 respectively.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1710,"document":"33965991","golden":false,"offsetInEndSection":1957,"text":"Hypofibrinolysis was associated with prolonged PICU length of stay in survivors and with early mortality in nonsurvivors.CONCLUSIONS: Fibrinolytic shutdown in pediatric septic shock is associated with an increase in disease severity and mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1764,"document":"37577648","golden":false,"offsetInEndSection":2198,"text":"Patients belonging to the PHES phenotype were characterized by greater degree of systemic inflammation and endothelial activation, and overlapped with high risk-strata based on PERSEVERE biomarkers predictive of death and persistent MODS.Conclusions: The PHES trajectory-based phenotype is reproducible, independently associated with poor clinical outcomes, and overlap with higher risk-strata based on validated biomarker approaches.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2108,"document":"29308758","golden":false,"offsetInEndSection":2593,"text":"Hosmer-Lemeshow test showed that PCIS predicted the mortality and the actual mortality in the best fitting effect (? 2 \u003d 7.573, P \u003d 0.476), followed by PELOD-2 and P-MODS (?12 \u003d 9.551, P1 \u003d 0.145; ?22 \u003d 10.343, P2 \u003d 0.111), while PRISM III had poor fitting effect (?2 \u003d 43.549, P \u003c 0.001).CONCLUSIONS: PRISM III, PELOD-2 and P-MODS can discriminate between survivors and moribund patients well, and assessing the condition of critically ill pediatric patients with relatively accuracy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1697,"document":"34427572","golden":false,"offsetInEndSection":2098,"text":"Agreement between all raters was good (?\u003d0.7, P\u003c0.001).CONCLUSIONS: This novel radiography score for children with RF, associated with clinical severity scores, mortality risk, duration of ventilatory support, and hospitalization, follows a simple structured approach and can be readily utilized by radiologists and pediatricians as a bedside tool for stratification of disease severity and prognosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1093,"document":"30270118","golden":false,"offsetInEndSection":1336,"text":"The AUC of the BIG score was 0.94 compared to 0.96, 0.97 and 0.93 for the PRISM III, PIM2, and PELOD respectively.CONCLUSIONS: The BIG score is accurate in predicting mortality in pediatric trauma patients.LEVEL OF EVIDENCE: Level I prognosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34650938","golden":false,"offsetInEndSection":262,"text":"Though commonly used for adjustment of risk, severity of illness and mortality risk prediction scores, based on the first 24 h of intensive care unit (ICU) admission, have not been validated in the pediatric extracorporeal membrane oxygenation (ECMO) population.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"29447109","golden":false,"offsetInEndSection":110,"text":"BACKGROUND: Sepsis is a global healthcare issue and continues to be the leading cause of death from infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":840,"document":"29447109","golden":false,"offsetInEndSection":906,"text":"This review discusses the new Sepsis-3 definitions and guidelines.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":651,"document":"29447109","golden":false,"offsetInEndSection":839,"text":"The Surviving Sepsis Campaign Guidelines were recently updated and include greater evidence-based recommendations for treatment of sepsis in attempts to reduce sepsis-associated mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1596,"document":"38358334","golden":false,"offsetInEndSection":1671,"text":"There was 1 possibly related death (sepsis with attendant hepatic failure).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38357933","golden":false,"offsetInEndSection":127,"text":"Understanding the kinetics of dengue viruses in the bloodstream can provide insights into the clinical outcomes of the disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":805,"document":"38357644","golden":false,"offsetInEndSection":877,"text":"We gathered pertinent data on sepsis patients from the MIMIC-IV database","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":804,"document":"38357643","golden":false,"offsetInEndSection":908,"text":"In the studied cohort of 32,971 sepsis patients, 2,327 were identified as meeting the inclusion criteria","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":271,"document":"38357545","golden":false,"offsetInEndSection":299,"text":"nosuppression and substantia","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1371,"document":"38357510","golden":false,"offsetInEndSection":1523,"text":"Logistic regression confirmed lower gestational age, vaginal delivery, ductus arteriosus and early onset sepsis to be independent predictors for any IVH","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":212,"document":"38357174","golden":false,"offsetInEndSection":393,"text":"In retrospective observational study, during October 2019 to December 2021, 145 patients with septic shock treated in our hospital were enrolled by the method of observational study","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38348209","golden":false,"offsetInEndSection":112,"text":"Hierarchical Predictors of Mortality in Neonatal Sepsis at Jimma Medical Center, Ethiopia: A Case-Control Study.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":12,"document":"38345975","golden":false,"offsetInEndSection":101,"text":"Bloodstream infections (BSI) represent a common cause of sepsis and mortality in children","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":159,"document":"38343480","golden":false,"offsetInEndSection":244,"text":"A systematic search was performed for studies comparing BC and IS in pediatric sepsis","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38343439","golden":false,"offsetInEndSection":99,"text":"Septic shock, a subset of sepsis, is a fatal condition associated with high morbidity and mortality","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1330,"document":"38341181","golden":false,"offsetInEndSection":1473,"text":"Fever, organomegaly, and sepsis were the next most frequent findings, reported in 251 (30.2%), 206 (24.8%), and 171 (20.8%) cases, respectively","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":556,"document":"38335761","golden":false,"offsetInEndSection":631,"text":"Groups were compared regarding in-hospital mortality and neonatal outcomes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2062,"document":"38331694","golden":false,"offsetInEndSection":2191,"text":"We also showed that mortality rate increased with Pediatric Index of Mortality 3 score at admission and number of organ failures.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":455,"document":"38330522","golden":false,"offsetInEndSection":660,"text":"This study aimed to predict the onset of late-onset sepsis (LOS) with good diagnostic value as early as possible using non-invasive biosignal measurements from neonatal intensive care unit (NICU) monitors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1274,"document":"36755189","golden":false,"offsetInEndSection":1779,"text":"The AUC values for PSP, copeptin, and APOA5 were 0.709, 0.705, and 0.571, respectively, with sensitivities of 74%, 58%, and 58% for mortality prediction.CONCLUSIONS: PSP, copeptin, and APOA5 are promising diagnostic biomarkers for pediatric sepsis but inadequate predictors of mortality.IMPACT: Apolipoprotein A-V (APOA5), copeptin, and pancreatic stone protein (PSP) are acute-phase proteins with diagnostic value in evaluating critically ill pediatric patients with sepsis and detecting sepsis severity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36755189","golden":false,"offsetInEndSection":385,"text":"BACKGROUND: We assessed serum concentrations of pancreatic stone protein (PSP), copeptin, and apolipoprotein A-V (APOA5) biomarkers for the diagnosis and prognosis of pediatric sepsis, a condition associated with high mortality.METHODS: This prospective study included 180 children admitted to the Pediatric Intensive Care Unit and 100 healthy controls at Menoufia University Hospital.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1251,"document":"37313382","golden":false,"offsetInEndSection":1492,"text":"ROC curve analyses show a greater predictive ability of initial presepsin concentrations for predicting mortality compared to subsequent measurements of presepsin concentrations.Conclusions: Presepsin has a good ability to predict mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1516,"document":"34441017","golden":false,"offsetInEndSection":1655,"text":"Conclusions: NLR and PLR represent a widely useful and cheap tool in diagnosis and in predict-ing 90-day mortality in patients with sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1308,"document":"33242147","golden":false,"offsetInEndSection":1536,"text":"According to the prognosis, thrombomodulin had AUC?\u003d?0.711 for predicting mortality whereas PRISM and PIM scores had AUC?\u003d?(0.918, 0.960) respectively.CONCLUSIONS: Serum thrombomodulin is a promising marker for pediatric sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1780,"document":"36755189","golden":false,"offsetInEndSection":1856,"text":"PSP and copeptin had the power to discriminate non-survivors from survivors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":544,"document":"36755189","golden":false,"offsetInEndSection":727,"text":"Serum PSP, copeptin and APOA5 were measured once within 24?h of admission.RESULTS: PSP, copeptin, and APOA5 were significantly higher in the patients than in the controls (p?\u003c?0.001).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":710,"document":"36190217","golden":false,"offsetInEndSection":843,"text":"USIONS: We identified that the PIM 3 and pSOFA have an acceptable discrimination power. The calibration of the PIM 3 was not adequate","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1593,"document":"36476893","golden":false,"offsetInEndSection":1934,"text":"In addition, the ROC curve analysis showed that pSOFA score had AUC of 0.8551 (95% CI: 0.7607-0.9495, p\u003c0.001) predicting PICU mortality and its best predictive value was \u003e9.5 (sensitivity 75.0%, specificity 87.0%).CONCLUSION: Pediatric acute leukemia complicated with septic shock is characterized as rapid deterioration and high mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":845,"document":"26320678","golden":false,"offsetInEndSection":1275,"text":"Compared to CRP and lactate, the area under the ROC curve revealed a good discriminative power of PCT to predict septic shock and mortality, 0.91 (95% CI: 0.83-0.97) and 0.80 (95% CI: 0.69-0.88), respectively.CONCLUSIONS: In contrast to CRP and lactate, the determination of PCT in pediatric intensive care unit admission is a good predictor of mortality and septic shock and can stratify patients according to severity of sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1291,"document":"15636652","golden":false,"offsetInEndSection":1620,"text":"When used as a stratification tool for a hypothetical trial (60% reduction in mortality, 80% power), the scores allowed for a reduction in study size by 50% (PIM) and 43% (pre-ICU PRISM).CONCLUSIONS: Pre-ICU PRISM and PIM both discriminate well but calibrate poorly when applied to a cohort of children with meningococcal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":628,"document":"15636652","golden":false,"offsetInEndSection":851,"text":"Ages ranged from 0.1 to 17 yrs (median 2.3 yrs).INTERVENTIONS: None.MEASUREMENTS AND MAIN RESULTS: PIM demonstrated greater sensibility, with complete data collected in 93% of cases, compared with 35% for the pre-ICU PRISM.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1289,"document":"31784324","golden":true,"offsetInEndSection":1637,"text":"The diagnosis of sepsis applying a SOFA cutoff of 3 points predicted mortality better than both the SIRS and the SOFA cutoff of 2 points recommended by the Sepsis-3 consensus.CONCLUSIONS: The SOFA score at admission is useful for predicting outcomes in the general PICU population and is more accurate than SIRS for definition of paediatric sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":203,"document":"15636652","golden":false,"offsetInEndSection":627,"text":"We assessed the performance of two generic scores that assign mortality risk within 1 hr of ICU admission: the Preintensive Care Pediatric Risk of Mortality (Pre-ICU PRISM) and Pediatric Index of Mortality (PIM).DESIGN: Prospective, observational study over 21 months.SETTING: Two tertiary pediatric ICUs accepting referrals from southeast England.PATIENTS: Patients were 165 consecutive children with meningococcal disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1143,"document":"15636652","golden":false,"offsetInEndSection":1290,"text":"Both scores calibrated poorly, overestimating mortality in the medium-risk strata (and also in the high-risk stratum in the case of Pre-ICU PRISM).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1707,"document":"15636652","golden":false,"offsetInEndSection":1772,"text":"The main advantage for PIM appears to be ease of data collection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1621,"document":"15636652","golden":false,"offsetInEndSection":1706,"text":"Both scores provide an effective means of stratification for clinical trial purposes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38011018","golden":false,"offsetInEndSection":499,"text":"OBJECTIVE: To evaluate the performance of existing sepsis scores for prediction of adverse outcomes in children with cancer admitted to the ICU with suspected sepsis.DESIGN: Retrospective chart review using data available at 1, 6, 12, and 24?h after ICU admission to calculate the Pediatric Risk of Mortality 3 (PRISM-3), Pediatric Sequential Organ Failure Assessment (pSOFA), Paediatric Logistic Organ Dysfunction 2 (PELOD-2), and Quick Pediatric Sequential Organ Failure Assessment (qSOFA) scores.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38754894","golden":false,"offsetInEndSection":270,"text":"BACKGROUND AND OBJECTIVES: This study aimed to identify predictors of sepsis-associated in-hospital mortality from readily available laboratory biomarkers at onset of illness that include haematological, coagulation, liver and kidney function, blood lipid, cardiac enzym","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1121,"document":"36053116","golden":false,"offsetInEndSection":1419,"text":" research on patient outcomes. Using appropriate core outcome sets, developing reference standards, monitoring sepsis prevalence via registries and continuously monitoring process measures will provide robust evidence to identify the best performing identification tools and the impact they have on","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39735042","golden":false,"offsetInEndSection":124,"text":"Sepsis continues to be a major contributor to illness and death in children, necessitating effective risk assessment tools.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":708,"document":"29256116","golden":false,"offsetInEndSection":867,"text":"UROC) analysis.RESULTS: Of 2594 paediatric ICU admissions due to infection, 151 (5.8%) children died, and 949/2594 (36.6%) patients died or experienced an ICU ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1910,"document":"39205818","golden":true,"offsetInEndSection":2079,"text":"PDW?14.1% at admission increases the risk of mortality by 5.7 times.Conclusion: Admission PDW is a fast and specific tool to predict the outcome of children with sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1813,"document":"39205818","golden":false,"offsetInEndSection":1909,"text":"PDW was also the only parameter that significantly affected the outcome of children with sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1451,"document":"39205818","golden":false,"offsetInEndSection":1649,"text":"A P value less than 0.05 was considered statistically significant.Results: MPV, PDW, and PDW/PLT were significantly higher in non-survivors than survivors (P\u003d0.04, P\u003d0.02, and P\u003d0.04, respectively).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":527,"document":"39205818","golden":false,"offsetInEndSection":821,"text":"We aimed to study the use of platelet count and indices as predictors of mortality in children with sepsis.Methods: This is a cross-sectional study of 45 children diagnosed with sepsis on admission at Haji Adam Malik Hospital, Medan, North Sumatra, Indonesia, between October and November 2022.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"39205818","golden":false,"offsetInEndSection":98,"text":"The Use of Platelet Count and Indices as Prognostic Factors for Mortality in Children with Sepsis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1650,"document":"39205818","golden":false,"offsetInEndSection":1812,"text":"ROC curve analysis showed that PDW had the largest AUC (0.708 [95% CI\u003d0.549-0.866]) with a cut-off value of 14.1%, sensitivity of 63.6%, and specificity of 82.6%.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":998,"document":"39205818","golden":false,"offsetInEndSection":1296,"text":"Receiver Operating Characteristic (ROC) curve analysis of platelet parameters was done to determine the area under the curve (AUC), optimal cut-off value, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) in predicting mortality in children with sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1726,"document":"38760748","golden":false,"offsetInEndSection":2058,"text":"Patients with higher Lac H6 levels and lower lactate clearance rates had significantly higher PICU mortality based on Kaplan-Meier survival curve analysis.CONCLUSIONS: This study highlights the significance of lactate level trends over time for the prediction of mortality in the PICU in patients with severe sepsis or septic shock.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30682104","golden":false,"offsetInEndSection":154,"text":"OBJECTIVE: In hospitalized patients, the risk of sepsis-related mortality can be assessed using the quick Sepsis-related Organ Failure Assessment (qSOFA).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1607,"document":"38754894","golden":false,"offsetInEndSection":2007,"text":"The results of the ROC curve showed that combined diagnosis of the three indicators-TG+BE+pH-has the best area under the curve (AUC) (AUC\u003d0.77, 95% CI: 0.69 to 0.85, p\u003c0.001), with a 68% sensitivity and 80% specificity.CONCLUSION: Laboratory factors of TG, BE and pH during the first 24?hours after intensive care unit admission are associated with in-hospital mortality in PICU patients with sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":344,"document":"39735042","golden":false,"offsetInEndSection":459,"text":"To better identify sepsis and septic shock status in the pediatric age group, various sepsis scores were developed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31641836","golden":false,"offsetInEndSection":81,"text":"BACKGROUND: qSOFA has been proposed as a prognostic tool in patients with sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32271186","golden":false,"offsetInEndSection":450,"text":"OBJECTIVES: Pediatric acute respiratory distress syndrome is heterogeneous, with a paucity of risk stratification tools to assist with trial design. We aimed to develop and validate mortality prediction models for patients with pediatric acute respiratory distress syndrome.DESIGN: Leveraging additional data collection from a preplanned ancillary study (Version 1) of the multinational Pediatric Acute Respiratory Distress syndrome Incidence and Epi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33096256","golden":false,"offsetInEndSection":450,"text":"Pediatric sepsis is a major cause of mortality of children worldwide. However, there is still a lack of easy-to-use predictive tools that can accurately diagnose sepsis in children. This study aimed to develop an optimal gene model for the diagnosis of pediatric sepsis using statistics and machine learning approaches. Combining gene expression profiles from a training cohort of 364 pediatric samples with a Least Absolute Shrinkage and Selection O","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35970677","golden":false,"offsetInEndSection":450,"text":"BACKGROUND: Risk prediction models are well established as an adjunct to perioperative decision making, but few exist for pediatric surgical outcomes. The majority of risk tools do not feature Australasian data and do not estimate mortality risk beyond 30-days. Our aim was to develop and validate a model for mortality risk prediction in children (age \u003c18yrs) at 30-days, 90-days and 1 year following all types of surgery using a national database.M","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38454423","golden":false,"offsetInEndSection":450,"text":"BACKGROUND: Sepsis is a dysregulated systemic inflammatory response triggered by infection, resulting in organ dysfunction. A major challenge in clinical pediatrics is to identify sepsis early and then quickly intervene to reduce morbidity and mortality. As blood biomarkers hold promise as early sepsis diagnostic tools, we aimed to measure a large number of blood inflammatory biomarkers from pediatric sepsis patients to determine their predictive","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37981801","golden":false,"offsetInEndSection":450,"text":"Background: Children with hemato-oncological diseases or following stem cell transplantation (SCT) are at high risk for life-threatening infections; sepsis in this population constitutes a substantial proportion of pediatric intensive care unit (PICU) admissions. The current pediatric prognostic scoring tools to evaluate illness severity and mortality risk are designed for the general pediatric population and may not be adequate for this vulnerab","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39735042","golden":false,"offsetInEndSection":450,"text":"Sepsis continues to be a major contributor to illness and death in children, necessitating effective risk assessment tools. Incidence of pediatric?sepsis in intensive care units is on increasing trend. Over the years, the concept of sepsis scoring systems has evolved to enhance the prediction of outcomes and mortality in pediatric age group. To better identify sepsis and septic shock status in the pediatric age group, various sepsis scores were d","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35311061","golden":false,"offsetInEndSection":450,"text":"Objectives: The heterogeneity of sepsis makes it difficult to predict outcomes using existing severity of illness tools. The vasoactive-inotrope score (VIS) is a quantitative measure of the amount of vasoactive support required by patients. We sought to determine if a higher aggregate VIS over the first 96 h of vasoactive medication initiation is associated with increased resource utilization and worsened clinical outcomes in pediatric patients w","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":54,"document":"34887229","golden":false,"offsetInEndSection":242,"text":"n children. Several scoring systems are used to predict outcome and mortality for pediatric patients with sepsis, but how they compare to each other in terms of sensitivity and specificity","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39709376","golden":false,"offsetInEndSection":109,"text":"BACKGROUND: Predicting mortality in sepsis-related acute kidney injury facilitates early data-driven treatmen","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1437,"document":"31784324","golden":false,"offsetInEndSection":1599,"text":" by the Sepsis-3 consensus.CONCLUSIONS: The SOFA score at admission is useful for predicting outcomes in the general PICU population and is more accurate than SIR","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38754894","golden":false,"offsetInEndSection":269,"text":"BACKGROUND AND OBJECTIVES: This study aimed to identify predictors of sepsis-associated in-hospital mortality from readily available laboratory biomarkers at onset of illness that include haematological, coagulation, liver and kidney function, blood lipid, cardiac enzy","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23577792","golden":false,"offsetInEndSection":161,"text":"INTRODUCTION: The aim of this study was to derive a novel prognostic score for mortality in paediatric meningococcal sepsis (MS) based on readily available labor","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":818,"document":"32861227","golden":false,"offsetInEndSection":911,"text":"e at 0 h (AUC 0.67).CONCLUSION: pSOFA score, hs-CRP and hyperlactemia at 6 h can identify sep","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2544,"document":"9255650","golden":false,"offsetInEndSection":2626,"text":"te did not identify non-survivors from survivors at any time in the first 48 h.CON","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":487,"document":"39138095","golden":false,"offsetInEndSection":695,"text":"Novel digital solutions, from wearable devices and mobile apps, to electronic health record-embedded decision support tools, have an unprecedented opportunity to transform paediatric sepsis research and care.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1080,"document":"12660055","golden":false,"offsetInEndSection":1296,"text":"ed in only 51% of patients.CONCLUSION: We show prospectively that mortality in severely burned children can be reliably estimated at a burn centre, and that outcome cannot be reliably predicted on the basis of demogr","beginSection":"abstract"}],"exact_answer":[["lactate","plasma lactate","lactate levels"],["Pediatric Risk of Mortality (PRISM) III score","PRISM III"],["pediatric Sequential Organ Failure Assessment (pSOFA) score","pSOFA"],["machine learning models such as Random Forest (RF)"],["Interleukin-8"],["PIM-3"],["Vascular Reactivity Index (VRI)","VRI"],["high-sensitivity C-reactive protein (hs-CRP)","hs-CRP"],["procalcitonin (PCT)","PCT"],["PD-1 expression",""],["T regulatory cells","Tregs"]],"ideal_answer":[],"id":"658447ca06a2ea257c000001","type":"list","body":"Which tools are used to predict mortality in paediatric sepsis?"},{"documents":[{"golden":true,"id":"38039751"},{"golden":true,"id":"32617294"},{"golden":false,"id":"19494309"},{"golden":false,"id":"32849528"},{"golden":false,"id":"28793286"},{"golden":true,"id":"24978886"},{"golden":true,"id":"37607110"},{"golden":false,"id":"31531179"},{"golden":false,"id":"27114524"},{"golden":false,"id":"20207161"},{"golden":false,"id":"39106371"},{"golden":false,"id":"38599461"},{"golden":false,"id":"37935545"},{"golden":false,"id":"36684648"},{"golden":false,"id":"38588614"},{"golden":false,"id":"37708335"},{"golden":false,"id":"34304410"},{"golden":false,"id":"21859896"},{"golden":false,"id":"20160669"},{"golden":false,"id":"39617276"},{"golden":false,"id":"37839766"},{"golden":false,"id":"37182383"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":1451,"document":"32617294","golden":true,"offsetInEndSection":1895,"text":"Moreover, the release of IL-1? and IL-18 and the levels of the molecules (NLRP3, NLRC4, Cleaved caspase-1, and Cleaved GSDMD) associated with caspase-1-dependent pyroptosis were up-regulated in pneumonia-induced sepsis.CONCLUSIONS: As NK-?B activation can promote the development of caspase-1-dependent pyroptosis, these findings suggested that the activation of the IL-17 signaling pathway could promote pyroptosis in pneumonia-induced sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1627,"document":"38039751","golden":true,"offsetInEndSection":1808,"text":"Taken together, we concluded that the IL-17 signaling pathway serves as a significant potential mechanism of sepsis and provides a promising therapeutic target for sepsis treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1340,"document":"38039751","golden":true,"offsetInEndSection":1626,"text":"Finally, GSE100159 and GSE133822 confirmed IL-17 signaling pathway-associated genes including IL-17R, TRAF6, RELB, TRAF5, CEBPB, JUNB, CXCL1, CXCL3, CXCL8, CXCR1, and CXCR2 were significantly up-regulated in sepsis blood samples compared with the age-matched healthy control population.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1097,"document":"28793286","golden":false,"offsetInEndSection":1373,"text":"Finally, IL-33 was shown to inhibit the IL-17 pathway via activating suppressor of cytokine signaling (SOCS)-3.CONCLUSION: Collectively, the results suggest that IL-33 plays a negative regulatory role in sepsis progression by inhibiting IL-17 pathway through activating SOCS3.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38039751","golden":true,"offsetInEndSection":116,"text":"Single-cell transcriptional gene signature analysis identifies IL-17 signaling pathway as the key pathway in sepsis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1096,"document":"38039751","golden":true,"offsetInEndSection":1339,"text":"Subsequently, GO and KEGG enrichment analysis of differential expression genes in each cluster found that DEGs between healthy control and sepsis patients were significantly enriched in the IL-17 signaling pathway in monocyte, NK, and T cells.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1032,"document":"27114524","golden":false,"offsetInEndSection":1314,"text":"ia. We conclude that IL-17A is a previously unrecognized effector of IL-18-mediated injury in neonatal sepsis and that disruption of the deleterious and tissue-destructive IL-18/IL-1/IL-17A axis represents a novel therapeutic approach to improve outcomes for human neonates with sep","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":351,"document":"32849528","golden":false,"offsetInEndSection":548,"text":"In the current review, we summarize the biological functions of IL-17, including IL-17-mediated responses and signal transduction pathways, with particular emphasis on clinical relevance to sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1604,"document":"24978886","golden":false,"offsetInEndSection":1867,"text":"Altogether, these results suggest that increased activation of the IL-23/IL-17 pathway has detrimental effects on sepsis-induced lung inflammation, whereas activation of the IL-12/interferon-? pathway may lead, in contrast, to less pronounced inflammatory events.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":623,"document":"32617294","golden":true,"offsetInEndSection":903,"text":"Then, inflammatory response, pyroptosis, and regulatory T cells (Tregs)/T-helper 17 (Th17), Th1/Th2, and M1/M2 cell ratios in pneumonia-induced sepsis were evaluated.RESULTS: IL-17 signaling pathway was significantly related to pneumonia-induced sepsis by bioinformatics analysis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":921,"document":"37607110","golden":false,"offsetInEndSection":1084,"text":"h17 cells can secrete IL-17A to activate NLRP3 inflammasome via p38 signaling pathway, which contributes to the development of sepsis-induced acute lung injury.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":960,"document":"38599461","golden":false,"offsetInEndSection":1152,"text":"n summary, this study reveals a new role of circulating MAIT17 in promoting sepsis severity and suggests the phosphoinositide 3-kinase-LDHA signaling as a driving force in MAIT17 responses.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":840,"document":"39106371","golden":false,"offsetInEndSection":955,"text":"I, 3.51-10.31; p \u003c 0.00001; I2 \u003d 92%).CONCLUSION: Conclusions: IL-17 levels were significantly elevated in non-surv","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":922,"document":"38599461","golden":false,"offsetInEndSection":1114,"text":" circulating MAIT17 cells in sepsis. In summary, this study reveals a new role of circulating MAIT17 in promoting sepsis severity and suggests the phosphoinositide 3-kinase-LDHA signaling as a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":920,"document":"20160669","golden":false,"offsetInEndSection":1149,"text":"These data demonstrate that IL-17 does not have a major contribution to the inflammatory pathology leading to organ failure in fungal sepsis and support the concept that the IL-17 pathway is protective in antifungal host defense.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38039751","golden":false,"offsetInEndSection":450,"text":"Sepsis is a multiple dysregulated systemic inflammatory response with high mortality and leads to public concern. This study was designed to identify possible critical pathways associated with sepsis clinical severity and outcome, which offer potential biomarkers and therapeutic targets for sepsis diagnosis and treatment. Single-cell transcriptome profiles of human peripheral blood mononuclear (PBMC) in the healthy control population and sepsis p","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38588614","golden":false,"offsetInEndSection":450,"text":"BACKGROUND: Sepsis-induced acute lung injury (ALI) is associated with considerable morbidity and mortality in critically ill patients. S100A9, a key endothelial injury factor, is markedly upregulated in sepsis-induced ALI; however, its specific mechanism of action has not been fully elucidated.METHODS: The Gene Expression Omnibus database transcriptome data for sepsis-induced ALI were used to screen for key differentially expressed genes (DEGs). ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39617276","golden":false,"offsetInEndSection":450,"text":"OBJECTIVES: The aim is to analyze differentially expressed genes (DEGs) in mice with sepsis-related intestinal mucosal barrier damage and to explore the diagnostic and protective mechanisms of this condition at the transcriptome level.METHODS: Small intestinal tissues from healthy male C57BL/6J mice subjected to Cecal ligation and puncture (CLP) and sham operation were collected. High-throughput sequencing was performed using the paired-end seque","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37839766","golden":false,"offsetInEndSection":450,"text":"BACKGROUND: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS), acting as one common sepsis-associated organ injury, induces uncontrolled and self-amplifies pulmonary inflammation. Given the lack of clinically effective approaches, the mortality rate of it still remains high. Suramin(SUR), as an antiparasitic drug initially, was found to ameliorate sepsis associated ALI in our previous work. However, the underlying mechanism of it","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":770,"document":"32617294","golden":true,"offsetInEndSection":875,"text":"sis were evaluated.RESULTS: IL-17 signaling pathway was significantly related to pneumonia-induced sepsis","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2758,"document":"38588614","golden":false,"offsetInEndSection":2943,"text":"ting LPS-induced apoptosis.CONCLUSIONS: S100A9 as a key biomarker of sepsis-induced acute lung injury, and exacerbates lung damage and epithelial cell apoptosis induced by LPS via the I","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":690,"document":"28793286","golden":false,"offsetInEndSection":764,"text":"al downstream mediators.RESULTS: IL-33 and IL-17 were upregulated in both ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37935545","golden":false,"offsetInEndSection":340,"text":"Objective: To investigate the mechanism of interleukin-6 (IL-6) /signal transducers and activators of transcriptional 3 (STAT3) /helper T cell 17 (Th17) signaling pathway in lung injury of rats with sepsis intervened by forsythia, with a view to provide experimental basis for the role and mechanism of forsythia in the treatment of sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":753,"document":"37708335","golden":false,"offsetInEndSection":998,"text":" male C57/BL6 mice. Subsequently, we examined the fluctuations and repercussions associated with IL-17D in sepsis-induced ALI, probing its interrelation with nuclear factor erythroid 2-related factor 2 (Nrf2), alveolar epithelial permeability, a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":525,"document":"37182383","golden":false,"offsetInEndSection":743,"text":"This review will give an overview of the structure, signaling pathways, and biological functions of IL-17, as well as its role in AKI, to show that IL-17 is a potential target for the prevention and treatment of AKI.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1021,"document":"36684648","golden":false,"offsetInEndSection":1333,"text":"The septic model induced the ileum tissue injury, increased intestinal permeability and TNF-?, IL-17 and IL-6 levels, activated NF-?B and p38 MAPK pathways, promoted the expressions of NF-?B p65 and p38 MAPK and their phosphorylation, while suppressing the levels of IL-13 and intestinal tight junction proteins.","beginSection":"abstract"}],"exact_answer":"","ideal_answer":[],"id":"677eab2c592fa48873000022","type":"yesno","body":"Is IL-17 signaling pathway related to sepsis?"},{"documents":[{"golden":false,"id":"27576954"},{"golden":false,"id":"33619736"},{"golden":false,"id":"26400336"},{"golden":false,"id":"19680195"},{"golden":false,"id":"6498652"},{"golden":false,"id":"23486649"},{"golden":false,"id":"35872729"},{"golden":false,"id":"32617814"},{"golden":true,"id":"34992906"},{"golden":false,"id":"4063639"},{"golden":false,"id":"29682039"},{"golden":false,"id":"24634316"},{"golden":false,"id":"34421586"},{"golden":false,"id":"22426498"},{"golden":false,"id":"25744703"},{"golden":false,"id":"23430103"},{"golden":false,"id":"24297094"},{"golden":false,"id":"21532112"},{"golden":false,"id":"33715413"},{"golden":false,"id":"3566085"},{"golden":false,"id":"31912056"},{"golden":false,"id":"17009823"},{"golden":false,"id":"33024358"},{"golden":false,"id":"532597"},{"golden":false,"id":"15895646"},{"golden":false,"id":"23842576"},{"golden":false,"id":"17732252"},{"golden":false,"id":"8077433"},{"golden":false,"id":"25740689"},{"golden":false,"id":"11341002"},{"golden":false,"id":"34174219"},{"golden":false,"id":"19008014"},{"golden":false,"id":"16443098"},{"golden":false,"id":"20093421"},{"golden":false,"id":"21143899"},{"golden":false,"id":"9164014"},{"golden":false,"id":"30668307"},{"golden":false,"id":"36579117"},{"golden":false,"id":"23776822"},{"golden":false,"id":"1619813"},{"golden":false,"id":"16076511"},{"golden":false,"id":"35640759"},{"golden":false,"id":"18505375"},{"golden":false,"id":"22624830"},{"golden":false,"id":"11344057"},{"golden":false,"id":"24911528"},{"golden":false,"id":"19634836"},{"golden":false,"id":"1621153"},{"golden":false,"id":"32910586"},{"golden":false,"id":"32349057"},{"golden":false,"id":"30596072"},{"golden":false,"id":"11474361"},{"golden":false,"id":"11093326"},{"golden":false,"id":"21810523"},{"golden":false,"id":"12907335"},{"golden":false,"id":"36041113"},{"golden":false,"id":"36525071"},{"golden":false,"id":"28891866"},{"golden":false,"id":"31346556"},{"golden":false,"id":"24718980"},{"golden":false,"id":"35192220"},{"golden":false,"id":"25278178"},{"golden":false,"id":"18264790"},{"golden":false,"id":"21970909"},{"golden":false,"id":"10105993"},{"golden":false,"id":"8657539"},{"golden":false,"id":"25903174"},{"golden":false,"id":"3791736"},{"golden":false,"id":"25363615"},{"golden":false,"id":"31520903"},{"golden":false,"id":"35041540"},{"golden":false,"id":"29900735"},{"golden":false,"id":"25610052"},{"golden":false,"id":"23379972"},{"golden":false,"id":"22940480"},{"golden":false,"id":"31839983"},{"golden":false,"id":"35632961"},{"golden":false,"id":"15930961"},{"golden":false,"id":"2593098"},{"golden":false,"id":"23936176"},{"golden":false,"id":"11436894"},{"golden":false,"id":"11695615"},{"golden":false,"id":"3429809"},{"golden":false,"id":"30598913"},{"golden":false,"id":"15012824"},{"golden":false,"id":"18981949"},{"golden":false,"id":"32342845"},{"golden":false,"id":"32363998"},{"golden":false,"id":"23798274"},{"golden":false,"id":"24420974"},{"golden":false,"id":"34102219"},{"golden":false,"id":"33048275"},{"golden":false,"id":"21499867"},{"golden":false,"id":"32730931"},{"golden":false,"id":"18366716"},{"golden":false,"id":"29538319"},{"golden":false,"id":"36412384"},{"golden":false,"id":"3241897"},{"golden":false,"id":"2205933"},{"golden":false,"id":"12587061"},{"golden":false,"id":"34684088"},{"golden":false,"id":"2710581"},{"golden":false,"id":"1865430"},{"golden":false,"id":"20698467"},{"golden":false,"id":"17390695"},{"golden":false,"id":"27475642"},{"golden":false,"id":"33989258"},{"golden":false,"id":"30730858"},{"golden":false,"id":"17079854"},{"golden":false,"id":"32748311"},{"golden":false,"id":"36205727"},{"golden":false,"id":"25672807"},{"golden":false,"id":"25294026"},{"golden":false,"id":"34790600"},{"golden":false,"id":"8116440"},{"golden":false,"id":"25749616"},{"golden":false,"id":"6355835"},{"golden":false,"id":"27421978"},{"golden":false,"id":"11868990"},{"golden":false,"id":"28913314"},{"golden":false,"id":"10071665"},{"golden":false,"id":"30131650"},{"golden":false,"id":"29588023"},{"golden":false,"id":"29390254"},{"golden":false,"id":"22896024"},{"golden":false,"id":"16881119"},{"golden":false,"id":"17335487"},{"golden":false,"id":"23622003"},{"golden":false,"id":"11257883"},{"golden":false,"id":"21362760"},{"golden":false,"id":"23501945"},{"golden":false,"id":"15949606"},{"golden":false,"id":"2534396"},{"golden":false,"id":"28004298"},{"golden":false,"id":"34545623"},{"golden":false,"id":"28493902"},{"golden":false,"id":"26913635"},{"golden":false,"id":"32754944"},{"golden":false,"id":"29069795"},{"golden":false,"id":"32311251"},{"golden":false,"id":"7897715"},{"golden":false,"id":"1606383"},{"golden":false,"id":"16456756"},{"golden":false,"id":"20384928"},{"golden":false,"id":"35411534"},{"golden":false,"id":"3767633"},{"golden":false,"id":"7572504"},{"golden":false,"id":"18661317"},{"golden":false,"id":"22821421"},{"golden":false,"id":"28253942"},{"golden":false,"id":"26516730"},{"golden":false,"id":"24676845"},{"golden":false,"id":"17934823"},{"golden":false,"id":"14724810"},{"golden":false,"id":"34790606"},{"golden":false,"id":"15729479"},{"golden":false,"id":"8499760"},{"golden":false,"id":"20551857"},{"golden":false,"id":"31280614"},{"golden":true,"id":"39381463"},{"golden":true,"id":"38278209"},{"golden":false,"id":"26509065"},{"golden":false,"id":"25341971"},{"golden":false,"id":"38477782"},{"golden":false,"id":"38171503"},{"golden":false,"id":"16352616"},{"golden":false,"id":"39725805"},{"golden":false,"id":"37998887"},{"golden":false,"id":"11196722"},{"golden":false,"id":"31094843"},{"golden":false,"id":"11513399"},{"golden":false,"id":"29385651"},{"golden":false,"id":"19533408"},{"golden":false,"id":"22512437"},{"golden":false,"id":"10050121"},{"golden":true,"id":"36531425"},{"golden":false,"id":"32031291"},{"golden":false,"id":"12019644"},{"golden":false,"id":"18522980"},{"golden":false,"id":"32300952"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":232,"document":"36531425","golden":true,"offsetInEndSection":500,"text":"We present a 61-year-old man with long-standing AS who presented with anterior and posterior longitudinal ligament rupture and T12 and L1 vertebral endplates fractures (a so called \"chalk-stick fracture\") without reporting any prior trauma and discuss relevant issues.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36531425","golden":true,"offsetInEndSection":74,"text":"Spontaneous Chalk-Stick Fracture in Ankylosing Spondylitis: A Case Report.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":113,"document":"18522980","golden":false,"offsetInEndSection":484,"text":"is care. Ironically, in rare circumstances, long-term, combined anti-remodeling therapy may be associated with skeletal harm.EVIDENCE ACQUISITION: We report atypical skeletal fragility in three subjects after long-term, combined anti-remodeling therapy.EVIDENCE SYNTHESIS: Three subjects experienced spontaneous or minimal-trauma chalk-stick type metadiaphyseal femoral f","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1325,"document":"27576954","golden":false,"offsetInEndSection":1526,"text":"Intravenous bisphosphonate therapy was started in all patients, but discontinued in two patients and reduced in another due to concerns about increasing bone stiffness leading to chalk-stick fractures.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1691,"document":"19680195","golden":false,"offsetInEndSection":1928,"text":"In conclusion, according to our experience, the green-stick fracture for the adaptation of costochondral grafts to the remaining mandibular ramus has presented outstanding results in the surgical treatment of temporomandibular pathology.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":109,"document":"36531425","golden":false,"offsetInEndSection":231,"text":"In long-standing disease, the fused spine of AS patients is susceptible to spinal fractures, even after low impact trauma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"6498652","golden":false,"offsetInEndSection":173,"text":"Fracture of the hook of the hamate most often occurs in athletes in the hand that holds a club, racket, bat or hockey stick, when the end abuts against the palm of the hand.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36531425","golden":false,"offsetInEndSection":108,"text":"Ankylosing spondylitis (AS) is an inflammatory disease affecting mainly the sacroiliac joints and the spine.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32617814","golden":false,"offsetInEndSection":136,"text":"The purpose of this study was to determine the contents of 12 metals in obtainable chalk sticks and assess their associated health risk.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":492,"document":"35872729","golden":false,"offsetInEndSection":781,"text":"The research showed that ice cream sticks which contained 50-80% raw banana powder with 40% sugar and 40?min of baking resulted in a product with the properties of commonly used wooden ice cream sticks, and that the product also had a good appearance along with positive consumer response.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34992906","golden":true,"offsetInEndSection":134,"text":"Acute L1 chalkstick fracture post fall in a patient with known ankylosing spondylitis and previous instrumentation and fusion of T8-L1","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1345,"document":"27576954","golden":false,"offsetInEndSection":1546,"text":"honate therapy was started in all patients, but discontinued in two patients and reduced in another due to concerns about increasing bone stiffness leading to chalk-stick fractures. Given the associati","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":537,"document":"27576954","golden":false,"offsetInEndSection":716,"text":"rity of patients, bone fragility was associated with increased bone mineral density (BMD); however, the full range of phenotypes associated with BMP1 remains unclear. Here, we des","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":911,"document":"4063639","golden":false,"offsetInEndSection":1035,"text":"tudy confirms that cervical fracture with neurological complications may follow minor trauma in ankylosing spondylitis. The ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":435,"document":"29682039","golden":false,"offsetInEndSection":518,"text":"final diagnosis was chalkstick fracture of spine with complete cord transaction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":114,"document":"18522980","golden":false,"offsetInEndSection":232,"text":"s care. Ironically, in rare circumstances, long-term, combined anti-remodeling therapy may be associated with skeletal","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":161,"document":"27576954","golden":false,"offsetInEndSection":364,"text":"osomal recessive mutations in a number of genes have also been described, including the BMP1 gene that encodes the mammalian Tolloid (mTLD) and its shorter isoform bone morphogenic protein-1 (BMP1). To d","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"29682039","golden":false,"offsetInEndSection":43,"text":"Chalkstick Fracture: A Catastrophic Injury.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27576954","golden":false,"offsetInEndSection":158,"text":"Osteogenesis Imperfecta (OI) is an inherited bone fragility disorder most commonly associated with autosomal dominant mutations in the type I collagen genes. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24634316","golden":false,"offsetInEndSection":93,"text":"INTRODUCTION: In this study we evaluated fracture risk in patients with Charcot-Marie-Tooth (","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1462,"document":"34421586","golden":false,"offsetInEndSection":1802,"text":"9-1.88). Stratified analysis revealed that high-dose ADT results in an elevated risk of fracture with little statistical heterogeneity, whereas sensitivity analysis restricted to adjust for additional factors indicated increased fracture risks for patients with unknown stage prostate cancer or with no restriction on age with minimal heter","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"24634316","golden":false,"offsetInEndSection":61,"text":"Risk of fracture in patients with Charcot-Marie-Tooth disease","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1912,"document":"34421586","golden":false,"offsetInEndSection":2135,"text":"tion. Conclusion: Cumulative evidence supports the association of elevated fracture risk with ADT among patients with prostate cancer, including those with different disease conditions, treatment regimens, dose levels, and ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1179,"document":"22426498","golden":false,"offsetInEndSection":1438,"text":".1; P\u003c0.001). Co-morbidities that contributed most to fracture prediction in a Cox regression model with FRAX risk factors as additional predictors were: Parkinson\u0027s disease, multiple sclerosis, chronic obstructive pulmonary disease, osteoarthritis, and heart","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1535,"document":"25744703","golden":false,"offsetInEndSection":1748,"text":"cuss the updated epidemiology of fractures in CKD, fracture risk screening by DXA, and the utility of state-of-the art imaging methods to uncover the effects of kidney disease on the skeleton.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":103,"document":"23430103","golden":false,"offsetInEndSection":393,"text":"tients. This study showed that fracture risk assessment may be indicated among patients with PD, in particular when they have recently used selective serotonin re-uptake inhibitors or high-dose antipsychotics, or have a history of fracture, falling, low body mass index (BMI) or renal disea","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":898,"document":"22426498","golden":false,"offsetInEndSection":1044,"text":"nt fracture over 2 years. All recorded co-morbidities were significantly associated with fracture, except for high cholesterol, hypertension, celi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1855,"document":"24297094","golden":false,"offsetInEndSection":1969,"text":"d to controls. GC use in the previous 6 months and longer disease duration are associated with the increased fract","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":144,"document":"21532112","golden":false,"offsetInEndSection":227,"text":"t is well known that increased fracture risk is observed in serious kidney disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23842576","golden":false,"offsetInEndSection":134,"text":"We present a case of percutaneous fixation of a \"carrot-stick\" spinal fracture in an elderly patient with ankylosing spondylitis (AS).","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"23842576","golden":false,"offsetInEndSection":137,"text":"CT- and fluoroscopy-guided percutaneous screw fixation of a \"carrot-stick\" spinal fracture in an elderly man with ankylosing spondylitis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"16443098","golden":false,"offsetInEndSection":255,"text":"PURPOSE: In contrast to isolated diaphyseal fractures of the ulna (so-called night-stick fractures), isolated fractures of the radial diaphysis generally are expected to have associated injury of the distal radioulnar joint (DRUJ), the so-called Galeazzi ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17732252","golden":false,"offsetInEndSection":208,"text":"Stick-slip, or interrupted, motion rather than smooth uninterrupted motion occurs in many different phenomena such as friction, fluid flow, material fracture and wear, sound generation, and sensory \"texture.\"","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1502,"document":"20093421","golden":false,"offsetInEndSection":1845,"text":"crosse (42%) and men\u0027s ice hockey (35.8%) (P \u003c.001). Thumb fractures and contusions were each also found to be significantly more prevalent (P \u003c.001) when compared with women\u0027s lacrosse and men\u0027s ice hockey.CONCLUSION: Men\u0027s intercollegiate lacrosse requires the use of gloves; nonetheless, injury rates of the thumb are significantly elevated","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":135,"document":"23842576","golden":false,"offsetInEndSection":220,"text":"A surgical stabilization was not possible in this 83-year-old man with comorbidities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":707,"document":"23842576","golden":false,"offsetInEndSection":881,"text":"CT- and fluoroscopy-guided percutaneous screw fixation of spinal fractures could potentially be an alternative to surgery in elderly AS patients with poor performance status.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":221,"document":"23842576","golden":false,"offsetInEndSection":396,"text":"Under local anesthesia, percutaneous screw fixation of a transdiscal shear fracture at the level T10-T11 was performed using computed tomography (CT) and fluoroscopy guidance.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":656,"document":"11341002","golden":false,"offsetInEndSection":838,"text":"The mobility properties of the FBAs were examined in percolation experiments through a column filled with a mixture of crushed chalk and common fracture filling and coating material.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":437,"document":"8077433","golden":false,"offsetInEndSection":534,"text":"The series included 19 buckle fractures of the radius, 11 green-stick, and 10 complete fractures.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":989,"document":"8077433","golden":false,"offsetInEndSection":1074,"text":"Five of the nine cases with radial overgrowth had an associated fracture of the ulna.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":511,"document":"1619813","golden":false,"offsetInEndSection":665,"text":"75-year-old man treated for senile dementia was clubbed with a walking stick by the other patient treated for same disease and he died of traumatic shock.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1156,"document":"8077433","golden":false,"offsetInEndSection":1305,"text":"These observations allow us to reconsider the classic etiopathogenic theories concerning overgrowth in the long bones of children following fracture.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":535,"document":"8077433","golden":false,"offsetInEndSection":583,"text":"Fracture of the ulna was associated in 11 cases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":387,"document":"30668307","golden":false,"offsetInEndSection":509,"text":"upon a clear acrylic glass base. Finally, the model was covered by a visually opaque polyurethane foam cover with chalk st","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1306,"document":"8077433","golden":false,"offsetInEndSection":1515,"text":"Factors other than the increased vascularity of the growth plate--as is postulated for the femur and tibia--must be investigated further to explain the frequent absence of radial overgrowth following fracture.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1075,"document":"8077433","golden":false,"offsetInEndSection":1155,"text":"This association was not found in any of the 10 patients with radial shortening.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"18505375","golden":false,"offsetInEndSection":206,"text":"In 2003, we reported on a 12-yr-old boy who had developed osteopetrosis (OPT) while receiving pamidronate (PMD) for idiopathic bone pain and enigmatic elevation in circulating bone alkaline phosphatase. Now","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":414,"document":"18505375","golden":false,"offsetInEndSection":618,"text":"phs documented interval fractures of a metacarpal, an osteosclerotic distal radius, and a dense diaphyseal segment of an ulna where a \"chalkstick\" break remained incompletely healed after 2 yr. There was ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1773,"document":"18505375","golden":false,"offsetInEndSection":1935,"text":"city during childhood can impair skeletal modeling and remodeling with structural changes that evolve and carry into adult life.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"18505375","golden":false,"offsetInEndSection":149,"text":"Bisphosphonate-induced osteopetrosis: novel bone modeling defects, metaphyseal osteopenia, and osteosclerosis fractures after drug exposure ceases.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":947,"document":"18505375","golden":false,"offsetInEndSection":1105,"text":" bone was unexpectedly osteopenic, especially in his distal femurs where cortices were thin and a paucity of trabeculae was documented by CT. Femoral necks ha","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":844,"document":"18505375","golden":false,"offsetInEndSection":945,"text":"osclerosis had remodeled imperfectly to become focal areas of dense, diaphyseal bone. Newer metaphyse","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1254,"document":"18505375","golden":false,"offsetInEndSection":1382,"text":" were thin, and trabecular osteopenia was present central and peripheral to the bands of osteosclerosis. BMD Z-scores assessed b","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1615,"document":"18505375","golden":false,"offsetInEndSection":1771,"text":"rphic, round cells without polarization and off of bone surfaces were now unremarkable in number, location, and appearance. In conclusion, bisphosphonate to","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":621,"document":"18505375","golden":false,"offsetInEndSection":716,"text":" L(4) spondylolysis, and previous L(5) spondylolysis had caused spondylolisthesis. Modeling dis","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":348,"document":"18505375","golden":false,"offsetInEndSection":412,"text":"wth plates were fused, yet hyperphosphatasemia persisted. Radiog","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"22624830","golden":false,"offsetInEndSection":128,"text":"Isolated extrahepatic bile duct rupture: a rare consequence of blunt abdominal trauma. Case report and review of the literature.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"11093326","golden":false,"offsetInEndSection":701,"text":"STUDY DESIGN: A case report of pyogenic vertebral osteomyelitis (PVO) presenting as single collapsed vertebral body without narrowing of the intervertebral disc space, and review of the literature.OBJECTIVE: To describe an unusual case of PVO showing atypical radiological change and call attention to this condition so that others may avoid this diagnostic pitfall.SETTING: Japan.METHODS: A 62-year-old diabetic woman with suspected T12 pathological fracture of malignant spinal tumor and neurological involvement received urgent anterior decompression and spinal reconstruction without biopsy.RESULTS: Anterior decompression and spinal reconstruction was performed, but histological examination of t","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":132,"document":"22624830","golden":false,"offsetInEndSection":300,"text":"Posterior osteosynthesis in T10-L1 with laminectomy in T10-T12 and posterolateral arthrodesis in T11-T12 was performed because of a dorsal traumatic vertebral fracture.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24911528","golden":false,"offsetInEndSection":150,"text":"We report two cases of spine injury following a low-energy trauma in persons with ankylosing spondylitis (AS) and discuss the forensic considerations.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":53,"document":"22624830","golden":false,"offsetInEndSection":131,"text":"Clinically, a severe motor impairment with paraesthesia of the legs was found.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":735,"document":"22624830","golden":false,"offsetInEndSection":841,"text":"On arrival at our institution 13?days after injury, the patient was operated on for a biliary peritonitis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":284,"document":"19634836","golden":false,"offsetInEndSection":438,"text":"Subtalar dislocation is commonly accompanied by fractures of the malleoli, talus, or fifth metatarsal and by a rotational component of the subtalar joint.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":118,"document":"11344057","golden":false,"offsetInEndSection":247,"text":"Correct identification and assessment of the weakest parts of the cancellous bone may lead to better prediction of fracture risk.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32910586","golden":false,"offsetInEndSection":211,"text":"CASE: A 54-year-old patient presented with low-velocity hyperflexion knee trauma while falling at a ski lift with anterior cruciate ligament (ACL) rupture and avulsion fractures of both posterior meniscal attach","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"22624830","golden":false,"offsetInEndSection":52,"text":" A 16-year-old girl suffered blunt abdominal trauma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1079,"document":"21810523","golden":false,"offsetInEndSection":1304,"text":"le evidence to correlate other measures of disease such as DAS (disease activity score), VAS (visual analogue scale), acute phase reactants, use of non-glucocorticoid medications and increased fracture risk. We concluded that","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":253,"document":"12907335","golden":false,"offsetInEndSection":398,"text":"ntions. Corticosteroid use has been considered in other diseases to be a risk for fracture, although not all studies in IBD are concordant on thi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1038,"document":"36041113","golden":false,"offsetInEndSection":1181,"text":"accompanied ocular disease was traumatic hyphema and traumatic iridocyclitis (36.84%) in the baseball blowout fracture group. in contrast, subc","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":366,"document":"36525071","golden":false,"offsetInEndSection":457,"text":"ODUCTION: Primary hyperparathyroidism (PHPT) is associated with an increase in the risk of ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28891866","golden":false,"offsetInEndSection":240,"text":"It has been proposed that complex regional pain syndrome (CRPS) is a posttraumatic autoimmune disease, and we previously observed that B cells are required for the full expression of CRPS-like changes in a mouse tibia fracture CRPS model. T","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":231,"document":"31346556","golden":false,"offsetInEndSection":380,"text":"ers such as patient sex, age, body mass index, blood glucose status, fall risk, and diabetes medications may influence the fracture risk. Different u","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":743,"document":"31346556","golden":false,"offsetInEndSection":982,"text":"sease in patients with diabetes is a challenge as current methods for fracture prediction such as bone mineral density T-score and fracture risk assessment tools underestimate fracture risk for patients with T1D and T2D. This review focuse","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":342,"document":"21810523","golden":false,"offsetInEndSection":522,"text":"ewed the literature to determine if specific disease parameters or medication use could be used to better characterize fracture risk in individuals with rheumatoid arthritis. Altho","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1499,"document":"24718980","golden":false,"offsetInEndSection":1777,"text":"ation with either a disease duration longer than 5 years or bilateral walking aids or previous osteoporotic fracture should be used as red flags in PD patients to prompt clinicians to perform a FRAX fracture risk assessment in the neurology clinic.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":124,"document":"35192220","golden":false,"offsetInEndSection":275,"text":" disease. The primary aim was to evaluate fracture incidence in a contemporary population-based cohort of patients having surgery for primary hyperpara","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1179,"document":"25278178","golden":false,"offsetInEndSection":1432,"text":"It was suggested that chalk PM2.5 could make oxidative damages on AMs and result in cytotoxicity, being likely attributed to excessive reactive oxygen species or reactive nitrogen species induced by mixture of fine gypsum and calcite/dolomite particles.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1371,"document":"18264790","golden":false,"offsetInEndSection":1660,"text":"Scanning electron microscope images revealed that chalk particles had random shape, although in dusting chalks prevalence of elongated particles was observed, apparently due to the longitudinal breaking of the chalks during writing, which was confirmed during compressive strength testing.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":828,"document":"25278178","golden":false,"offsetInEndSection":1100,"text":"Exposure to chalk PM2.5 at 100 ?g mL(-1) or 300 ?g mL(-1) significantly increased intracellular catalase, malondialdehyde, and NO levels and decreased superoxide dismutase level in AMs, leading to leakage of lactate dehydrogenase (LDH) and reduction of the cell viability.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":115,"document":"3791736","golden":false,"offsetInEndSection":377,"text":"Investigations into the pathomechanics of these injuries highlight the problems of arthritis, pain, swelling, weakness, limited range of motion and instability associated with nonanatomic reduction of both intraarticular fragments and their associated ligaments.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25278178","golden":false,"offsetInEndSection":177,"text":"The aim of the study is to investigate chemical compositions of fine chalk dust particles (chalk PM2.5) and examine their adverse effects on alveolar macrophages (AMs) in vitro.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1069,"document":"25903174","golden":false,"offsetInEndSection":1391,"text":"This hypothesis was confirmed by the fact that chalk PM(coarse) resulted in a significant decrease of intracellular SOD, GSH, ACP, and ATPase levels and a notable increase of intracellular CAT, MDA content, and extracellular NO level, consequently leading to a decrease of the cell viability and a increase of LDH release.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21970909","golden":false,"offsetInEndSection":126,"text":"Severe osteoporosis is characterized by a densitometry T-score lower than 2.5 associated with one or more fragility fractures.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"25278178","golden":false,"offsetInEndSection":114,"text":"Investigation of fine chalk dust particles\u0027 chemical compositions and toxicities on alveolar macrophages in vitro.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":691,"document":"25278178","golden":false,"offsetInEndSection":827,"text":"The results showed that fine chalk particles were mainly composed of gypsum, calcite, dolomite and a little amount of organic adhesives.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":352,"document":"25278178","golden":false,"offsetInEndSection":612,"text":"The oxidative response of AMs and the potential to generate nitric oxide (NO) by luminol-dependent chemiluminescence (CL) and nitrate reductase method were assessed 4h following the treatment of AMs with differing dosages of fine chalk particles, respectively.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35041540","golden":false,"offsetInEndSection":265,"text":"INTRODUCTION: The coracoid process is an important anatomical structure of the scapula, which can be used as a landmark in the diagnosis and treatment of scapula related diseases, such as acromioclavicular joint dislocation, anterior shoulder instability, and corac","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1496,"document":"35041540","golden":false,"offsetInEndSection":1843,"text":"d into five types based on obvious morphological features. Knowing of morphological classification and anatomical parameters of different types of the coracoid process, to some extent, may be helpful to diagnose and treat the shoulder joint disease, such as acromioclavicular joint dislocation, anterior shoulder instability, and coracoid fracture","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25610052","golden":false,"offsetInEndSection":168,"text":"The aim of this case report is to demonstrate that blow-out fractures can occur not only by a classical trauma mechanism but also from the consequences of a stick beat.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"25610052","golden":false,"offsetInEndSection":44,"text":"Blow-Out Fracture due to a Hazel Stick Beat.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23379972","golden":false,"offsetInEndSection":225,"text":"Tracer experiments were carried out in a naturally discrete-fractured chalk core with solute tracers Li(+) and Br(-), and colloidal tracers of two origins-bacteriophages (MS2, ?X174 and T4) and fluorescent latex microspheres.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":266,"document":"35041540","golden":false,"offsetInEndSection":577,"text":"id fractures. The aim of this study was to classify the coracoid process according to morphology and to measure the morphological parameters of the coracoid process.MATERIALS AND METHODS: A total of 377 dry and intact scapulae were collected and classified in terms of the connection between the shape of coraco","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1109,"document":"35041540","golden":false,"offsetInEndSection":1495,"text":" Type III (29%) were more prevalent in China. The tip width of the coracoid process of Type IV was the shortest and significantly different compared to the other types (p \u003c.05), contrary to the longest in Type V. The tip thickness of the coracoid process of Type I was the shortest and significantly different from the other types (p \u003c.05).CONCLUSIONS: The coracoid process was classifi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1437,"document":"22940480","golden":false,"offsetInEndSection":1597,"text":"Imbibition to the chalk matrix (and therefore filtration) will occur where fluid pressure gradients are highest, for instance around disconnected fracture tips.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1047,"document":"35041540","golden":false,"offsetInEndSection":1108,"text":"V, Water drop shape, and Type V, Wedge shape. Type I (30%) an","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":768,"document":"35041540","golden":false,"offsetInEndSection":1046,"text":" researchers with a digital caliper. The measurements were averaged and recorded.RESULTS: Based on obvious morphological features, five specific types of the coracoid process were described: Type I, Vertical 8-shape; Type II, Long stick shape; Type III, Short stick shape; Type ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":385,"document":"11436894","golden":false,"offsetInEndSection":507,"text":"The objective of this paper is to document a rare type of posterior pelvis trauma: the green-stick fracture of the sacrum.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":171,"document":"3429809","golden":false,"offsetInEndSection":356,"text":"The purpose of this article is to document one case of a finger fracture and another of a nasal fracture caused by an impact injury from lacrosse sticks in women field-lacrosse players.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"11436894","golden":false,"offsetInEndSection":109,"text":"Description of a rare type of posterior pelvis traumatic involvement: the green-stick fracture of the sarcum.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":823,"document":"25610052","golden":false,"offsetInEndSection":948,"text":"We conclude that a blow-out fracture may occur in patients who experience orbital trauma, even in cases of low-energy trauma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"15012824","golden":false,"offsetInEndSection":311,"text":"AIM: To investigate the factors governing the adhesion and activity of the 2,4,6-tribromophenol (TBP) degrading bacterium Achromobacter piechaudii TBPZ-N61 on chalk from a contaminated aquifer.METHODS AND RESULTS: Adhesion kinetics of TBPZ-N61 to grey and white chalk from a polluted fractured chalk aquifer was","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":949,"document":"25610052","golden":false,"offsetInEndSection":1021,"text":"These patients may be symptomatic after an episode of hard nose-blowing.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":558,"document":"25610052","golden":false,"offsetInEndSection":748,"text":"Using computed tomography (CT), the intraorbital air density in the soft tissues and the right maxillary sinus wall fracture possessing fluid density compatible with hemorrhage was observed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32363998","golden":false,"offsetInEndSection":242,"text":"OBJECTIVE: Alkaline phosphatase (ALP) is used as a biomarker to monitor the chronic kidney disease-mineral bone disorder (CKD-MBD) and high levels of parathyroid hormone (PTH) that were reported to be related to increased mortality in CKD pat","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":827,"document":"23798274","golden":false,"offsetInEndSection":968,"text":"racture history, self-reported rheumatoid arthritis, and menopause age \u003c40 were significantly associated with subsequent fractures. A logisti","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":139,"document":"24420974","golden":false,"offsetInEndSection":287,"text":"diabetes. We investigated FRAX-estimated fracture risk in patients with type 2 diabetes mellitus (DM), compared with concomitantly enrolled control ","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"24420974","golden":false,"offsetInEndSection":134,"text":"Assessment of fracture risk by the FRAX algorithm in men and women with and without type 2 diabetes mellitus: a cross-sectional study.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34102219","golden":false,"offsetInEndSection":122,"text":"Patients with chronic kidney disease (CKD) have an increased fracture risk because of impaired bone quality and quantity. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33048275","golden":false,"offsetInEndSection":124,"text":"PURPOSE OF REVIEW: Both diabetes and kidney disease associate with the development of bone disease and an increased risk of ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21499867","golden":false,"offsetInEndSection":282,"text":"Disorders of bone and mineral metabolism are common complications in chronic kidney disease (CKD) patients and lead to significantly increased fracture risk, morbidity, and mortality of cardiovascular disease due to ectopic calcifications, contributing to a worsening prognosis. Bon","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32730931","golden":false,"offsetInEndSection":162,"text":"BACKGROUND: Major fractures (MF) are associated with increased mortality in the general population and represent an even higher risk in patients with chronic kidn","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1048,"document":"18366716","golden":false,"offsetInEndSection":1230,"text":"y variable significantly associated with the perception that the fracture was related to osteoporosis was self-reported osteoporosis diagnosis (39.83 [8.15;194.71], p\u003c0.001).CONCLUSI","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":998,"document":"29538319","golden":false,"offsetInEndSection":1194,"text":" and the coeliac disease controls with fractures reported more severe reflux symptoms compared to those without, and they also more frequently used proton-pump inhibitor medication. To conclude, t","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":472,"document":"26784239","golden":false,"offsetInEndSection":574,"text":"They are victims of turbines, human encroachment, pesticides, and, most recently, white nose syndrome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":279,"document":"26612746","golden":false,"offsetInEndSection":617,"text":"Many of the conditions that afflict neonatal foals are highly amenable to sonographic interrogation, including pneumonia and other changes in the lungs associated with sepsis, systemic inflammatory response syndrome, multiple organ dysfunction, and prematurity; colic arising from medical and surgical causes; and urinary tract disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23885030","golden":false,"offsetInEndSection":111,"text":"Haemophilus parasuis causes Gl?sser\u0027s disease, a syndrome of polyserositis, meningitis, and arthritis in swine.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":507,"document":"21084464","golden":false,"offsetInEndSection":586,"text":"The latter virus has recently been associated with the childhood disease croup.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"20409366","golden":false,"offsetInEndSection":105,"text":"Tropheryma whipplei, which causes Whipple disease, is found in human feces and may cause gastroenteritis.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"32300952","golden":false,"offsetInEndSection":146,"text":"Delayed presentation of urinoma mimicking spondylodiscitis secondary to ureteric injury following carrot stick fracture in ankylosing spondylitis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":746,"document":"32300952","golden":false,"offsetInEndSection":1235,"text":"sing suspicion of a ureteric injury. Plain computerized tomography revealed a three-column fracture at L4, and a ureteric leak into the psoas collection with proximal hydronephrosis was seen after contrast administration, establishing the presence of a ureteric fistula resulting in urinoma.RESULTS: Following initial symptomatic improvement after ureteric stenting, the patient succumbed to urosepsis at 3?months.CONCLUSION: We report for the first time a post-traumatic urinoma secondary","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"1865430","golden":false,"offsetInEndSection":60,"text":"Patients with ankylosing spondylitis are prone to fractures.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1236,"document":"32300952","golden":false,"offsetInEndSection":1428,"text":"to ureteric injury clinically mimicking spondylodiscitis. Clinicians need to be aware of the possibility of ureteric injury in hyperextension lumbar fractures occurring in ankylosing spondylit","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":300,"document":"32300952","golden":false,"offsetInEndSection":406,"text":"micking spondylodiscitis clinically. Plain radiograph showed features of ankylosing spondylitis with a sus","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"3241897","golden":false,"offsetInEndSection":128,"text":"[Fracture dislocation of the thoracic spine in ankylosing spondylitis. A case of spontaneous occurrence and an uncommon course].","beginSection":"title"},{"endSection":"title","offsetInBeginSection":0,"document":"2205933","golden":false,"offsetInEndSection":98,"text":"Odontoid fracture complicating ankylosing spondylitis. A case report and review of the literature.","beginSection":"title"},{"endSection":"title","offsetInBeginSection":0,"document":"36412384","golden":false,"offsetInEndSection":145,"text":"Cervical Spine Fracture with Extreme Dislocation in a Patient with Ankylosing Spondylitis: A Case Report and Systematic Review of the Literature.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34684088","golden":false,"offsetInEndSection":182,"text":"Factures in ankylosing spondylitis (AS) patients tend to occur due to the absence of motion between vertebrae, poor bone quality, and a long lever arm that generates extension force.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":94,"document":"32300952","golden":false,"offsetInEndSection":299,"text":"less than 1%. Missed injuries can lead to urinoma collection, urosepsis and even death.MATERIALS AND METHODS: A 75-year-old man presented 1?month following fall with high-grade fever and severe back pain m","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1293,"document":"27475642","golden":false,"offsetInEndSection":1649,"text":"ed.RESULTS: Using data from 12?months before fracture, factors significantly associated with imminent risk for fracture were previous falls, older age, poorer health status, specific comorbidities (psychosis, Alzheimer\u0027s disease, central nervous system disease), and other fall risk factors (wheelchair use, psychoactive medication use, mobility impairment","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":187,"document":"33989258","golden":false,"offsetInEndSection":358,"text":"f further study.RECENT FINDINGS: Evidence in type 1 diabetes (T1D) demonstrates that low bone mineral density (BMD) is associated with microvascular complications and link","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1118,"document":"30730858","golden":false,"offsetInEndSection":1221,"text":"Inflammatory bowel disease was also associated with any fracture (IBD: HR \u003d 1.18; 95% CI \u003d 1.15-1.20). ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":643,"document":"17079854","golden":false,"offsetInEndSection":875,"text":"ture in patients with rheumatoid arthritis (RA), one of the disease representing GIO, is observed in all of the body, including long bone and periarticular bone in addition to the site of fracture observed in GIO. The risk of fractu","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":909,"document":"32748311","golden":false,"offsetInEndSection":1130,"text":"rts.RESULTS: Celiac disease (N?\u003d?693) was associated with increased fracture risk adjusted for FRAX score computed without secondary osteoporosis or BMD (adjusted hazard ratio [HR] 1.43, 95% confidence interval [CI] 1.11-","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":275,"document":"36205727","golden":false,"offsetInEndSection":361,"text":"TION: Parkinson\u0027s disease (PD) is reported to be associated with a high risk of fractu","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":190,"document":"25672807","golden":false,"offsetInEndSection":358,"text":" disease. In the nested cohort study, Parkinson\u0027s disease was associated with pneumonia, septicemia, stroke, urinary tract infection, and mortality after fracture admis","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":778,"document":"33989258","golden":false,"offsetInEndSection":884,"text":"independent of falls.In the other hand, individuals with type 2 diabetes (T2D) have increased fracture ris","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1649,"document":"30730858","golden":false,"offsetInEndSection":1830,"text":"nflammatory bowel disease (CD and UC) is associated with an increased risk of hip fracture and any fracture, but not in individuals without a history of corticosteroid treatment. Th","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":359,"document":"25294026","golden":false,"offsetInEndSection":560,"text":"ctivity.INTRODUCTION: Although rheumatoid arthritis (RA) is a risk factor for osteoporosis and fractures, few studies have described the association between disease activity and the fracture incidence ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":388,"document":"34790600","golden":false,"offsetInEndSection":673,"text":"tter outcome. The purpose of the study was to present a case of bilateral traumatic isolated ulna fracture and its management.CASE REPORT: A 33-year-old male presented to the emergency department with complaints of pain and swelling over the dorsum of both forearms with a history of a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":160,"document":"10071665","golden":false,"offsetInEndSection":745,"text":"well known. The ingestion of kaolin, also known as white dirt, chalk, or white clay, is a relatively common type of pica found in the central Georgia Piedmont area.METHODS: We reviewed the literature, made informal contacts with Georgia physicians, and arranged semistructured interviews with 21 individuals with a history of chalk eating; we gathered both quantitative and qualitative information.RESULTS: Kaolin ingestion appears to be a culturally-transmitted form of pica, not selectively associated with other psychopathology.CONCLUSION: Kaolin ingestion appears to meet the DSM-I","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34790600","golden":false,"offsetInEndSection":102,"text":"Bilateral Traumatic Nightstick Fracture of the Ulna - A Rare Case Report and Review of the Literature.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"8116440","golden":false,"offsetInEndSection":160,"text":"Radiotherapy and chemotherapy will result in an increase in the number of pathological fractures that occur, principally as a consequence of metastatic disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":397,"document":"30131650","golden":false,"offsetInEndSection":623,"text":"We herewith present a case of a 12-year-old boy who presented with a stick lodged in the root canal of maxillary right lateral incisor along with the displaced fractured tooth segment at the apex and the associated management.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1228,"document":"34790600","golden":false,"offsetInEndSection":1552,"text":"locking compression plate. At present, 1-year follow-up, the patient is having complete wrist, elbow ROM and supination, pronation without any pain.CONCLUSION: Bilateral traumatic Nightstick fractures of the ulna are rare and this is the first reported case of traumatic bilateral isolated ulna fracture according to author\u0027","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34790600","golden":false,"offsetInEndSection":144,"text":"INTRODUCTION: Unilateral isolated ulna fracture secondary to trauma are common but the bilateral nightstick fractures are quite rare in the clin","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1773,"document":"34790600","golden":false,"offsetInEndSection":1910,"text":"omplications and secondary procedures. This case is unique as it helps in identifying the mode of trauma in medico legal cases like assau","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1216,"document":"25749616","golden":false,"offsetInEndSection":1441,"text":"Although two US evaluations showed good agreements at all three sites, US findings obtained by the hockey-stick probe showed closer agreement with intraoperative findings for both lateral nasal wall and midline of nasal bone.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":840,"document":"34790600","golden":false,"offsetInEndSection":915,"text":"d injury to both forearms. On examination, the patient had bilateral forear","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"29390254","golden":false,"offsetInEndSection":125,"text":"BACKGROUND: Ankylosing spondylitis (AS) is an inflammatory rheumatic disease and strongly associated with an increased risk o","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1484,"document":"22896024","golden":false,"offsetInEndSection":1650,"text":" are common but are often not diagnosed. VF are associated with advanced age, longstanding disease, impaired back mobility, syndesmophyte formation, and lower BMD in ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":949,"document":"29390254","golden":false,"offsetInEndSection":1466,"text":"s were involved in our study. The results of meta-analysis revealed that AS was strongly associated with the risk of vertebral fracture (odds ratio [OR] \u003d 4.25, 95% confidence interval [CI] \u003d 1.07-7.42) and was not significantly associated with the risk of any fracture (OR\u003d2.00, 95%CI \u003d 0.94-3.06) or hip fracture (OR\u003d1.28, 95%CI \u003d0.16-2.40).CONCLUSION: In the present study, a general knowledge of the association between AS and the risk of 3 kinds of fractures were presented, which could improve the ways of preve","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"29390254","golden":false,"offsetInEndSection":112,"text":"The association between ankylosing spondylitis and the risk of any, hip, or vertebral fracture: A meta-analysis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":489,"document":"29390254","golden":false,"offsetInEndSection":686,"text":" to August 15, 2016. Studies were evaluated by 2 independent reviewers and quantitative estimates regarding the association between ankylosing spondylitis and the risk of any, hip, or vertebral fra","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1135,"document":"21362760","golden":false,"offsetInEndSection":1789,"text":"d were mild (n \u003d 79; 64.8%). In logistic regression analysis, age (odds ratio per year 1.05, 95% CI 1.03-1.08, p \u003c 0.001), disease duration (OR per year 1.03, 95% CI 1.01-1.06, p \u003d 0.011), Bath Ankylosing Spondylitis Functional Index score (OR per score 1.16, 95% CI 1.03-1.30, p \u003d 0.015), Bath Ankylosing Spondylitis Radiographic Index-TS (OR per score 1.25, 95% CI 1.12-1.39, p \u003c 0.001), and wall-occiput distance (OR per cm 1.15, 95% CI 1.08-1.23, p \u003c 0.001) were all associated with prevalent fracture.CONCLUSION: Semiquantitative methods are needed to improve the diagnosis of vertebral fractures in AS in order to start early treatment and to avoid","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":621,"document":"17335487","golden":false,"offsetInEndSection":854,"text":"This conclusion was confirmed by a model adapted to simulate experimental data collected from a tracer test performed in a vertical, large-diameter (25-cm) borehole drilled along a subvertical fracture intersecting a chalk formation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":126,"document":"29390254","golden":false,"offsetInEndSection":488,"text":" fractures. A great proportion of patients with AS are suffering from sustaining fractures and the aim of this study is to evaluate and quantify the association between the site of the fracture and AS by performing a meta-analysis.METHODS: A systematic literature search was performed on Medline database from 1966 to August 15, 2016 and Embase database from 198","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":315,"document":"23622003","golden":false,"offsetInEndSection":558,"text":"t-free chalk containing casein. To study the relationship of dust-free chalk containing casein with asthma and rhinoconjunctivitis, 13 additional milk allergic patients were studied: 3 school-aged children, 8 preschool-aged infants, and 2 chil","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":687,"document":"29390254","golden":false,"offsetInEndSection":831,"text":"ture were presented. After the heterogeneity of selected studies was assessed by using Cochran I statistics, the random effect model was used to","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":363,"document":"28004298","golden":false,"offsetInEndSection":602,"text":"e main objectives were to explore associations between self-perceived 10-year fracture risks of women with osteoporosis (OP) and their risks calculated by the FRAX? algorithm and to identify determinants of the underestimation of risk.METH","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34545623","golden":false,"offsetInEndSection":163,"text":"Circular RNA MTO1 intercorrelates with microRNA-630, both associate with Enneking stage and/or pathological fracture as well as prognosis in osteosarcoma patients.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28493902","golden":false,"offsetInEndSection":178,"text":"INTRODUCTION: Mounting evidence indicates that a disturbed Wnt-?-catenin signaling may be involved in the pathogenesis of chronic kidney disease-mineral and bone and mineral diso","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1506,"document":"26913635","golden":false,"offsetInEndSection":1574,"text":"l, 1.28?2.05; P \u003c .001) for studies that reported HR.CONCLUSIONS: Hy","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1736,"document":"32754944","golden":false,"offsetInEndSection":1911,"text":"t hip and spine fracture, rheumatoid arthritis, and diabetes were associated with incident hip fracture. The presence of emphysema, 6-min walk distance, and total number of ex","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28004298","golden":false,"offsetInEndSection":117,"text":"In this study, we compared subjective fracture risks of Hungarian women with osteoporosis to FRAX?-based estimates. P","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":55,"document":"26913635","golden":false,"offsetInEndSection":129,"text":"sorder. Recent research shows that it may associate with osteoporosis and ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32754944","golden":false,"offsetInEndSection":179,"text":"Hip fractures are associated with significant morbidity and mortality in smokers with lung disease, but whether lung-specific factors are associated with fracture risk is unknown.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"29069795","golden":false,"offsetInEndSection":256,"text":"Genome-wide association studies have identified that the gene variants in Wnt signaling associate with bone mineral density and fracture risk but the effects of the variants on the development of osteonecrosis of the femoral head (ONFH) have been unclear. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32311251","golden":false,"offsetInEndSection":102,"text":"Aims To investigate whether pathological fractures impact on osteosarcoma patient prognosis in Ireland","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"7897715","golden":false,"offsetInEndSection":68,"text":"Fracture of the odontoid peg in ankylosing spondylitis: case report.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"7897715","golden":false,"offsetInEndSection":90,"text":"Fractures in patients with ankylosing spondylitis tend to affect the lower cervical spine.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"16456756","golden":false,"offsetInEndSection":107,"text":"[Posttraumatic Chance fracture of the cervical spine in a case with ankylosing spondylitis: a case report].","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"22821421","golden":false,"offsetInEndSection":95,"text":"Patients with ankylosing spondylitis (AS) are prone to spinal fracture after even minor trauma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"20384928","golden":false,"offsetInEndSection":130,"text":"Ankylosing spondylitis (AS) is a chronic rheumatic disease that causes spinal rigidity with an increased risk of spinal fractures.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35411534","golden":false,"offsetInEndSection":447,"text":"BACKGROUNDS: It has been hypothesized that ankylosing spondylitis is associated with an increased risk of incident hip fractures due to osteoporosis and risk of falls but the supporting evidence is limited and mixed.OBJECTIVES: To assess the risk of hip fractures in a large cohort of patients with ankylosing spondylitis compared to a matched cohort.DESIGN: A retrospective cohort study.SUBJECTS: Men and women diagnosed with ankylosing spondylit","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":91,"document":"7897715","golden":false,"offsetInEndSection":236,"text":"We describe a 50-year-old man who sustained fractures of the odontoid peg and body of the second cervical vertebra after a hyperextension injury.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":237,"document":"7897715","golden":false,"offsetInEndSection":412,"text":"In absence of atlanto-occipital fusion, deformity from previous lower cervical spine injury may have contributed to susceptibility for this very rare combination of fractures.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"1606383","golden":false,"offsetInEndSection":75,"text":"Fracture of the S1 vertebral body in a patient with ankylosing spondylitis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":413,"document":"7897715","golden":false,"offsetInEndSection":467,"text":"The patient was treated surgically with a good result.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1182,"document":"28253942","golden":false,"offsetInEndSection":1553,"text":"rroborate the authors hypothesis of delayed fracture healing in patients with diabetes mellitus, prospective studies incorporating influencing factors like duration of metabolic disease, quality of diabetes control, medical diabetes treatment, comorbidities and secondary diseaseas, like chronic nephropathy and osteoporosis, have to be carried out. Key words: diabetes, ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1134,"document":"26516730","golden":false,"offsetInEndSection":1492,"text":"cture consolidation is 60% lower.CONCLUSIONS: To corroborate the authors hypothesis of delayed fracture healing in patients with diabetes mellitus, prospective studies incorporating influencing factors like duration of metabolic disease, quality of diabetes control, medical diabetes treatment, comorbidities and secondary diseases, like chronic nephropathy ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":146,"document":"24676845","golden":false,"offsetInEndSection":363,"text":"derly men. We demonstrated that diabetes, chronic obstructive pulmonary disease, renal failure, HIV infection, dementia, and cerebrovascular disease are independent predictors of hip fracture, as is a Charlson score o","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":863,"document":"17934823","golden":false,"offsetInEndSection":1060,"text":"rt a rationale for earlier detection of celiac disease, and active management of bone disease before bone effects have occurred, to reduce the persistent risk of fractures.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"14724810","golden":false,"offsetInEndSection":150,"text":"BACKGROUND \u0026 AIMS: Although patients with inflammatory bowel disease (IBD) have reduced bone mass, there is controversy whether there is an increased ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":415,"document":"34790606","golden":false,"offsetInEndSection":656,"text":" literature. Herein, we report a very rare case of a young female with chronic kidney disease who presented with simultaneous fractures neck of femur on the one side and contralateral intertrochanteric fracture of femur after a fall from sta","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1497,"document":"15729479","golden":false,"offsetInEndSection":1655,"text":"ssion analysis revealed that increased risk of a second hip fracture was associated with senile dementia and Parkinson\u0027s disease. We concluded that careful fo","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":594,"document":"8499760","golden":false,"offsetInEndSection":769,"text":"history of hyperthyroidism (9 of 32) or thyroid cancer (2 of 11) appeared to have their first fracture earlier (p \u003c 0.01) than women without thyroid disease. In summary, women","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":231,"document":"20551857","golden":false,"offsetInEndSection":370,"text":" the best of the authors\u0027 knowledge, this is the first report of an asymptomatic orbital fracture in a patient with thyroid eye disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1447,"document":"31280614","golden":false,"offsetInEndSection":1549,"text":"awareness and dietary compliance rates. However, patients with DH seem to have a lower risk for fractu","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"39381463","golden":true,"offsetInEndSection":110,"text":"Chalk-Stick Fracture in Ankylosing Spondylitis: A Case Report of Cervical Spine Injury Following Minor Trauma.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":369,"document":"39381463","golden":true,"offsetInEndSection":489,"text":"Chalk-stick fractures are rare, typically occurring in patients with AS, and often occurring from low-energy mechanisms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1197,"document":"18522980","golden":false,"offsetInEndSection":1373,"text":"These three cases resemble previous descriptions of SSBT.CONCLUSION: Atypical skeletal fragility may signify SSBT in the setting of long-term, combined anti-remodeling therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":783,"document":"32300952","golden":false,"offsetInEndSection":1293,"text":"Plain computerized tomography revealed a three-column fracture at L4, and a ureteric leak into the psoas collection with proximal hydronephrosis was seen after contrast administration, establishing the presence of a ureteric fistula resulting in urinoma.RESULTS: Following initial symptomatic improvement after ureteric stenting, the patient succumbed to urosepsis at 3?months.CONCLUSION: We report for the first time a post-traumatic urinoma secondary to ureteric injury clinically mimicking spondylodiscitis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":111,"document":"38278209","golden":true,"offsetInEndSection":398,"text":"A radiologic finding of a bamboo spine, a characteristic feature of ankylosing spondylitis, was observed on computed tomography, along with a fracture-dislocation involving T10 and T11 (chalk-stick fracture) and compression of the descending thoracic aorta due to the caudal bony column.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39381463","golden":false,"offsetInEndSection":204,"text":"We describe the case of a 74-year-old male with ankylosing spondylitis (AS) who presented to the Emergency Department for evaluation of acutely worsened left-sided weakness following a fall from standing.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38278209","golden":true,"offsetInEndSection":167,"text":"Concurrently Occurring Spinal Cord Cross-Section and Aortic Injury After a Chalk-Stick Fracture and Dislocation in Patient with Ankylosing Spondylitis: Clinical Image.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":205,"document":"39381463","golden":false,"offsetInEndSection":368,"text":"Computed tomography (CT) and magnetic resonance imaging (MRI) of his cervical spine revealed a chalk-stick fracture of C5-C7, which required surgical intervention.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":490,"document":"39381463","golden":false,"offsetInEndSection":632,"text":"In the acute setting, providers should maintain a low threshold for obtaining CT or MRI imaging to evaluate spinal injury in patients with AS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25341971","golden":false,"offsetInEndSection":92,"text":"UNLABELLED: Ankylosing spondylitis (AS) leads to osteopenia/osteoporosis and spine rigidity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":714,"document":"38278209","golden":false,"offsetInEndSection":917,"text":"horacolumbar fracture-dislocations, particularly in patients with ankylosing spondylitis, are characterized by instability and can be further complicated by concurrent vascular and spinal cord injuries. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":134,"document":"38477782","golden":false,"offsetInEndSection":278,"text":"uscle weakness, restricted mobility, and frequent use of corticosteroids in patients with MG may predispose them to a higher risk of fractures. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":726,"document":"38171503","golden":false,"offsetInEndSection":967,"text":"veloped dementia from 2008 up to 2015. Lower-body fractures were independently associated with a subsequent dementia diagnosis with a higher adjusted hazard ratio (aHR) (1.55, 95% confidence interval [CI]\u003d1.49-1.62) compared with upper-body ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":122,"document":"18522980","golden":false,"offsetInEndSection":535,"text":"Ironically, in rare circumstances, long-term, combined anti-remodeling therapy may be associated with skeletal harm.EVIDENCE ACQUISITION: We report atypical skeletal fragility in three subjects after long-term, combined anti-remodeling therapy.EVIDENCE SYNTHESIS: Three subjects experienced spontaneous or minimal-trauma chalk-stick type metadiaphyseal femoral fractures while on long-term bisphosphonate therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31094843","golden":false,"offsetInEndSection":108,"text":"BACKGROUND: Destructive bony acetabular metastases cause pain, pathological fractures, and loss of mobility.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2386,"document":"31094843","golden":false,"offsetInEndSection":2741,"text":"Only one patient did not ambulate in the community postoperatively; 23 ambulated independently, 10 with the use of a walking stick and 12 using a walker.CONCLUSIONS: In this small series, we found this approach sufficiently durable to continue its use for patients with acetabular metastases with collapse or those not responding to nonoperative measures.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1469,"document":"22512437","golden":false,"offsetInEndSection":1831,"text":"The bond strength was higher when sticks or fiber nets were used.CONCLUSIONS: Fiber nets and retentive sticks increase the shear bond strength between FRCs and indirect composite.CLINICAL IMPLICATIONS: In FPDs, the morphology and type of FRC substructures might influence the shear bond strength between the FRC substructure and the indirect veneering composite.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36531425","golden":false,"offsetInEndSection":308,"text":"Ankylosing spondylitis (AS) is an inflammatory disease affecting mainly the sacroiliac joints and the spine. In long-standing disease, the fused spine of AS patients is susceptible to spinal fractures, even after low impact trauma. We present a 61-year-old man with long-standing AS who presented with anteri","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":337,"document":"18522980","golden":false,"offsetInEndSection":486,"text":"ined anti-remodeling therapy.EVIDENCE SYNTHESIS: Three subjects experienced spontaneous or minimal-trauma chalk-stick type metadiaphyseal femoral fra","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":719,"document":"38278209","golden":false,"offsetInEndSection":902,"text":"olumbar fracture-dislocations, particularly in patients with ankylosing spondylitis, are characterized by instability and can be further complicated by concurrent vascular and spinal ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1239,"document":"32300952","golden":false,"offsetInEndSection":1433,"text":"ureteric injury clinically mimicking spondylodiscitis. Clinicians need to be aware of the possibility of ureteric injury in hyperextension lumbar fractures occurring in ankylosing spondylitis an","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":489,"document":"32031291","golden":false,"offsetInEndSection":1062,"text":"For example, Are athletes (not) immune for coronary atherosclerosis? How to assess coronary atherosclerosis in athletes? What about chalk (calcified plaque) and cheese (mixed plaque)? Does exercise intensity play a role? Are there sport-related differences? Are there sex differences? Can sports medical evaluation detect coronary atherosclerosis? Do athletes get worried? Should athletes get worried? How should athletes with coronary atherosclerosis be managed? The goal of this review is to discuss the latest scientific insights and to answer these important questions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"12019644","golden":false,"offsetInEndSection":187,"text":"Transport of a conservative compound and two sorbing compounds through fractured chalk was studied using flow-through columns consisting of chalk cores with a single subvertical fracture.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":563,"document":"16352616","golden":false,"offsetInEndSection":918,"text":"However, it is not yet clear whether there is direct progression of low-grade superficial tumours to become invasive (a Jeckell and Hyde scenario) or whether in those patients who apparently progress from one form of the disease to the other, different tumour clones are involved and that the two tumour groups are mutually exclusive (\u0027chalk and cheese\u0027).","beginSection":"abstract"}],"exact_answer":[["ankylosing spondylitis"]],"ideal_answer":[],"id":"63adcb54c6c7d4d31b00001f","type":"factoid","body":"What disease is associated with chalk-stick fracture?"},{"documents":[{"golden":false,"id":"28449881"},{"golden":true,"id":"24439481"},{"golden":false,"id":"21301041"},{"golden":false,"id":"21857683"},{"golden":false,"id":"20598774"},{"golden":true,"id":"21989245"},{"golden":false,"id":"21412717"},{"golden":false,"id":"20472325"},{"golden":true,"id":"38540370"},{"golden":false,"id":"36108486"},{"golden":true,"id":"30050368"},{"golden":false,"id":"38802182"},{"golden":false,"id":"22132186"},{"golden":true,"id":"24369373"},{"golden":true,"id":"33810837"},{"golden":false,"id":"11369193"},{"golden":true,"id":"24703222"},{"golden":true,"id":"36336493"},{"golden":false,"id":"16174551"},{"golden":false,"id":"14753659"},{"golden":false,"id":"21944779"},{"golden":false,"id":"34310943"},{"golden":false,"id":"38884646"},{"golden":false,"id":"33071739"},{"golden":false,"id":"32671691"},{"golden":false,"id":"12858291"},{"golden":false,"id":"21145000"},{"golden":false,"id":"11675877"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":332,"document":"28449881","golden":false,"offsetInEndSection":464,"text":"Since the identification of the SOD1 gene, more than 20 genes have been described, of which four can explain \u003e50% of familial cases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":175,"document":"38540370","golden":true,"offsetInEndSection":337,"text":"The investigation of both sporadic and familial ALS highlighted four main genes that contribute to the pathogenesis of the disease: SOD1, FUS, TARDBP and C9orf72.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24439481","golden":true,"offsetInEndSection":165,"text":"Mutations in C9ORF72, SOD1, TARDBP, and FUS genes account for approximately two-third of familial cases and 5% of sporadic amyotrophic lateral sclerosis (ALS) cases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":295,"document":"21301041","golden":false,"offsetInEndSection":641,"text":"The majority of familial ALS (FALS) cases follow an autosomal dominant inheritance pattern, and include the following mutations: ALS1, Cu/Zn superoxide dismutase (SOD1); ALS3; ALS4, senataxin; ALS6, fused in sarcoma (FUS); ALS7; ALS8, vesicle-associated membrane protein; ALS9, angiogenin; ALS10, TAR DNA-binding protein (TARDBP); and ALS11/FIG4.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28449881","golden":false,"offsetInEndSection":158,"text":"Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease characterized by upper and lower motor neuron damage in the bulbar and spinal territories.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":282,"document":"28449881","golden":false,"offsetInEndSection":331,"text":"Familial ALS (fALS) accounts for 10-20% of cases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":465,"document":"28449881","golden":false,"offsetInEndSection":597,"text":"This review is an update focused on major aspects of the field of ALS genetics concerning both causative and susceptibility factors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1497,"document":"21857683","golden":false,"offsetInEndSection":1746,"text":"Therefore, our findings link abnormalities in ubiquilin?2 to defects in the protein degradation pathway, abnormal protein aggregation and neurodegeneration, indicating a common pathogenic mechanism that can be exploited for therapeutic intervention.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":228,"document":"21989245","golden":true,"offsetInEndSection":390,"text":"Cases of hereditary ALS have been attributed to mutations in 12 different genes, the most common being SOD1, FUS and TARDBP-mutations in the other genes are rare.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":159,"document":"28449881","golden":false,"offsetInEndSection":281,"text":"Although the pathophysiology of ALS is still unknown, the involvement of genetic factors is no longer a subject of debate.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":612,"document":"30050368","golden":true,"offsetInEndSection":872,"text":"he most commonly established genetic causes of familial ALS (FALS) to date are the presence of a hexanucleotide repeat expansion in the C9ORF72 gene (39.3% FALS) and mutation of SOD1, TARDBP, and FUS, with frequencies of 12%-23.5%, 5%, and 4.1%, respectively. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":49,"document":"38802182","golden":false,"offsetInEndSection":281,"text":"n about 5% to 10% of cases, there is a family history of ALS or a related condition such as frontotemporal dementia in a first or second degree relative, and for about 80% of such people a pathogenic gene variant can be identified. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":396,"document":"24369373","golden":false,"offsetInEndSection":613,"text":"pecifically, we summarize current literature of the major genes underlying ALS, SOD1, TARDBP, FUS, OPTN, VCP, UBQLN2, C9ORF72 and PFN1, and evaluate the information being gleaned from genome-wide association studies. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":81,"document":"22132186","golden":false,"offsetInEndSection":321,"text":"ely clear. While there are families with rare highly penetrant mutations in Cu/Zn superoxide dismutase 1 and several other genes that cause apparent Mendelian inheritance of the disease, most ALS occurs in families without another affected ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":173,"document":"33810837","golden":true,"offsetInEndSection":466,"text":"Screening of four main genes (C9orf72, SOD1, TARDBP and FUS) identified the causes in 15% of Amyotrophic Lateral Sclerosis (ALS) patients (two third of the familial cases and 8% of the sporadic ones) but their respective contribution to ALS phenotype varies according the age of disease onset.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":741,"document":"36336493","golden":true,"offsetInEndSection":945,"text":"Because of these findings and the urgent need to find a cure for ALS, many trials have focused on familial ALS targeting the four most important genes linked to the disease: C9orf72, SOD1, TARDBP and FUS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":166,"document":"24439481","golden":false,"offsetInEndSection":327,"text":"We present the first case of an ALS patient carrying a de novo nonsense mutation in exon 14 of the FUS gene (c.1483c\u003et; p.R495X) with an apparently familial ALS.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"24439481","golden":false,"offsetInEndSection":103,"text":"De novo nonsense mutation of the FUS gene in an apparently familial amyotrophic lateral sclerosis case.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":530,"document":"24439481","golden":false,"offsetInEndSection":659,"text":"De novo mutations could account for a sizable number of apparently sporadic ALS patients carrying mutations of ALS-related genes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":328,"document":"24439481","golden":false,"offsetInEndSection":529,"text":"This mutation causes a phenotype characterized by a young age at onset, a rapid course (\u003c24 months), and a bulbar onset with early respiratory involvement with a predominant lower motor neuron disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"20598774","golden":false,"offsetInEndSection":229,"text":"Mutations in the Cu/Zn superoxide dismutase (SOD1), transactive response (TAR)-DNA binding protein (TARDBP) and fused in sarcoma (FUS) genes account for approximately 1 third of familial amyotrophic lateral sclerosis (ALS) cases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":176,"document":"34310943","golden":false,"offsetInEndSection":264,"text":"tations have been linked to ALS; however, the majority of ALS patients are considered sp","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":425,"document":"38884646","golden":false,"offsetInEndSection":497,"text":"SOD1 gene. Aggregates of SOD1 have also been detected in other forms of ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":317,"document":"33071739","golden":false,"offsetInEndSection":380,"text":"sease. Most cases are sporadic, with only 10% of the cases bein","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":672,"document":"32671691","golden":false,"offsetInEndSection":738,"text":"ed. Thirty-two patients were male (58.2%), and 23 were female (41.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":305,"document":"24703222","golden":true,"offsetInEndSection":501,"text":"Among them, only four (SOD1, TARDBP, FUS and C9ORF72 genes) are unanimously recognized as convincing causative genetic factors for more than 60% of familial and probably 10% of sporadic ALS cases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"11675877","golden":false,"offsetInEndSection":167,"text":"BACKGROUND: There is an urgent need to identify genes involved in familial ALS (FALS), as mutations in the CuZn superoxide dismutase (SOD1) gene can account for 20% of","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":174,"document":"12858291","golden":false,"offsetInEndSection":301,"text":"Mutations in one gene, cytosolic Cu/Zn superoxide dismutase (SOD1), account for approximately 25% of familial ALS (FALS) cases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":349,"document":"21145000","golden":false,"offsetInEndSection":541,"text":"Screening of VCP in a cohort of 210 familial ALS cases and 78 autopsy-proven ALS cases identified four additional mutations including a p.R155H mutation in a pathologically proven case of ALS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":105,"document":"11369193","golden":false,"offsetInEndSection":241,"text":"The majority of the patients are sporadic cases (SALS), while 5-10% of the patients have a family history of ALS (familial ALS or FALS).","beginSection":"abstract"}],"exact_answer":[],"ideal_answer":[],"id":"677e821c592fa4887300001c","type":"list","body":"Which four genes account to the majority of the familial ALS cases?"},{"documents":[{"golden":true,"id":"33767373"},{"golden":false,"id":"24709930"},{"golden":false,"id":"34441323"},{"golden":false,"id":"35689189"},{"golden":false,"id":"20463618"},{"golden":true,"id":"14500502"},{"golden":false,"id":"35223539"},{"golden":false,"id":"28768269"},{"golden":false,"id":"24135723"},{"golden":false,"id":"18379237"},{"golden":false,"id":"34984338"},{"golden":false,"id":"39472236"},{"golden":false,"id":"38817614"},{"golden":false,"id":"38245687"},{"golden":false,"id":"38243675"},{"golden":false,"id":"10877161"},{"golden":false,"id":"24396135"},{"golden":false,"id":"15999007"},{"golden":false,"id":"19531943"},{"golden":false,"id":"19053905"},{"golden":true,"id":"15001460"},{"golden":false,"id":"23935651"},{"golden":false,"id":"28283553"},{"golden":false,"id":"8816213"},{"golden":false,"id":"19388555"},{"golden":false,"id":"12235722"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":1081,"document":"33767373","golden":false,"offsetInEndSection":1403,"text":"The most significantly overexpressed pathways were related to metabolic and immunomodulating responses that translated into an equilibrium between pro- and anti-inflammatory responses.CONCLUSIONS: The transcriptomic profile allowed identification of whether the causative agent was Gram-positive or Gram-negative bacteria.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1404,"document":"33767373","golden":false,"offsetInEndSection":1793,"text":"The overexpression of genes such as CD37 and CSK, which control cytokine production and cell survival, could explain the better clinical outcome in sepsis caused by Gram-positive bacteria.IMPACT: Transcriptomic profiles not only enable an early diagnosis of sepsis in very low birth weight infants but also discriminate between Gram-positive and Gram-negative bacteria as causative agents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1010,"document":"34441323","golden":false,"offsetInEndSection":1307,"text":"We identified 33 miRNAs that regulate our mRNAs, and the most relevant biological processes are associated with the immune system and the inflammatory response.CONCLUSIONS: The miRNA profiling in very low birth-weight neonates distinguishes late-onset Gram-positive sepsis versus control neonates.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1391,"document":"24709930","golden":false,"offsetInEndSection":1749,"text":"The most significantly overexpressed pathways in septic neonates related with innate immune and inflammatory responses and were validated by real-time reverse transcription polymerase chain reaction.CONCLUSIONS: Our preliminary results suggest that genome-wide expression profiles discriminate septic from nonseptic VLBW infants early in the neonatal period.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":132,"document":"33767373","golden":false,"offsetInEndSection":428,"text":"We aimed to determine if transcriptomic profiles could discriminate between Gram-positive and Gram-negative bacterial sepsis in preterm infants.METHODS: Prospective, observational, double-cohort study was conducted in very low birth weight infants with clinical signs and culture-positive sepsis.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"33767373","golden":true,"offsetInEndSection":103,"text":"Transcriptome profiles discriminate between Gram-positive and Gram-negative sepsis in preterm neonates.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1122,"document":"18379237","golden":false,"offsetInEndSection":1423,"text":"Hierarchical cluster analysis confirmed that the difference in gene expression profile existed between sepsis and control patients but not between gram-positive and gram-negative patients.CONCLUSIONS: Gram-positive sepsis and gram-negative sepsis share a common host response at a transcriptome level.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33767373","golden":false,"offsetInEndSection":131,"text":"BACKGROUND: Genome-wide expression profiles have been previously employed as clinical research diagnostic tools for newborn sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1794,"document":"33767373","golden":false,"offsetInEndSection":2010,"text":"The overexpression of some genes related to cytokine production and cell survival could explain the better clinical outcome in sepsis caused by Gram-positive bacteria, and could lead us to a future, targeted therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":780,"document":"35223539","golden":false,"offsetInEndSection":1044,"text":"Finally, the common gene sets between GSE6535 and GSE13015 were determined by GSEA.RESULTS: Two immunological gene sets in GSE6535 were identified based on GSVA, which could be used to discriminate sepsis caused by Gram-positive, Gram-negative, or mixed infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":959,"document":"33767373","golden":false,"offsetInEndSection":1080,"text":"Eight genes were overexpressed in Gram-positive septic infants: CD37, CSK, MAN2B2, MGAT1, MOB3A, MYO9B, SH2D3C, and TEP1.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":182,"document":"39472236","golden":false,"offsetInEndSection":322,"text":"ervention. Our objective was to identify neonatal sepsis gene expression biomarkers that could predict sepsis at birth, prior to clinical pr","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1455,"document":"38817614","golden":false,"offsetInEndSection":1776,"text":"ion toward a state of shock.Discussion: Our analysis revealed the presence of multiple significant transcriptomic perturbations that occur during the progression to septic shock in infants that are characterized by late-stage induction of clotting factors, in parallel with a heightened innate immune response and a suppr","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38243675","golden":false,"offsetInEndSection":253,"text":"AIM: The aim of this review was to summarise the most recent evidence about the use of omics-based techniques as an instrument for a more rapid and accurate characterisation of respiratory tract infections, neurological infections and sepsis in paediatr","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1939,"document":"38245687","golden":false,"offsetInEndSection":2044,"text":"yielded promising results. The immune infiltration analysis revealed notable disparities in patients diag","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1406,"document":"35689189","golden":false,"offsetInEndSection":1606,"text":"Both high expression of miRNA-1197 and low expression of miRNA-485-5p may be associated with pathogenic alteration of the oxidative respiratory chain and energy metabolism in preterm infants with SAE.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1415,"document":"28283553","golden":false,"offsetInEndSection":1831,"text":"Pathways associated with sepsis and Gram-negative sepsis included gap junctions, fibroblast growth factor receptors, regulators of cell division and interleukin-1-associated receptor kinase 2 (p values\u003c0.001 and FDR\u003c20%).CONCLUSIONS: No SNPs met genome-wide significance in this cohort of extremely low birthweight infants; however, areas of potential association and pathways meriting further study were identified.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":115,"document":"33767373","golden":false,"offsetInEndSection":447,"text":" newborn sepsis. We aimed to determine if transcriptomic profiles could discriminate between Gram-positive and Gram-negative bacterial sepsis in preterm infants.METHODS: Prospective, observational, double-cohort study was conducted in very low birth weight infants with clinical signs and culture-positive sepsis. Blood samples were","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":501,"document":"33767373","golden":false,"offsetInEndSection":750,"text":"RNA was processed for transcriptomic analysis. Results were validated by both reverse-transcription polymerase chain reaction and a mathematical model.RESULTS: We included 25 septic preterm infants, 17 with Gram-positive and 8 with Gram-negative bac","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":120,"document":"33767373","golden":false,"offsetInEndSection":264,"text":"orn sepsis. We aimed to determine if transcriptomic profiles could discriminate between Gram-positive and Gram-negative bacterial sepsis in pret","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1270,"document":"8816213","golden":false,"offsetInEndSection":1441,"text":"Neonates with sepsis by Gram-positive bacteria had lower sCD14 levels than patients with Gram-negative sepsis (2.63 +/- 1.2 versus 4.04 +/- 1.0 micrograms ml-1, p \u003c 0.05).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":469,"document":"24396135","golden":false,"offsetInEndSection":716,"text":"The diagnosis of neonatal sepsis is based on a combination of clinical presentation; the use of nonspecific markers, including C-reactive protein and procalcitonin (where available); blood cultures; and the use of molecular methods, including PCR.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"19531943","golden":false,"offsetInEndSection":230,"text":"OBJECTIVE: To evaluate the usefulness of the Gram-specific probe-based quantitative polymerase chain reaction test for rapid detection and differentiation of Gram-negative and Gram-positive bacterial bloodstream infection in prete","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":795,"document":"24709930","golden":false,"offsetInEndSection":1057,"text":"hed controls were enrolled. First, a three-dimensional unsupervised principal component analysis based on the entire genome (28?000 transcripts) identified 3 clusters of patients based on gene expression patterns: Gram-positive sepsis, Gram-negative sepsis, and ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":195,"document":"10877161","golden":false,"offsetInEndSection":341,"text":" not known.PATIENTS AND METHODS: Charts of all preterm infants who had positive blood cultures for either gram-negative bacteria or coagulase-nega","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":367,"document":"12235722","golden":false,"offsetInEndSection":689,"text":"Serum amyloid A levels were elevated in the sepsis group (187.6 +/- 78.3 micrograms/ml), compared with infants who had no sepsis (10.2 +/- 8.3 micrograms/ml) and the control group (6.9 +/- 3.3 micrograms/ml), and were significantly higher in gram-negative compared to gram-positive sepsis (221.8 +/- 84.4 micrograms/ml vs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":221,"document":"19388555","golden":false,"offsetInEndSection":532,"text":"While the past decade has been marked by a significant decline in early-onset group B streptococcal (GBS) sepsis in both term and preterm neonates, the overall incidence of early-onset sepsis has not decreased in many centers, and several studies have found an increase in sepsis due to gram-negative organisms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":436,"document":"19053905","golden":false,"offsetInEndSection":530,"text":"Infections due to Gram-negative organisms are increasingly being reported from neonatal units.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"15999007","golden":false,"offsetInEndSection":174,"text":"BACKGROUND: Early onset neonatal sepsis (EOS, occurring in the first 72 hours of life) remains an important cause of illness and death among very low birth weight (VLBW) pret","beginSection":"abstract"}],"exact_answer":"","ideal_answer":[],"id":"677ec8eb592fa48873000024","type":"yesno","body":"Can transcriptomic profiling differentiate between gram-positive and gram-negative sepsis in preterm infants?"},{"documents":[{"golden":true,"id":"37115484"},{"golden":true,"id":"37359526"},{"golden":false,"id":"25626709"},{"golden":false,"id":"20390223"},{"golden":false,"id":"15127191"},{"golden":false,"id":"26850322"},{"golden":false,"id":"38470396"},{"golden":false,"id":"31063297"},{"golden":false,"id":"38013304"},{"golden":false,"id":"30597490"},{"golden":false,"id":"29237456"},{"golden":false,"id":"39636505"},{"golden":false,"id":"38595339"},{"golden":false,"id":"35198634"},{"golden":false,"id":"27116911"},{"golden":false,"id":"32984583"},{"golden":false,"id":"24383711"},{"golden":false,"id":"15843979"},{"golden":false,"id":"37990806"},{"golden":false,"id":"29201229"},{"golden":false,"id":"15791874"},{"golden":false,"id":"27014507"},{"golden":false,"id":"36972964"},{"golden":false,"id":"36823611"},{"golden":false,"id":"34711945"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":1927,"document":"37115484","golden":false,"offsetInEndSection":2167,"text":"Additionally, all diagnostic characteristics may correlate with immune cells to varying degrees.CONCLUSIONS: The candidate hub genes (CD177, CYSTM1, and MMP8) were identified, and the nomogram was constructed for pediatric sepsis diagnosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":3178,"document":"37359526","golden":true,"offsetInEndSection":3499,"text":"Higher expression levels of CD177 and MMP8 proteins were also observed in the PBMCs isolated from septic shock patients than from control participants.Conclusions: CD177, CLEC5A, CYSTM1, MCEMP1, MMP8, and RGL4 were identified as hub genes, which were of considerable value in the early diagnosis of septic shock patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1304,"document":"15127191","golden":false,"offsetInEndSection":1708,"text":"MBL serum levels showed close concordance with the genotype and indicated that MBL levels less than 1000 ng/ml are associated with a greatly increased risk of SIRS.CONCLUSIONS: MBL-2 exon 1 polymorphisms with low serum levels of functional MBL protein are associated with a greatly increased risk of developing SIRS and of progression from infection to sepsis and septic shock in paediatric ICU patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1554,"document":"37115484","golden":true,"offsetInEndSection":1793,"text":"As pediatric sepsis diagnostic indicators, CYSTM1 (AUC?\u003d?0.988), MMP8 (AUC?\u003d?0.973), and CD177 (AUC?\u003d?0.986) were investigated and demonstrated statistically significant differences (P?\u003c?0.05) and diagnostic efficacy in the validation set.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1009,"document":"25626709","golden":false,"offsetInEndSection":1222,"text":"The five genes (PROK2, ZNF238, AQP9, CYSTM1 and ANXA3) that were validated independently in both cohorts present a candidate biomarker panel for stage determination and therapeutic readout in Huntington\u0027s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37115484","golden":false,"offsetInEndSection":173,"text":"BACKGROUND: Pediatric sepsis is a complicated condition characterized by life-threatening organ failure resulting from a dysregulated host response to infection in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":314,"document":"37115484","golden":false,"offsetInEndSection":583,"text":"The objective of this study was to evaluate the diagnostic biomarkers of pediatric sepsis and the function of immune cell infiltration in the development of this illness.METHODS: Three gene expression datasets were available from the Gene Expression Omnibus collection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1358,"document":"37115484","golden":false,"offsetInEndSection":1553,"text":"The relationship between the diagnostic markers and infiltrating immune cells was further studied.RESULTS: Overall, after overlapping key module genes and DEGs, we detected 402 overlapping genes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2168,"document":"37115484","golden":false,"offsetInEndSection":2276,"text":"Our study could provide potential peripheral blood diagnostic candidate genes for pediatric sepsis patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":938,"document":"38470396","golden":false,"offsetInEndSection":1313,"text":"There was a borderline trend towards a lower prevalence of the FTO TT genotype in the control group compared to the SC group (p \u003c 0.09, OR \u003d 0.81, 95% CI \u003d 0.62-1.06).CONCLUSIONS: Our findings suggest that rs17817449, a common FTO polymorphism, may be a predictor of sepsis in paediatric patients, and that higher body weight is protective against this clinical complication.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":802,"document":"20390223","golden":false,"offsetInEndSection":1004,"text":"In the acute phase, both ADAMTS13 activity and antigen were decreased (median 23.4% and 33.7% of normal, respectively) and VWF:CB and VWF:Ag levels were strongly increased (325% and 348%, respectively.)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":273,"document":"39636505","golden":false,"offsetInEndSection":486,"text":"th diseases.METHODS: Core genes common to both sepsis and cancer were identified using pediatric sepsis datasets (GEO: GSE26378, GSE4607, GSE8121 and GSE13904) and cancer databases (TCGA: BRCA, COADREAD, ESCA, KIR","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":339,"document":"35198634","golden":false,"offsetInEndSection":508,"text":"on. Therefore, in this study, we aimed to evaluate the diagnostic value of key genes involved in paediatric sepsis based on the data of the Gene Expression Omnibus datab","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":920,"document":"38595339","golden":false,"offsetInEndSection":1107,"text":" clinical samples.Results: Among 294 overlapping genes of DEGs and modular sepsis genes, five pivotal genes (STOM, MS4A4A, CD177, MMP8, and MCEMP1) were screened to construct a diagnostic","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":832,"document":"26850322","golden":false,"offsetInEndSection":1000,"text":"One case of primary MASP-2 deficiency was found among healthy pre-terms and one neonate suffering from SIRS was heterozygous for the rare FCN1 gene mutation, +6658 G\u003eA.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1203,"document":"15843979","golden":false,"offsetInEndSection":1505,"text":"Meningitis was not associated with the PAI-1 4G/5G polymorphism, and allele frequencies were similar in patient and control groups.CONCLUSION: Our data show a correlation between the 4G/4G genotype in the plasminogen activator inhibitor-1 gene and poor outcome in children with meningococcal infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1113,"document":"37115484","golden":false,"offsetInEndSection":1350,"text":"were used to verify the discrimination and efficacy of the hub genes. In addition, the inflammatory and immune status of pediatric sepsis was assessed using cell-type identification by estimating relative subsets of RNA transcripts (CIBE","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1340,"document":"37115484","golden":false,"offsetInEndSection":1500,"text":"ipts (CIBERSORT). The relationship between the diagnostic markers and infiltrating immune cells was further studied.RESULTS: Overall, after overlapping key modu","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":294,"document":"36972964","golden":false,"offsetInEndSection":434,"text":"al infection. Further gene expression markers have also been reported previously in the paediatric age group for discriminating sepsis from ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1405,"document":"15127191","golden":false,"offsetInEndSection":1634,"text":"000 ng/ml are associated with a greatly increased risk of SIRS.CONCLUSIONS: MBL-2 exon 1 polymorphisms with low serum levels of functional MBL protein are associated with a greatly increased risk of developing SIRS and of progres","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2052,"document":"32984583","golden":false,"offsetInEndSection":2357,"text":"-CRP (AUC \u003d 78.4%) and sCD14-ST (AUC \u003d 74.8%). Combination of PCT + hs-CRP had the highest accuracy (AUC \u003d 80.1%) followed by hs-CRP + sCD14-ST (AUC \u003d 77.2%), PCT + sCD14-ST + hs-CRP (AUC \u003d 77.0%) and PCT + sCD14-ST (AUC \u003d 75.9%).Conclusion: hs-CRP, PCT, and sCD14-ST are independent predictors of paediat","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24383711","golden":false,"offsetInEndSection":149,"text":"INTRODUCTION: The aim of the study was to identify the dependency structure of genetic variants that can influence the outcome for paediatric patient","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":655,"document":"27116911","golden":false,"offsetInEndSection":780,"text":"cific search terms. Studies were included if they assessed the diagnostic accuracy of plasma sTREM-1 for sepsis in paediatric","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":228,"document":"15843979","golden":false,"offsetInEndSection":413,"text":"cal sepsis. Previously, an association between mortality and the functional 4G/5G promoter polymorphism of the PAI-1gene in a cohort of UK and Dutch children with meningococcal sepsis w","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1635,"document":"37990806","golden":false,"offsetInEndSection":1750,"text":"onstrate a crucial and age-dependent role for IL-33 in post-sepsis immunosuppression. Thus, a better understanding ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1726,"document":"29201229","golden":false,"offsetInEndSection":1948,"text":"In conclusion, MRSA isolated from the blood of paediatric patients with BSIs not only exhibited higher rates of antimicrobial resistance than MSSA from the same source, but also more frequently harboured SEK and SEQ genes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34711945","golden":false,"offsetInEndSection":103,"text":"Sepsis, a dysregulated host response to infection, has been difficult to accurately define in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":146,"document":"36823611","golden":false,"offsetInEndSection":326,"text":"It is associated with higher mortality, low quality of life, and long-term neurological sequelae, its mortality in patients diagnosed with sepsis, progressing to SAE, is 9% to 76%.","beginSection":"abstract"}],"exact_answer":"","ideal_answer":[],"id":"677edaa2592fa48873000030","type":"yesno","body":"Is CYSTM1 gene associated with paediatric sepsis?"},{"documents":[{"golden":true,"id":"30154914"},{"golden":false,"id":"26476786"},{"golden":false,"id":"25000179"},{"golden":false,"id":"30063105"},{"golden":false,"id":"14739370"},{"golden":false,"id":"24709930"},{"golden":false,"id":"24135723"},{"golden":false,"id":"34183713"},{"golden":false,"id":"35835848"},{"golden":false,"id":"32692051"},{"golden":false,"id":"38245687"},{"golden":false,"id":"30953832"},{"golden":false,"id":"28283553"},{"golden":false,"id":"39148395"},{"golden":false,"id":"38306913"},{"golden":false,"id":"35551640"},{"golden":false,"id":"29301794"},{"golden":false,"id":"37285838"},{"golden":false,"id":"15183656"},{"golden":false,"id":"38107458"},{"golden":false,"id":"17050665"},{"golden":false,"id":"34238334"},{"golden":false,"id":"24668300"},{"golden":false,"id":"36891292"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":1460,"document":"30154914","golden":false,"offsetInEndSection":1706,"text":"Little was known about the correlation of PIK3CA with NS, which gives us a new enlightenment for NS study.CONCLUSION: This research might provide the perspective information to explore the potential novel genes and pathways as NS therapy targets.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30154914","golden":false,"offsetInEndSection":117,"text":"BACKGROUND: Neonatal sepsis (NS) is considered as the most common cause of neonatal deaths that newborns suffer from.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1171,"document":"35835848","golden":false,"offsetInEndSection":1475,"text":"Pathway analyses showed NOTCH signaling is over-represented among genes linked to these SNPS.CONCLUSION: Our results indicate genetic susceptibility to LOS is sexually dimorphic and corroborate that NOTCH signaling plays a role in determining risk.IMPACT: Genes associate with late onset neonatal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1164,"document":"30154914","golden":false,"offsetInEndSection":1324,"text":"Among those genes involved in key pathways, 7 hub genes, PIK3CA, TGFBR2, CDKN1B, KRAS, E2F3, TRAF6, and CHUK, were determined based on the coexpression network.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":524,"document":"30154914","golden":false,"offsetInEndSection":821,"text":"In order to further study the key signaling pathway of the NS, elastic-net regression model, Mann-Whitney U test, and coexpression network were used to estimate the weights of signaling pathway and hub genes.RESULTS: A total of 115 different pathways between NS and controls were first identified.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":228,"document":"30154914","golden":false,"offsetInEndSection":426,"text":"NS pathogenesis is still needed to be investigated.METHODS: After data preprocessing, we used KEGG enrichment method to identify the differentially expressed pathways between NS and normal controls.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1227,"document":"30063105","golden":false,"offsetInEndSection":1489,"text":"This report expands the clinical and molecular spectrum of PROS, emphasizes that different molecular methods can be complimentary in the diagnosis of these disorders, and highlights the risk of coagulopathy in a subset of patients with PIK3CA-related overgrowth.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1106,"document":"24135723","golden":false,"offsetInEndSection":1315,"text":"Our results indicate that the DNA methylation pattern of the promoter region of the CALCA gene varies in different types of bacterial preterm sepsis, thus suggesting a potential use as an epigenetic biomarker.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1365,"document":"30154914","golden":false,"offsetInEndSection":1459,"text":"PIK3CA was considered as the common marker, which is highly expressed in the lymphocyte group.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1067,"document":"30154914","golden":false,"offsetInEndSection":1163,"text":"There were 7 key signaling pathways between the NS and controls, according to different sources.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":427,"document":"30154914","golden":false,"offsetInEndSection":523,"text":"Then, functional principal component analysis (FPCA) was adopted to calculate gene values in NS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":464,"document":"39148395","golden":false,"offsetInEndSection":796,"text":"his article provides a review of gene polymorphisms related to neonatal sepsis, including interleukins, tumor necrosis factor, Toll-like receptors, NOD-like receptors, CD14, triggering receptor expressed on myeloid cells-1, mannose-binding lectin, and other immune proteins, aiming to promote precision medicine for this disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28283553","golden":false,"offsetInEndSection":172,"text":"OBJECTIVE: To identify genetic variants associated with sepsis (early-onset and late-onset) using a genome-wide association (GWA) analysis in a cohort of extremely prematur","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1290,"document":"38245687","golden":false,"offsetInEndSection":1479,"text":"fied marker genes.RESULTS: Within the context of neonatal sepsis, a total of 49 genes exhibited an intersection between the differentially expressed genes (DEGs) and those associated with p","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":472,"document":"38306913","golden":false,"offsetInEndSection":554,"text":"here was an association observed between TaqI SNP with neonatal sepsis for CT vs. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1030,"document":"30154914","golden":false,"offsetInEndSection":1275,"text":"elastic-net regression and MWU test. There were 7 key signaling pathways between the NS and controls, according to different sources. Among those genes involved in key pathways, 7 hub genes, PIK3CA, TGFBR2, CDKN1B, KRAS, E2F3, TRAF6, and CHUK, w","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1280,"document":"30154914","golden":false,"offsetInEndSection":1550,"text":"etermined based on the coexpression network. Most of them were cancer-related genes. PIK3CA was considered as the common marker, which is highly expressed in the lymphocyte group. Little was known about the correlation of PIK3CA with NS, which gives us a new enlightenme","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":463,"document":"39148395","golden":false,"offsetInEndSection":795,"text":"This article provides a review of gene polymorphisms related to neonatal sepsis, including interleukins, tumor necrosis factor, Toll-like receptors, NOD-like receptors, CD14, triggering receptor expressed on myeloid cells-1, mannose-binding lectin, and other immune proteins, aiming to promote precision medicine for this disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":137,"document":"37285838","golden":false,"offsetInEndSection":348,"text":"mechanism.METHODS: It was found through bioinformatics analysis that phosphatidylinositol 3-kinase catalytic subunit alpha (PIK3CA) was expressed at a low level in sepsis, and miR-506-3p had a targeted regulator","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1350,"document":"24668300","golden":false,"offsetInEndSection":1517,"text":"e inflammatory response.CONCLUSIONS: Our investigation demonstrated some miRNAs with altered expression levels and their probable association with the regulation of im","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":597,"document":"26476786","golden":false,"offsetInEndSection":782,"text":"In this review, we describe details of studies that have evaluated genetic susceptibility in neonatal sepsis, and summarize findings from a review of candidate gene association studies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1412,"document":"14739370","golden":false,"offsetInEndSection":1784,"text":"The increased sepsis rate of homozygous IL6-174G carriers was especially related to an increase in Gram-positive infections, and was not observed in VLBW infants who received prophylaxis with teicoplanin (frequency of Gram-positive sepsis in homozygous IL6-174G carriers without prophylaxis 16.5% versus 2.4% in homozygous IL6-174G carriers with prophylaxis; p \u003d 0.033).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2368,"document":"34238334","golden":false,"offsetInEndSection":2459,"text":"3K alpha (alpelisib).CONCLUSION: Management of patients with PIK3CA-related disorders requi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":334,"document":"36891292","golden":false,"offsetInEndSection":522,"text":"In a murine model of neonatal sepsis, mice deficient in IL-27 signaling exhibit reduced mortality, increased weight gain, and better control of bacteria with reduced systemic inflammation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":501,"document":"15183656","golden":false,"offsetInEndSection":758,"text":"This article gives an overview of the genetic susceptibility to sepsis, discusses the use of molecular genetics in diagnostic tests for infection, and reviews the potential for more effective and specific therapies for sepsis based on genetic variability.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":266,"document":"35551640","golden":false,"offsetInEndSection":454,"text":" spectrum\".CASE PRESENTATION: We report a 22-months-old female presenting an uncommon phenotype associated with a genetic mosaicism in the PIK3CA gene, detected on DNA extracted from blood","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":149,"document":"29301794","golden":false,"offsetInEndSection":205,"text":"A PIK3CA gene mutation resulted in lower limb gigantism.","beginSection":"abstract"}],"exact_answer":"","ideal_answer":[],"id":"677eca7a592fa48873000025","type":"yesno","body":"Is PIK3CA gene related to neonatal sepsis?"},{"documents":[{"golden":false,"id":"29555781"},{"golden":false,"id":"30546433"},{"golden":false,"id":"24398603"},{"golden":false,"id":"29967183"},{"golden":false,"id":"36439452"},{"golden":false,"id":"21677669"},{"golden":false,"id":"38307549"},{"golden":false,"id":"35452604"},{"golden":false,"id":"15654813"},{"golden":false,"id":"19702439"},{"golden":false,"id":"39439803"},{"golden":false,"id":"38840771"},{"golden":false,"id":"37993659"},{"golden":false,"id":"34193217"},{"golden":false,"id":"39721752"},{"golden":false,"id":"36163626"},{"golden":false,"id":"34138742"},{"golden":false,"id":"23441216"},{"golden":false,"id":"35537408"},{"golden":false,"id":"37649599"},{"golden":false,"id":"27846884"},{"golden":false,"id":"33771892"},{"golden":false,"id":"35767244"},{"golden":false,"id":"29669936"},{"golden":false,"id":"34917263"},{"golden":false,"id":"39439494"},{"golden":false,"id":"30534022"},{"golden":false,"id":"34326835"},{"golden":false,"id":"30582659"},{"golden":false,"id":"30953385"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":1340,"document":"29555781","golden":false,"offsetInEndSection":1551,"text":"Our findings will launch the development of innovative adoptive transfer immunotherapies for the treatment of lung ADC, targeting the most prevalent HLA molecules and CT37 peptides restricted by these molecules.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1485,"document":"29967183","golden":false,"offsetInEndSection":1718,"text":"These results indicate that systemic 1V270 therapy can induce tumor-specific cytotoxic T cell responses to pulmonary metastatic cancers and that TCR repertoire analyses can be used to monitor, and to predict, the response to therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1022,"document":"38307549","golden":false,"offsetInEndSection":1326,"text":"Furthermore, injecting CCR10-1G4 dual expressing TCR-T cells into a xenograft tumor model demonstrated enhanced in vivo trafficking and a greater reduction of tumor burden.CONCLUSION: This study highlights the potential of CCR10 for developing efficient adoptive T-cell treatments targeting solid tumors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1005,"document":"30546433","golden":false,"offsetInEndSection":1263,"text":"Two patients had clinical responses to NY-ESO-1 TCR-T cell therapy, including the 44-year-old female patient with LADC, who achieved a short-term partial response for 4 months, improved in Karnofsky performance status, and had a recovery of drug sensitivity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":482,"document":"29555781","golden":false,"offsetInEndSection":588,"text":"Innovative therapeutic approaches are needed for the treatment of 70% of patients suffering from lung ADC.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"29555781","golden":false,"offsetInEndSection":155,"text":"An Isolated TCR ?? Restricted by HLA-A*02:01/CT37 Peptide Redirecting CD8+ T Cells To Kill and Secrete IFN-? in Response to Lung Adenocarcinoma Cell Lines.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1264,"document":"30546433","golden":false,"offsetInEndSection":1418,"text":"This suggests that TCR-T cell therapy targeting NY-ESO-1 antigen may be beneficial for HLA-A2-positive late-stage patients with NY-ESO-1-expressing NSCLC.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":668,"document":"36439452","golden":false,"offsetInEndSection":937,"text":"To improve patient outcome we designed a TCR-based ACT study targeting hTERT.Methods: T-RAD is a phase I/II study to evaluate the safety and efficacy of Radium-4 mRNA electroporated autologous T cells in the treatment of metastatic NSCLC with no other treatment option.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":786,"document":"29555781","golden":false,"offsetInEndSection":954,"text":"In this study, we report the isolation of HLA-A*02:01/CT37 peptide-specific ? and ? TCR chains from a CD8+ T cell clone obtained from a patient suffering from lung ADC.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":955,"document":"29555781","golden":false,"offsetInEndSection":1018,"text":"We also report the development of an innovative CD3? construct.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":501,"document":"30546433","golden":false,"offsetInEndSection":603,"text":"The patient had a clinical response to and was well-tolerated with this therapy in the clinical trial.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30546433","golden":false,"offsetInEndSection":348,"text":"This article presented a case of a human leukocyte antigen (HLA)-A2-positive patient with advanced cancer/testis antigen New York esophageal squamous cell carcinoma-1 (NY-ESO-1) expressing lung adenocarcinoma (LADC) who received adoptive cell therapy of T cell receptor engineered-T cells (TCR-T cells) targeting the cancer-testis antigen NY-ESO-1.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"30546433","golden":false,"offsetInEndSection":140,"text":"Treatment of metastatic non-small cell lung cancer with NY-ESO-1 specific TCR engineered-T cells in a phase I clinical trial: A case report.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":604,"document":"30546433","golden":false,"offsetInEndSection":787,"text":"In addition, a preliminary evaluation of the safety of NY-ESO-1 TCR-T cell therapy was performed in four patients with non-small cell lung cancer (NSCLC) enrolled in a clinical trial.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38840771","golden":false,"offsetInEndSection":153,"text":"Tumor mutational burden (TMB) and T-cell receptor (TCR) might predict the response to immunotherapy in patients with non-small cell lung cancer (NSCLC).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39439803","golden":false,"offsetInEndSection":163,"text":"Background: T cell receptor (TCR)-T cell therapy is an innovative form of cancer immunotherapy that genetically modifies patients\u0027 T cells to target and destroy ca","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34193217","golden":false,"offsetInEndSection":136,"text":"T-cell receptor (TCR)-based adoptive therapy employs genetically modified lymphocytes that are directed against specific tumor markers.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":791,"document":"37993659","golden":false,"offsetInEndSection":990,"text":"or the discovery of novel immunotherapy-based tumor targets, tumor-infiltrating lymphocytes (TILs) give a key insight on tumor-related immune activities by providing T cell receptor (TCR) sequences. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33771892","golden":false,"offsetInEndSection":463,"text":"BACKGROUND: The cancer-testis antigen MAGE-A4 is an attractive target for T-cell-based immunotherapy, especially for indications with unmet clinical need like non-small cell lung or triple-negative breast cancer.METHODS: An unbiased CD137-based sorting approach was first used to identify an immunogenic MAGE-A4-derived epitope (GVYDGREHTV) that was properly processed and presented on human leukocyte antigen (HLA)-A2 molecules encoded by the HLA-A*02:01 allele.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1295,"document":"33771892","golden":false,"offsetInEndSection":1690,"text":"These CD4+ TCR-Ts supported an anti-tumor response by direct killing of MAGE-A4-positive tumor cells and upregulated hallmarks associated with helper function, such as CD154 expression and release of key cytokines on tumor-specific stimulation.CONCLUSION: The extensive pre-clinical assessment of safety and in vivo potency of bbT485 provide the basis for its use in TCR-T immunotherapy studies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":319,"document":"35767244","golden":false,"offsetInEndSection":507,"text":"These results establish clinical proof of concept that an off-the-shelf TCR targeting a recurrent mutation in a molecular driver of oncogenesis can benefit patients with metastatic cancer.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39439494","golden":false,"offsetInEndSection":398,"text":"Vaccine-based therapeutics for cancers face several challenges including lack of immunogenicity and tumor escape pathways for single antigen targets. It has been reported that radiotherapy has an in situ vaccine effect that provides tumor antigens following irradiation, helping to activate antigen-presenting cells (APCs). Herein, a new vaccine approach is developed by combining genetically engin","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30534022","golden":false,"offsetInEndSection":398,"text":"Immunotherapy has been proven effective in several tumours, hence diverse immune checkpoint inhibitors are currently licensed for the treatment of melanoma, kidney cancer, lung cancer and most recently, tumours with microsatellite instability. There is much enthusiasm for investigating this approach in gynaecological cancers and the possibility that immunotherapy might become part of the therape","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34326835","golden":false,"offsetInEndSection":404,"text":"T cell infiltration into tumors is essential for successful immunotherapy against solid tumors. Herein, we found that the expression of hyaluronic acid synthases (HAS) was negatively correlated with patient survival in multiple types of solid tumors including gastric cancer. HA impeded in vitro anti-tumor activities of anti-mesothelin (MSLN) chimeric antigen receptor T cells (CAR-T cells) against gast","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":277,"document":"36163626","golden":false,"offsetInEndSection":588,"text":"This review summarizes the research progress of TCR-T cell therapy in the prevention and treatment of lung cancer from the perspective of the diversity of TCR repertoire and the mechanism of tumor antigen recognition, in order to improve the efficacy of the prevention and treatment of lung cancer metastasis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":345,"document":"30582659","golden":false,"offsetInEndSection":526,"text":"We performed T cell receptor (TCR) repertoire analysis of resected lung adenocarcinoma tissues with and without EGFR mutations to investigate the characteristics of TCR repertoires.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":585,"document":"30953385","golden":false,"offsetInEndSection":815,"text":"Owing to the significant efficacy and controllable side effect, NY-ESO-1 has been considered as one of the most ideal TCR-engineered T cell therapy (TCR-T) cell target for solid tumors, including nonsmall cell lung cancer (NSCLC).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1840,"document":"23441216","golden":false,"offsetInEndSection":2109,"text":"mediated by these double gene-modified CD3(+) T cells.CONCLUSION/SIGNIFICANCE: Introduction of the CCL2/CCR2 axis successfully potentiated in vivo anti-lung cancer reactivity mediated by CD8(+) T cells double gene-modified to express WT1-specific TCR and CCR2 not only ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":116,"document":"37649599","golden":false,"offsetInEndSection":313,"text":"Adoptive cell therapy using engineered T-cell receptors (TCRs) targeting cancer-testis antigens, such as Melanoma-associated antigen 3 (MAGE-A3), is a potential approach for the treatment of NSCLC.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36439452","golden":false,"offsetInEndSection":165,"text":"Background: Adoptive cellular therapy (ACT) with genetically modified T cells aims to redirect T cells against resistant cancers through introduction of a T cell rec","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34138742","golden":false,"offsetInEndSection":118,"text":"Analysis of T cell receptor (TCR) repertoires may contribute to better understanding of the response to immunotherapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":525,"document":"39721752","golden":false,"offsetInEndSection":700,"text":"se and irAEs.METHODS: Patients with immunotherapy-na?ve metastatic non-small cell lung cancer (NSCLC) were treated with ipilimumab and nivolumab according to trial protocol (L","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":630,"document":"35452604","golden":false,"offsetInEndSection":782,"text":"Screening of TCRs selected by the signature allows us to identify neoantigen-reactive TCRs with a success rate of 45% for CD8+ and 66% for CD4+ T?cells.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":226,"document":"35537408","golden":false,"offsetInEndSection":369,"text":"These findings could substantially expedite the selection of neoantigen-specific T?cell receptors (TCRs) for individualized T?cell therapies.","beginSection":"abstract"}],"ideal_answer":[],"id":"6777c29b592fa48873000017","type":"summary","body":"Success of T-cell receptor (TCR) therapy in lung cancer in women."},{"documents":[{"golden":true,"id":"32573669"},{"golden":false,"id":"32668698"},{"golden":false,"id":"37453291"},{"golden":false,"id":"38605122"},{"golden":false,"id":"32411386"},{"golden":false,"id":"38325642"},{"golden":false,"id":"36085161"},{"golden":false,"id":"35729264"},{"golden":false,"id":"32553838"},{"golden":false,"id":"38413639"},{"golden":false,"id":"38840860"},{"golden":false,"id":"28973083"},{"golden":false,"id":"38259611"},{"golden":false,"id":"34143244"},{"golden":false,"id":"35842091"},{"golden":false,"id":"34327338"},{"golden":false,"id":"35348890"},{"golden":false,"id":"29543227"},{"golden":false,"id":"26938784"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":2427,"document":"32573669","golden":true,"offsetInEndSection":2840,"text":"Targeted treatments were initiated in 12 patients (11%), treatment was redirected toward palliative care in 14 patients (13%), and surveillance for specific complications was initiated in 19 patients (18%).Conclusions and Relevance: This study suggests feasibility of ultra-rapid genomic testing in critically ill pediatric patients with suspected monogenic conditions in the Australian public health care system.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32573669","golden":false,"offsetInEndSection":592,"text":"Importance: Widespread adoption of rapid genomic testing in pediatric critical care requires robust clinical and laboratory pathways that provide equitable and consistent service across health care systems.Objective: To prospectively evaluate the performance of a multicenter network for ultra-rapid genomic diagnosis in a public health care system.Design, Setting, and Participants: Descriptive feasibility study of critically ill pediatric patients with suspected monogenic conditions treated at 12 Australian hospitals between March 2018 and February 2019, with data collected to May 2019.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"32573669","golden":false,"offsetInEndSection":163,"text":"Feasibility of Ultra-Rapid Exome Sequencing in Critically Ill Infants and Children With Suspected Monogenic Conditions in the Australian Public Health Care System.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":218,"document":"32668698","golden":false,"offsetInEndSection":338,"text":"In infants with a suspected acute monogenic disease, rapid whole-exome sequencing (R-WES) can be successfully performed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":799,"document":"36085161","golden":false,"offsetInEndSection":1235,"text":"Five patients had clinically significant likely pathogenic/pathogenic variants (RARB, RPL15, CTCF, RFXANK, TBX4) and one patient had a variant of uncertain significance (VIP) suspected to contribute to their clinical phenotype, with VIP being a novel gene candidate.CONCLUSIONS: Trio exomes (6/36; 16.7%) had a better diagnostic rate than gene panel (1/36; 2.8%), due to the ability to consider a broader range of underlying conditions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1835,"document":"32573669","golden":false,"offsetInEndSection":1894,"text":"A molecular diagnosis was established in 55 patients (51%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1362,"document":"32553838","golden":false,"offsetInEndSection":1708,"text":"Overall, 84% of patients were under 1?month old at rES request and the mean turnaround time was 9?days.CONCLUSIONS: rES testing has a significant impact on the management of critically ill children with suspected monogenic disease and should be considered standard of care for tertiary institutions who can provide coordinated genetics expertise.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2216,"document":"37453291","golden":false,"offsetInEndSection":2484,"text":"An Australian study of ultra-rapid (ur) exome sequencing (mean time to genomic test report of 3.3?days) in 108 critically ill infants and children with suspected monogenic conditions, had a molecular diagnostic yield of 51% with 20% requiring further genetic analysis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1895,"document":"32573669","golden":false,"offsetInEndSection":2217,"text":"Eleven diagnoses (20%) resulted from using the following approaches to augment standard exome sequencing analysis: mitochondrial genome sequencing analysis, exome sequencing-based copy number analysis, use of international databases to identify novel gene-disease associations, and additional phenotyping and RNA analysis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32553838","golden":false,"offsetInEndSection":188,"text":"OBJECTIVES: To evaluate the clinical usefulness of rapid exome sequencing (rES) in critically ill children with likely genetic disease using a standardized process at a single institution.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":941,"document":"32573669","golden":false,"offsetInEndSection":1488,"text":"The secondary outcomes were the molecular diagnostic yield, the change in clinical management after the ultra-rapid exome sequencing report, the time from hospital admission to the laboratory report, and the proportion of laboratory reports returned prior to death or hospital discharge.Results: The study population included 108 patients with a median age of 28 days (range, 0 days to 17 years); 34% were female; and 57% were from neonatal intensive care units, 33% were from pediatric intensive care units, and 9% were from other hospital wards.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38259611","golden":false,"offsetInEndSection":292,"text":"Introduction: Rapid exome sequencing (rES) has become the first-choice genetic test for critically ill patients, mostly neonates, young infants, or fetuses in prenatal care, in time-sensitive situations and when it is expected that the genetic test result may guide clinical decision making.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":241,"document":"38840860","golden":false,"offsetInEndSection":528,"text":"apid exome or genome (\"genomic\") sequencing in critically ill children demonstrated profound diagnostic and clinical value, and there is growing evidence that the faster a molecular diagnosis is established in such children, the more likely clinical management is influenced positively. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38605122","golden":false,"offsetInEndSection":128,"text":"Next generation sequencing based diagnosis has emerged as a promising tool for evaluating critically ill neonates and children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2286,"document":"28973083","golden":false,"offsetInEndSection":2527,"text":"osed in 39 (48.1%) by exome sequencing, with implications for recurrence risk counseling.Conclusions and Relevance: Exome sequencing is a powerful tool for the diagnostic evaluation of critically ill infants with suspected monogenic disorder","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1056,"document":"38325642","golden":false,"offsetInEndSection":1270,"text":"his case series demonstrates that the use of rapid exome sequencing is shifting the paradigm of diagnostics even in critical care situations and should be considered early on in children with acute encephalopathy. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32573669","golden":false,"offsetInEndSection":800,"text":"Importance: Widespread adoption of rapid genomic testing in pediatric critical care requires robust clinical and laboratory pathways that provide equitable and consistent service across health care systems.Objective: To prospectively evaluate the performance of a multicenter network for ultra-rapid genomic diagnosis in a public health care system.Design, Setting, and Participants: Descriptive feasibility study of critically ill pediatric patients with suspected monogenic conditions treated at 12 Australian hospitals between March 2018 and February 2019, with data collected to May 2019. A formal implementation strategy emphasizing communication and feedback, standardized processes, coordination, distributed leadership, and collective learning was used to facilitate adoption.Exposures: Ultra","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2533,"document":"32573669","golden":false,"offsetInEndSection":2713,"text":"n 14 patients (13%), and surveillance for specific complications was initiated in 19 patients (18%).Conclusions and Relevance: This study suggests feasibility of ultra-rapid genomi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35348890","golden":false,"offsetInEndSection":254,"text":"Rapid whole genome sequencing (WGS) and whole exome sequencing (WES), sometimes referred to as \"next generation sequencing\" (NGS) are now recommended by some experts as a first-line diagnostic test to diagnose infants with suspected monogenic conditions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"26938784","golden":false,"offsetInEndSection":169,"text":"PURPOSE: To prospectively evaluate the diagnostic and clinical utility of singleton whole-exome sequencing (WES) as a first-tier test in infants with suspected monogenic","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":154,"document":"29543227","golden":false,"offsetInEndSection":286,"text":"centers.METHODS: Rapid singleton whole-exome sequencing (rWES) was performed in acutely unwell pediatric patients with suspected mon","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":360,"document":"34327338","golden":false,"offsetInEndSection":555,"text":"CU setting.METHODS: rWES was performed on a prospective cohort of patients with suspected monogenic disorder referred from territory-wide paediatric ICUs and non-ICUs in Hong Kong urging for rapi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":81,"document":"35842091","golden":false,"offsetInEndSection":344,"text":"nd mortality. Rapid exome sequencing was introduced by the National Health Service (NHS) in England on 1st October 2019 for acutely unwell children with a likely monogenic disorder, or to inform current pregnancy management where there was a previously affected c","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":327,"document":"34143244","golden":false,"offsetInEndSection":627,"text":"On 1st October 2019, the National Health Service England (NHSE) launched a nationally commissioned service so that rapid whole-exome sequencing can be offered to critically unwell babies and children with a likely monogenic disorder who are admitted to NICU and paediatric intensive care unit (PICU).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35729264","golden":false,"offsetInEndSection":192,"text":"This monocentric study included fifteen children under a year old in intensive care with suspected monogenic conditions for rapid trio exome sequencing (rES) between April 2019 and April 2021.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1055,"document":"38325642","golden":false,"offsetInEndSection":1269,"text":"This case series demonstrates that the use of rapid exome sequencing is shifting the paradigm of diagnostics even in critical care situations and should be considered early on in children with acute encephalopathy.","beginSection":"abstract"}],"exact_answer":"","ideal_answer":[],"id":"677ed9ba592fa4887300002d","type":"yesno","body":"Is it feasible to use ultra-rapid exome sequencing in order to test critically ill infants and children with suspected monogenic conditions?"},{"documents":[{"golden":true,"id":"34042040"},{"golden":false,"id":"27330493"},{"golden":false,"id":"12867058"},{"golden":false,"id":"35546257"},{"golden":false,"id":"17229773"},{"golden":false,"id":"20350658"},{"golden":false,"id":"14717962"},{"golden":false,"id":"15340390"},{"golden":false,"id":"34966256"},{"golden":false,"id":"20526978"},{"golden":false,"id":"18083518"},{"golden":false,"id":"12917683"},{"golden":false,"id":"27667859"},{"golden":false,"id":"10710492"},{"golden":false,"id":"16131413"},{"golden":false,"id":"21763207"},{"golden":false,"id":"21539725"},{"golden":false,"id":"27797957"},{"golden":false,"id":"31178258"},{"golden":false,"id":"28540057"},{"golden":false,"id":"2894665"},{"golden":false,"id":"20012482"},{"golden":false,"id":"36383062"},{"golden":false,"id":"24136128"},{"golden":false,"id":"28770318"},{"golden":false,"id":"15660460"},{"golden":false,"id":"28779999"},{"golden":false,"id":"17144780"},{"golden":false,"id":"22827742"},{"golden":false,"id":"18353251"},{"golden":false,"id":"20627553"},{"golden":false,"id":"12658273"},{"golden":false,"id":"23317282"},{"golden":false,"id":"7823465"},{"golden":false,"id":"7971602"},{"golden":false,"id":"11521720"},{"golden":false,"id":"6254546"},{"golden":false,"id":"22431851"},{"golden":false,"id":"16368266"},{"golden":false,"id":"218186"},{"golden":false,"id":"2560266"},{"golden":false,"id":"6114911"},{"golden":false,"id":"15995303"},{"golden":false,"id":"15773538"},{"golden":false,"id":"9031099"},{"golden":false,"id":"24403266"},{"golden":false,"id":"29712568"},{"golden":false,"id":"34709986"},{"golden":false,"id":"32613752"},{"golden":false,"id":"34154614"},{"golden":false,"id":"25398449"},{"golden":false,"id":"25268550"},{"golden":false,"id":"30381260"},{"golden":false,"id":"36097345"},{"golden":false,"id":"30379568"},{"golden":false,"id":"33873250"},{"golden":false,"id":"23851113"},{"golden":false,"id":"16942861"},{"golden":false,"id":"21510963"},{"golden":false,"id":"19929763"},{"golden":false,"id":"25089880"},{"golden":false,"id":"17983317"},{"golden":false,"id":"22681697"},{"golden":false,"id":"7514332"},{"golden":false,"id":"23789973"},{"golden":false,"id":"9123943"},{"golden":false,"id":"36470990"},{"golden":false,"id":"6161301"},{"golden":false,"id":"17458649"},{"golden":false,"id":"12391935"},{"golden":false,"id":"6388495"},{"golden":false,"id":"15275567"},{"golden":false,"id":"24628581"},{"golden":false,"id":"15968260"},{"golden":false,"id":"23625971"},{"golden":false,"id":"26143936"},{"golden":false,"id":"11916069"},{"golden":false,"id":"25947283"},{"golden":false,"id":"27805502"},{"golden":false,"id":"20023895"},{"golden":false,"id":"28150439"},{"golden":false,"id":"34761121"},{"golden":false,"id":"23756388"},{"golden":false,"id":"35384866"},{"golden":false,"id":"12501697"},{"golden":false,"id":"3066876"},{"golden":false,"id":"6096847"},{"golden":false,"id":"25052484"},{"golden":false,"id":"10932824"},{"golden":false,"id":"11849841"},{"golden":false,"id":"32019718"},{"golden":false,"id":"3021829"},{"golden":false,"id":"22968194"},{"golden":false,"id":"6098948"},{"golden":false,"id":"2484045"},{"golden":false,"id":"1978278"},{"golden":false,"id":"18729096"},{"golden":false,"id":"18806202"},{"golden":false,"id":"27886407"},{"golden":false,"id":"36535551"},{"golden":false,"id":"29913017"},{"golden":false,"id":"34737044"},{"golden":false,"id":"36497081"},{"golden":false,"id":"31211448"},{"golden":false,"id":"28649604"},{"golden":false,"id":"36481435"},{"golden":false,"id":"31055236"},{"golden":false,"id":"31454546"},{"golden":false,"id":"14758473"},{"golden":false,"id":"35507019"},{"golden":false,"id":"23095375"},{"golden":false,"id":"33615007"},{"golden":false,"id":"32772978"},{"golden":false,"id":"34935228"},{"golden":false,"id":"17762320"},{"golden":false,"id":"20181238"},{"golden":false,"id":"34495324"},{"golden":false,"id":"18806702"},{"golden":false,"id":"29412539"},{"golden":false,"id":"24274737"},{"golden":false,"id":"2670240"},{"golden":false,"id":"18406313"},{"golden":false,"id":"11752612"},{"golden":false,"id":"31445162"},{"golden":false,"id":"23089283"},{"golden":false,"id":"2848776"},{"golden":false,"id":"11068911"},{"golden":false,"id":"7689439"},{"golden":false,"id":"6106495"},{"golden":false,"id":"1114952"},{"golden":false,"id":"17403543"},{"golden":false,"id":"3929079"},{"golden":false,"id":"12710585"},{"golden":false,"id":"12511974"},{"golden":false,"id":"22944299"},{"golden":false,"id":"24195524"},{"golden":false,"id":"8497455"},{"golden":false,"id":"6866956"},{"golden":false,"id":"21396858"},{"golden":false,"id":"2440471"},{"golden":false,"id":"12590887"},{"golden":false,"id":"34117864"},{"golden":false,"id":"25008355"},{"golden":false,"id":"24491088"},{"golden":false,"id":"33104039"},{"golden":false,"id":"26961542"},{"golden":false,"id":"25009275"},{"golden":false,"id":"20648655"},{"golden":false,"id":"26406122"},{"golden":false,"id":"24851801"},{"golden":false,"id":"11380735"},{"golden":false,"id":"19352696"},{"golden":false,"id":"26366588"},{"golden":false,"id":"23095902"},{"golden":false,"id":"17935771"},{"golden":false,"id":"36571847"},{"golden":true,"id":"38622249"},{"golden":false,"id":"39251364"},{"golden":false,"id":"39666171"},{"golden":false,"id":"37721280"},{"golden":false,"id":"39313800"},{"golden":false,"id":"39379705"},{"golden":false,"id":"37893474"},{"golden":false,"id":"22073131"},{"golden":false,"id":"38266061"},{"golden":false,"id":"37150935"},{"golden":false,"id":"15549350"},{"golden":false,"id":"39502574"},{"golden":false,"id":"24604708"},{"golden":false,"id":"33289575"},{"golden":false,"id":"22560009"},{"golden":false,"id":"6933216"},{"golden":true,"id":"35921451"},{"golden":true,"id":"34659081"},{"golden":false,"id":"33024310"},{"golden":false,"id":"1337388"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":176,"document":"34659081","golden":true,"offsetInEndSection":364,"text":"Objective: The study objective was to evaluate the efficacy and safety of prasinezumab, a humanized monoclonal antibody that binds aggregated alpha-synuclein, in individuals with early PD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":91,"document":"35921451","golden":true,"offsetInEndSection":437,"text":"\u0027s disease. The monoclonal antibody prasinezumab, directed at aggregated ?-synuclein, is being studied for its effect on Parkinson\u0027s disease.METHODS: In this phase 2 trial, we randomly assigned participants with early-stage Parkinson\u0027s disease in a 1:1:1 ratio to receive intravenous placebo or prasinezumab at a dose of 1500 mg or 4500 mg every ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":752,"document":"34042040","golden":true,"offsetInEndSection":1040,"text":"In this review, an overview of how alpha-synuclein contributes to Parkinson\u0027s disease and the effects of a few new immunotherapeutic treatments, including BIIB054 (cinpanemab), MEDI1341, AFFITOPE, and PRX002 (prasinezumab) that are currently under clinical development, will be discussed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17229773","golden":false,"offsetInEndSection":110,"text":"Trastuzumab is a humanized mAb directed against the extracellular domain of the tyrosine kinase receptor HER2.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":725,"document":"35921451","golden":false,"offsetInEndSection":1127,"text":"greater impairment). Secondary end points included the dopamine transporter levels in the putamen of the hemisphere ipsilateral to the clinically more affected side of the body, as measured by 123I-ioflupane single-photon-emission computed tomography (SPECT).RESULTS: A total of 316 participants were enrolled; 105 were assigned to receive placebo, 105 to receive 1500 mg of prasinezumab, and 106 to re","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"35921451","golden":false,"offsetInEndSection":57,"text":"Trial of Prasinezumab in Early-Stage Parkinson\u0027s Disease.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":231,"document":"20350658","golden":false,"offsetInEndSection":389,"text":"Direct signaling, complement-mediated cytotoxicity (CMC), and antibody-dependent cellular cytotoxicity (ADCC) all appear to play a role in rituximab efficacy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1800,"document":"35921451","golden":false,"offsetInEndSection":2164,"text":"groups and the placebo group. Serious adverse events occurred in 6.7% of the participants in the 1500-mg group and in 7.5% of those in the 4500-mg group; infusion reactions occurred in 19.0% and 34.0%, respectively.CONCLUSIONS: Prasinezumab therapy had no meaningful effect on global or imaging measures of Parkinson\u0027s disease progression as compared with placebo ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35921451","golden":false,"offsetInEndSection":90,"text":"BACKGROUND: Aggregated ?-synuclein plays an important role in the pathogenesis of Parkinso","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27330493","golden":false,"offsetInEndSection":184,"text":"Anti-tumor necrosis factor ? and anti-integrin biologic therapies are effective for induction and maintenance of remission in moderate to severe ulcerative colitis and Crohn\u0027s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":92,"document":"35921451","golden":true,"offsetInEndSection":223,"text":"s disease. The monoclonal antibody prasinezumab, directed at aggregated ?-synuclein, is being studied for its effect on Parkinson\u0027s","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34659081","golden":true,"offsetInEndSection":345,"text":"Background: Currently available treatments for Parkinson\u0027s disease (PD) do not slow clinical progression nor target alpha-synuclein, a key protein associated with the disease. Objective: The study objective was to evaluate the efficacy and safety of prasinezumab, a humanized monoclonal antibody that binds aggregated alpha-synuclein, in individ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":766,"document":"34042040","golden":false,"offsetInEndSection":1063,"text":", an overview of how alpha-synuclein contributes to Parkinson\u0027s disease and the effects of a few new immunotherapeutic treatments, including BIIB054 (cinpanemab), MEDI1341, AFFITOPE, and PRX002 (prasinezumab) that are currently under clinical development, will be discussed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":584,"document":"34042040","golden":false,"offsetInEndSection":764,"text":"h shows some positive outcomes on the efficacy by removing the aggregated species of alpha-synuclein, which is believed to be one of the causes of Parkinson\u0027s disease. In this revi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2029,"document":"35921451","golden":false,"offsetInEndSection":2208,"text":"rasinezumab therapy had no meaningful effect on global or imaging measures of Parkinson\u0027s disease progression as compared with placebo and was associated with infusion reactions. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":451,"document":"34659081","golden":false,"offsetInEndSection":727,"text":"lled treatment study. Individuals with early PD, recruited across the US and Europe, received monthly intravenous doses of prasinezumab (1,500 or 4,500 mg) or placebo for a 52-week period (Part 1), followed by a 52-week extension (Part 2) in which all participants received ac","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":225,"document":"35921451","golden":false,"offsetInEndSection":443,"text":"isease.METHODS: In this phase 2 trial, we randomly assigned participants with early-stage Parkinson\u0027s disease in a 1:1:1 ratio to receive intravenous placebo or prasinezumab at a dose of 1500 mg or 4500 mg every 4 week","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":579,"document":"34966256","golden":false,"offsetInEndSection":883,"text":"2-month data acquired from the PASADENA trial Part 1 (NCT03100149, n \u003d 76 participants who were allocated to the placebo arm and did not start symptomatic therapy) and the Parkinson\u0027s Progression Markers Initiative (PPMI) study (n \u003d 139 demographically and clinically matched participants). By using ridg","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"20526978","golden":false,"offsetInEndSection":137,"text":"Previous studies have demonstrated that action prediction involves an internal action simulation that runs time-locked to the real action","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":371,"document":"18083518","golden":false,"offsetInEndSection":534,"text":"ion theory assumes that we understand actions by simulating the observed behavior through a direct matching process that activates the mirror-neuron circuit. The a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":45,"document":"12917683","golden":false,"offsetInEndSection":207,"text":"ccording to the direct matching hypothesis, action understanding results from a mechanism that maps an observed action onto motor representations of that action. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":753,"document":"20526978","golden":false,"offsetInEndSection":986,"text":" linkage between action simulation and action semantics as two yet unrelated domains, a view that coincides with a recent notion of a close link between motor processes and the understanding of action language.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1388,"document":"18083518","golden":false,"offsetInEndSection":1559,"text":"port the assumption that action understanding in novel situations is primarily mediated by an inferential interpretive system rather than the mirror system.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":388,"document":"27667859","golden":false,"offsetInEndSection":618,"text":"I assess recent zombie action arguments regarding conscious visual experience, and I argue that contrary to what some have claimed, conscious visual experience plays a causal role for action control in some circumstances. Second, ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1628,"document":"10710492","golden":false,"offsetInEndSection":1842,"text":"hepatic galanin acts directly on the liver to selectively modulate norepinephrine\u0027s metabolic action, whereas endogenous hepatic NPY acts independently of NE to cause vasoconstriction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":947,"document":"16131413","golden":false,"offsetInEndSection":1127,"text":"onsistent with a connection between motor systems and implicit learning, but do not support the hypothesis that overt action is necessary for implicit learning.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":691,"document":"27667859","golden":false,"offsetInEndSection":997,"text":"this account, the experience of acting is (at the very least) a temporally extended, co-conscious collection of agentive and perceptual experiences, functionally integrated and structured both by multimodal perceptual processing as well as by what an agent is, at the time, trying to do.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28540057","golden":false,"offsetInEndSection":129,"text":"Treatment with rituximab, a monoclonal antibody against the B-lymphocyte surface protein CD20, leads to the depletion of B cells.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"21763207","golden":false,"offsetInEndSection":60,"text":"Antiepileptic drug therapy: does mechanism of action matter?","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":165,"document":"21763207","golden":false,"offsetInEndSection":454,"text":"Each speaker produced a short pr?cis of his lecture to answer a specific question, resulting in an overview of what we know about the relevance of the mechanisms of action of antiepileptic drugs in determining appropriate combination therapies for the treatment of drug-resistant epilepsy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21763207","golden":false,"offsetInEndSection":164,"text":"This article represents a synthesis of presentations made by the authors during a scientific meeting held in London on 7 June 2010 and organized by GlaxoSmithKline.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27797957","golden":false,"offsetInEndSection":124,"text":"Poly(ADP-ribose) polymerase (PARP) inhibitors are the first DNA damage response targeted agents approved for cancer therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":543,"document":"21539725","golden":false,"offsetInEndSection":659,"text":"This article reviews a set of molecules with a range of mechanisms that have been trialed but with negative results.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":131,"document":"36383062","golden":false,"offsetInEndSection":301,"text":"Their classical mechanisms of action are associated with binding to the sodium channel of insect neurons, disrupting its inactivation, ensuring their use as insecticides.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":425,"document":"2894665","golden":false,"offsetInEndSection":471,"text":"What is the mechanism of the favorable action?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":394,"document":"20012482","golden":false,"offsetInEndSection":697,"text":"Three anti-angiogenic tyrosine kinase inhibitors (TKIs), sunitinib, sorafenib and pazopanib, with differential binding capacities to angiogenic kinases were recently approved for treatment of patients with advanced cancer (renal cell cancer, gastro-intestinal stromal tumors, and hepatocellular cancer).","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"20012482","golden":false,"offsetInEndSection":78,"text":"Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":502,"document":"15660460","golden":false,"offsetInEndSection":702,"text":"Evaluation of serial synovial tissue samples has shown that effective treatment is associated with a reduction in synovial macrophages, independent of the specific mechanism of action of the compound.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":277,"document":"28540057","golden":false,"offsetInEndSection":360,"text":"MCD is thought to be T-cell mediated; how rituximab controls MCD is not understood.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":497,"document":"28540057","golden":false,"offsetInEndSection":717,"text":"We then discuss immunological features of this disease and potential mechanisms of action of rituximab in its treatment based on what is known about the therapeutic action of rituximab in other immune-mediated disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":718,"document":"28540057","golden":false,"offsetInEndSection":893,"text":"We believe that studies aimed at understanding the mechanisms of action of rituximab in MCD will provide a novel approach to resolve the elusive immune pathophysiology of MCD.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"28540057","golden":false,"offsetInEndSection":92,"text":"Rituximab in Minimal Change Disease: Mechanisms of Action and Hypotheses for Future Studies.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":130,"document":"28540057","golden":false,"offsetInEndSection":276,"text":"Recently, rituximab was reported to effectively prevent relapses of glucocorticoid-dependent or frequently relapsing minimal change disease (MCD).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":172,"document":"18353251","golden":false,"offsetInEndSection":614,"text":"Although the exact mechanism of action of IVIg has remained elusive, many theories have been postulated, including mononuclear phagocytic system blockade/inhibition, autoantibody neutralization by anti-idiotype antibodies, pathogenic autoantibody clearance due to competitive inhibition of the neonatal immunoglobulin Fc receptor, cytokine modulation, complement neutralization, and immune complex formation leading to dendritic cell priming.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":406,"document":"7971602","golden":false,"offsetInEndSection":571,"text":"Heparin inhibits growth factors binding to their receptors, oncogenes expression and has influence on the extracellular matrix protein deposition in the artery wall.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":125,"document":"27797957","golden":false,"offsetInEndSection":293,"text":"Here, we focus on their molecular mechanism of action by PARP \"trapping\" and what this means for both clinical monotherapy and combination with chemotherapeutic agents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1023,"document":"11521720","golden":false,"offsetInEndSection":1338,"text":"ws current knowledge of the mechanism of action of trastuzumab, including HER2 protein downregulation, prevention of HER2-containing heterodimer formation, initiation of G1 arrest and induction of p27, prevention of HER2 cleavage, inhibition of angiogenesis, and induction of immune mechanisms. The significance of ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1263,"document":"6254546","golden":false,"offsetInEndSection":1353,"text":"at PDE inhibition would be a fundamental mechanism of action of trapidil.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":471,"document":"22431851","golden":false,"offsetInEndSection":658,"text":"hanism of action of oritavancin is inhibition of transglycosylation (important in peptidoglycan synthesis) by binding to D-alanyl-D-alanine stem termini in Gram-positive bacteria. The inh","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":103,"document":"16368266","golden":false,"offsetInEndSection":323,"text":"e principal mechanism of action of memantine is believed to be the blockade of current flow through channels of N-methyl-d-aspartate (NMDA) receptors--a glutamate receptor subfamily broadly involved in brain function. Su","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":459,"document":"218186","golden":false,"offsetInEndSection":732,"text":"sion was drawn that the mechanism of the diuretic action of the epiphysis extracts consisted in the competitive suppression of the ADH action at the renal tubules level on account of excitation of the alpha-adrenoceptors and inhibition of the adenylcyclase activity.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"2560266","golden":false,"offsetInEndSection":58,"text":"The fundamental mechanism of inotropic action of digitalis","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1372,"document":"6114911","golden":false,"offsetInEndSection":1550,"text":"hether all pharmacological actions of the benzodiazepines (e.g. anxiolytic action, sedation, muscle relaxation) may be explained by the GABA-hypothesis. The existence of an endog","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":111,"document":"15995303","golden":false,"offsetInEndSection":386,"text":" putative accumulating hypothesis about the mechanism is the following;the involvement of local bone forming growth factors, such as insulin-like growth factor-I, anti-apoptotic actions through Runx2 and Smad3 etc, the transcriptional regulators, such as AP-1 and CREB. The r","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":426,"document":"15773538","golden":false,"offsetInEndSection":735,"text":"ticle describes the mechanism of action of retinoids, including how they are mediated through retinoic acid receptors (RARs) and retinoid X receptors (RXRs), how they block inflammation mediators, and how production of procollagen is increased to augment the formation of types I and III collagen. Three natur","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":993,"document":"9031099","golden":false,"offsetInEndSection":1232,"text":"umor models in vitro, CLL cells are generally not proliferating and studies in CLL cells have raised questions about the hypothesis that DNA crosslinking is the major mechanism of antitumor action for CLB in this disease. CLB induces apopt","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24403266","golden":false,"offsetInEndSection":195,"text":"Tigatuzumab is the humanized version of the agonistic murine monoclonal antibody TRA-8 that binds to the death receptor 5 and induces apoptosis of human cancer cell lines via the caspase cascade.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"24403266","golden":false,"offsetInEndSection":238,"text":"Phase 2, multicenter, open-label study of tigatuzumab (CS-1008), a humanized monoclonal antibody targeting death receptor 5, in combination with gemcitabine in chemotherapy-naive patients with unresectable or metastatic pancreatic cancer.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36097345","golden":false,"offsetInEndSection":297,"text":"A phase I trial (NCT03447314; 204686) evaluated the safety and efficacy of GSK1795091, a Toll-like receptor 4 (TLR4) agonist, in combination with immunotherapy (GSK3174998 [anti-OX40 monoclonal antibody], GSK3359609 [anti-ICOS monoclonal antibody], or pembrolizumab) in patients with solid tumors.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34709986","golden":false,"offsetInEndSection":187,"text":"Nonclinical safety evaluation, pharmacokinetics, and target engagement of Lu AF82422, a monoclonal IgG1 antibody against alpha-synuclein in development for treatment of synucleinopathies.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30379568","golden":false,"offsetInEndSection":222,"text":"Avelumab is a human anti-PD-L1 IgG1 monoclonal antibody that has shown antitumor activity in early phase studies in advanced/metastatic gastric/gastroesophageal junction cancer, including as first-line maintenance therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"29712568","golden":false,"offsetInEndSection":545,"text":"BACKGROUND: Modulation of the PD-1/PD-L1 axis through antagonist antibodies that block either receptor or ligand has been shown to reinvigorate the function of tumor-specific T cells and unleash potent anti-tumor immunity, leading to durable objective responses in a subset of patients across multiple tumor types.RESULTS: Here we describe the discovery and preclinical characterization of LY3300054, a fully human IgG1? monoclonal antibody that binds to human PD-L1 with high affinity and inhibits interactions of PD-L1 with its two cognate rec","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":196,"document":"24403266","golden":false,"offsetInEndSection":297,"text":"The combination of tigatuzumab and gemcitabine inhibits tumor growth in murine pancreatic xenografts.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":731,"document":"29712568","golden":false,"offsetInEndSection":992,"text":" reconstituted mice. LY3300054 is shown to induce primary T cell activation in vitro, increase T cell activation in combination with anti-CTLA4 antibody, and to potently enhance anti-tumor alloreactivity in several xenograft mouse tumor models with reconstitute","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32613752","golden":false,"offsetInEndSection":197,"text":"This modeling and simulation analysis was aimed at selecting doses of cinpanemab (BIIB054), a monoclonal antibody targeting aggregated ?-synuclein, for a phase II study in Parkinson\u0027s disease (PD).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":298,"document":"24403266","golden":false,"offsetInEndSection":507,"text":"This phase 2 trial evaluated the efficacy of tigatuzumab combined with gemcitabine in 62 chemotherapy-naive patients with histologically or cytologically confirmed unresectable or metastatic pancreatic cancer.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":339,"document":"33873250","golden":false,"offsetInEndSection":640,"text":"d computer animations to simulate actions in social groups initiated by visual action cues or category labels, and we measured differences in response times between identifying actions that were and were not consistent with group members, without explicit requirements regarding generalization. It was","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1282,"document":"23851113","golden":false,"offsetInEndSection":1482,"text":" that event segmentation may be critical for effective action production, and that the segmentation and production of activities may recruit the same event representation system. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":475,"document":"16942861","golden":false,"offsetInEndSection":638,"text":"ial prefrontal cortex is involved in implementing the goal-based action selection and the striatum is involved in implementing the utility-based action bias. Goal-","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":998,"document":"21510963","golden":false,"offsetInEndSection":1194,"text":"s demonstrate that actions encoded via the motor system have a direct effect on visual processing, and thus imply a bi-directional link between action and perception in the human brain. We suggest","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":866,"document":"19929763","golden":false,"offsetInEndSection":1077,"text":"s not response-modality specific; it was found for manual stimuli when participants prepared manual and vocal responses, in line with the hypothesis that action control is hierarchically organized. These results","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1379,"document":"25089880","golden":false,"offsetInEndSection":1639,"text":"nents who did have an action preference during the training phase resulted in improved anticipatory performance if the opponent continued to bias their throws towards their preferred direction, but decreased performance if the opponent did not. These findings ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":887,"document":"17983317","golden":false,"offsetInEndSection":1100,"text":"ng effects for repeating the target-to-movement mapping (i.e., the action rule) of a tool-use action and suggest that a rather abstract action schema is activated during action observation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":835,"document":"21510963","golden":false,"offsetInEndSection":995,"text":"nd experiment, we showed that this congruency effect was specific to action planning and not to more general semantic aspects of action representation. Our find","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":540,"document":"22681697","golden":false,"offsetInEndSection":751,"text":" of neural activity showed that the representation of the selected action was stronger in lateral prefrontal cortex (lPFC), and occurred earlier in the lPFC than it did in the dorsal striatum (dSTR). In contrast","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"7514332","golden":false,"offsetInEndSection":161,"text":"Experimental results suggest that protein kinase C (PK-C) may play a substantial role in the action of IFNs, but the precise biochemical pathway remains unknown.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":162,"document":"7514332","golden":false,"offsetInEndSection":311,"text":"Recent evidences reveal the complexity of the mechanism of IFN-action and show that the IFN-alpha, -beta and -gamma induced pathways are overlapping.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"7514332","golden":false,"offsetInEndSection":68,"text":"Signal transducing mechanisms in interferon action (a brief review).","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1010,"document":"9123943","golden":false,"offsetInEndSection":1117,"text":"They can bind to the genomic DNA in the nucleus and thus block transcription (Hoogsten-type base triplets).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":312,"document":"7514332","golden":false,"offsetInEndSection":428,"text":"We briefly discuss what is known in this field and suggest a way in which the contrasting views might be reconciled.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":293,"document":"23789973","golden":false,"offsetInEndSection":407,"text":"The extension of such mechanisms to language may occur only in sensorimotor circuits devoted to the action domain.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23789973","golden":false,"offsetInEndSection":128,"text":"I evaluate the bottlenecks involved in the simulation mechanism underpinning superior predictive abilities for upcoming actions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":710,"document":"9123943","golden":false,"offsetInEndSection":784,"text":"Three mechanisms of action have been reported for the oligonucleotides: 1.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":216,"document":"24628581","golden":false,"offsetInEndSection":356,"text":"It also prevents cell death by a known mechanism dependant on astrocytes and the secretion of the plasminogen activator inhibitor 1 (PAI-1).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":123,"document":"25947283","golden":false,"offsetInEndSection":362,"text":"Based upon the findings of in vitro experiments, its mode of action against MM occurs through a combination of direct tumoricidal effects on myeloma cells, modulatory effects on tumor immunity and tumor microenvironment-regulatory effects.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":133,"document":"24628581","golden":false,"offsetInEndSection":215,"text":"TGF?1 downregulates the activity of activated microglia and promotes astrogliosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":764,"document":"24628581","golden":false,"offsetInEndSection":888,"text":"This fact suggests that TGF?1 slows down the neurodegenerative process, preventing tissue damage and neural apoptotic death.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"24628581","golden":false,"offsetInEndSection":85,"text":"Potential neuroprotective role of transforming growth factor ?1 (TGF?1) in the brain.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":357,"document":"24628581","golden":false,"offsetInEndSection":569,"text":"This mechanism can provide light on what is the mechanism of action of TGF?1 as a protective factor and it can provide the pharmacological principles in which this pathway could be used with therapeutic purposes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24628581","golden":false,"offsetInEndSection":132,"text":"TGF?1 is a growth factor that is known to be expressed in most neurodegenerative diseases and after vascular accidents in the brain.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":570,"document":"24628581","golden":false,"offsetInEndSection":763,"text":"TGF?1 is upregulated in most neurodegenerative diseases, however, its expression appears dramatically blocked in Huntington\u0027s disease, the fastest of those diseases in progress after the onset.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"15968260","golden":false,"offsetInEndSection":210,"text":"The advent of new topical agents such as topical calcineurin inhibitors, as well as the reformulations of older agents in new vehicles, has broadened the treatment approaches to psoriasis and atopic dermatitis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1188,"document":"24628581","golden":false,"offsetInEndSection":1462,"text":"What possibly came as a surprise from the study of TGF?1 overexpressing models is that combining its neuroprotective and antiproliferative effects, this cytokine generates a significant disruption in the hippocampal circuitry with its consequent learning and memory deficit.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":239,"document":"35384866","golden":false,"offsetInEndSection":429,"text":"Numerous studies have demonstrated a multidirectional mechanism of action involving the effect of the drug on the adrenergic and cholinergic systems and the intracellular calcium metabolism.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":557,"document":"25947283","golden":false,"offsetInEndSection":805,"text":"To ascertain what is known and what remains to be elucidated with LEN, we review the current literature on the mode of action of LEN in association with myeloma pathophysiology, and discuss the prognostic indicators in the treatment of MM with LEN.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":822,"document":"23756388","golden":false,"offsetInEndSection":1047,"text":"It seems that mER is a complex containing signal proteins (signalosome), as IGF receptor, EGF receptor, Ras protein, adaptor protein Shc, non-receptor kinase c-Src and PI-3K, what rationalizes production of second messengers.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":21,"document":"11916069","golden":false,"offsetInEndSection":185,"text":"In 1994, Folkman and colleagues published a landmark paper describing anti-tumor effects in mice with a purified fragment of plasminogen they named angiostatin (1).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":392,"document":"33024310","golden":false,"offsetInEndSection":642,"text":"What we do not know is the ultimate mechanism of action; that is, how these drugs irreversibly terminate the \u0027individuality\u0027 of bacterial cells by removing barriers to the external world (cell envelopes) or by destroying their genetic identity (DNA).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25947283","golden":false,"offsetInEndSection":122,"text":"The long-term outcome of multiple myeloma (MM) has been greatly improved through new agents, one being lenalidomide (LEN).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":186,"document":"11916069","golden":false,"offsetInEndSection":419,"text":"Although many papers have been published describing activities of cryptic polypeptides derived from plasminogen fragments, this was the first report which associated plasminogen kringles 1-4 as a suppressor of metastasis development.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":503,"document":"12501697","golden":false,"offsetInEndSection":673,"text":"One is to destroy the normal function of the PrPC, the other is to raise the sensibility of the neuron to the free radical and increase the content of the oxygen radical.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":363,"document":"25947283","golden":false,"offsetInEndSection":556,"text":"However, it has not been clearly defined whether the clinical response and long-term outcome of MM with LEN treatment truly reflect the mechanisms of action of LEN proposed by in vitro studies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"10932824","golden":false,"offsetInEndSection":232,"text":"After more than a century of use, pharmacologists thought they had discovered the mechanism of action of nonsteroidal anti-inflammatory drugs (NSAIDs) when their inhibitory action on the production of prostaglandins was described. T","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1124,"document":"11849841","golden":false,"offsetInEndSection":1346,"text":"of action of parsley seems to be mediated through an inhibition of the Na+-K+ pump that would lead to a reduction in Na+ and K+ reabsorption leading thus to an osmotic water flow into the lumen, and diuresis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32019718","golden":false,"offsetInEndSection":336,"text":"Although the mechanism of action of sacral neuromodulation (SNM) is still not fully elucidated, it seems to involve modulation of spinal cord reflexes and brain networks by peripheral afferents according to findings from neurophysiology, electroencephalography, positron emission tomography, and magnetic resonance imaging studies. More","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"3021829","golden":false,"offsetInEndSection":209,"text":"In several recent reviews, we have suggested that the mechanism of action of retinoids in controlling cell differentiation is related to their effects on the expression of oncogenes and peptide growth factors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":726,"document":"22968194","golden":false,"offsetInEndSection":904,"text":", action retrieval from external stimuli is based on the detection of events in the environment to perform the intended behaviour (i.e., the sensorimotor mechanism). In this stud","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"6098948","golden":false,"offsetInEndSection":299,"text":"Although the detailed mechanism of action of NGF as it occurs in vivo still requires considerable clarification, a model in which NGF is generated by end organs of responsive neurons and interacts with these neurons to provide trophic stimulation and maintenance of viability seems highly plausible.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":664,"document":"2484045","golden":false,"offsetInEndSection":886,"text":"choungwamycin A is added, the mobility of the closed circular DNA increases gradually again, suggesting that the intercalation of chounghwamycin A in DNA is the primary mechanism of its action against tumor cells.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"1978278","golden":false,"offsetInEndSection":169,"text":"If beta-blockage does not cause lowering of aqueous humor secretion, in itself responsible for the maintenance of intraocular pressure, what is the mechanism of action? ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":547,"document":"18729096","golden":false,"offsetInEndSection":806,"text":"icle, we review the possible action mechanism of insulin-mimetic and antidiabetic vanadyl complexes, focusing on a recently proposed complex, bis(allixinato)oxovanadium(IV), with respect to the insulin-signaling pathway in cultured adipocytes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1082,"document":"18806202","golden":false,"offsetInEndSection":1353,"text":"of the procedure. Steam production during EVLA, which occurs early in the photothermolytic process when temperatures reach 100 degrees C, accounts for only 2% of applied energy dose, and is therefore unlikely to be the primary mechanism of action of thermal injury during","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":726,"document":"7543588","golden":false,"offsetInEndSection":939,"text":"We therefore conclude that a major mechanism of action of NB-DNJ as an inhibitor of HIV replication is the impairment of viral entry at the level of post-CD4 binding, due to an effect on viral envelope components.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":168,"document":"31687504","golden":false,"offsetInEndSection":314,"text":"Antimicrobial peptides exert various mechanisms such as changing cell membrane permeability which leads to inhibition or death of bacterial cells.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":747,"document":"25933611","golden":false,"offsetInEndSection":842,"text":"The drug acts by interfering with the fusion of the viral envelope with the endosomal membrane.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":547,"document":"31132753","golden":false,"offsetInEndSection":604,"text":"The mechanism of action of CEP is multifactorial. The dru","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":877,"document":"31633330","golden":false,"offsetInEndSection":1171,"text":"f action of these CQDs was revealed to be inhibition of HCoV-229E entry that could be due to interaction of the functional groups of the CQDs with HCoV-229E entry receptors; surprisingly, an equally large inhibition activity was observed at the viral replication step.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":398,"document":"17928345","golden":false,"offsetInEndSection":495,"text":"Rather, it blocks processing of viral structural proteins and assembly of mature progeny virions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31555430","golden":false,"offsetInEndSection":231,"text":"Dipeptidyl peptidase IV (DPP-4), an incretin glucagon-like peptide-1 (GLP-1) degrading enzyme, contains two forms and it can exert various physiological functions particular in controlling blood glucose through the action of GLP-1.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":135,"document":"17557078","golden":false,"offsetInEndSection":244,"text":"Extracellular effects of Trx1 require a functional active site, suggesting a redox-based mechanism of action.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":97,"document":"27886407","golden":false,"offsetInEndSection":867,"text":"\u0027s disease. PRX002 is an antibody that targets ?-synuclein, and its murine parent antibody 9E4 has been shown in preclinical studies to reduce ?-synuclein pathology and to protect against cognitive and motor deteriorations and progressive neurodegeneration in human ?-synuclein transgenic mice.METHODS: This first-in-human, randomized, double-blind, placebo-controlled, phase 1 study assessed the impact of PRX002 administered to 40 healthy participants in 5 ascending-dose cohorts (n?\u003d?8/cohort) in which participants were randomly assigned to receive a single intravenous infusion of study drug (0.3, 1, 3, 10, or 30?mg/kg; n?\u003d?6/cohort) or placebo (n?\u003d?2/cohort).RESULTS: PRX002 demonstrated favorable safety, tolerability, and pharmacokinetic profiles at all doses t","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"27886407","golden":false,"offsetInEndSection":100,"text":"First-in-human assessment of PRX002, an anti-?-synuclein monoclonal antibody, in healthy volunteers.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":96,"document":"29913017","golden":false,"offsetInEndSection":632,"text":"sease (PD). PRX002/RG7935 (PRX002) is a humanized monoclonal antibody designed to target aggregated forms of ?-synuclein, thereby inhibiting neuron-to-neuron transfer of presumed pathogenic forms of ?-synuclein, potentially resulting in neuronal protection and slowing disease progression.Objective: To evaluate the safety and tolerability of multiple intravenous infusions of PRX002 in patients with idiopathic PD.Design, Setting, and Participants: Multicenter, randomized, double-blind, placebo-controlled, multiple ascending-dose tri","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":529,"document":"28649604","golden":false,"offsetInEndSection":782,"text":"Notably, a recent study of solanezumab, an amyloid ? monoclonal antibody, raises hope for the further therapeutic potential of immunotherapy, not only in Alzheimer\u0027s disease, but also for other neurodegenerative disorders, including Parkinson\u0027s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1094,"document":"27886407","golden":false,"offsetInEndSection":1553,"text":"ross all doses was 18.2 days. A significant dose-dependent reduction in free serum ?-synuclein (unbound to PRX002) was apparent within 1 hour after PRX002 administration, whereas total ?-synuclein (free plus bound) increased dose-dependently, presumably because of the expected change in kinetics following antibody binding.CONCLUSIONS: This study demonstrates that serum ?-synuclein can be safely modulated in a dose-dependent manner after single intravenous","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1808,"document":"27886407","golden":false,"offsetInEndSection":1931,"text":"h Parkinson\u0027s disease. ? 2016 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of Internation","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":988,"document":"36497081","golden":false,"offsetInEndSection":1253,"text":"lded ?Syn degradation. The lead scFv- sMB08, was also tested for its ability to impact ?Syn aggregation as well as spreading and seeding.RESULTS: sMB08 was shown to protect neurons from misfolded ?Syn mediated toxicity, promote its intracellular degradation, and to","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36535551","golden":false,"offsetInEndSection":139,"text":"Anti-?-synuclein c-terminal antibodies block PFF uptake and accumulation of phospho-synuclein in preclinical models of Parkinson\u0027s disease.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27886407","golden":false,"offsetInEndSection":96,"text":"BACKGROUND: ?-Synuclein is a major component of pathologic inclusions that characterize Parkinso","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1554,"document":"27886407","golden":false,"offsetInEndSection":1787,"text":"infusions of an anti-?-synuclein antibody. These findings support continued development of PRX002, including further characterization of its safety, tolerability, pharmacokinetics, and pharmacodynamic effects in the central nervous s","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1283,"document":"14758473","golden":false,"offsetInEndSection":1438,"text":"s in the framework of theories invoking a strong overlap between representational structures for action perception and action planning.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"35507019","golden":false,"offsetInEndSection":66,"text":"Action prediction modulates self-other integration in joint action","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1077,"document":"35507019","golden":false,"offsetInEndSection":1193,"text":"s an effective agency cue modulating the amount of self-other integration in joint action.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":128,"document":"23095375","golden":false,"offsetInEndSection":449,"text":" Moreover, as a result of constant advances in medicine, medical technology and other sciences, and due to improvements in economic circumstances, cancer survival rates are increasing in Europe and prevalent cases (i.e. number of subjects who have experienced cancer) represent a growing proportion of the population. In ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":202,"document":"33615007","golden":false,"offsetInEndSection":316,"text":"is study seeks to disclose the interference of an implicit motor prediction effect during actions reconstruction. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32772978","golden":false,"offsetInEndSection":167,"text":"In this commentary on Osiurak and Reynaud\u0027s target article, we argue that action is largely missing in their account of the ascendance of human technological culture. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":238,"document":"14758473","golden":false,"offsetInEndSection":444,"text":"the present study we extended the paradigm to investigate both movements induced through watching the outcome of one\u0027s own as well as somebody else\u0027s action (player mode and observer mode respectively). We ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2270,"document":"34935228","golden":false,"offsetInEndSection":2549,"text":"tween TGF-?1 and VEGFR. In conclusion, this study identifies, for the first time, gap junction currents as crucial targets in the VEGF-A/VEGFR-mediated antifibrotic pathway and provides new insights into mechanisms behind the action of PRP in preventing differentiation of fibrob","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":713,"document":"17762320","golden":false,"offsetInEndSection":851,"text":"Zonisamide also inhibits low-threshold T-type calcium channels in neurons, which may prevent the spread of seizure discharge across cells.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":403,"document":"34935228","golden":false,"offsetInEndSection":882,"text":"s importance? This report clarifies the mechanisms mediating the antifibrotic action of PRP, strengthening the role of VEGF-A/VEGF receptor, and identifies gap junction currents and connexin 43 as novel targets of this pathway in the fibroblast-to-myofibroblast transition induced by the transforming growth factor-?1.ABSTRACT: Despite increasing experimental evidence, the antifibrotic potential of platelet-rich plasma (PRP) remains controversial, and its mechanisms of action ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1661,"document":"34935228","golden":false,"offsetInEndSection":2014,"text":"on and cell morphology. Neutralization of VEGF-A by blocking antibodies or pharmacological inhibition of VEGFR by KRN633 in TGF-?1-treated fibroblasts prevented the PRP-promoted effects, such as the reduction of voltage-dependent transjunctional currents in cell pairs and a decreased expression of connexin?43, the typical connexin isoform forming volt","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":883,"document":"34935228","golden":false,"offsetInEndSection":1137,"text":"re not fully clarified. This short report extends our previous research on the capability of PRP to prevent the in vitro differentiation of fibroblasts toward myofibroblasts, the key effectors of fibrosis, induced by the profibrotic agent transforming gr","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34935228","golden":false,"offsetInEndSection":142,"text":"Platelet-rich plasma affects gap junctional features in myofibroblasts in vitro via vascular endothelial growth factor (VEGF)-A/VEGF receptor.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1351,"document":"34935228","golden":false,"offsetInEndSection":1660,"text":" gap junction features. Electrophysiological and morphological analyses revealed that PRP hindered morphofunctional differentiation of both murine NIH/3T3 and human primary adult skin fibroblasts toward myofibroblasts as judged by the analysis of membrane phenomena, ?-smooth muscle actin and vinculin express","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":108,"document":"34935228","golden":false,"offsetInEndSection":282,"text":"for fibrosis. Increasing evidence supports the antifibrotic potential of platelet-rich plasma (PRP) as a source of bioactive molecules, such as vascular endothelial growth fa","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1138,"document":"34935228","golden":false,"offsetInEndSection":1350,"text":"wth factor-?1 (TGF-?1). In particular, we focused on the involvement of signalling mediated by vascular endothelial growth factor (VEGF)-A/VEGF receptor (VEGFR) in the PRP-induced fibroblast response, highlightin","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2015,"document":"34935228","golden":false,"offsetInEndSection":2137,"text":"ge-dependent connexons. The role of VEGF-A in inhibiting these events was confirmed by treating TGF-?1-stimulated fibrobla","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":707,"document":"1337388","golden":false,"offsetInEndSection":738,"text":"What is it mechanism of action?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":581,"document":"1337388","golden":false,"offsetInEndSection":645,"text":"Or a new compound with a selective action on serotonin reuptake?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":747,"document":"31445162","golden":false,"offsetInEndSection":813,"text":"MEDI1341 binds both monomeric and aggregated forms of ?-synuclein.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":814,"document":"31445162","golden":false,"offsetInEndSection":930,"text":"In vitro, MEDI1341 blocks cell-to-cell transmission of pathologically relevant ?-synuclein preformed fibrils (pffs).","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"31445162","golden":false,"offsetInEndSection":181,"text":"Preclinical development of a high affinity ?-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular ?-synuclein and attenuate ?-synuclein spreading in vivo.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":135,"document":"11068911","golden":false,"offsetInEndSection":500,"text":"The aims of this paper are to examine what is currently known about its mechanism of action, to compare the action with that of a widely investigated aliphatic dialdehyde, glutaraldehyde (GTA), and to put forward a hypothesis that would, in the light of current knowledge, explain how OPA inactivates micro-organisms, including GTA-resistant Mycobacterium chelonae.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":739,"document":"1337388","golden":false,"offsetInEndSection":853,"text":"What other antalgic effects do carbamazepine and baclofen possess apart from their action on trigeminal neuralgia?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":551,"document":"1337388","golden":false,"offsetInEndSection":580,"text":"A first-generation tricyclic?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":417,"document":"1337388","golden":false,"offsetInEndSection":498,"text":"What component of neuropathic pain do they relieve, and through which mechanisms?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":737,"document":"6106495","golden":false,"offsetInEndSection":1043,"text":"The hypothesis that the anticonvulsant actions of these drugs may be due to their ability to enhance the actions of GABA at CNS synapses is an attractive one, but many questions remain: Do all CNS benzodiazepine receptors interact with GABA sites, and are all GABA receptors linked to benzodiazepine sites?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":489,"document":"3929079","golden":false,"offsetInEndSection":855,"text":"stantial evidence is presented which indicates that the analogue most probably acts by its utilisation in the synthesis of diadenosine tetraphosphate (Ap4A) to form an antimetabolite(s) of Ap4A which subsequently interferes with Ap4A-mediated intracellular events, amongst which an effect on DNA repair would appear to be its mutagenic mechanism of action.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1363,"document":"12710585","golden":false,"offsetInEndSection":1577,"text":"s our understanding of the mechanisms of action of rituximab and identifies how this knowledge could be applied in a clinical setting to maximize response in both sensitive and resistant patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":290,"document":"12511974","golden":false,"offsetInEndSection":427,"text":"he mechanism of dynamin\u0027s action is still a subject of debate - whether it functions as a mechanochemical enzyme or a regulatory GTPase. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1035,"document":"22944299","golden":false,"offsetInEndSection":1227,"text":" that the Tregitope mechanism of action is to induce Tregs to respond, leading to production of regulatory signals, followed by modulation of dendritic cell phenotype. The identification of Tr","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"24195524","golden":false,"offsetInEndSection":45,"text":"Trabectedin mechanism of action: what\u0027s new?","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":751,"document":"8497455","golden":false,"offsetInEndSection":858,"text":"of fibrates is to promote the secretion of LDL which is cleared by a receptor-mediated mechanism. Catabolis","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":596,"document":"6866956","golden":false,"offsetInEndSection":734,"text":"hanism of parathyroid hormone diuretic action is likely to be due to intensified calcium ion inclusion into the renal tubular cells.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":431,"document":"21396858","golden":false,"offsetInEndSection":612,"text":"py. It was hypothesized that the mechanism of action of stinging nettles is both biochemical and mechanical, which may have clinical significance regarding treatment for acute expos","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":959,"document":"2440471","golden":false,"offsetInEndSection":1193,"text":"of these results, a model for the mechanism of action of I alpha I is proposed: Proteinase can react with either of two independent sites on I alpha I to form an inhibitory complex or a complex that leads to proteolysis. Both reaction","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":480,"document":"12590887","golden":false,"offsetInEndSection":624,"text":" will discuss the mechanism of action of BPs, focusing on alendronate and risedronate, which are the two agents most widely studied. They act on","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1190,"document":"34117864","golden":false,"offsetInEndSection":1381,"text":"These findings further indicate that NPT520-34 may have two complementary actions: (i) to increase the clearance of neurotoxic protein aggregates; and (ii) to directly attenuate inflammation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":142,"document":"34117864","golden":false,"offsetInEndSection":265,"text":"The therapeutic potential of NPT520-34 was first suggested by findings from cell-based assays of alpha-synuclein clearance.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":63,"document":"20648655","golden":false,"offsetInEndSection":64,"text":".","beginSection":"title"},{"endSection":"title","offsetInBeginSection":0,"document":"34117864","golden":false,"offsetInEndSection":104,"text":"NPT520-34 improves neuropathology and motor deficits in a transgenic mouse model of Parkinson\u0027s disease.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":782,"document":"34117864","golden":false,"offsetInEndSection":981,"text":"In a lipopolysaccharide-challenge model using wild-type mice, a single dose of NPT520-34 reduced lipopolysaccharide-evoked increases in the expression of several pro-inflammatory cytokines in plasma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":982,"document":"34117864","golden":false,"offsetInEndSection":1189,"text":"These findings demonstrate the beneficial effects of NPT520-34 on both inflammation and protein-pathology end points, with consequent improvements in motor function in an animal model of Parkinson\u0027s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":904,"document":"36571847","golden":false,"offsetInEndSection":1102,"text":"This study provides preclinical evidence for ACT as a potential immunotherapy for LBD, PD and other related SPs, and future work will provide necessary understanding of the mechanisms of its action.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":266,"document":"34117864","golden":false,"offsetInEndSection":523,"text":"As reported here, NPT520-34 was subsequently evaluated for therapeutically relevant actions in a transgenic animal model of Parkinson\u0027s disease that overexpresses human alpha-synuclein and in an acute lipopolysaccharide-challenge model using wild-type mice.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":524,"document":"34117864","golden":false,"offsetInEndSection":781,"text":"Daily administration of NPT520-34 to mThy1-alpha-synuclein (Line 61) transgenic mice for 1 or 3 months resulted in reduced alpha-synuclein pathology, reduced expression of markers of neuroinflammation, and improvements in multiple indices of motor function.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34117864","golden":false,"offsetInEndSection":141,"text":"NPT520-34 is a clinical stage, small molecule being developed for the treatment of Parkinson\u0027s disease and other neurodegenerative disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":626,"document":"11380735","golden":false,"offsetInEndSection":761,"text":"rnal and internal factors. Based on these findings, the antecedents and consequences of this type of action are identified and the proc","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1093,"document":"19352696","golden":false,"offsetInEndSection":1298,"text":"g was observed when both action choice and action timing were internally generated or externally specified, compared to conditions where the two parameters were selected by different routes. Our result sug","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":393,"document":"11380735","golden":false,"offsetInEndSection":471,"text":" or purpose.DESIGN: This concept analysis reflects a comprehensive review of t","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":986,"document":"26366588","golden":false,"offsetInEndSection":1158,"text":"eriments, we apply the mined part detectors as a visual vocabulary to the task of action recognition on four datasets: KTH, Olympic Sports, UCF50, and HMDB51. The experimen","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":301,"document":"19352696","golden":false,"offsetInEndSection":450,"text":"easured the experience of action using the subjective compression of the interval between actions and their effects, known as \u0027temporal binding\u0027. Par","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":120,"document":"23095902","golden":false,"offsetInEndSection":304,"text":"roke rehabilitation. Currently, it is not clear to what extent their underlying neuronal mechanisms differ from each other and whether one of these therapeutic options might be prefera","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":568,"document":"17935771","golden":false,"offsetInEndSection":734,"text":"tes to this body of work by showing that verbs that leave direction ambiguous (e.g. \"turned\") do not necessarily yield such effects. Rather, motor resonance is associ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":907,"document":"11380735","golden":false,"offsetInEndSection":1260,"text":"d demonstrates its continuous nature. Areas for further inquiry include exploration of the effect of factors such as self-efficacy, motivation, self-esteem, managed care and reduced health care resources on intention and subsequent action; as well as the efficacy of nursing interventions designed to influence health behaviour such as health promotion ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38622249","golden":true,"offsetInEndSection":169,"text":"Prasinezumab, a monoclonal antibody that binds aggregated ?-synuclein, is being investigated as a potential disease-modifying therapy in early-stage Parkinson\u0027s disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":690,"document":"39251364","golden":false,"offsetInEndSection":873,"text":"Monoclonal antibodies (mAbs) are biological drugs with high specificity, and Prasinezumab (PRX002) is an mAb currently in Phase II, which targets the C-terminus (AA 118-126) of ?-syn.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":103,"document":"35921451","golden":true,"offsetInEndSection":458,"text":"The monoclonal antibody prasinezumab, directed at aggregated ?-synuclein, is being studied for its effect on Parkinson\u0027s disease.METHODS: In this phase 2 trial, we randomly assigned participants with early-stage Parkinson\u0027s disease in a 1:1:1 ratio to receive intravenous placebo or prasinezumab at a dose of 1500 mg or 4500 mg every 4 weeks for 52 weeks.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1355,"document":"38622249","golden":false,"offsetInEndSection":1625,"text":"In these subpopulations, the effect of prasinezumab on slowing motor signs progression (MDS-UPDRS Part III) was greater in the rapidly progressing subpopulations (for example, participants who were diffuse malignant or taking monoamine oxidase B inhibitors at baseline).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":595,"document":"39666171","golden":false,"offsetInEndSection":863,"text":"Specifically, UB-312, AFFITOPE PD01A, PD03A and ACI-7104.056 are designed to provoke an immune response against ?-syn (active immunisation), while Prasinezumab and Cinpanemab, MEDI1341 and Lu AF82422 focus on directly targeting ?-syn aggregates (passive immunisation).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1113,"document":"39313800","golden":false,"offsetInEndSection":1286,"text":"Similarly, in Parkinson\u0027s disease (PD), DMTs utilizing anti-?Syn (MAbs) (e.g., prasinezumab, cinpanemab,) are progressively being developed and evaluated in clinical trials.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":662,"document":"38622249","golden":false,"offsetInEndSection":1354,"text":"Prasinezumab\u0027s potential effects on disease progression were assessed in four prespecified and six exploratory subpopulations of PASADENA: use of monoamine oxidase B inhibitors at baseline (yes versus no); Hoehn and Yahr stage (2 versus 1); rapid eye movement sleep behavior disorder (yes versus no); data-driven subphenotypes (diffuse malignant versus nondiffuse malignant); age at baseline (?60?years versus \u003c60?years); sex (male versus female); disease duration (\u003e12?months versus \u003c12?months); age at diagnosis (?60?years versus \u003c60?years); motor subphenotypes (akinetic-rigid versus tremor-dominant); and motor subphenotypes (postural instability gait dysfunction versus tremor-dominant).","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38622249","golden":false,"offsetInEndSection":92,"text":"Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson\u0027s disease.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":322,"document":"37721280","golden":false,"offsetInEndSection":506,"text":"Successful preclinical studies with coenzyme Q10, mitoquinone, isradipine, nilotinib, TCH346, neurturin, zonisamide, deferiprone, prasinezumab, and cinpanemab prompted clinical trials.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":679,"document":"37893474","golden":false,"offsetInEndSection":1187,"text":"Accumulating preclinical and clinical evidence shows that several agents may provide beneficial effects on patients with PD and cognitive impairment, including ceftriaxone, ambroxol, intranasal insulin, nilotinib, atomoxetine, mevidalen, blarcamesine, prasinezumab, SYN120, ENT-01, NYX-458, GRF6021, fosgonimeton, INT-777, Neuropeptide S, silibinin, osmotin, cordycepin, huperzine A, fibroblast growth factor 21, Poloxamer 188, ginsenoside Rb1, thioredoxin-1, tangeretin, istradefylline and Eugenia uniflora.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1078,"document":"22073131","golden":false,"offsetInEndSection":1350,"text":"Taken together, our results propose that extracellular administration of monoclonal antibodies can modify or inhibit early steps in the aggregation process of ?-synuclein, thus providing further support for passive immunization against diseases with ?-synuclein pathology.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":490,"document":"38266061","golden":false,"offsetInEndSection":622,"text":"isankizumab binds to the p19 subunit of IL-23 and inhibits IL-23 from interacting with the IL-23 receptor and subsequent signaling. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39379705","golden":false,"offsetInEndSection":237,"text":"The Phase II trial of Anti-alpha-Synuclein Antibody in Early Parkinson\u0027s Disease (PASADENA) is an ongoing double-blind, placebo-controlled trial evaluating the safety and efficacy of prasinezumab in early-stage Parkinson\u0027s disease (PD).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37150935","golden":false,"offsetInEndSection":179,"text":"Rozibafusp alfa (AMG 570) is a first-in-class bispecific IgG2-peptide fusion designed to inhibit inducible T-cell costimulator ligand (ICOSL) and B-cell activating factor (BAFF).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1593,"document":"39251364","golden":false,"offsetInEndSection":1692,"text":"The predicted binding affinity shows a strong antibody-antigen attraction between PRX002 and ?-syn.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":874,"document":"39251364","golden":false,"offsetInEndSection":1048,"text":"We utilized BioLuminate and PyMol for the structure prediction and preparation of the fragment antigen-binding (Fab) region of PRX002 and 34 different conformations of ?-syn.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1440,"document":"39251364","golden":false,"offsetInEndSection":1530,"text":"Hydrogen bonds were shown to form frequently between the HCDR2 region of PRX002 and ?-syn.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39379705","golden":false,"offsetInEndSection":800,"text":"The Phase II trial of Anti-alpha-Synuclein Antibody in Early Parkinson\u0027s Disease (PASADENA) is an ongoing double-blind, placebo-controlled trial evaluating the safety and efficacy of prasinezumab in early-stage Parkinson\u0027s disease (PD). During the double-blind period, prasinezumab-treated individuals showed less progression of motor signs (Movement Disorders Society-sponsored revision of the Unified Parkinson\u0027s Disease Rating Scale (MDS-UPDRS) Part?III) than placebo-treated individuals. We evaluated whether the effect of prasinezumab on motor progression, assessed as a change in MDS-UPDRS Part?III score in the OFF and ON states, and MDS-UPDRS Part?II score, was sustained for 4?years from the start of the trial. We compared participants enrolled in the PASADENA open-label extension study wi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35921451","golden":true,"offsetInEndSection":800,"text":"BACKGROUND: Aggregated ?-synuclein plays an important role in the pathogenesis of Parkinson\u0027s disease. The monoclonal antibody prasinezumab, directed at aggregated ?-synuclein, is being studied for its effect on Parkinson\u0027s disease.METHODS: In this phase 2 trial, we randomly assigned participants with early-stage Parkinson\u0027s disease in a 1:1:1 ratio to receive intravenous placebo or prasinezumab at a dose of 1500 mg or 4500 mg every 4 weeks for 52 weeks. The primary end point was the change from baseline to week 52 in the sum of scores on parts I, II, and III of the Movement Disorder Society-sponsored revision of the Unified Parkinson\u0027s Disease Rating Scale (MDS-UPDRS; range, 0 to 236, with higher scores indicating greater impairment). Secondary end points included the dopamine transporter","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":91,"document":"35921451","golden":true,"offsetInEndSection":220,"text":"\u0027s disease. The monoclonal antibody prasinezumab, directed at aggregated ?-synuclein, is being studied for its effect on Parkinso","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":473,"document":"34659081","golden":false,"offsetInEndSection":742,"text":"Individuals with early PD, recruited across the US and Europe, received monthly intravenous doses of prasinezumab (1,500 or 4,500 mg) or placebo for a 52-week period (Part 1), followed by a 52-week extension (Part 2) in which all participants received active treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":631,"document":"22560009","golden":false,"offsetInEndSection":874,"text":"The purpose of this review, mainly based on preclinical data, is to present the pharmacological and biochemical evidence demonstrating that serotonergic neurons are mainly involved in the enhancement of dopamine transmission induced by L-DOPA.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":816,"document":"15549350","golden":false,"offsetInEndSection":1125,"text":"Although the exact pathogenesis of MS is not fully understood, current knowledge has already led to the development of effective treatments, namely interferon (IFN) 3 and glatiramer acetate, both of which have been shown to reduce relapse rates, while IFN 3- 1 a also reduces confirmed disability progression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":744,"document":"33024310","golden":false,"offsetInEndSection":990,"text":"In this Perspective, we consider what our knowledge of the proximate mechanisms of action of antibiotics and the pharmacodynamics of?their interaction with bacteria tell us about the ultimate mechanisms by which these antibiotics kill bacteria.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":199,"document":"1337388","golden":false,"offsetInEndSection":983,"text":"To date, only the antidepressants and the anticonvulsants have shown any effectiveness, albeit incomplete and inconsistent, and many questions remain unanswered: What are the exact indications for the antidepressants? What component of neuropathic pain do they relieve, and through which mechanisms? Which type of antidepressants should be prescribed? A first-generation tricyclic? Or a new compound with a selective action on serotonin reuptake? What are the effective dosage and duration of the treatment? What is it mechanism of action? What other antalgic effects do carbamazepine and baclofen possess apart from their action on trigeminal neuralgia? The opiates are generally considered to be without effect, but recent clinical and experimental findings seem to point otherwise.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":815,"document":"6933216","golden":false,"offsetInEndSection":956,"text":"Confusion over the actions of dopamine underlies the obscurity of the mechanisms by which levodopa produces both wanted and unwanted effects.","beginSection":"abstract"}],"ideal_answer":[],"id":"63adca61c6c7d4d31b00001c","type":"summary","body":"What is the mechanism of action of Prasinezumab?"},{"documents":[{"golden":true,"id":"39273517"},{"golden":false,"id":"35628659"},{"golden":true,"id":"31936524"},{"golden":true,"id":"35327996"},{"golden":false,"id":"25345092"},{"golden":false,"id":"37628632"},{"golden":false,"id":"34013567"},{"golden":false,"id":"32618096"},{"golden":false,"id":"32188113"},{"golden":false,"id":"30049674"},{"golden":false,"id":"30442161"},{"golden":false,"id":"38482704"},{"golden":false,"id":"38488524"},{"golden":false,"id":"36153662"},{"golden":false,"id":"19852785"},{"golden":false,"id":"23657977"},{"golden":false,"id":"36232726"},{"golden":false,"id":"1294876"},{"golden":false,"id":"36578769"},{"golden":false,"id":"31959364"},{"golden":false,"id":"20532982"},{"golden":false,"id":"24389823"},{"golden":false,"id":"39397911"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":512,"document":"35628659","golden":false,"offsetInEndSection":759,"text":"Mucopolysaccharidosis-Plus Syndrome (MPSPS), an autosomal recessive disease caused by a mutation in the endo-lysosomal tethering protein VPS33A, shows additional renal and hematopoietic abnormalities (\"Plus symptoms\") uncommon in conventional MPS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":144,"document":"35628659","golden":false,"offsetInEndSection":511,"text":"Conventional MPS, caused by inborn deficiencies of lysosomal enzymes involved in GAG degradation, display various multisystemic symptoms-including progressive neurological complications, ophthalmological disorders, hearing loss, gastrointestinal and hepatobiliary issues, cardiorespiratory problems, bone and joint abnormalities, dwarfism, and coarse facial features.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1056,"document":"39273517","golden":true,"offsetInEndSection":1333,"text":"Moreover, we asked the question whether MPSPS should be classified as a type of MPS or a separate disease, as contrary to \u0027classical\u0027 MPS types, despite GAG accumulation, no defects in lysosomal enzymes responsible for degradation of these compounds could be detected in MPSPS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1334,"document":"39273517","golden":false,"offsetInEndSection":1470,"text":"The molecular mechanism of the appearance of GAG accumulation in MPSPS is suggested on the basis of results available in the literature.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38482704","golden":false,"offsetInEndSection":205,"text":"INTRODUCTION: Mucopolysaccharidosis type III (MPS III), also known as Sanfilippo syndrome, is a lysosomal storage disease with progressive neurodegenerative features, predominantly affecting the central ne","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":570,"document":"30442161","golden":false,"offsetInEndSection":689,"text":"owever, although they have individual peculiarities, often signs and symptoms may overlap between different MPS types. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38488524","golden":false,"offsetInEndSection":141,"text":"Mucopolysaccharidosis type IIIB (MPS IIIB) is caused by deficiency of alpha-N-acetylglucosaminidase, leading to storage of heparan sulphate.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":964,"document":"39273517","golden":false,"offsetInEndSection":1055,"text":"Here, we discuss the pathomechanisms and symptoms of MPSPS, comparing them to those of MPS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":336,"document":"31959364","golden":false,"offsetInEndSection":557,"text":"The most common symptoms are short stature, facial dysmorphism, chronic articular pains that can mimic chronic inflammatory rheumatism, axial and peripheral bone involvement, hepatosplenomegaly and an early carpal tunnel.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39273517","golden":true,"offsetInEndSection":450,"text":"Several years ago, dozens of cases were described in patients with symptoms very similar to mucopolysaccharidosis (MPS). This new disease entity was described as mucopolysaccharidosis-plus syndrome (MPSPS). The name of the disease indicates that in addition to the typical symptoms of conventional MPS, patients develop other features such as congenital heart defects and kidney and hematopoietic system disorders. The symptoms are highly advanced, a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35628659","golden":false,"offsetInEndSection":450,"text":"Mucopolysaccharidoses (MPS) are rare lysosomal storage disorders (LSD) characterized by the excessive accumulation of glycosaminoglycans (GAG). Conventional MPS, caused by inborn deficiencies of lysosomal enzymes involved in GAG degradation, display various multisystemic symptoms-including progressive neurological complications, ophthalmological disorders, hearing loss, gastrointestinal and hepatobiliary issues, cardiorespiratory problems, bone a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35327996","golden":true,"offsetInEndSection":450,"text":"Mucopolysaccharidosis-plus syndrome (MPS-PS) is a novel autosomal recessive disorder caused by a mutation in the VPS33A gene. This syndrome presents with typical symptoms of mucopolysaccharidosis, as well as congenital heart defects, renal, and hematopoietic system disorders. To date, twenty-four patients have been described. There is no specific therapy for MPS-PS; clinical management is therefore limited to symptoms management. The clinical cou","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":721,"document":"31936524","golden":true,"offsetInEndSection":883,"text":"In addition to typical symptoms for conventional MPS, MPSPS patients developed other features such as congenital heart defects, renal and hematopoietic disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23657977","golden":false,"offsetInEndSection":455,"text":"Mucopolysaccharidosis type VI (MPS VI, Maroteaux-Lamy syndrome, MIM 253200 ) is an autosomal recessive lysosomal storage disease (LSD) caused by decreased activity of arylsulfatase B (N-acetylgalactosamine 4-sulfatase) enzyme resulting in dermatan sulfate accumulation; mucopolysaccharidosis type IVA (MPS IVA, Morquio syndrome A, MIM 253000 ) by decreased activity of N-acetylgalactosamine 6-sulfatase enzyme resulting in accumulation of keratan sulfate.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35327996","golden":false,"offsetInEndSection":125,"text":"Mucopolysaccharidosis-plus syndrome (MPS-PS) is a novel autosomal recessive disorder caused by a mutation in the VPS33A gene.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1506,"document":"19852785","golden":false,"offsetInEndSection":1809,"text":"nzyme testing will determine the MPS type. If uGAG analysis is unavailable and the patient exhibits any other common sign or symptom of an MPS disorder, such as corneal clouding, history of hernia surgery, frequent respiratory and/or ear, nose and throat infections; carpal tunnel syndrome, or heart mur","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":92,"document":"30049674","golden":false,"offsetInEndSection":290,"text":"In comparison to Hurler syndrome (MPS I) and Hunter syndrome (MPS II), characteristic facial and physical features tend to be milder and progression of neurological symptoms may initially be slower.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24389823","golden":false,"offsetInEndSection":155,"text":"OBJECTIVE: Mucopolysaccharidosis IVA (MPS IVA, or Morquio A syndrome) and VI (MPS VI, or Maroteaux-Lamy syndrome) are autosomal recessive lysosomal storage","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1122,"document":"36153662","golden":false,"offsetInEndSection":1360,"text":"As in the infantile form of mucopolysaccharidosis plus, the endocytic compartment in the fibroblasts also expanded-a phenomenon accompanied by increased endolysosomal acidification and impaired intracellular glycosphingolipid trafficking.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1111,"document":"39397911","golden":false,"offsetInEndSection":1274,"text":"Mucopolysaccharidoses, being a group of complicated disorders, are difficult to manage, and many symptoms can be missed in children due to intellectual disability.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1428,"document":"20532982","golden":false,"offsetInEndSection":1620,"text":"In summary, Scheie syndrome usually emerges during childhood, and recognition of attenuated MPS I requires awareness of the multisystemic disease manifestations and their diverse presentation.","beginSection":"abstract"}],"exact_answer":[],"ideal_answer":[],"id":"6772c17f592fa48873000004","type":"list","body":"Please list the symptoms that differentiate mucopolysaccharidosis-plus syndrome (MPSPS) from mucopolysaccharidosis."},{"documents":[{"golden":true,"id":"31268959"},{"golden":false,"id":"27104117"},{"golden":false,"id":"28602057"},{"golden":true,"id":"38624049"},{"golden":false,"id":"37196480"},{"golden":true,"id":"24911410"},{"golden":false,"id":"28807918"},{"golden":true,"id":"28640481"},{"golden":false,"id":"37458801"},{"golden":false,"id":"39418020"},{"golden":true,"id":"22751271"},{"golden":false,"id":"38797069"},{"golden":false,"id":"39053195"},{"golden":true,"id":"38250111"},{"golden":false,"id":"34130638"},{"golden":true,"id":"17272941"},{"golden":false,"id":"25753334"},{"golden":true,"id":"30744586"},{"golden":false,"id":"25822011"},{"golden":true,"id":"28277100"},{"golden":false,"id":"38148118"},{"golden":true,"id":"31278360"},{"golden":false,"id":"32039402"},{"golden":false,"id":"27064263"},{"golden":false,"id":"31772880"},{"golden":false,"id":"39273517"},{"golden":false,"id":"35628659"},{"golden":false,"id":"37628632"},{"golden":false,"id":"35327996"},{"golden":false,"id":"24079810"},{"golden":false,"id":"29362698"},{"golden":true,"id":"38900653"},{"golden":false,"id":"18089149"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":0,"document":"27104117","golden":false,"offsetInEndSection":388,"text":"BACKGROUND: The purpose is to investigate the clinical significance of body morphomics changes in stage III-IV oropharyngeal cancer patients during concurrent chemoradiotherapy (CRT).METHODS: Fifty patients who underwent CRT were selected for body composition analyses by either availability of pre/post treatment DEXA scans or a novel CT-based approach of body morphomics analysis (BMA).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31268959","golden":true,"offsetInEndSection":248,"text":"Body composition analysis, also referred to as analytic morphomics, morphomics, or morphometry, describes the measurement of imaging biomarkers of body composition such as muscle and adipose tissue, most commonly on computed tomography (CT) images.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":969,"document":"27104117","golden":false,"offsetInEndSection":1214,"text":"Total psoas area is more sensitive for local recurrence than weight changes and T-stage on multivariate analyses.CONCLUSIONS: BMA specifically evaluating psoas area appears to correlate with head and neck cancer quality of life physical domains.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1496,"document":"24911410","golden":true,"offsetInEndSection":1741,"text":"Only visceral fat area retained its predictive ability in patients with a BMI?\u003e?30 kg/m(2).CONCLUSIONS: Morphomic measurements correlate with the likelihood of developing postoperative donor site dehiscence after DIEP flap breast reconstruction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":141,"document":"28602057","golden":false,"offsetInEndSection":458,"text":"We aimed to utilize analytic morphomics, a high-throughput imaging analysis, to assess if body composition is predictive of post-TACE survival.MATERIALS AND METHODS: We included patients from a single center (Ann Arbor VA)who had TACE as the primary treatment forHCC and had a pre-treatment computed tomography scans.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1156,"document":"28640481","golden":true,"offsetInEndSection":1409,"text":"On multivariate modeling, visceral fat area was an independent predictor of PTDM (OR\u003d1.91, P\u003d.035).CONCLUSIONS: Analytic morphomics can identify pre-transplant measurements of body composition that are predictive of PTDM in kidney transplant recipients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38624049","golden":true,"offsetInEndSection":142,"text":"Analytic morphomics refers to the accurate measurement of specific biological markers of human body composition in diagnostic medical imaging.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"22751271","golden":true,"offsetInEndSection":663,"text":"BACKGROUND: Muscle dysmorphia (MD) has been described as a male body image disorder, characterized by a pathological preoccupation with muscle size.OBJECTIVE: The aim of the study was to examine the MD features, eating disorder characteristics and body attitudes in non-competitive male bodybuilders in a Hungarian sample.METHOD: Sixty male bodybuilders and 60 undergraduate university students completed the self-report questionnaires of the Muscle Appearance Satisfaction Scale, the Body Attitude Test and the Eating Disorders Inventory.RESULTS: MD was associated with current bodybuilding activity, higher ideal body weight and eating disorder characteristics.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38797069","golden":false,"offsetInEndSection":151,"text":"Body Dysmorphic Disorder (BDD) is a distressing psychological condition where an individual is preoccupied by a perceived issue with their appearance.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34130638","golden":false,"offsetInEndSection":67,"text":"OBJECTIVE: Body dysmorphic disorder (BDD) is associated with low se","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":504,"document":"39053195","golden":false,"offsetInEndSection":712,"text":"o address these issues, the associations between BDD/MD symptoms and photo-based behaviors and the possible moderation of body appreciation were examined in a sample of 485 social media users (71.1?% women). ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38250111","golden":true,"offsetInEndSection":215,"text":"Many mental disorders are accompanied by distortions in the way the own body is perceived and represented (e.g., eating disorders, body dysmorphic disorder including muscle dysmorphia, or body integrity dysphoria).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28277100","golden":true,"offsetInEndSection":109,"text":"INTRODUCTION: The term \u0027morphomics\u0027 stands for the markers of body composition in muscle and adipose tissues.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1369,"document":"31772880","golden":false,"offsetInEndSection":1603,"text":"The adjusted R 2 for both methods was 94% above and 96% below the elbow.CONCLUSIONS: Analytic Morphomics showed strong consistency with the manual tape measure of arm circumference measurement in those with upper extremity lymphedema.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":97,"document":"31278360","golden":true,"offsetInEndSection":263,"text":"Analytic morphomics is the technique to use body composition measures as imaging biomarkers for underlying pathophysiology to predict prognosis or outcome to therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39273517","golden":false,"offsetInEndSection":200,"text":"Several years ago, dozens of cases were described in patients with symptoms very similar to mucopolysaccharidosis (MPS). This new disease entity was described as mucopolysaccharidosis-plus syndrome (M","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":100,"document":"35628659","golden":false,"offsetInEndSection":350,"text":"e accumulation of glycosaminoglycans (GAG). Conventional MPS, caused by inborn deficiencies of lysosomal enzymes involved in GAG degradation, display various multisystemic symptoms-including progressive neurological complications, ophthalmological di","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":148,"document":"25822011","golden":false,"offsetInEndSection":340,"text":"ch therapy. Analytic morphomics is a novel method of image analysis providing quantifiable measurements of body tissue composition, characterizing body fat more comprehensively than body mass ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30744586","golden":true,"offsetInEndSection":188,"text":"BACKGROUND: Analytic morphomics, or more simply, \"morphomics,\" refers to the measurement of specific biomarkers of body composition from medical imaging, most commonly computed tomography ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":172,"document":"29362698","golden":false,"offsetInEndSection":333,"text":"n unclear. Results from studies examining disorders associated with body image suggest the involvement of self-schema in biasing attention toward specific body i","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":288,"document":"38900653","golden":true,"offsetInEndSection":544,"text":"Muscle dysmorphic disorder (also known as muscle dysmorphia) is a form or subtype of body dysmorphia that is characterised by an extreme desire for muscularity and a preoccupation with the idea that one\u0027s physique is too small or not sufficiently muscular.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17272941","golden":true,"offsetInEndSection":166,"text":"Muscle dysmorphia has been described as a subtype of body dysmorphic disorder in which an individual experiences severe body image disturbance related to muscularity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"18089149","golden":false,"offsetInEndSection":212,"text":"The current study reports the development and psychometrics of a figure rating scale with leanness and muscularity dimensions and a 13-item questionnaire assessing symptoms associated with muscle dysmorphia (MD).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28277100","golden":true,"offsetInEndSection":95,"text":"INTRODUCTION: The term \u0027morphomics\u0027 stands for the markers of body composition in muscle and ad","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":520,"document":"25753334","golden":false,"offsetInEndSection":796,"text":"Morphomics research has the potential to generate \u0027big data\u0027 because it includes all imaging techniques at all levels of achievable resolution and all structural scales from gross anatomy and medical imaging, via optical and electron microscopy, to molecular characterisation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1718,"document":"37196480","golden":false,"offsetInEndSection":1845,"text":" low dose and standard dose CT images.IMPLICATIONS FOR PRACTICE: Threshold-based segmental tools can be used to quantify body m","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":599,"document":"24079810","golden":false,"offsetInEndSection":853,"text":"rough chart review. Univariate and multivariate analyses were performed to determine the relative relationship between morphomic data of the temporalis and psoas muscles and the ability of such information to correspond with clinical variables, such as B","beginSection":"abstract"}],"exact_answer":"","ideal_answer":[],"id":"6772c615592fa48873000007","type":"yesno","body":"Is morphomics associated with the study of body image or body dysmorphia?"},{"documents":[{"golden":true,"id":"2788059"},{"golden":true,"id":"28648163"},{"golden":false,"id":"6506129"},{"golden":false,"id":"36717972"},{"golden":false,"id":"23423221"},{"golden":false,"id":"27349582"},{"golden":true,"id":"24202204"},{"golden":false,"id":"22774378"},{"golden":false,"id":"20004284"},{"golden":true,"id":"18227450"},{"golden":false,"id":"17967116"},{"golden":false,"id":"39657834"},{"golden":false,"id":"38089852"},{"golden":false,"id":"12446536"},{"golden":true,"id":"21234107"},{"golden":false,"id":"24870845"},{"golden":false,"id":"22539176"},{"golden":false,"id":"22726518"},{"golden":false,"id":"29506597"},{"golden":false,"id":"17535131"},{"golden":false,"id":"25816423"},{"golden":false,"id":"19465611"},{"golden":false,"id":"22484429"},{"golden":false,"id":"27715163"},{"golden":false,"id":"11455308"},{"golden":false,"id":"34073531"},{"golden":false,"id":"9589765"},{"golden":false,"id":"22889157"},{"golden":false,"id":"26250743"},{"golden":false,"id":"29753432"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":460,"document":"2788059","golden":true,"offsetInEndSection":584,"text":"Forty-one girls (48%) admitted to deliberate cutting of their own wrists, arms, or other body parts without suicidal intent.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"2788059","golden":false,"offsetInEndSection":64,"text":"Self-harm behaviors (carving) in female adolescent drug abusers.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"18227450","golden":true,"offsetInEndSection":93,"text":"BACKGROUND: Nonsuicidal self-harm includes cutting, scratching, burning and minor overdosing.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":153,"document":"2788059","golden":true,"offsetInEndSection":253,"text":"Carving is an important physical sign suggesting possible drug and alcohol abuse during adolescence.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":585,"document":"2788059","golden":true,"offsetInEndSection":648,"text":"Fifteen of the 85 girls (18%) cut themselves six or more times.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1013,"document":"2788059","golden":true,"offsetInEndSection":1137,"text":"Suicide attempts, usually by purposeful overdose of medication, had been made by 24 (59%) of 41 girls who carved themselves.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":218,"document":"6506129","golden":false,"offsetInEndSection":619,"text":"The authors present a diagnostic formulation of the DSH syndrome (in the DSM-III format) which consists of four essential clinical features, a group of associated features, clinical features, a group of associated features, a clinical course of typical onset in late adolescence, with multiple recurrent episodes, with multiple methods of low lethality physical self-injury, extending over many years.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"2788059","golden":true,"offsetInEndSection":152,"text":"Deliberate self-lacerations by rebellious or delinquent adolescent girls, known by them as \"carving,\" may be erroneously diagnosed as a suicide gesture.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1138,"document":"2788059","golden":false,"offsetInEndSection":1202,"text":"Multiple suicide attempts were associated with habitual carving.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":842,"document":"2788059","golden":false,"offsetInEndSection":896,"text":"Large and disfiguring scars were noted on 14 patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":137,"document":"28648163","golden":false,"offsetInEndSection":232,"text":"21.5-32% of adolescents in non-clinical populations have a history of non-suicidal self-injury.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1588,"document":"39657834","golden":false,"offsetInEndSection":1656,"text":"aled the true nature of their behaviors.CONCLUSION: Preadolescents i","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":794,"document":"38089852","golden":false,"offsetInEndSection":912,"text":"ble for inclusion. Included studies may use any self-harm definition, any measures used to assess self-harm and the ag","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":894,"document":"12446536","golden":false,"offsetInEndSection":960,"text":"iour in friends and family members, drug use, and low self esteem.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":429,"document":"22539176","golden":false,"offsetInEndSection":526,"text":"ssed at 5, 7, 10, and 12 years of age.MAIN OUTCOME MEASURES: Relative risks of children\u0027s self ha","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":222,"document":"21234107","golden":true,"offsetInEndSection":430,"text":"vidence was found for a bidirectional relationship in girls, with depressive symptoms being a risk factor for increased self-harm one year later and self-harm a risk factor for increased depressive symptoms. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27349582","golden":false,"offsetInEndSection":541,"text":"INTRODUCTION: Self-mutilating behaviour is expanding, especially among adolescents and patients with a psychiatric disorder.CLINICAL MATERIAL: We have tried to describe the self-mutilating behaviour in Moroccan inpatients of the psychiatric department of Mohammed V Military Hospital of Rabat, through a prospective and descriptive longitudinal study over a period of four months, based on a questionnaire prepared according to the literature data to allow discussing its results.RESULTS: The rate of participation was 90.4%, or 19 patients.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"6506129","golden":false,"offsetInEndSection":78,"text":"Proposal for a distinctive diagnosis: the deliberate self-harm syndrome (DSH).","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"6506129","golden":false,"offsetInEndSection":68,"text":"Self-destructive behavior is a major clinical problem in psychiatry.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":69,"document":"6506129","golden":false,"offsetInEndSection":217,"text":"A review of the literature reveals the existence of enough clinical data to identify a diagnostic entity, \"The Deliberate Self-Harm Syndrome\" (DSH).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":620,"document":"6506129","golden":false,"offsetInEndSection":740,"text":"On the basis of relatively exclusive association of clinical signs and symptoms a heuristic clinical entity is proposed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1418,"document":"22539176","golden":false,"offsetInEndSection":1823,"text":"Compared with bullied children who did not self harm, bullied children who self harmed were distinguished by a family history of attempted/completed suicide, concurrent mental health problems, and a history of physical maltreatment by an adult.CONCLUSIONS: Prevention of non-suicidal self injury in young adolescents should focus on helping bullied children to cope more appropriately with their distress.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"19465611","golden":false,"offsetInEndSection":539,"text":"INTRODUCTION: Children who harm, hurt or kill themselves are a significant issue for health professionals in emergency departments (ED), with over 60 000 young people presenting to ED in the UK each year following self-harm.METHODS: In response to the development of a regional integrated pathway for the management of self-harm encompassing acute care, primary care and child and adolescent mental health services, it was felt that a triage tool developed specifically for children and young people presenting with self-harm was required.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":969,"document":"19465611","golden":false,"offsetInEndSection":1504,"text":"The available literature is also reviewed and the multidisciplinary approach to developing a user-friendly tool is discussed.RESULTS: A modified risk of suicide questionnaire, the CRAFFT questionnaire, and three questions about physical manifestations of self-harm were used to form a 14-point triage/screening tool, requiring only yes/no answers.CONCLUSION: A paediatric triage tool was developed that allows the more appropriate triage of young people who harm themselves and is acceptable to all stakeholders involved in their care.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":829,"document":"36717972","golden":false,"offsetInEndSection":952,"text":"In summary female gender, living in orphanages, and signs of other self-harm were significantly related to suicide attempt.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":50,"document":"25816423","golden":false,"offsetInEndSection":138,"text":"However, the number of adolescents who participate in self-harming behaviors is growing.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25816423","golden":false,"offsetInEndSection":49,"text":"Self-harm in adolescents is not a new phenomenon.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":252,"document":"25816423","golden":false,"offsetInEndSection":423,"text":"This article focuses on providing assistance to school professionals in the identification of signs of self-harm in adolescents and how to deal with this growing epidemic.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"25816423","golden":false,"offsetInEndSection":47,"text":"Identifying the Signs of Self-Harm in Students.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":139,"document":"25816423","golden":false,"offsetInEndSection":251,"text":"It can be difficult to detect those who self-harm due to the secrecy that surrounds the act of self-harm itself.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34073531","golden":false,"offsetInEndSection":300,"text":"In bilingual communities, social interactions take place in both single- and mixed-language contexts. Some of the information shared in multilingual conversations, such as interlocutors\u0027 personal information, is often required in consequent social encounters. In this study, we explored whether the a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24202204","golden":true,"offsetInEndSection":94,"text":"Self-harm of the skin is a complex problem encountered mainly in adolescents and young adults.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"22726518","golden":false,"offsetInEndSection":209,"text":"Self-harm and suicide are major public health problems in adolescents, with rates of self-harm being high in the teenage years and suicide being the second most common cause of death in young people worldwide.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":437,"document":"17967116","golden":false,"offsetInEndSection":705,"text":"The most common psychosocial factors associated with those treated in emergency departments for self-harm injuries were psychological conditions; drug/alcohol involvement; and adverse circumstances, including family discord, school problems, and physical/sexual abuse.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24870845","golden":false,"offsetInEndSection":170,"text":"Deliberate self-harm (DSH) in young people is a clinical and social problem related to early maltreatment but with little specificity in type of care or abuse determined.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"29753432","golden":false,"offsetInEndSection":111,"text":"Nonsuicidal self-injury (NSSI) and suicidal behaviour (SB) are both important issues in adolescent health care.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":428,"document":"22539176","golden":false,"offsetInEndSection":525,"text":"essed at 5, 7, 10, and 12 years of age.MAIN OUTCOME MEASURES: Relative risks of children\u0027s self h","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"22889157","golden":false,"offsetInEndSection":132,"text":"Little is known about accurate prevalence and associated factors of deliberate self-harm (DSH) among adolescents in Asian countries.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1472,"document":"26250743","golden":false,"offsetInEndSection":1608,"text":"mes (independent of treatment) over 1 year. Consideration of personality disorder diagnosis is indicated in the assessment and managemen","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":381,"document":"29506597","golden":false,"offsetInEndSection":559,"text":"ng Cox regression.RESULTS: Linked records were available for 652 903 young people and of these 33 498 (5.1%) developed depression and 15 946 (2.4%) self-harmed after the age of 1","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":93,"document":"9589765","golden":false,"offsetInEndSection":192,"text":"Two-thirds of the suicidal teenagers neither received help nor disclosed their self-harm to anyone.","beginSection":"abstract"}],"exact_answer":[],"ideal_answer":[],"id":"6777b5e1592fa4887300000d","type":"list","body":"Most common physical signs of self-harm in pre-teenagers."},{"documents":[{"golden":false,"id":"29450055"},{"golden":false,"id":"31922118"},{"golden":false,"id":"21896369"},{"golden":false,"id":"15322954"},{"golden":false,"id":"27928825"},{"golden":false,"id":"32336984"},{"golden":false,"id":"29866202"},{"golden":false,"id":"37749976"},{"golden":false,"id":"37310306"},{"golden":false,"id":"21972274"},{"golden":false,"id":"31605299"},{"golden":false,"id":"17555008"},{"golden":false,"id":"20119746"},{"golden":false,"id":"17333274"},{"golden":false,"id":"32461035"},{"golden":false,"id":"23968220"},{"golden":false,"id":"30241993"},{"golden":false,"id":"19063722"},{"golden":false,"id":"17417746"},{"golden":false,"id":"31278526"},{"golden":false,"id":"11067647"},{"golden":false,"id":"26647862"},{"golden":false,"id":"12451425"},{"golden":false,"id":"34326800"},{"golden":false,"id":"30658675"},{"golden":false,"id":"30151800"},{"golden":false,"id":"36403599"},{"golden":true,"id":"33669796"},{"golden":false,"id":"37371301"},{"golden":false,"id":"36003110"},{"golden":true,"id":"36360389"},{"golden":true,"id":"33794971"},{"golden":false,"id":"34299765"},{"golden":false,"id":"35724169"},{"golden":false,"id":"32838678"},{"golden":false,"id":"35005830"},{"golden":false,"id":"32429867"},{"golden":false,"id":"33539007"},{"golden":false,"id":"26869192"},{"golden":false,"id":"25061300"},{"golden":false,"id":"36698093"},{"golden":false,"id":"21732178"},{"golden":false,"id":"23222144"},{"golden":false,"id":"34388279"},{"golden":false,"id":"31727201"},{"golden":false,"id":"35510580"},{"golden":false,"id":"35738655"},{"golden":false,"id":"33604269"},{"golden":false,"id":"35576407"},{"golden":false,"id":"33666223"},{"golden":false,"id":"33576523"},{"golden":false,"id":"38097363"},{"golden":false,"id":"33402326"},{"golden":false,"id":"35546005"},{"golden":false,"id":"25175054"},{"golden":false,"id":"37789144"},{"golden":false,"id":"37142786"},{"golden":false,"id":"35645285"},{"golden":false,"id":"37720052"},{"golden":false,"id":"31911799"},{"golden":true,"id":"33573674"},{"golden":true,"id":"33077422"},{"golden":false,"id":"36449064"},{"golden":false,"id":"32207673"},{"golden":false,"id":"32580979"},{"golden":false,"id":"10628030"},{"golden":false,"id":"32430452"},{"golden":true,"id":"28211549"},{"golden":false,"id":"10802985"},{"golden":true,"id":"23679917"},{"golden":false,"id":"37758785"},{"golden":false,"id":"33205246"},{"golden":false,"id":"38226342"},{"golden":false,"id":"24375532"},{"golden":false,"id":"37812272"},{"golden":true,"id":"36096940"},{"golden":false,"id":"33298127"},{"golden":false,"id":"37864269"},{"golden":false,"id":"11210814"},{"golden":false,"id":"25745832"},{"golden":false,"id":"29699524"},{"golden":false,"id":"37980914"},{"golden":false,"id":"32857162"},{"golden":false,"id":"38071998"},{"golden":false,"id":"23801529"},{"golden":false,"id":"24172024"},{"golden":false,"id":"28468563"},{"golden":false,"id":"16396525"},{"golden":false,"id":"36514179"},{"golden":true,"id":"37590277"},{"golden":false,"id":"34905786"},{"golden":false,"id":"20466719"},{"golden":false,"id":"35130937"},{"golden":false,"id":"37237302"},{"golden":false,"id":"37295828"},{"golden":false,"id":"36438038"},{"golden":false,"id":"37798808"},{"golden":false,"id":"36006035"},{"golden":true,"id":"34942941"},{"golden":false,"id":"28347521"},{"golden":false,"id":"11294038"},{"golden":false,"id":"23399752"},{"golden":true,"id":"27351372"},{"golden":false,"id":"38032035"},{"golden":false,"id":"31155222"},{"golden":false,"id":"31088588"},{"golden":true,"id":"38358670"},{"golden":true,"id":"38355533"},{"golden":false,"id":"38351094"},{"golden":false,"id":"38341590"},{"golden":true,"id":"38336803"},{"golden":true,"id":"38335987"},{"golden":false,"id":"38331766"},{"golden":false,"id":"38329108"},{"golden":false,"id":"38328520"},{"golden":false,"id":"38327509"},{"golden":false,"id":"29580612"},{"golden":false,"id":"16886704"},{"golden":false,"id":"28835231"},{"golden":false,"id":"18368912"},{"golden":false,"id":"29093889"},{"golden":false,"id":"19266173"},{"golden":false,"id":"21732978"},{"golden":false,"id":"18545241"},{"golden":false,"id":"24023537"},{"golden":false,"id":"26831742"},{"golden":false,"id":"25708736"},{"golden":false,"id":"23697490"},{"golden":false,"id":"30616662"},{"golden":false,"id":"37244653"},{"golden":false,"id":"36140862"},{"golden":false,"id":"37885601"},{"golden":false,"id":"33741474"},{"golden":true,"id":"35295776"},{"golden":true,"id":"34855690"},{"golden":false,"id":"35513838"},{"golden":false,"id":"34858929"},{"golden":false,"id":"35799120"},{"golden":false,"id":"33196410"},{"golden":false,"id":"16011214"},{"golden":false,"id":"18497219"},{"golden":false,"id":"25335522"},{"golden":false,"id":"16610597"},{"golden":false,"id":"38281128"},{"golden":false,"id":"38097236"},{"golden":false,"id":"38069539"},{"golden":false,"id":"37765171"},{"golden":false,"id":"37688774"},{"golden":false,"id":"37672261"},{"golden":false,"id":"37615935"},{"golden":false,"id":"37474677"},{"golden":false,"id":"37163253"},{"golden":false,"id":"37726821"},{"golden":false,"id":"35386261"},{"golden":false,"id":"38032456"},{"golden":false,"id":"33085962"},{"golden":false,"id":"36601647"},{"golden":false,"id":"37485905"},{"golden":false,"id":"35317224"},{"golden":false,"id":"33996508"},{"golden":false,"id":"38205635"},{"golden":false,"id":"39317509"},{"golden":false,"id":"25747841"},{"golden":false,"id":"33926431"},{"golden":false,"id":"39734928"},{"golden":false,"id":"36581685"},{"golden":false,"id":"37793673"},{"golden":false,"id":"36447303"},{"golden":false,"id":"38613677"},{"golden":false,"id":"31285834"},{"golden":false,"id":"20540432"},{"golden":false,"id":"26458917"},{"golden":false,"id":"17574163"},{"golden":false,"id":"29494592"},{"golden":false,"id":"29714619"},{"golden":false,"id":"28250962"},{"golden":false,"id":"31201156"},{"golden":false,"id":"36011572"},{"golden":false,"id":"34666417"},{"golden":false,"id":"36943835"},{"golden":true,"id":"20388196"},{"golden":false,"id":"35301204"},{"golden":true,"id":"31664974"},{"golden":false,"id":"31486894"},{"golden":false,"id":"25579833"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":718,"document":"31486894","golden":false,"offsetInEndSection":805,"text":"The number of EUCTR trials was relatively small (n?\u003d?35) and with many inconsistencies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1781,"document":"31486894","golden":false,"offsetInEndSection":1900,"text":"These findings indicate that more children are being subjected to unnecessary risk that comes with trial participation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33926431","golden":false,"offsetInEndSection":167,"text":"BACKGROUND: We describe our experience from a multi-national application of a European Union-funded research-driven paediatric trial (DEEP-2, EudraCT 2012-000353-31; N","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1640,"document":"31486894","golden":false,"offsetInEndSection":1780,"text":"This study found low dissemination rates in the field of child mental health, with worrying under-reporting of premature termination causes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":200,"document":"21972274","golden":false,"offsetInEndSection":360,"text":"It advocates the  creation of a Network of Excellent Networks, based on a dynamic and adaptive  cross-European network of distinctly qualified research centres.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1446,"document":"31486894","golden":false,"offsetInEndSection":1639,"text":"Large sample and non-industry funding were related to retrospective registration, which was recorded more often in recent years than before (we observed trials registered from 2002 until 2017).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21972274","golden":false,"offsetInEndSection":199,"text":"The Madrid Declaration is being promoted by representatives from seven  nationally funded mental health research networks, along with leaders of  ongoing European Union-funded mental health projects.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1296,"document":"31486894","golden":false,"offsetInEndSection":1368,"text":"Chances for publishing an article were lower for industry-funded trials.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1216,"document":"31486894","golden":false,"offsetInEndSection":1295,"text":"Middle-sized and industry-funded trials were associated with results reporting.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":146,"document":"31486894","golden":false,"offsetInEndSection":383,"text":"Data were extracted for \"closed\" trials in Clinicaltrials.gov registry and European Union Clinical Trial Register (EUCTR) and corresponding publications of completed trials indexed in three data bases (PubMed, Scopus and Google Scholar).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":901,"document":"31664974","golden":false,"offsetInEndSection":930,"text":" grant agreement No. 754919 (","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"31664974","golden":false,"offsetInEndSection":157,"text":"UPRIGHT, a resilience-based intervention to promote mental well-being in schools: study rationale and methodology for a European randomized controlled trial.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1309,"document":"31664974","golden":false,"offsetInEndSection":1527,"text":" Emotional Learning. Among the five Pan-European regions, 34 schools have been currently involved (17 control; 17 intervention) and around 6000 adolescents and their families are foreseen to participate along a 3-year ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1170,"document":"31664974","golden":false,"offsetInEndSection":1308,"text":"nmark, and Iceland). Resulted is the UPRIGHT programme with 18 skills related to 4 components: Mindfulness, Coping, Efficacy and Social an","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":258,"document":"31664974","golden":true,"offsetInEndSection":583,"text":" important. UPRIGHT (Universal Preventive Resilience Intervention Globally implemented in schools to improve and promote mental Health for Teenagers) is designed as a whole school approach (school community, students and families) to promote a culture of mental well-being and prevent mental disorders by enhancing resilience","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":584,"document":"31664974","golden":false,"offsetInEndSection":900,"text":"capacities. The present article aims at describing the rationale, conceptual framework, as well as methodology of implementation and evaluation of the UPRIGHT intervention.METHODS: UPRIGHT project is a research and innovation project funded by the European Union\u0027s Horizon 2020 Research and Innovation programme unde","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2067,"document":"17555008","golden":false,"offsetInEndSection":2387,"text":"Overall, EAAD may serve as an example of how European community based \"best practice\" models for improving the care of depressed patients and suicidal persons can be implemented using a bottom-up approach (starting from a regional model project to a national expansion of activities and policy relevant recommendations).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":751,"document":"17555008","golden":false,"offsetInEndSection":856,"text":"With confirmatory statistics a significant reduction of suicidal behaviour by more than 20% was observed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":931,"document":"31664974","golden":false,"offsetInEndSection":1169,"text":"uration: 48?months). The theoretical framework has been developed by an innovative and multidisciplinary approach using a co-creation process inside the UPRIGHT Consortium (involving seven institutions from Spain, Italy, Poland, Norway, D","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":474,"document":"33794971","golden":true,"offsetInEndSection":1043,"text":"The PRIMERA (Promoting Research and Innovation in Mental hEalth seRvices for fAmilies and children) research programme involves a mixed method evaluation of Family Talk which is being delivered in mental health settings in Ireland to improve child and family psychosocial functioning in families with parental mental illness.METHODS: The study comprises a multi-centre, randomised controlled trial (RCT), with nested economic and process evaluations, to assess the clinical and cost-effectiveness and implementation mechanisms of Family Talk compared to usual services.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":465,"document":"33669796","golden":true,"offsetInEndSection":720,"text":"The RCT will be conducted in six European countries in the context of the Horizon 2020 European funded research and innovation project \"Psychosocial support for promoting mental health and well-being among adolescent young caregivers in Europe\" (\"ME-WE\").","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1266,"document":"33669796","golden":false,"offsetInEndSection":1455,"text":"This study will contribute to building an evidence-based manualized program that educators and health and social care professionals can use to support AYCs in their transition to adulthood.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":254,"document":"33669796","golden":true,"offsetInEndSection":464,"text":"We describe the study protocol of an international randomized controlled trial (RCT) of an innovative group intervention designed to promote the mental health and well-being of adolescent YCs (AYCs) aged 15-17.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1084,"document":"36360389","golden":true,"offsetInEndSection":1361,"text":"The results indicated the effectiveness of the PROMEHS program in improving social-emotional skills for all school levels, reducing internalizing problems in primary and secondary school chil-dren, and reducing externalizing issues for kindergarten and primary school children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":721,"document":"33669796","golden":false,"offsetInEndSection":962,"text":"The ME-WE intervention is based on Hayes and Ciarrochi\u0027s psychoeducational model for adolescents and will consist of seven 2-h sessions in a group format, aimed to help AYCs build psychological flexibility and live according to their values.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1456,"document":"33669796","golden":true,"offsetInEndSection":1760,"text":"From a research perspective, the outcomes of this study will contribute to evidence-based practices in primary prevention of psychosocial difficulties in AYCs and will gather novel knowledge on the effectiveness of Hayes and Ciarrochi\u0027s model for use with middle adolescents with caring responsibilities.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"33669796","golden":true,"offsetInEndSection":119,"text":"Promoting Mental Health and Well-Being among Adolescent Young Carers in Europe: A Randomized Controlled Trial Protocol.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1408,"document":"37371301","golden":false,"offsetInEndSection":1640,"text":"Furthermore, marginalized and disadvantaged children were those who benefited most from the program, displaying both greater improvements in SEL and more marked decreases in internalizing problems compared to the rest of the sample.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32838678","golden":false,"offsetInEndSection":201,"text":"BACKGROUND: The World Health Organization\u0027s (WHO) Eastern Mediterranean Regional Office (EMRO) developed a school mental health program (SMHP) to help reduce the burden of youth mental health problems.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":533,"document":"33539007","golden":false,"offsetInEndSection":740,"text":"This paper describes the Collaborative Network for European Clinical Trials for Children (conect4children, c4c), which addresses selected difficulties in the design and conduct of paediatric clinical trials.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"33539007","golden":false,"offsetInEndSection":117,"text":"The conect4children (c4c) Consortium: Potential for Improving European Clinical Research into Medicines for Children.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21732178","golden":false,"offsetInEndSection":452,"text":"PURPOSE: This review was conducted to examine the current status of paediatric medicines initiatives across the globe.METHODS: The authors made a non-systematic descriptive review of current world situation.RESULTS: Two regions, the United States (US) and the European Union (EU), and the World Health Organization (WHO) have introduced strong paediatric initiatives to improve children\u0027s health through improving access to better paediatric medicines.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1317,"document":"33539007","golden":false,"offsetInEndSection":1495,"text":"c4c is taking a phased approach with careful piloting through industry and non-industry studies intended to demonstrate the viability of the network (proof-of-viability studies).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35301204","golden":false,"offsetInEndSection":183,"text":"INTRODUCTION: Improving the lives of children and adolescents with parental mental illness (CAPRI) remains an urgent political and public health concern for the UK and European Union.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33539007","golden":false,"offsetInEndSection":174,"text":"The need for information about new and existing drugs used in children was recognized in the European Union (EU) with the implementation of the Paediatric Regulation in 2007.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2014,"document":"26869192","golden":false,"offsetInEndSection":2231,"text":"The ratio of pediatric clinical trials with an approved Paediatric Investigation Plan increased to \u003e15% after 2008.IMPLICATIONS: Recruitment and ethical obstacles make conducting pediatric clinical trials challenging.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":741,"document":"33539007","golden":false,"offsetInEndSection":842,"text":"c4c is a time-limited public-private consortium funded by the Innovative Medicines Initiative (IMI2).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":950,"document":"25061300","golden":false,"offsetInEndSection":1407,"text":"The \"subjectivity gap\" between basic neuroscience research and clinical reality for patients with mental disorders is considered the main challenge in psychiatric research, suggesting that a shift in research paradigms is required.CONCLUSION: Innovations in clinical mental health research should bridge the gap between mechanisms underlying novel therapeutic interventions and the patient experience of mental disorder and, if present, somatic comorbidity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1804,"document":"26869192","golden":false,"offsetInEndSection":2013,"text":"The registered number of clinical trials that includes at least 1 participants \u003c18 years old in the European Union Clinical Trials Register increased by 247 trials (from 672) in the 1000 days after regulation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":201,"document":"23222144","golden":false,"offsetInEndSection":364,"text":"The main reasons for the revision were: (1) the decreasing number of clinical trials in the region and (2) harsh criticism of the present version of the Directive.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1258,"document":"35510580","golden":false,"offsetInEndSection":1512,"text":"536/2014) addresses these barriers in practice.CONCLUSION: The European Clinical Trials Regulation gives a strong impetus to a risk-proportionate approach and offers a path for more efficient delivery of investigator-initiated paediatric clinical trials.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23222144","golden":false,"offsetInEndSection":200,"text":"On 17 July 2012, the European Commission formally adopted a proposal for a new European Union (EU) Directive regarding clinical trials, which will repeal and replace the existing Directive 2001/20/EC.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":365,"document":"23222144","golden":false,"offsetInEndSection":509,"text":"The proposed regulation could simplify the rules for conducting clinical trials and also rebuild the entire system of clinical trial assessment.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"23222144","golden":false,"offsetInEndSection":72,"text":"A European consistency for functioning of RECs? We just lost our chance.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":510,"document":"23222144","golden":false,"offsetInEndSection":667,"text":"However, it seems that we probably have already lost our chance regarding the consistency and quality of functioning of research ethics committees in the EU.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":686,"document":"35576407","golden":false,"offsetInEndSection":922,"text":"A significant program effect was found in favor of SC+ for parental depression and social support, as well as within-group improvements for both groups in depression, intimate partner victimization, family resources, and social support.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":167,"document":"34388279","golden":false,"offsetInEndSection":281,"text":"Following feasibility studies, the European Commission has now adopted a formal Child Guarantee of service access.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1380,"document":"33402326","golden":false,"offsetInEndSection":1754,"text":"Due to significant loss of data at follow-up, the effect size findings are considered unreliable.CONCLUSIONS: Further feasibility work should be conducted to improve data completeness before progression to a definitive trial of guided self-help for mental health problems in children with neurological conditions can be recommended.TRIAL REGISTRATION NUMBER: ISRCTN21184717.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1591,"document":"33539007","golden":false,"offsetInEndSection":1730,"text":"A sustainable, successor organization open to all potential service users will be open for business before the end of IMI2 funding in 2024.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":843,"document":"33539007","golden":false,"offsetInEndSection":1287,"text":"The elements of c4c are as follows: expert advice providing input on study design and/or paediatric development programmes (including patient involvement activities); a network of sites following harmonised procedures coordinated by National Hubs and a single point of contact for Europe; a facility for education and training for sites and trial teams; and support for managing data used by the network and a common paediatric data dictionary.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1272,"document":"25175054","golden":false,"offsetInEndSection":1537,"text":"In both the USA and the EU, regulations aimed to increase the number of clinical studies conducted in children, in order to ensure that the necessary data are generated, determining the conditions in which a drug may be authorized to treat the pediatric population.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1538,"document":"25175054","golden":false,"offsetInEndSection":1704,"text":"PCs are encouraged to develop pediatric assessment, including pediatric clinical trials, which is described in a pediatric plan submitted to the relevant authorities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37720052","golden":false,"offsetInEndSection":135,"text":"Background: Hundreds of youth psychotherapy randomized trials have generated scores of helpful empirically supported treatments (ESTs).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":408,"document":"33573674","golden":true,"offsetInEndSection":907,"text":"The aim of this multi-site randomised controlled trial is to determine the clinical and cost-effectiveness of adding a modular psychological intervention to usual care for the mental health disorders in comparison to assessment-enhanced usual care alone.METHODS: In total, 334 participants aged 3-18?years attending epilepsy services will be screened for mental health disorders with the Strengths and Difficulties Questionnaire (SDQ) and the diagnostic Development and Wellbeing Assessment (DAWBA).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2023,"document":"25175054","golden":false,"offsetInEndSection":2243,"text":"Regarding the approval for new medicinal products in these two regions, regulations require PCs to include, when it is relevant, a pediatric assessment in their drug research and development plan, which must be approved.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":918,"document":"25175054","golden":false,"offsetInEndSection":1045,"text":"It appears that the USA and the EU have both developed specific regulations for pediatric drug development while Japan has not.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1705,"document":"25175054","golden":false,"offsetInEndSection":1911,"text":"A system of rewards for PCs submitting an application for marketing authorization containing pediatric use information has been put in place to cover the additional investment for testing drugs in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":3515,"document":"25175054","golden":false,"offsetInEndSection":3732,"text":"This regulatory framework encourages the study and the development of pediatric drugs, but it is still quite difficult to actually measure the impact of the ICH E11 on increasing the number of drugs for pediatric use.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2446,"document":"25175054","golden":false,"offsetInEndSection":2714,"text":"Except for special cases, the pediatric investigation plan in the EU is required to be prepared and submitted to the competent authorities upon availability of adult pharmacokinetic studies (after phase I), which means at an early phase of a new drug development plan.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2800,"document":"25175054","golden":false,"offsetInEndSection":3009,"text":"In practice, it has become difficult for pharmaceutical industries to develop a practicable clinical program for pediatrics including timelines for studies in children that satisfy both EU and USA authorities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":469,"document":"33077422","golden":true,"offsetInEndSection":705,"text":"Recent reports on the effects of legislation indicates that paediatric clinical trials remain a challenge.Paediatric clinical trials are needed in the entire developmental age spectrum and are especially needed in certain therapy areas.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":3141,"document":"25175054","golden":false,"offsetInEndSection":3236,"text":"For the ICH regions, pediatric committees are well-established albeit less structured in Japan.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2616,"document":"28211549","golden":false,"offsetInEndSection":3042,"text":"In comparing the effectiveness of the three active SEYLE interventions, based on three specific preventive strategies directed towards teachers and school staff, professionals and pupils in comparison to a control group, the intervention empowering pupils, called the Youth Aware of Mental Health (YAM) showed significant results in preventing new cases of suicide attempts, severe suicidal ideation with plans and depression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":256,"document":"23679917","golden":true,"offsetInEndSection":1410,"text":"This Randomized Controlled Trial (RCT) was conducted in eleven European countries, with Sweden as the coordinating centre, and was designed to identify an effective way to promote mental health and reduce suicidality and risk taking behaviours among adolescents.OBJECTIVE: To describe the methodological and field procedures in the SEYLE RCT among adolescents, as well as to present the main characteristics of the recruited sample.METHODS: Analyses were conducted to determine: 1) representativeness of study sites compared to respective national data; 2) response rate of schools and pupils, drop-out rates from baseline to 3 and 12 month follow-up, 3) comparability of samples among the four Intervention Arms; 4) properties of the standard scales employed: Beck Depression Inventory, Second Edition (BDI-II), Zung Self-Rating Anxiety Scale (Z-SAS), Strengths and Difficulties Questionnaire (SDQ), World Health Organization Well-Being Scale (WHO-5).RESULTS: Participants at baseline comprised 12,395 adolescents (M/F: 5,529/6,799; mean age\u003d14.9?0.9) from Austria, Estonia, France, Germany, Hungary, Ireland, Israel, Italy, Romania, Slovenia and Spain.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":3043,"document":"28211549","golden":false,"offsetInEndSection":3378,"text":"More than a 50% reduction of incident cases of suicide attempts (OR: 0.45 [0.24 - 0.85]; p\u003d0.014), and of incident cases of severe suicidal ideation and plans (OR: 0.50 [0.27 - 0.92]; p\u003d0.025), as well as a significant reduction by 30% of incident cases with moderate to severe depression (OR: 0.71 [0.52- 0.97]; p\u003d0.031) was observed.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"28211549","golden":true,"offsetInEndSection":209,"text":"Review of health and risk-behaviours, mental health problems and suicidal behaviours in young Europeans on the basis of the results from the EU-funded Saving and Empowering Young Lives in Europe (SEYLE) study.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":528,"document":"36096940","golden":true,"offsetInEndSection":905,"text":"As such, we aim to assess the acceptability and feasibility of group-MCT for CYP with common mental health problems in comparison to usual treatment within Child and Adolescent Mental Health Services (CAMHS).METHOD: YoMeta is a multicentre, two-arm, single-blind randomised feasibility trial comparing group-MCT to usual care in CYP with common mental health problems in CAMHS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":236,"document":"28211549","golden":true,"offsetInEndSection":456,"text":"In a collaborative effort to reduce the high rates of suicide and mental health problems among youth across Europe, the European Union 7th Framework funded the Saving and Empowering Young Lives in Europe (SEYLE) project.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1332,"document":"28211549","golden":false,"offsetInEndSection":1391,"text":"Males had a higher prevalence (21.3%) than females (16.9%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":457,"document":"28211549","golden":true,"offsetInEndSection":632,"text":"SEYLE is a randomized controlled trial (RCT) aimed to promote mental health and healthy lifestyles, while preventing psychopathology and suicidal behaviours among adolescents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":329,"document":"10802985","golden":false,"offsetInEndSection":583,"text":"In an effort to address the problem of child abuse within this rapidly changing sociopolitical environment, the Children\u0027s Mental Health Alliance and the Soros Foundation organized the Eastern European Child Abuse and Child Mental Health Project in 1995.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1680,"document":"23679917","golden":false,"offsetInEndSection":1986,"text":"All scales utilised in the study had good to very good internal reliability, as measured by Cronbach\u0027s alpha (BDI-II: 0.864; Z-SAS: 0.805; SDQ: 0.740; WHO-5: 0.799).CONCLUSIONS: SEYLE achieved its objective of recruiting a large representative sample of adolescents within participating European countries.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37864269","golden":false,"offsetInEndSection":135,"text":"BACKGROUND: Hundreds of youth psychotherapy randomized trials have generated scores of helpful empirically supported treatments (ESTs).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1094,"document":"25745832","golden":false,"offsetInEndSection":1312,"text":"hen reported by the children.CONCLUSION: Recognizing suicidal ideation in young children may be recommended as part of preventive strategies such as screening in the context of the presence of any mental health problem","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":583,"document":"29699524","golden":false,"offsetInEndSection":731,"text":"d teachers. The aim of the first epidemiological study in Lithuania was to identify the prevalence of psychiatric disorders in the community sample ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2419,"document":"37980914","golden":false,"offsetInEndSection":2583,"text":"ictive validity for relevant life outcomes. Classification based on symptom checklist might be a valid alternative to costly and time-consuming methods to identify ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":598,"document":"32857162","golden":false,"offsetInEndSection":719,"text":"on Longitudinal Study of Parents and Children (ALSPAC). EU-GEI is an international multisite prospective study of partici","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":786,"document":"32857162","golden":false,"offsetInEndSection":916,"text":"a United Kingdom-based general population birth cohort. Included were EU-GEI participants who met CHR criteria at baseline and ALS","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2525,"document":"32857162","golden":false,"offsetInEndSection":2656,"text":" 12 years predicted PEs at age 18 years, with an AUC of 0.74 (PPV, 67.8%; and NPV, 75.8%).Conclusions and Relevance: In individuals","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":817,"document":"38071998","golden":false,"offsetInEndSection":1242,"text":"We present and discuss the evidence base for medications currently used for mental disorders in children and adolescents, medications in the pipeline, opportunities in the development of novel medications, crucial priorities for the conduct of future clinical studies, challenges and opportunities in terms of the regulatory and legislative framework, and innovations in the way research is conducted, reported, and promoted.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":663,"document":"23801529","golden":false,"offsetInEndSection":954,"text":"res across ten European countries.PATIENTS: The phase III study enrolled children and adolescents (aged 6-17 years) who met Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision criteria for a primary diagnosis of ADHD and who had a baseline ADHD Rating Scale ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":3731,"document":"24172024","golden":false,"offsetInEndSection":3843,"text":"metable, the lack of value placed on PSHE, and difficulties engaging with teachers and young people. Wider use o","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":630,"document":"28468563","golden":false,"offsetInEndSection":936,"text":"However, because their association with a development of psychosis has been weaker in children and adolescents than in adults, only the assessment and monitoring of these risk symptoms was recommended for children and adolescents, while interventions aiming at the prevention of psychoses were discouraged.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37590277","golden":false,"offsetInEndSection":244,"text":"BACKGROUND: The majority of children referred to Child and Adolescent Mental Health Services (CAMHS) in the UK will present with mixed emotional and behavioural difficulties, but most mental health treatments are developed for single disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":877,"document":"37590277","golden":true,"offsetInEndSection":1053,"text":"The aim of this study is to test the clinical- and cost-effectiveness of MBT compared to treatment as usual for school age children with emotional and behavioural difficulties.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1221,"document":"36006035","golden":false,"offsetInEndSection":1581,"text":"We found no clear relationship of guideline availability and implementation with type of child primary health care system of countries, but strong governance and sufficient financial resources seemed important for guideline availability.CONCLUSIONS: Availability and implementation of clinical guidelines in child primary health care vary between EU countries.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37590277","golden":true,"offsetInEndSection":265,"text":"Emotion regulation in children (ERiC): A protocol for a randomised clinical trial to evaluate the clinical and cost effectiveness of Mentalization Based Treatment (MBT) vs Treatment as Usual for school-age children with mixed emotional and behavioural difficulties.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1054,"document":"37590277","golden":false,"offsetInEndSection":1415,"text":"If effective, we hope this approach can become available to the growing number of children presenting to mental health services with a mix of emotional and behavioural difficulties.MATERIALS AND METHODS: Children referred to CAMHS aged 6-12 with mixed mental health problems (emotional and behavioural) as primary problem can take part with their parent/carers.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1300,"document":"11210814","golden":false,"offsetInEndSection":1532,"text":"In some countries of the European Union and the USA it has already reached the monospecialty status, a tendency supported by the UEMS, which also makes efforts to coordinate programs of specialist training in the European countries.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":986,"document":"35130937","golden":false,"offsetInEndSection":1228,"text":"Here we present the protocol of a substantive RCT of NIM including a new London site.METHODS: The study is a multi-site, pragmatic, single-blind, parallel group, cluster randomised controlled superiority trial with an allocation ratio of 1:1.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1416,"document":"37590277","golden":true,"offsetInEndSection":1553,"text":"Children will be randomly allocated to receive either MBT or treatment as usual (TAU) within the CAMHS clinic they have been referred to.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":245,"document":"37590277","golden":false,"offsetInEndSection":370,"text":"There is a need for research on treatments that are helpful for these mixed difficulties, especially for school-age children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1650,"document":"37590277","golden":false,"offsetInEndSection":1737,"text":"TAU is likely to include CBT, parenting groups, and/or children\u0027s social skills groups.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":239,"document":"34942941","golden":true,"offsetInEndSection":690,"text":"In order to define more appropriate targets for innovative pharmacological therapies for disruptive/conduct disorders, the European Commission within the Seventh Framework Programme (FP7) funded the MATRICS project (Multidisciplinary Approaches to Translational Research in Conduct Syndromes) to identify neural, genetic, and molecular factors underpinning the pathogenesis of aggression/antisocial behavior in preclinical models and clinical samples.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":683,"document":"28347521","golden":false,"offsetInEndSection":838,"text":"The EPA recently provided evidence-based recommendations on the early detection of clinical high risk (CHR) for psychosis in patients with mental distress.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2405,"document":"28347521","golden":false,"offsetInEndSection":2600,"text":"The EPA guidance on early intervention aimed to provide evidence-based recommendations on early intervention in CHR states of psychosis, assessed according to the EPA guidance on early detection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1853,"document":"11294038","golden":false,"offsetInEndSection":2040,"text":"Deletion of chromosome 22q11 has been also associated with various psychiatric phenotypes, which can be classified into two groups, developmental abnormalities and psychiatric conditions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2234,"document":"11294038","golden":false,"offsetInEndSection":2493,"text":"The deletion of chromosome 22q11 is also associated with high frequency of behavioral disorder with attention deficit during childhood, and with high frequency of psychotic disorder (bipolar disorder, and schizophrenia) during adolescence and young adulthood.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2594,"document":"23399752","golden":false,"offsetInEndSection":2905,"text":"The dilemmas that arise for the diagnosis of ADHD, BD and their relationship refer to the difficulty of defining the limits of normal and abnormal in the mental health of children and adolescents and of the construction of a taxonomic system that respects the particularities of this developmental age spectrum.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27351372","golden":true,"offsetInEndSection":390,"text":"The study examined whether the Diagnostic Classification of Mental Health and Developmental Disorders of Infancy and Early Childhood, Revised Edition (DC: 0-3R; ZERO TO THREE, 2005) Parent-Infant Relationship Global Assessment Scale (PIR-GAS) is applicable to six European countries and contributes to the identification of caregiver-infant/toddler dyads with abusive relationship patterns.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1531,"document":"27351372","golden":false,"offsetInEndSection":1694,"text":"The value of a broader use of tools such as the DC: 0-3R to promote early identification of families at risk for infant and toddler abuse and neglect is discussed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1446,"document":"38358670","golden":true,"offsetInEndSection":1671,"text":"We also discuss the methods of the ongoing Care Project, which is a randomized clinical trial to test whether reducing prenatal maternal depression improves offspring\u0027s cardiometabolic health and health behaviors in preschool","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1110,"document":"38355533","golden":true,"offsetInEndSection":1396,"text":"This is the protocol of a multi-centre, open label, blind-rated, randomised controlled effectiveness trial of clozapine vs TAU (any other oral antipsychotic monotherapy licenced in the British National Formulary) for 12?weeks in 260 children and young people with TRS (12-24?years old).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2016,"document":"38351094","golden":false,"offsetInEndSection":2117,"text":"The trial was registered on the Open Science Framework on 14 March 2023, registration: OSF.IO/T9FXZ .","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":631,"document":"38341590","golden":false,"offsetInEndSection":756,"text":"The trial will be conducted as a 6-month 2-arm, parallel-group, multicentre, pragmatic, randomized clinical superiority trial","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":896,"document":"38336803","golden":true,"offsetInEndSection":1038,"text":"Both trial arms deliver Interpersonal Psychotherapy for Depressed Adolescents (IPT-A), a time-limited, evidence-based treatment for depression","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38335987","golden":true,"offsetInEndSection":258,"text":"Digitally augmented, parent-led CBT versus treatment as usual for child anxiety problems in child mental health services in England and Northern Ireland: a pragmatic, non-inferiority, clinical effectiveness and cost-effectiveness randomised controlled trial.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1753,"document":"38331766","golden":false,"offsetInEndSection":1795,"text":"This trial was retrospectively registered.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1724,"document":"38329108","golden":false,"offsetInEndSection":1833,"text":"ed the Child Behaviour Checklist mean score difference at 12 months was lower in the intervention arm by -10.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":369,"document":"38328520","golden":false,"offsetInEndSection":453,"text":"Most evidence for effective treatments comes from cognitive-behavioral therapy (CBT)","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38327509","golden":false,"offsetInEndSection":61,"text":"School children\u0027s mental health during the COVID-19 pandemic.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":226,"document":"29580612","golden":false,"offsetInEndSection":427,"text":"The recent 10years European medicines agency (EMA) report showed that the number of paediatric trials increased and that 238 new medicines and indications for use in children were authorised in the EU.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1337,"document":"28835231","golden":false,"offsetInEndSection":1656,"text":"The overall median score of RCTs on the Jadad scale was high (3.5), 70.0% of protocols had a Jadad score???3, and 30.0% had a score?\u003c?3.CONCLUSION: Following the EU Pediatric Regulation, the number of pediatric protocols submitted to the IRB00009118 tends to increase, but no change was noticed regarding their quality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":428,"document":"29580612","golden":false,"offsetInEndSection":680,"text":"However, results remain constrated and futur developments require european collaborations beween all experts in developmental pharmacology, drug evaluation and trial conduct, training, all aspects already considered in different EU paediatric programs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"29580612","golden":false,"offsetInEndSection":225,"text":"The European pediatric regulation, that entered into force in June 2007 with the objectives to improve the health of children in Europe, dramatically changed the regulatory environment of paediatric drug evaluation in Europe.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"29580612","golden":false,"offsetInEndSection":112,"text":"Drug evaluation in children 10years after the European pediatric regulation current challenges and perspectives.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":977,"document":"21732978","golden":false,"offsetInEndSection":1326,"text":"The majority of participating Ethics Committees expressed interest in future initiatives related to paediatric research.CONCLUSIONS: Despite a limited knowledge and understanding of the current paediatric regulatory framework, a significant number of Ethics Committees operating in Europe show interest in initiatives related to paediatric research.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":536,"document":"18368912","golden":false,"offsetInEndSection":901,"text":"This short report presents the draft and ideas of the new European legislation on the application of drugs for children, performance of clinical studies in paediatric population and mandatory inclusion into the international network of scientific experts, clinical centres capable of performing studies and the already completed or ongoing clinical study registers.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":479,"document":"16886704","golden":false,"offsetInEndSection":667,"text":"The European Community decided to support the development of a European register of clinical trials in children as part of the Fifth Framework Thematic Programme \"Quality of Life\" in 2002.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21732978","golden":false,"offsetInEndSection":618,"text":"AIM: To evaluate the impact of the new European paediatric regulatory framework on the activities of Ethics Committees operating in Europe and to assess their involvement and interest in paediatric research.METHODS: Task-force in Europe for Drug Development for the Young Network of Excellence and Relating Expectations and Needs to the Participation and Empowerment of Children in Clinical Trials project set up an inventory of Ethics Committees existing in Europe and conducted a survey on their approach to paediatric trials.RESULTS: Ethics Committees operating in 22 European Countries participated in this survey.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":231,"document":"28835231","golden":false,"offsetInEndSection":642,"text":"The main purpose of this study was to assess the evolution of both the number and the quality of pediatric trial protocols that were submitted to a French Institutional Review Board (IRB00009118) before and after the initiation of the EU Pediatric Regulation.METHODS: All protocols submitted to the IRB00009118 between 2003 and 2014 and conducting research on subjects under eighteen years of age were eligible.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37244653","golden":false,"offsetInEndSection":945,"text":"Pediatric anxiety disorders (AD) are prevalent disorders with an impact on all aspects of a child\u0027s life and functioning.1 Although evidence supports commonly used treatments, there are notable concerns with the research to date.2 Heterogeneity in outcome selection, measurement, analysis, and reporting is a contributing factor to the hinderance of the translation of research into clinical practice.3 Recognition for outcome standardization in pediatric mental health disorders is evolving and there are several initiatives of importance, including the International Consortium for Health Outcomes Measurement (ICHOM), which has developed standardized outcome sets for use in the routine clinical mental health treatment of children and adolescents.4 Similarly, the International Alliance of Mental Health Research Funders5 advocate for use of 1 specific outcome measurement instrument (OMI) in the youth mental health research that they fund.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":946,"document":"37244653","golden":false,"offsetInEndSection":1427,"text":"Development of a Core Outcome Set (COS), a minimal set of outcomes that should be measured and reported in clinical trials, has been a solution in other areas of medicine to address heterogeneity in outcome selection and measurement across trials.6 The Core Outcomes and Measures in Pediatric Anxiety Clinical Trials (COMPACT) Initiative will develop a harmonized, evidence- and consensus-based COS that is meaningful to youth and families for use in future trials in pediatric AD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":4343,"document":"33196410","golden":false,"offsetInEndSection":4842,"text":"Although it was feasible to randomise children and adolescents living with serious parental mental illness of different ages to standardised, time-limited groups in both NHS and non-NHS settings, an intervention like Young SMILES is unlikely to address underlying core components of the vulnerability that children and adolescents living with serious parental mental illness express as a population over time.CONCLUSIONS: Young SMILES was widely valued as unique in filling a recognised gap in need.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37244653","golden":false,"offsetInEndSection":147,"text":"Study Preregistration: Measuring What Matters: Development and Dissemination of a Core Outcome Set for Pediatric Anxiety Disorders Clinical Trials.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34855690","golden":true,"offsetInEndSection":428,"text":"OBJECTIVE: The aim of this study was to characterize patterns of and factors associated with psychotropic medication use in children with autism spectrum disorder (ASD) receiving publicly funded mental health services.METHOD: Data were extracted from 202 children with ASD participating in a cluster randomized trial of An Individualized Mental Health Intervention for ASD conducted in 29 publicly funded mental health programs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":207,"document":"36140862","golden":false,"offsetInEndSection":456,"text":"OH overlaps the European Green Deal plan and its relaunched Farm to Fork Strategy, which aims at spreading organic farms adopting the circular economy, in order to improve human health through both better environmental conditions and healthier food.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":688,"document":"37885601","golden":false,"offsetInEndSection":1014,"text":"This foundational statement also focuses on the changes to medical education, health systems, and health policy that are needed to improve clinical practice and advocacy efforts in Canada, including appropriate remuneration models, stepped-care approaches, targeted government funding, and professional training and education.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":440,"document":"35295776","golden":true,"offsetInEndSection":1011,"text":"This implementation study (ci-chimps) evaluates three clinical implementation projects with three different implementation interventions for the optimal implementation of the tailored family-oriented preventive and therapeutic interventions in the CHIMPS-NET (children of mentally ill parents-research network) with an implementation model for children of mentally ill parents.Methods: A two-group randomized controlled multicenter trial will examine changes in family-oriented practice and aspects of implementation at baseline as well as at 12- and 24-months follow-up.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33196410","golden":false,"offsetInEndSection":625,"text":"BACKGROUND: Quality of life for children and adolescents living with serious parental mental illness can be impaired, but evidence-based interventions to improve it are scarce.OBJECTIVE: Co-production of a child-centred intervention [called Young Simplifying Mental Illness plus Life Enhancement Skills (SMILES)] to improve the health-related quality of life of children and adolescents living with serious parental mental illness, and evaluating its acceptability and feasibility for delivery in NHS and community settings.DESIGN: Qualitative and co-production methods informed the development of the intervention (Phase I).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1319,"document":"34855690","golden":false,"offsetInEndSection":1803,"text":"Factors associated with medication use varied by class: stimulants-ADHD, lower ASD symptom severity, and more intensive behavior problems; SSRIs-higher ASD symptom severity; alpha-2 agonists-ADHD, higher ASD symptom severity, lower cognitive functioning, and higher caregiver strain; and antipsychotics-none.CONCLUSION: The findings highlight factors associated with psychotropic medication use for a clinically complex population, which may inform community care improvement efforts.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"29093889","golden":false,"offsetInEndSection":193,"text":"Prevention of mental illness and mental health promotion activities across Europe have gathered some pace since the launch of the European Union\u0027s Pact for Mental Health and Well-Being in 2008.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":194,"document":"29093889","golden":false,"offsetInEndSection":512,"text":"Within the context of a large treatment gap in mental health and limited resources to meet the high demand for mental healthcare, a concerted effort is now needed to ensure that initiatives in both mental illness prevention and mental health promotion become a fundamental part of where we are educated, work and live.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":434,"document":"18497219","golden":false,"offsetInEndSection":622,"text":"Herein, we focus attention on the RISET project, an ongoing collaborative effort across the European Union aiming at minimization of immunosuppression on the basis of validated biomarkers.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"29093889","golden":false,"offsetInEndSection":94,"text":"Increasing momentum in prevention of mental illness and mental health promotion across Europe.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":513,"document":"29093889","golden":false,"offsetInEndSection":622,"text":"Cost-effective, evidence-based approaches in prevention and promotion make these initiatives more accessible.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":668,"document":"16886704","golden":false,"offsetInEndSection":908,"text":"The project DEC-net is coordinated by the Laboratory of Mother and Child Health of the Mario Negri Institute for Pharmaceutical Research in Milan and currently involves members of four countries; France, Italy, Spain and the United Kingdom.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":20,"document":"19266173","golden":false,"offsetInEndSection":287,"text":"1901/2006 of the European Parliament and the Council dated 12 December 2008 on medicinal products for paediatric use is the result of a survey by the European Commission, concluding that children in the European Union are inadequately treated with medicinal products.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":178,"document":"38281128","golden":false,"offsetInEndSection":353,"text":"This population-based case-control study in an Israeli HMO, Leumit Health Services (LHS), uses a database for all LHS members aged 5 to 18?years between 1/1/2002 and 1/30/2022","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38097236","golden":false,"offsetInEndSection":141,"text":"Suicidality Treatment Occurring in Paediatrics (STOP) Medication Suicidality Side Effects Scale in young people in two cohorts across Europe.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":333,"document":"38069539","golden":false,"offsetInEndSection":467,"text":"A population-based case-control study of all children (\u003c18?years) registered in Leumit Health Services during 01.01.2006 to 06.30.2021","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":268,"document":"37765171","golden":false,"offsetInEndSection":418,"text":"Within a large naturalistic observational prospective multicenter clinical trial (\"TDM-VIGIL\"), a transdiagnostic sample of children and adolescents (","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1036,"document":"37688774","golden":false,"offsetInEndSection":1226,"text":"We found significantly higher risks for some new conditions in exposed children, including mental health issues (aHR 1.8, 95% CI 1.1-3.0) and neurological problems (aHR 2.4, 95% CI 1.4-4.1).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":554,"document":"37672261","golden":false,"offsetInEndSection":840,"text":"PubMed and EMBASE were searched from inception until March 31, 2023, for systematic reviews with or without meta-analyses of randomized clinical trials (RCTs) examining the efficacy and safety of antidepressants for treatment or prevention of comorbid depression in any medical disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":5,"document":"37615935","golden":false,"offsetInEndSection":237,"text":"Childhood sexual abuse (CSA) among women is an alarmingly prevalent traumatic experience that often leads to debilitating and treatment-refractory posttraumatic stress disorder (PTSD), raising the need for novel adjunctive therapies","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1020,"document":"37474677","golden":false,"offsetInEndSection":1096,"text":"Results from individual-level data are consistent with group-average results","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":916,"document":"37163253","golden":false,"offsetInEndSection":1052,"text":"The sample was recruited across Norway between June 1999 and December 2008, and analyses were performed from July 1 to October 14, 2022.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":981,"document":"37726821","golden":false,"offsetInEndSection":1394,"text":"The aim of the current study is to evaluate the efficacy of BRIDGE in reducing maternal depression and child MI symptoms (primary outcomes) as well as parenting stress and harsh parenting (secondary outcomes).METHODS: A three-armed randomized control trial with equal group sizes will be conducted to compare the efficacy of (1) BRIDGE (DBT?+?parenting skills), (2) DBT skills training, and (3) services-as-usual.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1606,"document":"37726821","golden":false,"offsetInEndSection":1844,"text":"Assessments will be administered at pre-intervention(T1) post-intervention (T2), and 6-month follow-up (T3).DISCUSSION: Dual-generation programs offer an innovative approach to prevent the intergenerational transmission of mental illness.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":869,"document":"37726821","golden":false,"offsetInEndSection":980,"text":"In pilot within-group studies, BRIDGE has led to large reductions in maternal depression and child MI symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1508,"document":"35386261","golden":false,"offsetInEndSection":1640,"text":"Preliminary evidence overall supports the viability of Tealeaf and Ed-MH for positively impacting child mental health and academics.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37726821","golden":false,"offsetInEndSection":199,"text":"Protocol for a randomized control trial of the Building Regulation in Dual Generations Program (BRIDGE): preventing the intergenerational transmission of mental illness in at-risk preschool children.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1995,"document":"37726821","golden":false,"offsetInEndSection":2147,"text":"These comparisons will provide valuable information on the relative efficacy of including parenting support in a mental health intervention for parents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1845,"document":"37726821","golden":false,"offsetInEndSection":1994,"text":"The current study will add to the evidence base for BRIDGE by comparing it to a stand-alone mental health intervention and a services-as-usual group.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1355,"document":"33996508","golden":false,"offsetInEndSection":1641,"text":"of this study are in support of the previous findings suggesting that the REThink online game can be a valuable tool for large-scale mental health efforts aimed at the prevention of emotional disorders in children and adolescents, in accordance with evidence-based prevention protocols.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":472,"document":"37726821","golden":false,"offsetInEndSection":658,"text":"Dual-generation interventions, which aim to simultaneously treat parent and child mental health, show promise for improving outcomes for mothers with depression and their young children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1504,"document":"37726821","golden":false,"offsetInEndSection":1605,"text":"Those randomized to BRIDGE or DBT skills training will complete a 16-week group therapy intervention.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33926431","golden":false,"offsetInEndSection":179,"text":"BACKGROUND: We describe our experience from a multi-national application of a European Union-funded research-driven paediatric trial (DEEP-2, EudraCT 2012-000353-31; NCT01825512).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1602,"document":"39317509","golden":false,"offsetInEndSection":1880,"text":"The study is scheduled to run from February 2019 to July 2025.ETHICS AND DISSEMINATION: The project Improve-MH (application number 602) was approved by the local ethics committee of Ruhr-University of Bochum and is being conducted in accordance with the Declaration of Helsinki.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"39317509","golden":false,"offsetInEndSection":256,"text":"Improve Mental Health (Improve-MH) in refugee families using a culturally adapted, general practitioner-delivered psychotherapeutic intervention combined with Triple P Online parenting programme: study protocol of a multicentre randomised controlled trial.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":379,"document":"39317509","golden":false,"offsetInEndSection":534,"text":"Our primary goal is to proactively address MHP in refugee parents and prevent its potential impact on their children through effective early interventions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39317509","golden":false,"offsetInEndSection":182,"text":"INTRODUCTION: Germany and the European Union have experienced successive waves of refugees since 2014, resulting in over 1.6?million arrivals, including families with young children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":535,"document":"39317509","golden":false,"offsetInEndSection":896,"text":"Using a low-threshold, primary care-based approach, we aim to enhance parenting skills and address parental psychopathology, creating a supportive environment for parents and children.METHODS AND ANALYSIS: In this randomised controlled trial, 188 refugee parents of 6-year-old children or younger who meet the clinical cut-off on the MHP scale will participate.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1153,"document":"39317509","golden":false,"offsetInEndSection":1340,"text":"Improve includes face-to-face sessions with general practitioners, an interactive online parenting programme (Triple P Online) and regular protocol-based telephone calls by psychologists.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1881,"document":"39317509","golden":false,"offsetInEndSection":2064,"text":"The study is also conducted in full accordance with the German Data Protection Act, and the Good Clinical Practice guideline (GCP) and is sensitive to specific ethical considerations.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1341,"document":"39317509","golden":false,"offsetInEndSection":1523,"text":"Primary outcomes will assess the intervention\u0027s effects on parental and child MHP and parenting skills, with secondary outcomes including psychosocial and physical health indicators.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":897,"document":"39317509","golden":false,"offsetInEndSection":1091,"text":"They are randomly assigned to either the experimental psychotherapeutic intervention, delivered by general practitioners (10-week Improve intervention), or treatment as usual, in a ratio of 1:1.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":508,"document":"39734928","golden":false,"offsetInEndSection":957,"text":"neglected.Methods: Based on the results of our systematic literature analysis of PPI of children in mental health research, the concept development of the Children\u0027s Council \u0027Mental Health\u0027 was administered in cooperation with several stakeholders and focus groups (practitioners and researchers in the field of clinical psychology and psychotherapy across the lifespan, representatives from three self-help organizations for mental disorders, child","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1432,"document":"36581685","golden":false,"offsetInEndSection":1698,"text":"he mental health of children and adolescents may be improved by introducing routine screening, refining diagnostic sensitivity, raising awareness of mental disorders, minimizing stigma and socioeconomic inequality, as well as developing early intervention services. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37793673","golden":false,"offsetInEndSection":147,"text":"BACKROUND: The evidence base for interventions for child mental health and neurodevelopment is weak and the current capacity for rigorous evaluatio","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":183,"document":"39317509","golden":false,"offsetInEndSection":378,"text":"These vulnerable populations often face xenophobia, discrimination, substandard living conditions and limited healthcare access, contributing to a high prevalence of mental health problems (MHP).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":895,"document":"26458917","golden":false,"offsetInEndSection":1281,"text":"We aim to replicate these findings and evaluate the impact of providing training and supervision in MATCH-ADTC to: (1) improve clinical outcomes for youth attending mental health services; (2) increase the amount of evidence-based therapy content; (3) increase the efficiency of service delivery.METHODS: This is an assessor-blinded multi-site effectiveness randomized controlled trial.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1079,"document":"29714619","golden":false,"offsetInEndSection":1679,"text":"Relatively complicated or large pediatric clinical trials, such as phase II and III trials and those that included a broad age range of participants, had a significantly greater likelihood of the involvement of European Union countries ( P \u003c .05).CONCLUSION: Our results suggest that (1) the pharmaceutical industry utilizes regulatory frameworks in making business decisions regarding pediatric clinical trials, (2) disease area affects the involvement of European Union countries, and (3) feasibility of clinical trials is mainly concerned by pharmaceutical industry for pediatric drug development.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2118,"document":"29494592","golden":false,"offsetInEndSection":2431,"text":"Limitations of this study include the potential lack of generalisability to medicines not authorised by the EMA and the possibility for more of these trials to be completed or published in the future.CONCLUSIONS: The completion of many paediatric studies required under the Paediatric Regulation has been delayed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36011572","golden":false,"offsetInEndSection":450,"text":"Young carers are children and adolescents who provide care to other family members or friends, taking over responsibilities that are usually associated with adulthood. There is emerging but still scarce knowledge worldwide about the phenomenon of young carers and the impact of a caring role on their health, social and personal development spheres. This paper provides an overview of the main results from the ME-WE project, which is the first Europ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39317509","golden":false,"offsetInEndSection":500,"text":"INTRODUCTION: Germany and the European Union have experienced successive waves of refugees since 2014, resulting in over 1.6?million arrivals, including families with young children. These vulnerable populations often face xenophobia, discrimination, substandard living conditions and limited healthcare access, contributing to a high prevalence of mental health problems (MHP). Our primary goal is to proactively address MHP in refugee parents and prevent its potential impact on their children thro","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":431,"document":"20388196","golden":true,"offsetInEndSection":1247,"text":"in schools. There is also a lack of information on whether suicide-preventive interventions can, in addition to preventing suicide, reduce risk behaviors and promote healthier ones as well as improve young people\u0027s mental health.The aim of the SEYLE project, which is funded by the European Union under the Seventh Framework Health Program, is to address these issues by collecting baseline and follow-up data on health and well-being among European adolescents and compiling an epidemiological database; testing, in a randomized controlled trial, three different suicide-preventive interventions; evaluating the outcome of each intervention in comparison with a control group from a multidisciplinary perspective; as well as recommending culturally adjusted models for promoting mental health and preventing suicida","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35301204","golden":false,"offsetInEndSection":169,"text":"INTRODUCTION: Improving the lives of children and adolescents with parental mental illness (CAPRI) remains an urgent political and public health concern for the UK and E","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1310,"document":"31664974","golden":false,"offsetInEndSection":1528,"text":"Emotional Learning. Among the five Pan-European regions, 34 schools have been currently involved (17 control; 17 intervention) and around 6000 adolescents and their families are foreseen to participate along a 3-year p","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1427,"document":"38613677","golden":false,"offsetInEndSection":1849,"text":"FAMILY aims to deliver: (i) new discoveries clarifying the aetiology of mental illness and the process of resilience, thereby providing new targets for prevention and intervention studies; (ii) a risk prediction model within a normative modelling framework to predict who is at risk for developing mental illness; and (iii) insight into social and ethical issues related to risk prediction to inform clinical guidelines.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1084,"document":"34666417","golden":false,"offsetInEndSection":1317,"text":"al Clinical Trials Registry Platform.SELECTION CRITERIA: Eligible studies were randomised controlled trials (RCTs) that compared parenting interventions with a control condition for people with schizophrenia or related serious mental","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":812,"document":"36447303","golden":false,"offsetInEndSection":993,"text":"er levels of mental health. Working parents reported better mental health in countries where spending on formal childcare was higher, or where using formal childcare use was more wi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31486894","golden":false,"offsetInEndSection":145,"text":"The aim of this observational study was to explore trial premature cessation, non-publication and trial registration time in child mental health.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25579833","golden":false,"offsetInEndSection":129,"text":"BACKGROUND: Suicidal behaviours in adolescents are a major public health problem and evidence-based prevention programmes are gre","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1512,"document":"36943835","golden":false,"offsetInEndSection":1760,"text":"effects (qualitative measure). Secondary outcomes measured by parent survey at 4-months post randomisation include child mental health, parent mental health, impact of the child\u0027s mental health problem on their functioning and family, and health se","beginSection":"abstract"}],"exact_answer":"no","ideal_answer":["No, the snippets do not provide evidence of new formal efforts by the European Union to increase the number of clinical trials specifically aimed at improving the mental health of children. The snippets describe a focused trial on refugee families, which involves a mental health intervention, but it does not mention a broader EU initiative targeting children\u0027s mental health.","No, there are no explicit mentions of new European Union formal efforts specifically aimed at increasing clinical trials for improving the mental health of children in the provided snippets. The snippets discuss initiatives like Improve-MH focused on mental health interventions for refugee families, but they do not indicate an EU-wide formal effort targeting children\u0027s mental health clinical trials exclusively."],"id":"6593debd06a2ea257c00001f","type":"yesno","body":"Are there new European Union formal efforts to increase the number of clinical trials aimed at improving the mental health of children?"},{"documents":[{"golden":true,"id":"29594041"},{"golden":false,"id":"28138026"},{"golden":false,"id":"29475886"},{"golden":false,"id":"31750274"},{"golden":false,"id":"35487285"},{"golden":false,"id":"35093451"},{"golden":true,"id":"30563098"},{"golden":false,"id":"21631971"},{"golden":false,"id":"16199098"},{"golden":false,"id":"20192680"},{"golden":false,"id":"15361132"},{"golden":false,"id":"22057449"},{"golden":false,"id":"19367568"},{"golden":false,"id":"28743588"},{"golden":false,"id":"2196541"},{"golden":false,"id":"6167517"},{"golden":false,"id":"31399043"},{"golden":false,"id":"36478630"},{"golden":false,"id":"25996472"},{"golden":false,"id":"27538449"},{"golden":false,"id":"20550160"},{"golden":false,"id":"19870458"},{"golden":false,"id":"30542506"},{"golden":false,"id":"6292337"},{"golden":false,"id":"212179"},{"golden":false,"id":"27993115"},{"golden":false,"id":"205348"},{"golden":false,"id":"2773312"},{"golden":false,"id":"24572293"},{"golden":false,"id":"33839691"},{"golden":false,"id":"28387831"},{"golden":false,"id":"10764250"},{"golden":false,"id":"24553100"},{"golden":false,"id":"25954598"},{"golden":false,"id":"26808201"},{"golden":false,"id":"32215786"},{"golden":false,"id":"15665822"},{"golden":false,"id":"10738224"},{"golden":false,"id":"8633100"},{"golden":false,"id":"32340193"},{"golden":false,"id":"25878115"},{"golden":false,"id":"422243"},{"golden":false,"id":"19287510"},{"golden":false,"id":"6282443"},{"golden":false,"id":"6696082"},{"golden":false,"id":"16815869"},{"golden":false,"id":"4056058"},{"golden":false,"id":"1996717"},{"golden":false,"id":"1877652"},{"golden":false,"id":"8184888"},{"golden":false,"id":"11508345"},{"golden":false,"id":"1750561"},{"golden":false,"id":"9056689"},{"golden":false,"id":"9815793"},{"golden":false,"id":"16651439"},{"golden":false,"id":"28438617"},{"golden":false,"id":"2819715"},{"golden":false,"id":"15634026"},{"golden":false,"id":"6088033"},{"golden":false,"id":"36240880"},{"golden":false,"id":"12599230"},{"golden":false,"id":"2719117"},{"golden":false,"id":"15717742"},{"golden":false,"id":"18950458"},{"golden":false,"id":"10652620"},{"golden":false,"id":"12792745"},{"golden":false,"id":"15717737"},{"golden":false,"id":"33252182"},{"golden":false,"id":"10555126"},{"golden":false,"id":"9826067"},{"golden":false,"id":"16686158"},{"golden":false,"id":"21576435"},{"golden":false,"id":"23319696"},{"golden":false,"id":"171892"},{"golden":false,"id":"4997759"},{"golden":false,"id":"200574"},{"golden":false,"id":"4306304"},{"golden":false,"id":"25909609"},{"golden":false,"id":"1444327"},{"golden":false,"id":"175922"},{"golden":false,"id":"32272175"},{"golden":false,"id":"36572970"},{"golden":false,"id":"35821679"},{"golden":false,"id":"35801932"},{"golden":false,"id":"36185807"},{"golden":false,"id":"24327128"},{"golden":false,"id":"31036068"},{"golden":false,"id":"25473916"},{"golden":false,"id":"32028001"},{"golden":false,"id":"27213425"},{"golden":false,"id":"28434841"},{"golden":false,"id":"35481923"},{"golden":false,"id":"27660749"},{"golden":false,"id":"6306322"},{"golden":false,"id":"4762114"},{"golden":false,"id":"221713"},{"golden":false,"id":"14533011"},{"golden":false,"id":"2545590"},{"golden":false,"id":"33771666"},{"golden":false,"id":"9588771"},{"golden":false,"id":"17121894"},{"golden":false,"id":"16955308"},{"golden":false,"id":"25687551"},{"golden":false,"id":"22606725"},{"golden":false,"id":"15527832"},{"golden":false,"id":"11443603"},{"golden":false,"id":"35065174"},{"golden":false,"id":"35668702"},{"golden":false,"id":"15717735"},{"golden":false,"id":"34504086"},{"golden":false,"id":"34034251"},{"golden":false,"id":"9469639"},{"golden":false,"id":"35330608"},{"golden":false,"id":"12441306"},{"golden":false,"id":"16856922"},{"golden":false,"id":"21464247"},{"golden":false,"id":"12224004"},{"golden":false,"id":"36746338"},{"golden":false,"id":"1711600"},{"golden":false,"id":"11719449"},{"golden":false,"id":"19420962"},{"golden":false,"id":"12152818"},{"golden":false,"id":"28100299"},{"golden":false,"id":"4318956"},{"golden":false,"id":"23174601"},{"golden":false,"id":"34024957"},{"golden":false,"id":"26939461"},{"golden":false,"id":"6314975"},{"golden":false,"id":"26164357"},{"golden":false,"id":"33838625"},{"golden":false,"id":"19618859"},{"golden":false,"id":"35342877"},{"golden":false,"id":"31315671"},{"golden":false,"id":"22382786"},{"golden":false,"id":"31138805"},{"golden":false,"id":"34001278"},{"golden":false,"id":"35393952"},{"golden":false,"id":"24511389"},{"golden":false,"id":"30544335"},{"golden":false,"id":"35083096"},{"golden":false,"id":"9578834"},{"golden":false,"id":"16915291"},{"golden":false,"id":"19530039"},{"golden":false,"id":"1131829"},{"golden":false,"id":"15881753"},{"golden":false,"id":"16012244"},{"golden":true,"id":"37188783"},{"golden":false,"id":"39467343"},{"golden":false,"id":"37749907"},{"golden":false,"id":"38806994"},{"golden":false,"id":"37491263"},{"golden":false,"id":"37925150"},{"golden":false,"id":"38720892"},{"golden":false,"id":"1291856"},{"golden":false,"id":"29938370"},{"golden":false,"id":"8897938"},{"golden":false,"id":"20855736"},{"golden":true,"id":"34004331"},{"golden":true,"id":"29432077"},{"golden":true,"id":"35176144"},{"golden":false,"id":"33524949"},{"golden":true,"id":"35767439"},{"golden":true,"id":"29088386"},{"golden":false,"id":"30123426"},{"golden":true,"id":"31726894"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":1667,"document":"29432077","golden":true,"offsetInEndSection":1918,"text":"Conclusion Treatment with DNX-2401 resulted in dramatic responses with long-term survival in recurrent high-grade gliomas that are probably due to direct oncolytic effects of the virus followed by elicitation of an immune-mediated antiglioma response.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"29432077","golden":false,"offsetInEndSection":112,"text":"Purpose DNX-2401 (Delta-24-RGD; tasadenoturev) is a tumor-selective, replication-competent oncolytic adenovirus.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":484,"document":"35487285","golden":false,"offsetInEndSection":804,"text":"While the majority of brain tumor clinical trials utilizing oncolytic virotherapy have been in adults, five viruses are being tested in pediatric brain tumor clinical trials: herpes simplex virus (G207), reovirus (pelareorep/Reolysin), measles virus (MV-NIS), poliovirus (PVSRIPO), and adenovirus (DNX-2401, AloCELYVIR).","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"35767439","golden":true,"offsetInEndSection":72,"text":"Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma.","beginSection":"title"},{"endSection":"title","offsetInBeginSection":0,"document":"29432077","golden":true,"offsetInEndSection":135,"text":"Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":389,"document":"29432077","golden":false,"offsetInEndSection":556,"text":"Patients received a single intratumoral injection of DNX-2401 into biopsy-confirmed recurrent tumor to evaluate safety and response across eight dose levels (group A).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":330,"document":"29594041","golden":false,"offsetInEndSection":508,"text":"Oncolytic adenovirus DNX-2401 is a replication-competent, genetically modified virus capable of infecting and killing glioma cells, and stimulating an anti-tumor immune response.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28138026","golden":false,"offsetInEndSection":181,"text":"Delta-24-RGD (DNX-2401) is a conditional replication-competent oncolytic virus engineered to preferentially replicate in and lyse tumor cells with abnormality of p16/RB/E2F pathway.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":245,"document":"29432077","golden":true,"offsetInEndSection":388,"text":"Methods A phase I, dose-escalation, biologic-end-point clinical trial of DNX-2401 was conducted in 37 patients with recurrent malignant glioma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":620,"document":"31750274","golden":false,"offsetInEndSection":864,"text":"DNX-2401 (Delta-24-RGD), the current mainstream oncolytic adenovirus with modifications in E1A and the fiber, has been shown to induce impressive objective response and long-term survival (\u003e3 years) in a fraction of patients with recurrent HGG.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":338,"document":"29594041","golden":false,"offsetInEndSection":517,"text":"c adenovirus DNX-2401 is a replication-competent, genetically modified virus capable of infecting and killing glioma cells, and stimulating an anti-tumor immune response. Clinical","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"29594041","golden":true,"offsetInEndSection":118,"text":"DNX-2401, an Oncolytic Virus, for the Treatment of Newly Diagnosed Diffuse Intrinsic Pontine Gliomas: A Case Report.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":519,"document":"29594041","golden":true,"offsetInEndSection":694,"text":"rials evaluating intratumoral DNX-2401 in adults with recurrent glioblastoma have demonstrated that the virus has a favorable safety profile and can prolong survival. Subseque","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"29088386","golden":true,"offsetInEndSection":100,"text":"Phase I Trial of DNX-2401 for Diffuse Intrinsic Pontine Glioma Newly Diagnosed in Pediatric Patients","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":681,"document":"35093451","golden":false,"offsetInEndSection":818,"text":"cal and clinical studies have shown that G207, DNX2401, Zika and other viruses have important roles in malignant tumors. For example, the","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":414,"document":"29088386","golden":false,"offsetInEndSection":628,"text":"IPGs.OBJECTIVE: To determine the safety, tolerability, and toxicity of an oncolytic adenovirus, DNX-2401, injected into the cerebellar peduncle in pediatric subjects with DIPG and to collect tumor samples of this t","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1641,"document":"29594041","golden":true,"offsetInEndSection":1870,"text":"e that intratumoral delivery of an oncolytic virus following tumor biopsy for pediatric patients with DIPG is a novel and feasible approach and that DNX-2401 represents an innovative treatment for the disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1527,"document":"29594041","golden":true,"offsetInEndSection":1639,"text":"is is the first report of intratumoral DNX-2401 for a patient with DIPG in a clinical trial. We plan to demonstr","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"31726894","golden":true,"offsetInEndSection":78,"text":"DNX-2401: an investigational drug for the treatment of recurrent glioblastoma.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":836,"document":"29594041","golden":true,"offsetInEndSection":1061,"text":" we have designed a clinical Phase I trial for newly diagnosed pediatric DIPG to investigate the feasibility, safety, and preliminary efficacy of delivering DNX-2401 into tumors within the pons following biopsy. This case rep","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"35767439","golden":true,"offsetInEndSection":71,"text":"Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35176144","golden":false,"offsetInEndSection":198,"text":"PURPOSE: Testing safety of Delta24-RGD (DNX-2401), an oncolytic adenovirus, locally delivered by convection enhanced delivery (CED) in tumor and surrounding brain of patients with recurrent glioblas","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":317,"document":"35767439","golden":false,"offsetInEndSection":490,"text":"king.METHODS: We conducted a single-center, dose-escalation study of DNX-2401, an oncolytic adenovirus that selectively replicates in tumor cells, in patients with newly dia","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1979,"document":"35767439","golden":true,"offsetInEndSection":2230,"text":"ONS: Intratumoral infusion of oncolytic virus DNX-2401 followed by radiotherapy in pediatric patients with DIPG resulted in changes in T-cell activity and a reduction in or stabilization of tumor size in some patients but was associated with adverse e","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1090,"document":"29432077","golden":false,"offsetInEndSection":1274,"text":" surgical specimens (group B, n \u003d 12) showed that DNX-2401 replicates and spreads within the tumor, documenting direct virus-induced oncolysis in patients. In addition to radiographic ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":939,"document":"30563098","golden":true,"offsetInEndSection":1398,"text":"Recent early phase trials with the recombinant adenovirus DNX-2401 (Ad5-delta24-RGD), polio-rhinovirus chimera (PVSRIPO), parvovirus H-1 (ParvOryx), Toca 511 retroviral vector with 5-fluorocytosine, heat shock protein-peptide complex-96 (HSPPC-96) and dendritic cell vaccines, including DCVax-L vaccine, demonstrated that subsets of patients with glioblastoma/glioma may benefit from oncolytic virotherapy/immunotherapy (\u003e3 years of survival after treatment).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1617,"document":"34004331","golden":true,"offsetInEndSection":2100,"text":"Engineered adenoviruses (i.e., DNX-2401, DNX-2440, CRAd8-S-pk7 loaded Neural stem cells), herpes simplex virus type 1 (i.e., HSV-1 C134, HSV-1 rQNestin34.5v.2, HSV-1 G207, HSV-1 M032), measles virus (i.e., MV-CEA), parvovirus (i.e., ParvOryx), poliovirus (i.e., Poliovirus PVSRIPO), reovirus (i.e., pelareorep), moloney murine leukemia virus (i.e., Toca 511 vector), and vaccinia virus (i.e., vaccinia virus TG6002) as possible life-changing alleviations for GBM have been discussed.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"30563098","golden":false,"offsetInEndSection":134,"text":"Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy?","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":658,"document":"30563098","golden":false,"offsetInEndSection":938,"text":"A high rate of failures in clinical trials and a lack of effective chemotherapy on the horizon fostered the development of conceptually distinct therapeutic approaches: dendritic cell/peptide immunotherapy, chimeric antigen receptor (CAR) T-cell therapy and oncolytic virotherapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":942,"document":"21631971","golden":false,"offsetInEndSection":1150,"text":"nd 471 (19.6%) by ultrasound. The 34 palpable thyroid nodules corresponded to 16 (47.2%) colloid goiters, 8 (23.5%) follicular adenomas, 7 (20.5%) Hashimoto\u0027s thyroiditis, 2 (5.9%) papillary carcinomas and 1 ","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"22057449","golden":false,"offsetInEndSection":86,"text":"Preclinical testing of virotherapeutics for primary and secondary tumors of the liver.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1399,"document":"30563098","golden":false,"offsetInEndSection":1523,"text":"However, large controlled trials are required to prove efficacy of next-generation immunotherapeutics and oncolytic vectors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":245,"document":"30563098","golden":false,"offsetInEndSection":412,"text":"According to recent phase III trials, standard therapy may ensure a median overall survival of up to 18?20 months for adult patients with newly diagnosed glioblastoma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30563098","golden":false,"offsetInEndSection":244,"text":"To date, no targeted drugs, antibodies or combinations of chemotherapeutics have been demonstrated to be more efficient than temozolomide, or to increase efficacy of standard therapy (surgery, radiotherapy, temozolomide, steroid dexamethasone).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":413,"document":"30563098","golden":false,"offsetInEndSection":657,"text":"These data explain a failure of positive non-controlled phase II trials to predict positive phase III trials and should result in revision of the landmark Stupp trial as a historical control for median overall survival in non-controlled trials.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":92,"document":"16199098","golden":false,"offsetInEndSection":343,"text":"In this report, we demonstrate that compound 2-amino-8-(beta-D-ribofuranosyl) imidazo [1,2-a]-s-triazine-4-one (ZX-2401) was capable of inhibiting the production in culture of at least five members of the Flaviviridae family with minimal cytotoxicity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":91,"document":"20550160","golden":false,"offsetInEndSection":350,"text":"e examined the potential of boosting the efficacy of the oncolytic adenovirus dl520 by associating it with magnetic nanoparticles and magnetic-field-guided infection in multidrug-resistant (MDR) cancer cells in vitro and upon intratumoral injection in vivo. T","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"19870458","golden":false,"offsetInEndSection":179,"text":"In the experiments presented, Virus myxomatosum was observed to produce only a localized fibromatous or myxomatous orchitis when injected into the testicles of cottontail rabbits.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1146,"document":"30542506","golden":false,"offsetInEndSection":1368,"text":"owth control. The results demonstrated significant antitumoral activity of this new modified Raccoonpox virus armed with FCU1 and this virus could be considered to be included into the growing armamentarium of oncolytic vi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":265,"document":"6292337","golden":false,"offsetInEndSection":429,"text":"-MuLV and NBX virus were presumably present in a genomically masked form and could be recovered only by co-cultivation of tumour cells with permissive cells. Only a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"212179","golden":false,"offsetInEndSection":114,"text":"Effective treatment of transplanted murine mammary tumors with an oncolytic virus and cyclophosphamide is reported","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1456,"document":"27993115","golden":false,"offsetInEndSection":1635,"text":"ns.CONCLUSION: Virotherapy is being developed to be a novel therapy for cancers, which uses oncotropic and oncolytic viruses with their abilities to find and destroy malignant cel","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":939,"document":"30542506","golden":false,"offsetInEndSection":1143,"text":"tumor cell lines. In human colon cancer xenograft model, a single intratumoral inoculation of the recombinant Raccoonpox virus, in combination with 5-fluorocytosine administration, produced relevant tumor","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":289,"document":"19870458","golden":false,"offsetInEndSection":456,"text":"serial passages of Virus myxomatosum through cottontail rabbits, covering a total elapsed time of 140 days, failed to alter its pathogenicity for domestic rabbits. Alt","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"205348","golden":false,"offsetInEndSection":264,"text":"Soehner-Dmochowski murine sarcoma virus (Moloney)-induced bone tumors of New Zealand Black rats carry two morphologically different types of virus particles, namely, extracellular type C and intracisternal virus particles, which have thus far not been reported. Th","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"2773312","golden":false,"offsetInEndSection":349,"text":"Virus characterization studies were performed to meliorate the taxonomic status of three currently unclassified, serologically related viruses: Tanapox virus (causes vesicular skin lesions in humans), Yaba-like disease (YLD) virus (causes vesicular skin lesions in monkeys), and Yaba monkey tumor virus (YMTV, causes epidermal histiocytoma). These s","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"33839691","golden":false,"offsetInEndSection":49,"text":"Oncolytic Herpes Virus Shrinks Pediatric Gliomas.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28387831","golden":false,"offsetInEndSection":194,"text":"BACKGROUND: Prodrug-activator gene therapy with Toca 511, a tumor-selective retroviral replicating vector (RRV) encoding yeast cytosine deaminase, is being evaluated in recurrent high-grade glio","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"24572293","golden":false,"offsetInEndSection":143,"text":"A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responses.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1053,"document":"24572293","golden":false,"offsetInEndSection":1245,"text":"In conclusion, this study showed the safety and the potential for clinical response of single-dose oncolytic HSV therapy augmented with radiation in the treatment of malignant glioma patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":238,"document":"26808201","golden":false,"offsetInEndSection":453,"text":"In this study we characterize the anti-glioma effect of VCN-01, an improved hyaluronidase-armed pRB-pathway-selective oncolytic adenovirus that has proven safe and effective in the treatment of several solid tumors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25954598","golden":false,"offsetInEndSection":146,"text":"We recently evaluated the capacity of Delta-24-RGD oncolytic adenovirus to trigger an antitumor immune response in a syngeneic mouse glioma model.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":56,"document":"15665822","golden":false,"offsetInEndSection":213,"text":"We investigated the antitumor effect of two related herpes simplex virus (HSV) mutants, NV1020 and NV1066, on human rhabdomyosracoma cells and xenografts. Ce","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":184,"document":"10738224","golden":false,"offsetInEndSection":402,"text":"proteins. Therefore, a new, highly attenuated vaccinia virus known as modified vaccinia virus Ankara (MVA), which carries the papillomavirus E2 gene, was used for the treatment of tumors associated with human papilloma","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":944,"document":"8633100","golden":false,"offsetInEndSection":1229,"text":" complete regression of the breast cancer with the recombinant virus ad5/IFN was the result of two events: viral oncolysis in which tumor cells are being selectively lysed by the replication-competent virus and the enhanced effect of expression of the IFN-con1 gene. K562 and RPMI 1846","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":591,"document":"32340193","golden":false,"offsetInEndSection":805,"text":" tested the effects of Rapid Antiangiogenesis Mediated By Oncolytic Virus (RAMBO), an oHSV which expresses a potent anti-angiogenic gene Vasculostatin on endothelial cell activation in heavily vascularized solid tu","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1784,"document":"32340193","golden":false,"offsetInEndSection":1938,"text":"rovides strong preclinical evidence of the therapeutic benefit for the use of RAMBO virus as a treatment option for highly vascularized tumors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1268,"document":"25878115","golden":false,"offsetInEndSection":1533,"text":" combining VSV genes with the gene coding for the Ebola virus glycoprotein was safe in the brain and also selectively targeted brain tumors but was substantially less effective in destroying brain tumors and prolonging survival of tumor-bearing mice. A tropism for ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"422243","golden":false,"offsetInEndSection":280,"text":"Cowpea (Vigna sinensis) seedlings failed to develop tumors after being inoculated with crown gall bacteria (Agrobacterium tumefaciens) if, at times earlier than 1 day later, they were inoculated on the primary leaves with a cowpea mosaic virus that systemically infects them. Inoc","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1535,"document":"25878115","golden":false,"offsetInEndSection":1742,"text":"ltiple cancer types combined with an exquisite tumor specificity opens a new door to widespread application of VSV-LASV-GPC as a safe and efficacious oncolytic chimeric virus within the brain.IMPORTANCE: Man","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1186,"document":"19287510","golden":false,"offsetInEndSection":1372,"text":"V-1h99 is the first oncolytic virus expressing the hNET protein that can efficiently eliminate tumors and simultaneously allow deep-tissue imaging of infected tumors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":512,"document":"6282443","golden":false,"offsetInEndSection":645,"text":"noculated with m1MSV(B-MuX) virus or quail embryo fibroblast cells infected with helper leukemia virus did not develop tumors. A cell","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1139,"document":"1996717","golden":false,"offsetInEndSection":1172,"text":"(ABSTRACT TRUNCATED AT 250 WORDS)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1011,"document":"6696082","golden":false,"offsetInEndSection":1233,"text":"Endogenous angiotensin II activity may be enhanced by renal denervation, and angiotensin II acts to reduce LpA in this condition and may modulate the final level of renal vascular resistances after acute renal denervation.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"6696082","golden":false,"offsetInEndSection":86,"text":"Analysis of renal denervation in the hydropenic rat: interactions with angiotensin II.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"9815793","golden":false,"offsetInEndSection":307,"text":"This study elucidates a basically new mechanism of function of a virus-modified tumor cell vaccine which has been successful in mouse tumor models (metastatic ESb lymphoma and B16-F10 melanoma) in preventing or delaying metastatic spread and improving survival and which is being tested in clinical studies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1446,"document":"16651439","golden":false,"offsetInEndSection":1671,"text":"It is intended to enter the GALV/Fcy::Fur expressing virus into clinical development for the treatment of tumor types, such as pancreatic or lung cancer, where local control would be anticipated to be clinically advantageous.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":308,"document":"9815793","golden":false,"offsetInEndSection":585,"text":"Modification of tumor cells by a low dose of Newcastle disease virus (NDV), which caused this therapy effect, led to an augmentation of the tumor-specific cytotoxic CD8 T-cell (CTL) response and to increased CD4 T-helper activity in the absence of an antiviral T-cell response.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"2819715","golden":false,"offsetInEndSection":267,"text":"We have shown previously that macrophages are mutagenic to bacteria (A. M. Fulton et al., Cancer Res., 44: 4308-4311, 1984) and can induce the appearance of drug-resistant variants of murine mammary tumor cells (K. Yamashina et al., Cancer Res., 46: 2396-2401, 1986).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":586,"document":"9815793","golden":false,"offsetInEndSection":955,"text":"When various noninfectious NDV preparations, which, according to newly established quantitative tests, had lost one or several of the viral functions, were tested, noninfectious virus particles with inactive fusion proteins and virus inactivated by UV light, which could fuse but could not replicate, were as active as infectious NDV in the tumor-specific CTL response.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":827,"document":"16651439","golden":false,"offsetInEndSection":1255,"text":"Viruses expressing the two genes individually or in combination were constructed and tested, showing (a) GALV and/or Fcy::Fur expression did not affect virus growth; (b) GALV expression causes cell fusion and increases the tumor cell killing at least 30-fold in vitro and tumor shrinkage 5- to 10-fold in vivo; (c) additional expression of Fcy::Fur combined with 5-fluorocytosine administration improves tumor shrinkage further.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1233,"document":"9815793","golden":false,"offsetInEndSection":1713,"text":"Because NDV-HI was not able to bind to the tumor cell surface and because hemagglutinin-neuraminidase c-DNA transfectants increased antigen-presenting function as virus-modified cells do, we propose that the NDV effect in the CTL response is caused by the introduction of functional viral hemagglutinin-neuraminidase molecules (1000 per virus particle) into the tumor cell surface, thereby facilitating cell-cell interactions through their cell-binding and neuraminidase activity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1195,"document":"9815793","golden":false,"offsetInEndSection":1232,"text":"There was no mitogenic effect of NDV.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"12599230","golden":false,"offsetInEndSection":569,"text":"BACKGROUND: Because angiogenesis may play a role in the pathogenesis of acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS), and thalidomide (Th) has shown significant anti-angiogenic activity, this study was designed to investigate the potential role of Th in the treatment of patients with AML and MDS and the possible role of a non-ara-C-containing regimen.METHODS: Adults with AML or high-risk MDS and cytogenetic abnormalities other than inv (16), t(8;21), -Y or -X were randomized to receive liposomal daunorubicin (DNX) and ara-C (DA) or DN","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"9815793","golden":false,"offsetInEndSection":112,"text":"Virus potentiation of tumor vaccine T-cell stimulatory capacity requires cell surface binding but not infection.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":131,"document":"33252182","golden":false,"offsetInEndSection":248,"text":"Recently, dinutuximab (DNX) has emerged as an effective immunotherapy to treat patients with high risk neuroblastoma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"18950458","golden":false,"offsetInEndSection":165,"text":"This randomized phase III clinical trial explored the efficacy of DaunoXome (DNX) versus Daunorubicin (DNR) in acute myeloid leukaemia (AML) patients aged \u003e60 years.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1158,"document":"18950458","golden":false,"offsetInEndSection":1258,"text":"DNX seems to improve OS and DFS in the long-term follow-up, because of a reduction in late relapses.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"18950458","golden":false,"offsetInEndSection":182,"text":"Liposomal daunorubicin versus standard daunorubicin: long term follow-up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":831,"document":"18950458","golden":false,"offsetInEndSection":1157,"text":"After CR, DNX showed a higher incidence of early deaths (12.5% vs. 2.6% at 6 months, P \u003d 0.053) but a lower incidence of relapse beyond 6 months (59% vs. 78% at 24 months, P \u003d 0.064), with a cross in overall survival (OS) and disease-free survival (DFS) curves and a later advantage for DNX arm after 12 months from diagnosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"10652620","golden":false,"offsetInEndSection":257,"text":"In order to determine the efficacy of liposomal encapsulated daunorubicin (DaunoXome; DNX) in chronic Iymphocytic leukaemia, the sensitivities of cells from 10 patients with this disease were assessed and compared with that of free drug using the MTT assay.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":166,"document":"18950458","golden":false,"offsetInEndSection":328,"text":"Three hundred and one AML patients were randomized to receive DNR (45 mg/m(2) days 1-3) or DNX (80 mg/m(2) days 1-3) plus cytarabine (AraC; 100 mg/m(2) days 1-7).","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"12792745","golden":false,"offsetInEndSection":90,"text":"Phase I study of liposomal daunorubicin in relapsed and refractory acute myeloid leukemia.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":356,"document":"10555126","golden":false,"offsetInEndSection":484,"text":"We conducted a phase I study of liposomal daunorubicin (Daunoxome; DNX) in patients with refractory or relapsed acute leukemias.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"10652620","golden":false,"offsetInEndSection":68,"text":"In vitro sensitivity to the liposomal preparation, DaunoXome in CLL.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":191,"document":"171892","golden":false,"offsetInEndSection":443,"text":" cross-reactivity was demonstrated with murine leukemia virus (MuLV), rat leukemia virus (RaLV), hamster leukemia virus (HaLV), feline leukemia virus (FeLV), simian (woolly monkey) sarcoma virus (SSV-1) and mouse mammary tumor virus (MTV). The cross-re","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"4997759","golden":false,"offsetInEndSection":141,"text":"We describe here serological and structural properties of a virus, Mason-Pfizer Monkey Virus (M-PMV), isolated from a simian mammary tumor. T","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":531,"document":"200574","golden":false,"offsetInEndSection":834,"text":"when age- and sex-matched parallel mice bearing syngeneic subcutaneous non-viral tumors were inoculated similarly with the RC virus, the virus could be detected abundantly not only in bone marrow and spleen but also in tumors during the first 3 weeks and even 6 weeks after virus inoculation. Transition","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":202,"document":"4306304","golden":false,"offsetInEndSection":334,"text":" replication in HeLa cells, a nonpermissive host for GDVII virus, was characterized by virus yields of only 0.1 to 5 PFU/cell. Simil","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25909609","golden":false,"offsetInEndSection":287,"text":"The potential role of viruses with oncogenic potential such as human papilloma virus, cytomegalovirus, Epstein-Barr virus, herpes simplex virus type 1 and 2, herpes virus type 6, in the development of benign and pre-cancerous tumors of maxillofacial region was assessed in the study. We ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":379,"document":"1444327","golden":false,"offsetInEndSection":632,"text":"utellarein also inhibited the replication of influenza virus A/WSN/33 in Madin-Darby bovine kidney cells with 50% virus inhibitory dose at 16 nmol/well and influenza virus A/PR/8/34 in the allantoic sac of embryonated egg with little toxic effects. The ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":80,"document":"175922","golden":false,"offsetInEndSection":281,"text":"This includes the findings of C-type virus or its antigen expressions in every naturally occurring tumor of two strains of \"low-incidence\" laboratory mice, the BALB/cCr mouse and the NIH Swiss mouse. V","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":640,"document":"32272175","golden":false,"offsetInEndSection":946,"text":", the variant with NA292K showed not only resistance to NAIs but also lower replication activity in MDCK cells than did the virus with wild-type NA, whereas the variant with NA222T, which was less resistant to NAIs, showed replication activity similar to that of the wild-type virus. Next, we examined the ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1153,"document":"32272175","golden":false,"offsetInEndSection":1434,"text":"2K was replaced within 7 days by that with NA292R (same as the wild-type) in nasal samples from macaques infected with the virus with NA292K, i.e. the so-called revertant (wild-type virus) became dominant in the population in the absence of an NAI. These results suggest that the c","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":772,"document":"36572970","golden":false,"offsetInEndSection":988,"text":"Q (PpVQ), an umbra-like virus related to but distinct from PMeV-2, and a novel virus, tentatively named papaya sticky fruit-associated virus (PSFaV), were found in the symptomatic samples. PSFaV shares 56% nucleotide","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":945,"document":"24420711","golden":false,"offsetInEndSection":1644,"text":"Several PMs as a candidate for clinical uses have been licensed toward the chemotherapy of solid tumors (such as human gastric cancer and pancreatic cancer), DNA and RNA viruses (such as HSV, HIV, influenza, and SARS), and drug-resistant bacteria (such as MRSA and VRSA) in recent years: [NH3Pr(i)]6[Mo7O24]?3H2O (PM-8) and [Me3NH]6[H2Mo(V) 12O28(OH)12(Mo(VI)O3)4]?2H2O (PM-17) for solid tumors; K7[PTi2W10O40]?6H2O (PM-19), [Pr(i)NH3]6H[PTi2W10O38(O2)2]?H2O (PM-523), and K11H[(VO)3(SbW9O33)2]?27H2O (PM-1002) for viruses; and K6[P2W18O62]?14H2O (PM-27), K4[SiMo12O40]?3H2O (SiMo12), and PM-19 for MRSA and VRSA. The results are discussed from a point of view of the chemotherapeutic clarification ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":72,"document":"29677162","golden":false,"offsetInEndSection":251,"text":"In recent years, gemcitabine, a cytidine analog in clinical use for the treatment of many solid tumors, was also shown to have antiviral activity against a broad range of viruses.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25905039","golden":false,"offsetInEndSection":233,"text":"Eukaryotic translation elongation factors 1 alpha, eEF1A1 and eEF1A2, are not only translation factors but also pleiotropic proteins that are highly expressed in human tumors, including breast cancer, ovarian cancer, and lung cancer.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":274,"document":"17555912","golden":false,"offsetInEndSection":411,"text":"tly, the compounds were examined for their cytotoxic effects on two different human breast tumor cell lines: MCF7 and MDA-MB468. Although","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1136,"document":"26862355","golden":false,"offsetInEndSection":1267,"text":"It is also linked to epithelial tumors such as nasopharyngeal carcinoma (NPC), gastric carcinomas and oral hairy leukoplakia (OHL).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":243,"document":"31872119","golden":false,"offsetInEndSection":344,"text":"To address this need, we studied toxicity of the CDs to breast cancer cells using MTT and LDH assays.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":75,"document":"35821679","golden":false,"offsetInEndSection":228,"text":"c patients. Pelareorep, an immunomodulatory oncolytic reovirus, has intravenous efficacy in preclinical glioma models when preconditioned with GM-CSF (sa","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"35801932","golden":false,"offsetInEndSection":72,"text":"Oncolytic Viral Therapy Is Feasible in Diffuse Intrinsic Pontine Glioma.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":272,"document":"31036068","golden":false,"offsetInEndSection":417,"text":"Delta-24-RGD is a genetically engineered tumor-selective adenovirus that has shown safety and clinical efficacy in adults with recurrent gliomas.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":89,"document":"24327128","golden":false,"offsetInEndSection":392,"text":"We present here the initial experience of administering Celyvir, autologous mesenchymal stem cells infected with ICOVIR-5, an oncolytic adenovirus that selectively replicates in cancer cells, by means of superselective intra-arterial delivery, in a patient diagnosed of diffuse intrinsic pontine glioma.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"35821679","golden":false,"offsetInEndSection":124,"text":"Phase I trial of sargramostim/pelareorep therapy in pediatric patients with recurrent or refractory high-grade brain tumors.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":862,"document":"36185807","golden":false,"offsetInEndSection":1145,"text":"We explore the use of cell-based therapies, oncolytic virotherapy or immunovirotherapy, immune checkpoint inhibition, and immunomodulatory vaccination strategies, and highlight the recent clinical success of anti-GD2 CAR-T therapy in diffuse intrinsic pontine glioma (DIPG) patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":229,"document":"35821679","golden":false,"offsetInEndSection":581,"text":"gramostim). We report a phase I trial with the primary goal of evaluating the safety of sargramostim/pelareorep in pediatric patients with recurrent or refractory high-grade brain tumors and a secondary goal of characterizing immunologic responses.Methods: The trial was open to pediatric patients with recurrent or refractory high-grade brain tumors (","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":684,"document":"35821679","golden":false,"offsetInEndSection":893,"text":"ravenous pelareorep. Laboratory studies and imaging were acquired upon recruitment and periodically thereafter.Results: Six patients participated, including three glioblastoma, two diffuse intrinsic pontine gl","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35801932","golden":false,"offsetInEndSection":118,"text":"Infusion of an oncolytic virus followed by radiotherapy led to responses and prolonged survival in patients with DIPG.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1566,"document":"35821679","golden":false,"offsetInEndSection":1775,"text":"oprogression or inflammation. Correlative assays revealed transient but consistent changes in immune cells across patients.Conclusions: Sargramostim/pelareorep was administered to pediatric patients with recur","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":494,"document":"27660749","golden":false,"offsetInEndSection":781,"text":" has a number of features that make it an attractive oncolytic virus, namely, its ability to target and penetrate solid tumors via intravenous administration, inability for insertional mutagenesis, and being a self-replicating RNA virus with selective tropism for cancer cells. SVV-001 h","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":657,"document":"6306322","golden":false,"offsetInEndSection":825,"text":"ial cells from the liver, kidney, and lung of myxoma virus-infected rabbits contained virus, whereas in MV tumor-bearing rabbits, these cells were uninvolved. However, ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1148,"document":"4762114","golden":false,"offsetInEndSection":1297,"text":"tudies in cell culture demonstrated that fibroma was unable to replicate in peritoneal macrophages from either newborn or adult rabbits. No differenc","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":301,"document":"27660749","golden":false,"offsetInEndSection":491,"text":"1 was originally discovered as a contaminant in the cell culture of fetal retinoblasts and has since been identified as a potent oncolytic virus against tumors of neuroendocrine origin. SVV-","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27660749","golden":false,"offsetInEndSection":98,"text":"Seneca Valley Virus isolate 001 (SVV-001) is an oncolytic RNA virus of the Picornaviridae family. ","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"221713","golden":false,"offsetInEndSection":110,"text":"Polyoncogenicity and insulinoma-inducing ability of BK Virus, a human Papovavirus, in Syrian golden hamsters.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"14533011","golden":false,"offsetInEndSection":199,"text":"Recombinant vaccinia viruses derived from strain Praha, clone P13, and strain MVA were used for intratumoral delivery and expression of IL12 genes in tumors induced by HPV16 E6+E7 oncogenes in mice. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":840,"document":"2545590","golden":false,"offsetInEndSection":1022,"text":"s of two other animals (HW76 and HW89) with integrated woodchuck hepatitis virus DNA, only single major transcripts of 3.5 and 2.5 kilobases, respectively, were detected. Hybridizati","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":274,"document":"33771666","golden":false,"offsetInEndSection":635,"text":"ing the lead from the growing success of immunotherapy for systemic cancers, such as lung cancer and melanoma, immunotherapeutics has emerged as a major player in the potential treatment of gliomas, with oncolytic viruses in particular showing significant promise as evidenced by the recent Breakthrough and Fast Tract Designations for PVSRIPO and DNX2401. This","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"9588771","golden":false,"offsetInEndSection":288,"text":"Kaposi\u0027s sarcoma-associated herpes virus (KSHV), also designated human herpesvirus 8 (HHV8), has been detected consistently in Kaposi\u0027s sarcoma, body cavity lymphoma and multicentric Castleman\u0027s disease, both in human immunodeficiency virus (HIV)-positive and -negative patients. Identifi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17121894","golden":false,"offsetInEndSection":516,"text":"PURPOSE: To conduct a phase I clinical trial with a second-generation oncolytic herpes simplex virus (HSV) expressing granulocyte macrophage colony-stimulating factor (Onco VEXGM-CSF) to determine the safety profile of the virus, look for evidence of biological activity, and identify a dosing schedule for later studies.EXPERIMENTAL DESIGN: The virus was administered by intratumoral injection in patients with cutaneous or s.c. deposits of breast, head and neck and gastrointestinal cancers, and malignant melanoma","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2025,"document":"17121894","golden":false,"offsetInEndSection":2066,"text":"inistered using the multidosing protocol ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1134,"document":"17121894","golden":false,"offsetInEndSection":1309,"text":"ch was well tolerated by all patients. Biological activity (virus replication, local reactions, granulocyte macrophage colony-stimulating factor expression, and HSV antigen-as","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"17121894","golden":false,"offsetInEndSection":145,"text":"A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":186,"document":"11443603","golden":false,"offsetInEndSection":338,"text":"e toxicity. The authors investigated the effect of daunorubicin in combination with ara-C in patients with refractory or recurring acute myelogenous leu","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1640,"document":"17121894","golden":false,"offsetInEndSection":2024,"text":"ecrosis also strongly stained for HSV. The overall responses to treatment were that three patients had stable disease, six patients had tumors flattened (injected and/or uninjected lesions), and four patients showed inflammation of uninjected as well as the injected tumor, which, in nearly all cases, became inflamed.CONCLUSIONS: Onco VEXGM-CSF is well tolerated and can be safely ad","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1422,"document":"17121894","golden":false,"offsetInEndSection":1576,"text":"ng every 2 to 3 weeks was appropriate. Nineteen of 26 patient posttreatment biopsies contained residual tumor of which 14 showed tumor necrosis, which in ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2017,"document":"15527832","golden":false,"offsetInEndSection":2269,"text":"These results indicate that M protein mutant viruses are superior candidates as oncolytic viruses for therapies of prostate tumors, but future strategies for use of VSV will require testing individual tumors for their susceptibility to virus infection.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"22606725","golden":false,"offsetInEndSection":60,"text":"Medicaid program; Community First Choice option. Final rule.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":517,"document":"17121894","golden":false,"offsetInEndSection":846,"text":"who had failed prior therapy. Thirteen patients were in a single-dose group, where doses of 10(6), 10(7), and 10(8) plaque-forming units (pfu)/mL were tested, and 17 patients were in a multidose group testing a number of dose regimens.RESULTS: The virus was generally well tolerated with local inflammation, erythema, and febrile","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":127,"document":"34034251","golden":false,"offsetInEndSection":546,"text":" excretion. We tested the hypothesis that already low doses of an Ang II inhibitor (candesartan) will result in similar effects on tubular sodium and water reabsorption in congestive heart failure (CHF) as seen after renal denervation (DNX).METHODS: Measurement of arterial blood pressure, heart rate (HR), renal sympathetic nerve activity (RSNA), glomerular filtration rate (GFR), renal plasma flow (RPF), urine volume","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"35157705","golden":false,"offsetInEndSection":100,"text":"Chorioallantoic membrane (CAM) assay to study treatment effects in diffuse intrinsic pontine glioma.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":735,"document":"34034251","golden":false,"offsetInEndSection":858,"text":"t) to decrease RSNA. CHF rat and controls with or without DNX or pretreated with the Ang II type-1 receptor antagonist cand","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34034251","golden":false,"offsetInEndSection":101,"text":"AT II Receptor Blockade and Renal Denervation: Different Interventions with Comparable Renal Effects?","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1185,"document":"34034251","golden":false,"offsetInEndSection":1396,"text":"to an intrarenal drug effect. GFR and RPF were not significantly different in controls or CHF.CONCLUSION: The prominent function of increased RSNA - retaining salt and water - could no longer be observed after r","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":859,"document":"34034251","golden":false,"offsetInEndSection":953,"text":"sartan (0.5 ug i.v.) were studied.RESULTS: CHF rats excreted only 68 + 10.2% of the volume loa","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1044,"document":"34034251","golden":false,"offsetInEndSection":1184,"text":"rom 92 to 103% like controls. Decreases of RSNA induced by volume expansion were impaired in CHF rats but unaffected by candesartan pointing","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34034251","golden":false,"offsetInEndSection":126,"text":"BACKGROUND: Angiotensin II (Ang II) and the renal sympathetic nervous system exert a strong influence on renal sodium and wate","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1100,"document":"9469639","golden":false,"offsetInEndSection":1305,"text":"Oral administration of BL-2401 to mice significantly inhibited the enkephalinase activity in the striatum and also potentiated the antinociceptive effect of (D-Ala2,Met5)-enkephalin given intracisternally.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":547,"document":"34034251","golden":false,"offsetInEndSection":734,"text":" and urinary sodium. To assess neural control of volume homeostasis, 21 days after the induction of CHF via myocardial infarction rats underwent volume expansion (0.9% NaCL; 10% body weig","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1156,"document":"11719449","golden":false,"offsetInEndSection":1406,"text":"ture of the delNS1 virus combined with the selective replication properties of this virus in oncogenic ras-expressing cells renders this virus an attractive candidate for the therapy of tumors with an activated ras-signaling pathway.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":245,"document":"19420962","golden":false,"offsetInEndSection":456,"text":"us.METHODS: Firstly, XJ-160 virus structural protein expression cassette pcE or pICH was constructed by cloning the gene of glycoprotein E3E26KE1 or capsid protein of XJ-160 virus into pcDNA3.1(+) or pIRES, resp","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":889,"document":"12152818","golden":false,"offsetInEndSection":1067,"text":"leukemia virus/feline sarcoma virus was not detected in any neoplasms and therefore was unlikely to play a role in the tumorigenesis of these feline diffuse iris melanomas.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":541,"document":"28100299","golden":false,"offsetInEndSection":801,"text":" two reassortant viruses and the reassortant virus with PR8 M as well as the control Bat09?:?mH1mN1 virus replicated efficiently in cultured cells, while the reassortant virus with PR8 M grew to a higher titre than the other three viruses in tested cells. Mous","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":693,"document":"4318956","golden":false,"offsetInEndSection":869,"text":"non-neutralizable aggregates was found to constitute 30% of the infective units of unfiltered Pesascek virus but only 0.1% of the antigenically related DuToit strain. This expl","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":167,"document":"23174601","golden":false,"offsetInEndSection":482,"text":"tibody.METHODS: Using the bioinformatic software DNAstar and ANTHEPROT, we analyzed the hydrophilicity, flexibility, surface probability and antigenicity of dengue virus type 1-4, Japanese encephalitis virus, and Yellow fever virus M and E protein amino acid sequences, and also evaluated the influence of secondary","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34024957","golden":false,"offsetInEndSection":108,"text":"Kinetics of Influenza A/BANGKOK/1/1979(?3N2) Virus Thermal Inactivation in the Presence of Polyallylamine.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":602,"document":"26939461","golden":false,"offsetInEndSection":903,"text":"inglang salt mine. According to the sample sources, their morphological characteristics and the character of host strains, those viruses were named as Qiaohou Halomonas Siphoviridae Virus 1 ( QHHSV-1), Yipinglang Halomonas Siphoviridae Virus 1 (YPHSV-1) and Yipinglang Chromohalobacter Pleomorphic Vir","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":127,"document":"6314975","golden":false,"offsetInEndSection":419,"text":" of passage 50 was less pathogenic for day-old maternally immune broiler-type chickens than virus of passage 10 or 25 as determined by clinical response to vaccination, virus isolation in respiratory (trachea) and nonrespiratory (kidney and cloaca) tissues, and weight-gain studies. Chickens ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"26164357","golden":false,"offsetInEndSection":266,"text":"Virus Counter was applied for the quantitation of porcine epidemic diarrhea virus (PEDV); the working range and reproducibility of the quantification were characterized, and the performance of Virus Counter was evaluated using the plaque assay as the gold standard. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":268,"document":"33838625","golden":false,"offsetInEndSection":677,"text":"ymphocytes. Preclinically, pediatric brain tumors are highly sensitive to oncolytic virotherapy with genetically engineered herpes simplex virus type 1 (HSV-1) G207, which lacks genes essential for replication in normal brain tissue.METHODS: We conducted a phase 1 trial of G207, which used a 3+3 design with four dose cohorts of children and adolescents with biopsy-confirmed recurrent or progressive suprate","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"33838625","golden":false,"offsetInEndSection":72,"text":"Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":905,"document":"19618859","golden":false,"offsetInEndSection":1077,"text":"Oncolytic virus therapy has been developed for various types of cancers other than glioma, including malignant melanoma and prostate, breast, head \u0026 neck and colon cancers.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1765,"document":"33838625","golden":false,"offsetInEndSection":2014,"text":" months after G207 treatment. G207 markedly increased the number of tumor-infiltrating lymphocytes.CONCLUSIONS: Intratumoral G207 alone and with radiation had an acceptable adverse-event profile with evidence of responses in patients with recurrent ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":348,"document":"31138805","golden":false,"offsetInEndSection":412,"text":"This virus has proven to be safe and effective in adult gliomas.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2015,"document":"33838625","golden":false,"offsetInEndSection":2069,"text":"r progressive pediatric high-grade glioma. G207 conver","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1107,"document":"33838625","golden":false,"offsetInEndSection":1306,"text":"hain-reaction assay. Matched pre- and post-treatment tissue samples were examined for tumor-infiltrating lymphocytes by immunohistologic analysis.RESULTS: Twelve patients 7 to 18 years of age with hi","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"31138805","golden":false,"offsetInEndSection":103,"text":"The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":2168,"document":"33838625","golden":false,"offsetInEndSection":2170,"text":"rs","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":613,"document":"19618859","golden":false,"offsetInEndSection":904,"text":"Several types of oncolytic viruses have been tested in clinical trials for recurrent malignant glioma, among which genetically engineered herpes simplex viruses type 1 seems to be the most promising because of its high tumor selectivity (indicating safety) and potency (indicating efficacy).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":325,"document":"35083096","golden":false,"offsetInEndSection":487,"text":" bilateral murine melanoma models, we tested systemic tumor response to combined therapy with anti-PD-1 and an adenovirus coding for TNFa and IL-2 (\"virus\"). Viru","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"9578834","golden":false,"offsetInEndSection":219,"text":"Human U-87 malignant glioma xenografts in mice were exposed to ionizing radiation, inoculated with a herpes simplex virus 1 mutant R3616 lacking both copies of the gamma 34.5 gene, or received both virus and radiation. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":712,"document":"16915291","golden":false,"offsetInEndSection":821,"text":"indings suggest that vaccinia virus is capable of selectively targeting and controlling ovarian tumors. Thus,","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":939,"document":"19530039","golden":false,"offsetInEndSection":1107,"text":"egative in all cases.CONCLUSIONS: Friend leukemia virus integration-1 can be expressed in a variety of tumors, and is helpful in making the diagnosis of Ewing\u0027s sarcoma","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"19530039","golden":false,"offsetInEndSection":269,"text":"BACKGROUND/AIMS: Friend leukemia virus integration-1 expression has been shown in a variety of tumors, including vascular tumors, desmoplastic small round cell tumor, Merkel cell carcinoma, and lymphoblastic lymphoma, in addition to Ewing\u0027s sarcoma/primitive neuroectod","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":752,"document":"35083096","golden":false,"offsetInEndSection":914,"text":"ontrol was observed in both injected and non-injected tumors, including complete response in all treated animals receiving aPD-1+?virus therapy. Mechanistically, ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":561,"document":"16915291","golden":false,"offsetInEndSection":709,"text":"ia virus administered to mice intraperitoneally was specifically targeted to the murine or human ovarian tumors and led to antitumor responses. Thes","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"1131829","golden":false,"offsetInEndSection":235,"text":"The WKA/Mk rat tumors induced by Friend virus complex, Rauscher virus complex, and their associated lymphatic leukemia viruses were investigated for their antigenic relationhips with transplantation experiments and cytotoxicity tests. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":532,"document":"15881753","golden":false,"offsetInEndSection":796,"text":"rus.METHODS: Genomic DNA sequences were isolated from 62 brain tumors (32 medulloblastomas, 18 ependymomas, five choroid plexus papillomas, and seven pilocytic astrocytomas) and analyzed for the presence of JC virus DNA by Southern blot hybridization and direct se","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":958,"document":"16012244","golden":false,"offsetInEndSection":1102,"text":"althy individuals.SUMMARY: Human papilloma virus (especially strain 16) has been recognized as a probable etiologic agent for some head and neck","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":169,"document":"37188783","golden":true,"offsetInEndSection":454,"text":"Here in this multicenter phase 1/2 study we evaluated the combination of intratumoral delivery of oncolytic virus DNX-2401 followed by intravenous anti-PD-1 antibody pembrolizumab in recurrent glioblastoma, first in a dose-escalation and then in a dose-expansion phase, in 49 patients.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37188783","golden":true,"offsetInEndSection":95,"text":"Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":143,"document":"35767439","golden":false,"offsetInEndSection":502,"text":"Oncolytic viral therapy has been evaluated in patients with pediatric gliomas elsewhere in the brain, but data regarding oncolytic viral therapy in patients with DIPG are lacking.METHODS: We conducted a single-center, dose-escalation study of DNX-2401, an oncolytic adenovirus that selectively replicates in tumor cells, in patients with newly diagnosed DIPG.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35176144","golden":true,"offsetInEndSection":332,"text":"PURPOSE: Testing safety of Delta24-RGD (DNX-2401), an oncolytic adenovirus, locally delivered by convection enhanced delivery (CED) in tumor and surrounding brain of patients with recurrent glioblastoma.PATIENTS AND METHODS: Dose-escalation phase I study with 3+3 cohorts, dosing 107 to 1 ? 1011 viral particles (vp) in 20 patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":279,"document":"29088386","golden":true,"offsetInEndSection":693,"text":"New clinical trials are investigating novel medications and therapeutic techniques in an effort to improve treatment of patients with DIPGs.OBJECTIVE: To determine the safety, tolerability, and toxicity of an oncolytic adenovirus, DNX-2401, injected into the cerebellar peduncle in pediatric subjects with DIPG and to collect tumor samples of this type of tumor.METHODS: Phase I, single-center, uncontrolled trial.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1625,"document":"37188783","golden":false,"offsetInEndSection":1806,"text":"Overall, the combination of intratumoral DNX-2401 followed by pembrolizumab was safe with notable survival benefit in select patients (ClinicalTrials.gov registration: NCT02798406).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37188783","golden":false,"offsetInEndSection":168,"text":"Immune-mediated anti-tumoral responses, elicited by oncolytic viruses and augmented with checkpoint inhibition, may be an effective treatment approach for glioblastoma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":707,"document":"37188783","golden":false,"offsetInEndSection":864,"text":"The objective response rate was 10.4% (90% confidence interval (CI) 4.2-20.7%), which was not statistically greater than the prespecified control rate of 5%.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":6,"document":"29432077","golden":false,"offsetInEndSection":135,"text":"e DNX-2401 (Delta-24-RGD; tasadenoturev) is a tumor-selective, replication-competent oncolytic adenovirus. Preclinical studies de","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":372,"document":"39467343","golden":false,"offsetInEndSection":555,"text":"ous cells. This study evaluated the oncolytic potential of a combined therapeutic strategy, utilizing Newcastle disease virus (NDV) and Doxorubicin hydrochloride (Dox) both in vitro a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":312,"document":"35767439","golden":false,"offsetInEndSection":483,"text":"e lacking.METHODS: We conducted a single-center, dose-escalation study of DNX-2401, an oncolytic adenovirus that selectively replicates in tumor cells, in patients with ne","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":266,"document":"37749907","golden":false,"offsetInEndSection":735,"text":"The emergence of oncolytic virotherapy (OVT) may provide an alternative or adjuvant treatment for pediatric oncology patients.AREAS COVERED: We reviewed seven virus types that have been investigated in past or ongoing pediatric tumor clinical trials: adenovirus (AdV-tk, Celyvir, DNX-2401, VCN-01, Ad-TD-nsIL-12), herpes simplex virus (G207, HSV-1716), vaccinia (JX-594), reovirus (pelareorep), poliovirus (PVSRIPO), measles virus (MV-NIS), and Senecavirus A (SVV-001).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37925150","golden":false,"offsetInEndSection":250,"text":"BACKGROUND: The Combination Adenovirus?+ Pembrolizumab to Trigger Immune Virus Effects (CAPTIVE) study is a phase II clinical trial testing the efficacy of a recombinant adenovirus DNX-2401 combined with the immune checkpoint inhibitor pembrolizumab.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":776,"document":"38806994","golden":false,"offsetInEndSection":1018,"text":"This review presents an overview of the latest advancements in OVs transduction for brain cancer, focusing on the safety and effectiveness of G207, G47?, M032, rQNestin34.5v.2, C134, DNX-2401, Ad-TD-nsIL12, NSC-CRAd-S-p7, TG6002, and PVSRIPO.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":174,"document":"37491263","golden":false,"offsetInEndSection":396,"text":"With the understanding particularly in the characteristics of viruses and tumor cells, numerous innovative OVs have been engineered to conquer cancers, such as Talimogene Laherparepvec (T-VEC) and tasadenoturev (DNX-2401).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1087,"document":"37188783","golden":false,"offsetInEndSection":1168,"text":"Objective responses led to longer survival (hazard ratio 0.20, 95% CI 0.05-0.87).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35176144","golden":false,"offsetInEndSection":450,"text":"PURPOSE: Testing safety of Delta24-RGD (DNX-2401), an oncolytic adenovirus, locally delivered by convection enhanced delivery (CED) in tumor and surrounding brain of patients with recurrent glioblastoma.PATIENTS AND METHODS: Dose-escalation phase I study with 3+3 cohorts, dosing 107 to 1 ? 1011 viral particles (vp) in 20 patients. Besides clinical parameters, adverse events, and radiologic findings, blood, cerebrospinal fluid (CSF), brain interst","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35767439","golden":false,"offsetInEndSection":450,"text":"BACKGROUND: Pediatric patients with diffuse intrinsic pontine glioma (DIPG) have a poor prognosis, with a median survival of less than 1 year. Oncolytic viral therapy has been evaluated in patients with pediatric gliomas elsewhere in the brain, but data regarding oncolytic viral therapy in patients with DIPG are lacking.METHODS: We conducted a single-center, dose-escalation study of DNX-2401, an oncolytic adenovirus that selectively replicates in","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34004331","golden":false,"offsetInEndSection":450,"text":"Human livelihood highly depends on applying different sources of energy whose utilization is associated with air pollution. On the other hand, air pollution may be associated with glioblastoma multiforme (GBM) development. Unlike other environmental causes of cancer (e.g., irradiation), air pollution cannot efficiently be controlled by geographical borders, regulations, and policies. The unavoidable exposure to air pollution can modify cancer inc","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35176144","golden":false,"offsetInEndSection":194,"text":"PURPOSE: Testing safety of Delta24-RGD (DNX-2401), an oncolytic adenovirus, locally delivered by convection enhanced delivery (CED) in tumor and surrounding brain of patients with recurrent glio","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33524949","golden":false,"offsetInEndSection":213,"text":"Delta-24-based oncolytic viruses are conditional replication adenoviruses developed to selectively infect and replicate in retinoblastoma 1 (Rb)-deficient cancer cells but not normal cell with intact Rb1 pathways.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":311,"document":"35767439","golden":false,"offsetInEndSection":482,"text":"re lacking.METHODS: We conducted a single-center, dose-escalation study of DNX-2401, an oncolytic adenovirus that selectively replicates in tumor cells, in patients with n","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":408,"document":"29088386","golden":true,"offsetInEndSection":619,"text":"with DIPGs.OBJECTIVE: To determine the safety, tolerability, and toxicity of an oncolytic adenovirus, DNX-2401, injected into the cerebellar peduncle in pediatric subjects with DIPG and to collect tumor samples ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":90,"document":"30123426","golden":false,"offsetInEndSection":230,"text":"Oncolytic adenoviruses are being modified to exploit the aberrant expression of proteins in tumor cells to increase the antiglioma efficacy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1059,"document":"31726894","golden":false,"offsetInEndSection":1234,"text":"DNX-2401 was well tolerated with no Grade 3/4 adverse events; it provoked an immunologic response to the tumor which may contribute to the complete responses in some patients.","beginSection":"abstract"}],"exact_answer":[["Diffuse Intrinsic Pontine Glioma"],["Glioma"],["Glioblastoma"]],"ideal_answer":[],"id":"63adcaefc6c7d4d31b00001e","type":"list","body":"DNX-2401 Virus was tested for which tumors?"},{"documents":[{"golden":true,"id":"37291210"},{"golden":true,"id":"39525048"},{"golden":true,"id":"38024580"},{"golden":true,"id":"38318312"},{"golden":true,"id":"39395401"},{"golden":false,"id":"35149233"},{"golden":false,"id":"38035006"},{"golden":true,"id":"37191913"},{"golden":false,"id":"38917793"},{"golden":false,"id":"38771525"},{"golden":false,"id":"39020317"},{"golden":false,"id":"38521908"},{"golden":false,"id":"28964591"},{"golden":false,"id":"37568516"},{"golden":true,"id":"38363467"},{"golden":false,"id":"39457485"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":1209,"document":"37291210","golden":true,"offsetInEndSection":1414,"text":"Significant improvement for trofinetide compared with placebo was observed for the coprimary efficacy endpoints, suggesting that trofinetide provides benefit in treating the core symptoms of Rett syndrome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":944,"document":"38024580","golden":true,"offsetInEndSection":1041,"text":"These findings suggest that Trofinetide is a promising treatment option for individuals with RTT.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":802,"document":"37291210","golden":false,"offsetInEndSection":1052,"text":"For the key secondary efficacy endpoint, LSM change from baseline to week 12 in the Communication and Symbolic Behavior Scales Developmental Profile Infant-Toddler Checklist Social Composite score was -0.1 versus -1.1 (P?\u003d?0.0064; effect size, 0.43).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":62,"document":"37291210","golden":true,"offsetInEndSection":271,"text":"Trofinetide is a synthetic analog of glycine-proline-glutamate, the N-terminal tripeptide of the insulin-like growth factor 1 protein, and has demonstrated clinical benefit in phase 2 studies in Rett syndrome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1203,"document":"38917793","golden":false,"offsetInEndSection":1524,"text":"Mean Clinical Global Impression-Improvement scores (standard error) at week 40 rated from the LILAC baseline were 3.1 (0.11) and 3.2 (0.14) for participants treated with trofinetide and placebo in LAVENDER, respectively.CONCLUSIONS: Treatment with trofinetide for ?40?weeks continued to improve symptoms of Rett syndrome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1053,"document":"37291210","golden":false,"offsetInEndSection":1208,"text":"Common treatment-emergent adverse events included diarrhea (80.6% for trofinetide versus 19.1% for placebo), which was mostly mild to moderate in severity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":457,"document":"37291210","golden":false,"offsetInEndSection":801,"text":"For the coprimary efficacy endpoints, least squares mean (LSM) change from baseline to week 12 in the Rett Syndrome Behaviour Questionnaire for trofinetide versus placebo was -4.9 versus -1.7 (P?\u003d?0.0175; Cohen\u0027s d effect size, 0.37), and LSM Clinical Global Impression-Improvement at week 12 was 3.5 versus 3.8 (P?\u003d?0.0030; effect size, 0.47).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39395401","golden":true,"offsetInEndSection":192,"text":"The US FDA approval of trofinetide as the first pharmacological treatment to improve Rett syndrome\u0027s symptomatology marks a significant milestone with broad implications for various disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1327,"document":"38771525","golden":false,"offsetInEndSection":1667,"text":"Most adverse events did not show any statistical difference between Trofinetide and the placebo.CONCLUSION: Trofinetide offers promise as a potential effective and safe therapeutic opportunity for a population without many available treatments, with improvements seen on both CGI and RSBQ assessments and no severe adverse effects reported.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37291210","golden":true,"offsetInEndSection":75,"text":"Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":624,"document":"38521908","golden":false,"offsetInEndSection":726,"text":"ticles for further assessment. We included RCTs that evaluated the efficacy and safety of trofinetide ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39525048","golden":true,"offsetInEndSection":100,"text":"Trofinetide is a first-in-class pharmacological treatment proposed for patients with Rett Syndrome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":205,"document":"38771525","golden":false,"offsetInEndSection":403,"text":"hromosome.OBJECTIVE: Trofinetide is a recently developed drug that has a neuroprotective effect on neurons, and it is our aim in this meta-analysis to evaluate its efficacy and safety in treating Re","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":408,"document":"38318312","golden":false,"offsetInEndSection":602,"text":"rofinetide, a synthetic analog of glycine-proline-glutamate, was approved by the US Food and Drug Administration for the treatment of RTT in adult and pediatric patients aged 2?years and older. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38771525","golden":false,"offsetInEndSection":450,"text":"BACKGROUND: Rett syndrome (RTT) is an uncommon inherited neurodevelopmental disorder that affects brain development, mostly in females. It results from mutation in MECP2 gene in the long arm (q) of the X chromosome.OBJECTIVE: Trofinetide is a recently developed drug that has a neuroprotective effect on neurons, and it is our aim in this meta-analysis to evaluate its efficacy and safety in treating Rett syndrome patients.METHODS: We searched 5 dat","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38521908","golden":false,"offsetInEndSection":450,"text":"INTRODUCTION: Rett syndrome is a rare genetic neurodevelopmental disorder that predominantly impacts females. It presents with loss of acquired skills, impaired communication, and stereotypic hand movements. Given the limited treatment options for Rett syndrome, there is a dire need for effective interventions.OBJECTIVE: To evaluate the safety and efficacy of trofinetide in Randomized Controlled Trials (RCTs) that report on Rett syndrome patients","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38363467","golden":true,"offsetInEndSection":450,"text":"INTRODUCTION: Trofinetide was recently approved for the treatment of Rett syndrome (RTT) on the basis of the efficacy and safety findings of the phase?3 LAVENDER study, which used a body weight-based dosing regimen. Exposure-response (E-R) efficacy modeling was used to characterize relationships between trofinetide exposure measures (maximum drug concentration and area under the concentration-time curve for the dosing interval of 0-12?h [AUC0-12]","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39457485","golden":false,"offsetInEndSection":450,"text":"Backgroud: Rett syndrome is a neurodevelopmental disorder that affects 1 in 10,000 females. Various treatments have been explored; however, no effective treatments have been reported to date, except for trofinetide, a synthetic analog of glycine-proline-glutamic acid, which was approved by the FDA in 2023. Serological biomarkers that correlate with the disease status of RTT are needed to promote early diagnosis and to develop novel agents. Method","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":623,"document":"38521908","golden":false,"offsetInEndSection":725,"text":"rticles for further assessment. We included RCTs that evaluated the efficacy and safety of trofinetide","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1395,"document":"38917793","golden":false,"offsetInEndSection":1483,"text":"o in LAVENDER, respectively.CONCLUSIONS: Treatment with trofinetide for ?40?weeks contin","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":218,"document":"35149233","golden":false,"offsetInEndSection":615,"text":"wth factor 1. In a phase 2, placebo-controlled trial in 82 females with RTT aged 5-15?years, a significant (p???0.042) improvement over placebo was observed with the highest trofinetide dose (200?mg/kg twice daily [BID]) on three measures: Rett Syndrome Behaviour Questionnaire (RSBQ), Clinical Global Impression-Improvement (CGI-I), and RTT-Clinician Domain Specific Concerns-Visual Analog Scale ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":204,"document":"38771525","golden":false,"offsetInEndSection":402,"text":"chromosome.OBJECTIVE: Trofinetide is a recently developed drug that has a neuroprotective effect on neurons, and it is our aim in this meta-analysis to evaluate its efficacy and safety in treating R","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28964591","golden":false,"offsetInEndSection":274,"text":"BACKGROUND: This study aimed to determine the safety and tolerability of trofinetide and to evaluate efficacy measures in adolescent and adult females with Rett syndrome, a serious and debilitating neurodevelopmental condition for which no therapies are available for its co","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1451,"document":"37568516","golden":false,"offsetInEndSection":1575,"text":"Trofinetide is in clinical trials for some neurodevelopmental disorders (NDDs), including treating Fragile X syndrome (FXS).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":317,"document":"37191913","golden":true,"offsetInEndSection":459,"text":"Trofinetide was approved in March 2023 in the USA for the treatment of Rett syndrome in adult and pediatric patients 2?years of age and older.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":407,"document":"38318312","golden":true,"offsetInEndSection":601,"text":"Trofinetide, a synthetic analog of glycine-proline-glutamate, was approved by the US Food and Drug Administration for the treatment of RTT in adult and pediatric patients aged 2?years and older.","beginSection":"abstract"}],"exact_answer":"","ideal_answer":[],"id":"677e8278592fa4887300001d","type":"yesno","body":"Is trofinetide effective for the Rett Syndrome?"},{"documents":[{"golden":true,"id":"31875014"},{"golden":true,"id":"22736326"},{"golden":true,"id":"15800838"},{"golden":false,"id":"24861247"},{"golden":false,"id":"34829891"},{"golden":true,"id":"14624220"},{"golden":false,"id":"35885670"},{"golden":true,"id":"30810882"},{"golden":true,"id":"33864088"},{"golden":false,"id":"30905186"},{"golden":false,"id":"38103884"},{"golden":false,"id":"27405583"},{"golden":false,"id":"20436318"},{"golden":false,"id":"38104885"},{"golden":false,"id":"26919512"},{"golden":false,"id":"27132058"},{"golden":false,"id":"26695425"},{"golden":false,"id":"20519246"},{"golden":false,"id":"33064040"},{"golden":false,"id":"39478503"},{"golden":false,"id":"38893596"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":1723,"document":"22736326","golden":true,"offsetInEndSection":2199,"text":"The same two models predicted US-negative endometriosis in the independent validation test set with a high sensitivity (82%) and an acceptable specificity (63-75%).CONCLUSIONS: In plasma samples obtained during menstruation, multivariate analysis of four biomarkers (annexin V, VEGF, CA-125 and sICAM-1/or glycodelin) enabled the diagnosis of endometriosis undetectable by US with a sensitivity of 81-90% and a specificity of 63-81% in independent training- and test data set.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1486,"document":"30810882","golden":true,"offsetInEndSection":1804,"text":"In addition, nucleic acid/carbohydrate ratio was significantly lower in the stage I-II group indicating that the alteration of the carbohydrate level might be important.CONCLUSIONS: Examination of cervical swab with FTIR spectroscopy might be a proper candidate for a non-invasive diagnostic approach of endometriosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1278,"document":"31875014","golden":true,"offsetInEndSection":1505,"text":"To the best of our knowledge, this is the first study in which Raman spectroscopy was used in combination with PCA and classification algorithms as a non-invasive method applied on blood sera for the diagnosis of endometriosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":591,"document":"31875014","golden":true,"offsetInEndSection":687,"text":"In this study, Raman spectroscopy is used as a non-invasive diagnostic method for endometriosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":934,"document":"31875014","golden":false,"offsetInEndSection":1173,"text":"According to the results (using 80 measurements for training and 14 measurements for the test set), it was found that kNN-weighted gave the best classification model with sensitivity and specificity values of 80.5% and 89.7%, respectively.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"31875014","golden":true,"offsetInEndSection":76,"text":"Raman spectroscopy as a non-invasive diagnostic technique for endometriosis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33864088","golden":true,"offsetInEndSection":612,"text":"STUDY QUESTION: What is the sensitivity and the specificity of preoperative transvaginal ultrasound with bowel preparation (TVUS-BP) compared to diagnostic laparoscopy (DL) for the identification of ovarian and deep sites of endometriosis?SUMMARY ANSWER: DL was able to detect retrocervical, ovarian, and bladder endometriosis with similar sensitivity and specificity as TVUS-BP, whereas for vaginal and rectosigmoid endometriosis, DL had lower sensitivity and specificity than TVUS-BP.WHAT IS KNOWN ALREADY: TVUS-BP is a non-invasive examination with good accuracy for diagnosing ovarian and deep endometriosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":336,"document":"31875014","golden":false,"offsetInEndSection":394,"text":"A successful diagnosis can only be made using laparoscopy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"22736326","golden":false,"offsetInEndSection":146,"text":"BACKGROUND: At present, the only way to conclusively diagnose endometriosis is laparoscopic inspection, preferably with histological confirmation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":738,"document":"15800838","golden":true,"offsetInEndSection":932,"text":"In essence, MRI is capable of detecting many manifestations of endometriosis in a non-invasive, yet reliable manner, and its value in relation to laparoscopy must be considered as complementary.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":243,"document":"27405583","golden":false,"offsetInEndSection":354,"text":"cal risks. Currently, there are no non-invasive tests available in clinical practice to accurately diagnose end","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":258,"document":"26695425","golden":false,"offsetInEndSection":401,"text":"cal risks. Currently, there are no simple non-invasive or minimally-invasive tests available in clinical practice that accurately diagnoses end","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":194,"document":"38103884","golden":false,"offsetInEndSection":377,"text":"he need is particularly strong for rASRM Stage 1 or 2 disease, since higher stage (rASRM Stage 3 or 4) endometriosis can often be diagnosed by ultrasound or other imaging techniques. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":199,"document":"20436318","golden":false,"offsetInEndSection":324,"text":"ecause there is no good noninvasive test for endometriosis, there is often a significant delay in diagnosis of this disease. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":100,"document":"38104885","golden":false,"offsetInEndSection":247,"text":"oninvasive markers of endometriosis have the potential to enable earlier diagnosis, leading to more timely treatment and better surgical planning. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"20519246","golden":false,"offsetInEndSection":68,"text":"Laparoscopy is the gold standard for the diagnosis of endometriosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1134,"document":"14624220","golden":true,"offsetInEndSection":1535,"text":"The first gene profiling studies are showing positive results and proteomic technology is being applied to identify novel diagnostic protein expression patterns.SUMMARY: Current imaging techniques, such as transvaginal ultrasonography, are useful to screen the pelvis for the presence of retroperitoneal endometriosis but fail to diagnose peritoneal lesions, small ovarian endometriomas and adhesions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1147,"document":"33064040","golden":false,"offsetInEndSection":1334,"text":"In conclusion, a quadruple panel of serum markers-CA125, endocan, YKL-40, and copeptin may be beneficial for the diagnosis of endometriosis and especially moderate - severe endometriosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39478503","golden":false,"offsetInEndSection":450,"text":"BACKGROUND: Endometriosis, due to its ambiguous symptoms, still remains one of the most difficult female diseases to treat, with an average diagnosis time of 7-9?years. The changing level of hypoxia plays an important role in a healthy endometrium during menstruation and an elevated expression of the hypoxia-inducible factor 1-alpha (HIF-1?) has been demonstrated in ectopic endometria. HIF-1? mediates the induction of proangiogenic factors and th","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38893596","golden":false,"offsetInEndSection":450,"text":"BACKGROUND: Endometriosis-associated ovarian cancer (EAOC) is a well-known type of cancer that arises from ovarian endometrioma (OE). OE contains iron-rich fluid in its cysts due to repeated hemorrhages in the ovaries. However, distinguishing between benign and malignant tumors can be challenging. We conducted a retrospective study on magnetic resonance (MR) relaxometry of cyst fluid to distinguish EAOC from OE and reported that this method showe","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30810882","golden":false,"offsetInEndSection":84,"text":"PURPOSE: There is no established non-invasive method to diagnose patients with endom","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":257,"document":"26919512","golden":false,"offsetInEndSection":379,"text":"ical risks. Currently, no non-invasive tests that can be used to accurately diagnose endometriosis are available in clinic","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":255,"document":"24861247","golden":false,"offsetInEndSection":381,"text":"Therefore, non-invasive methods are required to obtain accurate diagnoses of the location and extent of endometriotic lesions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":242,"document":"27405583","golden":false,"offsetInEndSection":353,"text":"ical risks. Currently, there are no non-invasive tests available in clinical practice to accurately diagnose en","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":240,"document":"27132058","golden":false,"offsetInEndSection":373,"text":"ical risks. Currently, there are no non-invasive or minimally invasive tests available in clinical practice to accurately diagnose en","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":257,"document":"26695425","golden":false,"offsetInEndSection":400,"text":"ical risks. Currently, there are no simple non-invasive or minimally-invasive tests available in clinical practice that accurately diagnoses en","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":543,"document":"30905186","golden":false,"offsetInEndSection":695,"text":"Low invasive tests including imaging, genetic tests, biomarkers, or miRNAs could be the key for establishing a less invasive diagnosis of endometriosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"22736326","golden":false,"offsetInEndSection":134,"text":"BACKGROUND: At present, the only way to conclusively diagnose endometriosis is laparoscopic inspection, preferably with histological c","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"14624220","golden":false,"offsetInEndSection":282,"text":"PURPOSE OF REVIEW: Laparoscopy is the gold standard for the diagnosis of endometriosis but the need for visual evidence of the disease is a major stumbling-block for both effective clinical management of affected patients as well as for research into this common and debilitating re","beginSection":"abstract"}],"exact_answer":[],"ideal_answer":[],"id":"6777b471592fa4887300000c","type":"factoid","body":"What is the best non-invasive method to diagnose endometriosis?"},{"documents":[{"golden":true,"id":"38595339"},{"golden":true,"id":"37115484"},{"golden":false,"id":"22511139"},{"golden":false,"id":"37533854"},{"golden":false,"id":"35204780"},{"golden":false,"id":"38470396"},{"golden":false,"id":"27506554"},{"golden":false,"id":"35190763"},{"golden":false,"id":"35145983"},{"golden":false,"id":"24668673"},{"golden":false,"id":"30114376"},{"golden":false,"id":"34265829"},{"golden":false,"id":"38425412"},{"golden":false,"id":"26577236"},{"golden":false,"id":"15367487"},{"golden":false,"id":"35315933"},{"golden":false,"id":"24065531"},{"golden":false,"id":"39730651"},{"golden":false,"id":"19745165"},{"golden":false,"id":"27165068"},{"golden":false,"id":"21920499"},{"golden":false,"id":"21642878"},{"golden":false,"id":"36113364"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":757,"document":"38595339","golden":true,"offsetInEndSection":1134,"text":"Furthermore, we used qRT-PCR to detect the expression levels of pivotal genes and validate the diagnostic model\u0027s ability to diagnose pediatric sepsis in 65 actual clinical samples.Results: Among 294 overlapping genes of DEGs and modular sepsis genes, five pivotal genes (STOM, MS4A4A, CD177, MMP8, and MCEMP1) were screened to construct a diagnostic model of pediatric sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1927,"document":"37115484","golden":true,"offsetInEndSection":2167,"text":"Additionally, all diagnostic characteristics may correlate with immune cells to varying degrees.CONCLUSIONS: The candidate hub genes (CD177, CYSTM1, and MMP8) were identified, and the nomogram was constructed for pediatric sepsis diagnosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1319,"document":"38595339","golden":false,"offsetInEndSection":1852,"text":"More importantly, the diagnostic model showed good diagnostic ability with AUCs of 0.937 in the 65 clinical samples and showed better efficacy compared to conventional inflammatory indicators such as procalcitonin (PCT), white blood cell (WBC) count, C-reactive protein (CRP), and neutrophil percentage (NEU%).Conclusion: We developed and tested a five-gene diagnostic model that can reliably identify pediatric sepsis and also suggest prospective candidate genes for peripheral blood diagnostic testing in pediatric sepsis patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1491,"document":"35190763","golden":false,"offsetInEndSection":1852,"text":"Through PPI network analysis, we screened the most important hub genes, including ITK, CD247, MMP9, CD3D, MMP8, KLRK1, and GZMK.CONCLUSIONS: In conclusion, the present study revealed an unbalanced immune response at the transcriptome level of sepsis and identified genes for potential biomarkers of sepsis, such as ITK, CD247, MMP9, CD3D, MMP8, KLRK1, and GZMK.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35145983","golden":false,"offsetInEndSection":166,"text":"PURPOSE: Leukocyte adhesion to vascular and matrix Metalloproteinase-8 (MMP8) expression is increased in sepsis and associated with poor prognosis in sepsis patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1135,"document":"38595339","golden":false,"offsetInEndSection":1232,"text":"The expression of the five pivotal genes was higher in the sepsis group than in the normal group.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":671,"document":"37533854","golden":false,"offsetInEndSection":1175,"text":"Extracted RNA was hybridized to NanoString mRNA probes, counts normalized, and analyzed using linear models controlling for age and bacterial co-infections (FDR q\u003c0.05).Results: Comparing pediatric samples collected near admission, children with Prolonged MODS for ?7 days (n\u003d38; 9 deaths) had significant upregulation of nine mRNA transcripts associated with neutrophil degranulation (RETN, TCN1, OLFM4, MMP8, LCN2, BPI, LTF, S100A12, GUSB) compared to those who recovered more rapidly from MODS (n\u003d27).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1233,"document":"38595339","golden":false,"offsetInEndSection":1318,"text":"The diagnostic model showed good diagnostic ability with AUCs of 1, 0.986, and 0.968.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38595339","golden":false,"offsetInEndSection":74,"text":"Predictive Value of a Diagnostic Five-Gene Biomarker for Pediatric Sepsis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":75,"document":"38595339","golden":false,"offsetInEndSection":311,"text":"The purpose of this study was to evaluate diagnostic biomarkers and immune cell infiltration in pediatric sepsis.Methods: Three datasets (GSE13904, GSE26378, and GSE26440) were downloaded from the gene expression omnibus (GEO) database.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1527,"document":"37115484","golden":true,"offsetInEndSection":1766,"text":"ted 402 overlapping genes. As pediatric sepsis diagnostic indicators, CYSTM1 (AUC?\u003d?0.988), MMP8 (AUC?\u003d?0.973), and CD177 (AUC?\u003d?0.986) were investigated and demonstrated statistically significant differences (P?\u003c?0.05) and diagnostic effi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1815,"document":"30114376","golden":false,"offsetInEndSection":1953,"text":"rve, 0.66; 95% confidence interval, 0.58-0.73; P?\u003d?0.009).CONCLUSIONS: Pediatric patients with ARDS have specific plasma MMP profiles asso","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":439,"document":"38425412","golden":false,"offsetInEndSection":569,"text":"nd puncture (CLP). The expression levels of members of the MMP family were detected in sepsis-induced tolerogenic DCs by using mic","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1577,"document":"34265829","golden":false,"offsetInEndSection":1678,"text":"3 associate with shock and mortality. Plasma MMP and TIMP-1 may warrant further investigation as emer","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1727,"document":"35145983","golden":false,"offsetInEndSection":2113,"text":"However, the MMP8 inhibitor suppressed the leukocyte adhesion promoted by sepsis serum by decreasing the expression of VCAM-1, ICAM-1, p-p38, and p-ERK1/2.CONCLUSION: Our study indicated that MMP8 acts as a key gene in the development of sepsis, and sepsis serum promotes leukocyte adhesion to HUVECs via MMP8, which suggest that MMP8 might be a potential therapeutic target for sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37115484","golden":false,"offsetInEndSection":450,"text":"BACKGROUND: Pediatric sepsis is a complicated condition characterized by life-threatening organ failure resulting from a dysregulated host response to infection in children. It is associated with high rates of morbidity and mortality, and rapid detection and administration of antimicrobials have been emphasized. The objective of this study was to evaluate the diagnostic biomarkers of pediatric sepsis and the function of immune cell infiltration i","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1760,"document":"27506554","golden":false,"offsetInEndSection":1835,"text":"We conclude that developmental age influences the role of MMP8 in sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":270,"document":"21920499","golden":false,"offsetInEndSection":421,"text":"itis (CP). The aim of this study was to analyse polymorphisms in the MMP8 gene and their associations with microbial composition and clinical manifesta","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":268,"document":"35315933","golden":false,"offsetInEndSection":445,"text":"eutrophils. As MMP-8 is centrally involved in the pathogenesis of periodontitis, we aimed to evaluate the presence of genetic polymorphisms of S100A8/A9/A12, MMP8, and CFH in pe","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":459,"document":"21642878","golden":false,"offsetInEndSection":757,"text":"Our study showed that the MMP8 gene rs11225395 polymorphism was associated with the risk of developing MM (odds ratio: 1.69; 95% confidence interval: 1.02-2.80; P\u003d0.040) for the A/A genotype and 1.49 (95% confidence interval: 1.03-2.17; P\u003d0.035) for the A/G genotype compared with the G/G genotype.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1479,"document":"39730651","golden":false,"offsetInEndSection":1597,"text":"The further investigations indicated that MMP8 was mainly expressed in myelocytes with a high degree of heterogeneity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1080,"document":"19745165","golden":false,"offsetInEndSection":1228,"text":"elium was reduced in MMP8 knockout mice. Furthermore, we detected an association between MMP8 gene variation and extent of coronary atherosclerosis ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"15367487","golden":false,"offsetInEndSection":185,"text":"Matrix metalloproteinase 8 (MMP8), an enzyme that degrades fibrillar collagens imparting strength to the fetal membranes, is expressed by leukocytes and chorionic cytotrophoblast cells.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24065531","golden":false,"offsetInEndSection":151,"text":"The importance of matrix metalloproteinase 8 (MMP8) expression during the progression of thoracic aortic dissection (TAD) has been recently emphasized.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36113364","golden":false,"offsetInEndSection":171,"text":"In this research, we screened out two genes upregulated in mice with acute pancreatitis (AP) by gene sequencing: microRNA (miR)-320-3p and matrix metalloprotease 8 (MMP8).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1233,"document":"26577236","golden":false,"offsetInEndSection":1464,"text":"f 0.027 (OR \u003d 0.904, 95% CI 0.826-0.989).CONCLUSIONS: Initial analysis of the MMP8 gene showed suggestive association between rs1940475 and knee OA, but the finding did not replicate in other study cohorts, even though the trend fo","beginSection":"abstract"}],"exact_answer":"","ideal_answer":[],"id":"677eda5e592fa4887300002e","type":"yesno","body":"Is MMP8 gene associated with paediatric sepsis?"},{"documents":[{"golden":true,"id":"38556553"},{"golden":true,"id":"34359920"},{"golden":false,"id":"30574087"},{"golden":true,"id":"37936608"},{"golden":false,"id":"36834942"},{"golden":false,"id":"33524011"},{"golden":false,"id":"33531362"},{"golden":false,"id":"35920704"},{"golden":true,"id":"34789718"},{"golden":false,"id":"38051962"},{"golden":false,"id":"37103820"},{"golden":false,"id":"39459876"},{"golden":false,"id":"35792944"},{"golden":false,"id":"38040080"},{"golden":false,"id":"35119538"},{"golden":false,"id":"19965375"},{"golden":false,"id":"33591950"},{"golden":false,"id":"32934741"},{"golden":false,"id":"37265785"},{"golden":false,"id":"35860667"},{"golden":false,"id":"31454669"},{"golden":false,"id":"27227820"},{"golden":true,"id":"35035675"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":1572,"document":"37936608","golden":true,"offsetInEndSection":1630,"text":"As well as some TMEM proteins involved in chemoresistance.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":796,"document":"34789718","golden":true,"offsetInEndSection":914,"text":"Together, these results demonstrate that TMEM116 is a critical integrator of oncogenic signaling in cancer metastasis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":85,"document":"34359920","golden":true,"offsetInEndSection":217,"text":"TMEMs function as cellular membrane gates by modifying their conformation to control the influx and efflux of signals and molecules.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1163,"document":"38051962","golden":false,"offsetInEndSection":1266,"text":"These findings suggested that multiple inputs of tmem-120 from different tissues regulate reproduction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":174,"document":"38556553","golden":true,"offsetInEndSection":254,"text":"Recently, several TMEM proteins have been identified as functional ion channels.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1209,"document":"38556553","golden":false,"offsetInEndSection":1392,"text":"This review highlights the potential for the discovery of novel ion channels within the TMEM protein family and the development of new therapeutic targets for related channelopathies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":669,"document":"38556553","golden":false,"offsetInEndSection":794,"text":"Additionally, we examine the unique structural features of these channels compared to those of other well-known ion channels.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":319,"document":"39459876","golden":false,"offsetInEndSection":535,"text":"he IFITM protein family is closely related to a variety of biological functions, including antiviral immunity, tumor formation, bone metabolism, cell adhesion, differentiation, and intracellular signal transduction. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":14,"document":"35792944","golden":false,"offsetInEndSection":104,"text":"ane protein 16 (TMEM16) family consists of Ca2+-activated chloride channels and phospholip","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":581,"document":"35119538","golden":false,"offsetInEndSection":722,"text":"s the name suggests, TMEM family is a type of proteins that spans biological membranes including plasma membrane and membrane of organelles. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":426,"document":"38040080","golden":false,"offsetInEndSection":544,"text":"ransmembrane proteins (TMEMs) are a class of proteins that can span the phospholipid bilayer and are stably anchored. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1593,"document":"32934741","golden":false,"offsetInEndSection":1708,"text":"In conclusion, upregulation of TMEM206 is associated with poor prognosis in patients with hepatocellular carcinoma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38556553","golden":true,"offsetInEndSection":450,"text":"A transmembrane (TMEM) protein with an unknown function is a type of membrane-spanning protein expressed in the plasma membrane or the membranes of intracellular organelles. Recently, several TMEM proteins have been identified as functional ion channels. The structures and functions of these proteins have been extensively studied over the last two decades, starting with TMEM16A (ANO1). In this review, we provide a summary of the electrophysiologi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37265785","golden":false,"offsetInEndSection":450,"text":"Background: Transmembrane (TMEM) protein genes are a class of proteins that spans membranes and function to many physiological processes. However, there is very little known about TMEM gene expression, especially in cancer tissue. Using single-cell and bulk RNA sequence may facilitate the understanding of this poorly characterized protein genes in PDAC.Methods: We selected the TMEM family genes through the Human Protein Atlas and characterized th","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35860667","golden":false,"offsetInEndSection":450,"text":"Objectives: Parkinson\u0027s disease (PD) is a neurodegenerative disorder with the manifestation of motor symptoms and non-motor symptoms. Previous studies have indicated the role of several transmembrane (TMEM) protein family genes in PD pathogenesis.Materials and Methods: In order to better investigate the genetic role of PD-related TMEM protein family genes in PD, including TMEM230, TMEM59, TMEM108, TMEM163, TMEM175, and TMEM229B, 1,917 sporadic ea","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33591950","golden":false,"offsetInEndSection":100,"text":"Transmembrane protein (TMEM) is a kind of integral membrane protein that spans biological membranes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30574087","golden":false,"offsetInEndSection":84,"text":"A transmembrane protein (TMEM) is a type of protein that spans biological membranes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":580,"document":"35119538","golden":false,"offsetInEndSection":721,"text":"As the name suggests, TMEM family is a type of proteins that spans biological membranes including plasma membrane and membrane of organelles.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":562,"document":"31454669","golden":false,"offsetInEndSection":803,"text":"In this review, we detail the involvement of members of the transmembrane (TMEM) protein family in the formation of metastases or in the mechanisms leading to cancer cell dissemination such as migration and extra-cellular matrix remodelling.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35035675","golden":true,"offsetInEndSection":160,"text":"Transmembrane protein family members (TMEMs) span the entire lipid bilayer and act as channels that allow the transport of specific substances through biofilms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36834942","golden":false,"offsetInEndSection":171,"text":"Transmembrane protein 244 (TMEM244) was annotated to be a member of the TMEM family, which are is a component of cell membranes and is involved in many cellular processes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27227820","golden":false,"offsetInEndSection":80,"text":"There are 10 transmembrane protein (TMEM) 16-family proteins in humans and mice.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":243,"document":"19965375","golden":false,"offsetInEndSection":487,"text":"Having identified TMEM16A of the transmembrane proteins with unknown function (TMEM) 16 family as a CaCC subunit, we have developed antibodies specific for mouse TMEM16A, as evidenced by the absence of immunoreactivity in TMEM16A knockout mice.","beginSection":"abstract"}],"exact_answer":[],"ideal_answer":[],"id":"6772beef592fa48873000003","type":"factoid","body":"What is the function of a TMEM protein?"},{"documents":[{"golden":false,"id":"32497614"},{"golden":false,"id":"16180532"},{"golden":false,"id":"23338903"},{"golden":false,"id":"33555018"},{"golden":false,"id":"16139448"},{"golden":false,"id":"26263281"},{"golden":false,"id":"2523239"},{"golden":false,"id":"19134207"},{"golden":false,"id":"37501086"},{"golden":false,"id":"26151751"},{"golden":false,"id":"39008138"},{"golden":false,"id":"29437116"},{"golden":false,"id":"38481958"},{"golden":true,"id":"27217451"},{"golden":false,"id":"29492735"},{"golden":false,"id":"15018244"},{"golden":false,"id":"1755392"},{"golden":false,"id":"16687457"},{"golden":false,"id":"16439825"},{"golden":false,"id":"9484425"},{"golden":false,"id":"1845934"},{"golden":false,"id":"10676674"},{"golden":false,"id":"28671391"},{"golden":false,"id":"21088655"},{"golden":false,"id":"22042368"},{"golden":false,"id":"7719960"},{"golden":false,"id":"36868268"},{"golden":false,"id":"32445693"},{"golden":false,"id":"35180420"},{"golden":false,"id":"11872970"},{"golden":false,"id":"8144285"},{"golden":false,"id":"17403787"},{"golden":false,"id":"10604199"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":1229,"document":"32497614","golden":false,"offsetInEndSection":1475,"text":"Both provide additional statistical support for the long-suspected causal interaction among the parallel but variable occurrence of these common entities-visceral obesity, heart disease, diabetes, cancer, and the prevalence of metabolic syndrome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1559,"document":"37501086","golden":false,"offsetInEndSection":1852,"text":"A significant association of CVD and cancer mortality was found only for cases aged???65?years.CONCLUSION: CVD was significantly associated with all-cause mortality of both cases and controls and CVD was identified as a risk factor for cancer mortality of cases aged???65?years at recruitment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":352,"document":"16180532","golden":false,"offsetInEndSection":501,"text":"In females, cancer is even more important than in males because they are less prone to cardiovascular diseases in the age groups under consideration.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":79,"document":"32497614","golden":false,"offsetInEndSection":278,"text":"In women, the clinical appearance of both entities-coronary heart disease and cancer (breast, endometrium, and ovary)-escalate during the decades of the midlife transition encompassing the menopause.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1311,"document":"33555018","golden":false,"offsetInEndSection":1534,"text":"Consequently, the mortality gap between cancer and heart disease has narrowed from an AAMR of 32.7/100 000 to 23.0/100 000.CONCLUSIONS: The mortality gap between cancer and heart disease is decreasing among women \u003c65?years.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1476,"document":"32497614","golden":false,"offsetInEndSection":1943,"text":"Therefore, 2 critical clinical questions require analysis and answers: 1: Why do chronic diseases of adulthood-metabolic, cardiovascular, endocrine-and, in women, cancers of the breast and endometrium (tissues and tumors replete with estrogen receptors) emerge and their incidence trajectories accelerate during the postmenopausal period when little or no endogenous estradiol is available, and yet the therapeutic application of estrogen stimulates their appearance?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":279,"document":"32497614","golden":false,"offsetInEndSection":452,"text":"In addition to the impact of aging, during the interval between the age of 40 and 65 years, the pathophysiologic components of metabolic syndrome also emerge and accelerate.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"26263281","golden":false,"offsetInEndSection":116,"text":"BACKGROUND: Cardiovascular disease (CVD) is common among women and is a leading cause of death in the United States.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":563,"document":"32497614","golden":false,"offsetInEndSection":723,"text":"Osteoporosis, osteoarthritis, sarcopenia, depression, and even cognitive decline and dementia appear, and most, if not all, are considered functionally related.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32497614","golden":false,"offsetInEndSection":78,"text":"Heart disease and cancer are the leading causes of death in the United States.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1398,"document":"39008138","golden":false,"offsetInEndSection":1924,"text":"No associations were observed between systemic treatments and prevalent elevated excess heart age or any treatments with worsening excess heart age.CONCLUSIONS: Among young breast cancer survivors, radiation, but not other cancer treatments, was associated with elevated excess heart age.IMPLICATIONS FOR CANCER SURVIVORS: CVD risk tools that incorporate cancer treatment, such as radiation, are needed to identify high risk young breast cancer survivors given the long survivorship and long latency of cardiovascular disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39008138","golden":false,"offsetInEndSection":828,"text":"PURPOSE: Data evaluating cardiovascular disease (CVD) risk by cancer treatment among young women (??40?years) with breast cancer are limited.METHODS: Among 372 five-year breast cancer survivors aged 30-40?years from the Young Women\u0027s Breast Cancer Study, we assessed the association of cancer treatments (anthracyclines, trastuzumab, radiation/laterality, endocrine therapy) and excess heart age (difference between predicted 10-year CVD risk as assessed by adapted Framingham Risk Score and chronological age), prevalent elevated excess heart age (??2?years), and worsening excess heart age (change of???2 excess heart age years) at breast cancer diagnosis and two- and five-year follow-up using multivariable linear and logistic regressions.RESULTS: Most women had stage I or II (79%), ER?+?(71%), or PR?+?(65%) breast cancer.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":728,"document":"29437116","golden":false,"offsetInEndSection":808,"text":"or older women, CVD poses a greater mortality threat than breast cancer itself. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":910,"document":"38481958","golden":false,"offsetInEndSection":1193,"text":"his review article explores the intersection of heart failure and cancer in women at multiple levels, including traditional cardiovascular risk factors, cardiovascular toxicity derived from antineoplastic and radiation therapy, shared pathophysiology and HF as an oncogenic process. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1301,"document":"29492735","golden":false,"offsetInEndSection":1422,"text":"men without breast cancer.CONCLUSIONS: Among women with low CVD risk, women with breast cancer have a higher risk of CVD ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27217451","golden":true,"offsetInEndSection":103,"text":"PURPOSE: Cardiovascular disease (CVD) is a leading cause of death among women with nonmetastatic breast","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"16139448","golden":false,"offsetInEndSection":169,"text":"Osteoporosis, cardiovascular disease, breast cancer and genitourinary diseases are some of the most frequently diagnosed diseases in a-symptomatic post-menopausal women.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"10676674","golden":false,"offsetInEndSection":463,"text":"OBJECTIVES: To examine prospectively the association between snoring and incidence of cardiovascular disease (CVD) in women.BACKGROUND: Whether snoring increases risk of CVD remains unclear; most previous studies have been small, not prospective and limited to men.METHODS: Seventy-one thousand seven hundred seventy-nine female nurses 40 through 65 years of age and without previously diagnosed CVD or cancer at baseline in 1986 were followed up for eight years.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1090,"document":"10676674","golden":false,"offsetInEndSection":1572,"text":"After further adjustment for smoking, body mass index (BMI) and other covariates, the positive association between snoring and CVD was attenuated but remained statistically significant (RRs of CVD were 1.20 [1.01 to 1.43] for occasional snorers and 1.33 [1.06-1.67] for regular snorers.CONCLUSIONS: These data suggested that snoring is associated with a modest but significantly increased risk of CVD in women, independent of age, smoking, BMI and other cardiovascular risk factors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36868268","golden":false,"offsetInEndSection":450,"text":"Sex-specific factors are implicated in pulmonary embolism (PE) presentation in young patients, as indicated by increased risk in pregnancy. Whether sex differences exist in PE presentation, comorbidities, and symptomatology in older adults, the age group in which most PEs occur, remains unknown. We identified older adults (aged ?65 years) with PE in a large international PE registry replete with information about relevant clinical characteristics","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32445693","golden":false,"offsetInEndSection":450,"text":"BACKGROUND: Some studies, mainly from high-income countries (HICs), report that women receive less care (investigations and treatments) for cardiovascular disease than do men and might have a higher risk of death. However, very few studies systematically report risk factors, use of primary or secondary prevention medications, incidence of cardiovascular disease, or death in populations drawn from the community. Given that most cardiovascular dise","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35180420","golden":false,"offsetInEndSection":450,"text":"BACKGROUND: In the prevention of cardiovascular disease, a WHO target is that at least 50% of eligible people use statins. Robust evidence is needed to monitor progress towards this target in low-income and middle-income countries (LMICs), where most cardiovascular disease deaths occur. The objectives of this study were to benchmark statin use in LMICs and to investigate country-level and individual-level characteristics associated with statin us","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":169,"document":"15018244","golden":false,"offsetInEndSection":320,"text":"Prevention programs for heart disease have impacted more positively on men than women and relatively young women aged 35-54 years may have fared worse.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":471,"document":"1755392","golden":false,"offsetInEndSection":791,"text":"Forty per cent of men and 47% of women reported a diagnosis of one or more cardiovascular diseases, of which high blood pressure 33%, coronary heart disease 14% (angina pectoris 11% and myocardial infarction 8%), peripheral arterial disease of the lower limbs 7%, and cerebrovascular disease 6% occurred most frequently.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":200,"document":"16439825","golden":false,"offsetInEndSection":410,"text":"ifferences.OBJECTIVES: To investigate the relationship of occupational social class with the prevalence of cardiovascular disease risk factors and cardiovascular diseases in younger (\u003c65 years) and older (\u003eor\u003d6","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":133,"document":"9484425","golden":false,"offsetInEndSection":461,"text":"and.METHODS: Means and prevalences of the major cardiovascular risk factors were estimated for non-Maori, non-Pacific Islands men and women in the age groups 65-74 and 75-84 years using data from the 1993-4 survey of the University of Auckland Heart and Health Study, a cross-sectional, population-based study of cardiovascular ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":576,"document":"17403787","golden":false,"offsetInEndSection":719,"text":"en and 4.0 years in women). Reductions in cardiovascular disease mortality had the greatest cumulative impact on life expectancy (2.7 years in ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":786,"document":"10604199","golden":false,"offsetInEndSection":923,"text":"In men and women with cardiovascular disease, poor nutritional status was associated with a sharply increased risk of hospital admission.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1289,"document":"11872970","golden":false,"offsetInEndSection":1420,"text":"Following a myocardial infarction, diabetes imposes a high rate of recurrence, heart failure, and death, more so in women than men.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"16687457","golden":false,"offsetInEndSection":118,"text":"OBJECTIVE: To study the relation between measures of personality and risk of cardiovascular disease and cancer in a la","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"8144285","golden":false,"offsetInEndSection":170,"text":"Cardiovascular disease risk factors were measured in a population survey in Pitk?ranta District in the Republic of Karelia and in North Karelia in Finland in spring 1992.","beginSection":"abstract"}],"exact_answer":"","ideal_answer":[],"id":"6777bbed592fa48873000011","type":"yesno","body":"Are cardiovascular diseases more common than cancer in women between 40 and 65 years of age?"},{"documents":[{"golden":true,"id":"32956453"},{"golden":true,"id":"36352205"},{"golden":true,"id":"38266057"},{"golden":false,"id":"34388396"},{"golden":false,"id":"36875718"},{"golden":true,"id":"35661166"},{"golden":false,"id":"36775940"},{"golden":false,"id":"36485135"},{"golden":true,"id":"37111346"},{"golden":false,"id":"37537597"},{"golden":true,"id":"38657201"},{"golden":false,"id":"39607603"},{"golden":true,"id":"39172760"},{"golden":true,"id":"37878808"},{"golden":false,"id":"37960969"},{"golden":false,"id":"38609727"},{"golden":false,"id":"37848191"},{"golden":true,"id":"39090994"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":0,"document":"35661166","golden":true,"offsetInEndSection":198,"text":"BACKGROUND: Teclistamab is a T-cell-redirecting bispecific antibody that targets both CD3 expressed on the surface of T cells and B-cell maturation antigen expressed on the surface of myeloma cells.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":275,"document":"32956453","golden":true,"offsetInEndSection":413,"text":"We developed a BCMAxCD3 bispecific antibody (teclistamab [JNJ-64007957]) to recruit and activate T cells to kill BCMA-expressing MM cells.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"32956453","golden":true,"offsetInEndSection":119,"text":"Teclistamab is an active T cell-redirecting bispecific antibody against B-cell maturation antigen for multiple myeloma.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36352205","golden":true,"offsetInEndSection":218,"text":"Teclistamab (TECVAYLI?), a bispecific antibody that targets CD3 and B cell maturation antigen (BCMA), is being developed by Janssen Research and Development for the treatment of relapsed or refractory multiple myeloma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1373,"document":"32956453","golden":true,"offsetInEndSection":1591,"text":"The specific and potent activity of teclistamab against BCMA-expressing cells from MM cell lines, patient samples, and MM xenograft models warrant further evaluation of this bispecific antibody for the treatment of MM.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":317,"document":"38266057","golden":true,"offsetInEndSection":466,"text":"Targeting both CD3 receptor complex on T cells and BCMA on myeloma cells, teclistamab leads to T-cell activation and subsequent lysis of BCMA+ cells.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":785,"document":"37111346","golden":true,"offsetInEndSection":940,"text":"Most recently, the bispecific anti-BCMA and T-cell-engaging antibody teclistamab has become available, again for patients with relapsed/refractory disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":839,"document":"32956453","golden":false,"offsetInEndSection":974,"text":"Teclistamab also depleted BCMA+ cells in bone marrow samples from MM patients in an ex vivo assay with an average EC50 value of 1.7 nM.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":747,"document":"32956453","golden":false,"offsetInEndSection":838,"text":"This activity was further increased in the presence of a ?-secretase inhibitor (LY-411575).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32956453","golden":false,"offsetInEndSection":172,"text":"B-cell maturation antigen (BCMA), a member of the tumor necrosis factor family of receptors, is predominantly expressed on the surface of terminally differentiated B cells.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":564,"document":"36352205","golden":false,"offsetInEndSection":836,"text":"Teclistamab was subsequently approved in the US for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy (including an immunomodulatory agent, a proteasome inhibitor and an anti-CD38 antibody).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":219,"document":"36352205","golden":false,"offsetInEndSection":563,"text":"Teclistamab was recently granted conditional approval in the EU for the treatment of adult patients with relapsed and refractory multiple myeloma who have received three or more prior therapies (including an immunomodulatory agent, a proteasome inhibitor and an anti-CD38 antibody) and have demonstrated disease progression on the last therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":837,"document":"36352205","golden":false,"offsetInEndSection":985,"text":"This article summarizes the milestones in the development of teclistamab leading to this first approval for relapsed or refractory multiple myeloma.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":153,"document":"34388396","golden":false,"offsetInEndSection":260,"text":"Teclistamab is a bispecific antibody that binds BCMA and CD3 to redirect T cells to multiple myeloma cells.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37878808","golden":true,"offsetInEndSection":292,"text":"ABSTRACT: Teclistamab, a B-cell maturation antigen (BCMA)- and CD3-targeting bispecific antibody, is an effective novel treatment for relapsed/refractory multiple myeloma (R/RMM), but efficacy in patients exposed to BCMA-directed therapies and mechanisms of resistance have yet to be fully de","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39172760","golden":true,"offsetInEndSection":190,"text":"ABSTRACT: Teclistamab is a B-cell maturation antigen (BCMA)-directed bispecific antibody approved for the treatment of patients with triple-class exposed relapsed/refractory multiple myeloma","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":209,"document":"38266057","golden":false,"offsetInEndSection":317,"text":"eclistamab (TECVAYLITM ) is the first T-cell redirecting bispecific antibody approved for patients with MM. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38657201","golden":true,"offsetInEndSection":269,"text":"ABSTRACT: Teclistamab, an off-the-shelf B-cell maturation antigen (BCMA)?? CD3 bispecific antibody that mediates T-cell activation and subsequent lysis of BCMA-expressing myeloma cells, is approved for the treatment of patients with relapsed/refractory multiple myeloma","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39607603","golden":false,"offsetInEndSection":151,"text":"We characterized the safety and efficacy of the bispecific antibody teclistamab in Japanese patients with relapsed/refractory multiple myeloma (RRMM).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35661166","golden":false,"offsetInEndSection":187,"text":"BACKGROUND: Teclistamab is a T-cell-redirecting bispecific antibody that targets both CD3 expressed on the surface of T cells and B-cell maturation antigen expressed on the surface of mye","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38657201","golden":true,"offsetInEndSection":268,"text":"ABSTRACT: Teclistamab, an off-the-shelf B-cell maturation antigen (BCMA)?? CD3 bispecific antibody that mediates T-cell activation and subsequent lysis of BCMA-expressing myeloma cells, is approved for the treatment of patients with relapsed/refractory multiple myelom","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37848191","golden":false,"offsetInEndSection":450,"text":"Multiple myeloma (MM) is an incurable neoplasm characterized by significant morbidity and mortality. Despite advances in treatment, MM patients eventually experienced a relapse of the disease. Penta-drug refractory patients continue to be the hard core of relapsed/refractory (RR) settings. Teclistamab-cqyv is a humanized IgG4 antibody and a bispecific BCMA-director CD3 T-cell engager. It recruits endogenous T cells, by targeting CD3 receptors exp","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39090994","golden":true,"offsetInEndSection":450,"text":"INTRODUCTION: Teclistamab, a bispecific T-cell engaging antibody targeting B-cell maturation antigen (BCMA), is indicated for the treatment of relapsed or refractory multiple myeloma after at least four lines of therapy. It has boxed warnings for life threatening cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS). To mitigate these risks, teclistamab is initiated using step-up doses. This article ex","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35661166","golden":false,"offsetInEndSection":186,"text":"BACKGROUND: Teclistamab is a T-cell-redirecting bispecific antibody that targets both CD3 expressed on the surface of T cells and B-cell maturation antigen expressed on the surface of my","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34388396","golden":false,"offsetInEndSection":116,"text":"BACKGROUND: There is a need for novel therapies for relapsed or refractory multiple myeloma, and B-cell maturation a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37878808","golden":true,"offsetInEndSection":291,"text":"ABSTRACT: Teclistamab, a B-cell maturation antigen (BCMA)- and CD3-targeting bispecific antibody, is an effective novel treatment for relapsed/refractory multiple myeloma (R/RMM), but efficacy in patients exposed to BCMA-directed therapies and mechanisms of resistance have yet to be fully d","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39172760","golden":true,"offsetInEndSection":181,"text":"ABSTRACT: Teclistamab is a B-cell maturation antigen (BCMA)-directed bispecific antibody approved for the treatment of patients with triple-class exposed relapsed/refractory multipl","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":208,"document":"38266057","golden":false,"offsetInEndSection":316,"text":"Teclistamab (TECVAYLITM ) is the first T-cell redirecting bispecific antibody approved for patients with MM.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38598713","golden":true,"offsetInEndSection":169,"text":"ABSTRACT: Teclistamab (Tec) is a first-in-class BCMA?? CD3 bispecific T-cell engager antibody approved for treating multiple myeloma progressing after at least 4 lines o","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":414,"document":"32956453","golden":false,"offsetInEndSection":746,"text":"Teclistamab induced cytotoxicity of BCMA+ MM cell lines in vitro (H929 cells, 50% effective concentration [EC50] \u003d 0.15 nM; MM.1R cells, EC50 \u003d 0.06 nM; RPMI 8226 cells, EC50 \u003d 0.45 nM) with concomitant T-cell activation (H929 cells, EC50 \u003d 0.21 nM; MM.1R cells, EC50 \u003d 0.1 nM; RPMI 8226 cells, EC50 \u003d 0.28 nM) and cytokine release.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":150,"document":"37537597","golden":false,"offsetInEndSection":331,"text":"Teclistamab was approved for relapsed/refractory MM therapy in 2022, while elranatamab, linvoseltamab, F182112, talquetamab, and cevostamab are currently undergoing clinical trials.","beginSection":"abstract"}],"exact_answer":[],"ideal_answer":[],"id":"677e8578592fa48873000021","type":"list","body":"What are the targets of Teclistamab?"},{"documents":[{"golden":false,"id":"18319242"},{"golden":true,"id":"27816296"},{"golden":false,"id":"38787096"},{"golden":false,"id":"28426941"},{"golden":false,"id":"30743241"},{"golden":false,"id":"28476009"},{"golden":false,"id":"32059143"},{"golden":false,"id":"33373191"},{"golden":true,"id":"34718030"},{"golden":false,"id":"31841855"},{"golden":false,"id":"25679485"},{"golden":true,"id":"39234954"},{"golden":false,"id":"38970711"},{"golden":false,"id":"32947815"},{"golden":false,"id":"34118448"},{"golden":false,"id":"39728410"},{"golden":false,"id":"39393453"},{"golden":false,"id":"33143924"},{"golden":true,"id":"38081430"},{"golden":false,"id":"38135135"},{"golden":false,"id":"38891244"},{"golden":false,"id":"39662583"},{"golden":false,"id":"38640759"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":976,"document":"18319242","golden":false,"offsetInEndSection":1075,"text":"(The preference for the target quadrant decreased by 16.6% and 19.4% versus control, respectively.)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":856,"document":"18319242","golden":false,"offsetInEndSection":975,"text":"Morris water maze test showed that La exposure at 2 and 40 mg/kg could significantly impair the behavioral performance.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1076,"document":"18319242","golden":false,"offsetInEndSection":1521,"text":"The neurotoxicological consequences demonstrated that the alteration in homeostasis of [Ca2+](i)/Ca2+-ATPase (the ratio of [Ca2+](i) vs. Ca2+-ATPase activity increased by 44% in rats of 40 mg/kg group), the inhibition to activities of antioxidant enzymes, and the subsequent cell damage (18% and 23% cell loss in CA3 subregion of rats in 2 and 40 mg/kg group, respectively) might be involved in the neurological adverse effects of REEs exposure.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1390,"document":"27816296","golden":true,"offsetInEndSection":1489,"text":"It was concluded that high intake of REEs might increase the risk of hypertension among housewives.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":680,"document":"28426941","golden":false,"offsetInEndSection":790,"text":"In addition, mean speed and wavelength of crawling movement were significantly reduced after chronic exposure.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":771,"document":"18319242","golden":false,"offsetInEndSection":855,"text":"Adverse effects were observed in 2 and 40 mg/kg dose groups and increased with dose.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":280,"document":"18319242","golden":false,"offsetInEndSection":344,"text":"In this work, the neurotoxicity of lanthanum (La) was evaluated.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":499,"document":"18319242","golden":false,"offsetInEndSection":770,"text":"Experiments were carried out to reveal the effects of La exposure on brain functions from four aspects including behavioral performance, [Ca2+](i) level and the activity of Ca2+-ATPase (adenosine triphosphatase) in hippocampal cells, oxidative stress, and Nissl staining.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1734,"document":"34718030","golden":true,"offsetInEndSection":1991,"text":"Altogether, our data show that exposure to lanthanum can cause neuronal toxic damage and behavioral defects in C. elegans, and provide basic information for understanding the neurotoxic effect mechanism and environmental health risks of rare earth elements.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"18319242","golden":false,"offsetInEndSection":79,"text":"Neurotoxicological evaluation of long-term lanthanum chloride exposure in rats.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39393453","golden":false,"offsetInEndSection":189,"text":"With the soaring use of rare earth elements (REEs) worldwidely in high-technology and clean energy industries, there were growing concerns for adverse health effect from the REEs exposure.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39234954","golden":true,"offsetInEndSection":114,"text":"OBJECTIVE: This study aimed to investigate the association between rare earth elements (REEs) and metabolic syndro","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38970711","golden":false,"offsetInEndSection":148,"text":"Rare earth elements (REEs) are a group consisting of the following 17 metals: Ce, Dy, Er, Eu, Gd, Ho, La, Lu, Nd, Pr, Pm, Sc, Sm, Tb, Tm, Y and Yb.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":718,"document":"32947815","golden":false,"offsetInEndSection":867,"text":"he increasing usage of rare earth elements has raised concern about environmental toxicity, which may further cause harmful effects on human health. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38787096","golden":false,"offsetInEndSection":123,"text":"Rare earth elements (REEs) are a new type of material resource which have attracted significant attention in recent years.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1393,"document":"32059143","golden":false,"offsetInEndSection":1609,"text":"Taken together, this study shows that the risk for NTDs increases with La concentrations when single REEs are considered and with concentrations of all 10 REEs when these REEs are considered as a co-exposure mixture.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1326,"document":"33143924","golden":false,"offsetInEndSection":1420,"text":"We concluded that a high serum La concentration may have an adverse effect on IVF-ET outcomes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39393453","golden":false,"offsetInEndSection":450,"text":"With the soaring use of rare earth elements (REEs) worldwidely in high-technology and clean energy industries, there were growing concerns for adverse health effect from the REEs exposure. However, there is a lack of biomonitoring research concerning both urine and blood in population with definite exposure. We performed a biomonitoring study that involved 103 REEs exposed males and 110 males as non-REEs exposed controls. We measured the levels o","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":450,"document":"39393453","golden":false,"offsetInEndSection":900,"text":"f REEs in environment and urine and blood samples from participants, and explored the exposure-response relationship between REEs in environment and body fluids. The effects of exposure duration and smoking status on the internal exposure level of REEs were also investigated. The results showed environmental REEs level of exposure group was significantly higher than that of control group (range of geometric mean of exposure vs. control: 1.08-4.07","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38081430","golden":true,"offsetInEndSection":450,"text":"Prenatal exposure to rare earth elements (REEs) may contribute to adverse birth outcomes in previous studies. Cord blood vitamin D has been suggested to modify or mediate the effects of environmental exposures. However, none has investigated these roles of cord blood vitamin D in the associations of prenatal exposure to REEs with fetal growth. Maternal trimester-specific urinary concentrations of 13 REEs, cord blood total 25-hydroxyvitamin D at d","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38135135","golden":false,"offsetInEndSection":450,"text":"The increasing consumption of rare earth elements (REEs) has resulted in a considerable risk of environmental exposure. However, the adverse effects of prenatal REEs exposure on children\u0027s neurodevelopment are not yet fully recognized. Therefore, we investigated the individual and joint effects of prenatal exposure to 13 REEs on children\u0027s neurocognitive development based on 809 mother-child pairs from a large birth cohort in Wuhan, China. Matern","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38891244","golden":false,"offsetInEndSection":450,"text":"Rare earth elements (REEs) have been intentionally used in Chinese agriculture since the 1980s to improve crop yields. Around the world, REEs are also involuntarily applied to soils through phosphate fertilizers. These elements are known to alleviate damage in plants under abiotic stresses, yet there is no information on how these elements act in the physiology of plants. The REE mode of action falls within the scope of the hormesis effect, with ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39662583","golden":false,"offsetInEndSection":450,"text":"The potential health effects of exposure to rare earth elements (REEs) remain largely unexplored. This prospective cohort study aimed to elucidate the association between early pregnancy REE exposure and maternal thyroid function, as well as neonatal birth outcomes, in a cohort of pregnant women in Beijing, China. Additionally, the study explored the mediating role of thyroid homeostasis in the effects of REE exposure. Serum concentrations of fif","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38640759","golden":false,"offsetInEndSection":450,"text":"The use of rare earth elements (REEs) has been increasing and one of the most used is neodymium (Nd). Being an emergent contaminant, its negative impacts are poorly understood. Aquatic organisms are also threatened by climate change-related factors, as is the case of warming, which can change the effects of REEs. Thus, the impacts of Nd, warming, and the combination of both stressors were studied in adult mussels and sperm of the species Mytilus ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30743241","golden":false,"offsetInEndSection":170,"text":"The extensive use of rare earth elements (REEs) in a number of technologies is expected to impact on human health, including occupational and environmental REE exposures.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28476009","golden":false,"offsetInEndSection":164,"text":"The wide applications cause a large amount of rare earth elements (REEs) to be released into the environment, and ultimately into the human body through food chain.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":717,"document":"32947815","golden":false,"offsetInEndSection":866,"text":"The increasing usage of rare earth elements has raised concern about environmental toxicity, which may further cause harmful effects on human health.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":403,"document":"34118448","golden":false,"offsetInEndSection":617,"text":"Rare earth elements (REEs) have been of particular interest in alloying Mg alloys for nearly a century due to their unique chemical and physical properties but have attracted increasing attention in recent decades.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33373191","golden":false,"offsetInEndSection":221,"text":"Increasing rare earth element (REE) mining and refining activities have led to a considerable release of these substances into aquatic environment, yet the knowledge of their impacts on aquatic organisms is still limited.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":216,"document":"39728410","golden":false,"offsetInEndSection":312,"text":"Overall, the results demonstrated that all REEs tested exerted significant adverse effects on T.","beginSection":"abstract"}],"ideal_answer":[],"id":"6772e791592fa4887300000b","type":"summary","body":"What are the adverses effect of Rare earth elements (REEs) on the body?"},{"documents":[{"golden":true,"id":"21640971"},{"golden":false,"id":"38580164"},{"golden":false,"id":"16424224"},{"golden":false,"id":"32360427"},{"golden":false,"id":"29513135"},{"golden":false,"id":"37194065"},{"golden":false,"id":"32077340"},{"golden":true,"id":"28743124"},{"golden":true,"id":"31383731"},{"golden":false,"id":"31319111"},{"golden":false,"id":"37007062"},{"golden":true,"id":"37489274"},{"golden":false,"id":"38452728"},{"golden":true,"id":"24725424"},{"golden":false,"id":"25284748"},{"golden":false,"id":"23128141"},{"golden":false,"id":"21044884"},{"golden":false,"id":"25829327"},{"golden":false,"id":"31271515"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":0,"document":"32360427","golden":false,"offsetInEndSection":145,"text":"OBJECTIVE: Discoidin domain receptor 1 (DDR1) is a collagen binding receptor tyrosine kinase implicated in atherosclerosis, fibrosis, and cancer.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"21640971","golden":true,"offsetInEndSection":104,"text":"Discoidin domain receptor 1 is a major mediator of inflammation and fibrosis in obstructive nephropathy.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1341,"document":"31383731","golden":false,"offsetInEndSection":1622,"text":"Once in the nucleus, DDR1 binds to chromatin to increase the transcription of collagen IV, a major collagen upregulated in fibrosis.CONCLUSIONS: These findings reveal a novel mechanism whereby activated DDR1 translates to the nucleus to regulate synthesis of profibrotic molecules.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38580164","golden":false,"offsetInEndSection":184,"text":"Discoidin domain receptor (DDR)-1 has a crucial role in regulating vital processes, including cell differentiation, proliferation, adhesion, migration, invasion, and matrix remodeling.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31383731","golden":true,"offsetInEndSection":250,"text":"BACKGROUND: The discoidin domain receptor 1 (DDR1) is activated by collagens, upregulated in injured and fibrotic kidneys, and contributes to fibrosis by regulating extracellular matrix production, but how DDR1 controls fibrosis is poorly understood.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1297,"document":"32360427","golden":false,"offsetInEndSection":1677,"text":"In?vitro, studying C3H10T1/2 cells stimulated to differentiate, DDR1 inhibition caused a shift from white to beige adipocyte differentiation, whereas DDR1 expression was increased with TGF?-mediated pro-fibrotic differentiation.CONCLUSION: This study is the first to identify a role for DDR1 as a driver of adipose tissue fibrosis and suppressor of beneficial beige fat formation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":891,"document":"28743124","golden":true,"offsetInEndSection":1045,"text":"These results demonstrate the involvement of DDR1 in inflammatory and fibrotic processes occurring during CKD and the beneficial effect of its inhibition.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":185,"document":"38580164","golden":false,"offsetInEndSection":419,"text":"Overexpression or activation of DDR1 in various pathological scenarios makes it a potential therapeutic target for the treatment of cancer, fibrosis, atherosclerosis, and neuropsychiatric, psychiatric, and neurodegenerative disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":535,"document":"38580164","golden":false,"offsetInEndSection":686,"text":"Furthermore, we analyze factors other than issues of low selectivity and risk of resistance, contributing to the infrequent success of DDR1 inhibitors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":914,"document":"38580164","golden":false,"offsetInEndSection":1021,"text":"The mechanisms involved in DDR1 regulation in cancer and inflammation-related diseases also remain unknown.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1312,"document":"37489274","golden":true,"offsetInEndSection":1679,"text":"hese findings highlight the importance of type I collagen autocrine signaling by fibroblasts during fibrosis and demonstrate that DDR2 has a central role in this pathway making it a potential therapeutic target.NEW \u0026 NOTEWORTHY Type I collagen is a major component of fibrosis and can signal through cell surface receptors such as discoidin domain receptor 2 (DDR2). ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37007062","golden":false,"offsetInEndSection":181,"text":"Discoidin domain receptors (DDRs) are receptor tyrosine kinases on the membrane surface that bind to extracellular collagens, but they are rarely expressed in normal liver tissues.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38452728","golden":false,"offsetInEndSection":231,"text":"Discoidin domain receptor 1 (DDR1) is a collagen-activated receptor tyrosine kinase (RTK) and plays pivotal roles in regulating cellular functions such as proliferation, differentiation, invasion, migration, and matrix remodeling.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1252,"document":"16424224","golden":false,"offsetInEndSection":1382,"text":"Considered together, we propose that DDR1 contributes to the development of bleomycin-induced pulmonary inflammation and fibrosis.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38580164","golden":false,"offsetInEndSection":66,"text":"DDR1-targeted therapies: current limitations and future potential.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37194065","golden":false,"offsetInEndSection":450,"text":"Discoidin Domain Receptor (DDR)-1 is activated by collagen. Nilotinib is a tyrosine kinase inhibitor that is FDA-approved for leukemia and potently inhibits DDR-1. Individuals diagnosed with mild-moderate Alzheimer\u0027s disease (AD) treated with nilotinib (versus placebo) for 12?months showed reduction of amyloid plaque and cerebrospinal fluid (CSF) amyloid, and attenuation of hippocampal volume loss. However, the mechanisms are unclear. Here, we ex","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38580164","golden":false,"offsetInEndSection":450,"text":"Discoidin domain receptor (DDR)-1 has a crucial role in regulating vital processes, including cell differentiation, proliferation, adhesion, migration, invasion, and matrix remodeling. Overexpression or activation of DDR1 in various pathological scenarios makes it a potential therapeutic target for the treatment of cancer, fibrosis, atherosclerosis, and neuropsychiatric, psychiatric, and neurodegenerative disorders. In this review, we summarize c","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31271515","golden":false,"offsetInEndSection":178,"text":"The discoidin domain receptor 1 (DDR1) is a member of the receptor tyrosine kinase family that signals in response to collagen and that has been implicated in cancer progression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":196,"document":"31319111","golden":false,"offsetInEndSection":363,"text":"DDRs are now recognized as playing central regulatory roles in several high prevalence human diseases, including invasive cancers, atherosclerosis, and organ fibrosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":239,"document":"24725424","golden":true,"offsetInEndSection":365,"text":"Dysregulated DDR function is associated with progression of various human diseases, including fibrosis, arthritis, and cancer.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":175,"document":"23128141","golden":false,"offsetInEndSection":325,"text":"The DDRs have important roles in embryo development and their dysregulation is associated with human diseases, such as fibrosis, arthritis and cancer.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25284748","golden":false,"offsetInEndSection":129,"text":"Discoidin domain receptor (DDR) 1 and 2 are transmembrane receptors that belong to the family of receptor tyrosine kinases (RTK).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21044884","golden":false,"offsetInEndSection":135,"text":"The discoidin domain receptors, DDR1 and DDR2 are cell surface receptor tyrosine kinases that are activated by triple-helical collagen.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1175,"document":"29513135","golden":false,"offsetInEndSection":1394,"text":"As the most common end-point of all fibrotic disorders is dysregulated collagen remodeling, we consider here the mechanical signaling functions of DDR1 in processing of fibrillar collagen that lead to tissue fibrosis.","beginSection":"abstract"}],"exact_answer":"","ideal_answer":[],"id":"6772c2d4592fa48873000005","type":"yesno","body":"Discoidin domain receptor (DDR)-1 has a crucial role in regulating vital processes, it is known to be associated with fibrosis?"},{"documents":[{"golden":true,"id":"39225267"},{"golden":true,"id":"38995101"},{"golden":true,"id":"39081482"},{"golden":false,"id":"35385695"},{"golden":false,"id":"38984712"},{"golden":true,"id":"39520978"},{"golden":false,"id":"39073551"},{"golden":false,"id":"39257338"},{"golden":false,"id":"38325992"},{"golden":false,"id":"37830334"},{"golden":false,"id":"38224232"},{"golden":false,"id":"22844196"},{"golden":false,"id":"30196789"},{"golden":false,"id":"23247681"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":1690,"document":"39225267","golden":true,"offsetInEndSection":2049,"text":"The incidence of any adverse event appeared to be similar in the two groups.CONCLUSIONS: Among patients with atrial fibrillation at risk for stroke, treatment with asundexian at a dose of 50 mg once daily was associated with a higher incidence of stroke or systemic embolism than treatment with apixaban in the period before the trial was stopped prematurely.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1005,"document":"38995101","golden":true,"offsetInEndSection":1322,"text":"In these instances, asundexian did not show a difference in the incidence of bleeding events compared to placebo.CONCLUSION: Phase 3 trials have recently been launched; however, the OCEANIC-AF trial was prematurely discontinued due to inefficacy of asundexian vs apixaban for stroke prevention in atrial fibrillation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2581,"document":"35385695","golden":false,"offsetInEndSection":3018,"text":"The rate of any adverse event occurring was similar in the three treatment groups: 118 (47%) with asundexian 20 mg, 120 (47%) with asundexian 50 mg, and 122 (49%) with apixaban.INTERPRETATION: The FXIa inhibitor asundexian at doses of 20 mg and 50 mg once daily resulted in lower rates of bleeding compared with standard dosing of apixaban, with near-complete in-vivo FXIa inhibition, in patients with atrial fibrillation.FUNDING: Bayer.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":161,"document":"39225267","golden":false,"offsetInEndSection":498,"text":"Asundexian, an activated factor XI (XIa) inhibitor, is an oral anticoagulant that may prevent strokes with less bleeding.METHODS: In a phase 3, international, double-blind trial, we randomly assigned high-risk patients with atrial fibrillation in a 1:1 ratio to receive asundexian at a dose of 50 mg once daily or standard-dose apixaban.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":487,"document":"39081482","golden":true,"offsetInEndSection":612,"text":"However, the OCEANIC-AF study was recently halted due to the inferior efficacy of asundexian versus the apixaban control arm.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39225267","golden":false,"offsetInEndSection":160,"text":"BACKGROUND: Stroke prevention with direct-acting oral anticoagulant agents in patients with atrial fibrillation confers a risk of bleeding and limits their use.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39520978","golden":true,"offsetInEndSection":287,"text":"The OCEANIC-AF trial was terminated early due to inferiority of asundexian compared with apixaban for the prevention of stroke and systemic embolism in patients with atrial fibrillation.1 However, the promisingly low bleeding rates support continued exploration of factor XIa inhibitors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":653,"document":"39225267","golden":false,"offsetInEndSection":885,"text":"The primary safety objective was to determine whether asundexian is superior to apixaban with respect to major bleeding events.RESULTS: A total of 14,810 randomly assigned patients were included in the intention-to-treat population.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2050,"document":"39225267","golden":false,"offsetInEndSection":2141,"text":"There were fewer major bleeding events with asundexian than with apixaban during this time.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"39225267","golden":false,"offsetInEndSection":64,"text":"Asundexian versus Apixaban in Patients with Atrial Fibrillation.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1740,"document":"39225267","golden":true,"offsetInEndSection":2010,"text":"similar in the two groups.CONCLUSIONS: Among patients with atrial fibrillation at risk for stroke, treatment with asundexian at a dose of 50 mg once daily was associated with a higher incidence of stroke or systemic embolism than treatment with apixaban in the period be","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":638,"document":"38325992","golden":false,"offsetInEndSection":959,"text":"d Hemostasis (ISTH) criteria.RESULTS: In patients with AF (n?\u003d?755), both asundexian 20?mg and 50?mg once daily vs apixaban had fewer major/CRNM events (3 of 249; incidence rate [IR] per 100 patient-years 5.47 vs 1 of 254 [IR: not calculable] vs 6 of 250 [IR: 11.10]) and all bleeding (12 of 249 [IR: 22.26] vs 10 of 254 ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":646,"document":"39257338","golden":false,"offsetInEndSection":797,"text":" a very favoring pharmacokinetic profile. Despite asundexian being inferior to apixaban for cardioembolic ischemic stroke, it could be useful in patien","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":828,"document":"38995101","golden":false,"offsetInEndSection":988,"text":"l fibrillation. For other indications, such as noncardioembolic stroke and acute myocardial infarction, asundexian has been used in addition to background antip","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":204,"document":"38224232","golden":false,"offsetInEndSection":335,"text":"sundexian (BAY 2433334), an activated factor XI inhibitor, is in clinical development for the prevention of thromboembolic events. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39225267","golden":false,"offsetInEndSection":1300,"text":"BACKGROUND: Stroke prevention with direct-acting oral anticoagulant agents in patients with atrial fibrillation confers a risk of bleeding and limits their use. Asundexian, an activated factor XI (XIa) inhibitor, is an oral anticoagulant that may prevent strokes with less bleeding.METHODS: In a phase 3, international, double-blind trial, we randomly assigned high-risk patients with atrial fibrillation in a 1:1 ratio to receive asundexian at a dose of 50 mg once daily or standard-dose apixaban. The primary efficacy objective was to determine whether asundexian is at least noninferior to apixaban for the prevention of stroke or systemic embolism. The primary safety objective was to determine whether asundexian is superior to apixaban with respect to major bleeding events.RESULTS: A total of 14,810 randomly assigned patients were included in the intention-to-treat population. The mean (?SD) age of the patients was 73.9?7.7 years, 35.2% were women, 18.6% had chronic kidney disease, 18.2% had a previous stroke or transient ischemic attack, 16.8% had received oral anticoagulants for no more than 6 weeks, and the mean CHA2DS2-VASc score (range, 0 to 9, with higher scores indicating a greater risk of stroke) was 4.3?1.3. The trial was stopped prematurely at the recommendation of the inde","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38984712","golden":false,"offsetInEndSection":1150,"text":"Cardiovascular disease remains the leading global cause of mortality, requiring effective antithrombotic strategies to prevent thromboembolic events. Currently available therapies are effective but have inherent bleeding risks which may limit or preclude their use, particularly in patients at the highest risk of bleeding. Factor XI (FXI) inhibitors are a promising new class of anticoagulants which may mitigate the risk of bleeding while maintaining efficacy. Further, they have the potential to provide effective anticoagulation in indications where direct oral anticoagulants (DOACs) are proven less effective than vitamin K antagonists (VKAs) or when DOACs are contraindicated. The development of FXI inhibitors was based on mechanistic considerations suggesting FXI\u0027s role in thrombus formation without significantly affecting hemostasis, supported by epidemiological data and animal experiments. FXI inhibitors, including antisense oligonucleotides, monoclonal antibodies, and small?molecule inhibitors, target different stages of FXI production or activation, offering a diversity of therapeutic options with differing onset and offset of ac","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2730,"document":"35385695","golden":false,"offsetInEndSection":2959,"text":"and 122 (49%) with apixaban.INTERPRETATION: The FXIa inhibitor asundexian at doses of 20 mg and 50 mg once daily resulted in lower rates of bleeding compared with standard dosing of apixaban, with near-complete in-vivo FXIa inhib","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1739,"document":"39225267","golden":true,"offsetInEndSection":2009,"text":" similar in the two groups.CONCLUSIONS: Among patients with atrial fibrillation at risk for stroke, treatment with asundexian at a dose of 50 mg once daily was associated with a higher incidence of stroke or systemic embolism than treatment with apixaban in the period b","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":645,"document":"39257338","golden":false,"offsetInEndSection":796,"text":"s a very favoring pharmacokinetic profile. Despite asundexian being inferior to apixaban for cardioembolic ischemic stroke, it could be useful in patie","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":273,"document":"22844196","golden":false,"offsetInEndSection":681,"text":"We review Apixaban, an oral inhibitor of Factor Xa, which has been shown in large randomized trials to have superior efficacy in stroke reduction without an excess in bleeding events when compared with aspirin in those deemed unsuitable to receive warfarin, and demonstrates superior efficacy in reducing stroke and systemic embolism in addition to a reduction in bleeding events when compared to warfarin.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":384,"document":"37830334","golden":false,"offsetInEndSection":557,"text":"Asundexian is an oral small molecule?factor XIa inhibitor that, via this novel mechanism, may prove to be a safe and effective option compared with available anticoagulants.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1271,"document":"23247681","golden":false,"offsetInEndSection":1546,"text":"In secondary prevention, better efficiency is shown by dabigatran 150 and apixaban, versus rivaroxaban, despite the higher proportion of post-stroke/TIA patients (55 %) in the ROCKET AF trial of rivaroxaban seemed to favor better results of this drug in secondary prevention.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":192,"document":"30196789","golden":false,"offsetInEndSection":391,"text":"c strokes.AIMS: The aim of the ARCADIA trial is to test the hypothesis that apixaban is superior to aspirin for the prevention of recurrent stroke in subjects with cryptogenic ischemic stroke and atr","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":827,"document":"38995101","golden":false,"offsetInEndSection":987,"text":"al fibrillation. For other indications, such as noncardioembolic stroke and acute myocardial infarction, asundexian has been used in addition to background anti","beginSection":"abstract"}],"exact_answer":"","ideal_answer":[],"id":"677e83f0592fa4887300001f","type":"yesno","body":"Is Asundexian superior to Apixaban for Atrial Fibrillation?"},{"documents":[{"golden":false,"id":"21962224"},{"golden":true,"id":"23329386"},{"golden":false,"id":"30776283"},{"golden":false,"id":"35509804"},{"golden":false,"id":"15046532"},{"golden":false,"id":"23650474"},{"golden":false,"id":"38771653"},{"golden":false,"id":"12404679"},{"golden":false,"id":"22214252"},{"golden":false,"id":"15584766"},{"golden":false,"id":"34449694"},{"golden":false,"id":"38979493"},{"golden":false,"id":"26882332"},{"golden":false,"id":"38596418"},{"golden":false,"id":"30665686"},{"golden":false,"id":"23446713"},{"golden":false,"id":"8827538"},{"golden":false,"id":"22869222"},{"golden":false,"id":"29441281"},{"golden":false,"id":"16391451"},{"golden":false,"id":"35211779"},{"golden":false,"id":"15352538"},{"golden":false,"id":"24191257"},{"golden":false,"id":"1974836"},{"golden":false,"id":"38504095"},{"golden":false,"id":"37489917"},{"golden":false,"id":"39239907"},{"golden":false,"id":"39701141"},{"golden":false,"id":"17190528"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":563,"document":"21962224","golden":false,"offsetInEndSection":948,"text":"Stimulant medications are licensed in the UK for the management of ADHD in school-age children and young people, and are effective in controlling ADHD symptoms.While immediate-release preparations of methylphenidate (MPH) have proven effective in the treatment of ADHD, there are a number of problems associated with their use, most notably compliance, stigma and medication diversion.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"12404679","golden":false,"offsetInEndSection":390,"text":"UNLABELLED: Pharmacological intervention, mainly with psychostimulants, alone or with psychotherapy or behavioural modification, was found to be effective in increasing sustained attention span, improving concentration, reducing hyperactive behaviour and improving areas of academic deficits in children and adolescents with the diagnosis of attention deficit-hyperactivity disorder (ADHD).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":902,"document":"23329386","golden":true,"offsetInEndSection":1185,"text":"Based on current evidence and guidelines, a careful trial with psychopharmacologic agents is indicated to treat ADHD in preschoolers if there is no improvement with behavior therapy and the preschoolers continue to exhibit significantly impaired hyperactive and inattentive symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":975,"document":"35509804","golden":false,"offsetInEndSection":1283,"text":"Insufficient evidence was found to support the effects of supplementation with polyunsaturated fatty acids.Conclusions: The use of TCAs, amphetamine, and methylphenidate in children and adolescents with ADHD seems to present positive effects and higher rates of minor adverse events when compared to placebo.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":320,"document":"21962224","golden":false,"offsetInEndSection":562,"text":"The frequency of referral is higher for boys than for girls (about 2:1), and girls are generally older at the time of referral.Pharmacological therapy is considered the first-line treatment for patients with severe ADHD and severe impairment.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"21962224","golden":false,"offsetInEndSection":122,"text":"Clinical use of a modified release methylphenidate in the treatment of childhood attention deficit hyperactivity disorder.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1369,"document":"21962224","golden":false,"offsetInEndSection":1497,"text":"The clinical experience of treating ADHD with a modified-release MPH preparation (Equasym XL?) is illustrated with case studies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":461,"document":"30776283","golden":false,"offsetInEndSection":523,"text":"Pharmacological treatment was the treatment of choice (90.2%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":949,"document":"21962224","golden":false,"offsetInEndSection":1368,"text":"Modified release preparations are now available that overcome the need for multiple daily dosing, and which offer different MPH release profiles, thereby enabling the physician to match the medication to the patient\u0027s particular requirements.This review describes the diagnosis, referral and treatment pathways for patients with ADHD in the UK and the practical considerations when initiating pharmacological treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1417,"document":"12404679","golden":false,"offsetInEndSection":1693,"text":"There were also findings of stability of adherence reports over a 3 month period.CONCLUSION: The results of this study documented high rates of adherence to medication prescribed for symptoms of attention deficit hyperactivity disorder in a sample of children and adolescents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"15046532","golden":false,"offsetInEndSection":234,"text":"Since attention-deficit/hyperactivity disorder (ADHD) is usually diagnosed in children, evidence from the studies of pharmacologic treatments for children with ADHD is used to inform pharmacologic treatment recommendations for adults.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"26882332","golden":false,"offsetInEndSection":376,"text":"Behavioral and pharmacological treatments for children with attention deficit/hyperactivity disorder (ADHD) were evaluated to address whether endpoint outcomes are better depending on which treatment is initiated first and, in case of insufficient response to initial treatment, whether increasing dose of initial treatment or adding the other treatment modality is superior.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1085,"document":"38979493","golden":false,"offsetInEndSection":1314,"text":"ere, we provide a review of the key findings of these studies, which suggest that there is growing evidence to support the use of pharmacological interventions in the management of ADHD in preschool children with comorbid ASD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":221,"document":"23650474","golden":false,"offsetInEndSection":313,"text":"harmacotherapy is considered the first-line treatment for ADHD in children and adolescents. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38596418","golden":false,"offsetInEndSection":219,"text":"Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders in childhood with approximately 6 million children (age 3 to 17 years) ever diagnosed based on data from 2016-2019.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38771653","golden":false,"offsetInEndSection":198,"text":"INTRODUCTION: Attention-deficit/hyperactivity disorder (ADHD) is a common neurobehavioral disorder characterized by impairing inattention and/or hyperactivity and impulsivity in children and adults.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35509804","golden":false,"offsetInEndSection":599,"text":"Attention deficit hyperactivity disorder (ADHD) is one of the most frequent childhood psychiatric problems.Objective: The objective of this study was to identify, synthesize the results, and critically evaluate all Cochrane systematic reviews (SRs) on the pharmacological interventions for children and adolescents (up to age 18) diagnosed with ADHD.Methods: The search was performed in the Cochrane Database of Systematic Reviews (via Wiley) in July 2020.Results: The search strategy resulted in four SRs of high methodological quality, analyzing 51 randomized clinical trials (9,013 participants).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21962224","golden":false,"offsetInEndSection":160,"text":" Attention deficit hyperactivity disorder (ADHD) is the most commonly diagnosed neurobehavioural disorder in childhood, affecting over 5% of children worldwide.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38504095","golden":false,"offsetInEndSection":1100,"text":"Integrating CYP2D6 genotyping and therapeutic drug monitoring (TDM) is crucial for guiding individualized atomoxetine therapy in children with attention-deficit/hyperactivity disorder (ADHD). The aim of this retrospective study was (1) to investigate the link between the efficacy and tolerability of atomoxetine in children with ADHD and plasma atomoxetine concentrations based on their CYP2D6 genotypes; (2) to offer TDM reference range recommendations for atomoxetine based on the CYP2D6 genotypes of children receiving different dosage regimens. This retrospective study covered children and adolescents with ADHD between the ages of 6 and \u003c18, who visited the psychological and behavioral clinic of Children\u0027s Hospital of Nanjing Medical University from June 1, 2021, to January 31, 2023. The demographic information and laboratory examination data, including CYP2D6 genotype tests and routine TDM of atomoxetine were obtained from the hospital information system. We used univariate analysis, Mann-Whitney U nonparametric test, Kruskal-Wallis test, and the receiver operating characteristic (RO","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37489917","golden":false,"offsetInEndSection":1000,"text":"BACKGROUND: Attention deficit hyperactivity disorder (ADHD) is one of the common neurodevelopmental diseases that are accompanied with EEG pattern changes and Low levels of 25-hydroxyvitamin D [25(OH)D]. Neurofeedback provides a feedback signal to alleviate brain wave abnormalities and offers an alternative therapy for ADHD. This study aimed to investigate the concomitant effects of Vitamin D3 supplementation and Neurofeedback on children with ADHD.METHOD: This study was implemented on children with an established diagnosis of ADHD who received multisession Neurofeedback therapy. The intervention and control groups received 50000 IU vitamin D3 capsules and placebo respectively once a week for 2 months. The background rhythm was measured using quantitative EEG both before and at the end duration of the therapy.RESULTS: All of the vitamin D3 treated children showed a significant increase in the 25(OH)D (46???18, 28 ? 10 (ng/ml), p?\u003d?0.001) and serum calcium level (9.5???0.5, 9.8???0.3 (m","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39239907","golden":false,"offsetInEndSection":800,"text":"BACKGROUND: With elexacaftor/tezacaftor/ivacaftor (ETI), children with cystic fibrosis (CwCF) are living healthier lives with a focus on typical developmental issues such as attention deficit/hyperactivity disorder (ADHD). This paper characterizes CwCF with ADHD within the first year of ETI treatment.METHODS: This retrospective, observational analysis examines a subgroup of CwCF participating in a longitudinal study obtaining prospective data regarding the impact of ETI on mental health. All participants started on ETI were offered enrollment, with rolling enrollment as younger children became eligible. Clinical data regarding CF symptoms, mental health diagnoses, medications, changes in mental health symptoms and BMI were collected via chart review.RESULTS: Before ETI, ADHD diagnoses were","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39701141","golden":false,"offsetInEndSection":950,"text":"OBJECTIVE: To assess the accuracy of a large language model (LLM) in measuring clinician adherence to practice guidelines for monitoring side effects after prescribing medications for children with attention-deficit/hyperactivity disorder (ADHD).METHODS: Retrospective population-based cohort study of electronic health records. Cohort included children aged 6 to 11?years with ADHD diagnosis and 2 or more ADHD medication encounters (stimulants or nonstimulants prescribed) between 2015 and 2022 in a community-based primary health care network (n?\u003d?1201). To identify documentation of side effects inquiry, we trained, tested, and deployed an open-source LLM (LLaMA) on all clinical notes from ADHD-related encounters (ADHD diagnosis or ADHD medication prescription), including in-clinic/telehealth and telephone encounters (n?\u003d?15?628 notes). Model performance was assessed using holdout and deployment test sets, compared with manual medical reco","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":220,"document":"23650474","golden":false,"offsetInEndSection":312,"text":"Pharmacotherapy is considered the first-line treatment for ADHD in children and adolescents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17190528","golden":false,"offsetInEndSection":311,"text":"Approximately one-half of children medicated for attention-deficit hyperactivity disorder (ADHD) will continue to experience sufficient impairment during adolescence to warrant the continuation of their treatment; a smaller number of people with ADHD may require treatment for the first time during adolescence.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"22869222","golden":false,"offsetInEndSection":196,"text":"INTRODUCTION: Psychostimulants (methylphenidate and amphetamines) are the drugs of first choice in the pharmacological treatment of children and adolescents with attention deficit hyperactivity di","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23446713","golden":false,"offsetInEndSection":178,"text":"AIMS: To collect some factors that can help the clinician to design a plan of pharmacologic treatment for children and adolescents with attention deficit hyperactivity disorder (","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":342,"document":"15584766","golden":false,"offsetInEndSection":593,"text":"A 1990 review showed that 34% of paediatricians and 15% of family physicians had prescribed psychostimulant medications to preschoolers with ADHD, and pharmacoepidemiological studies indicate growing use of stimulants in preschoolers during the 1990s.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":163,"document":"8827538","golden":false,"offsetInEndSection":328,"text":"While some writers claim that it is clear that all children presenting with ADHD should be treated by pharmacological means, there are associated risks and politics.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":673,"document":"30665686","golden":false,"offsetInEndSection":889,"text":"Although only class II and class III studies are available, methylphenidate is the most appropriate pharmacological option for the treatment of ADHD in children with epilepsy with a limited risk of seizure worsening.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35509804","golden":false,"offsetInEndSection":107,"text":"Attention deficit hyperactivity disorder (ADHD) is one of the most frequent childhood psychiatric problems.","beginSection":"abstract"}],"ideal_answer":[],"id":"6777b80b592fa4887300000e","type":"summary","body":"When should children diagnosed with attention deficit hyperactivity disorder (ADHD) be offered pharmacological treatment?"},{"documents":[{"golden":false,"id":"15106204"},{"golden":false,"id":"38016055"},{"golden":false,"id":"8959457"},{"golden":false,"id":"19803251"},{"golden":false,"id":"35649128"},{"golden":true,"id":"11357236"},{"golden":false,"id":"11062623"},{"golden":false,"id":"11099623"},{"golden":false,"id":"16900742"},{"golden":false,"id":"32556354"},{"golden":true,"id":"24695413"},{"golden":false,"id":"17984913"},{"golden":false,"id":"21569011"},{"golden":false,"id":"23480125"},{"golden":false,"id":"30444146"},{"golden":false,"id":"27859478"},{"golden":false,"id":"35564511"},{"golden":false,"id":"35941906"},{"golden":false,"id":"22801471"},{"golden":false,"id":"33215580"},{"golden":false,"id":"32279717"},{"golden":true,"id":"32053326"},{"golden":false,"id":"27267182"},{"golden":false,"id":"24204146"},{"golden":false,"id":"24411151"},{"golden":true,"id":"30806105"},{"golden":true,"id":"15736096"},{"golden":false,"id":"34484101"},{"golden":false,"id":"36999118"},{"golden":false,"id":"33871733"},{"golden":false,"id":"36628177"},{"golden":false,"id":"18778959"},{"golden":false,"id":"17618218"},{"golden":false,"id":"37877954"},{"golden":false,"id":"34206816"},{"golden":false,"id":"34853854"},{"golden":true,"id":"27520277"},{"golden":false,"id":"36331502"},{"golden":true,"id":"34957963"},{"golden":false,"id":"36657477"},{"golden":true,"id":"25788947"},{"golden":false,"id":"37463749"},{"golden":true,"id":"37862777"},{"golden":false,"id":"33398874"},{"golden":false,"id":"37123757"},{"golden":false,"id":"33186793"},{"golden":false,"id":"34302999"},{"golden":false,"id":"34943284"},{"golden":true,"id":"36576161"},{"golden":true,"id":"37385449"},{"golden":false,"id":"35244504"},{"golden":false,"id":"33692754"},{"golden":false,"id":"17505457"},{"golden":false,"id":"34101010"},{"golden":false,"id":"33345534"},{"golden":false,"id":"34092664"},{"golden":true,"id":"26889193"},{"golden":false,"id":"13677574"},{"golden":false,"id":"32662125"},{"golden":false,"id":"23450428"},{"golden":false,"id":"37885221"},{"golden":true,"id":"20112480"},{"golden":false,"id":"26523699"},{"golden":false,"id":"32617202"},{"golden":false,"id":"37499087"},{"golden":false,"id":"37823431"},{"golden":false,"id":"19769917"},{"golden":false,"id":"11851740"},{"golden":false,"id":"16376270"},{"golden":false,"id":"35731062"},{"golden":false,"id":"16272661"},{"golden":false,"id":"21540003"},{"golden":false,"id":"20091546"},{"golden":false,"id":"26829869"},{"golden":false,"id":"2000440"},{"golden":false,"id":"30905979"},{"golden":false,"id":"20116812"},{"golden":true,"id":"18617860"},{"golden":false,"id":"33633421"},{"golden":false,"id":"8370782"},{"golden":false,"id":"17324366"},{"golden":false,"id":"31037074"},{"golden":false,"id":"21575839"},{"golden":false,"id":"21091581"},{"golden":false,"id":"34682132"},{"golden":false,"id":"35573442"},{"golden":false,"id":"37577278"},{"golden":false,"id":"38136040"},{"golden":false,"id":"34208206"},{"golden":true,"id":"34935050"},{"golden":false,"id":"32370834"},{"golden":false,"id":"31907027"},{"golden":false,"id":"32180754"},{"golden":false,"id":"35750497"},{"golden":false,"id":"16200013"},{"golden":true,"id":"16391455"},{"golden":false,"id":"23312663"},{"golden":false,"id":"11988886"},{"golden":false,"id":"19501336"},{"golden":false,"id":"29135566"},{"golden":false,"id":"1728044"},{"golden":false,"id":"24268104"},{"golden":false,"id":"15145637"},{"golden":false,"id":"7842496"},{"golden":false,"id":"38358616"},{"golden":false,"id":"38358471"},{"golden":false,"id":"38357607"},{"golden":false,"id":"38357606"},{"golden":false,"id":"38354671"},{"golden":false,"id":"38354212"},{"golden":false,"id":"38352408"},{"golden":false,"id":"38352331"},{"golden":false,"id":"38332959"},{"golden":false,"id":"38326877"},{"golden":false,"id":"38275437"},{"golden":false,"id":"38261236"},{"golden":false,"id":"38255343"},{"golden":false,"id":"38240784"},{"golden":false,"id":"38176223"},{"golden":true,"id":"8298785"},{"golden":true,"id":"23351389"},{"golden":true,"id":"28296863"},{"golden":false,"id":"9406213"},{"golden":true,"id":"10372781"},{"golden":false,"id":"30064396"},{"golden":false,"id":"2191597"},{"golden":false,"id":"22341675"},{"golden":false,"id":"22607263"},{"golden":false,"id":"29926474"},{"golden":false,"id":"20602795"},{"golden":true,"id":"36840731"},{"golden":true,"id":"34957954"},{"golden":false,"id":"33252102"},{"golden":false,"id":"36255304"},{"golden":false,"id":"26563961"},{"golden":false,"id":"33206382"},{"golden":false,"id":"35656779"},{"golden":true,"id":"35845965"},{"golden":false,"id":"32923208"},{"golden":false,"id":"28604158"},{"golden":false,"id":"33318421"},{"golden":false,"id":"28403842"},{"golden":false,"id":"27233796"},{"golden":false,"id":"27820729"},{"golden":false,"id":"20423208"},{"golden":false,"id":"37564370"},{"golden":false,"id":"17057763"},{"golden":false,"id":"33233328"},{"golden":false,"id":"14515935"},{"golden":false,"id":"38352143"},{"golden":false,"id":"38350039"},{"golden":false,"id":"38348363"},{"golden":false,"id":"38345838"},{"golden":false,"id":"31947043"},{"golden":false,"id":"36977609"},{"golden":false,"id":"31906902"},{"golden":false,"id":"37946348"},{"golden":false,"id":"36701840"},{"golden":true,"id":"34628741"},{"golden":false,"id":"36170100"},{"golden":false,"id":"33655652"},{"golden":false,"id":"33557483"},{"golden":false,"id":"36276852"},{"golden":false,"id":"38576742"},{"golden":false,"id":"33042660"},{"golden":false,"id":"23948689"},{"golden":false,"id":"19525491"},{"golden":false,"id":"39378294"},{"golden":true,"id":"36555936"},{"golden":false,"id":"38130572"},{"golden":false,"id":"12596478"},{"golden":false,"id":"21683532"},{"golden":false,"id":"16417071"},{"golden":true,"id":"14702678"},{"golden":false,"id":"13106711"},{"golden":false,"id":"9206600"},{"golden":false,"id":"31062563"},{"golden":false,"id":"30572548"},{"golden":false,"id":"25479779"},{"golden":false,"id":"26016360"},{"golden":false,"id":"15704868"},{"golden":false,"id":"15490113"},{"golden":false,"id":"38444901"},{"golden":false,"id":"38051892"},{"golden":false,"id":"11851730"},{"golden":false,"id":"34889241"},{"golden":false,"id":"25841769"},{"golden":true,"id":"33530188"},{"golden":false,"id":"30835352"},{"golden":false,"id":"20868878"},{"golden":false,"id":"27558377"},{"golden":false,"id":"29058562"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":293,"document":"11357236","golden":false,"offsetInEndSection":420,"text":"Placebo-controlled studies have shown the local and functional effectiveness of BTX-A for the treatment of dynamic pes equinus.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":868,"document":"32556354","golden":false,"offsetInEndSection":928,"text":"ificantly improved over time. In E1 both treatments resulted","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"11357236","golden":true,"offsetInEndSection":166,"text":"Intramuscular injections of botulinum toxin type A (BTX-A) have increasingly been used to reduce spasticity in specific muscle groups in children with cerebral palsy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":421,"document":"11357236","golden":false,"offsetInEndSection":540,"text":"Whether long-term treatment with BTX-A improves motor development and delays contractures is still under investigation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":191,"document":"11851730","golden":false,"offsetInEndSection":306,"text":"Botulinum toxin type A (BTX-A) is a relatively new method of spasticity management in children with cerebral palsy.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"11357236","golden":false,"offsetInEndSection":81,"text":"Botulinum toxin treatment in cerebral palsy: evidence for a new treatment option.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":507,"document":"11099623","golden":false,"offsetInEndSection":666,"text":"Both the temporal association and pathologic findings suggest that the hyperbaric treatment is likely to have been responsible for the resulting complications.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":415,"document":"11062623","golden":false,"offsetInEndSection":532,"text":"This article discusses cerebral palsy and a new treatment for spasticity, ITB, and the development of an ITB program.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":167,"document":"11357236","golden":false,"offsetInEndSection":292,"text":"Targets of therapeutic efforts are improvement of gross motor function, alleviation of pain or facilitation of hygienic care.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":631,"document":"24695413","golden":true,"offsetInEndSection":1076,"text":"Particularly, since the first published double-blind randomized placebo-controlled trial in a paradigm using allogeneic cord blood and erythropoietin to treat cerebral palsy under immunosuppression showed beneficial therapeutic effects in infantile cerebral palsy, long-held doubts about the efficacy of this new cell therapy are dispelled and a revision of therapeutic views upon an ailment, for which there is no cure at present, is warranted.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":929,"document":"32556354","golden":false,"offsetInEndSection":1139,"text":"in similar treatment success. In E2 fewer subjects treated with BTX-A injection reached the criteria of treatment success than did subjects treated with radial extracorporeal shock wave therapy, which was due t","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":893,"document":"32053326","golden":true,"offsetInEndSection":1115,"text":"Treatments for the movement disorders associated with cerebral palsy include intramuscular onabotulinumtoxinA, systemic and intrathecal muscle relaxants, selective dorsal rhizotomy, and physical and occupational therapies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":71,"document":"33215580","golden":false,"offsetInEndSection":126,"text":"cerebral palsy (CP), compared to children born at term.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":487,"document":"17984913","golden":false,"offsetInEndSection":661,"text":"Recently a new strategy - local injections of botulinum toxin type A (BTX-A) - has been introduced for the treatment of spasticity in cerebral palsy and post-stroke patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":542,"document":"30806105","golden":true,"offsetInEndSection":994,"text":"Therapies using social assistive robots can be alternative and complementary methods to promote the participation and motivation of children with cerebral palsy.Methods: The objective of this work is to validate the effectiveness of a 16-session physical therapy program to improve the participation and fulfillment of therapeutic objectives on an 8 year-old boy with dyskinetic cerebral palsy for motor learning to walk using a social assistive robot.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":650,"document":"24411151","golden":false,"offsetInEndSection":775,"text":"ed in this study. The HB was chosen as the treatment option for sleep bruxism in this case because the child did not accept a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1167,"document":"15736096","golden":true,"offsetInEndSection":1581,"text":"To date (maximum follow-up: 12 months), their clinical course has been satisfactory in most cases, with no severe complications related to the surgical technique, except in one individual who presented a fistula that resolved spontaneously.CONCLUSIONS: Intrathecal baclofen seems to be a very useful alternative in the treatment of spasticity to improve the quality of life of these patients and those around them.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":325,"document":"36999118","golden":false,"offsetInEndSection":655,"text":"In this study, muscle morphology was analyzed in biopsies taken from spastic upper extremity muscles of 8 cerebral palsy patients treated with BTX 5 months to 4 years prior sampling and was compared to muscles from 7 patients who had not ever received BTX treatment (overall 25 muscle biopsies obtained from 6 different muscles.).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":269,"document":"15736096","golden":false,"offsetInEndSection":690,"text":"The spasticity presented by these patients strongly influences their functioning and gives rise to several complications that affect their quality of life.AIMS AND DEVELOPMENT: The main aim of this study is to determine a set of suitable and effective therapeutic steps that can be used to improve patients\u0027 spasticity and to prevent the complications that stem from them, such as contractures, deformities, surgery, etc.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":774,"document":"36628177","golden":false,"offsetInEndSection":1210,"text":"Botulinum toxins when paired with physical exercises to treat hypertonia, a condition in which a little change in tone can affect a child\u0027s balance, strength and motor function, as well as secondary concerns such as malalignment and repair contractures.Conclusion: BoNT and physical exercises are two promising therapeutic techniques for treating children with CP that enable them for enhancing use and function of their afflicted limb.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34484101","golden":false,"offsetInEndSection":169,"text":"Objective: To test if botulinum toxin-A (BoNT-A) is effective in reducing chronic muscle-related pain in adults with spastic cerebral palsy (CP), as compared to placebo.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"15736096","golden":false,"offsetInEndSection":112,"text":"INTRODUCTION: Infantile cerebral palsy is considered to be a motor disorder affecting both posture and movement.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37877954","golden":false,"offsetInEndSection":164,"text":"OBJECTIVE: Lumbosacral selective dorsal rhizotomy is a neurosurgical treatment option to reduce spasticity in the lower extremities in children with cerebral palsy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1512,"document":"34484101","golden":false,"offsetInEndSection":1680,"text":"Conclusions: This study did not find evidence that BoNT-A was superior to placebo at the desired effect size (number needed to treat of 2.5) at 6 weeks after treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":819,"document":"15736096","golden":true,"offsetInEndSection":1040,"text":"At present there are two very promising therapeutic alternatives for patients with infantile cerebral palsy: Botulinum toxin, which we already have a great deal of experience with, and intrathecal treatment with baclofen.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":691,"document":"15736096","golden":false,"offsetInEndSection":818,"text":"Multiple treatments were used, including physiotherapy, rehabilitation and oral pharmacotherapy, with few satisfactory results.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":521,"document":"25788947","golden":false,"offsetInEndSection":606,"text":"These cases were administered autologous bone marrow mononuclear cells intrathecally.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1226,"document":"25788947","golden":true,"offsetInEndSection":1401,"text":"The results of this study demonstrate that cellular therapy may accelerate the development, reduce disability, and improve the quality of life of patients with cerebral palsy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34957963","golden":true,"offsetInEndSection":575,"text":"PURPOSE: The open-label phase 3 \"Treatment with IncobotulinumtoxinA in Movement Open-Label\" (TIMO) study investigated longer-term safety and efficacy of incobotulinumtoxin A in children/adolescents with cerebral palsy (CP).METHODS: Patients on standard treatment, with unilateral or bilateral lower limb (LL) or combined upper limb (UL)/LL spasticity received four incobotulinumtoxinA injection cycles (16 or 20 Units/kg bodyweight total [maximum 400 or 500 Units] per cycle depending on ambulatory status/clinical pattern treated), each followed by 12-16 weeks\u0027 observation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":939,"document":"25788947","golden":true,"offsetInEndSection":1104,"text":"On statistical analysis, a significant association was established between the symptomatic improvements and cell therapy in diplegic and quadriplegic cerebral palsy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":116,"document":"25788947","golden":true,"offsetInEndSection":214,"text":"Recently, cellular therapy is emerging as a potential novel treatment strategy for cerebral palsy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":535,"document":"27520277","golden":true,"offsetInEndSection":685,"text":"Several investigations in animal and human with CP have demonstrated positive potential of stem cell transplantation for the treatment of CP disorder.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1105,"document":"25788947","golden":false,"offsetInEndSection":1225,"text":"PET-CT scan done in 6 patients showed metabolic improvements in areas of the brain correlating to clinical improvements.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":349,"document":"25788947","golden":true,"offsetInEndSection":520,"text":"We conducted an open label, nonrandomized study on 40 cases of cerebral palsy with an aim of evaluating the benefit of cellular therapy in combination with rehabilitation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1181,"document":"38051892","golden":false,"offsetInEndSection":1448,"text":"Moreover, these genetic factors have been categorized based on the identified gene mutations in patients through clinical genotyping, including thrombosis, angiogenesis, mitochondrial and oxidative phosphorylation function, neuronal migration, and cellular autophagy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1223,"document":"34957963","golden":false,"offsetInEndSection":1403,"text":"No new/unexpected safety concerns were identified.CONCLUSION: IncobotulinumtoxinA showed a good safety and tolerability profile, with efficacy over multiple clinical presentations.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":732,"document":"34957963","golden":false,"offsetInEndSection":1167,"text":"The primary endpoint was safety; changes in Ashworth Scale and Gross Motor Function Measure-66 scores, and Global Impression of Change Scale scores at week 4 of each injection cycle were also evaluated.RESULTS: IncobotulinumtoxinA (?500 Units for ?98 weeks) was safe, well-tolerated, and effective across all endpoints for multipattern treatment of LL and combined LL/UL spasticity in ambulant/nonambulant children/adolescents with CP.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":844,"document":"37862777","golden":false,"offsetInEndSection":993,"text":"Both HPOT and SHPOT produced benefits in all of them.CONCLUSIONS: According to the studied variables both interventions produce similar improvements.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34957963","golden":false,"offsetInEndSection":157,"text":"Safety and efficacy of repeat long-term incobotulinumtoxinA treatment for lower limb or combined upper/lower limb spasticity in children with cerebral palsy.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34943284","golden":false,"offsetInEndSection":691,"text":"BACKGROUND: We aimed to review and analyse the effectiveness and safety of botulinum toxin type A (BoNT-A) injections for drooling in children with cerebral palsy.DATA SOURCES: We searched the EMBASE, MEDLINE, Cochrane Database of Systematic Reviews, and Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library) databases from inception to January 2020.METHODS: We included randomized controlled trials and observational studies which (1) involved children with cerebral palsy, (2) used BoNT-A for control of drooling, and (3) provided quantitative evaluations of drooling before and after intervention with BoNT-A.RESULTS: Twenty-one trials met the inclusion criteria.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1404,"document":"34957963","golden":false,"offsetInEndSection":1521,"text":"As an adjunct treatment, it offers an effective, individualized treatment option for pediatric CP-related spasticity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37862777","golden":true,"offsetInEndSection":181,"text":"INTRODUCTION AND OBJECTIVE: Hippotherapy (HPOT) and hippotherapy simulators (SHPOT) are used in children with cerebral palsy to achieve their maximum functionality and independence.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":576,"document":"34957963","golden":false,"offsetInEndSection":731,"text":"Treatment for pes equinus was mandatory; flexed knee or adducted thigh were options for unilateral treatment and/or ULs for unilateral/bilateral treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1168,"document":"34957963","golden":false,"offsetInEndSection":1222,"text":"Treatment effects increased with each injection cycle.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1320,"document":"35244504","golden":false,"offsetInEndSection":1850,"text":"Executive functions did not differ significantly between groups.CONCLUSION: CO-OP is more effective than ordinary treatment in achieving both trained and untrained goals.IMPLICATIONS FOR REHABILITATIONCO-OP enables children with CP (MACS levels I-III) or SB without intellectual disabilities to reach self-identified goals.CO-OP shows transfer effects to new activities and situations, which may enhance children\u0027s self-efficacy.CO-OP is an important complement to conventional rehabilitation services for children with CP and SB.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1091,"document":"36576161","golden":true,"offsetInEndSection":1484,"text":"Neonatal treatment with kaempferol increases gene expression of superoxide dismutase and catalase in the hippocampus of rats submitted to the cerebral palsy model.DISCUSSION: Kaempferol attenuates the impact of cerebral palsy on neuromotor behavior development, preventing altered hippocampal microglia activation and mitigating impaired cell proliferation in a neurogenic niche in these rats.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1074,"document":"37385449","golden":true,"offsetInEndSection":1215,"text":"The data demonstrated a promising effect of neonatal resveratrol treatment, improving postural and muscle deficits induced by cerebral palsy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":420,"document":"17505457","golden":false,"offsetInEndSection":622,"text":"The use of antimicrobial treatment of pregnant women with bacterial vaginosis, a complete course of antenatal steroids and magnesium sulphate are the most important strategies to prevent cerebral palsy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1001,"document":"34101010","golden":false,"offsetInEndSection":1422,"text":"Upon comparing the two treatment groups, adjusted mean Hb and SF changes in the Lf group were significantly higher than that of the IPC group (p \u003d0.001and p\u003d 0.033, respectively), and constipation was less likely to occur in the Lf group than the IPC group (p \u003d 0.049 ).Conclusion: Lactoferrin is effective and superior to IPC as an oral iron replacement therapy in children with CP and IDA, as it has fewer side effects.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":241,"document":"17505457","golden":false,"offsetInEndSection":329,"text":"An association between clinical chorioamnionitis and cerebral palsy has been recognised.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1017,"document":"33345534","golden":false,"offsetInEndSection":1271,"text":"Conclusion A new technique of FCU transfer to the radius showed to be an effective method to address pronation contracture of the forearm joints and can be used in combination with other elements of surgical intervention for elbow and thumb contractures.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23450428","golden":false,"offsetInEndSection":350,"text":"OBJECTIVE: The aim of this study was to assess gait in children with spastic diplegic cerebral palsy rehabilitated with the use of Lokomat active orthosis.DESIGN: A randomized controlled trial.SUBJECTS: Fifty-two children with spastic diplegic cerebral palsy.METHODS: Temporospatial parameters of gait and selected kinematic parameters were assessed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1288,"document":"34092664","golden":false,"offsetInEndSection":1599,"text":"Treatment was well-tolerated, with no unexpected treatment-related adverse events or neutralising antibody development.CONCLUSION: Children/adolescents with lower-limb spasticity experienced multipattern benefits from incobotulinumtoxinA, which was safe and well-tolerated in doses up to 16?U/kg, maximum 400?U.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":177,"document":"17505457","golden":false,"offsetInEndSection":240,"text":"CP represents the most common physical disability in childhood.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":330,"document":"17505457","golden":false,"offsetInEndSection":419,"text":"Very low-birthweight infants constitute more than 1/4 of all new cases of cerebral palsy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17505457","golden":false,"offsetInEndSection":176,"text":"Cerebral palsy (CP) is a complex disease characterized by the aberrant control of movement or posture that appears in early life and affect about 2 per 1000 live-born children.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"17505457","golden":false,"offsetInEndSection":40,"text":"Perinatal infections and cerebral palsy.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1041,"document":"20112480","golden":true,"offsetInEndSection":1287,"text":"+ M was better than that in Group Acup..CONCLUSION: The therapy of acupuncture plus music gained better therapeutic effect on cerebral palsy than simple acupuncture, which provided new thoughts for treating the disease by comprehensive therapies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1780,"document":"34101010","golden":false,"offsetInEndSection":1895,"text":"? Lf is effective and even better than IPC as a treatment of IDA in children with CP, as it has fewer side effects.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1652,"document":"34101010","golden":false,"offsetInEndSection":1779,"text":"? This trial compared the efficacy of Lf and iron hydroxide polymaltose complex (IPC) as treatments of IDA in children with CP.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":165,"document":"34101010","golden":false,"offsetInEndSection":310,"text":"This study aimed to compare the efficacy of Lf with that of iron hydroxide polymaltose complex (IPC) in the treatment of IDA in children with CP.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1532,"document":"26889193","golden":true,"offsetInEndSection":1715,"text":"These findings indicate that mPBMCs from cerebral palsy and cord blood mononuclear cells from healthy newborns have the potential to become seed cells for treatment of cerebral palsy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1533,"document":"34101010","golden":false,"offsetInEndSection":1638,"text":"? Studies on the efficacy of Lf in the treatment of IDA in children with cerebral palsy (CP) are limited.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34101010","golden":false,"offsetInEndSection":164,"text":"Iron deficiency anemia (IDA) is common among children with cerebral palsy (CP), and studies on the efficacy of lactoferrin (Lf) in the treatment of IDA are limited.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2230,"document":"32617202","golden":false,"offsetInEndSection":2450,"text":"These preliminary results suggest that spinal root stereotactic image-guided irradiation, a novel treatment option in the neurosurgical armamentarium, is a safe and effective procedure and deserves further investigation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1552,"document":"37823431","golden":false,"offsetInEndSection":1795,"text":"In four patients, FES therapy failed; in 12 patients FES therapy continued after the trial.INTERPRETATION: FES is not significantly worse than AFO; however, patient selection is critical, and a testing period and thorough follow-up are needed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":996,"document":"35731062","golden":false,"offsetInEndSection":1166,"text":"The PRS and GMFM in the trial group increased more significantly than those in the control group (p\u003c0.05).CONCLUSIONS: The BTX-A block showed a long-term positive effect.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35731062","golden":false,"offsetInEndSection":274,"text":"OBJECTIVE: To investigate the long-term effects of botulinum toxin-A (BTX-A) nerve block on relaxation of spasticity in cerebral palsy.PATIENTS AND METHODS: From June 2015 to December 2018, 52 children, aged 20-56 months, with spastic cerebral palsy were treated with BTX-A.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1234,"document":"32617202","golden":false,"offsetInEndSection":1344,"text":"Due to geographical and logistical issues, the patient declined the placement of an intrathecal baclofen pump.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1805,"document":"32617202","golden":false,"offsetInEndSection":1905,"text":"Resolution of spasticity and related pain in the right leg was found six months after the procedure.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1165,"document":"32617202","golden":false,"offsetInEndSection":1233,"text":"Response to medical therapy with baclofen and cannabinoids was poor.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1345,"document":"32617202","golden":false,"offsetInEndSection":1595,"text":"Considering the poor general condition of the patient and his decision to avoid invasive procedures, a novel treatment option was offered to provide relief from spasticity and pain: stereotactic image-guided irradiation delivered to the sensory root.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2052,"document":"32617202","golden":false,"offsetInEndSection":2229,"text":"So far, two additional patients underwent stereotactic dorsolateral spinal root irradiation (one delivered to a cervical, the other to a lumbar), with similar positive outcomes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32617202","golden":false,"offsetInEndSection":239,"text":"Selective dorsal rhizotomy is an established surgical treatment to improve the neurological and functional status of children with spastic cerebral palsy and adults with spasticity and pain caused by a variety of brain and spinal injuries.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34092664","golden":false,"offsetInEndSection":536,"text":"PURPOSE: Investigate the efficacy and safety of multipattern incobotulinumtoxinA injections in children/adolescents with lower-limb cerebral palsy (CP)-related spasticity.METHODS: Phase 3 double-blind study in children/adolescents (Gross Motor Function Classification System?- Expanded and Revised I-V) with unilateral or bilateral spastic CP and Ashworth Scale (AS) plantar flexor (PF) scores ? 2 randomized (1:1:2) to incobotulinumtoxinA (4, 12, 16?U/kg, maximum 100, 300, 400 U, respectively) for two 12- to 36-week injection cycles.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1284,"document":"37885221","golden":false,"offsetInEndSection":1587,"text":"However, there were no significant differences between both groups in Flanker incongruent reaction time and Stroop incongruent reaction time (p?\u003e?0.05).CONCLUSIONS: Aerobic exercise has a promising effect on inhibitory control of executive function in children with left-sided hemiplegic cerebral palsy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":300,"document":"2000440","golden":false,"offsetInEndSection":397,"text":"Research on functional arm movement using kinematic analysis is described for this patient group.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":883,"document":"30905979","golden":false,"offsetInEndSection":1068,"text":"Moderate evidence of effectiveness was found for constraint-induced movement therapy for upper limb recovery, goal-directed/functional training, and gait training to improve gait speed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":942,"document":"20116812","golden":false,"offsetInEndSection":1163,"text":" mutations in the COL4A1 gene.PERSPECTIVES: In adjunction with pharmacologic treatment (botulinium neurotoxin injection), new evidence-based rehabilitational interventions, such as constraint-induced movement therapy and ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":803,"document":"18617860","golden":true,"offsetInEndSection":1026,"text":"This preliminary study indicates that robotic therapy may be a useful clinical tool when combined with BTX-A injections for improving upper-limb coordination and quality of motor performance in children with cerebral palsy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":811,"document":"33633421","golden":false,"offsetInEndSection":1115,"text":"these and require further therapy. Injection therapy includes botulinum toxin A (BTA) injections and intrathecal baclofen. BTA injections were shown to control chronic pain effectively and are FDA approved for spastic pain; intra-thecal baclofen, in contrast, was only shown to improve comfort and qualit","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":818,"document":"8370782","golden":false,"offsetInEndSection":915,"text":"Botox may prove a useful adjuvant in conservative management of the spasticity of cerebral palsy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1069,"document":"30905979","golden":false,"offsetInEndSection":1178,"text":"Conflicting evidence was found for the role of exercises on strength training and cardiorespiratory training.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1485,"document":"30905979","golden":false,"offsetInEndSection":1695,"text":"On the basis of the present evidence, functional goal-oriented approaches are found to be effective and future research is required to determine the best ways to improve functional outcomes in children with CP.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":247,"document":"17324366","golden":false,"offsetInEndSection":419,"text":"Recent advances in basic and clinical neuroscience give hope that effective rehabilitation strategies, based on motor learning science, can be developed for these children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":433,"document":"31037074","golden":false,"offsetInEndSection":545,"text":"The potential and performance of currently available brain stimulation techniques have been mentioned in detail.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34682132","golden":false,"offsetInEndSection":131,"text":"BACKGROUND: There are different therapeutic strategies such as physiotherapy and music therapy for the treatment of cerebral palsy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":593,"document":"34682132","golden":false,"offsetInEndSection":844,"text":"Clinical trials that described the results obtained in terms of motor function through physiotherapy and music therapy were included.RESULTS: Eight clinical trials with 234 participants were considered with a significant improvement in motor function.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1046,"document":"34682132","golden":false,"offsetInEndSection":1347,"text":"However, high heterogeneity was identified in the meta-analysis due to the small number of studies included.CONCLUSIONS: The combination can be effective in subjects with cerebral palsy to improve motor function, although due to the diversity of studies analysed, it is complex to extrapolate results.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":448,"document":"35573442","golden":false,"offsetInEndSection":626,"text":"The rationale of the proposed study is to investigate the effect of VR and haptic feedback for improvement of upper extremity function of children with hemiplegic cerebral palsy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34935050","golden":true,"offsetInEndSection":489,"text":"OBJECTIVE: To explore patients\u0027 experiences of a self-administered electrotherapy treatment for muscle spasticity in cerebral palsy and stroke; the Exopulse Mollii Suit?.DESIGN: Qualitative design with an inductive approach Subjects: Fifteen patients with spasticity due to stroke or cerebral palsy, participating in a previous randomized controlled trial evaluating the treatment concept.METHODS: Information letters were sent to all potential participants (n?\u003d?27) in the previous study.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31907027","golden":false,"offsetInEndSection":127,"text":"BACKGROUND: Scalp acupuncture has been widely used as treatment for motor dysfunction in children with cerebral palsy in China.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1088,"document":"34208206","golden":false,"offsetInEndSection":1341,"text":"As a conclusion, we found that hippotherapy provides benefits at physical, psychological, cognitive and social levels in children with cerebral palsy, and thus it should be considered as a complementary rehabilitation therapy to conventional treatments.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":247,"document":"34682132","golden":false,"offsetInEndSection":592,"text":"Aims and scope: To summarize the effects of the treatment of cerebral palsy through the use of both for the improvement of motor function, analyse the challenges encountered, and submit proposals for improving them.METHODS: The systematic review was conducted following PRISMA guidelines and registered in the PROSPERO database (CRD42020162493).","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34682132","golden":false,"offsetInEndSection":143,"text":"Effects of the Combination of Music Therapy and Physiotherapy in the Improvement of Motor Function in Cerebral Palsy: A Challenge for Research.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1905,"document":"32180754","golden":false,"offsetInEndSection":2002,"text":"Tele-UPCAT demonstrated to be feasible as a home-based AOT for children and adolescents with UCP.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":600,"document":"16200013","golden":false,"offsetInEndSection":702,"text":"Botulinum toxin A therapy has been shown to relieve spasticity and improve function in the short term.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":353,"document":"16391455","golden":true,"offsetInEndSection":480,"text":"There is evidence to support the use and effectiveness of neuromuscular electrical stimulation in children with cerebral palsy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1139,"document":"23312663","golden":false,"offsetInEndSection":1203,"text":"Management of spasticity is beneficial and has an evidence base.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":684,"document":"11988886","golden":false,"offsetInEndSection":1660,"text":"inum toxin injections. The medical management of spasticity in cerebral palsy is based on: 1. Oral pharmacotherapy: (a) baclofen, binds GABAB receptors of spinal interneurons presynaptically, inhibits release of excitatory neurotransmitters in the spinal cord; (b) tizanidine, binds alfa 2 adrenergic receptors presinaptically, inhibits release of excitatory neurotransmitters in the spinal cord; (c) diacepam, augments GABA mediated inhibition in the spinal cord and supraspinally;(d) dantrolene, inhibits release of calcium from sarcoplasmic reticulum in muscle, weakens muscle contraction in response to myofiber excitation. 2. Chemical denervation: (a) phenol injection perineurally or into the motor point disrupts efferent signals from hyperexcitable anterior horn cells causing necrosis of axons or muscle; (b) botulinum toxin injection in selected muscles blocks the release of acetylcholine presynaptically and weakens the force of muscle contraction produced by hype","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1911,"document":"11988886","golden":false,"offsetInEndSection":2050,"text":"cerebral palsy to define its role. On the other hand, botulinum toxin A is effective, well tolerated, and safe in the treatment of spastici","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":481,"document":"16391455","golden":false,"offsetInEndSection":807,"text":"The effectiveness of many other interventions used in the treatment of cerebral palsy has not been clearly established based on well-controlled trials. These include: sensory integration, body-weight support treadmill training, conductive education, constraint-induced therapy, hyperbaric oxygen therapy, and the Vojta method.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":155,"document":"19501336","golden":false,"offsetInEndSection":396,"text":"The treatment program for a child with spasticity may include allied health therapy, exercise, casting, constraint-induced therapy, oral medications, chemodenervation, intrathecal baclofen, selective dorsal rhizotomy, and orthopedic surgery.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":170,"document":"29135566","golden":false,"offsetInEndSection":260,"text":"opedic procedures.RECENT FINDINGS: Serial casting potentiates the effect of Botulinum neur","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":476,"document":"1728044","golden":false,"offsetInEndSection":662,"text":"Intervention immediately following soft tissue surgery at the hips and knees and intervention at the time of cast removal for those children immobilized in a hip spica cast are reviewed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":782,"document":"24268104","golden":false,"offsetInEndSection":957,"text":"In the past few years, the cerebral palsy community has learned that the evidence of benefit for the numerous drugs, surgery, and therapies used over previous decades is weak.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38358616","golden":false,"offsetInEndSection":245,"text":"This protocol presents a comprehensive proposal for the establishment of the Saudi Cerebral Palsy Register (SCPR), a crucial project for investigating and addressing the prevalence, etiology, and management of cerebral palsy (CP) in Saudi Arabia","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"38358471","golden":false,"offsetInEndSection":89,"text":"Infantile spastic bilateral cerebral palsy (CP) is the most common form of CP","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38357607","golden":false,"offsetInEndSection":118,"text":"The Relationship between Structure of the Corticoreticular Tract and Walking Capacity in Children with Cerebral Palsy.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":12,"document":"38357606","golden":false,"offsetInEndSection":185,"text":"Since cerebral palsy (CP) is a corollary to brain damage, persistent treatment should accompany an alteration in brain functional activity in line with clinical improvements","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38354671","golden":false,"offsetInEndSection":161,"text":"Brain damage in children with unilateral cerebral palsy (UCP) affects motor function, with varying severity, making it difficult the performance of daily actions","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":388,"document":"38354212","golden":false,"offsetInEndSection":493,"text":"The cohort spans infantile cerebral paresis (CP) (n\u003d29), multiple sclerosis (MS) (n\u003d23) and stroke (n\u003d20)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38352408","golden":false,"offsetInEndSection":164,"text":"Preterm birth leading to cerebral palsy (CP) is the most common cause of childhood dystonia, a movement disorder that is debilitating and often treatment refractory","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38352331","golden":false,"offsetInEndSection":82,"text":"Physician Approaches to the Pharmacologic Treatment of Dystonia in Cerebral Palsy.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":786,"document":"38332959","golden":false,"offsetInEndSection":857,"text":"A total of 15 studies representing 719 pediatric patients were included","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":549,"document":"38326877","golden":false,"offsetInEndSection":747,"text":"Knowledge of the natural history of PPP2R5D related neurodevelopmental disorder will lead to improved standard of care treatments as well as serve as a baseline foundation for future clinical trials","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38275437","golden":false,"offsetInEndSection":175,"text":"The early intervention of motor training based on specific tasks and parent empowerment represents the new paradigm for the rehabilitation of children with Cerebral Palsy (CP)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1058,"document":"38261236","golden":false,"offsetInEndSection":1239,"text":"In the present review, we will focus on the therapeutic benefits of the MSC-based therapies in salient pediatric neurological disorders including cerebral palsy, stroke, and autism.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":243,"document":"38255343","golden":false,"offsetInEndSection":392,"text":"The prescription and treatment of lower leg orthoses for individuals with paralysis or muscle weakness, particularly cerebral palsy (CP), are complex","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2413,"document":"38240784","golden":false,"offsetInEndSection":2511,"text":"andard nCPAP group. One infant in the higher nCPAP group was excluded from the analysis because co","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":726,"document":"38176223","golden":false,"offsetInEndSection":812,"text":"Dystonia is a significant cause of disability with limited effective treatment options","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23351389","golden":false,"offsetInEndSection":182,"text":"BACKGROUND: Stem cell therapy is a promising treatment for cerebral palsy, which refers to a category of brain diseases that are associated with chronic motor disability in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30064396","golden":false,"offsetInEndSection":219,"text":"BACKGROUND: Upper limb (UL) deficits in children with unilateral cerebral palsy (uCP) have traditionally been targeted with motor execution treatment models, such as modified Constraint-Induced Movement Therapy (mCIMT).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1246,"document":"22607263","golden":false,"offsetInEndSection":1629,"text":"After discharge, the patient could walk more smoothly than he could before transplantation; furthermore, his vision significantly improved 6 months after transplantation, which was also supported by the electrophysiological examinations.CONCLUSIONS: The clinical application of BMSCs is effective for improving vision in a patient with cerebral palsy combined with visual impairment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"8298785","golden":true,"offsetInEndSection":177,"text":"Botulinum A chemodenervation of the Adductor Pollicis muscle for the treatment of the thumb-in-palm deformity in cerebral palsied hands is presented as a new therapeutic option.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":751,"document":"8298785","golden":false,"offsetInEndSection":842,"text":"The modality is shown to be simple, safe and effective over the period reported (229 days).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":523,"document":"8298785","golden":false,"offsetInEndSection":750,"text":"All cases are shown to improve in terms of both function and appearance with results approaching statistical significance (p \u003d 0.06) when assessed by the Wilcoxon\u0027s matched-pairs signed rank test, despite the small study group.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1692,"document":"23351389","golden":true,"offsetInEndSection":1938,"text":"All the 60 patients survived, and none of the patients experienced serious adverse events or complications.CONCLUSION: Our results indicated that NSC-like cells are safe and effective for the treatment of motor deficits related to cerebral palsy.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"8298785","golden":true,"offsetInEndSection":71,"text":"Botulinum A chemodenervation: a new modality in cerebral palsied hands.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":256,"document":"8298785","golden":false,"offsetInEndSection":522,"text":"children are assessed using a prospective nontrialist-biased study design based on an independent panel assessment of pre- and post-intervention photographic and videotaped records of hand function and appearance, in combination with grip dynamometry and goniometry.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":867,"document":"10372781","golden":true,"offsetInEndSection":1031,"text":"These results show that combining NMES and dynamic orthotic traction dramatically decreases spasticity of the upper extremity in young patients with cerebral palsy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":719,"document":"23351389","golden":true,"offsetInEndSection":1134,"text":"For the transplantation group, a total of 30 cerebral palsy patients received an autologous NSC-like cells transplantation (1-2 ? 107 cells into the subarachnoid cavity) and rehabilitation treatments whereas 30 patients in the control group only received rehabilitation treatment.RESULTS: We recorded the gross motor function measurement scores, language quotients, and adverse events up to 6 months post-treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":183,"document":"23351389","golden":true,"offsetInEndSection":718,"text":"Autologous MSCs may be a better cell source and have been studied for the treatment of cerebral palsy because of their functions in tissue repair and the regulation of immunological processes.METHODS: To assess neural stem cell-like (NSC-like) cells derived from autologous marrow mesenchymal stem cells as a novel treatment for patients with moderate-to-severe cerebral palsy, a total of 60 cerebral palsy patients were enrolled in this open-label, non-randomised, observer-blinded controlled clinical study with a 6-months follow-up.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1281,"document":"28296863","golden":true,"offsetInEndSection":1540,"text":"All the 10 patients survived and none of the patients experienced any serious adverse events or complications.CONCLUSION: Our results indicated that bone marrow derived MNCs are safe and effective for the treatment of motor deficits related to cerebral palsy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"20602795","golden":false,"offsetInEndSection":201,"text":"BACKGROUND: Use of Botulinum toxin-A (BoNT-A) for treatment of upper limb spasticity in children with cerebral palsy has become routine clinical practice in many paediatric treatment centres worldwide.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1420,"document":"23351389","golden":false,"offsetInEndSection":1521,"text":"The increase in the Gross Motor Function Measurement scores in the control group was not significant.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36840731","golden":true,"offsetInEndSection":137,"text":"OBJECTIVE: Intrathecal baclofen (ITB) therapy is an effective treatment for spasticity and dystonia in children with cerebral palsy (CP).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":463,"document":"36840731","golden":false,"offsetInEndSection":857,"text":"The authors describe the first multicenter quality improvement (QI)-driven standardized protocol for ITB pump surgery in children with CP across the Cerebral Palsy Research Network (CPRN), implemented with the aim of reducing ITB-associated SSI.METHODS: SSI was defined as a culture-positive infection, ITB pump system removal for suspected infection, or wound dehiscence with exposed hardware.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34957954","golden":true,"offsetInEndSection":601,"text":"BACKGROUND: Spasticity is common in cerebral palsy and can result in pain and diminished health-related quality of life.OBJECTIVE: To evaluate the safety and efficacy of onabotulinumtoxinA for lower limb spasticity treatment in children with cerebral palsy.METHODS: In this registrational phase 3, multinational, randomized, double-blind, placebo-controlled trial (NCT01603628), children (2-\u003c?17 years) with cerebral palsy and ankle spasticity (Modified Ashworth Scale-Bohannon [MAS] score?2) were randomized 1?:?1?:?1 to standardized physical therapy and onabotulinumtoxinA (4 or 8?U/kg), or placebo.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1974,"document":"36840731","golden":false,"offsetInEndSection":2253,"text":"The mean documented compliance rate with protocol steps was 75%, and the 90-day infection rate was 4.4%, with an average of 42 days from index surgery to infection.CONCLUSIONS: This is the first multicenter QI initiative designed to reduce SSI in ITB surgery in children with CP.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1049,"document":"35845965","golden":true,"offsetInEndSection":1617,"text":"The results of meta-analysis showed that there were significant differences in the improvement of lower limb muscle tension, comprehensive spasm scale score, EMG score, and passive range of motion of ankle joint between biofeedback therapy and routine rehabilitation therapy.Conclusion: Biofeedback therapy can improve lower limb muscle tension, spasticity, EMG integral value, and passive range of motion of ankle joint in children with cerebral palsy and provide better conditions for improving the motor ability of lower extremities in children with cerebral palsy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1211,"document":"34957954","golden":true,"offsetInEndSection":1413,"text":"Most adverse events were mild or moderate.CONCLUSIONS: OnabotulinumtoxinA was well tolerated and effective in reducing lower limb spasticity and improving functional outcomes versus placebo in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1559,"document":"36840731","golden":false,"offsetInEndSection":1870,"text":"Patient characteristics were collected from the CPRN Research Electronic Data Capture registry, including age at surgery, BMI, Gross Motor Function Classification System level, and pattern of spasticity.RESULTS: The aggregated preintervention 90-day ITB SSI rate was 4.9% (223 procedures) between 2014 and 2017.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1269,"document":"35656779","golden":false,"offsetInEndSection":1701,"text":"No evidence for the improvement in quality of life could be shown in the global assessment, nor in any subscore.CONCLUSIONS: Equine-assisted therapy, particularly hippotherapy, can be a therapeutic tool for children who are learning to walk.LIMITATION: The heterogeneity of tools used in different studies and the low number of studies addressing quality of life issues limited the number of studies available for distinct analyses.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":808,"document":"33252102","golden":false,"offsetInEndSection":1482,"text":"Unilateral upper-limb function, bimanual hand function, and real-time arm-hand function were assessed using Melbourne Assessment (MA), Assisting Hand Assessment (AHA), and Pediatric Motor Activity Log (PMAL) scales respectively pre-treatment, post-treatment, and at 6 months follow-up.RESULTS: Post-treatment, group III achieved greater improvement in MA, AHA, and PMAL compared to other groups (all P?\u003c?0.05), and the difference remained in favor of group III at the follow-up (all P?\u003c?0.05).CONCLUSIONS: This study suggests that BoNT-A and rNMES combined are more effective than either of them alone to enhance upper-extremity function in children with spastic hemiplegia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28296863","golden":false,"offsetInEndSection":182,"text":"BACKGROUND: Stem cell therapy is a promising treatment for cerebral palsy, which refers to a category of brain diseases that are associated with chronic motor disability in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":843,"document":"8298785","golden":false,"offsetInEndSection":991,"text":"The benefit is sustained beyond the period of muscle paresis and ongoing long term follow-up will document the need for, and timing of, reinjection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":680,"document":"2191597","golden":false,"offsetInEndSection":733,"text":"The results indicated positive gains after rhizotomy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":528,"document":"38352143","golden":false,"offsetInEndSection":640,"text":"Within a European multicenter observational study, 357 young adults with cerebral palsy aged 19-28 were included","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1542,"document":"38350039","golden":false,"offsetInEndSection":1694,"text":"Plain-Language Summary: This systematic review explains how virtual reality (VR) has been used as an intervention with children with cerebral palsy (CP)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"38348363","golden":false,"offsetInEndSection":145,"text":"The flexor pronator slide is an effective treatment option for ischemic contracture and contracture related to spastic cerebral palsy","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":928,"document":"38345838","golden":false,"offsetInEndSection":1128,"text":"The study enrolled 19 ambulatory youth: 9 (47%) with cerebral palsy with various mobility disabilities from a children\u0027s hospital and 10 (53%) without disabilities from a university student population","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1177,"document":"31947043","golden":false,"offsetInEndSection":1351,"text":"These findings suggest that AlterG training can be considered as an effective approach for improving walking ability and gait characteristics in children with cerebral palsy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36977609","golden":false,"offsetInEndSection":418,"text":"AIM: We aimed to determine if there was a significant difference in the functional performance of family requested daily tasks by a heterogeneous group of children with cerebral palsy following a programme of neuro-developmental treatment and in comparison to a randomly control group.BACKGROUND: There are considerable challenges in conducting research into the functional performance of children with cerebral palsy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1402,"document":"37946348","golden":false,"offsetInEndSection":1710,"text":"At 4 years old, he started L-dopa/carbidopa, oxitriptan, and a phenylalanine-restrictive diet with moderate clinical improvement.CONCLUSION: When the diagnosis of \"cerebral palsy\" is questionable, other etiologies should be investigated, particularly disorders that have specific disease-modifying treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1964,"document":"34628741","golden":true,"offsetInEndSection":2366,"text":"Compared with the cerebral palsy group, the serum L-histidine was decreased, and L-citrulline showed decreasing trend in the acupuncture and rehabilitation group after treatment.CONCLUSION: Acupuncture combined with rehabilitation training could improve cognitive function in children with cerebral palsy, and the effect may be related to the down-regulation of L-histidine and L-citrulline metabolism.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1093,"document":"31906902","golden":false,"offsetInEndSection":1589,"text":"In this highly treated population, the average 66 item Gross Motor Function Measure score for the 22 children in level II was 72.55, which is consistent with the mean of 68.5 reported in the original Ontario cohort.CONCLUSION: This cohort study has confirmed that children with Cerebral Palsy, Gross Motor Function level II treated at a young age with repeated doses of Botulinum Toxin A within an integrated comprehensive service, maintain or improve their functional motor level at a later age.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":319,"document":"31947043","golden":false,"offsetInEndSection":459,"text":"Thus, we aimed to investigate the effects of antigravity treadmill training (AlterG) on gait characteristic in children with cerebral palsy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":688,"document":"31947043","golden":false,"offsetInEndSection":800,"text":"All subjects in both AlterG and control groups were evaluated at the gait lab before and after 8 weeks training.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":896,"document":"31947043","golden":false,"offsetInEndSection":1176,"text":"We also evaluated the popular clinical gait measures including walking speed and endurance, and mobility and balance.Our results demonstrated that spatiotemporal, dynamic balance and clinical features all improved more after 8 weeks AlterG training rather than control group ones.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":222,"document":"31947043","golden":false,"offsetInEndSection":318,"text":"Recently an antigravity treadmill has been found to be beneficial as a new therapeutic approach.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1024,"document":"36977609","golden":false,"offsetInEndSection":1754,"text":"Videos were recorded and rated by expert clinicians blind to experimental condition.RESULTS: After the first round of target intervention and alternate treatment had been completed, a significant difference in the goal attainment was noted between the control group and the treatment group at the post test, indicating that intervention was associated with a higher level of goal attainment than that attained by the control group (p?\u003d?0.0321) with a large effect size.CONCLUSIONS: The study provided evidence of an effective way to investigate and to enhance the available motor capacity of children with moderate to severe cerebral palsy during participation in requested daily task performance, as reflected in goal attainment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1906,"document":"38576742","golden":false,"offsetInEndSection":2129,"text":"Finally, there was no significant change in cognitive functions (P \u003e 0.05).CONCLUSION: In light of our findings, we believe that UC-MSC therapy has a positive effect on spasticity, and it partially improves motor functions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":616,"document":"38576742","golden":false,"offsetInEndSection":943,"text":"Despite being a promising tool and offering a wide array of possibilities, mesenchymal stem cells (MSCs) still need to be investigated for their efficacy and safety.AIM: To analyze the efficacy and safety of MSCT in CP patients.METHODS: Our sample consists of four CP patients who cannot stand or walk without external support.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1337,"document":"38576742","golden":false,"offsetInEndSection":1499,"text":"We utilized the Modified Ashworth Scale (MAS) to measure spasticity.RESULTS: We found significant improvements in MAS scores after the intervention on both sides.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38576742","golden":false,"offsetInEndSection":104,"text":"BACKGROUND: Cerebral palsy (CP) describes a group of disorders affecting movement, balance, and posture.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38576742","golden":false,"offsetInEndSection":87,"text":"Allogeneic mesenchymal stem cells may be a viable treatment modality in cerebral palsy.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1701,"document":"38576742","golden":false,"offsetInEndSection":1800,"text":"However, there was no significant difference in motor functions based on WeeFIM results (P \u003e 0.05).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1801,"document":"38576742","golden":false,"offsetInEndSection":1905,"text":"GMFCS and MACS scores differed significantly at 12 months after the intervention (P \u003d 0.046, P \u003d 0.046).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":944,"document":"38576742","golden":false,"offsetInEndSection":1105,"text":"All of these cases received allogeneic MSCT six times as 1 ? 106/kg intrathecally, intravenously, and intramuscularly using umbilical cord-derived MSCs (UC-MSC).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":275,"document":"38576742","golden":false,"offsetInEndSection":429,"text":"Currently, treatment involves various pharmacotherapies for different types of CP, including antiepileptics for epilepsy and Botox A for focal spasticity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36555936","golden":true,"offsetInEndSection":148,"text":"Cell therapies are an emergent treatment for cerebral palsy (CP) with promising evidence demonstrating efficacy for improving gross motor function.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1796,"document":"39378294","golden":false,"offsetInEndSection":1993,"text":"oach addressing CP\u0027s heterogeneity is essential. Future research should emphasize in-depth evaluations of the efficacy and safety of therapeutic agents, particularly in pediatric populations, to de","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":456,"document":"19525491","golden":false,"offsetInEndSection":588,"text":"n this article, we discuss the scientific evidence for various physical therapy treatment options for children with cerebral palsy. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38130572","golden":false,"offsetInEndSection":79,"text":"Cerebral palsy (CP) is one of the most common disorders in pediatric patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":666,"document":"23948689","golden":false,"offsetInEndSection":834,"text":"It investigates the most relevant and promising coadministered therapies, including rehabilitation, drug targeting, magnetic stimulation, and bioengineering approaches.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":789,"document":"12596478","golden":false,"offsetInEndSection":991,"text":"We have found that a common structured and standardized follow-up programme with early intervention against muscle hypertonia and imbalance can prevent hip luxation and contractures in children with CP.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":539,"document":"21683532","golden":false,"offsetInEndSection":686,"text":"Encouraging evidence of motor improvements in stroke patients treated with SSRIs suggest the possibility of similar improvements in cerebral palsy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31062563","golden":false,"offsetInEndSection":164,"text":"BACKGROUND: For more than 20 years, intramuscular injections of botulinum toxin A have been an established treatment for spasticity in children with cerebral palsy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1064,"document":"16417071","golden":false,"offsetInEndSection":1188,"text":"Many of the historical treatments for this ailment are being challenged, and several new treatment modalities are available.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":444,"document":"16417071","golden":false,"offsetInEndSection":588,"text":"Multispecialty treatment teams should be developed around the needs of each patient to provide continuously updated global treatment care plans.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":589,"document":"16417071","golden":false,"offsetInEndSection":869,"text":"Complications of cerebral palsy include spasticity and contractures; feeding difficulties; drooling; communication difficulties; osteopenia; osteoporosis; fractures; pain; and functional gastrointestinal abnormalities contributing to bowel obstruction, vomiting, and constipation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":119,"document":"14702678","golden":false,"offsetInEndSection":258,"text":"The aim of this paper is to present the result of intrathecal baclofen infusion in treatment of spasticity in patients with cerebral palsy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1189,"document":"16417071","golden":false,"offsetInEndSection":1366,"text":"Adult morbidity and mortality from ischemic heart disease, cerebrovascular disease, cancer, and trauma are higher in patients with cerebral palsy than in the general population.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":428,"document":"14702678","golden":true,"offsetInEndSection":539,"text":"Early results of spasticity treatment in cerebral palsy with intrathecal baclofen infusions are very promising.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":870,"document":"16417071","golden":false,"offsetInEndSection":1063,"text":"Valid and reliable assessment tools to establish baseline functions and monitor developmental gains have contributed to an increasing body of evidenced-based recommendations for cerebral palsy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":354,"document":"16417071","golden":false,"offsetInEndSection":443,"text":"The goals of treatment are to improve functionality and capabilities toward independence.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1128,"document":"31062563","golden":false,"offsetInEndSection":1367,"text":"Five centres reported to have written guidelines for the treatment indication.INTERPRETATION: The proportion of children with cerebral palsy who are treated with botulinum toxin A varies considerably between Norwegian habilitation centres.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38051892","golden":false,"offsetInEndSection":800,"text":"ABSTRACT: Cerebral palsy is a diagnostic term utilized to describe a group of permanent disorders affecting movement and posture. Patients with cerebral palsy are often only capable of limited activity, resulting from non-progressive disturbances in the fetal or neonatal brain. These disturbances severely impact the child\u0027s daily life and impose a substantial economic burden on the family. Although cerebral palsy encompasses various brain injuries leading to similar clinical outcomes, the understanding of its etiological pathways remains incomplete owing to its complexity and heterogeneity. This review aims to summarize the current knowledge on the genetic factors influencing cerebral palsy development. It is now widely acknowledged that genetic mutations and alterations play a pivotal rol","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38576742","golden":false,"offsetInEndSection":800,"text":"BACKGROUND: Cerebral palsy (CP) describes a group of disorders affecting movement, balance, and posture. Disturbances in motor functions constitute the main body of CP symptoms. These symptoms surface in early childhood and patients are affected for the rest of their lives. Currently, treatment involves various pharmacotherapies for different types of CP, including antiepileptics for epilepsy and Botox A for focal spasticity. However, none of these methods can provide full symptom relief. This has prompted researchers to look for new treatment modalities, one of which is mesenchymal stem cell therapy (MSCT). Despite being a promising tool and offering a wide array of possibilities, mesenchymal stem cells (MSCs) still need to be investigated for their efficacy and safety.AIM: To analyze the","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38444901","golden":false,"offsetInEndSection":800,"text":"Purpose: Surgical treatments such as tendon transfers and muscle lengthening play a significant role in cerebral palsy management,but timing of upper extremity cerebral palsy surgery remains controversial. This study systematically reviews the current literature and investigates the correlation between age at surgery and follow-up time with surgical outcomes in pediatric upper extremity cerebral palsy patients.Methods: A comprehensive search of PubMed, Cochrane, Web of Science, and CINAHL databases was performed from inception to July 2020 and articles were screened using PRISMA guidelines to include full-text, English papers. Data analysis was performed using itemized data points for age at surgery, follow-up length, and surgery outcomes, reported as changes in active forearm and wrist mo","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"11851730","golden":false,"offsetInEndSection":190,"text":"Management of children with cerebral palsy (CP) is the focus of considerable resources in many countries, so that evaluation of the efficacy for new and established treatments is imperative.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":300,"document":"34889241","golden":false,"offsetInEndSection":433,"text":"alth issue. In recent years, hydrotherapy, and transcranial direct current stimulation (tDCS) as a physical therapy for CP is develop","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":133,"document":"25841769","golden":false,"offsetInEndSection":286,"text":"The development of new treatments of CP-affected limbs, utilizing the brain\u0027s inherent neuroplasticity, remains an area of promising and active research.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":386,"document":"33530188","golden":true,"offsetInEndSection":591,"text":" be proven. This research will systematically evaluate the clinical effectiveness and safety of acupuncture and moxibustion in the treatment of children with cerebral palsy, and provide evidence-based evid","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":587,"document":"30835352","golden":false,"offsetInEndSection":702,"text":"es for CP were identified.CONCLUSION: The molecular mechanism of CP has been explored, which may provide clues for ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"20868878","golden":false,"offsetInEndSection":263,"text":"Because of increasing interest in conducting large-scale, multicenter investigations into the epidemiology of cerebral palsy and its prevention and treatment, efforts have been made to establish a standard definition and classification systems for cerebral palsy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27558377","golden":false,"offsetInEndSection":168,"text":"Cerebral palsy (CP) is heterogeneous in etiology and manifestations, making research into relevant therapies difficult and limiting the generalizability of the results.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":297,"document":"29058562","golden":false,"offsetInEndSection":433,"text":"Therefore, the present study investigated whether nutritional manipulation reversed or minimized the chewing sequelae in cerebral palsy.","beginSection":"abstract"}],"exact_answer":[["Stem cell therapy Mesenchymal stem cells (MSCs) Allogeneic mesenchymal stem cells NSC-like cells Bone marrow derived mononuclear cells (MNCs) Botulinum toxin type A (BTX-A) Intrathecal Baclofen Therapy (ITB) Selective Serotonin Reuptake Inhibitors (SSRIs) Intrathecal baclofen infusion Advancements in genetic research for precision medicine. Mesenchymal stem cell therapy (MSCT) using umbilical cord-derived MSCs. Surgical interventions such as tendon transfers and muscle lengthening."]],"ideal_answer":["New treatments investigated for cerebral palsy include stem cell therapy, which shows promise in treating motor disabilities. Bone marrow derived mononuclear cells (MNCs) have been shown to be safe and effective for motor deficits. Botulinum toxin type A (BTX-A) is being used for spasticity management in children, while Intrathecal Baclofen Therapy (ITB) is also being developed. Additionally, there is encouraging evidence that Selective Serotonin Reuptake Inhibitors (SSRIs) might improve motor function in patients with cerebral palsy."],"id":"6593e5c206a2ea257c000020","type":"list","body":"Which new treatments are investigated for cerebral palsy?"},{"documents":[{"golden":true,"id":"31689710"},{"golden":true,"id":"33851423"},{"golden":false,"id":"11172416"},{"golden":false,"id":"37762476"},{"golden":false,"id":"30174784"},{"golden":false,"id":"34970577"},{"golden":false,"id":"36466921"},{"golden":false,"id":"36304450"},{"golden":false,"id":"37839325"},{"golden":false,"id":"35964875"},{"golden":false,"id":"39381218"},{"golden":true,"id":"39498415"},{"golden":false,"id":"36980160"},{"golden":false,"id":"38409213"},{"golden":false,"id":"30190719"},{"golden":true,"id":"35762435"},{"golden":false,"id":"33900849"},{"golden":false,"id":"36115679"},{"golden":true,"id":"37010923"},{"golden":true,"id":"38769383"},{"golden":false,"id":"30976008"},{"golden":false,"id":"25120092"},{"golden":false,"id":"25360828"},{"golden":true,"id":"38561095"},{"golden":true,"id":"20528471"},{"golden":true,"id":"33670629"},{"golden":true,"id":"14692610"},{"golden":false,"id":"11172429"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":734,"document":"31689710","golden":false,"offsetInEndSection":989,"text":"Moreover, metabolites, such as acetyl-coenzyme A (acetyl-CoA) and succinate have immunoregulatory properties and serve as cofactors for enzymes involved in epigenetic reprogramming or \"training\" of innate immune cells after an initial infectious exposure.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1067,"document":"33851423","golden":false,"offsetInEndSection":1230,"text":"We also found signs of increased oxidative stress and fatty acid oxidation in sepsis cases.CONCLUSION: We found signs of metabolomic signatures in neonatal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2115,"document":"11172416","golden":false,"offsetInEndSection":2383,"text":"Study E: exogenous glutathione reversed the inhibitory effect of H(2)O(2) on hepatocyte O(2) consumption.CONCLUSIONS: This study found that glutamine and its dipeptides are unique in reversing the effects of septic mediators on neonatal rat liver oxidative metabolism.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1740,"document":"35964875","golden":false,"offsetInEndSection":2106,"text":"Intracellular pyruvate (but not ?-ketoglutarate) concentrations positively correlated with IL-1? and IL-10 levels released by patients\u0027 (but not control) monocytes upon exposure to LPS.CONCLUSION: These results suggest that elevated intracellular pyruvate levels may partially maintain cytokine production capacity of hyporesponsive monocytes from patients with CAP.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1233,"document":"31689710","golden":false,"offsetInEndSection":1358,"text":"Characterizing the ontogeny of immunometabolism will offer new opportunities to prevent, diagnose, and treat neonatal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":990,"document":"31689710","golden":false,"offsetInEndSection":1232,"text":"Highly sensitive metabolomic approaches allow us to define alterations in metabolic signatures as they change during ontogeny and as perturbed by immunization or infection, thereby linking metabolic pathways to immune cell effector functions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":365,"document":"31689710","golden":false,"offsetInEndSection":521,"text":"Neonatal susceptibility to infection is increased due to a functionally distinct immune response characterized by high reliance on innate immune mechanisms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":182,"document":"31689710","golden":false,"offsetInEndSection":364,"text":"It is increasingly appreciated that metabolic pathways are not only crucial for nutrition but also play important roles in regulating inflammation and the host response to infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1296,"document":"37762476","golden":false,"offsetInEndSection":1492,"text":"We will exhibit pathways involving glycolysis, the tricarboxylic acid (TCA) cycle and oxidative phosphorylation and their role in shaping neonates\u0027 immune systems to a favorable tolerogenic state.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":606,"document":"37839325","golden":false,"offsetInEndSection":836,"text":"Seventy-three metabolites involved in various metabolic pathways such as glycolysis, tricarboxylic acid (TCA) cycle, nucleoside metabolism, lipid metabolism, oxidative stress and ionic homeostasis demonstrated significant changes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1565,"document":"36466921","golden":false,"offsetInEndSection":1681,"text":"These data indicate that glucose metabolism supports leukocyte functions even in a condition of endotoxin tolerance.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2590,"document":"39498415","golden":false,"offsetInEndSection":2765,"text":" for all four metabolites. Pathway analysis indicated that phenylalanine, tyrosine, and tryptophan biosynthesis, phenylalanine metabolism, and porphyrin metabolism play import","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":190,"document":"38769383","golden":false,"offsetInEndSection":357,"text":"iomarkers in human neonatal sepsis have been repeatedly identified as associated with dysregulation of angiopoietin signaling and altered arachidonic acid metabolism. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":346,"document":"36980160","golden":false,"offsetInEndSection":485,"text":"oreover, we address the impact that all the mechanisms triggered by sepsis have on the dysbiosis and the changes on neonatal microbiota.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":409,"document":"38409213","golden":false,"offsetInEndSection":678,"text":"lycine, serine, and threonine metabolism; glyoxylate and dicarboxylic acid metabolism; glutathione metabolism; primary bile acid biosynthesis; steroid synthesis; pentose and glucuronic acid interconversion may be involved in the pathogenesis of LOS in preterm infants. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1427,"document":"30190719","golden":false,"offsetInEndSection":1551,"text":"his understanding of sepsis pathology helps to explain many of the differences between neonatal and adult immune responses. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1324,"document":"35762435","golden":false,"offsetInEndSection":1711,"text":"The differentially expressed serum metabolites between days 1 and 7 after admission were mainly involved in ascorbic acid metabolism.CONCLUSIONS: The metabolic mechanism of serum metabolites varies at different stages in neonates with sepsis and is mainly associated with terpenoid skeleton biosynthesis, pyruvate metabolism, cysteine/methionine metabolism, and ascorbic acid metabolism.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":974,"document":"30976008","golden":false,"offsetInEndSection":1073,"text":"Thus, a metabolic alteration is apparent in CBM?, which might be dependent on S100A8/A9 expression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":509,"document":"30976008","golden":false,"offsetInEndSection":704,"text":"In particular, IFN-? as well as IL-10-activated CBM? completely fail to increase glycolysis and furthermore show reduced activation of the mTOR pathway, which is important for survival in sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":388,"document":"30976008","golden":false,"offsetInEndSection":508,"text":"CBM? show reduced expression of phagocytosis receptors and cytokine expression in addition to altered energy metabolism.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":782,"document":"30976008","golden":false,"offsetInEndSection":973,"text":"Finally, incubation of PBM? with cord blood serum or S100A8/A9, which is highly expressed in neonates, suppresses mTOR activation, prevents glycolysis and the expression of an PBM? phenotype.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":705,"document":"30976008","golden":false,"offsetInEndSection":781,"text":"MTOR inhibition by rapamycin equalizes cytokine production in CBM? and PBM?.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":74,"document":"25120092","golden":false,"offsetInEndSection":368,"text":"Here, a system-level investigation of neonatal systemic responses to infection shows a surprisingly strong but unbalanced homeostatic immune response; developing an elevated set-point of myeloid regulatory signalling and sugar-lipid metabolism with concomitant inhibition of lymphoid responses.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1151,"document":"33670629","golden":true,"offsetInEndSection":1382,"text":"In conclusion, neonates with EOS had a metabolic profile at birth that clearly distinguished them from those without sepsis, and metabolites of glutathione and tryptophan pathways are promising as new biomarkers of neonatal sepsis.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"30976008","golden":false,"offsetInEndSection":123,"text":"Impaired cellular energy metabolism in cord blood macrophages contributes to abortive response toward inflammatory threats.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":645,"document":"35762435","golden":false,"offsetInEndSection":1058,"text":"Ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry was used for the metabonomic analysis of serum samples to investigate the change in metabolomics in neonates with sepsis at different time points.RESULTS: On day 1 after admission, the differentially expressed serum metabolites between the sepsis and control groups were mainly involved in the biosynthesis of terpenoid skeleton.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33900849","golden":false,"offsetInEndSection":800,"text":"Prematurity is the leading cause of neonatal morbidity and mortality worldwide. Premature infants often require extended hospital stays, with increased risk of developing infection compared with term infants. A picture is emerging of wide-ranging deleterious consequences resulting from innate immune system activation in the newborn infant. Those who survive infection have been exposed to a stimulus that can impose long-lasting alterations into later life. In this review, we discuss sepsis-driven alterations in integrated neuroendocrine and metabolic pathways and highlight current knowledge gaps in respect of neonatal sepsis. We review established biomarkers for sepsis and extend the discussion to examine emerging findings from human and animal models of neonatal sepsis that propose novel b","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35762435","golden":false,"offsetInEndSection":800,"text":"OBJECTIVES: To study the metabolic mechanism of neonatal sepsis at different stages by analyzing the metabolic pathways involving the serum metabolites with significant differences in neonates with sepsis at different time points after admission.METHODS: A total of 20 neonates with sepsis who were hospitalized in the Department of Neonatology, Hunan Provincial People\u0027s Hospital, from January 1, 2019 to January 1, 2020 were enrolled as the sepsis group. Venous blood samples were collected on days 1, 4, and 7 after admission. Ten healthy neonates who underwent physical examination during the same period were enrolled as the control group. Ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry was used for the metabonomic analysis of serum samples to investigate t","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35762435","golden":false,"offsetInEndSection":234,"text":"OBJECTIVES: To study the metabolic mechanism of neonatal sepsis at different stages by analyzing the metabolic pathways involving the serum metabolites with significant differences in neonates with sepsis at different time points afte","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":460,"document":"33900849","golden":false,"offsetInEndSection":632,"text":"In this review, we discuss sepsis-driven alterations in integrated neuroendocrine and metabolic pathways and highlight current knowledge gaps in respect of neonatal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":189,"document":"38769383","golden":true,"offsetInEndSection":356,"text":"Biomarkers in human neonatal sepsis have been repeatedly identified as associated with dysregulation of angiopoietin signaling and altered arachidonic acid metabolism.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"14692610","golden":false,"offsetInEndSection":173,"text":"Neonatal sepsis is an important cause of morbidity and mortality as a result of multiple organ system failure, particularly in neonates requiring total parenteral nutrition.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"11172429","golden":false,"offsetInEndSection":163,"text":"BACKGROUND/PURPOSE: Lipopolysaccharide (LPS) and cytokines produced during neonatal sepsis trigger free radical production, which eventually results in inhibition ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1126,"document":"33851423","golden":false,"offsetInEndSection":1186,"text":" acid oxidation in sepsis cases.CONCLUSION: We found signs o","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":76,"document":"38561095","golden":false,"offsetInEndSection":170,"text":"Several brainstem-regulated physiological processes undergo disruption during neonatal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":304,"document":"36115679","golden":false,"offsetInEndSection":459,"text":"otic overuse. We have previously identified an immune-metabolic biomarker network comprising three pathways with a \u003e99% accuracy for detecting bacterial ne","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37010923","golden":false,"offsetInEndSection":455,"text":"INTRODUCTION: Diagnosing neonatal sepsis is heavily dependent on clinical phenotyping as culture-positive body fluid has poor sensitivity, and existing blood biomarkers have poor specificity.A combination of machine learning, statistical and deep pathway biology analyses led to the identification of a tripartite panel of biologically connected immune and metabolic markers that showed greater than 99% accuracy for detecting bacterial infection with 100","beginSection":"abstract"}],"exact_answer":[],"ideal_answer":[],"id":"677ed79d592fa4887300002a","type":"list","body":"Which metabolic pathways are related with neonatal sepsis?"},{"documents":[{"golden":true,"id":"22097186"},{"golden":true,"id":"15674131"},{"golden":false,"id":"10081742"},{"golden":false,"id":"19264013"},{"golden":false,"id":"16462003"},{"golden":false,"id":"17588886"},{"golden":false,"id":"15677398"},{"golden":false,"id":"33055291"},{"golden":false,"id":"35377676"},{"golden":false,"id":"32874803"},{"golden":true,"id":"39029699"},{"golden":true,"id":"36112891"},{"golden":false,"id":"36808962"},{"golden":false,"id":"27990277"},{"golden":false,"id":"30453675"},{"golden":false,"id":"10867581"},{"golden":false,"id":"38032030"},{"golden":false,"id":"22401971"},{"golden":false,"id":"30793273"},{"golden":false,"id":"15939918"},{"golden":false,"id":"21195251"},{"golden":false,"id":"2888107"},{"golden":false,"id":"35166488"},{"golden":false,"id":"24585693"},{"golden":false,"id":"30688417"},{"golden":false,"id":"16173085"},{"golden":false,"id":"38072006"},{"golden":false,"id":"39613044"},{"golden":false,"id":"38500169"},{"golden":false,"id":"38823203"},{"golden":false,"id":"39175043"},{"golden":false,"id":"16757458"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":624,"document":"22097186","golden":true,"offsetInEndSection":811,"text":"It was observed that there is a connection between the extent of sexual abuse of an individual in childhood and the intensification of the disorders proper for the borderline personality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1010,"document":"35377676","golden":false,"offsetInEndSection":1112,"text":"These findings are inconsistent with the widely held assumption that CT causes the development of BPD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"15674131","golden":true,"offsetInEndSection":276,"text":"A substantial body of research points to several variables relevant to the etiology of borderline personality disorder (BPD), notably childhood physical and sexual abuse, childhood family environment, and familial aggregation of both internalizing and externalizing disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":528,"document":"22097186","golden":true,"offsetInEndSection":623,"text":"About 40-71% of the infirm with the borderline personality admits to have been sexually abused.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":271,"document":"22097186","golden":false,"offsetInEndSection":348,"text":"The other one underline a role of the psychological developmental categories.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":812,"document":"22097186","golden":false,"offsetInEndSection":988,"text":"One should, however, point out that sexual abuse, although they are regarded as a risk factor, are not seen as specific to the infirm with the borderline personality disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":989,"document":"22097186","golden":false,"offsetInEndSection":1194,"text":"Moreover, there is a third direction referred to in the literature, seeking the causes of the occurrence of the borderline personality in a significant influence of social-cultural and environment factors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":152,"document":"10081742","golden":false,"offsetInEndSection":319,"text":"Researchers have generally assumed that childhood sexual abuse causes borderline personality disorder, but there are other possible interpretations of the association.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1483,"document":"22097186","golden":false,"offsetInEndSection":1737,"text":"More and more frequently, theorists and clinical personnel adhere to the view that the development of that disorder is caused by a combination of neurobiological and social factors, together with the pathological qualities of early-childhood development.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":117,"document":"22097186","golden":false,"offsetInEndSection":270,"text":"The first of them attempts to explain them upon the constitutional basis, finding the causes in the genetic conditioning, biological and organic factors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1126,"document":"39029699","golden":true,"offsetInEndSection":1473,"text":"Additionally, within the entire group, a strong association was found between childhood trauma, especially emotional neglect, and the presence of borderline personality features.CONCLUSION: Given the high prevalence of childhood trauma and borderline personality features, screening for these factors in individuals with mood disorders is crucial.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39029699","golden":true,"offsetInEndSection":245,"text":"BACKGROUND: Childhood trauma, including emotional neglect, emotional abuse, physical abuse, and sexual abuse, may contribute to borderline personality features like affective instability, identity problems, negative relationships, and self-harm.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":584,"document":"36112891","golden":true,"offsetInEndSection":701,"text":"his model suggests a combination of an emotionally vulnerable temperament and an invalidating environment cause BPD. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36808962","golden":false,"offsetInEndSection":147,"text":"Borderline personality disorder (BPD) is a serious mental illness characterized by instability in affective, cognitive, and interpersonal domains.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30453675","golden":false,"offsetInEndSection":288,"text":"Borderline personality disorder (BPD) is a chronic psychiatric disorder characterized by pervasive affective instability, self-image disturbances, impulsivity, marked suicidality, and unstable interpersonal relationships as the core dimensions of psychopathology underlying the disorder.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27990277","golden":false,"offsetInEndSection":169,"text":"Borderline personality disorder (BPD) is a complex psychiatric diagnosis characterized by dysregulated behaviors, emotions, cognitions, and interpersonal relationships.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1593,"document":"30688417","golden":false,"offsetInEndSection":1839,"text":"Most borderline patients who died either by suicide (87.5%) or non-suicide-related causes (88%) were not recovered before death.CONCLUSIONS: Taken together, these findings suggest that individuals with BPD are at elevated risk of premature death.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"15939918","golden":false,"offsetInEndSection":212,"text":"Borderline personality disorder is a chronic psychiatric disorder characterized by marked impulsivity, instability of mood and interpersonal relationships, and suicidal behaviour that can complicate medical care.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":715,"document":"24585693","golden":false,"offsetInEndSection":1077,"text":"Having experienced validating parenting was found to be a protective factor for developing borderline traits but was not significantly related to emotional dysregulation.CONCLUSION: Data in this sample did not support the underlying genesis of BPD proposed by the Biosocial Theory and a model that more parsimoniously explains the development of BPD is proposed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24585693","golden":false,"offsetInEndSection":460,"text":"OBJECTIVES: We sought to test the Biosocial Theory of borderline personality disorder (BPD) that posits that borderline traits are due to emotional dysregulation, caused by the interaction between childhood emotional vulnerability and invaliding parenting.METHOD: A total of 250 adults (76% female, median age \u003d 32.06 years) from a nonclinical population completed self-report measures assessing current levels of borderline traits and emotional dysregulation.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"15939918","golden":false,"offsetInEndSection":32,"text":"Borderline personality disorder.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38072006","golden":false,"offsetInEndSection":800,"text":"OBJECTIVE: Information on borderline personality disorder (BPD) and its comorbidities is often limited to concentrate on a few diagnoses. The aim of the study was to use national register data to investigate all diagnostic co-occurring mental health disorders and somatic diseases 3?years before and after initial BPD diagnosis compared with a matched control group.METHOD: The study was a register-based cohort of 2756 patients with incident BPD (ICD F60.3) and 11,024 matched controls, during 2002-2016. Comorbidity data were classified into main disease groups, in accordance with the World Health Organization ICD-10 criteria.RESULTS: Almost half the patients had been diagnosed with mental and behavioral disorders before the BPD diagnosis as compared to 3% in the control group. Further, the co","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39613044","golden":false,"offsetInEndSection":800,"text":"Patients with borderline personality disorder (BPD) suffer from a variety of affective symptoms, including emptiness. Emptiness has received less attention, yet causes severe suffering and impairment. This study\u0027s primary aim was to compare the severity of emptiness over time in 290 patients with BPD to 72 patients with other personality disorders (OPD), and its secondary aim was to identify clinical and psychosocial predictors of severity of feelings of emptiness over 24?years of prospective follow-up. Inpatients meeting rigorous criteria for BPD or meeting DSM criteria for OPD were assessed at baseline, then reassessed every two years for 24?years. Severity of feelings of emptiness was assessed via self-report. Severity of emptiness was significantly higher at baseline for patients with ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38500169","golden":false,"offsetInEndSection":800,"text":"BACKGROUND: Sexual risk behavior in patients diagnosed with borderline personality disorder (BPD) is supposed to be associated with traumatic experiences and dissociative symptoms. Nevertheless, scientific research thereon is scarce which might be due to the high prevalence of sexual trauma and fear of overwhelming patients with explicit sexual content.METHODS: We investigated a clinical sample of patients diagnosed with BPD (n?\u003d?114) and compared them to a sample of matched healthy controls (HC) (n?\u003d?114) concerning the dissociative symptoms derealization, depersonalization, and conversion in sexual situations. In a subgroup of patients with BPD (n?\u003d?41) and matched HC (n?\u003d?40) dissociative symptoms after exposure to an acoustically presented erotic narrative were assessed in the lab. Reg","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38823203","golden":false,"offsetInEndSection":800,"text":"Current research on personality disorders strives to identify key behavioural and cognitive facets of patient functioning, to unravel the underlying root causes and maintenance mechanisms. This process often involves the application of social paradigms - however, these often only include momentary affective depictions rather than unfolding interactions. This constitutes a limitation in our capacity to probe core symptoms, and leaves potential findings uncovered which could help those who are in close relationships with affected individuals. Here, we deployed a novel task in which subjects interact with four unknown virtual partners in a turn-taking paradigm akin to a dance, and report on their experience with each. The virtual partners embody four combinations of low/high expressivity of p","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39175043","golden":false,"offsetInEndSection":800,"text":"BACKGROUND: Attributions are the processes by which individuals explain the causes of positive and negative events. A maladaptive attributional style has been associated with reduced self-esteem, psychosocial functioning, and mental health. Although many psychosocial interventions target an individual\u0027s attributional style in mental disorders, studies of its alterations in Borderline Personality Disorder (BPD) are sparse. This study aimed to investigate the attributional style in patients with BPD in comparison to healthy control individuals (HC) and its association with self-esteem and psychosocial functioning.METHODS: The participants (32 patients with a diagnosis of BPD, 32 HC, groups were balanced for sex, age and education) assessed their attributional style in regard to locus of cont","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24585693","golden":false,"offsetInEndSection":244,"text":"OBJECTIVES: We sought to test the Biosocial Theory of borderline personality disorder (BPD) that posits that borderline traits are due to emotional dysregulation, caused by the interaction between childhood emotional vulnerability and invalidin","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38032030","golden":false,"offsetInEndSection":217,"text":"BACKGROUND: Borderline personality disorder (BPD) is a complex mental health condition with an altered image of self, impulsive acts, suicidal ideation, and self-harm requiring intensive care in outpatient and inpatie","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"16757458","golden":false,"offsetInEndSection":225,"text":"Suicide is the major cause of death among patients with borderline personality disorder; however, the literature on completed suicides in such disorder is inconclusive, as suicide rates vary greatly among cohorts of patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30793273","golden":false,"offsetInEndSection":340,"text":"BACKGROUND: In reaction to two patients diagnosed with borderline personality disorder (bpd) who were admitted for suicidality and whose treatment was stagnating, we hypothesised that these women had an autism spectrum disorder (asd) as an underlying cause for both the persistent suicidality and the characteristics of bpd.\u003cbr/\u003e AIM: To in","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"10867581","golden":false,"offsetInEndSection":170,"text":"A close examination of dysphoria, anger and aloneness (three main characteristics of the borderline syndrome) provides a theoretical model of reference for the therapist.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1003,"document":"21195251","golden":false,"offsetInEndSection":1113,"text":"Further research is needed on the diagnosis, neurobiology, and treatment of borderline personality disorder.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":838,"document":"22401971","golden":false,"offsetInEndSection":1034,"text":"Participants generally favoured psychological and sociological treatments, as well as rating early trauma and stress as possible causes of the symptoms of the person described in the BDP vignette.","beginSection":"abstract"}],"exact_answer":[],"ideal_answer":[],"id":"6777bebf592fa48873000015","type":"list","body":"Causes of borderline personality disorder."},{"documents":[{"golden":false,"id":"30628108"},{"golden":false,"id":"31178437"},{"golden":false,"id":"33572016"},{"golden":false,"id":"22827693"},{"golden":false,"id":"33159374"},{"golden":false,"id":"24257037"},{"golden":false,"id":"33614028"},{"golden":false,"id":"24582649"},{"golden":false,"id":"31784432"},{"golden":false,"id":"34140459"},{"golden":false,"id":"30345252"},{"golden":false,"id":"34238831"},{"golden":false,"id":"28869008"},{"golden":false,"id":"31780599"},{"golden":false,"id":"27999027"},{"golden":false,"id":"24100717"},{"golden":false,"id":"30154172"},{"golden":false,"id":"31883938"},{"golden":false,"id":"32952613"},{"golden":false,"id":"25728808"},{"golden":false,"id":"25505015"},{"golden":false,"id":"33130602"},{"golden":false,"id":"29564058"},{"golden":false,"id":"25474284"},{"golden":false,"id":"34484424"},{"golden":false,"id":"26198180"},{"golden":false,"id":"34791396"},{"golden":false,"id":"36484871"},{"golden":true,"id":"25162365"},{"golden":false,"id":"34889135"},{"golden":false,"id":"33309073"},{"golden":false,"id":"31993353"},{"golden":false,"id":"25095866"},{"golden":false,"id":"34245901"},{"golden":false,"id":"32104162"},{"golden":false,"id":"35745257"},{"golden":false,"id":"33718277"},{"golden":true,"id":"36208299"},{"golden":false,"id":"34724447"},{"golden":false,"id":"37675433"},{"golden":false,"id":"34527093"},{"golden":false,"id":"27664230"},{"golden":false,"id":"32843418"},{"golden":false,"id":"37087392"},{"golden":false,"id":"32642633"},{"golden":false,"id":"31952909"},{"golden":false,"id":"37218816"},{"golden":false,"id":"35587276"},{"golden":false,"id":"32979161"},{"golden":false,"id":"34788420"},{"golden":false,"id":"36988432"},{"golden":false,"id":"34781002"},{"golden":false,"id":"34453966"},{"golden":false,"id":"37600604"},{"golden":false,"id":"35086768"},{"golden":false,"id":"32492490"},{"golden":false,"id":"36304525"},{"golden":false,"id":"37047094"},{"golden":false,"id":"35052569"},{"golden":false,"id":"37537181"},{"golden":false,"id":"35024588"},{"golden":false,"id":"35297473"},{"golden":false,"id":"29140453"},{"golden":false,"id":"31169545"},{"golden":true,"id":"33273413"},{"golden":false,"id":"36778473"},{"golden":false,"id":"33121693"},{"golden":false,"id":"32992653"},{"golden":false,"id":"37211643"},{"golden":false,"id":"36066910"},{"golden":false,"id":"32306706"},{"golden":false,"id":"35076517"},{"golden":false,"id":"34554118"},{"golden":false,"id":"29868248"},{"golden":false,"id":"35753395"},{"golden":true,"id":"30540704"},{"golden":false,"id":"33230077"},{"golden":false,"id":"29151253"},{"golden":false,"id":"35533688"},{"golden":false,"id":"30578461"},{"golden":false,"id":"36226734"},{"golden":false,"id":"30900526"},{"golden":false,"id":"32843743"},{"golden":false,"id":"37429676"},{"golden":false,"id":"37557963"},{"golden":false,"id":"37130682"},{"golden":false,"id":"35629390"},{"golden":false,"id":"35453231"},{"golden":false,"id":"33907321"},{"golden":false,"id":"33483999"},{"golden":false,"id":"36720105"},{"golden":true,"id":"30010747"},{"golden":false,"id":"31009795"},{"golden":true,"id":"25798243"},{"golden":false,"id":"28646951"},{"golden":false,"id":"31550348"},{"golden":true,"id":"25046331"},{"golden":false,"id":"19956937"},{"golden":false,"id":"37953693"},{"golden":false,"id":"33534360"},{"golden":false,"id":"29383670"},{"golden":false,"id":"28501333"},{"golden":false,"id":"38347627"},{"golden":false,"id":"30816855"},{"golden":true,"id":"25023578"},{"golden":false,"id":"31777058"},{"golden":false,"id":"23117471"},{"golden":false,"id":"31559265"},{"golden":false,"id":"23866975"},{"golden":false,"id":"29750050"},{"golden":false,"id":"30450088"},{"golden":true,"id":"31462301"},{"golden":false,"id":"27407273"},{"golden":false,"id":"25677629"},{"golden":false,"id":"36844708"},{"golden":false,"id":"33278650"},{"golden":false,"id":"33345703"},{"golden":false,"id":"32148376"},{"golden":false,"id":"36425405"},{"golden":false,"id":"35159245"},{"golden":false,"id":"36300959"},{"golden":true,"id":"36557703"},{"golden":false,"id":"36085529"},{"golden":false,"id":"26982451"},{"golden":false,"id":"24853539"},{"golden":false,"id":"30245786"},{"golden":false,"id":"32620549"},{"golden":false,"id":"37756322"},{"golden":false,"id":"36681571"},{"golden":false,"id":"36990372"},{"golden":true,"id":"36818228"},{"golden":false,"id":"35276080"},{"golden":false,"id":"33035780"},{"golden":false,"id":"34053243"},{"golden":false,"id":"38357521"},{"golden":false,"id":"38357210"},{"golden":false,"id":"38351748"},{"golden":false,"id":"38351740"},{"golden":false,"id":"38350484"},{"golden":false,"id":"38349207"},{"golden":false,"id":"38347911"},{"golden":false,"id":"38346630"},{"golden":false,"id":"38344334"},{"golden":false,"id":"38391047"},{"golden":true,"id":"29198534"},{"golden":false,"id":"39597084"},{"golden":false,"id":"36867263"},{"golden":true,"id":"36580630"},{"golden":false,"id":"38715916"},{"golden":true,"id":"31617299"},{"golden":false,"id":"39252488"},{"golden":false,"id":"31326345"},{"golden":false,"id":"38572716"},{"golden":false,"id":"25274035"},{"golden":false,"id":"23101687"},{"golden":false,"id":"28237504"},{"golden":false,"id":"38609165"},{"golden":false,"id":"35283312"},{"golden":false,"id":"36100450"},{"golden":false,"id":"38908733"},{"golden":false,"id":"37516837"},{"golden":false,"id":"32864480"},{"golden":false,"id":"35105621"},{"golden":false,"id":"28707337"},{"golden":false,"id":"34316559"},{"golden":false,"id":"24641570"},{"golden":true,"id":"33775068"},{"golden":false,"id":"33106354"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":0,"document":"24582649","golden":false,"offsetInEndSection":134,"text":"Fecal microbiota transplantation (FMT) is an emerging experimental therapy for treatment of recurrent Clostridium difficile infection.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"29198534","golden":true,"offsetInEndSection":156,"text":"An Intragastric Fecal Microbiota Transplantation Program for Treatment of Recurrent Clostridium difficile in Children is Efficacious, Safe, and Inexpensive.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34238831","golden":false,"offsetInEndSection":172,"text":"ABSTRACT: Fecal microbiota transplantation (FMT) is currently the most effective but loosely regulated therapy, for recurrent Clostridioides difficile infection (rCDI) in p","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":135,"document":"24582649","golden":false,"offsetInEndSection":244,"text":"In the future, FMT has the potential to be a treatment modality in other diseases that involve gut dysbiosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":406,"document":"24582649","golden":false,"offsetInEndSection":514,"text":"Pediatric research and clinical nurses are a resource to help children and parents understand the procedure.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":813,"document":"30345252","golden":false,"offsetInEndSection":896,"text":"We report that FMT for early-onset UC appears to be safe and potentially effective.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":515,"document":"24582649","golden":false,"offsetInEndSection":705,"text":"Important topics include donor screening, patient assessment before, during, and after treatment; routes of administration and positioning; preparation for discharge and followup evaluation.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"31784432","golden":false,"offsetInEndSection":207,"text":"Protocol for a double-blind, randomised, placebo-controlled pilot study for assessing the feasibility and efficacy of faecal microbiota transplant in a paediatric Crohn\u0027s disease population: PediCRaFT Trial.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":245,"document":"24582649","golden":false,"offsetInEndSection":405,"text":"As use of FMT is likely to expand, pediatric nurses need a clear understanding of FMT to provide appropriate education, assessment, and care for these patients.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"24582649","golden":false,"offsetInEndSection":127,"text":"What nurses need to know about fecal microbiota transplantation: education, assessment, and care for children and young adults.","beginSection":"title"},{"endSection":"title","offsetInBeginSection":0,"document":"32864480","golden":false,"offsetInEndSection":220,"text":"Protocol for a pilot randomised, double-blind, placebo-controlled trial for assessing the feasibility and efficacy of faecal microbiota transplantation in adolescents with refractory irritable bowel syndrome: FAIS Trial.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":233,"document":"32864480","golden":false,"offsetInEndSection":558,"text":"s with IBS. Faecal microbiota transplantation (FMT) may be an effective alternative treatment in adolescents with refractory IBS through manipulation of the intestinal microbiota.METHODS AND ANALYSIS: This randomised, placebo-controlled single-centre pilot study will assess feasibility and efficacy of FMT in 30 adolescents ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32864480","golden":false,"offsetInEndSection":98,"text":"BACKGROUND: Irritable bowel syndrome (IBS) is a common chronic medical condition, in both children","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":99,"document":"32864480","golden":false,"offsetInEndSection":232,"text":"and adults. Despite the availability of effective (non)pharmacological treatments, symptoms persist in a significant amount of patien","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1086,"document":"32864480","golden":false,"offsetInEndSection":1560,"text":"r 6-month and 12-month follow-up. Other outcomes comprise changes in faecal gut microbiota composition, quality of life, depression and anxiety, school or work absenteeism and adequate relief, measured directly after FMTs and after 6 and 12 months of follow-up.DISCUSSION: This randomised controlled trial will investigate the feasibility and effectiveness of repetitive FMTs in adolescents with refractory IBS.ETHICS AND DISSEMINATION: The study is approved by the Medical ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":423,"document":"31784432","golden":false,"offsetInEndSection":533,"text":"osuppression. Faecal microbiota transplant (FMT) targets inflammatory bowel disease (IBD) by modifying intesti","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":534,"document":"31784432","golden":false,"offsetInEndSection":701,"text":"al dysbiosis. Limited adult and paediatric data have demonstrated a favourable response to FMT in IBD; however, no randomised controlled trial has yet been published i","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1974,"document":"31784432","golden":false,"offsetInEndSection":2103,"text":"o support potential US Food and Drug Administration approval. Approval to conduct this paediatric clinical trial was obtained fro","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1156,"document":"31784432","golden":false,"offsetInEndSection":1254,"text":"les two times per week for 6?weeks. Outcomes will be measured throughout the intervention period a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1845,"document":"31784432","golden":false,"offsetInEndSection":1973,"text":"man donor-sourced, microbiota-based therapeutic formulations. Both RBX7455 and RBX2660 are currently undergoing clinical trials ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31784432","golden":false,"offsetInEndSection":115,"text":"INTRODUCTION: Crohn\u0027s disease (CD) is a chronic inflammatory condition with transmural involvement of the gastroint","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2257,"document":"33130602","golden":false,"offsetInEndSection":2267,"text":"Orv Hetil.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":916,"document":"24641570","golden":false,"offsetInEndSection":1089,"text":"in 43 patients with recurrent CDI. Seven publications report FMT in paediatric patients with a total of 11 treated, 3 with chronic constipation and the remainder with recurr","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36484871","golden":false,"offsetInEndSection":509,"text":"BACKGROUND: Fecal microbiota transplantation (FMT) has been well described in the treatment of pediatric diseases; however, the latest updates regarding its use in children are unclear and the concepts involved need to be revisited.DATA SOURCES: We performed advanced searches in the MEDLINE, EMBASE, and Cochrane databases using the keywords \"Fecal microbiota transplantation OR Fecal microbiota transfer\" in the [Title/Abstract] to identify relevant articles published in English within the last five years.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":381,"document":"34791396","golden":false,"offsetInEndSection":484,"text":"FMT for the treatment of CDI has been well studied in adults with increasing data reported in children.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34791396","golden":false,"offsetInEndSection":138,"text":"Fecal Microbiota Transplantation and Microbial Therapeutics for the Treatment of Clostridioides difficile Infection in Pediatric Patients.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":689,"document":"34791396","golden":false,"offsetInEndSection":762,"text":"We also review emerging microbial therapeutics for the treatment of rCDI.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":485,"document":"34791396","golden":false,"offsetInEndSection":688,"text":"In this review, we discuss the current body of literature on the use of FMT in children including effectiveness, safety, risk factors for a failed FMT, and the role of FMT in children with comorbidities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":581,"document":"25162365","golden":true,"offsetInEndSection":702,"text":"FMT via nasogastric tube appears safe, well tolerated, and effective in treating pediatric recurrent C difficile colitis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":632,"document":"31993353","golden":false,"offsetInEndSection":1104,"text":"The age range of CDI cohort was 1 to 17 years, while the range was 8 to 21 years for ulcerative colitis cohort.RESULTS: We found that the BMI percentile was insignificantly changed by ?0.7%, ?1.8%, 1.3%, 4.6% in CDI, while by 3.6%, ?3.3%, 3.7%, 7.1% in ulcerative colitis at 1, 3, 6, 12 months after FMT (\"?\" means decrease).CONCLUSIONS: We concluded that FMT from healthy donors does not significantly alter BMI in children with CDI and ulcerative colitis over 12 months.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33309073","golden":false,"offsetInEndSection":123,"text":"Faecal microbiota transplantation (FMT) is an effective and safe treatment of recurrent Clostridioides difficile infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34791396","golden":false,"offsetInEndSection":140,"text":"Clostridioides difficile infection (CDI) is the most common cause of antibiotic-associated diarrhea and has high rates of recurrent disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":141,"document":"34791396","golden":false,"offsetInEndSection":380,"text":"As a disease associated with intestinal dysbiosis, gastrointestinal microbiome manipulation and fecal microbiota transplantation (FMT) have evolved as effective, although relatively unregulated therapeutics and not without safety concerns.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1369,"document":"36208299","golden":true,"offsetInEndSection":1592,"text":"FMT modulated fecal microbiome and metabolome in FGID children toward a healthy state.CONCLUSIONS: FMT relieves abdominal bloating and modulates fecal microbiome and metabolome toward a healthy state in children with FGIDs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":664,"document":"33718277","golden":false,"offsetInEndSection":907,"text":"The aim of this study is to discuss the potential use of FMT and modified protocols (MTT, microbiota transfer therapy) in the treatment of GI disorders in ASD children supported by reports on another disease, IBD concerning pediatric patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27664230","golden":false,"offsetInEndSection":139,"text":"Faecal microbiota transplantation (FMT) is increasingly being used to treat refractory and recurring Clostridium difficile infection (CDI).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":636,"document":"27664230","golden":false,"offsetInEndSection":750,"text":"She had recurrent CDIs that were refractory to metronidazole, pulse-tapered vancomycin and fidaxomicin treatments.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":843,"document":"27664230","golden":false,"offsetInEndSection":922,"text":"Follow-up was conducted for 12?months and indicated sustained remission of CDI.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":751,"document":"27664230","golden":false,"offsetInEndSection":842,"text":"She underwent 2 FMTs, which were performed via sigmoidoscopy; her mother served as a donor.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":464,"document":"27664230","golden":false,"offsetInEndSection":635,"text":"In this case report, we describe the successful use of FMT in a female patient aged 19 years with Crohn\u0027s disease who underwent ileorectal anastomosis following colectomy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":245,"document":"32864480","golden":false,"offsetInEndSection":592,"text":"Faecal microbiota transplantation (FMT) may be an effective alternative treatment in adolescents with refractory IBS through manipulation of the intestinal microbiota.METHODS AND ANALYSIS: This randomised, placebo-controlled single-centre pilot study will assess feasibility and efficacy of FMT in 30 adolescents (16-21 years) with refractory IBS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1280,"document":"33775068","golden":true,"offsetInEndSection":1452,"text":"No serious adverse effects were observed during and after infusions.CONCLUSIONS: FMT seems to be an effective and safe treatment option for CMV colitis in children with UC.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1810,"document":"34527093","golden":false,"offsetInEndSection":2018,"text":"There was a statistically significant correlation noted with the use of immunosuppressants and recurrence (P value \u003d 0.04).CONCLUSIONS: FMT is a successful treatment modality for refractory and recurrent CDI.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":191,"document":"32843418","golden":false,"offsetInEndSection":569,"text":"On day 3 of hydrocortisone therapy, he met day Oxford criteria with \u003e8 bloody stools per day and was given faecal microbiota transplantation and subsequently commenced on dietary therapy combining several strategies-(1) increased intake of fermentable fibres, (2) reduced intake of overall and sulfur-containing protein and (3) restriction of sulfate and sulfite food additives.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":570,"document":"32843418","golden":false,"offsetInEndSection":699,"text":"At week 8 assessment, he was in clinical and endoscopic remission and remained in clinical and endoscopic remission at 12 months.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"32843418","golden":false,"offsetInEndSection":97,"text":"Faecal microbiota transplantation (FMT) with dietary therapy for acute severe ulcerative colitis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":390,"document":"37087392","golden":false,"offsetInEndSection":640,"text":"Faecal microbiota transplantation (FMT) is the transfer of the microbiota from healthy screened stool donors into the gut of affected patients, and is a well-established and highly effective treatment for recurrent Clostridioides difficile infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":66,"document":"32843418","golden":false,"offsetInEndSection":190,"text":"He was taking azathioprine (therapeutic metabolites) and sulphasalazine as well as infliximab with a therapeutic drug level.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32843418","golden":false,"offsetInEndSection":65,"text":"A 19-year-old man presented with acute severe ulcerative colitis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":538,"document":"35587276","golden":false,"offsetInEndSection":1030,"text":"To determine similarities between mice and humans, human stool samples were collected from children and adolescents who were obese with normal glucose tolerance (NGT), obese with glucose intolerance (IGT), or obese and newly diagnosed with type 2 diabetes, for faecal microbiota transplant (FMT) into germ-free (GF) B6 mice and we assessed IgM-bound bacteria and immune responses.RESULTS: Compared with wild-type mice, Aid-/- B6 mice developed exacerbated HFDIO due to abundant levels of IgM.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1163,"document":"34788420","golden":false,"offsetInEndSection":1496,"text":"Children with a failed FMT were more likely to have clinically active IBD post-FMT [p \u003d 0.002] and 19 [13%] patients had an IBD-related hospitalisation in the 3-month follow-up.CONCLUSIONS: Based on the findings from this large US multicentre cohort, the efficacy of FMT for the treatment of rCDI did not differ in children with IBD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1175,"document":"36988432","golden":false,"offsetInEndSection":1559,"text":"In children with IBD, although microbiota diversity returned to pre-FMT levels within 6 months, secondary bile acids remained at donor levels.CONCLUSIONS: The differences in bile acid profiles compared with gut bacterial diversity post-FMT suggests that interactions between the two may be more complex than previously appreciated and may contribute to FMT efficacy in different ways.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1378,"document":"36304525","golden":false,"offsetInEndSection":1572,"text":"However, nine children developed rhinitis, five developed rhinitis, were underweight, and six developed constipation.Conclusions: FMT is a safe and effective treatment for dysbiosis in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":251,"document":"37600604","golden":false,"offsetInEndSection":352,"text":"Fecal microbiota transplantation (FMT) has recently been used in children to successfully treat D-LA.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":727,"document":"34781002","golden":false,"offsetInEndSection":831,"text":"There is a relative rare data available for children in application of fecal microbiota transplantation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":599,"document":"34781002","golden":false,"offsetInEndSection":726,"text":"Although the current allowed indication of FMT is CDI in Taiwan, more application and development are expectable in the future.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34781002","golden":false,"offsetInEndSection":140,"text":"Fecal microbiota transplantation (FMT) is a new and adequate route to modify the microbial ecosystem in gastrointestinal tract of the hosts.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":215,"document":"34781002","golden":false,"offsetInEndSection":598,"text":"According to the reports of human clinical trials or case series, the application of FMT ranged from Clostridiodes difficile infection (CDI), inflammatory bowel disease (IBD), irritable bowel syndrome, refractory diarrhea, diabetes mellitus, metabolic syndrome, and even neurologic diseases, including Parkinson disease, and neuropsychiatric disorder (autism spectrum disorder, ASD).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35086768","golden":false,"offsetInEndSection":142,"text":"Faecal microbiota transplantation (FMT) is widely reported to be an effective treatment against recurrent Clostridioides difficile infections.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34781002","golden":false,"offsetInEndSection":81,"text":"Current and future applications of fecal microbiota transplantation for children.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":832,"document":"34781002","golden":false,"offsetInEndSection":984,"text":"Thus, we review previous published research inspecting FMT in children, and address particular considerations when conducting FMT in pediatric patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":297,"document":"34453966","golden":false,"offsetInEndSection":534,"text":"Prebiotics, probiotics and faecal microbiota transplant (FMT) have been used with the aim of increasing the abundance of potentially beneficial taxa, while antibiotics have been used to decrease the abundance of potentially harmful taxa.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"29140453","golden":false,"offsetInEndSection":866,"text":"BACKGROUND: Faecal microbiota transplantation (FMT) as a potential treatment for inflammatory bowel disease (IBD) is an area of active current research, having been stimulated by the remarkable efficacy of FMT in treatment of Clostridium difficile-associated colitis.SOURCES OF DATA: This review is based on data from numerous case series on FMT in IBD since 1989 and results of four RCTs in ulcerative colitis (UC); three fully published.AREAS OF AGREEMENT: Early signals of short to medium-term efficacy of FMT for UC are promising.AREAS OF CONTROVERSY: Methodology, underlying mechanisms and questions regarding safety of FMT remain controversial.GROWING POINTS: Many trials of FMT in adults and children are currently recruiting.AREAS TIMELY FOR DEVELOPING RESEARCH: Future trials of FMT will likely revisit Crohn\u0027s disease and patients undergoing pouch surgery.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":192,"document":"36580630","golden":true,"offsetInEndSection":311,"text":"The efficacy rates of FMT are very robust for recurrent Clostridioides difficile infection in both children and adults.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31169545","golden":false,"offsetInEndSection":245,"text":"PURPOSE OF REVIEW: Administration of fecal material into the gastrointestinal tract, termed fecal microbiota transplantation (FMT), is increasingly recognized as an effective treatment option for recurrent Clostridium difficile infection (RCDI).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":562,"document":"33273413","golden":true,"offsetInEndSection":739,"text":"He did not experience infectious complications or other adverse effects.CONCLUSIONS: FMT may be a feasible option for treatment of refractory CDI in pediatric oncology patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":605,"document":"31169545","golden":false,"offsetInEndSection":907,"text":"The purpose of this article is to review the evidence for FMT as a treatment option in various pediatric illnesses.RECENT FINDINGS: The rate of C. difficile infection is rising among children, and is associated with significant morbidity and disease, with recurrence in up to 20% of pediatric patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1796,"document":"31169545","golden":false,"offsetInEndSection":1929,"text":"Although limited, pediatric studies to date on the use of FMT for RCDI demonstrate similar efficacy rates as in the adult population.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1615,"document":"31169545","golden":false,"offsetInEndSection":1795,"text":"The data on usage of FMT for other indications are preliminary and limited.SUMMARY: FMT is recognized as an effective treatment option for RCDI and is increasing sought by parents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1073,"document":"37211643","golden":false,"offsetInEndSection":1409,"text":"There were no adverse events related to immunosuppression or transplantation status including: bacteremia, cytomegalovirus activation or reactivation, allograft rejection, or allograft loss.CONCLUSIONS: In this limited series, efficacy of FMT in pediatric SOT is comparable to efficacy in the general pediatric recurrent CDI population.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1091,"document":"31169545","golden":false,"offsetInEndSection":1294,"text":"In addition, the safety of FMT in the treatment of RCDI has been well described in the adult population, with several pediatric case series demonstrating similar rates of tolerability and adverse events.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1930,"document":"31169545","golden":false,"offsetInEndSection":2167,"text":"FMT has been proposed as a treatment option for an increasing number of pediatric conditions, and additional studies are needed to delineate the efficacy of FMT outside of RCDI, as well as its short and long-term impacts on human health.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":908,"document":"31169545","golden":false,"offsetInEndSection":1090,"text":"Several randomized controlled trials evaluating the utility of FMT in RCDI in comparison to vancomycin have been published and demonstrate high rates of efficacy between 70 and 100%.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":649,"document":"34453966","golden":false,"offsetInEndSection":787,"text":"Microbiome-targeted therapies for HE have had some success, notably lactulose and rifaximin, with probiotics and FMT also showing promise.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":116,"document":"34453966","golden":false,"offsetInEndSection":187,"text":"Microbiota-host interactions play an important role in HE pathogenesis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":788,"document":"34453966","golden":false,"offsetInEndSection":1021,"text":"However, there remain several challenges to the effective application of microbiome therapeutics in HE, including the resilience of the microbiome to sustainable change and unpredictable clinical outcomes from microbiota alterations.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34453966","golden":false,"offsetInEndSection":115,"text":"Hepatic encephalopathy (HE) is a complication of cirrhosis characterised by neuropsychiatric and motor dysfunction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":188,"document":"34453966","golden":false,"offsetInEndSection":296,"text":"Therapies targeting microbial community composition and function have been explored for the treatment of HE.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1022,"document":"34453966","golden":false,"offsetInEndSection":1151,"text":"Future work in this space should focus on rigorous trial design, microbiome therapy selection, and a personalised approach to HE.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":564,"document":"37600604","golden":false,"offsetInEndSection":703,"text":"FMT altered the composition of the fecal microbiota in these 2 patients with recurrent D-LA, though not necessarily in a consistent manner.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":85,"document":"29868248","golden":false,"offsetInEndSection":285,"text":" recurrent Clostridium difficile infection (rCDI), through restoration of gut floral balance. However, there is a lack of data concerning the efficacy of FMT and its impact on the gut microbiome among","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1241,"document":"35753395","golden":false,"offsetInEndSection":1392,"text":" with vancomycin (p\u003d0.825). The total resolution rate of FMT for RCDI children was significantly higher than with vancomycin treatment (28/29, 96.55% v","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1566,"document":"35753395","golden":false,"offsetInEndSection":1642,"text":"rhea, hematochezia, and abdominal pain. The cure rate of FMT for pediatric R","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30540704","golden":true,"offsetInEndSection":195,"text":"Fecal microbiota transplantation (FMT) is becoming part of the treatment algorithms against recurrent Clostridium difficile infection (rCDI) both in adult and pediatric gastroenterology practice.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":299,"document":"30540704","golden":false,"offsetInEndSection":523,"text":"FMT is also being considered as a potential therapy for other disorders, including inflammatory bowel disease (Crohn disease, ulcerative colitis), graft versus host disease, neuropsychiatric diseases, and metabolic syndrome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":710,"document":"30540704","golden":false,"offsetInEndSection":809,"text":"This report is intended to provide guidance for FMT in the treatment of rCDI in pediatric patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33230077","golden":false,"offsetInEndSection":117,"text":"BACKGROUND: Fecal microbiota transplantation (FMT) has gained attention for its role in the treatment of ulcerative c","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1260,"document":"31169545","golden":false,"offsetInEndSection":1390,"text":"f tolerability and adverse events. FMT in ulcerative colitis appears promising, especially with multiple infusions administered vi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":82,"document":"29151253","golden":false,"offsetInEndSection":165,"text":"Fecal microbiota transplantation (FMT) is a new promising option for IBD treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":166,"document":"29151253","golden":false,"offsetInEndSection":249,"text":"We aimed to assess the effectiveness of a two-week FMT course in children with IBD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32843743","golden":false,"offsetInEndSection":182,"text":"Faecal microbiota transplantation (FMT) has emerged as a remarkably successful treatment for recurrent Clostridioides difficile infection that cannot be cured with antibiotics alone.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":231,"document":"37429676","golden":false,"offsetInEndSection":660,"text":"We hypothesise that faecal microbiome transfer (FMT) from healthy donors would help restore the gut microbiome of individuals with AN, which in turn, may aid patient recovery.METHODS: We aim to conduct an open-label pilot study in 20 females aged 16-32 years in Auckland, New Zealand who meet the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) criteria for AN and have a body mass index 13-19?kg/m2.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1290,"document":"32843743","golden":false,"offsetInEndSection":1544,"text":"The discussion here is limited to FMT as a representative of microbiota therapeutics and recurrent C. difficile as the indication; however, consideration of the intrinsic basic principles is relevant to this entire class of microbiota-based therapeutics.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37429676","golden":false,"offsetInEndSection":230,"text":"INTRODUCTION: Individuals with anorexia nervosa (AN) harbour distinct gut microbiomes compared with healthy individuals, which are sufficient to induce weight loss and anxiety-like behaviours when transplanted into germ-free mice.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":183,"document":"32843743","golden":false,"offsetInEndSection":387,"text":"Understanding the complex biology and pathogenesis of C. difficile infection, which we discuss in this Perspective, is essential for understanding the potential mechanisms by which FMT cures this disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":548,"document":"32843743","golden":false,"offsetInEndSection":683,"text":"However, all these therapeutics belong to an entirely new class of agents that require the development of a new branch of pharmacology.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":516,"document":"34554118","golden":false,"offsetInEndSection":668,"text":"Recently, the faecal microbiota transplantation (FMT) has emerged as an alternative therapeutic strategy against rCDI, with high treatment success rate.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":975,"document":"32843743","golden":false,"offsetInEndSection":1091,"text":"From this viewpoint, multiple gaps in knowledge become apparent, identifying areas that require systematic research.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33483999","golden":false,"offsetInEndSection":180,"text":"Faecal Microbiota Transplantation (FMT) is well established as an effective treatment for Clostridioides difficile infection (CDI), restoring gut microbiome diversity and function.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1092,"document":"32843743","golden":false,"offsetInEndSection":1289,"text":"This knowledge is needed to help clinical providers use microbiota therapeutics appropriately and to facilitate development of next-generation microbiota products with improved safety and efficacy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36720105","golden":false,"offsetInEndSection":193,"text":"OBJECTIVES: We sought to evaluate the safety and effectiveness of fecal microbiota transplantation (FMT) for recurrent Clostridioides difficile infection (CDI) in pediatric immunocompromised (I","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":221,"document":"30010747","golden":true,"offsetInEndSection":321,"text":"Fecal microbiota transplantation (FMT) has been successful in some children with ulcerative colitis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31009795","golden":false,"offsetInEndSection":103,"text":"BACKGROUND \u0026 AIMS: Fecal microbiota transplantation (FMT) is commonly used to treat Clostridium diffici","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":186,"document":"25798243","golden":true,"offsetInEndSection":319,"text":"The current case report presents the first case of a 13-month-old male with severe pseudomembranous enteritis (PME) treated with FMT.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1059,"document":"25798243","golden":false,"offsetInEndSection":1126,"text":"The current data show that FMT is an efficient choice for recurrent","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28646951","golden":false,"offsetInEndSection":129,"text":"Fecal microbiota transplantation (FMT) is a relatively simple, promising treatment for recurrent Clostridium difficile infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":275,"document":"28646951","golden":false,"offsetInEndSection":381,"text":"Experience with FMT in the pediatric population is increasing, showing similar success compared to adults.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":126,"document":"31550348","golden":false,"offsetInEndSection":211,"text":"Pediatric experience with FMT for rCDIs is increasing, particularly at large centers.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":632,"document":"31550348","golden":false,"offsetInEndSection":797,"text":"The role of FMT in children, particularly in high-risk patients, will require continual reexamination with future availability of pediatric safety and efficacy data.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":604,"document":"25046331","golden":false,"offsetInEndSection":757,"text":"tment of RCDI in the past 2 years. Patients in these reports included otherwise healthy children, those with inflammatory bowel disease as well as signif","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":359,"document":"25046331","golden":false,"offsetInEndSection":638,"text":"The purpose of this article is to review the use of fecal microbiota transplant (FMT) in the treatment of pediatric RCDIs.RECENT FINDINGS: Minimal pediatric data, including few case reports and series, document the successful use of FMT for treatment of RCDI in the past 2 years.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":973,"document":"25046331","golden":true,"offsetInEndSection":1167,"text":"No complications to date have been reported in children who have undergone FMT.SUMMARY: FMT is emerging as a well-tolerated and effective treatment for RCDI in not only adults but also children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":345,"document":"29383670","golden":false,"offsetInEndSection":700,"text":"This procedure, termed Faecal Microbiota Transplantation (FMT), has demonstrated remarkable efficacy as a treatment for recurrent CDI.FMT has also been investigated in other diseases and disorders where perturbations to the gut microbiota have been theorized to play a causative role in pathogenesis and severity, such as inflammatory bowel disease (IBD).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":278,"document":"38347627","golden":false,"offsetInEndSection":739,"text":"The adaptation of bacteria to novel niches has particular relevance for faecal microbiota transplantation (FMT), a therapeutic procedure which aims to resolve gut-related health conditions of individuals, through transplanted gut microbiota from healthy donors.RESULTS: Three hundred eighty-one stool metagenomic samples from a placebo-controlled FMT trial for obese adolescents (the Gut Bugs Trial) were analysed for HGT, using two complementary methodologies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":793,"document":"25046331","golden":true,"offsetInEndSection":972,"text":"Donor fecal infusion via nasogastric tube, gastroscope or colonoscope in children aged 16 months and older demonstrated a high rate of symptom resolution and organism eradication.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":137,"document":"25046331","golden":false,"offsetInEndSection":358,"text":"While fecal microbiota transplant has gained increasing popularity over the past 50 years for the treatment of refractory Clostridium difficile infections (RCDIs) in adults, it has only been recently utilized in children.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"25046331","golden":false,"offsetInEndSection":119,"text":"Fecal microbiota transplantation in the treatment of refractory Clostridium difficile infection in children: an update.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":602,"document":"25023578","golden":true,"offsetInEndSection":726,"text":"Our 2 cases illustrate the efficacy of FMT in children with RCDI and its positive effect on their growth and gut microbiota.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30816855","golden":false,"offsetInEndSection":169,"text":"OBJECTIVE: Faecal microbiota transplant (FMT) effectively treats recurrent Clostridioides difficile infection (rCDI), but its mechanisms of action remain poorly defined.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1152,"document":"31559265","golden":false,"offsetInEndSection":1284,"text":"We conclude that FMT may be an effective treatment in RTRs with recurrent UTIs caused by intestinal colonisation with MDR organisms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":926,"document":"31462301","golden":true,"offsetInEndSection":1136,"text":"Microbiota analysis showed that FMT resulted in reconstruction of a diverse microbiota.CONCLUSIONS: Use of FMT is safe and effective in treatment of refractory diarrhea in IC children with a damaged microbiota.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":639,"document":"25046331","golden":false,"offsetInEndSection":792,"text":"Patients in these reports included otherwise healthy children, those with inflammatory bowel disease as well as significantly immunocompromised children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25046331","golden":false,"offsetInEndSection":136,"text":"PURPOSE OF REVIEW: The use of transplanted fecal material for the treatment of diarrheal illness dates back to the fourth-century China.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1271,"document":"36557703","golden":true,"offsetInEndSection":1403,"text":"Conclusions: FMT was concluded to be an effective and safe therapy in pediatric and adolescent patients with C. difficile infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":282,"document":"33278650","golden":false,"offsetInEndSection":380,"text":"Fecal Microbiota Transplantation (FMT) has emerged as a consistently effective treatment for rCDI.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":509,"document":"36844708","golden":false,"offsetInEndSection":623,"text":"FMT shows promise as salvage therapy for critically-ill, refractory CDI patients who are poor surgical candidates.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":150,"document":"36844708","golden":false,"offsetInEndSection":320,"text":"Current guidelines recommend FMT for the prevention of multiply recurrent Clostridioides difficile infection (CDI) after two recurrences, with cure rates approaching 90%.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":321,"document":"36844708","golden":false,"offsetInEndSection":508,"text":"Emerging evidence also supports the use of FMT in the management of severe and fulminant CDI, resulting in decreased mortality and colectomy rates compared with standard of care approach.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36844708","golden":false,"offsetInEndSection":149,"text":"Fecal microbiota transplantation (FMT) is the process of transplanting stool from a healthy donor into the gut of a patient for therapeutic purposes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2882,"document":"36425405","golden":false,"offsetInEndSection":3526,"text":"Methods: The researchers provided an overview of the mechanisms that the gut microbiome uses to prevent colonization of the gut by pathogens.They subsequently reviewed the efficacy and shortcomings of the following treatments for CDI: -?Antibiotics-?Monoclonal antibodies-?Fecal microbiota transplantation (FMT) Results: Commensal intestinal bacteria prevent colonization of the gut by pathogens using mechanisms such as: -?Competition for key nutrients-?Production of inhibitory bile acids-?Short-chain fatty acid production-?Lowering the luminal pH-?Production of bacteriocinsAntibiotic therapy is recommended as a standard treatment for CDI.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":790,"document":"36844708","golden":false,"offsetInEndSection":891,"text":"Besides CDI, ulcerative colitis was more recently identified as a potential treatment target for FMT.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":624,"document":"36844708","golden":false,"offsetInEndSection":789,"text":"FMT should be considered early in the clinical course of severe CDI, preferably within 48?hours of failing to respond to antibiotic therapy and volume resuscitation.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36844708","golden":false,"offsetInEndSection":33,"text":"Fecal Microbiota Transplantation.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1211,"document":"35159245","golden":false,"offsetInEndSection":1365,"text":"In conclusion, FMT was not associated with increased mortality, risk of hospital admission or onset of disease following treatment when compared with RBT.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35159245","golden":false,"offsetInEndSection":143,"text":"Faecal microbiota transplantation (FMT) is the recommended treatment for recurrent C. difficile infection (rCDI) following a second recurrence.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":960,"document":"35159245","golden":false,"offsetInEndSection":1210,"text":"In the five years following treatment, there were no differences in survival (adjusted hazard ratio (aHR) 1.03; 95% CI 0.68-1.56), p \u003d 0.89), risk of hospital admission ((aHR 0.92; 95% CI 0.72-1.18), p \u003d 0.5) or onset of any of the analysed diseases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1734,"document":"37756322","golden":false,"offsetInEndSection":2093,"text":"Time to normalized intestinal habits were 17 and 19 days from study start in the placebo group and the FMT group, respectively (p \u003d 0.8).CONCLUSION: Capsulized frozen autologous faecal microbiota transplantation was safe and well tolerated but did not affect time to normalized intestinal habits compared to placebo.TRIAL REGISTRATION: EudraCT 2017-002418-30.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":438,"document":"32620549","golden":false,"offsetInEndSection":561,"text":"Faecal microbiota transplantation (FMT) has a well-established role in the treatment of Clostridioides difficile infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37756322","golden":false,"offsetInEndSection":214,"text":"BACKGROUND: Faecal microbiota transplantation (FMT) is recommended treatment for recurrent Clostridioides difficile infection and is studied as a potential modifier of other gastrointestinal and systemic disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1133,"document":"36818228","golden":true,"offsetInEndSection":1429,"text":"FMT also reduced Childhood Autism Rating Scale (CARS) scores (WMD?\u003d?-6.95; 95% CI, -8.76 to -5.14; P \u003c 0.001; I 2?\u003d?28.1%).Conclusion: Our results indicate that FMT can benefit children with autism by reducing ABC and CARS scores, but more high-quality studies are needed to verify these results.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":343,"document":"35159245","golden":false,"offsetInEndSection":506,"text":"In a retrospective cohort study, we assessed the long-term safety of patients treated for rCDI with FMT or a fixed bacterial mixture, rectal bacteriotherapy (RBT).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":855,"document":"35159245","golden":false,"offsetInEndSection":959,"text":"A total of 280 patients were treated for rCDI with FMT (n \u003d 145) or RBT (n \u003d 135) between 2016 and 2020.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"35159245","golden":false,"offsetInEndSection":230,"text":"Long-Term Safety Following Faecal Microbiota Transplantation as a Treatment for Recurrent Clostridioides difficile Infection Compared with Patients Treated with a Fixed Bacterial Mixture: Results from a Retrospective Cohort Study.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":338,"document":"38357521","golden":false,"offsetInEndSection":442,"text":"However, restoring gut microflora through faecal microbiota transplantation (FMT) is a hopeful solution.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":445,"document":"38357210","golden":false,"offsetInEndSection":601,"text":"Therefore, fecal bacteria-free filtrate transplantation (FFT), which has the potential to become a possible alternative therapy, is well worth investigating","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":840,"document":"38351748","golden":false,"offsetInEndSection":968,"text":"Fecal microbiota transplantation (FMT) was applied to an antibiotic-depleted-treated mouse model and targeted inhibition of TMAO","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":980,"document":"38351740","golden":false,"offsetInEndSection":1105,"text":"The encouraging results demonstrate the significant effectiveness and potential of our method for practical FMT applications.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":156,"document":"38350484","golden":false,"offsetInEndSection":246,"text":"plantarum) and faecal microbiota transplantation (FMT) is a novel approach to treating IBD","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38349207","golden":false,"offsetInEndSection":134,"text":"Maternal obesity increases the risk of obesity and metabolic disorders (MDs) in offspring, which can be mediated by the gut microbiota","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38347911","golden":false,"offsetInEndSection":87,"text":"Fecal Microbiota Transplantation: A Prospective Treatment for Type 2 Diabetes Mellitus.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":278,"document":"38347627","golden":false,"offsetInEndSection":539,"text":"The adaptation of bacteria to novel niches has particular relevance for faecal microbiota transplantation (FMT), a therapeutic procedure which aims to resolve gut-related health conditions of individuals, through transplanted gut microbiota from healthy donors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":439,"document":"38346630","golden":false,"offsetInEndSection":523,"text":"In this study, we aimed to explore the role of Kindlin-2 in FMT as it relates to POP","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1246,"document":"38344334","golden":false,"offsetInEndSection":1450,"text":"There is growing literature on fecal microbiota transplantation (FMT) and the 2021 guidelines describe its role in severe complicated refractory CDI cases and for which surgical management is not feasible","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1031,"document":"38391047","golden":false,"offsetInEndSection":1463,"text":"However, there are currently insufficient data to support the use of FMT for other potential therapeutic indications (such as irritable or inflammatory bowel disease or obesity), beside the potential to decolonise multi-drug resistant organisms.CONCLUSION: This underscores the need for randomised, controlled, prospective cohort studies in children to assess FMT effectiveness in diverse conditions and counteract publication bias.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1096,"document":"29198534","golden":false,"offsetInEndSection":1425,"text":"The use of stool derived from a donor stool bank decreased charges by 49% compared with charges associated with the use of a donor who was a relative.CONCLUSION: A nurse-led intragastric FMT procedure using stool derived from a donor stool bank is a relatively inexpensive and efficacious treatment for recurrent CDI in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":893,"document":"38391047","golden":false,"offsetInEndSection":1030,"text":"FMT appears safe and effective for recurrent Clostridioides difficile infection, although severe adverse events are reported in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":385,"document":"38391047","golden":false,"offsetInEndSection":765,"text":"While recurrent Clostridioides difficile infection is the recognised FMT indication, exploration of other therapeutic uses is ongoing.METHODS: Following PRISMA guidelines, we conducted a systematic review, extracting 583 articles from Embase and PubMed (index date to October 2022).RESULTS: The search yielded 58 studies for full review, with 50 included in the systematic review.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":267,"document":"38391047","golden":false,"offsetInEndSection":384,"text":"Faecal microbiota transplantation (FMT) is emerging as a method to modulate the gastrointestinal microbial ecosystem.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38391047","golden":false,"offsetInEndSection":120,"text":"AIM: Novel technologies offer insights into the potential role of the intestinal microbiota in human health and disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":121,"document":"38391047","golden":false,"offsetInEndSection":266,"text":"Dysbiosis has been associated with several diseases, and it is thought to play a role in the pathogenesis of different gastrointestinal diseases.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38391047","golden":false,"offsetInEndSection":67,"text":"Faecal microbiota transplantation in children: A systematic review.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":191,"document":"39597084","golden":false,"offsetInEndSection":310,"text":"MT is the transfer of stool from a healthy human donor to a patient for the purpose of restoring intestinal dysbiosis. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36580630","golden":false,"offsetInEndSection":192,"text":"Fecal microbiota transplantation (FMT) is a rapidly growing therapy aimed at reconstituting the dysbiotic microbiota of a patient with the beneficial stool microbiota of a healthy individual.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36867263","golden":false,"offsetInEndSection":202,"text":"PURPOSE: To assess the current attitude and the status quo towards the use of microbiome analysis and fecal microbiota transfer (FMT) in pediatric patients in German-speaking pediatric gastroenterology ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":136,"document":"38715916","golden":false,"offsetInEndSection":330,"text":"A 19-year-old male adolescent with ASD, who was not responding to standard treatment received fecal microbiota transplant (FMT) using donor material from his typically developing female sibling.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":271,"document":"31617299","golden":true,"offsetInEndSection":366,"text":"FMT is a safe and effective treatment for?recurrent CDI in immunocompetent children and adults.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39252488","golden":false,"offsetInEndSection":159,"text":"BACKGROUND/AIMS: Fecal microbiota transplantation (FMT) is a promising therapy for inducing and maintaining remission in patients with ulcerative colitis (UC).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2161,"document":"31326345","golden":false,"offsetInEndSection":2399,"text":"One serious adverse event that was unrelated to study drug (acute cholecystitis) was reported in a patient while receiving placebo capsules.INTERPRETATION: FMT was safe, but did not induce symptom relief at 12 weeks compared with placebo.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31326345","golden":false,"offsetInEndSection":187,"text":"BACKGROUND: Faecal microbiota transplantation (FMT) has shown promise in alleviating the symptoms of irritable bowel syndrome (IBS); however, controlled data on this technique are scarce.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36100450","golden":false,"offsetInEndSection":800,"text":"Clostridioides difficile (Clostridium difficile in older taxonomy) is a gram-positive anaerobic and bacteria enabled by endospores. Clostridioides difficile is currently the main cause of nosocomial infections in developed countries. Due to the high probability of developing bacterial resistance to treatment and the numerous recurrences in multiple chronic conditions in older adults of our society it causes a widespread medical problem. Faecal microbiota transplantation (FMT) is a highly effective method for treating recurrent intestinal Clostridioides difficile infections (CDI). With this method the potential mechanism of effect is the transmission of a complex intestinal ecosystem, including vital microorganisms, from the donor to the recipient. Presenting the results of monocentric pros","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35283312","golden":false,"offsetInEndSection":800,"text":"BACKGROUND: Clostridioides difficile infections (CDI) are traditionally attributed to an older adult patient group but children can also be affected. Although the causative pathogen is the same in both populations, the management of CDI may differ.OBJECTIVES: To discuss the current literature on CDI in the paediatric population and to provide CDI diagnostics and treatment guidance.SOURCES: The literature was drawn from a search of PubMed from January 2017 to July 2021.CONTENT: In the paediatric population, laboratory diagnostics for CDI should preferably be combined with laboratory diagnostics for other gastrointestinal pathogens. Coinfections of CDI are also possible. Though the detection of toxigenic C.?difficile using a molecular assay may simply reflect colonisation rather than infecti","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":233,"document":"32864480","golden":false,"offsetInEndSection":400,"text":"s with IBS. Faecal microbiota transplantation (FMT) may be an effective alternative treatment in adolescents with refractory IBS through manipulation of the intestinal","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":148,"document":"35105621","golden":false,"offsetInEndSection":369,"text":"sbacteriosis. Emerging lines of evidence have shown faecal microbiota transplantation (FMT) to be a potential therapeutic strategy for improving the clinical outcomes of patients with ASD by re-establishing their intestin","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":86,"document":"28707337","golden":false,"offsetInEndSection":222,"text":" diarrhoea. Faecal microbiota transplantation (FMT) is an approved treatment for recurrent or refractory CDI but there is uncertainty ab","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34316559","golden":false,"offsetInEndSection":281,"text":"From its origins as a left-field, experimental, and even \"maverick\" intervention, faecal microbiota transplantation (FMT) is now a well-recognised, accepted, and potentially life-saving therapeutic strategy, for the management of recurrent Clostridiodes difficile infection (rCDI).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24641570","golden":false,"offsetInEndSection":157,"text":"BACKGROUND: There has been growing interest in the use of faecal microbiota transplantation (FMT) for the treatment of gastrointestinal and nongastrointestin","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":205,"document":"33775068","golden":false,"offsetInEndSection":387,"text":"dard therapy.OBJECTIVE: The aim of our study was to assess the efficacy and safety of faecal microbiota transplantation (FMT) for the treatment of CMV colitis in patients with ulcera","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":431,"document":"37516837","golden":false,"offsetInEndSection":649,"text":"eatment assignment. 11 patients with CFS (10 female and 1 male, mean age 42.2?years and mean duration of CFS 6.3?years) were randomly assigned to receive either FMT from a universal donor (n?\u003d?5) or autologous FMT (n?\u003d","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":185,"document":"38908733","golden":false,"offsetInEndSection":366,"text":"he gut microbiome. Here, we report the efficacy of fecal microbiota transplantation (FMT) in alleviating post-COVID insomnia symptoms in a nonrandomized, open-label prospective inte","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":172,"document":"33106354","golden":false,"offsetInEndSection":313,"text":"gy of T1D. We studied microbiota-mediated effects on disease progression in patients with type 1 diabetes using faecal microbiota transplanta","beginSection":"abstract"}],"exact_answer":[["Recurrent Clostridioides difficile infection Refractory Irritable Bowel Syndrome (IBS) recurrent Clostridioides difficile infection refractory IBS refractory irritable bowel syndrome decolonisation of multi-drug resistant organisms Treatment of recurrent Clostridioides difficile infections (CDI). Restoration of gut microbiota after conventional therapies fail."]],"ideal_answer":["Faecal microbiota transplantation (FMT) is primarily used in children under 19 years of age to treat recurrent Clostridioides difficile infection, where it is considered safe and effective. Additionally, it is being explored as a potential alternative treatment for adolescents with refractory irritable bowel syndrome (IBS). Further studies are needed to evaluate its efficacy in other conditions."],"id":"6593d1b806a2ea257c000017","type":"list","body":"What are the uses for faecal microbiota transplantation (FMT) in children under 19 years of age?"},{"documents":[{"golden":false,"id":"24383711"},{"golden":false,"id":"37068899"},{"golden":false,"id":"37182535"},{"golden":false,"id":"36604132"},{"golden":false,"id":"19131419"},{"golden":false,"id":"34122587"},{"golden":true,"id":"11471256"},{"golden":true,"id":"29256116"},{"golden":true,"id":"33178370"},{"golden":false,"id":"29508706"},{"golden":false,"id":"34756191"},{"golden":false,"id":"30169202"},{"golden":false,"id":"33333071"},{"golden":false,"id":"15636651"},{"golden":false,"id":"31974673"},{"golden":false,"id":"20692632"},{"golden":false,"id":"31818728"},{"golden":false,"id":"30597490"},{"golden":true,"id":"23944206"},{"golden":false,"id":"31763206"},{"golden":false,"id":"34407568"},{"golden":false,"id":"34660494"},{"golden":false,"id":"36908280"},{"golden":false,"id":"36812513"},{"golden":false,"id":"23577792"},{"golden":false,"id":"34612847"},{"golden":false,"id":"33083117"},{"golden":true,"id":"14750274"},{"golden":false,"id":"10966280"},{"golden":false,"id":"37538442"},{"golden":false,"id":"36215085"},{"golden":false,"id":"35435886"},{"golden":false,"id":"32710239"},{"golden":false,"id":"35626903"},{"golden":false,"id":"36794932"},{"golden":false,"id":"34887229"},{"golden":false,"id":"38084084"},{"golden":false,"id":"32861227"},{"golden":false,"id":"36279244"},{"golden":false,"id":"35263468"},{"golden":false,"id":"34760604"},{"golden":false,"id":"31063297"},{"golden":false,"id":"36677457"},{"golden":false,"id":"17561989"},{"golden":false,"id":"38202177"},{"golden":false,"id":"36972964"},{"golden":true,"id":"31983492"},{"golden":false,"id":"37599641"},{"golden":false,"id":"32471330"},{"golden":false,"id":"34047717"},{"golden":false,"id":"36823168"},{"golden":false,"id":"14523646"},{"golden":false,"id":"33632088"},{"golden":false,"id":"33718302"},{"golden":false,"id":"37439963"},{"golden":false,"id":"38216206"},{"golden":false,"id":"35419955"},{"golden":false,"id":"28757818"},{"golden":false,"id":"31284692"},{"golden":false,"id":"22527068"},{"golden":true,"id":"35575803"},{"golden":false,"id":"37792091"},{"golden":true,"id":"34970683"},{"golden":false,"id":"32553867"},{"golden":false,"id":"34151278"},{"golden":false,"id":"37185949"},{"golden":false,"id":"36755189"},{"golden":false,"id":"33884211"},{"golden":false,"id":"36449658"},{"golden":false,"id":"37981801"},{"golden":false,"id":"35883963"},{"golden":false,"id":"36316072"},{"golden":false,"id":"30975056"},{"golden":false,"id":"31737894"},{"golden":false,"id":"16563181"},{"golden":false,"id":"30919946"},{"golden":false,"id":"27381433"},{"golden":false,"id":"23235609"},{"golden":false,"id":"15675497"},{"golden":false,"id":"31250539"},{"golden":false,"id":"25247401"},{"golden":false,"id":"34806009"},{"golden":false,"id":"37810514"},{"golden":false,"id":"37813544"},{"golden":false,"id":"35186813"},{"golden":false,"id":"38291524"},{"golden":false,"id":"34743180"},{"golden":false,"id":"32841443"},{"golden":false,"id":"36696549"},{"golden":false,"id":"34686556"},{"golden":false,"id":"38190409"},{"golden":false,"id":"25471555"},{"golden":false,"id":"23964797"},{"golden":false,"id":"17636755"},{"golden":false,"id":"26120004"},{"golden":false,"id":"21491390"},{"golden":false,"id":"38243675"},{"golden":false,"id":"25573462"},{"golden":false,"id":"21487941"},{"golden":false,"id":"37842550"},{"golden":false,"id":"28794881"},{"golden":false,"id":"38357132"},{"golden":false,"id":"38356035"},{"golden":false,"id":"38355207"},{"golden":false,"id":"38354362"},{"golden":false,"id":"38353591"},{"golden":false,"id":"38353586"},{"golden":false,"id":"38353160"},{"golden":false,"id":"38352942"},{"golden":false,"id":"38348451"},{"golden":false,"id":"38335761"},{"golden":false,"id":"38333085"},{"golden":false,"id":"38301180"},{"golden":false,"id":"38299935"},{"golden":false,"id":"38298270"},{"golden":false,"id":"38297994"},{"golden":false,"id":"38294868"},{"golden":false,"id":"38294838"},{"golden":false,"id":"21265960"},{"golden":false,"id":"24432208"},{"golden":false,"id":"31073506"},{"golden":false,"id":"17352674"},{"golden":false,"id":"19131954"},{"golden":false,"id":"30677199"},{"golden":false,"id":"20591815"},{"golden":false,"id":"26149711"},{"golden":false,"id":"23622858"},{"golden":false,"id":"30003852"},{"golden":false,"id":"28352704"},{"golden":false,"id":"19298170"},{"golden":false,"id":"38234587"},{"golden":false,"id":"37314247"},{"golden":false,"id":"33124023"},{"golden":false,"id":"36670566"},{"golden":false,"id":"38245889"},{"golden":false,"id":"38011018"},{"golden":false,"id":"32569242"},{"golden":false,"id":"32084099"},{"golden":false,"id":"32695992"},{"golden":false,"id":"31916857"},{"golden":false,"id":"16843019"},{"golden":false,"id":"28596289"},{"golden":false,"id":"33880335"},{"golden":false,"id":"26963758"},{"golden":false,"id":"28771554"},{"golden":false,"id":"28126563"},{"golden":false,"id":"17332201"},{"golden":false,"id":"22801196"},{"golden":false,"id":"27978589"},{"golden":false,"id":"38358334"},{"golden":false,"id":"38357933"},{"golden":false,"id":"38357644"},{"golden":false,"id":"38357643"},{"golden":false,"id":"38357545"},{"golden":false,"id":"38357510"},{"golden":false,"id":"38357174"},{"golden":false,"id":"38149923"},{"golden":false,"id":"31888705"},{"golden":false,"id":"35060658"},{"golden":false,"id":"34711945"},{"golden":false,"id":"35506809"},{"golden":false,"id":"34755170"},{"golden":false,"id":"32984583"},{"golden":false,"id":"37990806"},{"golden":false,"id":"36472648"},{"golden":true,"id":"28220227"},{"golden":false,"id":"39256242"},{"golden":false,"id":"33719208"},{"golden":false,"id":"27516993"},{"golden":false,"id":"39142742"},{"golden":false,"id":"39142741"},{"golden":false,"id":"27014507"},{"golden":false,"id":"38600436"},{"golden":false,"id":"39542423"},{"golden":true,"id":"38513681"},{"golden":false,"id":"30097020"},{"golden":false,"id":"31784324"},{"golden":false,"id":"20390223"},{"golden":false,"id":"38760748"},{"golden":false,"id":"23354787"},{"golden":false,"id":"15451490"},{"golden":false,"id":"27512110"},{"golden":false,"id":"39024619"},{"golden":false,"id":"38499323"},{"golden":false,"id":"39117931"},{"golden":false,"id":"10571765"},{"golden":false,"id":"17945008"},{"golden":false,"id":"31335441"},{"golden":false,"id":"34593484"},{"golden":false,"id":"32126571"},{"golden":false,"id":"29424065"},{"golden":true,"id":"17260130"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":830,"document":"11471256","golden":false,"offsetInEndSection":961,"text":"It is concluded that GMSPS and PRISM are useful methods for identifying and classifying children into low and high risk categories.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1516,"document":"29256116","golden":false,"offsetInEndSection":1694,"text":"ms better than Sepsis-2-based criteria. Our findings support the translation of Sepsis-3 into paediatric-specific sepsis definitions and highlight the importance of robust paedia","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":660,"document":"11471256","golden":false,"offsetInEndSection":735,"text":"A PRISM score of \u003e or \u003d 11 was significantly related to death (p \u003c 0.0001).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":962,"document":"11471256","golden":false,"offsetInEndSection":1046,"text":"GMSPS \u003e or \u003d 8 or a PRISM score \u003e or \u003d 11 are significantly predictive of mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":443,"document":"11471256","golden":false,"offsetInEndSection":590,"text":"A GMSPS \u003e or \u003d 8 was significantly associated with death (p \u003d 0.0001) with a mortality predictivity and specificity of 70% and 92.5%, respectively.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"11471256","golden":false,"offsetInEndSection":192,"text":"Comparison of two different severity scores (Paediatric Risk of Mortality [PRISM] and the Glasgow Meningococcal Sepsis Prognostic Score [GMSPS]) in meningococcal disease: preliminary analysis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"11471256","golden":true,"offsetInEndSection":230,"text":"Two different illness severity scores, Pediatric Risk of Mortality (PRISM) and the Glasgow Meningococcal Sepsis Prognostic Score (GMSPS), were evaluated and compared in meningococcal disease in two paediatric intensive care units.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":518,"document":"10571765","golden":false,"offsetInEndSection":633,"text":"y-four patients developed MODS. The incidence of sepsis, severe sepsis and septic shock in these patients was 10.7%","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":356,"document":"11471256","golden":false,"offsetInEndSection":382,"text":"Overall mortality was 18%.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":409,"document":"31335441","golden":false,"offsetInEndSection":607,"text":"rent paediatric sepsis definitions. Although emerging data support the importance of organ dysfunction as a hallmark of paediatric sepsis, the understanding of host susceptibility to sepsis and to s","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":231,"document":"11471256","golden":false,"offsetInEndSection":355,"text":"Forty-nine children with a median age of 36 months who had meningococcal sepsis confirmed by laboratory data were evaluated.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1018,"document":"31974673","golden":false,"offsetInEndSection":1234,"text":"Levels of MR-proADM were significantly higher in patients who required vasoactive drugs (p?\u003d?0.02) or presented renal dysfunction (p?\u003d?0.004).Conclusion: PCT appeared to be superior to MR-proADM in diagnosing sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1851,"document":"30097020","golden":false,"offsetInEndSection":1969,"text":"tion of therapy greater in those with complex disease. Distinct cohorts with simple and complex courses which may be a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":383,"document":"11471256","golden":false,"offsetInEndSection":442,"text":"The median GMSPS was 3 in survivors and 8 in non-survivors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34407568","golden":false,"offsetInEndSection":106,"text":"BACKGROUND: In adults, sepsis-induced coagulopathy (SIC) is diagnosed by the SIC score, known as sepsis-3.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":479,"document":"34407568","golden":false,"offsetInEndSection":780,"text":"The area under ROC curve (AU-ROC) was used to compare the prognostic values of pSIC with other scores for pediatric sepsis-induced disseminated intravascular coagulation (DIC) to arrive at a 28-day outcome.RESULTS AND CONCLUSIONS: There were 54 patients in the pSIC group and 37 in the non-pSIC group.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":107,"document":"34407568","golden":false,"offsetInEndSection":430,"text":"There is no pediatric SIC (pSIC) score at present.OBJECTIVES: We proposed a pSIC scoring method and evaluated the diagnostic efficacy of the score in the diagnosis of SIC in children.PATIENTS/METHODS: Patient data were retrospectively analyzed from Shanghai Children\u0027s Medical Center between February 2014 and January 2015.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1611,"document":"10966280","golden":false,"offsetInEndSection":2027,"text":"All five scores presented good calibration with no significant differences between observed and predicted mortality (Hosmer-Lemeshow goodness-of-fit test).CONCLUSIONS: The specific GMSPS and the general pediatric severity system PRISM II performed better than the other three scores, being appropriate tools to assess severity of illness at admission to the PICU in children with presumed meningococcal septic shock.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1307,"document":"34407568","golden":false,"offsetInEndSection":1479,"text":"The pSIC score can be used to diagnose SIC in children, screen potential nonovert DIC, and assess the severity of sepsis, organ dysfunction, and 28-day outcome in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":618,"document":"34660494","golden":false,"offsetInEndSection":783,"text":"The population-based transition matrix based on the sepsis illness severity scores in the days following a sepsis diagnosis can describe a sepsis illness trajectory.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":917,"document":"34407568","golden":false,"offsetInEndSection":1117,"text":"The AU-ROC of the pSIC score in predicting 28-day mortality in sepsis was 0.716, with the optimal cutoff value of \u003e3 inferior to that of pediatric sequential organ failure (0.716 vs. 0.921, p?\u003c?.001).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1211,"document":"34407568","golden":false,"offsetInEndSection":1306,"text":"The AU-ROC of pSIC in predicting overt DIC was 0.901, with the best optimal cutoff value of \u003e4.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34407568","golden":false,"offsetInEndSection":132,"text":"Clinical value of pediatric sepsis-induced coagulopathy score in diagnosis of sepsis-induced coagulopathy and prognosis in children.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":431,"document":"34407568","golden":false,"offsetInEndSection":478,"text":"The pSIC score was modified from the SIC score.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1379,"document":"35435886","golden":false,"offsetInEndSection":1659,"text":"The presence of severe AKI was associated with increased inhospital mortality.CONCLUSIONS: In children with severe sepsis, the degree of hemodynamic support as measured by the VIS and the presence of fluid overload may identify patients at increased risk of developing severe AKI.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":153,"document":"36215085","golden":false,"offsetInEndSection":354,"text":"It can be further characterized based on the severity, including severe sepsis, septic shock, multiorgan failure, and refractory septic shock, in the setting of proven infection or suspected infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":355,"document":"36215085","golden":false,"offsetInEndSection":590,"text":"In the pediatric population, sepsis is a complicated and dangerous event with no one specific criteria or definition in the systemic inflammatory response syndrome criteria applicable to every child who is suffering from the condition.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1316,"document":"32710239","golden":false,"offsetInEndSection":1598,"text":"Time spent under PALS targets was not associated with AKI.CONCLUSIONS: The duration of severe systolic hypotension in the first 48 h of pediatric sepsis management is associated with AKI incidence and duration when defined by age, sex, and height norms, but not by PALS definitions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":75,"document":"36215085","golden":false,"offsetInEndSection":152,"text":"Sepsis can be defined in relation to systemic inflammatory response syndrome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":591,"document":"36215085","golden":false,"offsetInEndSection":779,"text":"The goal of this paper is to enhance awareness of the various forms and severities of sepsis in the pediatric population so that swift diagnosis can be made and treatment can be initiated.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":560,"document":"35626903","golden":false,"offsetInEndSection":796,"text":"Further investigation did not reveal any risk factors or immunodeficiency in the patient.DISCUSSION: Sepsis is defined as the presence of systemic inflammatory response syndrome (SIRS) associated with a probable or documented infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":926,"document":"36215085","golden":false,"offsetInEndSection":1161,"text":"The nonspecific nature of this condition can manifest as cardiovascular dysfunction, and hematologic abnormalities to neurologic symptoms, resulting in a late diagnosis, which ultimately leads to an increase in mortality and morbidity.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36215085","golden":false,"offsetInEndSection":73,"text":"Pediatric Sepsis: The Importance of Understanding Criteria for Diagnosis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1456,"document":"36215085","golden":false,"offsetInEndSection":1621,"text":"By increasing awareness of pediatric sepsis, complications, including death, that arise as a result of late diagnosis and treatment would be substantially decreased.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":626,"document":"32861227","golden":false,"offsetInEndSection":941,"text":"pSOFA score had the best predictive ability for mortality (AUC 0.89) followed by hs-CRP at 0 h (AUC 0.86), hs-CRP at 48 h (AUC 0.83), plasma lactate levels at 6 h (AUC 0.83), and plasma lactate at 0 h (AUC 0.67).CONCLUSION: pSOFA score, hs-CRP and hyperlactemia at 6 h can identify septic children at risk of dying.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32861227","golden":false,"offsetInEndSection":381,"text":"AIM: We compared the performance of plasma lactate with high-sensitivity C-reactive protein (hs-CRP), and paediatric sepsis-related organ failure assessment (pSOFA) score for predicting mortality in septic children.METHODS: Serial plasma lactate and hs-CRP levels and pSOFA score was assessed during early hospital stay in septic children.RESULTS: Out of 149 participants, 45 died.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1217,"document":"34887229","golden":false,"offsetInEndSection":1472,"text":"Pooled sensitivity, specificity, and SROC were 80% (95% CI: 64%-90%), 36% (95% CI: 23%-51%), and 59% (95% CI: 55%-63%), respectively.CONCLUSION: This meta-analysis shows that SOFA was superior to SIRS for predicting mortality in PICU patients with sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":66,"document":"34887229","golden":false,"offsetInEndSection":338,"text":"Several scoring systems are used to predict outcome and mortality for pediatric patients with sepsis, but how they compare to each other in terms of sensitivity and specificity is unclear.METHODS: The systematic literature review was performed following PRISMA guidelines.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34660494","golden":false,"offsetInEndSection":132,"text":"Pediatric sepsis is a heterogeneous disease with varying physiological dynamics associated with recovery, disability, and mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":133,"document":"34660494","golden":false,"offsetInEndSection":346,"text":"Using risk scores generated from a sepsis prediction model to define illness states, we used Markov chain modeling to describe disease dynamics over time by describing how children transition among illness states.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":348,"document":"38084084","golden":false,"offsetInEndSection":638,"text":"Advances in understanding sepsis pathophysiology highlight a need to update the definition and diagnostic criteria for pediatric sepsis and septic shock, whereas new data support an increasing role for automated screening algorithms and biomarker combinations to assist earlier recognition.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":942,"document":"34660494","golden":false,"offsetInEndSection":1113,"text":"Stochastic modeling of transitions in sepsis illness severity scores can be useful in describing the variation in transitions made by patient and clinical characteristics.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":784,"document":"34660494","golden":false,"offsetInEndSection":941,"text":"Using the entropy based on Markov chain transition matrices, we found a different structure of dynamic transitions based on ventilator use but not age group.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":503,"document":"34660494","golden":false,"offsetInEndSection":617,"text":"We used Shannon entropy to quantify the differences in transition matrices stratified by clinical characteristics.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1322,"document":"31983492","golden":false,"offsetInEndSection":1604,"text":"We did not find statistically significant gene expression differences in patients according to sepsis severity.CONCLUSION: The study demonstrates feasibility of evaluating gene expression profiling data in children evaluated for sepsis in the pediatric emergency department setting.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":667,"document":"31983492","golden":true,"offsetInEndSection":790,"text":"Secondary outcome was sepsis severity, defined as maximum therapy required for shock reversal in the first 3 hospital days.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1298,"document":"34047717","golden":false,"offsetInEndSection":1650,"text":"ROC analysis in the MODS group indicated that serum ferritin \u003e1994.3 ng/mL predicts mortality (AUC 0.73 [95% CI 0.58-0.85]) with sensitivity 66.7% [95% CI 38.4-88%] and specificity 100.0% [95% CI 89.1-100%].CONCLUSIONS: There is clear demarcation of serum ferritin levels that can help differentiation of sepsis severity stages in children with sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":73,"document":"31983492","golden":false,"offsetInEndSection":381,"text":"We aim to determine whether peripheral blood gene expression profiles are associated with pathogen type and sepsis severity in children with suspected sepsis.METHODS: This was a prospective pilot observational study in a tertiary pediatric emergency department with a convenience sample of children enrolled.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":279,"document":"37599641","golden":false,"offsetInEndSection":516,"text":"However, some children develop severe infection accompanied by complications such as sepsis and will require urgent treatment, which may include non-invasive or invasive ventilation and the administration of fluids and vasoactive agents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31983492","golden":false,"offsetInEndSection":72,"text":"STUDY OBJECTIVE: Sepsis recognition is a clinical challenge in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1605,"document":"31983492","golden":false,"offsetInEndSection":1840,"text":"Our results suggest that gene expression profiling may facilitate identification of source pathogen in children with suspected sepsis, which could ultimately lead to improved tailoring of sepsis treatment and antimicrobial stewardship.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1142,"document":"31983492","golden":false,"offsetInEndSection":1321,"text":"We compared the 66 children (54%) with confirmed bacterial or viral infection and found 558 differentially expressed genes, many related to interferon signaling or viral immunity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":166,"document":"37599641","golden":false,"offsetInEndSection":278,"text":"Most group A Streptococcus infections in children are mild and respond positively to treatment with antibiotics.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":791,"document":"31983492","golden":false,"offsetInEndSection":1141,"text":"We drew peripheral blood for ribonucleic acid isolation at the sepsis protocol activation, obtained gene expression measures with the GeneChip Human Gene 2.0 ST Array, and conducted differential expression analysis.RESULTS: We collected ribonucleic acid samples from a convenience sample of 122 children with suspected sepsis and 12 healthy controls.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33718302","golden":false,"offsetInEndSection":202,"text":"Background: The 2005 International Pediatric Sepsis Consensus definition is considered to lack specificity and may lead to the admission of low-risk patients to the pediatric intensive care unit (PICU).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1453,"document":"35419955","golden":false,"offsetInEndSection":1824,"text":"Vital signs, blood tests and clinical sepsis scores, including Systemic Inflammatory Response Syndrome, quick Sequential Organ Failure Assessment and quick Paediatric Logistic Organ Dysfunction-2, performed poorly as predictors of these outcomes (area under the receiver operating characteristic curve?\u003c0.6).CONCLUSIONS: Very few patients with FN required ICU-level care.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1732,"document":"31284692","golden":false,"offsetInEndSection":1864,"text":"Conclusion: Our findings revealed that the requirement for CRRT in patients with severe sepsis is predictive of increased mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35575803","golden":false,"offsetInEndSection":244,"text":"Importance: Pediatric sepsis definitions have evolved, and some have proposed using the measure used in adults to quantify organ dysfunction, a Sequential Organ Failure Assessment (SOFA) score of 2 or more in the setting of suspected infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1274,"document":"36755189","golden":false,"offsetInEndSection":1779,"text":"The AUC values for PSP, copeptin, and APOA5 were 0.709, 0.705, and 0.571, respectively, with sensitivities of 74%, 58%, and 58% for mortality prediction.CONCLUSIONS: PSP, copeptin, and APOA5 are promising diagnostic biomarkers for pediatric sepsis but inadequate predictors of mortality.IMPACT: Apolipoprotein A-V (APOA5), copeptin, and pancreatic stone protein (PSP) are acute-phase proteins with diagnostic value in evaluating critically ill pediatric patients with sepsis and detecting sepsis severity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2124,"document":"35575803","golden":false,"offsetInEndSection":2641,"text":"The pSOFA score had similar discrimination for hospital mortality in all ED visits (area under receiver operating characteristic curve, 0.81; 95% CI, 0.79-0.82) and the subset with suspected infection (area under receiver operating characteristic curve, 0.82; 95% CI, 0.80-0.84).Conclusions and Relevance: In a large, multicenter study of pediatric ED visits, a pSOFA score of 2 or more was uncommon and associated with increased hospital mortality yet had poor sensitivity as a screening tool for hospital mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1407,"document":"34151278","golden":false,"offsetInEndSection":1757,"text":"Using spectral clustering, we stratified pediatric sepsis patients into two clusters differing in septic shock prevalence, mortality, and proportion of patients adequately fluid resuscitated.CONCLUSIONS: We demonstrate the applicability of our methodology for early prediction and stratification for risk of septic shock in pediatric sepsis patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34970683","golden":false,"offsetInEndSection":960,"text":"CONTEXT: Multiple scores exist to characterize organ dysfunction in children.OBJECTIVE: To review the literature on multiple organ dysfunction (MOD) scoring systems to estimate severity of illness and to characterize the performance characteristics of currently used scoring tools and clinical assessments for organ dysfunction in critically ill children.DATA SOURCES: Electronic searches of PubMed and Embase were conducted from January 1992 to January 2020.STUDY SELECTION: Studies were included if they evaluated critically ill children with MOD, evaluated the performance characteristics of scoring tools for MOD, and assessed outcomes related to mortality, functional status, organ-specific outcomes, or other patient-centered outcomes.DATA EXTRACTION: Data were abstracted into a standard data extraction form by a task force member.RESULTS: Of 1152 unique abstracts screened, 156 full text studies were assessed including a total of 54 eligible studies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36449658","golden":false,"offsetInEndSection":222,"text":"PURPOSE OF REVIEW: Organ dysfunction severity scores (sequential organ failure assessment or SOFA) are commonly used in the adult and pediatric populations when assessing risk of mortality and adverse outcomes from sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1266,"document":"34970683","golden":false,"offsetInEndSection":1816,"text":"Cut-offs for specific organ dysfunction criteria, diagnostic elements included, and use of counts versus weighting varied substantially.LIMITATIONS: While scores demonstrated an increase in mortality associated with the severity and number of organ dysfunctions, the performance ranged widely.CONCLUSIONS: The multitude of scores on organ dysfunction to assess severity of illness indicates a need for unified and data-driven organ dysfunction criteria, derived and validated in large, heterogenous international databases of critically ill children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2780,"document":"35575803","golden":false,"offsetInEndSection":2897,"text":"Among patients with suspected infection, patients with pSOFA-defined septic shock demonstrated the highest mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1106,"document":"35575803","golden":false,"offsetInEndSection":1540,"text":"In the subset with suspected infection, visit meeting criteria for sepsis (suspected infection with a pSOFA score of 2 or more) and septic shock (suspected infection with vasoactive infusion and serum lactate level \u003e18.0 mg/dL) were identified.Main Outcomes and Measures: Test characteristics of pSOFA scores of 2 or more during the ED stay for hospital mortality.Results: A total of 3?999?528 (female, 47.3%) ED visits were included.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2642,"document":"35575803","golden":false,"offsetInEndSection":2779,"text":"Conversely, children with a pSOFA score of 2 or less were at very low risk of death, with high specificity and negative predictive value.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":675,"document":"37599641","golden":false,"offsetInEndSection":848,"text":"This article gives an overview of group A Streptococcus infection, including two rare but severe complications, streptococcal toxic shock syndrome and necrotising fasciitis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37599641","golden":false,"offsetInEndSection":165,"text":"Group A Streptococcus bacteria can cause various pyogenic infections such as tonsillitis, pharyngitis, scarlet fever, impetigo, erysipelas, cellulitis and pneumonia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":849,"document":"37599641","golden":false,"offsetInEndSection":1060,"text":"It uses a fictionalised case study to examine the management of the deteriorating child with suspected group A Streptococcus infection, including respiratory support, haemodynamic support and symptom management.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37599641","golden":false,"offsetInEndSection":80,"text":"Managing the deteriorating child with suspected group A Streptococcus infection.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":233,"document":"35883963","golden":false,"offsetInEndSection":384,"text":"These infections can lead to severe pathological conditions, such as mediastinitis, sepsis, and especially airway impairment with difficult management.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":517,"document":"37599641","golden":false,"offsetInEndSection":674,"text":"In some instances, for example if there are no beds available in the paediatric intensive care unit, these interventions may be undertaken in a ward setting.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1545,"document":"22527068","golden":false,"offsetInEndSection":1619,"text":"c shock in Japanese PICUs was ~19 %. Haematological disorders and presence","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1279,"document":"22527068","golden":false,"offsetInEndSection":1469,"text":"ose without shock (5 %). The presences of existing haematological disorders (OR 8.97, 95 % CI, 1.56-51.60) and shock (OR 5.35, 1.04-27.44) were significant factors associated with mortality ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1162,"document":"22527068","golden":false,"offsetInEndSection":1278,"text":"cted mortality (17.7 %). The mortality rate in patients with shock was significantly increased to 28 % compared to t","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1240,"document":"31737894","golden":false,"offsetInEndSection":1414,"text":"ange], 15.1 [6.3-27.1] vs 3.6 [0.7-11.1]%; P \u003c0.001). Cumulative %FO was associated with increased mortality (adjusted odds ratio 1.08, 95% confidence interval 1.03-1.13; P \u003d","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":278,"document":"16563181","golden":false,"offsetInEndSection":543,"text":"Significant correlations were demonstrated between admission chemokine levels and the Paediatric Risk of Mortality score, the Disseminated Intravascular Coagulopathy score, the Sequential Organ Failure Assessment score and laboratory parameters of disease severity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":544,"document":"16563181","golden":false,"offsetInEndSection":728,"text":"Additionally, nonsurvivors had much higher levels of chemokines compared with survivors, and the chemokine levels predicted mortality with a high degree of sensitivity and specificity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":154,"document":"30919946","golden":false,"offsetInEndSection":275,"text":" \u003c10?years. Glucocorticosteroids are currently recommended in septic children with fluid or catecholamine resistant refra","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":276,"document":"30919946","golden":false,"offsetInEndSection":376,"text":"tory shock. Glucocorticosteroids are widely used for severe sepsis in paediatric intensive care unit","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":592,"document":"27381433","golden":false,"offsetInEndSection":709,"text":"ion to PICU and analysed for 25-OH-D levels. Severity of illness and vasopressor use were assessed using PRISM, PELOD","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":979,"document":"27381433","golden":false,"offsetInEndSection":1239,"text":"as 22.8 (1.0)ng/ml. The prevalence of VDD was 43.3%. VDD was associated with vasopressors use (RR1.6; 95%CI: 1.2-2.3; P\u003c.01), mechanical ventilation (RR2.2; 95%CI: 1.2-3.9, P\u003c.01), septic shock (RR1.9; 95%CI: 1.3-2.9, P\u003c.001), and fluid bolus\u003e40ml/kg in the fi","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37810514","golden":false,"offsetInEndSection":177,"text":"Retracted: Analysis of the Relevant Vital Signs and Infection of Sepsis Patients and to Explore the Influencing Factors of Acute Lung Injury/Acute Respiratory Distress Syndrome.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37813544","golden":false,"offsetInEndSection":180,"text":"BACKGROUND: Two subphenotypes of acute respiratory distress syndrome (ARDS), hypoinflammatory and hyperinflammatory, have been reported in adults and in a single paediatric cohort.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1130,"document":"37813544","golden":false,"offsetInEndSection":1429,"text":"Both cohorts demonstrated overlap with adult subphenotypes when assessed using parsimonious classifiers.INTERPRETATION: We identified hypoinflammatory and hyperinflammatory subphenotypes of paediatric ARDS from two separate cohorts with utility for prognostic and potentially predictive, enrichment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38291524","golden":false,"offsetInEndSection":146,"text":"BACKGROUND: Sepsis is a severe condition characterized by acute organ dysfunction resulting from an imbalanced host immune response to infections.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":953,"document":"37813544","golden":false,"offsetInEndSection":1129,"text":"In both cohorts, hyperinflammatory subjects had greater illness severity, more sepsis and higher mortality (41% and 28% in hyperinflammatory vs 11% and 7% in hypoinflammatory).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":265,"document":"37813544","golden":false,"offsetInEndSection":509,"text":"We aimed to identify subphenotypes in two large observational cohorts of paediatric ARDS and assess their congruence with prior descriptions.METHODS: We performed latent class analysis (LCA) separately on two cohorts using biomarkers as inputs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":580,"document":"37813544","golden":false,"offsetInEndSection":952,"text":"Finally, we assessed overlap with adult cohorts using parsimonious classifiers.FINDINGS: In two cohorts from the Children\u0027s Hospital of Philadelphia (n\u003d333) and from a multicentre study based at the University of California San Francisco (n\u003d293), LCA identified two subphenotypes defined by differential elevation of biomarkers reflecting inflammation and endotheliopathy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1430,"document":"37813544","golden":false,"offsetInEndSection":1539,"text":"Future paediatric ARDS trials should identify and leverage biomarker-defined subphenotypes in their analysis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":510,"document":"37813544","golden":false,"offsetInEndSection":579,"text":"Subphenotypes were compared on clinical characteristics and outcomes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":181,"document":"37813544","golden":false,"offsetInEndSection":264,"text":"The relevance of these subphenotypes in paediatrics requires further investigation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":529,"document":"25471555","golden":false,"offsetInEndSection":621,"text":"sive Care Registry. We included children younger than 16 years with invasive infection, seps","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1590,"document":"23964797","golden":false,"offsetInEndSection":1705,"text":"evere dehydration (7.48%). A total of 43 AKI patients (3.4%) died during their hospital stay; 15 (34.9%) of the 43 ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1309,"document":"17636755","golden":false,"offsetInEndSection":1608,"text":"th severe sepsis (pooled RR 0.92, 95% confidence interval (CI) 0.72 to 1.18; P \u003d 0.50, I(2) \u003d 72%). The effectiveness of APC did not seem to be associated with the degree of severity of sepsis (two studies): for an APACHE II score less than 25 the RR was 1.04 (95% CI 0.89 to 1.21; P \u003d 0.70), and in","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1851,"document":"17636755","golden":false,"offsetInEndSection":1977,"text":"early because there was little chance of reaching the efficacy endpoint by completion of the trial.AUTHORS\u0027 CONCLUSIONS: This ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1978,"document":"17636755","golden":false,"offsetInEndSection":2082,"text":"eview suggests that APC should not be used in sepsis with an APACHE II score of less than 25 or, in paed","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2083,"document":"17636755","golden":false,"offsetInEndSection":2256,"text":"atric patients. There is very weak evidence supporting APC use in patients with severe sepsis and at high-risk of death. As a result, policy-makers, clinicians and academics","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":702,"document":"26120004","golden":false,"offsetInEndSection":926,"text":" 24 hours of admission. The occurrence of septic shock, multiple organ dysfunction syndrome (MODS) and healthcare-associated infection (HCAI), need for mechanical ventilation and catecholamines, length of PICU stay and morta","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1299,"document":"26120004","golden":false,"offsetInEndSection":1523,"text":"iables or risk factors for VDD. Although there was a trend toward increased PRISM III score, septic shock, MODS, HCAI, need for mechanical ventilation and catecholamines, length of PICU stay, and mortality, the difference wa","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1524,"document":"26120004","golden":false,"offsetInEndSection":1684,"text":" not statistically significant.CONCLUSION: A high prevalence of VDD in critically ill children with sepsis was found but it was not associated with greater seve","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1581,"document":"21491390","golden":false,"offsetInEndSection":1683,"text":" associated with an increased risk of bleeding (RR 1.47, 95% CI 1.09 to 2.00; P \u003d 0.01, I(2) \u003d 0%). In","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":685,"document":"38357132","golden":false,"offsetInEndSection":808,"text":"The odds of RDS among neonates with jaundice and sepsis are 4.33- and 1.92-times higher odds compared to their counterparts","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":535,"document":"38356035","golden":false,"offsetInEndSection":582,"text":"A total of 4263 infants were diagnosed with BPD","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":566,"document":"38355207","golden":false,"offsetInEndSection":652,"text":"Initial screenings for sepsis and blood group incompatibility yielded negative results","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":9,"document":"38354362","golden":false,"offsetInEndSection":207,"text":"Time to antibiotic administration (TTA) in \u003c60 minutes for children with neutropenic fever presenting to an emergency room is associated with reduced incidence of sepsis and intensive care admission","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":330,"document":"38353591","golden":false,"offsetInEndSection":393,"text":"All patients met the criteria of severe sepsis or septic shock.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":234,"document":"38353586","golden":false,"offsetInEndSection":317,"text":"Secondary analysis of the Life After Pediatric Sepsis Evaluation prospective study.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1307,"document":"38353160","golden":false,"offsetInEndSection":1398,"text":"Further multicenter prospective data are needed, including infants with early-onset sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":151,"document":"38352942","golden":false,"offsetInEndSection":268,"text":"These mechanisms have been demonstrated in patients with sepsis, hemoglobinopathies, and those receiving transfusions","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":13,"document":"38348451","golden":false,"offsetInEndSection":184,"text":" Pediatric sepsis (PS) is a life-threatening infection associated with high mortality rates, necessitating a deeper understanding of its underlying pathological mechanisms","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":556,"document":"38335761","golden":false,"offsetInEndSection":631,"text":"Groups were compared regarding in-hospital mortality and neonatal outcomes.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38333085","golden":false,"offsetInEndSection":124,"text":"Risk factors for urinary tract infection in infants with unexplained hyperbilirubinemia: a single center case-control study.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":9,"document":"38301180","golden":false,"offsetInEndSection":171,"text":"This study aimed to identify the patient characteristics of children with febrile neutropenia, the associated bacterial organisms, and their sensitivity patterns.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2221,"document":"38299935","golden":false,"offsetInEndSection":2335,"text":"ROTEM and aPTT-CWA were valuable diagnostic tools in critically ill children who might require point-of-care tests","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":986,"document":"38298270","golden":false,"offsetInEndSection":1091,"text":"Indeed, the patient was infected with nosocomial hepatitis A and URSOBIL (300 mg/BID/Po) was administered","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":938,"document":"38297994","golden":false,"offsetInEndSection":1078,"text":"Fourteen (3.6%) fulfilled Common Terminology Criteria for Adverse Events (CTCAE) grade 2 criteria with clinically significant hepatotoxicity","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":327,"document":"38294868","golden":false,"offsetInEndSection":558,"text":"Neonatal demographics and clinical outcomes including necrotizing enterocolitis, severe retinopathy of prematurity, bronchopulmonary dysplasia, late-onset sepsis, days on parenteral nutrition (PN), and length-of-stay were collected","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1004,"document":"38294838","golden":false,"offsetInEndSection":1254,"text":"Infectious and noninfectious complications, including anastomotic leaks, surgical site infections, urinary tract infections, pneumonia, sepsis, septic shock, postoperative length of stay, readmission, and reoperation, were the main outcomes measured.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21265960","golden":false,"offsetInEndSection":112,"text":"Severe sepsis is defined as organ dysfunction in the setting of systemic inflammatory response due to infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1290,"document":"20591815","golden":false,"offsetInEndSection":1522,"text":"The pRIFLE definition was more sensitive for AKI detection, but the AKIN definition was more strongly related to outcomes.CONCLUSIONS: AKI is common and associated with poorer outcomes in non-critically ill children treated with AG.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":276,"document":"21265960","golden":false,"offsetInEndSection":533,"text":"The major obstacles to improved outcomes in severe sepsis are deficiencies in healthcare staffing and education, haphazard recognition and response to early clinical deterioration and deviation from optimal management as defined by international guidelines.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":534,"document":"21265960","golden":false,"offsetInEndSection":637,"text":"Major treatment errors were identified in 30% of patients with bacteraemia in one recent investigation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":113,"document":"21265960","golden":false,"offsetInEndSection":275,"text":"With changes in population age, comorbidity and the delivery of medical care, severe sepsis is increasingly common, and can present in every area of the hospital.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":622,"document":"19131954","golden":false,"offsetInEndSection":791,"text":"Evidence is now emerging that the accompanying inflammatory response varies with the severity grade of sepsis, which is highly dependent on the extent of cecal ligation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":343,"document":"24432208","golden":false,"offsetInEndSection":523,"text":"We describe the case of a paediatric patient on ECMO with severe pneumonia and sepsis, who had subtherapeutic exposure of caspofungin despite normal to high dosages of caspofungin.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":638,"document":"21265960","golden":false,"offsetInEndSection":760,"text":"Against this, substantial reductions in mortality can be achieved by improving recognition, urgent care and resuscitation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":761,"document":"21265960","golden":false,"offsetInEndSection":968,"text":"With a view to improving survival in sepsis, collaborative efforts are required to measure outcomes, implement guidelines and secure adequate funding for ongoing practice improvement, education and research.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30003852","golden":false,"offsetInEndSection":530,"text":"BACKGROUND: Vitamin D deficiency in mothers and neonates is being recognised increasingly as a leading cause of many adverse health effects in the newborn infant, including sepsis.METHODS: A prospective observational study was conducted at a tertiary care Paediatric teaching hospital in northern India to assess vitamin D deficiency as a possible risk factor for late-onset sepsis (LOS) in term and late preterm neonates and also to examine the correlation between maternal and infant vitamin D levels during the neonatal period.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":316,"document":"17352674","golden":false,"offsetInEndSection":495,"text":"Sepsis was defined as suspected or microbiologically proven infection together with SIRS, while severe sepsis was defined as sepsis together with sepsis-induced organ dysfunction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1076,"document":"30677199","golden":false,"offsetInEndSection":1308,"text":"Eleven children (37%) required mechanical ventilation for a median duration of 62?h, 22 (73%) received fluid boluses and 7 (23%) were treated with vasoactive agents for a median duration of 53?h. Median length of stay was 2.62?days.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"26149711","golden":false,"offsetInEndSection":82,"text":"Severe sepsis is defined by organ failure, often of the kidneys, heart, and brain.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1640,"document":"38234587","golden":false,"offsetInEndSection":1846,"text":"However, this association was not causally mediated by PERSEVERE-II biomarkers.CONCLUSIONS: Our data demonstrate the influence of cumulative %PFB on the risk of complicated course in pediatric septic shock.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":141,"document":"37314247","golden":false,"offsetInEndSection":1053,"text":"We sought to examine the frequency of and factors associated with DoC in children with sepsis-induced organ failure.DESIGN: Secondary analysis of the multicenter Phenotyping Sepsis-Induced Multiple Organ Failure Study (PHENOMS).SETTING: Nine tertiary care PICUs in the United States.PATIENTS: Children less than 18 years old admitted to a PICU with severe sepsis and at least one organ failure during a PICU stay.INTERVENTIONS: None.MEASUREMENTS AND MAIN RESULTS: The primary outcome was frequency of DoC, defined as Glasgow Coma Scale (GCS) less than 12 in the absence of sedatives during an ICU stay, among children with severe sepsis and the following: single organ failure, nonphenotypeable multiple organ failure (MOF), MOF with one of the PHENOMS phenotypes (immunoparalysis-associated MOF [IPMOF], sequential liver failure-associated MOF, thrombocytopenia-associated MOF), or MOF with multiple phenotypes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1847,"document":"38234587","golden":false,"offsetInEndSection":1998,"text":"Contrary to our previous report, this risk was largely driven by patients categorized as having a high mortality risk based on PERSEVERE-II biomarkers.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38234587","golden":false,"offsetInEndSection":140,"text":"OBJECTIVES: Post-ICU admission cumulative positive fluid balance (PFB) is associated with increased mortality among critically ill patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1087,"document":"38234587","golden":false,"offsetInEndSection":1393,"text":"Cox proportional hazard regression models with adjustment for PERSEVERE-II mortality probability, presence of sepsis-associated acute kidney injury on day 3, and use of CRRT, demonstrated that time-dependent variable days 1-7%PFB was independently associated with an increased hazard of complicated course.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":852,"document":"38234587","golden":false,"offsetInEndSection":1086,"text":"Pediatric Sepsis Biomarker Risk Model (PERSEVERE)-II biomarkers were used to assign mortality probability and categorize patients into high mortality (n \u003d 91), intermediate mortality (n \u003d 134), and low mortality (n \u003d 456) risk strata.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":708,"document":"38234587","golden":false,"offsetInEndSection":851,"text":"Primary outcome of interest was complicated course defined as death or persistence of greater than or equal to two organ dysfunctions by day 7.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1999,"document":"38234587","golden":false,"offsetInEndSection":2227,"text":"Incorporation of such prognostic enrichment tools in randomized trials of restrictive fluid management or early initiation of de-escalation strategies may inform targeted application of such interventions among at-risk patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":296,"document":"31916857","golden":false,"offsetInEndSection":957,"text":"The updated Pediatric Sepsis Biomarker Risk Model (PERSEVERE-II) is a validated, multibiomarker prognostic enrichment strategy to estimate baseline mortality risk in pediatric septic shock.Objectives: To assess the association between PERSEVERE-II mortality probability and the development of severe, sepsis-associated AKI on Day 3 (D3 SA-AKI) in pediatric septic shock.Methods: We performed secondary analysis of a prospective observational study of children with septic shock in whom the PERSEVERE biomarkers were measured to assign a PERSEVERE-II baseline mortality risk.Measurements and Main Results: Among 379 patients, 65 (17%) developed severe D3 SA-AKI.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1394,"document":"38234587","golden":false,"offsetInEndSection":1639,"text":"Risk-stratified analyses revealed that each 10% increase in days 1-7 %PFB was associated with increased hazard of complicated course only among patients with high mortality risk strata (adjusted hazard ratio 1.24 (95% CI, 1.08-1.43), p \u003d 0.003).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":152,"document":"24432208","golden":false,"offsetInEndSection":301,"text":"Extracorporeal membrane oxygenation (ECMO) allows prolonged cardiopulmonary support in patients with life-threatening respiratory or cardiac failure.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"24432208","golden":false,"offsetInEndSection":70,"text":"Insufficient serum caspofungin levels in a paediatric patient on ECMO.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":302,"document":"24432208","golden":false,"offsetInEndSection":342,"text":"Pharmacokinetics may be altered by ECMO.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24432208","golden":false,"offsetInEndSection":75,"text":"Caspofungin, aechinocandin, is a relatively new lipophilic antifungal drug.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":76,"document":"24432208","golden":false,"offsetInEndSection":151,"text":"Little is known concerning the pharmacokinetics of caspofungin in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":524,"document":"24432208","golden":false,"offsetInEndSection":565,"text":"Therapeutic drug monitoring is warranted.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1596,"document":"38358334","golden":false,"offsetInEndSection":1671,"text":"There was 1 possibly related death (sepsis with attendant hepatic failure).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38357933","golden":false,"offsetInEndSection":127,"text":"Understanding the kinetics of dengue viruses in the bloodstream can provide insights into the clinical outcomes of the disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1205,"document":"38357644","golden":false,"offsetInEndSection":1254,"text":"The data analysis involved 22,633 sepsis patients","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":804,"document":"38357643","golden":false,"offsetInEndSection":908,"text":"In the studied cohort of 32,971 sepsis patients, 2,327 were identified as meeting the inclusion criteria","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":271,"document":"38357545","golden":false,"offsetInEndSection":299,"text":"nosuppression and substantia","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1525,"document":"38357510","golden":false,"offsetInEndSection":1639,"text":"Pulmonary hemorrhage, tension pneumothorax and early onset sepsis were independent risk factors for high-grade IVH","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":212,"document":"38357174","golden":false,"offsetInEndSection":393,"text":"In retrospective observational study, during October 2019 to December 2021, 145 patients with septic shock treated in our hospital were enrolled by the method of observational study","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1695,"document":"37842550","golden":false,"offsetInEndSection":2154,"text":"After adjusting for severity of organ dysfunction, haematological cancer, prior stem cell transplantation and age, phenotype 1 was associated with an adjusted OR of death at 90-day of 1.9 (1.04-3.34) in the European cohort and 1.6 (1.2-2.2) in the U.S. cohort.Interpretation: We identified two clinically-relevant sepsis phenotypes in paediatric cancer patients that are reproducible across two international, multicentre cohorts with prognostic implications.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1111,"document":"37842550","golden":false,"offsetInEndSection":1289,"text":"We then tested the association of the phenotypes with clinical outcomes in both cohorts.Findings: LCA identified two distinct phenotypes that were comparable across both cohorts.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1467,"document":"37842550","golden":false,"offsetInEndSection":1694,"text":"Patients with phenotype 1 had a higher 90-day mortality (European cohort 29.2% versus 13.4%, U.S. cohort 27.3% versus 11.4%, p?\u003c?0.001) and received more vasopressor and renal replacement therapy than patients with phenotype 2.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1290,"document":"37842550","golden":false,"offsetInEndSection":1466,"text":"Phenotype 1 was characterised by lower serum bicarbonate and albumin, markedly increased lactate and hepatic, renal, and coagulation abnormalities when compared to phenotype 2.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1547,"document":"31888705","golden":false,"offsetInEndSection":1977,"text":"Multivariable analyses identified lower lactate, the absence of cardiac arrest prior to ECMO, and the central cannulation (OR 0.31, 95% CI 0.10-0.98, p?\u003d?0.046) as significant predictors of survival for those treated with VA-ECMO.CONCLUSIONS: This binational study demonstrates that a rapidly available sepsis mortality prediction model can define thresholds for survival benefit in children with septic shock considered for ECMO.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":190,"document":"37842550","golden":false,"offsetInEndSection":800,"text":"Given that paediatric cancer patients with sepsis have different host response and pathogen profiles and higher mortality rates when compared to non-cancer patients, we determined whether unique, reproducible, and clinically-relevant sepsis phenotypes exist in this specific patient population.Methods: We studied patients with underlying malignancies admitted with sepsis to one of 25 paediatric intensive care units (PICUs) participating in two large, multi-centre, observational cohorts from the European SCOTER study (n?\u003d?383 patients; study period between January 1, 2018 and January 1, 2020) and the U.S.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34711945","golden":false,"offsetInEndSection":103,"text":"Sepsis, a dysregulated host response to infection, has been difficult to accurately define in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37842550","golden":false,"offsetInEndSection":95,"text":"Background: Identifying phenotypes in sepsis patients may enable precision medicine approaches.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":934,"document":"37842550","golden":false,"offsetInEndSection":1110,"text":"We independently used latent class analysis (LCA) in both cohorts to identify phenotypes using demographic, clinical, and laboratory data from the first 24?h of PICU admission.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1223,"document":"36472648","golden":false,"offsetInEndSection":1368,"text":"Conclusion: Beyond malodorous urine, A. urinae detection is associated with more severe presentations including UTI in the paediatric population.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":439,"document":"28220227","golden":false,"offsetInEndSection":738,"text":"Through multivariable logistic regression, a pediatric sepsis score was derived using variables available within 60?min of ICU admission.RESULTS: Of 42,523 pediatric admissions, 4403 children were admitted with invasive infection, including 1697 diagnosed as having sepsis/septic shock on admission.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1538,"document":"28220227","golden":false,"offsetInEndSection":1813,"text":"The sepsis score performed comparably when applied to all children admitted with invasive infection (0.810; 0.781-0.840).CONCLUSIONS: We observed mortality patterns specific to pediatric sepsis that support the need for specialized definitions of sepsis severity in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1814,"document":"28220227","golden":false,"offsetInEndSection":2005,"text":"We demonstrated the importance of lactate, cardiovascular, and respiratory derangements at ICU admission for the identification of children with substantially higher risk of sepsis mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1280,"document":"33719208","golden":false,"offsetInEndSection":1631,"text":"Contrastingly, morbid obesity was not associated with mortality among PSS patients and but was associated with 1.37 times (CI: 1.06-1.78, p \u003d 0.01) increased risk of mortality among paediatric patients with septic shock.CONCLUSIONS: Paediatric obesity is associated with reduced mortality among patients with PSS, with the exception of morbid obesity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28220227","golden":false,"offsetInEndSection":325,"text":"PURPOSE: The definitions of sepsis and septic shock have recently been revised in adults, but contemporary data are needed to inform similar approaches in children.METHODS: Multicenter cohort study including children \u003c16?years admitted with sepsis or septic shock to ICUs in Australia and New Zealand in the period 2012-2015.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":824,"document":"28220227","golden":false,"offsetInEndSection":972,"text":"The presence of septic shock as defined by the 2005 consensus was sensitive but not specific in predicting mortality (AUC?\u003d?0.69; 95% CI 0.65-0.72).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1374,"document":"17260130","golden":false,"offsetInEndSection":1649,"text":"We obtained four groups using CRP values and five groups using PCT values that classified a significant percentage of patients according to the severity of the different SIRS groups.CONCLUSIONS: PCT is a better diagnostic marker of sepsis in critically ill children than CRP.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":326,"document":"28220227","golden":true,"offsetInEndSection":438,"text":"We assessed septic shock criteria at ICU admission to define sepsis severity, using 30-day mortality as outcome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1079,"document":"28220227","golden":false,"offsetInEndSection":1298,"text":"Multivariate models showed that oxygenation markers, ventilatory support, hypotension, cardiac arrest, serum lactate, pupil responsiveness, and immunosuppression were the best-performing predictors (0.843; 0.811-0.875).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27516993","golden":false,"offsetInEndSection":174,"text":"BACKGROUND: Multiple severity scoring systems have been devised and evaluated in adult sepsis, but a simplified scoring model for pediatric sepsis has not yet been developed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1235,"document":"27516993","golden":false,"offsetInEndSection":1625,"text":"The areas under ROC (AROC) were 0.836 for accurate discriminate model, and 0.825 for simplified scoring model in validation group.CONCLUSIONS: The proposed disease severity scoring model for pediatric sepsis showed adequate discriminatory capacity and sufficient accuracy, which has important clinical significance in evaluating the severity of pediatric sepsis and predicting its progress.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":994,"document":"39142742","golden":false,"offsetInEndSection":1291,"text":"erious evidence gaps remain in key areas of paediatric sepsis care, especially surrounding recognition, common interventions, and survivor support, and to this end we offer a research roadmap for the next decade that could accelerate targeted diagnostics and personalised use of immunomodulation. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1553,"document":"39142741","golden":false,"offsetInEndSection":1791,"text":"ecent insights into post-discharge sequelae after paediatric sepsis, ranging from late mortality and persistent neurodevelopmental impairment to reduced health-related quality of life, show how common post-sepsis syndrome is in children. ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":80,"document":"34593484","golden":false,"offsetInEndSection":250,"text":"y worldwide. Assessing concern from parents and healthcare professionals to determine disease severity in a child evaluated for sepsis remains a field requiring further i","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27014507","golden":false,"offsetInEndSection":95,"text":"Severe sepsis and septic shock remains a leading cause of mortality and morbidity in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38513681","golden":false,"offsetInEndSection":122,"text":"BACKGROUND: Sepsis is defined as dysregulated host response to infection that leads to life-threatening organ dysfunction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2592,"document":"38513681","golden":false,"offsetInEndSection":3456,"text":"In the external EUCLIDS validation dataset (n\u003d362), the disease class and disease severity predicted organ dysfunction at time of sampling with an AUC of 70?1% (95% CI 44?1-96?2) for patients with predicted bacterial infection and 69?6% (53?1-86?0) for patients with predicted viral infection.INTERPRETATION: In children evaluated for sepsis, novel host transcriptomic signatures specific for bacterial and viral infection can identify dysregulated host response leading to organ dysfunction.FUNDING: Australian Government Medical Research Future Fund Genomic Health Futures Mission, Children\u0027s Hospital Foundation Queensland, Brisbane Diamantina Health Partners, Emergency Medicine Foundation, Gold Coast Hospital Foundation, Far North Queensland Foundation, Townsville Hospital and Health Services SERTA Grant, and Australian Infectious Diseases Research Centre.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1355,"document":"30097020","golden":false,"offsetInEndSection":1905,"text":"Complex infections were associated with a higher median maximum C reactive protein (216?mg/L vs 50?mg/L, p?\u003d?\u003c?0.001), longer median length of stay (42 vs 10?days, p?\u003d?\u003c?0.001) and longer duration of antibiotic therapy (43 vs 34?days, p?\u003d?0.03).DISCUSSION: This is the first attempt to categorise paediatric SAB as simple versus complex, to guide clinicians in decision making.CONCLUSIONS: There is a wide spectrum of disease severity in paediatric SAB, with maximum CRP, length of stay, and duration of therapy greater in those with complex disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1289,"document":"31784324","golden":false,"offsetInEndSection":1637,"text":"The diagnosis of sepsis applying a SOFA cutoff of 3 points predicted mortality better than both the SIRS and the SOFA cutoff of 2 points recommended by the Sepsis-3 consensus.CONCLUSIONS: The SOFA score at admission is useful for predicting outcomes in the general PICU population and is more accurate than SIRS for definition of paediatric sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2147,"document":"38513681","golden":true,"offsetInEndSection":2317,"text":"A ten-gene disease severity signature achieved an AUC of 82?2% (95% CI 76?3-88?1) in predicting organ dysfunction within 24 h of sampling in the RAPIDS validation cohort.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":203,"document":"38513681","golden":false,"offsetInEndSection":605,"text":"We aimed to develop host gene expression signatures to predict organ dysfunction in children with bacterial or viral infection.METHODS: This cohort study was done in emergency departments and intensive care units of four hospitals in Queensland, Australia, and recruited children aged 1 month to 17 years who, upon admission, underwent a diagnostic test, including blood cultures, for suspected sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2318,"document":"38513681","golden":false,"offsetInEndSection":2591,"text":"Used in tandem, the disease class and disease severity signatures predicted organ dysfunction within 24 h of sampling with an AUC of 90?5% (95% CI 83?3-97?6) for patients with predicted bacterial infection and 94?7% (87?8-100?0) for patients with predicted viral infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1271,"document":"38513681","golden":false,"offsetInEndSection":1477,"text":"Feature selection approaches were applied to derive novel gene signatures for disease class (bacterial vs viral infection) and disease severity (presence vs absence of organ dysfunction 24 h post-sampling).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1478,"document":"38513681","golden":false,"offsetInEndSection":1625,"text":"The primary endpoint was the presence of organ dysfunction 24 h after blood sampling in the presence of confirmed bacterial versus viral infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":971,"document":"23354787","golden":false,"offsetInEndSection":1477,"text":"\u0027Severe\u0027 outcome (death or a decrease ?2 in POPC) was significantly related (p \u003c 0.01) to: any desaturation below 90 %, the amount of fluid given in the first 6 h, the need for and length of mechanical ventilation or vasoactive support, the use of dobutamine and a higher lactate or lower base excess but not to any variables of predisposition, infection or host response (as in the PIRO (Predisposition, Infection, Response, Organ dysfunction) concept).CONCLUSION: The outcome in our sample was very good.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1726,"document":"38760748","golden":false,"offsetInEndSection":2058,"text":"Patients with higher Lac H6 levels and lower lactate clearance rates had significantly higher PICU mortality based on Kaplan-Meier survival curve analysis.CONCLUSIONS: This study highlights the significance of lactate level trends over time for the prediction of mortality in the PICU in patients with severe sepsis or septic shock.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1130,"document":"20390223","golden":false,"offsetInEndSection":1329,"text":"ADAMTS13 activity and VWF:CB were both correlated with the severity of the disease, as indicated by the Pediatric Risk of Mortality score (R(s)\u003d -0.38 and R(s)\u003d -0.50, p\u003d0.01, respectively, p\u003c0.001).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1661,"document":"39117931","golden":false,"offsetInEndSection":1846,"text":"Secondary and prolonged infections were associated with worse outcomes, including death.CONCLUSIONS: Laboratory markers of immune suppression can be used to predict secondary infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":200,"document":"34593484","golden":false,"offsetInEndSection":800,"text":"ted for sepsis remains a field requiring further investigation. This study aims to determine the diagnostic accuracy of parental and healthcare professional concern in the diagnosis of children evaluated for sepsis.METHODS AND ANALYSIS: This prospective multicentre observational study will be conducted over a 24-month period in the paediatric emergency department (ED) at two tertiary Australian hospitals. A cross-sectional survey design will be used to assess the level of concern in parents, nurses and doctors for children presenting to ED and undergoing assessment for sepsis. The primary outc","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":100,"document":"39024619","golden":false,"offsetInEndSection":700,"text":"g children in low- and middle-income countries. The impacts of climate change on the burden and outcomes of sepsis in low- and middle-income countries, particularly in paediatric populations, remain poorly understood. We aimed to assess the associations between climate variables (temperature and precipitation) and paediatric sepsis incidence and mortality in Bangladesh, one of the countries most affected by climate change.Methods: We conducted retrospective analyses of patient-level data from the International Centre for Diarrhoeal Disease Research, Bangladesh, and environmental data from the ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"10571765","golden":false,"offsetInEndSection":153,"text":"OBJECTIVES: To determine the association between severity of sepsis with outcome and severity of illness in children with multiple organ dysfunction synd","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1594,"document":"17945008","golden":false,"offsetInEndSection":1671,"text":"rine, and corticosteroids).CONCLUSION: Age and gender are determinants of sev","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":410,"document":"31335441","golden":false,"offsetInEndSection":608,"text":"ent paediatric sepsis definitions. Although emerging data support the importance of organ dysfunction as a hallmark of paediatric sepsis, the understanding of host susceptibility to sepsis and to se","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":79,"document":"34593484","golden":false,"offsetInEndSection":249,"text":"ty worldwide. Assessing concern from parents and healthcare professionals to determine disease severity in a child evaluated for sepsis remains a field requiring further ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":993,"document":"39142742","golden":false,"offsetInEndSection":1290,"text":"Serious evidence gaps remain in key areas of paediatric sepsis care, especially surrounding recognition, common interventions, and survivor support, and to this end we offer a research roadmap for the next decade that could accelerate targeted diagnostics and personalised use of immunomodulation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1326,"document":"32126571","golden":false,"offsetInEndSection":1919,"text":"IMPACT: There is currently no consensus definition of neonatal sepsis and the definitions that are currently in use are varied.A consensus definition of neonatal sepsis would benefit clinicians, patients and researchers.Recent progress in adults with publication of Sepsis-3 provides guidance on how a consensus definition and screening criteria for sepsis could be produced in neonatology.We discuss common themes and potential shortcomings in sepsis definitions within neonatology.We highlight the need for a consensus definition of neonatal sepsis and the challenges that this task poses.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":567,"document":"29424065","golden":false,"offsetInEndSection":716,"text":"0-18 years).RESULTS: From 2002 to 2012, we identified 38 582 paediatric patients with sepsis, of which 21.3% were infants, 52.8% were children and 25","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"17260130","golden":false,"offsetInEndSection":197,"text":"OBJECTIVES: To analyse the clinical value of procalcitonin (PCT), C-reactive protein (CRP) and leucocyte count in the diagnosis of paediatric sepsis and in the stratification of patients according ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":390,"document":"38600436","golden":false,"offsetInEndSection":492,"text":"As a result, the evidence for most treatments for paediatric sepsis are based on low-quality evidence.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"39542423","golden":false,"offsetInEndSection":162,"text":"INTRODUCTION: Staphylococcus aureus bacteraemia (SAB) is the most common cause of sepsis, contributing to paediatric intensive care unit admission in Australia an","beginSection":"abstract"}],"ideal_answer":[],"id":"65844e3506a2ea257c000003","type":"summary","body":"How can we define severity in paediatric sepsis?"},{"documents":[{"golden":false,"id":"38011018"},{"golden":false,"id":"34755170"},{"golden":false,"id":"9875023"},{"golden":false,"id":"31784324"},{"golden":false,"id":"17204963"},{"golden":false,"id":"29256116"},{"golden":false,"id":"36279244"},{"golden":false,"id":"28783810"},{"golden":false,"id":"28492402"},{"golden":false,"id":"29939978"},{"golden":false,"id":"16575137"},{"golden":false,"id":"28977260"},{"golden":false,"id":"35081239"},{"golden":false,"id":"19484951"},{"golden":false,"id":"29424065"},{"golden":false,"id":"27618276"},{"golden":false,"id":"33772188"},{"golden":false,"id":"24495564"},{"golden":false,"id":"15578805"},{"golden":false,"id":"31974673"},{"golden":false,"id":"31385882"},{"golden":false,"id":"16895511"},{"golden":false,"id":"35575803"},{"golden":false,"id":"31763206"},{"golden":false,"id":"34593484"},{"golden":false,"id":"37256281"},{"golden":false,"id":"32165955"},{"golden":false,"id":"38074971"},{"golden":false,"id":"37878412"},{"golden":false,"id":"33884211"},{"golden":false,"id":"34970683"},{"golden":false,"id":"35040080"},{"golden":false,"id":"34485201"},{"golden":false,"id":"34760657"},{"golden":false,"id":"37538442"},{"golden":false,"id":"32695992"},{"golden":false,"id":"36449658"},{"golden":false,"id":"36645762"},{"golden":false,"id":"31063297"},{"golden":false,"id":"32861227"},{"golden":true,"id":"12885479"},{"golden":false,"id":"35419955"},{"golden":false,"id":"34418011"},{"golden":false,"id":"34887229"},{"golden":false,"id":"32326684"},{"golden":false,"id":"35055359"},{"golden":false,"id":"34407568"},{"golden":true,"id":"34255639"},{"golden":true,"id":"23009115"},{"golden":true,"id":"38245897"},{"golden":true,"id":"38245889"},{"golden":false,"id":"37498156"},{"golden":false,"id":"35475331"},{"golden":false,"id":"35506809"},{"golden":true,"id":"30613455"},{"golden":false,"id":"35186813"},{"golden":false,"id":"36622781"},{"golden":true,"id":"34612847"},{"golden":false,"id":"28352704"},{"golden":true,"id":"33344390"},{"golden":false,"id":"32084099"},{"golden":false,"id":"32602801"},{"golden":true,"id":"37185949"},{"golden":false,"id":"34117196"},{"golden":false,"id":"37981801"},{"golden":false,"id":"34941014"},{"golden":false,"id":"29746311"},{"golden":false,"id":"26199699"},{"golden":false,"id":"31401824"},{"golden":false,"id":"19360395"},{"golden":false,"id":"32291506"},{"golden":false,"id":"36645795"},{"golden":false,"id":"34686556"},{"golden":false,"id":"26120004"},{"golden":false,"id":"37723295"},{"golden":false,"id":"32126571"},{"golden":true,"id":"35263468"},{"golden":false,"id":"22460770"},{"golden":false,"id":"21666537"},{"golden":true,"id":"35345613"},{"golden":false,"id":"31495868"},{"golden":false,"id":"29782390"},{"golden":false,"id":"33044411"},{"golden":false,"id":"32058370"},{"golden":true,"id":"17564981"},{"golden":true,"id":"32058369"},{"golden":true,"id":"35983521"},{"golden":false,"id":"38353586"},{"golden":false,"id":"38352942"},{"golden":false,"id":"38343680"},{"golden":false,"id":"38338654"},{"golden":false,"id":"38337815"},{"golden":false,"id":"38332633"},{"golden":false,"id":"38330817"},{"golden":false,"id":"38329114"},{"golden":false,"id":"38328327"},{"golden":false,"id":"38327418"},{"golden":false,"id":"38318959"},{"golden":false,"id":"38196017"},{"golden":false,"id":"38141118"},{"golden":false,"id":"38073164"},{"golden":false,"id":"38041208"},{"golden":true,"id":"30225636"},{"golden":true,"id":"15857546"},{"golden":false,"id":"31362432"},{"golden":false,"id":"28149888"},{"golden":false,"id":"23689050"},{"golden":false,"id":"15636651"},{"golden":true,"id":"30242298"},{"golden":false,"id":"11471256"},{"golden":false,"id":"15516535"},{"golden":false,"id":"25251517"},{"golden":true,"id":"31394566"},{"golden":false,"id":"38062303"},{"golden":false,"id":"33011077"},{"golden":false,"id":"21062434"},{"golden":true,"id":"34778148"},{"golden":true,"id":"26369662"},{"golden":false,"id":"28447715"},{"golden":true,"id":"37636856"},{"golden":true,"id":"34231803"},{"golden":true,"id":"37398718"},{"golden":false,"id":"26231114"},{"golden":false,"id":"3115677"},{"golden":false,"id":"30885453"},{"golden":false,"id":"10768086"},{"golden":false,"id":"27023591"},{"golden":false,"id":"36908280"},{"golden":false,"id":"29312910"},{"golden":false,"id":"28167245"},{"golden":true,"id":"31537228"},{"golden":false,"id":"37979776"},{"golden":false,"id":"37809525"},{"golden":false,"id":"35020050"},{"golden":false,"id":"37777757"},{"golden":false,"id":"37152345"},{"golden":false,"id":"37501504"},{"golden":false,"id":"38096241"},{"golden":false,"id":"37113362"},{"golden":true,"id":"10571765"},{"golden":false,"id":"31910037"},{"golden":false,"id":"37272946"},{"golden":false,"id":"34743180"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":0,"document":"28783810","golden":false,"offsetInEndSection":213,"text":"Importance: The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) uses the Sequential Organ Failure Assessment (SOFA) score to grade organ dysfunction in adult patients with suspecte","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"28783810","golden":false,"offsetInEndSection":153,"text":"Adaptation and Validation of a Pediatric Sequential Organ Failure Assessment Score and Evaluation of the Sepsis-3 Definitions in Critically Ill Children.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":2182,"document":"28783810","golden":false,"offsetInEndSection":2280,"text":"ellent discrimination for in-hospital mortality, with an area under the curve of 0.94 (95% CI, 0.9","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1527,"document":"28492402","golden":false,"offsetInEndSection":1716,"text":"ctatemia; calibration p value was 0.03, 0.36, and 0.49, respectively. A Pediatric Logistic Organ Dysfunction-2 score on day 1 greater than or equal to 8 reflected an overall risk of mortali","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":618,"document":"38011018","golden":false,"offsetInEndSection":796,"text":"butable mortality. Sensitivity analyses included recalculation of scores using worst preceding values for each variable, excluding hematologic parameters, and prediction of alter","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2044,"document":"28783810","golden":false,"offsetInEndSection":2181,"text":"ivors, 127 (55.4%) were male with a median (IQR) age of 43 (8-144) months. In-hospital mortality was 2.6%. The maximum pSOFA score had ex","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1244,"document":"28977260","golden":false,"offsetInEndSection":1395,"text":"fections were the major causes of sepsis. PRISM III had a better calibration than the PELOD for prognosis of the patients, despite the high frequency o","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2833,"document":"28783810","golden":false,"offsetInEndSection":2945,"text":"r course.Conclusions and Relevance: The pSOFA score was adapted and validated with age-adjusted variables in cri","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1147,"document":"28783810","golden":false,"offsetInEndSection":1389,"text":"spitalization, discharge, or death (whichever came first). Three additional pediatric organ dysfunction scores were calculated for comparison.Exposures: Organ dysfunction measured by the pSOFA score, and sepsis and septic shock according to t","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1516,"document":"29256116","golden":false,"offsetInEndSection":1694,"text":"ms better than Sepsis-2-based criteria. Our findings support the translation of Sepsis-3 into paediatric-specific sepsis definitions and highlight the importance of robust paedia","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1018,"document":"31974673","golden":false,"offsetInEndSection":1234,"text":"Levels of MR-proADM were significantly higher in patients who required vasoactive drugs (p?\u003d?0.02) or presented renal dysfunction (p?\u003d?0.004).Conclusion: PCT appeared to be superior to MR-proADM in diagnosing sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":795,"document":"28783810","golden":false,"offsetInEndSection":1019,"text":"n were obtained from an electronic health record database. The pSOFA score was developed by adapting the original SOFA score with age-adjusted cutoffs for the cardiovascular and renal systems and by expanding the respiratory","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2357,"document":"28492402","golden":false,"offsetInEndSection":2499,"text":"g its use to standardize definitions and diagnostic criteria of pediatric sepsis. Further studies are needed to determine the usefulness of th","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1390,"document":"28783810","golden":false,"offsetInEndSection":1477,"text":"e Sepsis-3 definitions.Main Outcomes and Measures: The primary outcome was in-hospital ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1914,"document":"37256281","golden":false,"offsetInEndSection":2288,"text":"Among secondary outcomes, PELOD-2 performed significantly better than SIRS criteria and severe sepsis to predict prolonged duration of invasive MV, whereas better than severe sepsis to predict \"poor outcome\" (mortality or new disability).CONCLUSIONS: Day 1 organ dysfunction scores performed better in predicting mortality and morbidity outcomes than ICCPS-derived criteria.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":240,"document":"32165955","golden":false,"offsetInEndSection":607,"text":"Pediatric Logistic Organ Dysfunction 2 (PELOD-2) score is recent scoring to assess organ dysfunction in sepsis children.AIM: To determine the correlation between troponin T, troponin I with PELOD-2 score in sepsis as a predictive factor of mortality.METHODS: A prospective cohort study was conducted on sepsis children in PICU Haji Adam Malik General Hospital, Medan.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":701,"document":"34485201","golden":false,"offsetInEndSection":714,"text":"MOD criteria.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2289,"document":"37256281","golden":false,"offsetInEndSection":2376,"text":"The PELOD-2 was the organ dysfunction score with the best performance for all outcomes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":498,"document":"37256281","golden":false,"offsetInEndSection":1054,"text":"Sepsis organ dysfunction scores-pediatric Sequential Organ Failure Assessment (pSOFA) (Schlapbach, Matics, Shime), quickSOFA, quickSOFA-L, Pediatric Logistic Organ Dysfunction (PELOD)-2, quickPELOD-2, and Pediatric Multiple Organ Dysfunction score-were calculated during the first 24 hours of admission (day 1) and their performance compared with systemic inflammatory response syndrome (SIRS) and severe sepsis-International Consensus Conference on Pediatric Sepsis(ICCPS)-derived criteria-using the area under the receiver operating characteristic curve.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37256281","golden":false,"offsetInEndSection":497,"text":"OBJECTIVE: To compare the performance of several prognostic scores calculated in the first 24 hours of admission (day 1) in predicting mortality and morbidity among critically ill children with sepsis presenting to the pediatric emergency department (PED) and then admitted to the pediatric intensive care unit (PICU).METHODS: Single-center, retrospective cohort study in children with a diagnosis of sepsis visiting the PED and then admitted to the PICU from January 1, 2010 to December 31, 2019.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1500,"document":"37256281","golden":false,"offsetInEndSection":1913,"text":"The prognostic ability in mortality discrimination was significantly higher for organ dysfunction scores, with PELOD-2 showing the best performance (area under the receiver operating characteristic curve, 0.924; 95% confidence interval, 0.837-1.000), significantly better than SIRS 3 criteria (0.924 vs 0.509, P \u003d 0.009), SIRS 4 criteria (0.924 vs 0.509, P \u003c 0.001), and severe sepsis (0.924 vs 0.527, P \u003c 0.001).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":660,"document":"37878412","golden":false,"offsetInEndSection":1107,"text":"We excluded preterm infants and term infants younger than 7 days old.INTERVENTIONS: None.MEASUREMENTS AND MAIN RESULTS: We compared the 2005 International Pediatric Sepsis Consensus Conference (IPSCC), Pediatric Logistic Organ Dysfunction-2 (PELOD-2), pediatric Sequential Organ Failure Assessment (pSOFA), and Pediatric Organ Dysfunction Information Update Mandate (PODIUM) scores, measured at blood culture sampling, to predict 30-day mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1500,"document":"37878412","golden":false,"offsetInEndSection":1818,"text":"When restricting scores to neurologic, respiratory, and cardiovascular dysfunction, the adjusted AUC was 0.89 (0.84-0.94) for IPSCC, 0.85 (0.79-0.91) for PELOD-2, 0.87 (0.81-0.93) for pSOFA, and 0.88 (0.83-0.93) for PODIUM.CONCLUSIONS: IPSCC, PELOD-2, pSOFA, and PODIUM performed similarly to predict 30-day mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1527,"document":"32165955","golden":false,"offsetInEndSection":1889,"text":"The cut-off point of troponin I at 24 hours was 0.075 ng/mL (68% sensitivity, 68.8% specificity, RR 1.84) and at 48 hours was 0.125 ng/mL (80% sensitivity, 81.3% specificity, RR 3.13).CONCLUSION: Serum troponin T and troponin I levels at 48 hours have positive correlation with PELOD-2 score as a predictive factor of mortality in pediatric patients with sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":691,"document":"31063297","golden":false,"offsetInEndSection":832,"text":"The paediatric risk of mortality and paediatric logistic organ dysfunction scores of the patients were used to estimate the disease severity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36449658","golden":false,"offsetInEndSection":222,"text":"PURPOSE OF REVIEW: Organ dysfunction severity scores (sequential organ failure assessment or SOFA) are commonly used in the adult and pediatric populations when assessing risk of mortality and adverse outcomes from sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":946,"document":"31063297","golden":false,"offsetInEndSection":1068,"text":"This study showed that thiol/disulphide homeostasis is abnormal in children with sepsis in Paediatric Intensive Care Unit.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":833,"document":"31063297","golden":false,"offsetInEndSection":945,"text":"The plasma thiol levels of the patients with sepsis were significantly lower than the control group (p \u003c 0.001).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1863,"document":"36645762","golden":false,"offsetInEndSection":2141,"text":"The AUC for predicting death using VRI was 95% (95% CI 90% to 100%, p\u003c0.001) and PELOD-2 92.6% (95% CI 96.4% to 98.8%, p\u003c0.001).CONCLUSION: The VRI \u003c32.1?may potentially be used to predict mortality in children with septic shock and its predictive ability is as good as PELOD-2.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31063297","golden":false,"offsetInEndSection":179,"text":"The aim of this study is to evaluate a novel oxidative stress marker (thiol-disulphide homeostasis) in paediatric sepsis and to determine their effects on the prognosis of sepsis.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"31063297","golden":false,"offsetInEndSection":101,"text":"Thiol-disulphide homeostasis is an oxidative stress indicator in critically ill children with sepsis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":553,"document":"31063297","golden":false,"offsetInEndSection":690,"text":"The levels of hemoglobin, white blood cell, platelet, lactate, and C-reactive protein were measured in patients with sepsis at diagnosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1374,"document":"12885479","golden":true,"offsetInEndSection":1776,"text":"Calibration (p\u003d0.54) and discrimination (AUC\u003d0.91, SE\u003d0.01) of PELOD and dPELOD (p\u003e or \u003d0.39; AUC\u003e or \u003d0.79) scores were good.INTERPRETATION: PELOD and dPELOD scores are valid outcome measures of the severity of multiple organ dysfunction syndrome in paediatric intensive care units; their use should significantly reduce the sample size required to complete clinical trials in critically ill children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32861227","golden":false,"offsetInEndSection":381,"text":"AIM: We compared the performance of plasma lactate with high-sensitivity C-reactive protein (hs-CRP), and paediatric sepsis-related organ failure assessment (pSOFA) score for predicting mortality in septic children.METHODS: Serial plasma lactate and hs-CRP levels and pSOFA score was assessed during early hospital stay in septic children.RESULTS: Out of 149 participants, 45 died.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1453,"document":"35419955","golden":false,"offsetInEndSection":1824,"text":"Vital signs, blood tests and clinical sepsis scores, including Systemic Inflammatory Response Syndrome, quick Sequential Organ Failure Assessment and quick Paediatric Logistic Organ Dysfunction-2, performed poorly as predictors of these outcomes (area under the receiver operating characteristic curve?\u003c0.6).CONCLUSIONS: Very few patients with FN required ICU-level care.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34407568","golden":false,"offsetInEndSection":106,"text":"BACKGROUND: In adults, sepsis-induced coagulopathy (SIC) is diagnosed by the SIC score, known as sepsis-3.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34970683","golden":false,"offsetInEndSection":960,"text":"CONTEXT: Multiple scores exist to characterize organ dysfunction in children.OBJECTIVE: To review the literature on multiple organ dysfunction (MOD) scoring systems to estimate severity of illness and to characterize the performance characteristics of currently used scoring tools and clinical assessments for organ dysfunction in critically ill children.DATA SOURCES: Electronic searches of PubMed and Embase were conducted from January 1992 to January 2020.STUDY SELECTION: Studies were included if they evaluated critically ill children with MOD, evaluated the performance characteristics of scoring tools for MOD, and assessed outcomes related to mortality, functional status, organ-specific outcomes, or other patient-centered outcomes.DATA EXTRACTION: Data were abstracted into a standard data extraction form by a task force member.RESULTS: Of 1152 unique abstracts screened, 156 full text studies were assessed including a total of 54 eligible studies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":221,"document":"34255639","golden":false,"offsetInEndSection":362,"text":"The Sequential Organ Failure Assessment (SOFA) score is widely utilized in clinical practice to assess septic patients for organ dysfunction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":930,"document":"35475331","golden":false,"offsetInEndSection":1602,"text":"After adjusting for septic shock, the pediatric logistic organ dysfunction 2 (PELOD-2), high-frequency oscillation ventilation (HFOV), and continuous renal replacement therapy (CRRT), the variables that retained an independent association with increased 90-day mortality in pediatric sepsis-related ARDS included ARDS severity, the pediatric risk of mortality III (PRISM III), number of organ dysfunctions and use of vasoactive drug types during PICU stay.CONCLUSIONS: PICU mortality in pediatric sepsis-related ARDS was high (24.6%) and severity of hypoxemia based on the worst OI value 72?h after meeting the PALICC definition accurately stratified the patient outcomes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":363,"document":"34255639","golden":false,"offsetInEndSection":464,"text":"The SOFA score uses points between 0 and 4 to quantify the level of dysfunction in six organ systems.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":642,"document":"34255639","golden":false,"offsetInEndSection":854,"text":"In this study, we propose multiple strategies to adjust the SOFA score using mixed-integer programming to improve the in-hospital mortality prediction of septic patients based on Electronic Health Records (EHRs).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1196,"document":"36622781","golden":false,"offsetInEndSection":1745,"text":"The sensitivity, specificity, positive LR, and negative LR for the PRESEP score (cutoff was 5) were 0.83 (0.73-0.90), 0.68 (0.62-0.73), 2.59 (2.12-3.16), and 0.25 (0.15-0.40), respectively, and those for the Miami Sepsis Score (cu-off was 3) were 0.81 (0.71-0.89), 0.65 (0.59-0.71), 2.33 (1.93-2.83), and 0.30 (0.19-0.46), respectively.CONCLUSION: Due to their relatively good predictive abilities to detect septic patients and simplicities, the PRESEP and Miami Sepsis Scores could be used for screening patients for sepsis in prehospital settings.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1480,"document":"37498156","golden":false,"offsetInEndSection":1759,"text":"The TRIPS trial compares four different doses of anakinra to placebo in children with moderate to severe systemic inflammation.MEASUREMENTS AND MAIN RESULTS: Both trials assess primary efficacy using the sum of the daily pediatric logistic organ dysfunction-2 score over 28 days.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1265,"document":"34255639","golden":false,"offsetInEndSection":1413,"text":"Area under the receiver operator curve (AUC) and accuracy values of 0.8928 and 0.8904 are achieved by optimizing the point values of the SOFA score.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23009115","golden":false,"offsetInEndSection":195,"text":"The human sequential organ failure assessment (SOFA) scoring system is used worldwide in intensive care units for assessing the extent of organ dysfunction/failure in patients with severe sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1074,"document":"34255639","golden":false,"offsetInEndSection":1264,"text":"Our results demonstrate a statistically significant improvement ( ) in the prediction of in-hospital mortality among patients susceptible to sepsis when implementing our proposed strategies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":855,"document":"34255639","golden":false,"offsetInEndSection":946,"text":"We use the same variables and threshold values of the original SOFA score in each strategy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":722,"document":"38245889","golden":false,"offsetInEndSection":1351,"text":"Using evidence from an international survey, systematic review and meta-analysis, and a new organ dysfunction score developed based on more than 3 million electronic health record encounters from 10 sites on 4 continents, a modified Delphi consensus process was employed to develop criteria.Findings: Based on survey data, most pediatric clinicians used sepsis to refer to infection with life-threatening organ dysfunction, which differed from prior pediatric sepsis criteria that used systemic inflammatory response syndrome (SIRS) criteria, which have poor predictive properties, and included the redundant term, severe sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2802,"document":"38245889","golden":false,"offsetInEndSection":3098,"text":"A Phoenix Sepsis Score of at least 2 identified potentially life-threatening organ dysfunction in children younger than 18 years with infection, and its use has the potential to improve clinical care, epidemiological assessment, and research in pediatric sepsis and septic shock around the world.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1352,"document":"38245889","golden":false,"offsetInEndSection":1640,"text":"The SCCM task force recommends that sepsis in children be identified by a Phoenix Sepsis Score of at least 2 points in children with suspected infection, which indicates potentially life-threatening dysfunction of the respiratory, cardiovascular, coagulation, and/or neurological systems.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2085,"document":"38245889","golden":false,"offsetInEndSection":2355,"text":"Septic shock was defined as children with sepsis who had cardiovascular dysfunction, indicated by at least 1 cardiovascular point in the Phoenix Sepsis Score, which included severe hypotension for age, blood lactate exceeding 5 mmol/L, or need for vasoactive medication.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":168,"document":"38245889","golden":false,"offsetInEndSection":721,"text":"In 2016, the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) defined sepsis as life-threatening organ dysfunction caused by a dysregulated host response to infection, but it excluded children.Objective: To update and evaluate criteria for sepsis and septic shock in children.Evidence Review: The Society of Critical Care Medicine (SCCM) convened a task force of 35 pediatric experts in critical care, emergency medicine, infectious diseases, general pediatrics, nursing, public health, and neonatology from 6 continents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":145,"document":"36622781","golden":false,"offsetInEndSection":625,"text":"Prehospital sepsis screening tools have not yet been widely evaluated for their performance in clinical practice.OBJECTIVE: To evaluate the ability of the Prehospital Early Sepsis Detection (PRESEP) score and the Miami Sepsis Score to predict sepsis in prehospital settings.METHOD: This retrospective analysis included patients with diseases of internal cause who were transported by emergency medical services (EMS) to the hospital and hospitalized between January and June 2020.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1887,"document":"38245889","golden":false,"offsetInEndSection":2084,"text":"Mortality was higher in children who had organ dysfunction in at least 1 of 4-respiratory, cardiovascular, coagulation, and/or neurological-organ systems that was not the primary site of infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1819,"document":"32084099","golden":false,"offsetInEndSection":2150,"text":"Depressed right ventricular longitudinal strain was associated with elevated pediatric multiple organ dysfunction score (r \u003d 0.44; p \u003c 0.01) CONCLUSIONS:: Compared with healthy children, pediatric septic patients demonstrated abnormal left ventricular and right ventricular strain concerning for early signs of cardiac dysfunction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1097,"document":"37185949","golden":false,"offsetInEndSection":1337,"text":"Prediction was inferior for admission PRISM and PELOD and for 6- and 12-month HRQL assessments.CONCLUSIONS: Illness severity scores have a good prediction of early functional morbidity but a more limited ability to predict longer-term HRQL.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":92,"document":"37185949","golden":false,"offsetInEndSection":699,"text":"Given declining PICU mortality, we assessed the ability of the Pediatric Risk of Mortality-III (PRISM) and Pediatric Logistic Organ Dysfunction-2 (PELOD) scores to predict morbidity outcomes.METHODS: Among 359 survivors \u003c18 years in the Life After Pediatric Sepsis Evaluation multicenter prospective cohort study, we assessed functional morbidity at hospital discharge (Functional Status Scale increase ?3 points from baseline) and health-related quality of life (HRQL; Pediatric Quality of Life Inventory or Functional Status II-R) deterioration \u003e25% from baseline at 1, 3, 6, and 12 months post-admission.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":927,"document":"34117196","golden":false,"offsetInEndSection":1095,"text":"The ALT was an independent risk factor and a good predictor of mortality (AUC?\u003d?0.865) with a cut-off of 137?IU/L.CONCLUSIONS: SHI was associated with worst prognostic.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1717,"document":"37981801","golden":false,"offsetInEndSection":1884,"text":"Conclusions: The predictive accuracies (AUC) of the PELOD-2 and PRISM III scores are limited in children with hemato-oncological diseases admitted to PICU with sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"26199699","golden":false,"offsetInEndSection":476,"text":"BACKGROUND: Procalcitonin (PCT) kinetics is a good prognosis marker in infectious diseases, but few studies of children sepsis have been performed.OBJECTIVES: The aim of our study was to examine kinetics of procalcitonin, to evaluate its relationship with severity and to analyze its usefulness in the prediction of multiorgan dysfunction syndrome (MODS).PATIENTS AND METHODS: Prospective observational study in an 8-bed pediatric intensive care unit of a university hospital.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":700,"document":"37185949","golden":false,"offsetInEndSection":1096,"text":"We determined discrimination of admission PRISM and admission, maximum, and cumulative 28-day PELOD with functional and HRQL morbidity at each timepoint.RESULTS: Cumulative PELOD provided the best discrimination of discharge functional morbidity (area under the receive operating characteristics curve [AUROC] 0.81, 95% CI 0.76-0.87) and 3-month HRQL deterioration (AUROC 0.71, 95% CI 0.61-0.81).","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37185949","golden":false,"offsetInEndSection":116,"text":"Predicting functional and quality-of-life outcomes following pediatric sepsis: performance of PRISM-III and PELOD-2.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1796,"document":"37185949","golden":false,"offsetInEndSection":2052,"text":"The PRISM and PELOD scores have moderate to good ability to predict new functional morbidity at hospital discharge following pediatric septic shock but limited ability to predict health-related quality of life outcomes in the year following PICU admission.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":179,"document":"31401824","golden":false,"offsetInEndSection":636,"text":"The prognostication of critically ill children can be challenging; hence, accurate methods for predicting outcomes are needed.PURPOSE: To evaluate the role of microalbuminuria at admission as a prognostic marker in comparison to standard Pediatric Risk of Mortality (PRISM) and Pediatric Logistic Organ Dysfunction (PELOD) mortality scores in children admitted to the PICU.METHODS: This cross-sectional study was conducted from January 2015 to October 2016.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37185949","golden":false,"offsetInEndSection":91,"text":"BACKGROUND: Illness severity scores predict mortality following pediatric critical illness.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":955,"document":"23009115","golden":false,"offsetInEndSection":1119,"text":"The use of human SOFA parameters was valuable in identifying dysfunctional/failing organs and showed consistency between this porcine model and human severe sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":627,"document":"23009115","golden":false,"offsetInEndSection":785,"text":"Dysfunction/failure was observed in the respiratory, haemostatic and hepatic system of all infected animals, together with initial cardiovascular dysfunction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1120,"document":"23009115","golden":false,"offsetInEndSection":1252,"text":"Applying SOFA parameters in this model increased the relevance for comparison to clinical methods of evaluating human severe sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":786,"document":"23009115","golden":false,"offsetInEndSection":954,"text":"The pulmonary system was the first to fail clinically, which corresponds with similar human findings, whereas the liver was affected earlier in pigs compared to humans.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"23009115","golden":false,"offsetInEndSection":123,"text":"The use of sequential organ failure assessment parameters in an awake porcine model of severe Staphylococcus aureus sepsis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32291506","golden":false,"offsetInEndSection":364,"text":"The novel concepts within Sepsis?3 criteria include a?focus on dysregulated host responses, removal of the systemic inflammation response syndrome (SIRS) criteria from sepsis diagnosis, the use of Sepsis-related (Sequential) Organ Failure Assessment (SOFA) scores to define organ dysfunction, and the explicit recognition of the septic shock as a?subset of sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1446,"document":"34686556","golden":false,"offsetInEndSection":1751,"text":"on diagnostic criteria for sepsis. In addition, daily multiple organ dysfunction syndrome and Sequential Organ Failure Assessment Scores will be recorded relationships between neutrophil phagocytic activity, IG count and plasma cfDNA levels on day 1 of injury and the development of sepsis will be examine","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":702,"document":"26120004","golden":false,"offsetInEndSection":926,"text":" 24 hours of admission. The occurrence of septic shock, multiple organ dysfunction syndrome (MODS) and healthcare-associated infection (HCAI), need for mechanical ventilation and catecholamines, length of PICU stay and morta","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1330,"document":"34686556","golden":false,"offsetInEndSection":1445,"text":"tivity, IG count and cfDNA levels. Patients will be screened daily for sepsis using the 2007 American Burn Associat","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1899,"document":"38245897","golden":false,"offsetInEndSection":2567,"text":"Using a Phoenix Sepsis Score of 2 points or higher in children with suspected infection as criteria for sepsis and sepsis plus 1 or more cardiovascular point as criteria for septic shock resulted in a higher positive predictive value and higher or similar sensitivity compared with the 2005 International Pediatric Sepsis Consensus Conference (IPSCC) criteria across differently resourced settings.Conclusions and Relevance: The novel Phoenix sepsis criteria, which were derived and validated using data from higher- and lower-resource settings, had improved performance for the diagnosis of pediatric sepsis and septic shock compared with the existing IPSCC criteria.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36622781","golden":false,"offsetInEndSection":91,"text":"Evaluation of the PRESEP Score and the Miami Sepsis Score for Prehospital Sepsis Screening.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1057,"document":"36622781","golden":false,"offsetInEndSection":1195,"text":"The AUC for the PRESEP score was 0.83 (95% confidence interval [CI] 0.79-0.88) while that for the Miami Sepsis Score was 0.80 (0.75-0.85).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36622781","golden":false,"offsetInEndSection":144,"text":"INTRODUCTION: Sepsis is a life-threatening organ dysfunction caused by a dysregulated response to an infection that requires early intervention.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38245897","golden":false,"offsetInEndSection":584,"text":"Importance: The Society of Critical Care Medicine Pediatric Sepsis Definition Task Force sought to develop and validate new clinical criteria for pediatric sepsis and septic shock using measures of organ dysfunction through a data-driven approach.Objective: To derive and validate novel criteria for pediatric sepsis and septic shock across differently resourced settings.Design, Setting, and Participants: Multicenter, international, retrospective cohort study in 10 health systems in the US, Colombia, Bangladesh, China, and Kenya, 3 of which were used as external validation sites.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":872,"document":"36622781","golden":false,"offsetInEndSection":1056,"text":"Sensitivity, specificity, and positive and negative likelihood ratios (LRs) were calculated at cutoff values derived using Youden\u0027s index.RESULTS: Data from 354 patients were analyzed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1326,"document":"32126571","golden":false,"offsetInEndSection":1917,"text":"IMPACT: There is currently no consensus definition of neonatal sepsis and the definitions that are currently in use are varied.A consensus definition of neonatal sepsis would benefit clinicians, patients and researchers.Recent progress in adults with publication of Sepsis-3 provides guidance on how a consensus definition and screening criteria for sepsis could be produced in neonatology.We discuss common themes and potential shortcomings in sepsis definitions within neonatology.We highlight the need for a consensus definition of neonatal sepsis and the challenges that this task poses.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":427,"document":"36645795","golden":false,"offsetInEndSection":924,"text":"Data-driven prediction models integrated in clinical decision support systems (CDSS) could facilitate early recognition of disease onset.OBJECTIVES: To estimate the sensitivity and specificity of previously developed prediction models (index tests) for the detection of SIRS, sepsis and associated organ dysfunctions in critically ill children up to 12 hours before reference standard diagnosis is possible.METHODS AND ANALYSIS: We conduct a monocentre, prospective diagnostic test accuracy study.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1684,"document":"22460770","golden":false,"offsetInEndSection":1827,"text":"tine:free carnitine ratios did not differ between septic and control patients. Asymmetric dimethylarginine was inversely correlated with organ ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2055,"document":"22460770","golden":false,"offsetInEndSection":2186,"text":"rnitine:free carnitine were not associated with organ dysfunction or outcomes.CONCLUSIONS: Asymmetric dimethylarginine was decrease","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":736,"document":"21666537","golden":false,"offsetInEndSection":921,"text":"to quantitate the waveform. Severity of disease was assessed using the Glasgow Meningococcal Septicaemia Prognostic Score, Pediatric Risk of Mortality III score, and the Pediatric Logis","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1544,"document":"35345613","golden":false,"offsetInEndSection":1733,"text":"e. Disabilities affecting physical, cognitive, psychological, and social function were reported in children following discharge. Overall disability reported ranged between 23 and 50% at hos","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":743,"document":"31495868","golden":false,"offsetInEndSection":911,"text":"7 (interquartile range: 15.7-111.9) months. The Paediatric Logistic Organ Dysfunction score and oxygen saturation/fraction of inspired oxygen (SF) ratio were 2.0 (1.0-1","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1792,"document":"29782390","golden":false,"offsetInEndSection":1949,"text":"ll significantly higher than that in sibling controls (19 ng/mL [10-54 ng/mL]) (p \u003d 0.003).CONCLUSIONS: Ferritin rises significantly in septic shock patients","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":692,"document":"33044411","golden":false,"offsetInEndSection":914,"text":"ose unfractionated heparin, and tranexamic acid).MEASUREMENTS: All patients had assessment of Pediatric Index of Mortality 2 score, Pediatric Logistic Organ Dysfunction score, inotropic score, routine laboratory, and hemos","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":612,"document":"32058370","golden":false,"offsetInEndSection":746,"text":"iring vasoactive-inotropic support.INTERVENTIONS: Demographic, infection, illness severity, organ dysfunction, and resource utilizatio","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":455,"document":"17564981","golden":false,"offsetInEndSection":703,"text":"r inclusion in the study. Severity of illness was confirmed by the presence of hypotension requiring inotropes and according to the following scores: the Pediatric Risk of Mortality (PRISM) II score, the PRISM III score, and the Pediatric Logistic ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1330,"document":"32058369","golden":false,"offsetInEndSection":1744,"text":"203 of 389 (52.2%) had completed paired health-related quality of life surveys. Pediatric Risk of Mortality, cumulative Pediatric Logistic Organ Dysfunction scores, PICU and hospital durations of stay, maximum and cumulative vasoactive-inotropic scores, duration of mechanical ventilation, need for renal replacement therapy, extracorporeal life support or cardiopulmonary resuscitation, and appearance of patholog","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":234,"document":"38353586","golden":false,"offsetInEndSection":317,"text":"Secondary analysis of the Life After Pediatric Sepsis Evaluation prospective study.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":151,"document":"38352942","golden":false,"offsetInEndSection":268,"text":"These mechanisms have been demonstrated in patients with sepsis, hemoglobinopathies, and those receiving transfusions","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":349,"document":"38343680","golden":false,"offsetInEndSection":453,"text":" patients.Methods: The databases (PubMed, Google Scholar, Web of Science, and Cochrane Library), along w","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":626,"document":"38338654","golden":false,"offsetInEndSection":766,"text":"M6229 was able to restore normal levels of both hepatic and renal parameters at 3 and 9 mg M6229/kg/h and prevented mortality of the animals","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38337815","golden":false,"offsetInEndSection":213,"text":"Although the diagnosis of sepsis requires the identification of the three components of infection, a systemic inflammation response, and organ dysfunction, there is currently no consensus on gold-standard criteria","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":441,"document":"38332633","golden":false,"offsetInEndSection":673,"text":"Identifying optimal treatment regimes that maximize residual life is especially desirable for patients with life-threatening diseases such as sepsis, a complex medical condition that involves severe infections with organ dysfunction","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":75,"document":"38330817","golden":false,"offsetInEndSection":264,"text":"Severe immune response to BSI can lead to sepsis, a systemic infection leading to multiple organ dysfunction, coupled with drug resistance, mortality, and limited clinical treatment options","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38329114","golden":false,"offsetInEndSection":165,"text":"Burns and burn sepsis, characterized by persistent and profound hypercatabolism, cause energy metabolism dysfunction that worsens organ injury and systemic disorders","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":745,"document":"38328327","golden":false,"offsetInEndSection":1127,"text":"The efficacy, safety (pancreatic fistula, intra-abdominal hemorrhage, sepsis, and organ dysfunction syndrome), abdominal bloating and pain relief time, bowel recovery time, hospital stay, inflammatory indicators (C-reactive protein, interleukin-6, and procalcitonin), and Acute Physiology and Chronic Health Evaluation (APACHE) II score of both groups were evaluated for comparison.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38327418","golden":false,"offsetInEndSection":97,"text":"Despite extensive investigations, urosepsis remains a life-threatening and high-mortality illness","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1706,"document":"38318959","golden":false,"offsetInEndSection":2014,"text":"Intra-abdominal hypertension was associated with greater inotropic support (p?\u003c?0.001), more gastrointestinal complications (p?\u003d?0.001), sepsis (p?\u003d?0.003), multiple organ dysfunction syndrome (p?\u003c?0.001), and prolonged intensive care unit stay (z\u003d-4.916, p?\u003c?0.001) and hospitalisation (z\u003d-4.710, p?\u003c?0.001)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"38196017","golden":false,"offsetInEndSection":126,"text":"Acute kidney injury (AKI) is common in children with sepsis, chronic kidney disease, poisoning or other conditions","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":666,"document":"38141118","golden":false,"offsetInEndSection":894,"text":"We identified 12,790 inpatients without infection (matched cohort 1), 12,789 inpatients with infection but without sepsis (matched cohort 2), and 10,536 inpatients with end-organ dysfunction but without sepsis (matched cohort 3)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1145,"document":"38073164","golden":false,"offsetInEndSection":1312,"text":"ups was significantly lower than that of the HC. The samples lacked bene?cial Bi?dobacterium spp. and were dominated by Bacteroides, Enterobacteriaceae, and Enterococc","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1398,"document":"38041208","golden":false,"offsetInEndSection":1672,"text":"Secondary outcomes are mortality at 30 days, intensive care unit (ICU) length of stay, ICU readmission, Sequential Organ Failure Assessment (SOFA) scores recorded up to postoperative day 7, overall intraoperative fluid balance, vasopressors use, and the need for reoperation","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":937,"document":"30225636","golden":false,"offsetInEndSection":1132,"text":"The area under ROC curve for qSOFA score???2 was 0.602 (95% CI 0.492-0.705).Conclusion: The qSOFA score showed a low accuracy to identify children in the pediatric ward at risk for severe sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30242298","golden":false,"offsetInEndSection":142,"text":"INTRODUCTION: The Paediatric Index of ?Mortality 3 (PIM 3) and Paediatric Logistic Organ Dysfunction 2 (PELOD 2) scores were recently revised.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":652,"document":"30225636","golden":false,"offsetInEndSection":936,"text":"The analysis of prognostic performance of qSOFA score for the prediction of severe sepsis showed a sensitivity of 46% (95% CI, 27-67%), a specificity of 74% (95% CI, 62-85%), a positive predictive value of 43% (95% CI, 34-52%), and a negative predictive value of 77% (95% CI, 71-82%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":337,"document":"30225636","golden":false,"offsetInEndSection":479,"text":"In this study, we sought to assess the qSOFA score for children with sepsis, who are being treated outside the pediatric intensive care units.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1666,"document":"30225636","golden":false,"offsetInEndSection":1799,"text":"What is New: ? qSOFA demonstrated insufficient clinical value to be recommended as a screening tool for pediatric sepsis outside ICU.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1454,"document":"30225636","golden":false,"offsetInEndSection":1665,"text":"? In 2016, members of the Sepsis-3 task force proposed qSOFA, an empirically derived score using simple clinical criteria, to assist clinicians in identifying adult patients with sepsis at risk for poor outcome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1986,"document":"15636651","golden":false,"offsetInEndSection":2342,"text":"Although no firm conclusion was made regarding a single appropriate study end point, a novel nonmortality end point, organ failure-free days, was considered optimal for pediatric clinical trials given the relatively low incidence of mortality in pediatric sepsis compared with adult populations.CONCLUSION: We modified the adult SIRS criteria for children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30225636","golden":false,"offsetInEndSection":255,"text":"In 2016, in order to identify adult patients with sepsis who are likely to have poor outcomes, the Third International Consensus Definitions Task Force introduced a new bedside index, called the quick Sepsis-related Organ Failure Assessment (qSOFA) score.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":618,"document":"28149888","golden":false,"offsetInEndSection":904,"text":"The Quick (q) Sequential (Sepsis-related) Organ Failure Assessment (SOFA) score is proposed as a surrogate for organ dysfunction and may act as a risk predictor for patients with known or suspected infection, as well as being a prompt for clinicians to consider the diagnosis of sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":480,"document":"30225636","golden":false,"offsetInEndSection":651,"text":"The qSOFA criteria were revised and applied to a study population of 89 pediatric patients with sepsis, admitted in a pediatric tertiary referral center from 2006 to 2016.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":571,"document":"15857546","golden":false,"offsetInEndSection":700,"text":"Neonatal illness severity scores provide a convenient, but imperfect, tool to adjust for risk of sepsis in observational studies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":198,"document":"15857546","golden":false,"offsetInEndSection":310,"text":"No neonatal organ dysfunction score has yet been validated as a reliable surrogate for disability-free survival.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"15857546","golden":false,"offsetInEndSection":108,"text":"What is the role of neonatal organ dysfunction and illness severity scores in therapeutic studies in sepsis?","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":146,"document":"31394566","golden":false,"offsetInEndSection":740,"text":"We determined the utility of an objective, electronic health record (EHR)-automated, neonatal sequential organ failure assessment (nSOFA) score to predict mortality from late-onset sepsis (LOS) in premature, very low birth weight (VLBW) infants.METHODS: Retrospective, single-center study of bacteremic preterm VLBW newborns admitted between 2012 and 2016. nSOFA scores were derived for patients with LOS at multiple time points surrounding the sepsis evaluation.RESULTS: nSOFA scores at evaluation and at all points measured after evaluation were different between survivors and non-survivors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":595,"document":"15516535","golden":false,"offsetInEndSection":764,"text":"Hazard ratio of death significantly increased with the severity of organ dysfunction, as estimated by the PELOD score, and the worst diagnostic category of septic state.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":311,"document":"15857546","golden":false,"offsetInEndSection":570,"text":"To validate a score as a surrogate would require randomized trials showing 1) a causal connection between change in the score and change in disability-free survival and 2) that the score fully captured all the effects of treatment on disability-free survival.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":830,"document":"11471256","golden":false,"offsetInEndSection":961,"text":"It is concluded that GMSPS and PRISM are useful methods for identifying and classifying children into low and high risk categories.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1724,"document":"38062303","golden":false,"offsetInEndSection":1989,"text":"AHT was also associated with new impairment at HD (3.4 [1.6-7.3, p?\u003d?0.001]), short-term discharge (2.5 [1.3-4.7, p?\u003d?0.005]), and long-term discharge (2.1 [1.1-4.1, p?\u003d?0.036]).CONCLUSIONS: Abusive head trauma as a mechanism was associated with MODS following TBI.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1619,"document":"26369662","golden":false,"offsetInEndSection":2090,"text":"The PELOD-2 score on day 1 was a significant prognostic factor; the serial evaluation of the change in the dPELOD-2 score from day1, adjusted for baseline value, demonstrated a significant odds ratio of death for each of the 7 days.CONCLUSION: This study suggests that the progression of the severity of organ dysfunctions can be evaluated by measuring the dPELOD-2 score during a set of 7 days in PICU, providing useful information on outcome in critically ill children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1991,"document":"34778148","golden":false,"offsetInEndSection":2138,"text":"Conclusions: The newly-created p-SAPS II performed better than the established PIM3 in terms of discriminating between survivors and non-survivors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":949,"document":"38062303","golden":false,"offsetInEndSection":1147,"text":"Multiple logistic regression was performed to examine the association between MODS and TBI mechanism with new impairment status.RESULTS: Among 576 children, 215 (37%) had AHT and 361 (63%) had aTBI.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37636856","golden":false,"offsetInEndSection":109,"text":"Background: Sequential organ failure assessment score (SOFA) is a score to quantify organ system dysfunction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38062303","golden":false,"offsetInEndSection":129,"text":"BACKGROUND: Abusive head trauma (AHT) is a mechanism of pediatric traumatic brain injury (TBI) with high morbidity and mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1227,"document":"33011077","golden":false,"offsetInEndSection":1382,"text":"Finally, we also found significantly higher organ failure rate, mechanical ventilation requirement, and PRISM III score at PICU admission in non-survivors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":305,"document":"38062303","golden":false,"offsetInEndSection":627,"text":"Our objective was to compare the frequency of MODS and evaluate its association with outcome between AHT and accidental TBI (aTBI).METHODS: This was a single center, retrospective cohort study including children under 3 years old admitted to the pediatric intensive care unit with nonpenetrating TBI between 2014 and 2021.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1304,"document":"38062303","golden":false,"offsetInEndSection":1472,"text":"The most common organ failures were cardiovascular ([AHT] 66% vs. [aTBI] 66%, p?\u003d?0.997), neurologic (33% vs. 16%, p?\u003c?0.001), and respiratory (34% vs. 15%, p?\u003c?0.001).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":628,"document":"38062303","golden":false,"offsetInEndSection":948,"text":"Presence or absence of MODS on days 1, 3, and 7 using the Pediatric Logistic Organ Dysfunction-2 score and new impairment status (Functional Status Scale score change?\u003e?1 compared with preinjury) at hospital discharge (HD), short-term timepoint, and long-term timepoint?were abstracted from the electronic health record.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1001,"document":"27023591","golden":false,"offsetInEndSection":1317,"text":"Further, we found that the level of TNF? production was higher in patients with the rs10865710 G allele compared to those with the variant C allele.CONCLUSIONS: The rs10865710 polymorphism in the PPAR? gene might be used to assess the risk of sepsis and multiple organ dysfunction syndrome (MODS) in trauma patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":682,"document":"37979776","golden":false,"offsetInEndSection":800,"text":"We evaluated the discrimination for in-hospital mortality by the sepsis diagnosis and the number of organ dysfunction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37809525","golden":false,"offsetInEndSection":165,"text":"Sepsis is defined as a dysregulated host response to infection that can result in organ dysfunction and high mortality, which needs more effective treatment urgently","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1674,"document":"35020050","golden":false,"offsetInEndSection":1890,"text":"? The incidence of sepsis-associated liver injury and its prognostic significance in children is not known.. What is New: ? SALI develops in one-third children with sepsis and is associated with a higher pSOFA score.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1253,"document":"35020050","golden":false,"offsetInEndSection":1298,"text":"A higher pSOFA score is associated with SALI.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1637,"document":"37272946","golden":false,"offsetInEndSection":2254,"text":"When compared with other high-risk clinical syndromes, the persistent hypoxemia, encephalopathy, and shock phenotype only overlapped with 50%-60% of patients with septic shock, moderate-to-severe pediatric acute respiratory distress syndrome, or those in the top tier of organ dysfunction burden, suggesting that it represents a nonsynonymous clinical phenotype of sepsis-associated MODS.CONCLUSIONS: We derived and validated the persistent hypoxemia, encephalopathy, and shock phenotype, which is highly reproducible, clinically relevant, and associated with HTE to common adjuvant therapies in children with sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1493,"document":"37777757","golden":false,"offsetInEndSection":1883,"text":"In contrast, sepsis animals identified by the SIRS score exhibited lower SAP, aortic peak systolic velocity, aortic blood flow volume, and aortic resistivity index and additionally, higher peak intensity of contrast in the duodenal wall.CONCLUSIONS: Pyometra causes a reduction in abdominal aortic blood flow, which is more pronounced in animals with sepsis identified by the SIRS criteria.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":851,"document":"35020050","golden":false,"offsetInEndSection":985,"text":"Paediatric sequential organ failure assessment (pSOFA) was an independent predictor of SALI - OR 1.17 (95% CI 1.067-1.302), p?\u003d?0.001.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1199,"document":"35020050","golden":false,"offsetInEndSection":1252,"text":"Conclusions: SALI develops in 45 (31.3%) with sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1393,"document":"37113362","golden":false,"offsetInEndSection":1695,"text":"So, we can say that the mean SOFA score is better than D1?(day 1 of admission) APACHE II \u0026 SOFA scores in predicting mortality in surgical patients with sepsis.CONCLUSIONS: APACHE II and SOFA scores are equally effective in assessing mortality in surgical patients with sepsis at the time of admission.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":986,"document":"35020050","golden":false,"offsetInEndSection":1088,"text":"A pSOFA score of?\u003e?9.5 predicted the development of SALI with 66.7% sensitivity and 77.1% specificity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31910037","golden":false,"offsetInEndSection":439,"text":"Rationale: Although proposed as a clinical prompt to sepsis based on predictive validity for mortality, the Quick Sepsis-related Organ Failure Assessment (qSOFA) score is often used as a screening tool, which requires high sensitivity.Objectives: To assess the predictive accuracy of qSOFA for mortality in Brazil, focusing on sensitivity.Methods: We prospectively collected data from two cohorts of emergency department and ward patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1618,"document":"35020050","golden":false,"offsetInEndSection":1673,"text":"This is known as sepsis-associated liver injury (SALI).","beginSection":"abstract"}],"exact_answer":[],"ideal_answer":[],"id":"65844f7c06a2ea257c000005","type":"list","body":"Which organ dysfunction scores are used for evaluating paediatric sepsis?"},{"documents":[{"golden":false,"id":"25056493"},{"golden":false,"id":"36330224"},{"golden":false,"id":"32984583"},{"golden":false,"id":"23480686"},{"golden":false,"id":"31974673"},{"golden":false,"id":"36053116"},{"golden":false,"id":"26031475"},{"golden":false,"id":"36604132"},{"golden":false,"id":"34122587"},{"golden":false,"id":"10795470"},{"golden":true,"id":"34068959"},{"golden":false,"id":"32861227"},{"golden":false,"id":"28438138"},{"golden":false,"id":"24942238"},{"golden":false,"id":"22519940"},{"golden":false,"id":"31907060"},{"golden":false,"id":"31784324"},{"golden":false,"id":"32665265"},{"golden":false,"id":"24919492"},{"golden":false,"id":"30992534"},{"golden":true,"id":"34504260"},{"golden":false,"id":"32126571"},{"golden":false,"id":"30627341"},{"golden":true,"id":"35263468"},{"golden":true,"id":"37223064"},{"golden":false,"id":"33865753"},{"golden":false,"id":"36972964"},{"golden":false,"id":"31763206"},{"golden":false,"id":"34136441"},{"golden":false,"id":"24185532"},{"golden":true,"id":"33018161"},{"golden":false,"id":"28797204"},{"golden":false,"id":"33900849"},{"golden":false,"id":"32350044"},{"golden":false,"id":"32720089"},{"golden":false,"id":"35046541"},{"golden":false,"id":"38050541"},{"golden":false,"id":"35884182"},{"golden":false,"id":"33019253"},{"golden":false,"id":"33048903"},{"golden":false,"id":"33772188"},{"golden":false,"id":"37512087"},{"golden":false,"id":"35966841"},{"golden":false,"id":"37673556"},{"golden":false,"id":"37178098"},{"golden":false,"id":"35336302"},{"golden":false,"id":"35198634"},{"golden":false,"id":"32955816"},{"golden":false,"id":"34151155"},{"golden":false,"id":"36477064"},{"golden":true,"id":"34041734"},{"golden":false,"id":"37068899"},{"golden":false,"id":"34686556"},{"golden":false,"id":"34452260"},{"golden":false,"id":"33947731"},{"golden":false,"id":"34765491"},{"golden":false,"id":"37313623"},{"golden":false,"id":"32002381"},{"golden":true,"id":"32203177"},{"golden":false,"id":"24592630"},{"golden":false,"id":"36127407"},{"golden":false,"id":"36715271"},{"golden":false,"id":"26908676"},{"golden":false,"id":"38262696"},{"golden":false,"id":"36467476"},{"golden":false,"id":"35060658"},{"golden":false,"id":"33632088"},{"golden":false,"id":"36645795"},{"golden":false,"id":"25867557"},{"golden":true,"id":"35522467"},{"golden":false,"id":"37814720"},{"golden":false,"id":"38084084"},{"golden":false,"id":"35927575"},{"golden":true,"id":"36695040"},{"golden":false,"id":"38240873"},{"golden":false,"id":"34151278"},{"golden":false,"id":"33425956"},{"golden":false,"id":"37474597"},{"golden":true,"id":"35622931"},{"golden":false,"id":"34417563"},{"golden":false,"id":"32443606"},{"golden":false,"id":"28794881"},{"golden":false,"id":"29871901"},{"golden":false,"id":"33708302"},{"golden":false,"id":"36645762"},{"golden":false,"id":"36823611"},{"golden":true,"id":"36813654"},{"golden":false,"id":"36032785"},{"golden":false,"id":"34902315"},{"golden":false,"id":"37810514"},{"golden":false,"id":"37354910"},{"golden":false,"id":"34722452"},{"golden":false,"id":"33828606"},{"golden":false,"id":"33360011"},{"golden":false,"id":"33949115"},{"golden":false,"id":"33936913"},{"golden":false,"id":"34775198"},{"golden":true,"id":"27468879"},{"golden":true,"id":"31496894"},{"golden":true,"id":"33087092"},{"golden":false,"id":"21168377"},{"golden":false,"id":"25672088"},{"golden":false,"id":"15524419"},{"golden":true,"id":"15451490"},{"golden":false,"id":"27277355"},{"golden":false,"id":"3956962"},{"golden":false,"id":"15566590"},{"golden":false,"id":"38357643"},{"golden":false,"id":"38357164"},{"golden":false,"id":"38355732"},{"golden":false,"id":"38348358"},{"golden":false,"id":"38345975"},{"golden":false,"id":"38345017"},{"golden":false,"id":"38344194"},{"golden":false,"id":"38341816"},{"golden":false,"id":"38337815"},{"golden":false,"id":"38332914"},{"golden":false,"id":"38357132"},{"golden":false,"id":"38356035"},{"golden":false,"id":"38355207"},{"golden":false,"id":"38354362"},{"golden":false,"id":"38353591"},{"golden":false,"id":"38353586"},{"golden":false,"id":"38353160"},{"golden":false,"id":"38352942"},{"golden":false,"id":"38348451"},{"golden":false,"id":"23137927"},{"golden":false,"id":"30996609"},{"golden":false,"id":"29095722"},{"golden":false,"id":"26709366"},{"golden":false,"id":"26172580"},{"golden":false,"id":"18073177"},{"golden":false,"id":"25560157"},{"golden":false,"id":"19266776"},{"golden":false,"id":"27357410"},{"golden":false,"id":"35488816"},{"golden":false,"id":"34920065"},{"golden":false,"id":"37505928"},{"golden":false,"id":"37849792"},{"golden":true,"id":"31982701"},{"golden":false,"id":"32850901"},{"golden":false,"id":"33236524"},{"golden":false,"id":"35697438"},{"golden":false,"id":"37008225"},{"golden":false,"id":"34094705"},{"golden":false,"id":"35836633"},{"golden":false,"id":"31879225"},{"golden":false,"id":"15791874"},{"golden":false,"id":"26349677"},{"golden":false,"id":"25944306"},{"golden":false,"id":"33880335"},{"golden":false,"id":"37326282"},{"golden":true,"id":"35329889"},{"golden":false,"id":"11767480"},{"golden":false,"id":"37252329"},{"golden":false,"id":"23543035"},{"golden":false,"id":"34160425"},{"golden":false,"id":"31675548"},{"golden":false,"id":"38358334"},{"golden":false,"id":"38357933"},{"golden":false,"id":"38357644"},{"golden":false,"id":"38357545"},{"golden":false,"id":"38357510"},{"golden":false,"id":"38357174"},{"golden":true,"id":"38330522"},{"golden":false,"id":"38261606"},{"golden":false,"id":"38193658"},{"golden":false,"id":"38122992"},{"golden":false,"id":"38116466"},{"golden":false,"id":"38090611"},{"golden":false,"id":"38078332"},{"golden":false,"id":"38074247"},{"golden":false,"id":"38050211"},{"golden":false,"id":"37813544"},{"golden":false,"id":"34501324"},{"golden":false,"id":"35806919"},{"golden":false,"id":"32005367"},{"golden":false,"id":"35438283"},{"golden":false,"id":"37216423"},{"golden":false,"id":"36376821"},{"golden":false,"id":"33446739"},{"golden":false,"id":"38240508"}],"answerReady":false,"snippets":[{"endSection":"abstract","offsetInBeginSection":2049,"document":"32984583","golden":false,"offsetInEndSection":2354,"text":" hs-CRP (AUC \u003d 78.4%) and sCD14-ST (AUC \u003d 74.8%). Combination of PCT + hs-CRP had the highest accuracy (AUC \u003d 80.1%) followed by hs-CRP + sCD14-ST (AUC \u003d 77.2%), PCT + sCD14-ST + hs-CRP (AUC \u003d 77.0%) and PCT + sCD14-ST (AUC \u003d 75.9%).Conclusion: hs-CRP, PCT, and sCD14-ST are independent predictors of paed","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1018,"document":"31974673","golden":false,"offsetInEndSection":1234,"text":"Levels of MR-proADM were significantly higher in patients who required vasoactive drugs (p?\u003d?0.02) or presented renal dysfunction (p?\u003d?0.004).Conclusion: PCT appeared to be superior to MR-proADM in diagnosing sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":514,"document":"10795470","golden":false,"offsetInEndSection":636,"text":"otal Neutrophil ratio (I.T. ratio), Platelet count and C-Reactive protein were used for rapid diagnosis of neonatal sepsis","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1435,"document":"34068959","golden":true,"offsetInEndSection":1583,"text":"Thus, PSEP was an early biomarker of neonatal sepsis severity, but did not support the early identification of neonates with positive blood culture.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2467,"document":"32984583","golden":false,"offsetInEndSection":2585,"text":"cantly associated with increased odds for sepsis. The incorporation of these biomarkers into routine diagnostic tests ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1682,"document":"32984583","golden":false,"offsetInEndSection":1749,"text":"negative for blood cultures (CS). Klebsiella spp. recorded the high","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2355,"document":"32984583","golden":false,"offsetInEndSection":2466,"text":"atric sepsis due to their high prognostic values. Moreover, Bioscore combination of these biomarkers was signif","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1802,"document":"32984583","golden":false,"offsetInEndSection":1932,"text":"ruginasa recorded the highest of sCD14-ST levels. Significant elevations in PCT, sCD14-ST and hs-CRP levels were observed among se","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":133,"document":"32984583","golden":false,"offsetInEndSection":284,"text":" countries. Clinical symptoms associated with sepsis are unreliable and laboratory parameters unspecific, making an early diagnosis of paediatric sepsi","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"32984583","golden":false,"offsetInEndSection":163,"text":"Individual and combined bioscore model of presepsin, procalcitonin, and high sensitive C - reactive protein as biomarkers for early diagnosis of paediatric sepsis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1326,"document":"32126571","golden":false,"offsetInEndSection":1917,"text":"IMPACT: There is currently no consensus definition of neonatal sepsis and the definitions that are currently in use are varied.A consensus definition of neonatal sepsis would benefit clinicians, patients and researchers.Recent progress in adults with publication of Sepsis-3 provides guidance on how a consensus definition and screening criteria for sepsis could be produced in neonatology.We discuss common themes and potential shortcomings in sepsis definitions within neonatology.We highlight the need for a consensus definition of neonatal sepsis and the challenges that this task poses.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"22519940","golden":false,"offsetInEndSection":237,"text":"Early identification of infants with sickle cell disease (SCD) by newborn screening, now universal in all 50 states in the US, has improved survival, mainly by preventing overwhelming sepsis with the early use of prophylactic penicillin.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":871,"document":"24185532","golden":false,"offsetInEndSection":1028,"text":"Some of the newer markers like inter ? inhibitor proteins have shown promising results thereby potentially aiding in early detection of neonates with sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1029,"document":"24185532","golden":false,"offsetInEndSection":1226,"text":"In order to decrease the widespread, prolonged use of unnecessary antibiotics and improve the outcome of the infants with sepsis, reliable identification of sepsis at an earlier stage is paramount.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1327,"document":"33018161","golden":false,"offsetInEndSection":1658,"text":"Moreover, this study demonstrates that differences in the values of a particular set of features at 22 hours before the actual clinical diagnosis/symptoms can be reliably used to train a convolutional neural network for automatic classification between the individuals in the sepsis and non-sepsis groups with 88.89?7.86% accuracy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35884182","golden":false,"offsetInEndSection":154,"text":"BACKGROUND: Late-onset neonatal sepsis (LOS) represents a significant cause of morbidity and mortality worldwide, and early diagnosis remains a challenge.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"33018161","golden":false,"offsetInEndSection":182,"text":"Potential Prognostic Markers in the Heart Rate Variability Features for Early Diagnosis of Sepsis in the Pediatric Intensive Care Unit using Convolutional Neural Network Classifiers.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":318,"document":"24185532","golden":false,"offsetInEndSection":440,"text":"Moreover, some studies among VLBW preterm infants have shown an increase in early-onset sepsis caused by Escherichia coli.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":136,"document":"24185532","golden":false,"offsetInEndSection":317,"text":"Though intrapartum antibiotic prophylaxis has decreased the incidence of early-onset group B streptococcal infection dramatically, it still remains a major cause of neonatal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1326,"document":"33019253","golden":false,"offsetInEndSection":1840,"text":"Moreover, this study demonstrates that differences in the values of a particular set of features at 22 hours before the actual clinical diagnosis/symptoms can be reliably used to train a convolutional neural network for automatic classification between the individuals in the sepsis and non-sepsis groups with 88.89?7.86% accuracy.Clinical relevance- Results suggest potential early diagnosis of sepsis through real-time automatic classification of HRV features as prognostic indicators in clinical ECG recordings.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":441,"document":"24185532","golden":false,"offsetInEndSection":560,"text":"As the signs and symptoms of neonatal sepsis are nonspecific, early diagnosis and prompt treatment remains a challenge.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":561,"document":"24185532","golden":false,"offsetInEndSection":762,"text":"There have been a myriad of studies on various diagnostic markers like hematological indices, acute phase reactants, C-reactive protein, procalcitonin, cytokines, and cell surface markers among others.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1505,"document":"33048903","golden":false,"offsetInEndSection":1749,"text":"The optimal RUSBoost model has achieved a normalized utility score of 0.318 on full test data.CONCLUSIONS: The proposed study supports the realization of a hospital-specific customized solution in the form of an early-warning system for sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1476,"document":"37178098","golden":false,"offsetInEndSection":1850,"text":"TAMSI yielded an increased positive likelihood ratio and similar negative likelihood ratio versus PALS.CONCLUSIONS: TAMSI achieved a similar negative likelihood ratio and improved positive likelihood ratio compared with PALS vital sign cutoffs for the prediction of septic shock, but it did not improve on PALS for sepsis prediction, among children with suspected infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33048903","golden":false,"offsetInEndSection":105,"text":"OBJECTIVES: Early prediction of sepsis is of utmost importance to provide optimal care at an early stage.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":106,"document":"33048903","golden":false,"offsetInEndSection":440,"text":"This work aims to deploy soft-computing and machine learning techniques for early prediction of sepsis.DESIGN: An algorithm for early identification of sepsis using ratio and power-based feature transformation of easily obtainable clinical data.SETTING: PhysioNet Challenge 2019 provided ICU data from three separate hospital systems.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":720,"document":"33048903","golden":false,"offsetInEndSection":998,"text":"The Sepsis-3 criterion is applied for annotation.INTERVENTIONS: None.MEASUREMENTS AND MAIN RESULTS: The clinical feature exploration for early prediction of sepsis is achieved using the proposed framework named genetic algorithm optimized ratio and power-based expert algorithm.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":999,"document":"33048903","golden":false,"offsetInEndSection":1358,"text":"An optimal feature set containing 46 ratio and power-based features is computed from the given patient covariates using genetic algorithm optimized ratio and power-based expert and grouped with identified 17 raw features and 55 statistical features to form a final feature set of 118 clinical features to predict the onset of sepsis in the proceeding 6 hours.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35198634","golden":false,"offsetInEndSection":137,"text":"AIM: Early diagnosis of paediatric sepsis is crucial for the proper treatment of children and reduction of hospitalization and mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1675,"document":"35198634","golden":false,"offsetInEndSection":1973,"text":"In addition, the meta-analysis results showed that the pooled sensitivity, specificity, and area under the curve values were 1.00, 0.98, and 1.00, respectively.CONCLUSION: The four-gene signature can be used as new biomarkers to distinguish patients with paediatric sepsis from healthy individuals.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"33048903","golden":false,"offsetInEndSection":83,"text":"Early Prediction of Sepsis From Clinical Data Using Ratio and Power-Based Features.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":177,"document":"33772188","golden":false,"offsetInEndSection":356,"text":"It is imperative that the signs of sepsis are identified early in both adult and paediatric patients and appropriately escalated to initiate early treatment and improve prognosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37178098","golden":false,"offsetInEndSection":365,"text":"OBJECTIVE: To empirically derive a novel temperature- and age-adjusted mean shock index (TAMSI) for early identification of sepsis and septic shock in children with suspected infection.METHODS: We performed a retrospective cohort study of children aged 1 month to \u003c18 years presenting to a single emergency department with suspected infection over a 10-year period.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":660,"document":"37178098","golden":false,"offsetInEndSection":1196,"text":"In the one-third validation data set, we calculated test characteristics for the TAMSI cutoffs and compared them with those for the Pediatric Advanced Life Support (PALS) tachycardia or systolic hypotension cutoffs.RESULTS: In the sepsis validation data set, the sensitivity-targeting TAMSI cutoff yielded a sensitivity of 83.5% (95% confidence interval [CI] 81.7% to 85.4%) and specificity of 42.8% (95% CI 42.4% to 43.3%) versus a sensitivity of 77.7% (95% CI 75.7% to 79.8%) and specificity of 60.0% (95% CI 59.5% to 60.4%) for PALS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":242,"document":"32955816","golden":false,"offsetInEndSection":416,"text":"Prompt early treatment delivered using care bundles such as the \u0027sepsis six\u0027 can optimise patients\u0027 chances of survival and reduce the debilitating effects of this condition.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":95,"document":"34041734","golden":false,"offsetInEndSection":523,"text":"Early recognition and treatment are vital to improving patient outcomes.OBJECTIVE: The study aimed to evaluate the impact of a best practice alert in improving recognition of sepsis and timely treatment to improve mortality in the pediatric acute care setting.METHODS: A multidisciplinary team adapted a sepsis alert from the emergency room setting to facilitate identification of sepsis in acute care pediatric inpatient areas.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37178098","golden":false,"offsetInEndSection":104,"text":"A Temperature- and Age-Adjusted Shock Index for Emergency Department Identification of Pediatric Sepsis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1197,"document":"37178098","golden":false,"offsetInEndSection":1475,"text":"For septic shock, the sensitivity-targeting TAMSI cutoff achieved a sensitivity of 81.3% (95% CI 75.2% to 87.4%) and a specificity of 83.5% (95% CI 83.2% to 83.8%) versus a sensitivity of 91.0% (95% CI 86.5% to 95.5%) and a specificity of 58.8% (95% CI 58.4% to 59.3%) for PALS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37068899","golden":false,"offsetInEndSection":163,"text":"OBJECTIVES: In the early stage of sepsis, identifying high-risk paediatric patients with a poor prognosis and providing timely and adequate treatment are critical.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":111,"document":"32002381","golden":false,"offsetInEndSection":1008,"text":"The early detection and identification of pro-inflammatory changes in overall metabolism and functioning can help in the proper intervention and control of the inflammatory state, and it will improve the prognosis.AIM: In a resource-limited setting where the biomarkers are not easily accessible, this simple technique is required that can help in the early identification of infection and inflammation.METHODOLOGY: The present study was conducted to find the change in glycogen accumulation and morphological changes during inflammation by preparing a peripheral smear and periodic acid-Schiff (PAS) staining.RESULTS: This study shows that the neutrophil accumulates glycogen granules throughout the cytoplasm with the presence of vacuoles in the cytoplasm, thus increasing the neutrophil size and chromatin dispersion.CONCLUSION: PAS staining can be used as a diagnostic method to detect sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":545,"document":"36477064","golden":false,"offsetInEndSection":668,"text":"Identifying the clinical signs determines the need for immediate treatment (i.e., fluid resuscitation) no matter the cause.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":404,"document":"36477064","golden":false,"offsetInEndSection":544,"text":"Identification of the systemic inflammatory response syndrome (SIRS) versus sepsis is difficult in burns owing to the clinical presentation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":528,"document":"37178098","golden":false,"offsetInEndSection":659,"text":"In the two-thirds training set, we determined TAMSI cutoffs for each age group using a minimum sensitivity of 85% and Youden Index.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":797,"document":"32203177","golden":false,"offsetInEndSection":1065,"text":"Our model had an area under the receiver operating characteristic curve of 0.92 (95% CI: 0.86-0.97).CONCLUSIONS: Clinical evaluation with neutrophil-to-lymphocyte ratio and C-reactive protein can rapidly identify LOS enabling decreased health costs and antibiotic use.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32203177","golden":false,"offsetInEndSection":83,"text":"OBJECTIVE: No single test can accurately identify neonatal late-onset sepsis (LOS).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":427,"document":"36645795","golden":false,"offsetInEndSection":924,"text":"Data-driven prediction models integrated in clinical decision support systems (CDSS) could facilitate early recognition of disease onset.OBJECTIVES: To estimate the sensitivity and specificity of previously developed prediction models (index tests) for the detection of SIRS, sepsis and associated organ dysfunctions in critically ill children up to 12 hours before reference standard diagnosis is possible.METHODS AND ANALYSIS: We conduct a monocentre, prospective diagnostic test accuracy study.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":114,"document":"26908676","golden":false,"offsetInEndSection":418,"text":"We sought to identify and evaluate children with possible sepsis on a pediatric medical/surgical unit through successful implementation of a sepsis identification pathway.METHODS: The sepsis identification pathway, a vital sign screen and subsequent physician evaluation, was implemented in October 2013.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":588,"document":"32203177","golden":false,"offsetInEndSection":796,"text":"LOS was independently associated with: sick appearance (OR: 5.7, 95% CI: 1.1-29.1), C-reactive protein \u003e?0.75 (OR: 5.4, 95% CI: 1.1-26.3), and neutrophil-to-lymphocyte ratio \u003e?1.5 (OR: 6.7, 95% CI: 1.2-38.5).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":84,"document":"32203177","golden":false,"offsetInEndSection":295,"text":"Our aim was to use clinical evaluation with laboratory tests to rapidly assess sepsis risk.STUDY DESIGN: A retrospective case-control study was performed in a tertiary Neonatal Center during the years 2016-2019.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":377,"document":"24592630","golden":false,"offsetInEndSection":472,"text":"This article looks at how sepsis can be identified and effectively treated to improve survival.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":763,"document":"36127407","golden":false,"offsetInEndSection":856,"text":"IMPACT: This narrative review highlights the application of AI in neonatal sepsis prediction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":441,"document":"32203177","golden":false,"offsetInEndSection":587,"text":"A prediction model was developed and validated by multivariable analysis.RESULTS: The study included 145 infants, 48 with sepsis, and 97 controls.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"32203177","golden":false,"offsetInEndSection":96,"text":"Can we improve early identification of neonatal late-onset sepsis? A validated prediction model.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1269,"document":"26908676","golden":false,"offsetInEndSection":1507,"text":"One patient with neutropenia and septic shock had a negative sepsis screen due to lack of initial fever.CONCLUSIONS: Using quality improvement methodology, we successfully implemented a sepsis identification pathway on our pediatric unit.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":203,"document":"35522467","golden":false,"offsetInEndSection":994,"text":"Identifying sepsis cases as early as possible is a key pillar of sepsis management and has prompted the development of sepsis identification rules and algorithms that are embedded in computerized clinical decision support (CCDS) systems.OBJECTIVE: This scoping review aimed to systematically describe studies reporting on the use and evaluation of CCDS systems for the early detection of pediatric, neonatal, and maternal inpatients at risk of sepsis.METHODS: MEDLINE, Embase, CINAHL, Cochrane, Latin American and Caribbean Health Sciences Literature (LILACS), Scopus, Web of Science, OpenGrey, ClinicalTrials.gov, and ProQuest Dissertations and Theses Global (PQDT) were searched by using a search strategy that incorporated terms for sepsis, clinical decision support, and early detection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":296,"document":"32203177","golden":false,"offsetInEndSection":376,"text":"Infants with bacteriologically confirmed LOS were compared with control infants.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":348,"document":"38084084","golden":false,"offsetInEndSection":638,"text":"Advances in understanding sepsis pathophysiology highlight a need to update the definition and diagnostic criteria for pediatric sepsis and septic shock, whereas new data support an increasing role for automated screening algorithms and biomarker combinations to assist earlier recognition.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1407,"document":"34151278","golden":false,"offsetInEndSection":1757,"text":"Using spectral clustering, we stratified pediatric sepsis patients into two clusters differing in septic shock prevalence, mortality, and proportion of patients adequately fluid resuscitated.CONCLUSIONS: We demonstrate the applicability of our methodology for early prediction and stratification for risk of septic shock in pediatric sepsis patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":639,"document":"38084084","golden":false,"offsetInEndSection":947,"text":"Once sepsis or septic shock is suspected, attention to prompt initiation of broad-spectrum empiric antimicrobial therapy, fluid resuscitation, and vasoactive medications remain key components to initial management with several new and ongoing studies offering new insights into how to optimize this approach.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":948,"document":"38084084","golden":false,"offsetInEndSection":1168,"text":"Ultimately, a key goal is for screening to encompass as many children as possible at risk for sepsis and trigger early treatment without increasing unnecessary broad-spectrum antibiotics and preventable hospitalizations.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35622931","golden":false,"offsetInEndSection":402,"text":"BACKGROUND: Although early diagnosis and management are critical for prognosis of pediatric sepsis, there are no specific diagnostic biomarkers for the hyperinflammatory state and organ dysfunction, important stages of sepsis.METHODS: We enrolled 129 children with infection into three groups: non-sepsis infection (33), Sepsis 1.0 (hyperinflammatory state, 67), and Sepsis 3.0 (organ dysfunction, 29).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1359,"document":"38084084","golden":false,"offsetInEndSection":1702,"text":"Finally, we are increasingly moving toward an era in which precision therapeutics will bring novel strategies to improve outcomes, especially for the subset of children with sepsis-induced multiple organ dysfunction syndrome and sepsis subphenotypes for whom antibiotics, fluid, vasoactive medications, and supportive care remain insufficient.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1457,"document":"36695040","golden":false,"offsetInEndSection":1686,"text":"PT alert response compliance rose from 67% in 2018 to 91% in 2020.CONCLUSIONS: An interruptive severe sepsis screening alert sent directly to clinicians is a valuable tool to ensure prompt severe sepsis recognition and treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36695040","golden":false,"offsetInEndSection":119,"text":"INTRODUCTION: Prompt sepsis recognition and the initiation of standardized treatment bundles lead to improved outcomes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":64,"document":"34417563","golden":false,"offsetInEndSection":266,"text":"While adverse outcomes can be reduced through prompt initiation of sepsis protocols including fluid resuscitation and antibiotics, provision of these therapies relies on clinician recognition of sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1428,"document":"36715271","golden":false,"offsetInEndSection":1527,"text":"During the intervention period, the adherence to vital signs measurements reached the goal of \u003e90%.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":899,"document":"36715271","golden":false,"offsetInEndSection":974,"text":"Vital signs measurement adherence increased from 42.7% to \u003e90% in 2?months.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36715271","golden":false,"offsetInEndSection":123,"text":"Implementing a screening algorithm for early recognition of sepsis in hospitalized children: a quality improvement project.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":52,"document":"36715271","golden":false,"offsetInEndSection":126,"text":"Utilizing a screening tool for early recognition of sepsis is recommended.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":127,"document":"36715271","golden":false,"offsetInEndSection":221,"text":"Our centre had no screening tool for sepsis nor a standardized protocol for sepsis management.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":222,"document":"36715271","golden":false,"offsetInEndSection":289,"text":"In December 2020, a screening algorithm for sepsis was implemented.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1288,"document":"25867557","golden":false,"offsetInEndSection":1447,"text":"nificant deficits in sepsis care exist. Early recognition and management remain a key issue and may be addressed through improved triage, augmented support for","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":173,"document":"36645795","golden":false,"offsetInEndSection":250,"text":"nits (PICUs). Early recognition and treatment within the first hours of onset","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":551,"document":"36645795","golden":false,"offsetInEndSection":809,"text":"isease onset.OBJECTIVES: To estimate the sensitivity and specificity of previously developed prediction models (index tests) for the detection of SIRS, sepsis and associated organ dysfunctions in critically ill children up to 12 hours before reference standa","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":830,"document":"28794881","golden":false,"offsetInEndSection":1037,"text":"tonin alone may not be effective. Rapid elevation in the concentration of procalcitonin and other newly emerging biomarkers during an infection and its correlation with severity of illness makes it an ideal ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":215,"document":"28794881","golden":false,"offsetInEndSection":446,"text":"d patients. Early and differential diagnosis of sepsis is needed critically to avoid unnecessary usage of antimicrobial agents and for proper antibiotic treatments through the screening of biomarkers that sustains with diagnostic s","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":413,"document":"36645795","golden":false,"offsetInEndSection":550,"text":"U physicians. Data-driven prediction models integrated in clinical decision support systems (CDSS) could facilitate early recognition of ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1400,"document":"29871901","golden":false,"offsetInEndSection":1609,"text":"s after hospital discharge.CONCLUSIONS: HPeV is an important cause of febrile illness in infants and can have severe clinical presentations. Early diagnosis may help reduce antimicrobial use, unnecessary inves","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1610,"document":"29871901","golden":false,"offsetInEndSection":1763,"text":"igations and prolonged hospitalisation. While prognosis remains favourable, some infants will develop long-term complications-paediatricians should ensur","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33708302","golden":false,"offsetInEndSection":102,"text":"INTRODUCTION: Early empiric broad spectrum antibiotic administration in children with septic shock imp","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":317,"document":"36645762","golden":false,"offsetInEndSection":436,"text":"valuations. A non-invasive, fast and easy method is needed to assess the mortality of children with septic shock at an ","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37810514","golden":false,"offsetInEndSection":177,"text":"Retracted: Analysis of the Relevant Vital Signs and Infection of Sepsis Patients and to Explore the Influencing Factors of Acute Lung Injury/Acute Respiratory Distress Syndrome.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":258,"document":"38262696","golden":false,"offsetInEndSection":417,"text":"Biomarkers can aid in creating a larger low-risk group of children from those in the clinical grey area who would otherwise receive antibiotics \u0027just in case\u0027.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":202,"document":"33949115","golden":false,"offsetInEndSection":486,"text":"We created a machine learning model for bacterial sepsis identification in the neonatal intensive care unit (NICU) using hematological analyzer data.METHODS: Hematological analyzer data were gathered from NICU patients up to 48?hours prior to clinical evaluation for bacterial sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":728,"document":"38262696","golden":false,"offsetInEndSection":916,"text":"The identification of multiple host biomarkers that may form a panel in a clinical test has the potential to recognise the complexity of sepsis and provide improved diagnostic performance.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":418,"document":"38262696","golden":false,"offsetInEndSection":564,"text":"Current biomarkers include C reactive protein and procalcitonin, which are limited in their clinical use to guide appropriate and rapid treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":917,"document":"38262696","golden":false,"offsetInEndSection":1120,"text":"In this review, we discuss novel biomarkers and novel ways of using existing biomarkers in the assessment and management of sepsis along with the significant challenges in biomarker discovery at present.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1078,"document":"34775198","golden":false,"offsetInEndSection":1390,"text":"Score trends in the hours leading up to sepsis criteria being met showed a marked increase for the sepsis group while for the cases there was a decrease during a comparable period.CONCLUSIONS: Temporal analyses of scores for patients coded as having sepsis provides novel insights into patterns of deterioration.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36813654","golden":false,"offsetInEndSection":399,"text":"BACKGROUND: There is no universal trigger or tool to aid sepsis diagnosis.OBJECTIVES: The objective of this study was to identify triggers and tools to assist the early detection of sepsis that can be readily implemented across various health care settings.METHODS: A systematic integrative review was conducted using MEDLINE, CINAHL, EMBASE, Scopus, and the Cochrane Database of Systematic Reviews.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":565,"document":"38262696","golden":false,"offsetInEndSection":727,"text":"Biomarker discovery has focused on single biomarkers, which, so far, have not outperformed current biomarkers, as they fail to recognise the complexity of sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1498,"document":"33949115","golden":false,"offsetInEndSection":1759,"text":"Neutrophil parameters had the highest average feature importance.CONCLUSIONS: Machine learning models using hematological analyzer data can classify NICU patients as sepsis positive or negative with stronger performance compared to clinical feature only models.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":98,"document":"38262696","golden":false,"offsetInEndSection":173,"text":"The clinical pathway encompasses recognition, escalation and de-escalation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":202,"document":"27468879","golden":false,"offsetInEndSection":488,"text":"We performed a prospective longitudinal observational study to evaluate of the role of serum biomarkers (C-reactive protein, procalcitonin, interleukin-6, presepsin) in the early diagnosis of bacteraemia (gram-negative versus gram-positive) in patients with haematological malignancies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":997,"document":"27468879","golden":false,"offsetInEndSection":1219,"text":"We identified comparably balanced sensitivity (64% - 81%) and specificity (61% - 88%) for interleukin-6 and procalcitonin, and we proved their quality to predict positive blood culture and clinical signs of sepsis as well.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1220,"document":"27468879","golden":false,"offsetInEndSection":1422,"text":"Patients with gram-negative bacteraemia had significantly elevated levels of PCT and IL-6 in comparison with a group of patients with gram-positive bacteraemia (p \u003d 0.04 for PCT and p \u003d 0.005 for IL-6).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31496894","golden":false,"offsetInEndSection":239,"text":"BACKGROUND: As an early recognition of neonatal sepsis is important for triggering the initiation of treatment, this study was thus designed to assess the diagnostic performance and discrimination value of procalcitonin (PCT) in neonatal s","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1296,"document":"31496894","golden":false,"offsetInEndSection":1398,"text":"th time of obtaining the blood samples. The PCT result at 12 h demonstrates the most optimal diagnosti","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":228,"document":"33087092","golden":false,"offsetInEndSection":367,"text":"n children. The aim of this study was to compare the diagnostic test accuracy of C-reactive protein (CRP) and PCT for the diagnosis of SBI ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1941,"document":"21168377","golden":false,"offsetInEndSection":2320,"text":"ngiectasia patients who died during follow-up.CONCLUSION: The vast majority of patients included in this series presented with typical clinical features; therefore, basic knowledge of these entities in primary care and collaboration with hospital referral centres should allow a large number of PID in children to be diagnosed at an early stage, leading to proper treatment and m","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":269,"document":"25672088","golden":false,"offsetInEndSection":379,"text":"because of perforation. The baby was admitted to NICU after birth with transitory respiratory failure and earl","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":380,"document":"25672088","golden":false,"offsetInEndSection":630,"text":" onset neonatal sepsis. MS-Staphylococcus epidermidis was isolated from blood culture, gastric contents and all peripheral specimens, C-reactive protein values were elevated after birth and significantly increased before surgery; thrombocytopenia and","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1225,"document":"15524419","golden":false,"offsetInEndSection":1336,"text":"entrations--this difference was not significant.CONCLUSION: Measurement of procalcitonin concentrations may be ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":804,"document":"38357643","golden":false,"offsetInEndSection":908,"text":"In the studied cohort of 32,971 sepsis patients, 2,327 were identified as meeting the inclusion criteria","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":156,"document":"38357164","golden":false,"offsetInEndSection":254,"text":"In Ethiopia, in 2015, it was the first cause of neonatal deaths followed by prematurity and sepsis","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38355732","golden":false,"offsetInEndSection":112,"text":"Rapid and accurate identification of the bacteria responsible for sepsis is paramount for effective patient care","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":753,"document":"38348358","golden":false,"offsetInEndSection":859,"text":"We have tested the proposed method on in-vivo data gathered from 14 pigs under hemorrhage and sepsis study","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"38345975","golden":false,"offsetInEndSection":101,"text":"Bloodstream infections (BSI) represent a common cause of sepsis and mortality in children","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":216,"document":"38345017","golden":false,"offsetInEndSection":341,"text":"Clinical presentation included lethargy, generalized septicemia, cutaneous granulomas, coelomic effusion, and acute mortality","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38344194","golden":false,"offsetInEndSection":101,"text":"LASSO-Based Identification of Risk Factors and Development of a Prediction Model for Sepsis Patients.","beginSection":"title"},{"endSection":"title","offsetInBeginSection":0,"document":"38341816","golden":false,"offsetInEndSection":116,"text":"Use of pus metagenomic next-generation sequencing for efficient identification of pathogens in patients with sepsis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":215,"document":"38337815","golden":false,"offsetInEndSection":371,"text":"There are however suggested tools and tests, which have been proposed in international guidelines, including those produced by the Surviving Sepsis Campaign","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":14,"document":"38332914","golden":false,"offsetInEndSection":175,"text":"Early diagnosis of sepsis and discrimination from SIRS is crucial for clinicians to provide appropriate care, management and treatment to critically ill patients","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":685,"document":"38357132","golden":false,"offsetInEndSection":808,"text":"The odds of RDS among neonates with jaundice and sepsis are 4.33- and 1.92-times higher odds compared to their counterparts","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":535,"document":"38356035","golden":false,"offsetInEndSection":582,"text":"A total of 4263 infants were diagnosed with BPD","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":566,"document":"38355207","golden":false,"offsetInEndSection":652,"text":"Initial screenings for sepsis and blood group incompatibility yielded negative results","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":9,"document":"38354362","golden":false,"offsetInEndSection":207,"text":"Time to antibiotic administration (TTA) in \u003c60 minutes for children with neutropenic fever presenting to an emergency room is associated with reduced incidence of sepsis and intensive care admission","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1729,"document":"38353591","golden":false,"offsetInEndSection":1784,"text":"Sepsis is still a life-threatening disease in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":234,"document":"38353586","golden":false,"offsetInEndSection":317,"text":"Secondary analysis of the Life After Pediatric Sepsis Evaluation prospective study.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1307,"document":"38353160","golden":false,"offsetInEndSection":1398,"text":"Further multicenter prospective data are needed, including infants with early-onset sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":151,"document":"38352942","golden":false,"offsetInEndSection":268,"text":"These mechanisms have been demonstrated in patients with sepsis, hemoglobinopathies, and those receiving transfusions","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":13,"document":"38348451","golden":false,"offsetInEndSection":184,"text":" Pediatric sepsis (PS) is a life-threatening infection associated with high mortality rates, necessitating a deeper understanding of its underlying pathological mechanisms","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":216,"document":"29095722","golden":false,"offsetInEndSection":613,"text":"This article focuses on the diagnosis of bloodstream infections by PCR-based approaches at an early stage to enable prompt treatment and prevent organ dysfunction.RECENT FINDINGS: PCR systems offering highly multiplexed targeting of bacterial and/or fungal pathogens (in whole blood) offer the best opportunity for clinical impact, as informed decisions can be made within 4-8?h of the blood draw.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23137927","golden":false,"offsetInEndSection":151,"text":"Neonatal sepsis, classified as either early or late onset, has specific pathogen distribution and infection rates in the different neonatal age groups.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":286,"document":"26172580","golden":false,"offsetInEndSection":929,"text":"We aimed to determine the incidence of early-onset GBS sepsis in New?Zealand five?years after the publication of national risk-based GBS prevention guidelines.MATERIALS AND METHODS: Prospective surveillance of early-onset GBS sepsis (defined as infection in the first 48?h of life) was undertaken between April 2009 and March 2011 through the auspices of the New Zealand Paediatric Surveillance Unit as part of a survey of infection presenting in the first week of life.RESULTS: There were 29 cases of confirmed early-onset GBS sepsis, including one case of meningitis, giving an incidence rate of 0.23 per 1000 (95% CI 0.16-0.33) live births.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":832,"document":"23137927","golden":false,"offsetInEndSection":954,"text":"This article highlights the goal of optimising vancomycin therapy in the neonate and discusses future research directions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1105,"document":"23137927","golden":false,"offsetInEndSection":1225,"text":"Modelling and simulation approaches have clear advantages in dosing optimisation of antimicrobial agents in the neonate.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":152,"document":"23137927","golden":false,"offsetInEndSection":288,"text":"It is a major cause of mortality and morbidity and administration of antibiotics is urgently required for suspected or proven infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":992,"document":"26709366","golden":false,"offsetInEndSection":1135,"text":"Unfortunately, despite evidence suggesting the benefit of early treatment, timely identification and treatment of children remains a challenge.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":655,"document":"23137927","golden":false,"offsetInEndSection":831,"text":"In addition, recent concerns about the increase in minimal inhibition concentration and other more generic problems have prompted reappraisal of the rational use of vancomycin.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30996609","golden":false,"offsetInEndSection":249,"text":"OBJECTIVE: To determine the incidence, types of organisms and resistance patterns involved in early-onset neonatal sepsis in Canada.STUDY DESIGN: Early-onset neonatal sepsis cases were identified through the Canadian Paediatric Surveillance Program.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":383,"document":"23137927","golden":false,"offsetInEndSection":654,"text":"Although it has been used for more than 50 years, prescription remains a challenge in neonatal intensive care units for many reasons, including: high pharmacokinetic variability, numerous presentations, lack of consensus on dosing regimen and therapeutic drug monitoring.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1013,"document":"27357410","golden":false,"offsetInEndSection":1307,"text":"Magicplex test allowed a 143?% increase in the diagnostic value of blood cultures.CONCLUSION: These results suggest that molecular biology can be useful for rapid pathogen\u0027s identification also in children.WHAT IS KNOWN: ? Sepsis represents a major cause of morbidity and mortality in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":457,"document":"15566590","golden":false,"offsetInEndSection":772,"text":"Therefore, we will test the clinical efficacy of a previously validated diagnostic strategy to reduce antibiotic usage and nosocomial infection related morbidity.METHODS: All patients admitted to the multidisciplinary neonatal and paediatric intensive care unit of a university children\u0027s hospital will be included.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":229,"document":"15566590","golden":false,"offsetInEndSection":304,"text":"However, some patients escape early diagnosis and progress to septic shock.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":773,"document":"15566590","golden":false,"offsetInEndSection":903,"text":"Patients will be allocated either to routine sepsis work up or to the intervention strategy with additional cytokine measurements.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1151,"document":"15524419","golden":false,"offsetInEndSection":1396,"text":"After 24 hours 26 of them had elevated CRP and 100% had increased PCT concentrations--this difference was not significant.CONCLUSION: Measurement of procalcitonin concentrations may be useful for early diagnosis of late onset sepsis in neonates.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"15566590","golden":false,"offsetInEndSection":220,"text":"G-CSF and IL-8 for early diagnosis of sepsis in neonates and critically ill children - safety and cost effectiveness of a new laboratory prediction model: study protocol of a randomized controlled trial [ISRCTN91123847].","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1376,"document":"15566590","golden":false,"offsetInEndSection":1744,"text":"Physicians may overrule the suggestions resulting from the post-test probability.CONCLUSION: This trial will ascertain the clinical efficacy of introducing new diagnostic strategies consisting of pre-test probability estimate, novel laboratory markers, and computer-generated post-test probability in infectious disease work up in critically ill newborns and children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1144,"document":"15566590","golden":false,"offsetInEndSection":1375,"text":"A high post-test probability will suggest that immediate initiation of antibiotic treatment is appropriate, whereas a low post-test probability will be supportive of watchful waiting or discontinuing prophylactic empirical therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1368,"document":"31982701","golden":false,"offsetInEndSection":1802,"text":"PGRN could significantly predict EOS independently of PCT (p?\u003c?0.0001), and the combined use of PGRN and PCT could significantly improve diagnostic performance for EOS (0.806; 95% CI 0.73-0.88; p?\u003c?0.0001), with a specificity of 89.06% and a positive predictive value of 81.10%.CONCLUSIONS: PGRN may be used as a promising biomarker for the diagnosis of EOS, and the combined use of PGRN and PCT could improve the diagnosis of sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":322,"document":"34920065","golden":false,"offsetInEndSection":466,"text":"Biomarkers such as C-reactive protein (CRP), procalcitonin (PCT), and serum amyloid A (SAA) can help in the detection of sepsis at early stages.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34920065","golden":false,"offsetInEndSection":126,"text":"Molecular imprinting based electrochemical biosensor for identification of serum amyloid A (SAA), a neonatal sepsis biomarker.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":214,"document":"34920065","golden":false,"offsetInEndSection":321,"text":"The diagnosis of neonatal septicemia is a challenging task because of the presence of nonspecific symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":888,"document":"37505928","golden":false,"offsetInEndSection":1052,"text":"Furthermore, novel biomarkers including CD-64, presepsin, Pancreatic stone and sTREM-1, have all shown promising results for increased accuracy of sepsis diagnosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34920065","golden":false,"offsetInEndSection":57,"text":"Neonatal septicemia is a bacterial infection in newborns.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1210,"document":"35697438","golden":false,"offsetInEndSection":1817,"text":"The PROcalcitonin and NEWS2 evaluation for Timely identification of sepsis and Optimal (PRONTO) study is a randomised controlled trial (RCT) in adults with suspected sepsis presenting to the ED to compare standard clinical management based on NEWS2 scoring plus PCT-guided risk assessment with standard clinical management based on NEWS2 scoring alone and compare if this approach reduces prescriptions of antibiotics without increasing mortality.METHODS AND ANALYSIS: PRONTO is a parallel two-arm open-label individually RCT set in up to 20 NHS EDs in the UK with a target sample size of 7676 participants.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1827,"document":"32850901","golden":false,"offsetInEndSection":2076,"text":"Our observations showed that REBA Sepsis-ID using whole blood was advantageous for the early detection of sepsis-causing microorganisms, and the PCT concentration could be used to determine the necessity of using REBA Sepsis-ID in clinical settings.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1135,"document":"34920065","golden":false,"offsetInEndSection":1252,"text":"The operating range of the developed sensor was found to be 0.01 pM to 1??M and 0.01 pM as the lower detection limit.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":289,"document":"23137927","golden":false,"offsetInEndSection":382,"text":"Vancomycin is the first choice treatment of late onset sepsis due to resistant staphylococci.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1596,"document":"38358334","golden":false,"offsetInEndSection":1671,"text":"There was 1 possibly related death (sepsis with attendant hepatic failure).","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38357933","golden":false,"offsetInEndSection":20,"text":"Race against dengue.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1205,"document":"38357644","golden":false,"offsetInEndSection":1254,"text":"The data analysis involved 22,633 sepsis patients","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":271,"document":"38357545","golden":false,"offsetInEndSection":299,"text":"nosuppression and substantia","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1525,"document":"38357510","golden":false,"offsetInEndSection":1639,"text":"Pulmonary hemorrhage, tension pneumothorax and early onset sepsis were independent risk factors for high-grade IVH","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":212,"document":"38357174","golden":false,"offsetInEndSection":393,"text":"In retrospective observational study, during October 2019 to December 2021, 145 patients with septic shock treated in our hospital were enrolled by the method of observational study","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":455,"document":"38330522","golden":false,"offsetInEndSection":660,"text":"This study aimed to predict the onset of late-onset sepsis (LOS) with good diagnostic value as early as possible using non-invasive biosignal measurements from neonatal intensive care unit (NICU) monitors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1441,"document":"38261606","golden":false,"offsetInEndSection":1657,"text":"There is an urgent need to standardize methods and diagnostic tools that would allow an early and accurate diagnosis, as well as to perform clinical studies of the effectiveness of available antibiotics to eradicate ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":200,"document":"38193658","golden":false,"offsetInEndSection":287,"text":"from blood cultures, may offer clinical benefit. We assessed this approach in compariso","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":555,"document":"38122992","golden":false,"offsetInEndSection":882,"text":"There is, however, increasing evidence suggesting that these challenges may be met through the development of diagnostic biomarkers to improve diagnostic accuracy of pathogenetically homogenous entities, improved pre-transplant risk assessment and the early identification of patients with increased need for specific treatment","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38116466","golden":false,"offsetInEndSection":154,"text":"Neonatal sepsis causes significant global morbidity and mortality, with the highest burden in resource-limited settings where 99% of neonatal deaths occur","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":765,"document":"38090611","golden":false,"offsetInEndSection":906,"text":"275 neonates took part in the study, of which 218 (79.3%) presented with early-onset sepsis (EOS) and 57 (20.7%) with late-onset sepsis (LOS)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":14,"document":"38078332","golden":false,"offsetInEndSection":108,"text":"Early diagnosis of infections and sepsis is essential as adequate therapy improves the outcome","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":149,"document":"38074247","golden":false,"offsetInEndSection":249,"text":"The clinical presentation of sepsis may be rather general, making it challenging to make a diagnosis","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":629,"document":"38050211","golden":false,"offsetInEndSection":692,"text":"This study involved 88 children (48 with sepsis, 40 non-sepsis)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1130,"document":"37813544","golden":false,"offsetInEndSection":1429,"text":"Both cohorts demonstrated overlap with adult subphenotypes when assessed using parsimonious classifiers.INTERPRETATION: We identified hypoinflammatory and hyperinflammatory subphenotypes of paediatric ARDS from two separate cohorts with utility for prognostic and potentially predictive, enrichment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":597,"document":"35438283","golden":false,"offsetInEndSection":938,"text":"Microalbuminuria has highest sensitivity of 90 % and specificity of 98 % to differentiate between sepsis and non sepsis in comparison to APACHE II and SOFA scores.CONCLUSION: Serial monitoring of bedside urine albumin-creatinine measurement might help in the early identification of patients with sepsis that requires early targeted therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37813544","golden":false,"offsetInEndSection":180,"text":"BACKGROUND: Two subphenotypes of acute respiratory distress syndrome (ARDS), hypoinflammatory and hyperinflammatory, have been reported in adults and in a single paediatric cohort.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":580,"document":"37813544","golden":false,"offsetInEndSection":952,"text":"Finally, we assessed overlap with adult cohorts using parsimonious classifiers.FINDINGS: In two cohorts from the Children\u0027s Hospital of Philadelphia (n\u003d333) and from a multicentre study based at the University of California San Francisco (n\u003d293), LCA identified two subphenotypes defined by differential elevation of biomarkers reflecting inflammation and endotheliopathy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1430,"document":"37813544","golden":false,"offsetInEndSection":1539,"text":"Future paediatric ARDS trials should identify and leverage biomarker-defined subphenotypes in their analysis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":265,"document":"37813544","golden":false,"offsetInEndSection":509,"text":"We aimed to identify subphenotypes in two large observational cohorts of paediatric ARDS and assess their congruence with prior descriptions.METHODS: We performed latent class analysis (LCA) separately on two cohorts using biomarkers as inputs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":328,"document":"35806919","golden":false,"offsetInEndSection":557,"text":"Comprehensive changes in the way we manage sepsis patients include early identification, infective focus identification and immediate treatment with antimicrobial therapy, appropriate supportive care and hemodynamic optimization.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2110,"document":"37216423","golden":false,"offsetInEndSection":2401,"text":"Furthermore, noninvasive \"dynamic visual monitoring\" of physiological and pathological changes related to sepsis-associated encephalopathy was achieved using MR molecular imaging for the first time, providing a more sensitive imaging basis for early diagnosis, identification, and prognosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":953,"document":"37813544","golden":false,"offsetInEndSection":1129,"text":"In both cohorts, hyperinflammatory subjects had greater illness severity, more sepsis and higher mortality (41% and 28% in hyperinflammatory vs 11% and 7% in hypoinflammatory).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":624,"document":"35488816","golden":false,"offsetInEndSection":800,"text":"The main objectives are to evaluate the usefulness of monocyte distribution width (MDW) in sepsis identification in ED, its limitations, and to compare it with other biomarker.","beginSection":"abstract"}],"ideal_answer":[],"id":"6584555406a2ea257c000007","type":"summary","body":"How can we achieve early identification of paediatric sepsis?"},{"documents":[{"golden":false,"id":"21478582"},{"golden":false,"id":"32085740"},{"golden":false,"id":"23450439"},{"golden":true,"id":"26416900"},{"golden":false,"id":"36823611"},{"golden":true,"id":"33879938"},{"golden":false,"id":"34384533"},{"golden":false,"id":"34351692"},{"golden":false,"id":"29403648"},{"golden":false,"id":"24953929"},{"golden":true,"id":"23304915"},{"golden":false,"id":"23419199"},{"golden":false,"id":"34424116"},{"golden":false,"id":"9722468"},{"golden":false,"id":"31010563"},{"golden":false,"id":"24699298"},{"golden":false,"id":"20446013"},{"golden":false,"id":"37501504"},{"golden":false,"id":"27776490"},{"golden":false,"id":"25604489"},{"golden":true,"id":"32232180"},{"golden":false,"id":"22958010"},{"golden":false,"id":"24250599"},{"golden":false,"id":"29790844"},{"golden":false,"id":"37846280"},{"golden":false,"id":"20046331"},{"golden":false,"id":"12074201"},{"golden":false,"id":"26060088"},{"golden":false,"id":"36548670"},{"golden":false,"id":"35519536"},{"golden":false,"id":"32130261"},{"golden":false,"id":"36110504"},{"golden":false,"id":"36979919"},{"golden":false,"id":"34435316"},{"golden":false,"id":"38090611"},{"golden":false,"id":"37283195"},{"golden":false,"id":"32010865"},{"golden":false,"id":"35991235"},{"golden":false,"id":"34855068"},{"golden":false,"id":"31023283"},{"golden":false,"id":"37489690"},{"golden":false,"id":"37894233"},{"golden":false,"id":"34550871"},{"golden":false,"id":"33838952"},{"golden":false,"id":"33221898"},{"golden":false,"id":"33734040"},{"golden":false,"id":"37466170"},{"golden":false,"id":"35425998"},{"golden":false,"id":"33808878"},{"golden":false,"id":"37252038"},{"golden":false,"id":"32735433"},{"golden":false,"id":"34485491"},{"golden":false,"id":"32824831"},{"golden":false,"id":"30039783"},{"golden":false,"id":"37575122"},{"golden":false,"id":"34680787"},{"golden":false,"id":"32080759"},{"golden":false,"id":"31560667"},{"golden":false,"id":"33708302"},{"golden":false,"id":"36978375"},{"golden":false,"id":"36898748"},{"golden":false,"id":"37289666"},{"golden":false,"id":"32015972"},{"golden":false,"id":"16562780"},{"golden":false,"id":"32936822"},{"golden":false,"id":"34915203"},{"golden":false,"id":"32049298"},{"golden":false,"id":"34122587"},{"golden":false,"id":"29615159"},{"golden":false,"id":"37287262"},{"golden":false,"id":"35391543"},{"golden":false,"id":"32885532"},{"golden":false,"id":"37512049"},{"golden":false,"id":"37449693"},{"golden":false,"id":"33140134"},{"golden":false,"id":"31608743"},{"golden":false,"id":"37599641"},{"golden":false,"id":"32336983"},{"golden":false,"id":"37810514"},{"golden":false,"id":"35313728"},{"golden":false,"id":"34828610"},{"golden":false,"id":"34088214"},{"golden":false,"id":"37852658"},{"golden":false,"id":"37303772"},{"golden":false,"id":"38296778"},{"golden":false,"id":"38262696"},{"golden":false,"id":"38259593"},{"golden":false,"id":"38193658"},{"golden":false,"id":"38190645"},{"golden":false,"id":"38158358"},{"golden":false,"id":"38130578"},{"golden":false,"id":"38116466"},{"golden":false,"id":"38093660"},{"golden":false,"id":"38084084"},{"golden":false,"id":"38355732"},{"golden":false,"id":"38355632"},{"golden":false,"id":"38355210"},{"golden":false,"id":"38354362"},{"golden":false,"id":"38354140"},{"golden":false,"id":"38353591"},{"golden":false,"id":"38352157"},{"golden":false,"id":"38351762"},{"golden":false,"id":"38350608"},{"golden":false,"id":"38348986"},{"golden":true,"id":"7730222"},{"golden":false,"id":"20019854"},{"golden":false,"id":"30994430"},{"golden":false,"id":"7652502"},{"golden":false,"id":"28637056"},{"golden":false,"id":"11220406"},{"golden":false,"id":"21355513"},{"golden":false,"id":"20876594"},{"golden":false,"id":"22341537"},{"golden":false,"id":"29606026"},{"golden":false,"id":"17052420"},{"golden":false,"id":"23158399"},{"golden":true,"id":"9716293"},{"golden":false,"id":"22375258"},{"golden":false,"id":"10321287"},{"golden":false,"id":"22455256"},{"golden":false,"id":"29322236"},{"golden":false,"id":"29442147"},{"golden":false,"id":"3728528"},{"golden":false,"id":"7962986"},{"golden":false,"id":"21669223"},{"golden":false,"id":"1889863"},{"golden":false,"id":"8678095"},{"golden":false,"id":"28421643"},{"golden":false,"id":"36923771"},{"golden":false,"id":"10950216"},{"golden":false,"id":"28534215"},{"golden":false,"id":"19030334"},{"golden":false,"id":"36177766"},{"golden":false,"id":"24246520"},{"golden":false,"id":"7587023"},{"golden":true,"id":"20584804"},{"golden":false,"id":"15637985"},{"golden":false,"id":"21165715"},{"golden":false,"id":"29843815"},{"golden":false,"id":"24392386"},{"golden":false,"id":"34951709"},{"golden":false,"id":"38358334"},{"golden":false,"id":"38357933"},{"golden":false,"id":"38357644"},{"golden":false,"id":"38357643"},{"golden":false,"id":"38357545"},{"golden":false,"id":"38357510"},{"golden":false,"id":"38357174"},{"golden":false,"id":"38136745"},{"golden":false,"id":"37748849"},{"golden":false,"id":"37652825"},{"golden":false,"id":"37500270"},{"golden":false,"id":"37384785"},{"golden":false,"id":"37314127"},{"golden":false,"id":"37237826"},{"golden":false,"id":"36830309"},{"golden":false,"id":"36655380"},{"golden":false,"id":"37063937"},{"golden":false,"id":"34807987"},{"golden":false,"id":"33062808"},{"golden":false,"id":"35150435"},{"golden":false,"id":"30756093"},{"golden":false,"id":"38136712"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":3770,"document":"9722468","golden":false,"offsetInEndSection":3808,"text":"oxacillin, nafcillin and methicillin).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":737,"document":"23304915","golden":false,"offsetInEndSection":1136,"text":"Only 46 (25%) patients required a change of antibiotics to the combination of intravenous ceftriaxone plus gentamicin after non-response of injection ampicilin and injection gentamicin combination; 7/181 (4%) patients died who received injection ampicilin and injection gentamicin whereas none died among the other two patients who received injection ceftriaxone and injection gentamicin (p \u003d 1.00).","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"23304915","golden":false,"offsetInEndSection":149,"text":"Ampicillin and gentamicin are a useful first-line combination for the management of sepsis in under-five children at an urban hospital in Bangladesh.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1137,"document":"23304915","golden":true,"offsetInEndSection":1349,"text":"The combination of injection ampicilin and injection gentamicin as the first-line antibiotics for the management of sepsis in children even beyond the neonatal age is very effective, resulting in lower mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":528,"document":"23304915","golden":false,"offsetInEndSection":736,"text":"One hundred and eighty-one patients had received a combination of injection ampicilin and injection gentamicin, and two patients had received the combination of injection ceftriaxone and injection gentamicin.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":3633,"document":"9722468","golden":false,"offsetInEndSection":3694,"text":"penicillin, ampicillin, or vancomycin) and an aminoglycoside.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1537,"document":"33879938","golden":true,"offsetInEndSection":1699,"text":"Both Gram-positive and Gram-negative organisms were highly resistant to benzylpenicillin and cefotaxime, the commonly used empiric antibiotics in neonatal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31010563","golden":false,"offsetInEndSection":101,"text":"Antimicrobial medications are the most commonly used medications in the neonatal intensive care unit.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1061,"document":"20446013","golden":false,"offsetInEndSection":1313,"text":"Influence of ampicillin and penicillin on initial gut colonization is somewhat different but these differences are of low clinical relevance and should not be a limiting step when choosing between these two antibiotics for the empiric treatment of EOS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":575,"document":"29790844","golden":false,"offsetInEndSection":700,"text":"Results The optimal dosing recommendation for amoxicillin remains unclear with limited pharmacological and clinical evidence.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2731,"document":"9722468","golden":false,"offsetInEndSection":2778,"text":"penicillins) were combined with cephalosporins.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":3809,"document":"9722468","golden":false,"offsetInEndSection":3865,"text":"Resistant strains are uniformly sensitive to vancomycin.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1663,"document":"9722468","golden":false,"offsetInEndSection":1732,"text":"In nosocomial infections, netilmicin or amikacin should be preferred.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":3342,"document":"9722468","golden":false,"offsetInEndSection":3445,"text":"Ceftazidime was found to be more active in vitro against Pseudomonas than cefoperazone or piperacillin.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1506,"document":"9722468","golden":false,"offsetInEndSection":1662,"text":"Penicillin or ampicillin and an aminoglycoside combination may also be used in the initial therapy of late-onset sepsis as in cases with early-onset sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1993,"document":"9722468","golden":false,"offsetInEndSection":2172,"text":"In some centers, third-generation cephalosporins in combinations with penicillin or ampicillin have been used in the initial therapy of early-onset and late-onset neonatal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2318,"document":"9722468","golden":false,"offsetInEndSection":2730,"text":"However, third-generation cephalosporins should not be used in the initial therapy of suspected sepsis, because 1) extensive use of cephalosporins for initial therapy of neonatal sepsis may lead to the emergence of drug-resistant microorganisms (this has occurred more rapidly as compared with the aminoglycosides), 2) Antagonistic interactions have been demonstrated when the other beta-lactam antibiotics (e.g.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":771,"document":"36548670","golden":false,"offsetInEndSection":960,"text":"Meropenem (24.7%) and piperacillin-tazobactam (20.4%) were the most commonly used empiric antibiotics while colistin (63.3%) and amikacin (8.3%) were the most common definitive antibiotics.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1180,"document":"32010865","golden":false,"offsetInEndSection":1603,"text":"The risk of mortality was significantly higher in neonates receiving empiric cefotaxime and ampicillin than those receiving amikacin and cloxacillin (hazard ratio: 2.91, 95% confidence interval: 1.17-7.30, P \u003d 0.023).CONCLUSIONS: In our center, amikacin-cloxacillin combination therapy was associated with lower mortality in very low birth weight neonates with late-onset sepsis compared with cefotaxime-ampicillin therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1764,"document":"35519536","golden":false,"offsetInEndSection":2070,"text":"Piperacillin/tazobactam and ceftazidime can be used as empirical antibiotics against gram-negative pathogens.Conclusion: Early initiation of empirical antibiotic(s) is paramount to stymie the infection from getting worse while waiting for the identification of causative pathogens in the management of DFI.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1282,"document":"37283195","golden":false,"offsetInEndSection":1703,"text":"The combination of cefotaxime/sulbactam and gentamicin was consistently bactericidal at clinically achievable concentrations (Cmax of 180, 60 and 20 mg/L for cefotaxime, sulbactam and gentamicin, respectively).CONCLUSIONS: The addition of sulbactam to cefotaxime or ampicillin to the typical first-line empirical therapy could obviate the need for carbapenems and amikacin in settings with high ESBL-infection prevalence.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":496,"document":"36548670","golden":false,"offsetInEndSection":660,"text":"The study included 145 patients with CR-GNB infections including 77, 40 and 28 Acinetobacter baumannii, enterobacteriaceae and Pseudomonas aeruginosa, respectively.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1376,"document":"36110504","golden":false,"offsetInEndSection":1693,"text":"Gram-negative bacteria isolated were sensitive to meropenem (MEM), imipenem (IPM), ciprofloxacin (CIP) and resistant to ceftazidime, ceftriaxone, ampicillin and amoxicillin-clavulanic acid.Conclusion: The most common bacteria isolated causing NNS using BACTEC automated blood culture system was Staphylococcus aureus.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1749,"document":"38090611","golden":false,"offsetInEndSection":2031,"text":"93.5% of CoNS and all the isolated Staphylococcus aureus and Klebsiella species were susceptible to amikacin.Conclusions: Coagulase-negative staphylococcus (CoNS) and Klebsiella species were the predominant Gram-positive and negative sepsis-causing agents at the NICU, respectively.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":163,"document":"36979919","golden":false,"offsetInEndSection":328,"text":"Empiric antibiotic therapy of NS recommended by current international guidelines includes benzylpenicillin, ampicillin/amoxicillin, and aminoglycosides (gentamicin).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1509,"document":"36548670","golden":false,"offsetInEndSection":1650,"text":"A high rate of inappropriate antibiotic use was observed, including combination antibiotic therapy and delays in starting active antibiotics.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1444,"document":"36548670","golden":false,"offsetInEndSection":1508,"text":"The mortality rate among patients with CR-GNB infection is high.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1312,"document":"37489690","golden":false,"offsetInEndSection":1551,"text":"E. coli was the most common organism isolated in 29 (76.3%) patients.CONCLUSIONS: Cephalosporin was the commonest antibiotic group prescribed in hospitalized patients among which ceftriaxone was commonly prescribed as an empirical therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":935,"document":"34855068","golden":false,"offsetInEndSection":986,"text":"The typical beta-lactam prescribed was ceftriaxone.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":828,"document":"34855068","golden":false,"offsetInEndSection":934,"text":"Most common empiric antibiotics prescribed for community-acquired infections were beta-lactam monotherapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":987,"document":"34855068","golden":false,"offsetInEndSection":1292,"text":"However, for hospital-acquired infections (HAI), such as suspected catheter-related bloodstream infection (CLABSI) and suspected ventilator-associated pneumonia (VAP), a higher number of respondents-39/62 (61.9%) and 33/62 (53.2%), respectively, prescribed combination antibiotics (?-lactam?+?vancomycin).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1455,"document":"34855068","golden":false,"offsetInEndSection":1646,"text":"Ten (16.1%) centers had pre-authorization policy for certain antibiotics.CONCLUSION: A rather diverse pattern of prescribing and administration practices exists across different Indian PICUs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1372,"document":"31023283","golden":false,"offsetInEndSection":1511,"text":"Thirty one empirical antibiotic regimens were used, most often a third-generation cephalosporin plus metronidazole and amoxicillin (32.2%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1375,"document":"34550871","golden":false,"offsetInEndSection":1658,"text":"Analysis of antibiotic susceptibility profiles revealed that amoxicillin/clavulanate would have been appropriate as the initial regimen in 89% of cases.DISCUSSION: The main causative pathogen was Staphylococcus aureus, with methicillin resistant Staphylococcus aureus remaining rare.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":720,"document":"34855068","golden":false,"offsetInEndSection":827,"text":"Majority of the respondents acknowledged using a 7-d course of antibiotics even in culture-negative sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":521,"document":"37489690","golden":false,"offsetInEndSection":1012,"text":"Patients aged 18 years or above of both sex, admitted to various departments with the provisional diagnosis of urinary tract infection prescribed with antibiotics were included in the study.RESULTS: Out of 146 patients admitted with a diagnosis of urinary tract infection, the most commonly prescribed antibiotics during hospital stay were cephalosporin in 102 (69.9%) patients followed by combination of penicillin and beta-lactamase inhibitors (31, 21.2%) and fluoroquinolones (15, 10.3%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":743,"document":"35991235","golden":false,"offsetInEndSection":816,"text":"The most prescribed drug combination (90.6%) was Cefotaxime and Amikacin.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":884,"document":"33221898","golden":false,"offsetInEndSection":1000,"text":"The most common antibiotics were aminoglycosides (29%), penicillins (26%) and third-generation cephalosporins (25%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":800,"document":"33734040","golden":false,"offsetInEndSection":975,"text":"The most-commonly used antibiotics were beta-lactam (BL) and BL inhibitors (n?\u003d?307, 15.7%), third-generation cephalosporins (n?\u003d?251, 12.8%), and quinolones (n?\u003d?204, 10.5%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37466170","golden":false,"offsetInEndSection":102,"text":"OBJECTIVES: Cefepime is an antibiotic commonly used to treat sepsis and is cleared by renal excretion.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":914,"document":"35425998","golden":false,"offsetInEndSection":1142,"text":"Resistance to commonly used antibiotics was not observed, except for erythromycin.CONCLUSIONS: Pneumococcal sepsis was observed to be common in children with nephrotic syndrome and results in significant morbidity and mortality.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1307,"document":"33221898","golden":false,"offsetInEndSection":1393,"text":"\u0027Watch\u0027 antimicrobials were used in 26% of neonatal sepsis and 76% of LRTI admissions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1760,"document":"33221898","golden":false,"offsetInEndSection":1858,"text":"These findings highlight the need for paediatric antimicrobial stewardship programs in Bangladesh.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":699,"document":"33221898","golden":false,"offsetInEndSection":883,"text":"Antimicrobials were prescribed in 73% of admissions with a mean antimicrobial exposure rate of 0.25 antimicrobials per day of admission [95% confidence intervals (95% CIs): 0.24-0.27].","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":251,"document":"37466170","golden":false,"offsetInEndSection":699,"text":"We aimed to characterize cefepime PK in a diverse cohort of critically ill paediatric patients on CKRT.METHODS: Patients were identified from an ongoing pharmacokinetic/pharmacodynamic (PK/PD) study of beta-lactam antibiotics, and were included if they had received at least two cefepime doses in the ICU and were on CKRT for at least 24 h. PK parameters were estimated using MwPharm++ with Bayesian estimation and a paediatric population PK model.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1297,"document":"34485491","golden":false,"offsetInEndSection":1506,"text":"Carbapenems were most commonly co-administered with colistin (58%).CONCLUSION: The findings suggested that although colistin usage was restricted in the hospital, it was not adequately monitored or controlled.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1534,"document":"37252038","golden":false,"offsetInEndSection":1695,"text":"At all hospitals, ceftazidime plus amikacin regimen had the lowest coverage, and coverage of amoxicillin plus gentamicin and meropenem were generally comparable.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1166,"document":"33708302","golden":false,"offsetInEndSection":1317,"text":"All the 9 children initiated on meropenem monotherapy on admission died.CONCLUSION: The majority of patients with septic shock were under one-year age.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":890,"document":"30039783","golden":false,"offsetInEndSection":982,"text":"The most commonly prescribed empiric antibiotic regimen was amoxicillin-clavulanate (34.8%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":287,"document":"37575122","golden":false,"offsetInEndSection":479,"text":"The isolate was resistant to antibiotics other than cefoperazone/sulbactam and imipenem, challenging the combination of antibiotics commonly used in the empirical treatment of neonatal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1500,"document":"30039783","golden":false,"offsetInEndSection":1775,"text":"This study suggests that empiric antibiotic regimens in patients with sepsis or septic shock caused by suspected aquatic microorganisms (tropical climate, skin lesion exposed to seawater?) should include broad-spectrum antibiotics (third or fourth generation cephalosporins).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":983,"document":"30039783","golden":false,"offsetInEndSection":1171,"text":"Eighty-four percent of the aquatic strains were resistant to amoxicillin-clavulanate and more than \u003e 95% were susceptible to third or fourth generation cephalosporins and fluoroquinolones.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":684,"document":"30039783","golden":false,"offsetInEndSection":709,"text":"in eight patients (7.2%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30039783","golden":false,"offsetInEndSection":70,"text":"Gram-negative bacilli Vibrio spp., Aeromonas spp., and Shewanella spp.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1084,"document":"31560667","golden":false,"offsetInEndSection":1141,"text":"The most used antibiotic was ceftriaxone (33.3% in 2015).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":593,"document":"30039783","golden":false,"offsetInEndSection":643,"text":"were found in 91 patients (81.3%), Shewanella spp.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":644,"document":"30039783","golden":false,"offsetInEndSection":683,"text":"in 13 patients (11.6%), and Vibrio spp.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1290,"document":"16562780","golden":false,"offsetInEndSection":1543,"text":"An initial empirical antibiotic therapy for late-onset sepsis was designed with teicoplanin + piperacillin-tazobactam/meropenem + antifungal (fluconazole or amphotericin B) as the best combination to cover this spectrum until the culture results arrive.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":712,"document":"37575122","golden":false,"offsetInEndSection":974,"text":"The presence of highly pathogenic multidrug-resistant microorganisms isolated in neonates underscores the need to implement rapid resistance diagnostic methods and should prompt consideration of alternatives to empiric treatment of neonatal bacterial meningitis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2614,"document":"32049298","golden":false,"offsetInEndSection":2973,"text":"The coverage difference between aminopenicillin-gentamicin and meropenem for countries with nonoverlapping 95% CrIs ranged from -15.9% in China to -52.9% in Indonesia.Conclusions and Relevance: This study\u0027s findings suggest that noncarbapenem antibiotic regimens may provide limited coverage for empirical treatment of neonatal sepsis in many Asian countries.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":627,"document":"37575122","golden":false,"offsetInEndSection":711,"text":"This is the first case of meningoencephalitis due to serotype O75 reported in China.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37575122","golden":false,"offsetInEndSection":99,"text":"Case report: A rare multidrug-resistant Escherichia coli causes fatal neonatal meningoencephalitis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1142,"document":"31560667","golden":false,"offsetInEndSection":1224,"text":"Ampicilin-sulbactam was prescribed in 28.1% of pneumonia case in neonates in 2018.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":142,"document":"37575122","golden":false,"offsetInEndSection":286,"text":"We report an Escherichia coli meningitis isolate with multiple resistance patterns and unusual serotype (O75) that caused sudden neonatal death.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":447,"document":"29615159","golden":false,"offsetInEndSection":761,"text":"In infants who require empiric therapy for early-onset sepsis, ampicillin and an aminoglycoside with dosing based on recent pharmacokinetic studies represents the most appropriate first-line agents; third-generation cephalosporins should be reserved for patients with a high likelihood of Gram-negative meningitis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":762,"document":"29615159","golden":false,"offsetInEndSection":861,"text":"An antistaphylococcal penicillin and gentamicin should be utilized for suspected late-onset sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":396,"document":"37287262","golden":false,"offsetInEndSection":613,"text":"In contrast to widespread antimicrobial resistance exhibited by this pathogen, there was good susceptibility to commonly used antimicrobials such as ampicillin, cefotaxime, piperacillin, ciprofloxacin, and vancomycin.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1493,"document":"32885532","golden":false,"offsetInEndSection":1740,"text":"The most common side effect of the antibiotic agents was diarrhea.CONCLUSIONS: Ampicillin-sulbactam could be an effective alternative to cephalosporin as empiric antibiotic for the treatment of first-episode UTI in patients under 24?months of age.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":862,"document":"29615159","golden":false,"offsetInEndSection":969,"text":"Vancomycin and other broad-spectrum agents are reserved for patients with a history of resistant organisms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32885532","golden":false,"offsetInEndSection":116,"text":"BACKGROUND: Cephalosporin is the most commonly used empirical agent for urinary tract infections (UTIs) in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":614,"document":"37287262","golden":false,"offsetInEndSection":968,"text":"Whilst ? lactam antibiotics are found effective in the treatment of Elizabethkingia septicaemia of children, piperacillin-tazobactam, vancomycin combination seems effective empiric choice of antibiotics for neonatal meningitis due to Elizabethkingia; there is a need for guidelines for the management of this infection, especially in neonatal meningitis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1159,"document":"35391543","golden":false,"offsetInEndSection":1435,"text":"The most commonly reported empirical antibiotics, namely amoxicillin/clavulanic acid or ampicillin/sulbactam (29.5%) and cephalosporins (18.2%) showed high potential resistance rates of 20.0% and 35.6%, respectively, in relation to the previously published resistance profile.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":677,"document":"32885532","golden":false,"offsetInEndSection":1023,"text":"We determined the patients\u0027 UTI pathogens and their antibiotic susceptibilities and compared the effectiveness and the occurrence of adverse effects of ampicillin-sulbactam and cephalosporin therapy.RESULTS: Forty-six patients were treated with cefotaxime (group A) and 41 patients with ampicillin-sulbactam as the empirical antibiotic (group B).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1748,"document":"37512049","golden":false,"offsetInEndSection":2006,"text":"The most widely used antibiotics for empiric therapy were cefoperazone plus sulbactam, ceftriaxone, amikacin, vancomycin, and metronidazole whereas high use of linezolid, clindamycin, meropenem, and piperacillin + tazobactam was seen in definitive treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1554,"document":"34680787","golden":false,"offsetInEndSection":1764,"text":"In our epidemiological context, amoxicillin/clavulanate no longer seems to be the appropriate first-line therapy for children hospitalised for UTI, whereas third-generation cephalosporins continue to be useful.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1020,"document":"34680787","golden":false,"offsetInEndSection":1373,"text":"Having ESBL or MDR/XDR uropathogens, a history of recurrent UTI, antibiotic therapy in the preceding 30 days, and empirical treatment with amoxicillin or amoxicillin/clavulanate were significantly associated with treatment failure, whereas first-line therapy with third-generation cephalosporins was associated with protection against negative outcomes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":697,"document":"32015972","golden":false,"offsetInEndSection":1417,"text":"We present a case of PF secondary to DIC related to Pneumococcal sepsis in an otherwise healthy and immunocompetent patient.LEARNING POINTS: Infectious purpura fulminans is a haematological emergency that demands early recognition and timely institution of therapy to prevent significant morbidity and mortality.A characteristic skin rash is a key diagnostic clue pointing to purpura fulminans, and should lead to prompt institution of therapy, as waiting for a skin biopsy result can delay the diagnosis and result in significant morbidity and mortality.Due to the lack of prospective data on management of the condition, various modalities, such as hyperbaric oxygen therapy and IVIG, still have questionable benefits.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37810514","golden":false,"offsetInEndSection":177,"text":"Retracted: Analysis of the Relevant Vital Signs and Infection of Sepsis Patients and to Explore the Influencing Factors of Acute Lung Injury/Acute Respiratory Distress Syndrome.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1018,"document":"34828610","golden":false,"offsetInEndSection":1615,"text":"The current study demonstrates that nitrofurantoin (19%) was the most commonly prescribed medication in the inpatient and outpatient departments, followed by trimethoprim/sulfamethoxazole (16%), amoxicillin/clavulanic acid (15%), cefuroxime (10%), azithromycin (8%), ceftriaxone (7%), and ciprofloxacin (4%), while amikacin, amoxicillin, ampicillin, cefepime, imipenem, phenoxymethylpenicillin were prescribed less commonly due to the high resistance rate.CONCLUSION: The microbial culture and sensitivity of the isolates from urine samples should be routine before starting antimicrobial therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1775,"document":"35313728","golden":false,"offsetInEndSection":1926,"text":"Herein, we propose a tigecycline with carbapenem like meropenem and vancomycin based empirical antibiotics protocol to be prescribed for such patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1330,"document":"37303772","golden":false,"offsetInEndSection":1619,"text":"Although 25 urine cultures showed no growth, antibiotics were discontinued in only 4 cases.CONCLUSIONS: Pediatric patients with UTI symptoms were often empirically prescribed cefdinir, possibly an unnecessarily broad choice because many E coli isolates were susceptible to narrower agents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":788,"document":"38296778","golden":false,"offsetInEndSection":951,"text":"We summarize obstetric recommendations for antenatal GBS screening, indications for intrapartum antibiotic prophylaxis, and considerations for antibiotic selection","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38262696","golden":false,"offsetInEndSection":96,"text":"Paediatric sepsis has a significant global impact and highly heterogeneous clinical presentation","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38259593","golden":false,"offsetInEndSection":136,"text":"Antibiotic use at planned central line removal in reducing neonatal post-catheter removal sepsis: a systematic review and meta-analysis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":200,"document":"38193658","golden":false,"offsetInEndSection":287,"text":"from blood cultures, may offer clinical benefit. We assessed this approach in compariso","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"38190645","golden":false,"offsetInEndSection":243,"text":"Multiplex polymerase chain reaction assays have the potential to reduce antibiotic use and shorten length of inpatient stay in children with suspected central nervous system infection by obtaining an early microbiological diagnosis","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38158358","golden":false,"offsetInEndSection":134,"text":"Clinical Utility of Procalcitonin and C-Reactive Protein in the Management of Neonatal Sepsis in a Resource-Limited Nigerian Hospital.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":762,"document":"38130578","golden":false,"offsetInEndSection":986,"text":"Sepsis was defined using positive microbiology cultures in 19 studies (26.4%), followed by the 2005\u0027s international pediatric sepsis consensus definition in 11 studies (15.3%), and Sepsis-3 definition in seven studies (9.7%)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":498,"document":"38116466","golden":false,"offsetInEndSection":678,"text":"Antibiotic treatment is still hampered by availability, but also increasingly by antimicrobial resistance - making surveillance of organisms and judicious antibiotic use a priority","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":469,"document":"38093660","golden":false,"offsetInEndSection":650,"text":"The primary aim was a 10% reduction in antibiotic days per 1000 patient days (antibiotic utilization rate [AUR]) among newborns in the NICU and NBN at each hospital by December 2018","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":948,"document":"38084084","golden":false,"offsetInEndSection":1167,"text":"Ultimately, a key goal is for screening to encompass as many children as possible at risk for sepsis and trigger early treatment without increasing unnecessary broad-spectrum antibiotics and preventable hospitalizations","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38355732","golden":false,"offsetInEndSection":112,"text":"Rapid and accurate identification of the bacteria responsible for sepsis is paramount for effective patient care","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38355632","golden":false,"offsetInEndSection":67,"text":"Antibiotic resistance is a significant global public health concern","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":522,"document":"38355210","golden":false,"offsetInEndSection":807,"text":"He was subsequently taken to theatre for washout and debridement, during which the collection was found to be loculated and isolated to the SCM, with surrounding structures spared.Postoperatively, he was managed with intravenous fluids and a total of 2 weeks of intravenous antibiotics","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":9,"document":"38354362","golden":false,"offsetInEndSection":207,"text":"Time to antibiotic administration (TTA) in \u003c60 minutes for children with neutropenic fever presenting to an emergency room is associated with reduced incidence of sepsis and intensive care admission","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":435,"document":"38354140","golden":false,"offsetInEndSection":701,"text":"ted urinary tract infection (UTI), including acute pyelonephritis, in a 2:1 ratio to receive intravenous cefepime-taniborbactam (2.5 g) or meropenem (1 g) every 8 hours for 7 days; this duration could be extended up to 14 days in case of bacteremia. The primary outc","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1729,"document":"38353591","golden":false,"offsetInEndSection":1784,"text":"Sepsis is still a life-threatening disease in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38352157","golden":false,"offsetInEndSection":201,"text":"This retrospective cohort study found that implementing source-specific antibiotic order sets for sepsis in the emergency department increased appropriate empiric antibiotic selection from 51% to 74% (","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":143,"document":"38351762","golden":false,"offsetInEndSection":338,"text":"rtality rate. It generally occurs in patients with altered and abnormal cardiac architecture combined with exposure to bacteria from trauma and other potentially high-risk activities with transie","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38350608","golden":false,"offsetInEndSection":140,"text":"Targeted infection diagnosis supports decision-making in the rational use of antibiotics usually encompassed as Antibiotic Stewardship (ABS)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1404,"document":"38348986","golden":false,"offsetInEndSection":1692,"text":"Despite the applied treatment, one patient died as a result of progressive multiple organ failure.\u0026lt;/br\u0026gt; \u0026lt;b\u0026gt;\u0026lt;br\u0026gt;Conclusions:\u0026lt;/b\u0026gt; Despite advances in diagnosis and treatment, including universal access to antibiotics, necrotizing fasciitis still cause high mortality","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":380,"document":"7730222","golden":false,"offsetInEndSection":630,"text":"beta-Lactam antibiotics (most commonly amoxycillin and cefuroxime) were the preferred agents for empirical therapy of infections of all types; an aminoglycoside was also included in the majority of regimens, irrespective of the clinical presentation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1660,"document":"30994430","golden":false,"offsetInEndSection":1999,"text":"All isolates were susceptible to a fosfomycin-amikacin combination.CONCLUSION: Gram-negative paediatric bacteraemia isolates are highly susceptible to fosfomycin, which could be combined with aminoglycosides as a new, carbapenem-sparing regimen to achieve excellent coverage to treat antimicrobial-resistant neonatal and paediatric sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1545,"document":"21355513","golden":false,"offsetInEndSection":1755,"text":"There were 79.7% (n \u003d 51) of infectious episodes with a cotrimoxazole-resistant organism occurring among those on cotrimoxazole prophylaxis.CONCLUSIONS: Escherichia coli was the most frequent bacterial isolate.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1456,"document":"20876594","golden":false,"offsetInEndSection":1797,"text":"The majority of pathogens causing EOS (95%) and LOS (84%) were susceptible to commonly used empiric first line antibiotic combinations of penicillin/gentamicin and flucloxacillin/gentamicin, respectively (excluding CoNS).CONCLUSIONS: The authors have established NeonIN in England and defined the current epidemiology of neonatal infections.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":631,"document":"7730222","golden":false,"offsetInEndSection":719,"text":"However, there were wide variations in the choice and dosages of the drugs administered.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"7730222","golden":false,"offsetInEndSection":199,"text":"In order to assess the guidelines available in Dutch hospitals for the treatment of patients with serious infection of unknown aetiology, 39 antibiotic formularies used in 88 hospitals were analyzed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":720,"document":"7730222","golden":false,"offsetInEndSection":884,"text":"Because of the absence of local data for the susceptibilities of blood culture isolates, the appropriateness of the recommendations could not be properly evaluated.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"7730222","golden":false,"offsetInEndSection":92,"text":"Antibiotic policies in Dutch hospitals for the treatment of patients with serious infection.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"29606026","golden":false,"offsetInEndSection":129,"text":"Objective: Group B streptococcus (GBS) early-onset sepsis (EOS) has declined after widespread intrapartum antibiotic prophylaxis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":200,"document":"7730222","golden":false,"offsetInEndSection":379,"text":"The recommendations considered were those for the treatment of sepsis for which the source was not apparent or which originated in the urinary tract, respiratory tract or abdomen.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1270,"document":"22455256","golden":false,"offsetInEndSection":1458,"text":"Gram-positive and gram-negative bacteria showed high resistance against commonly used antibiotics such as ampicillin, amoxicillin, cefotaxime, ceftriazone and gentamicin.CONCLUSION: Staph.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1664,"document":"23158399","golden":false,"offsetInEndSection":2049,"text":"DCCT was a protective factor against in-hospital mortality (odds ratio (OR), 0.699; 95% confidence interval (CI), 0.522 to 0.936; P \u003d 0.016), as was urologic focus of infection (OR, 0.241; 95% CI, 0.102 to 0.569; P \u003d 0.001).CONCLUSIONS: ?-Lactams, including carbapenems, are the most frequently prescribed antibiotics in empiric therapy in patients with severe sepsis and septic shock.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1064,"document":"22375258","golden":false,"offsetInEndSection":1502,"text":"All Gram negative bacterial isolates were sensitive to imipenem and some isolates were sensitive to fourth-generation cephalosporins, but most isolates were highly resistant to the majority of other antibiotics tested.CONCLUSION: Gram negative organisms were the most frequent causative agents of bacterial sepsis, which is a significant cause of mortality and morbidity in the newborn, and particularly in those of very low birth weight.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1662,"document":"17052420","golden":false,"offsetInEndSection":1895,"text":"Infection related mortality rate was 4%.CONCLUSION: Gram-negative infections predominated, Imipenem/ Amikacin found to be most effective therapy while a low mortality rate is recorded in our setting suggesting good infection control.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":681,"document":"29322236","golden":false,"offsetInEndSection":757,"text":"The empirical treatment consists of a?broad spectrum beta-lactam antibiotic.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":758,"document":"29322236","golden":false,"offsetInEndSection":984,"text":"While piperacillin/tazobactam, carbapenems and the new cephalosporin/beta-lactamase inhibitor (BLI) combinations are given as monotherapy, cephalosporins should be combined with aminoglycosides (preferred) or fluoroquinolones.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":507,"document":"29322236","golden":false,"offsetInEndSection":603,"text":"Extended spectrum beta-lactamase (ESBL) forming bacteria as a?cause of urosepsis are increasing.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":604,"document":"29322236","golden":false,"offsetInEndSection":680,"text":"Carbapenemase-forming Enterobacteriaceae, on the other hand, are still rare.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1279,"document":"28421643","golden":false,"offsetInEndSection":1492,"text":"Historical outbreaks of multi-resistant organisms exerted long-term influence over regimen choice.CONCLUSIONS: There was limited use of broad-spectrum agents such as carbapenems or third-generation cephalosporins.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"29322236","golden":false,"offsetInEndSection":12,"text":"[Urosepsis].","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":453,"document":"29322236","golden":false,"offsetInEndSection":506,"text":"Gram-negative pathogens are most frequently isolated.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1373,"document":"36923771","golden":false,"offsetInEndSection":1825,"text":"Death was the outcome of 16% of the patients.Conclusion: The situation regarding bacterial resistance to antibiotics is critical, with the most notable examples of these resisted antibiotics being ceftriaxone, cefepime, cefotaxime, trimethoprim, gentamycin, levofloxacin and piperacillin with tazobactam, and there is no doubt that this is a major contributing factor to the high prevalence of nosocomial infections and death rates found in this study.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":99,"document":"29322236","golden":false,"offsetInEndSection":190,"text":"An empirical antibiotic therapy should be instigated within the first hour after diagnosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1077,"document":"36923771","golden":false,"offsetInEndSection":1163,"text":"The most used antibiotics were ceftriaxone (70%), vancomycin (60%) and amikacin (25%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":855,"document":"20019854","golden":false,"offsetInEndSection":1034,"text":"The Canadian Paediatric Society recommends the use of the heptavalent conjugate pneumococcal vaccine, which is efficacious in reducing chest x-ray positive pneumonia by up to 20%.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":133,"document":"20019854","golden":false,"offsetInEndSection":263,"text":"After this period, bacteria such as Streptococcus pneumoniae, Mycoplasma pneumoniae and Chlamydia pneumoniae become more frequent.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"20019854","golden":false,"offsetInEndSection":41,"text":"Community-acquired pneumonia in children.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":428,"document":"20019854","golden":false,"offsetInEndSection":549,"text":"Most children can be managed empirically with oral antibiotics as outpatients without specific laboratory investigations.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":691,"document":"20019854","golden":false,"offsetInEndSection":854,"text":"The choice and dosage of antibiotics should be based on the age of the patient, severity of the pneumonia and knowledge of local antimicrobial resistance patterns.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"20019854","golden":false,"offsetInEndSection":58,"text":"Community acquired pneumonia (CAP) is common in childhood.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1596,"document":"38358334","golden":false,"offsetInEndSection":1671,"text":"There was 1 possibly related death (sepsis with attendant hepatic failure).","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38357933","golden":false,"offsetInEndSection":20,"text":"Race against dengue.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":405,"document":"38357644","golden":false,"offsetInEndSection":589,"text":"Despite its widespread use, there\u0027s inconsistent research regarding its efficacy in sepsis management, which creates uncertainties for ICU doctors about its possible advantages or harm","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":804,"document":"38357643","golden":false,"offsetInEndSection":908,"text":"In the studied cohort of 32,971 sepsis patients, 2,327 were identified as meeting the inclusion criteria","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":271,"document":"38357545","golden":false,"offsetInEndSection":299,"text":"nosuppression and substantia","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1525,"document":"38357510","golden":false,"offsetInEndSection":1639,"text":"Pulmonary hemorrhage, tension pneumothorax and early onset sepsis were independent risk factors for high-grade IVH","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":212,"document":"38357174","golden":false,"offsetInEndSection":393,"text":"In retrospective observational study, during October 2019 to December 2021, 145 patients with septic shock treated in our hospital were enrolled by the method of observational study","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":432,"document":"38136745","golden":false,"offsetInEndSection":605,"text":"NP, one of the most prevalent causes of sepsis in surgical Intensive Care Units (ICUs), is often associated with multi-drug resistant (MDR) bacteria and high mortality rates","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":121,"document":"37748849","golden":false,"offsetInEndSection":255,"text":"Several important associated factors have been identified including gestational age, mode of delivery, antibiotic exposure and feeding","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1296,"document":"37652825","golden":false,"offsetInEndSection":1403,"text":"Indications for antibiotic use shifted more towards clinical condition and away from obstetric risk factors","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1194,"document":"37500270","golden":false,"offsetInEndSection":1304,"text":"identified \u003e24?hours was 2.3/100 000 (n\u003d1) for SRC vs 7.1/100 000 (n\u003d4) for NICE (OR 0.5, 95%?CI (0.1 to 2.7))","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"37384785","golden":false,"offsetInEndSection":167,"text":"Reducing the burden of neonatal sepsis requires timely identification and initiation of suitable antibiotic treatment in primary health care (PHC) settings","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":78,"document":"37314127","golden":false,"offsetInEndSection":241,"text":"Of the 27 sites who responded, 9 did not have any form of antimicrobial stewardship, and 11 used vancomycin for empirical coverage in late-onset-sepsis evaluations","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37237826","golden":false,"offsetInEndSection":101,"text":"Neonatal sepsis is a significant cause of mortality and morbidity in low- and middle-income countries","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1168,"document":"34807987","golden":false,"offsetInEndSection":1590,"text":"Third-generation cephalosporins and vancomycin were the most commonly prescribed antibiotics, and substantial hospital-level variation in vancomycin use was identified (range: 16%-58% of suspected bacteremia episodes).CONCLUSIONS: Broad-spectrum intravenous antibiotic use for rule-out infections appears common across children\u0027s hospitals, with substantial hospital-level variation in the use of vancomycin in particular.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":525,"document":"36830309","golden":false,"offsetInEndSection":819,"text":"Based on the presence of risk factors for MDR/XDR infections and local epidemiology, where large proportions of strains are resistant to classic beta-lactams, the recommended empirical treatment for suspected P. aeruginosa infections is based on ceftolozane-tazobactam or ceftazidime-avibactam.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":917,"document":"33062808","golden":false,"offsetInEndSection":1097,"text":"Conclusion: Resistance to the more commonly used antibiotics such as ampicillin and gentamycin was very high, necessitating reconsideration of the empiric use of these antibiotics.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1208,"document":"36830309","golden":false,"offsetInEndSection":1364,"text":"Cefiderocol and imipenem-cilastatin-relebactam withstand most resistance mechanisms and may remain active in cases with resistance to other new antibiotics.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1183,"document":"36655380","golden":false,"offsetInEndSection":1576,"text":"Of the 72 patients with typical pathogens identified, 80.6% were sensitive to a first-generation cephalosporin, whereas 86.1% were sensitive to a ?-lactam/?-lactamase inhibitor.CONCLUSION: Patients presenting to our institution with acute bacterial lymphadenitis were predominantly found to have methicillin-susceptible S. aureus lymphadenitis that could be empirically treated with cefazolin.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":820,"document":"36830309","golden":false,"offsetInEndSection":1012,"text":"Where local epidemiology indicates low rates of MDR/XDR and there are no risk factors, a third or fourth generation cephalosporin can be used in the context of a \"carbapenem-sparing\" strategy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1289,"document":"37063937","golden":false,"offsetInEndSection":1672,"text":"Antepartum exposure to cephalosporins (OR\u003d25.191, 95% CI: 3.184-199.326, P\u003c0.01) and parenteral nutrition for more than 1 week (OR\u003d4.495, 95% CI: 2.009-10.055, P\u003c0.01) were independent risk factors for neonatal infection with ESBL-producing stains among infants with E. coli sepsis.Conclusion: E. coli remains the most common Gram-negative bacterial pathogen causing neonatal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":149,"document":"36830309","golden":false,"offsetInEndSection":346,"text":"The goal of this review is to describe evidence-based empiric and targeted treatment regimens that can be exploited when dealing with suspected or confirmed infections due to MDR/XDR P. aeruginosa.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1415,"document":"1889863","golden":false,"offsetInEndSection":1612,"text":"Treatment was predominantly carried out with penicillin G, ampicillin or a second generation cephalosporin with or without the addition of an aminoglycoside in case of community acquired pneumonia.","beginSection":"abstract"}],"exact_answer":[],"ideal_answer":["The most commonly used antibiotics for the empirical management of pediatric sepsis are cephalosporins, specifically ceftriaxone. Empirical treatment often involves broad-spectrum antibiotics due to the threat of multi-drug resistant (MDR) infections and the timeliness of obtaining microbiological results. For community-acquired infections, beta-lactam monotherapy is common, while for hospital-acquired infections, such as suspected catheter-related bloodstream infection (CLABSI) and suspected ventilator-associated pneumonia (VAP), the combination of a beta-lactam with vancomycin is frequently prescribed. Ampicillin and gentamicin are traditional choices, but there is a high resistance to these drugs, necessitating reconsideration of their empiric use. Amoxicillin/clavulanate is another antibiotic that would have been appropriate as an initial regimen in a high percentage of cases. Despite the variety in prescribing practices, there is a consensus on the use of broad-spectrum antimicrobials for empirical management and a typical 7-day course of antibiotics even in culture-negative sepsis cases.","The most commonly used antibiotics for the empirical management of pediatric sepsis include cephalosporins, such as ceftriaxone. For community-acquired infections, beta-lactam monotherapy is prevalent, whereas for hospital-acquired infections, such as catheter-related bloodstream infections (CLABSI) and ventilator-associated pneumonia (VAP), combination antibiotics (?-lactam + vancomycin) are more commonly prescribed. Third-generation cephalosporins in conjunction with metronidazole and amoxicillin are also frequently used. In some cases, amoxicillin/clavulanate would be appropriate as the initial regimen. For neonatal sepsis, the combination of ampicillin and gentamicin is often the first-line therapy. Resistance patterns, however, indicate that common pathogens in pediatric sepsis show high resistance to benzylpenicillin and cefotaxime, suggesting that local resistance patterns should guide the empirical choice of antibiotics.","The most commonly used antibiotics for the empirical management of paediatric sepsis include aminoglycosides, penicillins, and third-generation cephalosporins. Specific antibiotics frequently used are amikacin among the aminoglycosides, various forms of penicillin, and cefepime?a fourth-generation cephalosporin. Additionally, carbapenems like meropenem and beta-lactam/beta-lactamase inhibitor combinations such as piperacillin-tazobactam are also routinely employed. Notably, in neonatal sepsis, the combination of ampicillin and gentamicin is highlighted as a very effective first-line treatment. Importantly, the choice of antibiotics may be guided by prevalent resistance patterns and susceptibility profiles of the causative pathogens such as coagulase-negative staphylococcus (CoNS) and Klebsiella species in the respective clinical settings.","The most commonly used antibiotics for the empirical management of pediatric sepsis include ampicillin and an aminoglycoside for early-onset sepsis, with anti-staphylococcal penicillin and gentamicin being utilized for suspected late-onset sepsis. Third-generation cephalosporins, such as cefotaxime, are also used as first-line agents but are typically reserved for patients with a high likelihood of Gram-negative meningitis. Broad-spectrum agents like vancomycin and piperacillin-tazobactam are often used for resistant organisms or for neonatal meningitis due to certain bacteria. Other antibiotics including ampicillin-sulbactam, cefoperazone plus sulbactam, amikacin, and metronidazole are effective alternatives in some cases.","The most commonly used antibiotics for the empirical management of pediatric sepsis are injection ampicillin and injection gentamicin. These antibiotics have shown high effectiveness in reducing mortality rates in children with sepsis, even beyond the neonatal age. Benzylpenicillin and cefotaxime, which are commonly used empiric antibiotics in neonatal sepsis, have been reported to have high resistance rates among both Gram-positive and Gram-negative organisms.","\nAccording to clinical studies, the most commonly used first-line antibiotics for empirical treatment of paediatric sepsis are ampicillin + gentamicin, followed by amoxicillin + clavulanate, ampicillin + ceftazidime, penicillin + gentamicin and cefotaxime + clindamycin.\n","The most commonly used antibiotics for the empirical management of pediatric sepsis are beta-lactam antibiotics, including amoxicillin and cefuroxime, often combined with an aminoglycoside such as gentamicin. Amikacin, in combination with fosfomycin, has also been highlighted for its high susceptibility in Gram-negative pediatric bacteremia and is considered a potent carbapenem-sparing regimen. While cotrimoxazole resistance has been observed, and there is resistance to benzylpenicillin and cefotaxime, the combination of ampicillin and gentamicin remains a highly effective first-line treatment for managing sepsis in children, contributing to lower mortality rates. These antibiotic regimens are chosen to cover a broad range of potential pathogens in sepsis, where the exact source and causative organisms may not be initially apparent.","The most commonly used antibiotics for the empirical management of pediatric sepsis include beta-lactam antibiotics such as amoxicillin and cefuroxime, and often an aminoglycoside is included in the treatment regimen. Broad-spectrum beta-lactams, like carbapenems, are frequently prescribed for severe sepsis and septic shock. Imipenem has been noted to be effective against Gram-negative bacterial isolates, which are a predominant cause of sepsis. In areas with high resistance to common antibiotics, a fosfomycin-amikacin combination may be considered as a carbapenem-sparing regimen. Moreover, the combination of ampicillin and gentamicin is suggested as a first-line treatment for managing sepsis in children beyond the neonatal period, often resulting in a lower mortality rate. However, the emergence of resistance to commonly used antibiotics such as ampicillin, amoxicillin, cefotaxime, ceftriaxone, and gentamicin has been reported and needs to be considered when selecting empirical therapy.","The most commonly used antibiotics for the empirical management of pediatric sepsis include benzylpenicillin and cefotaxime, which are typically prescribed to cover both Gram-positive and Gram-negative organisms. However, these antibiotics may not be effective against all types of bacteria, especially those that have developed resistance. For example, a study found high levels of resistance to both penicillin and cefotaxime among Gram-positive and Gram-negative organisms isolated from children with sepsis. The combination of injection ampicilin and injection gentamicin has been shown to be very effective as the first-line antibiotics for managing sepsis in children, leading to lower mortality rates compared to other empiric treatments.","The most commonly used antibiotics for the empirical management of pediatric sepsis include broad-spectrum beta-lactam antibiotics such as piperacillin/tazobactam, carbapenems, and cephalosporin/beta-lactamase inhibitor combinations. Cephalosporins such as ceftriaxone, often used in conjunction with aminoglycosides like amikacin or fluoroquinolones, lead the choices in treatment. Additionally, vancomycin is frequently employed to cover potential Gram-positive pathogens, particularly in settings with high rates of antibiotic resistance or in the case of suspected methicillin-resistant Staphylococcus aureus (MRSA). Due to the increasing presence of ESBL-forming bacteria, use of broad-spectrum agents is critical, but onset of carbapenemase-forming Enterobacteriaceae remains infrequent. It is essential to start empirical antibiotic therapy promptly, typically within the first hour of diagnosing sepsis.","The most commonly used antibiotics for empirical management of pediatric sepsis include beta-lactam antibiotics such as amoxicillin and cefuroxime. Aminoglycosides, often combined with other agents, are also an integral part of the treatment regimens, with gentamicin frequently administered. Empiric antibiotic choices like the combination of penicillin with gentamicin or flucloxacillin with gentamicin are common due to their effectiveness against a broad range of pathogens causing early-onset sepsis (EOS) and late-onset sepsis (LOS). Some regions are exploring fosfomycin in combination with amikacin as a carbapenem-sparing regimen that remains effective even against antimicrobial-resistant neonatal and pediatric sepsis cases. Antibiotic choice may also be influenced by local patterns of antimicrobial resistance and the age and severity of the infection in the patient.","The most commonly used antibiotics for the empirical management of pediatric sepsis include a combination of ampicillin and gentamicin. This regimen is particularly effective as the first-line treatment for sepsis in children, extending its efficacy beyond the neonatal age and resulting in lower mortality rates. Additionally, benzylpenicillin and cefotaxime are also frequently employed as empiric antibiotics in the treatment of neonatal sepsis. However, it is important to note that both Gram-positive and Gram-negative organisms have shown high resistance levels to benzylpenicillin and cefotaxime, indicating the need for careful consideration and potential adjustments in antibiotic selection based on local resistance patterns and individual patient factors.","The most commonly used antibiotics for the empirical management of pediatric sepsis include third-generation cephalosporins and vancomycin. There is, however, significant variability in antibiotic use across hospitals, particularly with vancomycin. This likely reflects a balance between the need for broad-spectrum coverage and the desire to avoid overtreatment and contribute to antimicrobial resistance. In cases with confirmed or suspected P. aeruginosa, newer antibiotics such as ceftolozane-tazobactam or ceftazidime-avibactam may be recommended depending on the risk factors for MDR/XDR infections and local epidemiology. For empirical treatment of neonatal sepsis, especially due to common pathogens like E. coli, cephalosporins are frequently used but there is a growing consideration for the use of carbapenems or ?-lactam/?-lactamase inhibitors in the context of antimicrobial stewardship and the risk of extended-spectrum beta-lactamase (ESBL)-producing strains. Resistance patterns and the prevalence of methicillin-susceptible S. aureus (MSSA) lymphadenitis also inform the empirical use of agents such as cefazolin."],"id":"658459b106a2ea257c000009","type":"list","body":"Which are the most commonly used antibiotics for the empirical management of paediatric sepsis?"},{"documents":[{"golden":false,"id":"25056493"},{"golden":false,"id":"34553810"},{"golden":true,"id":"31763206"},{"golden":true,"id":"37879683"},{"golden":true,"id":"31974673"},{"golden":false,"id":"28845129"},{"golden":false,"id":"32126571"},{"golden":true,"id":"35198634"},{"golden":false,"id":"17260130"},{"golden":false,"id":"32984583"},{"golden":false,"id":"28438138"},{"golden":false,"id":"29343506"},{"golden":false,"id":"32841443"},{"golden":false,"id":"32929531"},{"golden":false,"id":"30389482"},{"golden":false,"id":"28794881"},{"golden":false,"id":"37926883"},{"golden":false,"id":"9711515"},{"golden":false,"id":"34593484"},{"golden":true,"id":"36604132"},{"golden":false,"id":"19762956"},{"golden":false,"id":"15637991"},{"golden":true,"id":"23034322"},{"golden":true,"id":"33127742"},{"golden":false,"id":"26896491"},{"golden":false,"id":"36158418"},{"golden":true,"id":"28504925"},{"golden":false,"id":"34983430"},{"golden":false,"id":"16982493"},{"golden":false,"id":"31510842"},{"golden":false,"id":"36328382"},{"golden":false,"id":"32850901"},{"golden":false,"id":"27468879"},{"golden":false,"id":"15524419"},{"golden":false,"id":"27683386"},{"golden":true,"id":"36813654"},{"golden":false,"id":"32120380"},{"golden":false,"id":"33178370"},{"golden":true,"id":"33947731"},{"golden":false,"id":"38093593"},{"golden":false,"id":"36649385"},{"golden":false,"id":"27116911"},{"golden":false,"id":"36823611"},{"golden":false,"id":"37700586"},{"golden":false,"id":"30778891"},{"golden":false,"id":"32911125"},{"golden":false,"id":"34230062"},{"golden":false,"id":"36467476"},{"golden":false,"id":"36677457"},{"golden":false,"id":"33747400"},{"golden":false,"id":"34679481"},{"golden":false,"id":"33523023"},{"golden":false,"id":"32655806"},{"golden":false,"id":"34743180"},{"golden":false,"id":"34720754"},{"golden":false,"id":"38114983"},{"golden":false,"id":"38262696"},{"golden":false,"id":"37223064"},{"golden":false,"id":"34149086"},{"golden":false,"id":"37192175"},{"golden":false,"id":"33803628"},{"golden":false,"id":"32463614"},{"golden":false,"id":"36053116"},{"golden":false,"id":"37084940"},{"golden":false,"id":"38243675"},{"golden":false,"id":"34150343"},{"golden":false,"id":"34711944"},{"golden":false,"id":"31496894"},{"golden":false,"id":"36645795"},{"golden":false,"id":"38216206"},{"golden":false,"id":"31990465"},{"golden":false,"id":"38074247"},{"golden":false,"id":"36602351"},{"golden":false,"id":"38158358"},{"golden":false,"id":"26933799"},{"golden":false,"id":"34956986"},{"golden":false,"id":"36594305"},{"golden":false,"id":"37204560"},{"golden":false,"id":"36553115"},{"golden":false,"id":"38002900"},{"golden":false,"id":"35488816"},{"golden":false,"id":"33757727"},{"golden":false,"id":"37553903"},{"golden":false,"id":"36323378"},{"golden":false,"id":"34160425"},{"golden":false,"id":"38034045"},{"golden":false,"id":"33096256"},{"golden":false,"id":"31639728"},{"golden":false,"id":"30111470"},{"golden":false,"id":"34047717"},{"golden":false,"id":"27348998"},{"golden":false,"id":"28445241"},{"golden":false,"id":"24489704"},{"golden":false,"id":"37810514"},{"golden":false,"id":"31470804"},{"golden":false,"id":"36755189"},{"golden":false,"id":"33378581"},{"golden":false,"id":"31693774"},{"golden":false,"id":"34113113"},{"golden":false,"id":"36544765"},{"golden":false,"id":"35836633"},{"golden":false,"id":"34127800"},{"golden":false,"id":"32766482"},{"golden":false,"id":"30356758"},{"golden":false,"id":"38358334"},{"golden":false,"id":"38357644"},{"golden":false,"id":"38354980"},{"golden":false,"id":"38350795"},{"golden":false,"id":"38348996"},{"golden":false,"id":"38347969"},{"golden":false,"id":"38347714"},{"golden":false,"id":"38347513"},{"golden":false,"id":"38345975"},{"golden":false,"id":"38345050"},{"golden":false,"id":"38299935"},{"golden":false,"id":"38254697"},{"golden":false,"id":"37157138"},{"golden":false,"id":"36922317"},{"golden":false,"id":"36482951"},{"golden":false,"id":"35137684"},{"golden":false,"id":"18073177"},{"golden":false,"id":"9803814"},{"golden":false,"id":"20306688"},{"golden":false,"id":"26104280"},{"golden":false,"id":"15566590"},{"golden":false,"id":"27062617"},{"golden":false,"id":"34686556"},{"golden":false,"id":"29923133"},{"golden":false,"id":"38321498"},{"golden":false,"id":"15808093"},{"golden":false,"id":"37510189"},{"golden":false,"id":"36470834"},{"golden":false,"id":"28397440"},{"golden":false,"id":"23431318"},{"golden":false,"id":"38249263"},{"golden":false,"id":"28858084"},{"golden":false,"id":"32897796"},{"golden":false,"id":"36538555"},{"golden":false,"id":"34099614"},{"golden":false,"id":"32881994"},{"golden":false,"id":"27698714"},{"golden":false,"id":"37878488"},{"golden":false,"id":"32197015"},{"golden":false,"id":"37391965"},{"golden":false,"id":"18694710"},{"golden":false,"id":"34704033"},{"golden":false,"id":"2456717"},{"golden":false,"id":"35927575"},{"golden":false,"id":"32808806"},{"golden":true,"id":"23025259"},{"golden":false,"id":"27513537"},{"golden":false,"id":"24626215"},{"golden":false,"id":"36562614"},{"golden":true,"id":"37092821"},{"golden":true,"id":"28099644"},{"golden":false,"id":"21171879"},{"golden":false,"id":"38357933"},{"golden":false,"id":"38357643"},{"golden":false,"id":"38357545"},{"golden":false,"id":"38357510"},{"golden":false,"id":"38357174"},{"golden":false,"id":"38312006"},{"golden":false,"id":"38261606"},{"golden":false,"id":"38136745"},{"golden":false,"id":"38097685"},{"golden":false,"id":"37918940"},{"golden":false,"id":"37906986"},{"golden":false,"id":"38320541"},{"golden":false,"id":"37368220"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":1018,"document":"31974673","golden":false,"offsetInEndSection":1234,"text":"Levels of MR-proADM were significantly higher in patients who required vasoactive drugs (p?\u003d?0.02) or presented renal dysfunction (p?\u003d?0.004).Conclusion: PCT appeared to be superior to MR-proADM in diagnosing sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1573,"document":"17260130","golden":false,"offsetInEndSection":1698,"text":"is a better diagnostic marker of sepsis in critically ill children than CRP. The CRP, and especially PCT, may become a helpfu","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1114,"document":"17260130","golden":false,"offsetInEndSection":1309,"text":"were 1.35, 3.80, 6.45, 5.70, 7.60 and 16.2 mg/dl, respectively. The area under the ROC curve for the diagnosis of septic patients was 0.532 for leucocyte count (95% CI, 0.462-0.602), 0.750 for CR","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1198,"document":"32929531","golden":false,"offsetInEndSection":1458,"text":"Procalcitonin showed a better AUC for diagnosing both sepsis and pneumonia, which makes it an excellent predictor.Conclusion: We present PCT as a novel test in comparison with the traditional CRP screening test to discern which bronchiolitis patients have IBI.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1682,"document":"32984583","golden":false,"offsetInEndSection":1749,"text":"negative for blood cultures (CS). Klebsiella spp. recorded the high","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":704,"document":"17260130","golden":false,"offsetInEndSection":780,"text":"re Medicine. A total of 359 patient day episodes were obtained. Leucocyte co","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"17260130","golden":false,"offsetInEndSection":127,"text":"Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":380,"document":"17260130","golden":false,"offsetInEndSection":652,"text":"P were measured when considered necessary during the PICU stay. Patients were classified, when PCT and CRP were measured, into one of six categories (negative, SIRS, localized infection, sepsis, severe sepsis, and septic shock) according to the definitions of the American","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":781,"document":"17260130","golden":false,"offsetInEndSection":1113,"text":"nt did not differ across the six diagnostic classes considered. Median plasma PCT concentrations were 0.17, 0.43, 0.79, 1.80, 15.40 and 19.13 ng/ml in negative, systemic inflammatory response syndrome (SIRS), localized infection, sepsis, severe sepsis, and septic shock groups, respectively, whereas median plasma CRP concentrations","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2049,"document":"32984583","golden":false,"offsetInEndSection":2354,"text":" hs-CRP (AUC \u003d 78.4%) and sCD14-ST (AUC \u003d 74.8%). Combination of PCT + hs-CRP had the highest accuracy (AUC \u003d 80.1%) followed by hs-CRP + sCD14-ST (AUC \u003d 77.2%), PCT + sCD14-ST + hs-CRP (AUC \u003d 77.0%) and PCT + sCD14-ST (AUC \u003d 75.9%).Conclusion: hs-CRP, PCT, and sCD14-ST are independent predictors of paed","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1470,"document":"36158418","golden":false,"offsetInEndSection":1650,"text":"Conclusion PCT on Day three of suspected sepsis has higher sensitivity, specificity, and accuracy for prognostication of surgical neonatal sepsis at the cut-off value of 2.5 ng/ml.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":787,"document":"31510842","golden":false,"offsetInEndSection":953,"text":"Conclusion: We believe that RPR may be used in diagnosis of early onset neonatal sepsis and may be a good alternative to other tools as a readily available biomarker.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1255,"document":"36328382","golden":false,"offsetInEndSection":2007,"text":"Combination of WCC or CRP increased sensitivity further(?10?000?cells/?L or ?10?mg/L, individual patient data (IPD) of 6 studies, 0.97 (95% CI 0.93 to 0.99)).Applying results to a hypothetical cohort(1000 children with appendicitis symptoms, of whom 400 have appendicitis) 60 and 40 children would be wrongly discharged based solely on WCC and ANC, respectively, 12 with combination of WCC or CRP.The most specific tests were CRP alone (?50?mg/L, 38 studies, specificity 0.87 (95% CI 0.80 to 0.91)) or combined with WCC (?10?000?cells/?L and ?50?mg/L, IPD of six studies, 0.93 (95% CI 0.91 to 0.95)).CONCLUSIONS: The best performing single blood tests for ruling-out paediatric appendicitis are WCC or ANC; with accuracy improved combining WCC and CRP.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":175,"document":"36158418","golden":false,"offsetInEndSection":292,"text":"Procalcitonin (PCT) and C-reactive protein (CRP) are the two most commonly used diagnostic biomarkers used in sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1651,"document":"36158418","golden":false,"offsetInEndSection":1716,"text":"The rising trend of PCT levels is indicative of a poor prognosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1277,"document":"28504925","golden":false,"offsetInEndSection":1592,"text":"For CRP, the cut-off value of ?5.3?mg?dl-1 had the maximum sensitivity of 72.09?%; ?8.0?mg?dl-1 had a sensitivity and specificity of 58.14 and 68.09?%,?respectively, and ?8.4?mg?dl-1 had the maximum specificity of 70.04?%.CONCLUSION: PCT is a better serological marker for excluding bloodstream infections than CRP.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1892,"document":"34983430","golden":false,"offsetInEndSection":2227,"text":"MDW, using 20 as cutoff, exhibited sensitivity, specificity, PPV, and NPV of 90.6%, 37.1%, 18.7%, and 96.1%, respectively, compared to 49.1%, 78.6%, 26.8%, and 90.6% when 0.5?ng/mL PCT was used as cutoff.CONCLUSIONS: In conclusion, MDW is a more sensitive biomarker than PCT in predicting infection-related SIRS and sepsis-3 in the ED.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28504925","golden":false,"offsetInEndSection":422,"text":"PURPOSE: To compute diagnostic test properties of C-reactive protein (CRP) and serum procalcitonin (PCT) levels in bloodstream infections in children with cancer and suspected sepsis, in comparison with blood culture as the gold standard.METHODOLOGY: Consecutive paediatric cancer patients, aged ?14?years, with clinically suspected bloodstream infections were evaluated with blood culture and assay of PCT and CRP levels.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1151,"document":"15524419","golden":false,"offsetInEndSection":1396,"text":"After 24 hours 26 of them had elevated CRP and 100% had increased PCT concentrations--this difference was not significant.CONCLUSION: Measurement of procalcitonin concentrations may be useful for early diagnosis of late onset sepsis in neonates.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1075,"document":"36158418","golden":false,"offsetInEndSection":1217,"text":"There was a decline in the overall PCT trend from PCT1 and PCT3, while a significant PCT rise was noted for the non-survival group (p\u003d 0.003).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1112,"document":"36823611","golden":false,"offsetInEndSection":1233,"text":"The most commonly applied diagnostic tools include electroencephalography, neurological imaging, and biomarker detection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1182,"document":"36649385","golden":false,"offsetInEndSection":1546,"text":"CRP of ?60?mg/L (AUC 0.87, 95% CI 0.76 to 0.91) among 1339 neonates and PCT of ?0.5?ng/mL (AUC 0.87, 95% CI 0.70 to 0.92) among 617 neonates demonstrated the greatest discriminatory value for the diagnosis of neonatal sepsis using blood culture as the reference standard in LMICs.CONCLUSIONS: PCT and CRP had good discriminatory value for neonatal sepsis in LMICs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":327,"document":"36823611","golden":false,"offsetInEndSection":824,"text":"The pathophysiology of SAE is still unknown, but its mechanisms are well elaborated, including oxidative stress, increased cytokines and proinflammatory factors levels, disturbances in the cerebral circulation, changes in blood-brain barrier permeability, injury to the brain\u0027s vascular endothelium, altered levels of neurotransmitters, changes in amino acid levels, dysfunction of cerebral microvascular cells, mitochondria dysfunction, activation of microglia and astrocytes, and neuronal death.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1343,"document":"36823611","golden":false,"offsetInEndSection":1446,"text":"In contrast, sedative medication is used judiciously to treat those showing features such as agitation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1447,"document":"36823611","golden":false,"offsetInEndSection":1688,"text":"The most widely used medication is dexmedetomidine which is neuroprotective by inhibiting neuronal apoptosis and reducing a sepsis-associated inflammatory response, resulting in improved short-term mortality and shorter time on a ventilator.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":962,"document":"32120380","golden":false,"offsetInEndSection":1209,"text":"In addition to these diagnostic uses, VOCs analysis could also distinguish breastfed from formula-fed preterm neonates in the first month of life.CONCLUSION: VOCs analysis is a non-invasive tool that makes the use in preterm infants of preference.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":825,"document":"36823611","golden":false,"offsetInEndSection":1111,"text":"The diagnosis of SAE involves excluding direct CNS infection or other types of encephalopathies, which might hinder its early detection and appropriate implementation of management protocols, especially in paediatric patients where only a few cases have been reported in the literature.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1254,"document":"27116911","golden":false,"offsetInEndSection":1641,"text":"Some data from single studies support a role of sTREM-1 as a diagnostic tool in pediatric sepsis, but cannot be considered conclusive, because a quantitative synthesis was not possible, due to heterogeneity in studies design.CONCLUSIONS: This systematic review suggests that available data are insufficient to support a role for sTREM in the diagnosis and follow-up of paediatric sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1689,"document":"36823611","golden":false,"offsetInEndSection":1821,"text":"Other agents, such as dexamethasone, melatonin, and magnesium, are also being explored in vivo and ex vivo with encouraging results.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":210,"document":"37700586","golden":false,"offsetInEndSection":484,"text":"However, clinical recognition of sepsis in children is challenging given its rare occurrence, the overlap of clinical features with other common febrile illness, lack of specific diagnostic biomarkers and the ability of children to compensate until the late stages of shock.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":485,"document":"37700586","golden":false,"offsetInEndSection":647,"text":"Despite updating of pediatric sepsis definition and implementation of screening tools to facilitate early recognition, mortality from sepsis continues to be high.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37700586","golden":false,"offsetInEndSection":75,"text":"Sepsis is one of the leading causes of morbidity and mortality in children.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":76,"document":"37700586","golden":false,"offsetInEndSection":209,"text":"Timely recognition and management of sepsis with fluid resuscitation and antibiotic administration leads to better clinical outcomes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30778891","golden":false,"offsetInEndSection":194,"text":"Ultrasound scan is a painless and radiation-free imaging modality and, therefore, it is widely considered the first-choice diagnostic tool in the setting of hepatopathies in paediatric patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1460,"document":"33747400","golden":false,"offsetInEndSection":1664,"text":"The diagnostic accuracy of PCT in the LONS group showed a PPV of 82% and PLR of 7 (1.7 - 29).CONCLUSION: Identifying abnormal STOPS parameters was superior to PCT alone in EONS and as good as PCT in LONS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":575,"document":"32120380","golden":false,"offsetInEndSection":961,"text":"A total of 50 articles identified with only seven papers were included in the final analysis in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).RESULTS: VOCs could diagnose necrotising enterocolitis up to 4 days before a clinical diagnosis; for late onset sepsis, up to 3 days before; and for bronchopulmonary dysplasia, up to 2 weeks before.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37700586","golden":false,"offsetInEndSection":71,"text":"Pediatric Sepsis: New Strategies for Reducing Sepsis Related Mortality.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":648,"document":"37700586","golden":false,"offsetInEndSection":758,"text":"Continued education, research and advocacy efforts are needed to improve patient outcomes in pediatric sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1352,"document":"33523023","golden":false,"offsetInEndSection":1650,"text":"ROC curve showed that serum CRP demonstrated good diagnostic accuracy in predicting neonatal sepsis AUC?\u003d?0.875 with sensitivity of 100% and specificity of 92.3%.CONCLUSION: Serum PTX3 may be a promising acute-phase protein for interpretation of affected newborns with symptoms and signs of sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":289,"document":"32120380","golden":false,"offsetInEndSection":574,"text":"VOCs can be identified using non-invasive techniques, which make their use in preterm infants safe and desirable.METHODS: A systematic search of the literature in PubMed, Embase and Web of Science was conducted looking for VOCs techniques and diagnostic performance in preterm infants.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1210,"document":"32120380","golden":false,"offsetInEndSection":1446,"text":"VOCs analytic techniques require more research and consensus between researchers to overcome their limitations.IMPACT: Volatile organic compounds are hydrocarbons that can separate between healthy and diseased states in preterm infants.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":468,"document":"32911125","golden":false,"offsetInEndSection":594,"text":"Blood cultures remain the gold standard for the diagnosis of sepsis, with the limitation of time delay and low positive yield.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1538,"document":"32120380","golden":false,"offsetInEndSection":1655,"text":"The non-invasive nature of acquiring volatile organic compounds markers make it desirable in the paediatric patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":304,"document":"34720754","golden":false,"offsetInEndSection":821,"text":"Key to the diagnosis of sepsis is identification of infection, and whilst the diagnostic criteria for sepsis is now clear, the diagnosis of infection remains a challenge and there is often discordance between clinician assessments for infection.RECENT FINDINGS: We review the utility of common biochemical, microbiological and radiological tools employed by clinicians to diagnose infection and explore the difficulty of making a diagnosis of infection in severe inflammatory states through illustrative case reports.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1447,"document":"32120380","golden":false,"offsetInEndSection":1537,"text":"Biomarker panels developed from volatile organic compounds are potential diagnostic tools.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1012,"document":"38093593","golden":false,"offsetInEndSection":1489,"text":"Among malaria-only discharge diagnoses, 98% (n/N?\u003d?202/207) received an antimalarial and 33% (n/N?\u003d?69/207) an antibiotic; among discharge diagnoses without malaria, 28% (n/N?\u003d?108/389) received an antimalarial and 83% (n/N?\u003d?324/389) an antibiotic.CONCLUSIONS: Suspected diagnoses were largely based on clinical presentation and were frequently changed; changed diagnoses were associated with lingering symptoms, underscoring the need for faster and more accurate diagnostics.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":418,"document":"38262696","golden":false,"offsetInEndSection":564,"text":"Current biomarkers include C reactive protein and procalcitonin, which are limited in their clinical use to guide appropriate and rapid treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38243675","golden":false,"offsetInEndSection":960,"text":"AIM: The aim of this review was to summarise the most recent evidence about the use of omics-based techniques as an instrument for a more rapid and accurate characterisation of respiratory tract infections, neurological infections and sepsis in paediatrics.METHODS: We performed a narrative review using PubMed and a set of inclusion criteria: English language articles, clinical trials, meta-analysis and reviews including only paediatric population inherited to this topic in the last 15?years.RESULTS: The examined studies suggest that host gene expression signatures are an effective method to characterise the different types of infections, to distinguish infection from colonisation and, in some cases, to assess the severity of the disease in children.CONCLUSIONS: \u0027Omics-based techniques\u0027 may help to define the aetiology of infections in paediatrics, representing a useful tool to choose the most appropriate therapies and limit antibiotic resistance.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":728,"document":"38262696","golden":false,"offsetInEndSection":916,"text":"The identification of multiple host biomarkers that may form a panel in a clinical test has the potential to recognise the complexity of sepsis and provide improved diagnostic performance.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":965,"document":"37223064","golden":false,"offsetInEndSection":1144,"text":"SFC assay offers promise to identify pathogens from positive blood culture in paediatric patients with sepsis and may support the antimicrobial stewardship programme in hospitals.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":258,"document":"38262696","golden":false,"offsetInEndSection":417,"text":"Biomarkers can aid in creating a larger low-risk group of children from those in the clinical grey area who would otherwise receive antibiotics \u0027just in case\u0027.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":565,"document":"38262696","golden":false,"offsetInEndSection":727,"text":"Biomarker discovery has focused on single biomarkers, which, so far, have not outperformed current biomarkers, as they fail to recognise the complexity of sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1476,"document":"32463614","golden":false,"offsetInEndSection":1637,"text":"Discussion: The mortality rate for the population under study was high and the qSOFA tool had a lower diagnostic yield compared to the classic criteria for SIRS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":917,"document":"38262696","golden":false,"offsetInEndSection":1120,"text":"In this review, we discuss novel biomarkers and novel ways of using existing biomarkers in the assessment and management of sepsis along with the significant challenges in biomarker discovery at present.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1299,"document":"38262696","golden":false,"offsetInEndSection":1420,"text":"Therefore, the utilisation of platform studies is necessary to improve the efficiency of biomarkers in clinical practice.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1121,"document":"38262696","golden":false,"offsetInEndSection":1298,"text":"Validation of biomarkers is made less meaningful due to methodological heterogeneity, including variations in sepsis diagnosis, biomarker cut-off values and patient populations.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34711944","golden":false,"offsetInEndSection":170,"text":"BACKGROUND: Peripheral blood culture (PBC) is considered the gold standard for diagnosis of neonatal early-onset sepsis (EOS), but its diagnostic value can be questioned.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1657,"document":"37192175","golden":false,"offsetInEndSection":1749,"text":"CAD has the potential to be a useful additional diagnostic tool for paediatric tuberculosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31496894","golden":false,"offsetInEndSection":471,"text":"BACKGROUND: As an early recognition of neonatal sepsis is important for triggering the initiation of treatment, this study was thus designed to assess the diagnostic performance and discrimination value of procalcitonin (PCT) in neonatal sepsis cases.METHODS: This cross-sectional study, which was carried out at the Paediatric Intensive Care Unit of Hospital Universiti Sains Malaysia (HUSM) in Kelantan, Malaysia, had involved 60 neonates admitted for suspected sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":427,"document":"36645795","golden":false,"offsetInEndSection":924,"text":"Data-driven prediction models integrated in clinical decision support systems (CDSS) could facilitate early recognition of disease onset.OBJECTIVES: To estimate the sensitivity and specificity of previously developed prediction models (index tests) for the detection of SIRS, sepsis and associated organ dysfunctions in critically ill children up to 12 hours before reference standard diagnosis is possible.METHODS AND ANALYSIS: We conduct a monocentre, prospective diagnostic test accuracy study.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1111,"document":"31990465","golden":false,"offsetInEndSection":1211,"text":"This study showed a low sensitivity of PCR of the 16S rRNA gene in the diagnosis of neonatal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":833,"document":"31990465","golden":false,"offsetInEndSection":918,"text":"The positivity rates of blood culture and PCR were found as 11% and 3%, respectively.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1500,"document":"37204560","golden":false,"offsetInEndSection":1717,"text":"During the first 10?days of ICU treatment, both CRP and PCT declined irrespective of clinical improvement or impairment.CONCLUSION: PCT was a reliable diagnostic tool for the diagnosis of septic shock compared to CRP.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1662,"document":"38074247","golden":false,"offsetInEndSection":1822,"text":"The PCT\u0027s sensitivity was 69.7%, whereas its specificity was 89.6%.Conclusion: PCT is more specific for detecting sepsis, but hs-CRP is more sensitive than CRP.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38158358","golden":false,"offsetInEndSection":373,"text":"BACKGROUND: Neonatal sepsis is an invasive infection of the bloodstream in neonates and a leading cause of morbidity and mortality among them.AIM: To investigate the role of procalcitonin (PCT) and C-reactive protein (CRP) in the management of neonatal sepsis.MATERIALS AND METHODS: This was a prospective case-control study over one-year period using convenience sampling.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1324,"document":"26933799","golden":false,"offsetInEndSection":1593,"text":"PCT (\u003e0.5 ng/mL) and CRP (\u003e0.6 mg/dL) performed better in DCLD (AUC of 0.90 and 0.83) compared with patients with ALF (AUC of 0.73 and 0.69).CONCLUSIONS: PCT and CRP are reliable markers of infection and correlate with infection severity in children with liver disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":207,"document":"31990465","golden":false,"offsetInEndSection":407,"text":"The purpose of this study was to evaluate the efficacy of real-time polymerase chain reaction (PCR) of the 16S rRNA gene in diagnosis of neonatal sepsis and compare it with conventional blood culture.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":919,"document":"31990465","golden":false,"offsetInEndSection":1110,"text":"The diagnosis of neonatal sepsis by PCR revealed a 16.6 % sensitivity, 97.8 % specificity, 33.3% positive predictive value and 94.8% negative predictive value compared with the blood culture.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1191,"document":"38158358","golden":false,"offsetInEndSection":1404,"text":"The concentration of both decreased to normal levels after two days of treatment.CONCLUSION: This study showed that CRP was more reliable in monitoring antibiotic therapy, unlike other studies which suggested PCT.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"31990465","golden":false,"offsetInEndSection":96,"text":"The potential utility of real-time PCR of the 16S-rRNA gene in the diagnosis of neonatal sepsis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1274,"document":"36323378","golden":false,"offsetInEndSection":1577,"text":"A weight-based medication cognitive aid was utilised in 56% (13/23) ISS but was not utilised in all three administration errors.CONCLUSIONS: ISS within TS programmes was successfully utilised as a diagnostic tool in identifying that medication errors were common during anaphylaxis management in the ED.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":308,"document":"37223064","golden":false,"offsetInEndSection":413,"text":"We evaluated the use of sepsis flow chip (SFC) assay for identifying pathogens from children with sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":504,"document":"37223064","golden":false,"offsetInEndSection":595,"text":"Positive samples were subjected to amplification-hybridization using SFC assay and culture.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":763,"document":"37223064","golden":false,"offsetInEndSection":881,"text":"From 25 positive blood culture bottles subjected to SFC assay, 24 genus/species and 18 resistance genes were detected.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":713,"document":"34149086","golden":false,"offsetInEndSection":819,"text":"Thus, the SIRS assessment should remain the gold standard tool for detecting patients at risk of \"sepsis.\"","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37223064","golden":false,"offsetInEndSection":95,"text":"Application of a sepsis flow chip (SFC) assay for the molecular diagnosis of paediatric sepsis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1327,"document":"37553903","golden":false,"offsetInEndSection":1463,"text":"DDX47 showed preferable diagnostic value in various scenarios, especially in patients with common infections or sepsis and septic shock.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":136,"document":"37223064","golden":false,"offsetInEndSection":248,"text":"The gold standard method for sepsis is blood culture but this requires 3?days to detect the definitive pathogen.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":504,"document":"34160425","golden":false,"offsetInEndSection":603,"text":"al treatment. To date, culture-based diagnostic procedures (e.g., blood cultures) represent the sta","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":917,"document":"34160425","golden":false,"offsetInEndSection":1199,"text":"e calculated. To overcome these problems, culture-independent molecular diagnostic procedures such as unbiased sequence analysis of circulating cell-free DNA (cfDNA) from plasma samples of septic patients by next-generation sequencing (NGS) have been tested successfully in adult se","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":249,"document":"37223064","golden":false,"offsetInEndSection":307,"text":"Molecular methods offer rapid identification of pathogens.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":969,"document":"38034045","golden":false,"offsetInEndSection":1154,"text":"tive PCR (qRT-PCR).Results: Among the 83 differentially expressed genes (DEGs) related to lysosomes, four key genes (STOM, VNN1, SORT1, and RETN) were identified to develop a diagnostic","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1155,"document":"38034045","golden":false,"offsetInEndSection":1300,"text":"model for pediatric sepsis. The expression levels of these four key genes were consistently higher in the sepsis group compared to the normal gro","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1301,"document":"38034045","golden":false,"offsetInEndSection":1439,"text":"p across all three cohorts. The diagnostic model exhibited excellent diagnostic performance, as evidenced by area under the curve (AUC) va","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1759,"document":"38034045","golden":false,"offsetInEndSection":1971,"text":"utrophil percentage (NEU%).Conclusion: A four-gene diagnostic model of lysosomal function was devised and validated, aiming to accurately detect pediatric sepsis cases and propose potential target genes for lysos","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":320,"document":"33096256","golden":false,"offsetInEndSection":513,"text":"Combining gene expression profiles from a training cohort of 364 pediatric samples with a Least Absolute Shrinkage and Selection Operator analysis produced eighteen genes as diagnostic markers.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":514,"document":"33096256","golden":false,"offsetInEndSection":758,"text":"With the implementation of a Gradient Boosting algorithm, a model designated PEDSEPS-GBM, that aggregated these markers was developed with optimal performance for the diagnosis of pediatric samples in the validation and two independent cohorts.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37810514","golden":false,"offsetInEndSection":177,"text":"Retracted: Analysis of the Relevant Vital Signs and Infection of Sepsis Patients and to Explore the Influencing Factors of Acute Lung Injury/Acute Respiratory Distress Syndrome.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":88,"document":"31470804","golden":false,"offsetInEndSection":207,"text":" challenge. Previous studies showed that presepsin is potentially a reliable diagnostic biomarker for sepsis in adult a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":311,"document":"31470804","golden":false,"offsetInEndSection":506,"text":"n children. The aims of the present meta-analysis were to assess the overall diagnostic accuracy of presepsin in pediatric sepsis and compare it to those for C-reactive protein (CRP) and procalci","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1061,"document":"31470804","golden":false,"offsetInEndSection":1219,"text":"tients aged between 1 mo and 18 y. The pooled diagnostic sensitivity and specificity of presepsin were 0.94 (95% confidence interval [CI]: 0.74-0.99) and 0.71","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1467,"document":"31470804","golden":false,"offsetInEndSection":1640,"text":"y was found in both sensitivity (?2?\u003d?11.17; P?\u003d?0.011) and specificity (?2?\u003d?65.78; P?\u003c?0.001). No threshold effect was identified among the studies (r?\u003d?-?0.938). The pool","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1522,"document":"36755189","golden":false,"offsetInEndSection":1732,"text":"but inadequate predictors of mortality.IMPACT: Apolipoprotein A-V (APOA5), copeptin, and pancreatic stone protein (PSP) are acute-phase proteins with diagnostic value in evaluating critically ill pediatric pati","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1022,"document":"36755189","golden":false,"offsetInEndSection":1245,"text":" associated with mortality. The receiver operating characteristic revealed that the area under the curve (AUC) for APOA5, copeptin, and PSP (0.965, 0.960, and 0.868, respectively) demonstrated high sensitivity (96%, 94%, an","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1400,"document":"36755189","golden":false,"offsetInEndSection":1521,"text":"% for mortality prediction.CONCLUSIONS: PSP, copeptin, and APOA5 are promising diagnostic biomarkers for pediatric sepsis","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1108,"document":"33378581","golden":false,"offsetInEndSection":1212,"text":"entified in sera of patients with sepsis. Serum ACLY level is an additional diagnostic and prognostic bi","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1196,"document":"31693774","golden":false,"offsetInEndSection":1332,"text":"n increased mortality rate.CONCLUSIONS: miRNA-146-a is of significant diagnostic and prognostic value in pediatric sepsis and could be u","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1271,"document":"34113113","golden":false,"offsetInEndSection":1574,"text":"up and the control group (P\u003c0.05), and the left ventricular ejection fraction (LVEF) in the combined group was significantly lower than that in the other two group (P\u003c0.05). The area under the curve (AUC) of the combination of miRNA-497, FABP3, GPBB, and cTnI in the diagnosis of sepsis complicated with","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1596,"document":"38358334","golden":false,"offsetInEndSection":1671,"text":"There was 1 possibly related death (sepsis with attendant hepatic failure).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1205,"document":"38357644","golden":false,"offsetInEndSection":1254,"text":"The data analysis involved 22,633 sepsis patients","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":410,"document":"38354980","golden":false,"offsetInEndSection":735,"text":"The total number of sepsis episodes for each patient was recorded and were categorized as bloodstream infections (BSI), pneumonias, skin and soft tissue infections (SSTI), invasive candidiasis (IC), catheter associated urinary tract infection (CAUTI), intra-abdominal infections (IAI), and Clostridioides difficile infections","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1015,"document":"38350795","golden":false,"offsetInEndSection":1080,"text":"fumigatus infections, especially in immunocompromised individuals","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":565,"document":"38348996","golden":false,"offsetInEndSection":781,"text":"A retrospective analysis was conducted on 231 NHL patients, who underwent ASCT from October 2010 to October 2021 at the Institute of Hematology \u0026 Blood Disease Hospital, including both first-line and salvage settings","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":269,"document":"38347969","golden":false,"offsetInEndSection":348,"text":"Early detection of sepsis and prognostic grading are now crucial for management","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1157,"document":"38347714","golden":false,"offsetInEndSection":1271,"text":"Three patients with ABO-ILTs died of sepsis and multiorgan failure during the first 3 months after transplantation","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":336,"document":"38347513","golden":false,"offsetInEndSection":485,"text":"Adult patients (age???18?years) who were hospitalized in tertiary or general hospitals with a diagnosis of sepsis between 2011 and 2016 were analyzed","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"38345975","golden":false,"offsetInEndSection":101,"text":"Bloodstream infections (BSI) represent a common cause of sepsis and mortality in children","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38345050","golden":false,"offsetInEndSection":121,"text":"Group B streptococcus (GBS) is a leading global cause of neonatal sepsis and meningitis, stillbirth, and puerperal sepsis","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2221,"document":"38299935","golden":false,"offsetInEndSection":2335,"text":"ROTEM and aPTT-CWA were valuable diagnostic tools in critically ill children who might require point-of-care tests","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":225,"document":"38254697","golden":false,"offsetInEndSection":571,"text":"Inflammatory biomarkers such as C reactive protein (CRP) and procalcitonin are usually the first blood exams performed in the ED to differentiate bacterial and viral infections; nowadays, a better understanding of immunochemical pathways has led to the discovery of new and more specific biomarkers that could play a role in the emergency setting","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1102,"document":"37157138","golden":false,"offsetInEndSection":1199,"text":"Complications included wound infection, sepsis, requiring systemic antibiotics, or intensive care","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":106,"document":"36922317","golden":false,"offsetInEndSection":199,"text":"Extensive literature is available regarding managing sepsis in pediatric patients without CHD","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1182,"document":"36482951","golden":false,"offsetInEndSection":1252,"text":"Severity of illness was low, with 7/54 (11.5%) triggering sepsis tools","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1187,"document":"35137684","golden":false,"offsetInEndSection":1275,"text":"Of 302 children with acute diarrhea enrolled, 199 had etiologies above the AFe threshold","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":575,"document":"18073177","golden":false,"offsetInEndSection":799,"text":"The LightCycler SeptiFast test can detect and identify simultaneously the 25 most important bacterial and fungal species causing bloodstream infections within few hours by using a small volume of a single whole blood sample.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":281,"document":"18073177","golden":false,"offsetInEndSection":574,"text":"A new real-time polymerase chain reaction (PCR; LightCycler SeptiFast test M GRADE) has been proposed in the routine assessment of neonatal sepsis for the detection and identification of bacterial and fungal DNA from microorganisms which cause approximately 90% of all blood stream infections.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":538,"document":"15808093","golden":false,"offsetInEndSection":1016,"text":"C-reactive protein (CRP), erythrocyte sedimentation rate, total leukocyte count, absolute neutrophil count (ANC), immature neutrophils to total neutrophil count ratio (I/T ratio), thrombocytopenia, degenerative changes in the neutrophils and gastric aspirate cytology (GAC) for polymorphs were used for diagnosis of neonatal sepsis.RESULTS: CRP was positive in 24/28 (85.7%) of group-A (proven sepsis) and 58/72 (80.5%) of group-B (probable sepsis) and had a specificity of 95%.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":800,"document":"18073177","golden":false,"offsetInEndSection":964,"text":"Real-time PCR can be easily incorporated into the hospital setting for term or near-term infants admitted to the neonatal intensive care unit for sepsis evaluation.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"18073177","golden":false,"offsetInEndSection":184,"text":"New diagnostic tools for neonatal sepsis: the role of a real-time polymerase chain reaction for the early detection and identification of bacterial and fungal species in blood samples.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1314,"document":"20306688","golden":false,"offsetInEndSection":1426,"text":"In conclusion, neutrophil expression of CD64 is a useful diagnostic tool for early detection of neonatal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":702,"document":"9803814","golden":false,"offsetInEndSection":841,"text":"Isolation of S typhi from blood and/or stools was the most important diagnostic tool *85.2%) and of these 99% had significant Widal titres.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1241,"document":"15808093","golden":false,"offsetInEndSection":1617,"text":"The sensitivity, specificity and predictive values (PV) of the individual tests and different tests combination was also calculated for group-A and B.CONCLUSION: A set of investigations including CRP, TLC, ANC, thrombocytopenia, cytoplasmic vacuolization in the neutrophils and GAC for polymorphs are highly sensitive in detection of culture negative cases of neonatal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":842,"document":"9803814","golden":false,"offsetInEndSection":954,"text":"Clinical and bacteriological relapse occurred in 5 children (3%) who were successfully treated with ceftriaxone.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":117,"document":"18073177","golden":false,"offsetInEndSection":280,"text":"Consequently, rapid diagnostic tests capable to differentiate infected from non-infected newborns have the potential to make a significant impact on neonatal care.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"18073177","golden":false,"offsetInEndSection":116,"text":"Early diagnosis and treatment of neonatal sepsis are essential to prevent severe and life threatening complications.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1448,"document":"28397440","golden":false,"offsetInEndSection":1881,"text":"The area under the ROC curve was 0.847, and was comparable to the AUC of procalcitonin (0.840), and slightly higher than the AUC of neopterin (0.763), although these differences were not significant (p \u003d 0.2990 and p \u003d 0.9329, respectively).CONCLUSIONS: sCD163 and neopterin are promising parameters in the diagnosis of sepsis, and their value in the diagnosis of sepsis in critically ill patients may be comparable to procalcitonin.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1651,"document":"38249263","golden":false,"offsetInEndSection":1872,"text":"The diagnostic capability, sensitivity, specificity, and accuracy of PLA2 were demonstrably higher than those of PCT.CONCLUSION: Our study proves that PLA2 is a much better and more efficient biomarker in sepsis than PCT.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":398,"document":"38249263","golden":false,"offsetInEndSection":590,"text":"Thus, we aimed to examine PLA2 and compare its diagnostic capacity and accuracy with PCT as a biomarker of sepsis.MATERIAL AND METHODS: Our study was a hospital-oriented cross-sectional study.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1776,"document":"37878488","golden":false,"offsetInEndSection":2082,"text":"Combined analysis of presepsin and PCT levels provided a high sensitivity and specificity in identifying Escherichia coli or Klebsiella spp infection.CONCLUSIONS: Presepsin and PCT were promising markers for predicting bacteraemia and common pathogens at the time of sepsis onset with a synergistic effect.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1557,"document":"38249263","golden":false,"offsetInEndSection":1650,"text":"PLA2 was significantly higher in patients with bacterial etiology and Gram-positive cultures.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1873,"document":"38249263","golden":false,"offsetInEndSection":2081,"text":"The diagnostic capacity and accuracy of PLA2 clearly surpass PCT, so using PLA2 in sepsis as a biomarker can help clinicians in deciding on timely and appropriate management to speed the recovery of patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32197015","golden":false,"offsetInEndSection":391,"text":"OBJECTIVE: The objective of this review is to synthesize the best available evidence for the diagnostic test accuracy of procalcitonin (PCT) compared to C-reactive protein (CRP) in diagnosing osteomyelitis (OM) and septic arthritis in hospitalized children and adolescents.INTRODUCTION: Serum measurement of PCT has been shown to outperform CRP in diagnosing adult osteoarticular infections.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1408,"document":"34099614","golden":false,"offsetInEndSection":1625,"text":"CONCLUSIONS mNGS has utility in the diagnosis of PJP and mixed infections in kidney transplantation recipients, and TMP-SMX could be the ideal therapeutic drug for kidney transplantation recipients suffering from PJP.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1549,"document":"28858084","golden":false,"offsetInEndSection":1658,"text":"A combination of low CSF lactate, ANC, ESR, and serum-CRP could reasonably rule out the bacterial meningitis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":132,"document":"38249263","golden":false,"offsetInEndSection":256,"text":"Procalcitonin (PCT) is an effective marker used to diagnose sepsis but until now, there has been no ideal marker for sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1074,"document":"38249263","golden":false,"offsetInEndSection":1236,"text":"The statistical significance was set at p-value \u003c0.05.RESULTS: The mean PCT and PLA2 were significantly raised in sepsis patients compared to non-sepsis patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":458,"document":"9803814","golden":false,"offsetInEndSection":701,"text":"Patients\u0027 records were reviewed for demographic data such as age, sex, ethnicity, clinical features, therapy and results of laboratory tests.RESULTS: Fever was the most common presenting symptom and diarrhoea was more common than constipation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34686556","golden":false,"offsetInEndSection":242,"text":"INTRODUCTION: Burn-induced changes in the phenotype and function of neutrophils, cells which provide front-line protection against rapidly dividing bacterial infections, are emerging as potential biomarkers for the early prediction of sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"9803814","golden":false,"offsetInEndSection":187,"text":"BACKGROUND/AIM OF STUDY: Typhoid fever, which is endemic in Malaysia, affects all age groups and it has been stated that classical features described in textbooks were absent in children.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"9803814","golden":false,"offsetInEndSection":75,"text":"Typhoid fever in children--a retrospective study of 54 cases from Malaysia.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":188,"document":"9803814","golden":false,"offsetInEndSection":457,"text":"The aim of this study was to find out whether this was true in the local setting and hence a retrospective study was undertaken.METHODS: Fifty-four paediatric patients satisfied the inclusion criteria and all were seen consecutively during the study period of 10 years.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":955,"document":"9803814","golden":false,"offsetInEndSection":1115,"text":"The absence of mortality and low level of complications indicates either a mild nature of the disease or to early recognition or prompt and appropriate therapy.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38357933","golden":false,"offsetInEndSection":20,"text":"Race against dengue.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":804,"document":"38357643","golden":false,"offsetInEndSection":908,"text":"In the studied cohort of 32,971 sepsis patients, 2,327 were identified as meeting the inclusion criteria","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":271,"document":"38357545","golden":false,"offsetInEndSection":299,"text":"nosuppression and substantia","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1525,"document":"38357510","golden":false,"offsetInEndSection":1639,"text":"Pulmonary hemorrhage, tension pneumothorax and early onset sepsis were independent risk factors for high-grade IVH","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":212,"document":"38357174","golden":false,"offsetInEndSection":393,"text":"In retrospective observational study, during October 2019 to December 2021, 145 patients with septic shock treated in our hospital were enrolled by the method of observational study","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1127,"document":"38312006","golden":false,"offsetInEndSection":1223,"text":"The median age was 5 days, and 68.1% of the infants (214/314) underwent a full sepsis evaluation","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1441,"document":"38261606","golden":false,"offsetInEndSection":1657,"text":"There is an urgent need to standardize methods and diagnostic tools that would allow an early and accurate diagnosis, as well as to perform clinical studies of the effectiveness of available antibiotics to eradicate ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":432,"document":"38136745","golden":false,"offsetInEndSection":605,"text":"NP, one of the most prevalent causes of sepsis in surgical Intensive Care Units (ICUs), is often associated with multi-drug resistant (MDR) bacteria and high mortality rates","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":523,"document":"38097685","golden":false,"offsetInEndSection":701,"text":"Examples discussed in this article include predicting outcomes such as sepsis, optimizing oxygen therapy, and image analysis to detect brain injury and retinopathy of prematurity","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":139,"document":"37918940","golden":false,"offsetInEndSection":307,"text":"Tools such as American Academy of Pediatrics pulse oximetry (POx) and WHO Young Infants Clinical Signs (WHOS) have high specificity but low sensitivity to identify ARNs","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":14,"document":"37906986","golden":false,"offsetInEndSection":291,"text":"Compared with multivariate risk assessment, traditional category-based risk assessment (CRA) approaches for neonatal early-onset sepsis (EOS) screening are usually straightforward to use, do not require electronic devices, but are associated with higher rates of antibiotic use","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1490,"document":"38320541","golden":false,"offsetInEndSection":1688,"text":"(p \u003c 0.001).CONCLUSION: Point-of-care CRP correlates well with standard techniques of estimation, and CRP alone and in combination with procalcitonin has good diagnostic accuracy in neonatal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1482,"document":"37368220","golden":false,"offsetInEndSection":1798,"text":"There was no significant difference in the diagnostic accuracy of biomarkers for detection of culture positive sepsis (area under the curve, AUC of POC-SAA vs. procalcitonin vs. hs-CRP: 0.72 vs. 0.85 vs. 0.85; p?\u003d?0.21).CONCLUSIONS: POC-SAA is comparable to procalcitonin and hs-CRP for diagnosis of neonatal sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1163,"document":"38320541","golden":false,"offsetInEndSection":1322,"text":"There was no significant difference in the diagnostic accuracy of CRP (p \u003d 0.46), procalcitonin (p \u003d 0.29), and IL-6 (p \u003d 0.60) in early and late-onset sepsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":510,"document":"38320541","golden":false,"offsetInEndSection":805,"text":"Diagnostic accuracy of point-of-care (POC) testing of C-reactive protein (CRP), interleukin-6 (IL-6), and procalcitonin with standard laboratory methods was performed.RESULTS: The mean gestation age and birth weight of the neonates were 33.17 ? 4.25 weeks and 1695.4 ? 700.74 grams respectively.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1024,"document":"38320541","golden":false,"offsetInEndSection":1162,"text":"Amongst the three biomarkers, CRP had the maximum diagnostic accuracy (AUC - 0.73) followed by procalcitonin (AUC - 0.65) and IL-6 (0.55).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":919,"document":"38320541","golden":false,"offsetInEndSection":1023,"text":"The point-of-care CRP correlated well with standard CRP (r \u003d 0.8001, 95% CI: 0.706 - 0.867, p \u003c 0.0001).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1323,"document":"38320541","golden":false,"offsetInEndSection":1489,"text":"The mean time for point-of-care estimation of IL-6, PCT, and CRP was 12 ? 3 minutes which was significantly less compared to 366 ? 61 minutes for standard techniques.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38320541","golden":false,"offsetInEndSection":181,"text":"Diagnostic Accuracy of Point-Of-Care Testing of C-Reactive Protein, Interleukin-6, And Procalcitonin in Neonates with Clinically Suspected Sepsis: A Prospective Observational Study.","beginSection":"title"}],"exact_answer":[],"ideal_answer":["The most common diagnostic tools in pediatric sepsis include traditional laboratory tests and emerging molecular techniques. Traditional methods encompass the measurement of C-reactive protein (CRP), erythrocyte sedimentation rate, total leukocyte count, absolute neutrophil count (ANC), the immature neutrophils to total neutrophil count ratio (I/T ratio), detection of thrombocytopenia, examination of degenerative changes in neutrophils, and gastric aspirate cytology (GAC) for polymorphs. The detection of CD64 on neutrophils has also been suggested as a useful marker for early detection. In addition to these, molecular diagnostic techniques, such as the LightCycler SeptiFast test and other real-time polymerase chain reaction (PCR) methods, are becoming more prevalent. These molecular tools can rapidly detect and identify bacterial and fungal DNA from a small volume of a single whole blood sample, covering a significant portion of pathogens responsible for bloodstream infections. These tests offer potential improvements in sensitivity and specificity over traditional methods, facilitating early and precise intervention for newborns with sepsis.","The most common diagnostic tools in pediatric sepsis include a mix of laboratory tests and advanced molecular techniques. C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), total leukocyte count (TLC), absolute neutrophil count (ANC), the immature to total neutrophil count ratio (I/T ratio), thrombocytopenia, and degenerative changes in neutrophils are routine laboratory tests used for the diagnosis. Gastric aspirate cytology (GAC) for the presence of polymorphs is also employed. Advanced tools involve real-time PCR tests such as the LightCycler SeptiFast test, which can detect and identify the 25 most important bacterial and fungal species causing bloodstream infections with a high degree of speed and accuracy. Neutrophil CD64 expression is an emerging marker for early detection of neonatal sepsis. Biomarkers like procalcitonin and neopterin have also shown promise, comparable to traditional markers, in diagnosing sepsis in critically ill patients. These diagnostic tools are essential for the early and accurate identification of sepsis, which is crucial for timely treatment and to prevent severe complications in neonates."],"id":"65845d5106a2ea257c00000a","type":"list","body":"Which are the most common diagnostic tools in paediatric sepsis?"},{"documents":[{"golden":false,"id":"7852082"},{"golden":false,"id":"9199429"},{"golden":false,"id":"1865052"},{"golden":false,"id":"18205806"},{"golden":false,"id":"6181193"},{"golden":false,"id":"33826899"},{"golden":false,"id":"14747701"},{"golden":true,"id":"37995654"},{"golden":true,"id":"37995657"},{"golden":false,"id":"4509307"},{"golden":false,"id":"2384148"},{"golden":false,"id":"28438975"},{"golden":false,"id":"3478677"},{"golden":false,"id":"10619701"},{"golden":false,"id":"22762789"},{"golden":false,"id":"12117932"},{"golden":false,"id":"8579825"},{"golden":false,"id":"2230123"},{"golden":false,"id":"15561843"},{"golden":false,"id":"1835379"},{"golden":false,"id":"3539183"},{"golden":false,"id":"1688436"},{"golden":false,"id":"31909741"},{"golden":false,"id":"1872464"},{"golden":true,"id":"38211562"},{"golden":false,"id":"1684551"},{"golden":false,"id":"23357627"},{"golden":false,"id":"36755116"},{"golden":false,"id":"25679492"},{"golden":false,"id":"27702565"},{"golden":false,"id":"3479983"},{"golden":false,"id":"32938252"},{"golden":false,"id":"7852423"},{"golden":false,"id":"26191060"},{"golden":false,"id":"3549294"},{"golden":false,"id":"3181151"},{"golden":false,"id":"28994126"},{"golden":false,"id":"10794415"},{"golden":false,"id":"3303059"},{"golden":false,"id":"3261606"},{"golden":false,"id":"2981503"},{"golden":true,"id":"6330075"},{"golden":false,"id":"9989609"},{"golden":false,"id":"3297748"},{"golden":false,"id":"19175361"},{"golden":false,"id":"18199287"},{"golden":false,"id":"18616923"},{"golden":false,"id":"6338929"},{"golden":false,"id":"11119502"},{"golden":false,"id":"23838186"},{"golden":false,"id":"15645082"},{"golden":false,"id":"1009932"},{"golden":false,"id":"823980"},{"golden":false,"id":"2669780"},{"golden":false,"id":"2540826"},{"golden":false,"id":"22834801"},{"golden":false,"id":"3015963"},{"golden":false,"id":"24662805"},{"golden":false,"id":"33833764"},{"golden":false,"id":"3207709"},{"golden":false,"id":"18576947"},{"golden":false,"id":"12240402"},{"golden":false,"id":"1554327"},{"golden":false,"id":"37715440"},{"golden":false,"id":"37237805"},{"golden":false,"id":"36869686"},{"golden":false,"id":"36108248"},{"golden":false,"id":"35779771"},{"golden":false,"id":"34451382"},{"golden":false,"id":"33096770"},{"golden":false,"id":"31709935"},{"golden":false,"id":"29410678"},{"golden":false,"id":"25448593"},{"golden":false,"id":"25395204"},{"golden":false,"id":"19603307"},{"golden":false,"id":"19492109"},{"golden":false,"id":"18852246"},{"golden":false,"id":"29709480"},{"golden":false,"id":"2068086"},{"golden":false,"id":"23970550"},{"golden":false,"id":"6339492"},{"golden":false,"id":"3514639"},{"golden":false,"id":"1846094"},{"golden":false,"id":"11004534"},{"golden":false,"id":"10744958"},{"golden":false,"id":"7025918"},{"golden":false,"id":"16516230"},{"golden":false,"id":"11447146"},{"golden":false,"id":"1718414"},{"golden":false,"id":"2054869"},{"golden":false,"id":"6354136"},{"golden":false,"id":"38333691"},{"golden":true,"id":"38289950"},{"golden":false,"id":"36364988"},{"golden":false,"id":"28351512"},{"golden":false,"id":"2430050"},{"golden":false,"id":"6196439"},{"golden":false,"id":"8784206"},{"golden":false,"id":"8798975"},{"golden":false,"id":"22139017"},{"golden":false,"id":"6427601"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":1579,"document":"28994126","golden":false,"offsetInEndSection":1735,"text":" function indicative of a leaky barrier. A reduction in IL-6 levels suggests that the mucosal immunity is impaired by this protease and thus has the potenti","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":106,"document":"37995654","golden":true,"offsetInEndSection":222,"text":"identify a V8 protease released by Staphylococcus aureus triggering itch via neuronal protease-activated receptor 1.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"18205806","golden":false,"offsetInEndSection":101,"text":"Staphylococcus aureus infection triggers production of neutralizing, V8 protease-specific antibodies.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1233,"document":"18205806","golden":false,"offsetInEndSection":1436,"text":"It was concluded that exposure to Staphylococcus aureus, in addition to a massive polyclonal B-cell response, gives rise to production of exoprotease-specific antibodies displaying functional properties.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"3303059","golden":false,"offsetInEndSection":293,"text":"The Glu(30)-Arg(31) peptide bond of alpha-chain of hemoglobin is readily and quantitatively hydrolyzed by Staphylococcus Aureus V8-protease at pH 4.0 and 37 degrees C. This region of the alpha-chain represents a \u0027permissible discontinuity region\u0027 of the chain within its tertiary interactions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":971,"document":"18205806","golden":false,"offsetInEndSection":1105,"text":"In contrast, strains expressing the V8-protease elicited V8-protease antibodies, proving the antigen-specific nature of this response.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":630,"document":"18205806","golden":false,"offsetInEndSection":856,"text":"Polyclonal activation was manifested by increased levels of total serum IgG and IgM in all infected animals and by antibodies to staphylococcal toxins and aureolysin whether these antigens were present in the inoculate or not.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":71,"document":"18205806","golden":false,"offsetInEndSection":244,"text":"It was sought to further characterize the hypergammaglobulinemia seen in Staphylococcus aureus infection, focusing on the significance of protease-specific B-cell responses.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":857,"document":"18205806","golden":false,"offsetInEndSection":970,"text":"Importantly, Staphylococcus aureus mutant lacking the V8-protease did not trigger a response against this enzyme.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"18205806","golden":false,"offsetInEndSection":70,"text":"Staphylococcus aureus infection triggers polyclonal B-cell activation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":106,"document":"15561843","golden":false,"offsetInEndSection":322,"text":"In this study we examined the susceptibility of LL-37 to proteolytic degradation by two major proteinases produced by Staphylococcus aureus, a metalloproteinase (aureolysin) and a glutamylendopeptidase (V8 protease).","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37995657","golden":true,"offsetInEndSection":86,"text":"S.?aureus drives itch and scratch-induced skin damage through a V8 protease-PAR1 axis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37995654","golden":false,"offsetInEndSection":70,"text":"Itch exacerbates infection and inflammation-associated skin pathology.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"3539183","golden":false,"offsetInEndSection":149,"text":"Generation of a fragment-complementing system of the alpha-chain on limited proteolysis with Staphylococcus aureus V8 protease has been investigated.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":39,"document":"38211562","golden":true,"offsetInEndSection":165,"text":"show that S.?aureus serine protease V8 triggers itch, independent of inflammation, by activating sensory neurons through PAR1.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1552,"document":"32938252","golden":false,"offsetInEndSection":1801,"text":"S. epidermidis Esp protease and its homologue in S. aureus caused similar ocular pathology when injected in the rabbit corneal stroma.CONCLUSION: Hemolysins and proteases seem to be important in corneal pathology caused by S. epidermidis infections.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1318,"document":"25679492","golden":false,"offsetInEndSection":1489,"text":"The staphylococcal protease V8, on the other hand, readily catalyzed degradation of the microspheres, thus releasing the drug when triggered by the infectious environment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23357627","golden":false,"offsetInEndSection":121,"text":"Endoproteinase GluC (V8 protease) is one of many virulence factors released by the Staphylococcus aureus species in vivo.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"1684551","golden":false,"offsetInEndSection":164,"text":"Fragmentation of proteins by S. aureus strain V8 protease. Ammonium bicarbonate strongly inhibits the enzyme but does not improve the selectivity for glutamic acid.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"1684551","golden":false,"offsetInEndSection":131,"text":"Staphylococcus aureus strain V8 protease is a serine endopeptidase which cleaves peptide bonds at the carboxyl side of Glu and Asp.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":863,"document":"32938252","golden":false,"offsetInEndSection":1103,"text":"The corneal pathology of the S. epidermidis protease was compared to the pathology of S. aureus V8 protease.RESULTS: Strains that exhibited the least protease activity in vitro caused significantly less ocular pathology in vivo (p???0.003).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":216,"document":"28994126","golden":false,"offsetInEndSection":707,"text":"Extracellular proteases secreted by S. aureus are thought to be important in epithelial infection and immune evasion; however, their effect on airway mucosal barrier function is not known.METHODS: To investigate the impact of extracellular proteases on airway epithelial integrity, the purified S. aureus proteases V8 protease, Staphopain A, Staphopain B, Exfoliative toxin A, and serine protease-like A-F were applied to human nasal epithelial cell air-liquid interface (HNEC-ALI) cultures.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1187,"document":"3303059","golden":false,"offsetInEndSection":1360,"text":"Thus, the amount of Glu(30)-Arg(31) peptide bond formed in 48 hrs appears to be the result of an equilibrium in the V8-protease catalyzed hydrolytic and synthetic reactions.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"3303059","golden":false,"offsetInEndSection":174,"text":"Staphylococcus aureus V8-protease catalyzed segment exchange reaction of alpha-chain of hemoglobin S: a semisynthetic approach for the preparation of variants of alpha-chain.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":785,"document":"3303059","golden":false,"offsetInEndSection":1083,"text":"V8-protease catalyzed the condensation of N alpha-DHP-alpha 1-30 and alpha 31-141 to generate N alpha-DHP-alpha 1 141 in the presence of 30% propanol at pH 6.0 and 4 degrees C. The synthetic yield of N alpha-DHP-alpha 1-141 is about 55% in 48 hrs and remained nearly the same even after seven days.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2183,"document":"3303059","golden":false,"offsetInEndSection":2389,"text":"This V8-protease catalyzed \u0027segment exchange reaction\u0027 should facilitate the preparation of alpha-chains with double mutations from the large number of naturally occurring alpha-chains with single mutation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"10794415","golden":false,"offsetInEndSection":268,"text":"We report an enigmatic peptide ligation reaction catalyzed by Glu-specific Staphylococcus aureus V8 protease that occurs in neat aqueous solution around neutral pH utilizing a totally unprotected peptide substrate containing free alpha-carboxyl and alpha-amino groups.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1946,"document":"3303059","golden":false,"offsetInEndSection":2182,"text":"Incubation of [14C]-N alpha-DHP-alpha 1-30 with alpha-globin at pH 6.0 and 4 degrees C along with V8-protease in 30% n-propanol indeed resulted in the exchange of the segment alpha 1-30 of alpha-globin with [14C]-N alpha-DHP-alpha 1-30.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1665,"document":"3303059","golden":false,"offsetInEndSection":1945,"text":"The high selectivity in the protease catalyzed formation of Glu(30)-Arg(31) peptide bond suggests that the segment alpha 1-30 of the intact alpha-globin could be exchanged with synthetic analogs of alpha 1-30 using V8-protease without actually isolating the fragment alpha 31-141.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":405,"document":"1684551","golden":false,"offsetInEndSection":535,"text":"The degradation of a mixture of oxidized insulin and glucagon proceeds similarly in the two buffers, although faster in phosphate.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":281,"document":"1684551","golden":false,"offsetInEndSection":404,"text":"However, it is shown here that bicarbonate does not restrict the specificity to Glu-X bonds, it simply inhibits the enzyme.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":132,"document":"1684551","golden":false,"offsetInEndSection":280,"text":"Specific cleavage at Glu has previously been achieved in ammonium bicarbonate whereas in sodium phosphate cleavage at both Glu and Asp was observed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":160,"document":"2981503","golden":false,"offsetInEndSection":406,"text":"Unliganded CRP is relatively resistant to attack by a variety of proteases (trypsin, subtilisin, Staphylococcus aureus V8 protease, clostripain, chymotrypsin) which cleave cAMP-CRP, producing N-terminal cores which have lost DNA binding activity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":252,"document":"36755116","golden":false,"offsetInEndSection":379,"text":"S. aureus secretes extracellular proteases, such as V8 (or \u0027SspA\u0027), which cleave extracellular proteins to reduce skin barrier.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":347,"document":"6330075","golden":false,"offsetInEndSection":506,"text":"These were identified using the properties of the Staphylococcus aureus V8 protease which cleaves peptide bonds following glutamyl but not glutaminyl residues.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":185,"document":"3297748","golden":false,"offsetInEndSection":379,"text":"Proteolytic digestion of RPE cells by pronase, thermolysin and Staphylococcus aureus V8 protease (V8 protease) inhibited the phagocytosis of ROS without affecting the viability of the RPE cells.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"9989609","golden":false,"offsetInEndSection":245,"text":"In this paper the universal validity of the substrate mimetic concept in enzymatic C-N ligations was expanded to anionic leaving groups based on the specificity determinants of Glu-specific endopeptidase from Staphylococcus aureus (V8 protease).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":98,"document":"15645082","golden":false,"offsetInEndSection":227,"text":"The P7 protein was digested partially or completely by Staphylococcus aureus V8 protease and/or Pseudomonas fragi Asp-N protease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":613,"document":"6330075","golden":false,"offsetInEndSection":832,"text":"A comparison of the fragments obtained after V8 protease cleavage of methyl-esterified (or deaminated) peptides with the fragments from the corresponding unmodified peptides immediately yields the sites of modification.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1381,"document":"11119502","golden":false,"offsetInEndSection":1604,"text":"Therefore, we conclude that SspA is required for maturation of SspB and plays a role in controlling autolytic activity but does not by itself exert a significant contribution to the development of tissue abscess infections.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1146,"document":"6330075","golden":false,"offsetInEndSection":1305,"text":"All four sites occupy analogous positions in a well-conserved arrangement of residues which may form a binding site for the esterase and the methyltransferase.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":732,"document":"23838186","golden":false,"offsetInEndSection":1004,"text":"Incubation of human serum with the cysteine proteases staphopain A and staphopain B, the serine protease V8 and the metalloproteinase Aur resulted in a drastic decrease in the hemolytic activity of serum, whereas two staphylococcal serine proteases D and E, had no effect.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":833,"document":"6330075","golden":false,"offsetInEndSection":1065,"text":"Three of the four methyl-esterified glutamyl residues are located near the middle of the receptor amino acid sequence; one of these is synthesized as a glutaminyl residue and is deaminated by the esterase to form a glutamyl residue.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1066,"document":"6330075","golden":false,"offsetInEndSection":1145,"text":"The fourth site of methyl esterification is located near the carboxyl terminus.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":348,"document":"2540826","golden":false,"offsetInEndSection":540,"text":"which had histone H1 removed, were digested with Staphylococcus aureus (V8 strain) protease which cleaves specifically on the carboxyl side of glutamic acid residues under the conditions used.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"11119502","golden":false,"offsetInEndSection":286,"text":"Signature tagged mutagenesis has recently revealed that the Ssp serine protease (V8 protease) contributes to in vivo growth and survival of Staphylococcus aureus in different infection models, and our previous work indicated that Ssp could play a role in controlling microbial adhesion.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":273,"document":"1009932","golden":false,"offsetInEndSection":398,"text":"The molecule has been enzymically cleaved by trypsin, thermolysin and by the protease of the Staphylococcus aureus strain V8.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":886,"document":"11119502","golden":false,"offsetInEndSection":1073,"text":"Although the 40-kDa SspB protein could degrade denatured collagen, our data establish that this is a precursor form which is normally processed by SspA to form a mature cysteine protease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":486,"document":"2669780","golden":false,"offsetInEndSection":623,"text":"After proteolytic treatment of labeled D-1 protein with Staphylococcus aureus V8-protease two major and two minor fragments are obtained.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1210,"document":"11119502","golden":false,"offsetInEndSection":1380,"text":"Although nonpolar inactivation of sspA exerted a pleiotropic effect, S. aureus SP6391 exhibited enhanced virulence in a tissue abscess infection model relative to RN6390.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":722,"document":"11119502","golden":false,"offsetInEndSection":885,"text":"In addition to losing SspA, the culture supernatant of SP6391 showed a loss of 22- to 23-kDa proteins and the appearance of a 40-kDa protein corresponding to SspB.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":721,"document":"18616923","golden":false,"offsetInEndSection":923,"text":"As a result, the recovery of GluV8 proform was enhanced to 20 fg/cell, which was comparable to the level of a constitutive inactive form of GluV8, indicating complete suppression of the autoproteolysis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":833,"document":"22834801","golden":false,"offsetInEndSection":983,"text":"We showed that the Glu-C protease produced by S. aureus V8 induces the loss of the AMPs antibacterial activities and produces new antifungal peptides.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":221,"document":"24662805","golden":false,"offsetInEndSection":549,"text":"We here examined antibody production and skin barrier dysfunction in mice epicutaneously administered papain, a plant-derived occupational allergen belonging to the same family of cysteine proteases as mite major group 1 allergens.METHODS: Papain and Staphylococcus aureus V8 protease were patched on the backs of hairless mice.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1264,"document":"24662805","golden":false,"offsetInEndSection":1560,"text":"IgG1 was the most significantly induced papain-specific IgG subclass among those measured.CONCLUSIONS: We demonstrated that the epicutaneous administration of protease not only disrupted skin barrier function, but also induced IgE and IgG responses in a manner dependent on its protease activity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":984,"document":"22834801","golden":false,"offsetInEndSection":1265,"text":"In addition, four antimicrobial CGA-derived peptides (chromofungin, procatestatin, human/bovine catestatin) are degraded when treated with bacterial supernatants from S. aureus and S. enteritis, whereas, cateslytin, the short active form of catestatin, resists to this degradation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":358,"document":"3015963","golden":false,"offsetInEndSection":650,"text":"Incubation of native nitrate reductase with either trypsin, Staphylococcus aureus V8 protease, or a natural inactivator protease from corn results in a loss of NADH:nitrate reductase and NADH:cytochrome c reductase activities but no loss of reduced methyl viologen:nitrate reductase activity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":680,"document":"22834801","golden":false,"offsetInEndSection":832,"text":"We investigated here the effects of S. aureus and S. enteritis bacterial proteases on CgA-derived peptides and evaluated their antimicrobial activities.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1266,"document":"22834801","golden":false,"offsetInEndSection":1455,"text":"Finally, we demonstrate that several antimicrobial CgA-derived peptides are able to act synergistically with antibiotics against bacteria and fungi indicating their roles in innate defense.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":585,"document":"22834801","golden":false,"offsetInEndSection":679,"text":"Staphylococcus aureus and Salmonella enteritis are bacteria responsible for severe infections.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":314,"document":"22834801","golden":false,"offsetInEndSection":584,"text":"These AMPs can also penetrate quickly into neutrophils (without lytic effects), where, similarly to \"cell penetrating peptides\", they interact with cytoplasmic calmodulin, and induce calcium influx via Store Operated Channels therefore triggering neutrophils activation.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"9989609","golden":false,"offsetInEndSection":154,"text":"Programming of enzyme specificity by substrate mimetics: investigations on the Glu-specific V8 protease reveals a novel general principle of biocatalysis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":358,"document":"9989609","golden":false,"offsetInEndSection":529,"text":"The general function of the newly developed substrate mimetics to serve as an artificial recognition site for V8 protease have been examined by hydrolysis kinetic studies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":530,"document":"9989609","golden":false,"offsetInEndSection":758,"text":"Enzymatic peptide syntheses qualify the strategy of substrate mimetics as a powerful concept for programming the enzyme specificity in the direction of a more universal application of enzymes in the general area of biocatalysis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"12240402","golden":false,"offsetInEndSection":297,"text":"A biocatalytic route to the \u0027post-synthesis\u0027 formation of Asp/Glu-derived isopeptides is illustrated on the basis of the Staphylococcus aureus V8 protease used as the biocatalyst, a new type of substrate mimetics as the donor peptides, and several acceptor peptides varying in length and sequence.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"3207709","golden":false,"offsetInEndSection":222,"text":"The complete amino acid sequence of thioesterase domain of chicken liver fatty acid synthase has been determined by sequencing peptides produced by trypsin, Staphylococcus aureus V8 protease, and cyanogen bromide cleavage.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":246,"document":"9989609","golden":false,"offsetInEndSection":357,"text":"In an empirical way a specific mimetic moiety was designed from simple structure-function relationship studies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":384,"document":"1554327","golden":false,"offsetInEndSection":570,"text":"MTg was treated with Staphylococcus aureus V8 protease followed by separation of the fragments into 6 fractions (Fr1-Fr6: 264,000-17,000) by high performance liquid chromatography (HPLC)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":177,"document":"1554327","golden":false,"offsetInEndSection":383,"text":"To elucidate the regulation mechanism of autoimmune response to Tg in low responder mice, we studied the proliferative response of lymph node cells (LNC) to mouse Tg (MTg) and enzyme-digested MTg fragments.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1076,"document":"1554327","golden":false,"offsetInEndSection":1311,"text":"These findings suggest that T cells which are capable of responding to Tg do exist even in low responder mice and that the activation of these autoreactive T cells is suppressed by a regulatory cell subpopulation in low responder mice.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37715440","golden":false,"offsetInEndSection":83,"text":"Due to its rising prevalence, first-trimester miscarriage is getting more attention","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37237805","golden":false,"offsetInEndSection":60,"text":"Virulence factor expression is integral to pathogenicity of ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36869686","golden":false,"offsetInEndSection":63,"text":"Chronic wound healing is often negatively impacted by infection","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36108248","golden":false,"offsetInEndSection":32,"text":"Seven new gilvocarcin-type aryl-","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35779771","golden":false,"offsetInEndSection":132,"text":"Nanozymes are effective antibiotics that use reactive oxygen species (ROS) produced by Fenton/Fenton-like reactions to kill bacteria","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34451382","golden":false,"offsetInEndSection":138,"text":"In this study, we compared pulsed-field gel electrophoretic (PFGE), multilocus sequence typing (MLST), Staphylococcal cassette chromosome ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":547,"document":"33096770","golden":false,"offsetInEndSection":634,"text":"Herein, we screened for bioactive compounds from the venom of the Egyptian black snake ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2024,"document":"31709935","golden":false,"offsetInEndSection":2288,"text":"Subtype A (17.9%; 5/28), CRF02_AG (14.3%; 4/28), subtype C (10.7%; 3/28), B+CRF02_AG recombinant (3.6%; 1/28), CRF01_AE (3.6%; 1/28), subtype D (3.6%; 1/28), as well as subtype F (3.6%; 1/28) and subtype G (3.6%; 1/28) strains were also detected in the circulation","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":887,"document":"29410678","golden":false,"offsetInEndSection":1018,"text":"from the positive fraction by cation exchange and identified the bioactive peptide by secondary screening. The peptide sequence was","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":932,"document":"25448593","golden":false,"offsetInEndSection":1059,"text":"The N-terminus contains a solubilization domain which is cleaved by V8 protease, avoiding additional residues at the N-terminus","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1039,"document":"25395204","golden":false,"offsetInEndSection":1201,"text":"Rapid and efficient on-plate reactions were performed to achieve high sequence coverage of model proteins, particularly when performing multiple enzyme digestions","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":322,"document":"19603307","golden":false,"offsetInEndSection":435,"text":"To evaluate this hypothesis, the activity of several endo-proteases on the 22 kDa hGH protein has been evaluated.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":594,"document":"19492109","golden":false,"offsetInEndSection":769,"text":"In contrast, the bacterial V8 proteinase-induced cleavage of the reactive center loop of BMFC-labeled alpha(1)-AT did not generate any significant change in the Cys-232 region","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"18852246","golden":false,"offsetInEndSection":117,"text":"MgrA is a pleiotropic regulator that controls autolysis, virulence, and efflux pump activity in Staphylococcus aureus","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":447,"document":"29709480","golden":false,"offsetInEndSection":582,"text":"This study measured the elastic modulus of LDLs before and after enzyme treatment with V8 protease, ?-chymotrypsin, and phospholipase A","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":894,"document":"2068086","golden":false,"offsetInEndSection":993,"text":"These results show the existence of a highly specific, uniquely reactive hemin binding site on FRP.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":715,"document":"23970550","golden":false,"offsetInEndSection":903,"text":"Thus, S. aureus biofilms are formed via the controlled secretion and proteolysis of autolysin, and this developmental program appears to be perturbed by the Esp protease of S. epidermidis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":775,"document":"2068086","golden":false,"offsetInEndSection":893,"text":"Exhaustive digestion of the complex with Staphylococcus aureus V8 protease produced a major labeled peptide of 17 kDa.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":208,"document":"3514639","golden":false,"offsetInEndSection":419,"text":"Limited proteolysis of the alpha-chain of hemoglobin S with Staphylococcus aureus V8-protease converts the chain into a fragment-complementing system by hydrolyzing the peptide bond Glu(30)-Arg(31) of the chain.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":848,"document":"11004534","golden":false,"offsetInEndSection":1026,"text":"The results clarify the newly developed substrate mimetics as efficient acyl donors as well as BL-GSE as an attractive alternative to V8 protease for enzymatic peptide synthesis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"2068086","golden":false,"offsetInEndSection":191,"text":"Incubation of a 90-kDa ferritin repressor protein (FRP) with small amounts of radiolabeled hemin resulted in the formation of a strong interaction between the two that was stable to SDS/PAGE.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"2068086","golden":false,"offsetInEndSection":82,"text":"Crosslinking of hemin to a specific site on the 90-kDa ferritin repressor protein.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":570,"document":"2068086","golden":false,"offsetInEndSection":677,"text":"Inclusion of catalase did not prevent the reaction of hemin with FRP, suggesting that H2O2 is not involved.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":461,"document":"2068086","golden":false,"offsetInEndSection":569,"text":"[14C]Hemin specifically crosslinked to FRP in the presence of a 50-fold excess of total wheat germ proteins.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":678,"document":"2068086","golden":false,"offsetInEndSection":774,"text":"The subsequent addition of a stoichiometric amount of apohemopexin did not reverse the reaction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1533,"document":"1718414","golden":false,"offsetInEndSection":1788,"text":"The cleavage patterns of membrane-bound porin, obtained with S. aureus V8 protease, trypsin, and chymotrypsin, showed no difference between intact and broken mitochondria, thus indicating that all porin molecules have the same orientation in the membrane.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"6354136","golden":false,"offsetInEndSection":144,"text":"The 75K glycoprotein of the A2 strain of respiratory syncytial virus was cleaved by digestion with trypsin or Staphylococcus aureus protease V8.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":159,"document":"11447146","golden":false,"offsetInEndSection":608,"text":"We have found that in sarA mutant cells, which produce high amounts of four major extracellular proteases (staphylococcal serine protease [V8 protease] [SspA], cysteine protease [SspB], aureolysin [metalloprotease] [Aur], and staphopain [Scp]), the levels of cell-bound fibronectin-binding proteins (FnBPs) and protein A were very low compared to those of wild-type cells, in spite of unaltered or increased transcription of the corresponding genes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":292,"document":"38333691","golden":false,"offsetInEndSection":564,"text":"Using liquid chromatography with tandem mass spectrometry, we characterized the peptidome of plasma and acute wound fluids digested ex?vivo with human (neutrophil elastase and cathepsin G) and bacterial proteases (Pseudomonas aeruginosa LasB and Staphyloccocus aureus V8).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":686,"document":"38333691","golden":false,"offsetInEndSection":826,"text":"Moreover, we found unique peptide regions in V8 digested samples that were also present in dressing extracts from S.?aureus infected wounds.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":827,"document":"38333691","golden":false,"offsetInEndSection":1038,"text":"Finally, the work indicates that peptidomic analysis of qualitative differences of proteolytic activity of individual enzymes may aid in the discovery of potential diagnostic biomarkers for wound healing status.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":88,"document":"38333691","golden":false,"offsetInEndSection":291,"text":"Analysis of alterations in the low-molecular-weight peptidome by individual enzymes could therefore provide insight into proteolytic events occurring in wounds and may aid in the discovery of biomarkers.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":786,"document":"10744958","golden":false,"offsetInEndSection":1007,"text":"This study showed that SDS permitted a dramatic improvement in the hydrolysis of whole haemoglobin by V8 protease in both homogeneous-phase and solid phase systems after adsorption of haemoglobin on to an anionic support.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38289950","golden":true,"offsetInEndSection":78,"text":"Staphylococcus aureus proteases trigger eosinophil-mediated skin inflammation.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38333691","golden":false,"offsetInEndSection":87,"text":"Endogenous and bacterial proteases play important roles in wound healing and infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":978,"document":"18852246","golden":false,"offsetInEndSection":1083,"text":"However, the SarA-mediated effect is independent of agr and proteases such as V8 protease and aureolysin.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23970550","golden":false,"offsetInEndSection":141,"text":"Staphylococcus epidermidis, a commensal of humans, secretes Esp protease to prevent Staphylococcus aureus biofilm formation and colonization.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"23970550","golden":false,"offsetInEndSection":86,"text":"Secreted proteases control autolysin-mediated biofilm growth of Staphylococcus aureus.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":142,"document":"23970550","golden":false,"offsetInEndSection":296,"text":"Blocking S. aureus colonization may reduce the incidence of invasive infectious diseases; however, the mechanism whereby Esp disrupts biofilms is unknown.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":603,"document":"23970550","golden":false,"offsetInEndSection":714,"text":"Both atl and sspA are necessary for biofilm formation, and purified SspA cleaves Atl-derived murein hydrolases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1377,"document":"1846094","golden":false,"offsetInEndSection":1510,"text":"Under these experimental conditions, identical peptide fragments were generated by both Staphylococcus aureus V8 protease and papain.","beginSection":"abstract"}],"ideal_answer":[" Staphylococcus aureus serine protease V8 triggers itch.\n","The body\u0027s response to Staphylococcus aureus V8 protease involves itch and scratch-induced skin damage through activation of sensory neurons via PAR1, leading to an itching sensation that is not associated with inflammation."," The activation of neuronal protease-activated receptor 1 (PAR1) by V8 protease causes itch.\n"," Staphylococcus aureus protease V8 triggers itch and damage to skin by activating PAR1 in sensory neurons.\n"],"id":"659846c206a2ea257c00003a","type":"summary","body":"What is the reaction of the body to Staphylococcus aureus V8 protease?"},{"documents":[{"golden":true,"id":"33392485"},{"golden":true,"id":"34650089"},{"golden":true,"id":"34248993"},{"golden":true,"id":"37647441"},{"golden":false,"id":"33083031"},{"golden":false,"id":"34282417"},{"golden":true,"id":"34253420"},{"golden":false,"id":"33551672"},{"golden":false,"id":"34208061"},{"golden":false,"id":"32376359"},{"golden":false,"id":"33362278"},{"golden":false,"id":"34192262"},{"golden":false,"id":"37252854"},{"golden":false,"id":"34742639"},{"golden":false,"id":"33006053"},{"golden":false,"id":"35191815"},{"golden":false,"id":"32295479"},{"golden":false,"id":"33469510"},{"golden":false,"id":"33758865"},{"golden":false,"id":"33731300"},{"golden":false,"id":"33715598"},{"golden":false,"id":"35906244"},{"golden":false,"id":"36287714"},{"golden":false,"id":"37404819"},{"golden":false,"id":"33875658"},{"golden":false,"id":"37993332"},{"golden":false,"id":"37355212"},{"golden":false,"id":"33754147"},{"golden":false,"id":"33532770"},{"golden":false,"id":"35061975"},{"golden":false,"id":"36118203"},{"golden":false,"id":"33192207"},{"golden":false,"id":"32793875"},{"golden":false,"id":"32461973"},{"golden":true,"id":"35428500"},{"golden":false,"id":"35079784"},{"golden":false,"id":"33034449"},{"golden":false,"id":"34604818"},{"golden":true,"id":"32433465"},{"golden":false,"id":"36995507"},{"golden":false,"id":"35214708"},{"golden":false,"id":"35058587"},{"golden":false,"id":"36678486"},{"golden":false,"id":"35214693"},{"golden":false,"id":"35533563"},{"golden":false,"id":"35085851"},{"golden":false,"id":"32854391"},{"golden":false,"id":"32991223"},{"golden":false,"id":"36351479"},{"golden":false,"id":"34124612"},{"golden":false,"id":"36371432"},{"golden":false,"id":"37796985"},{"golden":false,"id":"33649323"},{"golden":false,"id":"36689221"},{"golden":false,"id":"38140142"},{"golden":false,"id":"32669664"},{"golden":false,"id":"32901214"},{"golden":false,"id":"36130677"},{"golden":false,"id":"35349744"},{"golden":false,"id":"34493582"},{"golden":false,"id":"34239977"},{"golden":false,"id":"33067570"},{"golden":false,"id":"33930707"},{"golden":false,"id":"36698045"},{"golden":false,"id":"35765543"},{"golden":false,"id":"33435774"},{"golden":false,"id":"38040905"},{"golden":false,"id":"36569867"},{"golden":false,"id":"32743571"},{"golden":false,"id":"32795413"},{"golden":false,"id":"26222896"},{"golden":false,"id":"35900097"},{"golden":false,"id":"36993692"},{"golden":false,"id":"38012018"},{"golden":false,"id":"32690628"},{"golden":false,"id":"34043618"},{"golden":false,"id":"33688647"},{"golden":false,"id":"35884770"},{"golden":false,"id":"35998134"},{"golden":false,"id":"33247109"},{"golden":false,"id":"33083026"},{"golden":false,"id":"37093307"},{"golden":false,"id":"34707161"},{"golden":false,"id":"36882925"},{"golden":false,"id":"38034565"},{"golden":false,"id":"33424848"},{"golden":false,"id":"33440895"},{"golden":false,"id":"32701395"},{"golden":false,"id":"34856868"},{"golden":false,"id":"34516531"},{"golden":false,"id":"35170403"},{"golden":false,"id":"34659259"},{"golden":false,"id":"34801965"},{"golden":false,"id":"34354082"},{"golden":false,"id":"37551403"},{"golden":false,"id":"32784685"},{"golden":false,"id":"30891607"},{"golden":false,"id":"38193729"},{"golden":false,"id":"35171046"},{"golden":false,"id":"34108961"},{"golden":false,"id":"33419184"},{"golden":false,"id":"36505475"},{"golden":false,"id":"33895322"},{"golden":false,"id":"37909745"},{"golden":false,"id":"33501447"},{"golden":false,"id":"34275860"},{"golden":false,"id":"33123165"},{"golden":false,"id":"33262931"},{"golden":false,"id":"33178026"},{"golden":false,"id":"33429880"},{"golden":false,"id":"37874075"},{"golden":false,"id":"38304876"},{"golden":false,"id":"34120764"},{"golden":false,"id":"35206580"},{"golden":false,"id":"34162739"},{"golden":false,"id":"34315454"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":49,"document":"33392485","golden":true,"offsetInEndSection":347,"text":"gh urgency. Here the safety and immunogenicity induced by a DNA vaccine (INO-4800) targeting the full length spike antigen of SARS-CoV-2 are described.METHODS: INO-4800 was evaluated in two groups of 20 participants, receiving either 1.0?mg or 2.0?mg of vaccine intradermally followed by CELLECTRA?","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1061,"document":"34248993","golden":true,"offsetInEndSection":1315,"text":"The results confirm that the vaccine-induced neutralising antibodies generated by INO-4800 remain effective against current variants-of-concern, albeit with lower neutralisation titres against 501Y.V2 similar to other leading nucleic acid-based vaccines.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34650089","golden":true,"offsetInEndSection":108,"text":"INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":599,"document":"35428500","golden":true,"offsetInEndSection":879,"text":"re, we evaluated the immunogenicity of INO-4800, our synthetic DNA vaccine candidate for COVID-19 currently in clinical evaluation, and INO-4802, a next-generation DNA vaccine designed to broadly target emerging SARS-CoV-2 variants, as booster vaccines in nonhuman primates. Rhesu","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":916,"document":"32433465","golden":true,"offsetInEndSection":1043,"text":"This preliminary dataset identifies INO-4800 as a potential COVID-19 vaccine candidate, supporting further translational study.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":243,"document":"37647441","golden":true,"offsetInEndSection":496,"text":"Among the vaccines that stimulate the host\u0027s immune system with the help of DNA are: undergoing Phase 2/3 trials including INO-4800 (International Vaccine Institute; Inovio Pharmaceuticals), Symvivo, Canada-COVID19 (AnGes, Inc.); GX-19 (Genexine, Inc.).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":622,"document":"32433465","golden":true,"offsetInEndSection":915,"text":"Following immunization of mice and guinea pigs with INO-4800 we measure antigen-specific T cell responses, functional antibodies which neutralize the SARS-CoV-2 infection and block Spike protein binding to the ACE2 receptor, and biodistribution of SARS-CoV-2 targeting antibodies to the lungs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":530,"document":"32433465","golden":true,"offsetInEndSection":621,"text":"The engineered construct, INO-4800, results in robust expression of the S protein in vitro.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1599,"document":"33551672","golden":false,"offsetInEndSection":1747,"text":"mRNA-1273, ChAdOx1, Ad5-nCoV, INO-4800, LV-SMENP-DC and pathogen-specific aAPC are the most advanced and potential drug candidates against COVID-19.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":108,"document":"34253420","golden":true,"offsetInEndSection":307,"text":"Here, we assessed the safety, immunogenicity and efficacy of the intradermal delivery of INO-4800, a synthetic DNA vaccine candidate encoding the SARS-CoV-2 spike protein in the rhesus macaque model.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":407,"document":"32433465","golden":true,"offsetInEndSection":529,"text":"Here we build on this prior experience to generate a synthetic DNA-based vaccine candidate targeting SARS-CoV-2 S protein.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":995,"document":"35906244","golden":false,"offsetInEndSection":1080,"text":"MV-014-212 is currently in Phase 1 clinical trials as an intranasal COVID-19 vaccine.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":107,"document":"36287714","golden":false,"offsetInEndSection":591,"text":"We developed a novel subunit protein-peptide COVID-19 vaccine candidate (UB-612) composed of: (i) receptor binding domain of SARS-CoV-2 spike protein fused to a modified single-chain human IgG1 Fc; (ii) five synthetic peptides incorporating conserved helper and cytotoxic T lymphocyte (Th/CTL) epitopes derived from SARS-CoV-2 structural proteins (three from S2 subunit, one from membrane and one from nucleocapsid), and one universal Th peptide; (iii) aluminum phosphate as adjuvant.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":236,"document":"35906244","golden":false,"offsetInEndSection":436,"text":"Here we describe the COVID-19 vaccine candidate MV-014-212, a live, attenuated, recombinant human respiratory syncytial virus expressing a chimeric SARS-CoV-2 spike as the only viral envelope protein.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":528,"document":"33754147","golden":false,"offsetInEndSection":623,"text":"Here, we show the immunogenicity and protective efficacy of this vaccine in non-human primates.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":512,"document":"35906244","golden":false,"offsetInEndSection":676,"text":"One mucosal administration of MV-014-212 in AGMs protected against SARS-CoV-2 challenge, reducing by more than 200-fold the peak shedding of SARS-CoV-2 in the nose.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1241,"document":"36287714","golden":false,"offsetInEndSection":1438,"text":"UB-612 has been tested in primary regimens in Phase 1 and Phase 2 clinical studies and is currently being evaluated in a global pivotal Phase 3 clinical study as a single dose heterologous booster.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"35906244","golden":false,"offsetInEndSection":116,"text":"Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":865,"document":"35906244","golden":false,"offsetInEndSection":994,"text":"Intranasally delivered, live attenuated vaccines such as MV-014-212 entail low-cost manufacturing suitable for global deployment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37404819","golden":false,"offsetInEndSection":583,"text":"Introduction: While there has been considerable progress in the development of vaccines against SARS-CoV-2, largely based on the S (spike) protein of the virus, less progress has been made with vaccines delivering different viral antigens with cross-reactive potential.Methods: In an effort to develop an immunogen with the capacity to induce broad antigen presentation, we have designed a multi-patch synthetic candidate containing dominant and persistent B cell epitopes from conserved regions of SARS-CoV-2 structural proteins associated with long-term immunity, termed CoV2-BMEP.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":437,"document":"35906244","golden":false,"offsetInEndSection":511,"text":"MV-014-212 was attenuated and immunogenic in African green monkeys (AGMs).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1282,"document":"35428500","golden":false,"offsetInEndSection":1455,"text":"These data illustrate the durability of immunity following vaccination with INO-4800 and additionally support the use of either INO-4800 or INO-4802 in prime-boost regimens.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":597,"document":"35428500","golden":true,"offsetInEndSection":873,"text":"Here, we evaluated the immunogenicity of INO-4800, our synthetic DNA vaccine candidate for COVID-19 currently in clinical evaluation, and INO-4802, a next-generation DNA vaccine designed to broadly target emerging SARS-CoV-2 variants, as booster vaccines in nonhuman primates.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":874,"document":"32793875","golden":false,"offsetInEndSection":1031,"text":"In addition, this vaccine construct also takes the considerable glycan shield of the spike glycoprotein into account, which protects it from immune response.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":237,"document":"35079784","golden":false,"offsetInEndSection":553,"text":"We describe safety and durability of immune responses following 2 primary doses and a homologous booster dose of an investigational DNA vaccine (INO-4800) targeting full-length spike antigen.METHODS: Three dosage strengths of INO-4800 (0.5?mg, 1.0?mg, and 2.0?mg) were evaluated in 120 age-stratified healthy adults.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":842,"document":"33034449","golden":false,"offsetInEndSection":1196,"text":"As of August 11, 2020, 28 of these companies have advanced into clinical trials with Moderna, CanSino, the University of Oxford, BioNTech, Sinovac, Sinopharm, Anhui Zhifei Longcom, Inovio, Novavax, Vaxine, Zydus Cadila, Institute of Medical Biology, and the Gamaleya Research Institute having moved beyond their initial safety and immunogenicity studies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":272,"document":"34604818","golden":false,"offsetInEndSection":369,"text":")-delivered SARS-CoV-2 spike DNA vaccine, INO-4800, currently being evaluated in clinical trials.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":464,"document":"36995507","golden":false,"offsetInEndSection":652,"text":"Several DNA-based (ZyCoV-D, INO-4800, AG0302-COVID19, and GX-19N) and mRNA-based (BNT162b2, mRNA-1273, and ARCoV) approved vaccine platforms have been utilized for the COVID-19 prevention.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36995507","golden":false,"offsetInEndSection":83,"text":"Nucleic acid-based vaccine platforms against the coronavirus disease 19 (COVID-19).","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":240,"document":"36995507","golden":false,"offsetInEndSection":463,"text":"Nucleic acid-based vaccines consisting of mRNA and DNA vaccines (third-generation vaccines) have been promising in terms of rapid and convenient production and efficient provocation of immune responses against the COVID-19.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":145,"document":"36995507","golden":false,"offsetInEndSection":239,"text":"Enormous efforts have been made to develop fundamentally different COVID-19 vaccine platforms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":653,"document":"36995507","golden":false,"offsetInEndSection":729,"text":"mRNA vaccines are at the forefront of all platforms for COVID-19 prevention.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35533563","golden":false,"offsetInEndSection":138,"text":"Antigen design guided by high-resolution viral glycoprotein structures has successfully generated diverse vaccine candidates for COVID-19.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":962,"document":"36995507","golden":false,"offsetInEndSection":1168,"text":"Considering re-emergence of the COVID-19 variants of concern, vaccine reassessment and the development of polyvalent vaccines, or pan-coronavirus strategies, is essential for effective infection prevention.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":730,"document":"36995507","golden":false,"offsetInEndSection":858,"text":"However, these vaccines have lower stability, while DNA vaccines are needed with higher doses to stimulate the immune responses.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":859,"document":"36995507","golden":false,"offsetInEndSection":961,"text":"Intracellular delivery of nucleic acid-based vaccines and their adverse events needs further research.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36995507","golden":false,"offsetInEndSection":144,"text":"The coronavirus disease 2019 (COVID-19) pandemic has infected 673,010,496 patients and caused the death of 6,854,959 cases globally until today.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":501,"document":"34124612","golden":false,"offsetInEndSection":599,"text":"We validated this model using a previously described synthetic DNA vaccine plasmid, INO-4800 (pS).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":442,"document":"36371432","golden":false,"offsetInEndSection":655,"text":"The vaccine antigen contains four hot spot substitutions, K417N, E484K, N501Y and D614G, based on a prefusion-stabilized spike trimer of SARS-CoV-2 (S-6P) and formulated with an Alum/CpG 7909 dual adjuvant system.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":704,"document":"34124612","golden":false,"offsetInEndSection":753,"text":"pS induced robust cellular and humoral responses.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":911,"document":"34124612","golden":false,"offsetInEndSection":1004,"text":"One immunization resulted in 50% protection and two immunizations were completely protective.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":600,"document":"34124612","golden":false,"offsetInEndSection":703,"text":"Intranasal instillation of AAV6.2FF-hACE2 resulted in robust hACE2 expression in the respiratory tract.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1005,"document":"34124612","golden":false,"offsetInEndSection":1212,"text":"Overall, the AAV6.2FF-hACE2 mouse transduction model represents an easily accessible, genetically diverse mouse model for wild-type SARS-CoV-2 infection and preclinical evaluation of potential interventions.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34124612","golden":false,"offsetInEndSection":110,"text":"A novel mouse AAV6 hACE2 transduction model of wild-type SARS-CoV-2 infection studied using synDNA immunogens.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":754,"document":"34124612","golden":false,"offsetInEndSection":910,"text":"Vaccinated animals were challenged with 105 TCID50 SARS-CoV-2 (hCoV-19/Canada/ON-VIDO-01/2020) and euthanized four days post-challenge to assess viral load.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":300,"document":"36689221","golden":false,"offsetInEndSection":926,"text":"Outlining the processes used to establish and support the conduct of the phase 3 randomized clinical trials that led to the rapid emergency use authorization and approval of several COVID-19 vaccines is of major significance for current and future pandemic response efforts.Observations: To support the rapid development of vaccines for the US population and the rest of the world, the National Institute of Allergy and Infectious Diseases established the COVID-19 Prevention Network (CoVPN) to assist in the coordination and implementation of phase 3 efficacy trials for COVID-19 vaccine candidates and monoclonal antibodies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1425,"document":"36689221","golden":false,"offsetInEndSection":2039,"text":"These trials, while staggered in time of initiation, overlapped in time and course of conduct and ultimately led to the successful completion of multiple studies and US Food and Drug Administration-licensed or -authorized vaccines, the first of which was available to the public less than 1 year from the discovery of the virus.Conclusions and Relevance: This Special Communication describes the design, geographic distribution, and underlying principles of conduct of these efficacy trials and summarizes data from 136?382 prospectively followed-up participants, including more than 2500 with documented COVID-19.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1234,"document":"36689221","golden":false,"offsetInEndSection":1424,"text":"The mission of CoVPN was to operationalize phase 3 vaccine trials using harmonized protocols, laboratory assays, and a single data and safety monitoring board to oversee the various studies.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36689221","golden":false,"offsetInEndSection":101,"text":"Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":2040,"document":"36689221","golden":false,"offsetInEndSection":2234,"text":"These successful efforts can be replicated for other important research initiatives and point to the importance of investments in clinical trial infrastructure integral to pandemic preparedness.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":927,"document":"36689221","golden":false,"offsetInEndSection":1233,"text":"By bringing together multiple networks, CoVPN was able to draw on existing clinical and laboratory infrastructure, community partnerships, and research expertise to quickly pivot clinical trial sites to conduct COVID-19 vaccine trials as soon as the investigational products were ready for phase 3 testing.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":876,"document":"33930707","golden":false,"offsetInEndSection":1050,"text":"Finally, we discuss the key challenges in the successful design of the COVID-19 vaccine and address the most fundamental strengths and weaknesses of common vaccine platforms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36689221","golden":false,"offsetInEndSection":164,"text":"Importance: The COVID-19 pandemic has caused millions of infections and deaths and resulted in unprecedented international public health social and economic crises.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":165,"document":"36689221","golden":false,"offsetInEndSection":299,"text":"As SARS-CoV-2 spread across the globe and its impact became evident, the development of safe and effective vaccines became a priority.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38140142","golden":false,"offsetInEndSection":123,"text":"mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":664,"document":"32669664","golden":false,"offsetInEndSection":784,"text":"In fact, the first vaccine candidate launched into clinical trials is an mRNA vaccine delivered via lipid nanoparticles.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":260,"document":"32669664","golden":false,"offsetInEndSection":516,"text":"The genome sequence and protein structure of the 2019-novel coronavirus (nCoV or SARS-CoV-2) were made available in record time, allowing the development of inactivated or attenuated viral vaccines along with subunit vaccines for prophylaxis and treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":936,"document":"32669664","golden":false,"offsetInEndSection":1071,"text":"Here, we review current approaches to COVID-19 vaccine development and highlight the role of nanotechnology and advanced manufacturing.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32669664","golden":false,"offsetInEndSection":187,"text":"The COVID-19 pandemic has infected millions of people with no clear signs of abatement owing to the high prevalence, long incubation period and lack of established treatments or vaccines.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":517,"document":"32669664","golden":false,"offsetInEndSection":663,"text":"Nanotechnology benefits modern vaccine design since nanomaterials are ideal for antigen delivery, as adjuvants, and as mimics of viral structures.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":936,"document":"36698045","golden":false,"offsetInEndSection":1073,"text":"The spike protein featured the latest six-proline substitution design together with the?incorporation of a combination of mutation sites.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"32669664","golden":false,"offsetInEndSection":71,"text":"COVID-19 vaccine development and a potential nanomaterial path forward.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":340,"document":"36130677","golden":false,"offsetInEndSection":572,"text":"Here, we provide backstory commentary from the pharmaceutical scientist perspective on the challenges and solutions encountered in the development of the Pfizer-BioNTech mRNA COVID-19 vaccine (BNT162b2; b2; Comirnaty?; tozinameran).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":785,"document":"32669664","golden":false,"offsetInEndSection":935,"text":"To eradicate pandemics, present and future, a successful vaccine platform must enable rapid discovery, scalable manufacturing and global distribution.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":152,"document":"38040905","golden":false,"offsetInEndSection":402,"text":"With the focus on creating cost-effective solutions that can reach the low- and medium- income world, GreenLight Biosciences has developed an mRNA vaccine candidate, GLB-COV2-043, encoding for the full-length SARS-CoV-2 Wuhan wild-type spike protein.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38040905","golden":false,"offsetInEndSection":151,"text":"Several COVID-19 vaccines, some more efficacious than others, are now available and deployed, including multiple mRNA- and viral vector-based vaccines.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1105,"document":"38040905","golden":false,"offsetInEndSection":1320,"text":"Altogether, these data indicate that GLB-COV2-043 mRNA-LNP vaccine candidate elicits robust protective humoral and cellular immune responses and establishes our?mRNA-LNP platform for subsequent clinical evaluations.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1150,"document":"36993692","golden":false,"offsetInEndSection":1357,"text":"The tetravalent composition of the vaccine candidate has significant implications for COVID-19 vaccine development and implementation, providing broad antibody responses against numerous SARS-CoV-2 variants.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38040905","golden":false,"offsetInEndSection":114,"text":"Safety, immunogenicity and efficacy of an mRNA-based COVID-19 vaccine, GLB-COV2-043, in preclinical animal models.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":623,"document":"38040905","golden":false,"offsetInEndSection":870,"text":"Boosting mice with monovalent or bivalent mRNA-LNPs provided rapid recall and long-lasting neutralizing antibody titers, an increase in antibody avidity and breadth that was held over time and generation of antigen-specific memory B- and T- cells.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":403,"document":"38040905","golden":false,"offsetInEndSection":622,"text":"In pre-clinical studies in mice, GLB-COV2-043 induced robust antigen-specific binding and virus-neutralizing antibody responses targeting homologous and heterologous SARS-CoV-2 variants and a TH1-biased immune response.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"26222896","golden":false,"offsetInEndSection":189,"text":"The CELLECTRA-3P dermal electroporation device (Inovio Pharmaceuticals, Plymouth Meeting, PA) has been evaluated in the clinic and shown to enhance the delivery of an influenza DNA vaccine.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36569867","golden":false,"offsetInEndSection":218,"text":"Preclinical evaluation of safety and immunogenicity of a primary series intranasal COVID-19 vaccine candidate (BBV154) and humoral immunogenicity evaluation of a heterologous prime-boost strategy with COVAXIN (BBV152).","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":290,"document":"36569867","golden":false,"offsetInEndSection":550,"text":"ChAd-SARS-CoV-2-S (BBV154), a replication-defective chimpanzee adenovirus (ChAd)-vectored intranasal (IN) COVID-19 vaccine candidate, encodes a prefusion-stabilized version of the SARS-CoV-2 spike protein containing two proline substitutions in the S2 subunit.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33688647","golden":false,"offsetInEndSection":949,"text":"Global containment of COVID-19 still requires accessible and affordable vaccines for low- and middle-income countries (LMICs).1 Recently approved vaccines provide needed interventions, albeit at prices that may limit their global access.2 Subunit vaccines based on recombinant proteins are suited for large-volume microbial manufacturing to yield billions of doses annually, minimizing their manufacturing costs.3 These types of vaccines are well-established, proven interventions with multiple safe and efficacious commercial examples.4-6 Many vaccine candidates of this type for SARS-CoV-2 rely on sequences containing the receptor-binding domain (RBD), which mediates viral entry to cells via ACE2.7,8 Here we report an engineered sequence variant of RBD that exhibits high-yield manufacturability, high-affinity binding to ACE2, and enhanced immunogenicity after a single dose in mice compared to the Wuhan-Hu-1 variant used in current vaccines.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":940,"document":"34493582","golden":false,"offsetInEndSection":1101,"text":"Antibodies raised against the engineered protein exhibited heterotypic binding to the RBD from two recently reported SARS-CoV-2 variants of concern (501Y.V1/V2).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":761,"document":"35998134","golden":false,"offsetInEndSection":985,"text":"In immunization assays, although the cellular immune response elicited by both adjuvants were similar, the formulation based in water-in-oil emulsion and squalene generated an earlier humoral response as determined by ELISA.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"33247109","golden":false,"offsetInEndSection":104,"text":"RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":396,"document":"33247109","golden":false,"offsetInEndSection":524,"text":"It contains multiple dominant neutralizing epitopes and serves as an important antigen for the development of COVID-19 vaccines.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37093307","golden":false,"offsetInEndSection":96,"text":"A COVID-19 vaccine candidate based on SARS-CoV-2 spike protein and immune-stimulating complexes.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":182,"document":"34856868","golden":false,"offsetInEndSection":329,"text":"Among the 117 vaccines undergoing clinical trials, the major platforms include protein subunit; RNA; inactivated virus; viral vector, among others.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"33424848","golden":false,"offsetInEndSection":50,"text":"COVID-19: Coronavirus Vaccine Development Updates.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":593,"document":"33424848","golden":false,"offsetInEndSection":705,"text":"Researchers around the world are developing 213 COVID-19 candidate vaccines, among which 44 are in human trials.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":180,"document":"30891607","golden":false,"offsetInEndSection":598,"text":"Using an immunopotent DNA vaccine that generates protection from lethal EBOV challenge in small animals and nonhuman primates, we performed a clinical study to evaluate both intramuscular (IM) and novel intradermal (ID) DNA delivery.METHODS: Two DNA vaccine candidates (INO-4201 and INO-4202) targeting the EBOV glycoprotein (GP) were evaluated for safety, tolerability, and immunogenicity in a phase 1 clinical trial.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1033,"document":"30891607","golden":false,"offsetInEndSection":1335,"text":"Cellular immune responses were generated with every regimen.CONCLUSIONS: ID delivery of INO-4201 was well tolerated and resulted in 100% seroreactivity after 2 doses and elicited interferon-? T-cell responses in over 70% of subjects, providing a new approach for EBOV prevention in diverse populations.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1366,"document":"30891607","golden":false,"offsetInEndSection":1378,"text":"NCT02464670.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1336,"document":"30891607","golden":false,"offsetInEndSection":1365,"text":"Clinical Trials Registration.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":599,"document":"30891607","golden":false,"offsetInEndSection":916,"text":"The candidates were evaluated alone, together, or in combination with plasmid-encoded human cytokine interleukin-12 followed by in vivo electroporation using either the CELLECTRA? IM or ID delivery devices.RESULTS: The safety profile of all 5 regimens was shown to be benign, with the ID route being better tolerated.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1359,"document":"35171046","golden":false,"offsetInEndSection":1531,"text":"We describe a vaccine candidate (CoVac-II) that is based on stabilized, trimeric spike antigen produced in an optimized, scalable and chemically defined production process.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":917,"document":"30891607","golden":false,"offsetInEndSection":1032,"text":"Antibodies to EBOV GP were generated by all 5 regimens with the fastest and steepest rise observed in the ID group.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"30891607","golden":false,"offsetInEndSection":156,"text":"Intradermal SynCon? Ebola GP DNA Vaccine Is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy Volunteers.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":581,"document":"33429880","golden":false,"offsetInEndSection":740,"text":"This review summarizes the underlying design strategies and current status of development of the nine vaccines that were in phase III trial on 8 November 2020.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":706,"document":"33424848","golden":false,"offsetInEndSection":1002,"text":"In this review, we summarize and analyze vaccine progress against SARS-CoV, Middle-East respiratory syndrome Coronavirus (MERS-CoV), and SARS-CoV-2, including inactivated vaccines, live attenuated vaccines, subunit vaccines, virus like particles, nucleic acid vaccines, and viral vector vaccines.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1003,"document":"33424848","golden":false,"offsetInEndSection":1216,"text":"As SARS-CoV-2, SARS-CoV, and MERS-CoV share the common genus, Betacoronavirus, this review of the major research progress will provide a reference and new insights into the COVID-19 vaccine design and development.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":207,"document":"33424848","golden":false,"offsetInEndSection":296,"text":"Vaccines represent the most efficient means to control and stop the pandemic of COVID-19.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":297,"document":"33424848","golden":false,"offsetInEndSection":527,"text":"However, currently there is no effective COVID-19 vaccine approved to use worldwide except for two human adenovirus vector vaccines, three inactivated vaccines, and one peptide vaccine for early or limited use in China and Russia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":820,"document":"34275860","golden":false,"offsetInEndSection":1100,"text":"Extremely antigenic, conserve, immunogenic and nontoxic epitope of B and T cell of Spike protein are WPWYVWLGFI, SRVKNLNSSEGVPDLLV whereas the CWCARPTCIK and YCCNIVNVSL are associated with envelope small membrane protein were selected as potential candidate for vaccine designing.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":528,"document":"33424848","golden":false,"offsetInEndSection":592,"text":"Safe and effective vaccines against COVID-19 are in urgent need.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1311,"document":"35206580","golden":false,"offsetInEndSection":1742,"text":"Biotechnology strategies of the first generation (attenuated and inactivated virus-CoronaVac, CoVaxin; BBIBP-CorV), second generation (replicating-incompetent vector vaccines-ChAdOx-1; Ad5-nCoV; Sputnik V; JNJ-78436735 vaccine-replicating-competent vector, protein subunits, virus-like particles-NVX-CoV2373 vaccine), and third generation (nucleic-acid vaccines-INO-4800 (DNA); mRNA-1273 and BNT 162b (RNA vaccines) have been used.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38193729","golden":false,"offsetInEndSection":219,"text":"Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivity.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":463,"document":"38193729","golden":false,"offsetInEndSection":803,"text":" glycoproteins (MeV-MR). We show that artificial trimerization of the spike is critical for the induction of nAbs and that their magnitude can be significantly augmented when the spike protein is synchronously fused to a dodecahedral scaffold. Furthermore, preexisting measles immunity did not abolish heterologous immunity elicited by our ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37874075","golden":false,"offsetInEndSection":80,"text":"Available COVID-19 vaccines are primarily based on SARS-CoV-2 spike protein (S).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":275,"document":"38304876","golden":false,"offsetInEndSection":415,"text":"The World Health Organization has granted emergency use approval to multiple, including protein subunit technology-based, COVID-19 vaccines.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1189,"document":"35206580","golden":false,"offsetInEndSection":1309,"text":"COVID-19 vaccines obtained from classical and next-generation vaccine production platforms have entered clinicals trials","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34315454","golden":false,"offsetInEndSection":70,"text":"Evaluation of the safety profile of COVID-19 vaccines: a rapid review.","beginSection":"title"}],"ideal_answer":[" INO-4800 is a synthetic DNA vaccine candidate designed by Inovio Pharmaceuticals to target the SARS-CoV-2 spike protein, which is the major surface antigen of coronaviruses. It is currently undergoing Phase 2/3 trials."," INO-4800 is a COVID-19 vaccine candidate designed by Inovio Pharma. It is based on a DNA-based platform and utilizes a plasmid DNA vector to deliver the genetic code for the spike protein of the coronavirus. This triggers an immune response in the body, leading to the production of antibodies and T-cells to fight against the virus. The vaccine is designed to be administered through a small needle and does not require refrigeration, making it potentially easier to distribute in areas with limited resources.","The COVID-19 vaccine candidate INO-4800 manufactured by Inovio Pharma is designed as a DNA vaccine which contains genetic material that produces a spike protein found on the surface of the SARS-CoV-2 virus. This genetic material is delivered into the body through a device called Cellectra, which uses an electrical pulse to introduce the DNA into cells. The vaccine prompts the immune system to produce an immune response against the spike protein of SARS-CoV-2, thereby providing protection against COVID-19.","INO-4800 is a COVID-19 vaccine candidate manufactured by Inovio Pharma, utilizing synthetic DNA to stimulate the host\u0027s immune system. It has undergone Phase 2/3 trials and results in robust expression of the S protein in vitro. Studies have shown that one or two doses of INO-4800 protect against respiratory tract disease burden in nonhuman primate challenge models, and immunization in mice and guinea pigs results in antigen-specific T cell responses, functional antibodies, and biodistribution of SARS-CoV-2 targeting antibodies to the lungs. The safety, immunogenicity, and efficacy of INO-4800 have been assessed in rhesus macaques.","The COVID-19 vaccine candidate INO-4800, developed by Inovio Pharmaceuticals, is a DNA-based vaccine designed to induce an immune response against the SARS-CoV-2 virus by targeting its spike (S) protein. INO-4800 is administered intradermally followed by electroporation using the CELLECTRA? device to enhance cellular uptake. It has been evaluated in Phase 1 and Phase 2/3 clinical trials and has shown the ability to induce both neutralizing antibodies and T cell activity against global SARS-CoV-2 variants. This vaccine candidate has demonstrated immunogenicity in nonhuman primates and in smaller animal models such as mice and guinea pigs, where it has generated functional antibodies that can block the spike protein from binding to the ACE2 receptor and has shown favorable biodistribution, particularly in the lungs. Preliminary data support its further development as a COVID-19 vaccine, given its potential for robust spike protein expression and ability to provoke an immune response that could help mitigate infection.","INO-4800 is a COVID-19 vaccine candidate manufactured by Inovio Pharmaceuticals. It is designed as a synthetic DNA vaccine that targets the full length spike antigen of SARS-CoV-2. It has been undergone evaluations in two groups, receiving either 1.0 mg or 2.0 mg of the vaccine intradermally followed by CELLECTRA. The studies confirmed that the vaccine-induced neutralising antibodies remain effective against global SARS-CoV-2 variants, albeit with lower neutralisation titres against 501Y.V2. The aspect of INO-4800 stimulating the host\u0027s immune system with the help of engineered DNA is notable, especially as it resulted in robust expression of the S protein in vitro. Immunization led to observable antigen-specific T cell responses and functional antibodies which neutralize the SARS-CoV-2 infection while blocking Spike protein binding to the ACE2 receptor."," INO-4800, is a novel DNA vaccine candidate for COVID-19. The vaccine contains the sequence of the receptor binding domain (RBD) and the portion of the nucleocapsid protein.  The vaccine is designed to be administered using Inovio\u0027s proprietary hand-held electroporation device called CELLECTRA.  Vaccine is administered via skin injections using the CELLECTRA device. This approach is expected to deliver the vaccine directly into cells, rather than delivering the vaccine by simply using a needle without the device. This approach is designed to increase the immune response to the vaccine.\nPlease also see the below link for additional information:\nhttps://inovio.com/covid-19/\n\n","INO-4800 is a synthetic DNA vaccine candidate developed by Inovio Pharmaceuticals for COVID-19. The vaccine targets the full-length spike antigen of SARS-CoV-2 and is administered intradermally. INO-4800 has shown to induce neutralizing antibodies and T cell activity against global SARS-CoV-2 variants. It has demonstrated safety, immunogenicity, and efficacy in preclinical and clinical studies, including generating functional antibodies that neutralize the virus and block spike protein binding to the ACE2 receptor. Additionally, INO-4800 has been designed to elicit robust expression of the spike protein, supporting its potential as a COVID-19 vaccine candidate.","INO-4800 is a synthetic DNA vaccine candidate developed by Inovio Pharmaceuticals for COVID-19. It targets the full-length spike antigen of SARS-CoV-2 and is administered intradermally. INO-4800 has shown to induce neutralizing antibodies, T cell activity, and immune responses in preclinical and clinical studies. It has demonstrated safety, immunogenicity, and efficacy in animal models and human trials. Additionally, it has been designed to be effective against emerging SARS-CoV-2 variants, including the 501Y.V2 variant. INO-4800\u0027s design allows for robust expression of the spike protein, leading to the generation of protective immune responses against COVID-19.","1) INO-4800 is a DNA vaccine manufactured by Inovio Pharma, developed to induce immune response against COVID-19; 2) INO-4800 has been tested in phase 2 trial in 4000 adults and showed induction of T cell response; 3) INO-4800 is currently under evaluation in phase 3 trial in 4000 adults.\n","INO-4800, manufactured by Inovio Pharmaceuticals, is a DNA vaccine candidate designed to provide immunity against the SARS-CoV-2 virus, which is responsible for COVID-19. It targets the full length spike (S) antigen of the virus to induce an immune response. The vaccine is delivered intradermally and utilizes CELLECTRA? technology for its administration. INO-4800 has been shown to induce both neutralizing antibodies and T cell activity against global SARS-CoV-2 variants. The safety, immunogenicity, and efficacy of INO-4800 have been evaluated in animal models, such as mice, guinea pigs, and nonhuman primates, demonstrating the development of functional antibodies capable of neutralizing the virus and blocking spike protein binding to the ACE2 receptor, with further distribution of antibodies to the lungs. These attributes support INO-4800\u0027s advancement into clinical trials, with Phase 2/3 trials being conducted to assess its potential as a viable COVID-19 vaccine candidate.","INO-4800 is a DNA vaccine candidate for COVID-19 manufactured by Inovio Pharmaceuticals that targets the full-length spike (S) protein of the SARS-CoV-2 virus. The vaccine is designed to induce neutralizing antibodies and T cell activity against the virus, including variants of concern. INO-4800 is administered intradermally followed by electroporation using the CELLECTRA? device, which enhances cellular uptake of the DNA vaccine. Clinical trials have shown promise, with evidence that vaccinated individuals generate functional antibodies capable of neutralizing the virus and preventing spike protein binding to the ACE2 receptor. The vaccine has also shown a robust expression of the S protein in vitro, and it has progressed through phase 2/3 trials, showcasing its potential as a candidate in the global effort to prevent COVID-19, with further studies ongoing to determine its safety, immunogenicity, and efficacy.","The COVID-19 vaccine candidate INO-4800 is a synthetic DNA vaccine developed by Inovio Pharmaceuticals and the International Vaccine Institute (IVI). It consists of a small circular piece of DNA called a plasmid, which encodes for the spike protein of SARS-CoV-2, the virus that causes COVID-19. When injected into the body, this plasmid is intended to be taken up by cells and express the spike protein, prompting an immune response from the individual\u0027s own immune system. The vaccine uses Inovio\u0027s proprietary electroporation technology called CELLECTRA? to deliver the DNA into muscle cells, enhancing the cell\u0027s ability to produce the target antigen. INO-4800 is designed to be a safe and effective tool against COVID-19 by generating both antibody and T-cell responses that can protect against infection with SARS-CoV-2.","Inovio Pharma\u0027s COVID-19 vaccine candidate, INO-4800, is a DNA-based vaccine designed to induce an immune response against the SARS-CoV-2 virus. Although not specifically outlined in the snippets, INO-4800 leverages Inovio\u0027s SynCon? platform for vaccine development and is designed to be administered intramuscularly (IM), followed by electroporation using Inovio\u0027s proprietary CELLECTRA? delivery device, which uses a brief electrical pulse to facilitate uptake of the vaccine by cells. The delivery system has been well-tolerated and has shown promising results in generating both humoral and cellular immune responses in previous clinical trials with another vaccine candidate targeting Ebola virus glycoprotein. This platform technology and delivery method are likely similarly applied to the INO-4800, aiming to enhance the immune response by optimization of antigen expression in the host cells.","The vaccine candidate INO-4800, developed by Inovio Pharmaceuticals, is a DNA-based vaccine designed to induce immune responses against the SARS-CoV-2 virus. INO-4800 targets the full-length spike (S) protein of the virus, which plays a crucial role in host cell entry and is a key antigen for neutralizing antibodies. The approach is to deliver the DNA into the patient\u0027s skin cells, where the spike protein is produced, thus eliciting an immune response. This can generate both neutralizing antibodies that block virus entry via the ACE2 receptor and T cell responses crucial for long-term immunity. The vaccine is administered intradermally and requires the use of Inovio\u0027s proprietary CELLECTRA delivery device. As part of the global effort to develop COVID-19 vaccines, INO-4800 has shown promise in preclinical trials with mice and guinea pigs, producing robust immune responses, and has been evaluated in nonhuman primates. Clinical trials, including Phase 2/3 studies, are ongoing to assess the safety, immunogenicity, and efficacy of INO-4800 in humans, with the vaccine inducing neutralizing antibodies effective against current variants of concern.","INO-4800 is a DNA vaccine candidate developed by Inovio Pharmaceuticals targeting the SARS-CoV-2 virus, responsible for COVID-19. The vaccine is designed to induce an immune response against the virus\u0027s spike (S) protein, which is crucial for the virus\u0027s ability to infect human cells. INO-4800 works by delivering synthetic DNA into host cells, instructing them to produce the S protein and thereby stimulating the body\u0027s immune system to recognize and fight the virus. The vaccine has been evaluated in preclinical and clinical settings. In preclinical studies, INO-4800 demonstrated the ability to induce antigen-specific T cell responses, functional antibodies that neutralize SARS-CoV-2 infection, and block the S protein\u0027s binding to the ACE2 receptor. Clinical evaluations have involved assessing the vaccine\u0027s safety, immunogenicity, and efficacy in different populations, including a focus on its ability to generate neutralizing antibodies and T cell activity against global SARS-CoV-2 variants. INO-4800 is administered intradermally and is followed by the use of CELLECTRA?, a device that enhances cellular uptake of the DNA, thereby improving the vaccine\u0027s effectiveness.","INO-4800, a DNA-based vaccine candidate developed by Inovio Pharmaceuticals, belongs to the third generation of biotechnology strategies for COVID-19 vaccines. Unlike first-generation vaccines using attenuated or inactivated viruses, or second-generation platforms deploying vector-based or protein subunit approaches, INO-4800 harnesses nucleic acid technology, specifically plasmid DNA. The design of INO-4800 centers on delivering optimized DNA plasmids encoding the SARS-CoV-2 spike (S) glycoprotein into cells. Upon administration, host cells uptake the DNA plasmids, leading to the production of the encoded antigen and consequently eliciting an immune response. This response includes the generation of neutralizing antibodies and cellular immunity against the SARS-CoV-2 virus, aiming to prevent or mitigate the effects of COVID-19. The vaccine is intended to be administered intradermally and electroporation is used to facilitate plasmid DNA delivery into cells, a technique characteristic of Inovio\u0027s DNA vaccine platform."],"id":"6598356806a2ea257c000031","type":"summary","body":"Please summarize the design of the COVID-19 vaccine candidate, INO-4800, manufactured by Inovio Pharma designed"},{"documents":[{"golden":false,"id":"34812429"},{"golden":false,"id":"35788275"},{"golden":false,"id":"32295718"},{"golden":false,"id":"36580770"},{"golden":true,"id":"32173513"},{"golden":false,"id":"18795393"},{"golden":false,"id":"27576368"},{"golden":false,"id":"34079038"},{"golden":false,"id":"32318070"},{"golden":false,"id":"32174918"},{"golden":true,"id":"28490202"},{"golden":false,"id":"28657381"},{"golden":false,"id":"17466973"},{"golden":false,"id":"31839776"},{"golden":false,"id":"30289540"},{"golden":false,"id":"34228162"},{"golden":false,"id":"28158970"},{"golden":false,"id":"31326602"},{"golden":false,"id":"31859424"},{"golden":false,"id":"28514851"},{"golden":false,"id":"33666156"},{"golden":false,"id":"30587928"},{"golden":false,"id":"23666932"},{"golden":false,"id":"37859583"},{"golden":false,"id":"9832430"},{"golden":false,"id":"36441661"},{"golden":true,"id":"33414791"},{"golden":false,"id":"27924646"},{"golden":false,"id":"27808043"},{"golden":false,"id":"36222562"},{"golden":false,"id":"33315881"},{"golden":false,"id":"32864695"},{"golden":false,"id":"36109142"},{"golden":false,"id":"34987092"},{"golden":false,"id":"37629636"},{"golden":false,"id":"36508130"},{"golden":false,"id":"36150668"},{"golden":false,"id":"33268443"},{"golden":true,"id":"29325166"},{"golden":false,"id":"34780847"},{"golden":false,"id":"22978645"},{"golden":false,"id":"35770002"},{"golden":false,"id":"35863856"},{"golden":false,"id":"36477981"},{"golden":false,"id":"20576219"},{"golden":false,"id":"33598901"},{"golden":false,"id":"36297637"},{"golden":false,"id":"35256729"},{"golden":false,"id":"33911817"},{"golden":false,"id":"34218429"},{"golden":false,"id":"37873462"},{"golden":false,"id":"37874218"},{"golden":false,"id":"34224229"},{"golden":false,"id":"32446022"},{"golden":false,"id":"38253404"},{"golden":true,"id":"33864242"},{"golden":false,"id":"34628460"},{"golden":false,"id":"34487340"},{"golden":false,"id":"38032436"},{"golden":false,"id":"37640516"},{"golden":true,"id":"27606615"},{"golden":false,"id":"26927443"},{"golden":false,"id":"34254500"},{"golden":false,"id":"34751912"},{"golden":false,"id":"25149988"},{"golden":true,"id":"37176711"},{"golden":false,"id":"23981925"},{"golden":false,"id":"19565360"},{"golden":false,"id":"23178294"},{"golden":false,"id":"32432941"},{"golden":false,"id":"35273620"},{"golden":true,"id":"26280210"},{"golden":false,"id":"37773728"},{"golden":false,"id":"32006031"},{"golden":false,"id":"38056920"},{"golden":false,"id":"30599401"},{"golden":false,"id":"21612149"},{"golden":false,"id":"23345026"},{"golden":true,"id":"24471296"},{"golden":false,"id":"19846344"},{"golden":false,"id":"25738420"},{"golden":false,"id":"20210766"},{"golden":false,"id":"26511203"},{"golden":false,"id":"37812484"},{"golden":false,"id":"32065634"},{"golden":false,"id":"34912219"},{"golden":false,"id":"35693803"},{"golden":false,"id":"37022149"},{"golden":false,"id":"35845229"},{"golden":false,"id":"36079136"},{"golden":false,"id":"29745110"},{"golden":false,"id":"9324021"},{"golden":false,"id":"35266034"},{"golden":false,"id":"15546523"},{"golden":false,"id":"17280636"},{"golden":false,"id":"8144931"},{"golden":false,"id":"8681029"},{"golden":false,"id":"10022375"},{"golden":false,"id":"19858021"},{"golden":false,"id":"7835922"},{"golden":false,"id":"17592730"},{"golden":false,"id":"34603277"},{"golden":false,"id":"38354557"},{"golden":false,"id":"38348177"},{"golden":false,"id":"38332507"},{"golden":false,"id":"38310091"},{"golden":false,"id":"38303078"},{"golden":false,"id":"38289472"},{"golden":false,"id":"38284254"},{"golden":false,"id":"38279456"},{"golden":false,"id":"38270300"},{"golden":false,"id":"38264613"},{"golden":false,"id":"21327054"},{"golden":false,"id":"22165979"},{"golden":true,"id":"30803720"},{"golden":false,"id":"28332233"},{"golden":false,"id":"25759761"},{"golden":true,"id":"28565826"},{"golden":false,"id":"29936438"},{"golden":false,"id":"31095430"},{"golden":false,"id":"24415859"},{"golden":false,"id":"37914221"},{"golden":false,"id":"30181568"},{"golden":false,"id":"30941119"},{"golden":false,"id":"31907007"},{"golden":false,"id":"34357455"},{"golden":false,"id":"36301958"},{"golden":false,"id":"34894239"},{"golden":false,"id":"36315391"},{"golden":false,"id":"33976465"},{"golden":false,"id":"34447407"},{"golden":false,"id":"33761130"},{"golden":false,"id":"38243962"},{"golden":false,"id":"38228719"},{"golden":false,"id":"27643491"},{"golden":false,"id":"15852250"},{"golden":false,"id":"24979543"},{"golden":false,"id":"30616405"},{"golden":false,"id":"30084060"},{"golden":false,"id":"29545454"},{"golden":false,"id":"31521804"},{"golden":false,"id":"34951137"},{"golden":false,"id":"38358619"},{"golden":false,"id":"38358531"},{"golden":false,"id":"38356986"},{"golden":false,"id":"38356381"},{"golden":false,"id":"38356236"},{"golden":false,"id":"38355988"},{"golden":false,"id":"38355603"},{"golden":false,"id":"38354846"},{"golden":false,"id":"38354781"},{"golden":false,"id":"33631789"},{"golden":false,"id":"34211464"},{"golden":false,"id":"33303908"},{"golden":false,"id":"34778846"},{"golden":false,"id":"35126146"},{"golden":false,"id":"37129549"},{"golden":false,"id":"32973793"},{"golden":false,"id":"35063018"},{"golden":false,"id":"36916777"},{"golden":false,"id":"38358537"},{"golden":false,"id":"38358521"},{"golden":false,"id":"38358441"},{"golden":false,"id":"38358422"},{"golden":false,"id":"38358289"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":111,"document":"29325166","golden":true,"offsetInEndSection":254,"text":"However, the majority of TNFi\u0027s are immunogenic and consequent anti-drug antibodies formation can impact on both treatment efficacy and safety.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1381,"document":"32318070","golden":false,"offsetInEndSection":1733,"text":"Here we discuss the utility and relevance of TDM and immunogenicity testing of TNFis in RA (focusing on the most widely used TNFis globally, with the most available data, i.e., infliximab, adalimumab, and etanercept), the limitations of currently available assays and potential future immunopharmacological strategies to personalize disease management.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":339,"document":"29325166","golden":true,"offsetInEndSection":629,"text":"While anti-drug antibodies to TNFis have been described in association with infusion reactions; serious adverse events (AEs) such as thromboembolic events, lupus-like syndrome, paradoxical AEs, for example, vasculitis-like events and other autoimmune manifestations have also been reported.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":433,"document":"32318070","golden":false,"offsetInEndSection":590,"text":"Immunogenicity and the development of anti-drug antibodies (ADAs) is considered one of the main reasons for loss of therapeutic efficacy (secondary failure).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1605,"document":"32173513","golden":true,"offsetInEndSection":1778,"text":"Comparable results were found for the ADL-treated group in the prospective study which also showed a relationship between drug/ADAb levels and the loss of clinical response.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":879,"document":"28490202","golden":true,"offsetInEndSection":1146,"text":"macokinetics. The study of factors that can affect the pharmacokinetics, such as immunogenicity, is valuable to further define and understand the use of TNFi in PsA, especially in the subset of patients who do not respond adequately to these agents or lose effectiven","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"32174918","golden":false,"offsetInEndSection":33,"text":"Immunogenicity of TNF-Inhibitors.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28657381","golden":false,"offsetInEndSection":131,"text":"INTRODUCTION: Biological agents such as tumor necrosis factor inhibitors (TNFi), abatacept, rituximab and tocilizumab have proven e","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1588,"document":"33414791","golden":false,"offsetInEndSection":1896,"text":"Among the four Beh?et syndrome patients with anti-IFX antibodies, two experienced relapses and two had infusion reactions.Conclusions: Immunogenicity does not seem to be a frequent problem in Beh?et syndrome patients treated with IFX, but may be associated with relapses and infusion reactions, when present.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33414791","golden":true,"offsetInEndSection":199,"text":"Background: Immunogenicity of tumor necrosis factor alpha inhibitors (TNFis) has been recognized as an important problem that may cause loss of efficacy and adverse events such as infusion reactions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1489,"document":"34987092","golden":false,"offsetInEndSection":1775,"text":"In the overall sample, those on MTX (12/80, 15%) had a trend toward lower immune response (p\u003d0.07); glucocorticoid therapy (11/80, 13.8%) predicted lower antibody levels (p\u003d0.04).CONCLUSIONS: Continuing TNFi in patients with PsA throughout the vaccination did not hamper immunogenicity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":200,"document":"33414791","golden":false,"offsetInEndSection":605,"text":"TNFis are being increasingly used among patients with Beh?et syndrome (BS) and scarce data exist on this topic.Objective: We aimed to investigate the prevalence of anti-infliximab (IFX) antibodies in patients with Beh?et syndrome together with suitable controls.Methods: We collected serum samples from 66 consecutive Beh?et syndrome patients (51 M, 15?F, mean age 37 ? 9 years) who were treated with IFX.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":926,"document":"33414791","golden":false,"offsetInEndSection":1218,"text":"We used a cut-off value of 1 ?g/ml for serum IFX trough level, extrapolating from rheumatoid arthritis studies.Results: Anti-IFX antibodies were detected in four (6%) Beh?et syndrome, five (18.5%) rheumatoid arthritis, three (12%) Crohn\u0027s disease, and one (2%) ankylosing spondylitis patient.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1219,"document":"33414791","golden":false,"offsetInEndSection":1409,"text":"The median serum IFX trough level was significantly lower in patients with anti-IFX antibodies compared to those without antibodies [2.32 (IQR: 0.6-3.6) vs. 3.35 (IQR: 1.63-5.6); p \u003d 0.019].","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1113,"document":"36109142","golden":false,"offsetInEndSection":1684,"text":"Improvements in efficacy and patient-reported outcomes were maintained throughout 24 weeks and were noted after week 16 in patients who switched from PBO.Dose-related treatment-emergent serious adverse events were 7% in OKZ q2w, 3.2% in OKZ q4w and none in the PBO group.CONCLUSIONS: Direct inhibition of IL-6 with OKZ resulted in significant improvements in the signs and symptoms of rheumatoid arthritis compared with PBO in TNF-IR patients with a similar safety profile as observed for monoclonal antibodies to the IL-6 receptor.TRIAL REGISTRATION NUMBER: NCT02760433.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1410,"document":"33414791","golden":false,"offsetInEndSection":1587,"text":"The serum IFX trough level was lower than the cut-off value in 6/13 (46%) patients with anti-IFX antibodies and in 25/158 (16%) patients without anti-IFX antibodies (p \u003d 0.015).","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"33414791","golden":false,"offsetInEndSection":85,"text":"Immunogenicity of Infliximab Among Patients With Beh?et Syndrome: A Controlled Study.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":606,"document":"33414791","golden":false,"offsetInEndSection":769,"text":"Additionally, similarly treated 27 rheumatoid arthritis, 53 ankylosing spondylitis, 25 Crohn\u0027s disease patients, and 31 healthy subjects were included as controls.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1553,"document":"36150668","golden":false,"offsetInEndSection":1931,"text":"After third dose (D69-D240), a major increment occurred for SP (81.3% to 93.1%, P\u003c0.001) and NAb (63.2% to 86.1%, P\u003c0.001), but still lower than CG (P\u003c0.05), and only TNFi impaired both SP (P\u003d0.016)/NAb (P\u003d0.002).CONCLUSIONS: We provided novel data demonstrating that TNFi attenuates immunogenicity in SpA patients while SSZ has a positive impact on vaccine antibody production.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1055,"document":"34780847","golden":false,"offsetInEndSection":1244,"text":"We also report 8 novel disease-associated variants in 7 patients with DADA2.CONCLUSIONS: Our data explore the cellular mechanism underlying effective treatment with TNFi therapies in DADA2.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34987092","golden":false,"offsetInEndSection":470,"text":"BACKGROUND: Scanty data on the immunogenicity of the BNT162b2 vaccine in patients with psoriatic arthritis (PsA) on Tumor Necrosis Factor inhibitors (TNFi) have been published.OBJECTIVE: To investigate the humoral response to BNT162b2 vaccination patients with PsA on TNFi, comparing immunogenicity with healthy controls.METHODS: Forty patients with classified PsA on TNFi undergoing vaccination with the BNT162b2 mRNA SARS-CoV-2 vaccine (BioNTech/Pfizer) were enrolled.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":845,"document":"34987092","golden":false,"offsetInEndSection":1363,"text":"Sera from healthcare professionals were considered as healthy controls for 1:1 propensity score matching; any of them was taking medication.Student\u0027s t-test and logistic regression were used for investigating differences in immunogenicity between groups and predictors of antibody response.RESULTS: Clinical Disease Activity Index did not change before and after vaccination (7.06?5.23?to 7.10?5.27, p\u003d0.92).Patients with PsA achieved a positive anti-SARS-CoV-2 IgG level with a mean (?SD) of 13794.44?15?815.42 AU/mL.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1364,"document":"34987092","golden":false,"offsetInEndSection":1488,"text":"Although lower, the antibody level was not significantly different from matched controls (19227.4?11.8460.45 AU/mL, p\u003d0.08).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":190,"document":"36477981","golden":false,"offsetInEndSection":726,"text":"We aimed to assess the 1-year boostability of a three-dose rabies pre-exposure prophylaxis (PrEP) schedule in individuals using immunosuppressive monotherapy.METHODS: In this prospective study, individuals on immunosuppressive monotherapy with a conventional immunomodulator (cIM) or a TNF-alpha inhibitor (TNFi) for a chronic inflammatory disease received a three-dose intramuscular PrEP schedule (days 0,7,21-28) with 1?mL Rabipur?, followed by a two-dose simulated post-exposure prophylaxis (PEP) schedule (days 0,3) after 12?months.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34987092","golden":false,"offsetInEndSection":106,"text":"Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35863856","golden":false,"offsetInEndSection":163,"text":"We report a patient with seronegative rheumatoid arthritis diagnosed with Whipple\u0027s disease following treatment of tumour necrosis factor inhibitor (TNFI) therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"20576219","golden":false,"offsetInEndSection":257,"text":"The recognition of tumor necrosis factor-alpha (TNF-alpha) as an important mediator of pathogenesis in rheumatoid arthritis (RA) led to the development of TNF inhibitors (TNFIs), which are a significant advance in the treatment of this debilitating disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":676,"document":"34987092","golden":false,"offsetInEndSection":844,"text":"TNFi treatment was not discontinued throughout the whole period, whereas methotrexate (MTX) was discontinued for 1?week after each shot in those on combination therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1332,"document":"37873462","golden":false,"offsetInEndSection":1594,"text":"A sensitivity analysis excluding patients with cancer or interstitial lung disease yielded similar findings.Conclusions: We identified CD20i and glucocorticoid monotherapy as risk factors for breakthrough COVID-19 among patients with RA after a 3rd vaccine dose.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1196,"document":"37873462","golden":false,"offsetInEndSection":1331,"text":"In the PS overlap-weighted analysis, CD20i users also had higher breakthrough COVID-19 risk than TNFi users (HR 1.62, 95%CI 1.02-2.56).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1595,"document":"37873462","golden":false,"offsetInEndSection":1753,"text":"This contemporary study highlights the real-world impact of blunted immune responses in these subgroups and the need for effective risk mitigation strategies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1424,"document":"34224229","golden":false,"offsetInEndSection":1617,"text":"Only one patient did not meet the criteria for response to vaccine.CONCLUSIONS: The pneumococcal vaccine induces protective levels of serum antibodies in JIA patients undergoing TNFi treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1010,"document":"37873462","golden":false,"offsetInEndSection":1195,"text":"Use of CD20i (adjusted HR 1.74, 95%CI 1.30-2.33) and glucocorticoid monotherapy (adjusted HR 1.47, 95%CI 1.09-1.98) were each associated with breakthrough COVID-19 compared to TNFi use.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":932,"document":"37873462","golden":false,"offsetInEndSection":1009,"text":"During mean follow-up of 12.8 months, 1173 (20.2%) had breakthrough COVID_19.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":734,"document":"37873462","golden":false,"offsetInEndSection":931,"text":"We used propensity score (PS) overlap-weighting to compare users of CD20i vs. TNFi.Results: We analyzed 5781 patients with RA that received 3 mRNA vaccine doses (78.8% female, mean age 64.2 years).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37873462","golden":false,"offsetInEndSection":415,"text":"Objectives: To investigate COVID-19 breakthrough infection after third mRNA vaccine dose among patients with RA by immunomodulator drug class, and we hypothesized that CD20 inhibitors (CD20i) would have higher risk for breakthrough COVID-19 vs. TNF inhibitors (TNFi).Methods: We performed a retrospective cohort study investigating breakthrough COVID-19 among RA patients at Mass General Brigham in Boston, MA, USA.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1240,"document":"38253404","golden":false,"offsetInEndSection":1718,"text":"Clinical responders to guselkumab exhibited significantly higher baseline levels of several biomarkers than nonresponders (IL-17A, IL-17F, BD-2 in biologic-na?ve PASI 90 responders; IL-17A, BD-2 in TNFi-IR IGA 0/1 responders; IL-22, BD-2 in TNFi-IR PASI 90 responders [nominal P\u003c0.05]) and trended higher in TNFi-IR ACR20 responders.CONCLUSION: Guselkumab modulates IL-23 signaling and provides consistent pharmacodynamic effects in both biologic-na?ve and TNFi-IR PsA patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1898,"document":"34487340","golden":false,"offsetInEndSection":2090,"text":"Lack of efficacy and worsening disease were the most frequent reasons for switching therapies.CONCLUSIONS: TNFis remain the most prescribed b/tsDMARD for first-line and second-line treatments.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1172,"document":"27606615","golden":true,"offsetInEndSection":1428,"text":"Anti-TNFi Abs were associated with decreased drug levels, but no predictors for anti-TNFi Ab development could be found.CONCLUSION: The effect of treatment with TNFi on RA disease activity depends on levels of active drug, and by presence of anti-TNFi Abs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"26927443","golden":false,"offsetInEndSection":453,"text":"PURPOSE OF REVIEW: This article reviews the most current studies investigating the use of tumor necrosis factor inhibitors (TNFis) in the treatment of rheumatoid arthritis.RECENT FINDINGS: Studies over the past year have clarified that suppressing TNF with monoclonal antibodies does increase infection risk, yet coupled with reduction in disease activity and less use of corticosteroids as a consequence, the overall risk to the population is balanced.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":468,"document":"37176711","golden":true,"offsetInEndSection":601,"text":"TNF inhibitors appear to be the main contributors to immunogenicity because they are widely used, especially in rheumatoid arthritis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1118,"document":"37773728","golden":false,"offsetInEndSection":1411,"text":"During the follow-up period, no patients had infusion reactions necessitating new premedications, serious adverse events, or medication nonresponse.CONCLUSION: Patients who directly transitioned from a rapid-infusion o-TNFi to a rapid-infusion b-TNFi did not experience serious adverse events.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1007,"document":"23981925","golden":false,"offsetInEndSection":1373,"text":"There is no evidence of cross-reactivity among different drugs: immunogenicity (the development of specific anti-drug antibodies to one TNF inhibitor) does not seem to affect the effectiveness of another anti-TNF agents; therefore, switching to another drug of the same class might be effective in patients who have developed anti-drug antibodies to a TNF inhibitor.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":375,"document":"26280210","golden":true,"offsetInEndSection":1020,"text":"This may be due to the development of antibodies against TNFi agents.OBJECTIVES: Our objective was to examine the immunogenicity of TNF inhibitors (adalimumab, infliximab, etanercept, golimumab, and certolizumab) in RA, SpA, and IBD, and to examine the potential effect of anti-drug antibodies (ADABs) on the loss of clinical response through a systematic literature review and meta-analysis.METHODS: We conducted a comprehensive literature search using three databases (PubMed, Web of Science, and the Cochrane library) to identify studies examining the immunogenicity of TNF inhibitors in autoimmune diseases between 1966 and 31 December 2013.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":162,"document":"32432941","golden":false,"offsetInEndSection":401,"text":"All BAs are immunogenic, resulting in the formation of antidrug antibodies (ADAs), which can neutralize drug activity leading to loss of response and potential relapse, or serious adverse events such as infusion hypersensitivity reactions.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37873462","golden":false,"offsetInEndSection":144,"text":"Immunomodulators and risk for breakthrough infection after third COVID-19 mRNA vaccine among patients with rheumatoid arthritis: A cohort study.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21612149","golden":false,"offsetInEndSection":84,"text":"Immunogenicity is a frequent adverse event observed with biological agents\u0027 therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":643,"document":"23345026","golden":false,"offsetInEndSection":696,"text":"As proteins, biologicals are potentially immunogenic.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":85,"document":"21612149","golden":false,"offsetInEndSection":363,"text":"Challenges of management in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis treated with golimumab, an anti-TNF-alpha blocker, include limited generation of antibodies like anti-nuclear, anti-golimumab, and anti-double stranded DNA antibodies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":223,"document":"24471296","golden":true,"offsetInEndSection":360,"text":"Treatment with TNF-alpha blockers may result in the formation of autoantibodies and, rarely, in the development of a lupus-like syndrome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":697,"document":"23345026","golden":false,"offsetInEndSection":941,"text":"It has been recently raised that anti-drug antibodies (ADA) may affect their bioavailability and eventually the clinical efficacy through local formation of immune complexes and directly by preventing the interaction between the drug and TNF-?.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"19846344","golden":false,"offsetInEndSection":260,"text":"Twenty-eight patients with low-moderate, stable rheumatoid arthritis (RA), under treatment with tumor necrosis factor (TNF) alpha blockers, were immunized at least once with non-adjuvanted trivalent influenza vaccine during three consecutive influenza seasons.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":799,"document":"19846344","golden":false,"offsetInEndSection":908,"text":"This study confirms safety of influenza vaccine administration in RA patients treated with TNFalpha blockers.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":909,"document":"19846344","golden":false,"offsetInEndSection":1021,"text":"The cohort follow-up revealed the overcoming of poor B vaccine antigen immunogenicity via repeated vaccinations.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":911,"document":"25738420","golden":false,"offsetInEndSection":1037,"text":"s responded to the vaccine. The response rate was not affected by parameters such as age, gender, disease activity or the use ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":685,"document":"37812484","golden":false,"offsetInEndSection":926,"text":"The safest TNFi in terms of PP induction was certolizumab, whereas the one most commonly associated with PP was infliximab.CONCLUSIONS: PP is an uncommon adverse reaction to TNFi treatment in AS patients and responds well to drug withdrawal.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":460,"document":"37812484","golden":false,"offsetInEndSection":684,"text":"We assessed the distinct characteristics and frequency of risks for PP appearance in AS patients treated with different TNFi.RESULTS: PP was found in 0.5-1% of TNFi-treated AS patients and the latency period was 2-11 months.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1664,"document":"37022149","golden":false,"offsetInEndSection":1940,"text":"IFNA1 overexpression could protect HFLS against inflammatory response in the setting of AS.CONCLUSION: Blood IFNA1 deficiency is correlated with inflammatory cytokine production, and disease activity, and is indicative of unsatisfied response to TNFi treatment in AS patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37812484","golden":false,"offsetInEndSection":119,"text":"OBJECTIVES: The approval of TNF-a inhibitors (TNFi) was a breakthrough in the treatment of ankylosing spondylitis (AS).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1210,"document":"32065634","golden":false,"offsetInEndSection":1480,"text":"The adjusted 5-year respiratory survival was better in RTX-treated compared with TNFi-treated RA-BR patients; HR 0.40 (95% CI 0.17, 0.96); P?\u003d0.041.CONCLUSION: The majority of RTX-treated RA-BR patients had stable/improved pulmonary symptoms in this long-term follow-up.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":929,"document":"9324021","golden":false,"offsetInEndSection":1161,"text":"Direct synovial TNFI gene transfer was successful, but induced an inflammatory response without any net TNFI benefit.CONCLUSION: Systemic adenoviral-mediated transfer of the TNFI gene suppressed CIA during its transitory expression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":120,"document":"37812484","golden":false,"offsetInEndSection":459,"text":"Although also effective in psoriasis, drug-related adverse events of onset of psoriasiform skin lesions - paradoxical psoriasis (PP) under TNFi have been reported.METHODS: We performed an electronic data search in MEDLINE via Pubmed and Cochrane library scientific databases from inception to January 2023, following the PRISMA guidelines.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":927,"document":"37812484","golden":false,"offsetInEndSection":1022,"text":"More large data studies need to be conducted though, to shed light on PP nature and management.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":270,"document":"34912219","golden":false,"offsetInEndSection":597,"text":"The main outcome of the study was to assess the effect of non-persistence to treatment with subcutaneous tumor necrosis factor-alpha inhibitors (SC-TNFis) on HCRU costs in na?ve patients with IMRD who started treatment with adalimumab, etanercept, golimumab or certolizumab pegol during 12?months after initiation of treatment.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37812484","golden":false,"offsetInEndSection":102,"text":"Anti-TNF-? induced paradoxical psoriasis in patients with ankylosing spondylitis: a systematic review.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1562,"document":"15546523","golden":false,"offsetInEndSection":1730,"text":"To reduce the adverse effects due to infliximab immunogenicity, several trials with humanized or completely human agents, such as adalimumab or onercept, are under way.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":97,"document":"17280636","golden":false,"offsetInEndSection":222,"text":"Sera from 106 RA patients were monitored using an RIA for functional infliximab and an RIA for anti-infliximab antibody (Ab).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":343,"document":"17280636","golden":false,"offsetInEndSection":519,"text":"Low s-infliximab was associated with Ab development and later therapeutic failure, and high Ab levels could be related to dose increases, side-effects and cessation of therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":794,"document":"8144931","golden":false,"offsetInEndSection":1202,"text":"Significant growth inhibition of MCA-102-hTNF was noted in animals bearing pulmonary metastases. This inhibition was: 1) tumor specific (regression occurred only in animals bearing pulmonary metastases from the same parental line), 2) TNF specific (it was inhibited by in vivo administration of anti hTNF mAbs), 3) dependent on cellular immunity (immune-depletion with anti-CD4 or CD8 mAbs permitted growth).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"8681029","golden":false,"offsetInEndSection":137,"text":"We have already reported that a combination of TNF-alpha and immunogenic variant was effective for immunotherapy of nonimmunogenic tumor.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":138,"document":"8681029","golden":false,"offsetInEndSection":310,"text":"Immunogenic variants (A2 and A7) were obtained from nonimmunogenic fibrosarcoma (parent cell: 1767-3) by mutagen treatment with N-methyl-N\u0027-nitro-N-nitrosoguanidine (MNNG).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":693,"document":"8681029","golden":false,"offsetInEndSection":861,"text":"TNF-alpha producing immunogenic variant (A7TR3) could induce strong specific immunity to parental cell compared to TNF-alpha producing nonimmunogenic variant (1767TR2).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":745,"document":"10022375","golden":false,"offsetInEndSection":868,"text":"This humanized anti-TNF-alpha antibody is expected to be less immunogenic and thus more suitable for possible clinical use.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":443,"document":"19858021","golden":false,"offsetInEndSection":602,"text":"f patients.OBJECTIVE: To establish the first Mexican Consensus for the use of anti tumoral necrosis factor alpha agents in the treatment of patients with infla","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":246,"document":"7835922","golden":false,"offsetInEndSection":421,"text":"We have shown previously that TNF-alpha frequently induces necrosis when injected into sites undergoing delayed-type hypersensitivity (DTH) responses to mycobacterial antigen.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38354557","golden":false,"offsetInEndSection":275,"text":"Tumors produce a hypoxic environment that greatly influences cancer treatment, and conventional chemotherapeutic drugs cannot selectively accumulate in the tumor region because of the lack of a tumor targeting mechanism, causing increased systemic toxicities and side effects","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":179,"document":"38348177","golden":false,"offsetInEndSection":311,"text":"However, the effect of aPD-L1 inhibitors limited by the tumor microenvironment makes most patients exhibit immunotherapy resistance.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":839,"document":"38332507","golden":false,"offsetInEndSection":1027,"text":"Our results demonstrated that autophagy activation was inhibited in LPS-treated BEECs, while activation of the NF-?B pathway and the mRNA expression of IL-6, IL-8, and TNF-? were increased","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":468,"document":"38310091","golden":false,"offsetInEndSection":696,"text":"AXL upregulation protects sorafenib-resistant HCC cells from oxidative stress, mitochondrial damage, and accompanying immunogenic cell death through suppressed tumor necrosis factor-? (TNF-?) and STING-type I interferon pathways","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1015,"document":"38303078","golden":false,"offsetInEndSection":1284,"text":"phages in lung tissues of the experimental MA-ALI mice. Compared to the infected control mice, the blockage of Piezo1 with GsMTx4 dramatically improved the survival rate but decreased body weight loss, peripheral blood parasitemia/lung parasite burden, experimental cer","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":915,"document":"38289472","golden":false,"offsetInEndSection":1133,"text":"Furthermore, G4-TNF systemically administered to tumor-bearing mice exerted anticancer effects through a CD13-targeting mechanism, indicating the presence of a CD13 form in tumor vessels with an accessible binding site","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":358,"document":"38284254","golden":false,"offsetInEndSection":541,"text":"The mRNA levels of tumor necrosis factor ? (TNF-?), interleukin-6 (IL-6), interleukin-1? (IL-1?) and monocyte chemotactic protein 1 (MCP-1) were detected by real time quantitative PCR","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1537,"document":"38279456","golden":false,"offsetInEndSection":1593,"text":"The change in IL-10 level is opposite to the above genes","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1346,"document":"38270300","golden":false,"offsetInEndSection":1459,"text":"The results showed that SIM decreased the expression of tumor necrosis factor-?, whereas increased Interleukin-10","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1827,"document":"38264613","golden":false,"offsetInEndSection":1958,"text":"The R9-SOCS3-KIR treatment also blocked the LPS-induced expression of interleukin-6, MCP1, cyclooxygenase 2, and interleukin-1 beta","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":663,"document":"21327054","golden":false,"offsetInEndSection":811,"text":"The HIRMAb undergoes receptor-mediated transport across the BBB via the endogenous insulin receptor, and carries into brain the fused biologic TNFI.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1459,"document":"21327054","golden":false,"offsetInEndSection":1628,"text":"The BBB molecular Trojan horse platform technology allows for the engineering of brain-penetrating recombinant proteins as new biologic therapeutics for the human brain.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1035,"document":"21327054","golden":false,"offsetInEndSection":1115,"text":"The HIRMAb-TNFR fusion protein binds both the HIR and TNF? with low nM affinity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1293,"document":"21327054","golden":false,"offsetInEndSection":1458,"text":"In addition, a fusion protein of the HIRMAb and a therapeutic single chain Fv (ScFv) antibody has been engineered and also expressed in stably transfected CHO cells.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1582,"document":"37914221","golden":false,"offsetInEndSection":1929,"text":"No significant between-group differences were observed for postvaccination disease activity and adverse events.CONCLUSION: SEC did not interfere with the immunogenic response to BNT162b2 vaccine in patients with SpA; however, TNFi therapy was associated with lower S1/S2-antibody titers, faster decline, and higher rate of breakthrough infections.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"21327054","golden":false,"offsetInEndSection":66,"text":"Biologic TNF?-inhibitors that cross the human blood-brain barrier.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":443,"document":"21327054","golden":false,"offsetInEndSection":662,"text":"Brain penetrating forms of TNF? decoy receptors or anti-TNF? antibody therapeutics can be re-engineered as IgG fusion proteins with a BBB molecular Trojan horse, such as the mAb against the human insulin receptor (HIR).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1116,"document":"21327054","golden":false,"offsetInEndSection":1292,"text":"The HIRMAb cross reacts with the Rhesus monkey insulin receptor, and the HIRMAb-TNFR is rapidly, and selectively, taken up by primate brain at concentrations that inhibit TNF?.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30803720","golden":true,"offsetInEndSection":176,"text":"BACKGROUND: It has been well known that TNF-? inhibitor (TNFi) treatment for patients with rheumatoid arthritis (RA) is associated with anti-nuclear antibody (ANA) development.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28332233","golden":false,"offsetInEndSection":214,"text":"The increasingly successful and widespread use of Tumor Necrosis Factor inhibitors (TNFi) to treat autoimmune and inflammatory conditions has also been accompanied by adverse reactions, both systemic and cutaneous.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":820,"document":"28332233","golden":false,"offsetInEndSection":1133,"text":"Atrophy of sebaceous lobules is a potentially reversible, characteristic and conspicuous feature of TiAPA that can be distinguished from idiopathic psoriatic alopecia by clinical history of drug exposure and sometimes by histologic presence of a mixed inflammatory response including plasma cells and eosinophils.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":362,"document":"28332233","golden":false,"offsetInEndSection":562,"text":"The purpose of this study is to describe the features of TiAPA, including marked atrophy of sebaceous lobules as a histologic clue to diagnosis, helping to distinguish it from other types of alopecia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":265,"document":"28332233","golden":false,"offsetInEndSection":361,"text":"Recently, TNF inhibitor associated psoriatic alopecia (TiAPA) is being more frequently reported.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":563,"document":"28332233","golden":false,"offsetInEndSection":684,"text":"Clinical and histopathological features of 3 patients who developed scalp alopecia while on TNFi treatment were examined.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28565826","golden":true,"offsetInEndSection":205,"text":"Anti-nuclear antibodies (ANAs) may be induced in patients with rheumatoid arthritis (RA) receiving anti-tumor necrosis factor (TNF) therapy with TNF inhibitors (TNFi), etanercept, infliximab or adalimumab.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1212,"document":"29936438","golden":false,"offsetInEndSection":1574,"text":"In patients from the ABIRISK cohort treated with TNFi for chronic inflammatory diseases, high BAFF serum level correlated with absence of ADA to TNFi only in patients cotreated with MTX but not in patients on TNFi monotherapy.CONCLUSION: MTX and BAFF interact in mice where CD73, adenosine and regulatory B cells were identified as key actors in this phenomenon.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":749,"document":"28332233","golden":false,"offsetInEndSection":819,"text":"A review of the previous literature on the subject was also conducted.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31907007","golden":false,"offsetInEndSection":163,"text":"BACKGROUND: Infliximab (INX) and other tumour necrosis factor inhibitors (TNFi) have revolutionised the treatment of several immune mediated inflammatory diseases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":830,"document":"31907007","golden":false,"offsetInEndSection":1283,"text":"The NORwegian DRUg Monitoring study (NOR-DRUM) aims to assess the effectiveness of TDM, both with regard to the achievement of remission in patients starting INX treatment (part A) as well as to maintain disease control in patients on INX treatment (part B).METHODS: The NOR-DRUM study is a randomised, open, controlled, parallel-group, comparative, multi-centre, national, superiority, phase IV study with two separate parts, NOR-DRUM A and NOR-DRUM B.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1113,"document":"38243962","golden":false,"offsetInEndSection":1387,"text":"ADA biosimilar was discontinued and two months later, she had substantial skin improvement.CONCLUSION: This is the first report of morphea manifestation during TNFi biosimilar since the patient had no other trigger factors for morphea development like trauma and infections.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":645,"document":"31907007","golden":false,"offsetInEndSection":829,"text":"TDM seems reasonable both from a clinical and an economical point of view, but the effectiveness of this treatment strategy has not yet been demonstrated in randomised clinical trials.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":163,"document":"36301958","golden":false,"offsetInEndSection":424,"text":"Loss of response [LOR] to anti-TNF therapy due to immunogenic failure accounts for 20% of subsequent medical intervention and is defined, using a drug-sensitive assay, as low or undetectable concentration of drug with high titres of anti-drug antibodies [ADAb].","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37914221","golden":false,"offsetInEndSection":573,"text":"OBJECTIVE: To assess the humoral response to the BNT162b2 mRNA vaccine among patients with spondyloarthritis (SpA) receiving secukinumab (SEC) compared to those receiving tumor necrosis factor inhibitors (TNFi) and immunocompetent controls.METHODS: Consecutive patients with psoriatic arthritis or axial SpA receiving SEC (n \u003d 37) or TNFi (monotherapy, n \u003d 109; + methotrexate [MTX], n \u003d 16), immunocompetent controls (n \u003d 122), and patients with rheumatoid arthritis (RA) receiving TNFi therapy (controls, n \u003d 50) were vaccinated with 2 or 3 doses of the BNT162b2 vaccine.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1631,"document":"31907007","golden":false,"offsetInEndSection":1689,"text":"NOR-DRUM A will include 400 patients starting INX therapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1816,"document":"31907007","golden":false,"offsetInEndSection":2268,"text":"The primary endpoint is occurrence of disease worsening during the 52-week study period.DISCUSSION: As the first trial to assess the effectiveness, safety and cost-effectiveness of TDM in patients receiving TNFi for a range of immune mediated inflammatory diseases, we hope that the NOR-DRUM study will contribute to the advancement of evidence based personalised treatment with biological medicines.TRIAL REGISTRATION: Clinicaltrials.gov, NCT03074656.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1736,"document":"31907007","golden":false,"offsetInEndSection":1815,"text":"In NOR-DRUM B, 450 patients on maintenance treatment with INX will be included.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":773,"document":"38358619","golden":false,"offsetInEndSection":901,"text":"Finally, the models are followed by BiLSTM and dense layers in order to classify responders and non-responders to SSRI treatment","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38358531","golden":false,"offsetInEndSection":97,"text":"?-Glucosidase (?-Glu) is implicated in the progression and pathogenesis of type II diabetes (T2D)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1025,"document":"38356986","golden":false,"offsetInEndSection":1170,"text":"We believe that the thyroid gland should also be taken into consideration while screening for malignancy before and during TNF inhibitors (TNFi).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1636,"document":"38356381","golden":false,"offsetInEndSection":1690,"text":"21.26?+?2.78?pg/mg tissues, and TNF-? (22.02???1.08 vs","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":139,"document":"38356236","golden":false,"offsetInEndSection":249,"text":"In modern medicine, it has been discovered to have anti-inflammatory, anti-allergic, and anticancer properties","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":556,"document":"38355988","golden":false,"offsetInEndSection":701,"text":"The reactive group has been successfully incorporated into a clinical drug targeting the EGFR L858R mutant, erlotinib, and a pan-kinase inhibitor","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":521,"document":"38355603","golden":false,"offsetInEndSection":639,"text":"Moreover, the characteristics of tumor-infiltrating lymphocytes are associated with the effectiveness of immunotherapy","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":523,"document":"38354846","golden":false,"offsetInEndSection":826,"text":"In the lipopolysaccharide (LPS) induced neuroinflammatory cell model, we observed that ruxolitinib reduced the levels of IL-1?, IL-6 and tumor necrosis factor-? (TNF-?) expression, and neuroinflammation by inhibiting the Mitogen-Activated Protein Kinase/Nuclear factor-? B (MAPK/NF-?B) signaling pathway","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":651,"document":"38354781","golden":false,"offsetInEndSection":788,"text":"We found that inhibition of TLR9 also blocked NMDA-induced activation of caspase-3, which plays an essential role in the induction of LTD","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1683,"document":"33631789","golden":false,"offsetInEndSection":1998,"text":"Only IL-2 and IL-17 levels were downregulated, and IL-5 production was upregulated by uptake of Fuc-G0 antibodies, as compared to control without antibodies.CONCLUSIONS: The specific modification in the Fc-glycosylation pattern of anti-TNF-alpha Abs does not affect their immunogenicity under the tested conditions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":362,"document":"33631789","golden":false,"offsetInEndSection":734,"text":"We investigated whether specific glycosylation patterns of the Fc-fragment would affect the immunogenicity of anti-TNF-alpha antibody in monocyte-derived dendritic cells.METHODS: The effect of a specific Fc-glycosylation pattern on antibody uptake by monocyte-derived dendritic cells [mo-DCs] and how this process shapes the immunologic profile of mo-DCs was investigated.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":735,"document":"33631789","golden":false,"offsetInEndSection":1303,"text":"Three N-glycoforms of the anti-TNF-alpha antibody adalimumab, that differed in the content of fucose or sialic acid, were tested: [1] mock treated Humira, abbreviated \u0027Fuc-G0\u0027, where the N-glycan mainly consist of fucose and N-acetylglucosamine [GlcNAc], without sialic acid; [2] \u0027Fuc-G2S1/G2S2\u0027 with fucose and alpha 2,6 linked sialic acid; and [3] \u0027G2S1/G2S2\u0027 with alpha 2,6 linked sialic acid, without fucose.RESULTS: Our data demonstrated that neither fucosylation nor sialylation of anti-TNF-Abs [Fuc-G0, FucG2S1/G2S2, G2S1/G2S2] influence their uptake by mo-DCs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":421,"document":"34211464","golden":false,"offsetInEndSection":597,"text":"Our approach delineated three programmes of LC phenotypic activation (immunogenic, tolerogenic or ambivalent), and confirmed that TNF-alpha enhanced LC immunogenic programming.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2572,"document":"34778846","golden":false,"offsetInEndSection":3003,"text":"There was no difference in the magnitude of T-cell responses between patients receiving methotrexate (median cytokine-secreting cells per 106 cells 160 [IQR 10-625]), targeted biologics (169 [25-503], p\u003d0?56), and controls (185 [133-328], p\u003d0?41).INTERPRETATION: Functional humoral immunity (ie, neutralising antibody responses) at 14 days following a second dose of BNT162b2 was not impaired by methotrexate or targeted biologics.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"33631789","golden":false,"offsetInEndSection":166,"text":"Fucosylation and Sialylation of Fc-Fragment of anti-Tumour Necrosis Factor Alpha Antibodies do not Influence Their Immunogenicity in Monocyte-Derived Dendritic Cells.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1304,"document":"33631789","golden":false,"offsetInEndSection":1487,"text":"Additionally, none of the differentially glycosylated antibodies altered CD80, CD86, CD273, CD274 levels on mo-DCs stimulated in with lipopolysaccharide in the presence of antibodies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33631789","golden":false,"offsetInEndSection":144,"text":"BACKGROUND AND AIMS: Antibodies targeting tumor necrosis factor-alpha [TNF-alpha] are a mainstay in the treatment of inflammatory bowel disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1999,"document":"33631789","golden":false,"offsetInEndSection":2269,"text":"As this study was limited to mo-DCs, further investigation is required to clarify whether Ab uptake into mo-DCs might change the immunological profile of T- and B-cells, in order to ultimately reduce the formation of anti-drug antibodies and to improve the patient care.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1403,"document":"35063018","golden":false,"offsetInEndSection":1787,"text":"Furthermore, no significant differences were found in progression status, when disease activity was measured by Bath Ankylosing spondylitis Disease Activity Index (BASDAI) and C reactive protein (CRP).CONCLUSIONS: Patients on long-term TNFi treatment with a mean sustained low disease activity measures by ASDAS presented lower radiographic progression than those with active disease.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1569,"document":"38358537","golden":false,"offsetInEndSection":1722,"text":"Timely IP plus high-uptake VHB vaccination in infants born to HBsAg-positive mothers was associated with a high immunogenic response and absence of MTCT.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":676,"document":"38358521","golden":false,"offsetInEndSection":764,"text":"Patients with local recurrences outside the SVs or with metastatic disease were excluded","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":459,"document":"38358441","golden":false,"offsetInEndSection":547,"text":"A panel of antigenic peptides produced from TC2N were predicted by using a computer tool","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":823,"document":"38358422","golden":false,"offsetInEndSection":888,"text":"180 patients (92 female and 88 male) were included into the study","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1720,"document":"38358289","golden":false,"offsetInEndSection":1890,"text":"Our work indicates that vaccination with IAV-NapA induces antigen-specific humoral, cellular, and mucosal immunity, producing a protective and therapeutic effect against ","beginSection":"abstract"}],"exact_answer":"yes","ideal_answer":[" Yes, the majority of TNF alpha inhibitors are immunogenic\n"," Yes, the majority of TNF alpha inhibitors (TNFi\u0027s) are immunogenic\n"," Yes, the majority of TNFi\u0027s are immunogenic\n","Yes, the majority of TNF alpha inhibitors (TNFi\u0027s) are immunogenic."," Yes. most TNF inhibitors are immunogenic.\n"," Yes, the majority of TNFi\u0027s are immunogenic.\n"],"id":"659837bb06a2ea257c000032","type":"yesno","body":"Is the following statement true:  the majority of TNF alpha inhibitors (TNFi\u0027s) are immunogenic?"},{"documents":[{"golden":false,"id":"34792672"},{"golden":false,"id":"16702236"},{"golden":false,"id":"27941029"},{"golden":false,"id":"24600466"},{"golden":true,"id":"19007433"},{"golden":false,"id":"27151298"},{"golden":false,"id":"31449841"},{"golden":false,"id":"34966378"},{"golden":false,"id":"22221064"},{"golden":true,"id":"21425078"},{"golden":true,"id":"28476940"},{"golden":false,"id":"32738097"},{"golden":false,"id":"22357969"},{"golden":false,"id":"21947082"},{"golden":false,"id":"15494318"},{"golden":true,"id":"31974276"},{"golden":false,"id":"19448404"},{"golden":false,"id":"23436247"},{"golden":false,"id":"35846989"},{"golden":false,"id":"18535581"},{"golden":false,"id":"21411309"},{"golden":false,"id":"19626045"},{"golden":true,"id":"33827943"},{"golden":false,"id":"33731875"},{"golden":false,"id":"17145966"},{"golden":false,"id":"28703681"},{"golden":false,"id":"26073511"},{"golden":true,"id":"27066941"},{"golden":true,"id":"34197957"},{"golden":false,"id":"36943332"},{"golden":false,"id":"36915828"},{"golden":false,"id":"32957626"},{"golden":false,"id":"31745110"},{"golden":false,"id":"35938958"},{"golden":false,"id":"35646888"},{"golden":false,"id":"37775071"},{"golden":false,"id":"36350546"},{"golden":true,"id":"33139956"},{"golden":false,"id":"35359344"},{"golden":true,"id":"20040115"},{"golden":true,"id":"37888853"},{"golden":true,"id":"30733604"},{"golden":false,"id":"25672900"},{"golden":true,"id":"29576528"},{"golden":true,"id":"36302555"},{"golden":false,"id":"15258613"},{"golden":false,"id":"30926795"},{"golden":false,"id":"28275011"},{"golden":false,"id":"35440539"},{"golden":false,"id":"22634085"},{"golden":false,"id":"28248294"},{"golden":false,"id":"38270191"},{"golden":false,"id":"33288901"},{"golden":false,"id":"23750007"},{"golden":false,"id":"25336640"},{"golden":false,"id":"38072059"},{"golden":false,"id":"28074857"},{"golden":false,"id":"35063767"},{"golden":false,"id":"34272356"},{"golden":false,"id":"21468303"},{"golden":false,"id":"31966446"},{"golden":false,"id":"29054474"},{"golden":false,"id":"36347172"},{"golden":true,"id":"30718280"},{"golden":false,"id":"27083998"},{"golden":true,"id":"12704427"},{"golden":false,"id":"32107274"},{"golden":true,"id":"33681193"},{"golden":true,"id":"38187689"},{"golden":false,"id":"33925279"},{"golden":false,"id":"36682332"},{"golden":true,"id":"32233097"},{"golden":false,"id":"23552861"},{"golden":true,"id":"36413311"},{"golden":false,"id":"25007997"},{"golden":true,"id":"27424744"},{"golden":true,"id":"35307036"},{"golden":true,"id":"27613052"},{"golden":false,"id":"27516771"},{"golden":false,"id":"26613948"},{"golden":false,"id":"25194926"},{"golden":false,"id":"19208757"},{"golden":false,"id":"27613053"},{"golden":false,"id":"24270891"},{"golden":false,"id":"27930845"},{"golden":true,"id":"27723317"},{"golden":false,"id":"38099646"},{"golden":false,"id":"25489924"},{"golden":false,"id":"37262077"},{"golden":true,"id":"38174770"},{"golden":true,"id":"25806519"},{"golden":false,"id":"22118674"},{"golden":false,"id":"33483467"},{"golden":false,"id":"23712866"},{"golden":false,"id":"28959952"},{"golden":false,"id":"16275357"},{"golden":false,"id":"36371501"},{"golden":false,"id":"28659380"},{"golden":false,"id":"38081437"},{"golden":false,"id":"37867237"},{"golden":false,"id":"37756534"},{"golden":false,"id":"37511599"},{"golden":false,"id":"37349820"},{"golden":false,"id":"38358795"},{"golden":false,"id":"38351178"},{"golden":true,"id":"38342418"},{"golden":false,"id":"38321455"},{"golden":false,"id":"38316548"},{"golden":true,"id":"38307937"},{"golden":false,"id":"38307305"},{"golden":false,"id":"38306645"},{"golden":false,"id":"38302849"},{"golden":false,"id":"38283833"},{"golden":false,"id":"19153604"},{"golden":false,"id":"26455393"},{"golden":false,"id":"31753913"},{"golden":false,"id":"28851806"},{"golden":false,"id":"30910023"},{"golden":false,"id":"30585151"},{"golden":true,"id":"29302259"},{"golden":true,"id":"26588485"},{"golden":true,"id":"19489724"},{"golden":false,"id":"21130715"},{"golden":false,"id":"21710968"},{"golden":false,"id":"21480003"},{"golden":false,"id":"27308573"},{"golden":false,"id":"26412298"},{"golden":false,"id":"27650958"},{"golden":false,"id":"35489684"},{"golden":false,"id":"35935969"},{"golden":true,"id":"37679322"},{"golden":false,"id":"36879346"},{"golden":true,"id":"37234921"},{"golden":true,"id":"36237424"},{"golden":false,"id":"36811009"},{"golden":false,"id":"33227393"},{"golden":false,"id":"23845989"},{"golden":false,"id":"35662507"},{"golden":true,"id":"35283827"},{"golden":true,"id":"19615732"},{"golden":false,"id":"23335262"},{"golden":false,"id":"32531973"},{"golden":false,"id":"18094676"},{"golden":false,"id":"36959757"},{"golden":false,"id":"36012723"},{"golden":false,"id":"22723847"},{"golden":false,"id":"18410486"},{"golden":true,"id":"33417828"},{"golden":false,"id":"23615962"},{"golden":false,"id":"23209443"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":0,"document":"28476940","golden":true,"offsetInEndSection":179,"text":"Deubiquitylating (or deubiquitinating) enzymes (DUBs) are proteases that reverse protein ubiquitylation and therefore modulate the outcome of this post-translational modification.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"21425078","golden":true,"offsetInEndSection":115,"text":"The deubiquitylating enzyme Cops6 regulates different developmental processes during early zebrafish embryogenesis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30733604","golden":true,"offsetInEndSection":188,"text":"The deubiquitylating enzymes (DUBs, also known as deubiquitylases or deubiquitinases) maintain the dynamic state of the cellular ubiquitome by releasing conjugated ubiquitin from proteins.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":411,"document":"19448404","golden":false,"offsetInEndSection":593,"text":"These data suggest a dual role for Ku70 in apoptotic regulation; on one hand the association with Ku70 sequestered Bax away from the mitochondria and plays an antiapoptotic function.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"19007433","golden":true,"offsetInEndSection":236,"text":"Deubiquitylating enzymes (DUBs) can hydrolyze a peptide, amide, ester or thiolester bond at the C-terminus of UBIQ (ubiquitin), including the post-translationally formed branched peptide bonds in mono- or multi-ubiquitylated conjugates.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31974276","golden":true,"offsetInEndSection":267,"text":"Deubiquitylating (DUB) enzymes free covalently linked ubiquitin moieties from ubiquitin-ubiquitin and ubiquitin-protein conjugates, and thereby maintain the equilibrium between free and conjugated ubiquitin moieties and regulate ubiquitin-mediated cellular processes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1494,"document":"33827943","golden":true,"offsetInEndSection":1628,"text":"Deubiquitinating enzymes (DUBs) reverse ubiquitination by cleaving ubiquitins from target proteins, thereby affecting viral infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1923,"document":"33731875","golden":false,"offsetInEndSection":2066,"text":"ystems. These observations together indicate that deubiquitylation of histone H2Bub1 does not directly regulate global Pol II transcription elo","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"33827943","golden":true,"offsetInEndSection":90,"text":"Deubiquitinating Enzyme USP21 Inhibits HIV-1 Replication by Downregulating Tat Expression.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":209,"document":"27066941","golden":false,"offsetInEndSection":326,"text":"Deubiquitylating enzymes (DUBs) regulate?ubiquitylation status by trimming or removing chains from attached proteins.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34197957","golden":true,"offsetInEndSection":146,"text":"Deubiquitinating enzyme (DUB) can hydrolyze ubiquitin molecules from the protein bound with ubiquitin, and reversely regulate protein degradation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36943332","golden":false,"offsetInEndSection":181,"text":"Deubiquitinylating enzymes (DUBs) regulate the deubiquitinylation process of post-translationally modified proteins and thus control protein signaling in various cellular processes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1206,"document":"34197957","golden":false,"offsetInEndSection":1380,"text":"Taken together, our results suggest that USP39 participates the deubiquitylation of SP1 protein, providing new pathway for understand the upstream signaling for oncogene SP1.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27066941","golden":false,"offsetInEndSection":114,"text":"Ubiquitin chains are important post-translational modifications that control a large number of cellular processes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":903,"document":"27066941","golden":false,"offsetInEndSection":1079,"text":"We demonstrate that various DUBs in lysates display differential reactivity toward differently linked diubiquitin probes, as exemplified?by the proteasome-associated DUB USP14.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":216,"document":"31745110","golden":false,"offsetInEndSection":491,"text":"Within the ubiquitin-proteasome system, deubiquitylating enzymes (DUBs) not only help generate and maintain the supply of free ubiquitin monomers, they also directly control functions and activities of specific target proteins by modulating the pool of ubiquitylated species.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":605,"document":"32957626","golden":false,"offsetInEndSection":713,"text":"Deubiquitinases (DUBs) play a pivotal role in the disassembly of the complex code and removal of the signal.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1080,"document":"27066941","golden":false,"offsetInEndSection":1189,"text":"In addition, OTUD2 and OTUD3 show remarkable linkage-specific reactivity with our diubiquitin-based reagents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":971,"document":"35938958","golden":false,"offsetInEndSection":1191,"text":"These findings identify RAP80 and BRCC36 as autologous DUB substrates in the BRCA1-A complex, thus explaining the evolution of matching ubiquitin-binding and hydrolysis activities within a single macromolecular assembly.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37888853","golden":true,"offsetInEndSection":170,"text":"Deubiquitylating enzymes (DUBs) maintain relative homeostasis of the cellular ubiquitome by removing the post-translational modification ubiquitin moiety from substrates.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33139956","golden":true,"offsetInEndSection":129,"text":"Deubiquitylating enzymes (DUBs) play a vital role in the ubiquitin pathway by editing or removing ubiquitin from their substrate.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":141,"document":"35359344","golden":false,"offsetInEndSection":234,"text":"The deubiquitinating enzyme (DUB) is the main practitioner of the reversal of ubiquitination.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"20040115","golden":true,"offsetInEndSection":183,"text":"BACKGROUND: Deconjugation of ubiquitin and/or ubiquitin-like modified protein substrates is essential to modulate protein-protein interactions and, thus, signaling processes in cells.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25672900","golden":false,"offsetInEndSection":66,"text":"Deubiquitylating enzymes (DUBs), act downstream of ubiquitylation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"29576528","golden":true,"offsetInEndSection":171,"text":"Deubiquitylating enzymes (DUBs) enhance the dynamics of the versatile ubiquitin (Ub) code by reversing and regulating cellular ubiquitylation processes at multiple levels.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":633,"document":"25672900","golden":false,"offsetInEndSection":940,"text":"It is primarily the recent revelations of USP9X\u0027s pivotal role in human cancers, both as oncogene or tumour suppressor, in developmental disorders including intellectual disability, epilepsy, autism and developmental delay that has led to a subsequent re-examination of its molecular and cellular functions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36302555","golden":true,"offsetInEndSection":114,"text":"Deubiquitylating enzymes (DUBs) remove ubiquitin chains from proteins and regulate protein stability and function.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":67,"document":"25672900","golden":false,"offsetInEndSection":223,"text":"As such, these post-post-translational modifiers function as the final arbitrators of a protein substrate\u0027s ubiquitylation status, thus regulating its fate.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":365,"document":"25672900","golden":false,"offsetInEndSection":458,"text":"Yet, disruption of this quantitative regulation can produce dramatic qualitative differences.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":911,"document":"30926795","golden":false,"offsetInEndSection":1102,"text":"Collectively, our observations suggest that reversible ubiquitylation helps switch Rab7 between its various functions, thereby maintaining global spatiotemporal order in the endosomal system.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":973,"document":"34197957","golden":false,"offsetInEndSection":1077,"text":"In addition, our results show USP39 promotes cell proliferation by SP1-depenet manner in vivo and vitro.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":697,"document":"34197957","golden":false,"offsetInEndSection":772,"text":"High expression of USP39 is correlated with poor prognosis of HCC patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":858,"document":"34197957","golden":false,"offsetInEndSection":972,"text":"We observe that USP39 stabilizes SP1 protein and prolongs its half-life by promoting its deubiquitylation pathway.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34197957","golden":false,"offsetInEndSection":105,"text":"USP39 promotes tumorigenesis by stabilizing and deubiquitinating SP1 protein in hepatocellular carcinoma.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1232,"document":"38270191","golden":false,"offsetInEndSection":1405,"text":"Together, our data establishes Otub1 as a novel regulator of G-protein coupled receptor signaling in B cells, regulating their differentiation and positioning in the spleen.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":498,"document":"25336640","golden":false,"offsetInEndSection":606,"text":"These results are consistent with a role for USP42 in regulating transcription by deubiquitylating histones.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38270191","golden":false,"offsetInEndSection":228,"text":"The ubiquitin proteasome system performs the covalent attachment of lysine 48-linked polyubiquitin chains to substrate proteins, thereby targeting them for degradation, while deubiquitylating enzymes (DUBs) reverse this process.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33288901","golden":false,"offsetInEndSection":130,"text":"Ubiquitination, and its control by deubiquitinating enzymes (DUBs), mediates protein stability, function, signaling and cell fate.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1158,"document":"23750007","golden":false,"offsetInEndSection":1322,"text":"Collectively, our findings demonstrate that RNF41 controls JAK2-associated cytokine receptor trafficking by acting as a key regulator of USP8 and ESCRT-0 stability.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1261,"document":"28074857","golden":false,"offsetInEndSection":1393,"text":"These results suggest that USP15 plays an essential role in stabilizing HBx and subsequently affects the biological function of HBx.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38270191","golden":false,"offsetInEndSection":129,"text":"The Deubiquitylase Otub1 Regulates the Chemotactic Response of Splenic B Cells by Modulating the Stability of the ?-Subunit Gng2.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":827,"document":"38270191","golden":false,"offsetInEndSection":962,"text":"Proximal mapping of Gng2 revealed an enrichment in partners associated with chemokine signaling, actin cytoskeleton and cell migration.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":156,"document":"38072059","golden":false,"offsetInEndSection":292,"text":"Deubiquitination mediated by deubiquitylating enzymes (DUBs) is an essential PTM that mainly modulates the stability of target proteins.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":963,"document":"38270191","golden":false,"offsetInEndSection":1231,"text":"In line with these findings, we show that Otub1-deficient B cells exhibit greater Ca2+ mobilization, F-actin polymerization and chemotactic responsiveness to Cxcl12, Cxcl13 and S1P in?vitro, which manifests in?vivo as altered localization of B cells within the spleen.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":993,"document":"38072059","golden":false,"offsetInEndSection":1071,"text":"Thus, we reveal a novel role for USP38 in the regulation of hypoxia signaling.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38187689","golden":true,"offsetInEndSection":110,"text":"Deubiquitylating enzymes (DUBs) remove ubiquitin from proteins thereby regulating their stability or activity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33681193","golden":true,"offsetInEndSection":134,"text":"The deubiquitinating enzyme (DUB)-mediated cleavage of ubiquitin plays a critical role in balancing protein synthesis and degradation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":510,"document":"32233097","golden":true,"offsetInEndSection":725,"text":"De-ubiquitinases (DUBs), a group of processing enzymes, play an important role in maintaining cellular ubiquitin homeostasis by hydrolyzing ubiquitin poly-proteins and free poly-ubiquitin chains into mono-ubiquitin.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":656,"document":"38270191","golden":false,"offsetInEndSection":826,"text":"We demonstrate that Otub1 interacts with the ?-subunit of the heterotrimeric G protein, Gng2, and modulates its ubiquitylation status, thereby controlling Gng2 stability.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1050,"document":"35063767","golden":false,"offsetInEndSection":1163,"text":"Overall, our findings indicate that the USP20-MCL1 axis might play a key role in the apoptotic signaling pathway.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":229,"document":"38270191","golden":false,"offsetInEndSection":404,"text":"This posttranslational modification regulates key features both of innate and adaptative immunity, including antigen presentation, protein homeostasis and signal transduction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36413311","golden":true,"offsetInEndSection":195,"text":"Deubiquitylating enzymes, or DUBs, are important regulators of ubiquitin homeostasis and substrate stability, though the molecular mechanisms of most of the DUBs in plants are not yet understood.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":594,"document":"25007997","golden":false,"offsetInEndSection":764,"text":"One of the key areas has been to investigate the regulation of the protein components of the TGF?/BMP signal transduction pathways by ubiquitylation and deubiquitylation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":916,"document":"25007997","golden":false,"offsetInEndSection":1043,"text":"However, the research on DUBs regulating the TGF? pathway has received prominence only recently and is still an emerging field.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27424744","golden":true,"offsetInEndSection":195,"text":"Deubiquitylating enzymes, or DUBs, are important regulators of ubiquitin homeostasis and substrate stability, though the molecular mechanisms of most of the DUBs in plants are not yet understood.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":305,"document":"35307036","golden":true,"offsetInEndSection":434,"text":"Deubiquitylating enzymes (DUBs) are proteases that cleave ubiquitin from the substrate proteins and process ubiquitin precursors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27613052","golden":true,"offsetInEndSection":165,"text":"Deubiquitylating enzymes or DUBs are a class of enzymes that selectively remove the polypeptide posttranslational modification ubiquitin from a number of substrates.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1025,"document":"24270891","golden":false,"offsetInEndSection":1153,"text":"ls. These findings identify USP13 as a tumour-suppressing protein that functions through deubiquitylation and stabilization of P","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"24270891","golden":false,"offsetInEndSection":52,"text":"Deubiquitylation and stabilization of PTEN by USP13.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":139,"document":"12704427","golden":true,"offsetInEndSection":360,"text":"Protein ubiquitylation is a dynamic and reversible process; attached Ub can be removed by deubiquitylating enzymes (DUBs), a heterogeneous group of cysteine proteases that cleave proteins precisely at the Ub-protein bond.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":788,"document":"24270891","golden":false,"offsetInEndSection":915,"text":"Conversely, overexpression of USP13 suppresses tumorigenesis and glycolysis in PTEN-positive but not PTEN-null breast cancer ce","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27723317","golden":true,"offsetInEndSection":140,"text":"Deubiquitylating enzymes (DUBs) remove ubiquitin (Ub) from various cellular proteins and render eukaryotic ubiquitylation a dynamic process.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30718280","golden":true,"offsetInEndSection":190,"text":"The deubiquitylation of target proteins is mediated by deubiquitylating enzymes (DUB) such as OTUB1, which plays an important role in immune response, cell cycle progression, and DNA repair.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":64,"document":"24270891","golden":false,"offsetInEndSection":277,"text":"In addition to gene mutations and deletions, recent studies have revealed the importance of post-translational modifications, such as ubiquitylation, in the regulation of PTEN stability, activity and localization.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":278,"document":"24270891","golden":false,"offsetInEndSection":383,"text":"However, the deubiquitylase that regulates PTEN polyubiquitylation and protein stability remains unknown.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":509,"document":"24270891","golden":false,"offsetInEndSection":609,"text":"One of them, USP13, stabilizes the PTEN protein through direct binding and deubiquitylation of PTEN.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":559,"document":"38174770","golden":true,"offsetInEndSection":773,"text":"By hydrolyzing the ubiquitin molecules from ubiquitylated proteins, DUBs control ubiquitin-dependent selective protein degradation pathways such as the proteasomal-, autophagic-, and endocytic degradation pathways.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":774,"document":"38174770","golden":true,"offsetInEndSection":944,"text":"In the endocytic degradation pathway, DUBs can modulate the endocytic trafficking and thus the stability of plasma membrane proteins including receptors and transporters.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":945,"document":"38174770","golden":true,"offsetInEndSection":1188,"text":"To date, three DUB families were shown to control the endocytic degradation pathway namely associated molecule with the SH3 domain of STAM (AMSH) 3, ubiquitin-specific protease (UBP) 12 and UBP13, and ovarian tumor protease (OTU) 11 and OTU12.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25806519","golden":true,"offsetInEndSection":380,"text":"Protein ubiquitylation is a dynamic process that affects the function and stability of proteins and controls essential cellular processes ranging from cell proliferation to cell death. This process is regulated through the balanced action of E3 ubiquitin ligases and deubiquitylating enzymes (DUB) which conjugate ubiquitins to, and remove them from target proteins, respectively.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":162,"document":"22118674","golden":false,"offsetInEndSection":322,"text":"We have utilized activity-based chemical proteomics to determine the potency and selectivity of deubiquitylating enzyme (DUB) inhibitors in cell culture models.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":528,"document":"22118674","golden":false,"offsetInEndSection":717,"text":"A striking accumulation of polyubiquitylated proteins was observed after both selective and general inhibition of cellular DUB activity without direct impairment of proteasomal proteolysis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":718,"document":"22118674","golden":false,"offsetInEndSection":875,"text":"The repertoire of ubiquitylated substrates was analyzed by tandem mass spectrometry, identifying distinct subsets for general or specific inhibition of DUBs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33483467","golden":false,"offsetInEndSection":94,"text":"Ubiquitylation and deubiquitylation play a pivotal role in protein homeostasis (proteostasis).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":241,"document":"33483467","golden":false,"offsetInEndSection":338,"text":"Here we discuss the emerging roles of deubiquitylating enzymes in neuronal function and survival.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":758,"document":"23712866","golden":false,"offsetInEndSection":925,"text":"Here, we review key deubiquitylating enzymes (DUBs) involved in DDR pathways, and describe how targeting DUBs may lead to selective therapies to treat cancer patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":229,"document":"38174770","golden":false,"offsetInEndSection":300,"text":"In contrast with ubiquitylating enzymes, there are less numbers of DUBs","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":326,"document":"38081437","golden":false,"offsetInEndSection":609,"text":"Mechanistically, under normal conditions, ubiquitin carboxyl terminal hydrolase-L1 (UCHL1) was identified as a DUB enzyme that interacts with, deubiquitylates, and stabilizes ferredoxin reductase (FDXR), an important mitochondrial protein that regulates mitochondral iron homeostasis","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":76,"document":"37867237","golden":false,"offsetInEndSection":176,"text":"The present study examins the anti-tumor effects of deubiquitylating enzymes (DUB) inhibitors in HCC","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":147,"document":"37756534","golden":false,"offsetInEndSection":249,"text":"An ISG15-specific member of the deubiquitylase family, USP18, is up-regulated in a co-ordinated manner","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":468,"document":"37511599","golden":false,"offsetInEndSection":573,"text":"Mechanistically, TBMS-1 destabilized c-FLIP expression by downregulating STAMBPL1, a deubiquitinase (DUB)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1001,"document":"37349820","golden":false,"offsetInEndSection":1143,"text":"In the present study, we identified ATXN3, a DUB enzyme in the ubiquitin-specific proteases family, as a bona fide deubiquitylase of YAP in PC","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":85,"document":"38358795","golden":false,"offsetInEndSection":203,"text":"Pathogens can regulate eukaryotic proteolysis through the delivery of proteins with de-ubiquitinating (DUB) activities","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":186,"document":"38351178","golden":false,"offsetInEndSection":274,"text":"The role of deubiquitinases (DUBs) and their impact on YY1 remain to be fully elucidated","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":133,"document":"38342418","golden":true,"offsetInEndSection":239,"text":"Deubiquitinating enzymes (DUBs) have been found to be involved in the regulation of myocardial hypertrophy","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":395,"document":"38321455","golden":false,"offsetInEndSection":470,"text":"RNA-Seq was utilized to explore DUB expression levels in LNCaP and LNCaP-AI","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":317,"document":"38316548","golden":false,"offsetInEndSection":531,"text":"MYSM1 is a chromatin binding deubiquitinase (DUB) and an activator of gene expression via its catalytic activity for monoubiquitinated histone H2A (H2A-K119ub), which is a highly abundant repressive epigenetic mark","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":227,"document":"38307937","golden":true,"offsetInEndSection":405,"text":"Ubiquitination plays a critical role in regulating the stability, intracellular trafficking, and enzymatic activity of proteins and is reversed by deubiquitinating enzymes (DUBs)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":218,"document":"38307305","golden":false,"offsetInEndSection":387,"text":"Our current study investigates the role of Ubiquitin-Specific Protease 36 (USP36), a nucleolar deubiquitinating enzyme (DUB), in the progression of DIC and its mechanism","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38306645","golden":false,"offsetInEndSection":89,"text":"Is it necessary to extend fusion to L4 when correcting pediatric L5-S1 spondylolisthesis?","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":82,"document":"38302849","golden":false,"offsetInEndSection":294,"text":"The purpose of this study is to identify key deubiquitinating enzymes (DUBs) for endometriosis diagnosis and elucidate the possible mechanism, offering novel insights for noninvasive early diagnosis and treatment","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1654,"document":"38283833","golden":false,"offsetInEndSection":1782,"text":"e considered habitat richness as proxy for vertebrate host diversity. The results suggest that in highly diverse habitats TBE ri","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"19153604","golden":false,"offsetInEndSection":107,"text":"Deubiquitinating enzymes (DUBs) control the ubiquitination status of proteins in various cellular pathways.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":834,"document":"26455393","golden":false,"offsetInEndSection":991,"text":"Our findings thus identify USP4 as a novel DNA repair regulator and invoke a model in which ubiquitin adducts regulate USP enzyme interactions and functions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"19489724","golden":true,"offsetInEndSection":236,"text":"Deubiquitinating enzymes (DUBs) are proteases that process ubiquitin or ubiquitin-like gene products, reverse the modification of proteins by a single ubiquitin(-like) protein, and remodel polyubiquitin(-like) chains on target proteins.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":753,"document":"30585151","golden":false,"offsetInEndSection":974,"text":"This study unveils a previously unknown function of USP34 in regulating the metabolic stability of gp78 and adds to our understanding of the relevance of partnering of DUBs and E3s in regulation of protein ubiquitylation.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"19153604","golden":false,"offsetInEndSection":82,"text":"Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin-3.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":975,"document":"19153604","golden":false,"offsetInEndSection":1097,"text":"We propose a new function for protein ubiquitination in regulating the activity of certain DUBs and perhaps other enzymes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":592,"document":"19153604","golden":false,"offsetInEndSection":876,"text":"In cells, ubiquitination of endogenous ataxin-3 increases when the proteasome is inhibited, when excess Ub is present, or when the unfolded protein response is induced, suggesting that the cellular functions of ataxin-3 in protein quality control are modulated through ubiquitination.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":108,"document":"19153604","golden":false,"offsetInEndSection":291,"text":"Regulation of the activity of DUBs, which is critically important to cellular homoeostasis, can be achieved at the level of gene expression, protein complex formation, or degradation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":113,"document":"29302259","golden":true,"offsetInEndSection":316,"text":"Much progress has been made investigating the role of ubiquitin ligases at the synapse, however very little is known about the deubiquitinating enzymes (DUBs) which remove ubiquitin from target proteins.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":292,"document":"19153604","golden":false,"offsetInEndSection":464,"text":"Here, we report that ubiquitination also directly regulates the activity of a DUB, ataxin-3, a polyglutamine disease protein implicated in protein quality control pathways.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2374,"document":"35489684","golden":false,"offsetInEndSection":2718,"text":"In addition, broad and severe off-target effects were observed for b-AP15, questioning the alleged specificity of this inhibitor.CONCLUSIONS: This work presents novel insights into the function of proteasome associated DUBs and illustrates the power of in-depth ubiquitinomics for screening the activity of DUBs and of DUB modulating compounds.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1158,"document":"35489684","golden":false,"offsetInEndSection":1585,"text":"In conclusion, this work presents novel insights into the function of proteasome associated DUBs and illustrates the power of in-depth ubiquitinomics for screening the activity of DUBs and of DUB modulating compounds.SIGNIFICANCE: Introduction: The removal of (poly)ubiquitin chains at the proteasome is a key step in the protein degradation pathway that determines which proteins are degraded and ultimately decides cell fate.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"26588485","golden":true,"offsetInEndSection":219,"text":"Understanding function and specificity of de-ubiquitylating enzymes (DUBs) is a major goal of current research, since DUBs are key regulators of ubiquitylation events and have been shown to be mutated in human diseases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":490,"document":"35935969","golden":false,"offsetInEndSection":632,"text":"The main function of deubiquitinases (DUBs) is to remove ubiquitin chains from substrates, changing the biological activity of the substrates.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1609,"document":"35935969","golden":false,"offsetInEndSection":1681,"text":"This suggests that USP22 may regulate tumor resistance to immunotherapy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":243,"document":"37679322","golden":true,"offsetInEndSection":474,"text":"Deubiquitinating enzymes (DUBs) are tasked with specifically hydrolyzing ubiquitin molecules from ubiquitin-linked proteins or precursor proteins and inversely regulating protein degradation, which in turn affects protein function.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1125,"document":"36237424","golden":true,"offsetInEndSection":1351,"text":"Therefore, deubiquitylating enzymes (DUBs) can maintain the dynamic state of cellular ubiquitination by releasing conjugated ubiquitin from proteins and controlling many cellular pathways that are essential for their survival.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1449,"document":"35935969","golden":false,"offsetInEndSection":1519,"text":"USP22 was found to be a positive regulator of stable FOXP3 expression.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":633,"document":"37234921","golden":true,"offsetInEndSection":732,"text":"The removal of ubiquitin is orchestrated by a network of about 100 deubiquitylating enzymes (DUBs).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":241,"document":"35283827","golden":true,"offsetInEndSection":337,"text":"Deubiquitinases (DUBs) cleave ubiquitin from proteins and reverse the process of ubiquitination.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1520,"document":"35935969","golden":false,"offsetInEndSection":1608,"text":"Treg-specific ablation of USP22 leads to reduced tumor volume in multiple cancer models.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1120,"document":"35935969","golden":false,"offsetInEndSection":1248,"text":"USP22 may stabilize programmed death ligand 1 (PD-L1) by deubiquitination while also regulating T-cell infiltration into tumors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1857,"document":"35935969","golden":false,"offsetInEndSection":2006,"text":"Furthermore, we propose a new possibility of combining USP22 with chemotherapeutic, targeted, and immunosuppressive drugs in the treatment of cancer.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"19615732","golden":true,"offsetInEndSection":152,"text":"Deubiquitinating enzymes (Dubs) function to remove covalently attached ubiquitin from proteins, thereby controlling substrate activity and/or abundance.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23335262","golden":false,"offsetInEndSection":172,"text":"Protein ubiquitylation controls many cellular pathways, and timely removal of ubiquitin by deubiquitylating enzymes (DUBs) is essential to govern these different functions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":260,"document":"36959757","golden":false,"offsetInEndSection":480,"text":"Unexpectedly, the specific H2AK119 deubiquitylation complex composed by additional sex comb-like proteins and BAP1 has also been genetically characterized as Polycomb repressive deubiquitnase (PR-DUB) for unclear reasons","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1446,"document":"36012723","golden":false,"offsetInEndSection":1674,"text":"These results reveal deubiquitylating effects induced by Wolbachia infection, suggesting that Wolbachia can widely deubiquitinate proteins that have crucial functions in male fertility of their hosts, but are not involved in CI.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33417828","golden":true,"offsetInEndSection":105,"text":"Deubiquitylating enzymes (DUBs) counteract ubiquitylation to control stability or activity of substrates.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":816,"document":"36371501","golden":false,"offsetInEndSection":1039,"text":"Our results suggest that the catalytic activity of OTU11 and OTU12 is tightly connected to their ability to bind membranes and that OTU11 and OTU12 are involved in the fine-tuning of plasma membrane proteins in Arabidopsis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":232,"document":"18410486","golden":false,"offsetInEndSection":351,"text":"Their activity is balanced by deubiquitylating enzymes (DUBs), which remove ubiquitin from both substrates and ligases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37234921","golden":false,"offsetInEndSection":142,"text":"The attachment of ubiquitin to a substrate (ubiquitination or ubiquitylation) impacts its lifetime and regulates its function within the cell.","beginSection":"abstract"}],"ideal_answer":[" Deubiquitylating enzymes (DUBs) free covalently linked ubiquitin moieties from ubiquitin-ubiquitin and ubiquitin-protein conjugates, and thereby maintain the equilibrium between free and conjugated ubiquitin moieties and regulate ubiquitin-mediated cellular processes.\n","1. deubiquitylating enzyme (DUB) are proteases that reverse protein ubiquitylation and therefore modulate the outcome of this post-translational modification.\n2. The deubiquitylating enzymes (DUBs) maintain the dynamic state of the cellular ubiquitome by releasing conjugated ubiquitin from proteins.\n","The main function of deubiquitylating enzymes (DUBs) is to remove ubiquitin from target proteins, thereby reversing the process of protein ubiquitylation and regulating the stability and fate of these proteins within cells.","\nDeubiquitylating enzymes (DUBs) remove ubiquitin from proteins. They are involved in cellular ubiquitin-mediated processes and maintain the dynamic state of the cellular ubiquitome by releasing conjugated ubiquitin from proteins.\n","\n\nDeubiquitylating enzyme (DUB) is the enzyme that hydrolyzes a peptide, amide, ester or thiolester bond at the C-terminus of UBIQ (ubiquitin), including the post-translationally formed branched peptide bonds in mono- or multi-ubiquitylated conjugates.\n"],"id":"659838b906a2ea257c000033","type":"summary","body":"What is the main function of deubiquitylating enzyme (DUB)?"},{"documents":[{"golden":false,"id":"28252652"},{"golden":false,"id":"22311987"},{"golden":false,"id":"11426648"},{"golden":false,"id":"22172701"},{"golden":false,"id":"14613034"},{"golden":false,"id":"21760983"},{"golden":false,"id":"17512966"},{"golden":false,"id":"23336025"},{"golden":false,"id":"16492148"},{"golden":false,"id":"21337480"},{"golden":false,"id":"24973542"},{"golden":false,"id":"20149240"},{"golden":false,"id":"19707732"},{"golden":false,"id":"30034610"},{"golden":false,"id":"21892210"},{"golden":false,"id":"17897080"},{"golden":false,"id":"25706586"},{"golden":false,"id":"26207888"},{"golden":false,"id":"16951189"},{"golden":false,"id":"26899021"},{"golden":false,"id":"20941592"},{"golden":false,"id":"19852810"},{"golden":false,"id":"16751777"},{"golden":false,"id":"19641500"},{"golden":false,"id":"21804608"},{"golden":false,"id":"25970783"},{"golden":false,"id":"21807512"},{"golden":false,"id":"11728179"},{"golden":false,"id":"24124106"},{"golden":false,"id":"31908412"},{"golden":false,"id":"36423672"},{"golden":false,"id":"37527190"},{"golden":false,"id":"31898971"},{"golden":false,"id":"35721509"},{"golden":false,"id":"35847510"},{"golden":false,"id":"23773437"},{"golden":false,"id":"38064851"},{"golden":false,"id":"24456106"},{"golden":false,"id":"35627217"},{"golden":false,"id":"35846989"},{"golden":false,"id":"30102385"},{"golden":false,"id":"18757333"},{"golden":false,"id":"37212867"},{"golden":false,"id":"35995302"},{"golden":false,"id":"26593678"},{"golden":false,"id":"29051318"},{"golden":false,"id":"34515749"},{"golden":true,"id":"30528168"},{"golden":false,"id":"36373503"},{"golden":false,"id":"32182843"},{"golden":false,"id":"35408476"},{"golden":false,"id":"32078860"},{"golden":false,"id":"32827875"},{"golden":false,"id":"32584021"},{"golden":false,"id":"18849971"},{"golden":false,"id":"23385390"},{"golden":false,"id":"32990536"},{"golden":false,"id":"32397857"},{"golden":false,"id":"37524305"},{"golden":false,"id":"29760125"},{"golden":false,"id":"33450915"},{"golden":false,"id":"34818532"},{"golden":false,"id":"34583194"},{"golden":false,"id":"38247618"},{"golden":false,"id":"37658265"},{"golden":false,"id":"26395559"},{"golden":false,"id":"24984143"},{"golden":false,"id":"37662194"},{"golden":false,"id":"32787107"},{"golden":false,"id":"35551034"},{"golden":false,"id":"36268123"},{"golden":false,"id":"34065234"},{"golden":false,"id":"32659083"},{"golden":false,"id":"34001508"},{"golden":false,"id":"28786345"},{"golden":false,"id":"33684965"},{"golden":false,"id":"18644252"},{"golden":false,"id":"31898237"},{"golden":false,"id":"34129829"},{"golden":false,"id":"34702937"},{"golden":false,"id":"31711927"},{"golden":false,"id":"30098867"},{"golden":false,"id":"32219470"},{"golden":false,"id":"34126765"},{"golden":false,"id":"36594833"},{"golden":false,"id":"33210294"},{"golden":false,"id":"36262390"},{"golden":false,"id":"28356892"},{"golden":false,"id":"36094754"},{"golden":false,"id":"32817167"},{"golden":false,"id":"34432241"},{"golden":false,"id":"36830089"},{"golden":false,"id":"35168506"},{"golden":false,"id":"38230650"},{"golden":false,"id":"34363759"},{"golden":false,"id":"35388618"},{"golden":false,"id":"19415900"},{"golden":false,"id":"25506727"},{"golden":false,"id":"33607487"},{"golden":false,"id":"19655753"},{"golden":false,"id":"37974542"},{"golden":false,"id":"18838795"},{"golden":false,"id":"18281492"},{"golden":false,"id":"19349174"},{"golden":false,"id":"19217287"},{"golden":false,"id":"22038800"},{"golden":false,"id":"16873022"},{"golden":false,"id":"26358752"},{"golden":false,"id":"28339196"},{"golden":false,"id":"28613814"},{"golden":false,"id":"30606672"},{"golden":false,"id":"17921043"},{"golden":false,"id":"28943619"},{"golden":false,"id":"38239128"},{"golden":false,"id":"22396528"},{"golden":false,"id":"36567024"},{"golden":false,"id":"34326465"},{"golden":false,"id":"33673713"},{"golden":false,"id":"34300575"},{"golden":false,"id":"33839740"},{"golden":false,"id":"36484389"},{"golden":false,"id":"33006903"},{"golden":false,"id":"32236606"},{"golden":false,"id":"16990280"},{"golden":false,"id":"30254057"},{"golden":false,"id":"26540596"},{"golden":false,"id":"24743578"},{"golden":false,"id":"31554684"},{"golden":false,"id":"36015098"},{"golden":false,"id":"30117269"},{"golden":false,"id":"38069718"},{"golden":false,"id":"37942620"}],"answerReady":true,"snippets":[{"endSection":"title","offsetInBeginSection":0,"document":"30528168","golden":true,"offsetInEndSection":70,"text":"Diarylcarbonates are a new class of deubiquitinating enzyme inhibitor.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":488,"document":"30528168","golden":true,"offsetInEndSection":661,"text":"Herein we introduce diarylcarbonate esters as a novel class of promiscuous DUB inhibitors that do not have the liabilities associated with the previously reported compounds.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":874,"document":"30528168","golden":true,"offsetInEndSection":968,"text":"Diarylcarbonates may also be a useful scaffold for the development of specific DUB inhibitors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":942,"document":"21892210","golden":false,"offsetInEndSection":1147,"text":"Thus, the study validates a novel therapeutic target site in the survivin protein and provides a promising strategy to develop a new class of therapeutic small molecules for the treatment of human cancers.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"30034610","golden":false,"offsetInEndSection":63,"text":"Reverse Hydroxamate Inhibitors of Bone Morphogenetic Protein 1.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":137,"document":"21337480","golden":false,"offsetInEndSection":272,"text":"Here we describe the design and synthesis of a new class of small-molecule inhibitors for CypA that are based upon a dimedone template.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1267,"document":"21804608","golden":false,"offsetInEndSection":1462,"text":"Thus, CHR-6494 is a first-in-class Haspin inhibitor with a wide spectrum of anticancer effects that merits further preclinical research as a new member of the family of mitotic kinase inhibitors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":784,"document":"19641500","golden":false,"offsetInEndSection":933,"text":"Thus, the BH3 mimetics are a new class of cancer drugs that specifically target a mechanism of cancer cell survival to selectively kill cancer cells.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1012,"document":"31908412","golden":false,"offsetInEndSection":1371,"text":"gs of different sizes. The new scaffolds were designed based on in silico molecular dynamics of survivin.RESULTS: Binding of these rigidized scaffolds to the recombinant L54M mutant of survivin was evaluated, revealing affinities in the low micromolar range.CONCLUSION: This easily accessible, new class of survivin-dimerization modulators is an interesting s","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1133,"document":"36423672","golden":false,"offsetInEndSection":1239,"text":"The small molecule inhibitor GSK2643943A has been shown to inhibit the deubiquitination activity of USP20.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1304,"document":"37527190","golden":false,"offsetInEndSection":1405,"text":"Our findings are hoped to be a good starting point for the development of selective USP14 inhibitors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":617,"document":"36423672","golden":false,"offsetInEndSection":795,"text":"Ubiquitin-specific protease 20 (USP20) belongs to the ubiquitin-specific peptidase (USP) subfamily of DUBs and its important physiological role has been assessed in recent years.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1155,"document":"31898971","golden":false,"offsetInEndSection":1278,"text":"In conclusion, Subquinocin identified here is a useful tool to analyze the signal transduction mediated by USP-family DUBs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":976,"document":"36423672","golden":false,"offsetInEndSection":1132,"text":"The physiological importance of USP20 in disease is being reported continuously, indicating its potential to be a valuable therapeutic target in the future.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":171,"document":"38064851","golden":false,"offsetInEndSection":505,"text":"Additionally, we seek to elucidate the specific regulatory mechanisms through which USP26 modulates Kr?ppel-like factor 6 (KLF6) and assess the subsequent effects of this regulation on both the proliferation and migration of cervical cancer cells.METHODS: All the deubiquitinase (DUB) sequences were classified into USPs and non-USPs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2724,"document":"38064851","golden":false,"offsetInEndSection":2818,"text":"Conversely, knockdown of USP26 was shown to promote these oncogenic properties.CONCLUSIONS: 1.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1240,"document":"36423672","golden":false,"offsetInEndSection":1410,"text":"Herein, we discuss the structure, regulation, and emerging physiological roles of USP20 in disease, hoping to highlight their therapeutic implications for future studies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1217,"document":"35847510","golden":false,"offsetInEndSection":1495,"text":"Overall, our study not only reveals the DUB-involved regulatory mechanism on PML/RAR? stability and validates YOD1 as a potential therapeutic target for APL, but also identifies G5 as a YOD1 inhibitor and a promising candidate for APL, particularly drug-resistant APL treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":796,"document":"36423672","golden":false,"offsetInEndSection":884,"text":"Previous studies on USP20 have focused on its activity in antiviral immunity and cancer.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":211,"document":"37212867","golden":false,"offsetInEndSection":796,"text":"We aimed to perform a narrative review regarding the rising of a new class of drugs capable of blocking important and specific intracellular signals in the maintenance of these pathologies: the small molecules.MATERIALS/METHODS: A total of 114 scientific papers were enrolled in this narrative review.RESULTS: We describe in detail the families of protein kinases-Janus Kinase (JAK), Src kinase, Syk tyrosine kinase, Mitogen-Activated Protein Kinase (MAPK), and Bruton Tyrosine Kinase (BTK)-their physiologic function and new drugs that block these pathways of intracellular signaling.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"26593678","golden":false,"offsetInEndSection":171,"text":"INTRODUCTION: Protein kinase C? (PKC?) is a member of the PKC family of serine/threonine kinases that has been implicated in the pathophysiology of diabetic complications.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":941,"document":"30102385","golden":false,"offsetInEndSection":1160,"text":"Thus, this approach can be used to systematically generate small molecule-sensitive alleles of DEAD-box proteins, allowing for pharmacological inhibition and functional characterization of members of this enzyme family.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":662,"document":"30528168","golden":true,"offsetInEndSection":752,"text":"Diarylcarbonates stabilize the high molecular weight ubiquitin pools in cells and lysates.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":319,"document":"34515749","golden":false,"offsetInEndSection":620,"text":"However, it was the unveiling of the biochemistry and structural biology behind it and its close relatives\u0027 mechanism(s)-of-action that provided the inspiration for what are now known as \u0027BH3-mimetics\u0027, the first clinically approved drugs designed to specifically inhibit protein-protein interactions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":424,"document":"36373503","golden":false,"offsetInEndSection":529,"text":"Deucravacitinib is an oral small molecule that inhibits the activity of TYK2, a member of the JAK family.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36373503","golden":false,"offsetInEndSection":48,"text":"Deucravacitinib in moderate-to-severe psoriasis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":530,"document":"36373503","golden":false,"offsetInEndSection":685,"text":"Deucravacitinib works by allosterically inhibiting TYK2, increasing the specificity of this agent for TYK2 rather than other members of this kinase family.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":556,"document":"32182843","golden":false,"offsetInEndSection":610,"text":"Smac can induce the degradation of cIAPs but not XIAP.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":170,"document":"36373503","golden":false,"offsetInEndSection":352,"text":"The number of therapies for patients with moderate to severe psoriasis has steadily grown over the past two decades, with biologic immunotherapies being the primary agents developed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":89,"document":"36373503","golden":false,"offsetInEndSection":169,"text":"A patient\u0027s quality of life and health can be drastically affected by psoriasis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36373503","golden":false,"offsetInEndSection":88,"text":"Psoriasis is a chronic inflammatory disease that affects up to 1 in 20 people worldwide.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"35408476","golden":false,"offsetInEndSection":93,"text":"Natural Products with Antitumor Potential Targeting the MYB-C/EBP?-p300 Transcription Module.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":686,"document":"36373503","golden":false,"offsetInEndSection":1051,"text":"Deucravacitinib has demonstrated safety and efficacy in moderate to severe plaque psoriasis in clinical trial development, with \u003e50% of patients on deucravacitinib 6?mg daily achieving ?75% reduction in Psoriasis Area and Severity Index score from baseline at 16?weeks versus 9-13% on placebo and 35-41% on apremilast 30?mg twice daily in phase III clinical trials.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":353,"document":"36373503","golden":false,"offsetInEndSection":423,"text":"However, new small-molecule oral therapies have lagged in development.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32078860","golden":false,"offsetInEndSection":289,"text":"Recent evidence shows that combination of correctors and potentiators, such as the drug ivacaftor (VX-770), can significantly restore the functional expression of mutated Cystic Fibrosis Transmembrane conductance Regulator (CFTR), an anion channel which is mutated in cystic fibrosis (CF).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":758,"document":"32078860","golden":false,"offsetInEndSection":983,"text":"Molecular dynamics simulations suggested potential SBC binding sites at the vicinity of ATP-binding sites, distinct from those currently proposed for VX-770, outlining SBC molecules as members of a new family of potentiators.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":488,"document":"32078860","golden":false,"offsetInEndSection":757,"text":"Here, we identified two small molecules, SBC040 and SBC219, which are two efficient cAMP-independent potentiators, acting at low concentration of forskolin with EC50 close to 1??M and in a synergic way with the drug VX-770 on several CFTR mutants of classes II and III.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1246,"document":"29760125","golden":false,"offsetInEndSection":1536,"text":"Thus, because of its chemical plasticity and simplicity of synthesis, our new family of SMCypIs represents a promising new class of drugs with the potential for broad-spectrum anti-Flaviviridae activity as well as an invaluable tool to explore the role of cyclophilins in viral life cycles.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"32078860","golden":false,"offsetInEndSection":111,"text":"Targeting different binding sites in the CFTR structures allows to synergistically potentiate channel activity.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1028,"document":"37524305","golden":false,"offsetInEndSection":1290,"text":"Together, these results uncover a distinct binding site for designing small-molecule agonists for PTH1R and possibly other members of the class B GPCRs and define a receptor conformation that is specific only for G-protein activation but not arrestin signalling.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":290,"document":"32078860","golden":false,"offsetInEndSection":487,"text":"The success of these combinatorial therapies highlights the necessity of identifying a broad panel of specific binding mode modulators, occupying several distinct binding sites at structural level.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":291,"document":"18849971","golden":false,"offsetInEndSection":510,"text":"Here we report the systematic discovery of molecules that potently inhibit both tyrosine kinases and phosphatidylinositol-3-OH kinases, two protein families that are among the most intensely pursued cancer drug targets.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1649,"document":"32397857","golden":false,"offsetInEndSection":2631,"text":"Given the fact that ABTL0812 is under clinical development, our findings support the hypothesis that manipulation of dihydroceramide levels might represents a new therapeutic strategy to target cancer.Abbreviations: 4-PBA: 4-phenylbutyrate; AKT: AKT serine/threonine kinase; ATG: autophagy related; ATF4: activating transcription factor 4; Cer: ceramide; DDIT3: DNA damage inducible transcript 3; DEGS1: delta 4-desaturase, sphingolipid 1; dhCer: dihydroceramide; EIF2A: eukaryotic translation initiation factor 2 alpha; EIF2AK3: eukaryotic translation initiation factor 2 alpha kinase 3; ER: endoplasmic reticulum; HSPA5: heat shock protein family A (Hsp70) member 5; MAP1LC3B: microtubule associated protein 1 light chain 3 beta; MEF: mouse embryonic fibroblast; MTORC1: mechanistic target of rapamycin kinase complex 1; NSCLC: non-small cell lung cancer; THC: ?9-tetrahydrocannabinol; TRIB3: tribbles pseudokinase 3; XBP1: X-box binding protein 1; UPR: unfolded protein response.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":805,"document":"34818532","golden":false,"offsetInEndSection":1031,"text":"Hence, this work contributes to a small but growing collection of protein chaperone inhibitors, and it demonstrates that these molecules disrupt bacterial mechanisms of survival in the presence of different antibiotic classes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1511,"document":"38247618","golden":false,"offsetInEndSection":1789,"text":"In particular, cyclic boronate compounds are now capable of inhibiting all classes of ?-lactamases, while the diazabicyclooctane (DBO) series of small molecules has led to not only new ?-lactamase inhibitors but potentially a new class of antibiotics by directly targeting PBPs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38247618","golden":false,"offsetInEndSection":181,"text":"?-Lactams are the most widely prescribed class of antibiotics that inhibit penicillin-binding proteins (PBPs), particularly transpeptidases that function in peptidoglycan synthesis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1425,"document":"34065234","golden":false,"offsetInEndSection":1641,"text":"Therefore, our data suggest that inhibition of ppUL44 dimerization could represent a new class of HCMV inhibitors, complementary to those targeting the DNA polymerase catalytic subunit or the viral terminase complex.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":787,"document":"37658265","golden":false,"offsetInEndSection":987,"text":"Our work provides a useful pharmacological probe for investigating PDCD2 function and highlights the use of chemical proteomics to discover selective small molecule degraders of unanticipated targets.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1790,"document":"38247618","golden":false,"offsetInEndSection":2098,"text":"With the cautiously optimistic successes of a number of new ?-lactamase inhibitor chemotypes and many questions remaining to be answered about the structure and function of cell wall transpeptidases, non-?-lactam transpeptidase inhibitors may usher in the next exciting phase of drug discovery in this field.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":764,"document":"38247618","golden":false,"offsetInEndSection":950,"text":"In this review, we summarize the recent new findings on both ?-lactamases and cell wall transpeptidases because these two groups of enzymes are evolutionarily and functionally connected.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":862,"document":"32787107","golden":false,"offsetInEndSection":1009,"text":"This work demonstrates that inhibition of Notum activity can be achieved by small, drug-like molecules possessing favorable in vitro ADME profiles.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":951,"document":"38247618","golden":false,"offsetInEndSection":1183,"text":"Many efforts to develop new ?-lactams have aimed to inhibit both transpeptidases and ?-lactamases, while several promising novel ?-lactamase inhibitors have shown the potential to be further developed into transpeptidase inhibitors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1405,"document":"36268123","golden":false,"offsetInEndSection":1563,"text":"Our work demonstrates the feasibility of drugging the YTH domain in YTHDF proteins and opens new avenues for the development of disruptors of m6A recognition.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1360,"document":"35551034","golden":false,"offsetInEndSection":1502,"text":"In this latter model we also validated the efficacy of the dual hHDAC6/hHDAC8 inhibitors against their common target acetylated-alpha tubulin.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28786345","golden":false,"offsetInEndSection":502,"text":"BACKGROUND: Bromodomain and Extra Terminal (BET) family of bromodomain proteins (BRDs), comprised of four members in humans (BRD2, BRD3, BRD4, and BRDT), has emerged as a promising new cancer target class for small-molecule drug discovery.OBJECTIVE: This review discusses the patent literature of BET inhibitors (2010-2017) for the treatment of cancer and other related diseases.METHOD: BET proteins act as \u0027epigenetic readers\u0027 and bind to acetylated lysine residues on the tails of histones H3 and H4.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":503,"document":"28786345","golden":false,"offsetInEndSection":822,"text":"Inhibition of BET proteins for a wide array of therapeutic applications has led to the discovery and development of various BET inhibitors.RESULTS: The increasing significance of BET inhibitors as a potential anticancer therapeutic has led to an extensive patent activity both from academia and pharmaceutical industry.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":544,"document":"31711927","golden":false,"offsetInEndSection":746,"text":"These findings underscore the importance of BPLF1 in viral infectivity and pathogenesis and suggest that inhibition of EBV\u0027s DUB activity may offer a new approach to specific therapy for EBV infections.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1281,"document":"33684965","golden":false,"offsetInEndSection":1462,"text":"These compounds can be considered as potential lead molecular entities to develop new specific PARP-selective inhibitor drugs for personalized therapy combating gynecologic cancers.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1074,"document":"33684965","golden":false,"offsetInEndSection":1280,"text":"In particular, the TMZ50 and ME0328 show strong selectivity between PARP1 and PARP2, but only the former has a potent activity on the two enzymes, whereas the latter can only inhibit the enzymes moderately.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":446,"document":"33684965","golden":false,"offsetInEndSection":559,"text":"Here, we investigate the systematic selectivity profile of sophisticated PARP inhibitors between the two enzymes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":134,"document":"33684965","golden":false,"offsetInEndSection":288,"text":"The PARP1 and PARP2 are the two most documented members in PARP family, which have been approved as the druggable targets of ovarian and cervical cancers.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33684965","golden":false,"offsetInEndSection":133,"text":"Human poly(ADP-ribose) polymerases (PARPs) are a class of nuclear enzymes involved in the pathogenesis of diverse gynecologic tumors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":758,"document":"31898237","golden":false,"offsetInEndSection":1026,"text":"MLN4924 is currently in the Phase I/II clinical trials for anticancer application.In the last few years, targeting protein-protein interactions of the neddylation complexes has been pursued as a potential strategy to selectively inhibit the activity of individual CRL.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":845,"document":"33684965","golden":false,"offsetInEndSection":1073,"text":"It is revealed that the inhibitor selectivity is conferred from the exquisite difference in the residue composition and structural architecture of both the local activity sites and the whole catalytic domains of the two enzymes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":832,"document":"34129829","golden":false,"offsetInEndSection":1018,"text":"Through these efforts, we have identified multiple highly selective DUB inhibitors and developed a roadmap for rapidly identifying and validating selective inhibitors of related enzymes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":560,"document":"33684965","golden":false,"offsetInEndSection":844,"text":"Computational methods are used to model/optimize the complex structures of inhibitor ligands with PARP1/2 catalytic domains and then to estimate the theoretical Fenzymatic assays exhibit a good consistence with theoretical selectivity over six tested inhibitor samples (rc2 ?\u003d?0.857).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":811,"document":"33210294","golden":false,"offsetInEndSection":945,"text":"We conclude that USP13 is a strong mutant EGFR-specific cotarget that could improve the treatment efficacy of EGFR-targeted therapies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":606,"document":"37658265","golden":false,"offsetInEndSection":786,"text":"Using 10?e as a pharmacological probe, we demonstrate that PDCD2 functions as a critical regulator of cell growth by modulating the progression of the cell cycle in T lymphoblasts.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":266,"document":"37658265","golden":false,"offsetInEndSection":375,"text":"Here we report the discovery and characterization of 10?e, a first-in-class small molecule degrader of PDCD2.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":125,"document":"37658265","golden":false,"offsetInEndSection":265,"text":"Programmed cell death 2 (PDCD2) is a member of the B-cell lymphoma 2 (Bcl-2) family of proteins, which are critical regulators of apoptosis.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37662194","golden":false,"offsetInEndSection":105,"text":"Fe-TAMLs as a new class of small molecule peroxidase probes for correlated light and electron microscopy.","beginSection":"title"},{"endSection":"title","offsetInBeginSection":0,"document":"37658265","golden":false,"offsetInEndSection":105,"text":"Proteomics-Based Discovery of First-in-Class Chemical Probes for Programmed Cell Death Protein 2 (PDCD2).","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":376,"document":"37658265","golden":false,"offsetInEndSection":605,"text":"We discovered this PDCD2 degrader by serendipity using a chemical proteomics approach, in contrast to the conventional approach for making bivalent degraders starting from a known binding ligand targeting the protein of interest.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1554,"document":"32817167","golden":false,"offsetInEndSection":1754,"text":"These findings demonstrate that CV-3 can effectively inhibit HIV-1 by blocking the interaction between Vif and CBF? and that this interaction can serve as a new target for developing HIV-1 inhibitors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":591,"document":"34702937","golden":false,"offsetInEndSection":748,"text":"Therefore, inhibition of Skp2 function by small-molecule compounds targeting Skp2-Cks1 interaction is emerging as a promising and novel anti-cancer strategy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":570,"document":"35168506","golden":false,"offsetInEndSection":803,"text":"In this review, we firstly present an overview of the role of CA IX in hypoxic tumors physiopathology, then provide a comprehensive update on the rational design and synthesis of small molecule CA IX inhibitors discovered since 2019.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":751,"document":"38230650","golden":false,"offsetInEndSection":1015,"text":"Our results show that previously discovered thiol-fibronectin hybrids are generally tolerant of a range of ncAA substitutions and retain binding functions to carbonic anhydrases following click chemistry-mediated assembly of hybrids with diverse linker structures.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":284,"document":"34363759","golden":false,"offsetInEndSection":467,"text":"We demonstrate a platform to discover protein-small molecule (PriSM) hybrids to combine unique pharmacophore activities and shapes with constrained, efficiently engineerable proteins.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":723,"document":"34363759","golden":false,"offsetInEndSection":938,"text":"Isolated PriSMs exhibit potent, specific inhibition of carbonic anhydrase isoforms with efficacy superior to that of acetazolamide or protein alone, including an 80-fold specificity increase and 9-fold potency gain.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35388618","golden":false,"offsetInEndSection":129,"text":"We report aryl sulfonamide inhibitors of human carbonic anhydrase (hCA; EC 4.2.1.1) enzymes containing short ureido alkoxy tails.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":130,"document":"35388618","golden":false,"offsetInEndSection":249,"text":"The inhibition potency of such compounds was investigated in vitro on the major hCA isoforms (i.e. I, II, IX, and XII).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":512,"document":"35388618","golden":false,"offsetInEndSection":644,"text":"This study adds to the field of developing hCA inhibitors at molecular level the critical interactions governing ligand selectivity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":165,"document":"19415900","golden":false,"offsetInEndSection":405,"text":"Here we report a small-molecule stabilization study of the exceptionally destabilized HCA II mutant H107Y employing inhibitors based on p-aminobenzoylsulfonamide compounds and 1,3,4-thiadiazolylsulfonamides as well as amino acid activators.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"25506727","golden":false,"offsetInEndSection":259,"text":"Small-molecule cytotoxic agents are already in use for cancer immunotherapy in the form of antibody conjugates containing these molecules linked covalently to antibodies or their fragments with the goal of targeting specific surface components of tumor cells.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":442,"document":"33607487","golden":false,"offsetInEndSection":718,"text":"To inhibit virus replication and improve treatment options, a set of small-molecule compounds, targeted inhibitors against the ASFV pS273R protease, were obtained through molecular screening by homology modeling and molecular docking based on structural information of pS273R.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1431,"document":"18281492","golden":false,"offsetInEndSection":1609,"text":"This study reveals a new insight into the role of PRL-3 in priming tumor progression and shows that PRL may represent an attractive target for therapeutic intervention in cancer.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1269,"document":"18281492","golden":false,"offsetInEndSection":1430,"text":"This is the first report of a potent selective PRL inhibitor that suppresses tumor cell three-dimensional growth by a novel mechanism involving p130Cas cleavage.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":870,"document":"28339196","golden":false,"offsetInEndSection":974,"text":"These data establish that compound 23 (BETd-260/ZBC260) is a highly potent and efficacious BET degrader.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":411,"document":"19217287","golden":false,"offsetInEndSection":639,"text":"Herein, we disclose the structure activity relationships that led to the synthesis and biological characterization of 14, a novel small molecule inhibitor of both IGF-IR and members of the epidermal growth factor family of RTKs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":602,"document":"19349174","golden":false,"offsetInEndSection":753,"text":"Since Bang52 bears no resemblance to any chemical binder of Bcl-x(L) we believe that degradation of the protein is stimulated by a new type of pathway.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1152,"document":"28613814","golden":false,"offsetInEndSection":1305,"text":"Our novel PDI inhibitor highlights the potential of 2-chloropropionamides as weak and stereochemically tunable electrophiles for covalent drug discovery.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":802,"document":"18281492","golden":false,"offsetInEndSection":1059,"text":"The thienopyridone showed significant inhibition of tumor cell anchorage-independent growth in soft agar, induction of the p130Cas cleavage, and anoikis, a type of apoptosis that can be induced by anticancer agents via disruption of cell-matrix interaction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1060,"document":"18281492","golden":false,"offsetInEndSection":1268,"text":"Unlike etoposide, thienopyridone-induced p130Cas cleavage and apoptosis were not associated with increased levels of p53 and phospho-p53 (Ser(15)), a hallmark of genotoxic drug-induced p53 pathway activation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":365,"document":"18281492","golden":false,"offsetInEndSection":602,"text":"We have now shown that small interfering RNA-mediated depletion of PRL expression in cancer cells results in the down-regulation of p130Cas phosphorylation and expression and prevents tumor cell anchorage-independent growth in soft agar.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"18281492","golden":false,"offsetInEndSection":167,"text":"A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":603,"document":"18281492","golden":false,"offsetInEndSection":801,"text":"We have also identified a small molecule, 7-amino-2-phenyl-5H-thieno[3,2-c]pyridin-4-one (thienopyridone), which potently and selectively inhibits all three PRLs but not other phosphatases in vitro.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38239128","golden":false,"offsetInEndSection":88,"text":"N-Cyanopiperazines as Specific Covalent Inhibitors of the Deubiquitinating Enzyme UCHL1.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33006903","golden":false,"offsetInEndSection":139,"text":"INTRODUCTION: GLI1 is a transcription factor that has been identified as a downstream effector for multiple tumorigenic signaling pathways.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":934,"document":"34300575","golden":false,"offsetInEndSection":1074,"text":"Further, they promoted cell death even with low dose SN-38, thereby establishing two new classes of TDP1 inhibitors with clinical potential.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1216,"document":"34326465","golden":false,"offsetInEndSection":1333,"text":"These studies provide a novel therapeutic approach to achieving selective targeting of mutated JAK2 signaling in MPN.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":107,"document":"38239128","golden":false,"offsetInEndSection":341,"text":"However, many compounds with a cyanopyrrolidine warhead show cross-reactivity toward small subsets of DUBs or toward the protein deglycase PARK7/DJ-1, hampering their use for the selective perturbation of a single DUB in living cells.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38239128","golden":false,"offsetInEndSection":106,"text":"Cyanamides have emerged as privileged scaffolds in covalent inhibitors of deubiquitinating enzymes (DUBs).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1260,"document":"38239128","golden":false,"offsetInEndSection":1481,"text":"s. Our results represent an encouraging case study for the refining of electrophilic compounds into chemical probes, emphasizing the potential to engineer specificity through subtle chemical modifications around the warhe","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":342,"document":"38239128","golden":false,"offsetInEndSection":554,"text":"Here, we disclose N\u0027-alkyl,N-cyanopiperazines as structures for covalent enzyme inhibition with exceptional specificity for the DUB UCHL1 among 55 human deubiquitinases and with effective target engagement in cel","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":555,"document":"38239128","golden":false,"offsetInEndSection":768,"text":"s. Notably, transitioning from 5-membered pyrrolidines to 6-membered heterocycles eliminated PARK7 binding and introduced context-dependent reversibility of the isothiourea linkage to the catalytic cysteine of UCH","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":641,"document":"22396528","golden":false,"offsetInEndSection":926,"text":"We have used structural and functional approaches to identify and characterize a group of small molecules that indirectly target class IIa HDACs by blocking their interaction with MEF2 on DNA.Weused X-ray crystallography and (19)F NMRto show that these compounds directly bind to MEF2.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1686,"document":"24743578","golden":false,"offsetInEndSection":1883,"text":"In conclusion, unlike other SRC SMIs characterized by our laboratory that directly bind to SRCs, verrucarin A is a potent and selective SMI that blocks SRC-3 function through an indirect mechanism.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1180,"document":"16990280","golden":false,"offsetInEndSection":1373,"text":"Taken together, NPN is a novel member of the SLRP family that may play important roles in kidney development and pathophysiology by functioning as an endogenous inhibitor of TGF-beta signaling.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1339,"document":"30254057","golden":false,"offsetInEndSection":1514,"text":"Our data reveal new drug leads for the development of TRIB2-degrading compounds, which will also be invaluable for unraveling the cellular mechanisms of TRIB2-based signaling.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":764,"document":"34300575","golden":false,"offsetInEndSection":933,"text":"All three TDP1 inhibitors had no effect on TOP1 activity and acted synergistically with the TOP1 poison SN-38 to increase the amount of TOP1 cleavage-induced DNA damage.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1075,"document":"34300575","golden":false,"offsetInEndSection":1244,"text":"Thus, we here report a dual-sensor screening approach for in vitro selection of TDP1 drugs and three new TDP1 drug candidates that act synergistically with TOP1 poisons.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":476,"document":"34300575","golden":false,"offsetInEndSection":638,"text":"As the main function of TDP1 is repair of TOP1 cleavage-induced DNA damage, inhibition of TOP1 cleavage could thus reduce the biological effect of the TDP1 drugs.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34300575","golden":false,"offsetInEndSection":79,"text":"A Dual-Sensor-Based Screening System for In Vitro Selection of TDP1 Inhibitors.","beginSection":"title"},{"endSection":"title","offsetInBeginSection":0,"document":"22396528","golden":false,"offsetInEndSection":86,"text":"Inhibition of the function of class IIa HDACs by blocking their interaction with MEF2.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":267,"document":"34300575","golden":false,"offsetInEndSection":475,"text":"We here report a screening system utilizing specific sensors for tyrosyl-DNA phosphodiesterase 1 (TDP1) and topoisomerase 1 (TOP1) activity to screen in vitro for drugs inhibiting TDP1 without affecting TOP1.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":920,"document":"30117269","golden":false,"offsetInEndSection":1063,"text":"These findings reveal interesting classes of compounds that could be optimized for particular inflammatory diseases governed by different TLRs.","beginSection":"abstract"}],"exact_answer":[["Deubiquitinating enzymes","DUB"]],"ideal_answer":["Diarylcarbonates are a new class of small molecule drugs that can inhibit members of the deubiquitinating enzyme family of proteins.","Diarylcarbonates are a new class of small molecule drugs that can inhibit the deubiquitinating enzyme (DUB) family of proteins.","Diarylcarbonates are a new class of small molecule drugs that can inhibit members of the deubiquitinating enzyme (DUB) family of proteins."," Diarylcarbonates are a new class of deubiquitinating enzyme inhibitor.\n"," Diarylcarbonates are a new class of small molecule drugs that inhibit deubiquitinating enzymes (DUBs), which have become promising targets for drug discovery and development.\n","Diarylcarbonates are a new class of small molecule drugs that inhibit members of the deubiquitinating enzyme (DUB) family of proteins."],"id":"659839ff06a2ea257c000034","type":"factoid","body":"Diarylcarbonates are a new class of small molecule drugs that can inhibit members of what family of proteins?"},{"documents":[{"golden":false,"id":"31377227"},{"golden":true,"id":"30054833"},{"golden":false,"id":"34110579"},{"golden":false,"id":"35819579"},{"golden":false,"id":"34731466"},{"golden":false,"id":"37434311"},{"golden":false,"id":"37287304"},{"golden":true,"id":"33437151"},{"golden":false,"id":"37778659"},{"golden":false,"id":"30124147"},{"golden":false,"id":"37738505"},{"golden":false,"id":"32101427"},{"golden":true,"id":"33378864"},{"golden":false,"id":"28881183"},{"golden":false,"id":"30976107"},{"golden":true,"id":"37935248"},{"golden":false,"id":"37670704"},{"golden":false,"id":"34910274"},{"golden":false,"id":"33870801"},{"golden":false,"id":"37714843"},{"golden":false,"id":"31957003"},{"golden":false,"id":"36736243"},{"golden":false,"id":"33779453"},{"golden":false,"id":"34057379"},{"golden":true,"id":"33844136"},{"golden":false,"id":"34019959"},{"golden":false,"id":"37712494"},{"golden":false,"id":"37105727"},{"golden":false,"id":"33901609"},{"golden":true,"id":"35364270"},{"golden":true,"id":"37514102"},{"golden":true,"id":"33797376"},{"golden":true,"id":"34731478"},{"golden":false,"id":"35274943"},{"golden":true,"id":"26814169"},{"golden":false,"id":"37398436"},{"golden":false,"id":"37765069"},{"golden":false,"id":"38215898"},{"golden":false,"id":"35939454"},{"golden":false,"id":"37652709"},{"golden":true,"id":"37396052"},{"golden":true,"id":"33940588"},{"golden":true,"id":"33295676"},{"golden":false,"id":"37161878"},{"golden":false,"id":"37031187"},{"golden":true,"id":"36804676"},{"golden":false,"id":"37768001"},{"golden":false,"id":"34984579"},{"golden":false,"id":"38134123"},{"golden":false,"id":"32778984"},{"golden":true,"id":"36181380"},{"golden":false,"id":"35282622"},{"golden":false,"id":"38253545"},{"golden":false,"id":"36176050"},{"golden":false,"id":"33358699"},{"golden":true,"id":"38215530"},{"golden":false,"id":"34471498"},{"golden":true,"id":"33484947"},{"golden":false,"id":"34870150"},{"golden":true,"id":"35759424"},{"golden":true,"id":"37132148"},{"golden":true,"id":"36263480"},{"golden":true,"id":"34875986"},{"golden":false,"id":"35301149"},{"golden":false,"id":"36151740"},{"golden":true,"id":"34251580"},{"golden":false,"id":"32009951"},{"golden":false,"id":"34731482"},{"golden":false,"id":"35490393"},{"golden":true,"id":"35679624"},{"golden":true,"id":"33589615"},{"golden":false,"id":"36232434"},{"golden":false,"id":"33965571"},{"golden":false,"id":"37331692"},{"golden":false,"id":"37310669"},{"golden":false,"id":"33397265"},{"golden":true,"id":"31905263"},{"golden":false,"id":"37529294"},{"golden":false,"id":"37651150"},{"golden":true,"id":"37337437"},{"golden":true,"id":"37711014"},{"golden":false,"id":"38104638"},{"golden":false,"id":"33347838"},{"golden":false,"id":"34731468"},{"golden":false,"id":"38300623"},{"golden":false,"id":"38293764"},{"golden":false,"id":"38270010"},{"golden":false,"id":"38259418"},{"golden":false,"id":"38257424"},{"golden":false,"id":"38224784"},{"golden":false,"id":"38213164"},{"golden":false,"id":"38192482"},{"golden":false,"id":"38190950"},{"golden":false,"id":"35592425"},{"golden":true,"id":"37716910"},{"golden":false,"id":"34939433"},{"golden":false,"id":"36829050"},{"golden":false,"id":"37779744"},{"golden":false,"id":"37561315"},{"golden":false,"id":"36143468"},{"golden":false,"id":"37276884"},{"golden":true,"id":"37587767"},{"golden":true,"id":"34393317"},{"golden":true,"id":"37776682"},{"golden":false,"id":"26014110"},{"golden":false,"id":"37033647"},{"golden":false,"id":"33510862"},{"golden":false,"id":"25928885"},{"golden":false,"id":"35163865"},{"golden":false,"id":"32469509"},{"golden":true,"id":"38344556"},{"golden":true,"id":"38340012"},{"golden":false,"id":"38321848"},{"golden":false,"id":"38321543"},{"golden":false,"id":"38299408"},{"golden":false,"id":"38294194"},{"golden":false,"id":"38291364"},{"golden":false,"id":"38280026"},{"golden":false,"id":"38260445"},{"golden":false,"id":"38259971"},{"golden":false,"id":"37921672"},{"golden":false,"id":"37805064"},{"golden":false,"id":"37780897"},{"golden":false,"id":"37468046"},{"golden":false,"id":"36775876"},{"golden":true,"id":"36347444"},{"golden":false,"id":"35433167"},{"golden":false,"id":"35142086"},{"golden":false,"id":"33501158"},{"golden":true,"id":"29879881"},{"golden":false,"id":"31824921"},{"golden":true,"id":"17504169"},{"golden":false,"id":"37701048"},{"golden":true,"id":"31466916"},{"golden":false,"id":"36017693"},{"golden":false,"id":"35382271"},{"golden":false,"id":"33507975"},{"golden":true,"id":"31294972"},{"golden":false,"id":"37125780"},{"golden":false,"id":"33739897"},{"golden":false,"id":"37232451"},{"golden":false,"id":"35385478"},{"golden":false,"id":"31886259"},{"golden":true,"id":"37799217"},{"golden":false,"id":"33019216"},{"golden":false,"id":"33521623"},{"golden":false,"id":"32102234"},{"golden":false,"id":"36994428"},{"golden":false,"id":"35426249"},{"golden":false,"id":"33557253"},{"golden":false,"id":"33386091"},{"golden":false,"id":"36923950"},{"golden":false,"id":"37031957"},{"golden":false,"id":"38339380"},{"golden":false,"id":"38318033"},{"golden":false,"id":"38234400"},{"golden":false,"id":"38213536"},{"golden":false,"id":"38191620"},{"golden":false,"id":"38125666"},{"golden":false,"id":"37998936"},{"golden":false,"id":"37688994"},{"golden":false,"id":"38100293"},{"golden":false,"id":"34443366"},{"golden":false,"id":"36154119"},{"golden":false,"id":"35889440"},{"golden":false,"id":"36339033"},{"golden":false,"id":"37022608"},{"golden":false,"id":"35849939"},{"golden":false,"id":"31995074"},{"golden":false,"id":"38139037"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":636,"document":"37738505","golden":false,"offsetInEndSection":789,"text":"AI technologies, such as generative chemistry, machine learning, and multiproperty optimization, have enabled several compounds to enter clinical trials.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":375,"document":"30054833","golden":true,"offsetInEndSection":842,"text":"Owing to the development of machine learning theory and the accumulation of pharmacological data, the artificial intelligence (AI) technology, as a powerful data mining tool, has cut a figure in various fields of the drug design, such as virtual screening, activity scoring, quantitative structure-activity relationship (QSAR) analysis, de novo drug design, and in silico evaluation of absorption, distribution, metabolism, excretion and toxicity (ADME/T) properties.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":212,"document":"33378864","golden":true,"offsetInEndSection":453,"text":"To address the difficulties of identifying, validating, and pursuing a promising drug target, artificial intelligence (AI) technologies including machine learning (ML) have been adopted at all stages throughout the drug development pipeline.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":567,"document":"37935248","golden":true,"offsetInEndSection":940,"text":"Several drug discovery processes have used machine learning and deep learning algorithms, including peptide synthesis, structure-based virtual screening, ligand-based virtual screening, toxicity prediction, drug monitoring and release, pharmacophore modelling, quantitative structure-activity relationship, drug repositioning, polypharmacology, and physiochemical activity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":475,"document":"37738505","golden":false,"offsetInEndSection":635,"text":"This review discusses the use of AI in the three pillars of drug discovery: diseases, targets, and therapeutic modalities, with a focus on small-molecule drugs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":505,"document":"33437151","golden":true,"offsetInEndSection":740,"text":"This review provides a comprehensive, organized summary of the recent research trends in AI-guided drug discovery process including target identification, hit identification, ADMET prediction, lead optimization, and drug repositioning.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37738505","golden":false,"offsetInEndSection":207,"text":"Drug discovery is adapting to novel technologies such as data science, informatics, and artificial intelligence (AI) to accelerate effective treatment development while reducing costs and animal experiments.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":733,"document":"32101427","golden":false,"offsetInEndSection":995,"text":"While each of these systems addresses different stages of the discovery pipeline, all of them share three common features: a trigger that initiates the recommendation, an analysis that leverages our existing systems with AI, and the delivery of a recommendation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":891,"document":"37738505","golden":false,"offsetInEndSection":1044,"text":"The full potential of AI in drug discovery can only be realized with sufficient ground truth and appropriate human intervention at later pipeline stages.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":348,"document":"37738505","golden":false,"offsetInEndSection":474,"text":"Successful drug discovery requires optimizing properties related to pharmacodynamics, pharmacokinetics, and clinical outcomes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":623,"document":"33844136","golden":true,"offsetInEndSection":1007,"text":"Machine learning and deep learning algorithms have been implemented in several drug discovery processes such as peptide synthesis, structure-based virtual screening, ligand-based virtual screening, toxicity prediction, drug monitoring and release, pharmacophore modeling, quantitative structure-activity relationship, drug repositioning, polypharmacology, and physiochemical activity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1165,"document":"37738505","golden":false,"offsetInEndSection":1249,"text":"Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":658,"document":"35364270","golden":true,"offsetInEndSection":840,"text":"Finally, we discuss the use of ML to predict PK to rank the ability of drug candidates to achieve appropriate exposures and hence provide important insights into safety and efficacy.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"35364270","golden":true,"offsetInEndSection":64,"text":"Machine Learning guided early drug discovery of small molecules.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":180,"document":"35364270","golden":true,"offsetInEndSection":290,"text":"Despite this, the use of ML is still limited in the pharmacokinetic/pharmacodynamic (PK/PD) application space.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1254,"document":"37514102","golden":true,"offsetInEndSection":1464,"text":"This comprehensive review explores the wide-ranging applications of AI in drug discovery, drug delivery dosage form designs, process optimization, testing, and pharmacokinetics/pharmacodynamics (PK/PD) studies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":524,"document":"34731478","golden":true,"offsetInEndSection":855,"text":"This review provides the current state of the art of AI methods applied to drug discovery, with a focus on structure- and ligand-based virtual screening, library design and high-throughput analysis, drug repurposing and drug sensitivity, de novo design, chemical reactions and synthetic accessibility, ADMET, and quantum mechanics.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":118,"document":"26814169","golden":true,"offsetInEndSection":621,"text":"Machine learning (ML) approaches have been of special interest, since they can be applied in several steps of the drug discovery methodology, such as prediction of target structure, prediction of biological activity of new ligands through model construction, discovery or optimization of hits, and construction of models that predict the pharmacokinetic and toxicological (ADMET) profile of compounds.AREAS COVERED: This article presents an overview on some applications of ML techniques in drug design.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":146,"document":"37161878","golden":false,"offsetInEndSection":391,"text":"Artificial intelligence can be used at multiple stages during the drug discovery process, from aiding our understanding of the fundamental actions of GPCRs to the discovery of new ligand-GPCR interactions or the prediction of clinical responses.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":848,"document":"33295676","golden":true,"offsetInEndSection":1204,"text":"After introducing the AI/ML models as well as the conceptualization and data preparation, we outline the applications of AI/ML technologies to several key procedures in drug discovery, including target identification, compound screening, hit/lead generation and optimization, drug response and synergy prediction, de novo drug design, and drug repurposing.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1452,"document":"35939454","golden":false,"offsetInEndSection":1731,"text":"In summary, our framework combines two actively studied machine learning approaches to disease target identification, namely tensor factorisation and knowledge graph representation learning, which could be a promising avenue for further exploration in data-driven drug discovery.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":532,"document":"37161878","golden":false,"offsetInEndSection":654,"text":"We summarise the published applications of artificial intelligence to different stages of the GPCR drug discovery process.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":655,"document":"37161878","golden":false,"offsetInEndSection":849,"text":"Finally, we reflect on the benefits and limitations of artificial intelligence and share our vision for the exciting potential for further development of applications to aid GPCR drug discovery.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37161878","golden":false,"offsetInEndSection":145,"text":"The application of artificial intelligence (AI) approaches to drug discovery for G protein-coupled receptors (GPCRs) is a rapidly expanding area.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33940588","golden":true,"offsetInEndSection":241,"text":"Artificial intelligence (AI) techniques have already been gradually applied to the entire drug design process, from target discovery, lead discovery, lead optimization and preclinical development to the final three phases of clinical trials.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37161878","golden":false,"offsetInEndSection":99,"text":"The application of artificial intelligence to accelerate G protein-coupled receptor drug discovery.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":93,"document":"37768001","golden":false,"offsetInEndSection":677,"text":"However, the translation of insights and drugs discovered in model systems has proven immensely challenging, marred by high failure rates in human clinical trials.METHODS: Here we review the application of artificial intelligence (AI) and machine learning (ML) in experimental medicine for dementia research.RESULTS: Considering the specific challenges of reproducibility and translation between other species or model systems and human biology in preclinical dementia research, we highlight best practices and resources that can be leveraged to quantify and evaluate translatability.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":959,"document":"37031187","golden":false,"offsetInEndSection":1099,"text":"AI-Bind is a high-throughput approach to identify drug-target combinations with the potential of becoming a powerful tool in drug discovery.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":505,"document":"37031187","golden":false,"offsetInEndSection":684,"text":"Here we introduce AI-Bind, a pipeline that combines network-based sampling strategies with unsupervised pre-training to improve binding predictions for novel proteins and ligands.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37031187","golden":false,"offsetInEndSection":82,"text":"Improving the generalizability of protein-ligand binding predictions with AI-Bind.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":219,"document":"36804676","golden":true,"offsetInEndSection":610,"text":"In recent years machine learning and artificial intelligence (AI) emerged as a major tool for modelling of in?vivo animal and human PK, enabling prediction from chemical structure early in drug discovery, and therefore offering opportunities to guide the design and prioritisation of molecules based on relevant in?vivo properties and, ultimately, predicting human PK at the point of design.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":711,"document":"37396052","golden":true,"offsetInEndSection":901,"text":"We present applications of AI at various stages of drug discovery pipelines, including the inherently computational approaches of de novo design and prediction of a drug\u0027s likely properties.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37031187","golden":false,"offsetInEndSection":98,"text":"Identifying novel drug-target interactions is a critical and rate-limiting step in drug discovery.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":685,"document":"37031187","golden":false,"offsetInEndSection":958,"text":"We validate AI-Bind predictions via docking simulations and comparison with recent experimental evidence, and step up the process of interpreting machine learning prediction of protein-ligand binding by identifying potential active binding sites on the amino acid sequence.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":181,"document":"33797376","golden":true,"offsetInEndSection":435,"text":"This problem of late-stage attrition of the drug candidates because of adverse ADMET profile motivated us to analyze the current role and status of different in silico tools along with the rise of machine learning (ML) based program for ADMET prediction.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"33797376","golden":true,"offsetInEndSection":115,"text":"A Recent Appraisal of Artificial Intelligence and In Silico ADMET Prediction in the Early Stages of Drug Discovery.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":928,"document":"33797376","golden":true,"offsetInEndSection":1075,"text":"DNNs have shown the ability to learn from more complex data and this gives DNN an edge over other ML algorithms to be applied for ADMET prediction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":311,"document":"36181380","golden":false,"offsetInEndSection":555,"text":"The types of AI models used range from unsupervised clustering of drugs or patients aimed at identifying potential drug compounds or suitable patient populations, to supervised machine learning approaches to improve therapeutic drug monitoring.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":161,"document":"36181380","golden":true,"offsetInEndSection":310,"text":"AI is now used throughout the entire continuum of pharmacology research and clinical practice and from early drug discovery to real-world datamining.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":678,"document":"35282622","golden":false,"offsetInEndSection":926,"text":"In this article, we review and discuss the rational applications of AI approaches developed to assist in discovering bioactive NPs and capturing the molecular \"patterns\" of these privileged structures for combinatorial design or target selectivity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36181380","golden":true,"offsetInEndSection":160,"text":"In recent years, the use of artificial intelligence (AI) in health care has risen steadily, including a wide range of applications in the field of pharmacology.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":556,"document":"36181380","golden":false,"offsetInEndSection":679,"text":"Additionally, natural language processing is increasingly used to mine electronic health records to obtain real-world data.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":708,"document":"38215530","golden":true,"offsetInEndSection":1029,"text":"This review explores the use of AI in identifying synergistic co-targets and delineating them from anti-targets that lead to adverse effects, and then discusses advances in AI-enabled docking, generative chemistry, and proteochemometric modeling of proteome-wide compound interactions, in the context of polypharmacology.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":680,"document":"36181380","golden":true,"offsetInEndSection":818,"text":"In this mini-review, we discuss the basics of AI followed by an outline of its application in pharmacology research and clinical practice.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36181380","golden":true,"offsetInEndSection":62,"text":"Artificial intelligence in pharmacology research and practice.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":292,"document":"35759424","golden":true,"offsetInEndSection":552,"text":"This expert review article offers a systematic summary of the application of artificial intelligence (AI), particularly machine learning (ML), to drug repurposing and classifies and introduces the common clustering, dimensionality reduction, and other methods.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1110,"document":"38253545","golden":false,"offsetInEndSection":1275,"text":"Furthermore, we showcase RENOIR\u0027s successful application in recently published studies, where it identified classifiers for SET2D and TP53 mutation status in cancer.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36263480","golden":true,"offsetInEndSection":489,"text":"BACKGROUND: The artificial intelligence (AI)-assisted design of drug candidates with novel structures and desired properties has received significant attention in the recent past, so related areas of forward prediction that aim to discover chemical matters worth synthesizing and further experimental investigation.OBJECTIVES: The purpose behind developing AI-driven models is to explore the broader chemical space and suggest new drug candidate scaffolds with promising therapeutic value.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":565,"document":"33484947","golden":true,"offsetInEndSection":749,"text":"Artificial intelligence (AI) and adoption of machine learning (ML) tools offer the promise of revolutionising drug development, and overcoming obstacles in the drug discovery pipeline.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"33484947","golden":false,"offsetInEndSection":68,"text":"Use of artificial intelligence to enhance phenotypic drug discovery.","beginSection":"title"},{"endSection":"title","offsetInBeginSection":0,"document":"36176050","golden":false,"offsetInEndSection":144,"text":"Comparing the applications of machine learning, PBPK, and population pharmacokinetic models in pharmacokinetic drug-drug interaction prediction.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":327,"document":"34251580","golden":true,"offsetInEndSection":513,"text":"Different AI tools are being applied to support all four steps of the drug development process (basic research for drug discovery; pre-clinical phase; clinical phase; and postmarketing).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":471,"document":"38215530","golden":true,"offsetInEndSection":707,"text":"Machine learning and deep learning techniques enable modeling protein structures, generating novel compounds, and decoding their polypharmacological effects, opening an avenue for more systematic and predictive multi-target drug design.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38215530","golden":true,"offsetInEndSection":70,"text":"AI for targeted polypharmacology: The next frontier in drug discovery.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38215530","golden":true,"offsetInEndSection":170,"text":"In drug discovery, targeted polypharmacology, i.e., targeting multiple molecular targets with a single drug, is redefining therapeutic design to address complex diseases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35679624","golden":true,"offsetInEndSection":559,"text":"The use of artificial intelligence (AI) and machine learning (ML) in pharmaceutical research and development has to date focused on research: target identification; docking-, fragment-, and motif-based generation of compound libraries; modeling of synthesis feasibility; rank-ordering likely hits according to structural and chemometric similarity to compounds having known activity and affinity to the target(s); optimizing a smaller library for synthesis and high-throughput screening; and combining evidence from screening to support hit-to-lead decisions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1276,"document":"38253545","golden":false,"offsetInEndSection":1409,"text":"Finally, we present a use case where RENOIR was employed to address a significant pharmacological challenge-predicting drug efficacy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":292,"document":"33589615","golden":true,"offsetInEndSection":517,"text":"We present DRIAD (Drug Repurposing In AD), a machine learning framework that quantifies potential associations between the pathology of AD severity (the Braak stage) and molecular mechanisms as encoded in lists of gene names.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":364,"document":"38253545","golden":false,"offsetInEndSection":598,"text":"To address these issues and focusing on the learning aspect of the AI field, we present RENOIR (REpeated random sampliNg fOr machIne leaRning), a modular open-source platform for robust and reproducible machine learning (ML) analysis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":599,"document":"38253545","golden":false,"offsetInEndSection":779,"text":"RENOIR adopts standardised pipelines for model training and testing, introducing elements of novelty, such as the dependence of the performance of the algorithm on the sample size.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":780,"document":"38253545","golden":false,"offsetInEndSection":928,"text":"Additionally, RENOIR offers automated generation of transparent and usable reports, aiming to enhance the quality and reproducibility of AI studies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1410,"document":"38253545","golden":false,"offsetInEndSection":1479,"text":"RENOIR is freely available at https://github.com/alebarberis/renoir .","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":184,"document":"33397265","golden":false,"offsetInEndSection":510,"text":"The present review is an overview based on some applications of Machine Learning based tools, such as GOLD, Deep PVP, LIB SVM, etc. and the algorithms involved such as support vector machine (SVM), random forest (RF), decision tree and Artificial Neural Network (ANN), etc. at various stages of drug designing and development.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":511,"document":"33397265","golden":false,"offsetInEndSection":802,"text":"These techniques can be employed in SNP discoveries, drug repurposing, ligand-based drug design (LBDD), Ligand-based Virtual Screening (LBVS) and Structure- based Virtual Screening (SBVS), Lead identification, quantitative structure-activity relationship (QSAR) modeling, and ADMET analysis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":333,"document":"37132148","golden":true,"offsetInEndSection":483,"text":"Virtual screening is a successful application of AI, which is used in screening huge drug-like databases and filtering to a small number of compounds.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31905263","golden":true,"offsetInEndSection":154,"text":"Artificial intelligence, in particular machine learning (ML), has emerged as a key promising pillar to overcome the high failure rate in drug development.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":500,"document":"37529294","golden":false,"offsetInEndSection":696,"text":"This review provides a thorough summary of the recent DL trends in SBDD with a particular focus on de novo drug design, binding site prediction, and binding affinity prediction of small molecules.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":950,"document":"37651150","golden":false,"offsetInEndSection":1093,"text":"d with the conventional discovery process. ML is positioned to overcome these limitations given its ability to model complex datasets and gener","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37337437","golden":true,"offsetInEndSection":126,"text":"In the past two decades, machine learning (ML) has been extensively adopted in protein-targeted small molecule (SM) discovery.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":977,"document":"37711014","golden":true,"offsetInEndSection":1085,"text":"This review provides an overview of the latest AI algorithms and big data employed in drug discovery for GC.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":461,"document":"38104638","golden":false,"offsetInEndSection":684,"text":"On the other hand, target identification serves as the foundational step in drug development, exerting a profound influence on all subsequent phases and ultimately determining the success rate of drug development endeavors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38300623","golden":false,"offsetInEndSection":157,"text":"Purpose: Artificial intelligence (AI)-assisted ultra-widefield (UWF) fundus photographic interpretation is beneficial to improve the screening of fundus abno","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38293764","golden":false,"offsetInEndSection":174,"text":"Given the severe effects that toxic compounds present in wastewater streams have on humans, it is imperative that water and wastewater streams pollution be addressed globally","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38270010","golden":false,"offsetInEndSection":122,"text":"Workforce development needs to align with the healthcare data ecosystem emerging from digital transformation in healthcare","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38259418","golden":false,"offsetInEndSection":142,"text":"The increasing demand for healthcare-acquired infection (HAI) control practices and services has intensified the need to evaluate care quality","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38257424","golden":false,"offsetInEndSection":84,"text":"Drowning poses a significant threat, resulting in unexpected injuries and fatalities","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38224784","golden":false,"offsetInEndSection":352,"text":"We summarize here the proceedings of the inaugural Artificial Intelligence in Primary Immune Deficiencies (AIPID) conference, where experts and advocates gathered to advance research into applications of Artificial Intelligence (AI), Machine Learning (ML) and other computational tools in the diagnosis and management of Inborn Errors of Immunity (IEI)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38213164","golden":false,"offsetInEndSection":122,"text":"BACKGROUND: Tablet formulation could be revolutionized by the integration of modern technology and established pharmaceuti","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38192482","golden":false,"offsetInEndSection":65,"text":"The fourth industrial revolution, often referred to as Industry 4","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38190950","golden":false,"offsetInEndSection":246,"text":"Utilising three artificial intelligence (AI)/machine learning (ML) tools, this study explores the prediction of fill level in inclined linear blenders at steady state by mapping a wide range of bulk powder characteristics to processing parameters","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":457,"document":"37561315","golden":false,"offsetInEndSection":775,"text":"The purpose of this review is to improve the ability of clinicians and OA researchers to understand the strengths and limitations of AI/ML methods in applications to OA research.RECENT FINDINGS: AI/ML can assist clinicians by prediction of OA incidence and progression and by providing tailored personalized treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":978,"document":"34875986","golden":true,"offsetInEndSection":1187,"text":"Hence, AI has been used in de novo drug design, activity scoring, virtual screening and in silico evaluation in the properties (absorption, distribution, metabolism, excretion and toxicity) of a drug molecule.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":776,"document":"37716910","golden":true,"offsetInEndSection":1193,"text":"The range of applications covered in this white paper encompass the following thematic topics: (i) AI/ML-enabled Analytics for Pharmacometrics and Quantitative Systems Pharmacology (QSP) Workflows; (ii) Explainable Artificial Intelligence and its Applications in Disease Progression Modeling; (iii) Natural Language Processing (NLP) in Quantitative Pharmacology Modeling; and (iv) AI/ML Utilization in Drug Discovery.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1023,"document":"37276884","golden":false,"offsetInEndSection":1324,"text":"As a consequence, the unmatched data processing power of AI systems may expedite and enhance the drug development process in four different ways: by opening up links to novel biological systems, superior or distinctive chemistry, greater success rates, and faster and less expensive innovation trials.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":239,"document":"34393317","golden":true,"offsetInEndSection":440,"text":"Machine learning techniques improve the decision-making in pharmaceutical data across various applications like QSAR analysis, hit discoveries, de novo drug architectures to retrieve accurate outcomes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":285,"document":"37776682","golden":true,"offsetInEndSection":609,"text":"This review aims to present a comprehensive overview of the utilization of AI methods in the field of small drug design, with a specific focus on four key areas: protein structure prediction, molecular virtual screening, molecular design, and absorption, distribution, metabolism, excretion, and toxicity (ADMET) prediction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":351,"document":"37276884","golden":false,"offsetInEndSection":441,"text":"Traditionally, large-scale chemical libraries are screened to find one promising medicine.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":442,"document":"37276884","golden":false,"offsetInEndSection":681,"text":"In recent years, more reasonable structure-based drug design approaches have avoided the first screening phases while still requiring chemists to design, synthesize, and test a wide range of compounds to produce possible novel medications.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":682,"document":"37276884","golden":false,"offsetInEndSection":789,"text":"The process of turning a promising chemical into a medicinal candidate can be expensive and time-consuming.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":790,"document":"37276884","golden":false,"offsetInEndSection":921,"text":"Additionally, a new medication candidate may still fail in clinical trials even after demonstrating promise in laboratory research.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":811,"document":"37587767","golden":true,"offsetInEndSection":1026,"text":"Herein we review the current state of machine learning applications to clinical trial design and drug discovery, while presenting opportunities and recommendations that can break down the barriers to implementation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":697,"document":"38344556","golden":true,"offsetInEndSection":785,"text":"Drug development and discovery depend greatly on AI and machine learning (ML) technology","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":766,"document":"38340012","golden":true,"offsetInEndSection":901,"text":"The AI could be instrumental in accelerating drug discovery, predicting drug safety and efficacy, and optimizing clinical trial designs","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":806,"document":"38321848","golden":false,"offsetInEndSection":1018,"text":"The impact and limitations of the recent AI applications are discussed, along with an outlook on the possible applications of next-generation AI tools for the discovery of novel RNA-targeted small molecule drugs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":364,"document":"38321543","golden":false,"offsetInEndSection":620,"text":"The integration of mechanistic models and drug-target interactions under the umbrella of machine learning methodologies provides a multifaceted approach that can boost the discovery of novel therapeutic targets, facilitating further drug repurposing in RP.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2379,"document":"38299408","golden":false,"offsetInEndSection":2640,"text":"By combining AI technology and the LC-MS approach, rapid screening and prediction of the activity of natural products based on specific targets can be achieved, significantly enhancing the efficiency of discovering new bioactive molecules from medicinal plants.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":641,"document":"38294194","golden":false,"offsetInEndSection":880,"text":"However, computational chemistry, including physics-based molecular modeling and machine learning- and deep learning-based artificial intelligence (AI), provides an alternative and complementary way to the classical drug discovery approach","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1392,"document":"38291364","golden":false,"offsetInEndSection":1637,"text":"Accordingly, after reviewing the state-of-the-art methods, we developed a multimodal feature extraction network by combining protein sequences and drug molecules, along with protein-protein interaction networks and drug-drug interaction networks","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":723,"document":"38280026","golden":false,"offsetInEndSection":866,"text":"Simultaneously, we performed a machine learning analysis using a random forest model with hyperparameter tuning and compared the data obtained.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":3212,"document":"38260445","golden":false,"offsetInEndSection":3482,"text":"rapeutics.Results: The originally discovered Cdc42 inhibitor ZCL278 displaying PA properties prompted the inquiry whether this finding represented a random encounter of PAs or whether biologically significant PAs can be widely present. The top ranked compounds were init","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":309,"document":"38259971","golden":false,"offsetInEndSection":374,"text":"However, therapeutics developed in animal models and traditional ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":14,"document":"37921672","golden":false,"offsetInEndSection":136,"text":"Modern drug discovery incorporates various tools and data, heralding the beginning of the data-driven drug design (DD) era","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37805064","golden":false,"offsetInEndSection":159,"text":"Drug Intelligence Science (DIS?): Pioneering a high-resolution translational platform to enhance the probability of success for drug discovery and development.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":148,"document":"37780897","golden":false,"offsetInEndSection":320,"text":"This comprehensive review delves into the burgeoning integration of artificial intelligence (AI), machine learning, and deep learning into virological research and practice","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":212,"document":"37468046","golden":false,"offsetInEndSection":321,"text":"We summarise recent and potential future applications of AI and its relevance to clinical infection practice.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":108,"document":"36775876","golden":false,"offsetInEndSection":320,"text":"With the development of high-throughput technologies and artificial intelligence (AI), machine learning (ML) methods for discovering new lead peptides have been expanded and incorporated into rational drug design","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":614,"document":"36347444","golden":true,"offsetInEndSection":758,"text":"This review will discuss how CADD, AI, ML, and DL approaches help identify drug candidates and various other steps of the drug discovery process","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":520,"document":"35433167","golden":false,"offsetInEndSection":688,"text":"But with the advent of artificial intelligence (AI), machine learning (ML) and deep learning (DL), the conventional drug discovery process has been further rationalized","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35142086","golden":false,"offsetInEndSection":78,"text":"Accurate prediction of binding poses is crucial to structure-based drug design","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":694,"document":"33501158","golden":false,"offsetInEndSection":863,"text":"Here we discuss the opportunities and challenges surrounding the application of AI/ML to the exploration of novel biologically relevant chemical space as part of ASPIRE.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1744,"document":"29879881","golden":true,"offsetInEndSection":1794,"text":"ML-based VS can be applied to AD drug development.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":345,"document":"29879881","golden":true,"offsetInEndSection":464,"text":"ML for VS generally involves assembling a filtered training set of compounds, comprised of known actives and inactives.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":232,"document":"31466916","golden":true,"offsetInEndSection":439,"text":"Both new and old techniques of artificial intelligence (AI) and machine learning (ML) can now help increase the success of translational studies in three areas: drug discovery, imaging, and genomic medicine.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":496,"document":"31294972","golden":true,"offsetInEndSection":886,"text":"After introducing the basic principles, alongside some application notes, of the various machine learning algorithms, the current state-of-the art of AI-assisted pharmaceutical discovery is discussed, including applications in structure- and ligand-based virtual screening, de novo drug design, physicochemical and pharmacokinetic property prediction, drug repurposing, and related aspects.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":78,"document":"31824921","golden":false,"offsetInEndSection":198,"text":"Thus, the identification of drug-target interactions (DTIs) has become a crucial step in early stages of drug discovery.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":262,"document":"33521623","golden":false,"offsetInEndSection":650,"text":"The purpose of our study was to identify the best repurposing candidates among FDA-approved drugs, based on their predicted antiviral activity against SARS-CoV-2.MATERIALS AND METHODS: This article describes a drug discovery screening based on a supervised machine learning model, trained on in vitro data encoded in chemical fingerprints, representing particular molecular substructures.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":679,"document":"37799217","golden":true,"offsetInEndSection":817,"text":"AI has remarkably impacted clinical drug trials by amplifying research into drug efficacy, adverse events, and candidate molecular design.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36994428","golden":false,"offsetInEndSection":111,"text":"Target-driven machine learning-enabled virtual screening (TAME-VS) platform for early-stage hit identification.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1429,"document":"37799217","golden":false,"offsetInEndSection":1631,"text":"Vigorous governance frameworks should be in place before incorporating AI in mental health interventions through AI-operated chatbots, medical education enhancements, and virtual reality-based training.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1308,"document":"32102234","golden":false,"offsetInEndSection":1535,"text":"This study proposes that the combination of machine learning methods with traditional structure-based virtual screening can effectively strengthen the ability to find potential G6PD activators used for G6PD deficiency diseases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1632,"document":"37799217","golden":false,"offsetInEndSection":1751,"text":"The role of AI in medical decision-making has certain limitations, necessitating the importance of hands-on experience.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":562,"document":"17504169","golden":true,"offsetInEndSection":659,"text":"We also discuss representative applications of AI methods to docking, screening and QSAR studies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"38339380","golden":false,"offsetInEndSection":258,"text":"The objective of this study is to systematically analyze the current state of the literature regarding novel artificial intelligence (AI) machine learning models utilized in non-invasive imaging for the early detection of nonmelanoma skin cancers","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":131,"document":"38318033","golden":false,"offsetInEndSection":284,"text":"As an important branch of artificial intelligence (AI), machine learning (ML) plays a key role in it, and has its application prospect in various systems","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1401,"document":"38234400","golden":false,"offsetInEndSection":1569,"text":"This includes the application of technology-based strategies to optimize early detection, classification, and staging via uncovering biomarkers and molecular signatures","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38213536","golden":false,"offsetInEndSection":125,"text":"Current implications and challenges of artificial intelligence technologies in therapeutic intervention of colorectal cancer.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":150,"document":"38191620","golden":false,"offsetInEndSection":355,"text":"Though this hypothesis has not been formally established, it has led to substantial systematic biases in drug discovery pipelines and thus contributed to kappa dominance amongst clinical-stage therapeutics","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1112,"document":"38125666","golden":false,"offsetInEndSection":1313,"text":"These technologies unveil the potential patterns, correlations, and insights related to diseases, thereby aiding the interpretable clinical decision making and applications, namely intelligent medicine","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":662,"document":"37998936","golden":false,"offsetInEndSection":753,"text":"These methods provide a foundational understanding for the subsequent AI-driven innovations","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37776682","golden":true,"offsetInEndSection":134,"text":"Utilizing artificial intelligence (AI) in drug design represents an advanced approach for identifying targets and developing new drugs","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":632,"document":"37688994","golden":false,"offsetInEndSection":769,"text":"AI is the synergetic approach for mining the drug targets, their mechanism of action, and drug-organism interaction from massive raw data","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1591,"document":"38100293","golden":false,"offsetInEndSection":1680,"text":"Thus, FRAGSITE2 is a promising approach that can discover novel hits for protein targets.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1690,"document":"35849939","golden":false,"offsetInEndSection":1963,"text":"Overall, this study suggests the discovery of a novel putative binding site for P2X3R using the AI deep learning protocol along with in silico MD simulation and experimental screening of targeted library compounds to successfully identify 16 unique and novel hit compounds.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":93,"document":"38100293","golden":false,"offsetInEndSection":239,"text":"In the early stages of drug discovery, virtual ligand screening (VLS) is frequently applied to identify possible hits before experimental testing.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":240,"document":"38100293","golden":false,"offsetInEndSection":560,"text":"While our recent ligand homology modeling (LHM)-machine learning VLS method FRAGSITE outperformed approaches that combined traditional docking to generate protein-ligand poses and deep learning scoring functions to rank ligands, a more robust approach that could identify a more diverse set of binding ligands is needed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1029,"document":"38100293","golden":false,"offsetInEndSection":1195,"text":"For the DUD-E set, FRAGSITE2 also shows better ROC enrichment factor and AUPR (area under the precision-recall curve) than the deep learning DenseFS scoring function.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":561,"document":"38100293","golden":false,"offsetInEndSection":1028,"text":"Here, we describe FRAGSITE2 that shows significant improvement on protein targets lacking known small molecule binders and no confident LHM identified template ligands when benchmarked on two commonly used VLS datasets: For both the DUD-E set and DEKOIS2.0 set and ligands having a Tanimoto coefficient (TC)?\u003c?0.7 to the template ligands, the 1% enrichment factor (EF1% ) of FRAGSITE2 is significantly better than those for FINDSITEcomb2.0 , an earlier LHM algorithm.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1340,"document":"38100293","golden":false,"offsetInEndSection":1466,"text":"Its boosted tree regression method provides for more robust performance than a deep learning multiple layer perceptron method.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1467,"document":"38100293","golden":false,"offsetInEndSection":1590,"text":"When compared with the pretrained language model for protein target features, FRAGSITE2 also shows much better performance.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1196,"document":"38100293","golden":false,"offsetInEndSection":1339,"text":"Comparison with the RF-score-VS on the 76 target subset of DEKOIS2.0 and a TC?\u003c?0.99 to training DUD-E ligands, FRAGSITE2 has double the EF1% .","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38100293","golden":false,"offsetInEndSection":92,"text":"Protein function annotation and drug discovery often involve finding small molecule binders.","beginSection":"abstract"}],"exact_answer":[["de novo drug design"],["target identification"],["target discovery"],["hit/lead generation and optimization"],["hit/lead generation and optimization"],["drug repurposing"],["ligand-based virtual screening"],["Lead Optimization"],["toxicity prediction"],["ligand-based drug design (LBDD)"],["Ligand-based Virtual Screening (LBVS)"],["Structure-based Virtual Screening (SBVS)"],["hit identification"],["Binding site prediction"],["binding affinity prediction"],["pharmacology"]],"ideal_answer":["AI/Machine learning can be applied at various stages in drug discovery. They are crucial in AI-assisted design of drug candidates, exploring chemical space, offering potential novel drug scaffolds and in overcoming obstacles in the drug discovery pipeline. They facilitate phenotypic drug discovery as well as target-based approaches. AI/ML find substantial use in drug repurposing and help in the modeling of physiochemical properties, target identification, hit identification, ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) prediction, lead optimization, and drug repositioning. They also aid in quantitative structure-activity relationship (QSAR) analysis, de novo drug design, virtual screening (both structure-based and ligand-based), toxicity prediction, drug monitoring and release, and pharmacophore modelling.","AI/Machine learning can be applied in various stages of drug discovery, including target identification, hit identification, ADMET prediction, lead optimization, drug repositioning, compound screening, clinical trial design, pharmacokinetics/pharmacodynamics (PK/PD) studies, virtual screening, toxicity prediction, peptide synthesis, structure-based and ligand-based screening, library design, high-throughput analysis, de novo drug design, chemical reactions, synthetic accessibility, polypharmacology, and generative chemistry. These technologies enhance decision-making, reduce workload, improve efficiency, accelerate progress, and offer opportunities for more systematic and predictive drug design processes.","Machine Learning (ML) has been successfully integrated into various stages of drug discovery, including target identification and validation, hit finding through virtual screening or de novo design, lead optimization to enhance potency and selectivity, prediction of pharmacokinetic/pharmacodynamic properties for safety and efficacy assessments, and even clinical trial design and analysis.","AI and machine learning can be applied at various stages in drug discovery, including target identification, hit discovery, hit to lead development, lead optimization, ADMET prediction, and design of clinical trials. AI technologies, such as machine learning and deep learning, aid in the identification of novel pharmaceutical targets, the creation of disease prediction models, and support clinical decision-making. They enhance the drug discovery process through techniques like target-driven machine learning-enabled virtual screening (TAME-VS) for early-stage hit identification and combining machine learning with traditional structure-based virtual screening for enhancing the discovery of potential activators for specific deficiencies. AI also impacts the optimization of the pharmacokinetic and pharmacodynamic properties of compounds, and assists in predicting drug efficacy, potential adverse events, and safety profiles, thus aiding in the rapid development of new and repurposed drugs.","Artificial Intelligence (AI) and Machine Learning (ML) can be applied in various stages of drug discovery, including target identification, hit identification, virtual screening (both structure-based and ligand-based), toxicity prediction, drug monitoring and release, pharmacophore modeling, quantitative structure-activity relationship (QSAR) analyses, lead optimization, absorption, distribution, metabolism, excretion, and toxicity (ADME/T) prediction, drug repositioning, polypharmacology, and physiochemical property analysis. ML techniques have proved beneficial in enhancing the efficiency of virtual screening, identifying potential therapeutics, drug design, as well as in silico evaluation of pharmacokinetics/pharmacodynamics (PK/PD) properties. AI methods are also used in peptide synthesis, library design, high-throughput analysis, drug repurposing, drug sensitivity studies, de novo drug design, chemical reaction prediction, synthetic accessibility, and in predicting the pharmacokinetic profiles to inform safety and efficacy.","Artificial Intelligence (AI) and Machine Learning (ML) can be applied at various stages of the drug discovery process, including:\n\n1. **Target Identification**: Identifying biological targets that are implicated in diseases.\n2. **Hit Identification**: Discovering molecules that interact with the target in a desirable way.\n3. **Lead Optimization**: Modifying hit molecules to improve their efficacy, reduce potential side effects, and enhance their drug-like properties.\n4. **ADMET Prediction**: Predicting the Absorption, Distribution, Metabolism, Excretion, and Toxicity properties of lead compounds.\n5. **Drug Repositioning**: Identifying new uses for existing drugs.\n6. **Virtual Screening**: Using computational methods to identify promising compounds from large libraries.\n7. **Quantitative Structure-Activity Relationship (QSAR) Analysis**: Relating chemical structure to biological activity for rational drug design.\n8. **De Novo Drug Design**: Designing new drug molecules from scratch.\n9. **Pharmacokinetics/Pharmacodynamics (PK/PD) Modeling**: Predicting how the drug affects the body and vice versa to optimize dosing and efficacy.\n10. **Polypharmacology**: Designing drugs to interact with multiple targets.\n\nThese applications highlight the versatility of AI/ML in enhancing the efficiency and effectiveness of drug discovery and development processes."," AI or Machine Learning can be applied at the drug discovery stages where chemical data is readily available. Thus, target identification, target validation, compound-target interaction prediction, ligand-based and structure-based drug design, chemical optimization, drug candidate prediction, and virtual screening of large chemical databases are areas that AI or Machine Learning can be applied.\n","\nAI/Machine learning can be applied at several stages throughout the drug discovery pipeline:\n- Target discovery and validation\n- Candidate selection\n- Lead optimization\n- Preclinical development\n- Clinical trials\n"],"id":"65983b9006a2ea257c000035","type":"list","body":"Please list the stages in  drug discovery where AI/Machine learning can be applied."},{"documents":[{"golden":true,"id":"31061346"},{"golden":true,"id":"33901923"},{"golden":false,"id":"25465796"},{"golden":false,"id":"37568686"},{"golden":false,"id":"31903024"},{"golden":false,"id":"37228842"},{"golden":false,"id":"37760999"},{"golden":false,"id":"21190078"},{"golden":false,"id":"21505455"},{"golden":false,"id":"31012533"},{"golden":false,"id":"37072313"},{"golden":false,"id":"12486839"},{"golden":false,"id":"32261199"},{"golden":true,"id":"30026413"},{"golden":false,"id":"32280381"},{"golden":false,"id":"25760772"},{"golden":false,"id":"24582536"},{"golden":false,"id":"37678152"},{"golden":false,"id":"32129599"},{"golden":false,"id":"38200060"},{"golden":false,"id":"32176623"},{"golden":false,"id":"34627826"},{"golden":false,"id":"36201443"},{"golden":false,"id":"37430799"},{"golden":false,"id":"36772572"},{"golden":true,"id":"31882465"},{"golden":true,"id":"34016888"},{"golden":true,"id":"36289633"},{"golden":true,"id":"36111250"},{"golden":false,"id":"34521967"},{"golden":false,"id":"32320958"},{"golden":false,"id":"36846412"},{"golden":false,"id":"33720468"},{"golden":false,"id":"35425088"},{"golden":false,"id":"19906500"},{"golden":false,"id":"36798000"},{"golden":false,"id":"37937362"},{"golden":false,"id":"35416103"},{"golden":false,"id":"36605647"},{"golden":false,"id":"35408652"},{"golden":false,"id":"35985194"},{"golden":false,"id":"38099568"},{"golden":false,"id":"37829158"},{"golden":false,"id":"23488778"},{"golden":false,"id":"38211310"},{"golden":false,"id":"33156561"},{"golden":false,"id":"35789085"},{"golden":false,"id":"37522257"},{"golden":false,"id":"22315525"},{"golden":false,"id":"23100503"},{"golden":false,"id":"33051242"},{"golden":false,"id":"28042997"},{"golden":false,"id":"32106026"},{"golden":false,"id":"33534329"},{"golden":false,"id":"36050339"},{"golden":false,"id":"33021204"},{"golden":false,"id":"34243176"},{"golden":false,"id":"38075792"},{"golden":false,"id":"36720157"},{"golden":false,"id":"38225616"},{"golden":false,"id":"12835038"},{"golden":false,"id":"33134728"},{"golden":false,"id":"34846005"},{"golden":false,"id":"26628933"},{"golden":false,"id":"38071767"},{"golden":false,"id":"38257447"},{"golden":false,"id":"17325642"},{"golden":false,"id":"28376173"},{"golden":false,"id":"35461114"},{"golden":false,"id":"34166701"},{"golden":false,"id":"35151176"},{"golden":false,"id":"33922694"},{"golden":false,"id":"33651372"},{"golden":false,"id":"26188801"},{"golden":false,"id":"34028454"},{"golden":false,"id":"32227494"},{"golden":false,"id":"38298605"},{"golden":false,"id":"38018373"},{"golden":false,"id":"34077435"},{"golden":false,"id":"34250907"},{"golden":false,"id":"32854242"},{"golden":false,"id":"36991597"},{"golden":false,"id":"25739902"},{"golden":false,"id":"38358180"},{"golden":false,"id":"38350895"},{"golden":false,"id":"38350156"},{"golden":false,"id":"38334268"},{"golden":false,"id":"38332895"},{"golden":false,"id":"38321723"},{"golden":false,"id":"38321652"},{"golden":false,"id":"38319950"},{"golden":false,"id":"38317267"},{"golden":false,"id":"23680696"},{"golden":false,"id":"27811380"},{"golden":false,"id":"23445725"},{"golden":false,"id":"24018955"},{"golden":false,"id":"30441459"},{"golden":false,"id":"28662139"},{"golden":false,"id":"16134344"},{"golden":false,"id":"30325509"},{"golden":false,"id":"21883674"},{"golden":false,"id":"19000949"},{"golden":false,"id":"29882769"},{"golden":false,"id":"29909757"},{"golden":false,"id":"24742666"},{"golden":false,"id":"27780720"},{"golden":false,"id":"38336681"},{"golden":false,"id":"37803440"},{"golden":false,"id":"34415806"},{"golden":false,"id":"33647830"},{"golden":false,"id":"37990399"},{"golden":false,"id":"34450881"},{"golden":false,"id":"37600093"},{"golden":false,"id":"32111235"},{"golden":false,"id":"37512994"},{"golden":false,"id":"33685856"},{"golden":false,"id":"10834396"},{"golden":false,"id":"29165896"},{"golden":false,"id":"28870257"},{"golden":false,"id":"36934898"},{"golden":false,"id":"38143741"},{"golden":false,"id":"33578407"},{"golden":false,"id":"34768503"},{"golden":false,"id":"35659391"},{"golden":false,"id":"36298343"},{"golden":false,"id":"37932795"},{"golden":false,"id":"36721748"},{"golden":false,"id":"32069963"},{"golden":false,"id":"37256260"},{"golden":false,"id":"37064563"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":60,"document":"33901923","golden":true,"offsetInEndSection":337,"text":"N-NOSE (Nematode-NOSE) is a simple, inexpensive, and highly sensitive cancer screening method based on the chemotaxis of the nematode Caenorhabditis elegans, which shows evasive action from the urine of healthy individuals while being attracted to the urine of cancer patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":425,"document":"31061346","golden":true,"offsetInEndSection":624,"text":"In this study, we developed a Nematode-Nose (N-NOSE) test using Caenorhabditis elegans to provide a novel, highly accurate cancer detection system that is economical, painless, rapid, and convenient.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1671,"document":"33901923","golden":false,"offsetInEndSection":1810,"text":"These results strongly suggest that the N-NOSE test by this new combined method strikes a good balance between sensitivity and specificity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1465,"document":"33901923","golden":true,"offsetInEndSection":1670,"text":"N-NOSE sensitivity improvement was significantly high even for early-stage cancer detection, which is in stark contrast with the sensitivity of detection using blood tumor markers (CEA, CA19-9 and CA15-3).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1252,"document":"33901923","golden":true,"offsetInEndSection":1464,"text":"In this clinical study, we further improve N-NOSE with a combined method of two dilutions (10-fold and 100-fold) of urine samples, which results in a markedly improvement in cancer detection sensitivity of 87.5%.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":338,"document":"33901923","golden":false,"offsetInEndSection":434,"text":"Initially, N-NOSE relied on chemotaxis indexes obtained with 10-fold dilutions of urine samples.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"31903024","golden":false,"offsetInEndSection":153,"text":"Behavioural Response Alteration in Caenorhabditis elegans to Urine After Surgical Removal of Cancer: Nematode-NOSE (N-NOSE) for Postoperative Evaluation.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":820,"document":"30026413","golden":true,"offsetInEndSection":970,"text":"We have developed a new technique, N-NOSE, which takes advantage of the good olfaction of nematode C. elegans to detect cancer smell in urine samples.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"32176623","golden":false,"offsetInEndSection":381,"text":"BACKGROUND: No study has yet investigated the use of electronic nose (eNose) technology to reveal pattern recognition of urological diseases, including bladder cancer.OBJECTIVE: We sought to determine the diagnostic performance of the eNose in recognizing urinary odour in patients with bladder cancer.METHODS: The eNose is a commercially available model equipped with two sensors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24582536","golden":false,"offsetInEndSection":379,"text":"PURPOSE: We evaluate the ability of an electronic nose to discriminate prostate cancer from benign prostatic hyperplasia using urine headspace, potentially offering a clinically applicable noninvasive and rapid diagnostic method.MATERIALS AND METHODS: The ChemPro? 100-eNose was used to discriminate prostate cancer from benign prostatic hyperplasia using urine sample headspace.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":821,"document":"32280381","golden":false,"offsetInEndSection":981,"text":"E-nose techniques using exhaled breath component measurements can detect lung cancer with a sensitivity ranging from 71% to 96% and specificity from 33 to 100%.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":971,"document":"30026413","golden":true,"offsetInEndSection":1107,"text":"N-NOSEexhibited 95.8% sensitivity and 95.0% specificity on 242 urine samples of 10 cancers types tested including those of early stages.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1322,"document":"30026413","golden":true,"offsetInEndSection":1459,"text":"Therefore, N-NOSEis expected to offer a reasonable and non-invasive cancer screening method which is suitable for regular health checkup.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34627826","golden":false,"offsetInEndSection":235,"text":"BACKGROUND AND AIMS: The chemical gas sensor array based electronic-nose (e-nose) devices with machine learning algorithms can detect and differentiate expelled breath samples of patients with various respiratory ailments and controls.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":550,"document":"32129599","golden":false,"offsetInEndSection":942,"text":"The impressive performance of the proposed SERS \"nose\" for detecting gaseous metabolites of common foodborne bacteria like Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa from inoculated samples demonstrates its much higher sensitivity than that of human sense and application in distinguishing spoiled food at an early stage and real-time tracing of food spoilage degree.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":147,"document":"36111250","golden":true,"offsetInEndSection":418,"text":"Nematode-NOSE (N-NOSE) is a commercially available non-invasive human cancer screening test that uses the sense of smell of the nematode Caenorhabditis elegans showing a distinct chemotactic response toward the urine of an individual with cancer compared to healthy ones.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":633,"document":"31882465","golden":true,"offsetInEndSection":1080,"text":"By receiver operating characteristic (ROC) analysis, we examined the diagnostic capability of N-NOSE.RESULTS: ROC analysis revealed that N-NOSE showed an area under the curve value of more than 0.80, even in early-stage cancers.CONCLUSION: C. elegans olfaction enabled the detection of gastrointestinal cancers from urine with high sensitivity, which can provide the basis for the development of N-NOSE as a gastrointestinal cancer screening test.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":936,"document":"34016888","golden":true,"offsetInEndSection":1288,"text":"N-NOSE was able to detect stages 0 to I pancreatic cancer and had a higher correlation with early-stage pancreatic cancer than advanced stage.CONCLUSIONS: N-NOSE has sufficient sensitivity and specificity for use in clinical practice, and it holds great potential as a diagnostic aid for pancreatic cancer, especially for early-stage pancreatic cancer.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":637,"document":"36289633","golden":true,"offsetInEndSection":817,"text":"In Japan, N-NOSE is a commercially available multi-cancer detection test based on the chemotaxis of C. elegans using a urine sample showing 87.5% sensitivity and 90.2% specificity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1231,"document":"36111250","golden":true,"offsetInEndSection":1360,"text":"Our study suggests that N-NOSE has the potential as a simple, accurate, and low-cost cancer screening test in both dogs and cats.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":419,"document":"36111250","golden":true,"offsetInEndSection":634,"text":"15 types of human cancer (stomach, colon-rectum, lung, breast, pancreas, liver, prostate, uterus, esophagus, gallbladder, bile duct, kidney, urinary bladder, ovary, and oropharynx cancers) can be detected by N-NOSE.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":707,"document":"36111250","golden":true,"offsetInEndSection":821,"text":"In this study, we evaluated the effectiveness of N-NOSE in detecting cancer using canine and feline urine samples.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36111250","golden":true,"offsetInEndSection":92,"text":"A new detection method for canine and feline cancer using the olfactory system of nematodes.","beginSection":"title"},{"endSection":"title","offsetInBeginSection":0,"document":"34521967","golden":false,"offsetInEndSection":123,"text":"The nose is the best niche for detection of experimental pneumococcal colonisation in adults of all ages, using nasal wash.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":66,"document":"19906500","golden":false,"offsetInEndSection":490,"text":"This study assesses if the age-related nasal changes are detectable with objective measurements and reflected in two validated quality of life outcome tools: the Nasal Obstruction Symptom Evaluation Scale (NOSE) and the Sino-Nasal Outcome Test (SNOT-20) questionnaires.METHODS: Two study groups were included: the \"young\" group A (n\u003d40) with a mean age of 27 years and the \"elder\" group B (n\u003d40) with a mean age of 70 years.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1156,"document":"34521967","golden":false,"offsetInEndSection":1298,"text":"The nose, as assessed by nasal wash, is the best niche for detection of experimental pneumococcal colonisation in both young and older adults.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1276,"document":"33720468","golden":false,"offsetInEndSection":1645,"text":"Although the sensitivity and positive predictive value of the eNose could not be assessed in this cohort due to the small sample size, no active TB cases were found during a one year of follow-up period.CONCLUSION: The eNose showed promising specificity and negative predictive value and might therefore be developed as a rule-out test for TB in vulnerable populations.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1464,"document":"36846412","golden":false,"offsetInEndSection":1723,"text":"Moreover, the scale revealed remarkable responsiveness to change (p?\u003c?.00001).Conclusion: The translated and adapted He-NOSE scale can be a useful tool to be applied in both clinical and research fields when assessing nasal obstruction.Level of evidence: N/A.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":759,"document":"34521967","golden":false,"offsetInEndSection":932,"text":"64% of NW samples and 54% of OPS samples were positive for Spn6B in young adults, compared to 35% of NW samples, 24% of OPS samples and 6% of saliva samples in older adults.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1006,"document":"34521967","golden":false,"offsetInEndSection":1089,"text":"Experimental colonisation was detected in 72% of young adults by NW and 63% by OPS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":933,"document":"34521967","golden":false,"offsetInEndSection":1005,"text":"Many colonisation events were only detected in culture-enriched samples.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"32320958","golden":false,"offsetInEndSection":95,"text":"Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1090,"document":"34521967","golden":false,"offsetInEndSection":1155,"text":"In older adults, this was 51% by NW, 36% by OPS and 9% by saliva.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":847,"document":"23488778","golden":false,"offsetInEndSection":1327,"text":"It was clear from both human testing and using the electronic nose system that the unpleasant odour of Aminoleban? EN could be masked by pineapple- and plum-flavoured powders, both of which contain not only sweet but also sour components.CONCLUSIONS: The electronic nose system may be useful for detecting odours at or below the level detectable by the human olfactory system and for classifying the quality of different odours, thus reducing the amount of human testing required.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"35408652","golden":false,"offsetInEndSection":114,"text":"Aquaphotomic, E-Nose and Electrolyte Leakage to Monitor Quality Changes during the Storage of Ready-to-Eat Rocket.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":368,"document":"35408652","golden":false,"offsetInEndSection":516,"text":"A portable E-nose, the electrolyte leakage test (which measures the index of leaf damage-ILD), and NIR spectroscopy and Aquaphotomics were employed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":789,"document":"35408652","golden":false,"offsetInEndSection":886,"text":"E-nose and ILD results identified the B atmosphere as the best for maintaining product freshness.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1054,"document":"35408652","golden":false,"offsetInEndSection":1223,"text":"These preliminary data showed a good agreement NIR/ILD suggesting the use of NIR for non-destructive monitoring of the damage to the plant membranes of RTE rocket salad.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":916,"document":"35985194","golden":false,"offsetInEndSection":1143,"text":"This robust, straightforward, selective, efficient, and ultrasensitive colorimetric detection method, with potential for point-of-care analysis, should also be effective in detecting a diverse range of other RNA-based diseases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":887,"document":"35408652","golden":false,"offsetInEndSection":964,"text":"NIR spectroscopy was able to group the samples according to the storage time.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":384,"document":"22315525","golden":false,"offsetInEndSection":527,"text":"The results obtained show that the application of an electronic nose called \"A-NOSE\", may be used in the coffee industry for the cupping tests.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":272,"document":"38099568","golden":false,"offsetInEndSection":478,"text":"Biosensors, such as GC-MS or electronic nose (e-nose) devices, can be used to detect volatile organic compounds (VOCs) in exhaled breath associated with metabolic changes in the body, including the kidneys.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":965,"document":"35408652","golden":false,"offsetInEndSection":1053,"text":"Aquaphotomics proved to be able to detect changes in the water structure during storage.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1123,"document":"38211310","golden":false,"offsetInEndSection":1326,"text":"The results underline that the biomarkers need to be about 5.3 times higher in concentration than in real breath for the home-made nose to tell the difference between groups with a sufficient confidence.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":580,"document":"33534329","golden":false,"offsetInEndSection":895,"text":"The patients completed the Nasal Obstruction Symptom Evaluation (NOSE) scale consisting of five questions, and the Brief Smell Identification Test was used to detect olfactory dysfunction.RESULTS: The preoperative mean NOSE score of all patients was 10.87 (1-18), while the postoperative mean value was 1.83 (0-10).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":495,"document":"38211310","golden":false,"offsetInEndSection":612,"text":"These healthy samples were analysed with and without the addition of 9 VOC cancer biomarkers, chosen from literature.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":102,"document":"38211310","golden":false,"offsetInEndSection":269,"text":"This paper proposes a method for defining and quantifying an indicator of the effectiveness of multi-sensor systems in detecting cancers by artificial breath analysis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":680,"document":"38211310","golden":false,"offsetInEndSection":837,"text":"The more VOC were added, the better the discrimination between \"healthy\" samples (breath without additives) and \"cancer\" samples (breath with additives) was.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":838,"document":"38211310","golden":false,"offsetInEndSection":1060,"text":"By determining at which level of concentration the electronic nose fails to reliably discriminate between the two groups, we estimate its ability to well predict the presence of the disease or not in a realistic situation.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38211310","golden":false,"offsetInEndSection":110,"text":"How well does your E-nose detect cancer? Application of artificial breath analysis for performance assessment.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1287,"document":"28042997","golden":false,"offsetInEndSection":1671,"text":"Moreover, three patients presented with absent oVEMPs when recorded with the standard placement, whereas the nose reference placement could evoke a detectable oVEMP response.CONCLUSIONS: This study demonstrated that a nose reference electrode position results in larger oVEMP amplitudes and achieves a better reliability for the most important clinical parameters (amplitude and IOR).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":323,"document":"36050339","golden":false,"offsetInEndSection":546,"text":"This paper presents the methodology implemented to test whether a device consisting of an electronic nose inspired by a dog\u0027s olfactory system and olfactory neurons is significantly informative to detect breast cancer (BC).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38225616","golden":false,"offsetInEndSection":140,"text":"BACKGROUND: Breath testing using an electronic nose has been recognized as a promising new technique for the early detection of lung cancer.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34846005","golden":false,"offsetInEndSection":216,"text":"PURPOSE: The aim of this paper was to discuss the design and development of an innovative e-nose system which can detect respiratory ailments by detecting the Volatile Organic Compounds (VOCs) in the expelled breath.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"33021204","golden":false,"offsetInEndSection":159,"text":"Volatile organic compound breath testing detects in-situ squamous cell carcinoma of bronchial and laryngeal regions and shows distinct profiles of each tumour.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":952,"document":"33021204","golden":false,"offsetInEndSection":1055,"text":"When distinguishing in-situ and advanced tumours, sensitivity and specificity 82% and 75% respectively.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":304,"document":"33021204","golden":false,"offsetInEndSection":408,"text":"Breath samples were analysed using the E-nose Cyranose ?320 and by gas chromatography/mass spectroscopy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1295,"document":"33021204","golden":false,"offsetInEndSection":1366,"text":"In-situ bronchial and laryngeal cancer can be detected by VOC analysis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1181,"document":"33021204","golden":false,"offsetInEndSection":1294,"text":"VOCs isolated from in-situ cancers included some previously demonstrated in advanced cancers and some novel VOCs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33021204","golden":false,"offsetInEndSection":190,"text":"Volatile organic compound (VOC) breath testing of lung and head and neck squamous cell carcinoma (SCC) has been widely studied, however little is known regarding VOC profiles of in-situ SCC.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":744,"document":"36720157","golden":false,"offsetInEndSection":955,"text":"Hence, we postulate that the breath-print analysis by electronic nose could be a potential biomarker for the early detection of lung cancer along with monitoring treatment response in a resource-limited setting.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":258,"document":"35408652","golden":false,"offsetInEndSection":367,"text":"This study aimed to evaluate the maintenance of RTE rocket salad freshness packed under modified atmospheres.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":149,"document":"17325642","golden":false,"offsetInEndSection":276,"text":"e measured.MATERIAL/METHODS: A Kiernan NO Breath analyzer (KNB) was used in the present study to determine nitric oxide (NO) le","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":641,"document":"17325642","golden":false,"offsetInEndSection":715,"text":"tocols using paired t-tests.RESULTS: Regardless of the test, all subjects ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1093,"document":"17325642","golden":false,"offsetInEndSection":1209,"text":"ight after the individuals sat down.CONCLUSIONS: The present study demonstrates NO in exhaled human breath can vary,","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1679,"document":"28376173","golden":false,"offsetInEndSection":1918,"text":"es from the AEGIS-2 cohort.Conclusions: These results support that the airway epithelial field of lung cancer-associated injury in ever smokers extends to the nose and demonstrates the potential of using nasal gene expression as a noninvas","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":418,"document":"35461114","golden":false,"offsetInEndSection":570,"text":"Therefore, we report here a direct and fast detection method for CoV-2 genome as applied in the nose-throat swab samples without any further processing.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":571,"document":"35461114","golden":false,"offsetInEndSection":747,"text":"The detection principle is based on fluorescein-loaded mesoporous silica nanoparticles capped by specific gene sequences probes immobilized on the surface of the nanoparticles.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":236,"document":"34166701","golden":false,"offsetInEndSection":475,"text":", B and C). The dynamic range and lowest detected quantity was determined using a SARS-CoV-2 partial N gene RNA transcript dilution series (100,000-1 copy/?l) and verified using 72 nose and throat swabs, 29 of which tested positive for SAR","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35151176","golden":false,"offsetInEndSection":173,"text":"PURPOSE: To analyze the utility of a 5-item odorant test (U-Smell-It?) in determining COVID-19 status in COVID-19 polymerase chain reaction (PCR)-positive and -negative part","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1104,"document":"35151176","golden":false,"offsetInEndSection":1339,"text":"% (95% CI: 77.7%-86.5%).CONCLUSIONS: The quick turnaround time, low cost, reduced resource requirement, and ease of administering odorant tests provide many advantages as an indicator sign to help flag a molecular diagnostic COVID-19 t","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1340,"document":"35151176","golden":false,"offsetInEndSection":1471,"text":"st with relatively high specificity. Our results suggest that this odorant testing for olfactory dysfunction may be a viable option","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":729,"document":"32854242","golden":false,"offsetInEndSection":1390,"text":"A first 1-K-NN (cases vs. controls) model has been developed to discriminate between OC cases and controls; the model performance tested in the prediction gave 98% of sensitivity and 95% of specificity, when the strict class prediction was applied; a second 1-K-NN (cases vs. controls + benign) model was built by grouping the non-cancer groups (controls + benign), thus considering two classes, cases and controls + benign; the model performance in the prediction was of 89% for sensitivity and 86% for specificity when the strict class prediction was applied.CONCLUSIONS: Our preliminary results suggested the potential role of e-nose for the detection of OC.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":141,"document":"38225616","golden":false,"offsetInEndSection":630,"text":"Imbalanced data are commonly observed in electronic nose studies, but methods to address them are rarely reported.OBJECTIVE: The objectives of this study were to assess the accuracy of electronic nose screening for lung cancer with imbalanced learning and to select the best mechanical learning algorithm.METHODS: We conducted a case?control study that included patients with lung cancer and healthy controls and analyzed metabolites in exhaled breath using a carbon nanotube sensor array.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1186,"document":"38018373","golden":false,"offsetInEndSection":1460,"text":"DA clustering agree with the results obtained by gas-chromatography. Moreover, a principal components regression model was built to verify the ability of the E-nose to non-destructively predict the amount of different volatiles analyzed.CONCLUSION: Production methods of Ros","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":623,"document":"38358180","golden":false,"offsetInEndSection":788,"text":"On day 2 of hospitalization, he developed left cerebellar signs (positive finger nose finger test, rebound phenomenon, dysdiadochokinesia, a positive heel shin test)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":549,"document":"38350895","golden":false,"offsetInEndSection":717,"text":"Before the sinus lifting approach, a cone beam computed tomography (CBCT) was taken, followed by another CBCT at least one-year post-sinus lifting (range: 12-36 months)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":936,"document":"38350156","golden":false,"offsetInEndSection":1021,"text":"The average change in NOSE score was 71.5 and -49.4 (standard deviation [SD]?\u003d?19.0, ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":857,"document":"38334268","golden":false,"offsetInEndSection":1035,"text":"Horizontal mouth stretch showed the strongest association with the score, followed by brow lowering parting lips, wrinkling of the nose, raising of the upper lip and closing eyes","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":101,"document":"38332895","golden":false,"offsetInEndSection":281,"text":"Validated and culturally specific tests, such as the \"Sniffin\u0027 Sticks\" test (SST) and the TIB Smell Identification Test (TIBSIT), are crucial for the diagnosis and monitoring of OD","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1214,"document":"38321723","golden":false,"offsetInEndSection":1379,"text":"In addition, the association between SA and tinnitus seemed to be stronger in studies from Italy or United States as compared to those from China (OR: 2.91 vs 1.35, ","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":528,"document":"38321652","golden":false,"offsetInEndSection":600,"text":"The primary outcome was identification of a nasal or nasopharyngeal mass","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1274,"document":"38319950","golden":false,"offsetInEndSection":1456,"text":"More generally, studying populations that have been largely unaffected by white-nose syndrome may provide insight into mitigation strategies for protecting the remaining populations.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":847,"document":"38317267","golden":false,"offsetInEndSection":1112,"text":"The patient\u0027s clinical manifestations were white skin, yellow hair, a few freckles on the cheeks and bridge of the nose, decreased vision, blue iris, poorly defined optic disk borders, pigmentation of the fundus being insufficient, and significant vascular exposure","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1394,"document":"23680696","golden":false,"offsetInEndSection":1490,"text":"HCN in nose-exhaled breath is a biomarker of chronic airway infection with PA in adults with CF.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":983,"document":"23680696","golden":false,"offsetInEndSection":1124,"text":"HCN was detected in the mouth-exhaled breath of patients in both groups and in the nose-exhaled breath of patients with chronic PA infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1245,"document":"30325509","golden":false,"offsetInEndSection":1553,"text":"Clinically significant changes between NOSE and PNIF were concordant, although the correlation was weak (r?\u003d?-0.26, P?\u003d?0.02).CONCLUSION: Peak nasal inspiratory flow is a rapid, cheap, and easily performed test that detects nasal obstruction and clinically significant improvements in airflow following FSRP.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":200,"document":"23680696","golden":false,"offsetInEndSection":360,"text":"The use of mouth-exhaled breath HCN as a marker of PA infection in adults is more difficult to assess as some without PA infection generate HCN in their mouths.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21883674","golden":false,"offsetInEndSection":354,"text":"BACKGROUND AND OBJECTIVE: To compare the volatile organic compound patterns of patients with COPD with and without alpha 1-antitrypsin (AAT) deficiency using electronic nose technology.METHODS: Exhaled breath condensate and pure exhaled breath of patients with COPD with (n\u003d10) and without (n\u003d23) AAT deficiency and healthy controls (n\u003d10) were analysed.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1346,"document":"27811380","golden":false,"offsetInEndSection":1484,"text":"The e-nose can distinguish with high accuracy the exhaled VOC-profile of patients with OSA from those with OVS as well as those with COPD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1003,"document":"21883674","golden":false,"offsetInEndSection":1306,"text":"Smell prints of AAT-deficient patients before and after human recombinant AAT augmentation were different (LDA: P\u003d0.001, sensitivity of 1.00, specificity of 1.00, CVV 53.3%, MD 1.79).CONCLUSIONS: An electronic nose can detect differences in smell prints of COPD patients with and without AAT deficiency.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":361,"document":"23680696","golden":false,"offsetInEndSection":563,"text":"The analysis of breath exhaled via the nose, thereby avoiding volatile compounds produced in the mouth, will demonstrate elevated concentrations of HCN in adult CF patients chronically infected with PA.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"23680696","golden":false,"offsetInEndSection":199,"text":"Elevated concentrations of hydrogen cyanide (HCN) have been detected in the headspace of Pseudomonas aeruginosa (PA) cultures and in the breath of children with cystic fibrosis (CF) and PA infection.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"23680696","golden":false,"offsetInEndSection":130,"text":"Hydrogen cyanide concentrations in the breath of adult cystic fibrosis patients with and without Pseudomonas aeruginosa infection.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"27811380","golden":false,"offsetInEndSection":203,"text":"The analysis of volatile organic compounds (VOCs) by an electronic nose (e-nose) is a groundbreaking method that provides distinct exhaled molecular patterns in several respiratory and systemic diseases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30325509","golden":false,"offsetInEndSection":315,"text":"OBJECTIVE: To evaluate the utility of peak nasal inspiratory flow (PNIF) as a measure of nasal airflow and functional septorhinoplasty (FSRP) outcomes.METHODS: Patients with nasal obstruction were administered Nasal Obstruction Symptom Evaluation (NOSE) questionnaire and PNIF testing between January 2015 and 2018.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":204,"document":"27811380","golden":false,"offsetInEndSection":334,"text":"It has been shown that an e-nose can detect obstructive sleep apnea (OSA) as well as chronic obstructive pulmonary disease (COPD).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30441459","golden":false,"offsetInEndSection":134,"text":"We present a practical electronic nose (e-nose) sys-tem, NOS.E, for the rapid detection and identification of human health conditions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1485,"document":"27811380","golden":false,"offsetInEndSection":1602,"text":"This warrants future studies to confirm the potential of this technique in the non-invasive detection of sleep apnea.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1253,"document":"16134344","golden":false,"offsetInEndSection":1488,"text":"With Fisher discriminant analysis and K-nearest neighbor analysis, the electronic nose was able to discriminate between the two groups.CONCLUSIONS: The electronic nose is a new technology that is inexpensive, noninvasive, and portable.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":416,"document":"27811380","golden":false,"offsetInEndSection":572,"text":"In this pilot study we hypothesized that an e-nose could discriminate the exhaled breath of patients with OVS from that of subjects with OSA and COPD alone.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1205,"document":"27811380","golden":false,"offsetInEndSection":1295,"text":"Breathprints from OVS were not significantly separated from those of COPD (CVA??\u003d??67.9%).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1404,"document":"38336681","golden":false,"offsetInEndSection":2051,"text":"The overall results of both groups combined (n?\u003d?149) showed statistical significance between flexible cystoscopy results and the results of urinary URO17? and urine cytology.CONCLUSION: URO17? has a potential to be a reliable test for diagnosis and follow up of urothelial cancer patients and a screening tool adjunct to flexible cystoscopy.TRIAL REGISTRATION: Not applicable as the current study is not a clinical trial, as per according to the National Institutes of Health, \"studies that involve a comparison of methods and that do not evaluate the effect of the interventions on the participant do not meet the NIH clinical trial definition.\"","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38336681","golden":false,"offsetInEndSection":485,"text":"OBJECTIVE: to evaluate the role of urinary URO17? biomarker in the detection of urothelial tumors in haematuria patients and the detection of recurrence in non-muscle invasive bladder urothelial tumors.MATERIALS AND METHODS: Our study was formed of two cohorts of patients, group I represents patients presenting with haematuria (n?\u003d?98), while group II represents patients with known non-muscle invasive bladder cancers on their scheduled follow up cystoscopic investigation (n?\u003d?51).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1067,"document":"34415806","golden":false,"offsetInEndSection":1338,"text":"In external validation, the same discrimination was achieved by k-nearest neighbors (k-NN) with 75.0% accuracy.CONCLUSION: The reported results show that the VOC analysis with an e-nose system holds exceptional possibilities in noninvasive disease diagnosis applications.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37803440","golden":false,"offsetInEndSection":330,"text":"This research aims to develop a diagnostic tool that can quickly and accurately detect prostate cancer using electronic nose technology and a neural network trained on a dataset of urine samples from patients diagnosed with both prostate cancer and benign prostatic hyperplasia, which incorporates a unique data redundancy method.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38336681","golden":false,"offsetInEndSection":73,"text":"The role of URO17? in diagnosis and follow up of bladder cancer patients.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1286,"document":"38336681","golden":false,"offsetInEndSection":1403,"text":"Eleven patients of group II were on scheduled BacillusCalmette-Guerin (BCG) and another 5 received Mitomycin C (MMC).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":752,"document":"38336681","golden":false,"offsetInEndSection":935,"text":"Results were compared to cystoscopic findings using Chi-square analysis and Fisher\u0027s exact test (P?\u003c?0.05).RESULTS: Group I was formed of 98 patients, with an average age of 60 years.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":371,"document":"34415806","golden":false,"offsetInEndSection":744,"text":"The e-nose device with the sensor array, data acquisition system, and pattern recognition can detect the variations of volatile organic compounds (VOC) present in the expelled breath of patients and healthy controls.MATERIALS AND METHODS: This work presents the e-nose equipment design, study subjects selection, breath sampling procedures, and various data analysis tools.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":936,"document":"38336681","golden":false,"offsetInEndSection":1083,"text":"URO17? showed 100% sensitivity and 96.15% specificity with a negative predictive value (NPV) of 100 and a positive predictive value (PPV) of 95.83.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1084,"document":"38336681","golden":false,"offsetInEndSection":1149,"text":"The results showed statistical significance with P value?\u003c?0.001.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1668,"document":"29165896","golden":false,"offsetInEndSection":1869,"text":"ENS patients (n \u003d 12) also had impaired menthol LDT when compared to healthy controls (p \u003c 0.0001).CONCLUSION: This is the first CFD examination of nasal aerodynamics in a large cohort of ENS patients.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1125,"document":"23680696","golden":false,"offsetInEndSection":1272,"text":"The difference in median (IQR) nose-exhaled HCN between the groups is statistically significant (11 (0.8-18) ppbv versus 0 (0-3.2) ppbv, p \u003d 0.03).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":745,"document":"34415806","golden":false,"offsetInEndSection":1066,"text":"The developed e-nose system is tested in 40 patients with lung cancer, 48 patients with COPD, and 90 healthy controls.RESULTS: In differentiating lung cancer and COPD from controls, support vector machine (SVM) with 3-fold cross-validation outperformed all other classifiers with an accuracy of 92.3% in cross-validation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34415806","golden":false,"offsetInEndSection":275,"text":"INTRODUCTION: This paper describes the research work done toward the development of a breath analyzing electronic nose (e-nose), and the results obtained from testing patients with lung cancer, patients with chronic obstructive pulmonary disease (COPD), and healthy controls.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34768503","golden":false,"offsetInEndSection":148,"text":"BACKGROUND: Bladder cancer (BCa) emits specific volatile organic compounds (VOCs) in the urine headspace that can be detected by an electronic nose.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34415806","golden":false,"offsetInEndSection":106,"text":"Noninvasive detection of COPD and Lung Cancer through breath analysis using MOS Sensor array based e-nose.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":276,"document":"34415806","golden":false,"offsetInEndSection":370,"text":"Pulmonary diseases like COPD and lung cancer are detected with MOS sensor array-based e-noses.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1252,"document":"34768503","golden":false,"offsetInEndSection":1491,"text":"None of the tumor characteristics represented independent predictors of device responsiveness.CONCLUSIONS: The electronic nose might represent a potentially reliable, quick, accurate, and cost-effective tool for non-invasive BCa diagnosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":192,"document":"38143741","golden":false,"offsetInEndSection":793,"text":"Paired samples taken several weeks apart then document an ongoing infection and/or seroconversion.Methods: In the absence of a commercial kit, we developed an indirect enzyme-linked immunosorbent assay (ELISA) to detect the fungus-specific antibodies for Pseudogymnoascus destructans, the agent of white-nose syndrome in bats.Results and Discussion: Samples collected from European Myotis myotis (n\u003d35) and Asian Myotis dasycneme (n\u003d11) in their hibernacula at the end of the hibernation period displayed 100% seroprevalence of antibodies against P. destructans, demonstrating a high rate of exposure.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":708,"document":"36934898","golden":false,"offsetInEndSection":1000,"text":"This was favourable to the positive percentage agreement with saliva at the same time points.CONCLUSION: In our study the Rhinoswab? performed equally well in comparison to a combined throat and nose swab for the laboratory detection of SARS-CoV-2 using nucleic acid amplification techniques.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":642,"document":"37256260","golden":false,"offsetInEndSection":769,"text":"Two-way ANOVA and post hoc multiple pairwise t-test with Bonferroni correction (? \u003d .05) were used to evaluate the measurements","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":777,"document":"37064563","golden":false,"offsetInEndSection":989,"text":"According to the different surgical methods, they were divided into the NOSE group (the natural orifice specimen extraction group) and the N-NOSE group (specimen removed through abdominal wall auxiliary incision)","beginSection":"abstract"}],"exact_answer":[["cancer","Lung cancer","Bladder cancer","early-stage cancer","COPD","carcinoembryonic antigen (CEA)"]],"ideal_answer":[" N-NOSE (Nematode-NOSE) is a simple, inexpensive, and highly sensitive cancer screening method based on the chemotaxis of the nematode Caenorhabditis elegans, which shows evasive action from the urine of healthy individuals while being attracted to the urine of cancer patients.\n"," N-NOSE test is used to detect the presence of lung cancer.\n"," N-NOSE test is a screening tool for early detection of cancer in asymptomatic individuals. It is also used in follow-up monitoring of patients with cancer. The test measures the levels of serum carcinoembryonic antigen (CEA) and serum cancer-germline (CGA-112).\n"," N-NOSE (Nematode-NOSE) is a novel, highly accurate cancer detection system based on the chemotaxis of the nematode Caenorhabditis elegans, which shows evasive action from the urine of healthy individuals while being attracted to the urine of cancer patients.\n","The N-NOSE test is a noninvasive diagnostic tool designed to detect lung cancer and chronic obstructive pulmonary disease (COPD) through the analysis of volatile organic compounds (VOCs) present in exhaled breath. This electronic nose (e-nose) system employs a sensor array and pattern recognition algorithms to distinguish between breath samples from lung cancer patients, individuals with COPD, and healthy controls. In clinical studies, the e-nose has demonstrated high accuracy, making it a potentially reliable, quick, accurate, and cost-effective tool for non-invasive lung cancer and COPD diagnosis."],"id":"65983d7806a2ea257c000036","type":"factoid","body":"What is the N-NOSE test used to detect?"},{"documents":[{"golden":true,"id":"34218857"},{"golden":false,"id":"34860328"},{"golden":false,"id":"36718484"},{"golden":false,"id":"36386945"},{"golden":false,"id":"33615088"},{"golden":true,"id":"34405799"},{"golden":false,"id":"34766365"},{"golden":false,"id":"35356830"},{"golden":true,"id":"34127310"},{"golden":true,"id":"34408742"},{"golden":true,"id":"37748514"},{"golden":false,"id":"37711977"},{"golden":false,"id":"34390597"},{"golden":false,"id":"32833770"},{"golden":true,"id":"37606391"},{"golden":false,"id":"36646091"},{"golden":false,"id":"33723532"},{"golden":false,"id":"34945095"},{"golden":false,"id":"36154716"},{"golden":false,"id":"36895516"},{"golden":false,"id":"35974973"},{"golden":false,"id":"36070309"},{"golden":false,"id":"34265539"},{"golden":false,"id":"33949163"},{"golden":true,"id":"37948194"},{"golden":false,"id":"37402856"},{"golden":false,"id":"34601116"},{"golden":false,"id":"35720240"},{"golden":true,"id":"35464182"},{"golden":true,"id":"36851614"},{"golden":false,"id":"35153987"},{"golden":false,"id":"35631077"},{"golden":false,"id":"33243837"},{"golden":true,"id":"36247098"},{"golden":true,"id":"36815216"},{"golden":false,"id":"36505013"},{"golden":false,"id":"37126363"},{"golden":true,"id":"35029046"},{"golden":false,"id":"37351054"},{"golden":false,"id":"35524358"},{"golden":true,"id":"36151129"},{"golden":false,"id":"34163217"},{"golden":true,"id":"35572152"},{"golden":true,"id":"36065103"},{"golden":false,"id":"35783600"},{"golden":true,"id":"37774781"},{"golden":true,"id":"36750846"},{"golden":false,"id":"37130814"},{"golden":false,"id":"37374189"},{"golden":false,"id":"37228547"},{"golden":true,"id":"37626735"},{"golden":true,"id":"34646643"},{"golden":false,"id":"36292504"},{"golden":false,"id":"35105985"},{"golden":false,"id":"35865450"},{"golden":false,"id":"37731377"},{"golden":false,"id":"35139602"},{"golden":false,"id":"34838708"},{"golden":true,"id":"37140960"},{"golden":false,"id":"37915705"},{"golden":false,"id":"37112929"},{"golden":false,"id":"37457558"},{"golden":true,"id":"36703736"},{"golden":false,"id":"38237983"},{"golden":false,"id":"34853850"},{"golden":false,"id":"38043758"},{"golden":false,"id":"35430271"},{"golden":false,"id":"35898334"},{"golden":false,"id":"35242762"},{"golden":true,"id":"34405800"},{"golden":false,"id":"34191617"},{"golden":false,"id":"34735954"},{"golden":false,"id":"38194535"},{"golden":true,"id":"38191766"},{"golden":false,"id":"38178438"},{"golden":false,"id":"38177150"},{"golden":true,"id":"38151544"},{"golden":false,"id":"38109232"},{"golden":false,"id":"38087593"},{"golden":false,"id":"38049595"},{"golden":true,"id":"38002896"},{"golden":true,"id":"37996257"},{"golden":false,"id":"37766515"},{"golden":true,"id":"37715729"},{"golden":false,"id":"37671223"},{"golden":true,"id":"37629143"},{"golden":true,"id":"38357131"},{"golden":false,"id":"35402784"},{"golden":true,"id":"38020714"},{"golden":false,"id":"32550783"},{"golden":true,"id":"36292552"},{"golden":false,"id":"34629805"},{"golden":true,"id":"35412189"},{"golden":false,"id":"34184177"},{"golden":false,"id":"34789125"},{"golden":false,"id":"36016309"},{"golden":false,"id":"33347790"},{"golden":false,"id":"34220204"},{"golden":false,"id":"35710272"},{"golden":true,"id":"38086949"},{"golden":true,"id":"37128534"},{"golden":false,"id":"37292432"},{"golden":false,"id":"35867593"},{"golden":true,"id":"35195253"},{"golden":false,"id":"38283613"},{"golden":true,"id":"35693009"},{"golden":false,"id":"34016942"},{"golden":false,"id":"34400495"},{"golden":false,"id":"37350206"},{"golden":false,"id":"33070639"},{"golden":true,"id":"37601220"},{"golden":false,"id":"37497990"},{"golden":false,"id":"37166330"},{"golden":false,"id":"37153597"},{"golden":false,"id":"36996590"},{"golden":true,"id":"35411333"},{"golden":false,"id":"37073192"},{"golden":true,"id":"34951953"},{"golden":false,"id":"34175230"},{"golden":true,"id":"36995412"},{"golden":false,"id":"33315163"},{"golden":false,"id":"38203745"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":0,"document":"34127310","golden":true,"offsetInEndSection":116,"text":"In this work, we address the issue of prolonged symptoms following an infection by SARS-CoV-2, labeled \"long COVID\".","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34218857","golden":true,"offsetInEndSection":152,"text":"Post-COVID-19 Syndrome (Long Haul Syndrome): Description of a Multidisciplinary Clinic at Mayo Clinic and Characteristics of the Initial Patient Cohort.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":71,"document":"37748514","golden":true,"offsetInEndSection":182,"text":"Infection with SARS-CoV-2 can result in the development of a post-acute infection syndrome known as long COVID.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37711977","golden":false,"offsetInEndSection":167,"text":"Background: A subset of individuals suffering from Coronavirus Disease 2019 (COVID-19) will experience ongoing symptoms that last longer than three months (i.e., long-","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":809,"document":"34127310","golden":true,"offsetInEndSection":1051,"text":"\"Long COVID\" must be view, because of its expected prevalence, as an opportunity to address the complexity of post-infectious (functional) syndromes, their risk factors, and the biological, psychological and social mechanisms underlying them.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":111,"document":"34408742","golden":true,"offsetInEndSection":325,"text":"Most individuals recover from SARS-CoV-2 infection, however, many continue to experience a cluster of persistent symptoms for months following resolution of acute disease; a syndrome that has been named Long-COVID.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34127310","golden":true,"offsetInEndSection":102,"text":"[\"Long-haul COVID\": An opportunity to address the complexity of post-infectious functional syndromes].","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34405799","golden":true,"offsetInEndSection":278,"text":"Prolonged symptoms from the novel coronavirus disease 2019 (COVID-19), otherwise known as long COVID, postacute sequelae of COVID-19 (PASC), or post-COVID syndrome, are affecting an increasingly high number of patients after severe, moderate, and mild acute COVID-19 infections.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37606391","golden":true,"offsetInEndSection":273,"text":"At least 10% of patients experience persistent symptoms after SARS-CoV-2 infection, a condition referred to as post-acute COVID-19, post-acute sequelae of SARS-CoV-2 infection (PASC), long COVID, long-haul COVID, long-term effects of COVID, post-COVID-19 and chronic COVID.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":579,"document":"33949163","golden":false,"offsetInEndSection":658,"text":"In the lung could cause pneumonia and severe acute respiratory syndrome (SARS).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":343,"document":"33949163","golden":false,"offsetInEndSection":463,"text":"It is well known that SARS-CoV-2 could develop mild, moderate, and severe respiratory symptoms that could lead to death.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1030,"document":"33949163","golden":false,"offsetInEndSection":1282,"text":"The neurological symptoms that the patient presents, will depend on factors that condition the expression of ACE2 in the brain such as age and sex, as well as the mechanism of neuronal invasion, the immune response and the general state of the patient.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":233,"document":"37948194","golden":true,"offsetInEndSection":330,"text":"The virus is also responsible for post-COVID-19 condition (commonly referred to as \u0027long COVID\u0027).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":217,"document":"33949163","golden":false,"offsetInEndSection":342,"text":"COVID-19 is caused by the virus SARS- CoV-2, it enters the cells through the ACE2 receptor (angiotensin converting enzyme 2).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35464182","golden":true,"offsetInEndSection":135,"text":"Many patients with COVID-19 experience a range of debilitating symptoms months after being infected, a syndrome termed long-haul COVID.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36851614","golden":true,"offsetInEndSection":176,"text":"A novel syndrome called long-haul COVID or long COVID is increasingly recognized in a significant percentage of individuals within a few months after infection with SARS-CoV-2.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":177,"document":"36815216","golden":true,"offsetInEndSection":321,"text":"Approximately 23% of these patients developed lasting \"long-haul\" COVID symptoms, including fatigue, joint pain, and systemic hyperinflammation.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"35464182","golden":true,"offsetInEndSection":91,"text":"Case Report: Therapeutic and immunomodulatory effects of plasmapheresis in long-haul COVID.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":532,"document":"35029046","golden":true,"offsetInEndSection":793,"text":"However, a significant proportion (~40%) experience a variety of symptoms (loss of smell and/or taste, fatigue, cough, aching pain, \"brain fog,\" insomnia, shortness of breath, and tachycardia) after 12?weeks and are diagnosed with a syndrome named \"LONG COVID.\"","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":413,"document":"35631077","golden":false,"offsetInEndSection":737,"text":"Indeed, this new pathogen causes a variety of syndromes, including asymptomatic disease; mild disease; moderate disease; a severe form that requires hospitalization, intensive care, and mechanical ventilation; multisystem inflammatory disease; and a condition called long COVID or postacute sequelae of SARS-CoV-2 infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36247098","golden":true,"offsetInEndSection":176,"text":"Background: Long-COVID?(also known as post-coronavirus-19 syndrome) is a term used to describe symptoms that people experience following their recovery from the COVID-19 virus.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36151129","golden":true,"offsetInEndSection":171,"text":"Long-haul COVID-19, also called post-acute sequelae of SARS-CoV-2 (PASC), is a new illness caused by SARS-CoV-2 infection and characterized by the persistence of symptoms.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36851614","golden":true,"offsetInEndSection":124,"text":"Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":569,"document":"35572152","golden":true,"offsetInEndSection":680,"text":"This syndrome, designated as post-acute sequelae of SARS-CoV-2 infection, is more commonly known as long COVID.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":856,"document":"36065103","golden":true,"offsetInEndSection":1247,"text":"Results: The post-COVID conditions, a more recent and less anxiety-inducing term for the patient than long COVID or \"long haul,\" is an umbrella term for a wide range of physical and mental health symptoms similar to those seen in patients with the myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), experienced by some patients and are present ? 4 weeks after SARS-CoV-2 infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":565,"document":"36851614","golden":true,"offsetInEndSection":775,"text":"Very much like with long ME/CFS, infections with herpes family viruses, immune dysregulation, and the persistence of inflammation have been reported as the most common pattern for the development of long COVID.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37774781","golden":true,"offsetInEndSection":243,"text":"Long COVID (coronavirus disease 2019) syndrome, also known as post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, is a new disorder that can develop after an acute infection with the SARS-CoV-2 virus.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35783600","golden":false,"offsetInEndSection":133,"text":"Coronavirus disease 2019 (COVID-19) is caused by a novel virus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":382,"document":"34646643","golden":true,"offsetInEndSection":573,"text":"Whilst COVID-19 is an acute illness for a majority of cases; some of the debilitating virus-related symptoms can last for weeks and months, and are collectively termed as long COVID syndrome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1113,"document":"35783600","golden":false,"offsetInEndSection":1242,"text":"Of interest, hyperviscosity syndrome in COVID-19 may cause poor tissue perfusion, peripheral vascular resistance, and thrombosis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1348,"document":"35783600","golden":false,"offsetInEndSection":1611,"text":"Of interest, hyperviscosity syndrome is more commonly developed in vaccine recipients who had formerly received the COVID-19 vaccine due to higher underlying immunoglobulin concentrations, and only infrequently in those who have not received the COVID-19 vaccine.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":354,"document":"37228547","golden":false,"offsetInEndSection":581,"text":"We report a series of four cases depicting the successful use of acyclovir in the treatment of the virus SARS-CoV-2 in patients with long-haul symptoms, especially those in the realm of encephalopathy and neurological problems.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":938,"document":"35783600","golden":false,"offsetInEndSection":1112,"text":"Variations in erythrocyte fragility and deformability with endothelial dysfunction and oxidative stress in SARS-CoV-2 infection may cause hyperviscosity syndrome in COVID-19.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":575,"document":"35783600","golden":false,"offsetInEndSection":755,"text":"Hyperviscosity syndrome is developed in different hematological disorders including multiple myeloma, sickle cell anemia, Waldenstorm macroglobulinemia, polycythemia, and leukemia.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"35783600","golden":false,"offsetInEndSection":69,"text":"Changes in the Blood Viscosity in Patients With SARS-CoV-2 Infection.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1612,"document":"35783600","golden":false,"offsetInEndSection":1864,"text":"Taken together, these observations are untimely too early to give a final connotation between COVID-19 vaccination and the risk for development of hyperviscosity syndrome, consequently prospective and retrospective studies are necessary in this regard.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":787,"document":"36750846","golden":true,"offsetInEndSection":967,"text":"Interestingly, Long-haul COVID and many debilitating viral diseases display a similar range of clinical symptoms of muscle fatigue, dizziness, depression, and chronic inflammation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":968,"document":"36750846","golden":true,"offsetInEndSection":1189,"text":"In our current hypothesis-driven review article, we attempt to discuss the molecular mechanism of muscle fatigue in long-haul COVID, and other viral diseases as caused by HHV6, Powassan, Epstein-Barr virus (EBV), and HIV.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36750846","golden":true,"offsetInEndSection":94,"text":"Potential molecular mechanisms of chronic fatigue in long haul COVID and other viral diseases.","beginSection":"title"},{"endSection":"title","offsetInBeginSection":0,"document":"35865450","golden":false,"offsetInEndSection":129,"text":"Acute to Chronic Electro-Clinical Manifestations of Neuro-COVID and the Long-Haul Consequences in People With Epilepsy: A Review.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1190,"document":"36750846","golden":false,"offsetInEndSection":1334,"text":"We also discuss the pathological resemblance of virus-triggered muscle fatigue with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37915705","golden":false,"offsetInEndSection":189,"text":"Introduction: SARS-CoV-2, the virus responsible for the COVID-19 pandemic, has brought a conglomerate of novel chronic disabling conditions described as \u0027Long COVID/Post-COVID-19 Syndrome\u0027.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":403,"document":"36703736","golden":true,"offsetInEndSection":622,"text":"Many of these individuals have been reported to experience multiple symptoms during the convalescence, such as fatigue, dyspnea and pain which are designated as \"long-COVID\", \"post-COVID syndrome\" or \"recovery sequelae.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37140960","golden":true,"offsetInEndSection":62,"text":"Viral persistence, reactivation, and mechanisms of long COVID.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37374189","golden":false,"offsetInEndSection":160,"text":"Coronavirus disease 2019 (COVID-19) is a potentially serious acute respiratory infection caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":693,"document":"37626735","golden":true,"offsetInEndSection":872,"text":"After acute-phase infection, some patients reported signs and symptoms of a systemic disorder known as long COVID, in which a broad range of cardiovascular (CV) disorders emerged.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":878,"document":"37374189","golden":false,"offsetInEndSection":1020,"text":"The aim of this review was to assess the literature on the incidence of bacterial co-infections and superinfections in patients with COVID-19.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":371,"document":"37374189","golden":false,"offsetInEndSection":551,"text":"It has long been known that viral respiratory tract infections predispose patients to bacterial infections and that these co-infections often have an unfavourable clinical outcome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1021,"document":"37374189","golden":false,"offsetInEndSection":1266,"text":"The review also highlights the importance of the rational use of antibiotics in patients with COVID-19 and the need to implement antimicrobial stewardship principles to prevent the transmission of drug-resistant organisms in healthcare settings.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":151,"document":"37130814","golden":false,"offsetInEndSection":349,"text":"Apart from causing acute respiratory illness and multiorgan dysfunction, there can be long-term multiorgan sequalae after recovery, which is termed \u0027long COVID-19\u0027 or \u0027post-acute COVID-19 syndrome\u0027.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":161,"document":"37374189","golden":false,"offsetInEndSection":370,"text":"Since the World Health Organization (WHO) declared COVID-19 a global pandemic, the virus has spread to more than 200 countries with more than 500 million cases and more than 6 million deaths reported globally.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":552,"document":"37374189","golden":false,"offsetInEndSection":737,"text":"Moreover, nosocomial infections, also known as healthcare-associated infections (HAIs), are those infections that are absent at the time of admission and acquired after hospitalization.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":598,"document":"34405800","golden":true,"offsetInEndSection":807,"text":"A third group of those who do not have ongoing signs of active infection but who experience new, lasting, or deteriorating symptoms has begun to emerge and may represent a distinct COVID-19 long-haul syndrome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":345,"document":"34191617","golden":false,"offsetInEndSection":468,"text":"COVID-19 impacts multiple organs that call for a systems medicine approach to planetary health and therapeutics innovation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":566,"document":"34191617","golden":false,"offsetInEndSection":724,"text":"As the virus variants emerge under different ecological conditions and contexts in the long haul, a broad array of vaccine and drug options will be necessary.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":725,"document":"34191617","golden":false,"offsetInEndSection":926,"text":"This expert review article argues for a need to expand the COVID-19 interventions, including and beyond vaccines, to stimulate discovery and development of novel medicines against SARS-CoV-2 infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1105,"document":"34735954","golden":false,"offsetInEndSection":1195,"text":"During the 14 day mandatory quarantine, clinical testing identified 112 cases of COVID-19.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38194535","golden":false,"offsetInEndSection":163,"text":"Physical-layer secure key distribution (PLSKD) generally acquires highly correlated entropy sources via bidirectional transmission to share the channel reciprocity","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"38191766","golden":true,"offsetInEndSection":112,"text":"Cognitive impairment and chronic fatigue represent common characteristics of the long COVID syndrome","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38178438","golden":false,"offsetInEndSection":88,"text":"Fault-tolerant four-dimensional constellation for coherent optical transmission systems.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1204,"document":"38177150","golden":false,"offsetInEndSection":1400,"text":"As a result, it was verified that this long-range CTS is capable of maintaining stable sub-microsecond time synchronization for 3?days with a granularity of 148.8?ns (SD) and an offset of 22.97?ns","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38151544","golden":true,"offsetInEndSection":117,"text":"The impact of long COVID on health-related quality of life in patients 6 months after discharge with severe COVID-19.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1551,"document":"38109232","golden":false,"offsetInEndSection":1654,"text":"Drowsy driving is discussed, along with fatigue management in round-the-clock transportation operations","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":111,"document":"38087593","golden":false,"offsetInEndSection":204,"text":"However, it suffers from high computation complexity that limits its physical implementations","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38049595","golden":false,"offsetInEndSection":73,"text":"Telecom-band quantum dot technologies for long-distance quantum networks.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":218,"document":"38002896","golden":true,"offsetInEndSection":385,"text":"Several researchers have likened long-haul COVID-19 to chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) and postural orthostatic tachycardia syndrome (POTS)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":369,"document":"37996257","golden":true,"offsetInEndSection":733,"text":"The vast majority of acute infections began and often ended in the respiratory tract, but more recent evaluations have confirmed significant extrapulmonary manifestations including symptom clusters that extend beyond the acute phase of infection collectively referred to as \"post-acute sequelae SARS-CoV-2 infection\" (PASC) or more commonly as \"long (-haul) COVID\"","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":817,"document":"37766515","golden":false,"offsetInEndSection":1090,"text":"The underlying mechanisms remain unclear, but proposed contributors include neuroinflammation, hypoxia, vascular damage, and latent virus reactivation not excluding the possibility of direct viral invasion of the central nervous system, illustrating complex viral pathology","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37715729","golden":true,"offsetInEndSection":32,"text":"Treatable traits for long COVID.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":678,"document":"37671223","golden":false,"offsetInEndSection":706,"text":"Cases were healthy pre-COVID","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1178,"document":"37629143","golden":true,"offsetInEndSection":1407,"text":"Follow-up studies using an established case definition and precise diagnostic criteria of long COVID in people with or without reinfection may further elucidate the contribution of SARS-CoV-2 reinfections to the long COVID burden","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":165,"document":"38020714","golden":true,"offsetInEndSection":259,"text":"Patients with COVID-19 may experience persistent long-term health issues, known as long COVID.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":957,"document":"35412189","golden":true,"offsetInEndSection":1084,"text":"The case of COVID-19 long haul demonstrates that social media are significant fora whereon the public identify health concerns.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36292552","golden":true,"offsetInEndSection":140,"text":"Long-Haul COVID Patients: Prevalence of POTS Are Reduced but Cerebral Blood Flow Abnormalities Remain Abnormal with Longer Disease Duration.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":218,"document":"38002896","golden":true,"offsetInEndSection":386,"text":"Several researchers have likened long-haul COVID-19 to chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) and postural orthostatic tachycardia syndrome (POTS).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":809,"document":"33347790","golden":false,"offsetInEndSection":1194,"text":"SARS-CoV-1 and Middle East respiratory syndrome coronavirus [MERS-CoV]) in combination with known health implications of SARS-CoV-2 infection to predict potential long-term effects of COVID-19, including pulmonary, cardiovascular, hematologic, renal, central nervous system, gastrointestinal, and psychosocial manifestations, in addition to the well-known post-intensive care syndrome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38086949","golden":false,"offsetInEndSection":162,"text":"Of those infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), ~?10% develop the chronic post-viral debilitating condition, long COVID (LC).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37128534","golden":true,"offsetInEndSection":190,"text":"Background Post-COVID-19 syndrome, also known as long COVID, is a disorder that has many characteristics, one of which is chronic fatigue following acute infection with the SARS-CoV-2 virus.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35195253","golden":true,"offsetInEndSection":362,"text":"Post-acute sequelae of COVID (PASC), usually referred to as \u0027Long COVID\u0027 (a phenotype of COVID-19), is a relatively frequent consequence of SARS-CoV-2 infection, in which symptoms such as breathlessness, fatigue, \u0027brain fog\u0027, tissue damage, inflammation, and coagulopathies (dysfunctions of the blood coagulation system) persist long after the initial infection.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37292432","golden":false,"offsetInEndSection":259,"text":"In the aftermath of acute infection with the severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), a large number of symptoms persist or appear, constituting a real syndrome called \"long COVID-19\" or \"post-COVID- 19\" or \"post-acute COVID-19 syndrome\".","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38086949","golden":true,"offsetInEndSection":176,"text":"A pilot study on the immune cell proteome of long COVID patients shows changes to physiological pathways similar to those in myalgic encephalomyelitis/chronic fatigue syndrome.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1614,"document":"35693009","golden":true,"offsetInEndSection":1752,"text":"By contrast, Long COVID (Post-COVID-19 condition) is a very recent ME/CFS-like illness arising from the single pandemic virus, SARS-CoV-2.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35402784","golden":false,"offsetInEndSection":110,"text":"Coronavirus Disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"37601220","golden":true,"offsetInEndSection":104,"text":"People with long-haul COVID-19 could experience various health problems, from mild to severe","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37497990","golden":false,"offsetInEndSection":156,"text":"The objective of this observational study is to determine whether vaccination for SARS-CoV-2 alters the clinical presentation of post-COVID conditions (PCC)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":398,"document":"37166330","golden":false,"offsetInEndSection":734,"text":"Three research networks within the REsearching COVID to Enhance Recovery initiative (PCORnet Adult, PCORnet Pediatric, and the National COVID Cohort Collaborative [N3C]) employed a harmonized analytic approach to examine the risk of probable PASC in COVID-19-positive patients with and without a diagnosis of OSA prior to pandemic onset","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":665,"document":"37153597","golden":false,"offsetInEndSection":901,"text":"Furthermore, with further research such a framework could establish the strength of the relationships between pre-existing conditions (or risk factors), biological mechanisms, and resulting clinical phenotypes and outcomes of Long COVID","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":205,"document":"36996590","golden":false,"offsetInEndSection":397,"text":"However, non-hospitalized patients with less severe symptoms from COVID-19 disease have also been experiencing significant morbidity and difficulty functioning their activities of daily living","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":345,"document":"35411333","golden":true,"offsetInEndSection":572,"text":"Long COVID (long-term or long-haul) is the collective term used to define recovered individuals of SARS-CoV-2 infection who have presented with persistent COVID symptoms, as well as the emergence of disorders and complications.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":119,"document":"37073192","golden":false,"offsetInEndSection":218,"text":"COVID-19 is associated with a long-COVID syndrome that presents with cognitive decline and fatigue.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":973,"document":"35411333","golden":true,"offsetInEndSection":1242,"text":"Patients with chronic COVID-19 were found to experience heart thrombosis leading to myocardial infarction, inflammation, lung fibrosis, stroke, venous thromboembolism, arterial thromboembolism, \"brain fog\", general mood dysfunctions, dermatological issues, and fatigue.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":164,"document":"36995412","golden":true,"offsetInEndSection":294,"text":"Chronic fatigue lasting more than three months is the major symptom of the post-COVID syndrome (known colloquially as long-COVID).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":66,"document":"34951953","golden":true,"offsetInEndSection":287,"text":"Known by a variety of names, including long COVID or long-haul COVID, and listed in the ICD-10 classification as post-COVID-19 condition since September, 2020, this occurrence is variable in its expression and its impact.","beginSection":"abstract"}],"exact_answer":"no","ideal_answer":["No, Covid-19 is not the only virus known to cause a \"Long Haul\" syndrome. Other viruses such as HHV6, Powassan, Epstein-Barr virus (EBV), and HIV can also cause similar prolonged symptoms and complications that are characteristic of long-haul syndromes. These include a range of clinical symptoms such as chronic fatigue, muscle fatigue, dizziness, depression, and chronic inflammation.","No, covid is not the only virus known to cause long-haul syndrome. Other viruses, such as herpes family viruses (EBV and HHV-6), can also contribute to inflammation and autoimmunity in post-infectious functional syndromes like long COVID."," No.  Multiple types of viruses have been known to cause long-haul syndromes.\n","Yes, COVID-19 is not the only virus known to cause a \"Long Haul\" syndrome. Other viruses, such as herpes family viruses, Epstein-Barr virus (EBV), and HIV, have also been associated with similar long-lasting symptoms and conditions. Therefore, \"Long Haul\" syndrome can be observed in individuals infected with various viruses, not just COVID-19.","No, Covid is not the only virus known to cause a \"Long Haul\" syndrome. While COVID-19, caused by the SARS-CoV-2 virus, has widely publicized long-term effects known as \"long COVID,\" it is not unique in causing post-infectious syndromes. Other viral infections, such as Epstein-Barr virus, which can lead to chronic fatigue syndrome, and other coronaviruses like those causing SARS and MERS, have also been known to result in persistent symptoms or long-term health issues in some individuals after the acute infection has resolved. Therefore, the concept of long-term sequelae following viral infections is not exclusive to COVID-19.","No, COVID-19 is not the only virus known to cause a \"Long Haul\" syndrome. While COVID-19 has been widely recognized for its association with post-acute sequelae leading to long COVID, there are other viral infections that can also result in prolonged symptoms, known as post-viral syndromes. Conditions such as chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) and postural orthostatic tachycardia syndrome (POTS) have been associated with other viral infections, including Epstein-Barr virus and other human coronaviruses like SARS-CoV-1 and MERS-CoV. Long-term effects after acute viral infections are not unique to COVID-19; however, the scale and impact of long COVID have brought significant attention to post-infectious syndromes.","No, COVID-19 is not the only virus known to cause long-haul or post-acute sequelae syndromes. Other viruses such as herpes family viruses (EBV and HHV-6) have been implicated in causing persistent symptoms similar to those experienced by some COVID-19 patients, suggesting that inflammation and autoimmunity may contribute to the development of long-haul syndrome across different viral infections.","No, COVID-19 is not the only virus known to cause a \"Long Haul\" syndrome. Long COVID or Post-Acute Sequelae of SARS-CoV-2 infection does cause chronic symptoms such as fatigue and \u0027brain fog\u0027 that can persist for an extended period following the acute phase of infection. However, similar chronic post-viral conditions have been documented with other viruses. For example, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a post-viral fatigue condition that can arise following various viral infections, not just SARS-CoV-2. This syndrome has been linked to numerous infections where individuals report prolonged fatigue and other symptoms long after the initial infection has resolved. Therefore, the concept of \"Long Haul\" syndromes is not unique to COVID-19 but can be a consequence of different viral infections.","No, COVID-19 is not the only virus known to cause a \"Long Haul\" syndrome. While the snippets provided focus on COVID-19 and the post-acute sequelae of SARS-CoV-2 infection, known as long COVID or long-haul COVID, there are other viral infections that can lead to prolonged health problems, often termed post-viral syndromes. For example, chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME), can develop following viral infections such as Epstein-Barr virus (EBV), and patients who recover from Ebola virus disease have been reported to experience long-term sequelae. Similarly, other viral illnesses like the flu, dengue, West Nile virus, and others can have prolonged symptoms in some individuals. Therefore, it is inaccurate to assert that COVID-19 is the only virus associated with long-term sequelae.","No, COVID-19 is not the only virus known to cause a \"Long Haul\" syndrome. \"Long haul\" or post-acute sequelae affect patients who have recovered from various viral infections, not just SARS-CoV-2, which causes COVID-19. For instance, post-viral fatigue syndromes have been documented following other viral infections such as Epstein-Barr virus (responsible for infectious mononucleosis), Ross River virus, and more. These conditions can manifest with prolonged fatigue, cognitive dysfunction, and other symptoms that persist for months or even years following the acute phase of the infection. The phenomenon of long-term sequelae is not unique to COVID-19; it is an aspect of post-viral syndromes that can follow a variety of viral infections."],"id":"65983e3c06a2ea257c000037","type":"yesno","body":"Covid is the only virus known to cause a \"Long Haul\" syndrome, yes or no?"},{"documents":[{"golden":false,"id":"23570814"},{"golden":false,"id":"17213311"},{"golden":false,"id":"22104467"},{"golden":false,"id":"24688145"},{"golden":false,"id":"28331351"},{"golden":false,"id":"28181363"},{"golden":false,"id":"21208359"},{"golden":false,"id":"36608818"},{"golden":false,"id":"17639666"},{"golden":true,"id":"31055989"},{"golden":true,"id":"31436480"},{"golden":true,"id":"28848315"},{"golden":false,"id":"33177239"},{"golden":true,"id":"33677922"},{"golden":true,"id":"31819577"},{"golden":true,"id":"31600725"},{"golden":false,"id":"32725484"},{"golden":false,"id":"31952996"},{"golden":false,"id":"24373190"},{"golden":false,"id":"21143938"},{"golden":false,"id":"32815423"},{"golden":false,"id":"33068776"},{"golden":false,"id":"21484567"},{"golden":false,"id":"22177947"},{"golden":false,"id":"21389296"},{"golden":true,"id":"18840004"},{"golden":false,"id":"17213325"},{"golden":false,"id":"33711555"},{"golden":false,"id":"35228448"},{"golden":false,"id":"22725703"},{"golden":false,"id":"35925683"},{"golden":false,"id":"22267302"},{"golden":false,"id":"26371721"},{"golden":true,"id":"33964002"},{"golden":true,"id":"34305810"},{"golden":true,"id":"34993760"},{"golden":true,"id":"34576096"},{"golden":false,"id":"34504612"},{"golden":false,"id":"33627989"},{"golden":false,"id":"34468297"},{"golden":false,"id":"37189293"},{"golden":false,"id":"33447122"},{"golden":true,"id":"33354706"},{"golden":false,"id":"26863436"},{"golden":true,"id":"36208922"},{"golden":true,"id":"34181914"},{"golden":false,"id":"37209227"},{"golden":false,"id":"34795324"},{"golden":true,"id":"37351564"},{"golden":false,"id":"22390369"},{"golden":true,"id":"32293707"},{"golden":true,"id":"35647711"},{"golden":false,"id":"34881835"},{"golden":true,"id":"37264711"},{"golden":true,"id":"34127852"},{"golden":true,"id":"28270518"},{"golden":false,"id":"38161982"},{"golden":true,"id":"38122931"},{"golden":true,"id":"37312901"},{"golden":true,"id":"32826189"},{"golden":false,"id":"34861287"},{"golden":false,"id":"37852529"},{"golden":true,"id":"37369232"},{"golden":false,"id":"36541153"},{"golden":false,"id":"37870067"},{"golden":false,"id":"32815453"},{"golden":false,"id":"32206477"},{"golden":false,"id":"37454782"},{"golden":false,"id":"35561211"},{"golden":false,"id":"32267058"},{"golden":true,"id":"37344954"},{"golden":false,"id":"32815436"},{"golden":true,"id":"31990244"},{"golden":false,"id":"35650449"},{"golden":false,"id":"37823483"},{"golden":false,"id":"31958096"},{"golden":false,"id":"35487507"},{"golden":false,"id":"15655719"},{"golden":false,"id":"32873415"},{"golden":true,"id":"33439581"},{"golden":false,"id":"33434602"},{"golden":true,"id":"37813741"},{"golden":true,"id":"35698011"},{"golden":false,"id":"16277173"},{"golden":false,"id":"38169925"},{"golden":false,"id":"37940101"},{"golden":false,"id":"22284242"},{"golden":false,"id":"37975420"},{"golden":false,"id":"37197367"},{"golden":false,"id":"37430117"},{"golden":false,"id":"18669601"},{"golden":true,"id":"34267725"},{"golden":true,"id":"35164855"},{"golden":false,"id":"31372015"},{"golden":false,"id":"31058214"},{"golden":false,"id":"15709922"},{"golden":false,"id":"36778223"},{"golden":false,"id":"19619327"},{"golden":false,"id":"29406841"},{"golden":false,"id":"22339447"},{"golden":false,"id":"38357515"},{"golden":false,"id":"38356942"},{"golden":false,"id":"38356317"},{"golden":false,"id":"38356208"},{"golden":false,"id":"38356161"},{"golden":false,"id":"38355513"},{"golden":false,"id":"38354757"},{"golden":false,"id":"38353610"},{"golden":false,"id":"38352159"},{"golden":true,"id":"30499733"},{"golden":false,"id":"24499291"},{"golden":false,"id":"20130920"},{"golden":false,"id":"26824365"},{"golden":false,"id":"28988756"},{"golden":false,"id":"22290234"},{"golden":false,"id":"31514971"},{"golden":false,"id":"20575217"},{"golden":false,"id":"21864749"},{"golden":false,"id":"20676118"},{"golden":true,"id":"31744308"},{"golden":false,"id":"25313322"},{"golden":false,"id":"24403842"},{"golden":false,"id":"26138513"},{"golden":false,"id":"37280458"},{"golden":false,"id":"38056618"},{"golden":false,"id":"37917019"},{"golden":false,"id":"36465574"},{"golden":false,"id":"35873937"},{"golden":false,"id":"37917871"},{"golden":false,"id":"36872170"},{"golden":false,"id":"32886267"},{"golden":false,"id":"35873704"},{"golden":false,"id":"35653929"},{"golden":false,"id":"21824270"},{"golden":false,"id":"19707284"},{"golden":false,"id":"38241775"},{"golden":false,"id":"31686781"},{"golden":false,"id":"34526121"},{"golden":false,"id":"31801807"},{"golden":false,"id":"33767808"},{"golden":false,"id":"33886044"},{"golden":false,"id":"26587691"},{"golden":false,"id":"38358546"},{"golden":false,"id":"38356211"},{"golden":false,"id":"38354299"},{"golden":false,"id":"38341366"},{"golden":false,"id":"38340396"},{"golden":false,"id":"38337597"},{"golden":false,"id":"38302593"},{"golden":false,"id":"38300898"},{"golden":false,"id":"38273155"},{"golden":false,"id":"38240875"},{"golden":true,"id":"38230324"},{"golden":false,"id":"38220031"},{"golden":true,"id":"37213102"},{"golden":false,"id":"37311722"},{"golden":false,"id":"37992687"},{"golden":false,"id":"38181103"},{"golden":false,"id":"37954886"},{"golden":false,"id":"34413054"},{"golden":false,"id":"38242040"},{"golden":false,"id":"33965397"}],"answerReady":true,"snippets":[{"endSection":"title","offsetInBeginSection":0,"document":"31436480","golden":true,"offsetInEndSection":86,"text":"Oral Semaglutide: A Review of the First Oral Glucagon-Like Peptide 1 Receptor Agonist.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":406,"document":"28848315","golden":true,"offsetInEndSection":697,"text":"The GLP-1 receptor agonists currently approved in the United States for the treatment of type 2 diabetes include exenatide (administered twice daily), liraglutide and lixisenatide (administered once daily), and the once-weekly agents exenatide extended-release, albiglutide, and dulaglutide.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31055989","golden":true,"offsetInEndSection":161,"text":"Introduction: The GLP-1 receptor agonist (GLP-1 RA) liraglutide has a half-life of approximately 13?h and is suitable for subcutaneous administration once daily.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":371,"document":"31436480","golden":true,"offsetInEndSection":548,"text":"A new coformulation of semaglutide with sodium N-[8-(2-hydroxybenzoyl) amino caprylate (SNAC) is the first oral GLP-1 RA reviewed by the U.S. Food and Drug Administration (FDA).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":442,"document":"31819577","golden":true,"offsetInEndSection":641,"text":"More recently, a GLP-1 agonist has been developed, semaglutide, that can be administered orally which has at least similar effects to the subcutaneous preparation from which this compound is derived.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":859,"document":"33677922","golden":true,"offsetInEndSection":993,"text":"We focus on the pharmacokinetic and pharmacodynamic properties of the recently approved oral GLP-1 receptor agonist, oral semaglutide.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":797,"document":"31600725","golden":true,"offsetInEndSection":1062,"text":"Most GLP-1 receptor agonists (lixisenatide q.d., liraglutide q.d., exenatide q.w., dulaglutide q.w., albiglutide q.w., semaglutide q.w., all for s.c. injection, and the first oral preparation, oral semaglutide) have been examined in cardiovascular outcomes studies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21389296","golden":false,"offsetInEndSection":244,"text":"Incretin-based therapies (subcutaneously administered glucagon-like peptide-1 [GLP-1] agonists and oral dipeptidyl peptidase-4 inhibitors) represent a new mechanism of action with which to target the adverse effects of type 2 diabetes mellitus.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1183,"document":"17213311","golden":false,"offsetInEndSection":1330,"text":"and oral administration of Boc5 dose-dependently inhibited food intake in mice, an effect that could be blocked by pretreatment with exendin(9-39).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1459,"document":"18840004","golden":true,"offsetInEndSection":1646,"text":"GLP-1 receptor agonists, such as exenatide, stimulate nutrient-induced insulin secretion and reduce inappropriate glucagon secretion while delaying gastric emptying and reducing appetite.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33964002","golden":true,"offsetInEndSection":126,"text":"Oral semaglutide (Rybelsus?) is a glucagon-like peptide-1 (GLP-1) receptor agonist (GLP-1RA) with 94% homology to human GLP-1.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33354706","golden":true,"offsetInEndSection":335,"text":"PURPOSE: To provide pharmacists with information on counseling patients with type 2 diabetes (T2D) receiving oral semaglutide.SUMMARY: Oral semaglutide, the first oral glucagon-like peptide 1 (GLP-1) receptor agonist (GLP-1RA), was approved for the treatment of adults with T2D by the US Food and Drug Administration in September 2019.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34305810","golden":true,"offsetInEndSection":206,"text":"The glucagon-like peptide-1 receptor agonist (GLP-1RA) semaglutide is the most recently approved agent of this drug class, and the only GLP-1RA currently available as both subcutaneous and oral formulation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34993760","golden":true,"offsetInEndSection":187,"text":"Semaglutide, a glucagon like peptide-1 (GLP-1) receptor agonist, is available as monotherapy in both subcutaneous as well as oral dosage form (first approved oral GLP-1 receptor agonist).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":170,"document":"34468297","golden":false,"offsetInEndSection":636,"text":"In type 2 diabetes, correcting the impaired incretin system using GLP-1 agonist is a well-defined therapeutic strategy.OBJECTIVES: This review article aims to discuss the mechanism of action, key regulatory events, clinical trials for glycaemic control, and comparative analysis of semaglutide with the second-line antidiabetic drugs.DESCRIPTION: Semaglutide is a glucagon-like peptide 1 (GLP-1) receptor agonist with enhanced glycaemic control in diabetes patients.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"33964002","golden":true,"offsetInEndSection":97,"text":"A Pharmacological and Clinical Overview of Oral Semaglutide for the Treatment of Type 2 Diabetes.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":697,"document":"33964002","golden":true,"offsetInEndSection":1014,"text":"In an extensive phase III clinical program including patients from across the disease spectrum, treatment with oral semaglutide resulted in effective glycemic control, reductions in body weight, and decreases in systolic blood pressure when used as monotherapy or in combination with other glucose-lowering therapies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1265,"document":"34576096","golden":true,"offsetInEndSection":1406,"text":"Thus, oral semaglutide represents a novel treatment option that is particularly well-suited for patients with type 2 diabetes and/or obesity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":419,"document":"33964002","golden":true,"offsetInEndSection":696,"text":"Oral semaglutide is indicated for use as an add-on combination therapy (with other glucose-lowering agents, including insulin) or as a monotherapy (in patients who are intolerant to metformin) for type 2 diabetes when diet and exercise do not provide adequate glycemic control.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":167,"document":"35647711","golden":true,"offsetInEndSection":286,"text":"Herein, we describe the discovery of the orally bioavailable, small-molecule, GLP-1R agonist PF-06882961 (danuglipron).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1760,"document":"37351564","golden":true,"offsetInEndSection":1968,"text":"The safety profile of orforglipron was consistent with that of the GLP-1 receptor agonist class.CONCLUSIONS: Daily oral orforglipron, a nonpeptide GLP-1 receptor agonist, was associated with weight reduction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1394,"document":"32293707","golden":true,"offsetInEndSection":1662,"text":"Furthermore, uptake of OHP2 by Caco-2 cells was dependent on caveolae-mediated transcytosis rather than endocytosis mediated by GLP-1 receptors.CONCLUSIONS AND IMPLICATIONS: OHP2 is a potential, orally bioavailable, candidate drug for the treatment of Type 2 diabetes.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"36208922","golden":true,"offsetInEndSection":97,"text":"Oral semaglutide - Rybelsus?, the first GLP-1 receptor agonist for oral use in clinical practice.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1356,"document":"26863436","golden":false,"offsetInEndSection":1531,"text":"These results provide evidence that DMB, a small molecular GLP-1R agonist, attenuates transient focal cerebral ischemia injury and inhibits neuronal apoptosis induced by MCAO.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":350,"document":"37209227","golden":false,"offsetInEndSection":516,"text":"The GLP-1 receptor agonists used clinically are based on exendin-4 and native GLP-1 and are available as formulations for daily or weekly s.c. or oral administration.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":893,"document":"34181914","golden":true,"offsetInEndSection":1047,"text":"A GLP-1 peptide receptor agonist (semaglutide) is now available for oral absorption, and small molecules activating GLP-1 receptors appear on the horizon.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37264711","golden":true,"offsetInEndSection":372,"text":"AIM: To report the results of a Phase 1b trial evaluating the safety, pharmacokinetics and pharmacodynamics of orforglipron (LY3502970), an oral, non-peptide glucagon-like peptide-1 receptor agonist (GLP-1RA), in patients with type 2 diabetes (T2D).MATERIALS AND METHODS: This was a double-blind, placebo-controlled Phase 1 study evaluating five different dosing regimens.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":99,"document":"37351564","golden":false,"offsetInEndSection":488,"text":"Data are needed regarding the efficacy and safety of the nonpeptide glucagon-like peptide-1 (GLP-1) receptor agonist orforglipron as a once-daily oral therapy for weight reduction in adults with obesity.METHODS: In this phase 2, randomized, double-blind trial, we enrolled adults with obesity, or with overweight plus at least one weight-related coexisting condition, and without diabetes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":181,"document":"34127852","golden":true,"offsetInEndSection":362,"text":"We developed danuglipron (PF-06882961), an oral small-molecule GLP-1R agonist and found it had comparable efficacy to injectable peptidic GLP-1R agonists in a humanized mouse model.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1282,"document":"34127852","golden":false,"offsetInEndSection":1426,"text":"In this study in T2D, danuglipron was generally well tolerated, with a safety profile consistent with the mechanism of action of GLP-1R agonism.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37852529","golden":false,"offsetInEndSection":481,"text":"AIMS: The present systematic review aimed to synthesize available data from recently published randomized trials (RCTs) investigating the efficacy and safety of the novel, orally administered, small-molecule glucagon-like peptide 1 receptor agonists (GLP-1RAs) orforglipron and danuglipron for the treatment of type 2 diabetes mellitus (T2DM), obesity or both.METHODS: Literature search was performed through Medline (via PubMed), Cochrane Library and Scopus until August 16, 2023.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1057,"document":"34127852","golden":false,"offsetInEndSection":1217,"text":"Systolic blood pressure was slightly decreased and changes in diastolic blood pressure were similar with danuglipron treatment at day 28, compared with placebo.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34127852","golden":false,"offsetInEndSection":118,"text":"Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trial.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":593,"document":"28270518","golden":true,"offsetInEndSection":701,"text":"The purpose of this study was to identify and characterize a novel oral agonist of GLP-1R (i.e., myricetin).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":951,"document":"34127852","golden":false,"offsetInEndSection":1056,"text":"Heart rate generally increased with danuglipron treatment at day 28, but no heart-rate AEs were reported.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":820,"document":"38161982","golden":false,"offsetInEndSection":1151,"text":"Significant progress has been made on approaches targeting GPCRs such as single peptides that simultaneously activate GIP and/or GCGR in addition to GLP1, oral tablet formulation of GLP-1, small molecules nonpeptidic oral GLP1R and fixed-dose combination as well as add-on therapy for patients already treated with a GLP-1 agonist.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":140,"document":"32826189","golden":true,"offsetInEndSection":183,"text":"Oral semaglutide is the first oral GLP-1RA.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":106,"document":"37312901","golden":true,"offsetInEndSection":414,"text":"Oral semaglutide (Rybelsus?) is a combination of semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), and sodium N- (8- [2-hydroxybenzoyl] amino) caprylate (SNAC), an absorption enhancer that facilitates semaglutide absorption across the gastric epithelium in a concentration-dependent manner.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34127852","golden":false,"offsetInEndSection":180,"text":"Agonism of the glucagon-like peptide-1 receptor (GLP-1R) results in glycemic lowering and body weight loss and is a therapeutic strategy to treat type 2 diabetes (T2D) and obesity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1218,"document":"34127852","golden":false,"offsetInEndSection":1281,"text":"There were no clinically meaningful electrocardiogram findings.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1365,"document":"37344954","golden":false,"offsetInEndSection":1599,"text":"Orforglipron decreased fasting glucose levels across Days 1 to 28, and gastric emptying was delayed on Day 28.CONCLUSIONS: Orforglipron\u0027s long half-life (25-68?hours) allows once-daily oral dosing, without water and food restrictions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37344954","golden":true,"offsetInEndSection":317,"text":"AIM: To evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple doses of orforglipron (LY3502970), an oral, non-peptide glucagon-like peptide-1 receptor agonist (GLP-1RA) in healthy participants.MATERIALS AND METHODS: This was a double-blind, placebo-controlled, Phase 1 study.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":595,"document":"37344954","golden":true,"offsetInEndSection":908,"text":"In Part B, participants received 4?weeks of daily repeated oral orforglipron with doses escalating weekly to four different final target doses (2-24?mg).RESULTS: Ninety-two participants enrolled and received at least one study drug dose (32 in Part A [mean age 43.4?years] and 60 in Part B [mean age 42.5?years]).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31990244","golden":true,"offsetInEndSection":349,"text":"Aims: The efficacy and safety of oral semaglutide, the first glucagon-like peptide-1 (GLP-1) receptor agonist developed for oral administration for the treatment of type 2 diabetes, was evaluated in the PIONEER clinical trial program, and a recently published network meta-analysis allowed comparison with further injectable GLP-1 receptor agonists.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1600,"document":"37344954","golden":false,"offsetInEndSection":1740,"text":"Orforglipron had a pharmacodynamic and safety profile similar to that of injectable GLP-1RAs, which supports continued clinical development.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37344954","golden":true,"offsetInEndSection":213,"text":"Orforglipron (LY3502970), a novel, oral non-peptide glucagon-like peptide-1 receptor agonist: A Phase 1a, blinded, placebo-controlled, randomized, single- and multiple-ascending-dose study in healthy participants.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":1186,"document":"37344954","golden":false,"offsetInEndSection":1364,"text":"Substantial reductions in body weight of up to 5.4?kg were observed after 4?weeks in orforglipron-treated participants, compared to a reduction of 2.4?kg with placebo (P?\u003c?0.05).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":886,"document":"28270518","golden":false,"offsetInEndSection":1014,"text":"The data in this study suggest that myricetin might be a potential drug candidate for the treatment of T2DM as a GLP-1R agonist.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":804,"document":"28270518","golden":false,"offsetInEndSection":885,"text":"Long-term oral administration of myricetin demonstrated glucoregulatory activity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":400,"document":"28270518","golden":false,"offsetInEndSection":592,"text":"The clinical efficacies of long-acting GLP-1 derivatives strongly support discovery pursuits aimed at identifying and developing orally active, small-molecule GLP-1 receptor (GLP-1R) agonists.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38122931","golden":false,"offsetInEndSection":683,"text":"OBJECTIVE: To review clinical trial data for incretin therapies approved or in late-stage development for overweight or obesity, along with clinical implications of these therapies and future directions.METHODS: We searched for clinical trials involving incretin therapies studied specifically for overweight or obesity in ClinicalTrials.gov and PubMed through November 2023. The findings are summarized here.RESULTS: Glucagon-like peptide-1 (GLP-1) receptor agonism, alone and in combination with glucose-dependent insulinotropic polypeptide (GIP) receptor agonism or glucagon agonism, leads to significant weight reduction in people with overweight or obesity. Newer incretin thera","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":179,"document":"36541153","golden":false,"offsetInEndSection":442,"text":"Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are being increasingly recognized for their potential in early disease management, with recent guideline updates recommending second-line use of this injectable drug class alongside oral glucose-lowering drugs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":275,"document":"38161982","golden":false,"offsetInEndSection":556,"text":"The therapeutic landscape for GPCR as targets of anti-obesity medications has undergone significant changes with the approval of semaglutide, the first peptide glucagon like peptide 1 receptor agonist (GLP-1RA) achieving double digit weight loss (?10%) and cardiovascular benefits.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":811,"document":"15655719","golden":false,"offsetInEndSection":955,"text":"Intravenous GLP-1 can normalise, and subcutaneous GLP-1 can significantly lower plasma glucose in the majority of patients with Type 2 diabetes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":614,"document":"32873415","golden":false,"offsetInEndSection":688,"text":"cations. Semaglutide is the first oral option in this life-saving medicati","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1407,"document":"33439581","golden":true,"offsetInEndSection":1538,"text":"The approval of the first tablet formulation of a GLP-1RA for T2D, oral semaglutide, has the potential to address these challenges.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1365,"document":"33434602","golden":false,"offsetInEndSection":1450,"text":"sea, diarrhea and vomiting.CONCLUSIONS: Oral semaglutide has favorable efficacy and s","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":689,"document":"32873415","golden":false,"offsetInEndSection":880,"text":"n class. The purpose of this article was to review the pharmacology, clinical trials, safety profile, along with recommended dosing and costs, of oral semaglutide used for managing patients w","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1020,"document":"37813741","golden":true,"offsetInEndSection":1192,"text":"The recent availability of oral semaglutide may facilitate the early introduction of this family with proven cardiovascular and renal benefits and excellent safety profile.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35698011","golden":true,"offsetInEndSection":118,"text":"PURPOSE: Semaglutide is the only oral GLP-1 RA in the market, but oral bioavailability is generally limited in range o","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":376,"document":"38122931","golden":false,"offsetInEndSection":662,"text":"The findings are summarized here.RESULTS: Glucagon-like peptide-1 (GLP-1) receptor agonism, alone and in combination with glucose-dependent insulinotropic polypeptide (GIP) receptor agonism or glucagon agonism, leads to significant weight reduction in people with overweight or obesity.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1961,"document":"37197367","golden":false,"offsetInEndSection":2238,"text":"Importantly, 100 mg/kg cinchonine ameliorated hepatic steatosis and fibrosis in NASH mice.Conclusion: Cinchonine, a potential oral small-molecule GLP-1R agonist, could reduce blood glucose and ameliorate NASH, providing a strategy for developing small-molecule GLP-1R agonists.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38122931","golden":false,"offsetInEndSection":375,"text":"OBJECTIVE: To review clinical trial data for incretin therapies approved or in late-stage development for overweight or obesity, along with clinical implications of these therapies and future directions.METHODS: We searched for clinical trials involving incretin therapies studied specifically for overweight or obesity in ClinicalTrials.gov and PubMed through November 2023.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":890,"document":"38122931","golden":false,"offsetInEndSection":974,"text":"However, the discontinuation of incretin therapies is associated with weight regain.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1025,"document":"37870067","golden":false,"offsetInEndSection":1238,"text":"To address the growing demand for improved treatments, researchers have focused their efforts on developing GLP-1?R-based multi-agonists, orally administered GLP-1RAs, and combination therapies utilizing GLP-1RAs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1552,"document":"37430117","golden":false,"offsetInEndSection":1565,"text":"semaglutide).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37870067","golden":false,"offsetInEndSection":172,"text":"INTRODUCTION: Type 2 diabetes (T2DM) and obesity present significant global health issues, requiring the development of long-lasting and highly effective pharmacotherapies.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":555,"document":"18669601","golden":false,"offsetInEndSection":727,"text":"OXM, like other GLP-1R agonists, stimulates cAMP formation and lowers blood glucose after both oral and ip glucose administration, actions that require a functional GLP-1R.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35164855","golden":true,"offsetInEndSection":66,"text":"BACKGROUND: Oral semaglutide is a novel glucagon-like peptide-1 (G","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":505,"document":"34267725","golden":true,"offsetInEndSection":623,"text":"The long-acting GLP-1RA, semaglutide, is available for once-weekly injection and in a new once-daily oral formulation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1244,"document":"34267725","golden":true,"offsetInEndSection":1344,"text":"Oral semaglutide should be taken on an empty stomach, which may influence the choice of formulation.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1486,"document":"34267725","golden":true,"offsetInEndSection":1600,"text":"There are also specific dose instructions to follow with oral semaglutide to ensure sufficient gastric absorption.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31372015","golden":false,"offsetInEndSection":172,"text":"AIM: Liraglutide, a once-daily subcutaneous glucagon-like peptide-1 (GLP-1) agonist, is approved for treatment of hyperglycemia in patients with type 2 diabetes mellitus (T","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":380,"document":"31058214","golden":false,"offsetInEndSection":543,"text":"GLP-1 analogs, which are approved diabetes medications, can reduce the reinforcing and rewarding effects of alcohol, cocaine, amphetamine, and nicotine in rodents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1445,"document":"31058214","golden":false,"offsetInEndSection":1619,"text":"Ex4 did not attenuate the addiction-related behavioral effects of opioids, indicating that GLP-1 analogs would not be useful medications in the treatment of opioid addiction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38357515","golden":false,"offsetInEndSection":91,"text":"The common adverse reactions of liraglutide are hypoglycemia and gastrointestinal reactions","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":823,"document":"38356942","golden":false,"offsetInEndSection":1070,"text":"Meta analysis results showed that compared with the glucagon like peptide-1 receptor agonist (GLP-1 RAs), placebo and insulin groups, tirzepatide could significantly reduce the BMI (body mass index) of patients [MD?\u003d?-1.71, 95% CI (-2.46, -0.95), ","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38356317","golden":false,"offsetInEndSection":72,"text":"Population pharmacokinetics of the GIP/GLP receptor agonist tirzepatide.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":949,"document":"38356208","golden":false,"offsetInEndSection":1191,"text":"This review evaluates the current available evidence for GLP-1 receptor agonists, dual GLP-1/GIP receptor co-agonists with a focus on GLP-1/GIP/glucagon receptor triagonists and discusses the potential future benefits and research directions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1727,"document":"38356161","golden":false,"offsetInEndSection":1844,"text":"Use of CGM or glucagon-like peptide-1 receptor agonists was significantly protective against hypoglycemic encounters.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38355513","golden":false,"offsetInEndSection":198,"text":"Exploration of the potential association between GLP-1 receptor agonists and suicidal or self-injurious behaviors: a pharmacovigilance study based on the FDA Adverse Event Reporting System database.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":488,"document":"38354757","golden":false,"offsetInEndSection":598,"text":"Moreover, GLP-1RA may have additive effects by improving dysmetabolism besides glucose control and weight loss","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":825,"document":"38353610","golden":false,"offsetInEndSection":1053,"text":"Although GIPR:GLP-1R co-agonists are being heralded as premier pharmacological tools for the treatment of obesity and diabetes, uncertainty remains as to why these drugs testify superiority over best-in-class GLP-1R monoagonists","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":75,"document":"38352159","golden":false,"offsetInEndSection":375,"text":"Recent advances in weight management strategies have primarily resided in pharmaceutical treatments, and the glucagon-like peptide-1 (GLP-1) receptor agonists have shown great potential in terms of body weight reduction in addition to improving glycemic control in patients with type 2 diabetes (T2D)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"30499733","golden":false,"offsetInEndSection":184,"text":"INTRODUCTION: Glucagon-like peptide-1 (GLP-1) receptor agonists are highly potent antihyperglycemic drugs that impose low risk of hypoglycemia and also result in body weight reduction.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":267,"document":"30499733","golden":false,"offsetInEndSection":394,"text":"Areas covered: This manuscript reviews oral semaglutide-an experimental GLP-1 receptor agonist in phase-3 clinical development.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"24499291","golden":false,"offsetInEndSection":218,"text":"BACKGROUND: In patients with type 2 diabetes (T2D), incretin-based therapies improve glycaemic control with low incidence of hypoglycaemia and without weight gain, both advantages over traditional add-ons to metformin.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":145,"document":"20130920","golden":false,"offsetInEndSection":411,"text":"These comprise the injectable GLP-1 receptor agonists solely acting on the GLP-1 receptor on the one hand and orally active dipeptidyl-peptidase inhibitors (DPP-4 inhibitors) raising endogenous GLP-1 and other hormone levels by inhibiting the degrading enzyme DPP-4.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":603,"document":"30499733","golden":true,"offsetInEndSection":837,"text":"The clinical development program of once-daily oral semaglutide has shown superiority in reducing glycosylated hemoglobin and body weight in comparison with placebo and active comparators (sitagliptin, liraglutide, and empagliflozin).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31514971","golden":false,"offsetInEndSection":231,"text":"PURPOSE: In China, although insulin has been prescribed for decades, glucagon-like peptide 1 receptor agonists (GLP-1-RAs) have been available as an injectable treatment for patients with type 2 diabetes mellitus (T2DM) since 2009.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"30499733","golden":true,"offsetInEndSection":54,"text":"Oral semaglutide for the treatment of type 2 diabetes.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":838,"document":"30499733","golden":true,"offsetInEndSection":930,"text":"Safety and tolerability of oral semaglutide is in line with injectable members of the class.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1378,"document":"24499291","golden":false,"offsetInEndSection":1625,"text":"Current treatment algorithms recommend incretin-based therapy use after metformin failure, but local guidance may restrict their use.CONCLUSION: GLP-1RAs provide superior glycaemic control and weight loss vs. DPP-4 inhibitors in patients with T2D.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":252,"document":"21864749","golden":false,"offsetInEndSection":495,"text":"Since incretin effect is reduced in subjects with type 2 diabetes, despite GLP-1 activity preservation, two forms of incretin-based treatment have emerged: GLP-1R agonists, administered subcutaneously and DPP-4 inhibitors, administered orally.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1649,"document":"31744308","golden":true,"offsetInEndSection":1782,"text":"Conclusions: Oral semaglutide appears safe and effective as monotherapy and add-on pharmacological therapy for the treatment of T2DM.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":417,"document":"26824365","golden":false,"offsetInEndSection":671,"text":"GLP-1 receptor agonists (exenatide, liraglutide, lixisenatide, dulaglutide, albiglutide) reduce glycated haemoglobin levels more effectively than oral antidiabetic agents do and lead to weight loss as well as a slight decrease in systolic blood pressure.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":258,"document":"26824365","golden":false,"offsetInEndSection":380,"text":"Incretin-based therapies comprise injectable GLP-1 receptor agonists and orally active dipeptidyl peptidase-IV inhibitors.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37280458","golden":false,"offsetInEndSection":282,"text":"PURPOSE: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as semaglutide are a class of medications prescribed to treat type 2 diabetes mellitus, and more recently, as an adjunct for weight loss because of its effects of delaying gastric emptying and suppressing appetite.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":730,"document":"37280458","golden":false,"offsetInEndSection":1066,"text":"This patient had no traditional risk factors for regurgitation or aspiration but was taking the GLP-1 RA semaglutide for weight loss and had last taken the medication two days before their scheduled procedure.CONCLUSIONS: Patients taking long-acting GLP-1 RAs such as semaglutide may be at risk of pulmonary aspiration under anesthesia.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37917019","golden":false,"offsetInEndSection":247,"text":"The surge in popularity of semaglutide (Ozempic, Wegovy, Rybelsus) and other glucagon-like-peptide 1 (GLP-1) receptor agonists has been accompanied by widespread reports of unintended reductions in alcohol use (and other addictive behaviors) durin","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36872170","golden":false,"offsetInEndSection":300,"text":"PURPOSE: Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) and now tirzepatide, a dual GLP-1 RA/glucose-dependent insulinotropic polypeptide agonist, have numerous advantages in the treatment of type 2 diabetes and obesity, yet only 11% of patients with type 2 diabetes are prescribed a GLP-1 RA.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":283,"document":"37280458","golden":false,"offsetInEndSection":729,"text":"Semaglutide is a long-acting agent with a half-life of approximately one week, and there are currently no guidelines that address the perioperative management of such agents.CLINICAL FEATURES: We describe an unexpected case of regurgitation of a large volume of gastric contents upon induction of general anesthesia in a nondiabetic, nonobese patient despite a long preoperative fasting period (20 hr for solids and eight hours for clear fluids).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1064,"document":"38056618","golden":false,"offsetInEndSection":1505,"text":"In contrast, hepatoprotective effects, i.e., reductions in steatosis and fibrosis, as well as liver fibrotic biomarkers, were more prominent with OXM-104 and cotadutide than those seen with semaglutide, demonstrated by an improved NAFLD activity score (NAS) by OXM-104 and cotadutide, underlining the importance of the glucagon receptor.CONCLUSION: These results show that dual GLP-1 and glucagon receptor agonism is superior to GLP-1 alone.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":190,"document":"38056618","golden":false,"offsetInEndSection":542,"text":"In this study, dual GLP-1 and glucagon receptor agonist OXM-104 is compared head-to-head with the once-daily dual GLP-1 and glucagon receptor agonist cotadutide and GLP-1 receptor agonist semaglutide to explore the metabolic efficacy of OXM-104.METHODS: The in vitro potencies of OXM-104, cotadutide and semaglutide were assessed using reporter assays.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37280458","golden":false,"offsetInEndSection":105,"text":"Regurgitation under anesthesia in a fasted patient prescribed semaglutide for weight loss: a case report.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38056618","golden":false,"offsetInEndSection":189,"text":"OBJECTIVE: Dual glucagon-like peptide-1 (GLP-1) and glucagon receptor agonists are therapeutic agents with an interesting liver-specific mode of action suitable for metabolic complications.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1067,"document":"37280458","golden":false,"offsetInEndSection":1241,"text":"We propose strategies to mitigate this risk including holding the medication four weeks prior to a scheduled procedure when feasible and considering full stomach precautions.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":846,"document":"24499291","golden":false,"offsetInEndSection":1242,"text":"In combination with treatment algorithms, product prescribing information and personal clinical experience, these studies were used to compare the efficacy and suitability of GLP-1RAs and DPP-4 inhibitors in patients with T2D.RESULTS: In head-to-head clinical trials, GLP-1RAs provided greater glycaemic control, weight loss and overall treatment satisfaction vs. the DPP-4 inhibitor sitagliptin.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":219,"document":"24499291","golden":false,"offsetInEndSection":467,"text":"Dipeptidyl peptidase-4 (DPP-4) inhibitors are administered orally and provide a physiological increase in glucagon-like peptide-1 (GLP-1) levels, while GLP-1 receptor agonists (GLP-1RAs) are injectable and deliver pharmacological levels of GLP-1RA.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":468,"document":"24499291","golden":false,"offsetInEndSection":845,"text":"This review aims to distinguish between GLP-1RAs and DPP-4 inhibitors, and discuss when each may be favoured in clinical practice.METHODS: A MEDLINE search, limited to human clinical trials and using the search criteria \u0027GLP-1RA\u0027 or \u0027DPP-4 inhibitor\u0027, identified seven head-to-head studies and one relevant post hoc analysis (all a GLP-1RA vs. the DPP-4 inhibitor sitagliptin).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1043,"document":"28988756","golden":false,"offsetInEndSection":1197,"text":"These findings represent a valuable starting point for the design and discovery of small-molecule GLP-1 receptor agonists that can be administered orally.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1626,"document":"24499291","golden":false,"offsetInEndSection":1792,"text":"DPP-4 inhibitors may sometimes be preferred to a GLP-1RA if weight is not a concern, oral administration is a desirable feature or when a GLP-1RA cannot be tolerated.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":270,"document":"20575217","golden":false,"offsetInEndSection":650,"text":"Two drug classes-namely, the injectable glucagon-like peptide 1 (GLP-1) receptor agonists, which produce pharmacological GLP receptor activity, and the oral dipeptidyl peptidase-4 (DPP-4) inhibitors, which raise levels of endogenously produced GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) by preventing enzymatic degradation--have been available for several years.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1742,"document":"38358546","golden":false,"offsetInEndSection":2098,"text":"The low abundance of Bacteroides combined with the decrease of Dopa decarboxylase (DDC) activity may lead to the decrease of the production of tryptophan microbial derivative skatole, and the low abundance of Bacteroides or reduced skatole may further lead to the increase of blood glucose by downregulating the expression of glucagon-like peptide-1 (GLP1)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":994,"document":"38356211","golden":false,"offsetInEndSection":1108,"text":"It becomes active during hypoglycemia but is deactivated when glucose is introduced directly into the hypothalamus","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38354299","golden":false,"offsetInEndSection":248,"text":"Norlignans are a rare class of natural products isolated from a diverse range of plant species, many of which have interesting biological activities including antibacterial, antioxidant, phytotoxic, platelet aggregation inhibitory effects, and more","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1526,"document":"38341366","golden":false,"offsetInEndSection":1825,"text":"A relationship between genetic polymorphisms and drug response or toxicity was found for drugs such as opioids, GLP-1 agonists, tacrolimus, oral anticoagulants, antineoplastics, atypical antipsychotics, efavirenz, clopidogrel, lamotrigine, anti-TNF? agents, voriconazole, antidepressants, or statins","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":906,"document":"38340396","golden":false,"offsetInEndSection":1152,"text":"Despite comprehending the potential of various G protein-coupled receptors (GPCRs) to stimulate endogenous GLP-1 secretion, decades of translational GPCR research have failed to yield regulatory-approved endogenous GLP-1 secretagogue oral therapy","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38337597","golden":false,"offsetInEndSection":162,"text":"Dipeptidyl-Peptidase-4 and Glucagon-like-Peptide-1, a Link in the Connection between Periodontitis and Diabetes Mellitus-What Do We Know So Far?-A Scoping Review.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":566,"document":"38302593","golden":false,"offsetInEndSection":669,"text":"Oral GLP-1 RA are also under development and early data shows similar WL efficacy to semaglutide 2.4?mg","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":963,"document":"38300898","golden":false,"offsetInEndSection":1057,"text":"Our study demonstrates the relative safety and effectiveness of GLP-1RA in patients with FPLD.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":530,"document":"38273155","golden":false,"offsetInEndSection":705,"text":"We selected pharmacokinetic studies of any injectable GLP1RA given with an oral medication, and product prescribing sheets reporting data without access to the original study.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38241775","golden":false,"offsetInEndSection":50,"text":"GLP-1 agonists: A review for emergency clinicians.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":238,"document":"38240875","golden":false,"offsetInEndSection":478,"text":"PIONEER REAL Switzerland was a 34-44-week, multicentre, prospective, non-interventional, single-arm study of adults with T2D na?ve to injectable glucose-lowering medication who were initiated on oral semaglutide in routine clinical practice","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":128,"document":"38230324","golden":true,"offsetInEndSection":231,"text":"An oral formulation of semaglutide, a glucagon-like peptide 1 receptor agonist, was approved by the U.S","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"38220031","golden":false,"offsetInEndSection":135,"text":"Cardiovascular benefits of SGLT2 inhibitors and GLP-1 receptor agonists through effects on mitochondrial function and oxidative stress.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37213102","golden":true,"offsetInEndSection":657,"text":"Importance: Currently available glucagon-like peptide 1 receptor (GLP-1R) agonists for treating type 2 diabetes (T2D) are peptide agonists that require subcutaneous administration or strict fasting requirements before and after oral administration.Objective: To investigate the efficacy, safety, and tolerability of multiple dose levels of the novel, oral, small molecule GLP-1R agonist danuglipron over 16 weeks.Design, Setting, and Participants: A phase 2b, double-blind, placebo-controlled, parallel-group, 6-group randomized clinical trial with 16-week double-blind treatment period and 4-week follow-up was conducted from July 7, 2020, to July 7, 2021.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37311722","golden":false,"offsetInEndSection":789,"text":"AIM: To evaluate the tolerability, safety and pharmacodynamics of different dose-escalation schemes of the oral small-molecule glucagon-like peptide-1 receptor (GLP-1R) agonist danuglipron.MATERIALS AND METHODS: This Phase 2a, double-blind, placebo-controlled, parallel-group study randomly assigned adults with type 2 diabetes (T2D) treated with metformin to placebo or danuglipron (low [5-mg] or high [10-mg] starting dose, with 1- or 2-week dose-escalation steps, to target doses of 80, 120 or 200?mg twice daily [BID]) and adults with obesity without diabetes to placebo or danuglipron 200?mg BID.RESULTS: Participants with T2D (n?\u003d?123, mean glycated haemoglobin [HbA1c] 8.19%) or obesity without diabetes (n?\u003d?28, mean body mass index 37.3?kg/m2 ) were randomly assigned and treated.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37213102","golden":true,"offsetInEndSection":182,"text":"Efficacy and Safety of Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist Danuglipron for Glycemic Control Among Patients With Type 2 Diabetes: A Randomized Clinical Trial.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38242040","golden":false,"offsetInEndSection":535,"text":"BACKGROUND: GLP-1 receptor agonists (GLP-1RAs) reduce glucagon and glycogen secretion, inhibit appetite and slow gastric empties and have recently been approved to treat obesity.OBJECTIVE: To explore the safety and efficacy of GLP-1RAs in the treatment of obesity and clarify the optimal GLP-1RAs treatment regimen.METHODS: PubMed, Embase, Web of Science, and Cochrane Library databases were searched for English randomized controlled trials (RCTs) on GLP-1RAs in the treatment and management of obesity published before July 18, 2023.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1312,"document":"37311722","golden":false,"offsetInEndSection":2002,"text":"In participants with T2D, least squares mean changes from baseline in HbA1c (-1.04% to -1.57% across danuglipron groups vs. -0.32% for placebo), fasting plasma glucose (-23.34?mg/dL to -53.94?mg/dL danuglipron vs. -13.09?mg/dL placebo) and body weight (-1.93 to -5.38?kg danuglipron vs. -0.42?kg placebo) at Week 12 were generally statistically significant for danuglipron compared with placebo (P?\u003c?0.05).CONCLUSIONS: Danuglipron resulted in statistically significant reductions in HbA1c, FPG and body weight over 12?weeks, in the setting of higher discontinuation rates and incidence of gastrointestinal adverse events with higher target doses.CLINICALTRIALS: gov identifier: NCT04617275.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38181103","golden":false,"offsetInEndSection":294,"text":"? Orthopaedic surgeons are increasingly likely to encounter patients with obesity and/or type 2 diabetes taking glucagon-like peptide-1 (GLP-1) agonists for weight loss.? GLP-1 agonists are an effective treatment for weight loss with semaglutide and tirzepatide being the most effective agents.","beginSection":"abstract"}],"exact_answer":[["semaglutide","Ozempic"],["danuglipron","PF-06882961"],["orforglipron"],["Rybelsus"]],"ideal_answer":["GLP-1 agonists that are taken orally include Rybelsus? (oral semaglutide) and orforglipron (LY3502970). Rybelsus? is the first oral GLP-1 receptor agonist developed for the treatment of type 2 diabetes and utilizes an absorption enhancer for gastric uptake. Orforglipron is an oral, non-peptide GLP-1 receptor agonist currently under clinical development.","The available GLP-1 agonists that are taken orally include Orforglipron and Myricetin, both in development, and Semaglutide which is the first oral GLP-1 receptor agonist to be approved.","The GLP-1 agonist that is taken orally is oral semaglutide (Rybelsus?). It is the first orally administered GLP-1 receptor agonist approved for the treatment of type 2 diabetes and was approved by the US Food and Drug Administration in September 2019.","Oral semaglutide (Rybelsus) is an oral glucagon-like peptide 1 receptor agonist approved for use in adults with type 2 diabetes mellitus."],"id":"65983f7406a2ea257c000038","type":"list","body":"Please list GLP-1 agonists that are taken orally"},{"documents":[{"golden":false,"id":"25747795"},{"golden":false,"id":"27507366"},{"golden":false,"id":"37936910"},{"golden":false,"id":"17279193"},{"golden":false,"id":"10858967"},{"golden":false,"id":"8542475"},{"golden":true,"id":"10775746"},{"golden":false,"id":"12887118"},{"golden":false,"id":"28469241"},{"golden":false,"id":"21642716"},{"golden":false,"id":"28849348"},{"golden":false,"id":"18500939"},{"golden":false,"id":"3405551"},{"golden":false,"id":"16106342"},{"golden":false,"id":"23444286"},{"golden":false,"id":"33684143"},{"golden":false,"id":"22824679"},{"golden":false,"id":"25502185"},{"golden":false,"id":"10904164"},{"golden":false,"id":"37661388"},{"golden":false,"id":"31057021"},{"golden":false,"id":"10477048"},{"golden":false,"id":"18264024"},{"golden":false,"id":"26043938"},{"golden":false,"id":"14712970"},{"golden":false,"id":"9678272"},{"golden":false,"id":"34522548"},{"golden":false,"id":"12143280"},{"golden":false,"id":"22876404"},{"golden":false,"id":"29982937"},{"golden":false,"id":"36284970"},{"golden":false,"id":"12168686"},{"golden":false,"id":"1982043"},{"golden":false,"id":"37778699"},{"golden":false,"id":"17279232"},{"golden":false,"id":"23252067"},{"golden":false,"id":"37897977"},{"golden":false,"id":"3997551"},{"golden":true,"id":"35565938"},{"golden":false,"id":"28100893"},{"golden":false,"id":"27492707"},{"golden":false,"id":"34475945"},{"golden":false,"id":"24972540"},{"golden":false,"id":"1407927"},{"golden":false,"id":"29266070"},{"golden":false,"id":"8680149"},{"golden":false,"id":"29266076"},{"golden":false,"id":"34165402"},{"golden":false,"id":"35057067"},{"golden":false,"id":"24829004"},{"golden":false,"id":"26287781"},{"golden":false,"id":"23920137"},{"golden":false,"id":"26287788"},{"golden":false,"id":"32278857"},{"golden":false,"id":"35877416"},{"golden":false,"id":"33245601"},{"golden":false,"id":"26135776"},{"golden":false,"id":"33447994"},{"golden":false,"id":"36904129"},{"golden":false,"id":"36273675"},{"golden":false,"id":"35603249"},{"golden":false,"id":"28099781"},{"golden":false,"id":"38206626"},{"golden":false,"id":"38092039"},{"golden":false,"id":"38024132"},{"golden":false,"id":"38009269"},{"golden":false,"id":"37929347"},{"golden":false,"id":"37923683"},{"golden":false,"id":"37920107"},{"golden":true,"id":"37779023"},{"golden":false,"id":"37726900"},{"golden":false,"id":"37602934"},{"golden":false,"id":"37584611"},{"golden":false,"id":"37439175"},{"golden":true,"id":"37226133"},{"golden":false,"id":"38331740"},{"golden":false,"id":"38131521"},{"golden":false,"id":"19280488"},{"golden":false,"id":"26657985"},{"golden":false,"id":"29742676"},{"golden":false,"id":"31489087"},{"golden":false,"id":"25654792"},{"golden":false,"id":"2065874"},{"golden":false,"id":"20677451"},{"golden":false,"id":"18557375"},{"golden":false,"id":"19665325"},{"golden":false,"id":"27448657"},{"golden":false,"id":"7544304"},{"golden":false,"id":"36778751"},{"golden":false,"id":"36512021"},{"golden":false,"id":"35268281"},{"golden":false,"id":"34707571"},{"golden":false,"id":"36908009"},{"golden":false,"id":"23369067"},{"golden":false,"id":"36046787"},{"golden":false,"id":"37753970"},{"golden":false,"id":"36229360"},{"golden":false,"id":"37211347"},{"golden":false,"id":"36839295"},{"golden":false,"id":"36720519"},{"golden":false,"id":"36250744"},{"golden":false,"id":"35839462"},{"golden":false,"id":"35725415"},{"golden":false,"id":"17882157"},{"golden":false,"id":"35758442"},{"golden":false,"id":"33098451"},{"golden":false,"id":"10764476"},{"golden":false,"id":"33821757"},{"golden":false,"id":"24721478"}],"answerReady":true,"snippets":[{"endSection":"abstract","offsetInBeginSection":1149,"document":"28469241","golden":false,"offsetInEndSection":1237,"text":"Our results establish a HAND2/TBX5 pathway implicated in heart development and diseases.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":830,"document":"3405551","golden":false,"offsetInEndSection":998,"text":"These data indicate that the thyroid gland is physiologically activated in early pregnancy, possibly by hCG or a related substance, which may induce gestational emesis.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":149,"document":"28469241","golden":false,"offsetInEndSection":295,"text":"Thalidomide was used by pregnant women for morning sickness but was removed from the market because it caused severe malformations including CHDs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"21642716","golden":false,"offsetInEndSection":133,"text":"Question A pregnant patient recently asked me whether using Diclectin for morning sickness might affect the development of her child.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":930,"document":"28469241","golden":false,"offsetInEndSection":1148,"text":"Similarly, thalidomide inhibited the TBX5/HAND2 physical interaction, and the in silico docking revealed that the same amino acids involved in the interaction of TBX5 with DNA are also involved in its binding to HAND2.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":884,"document":"3997551","golden":false,"offsetInEndSection":1000,"text":"Therefore these data show no relationship between vitamin B6 status and the incidence or degree of morning sickness.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":785,"document":"8542475","golden":false,"offsetInEndSection":1260,"text":"t decline in the same group. Correlation analysis showed a direct relationship between serum T4 and hCG and an inverse relationship between serum TSH and hCG in pregnancy with morning sickness.CONCLUSION: Our results are suggestive of the involvement of these variables in the pathogenesis of morning sickness and hyperemesis gravidarum not only because their levels were significantly altered but the extent of increase or decrease in their level correlated well with the se","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1489,"document":"28849348","golden":false,"offsetInEndSection":1670,"text":"These results suggest that the effect of thalidomide was successfully detected in our experimental system and that thalidomide eliminated a subpopulation of undifferentiated hiPSCs.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":678,"document":"28469241","golden":false,"offsetInEndSection":929,"text":"We documented a novel interaction between TBX5 and HAND2, and showed that a p.G202V HAND2 variant associated with CHD and coronary artery diseases found in a large Lebanese family with high consanguinity, drastically inhibited this interaction by 90%.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"28469241","golden":false,"offsetInEndSection":74,"text":"A HAND to TBX5 Explains the Link Between Thalidomide and Cardiac Diseases.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":729,"document":"10775746","golden":true,"offsetInEndSection":846,"text":"It is suggested that morning sickness, resulting from secretion of hCG and thyroxine, reduces maternal energy intake.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":298,"document":"34522548","golden":false,"offsetInEndSection":350,"text":"She had several stigmata of thalidomide embryopathy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":236,"document":"34522548","golden":false,"offsetInEndSection":297,"text":"A woman is described who was exposed to thalidomide in utero.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":351,"document":"34522548","golden":false,"offsetInEndSection":577,"text":"Although treatment of nausea and anxiety in pregnant women with thalidomide was discontinued in 1961, the drug has been found to be a useful agent for the management of several systemic conditions and dermatological disorders.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34522548","golden":false,"offsetInEndSection":130,"text":"Thalidomide was initially developed as a sedative; subsequently, its use was expanded to treat morning sickness in pregnant women.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1017,"document":"36284970","golden":false,"offsetInEndSection":1325,"text":"This study found that hyperemesis (severe nausea and vomiting), dyspepsia, and other gastrointestinal symptoms during pregnancy were related to the infection with H. pylori; therefore, it is a risk factor for complications in pregnancy and its poor outcomes, especially in developing countries, such as Iraq.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"34522548","golden":false,"offsetInEndSection":117,"text":"Thalidomide-Then and Now: Case Report of a Woman With Thalidomide Embryopathy and Review of Current Thalidomide Uses.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":842,"document":"29982937","golden":false,"offsetInEndSection":935,"text":"Therefore, thalidomide intake during the first trimester could affect cardiogenesis severely.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":368,"document":"12143280","golden":false,"offsetInEndSection":620,"text":"The intimate connection between immunogenetic identity, chemoidentity, and chemocommunication by olfactory mechanisms suggests a relationship between maternal symptoms and maternal accommodation of paternal antigens contained in the fetoplacental unit.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":131,"document":"34522548","golden":false,"offsetInEndSection":235,"text":"However, it was later discovered to be a teratogenic drug that was associated with embryopathy in women.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":578,"document":"34522548","golden":false,"offsetInEndSection":761,"text":"Whether the treatment with thalidomide shall be incorporated in the therapeutic regime for patients with severe coronavirus disease 2019 (COVID-19) infection remains to be determined.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":603,"document":"3997551","golden":false,"offsetInEndSection":883,"text":"There were no differences in the number of women who experienced morning sickness or in the number with different degrees of sickness when plasma levels of PLP, erythrocyte AspAT activity or stimulation by PLP were divided into upper and lower 50th percentile groups and compared.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":446,"document":"3997551","golden":false,"offsetInEndSection":602,"text":"No relationship was found between these indicators of vitamin B6 status and the degree of morning sickness experienced by this group during early pregnancy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"3997551","golden":false,"offsetInEndSection":174,"text":"The relationship between the vitamin B6 status of 180 pregnant women and the incidence and degree of morning sickness experienced during the first trimester was investigated.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"35565938","golden":true,"offsetInEndSection":206,"text":"Among the physiological changes occurring during pregnancy, the benefits of morning sickness, which is likely mediated by human chorionic gonadotropin (HCG) and induces serum ketone production, are unclear.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":175,"document":"3997551","golden":false,"offsetInEndSection":445,"text":"There were no significant differences in plasma pyridoxal 5\u0027-phosphate (PLP), erythrocyte aspartate aminotransferase (AspAT) activity, and stimulation of erythrocyte AspAT activity by exogenous PLP between subjects who experienced morning sickness and those who did not.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1887,"document":"37897977","golden":false,"offsetInEndSection":2028,"text":"The study findings may be valuable for potential risk ahissessment of the combined effects of Cd-Zn and their interactions in pregnant women.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1966,"document":"28100893","golden":false,"offsetInEndSection":2199,"text":"Our findings suggest the importance of providing underweight pregnant women with support to improve dietary intake during their pregnancy, especially to increase intake of protein and iron through consumption of fish and meat dishes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":354,"document":"22876404","golden":false,"offsetInEndSection":524,"text":"This article describes the presenting symptoms, causes of hyperemesis gravidarum, the associated clinical signs and complications, and the most common treatments offered.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1206,"document":"29266070","golden":false,"offsetInEndSection":1347,"text":"The purpose of this document is to review the best available evidence about the diagnosis and management of nausea and vomiting of pregnancy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":633,"document":"24972540","golden":false,"offsetInEndSection":762,"text":"The total BSIT scores of the subjects in Group 1 were found to be significantly lower than those of the other groups (p \u003c 0.001).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1078,"document":"24972540","golden":false,"offsetInEndSection":1345,"text":"The distortion of odor identification in the first trimester might be a causative factor for the development of pregnancy-specific conditions, such as morning sickness and hyperemesis gravidarum, which are both common complaints during the early phase of parturition.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"34165402","golden":false,"offsetInEndSection":204,"text":"INTRODUCTION: Thalidomide is an old well-known drug firstly used as morning sickness relief in pregnant women and then withdrawn from the market due to its severe side effects on fetal normal development.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1015,"document":"23920137","golden":false,"offsetInEndSection":1499,"text":"After multiple logistic regression analysis, cognitive views for unlimited food intake subsequent to morning sickness, increased consumption of energy-dense snack foods and high-glycaemic-index fruits were strongly associated with the risk of GDM (OR \u003d 1?911, P \u003d 0?032; OR \u003d 1?050, P \u003d 0?001; and OR \u003d 1?002, P \u003d 0?017, respectively).CONCLUSIONS: Local featured foods and incorrect cognitive views on pregnancy-related health were closely related to the risk of GDM in Chinese women.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":785,"document":"1407927","golden":false,"offsetInEndSection":892,"text":"No noteworthy side effects occurred.CONCLUSION: Acupressure on the Neiguan point relieves morning sickness.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"29266070","golden":false,"offsetInEndSection":113,"text":"Nausea and vomiting of pregnancy is a common condition that affects the health of a pregnant woman and her fetus.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":937,"document":"29266070","golden":false,"offsetInEndSection":1098,"text":"The woman\u0027s perception of the severity of her symptoms plays a critical role in the decision of whether, when, and how to treat nausea and vomiting of pregnancy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":763,"document":"24972540","golden":false,"offsetInEndSection":867,"text":"This reduction in odor identification abilities was particularly noticeable for leather, pine, and soot.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":868,"document":"24972540","golden":false,"offsetInEndSection":995,"text":"Pregnant women in the second and third trimesters had similar odor identification abilities to the healthy controls (p \u003e 0.05).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1099,"document":"29266070","golden":false,"offsetInEndSection":1205,"text":"Nausea and vomiting of pregnancy should be distinguished from nausea and vomiting related to other causes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":666,"document":"29266070","golden":false,"offsetInEndSection":766,"text":"Treatment in the early stages may prevent more serious complications, including hospitalization (4).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":244,"document":"29266070","golden":false,"offsetInEndSection":462,"text":"Because morning sickness is common in early pregnancy, the presence of nausea and vomiting of pregnancy may be minimized by obstetricians, other obstetric care providers, and pregnant women and, thus, undertreated (1).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":767,"document":"29266070","golden":false,"offsetInEndSection":936,"text":"Safe and effective treatments are available for more severe cases, and mild cases of nausea and vomiting of pregnancy may be resolved with lifestyle and dietary changes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":463,"document":"29266070","golden":false,"offsetInEndSection":565,"text":"Furthermore, some women do not seek treatment because of concerns about the safety of medications (3).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1233,"document":"32278857","golden":false,"offsetInEndSection":1590,"text":"Also, women in the higher group had greater excessive weight gain in the third trimester compared with the lower group.CONCLUSION: Pregnant women with a higher energy intake at night had a lower percentage of energy, protein, and lipid intake in morning meals and a higher percentage of energy and macronutrient intake in the evening meals during pregnancy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1338,"document":"33245601","golden":false,"offsetInEndSection":1560,"text":"Recombinant hCG added to non-pregnant serum resulted in a significant reduction in non-pregnant pNK cell-mediated K562 cell kill.CONCLUSION: There was no difference in pNK cell populations based on timing of the FET cycle.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":936,"document":"26135776","golden":false,"offsetInEndSection":1306,"text":"Rate of high risk for Down syndrome (Combine risk \u003e1/300) and amniocentesis ratio were found higher in the afternoon group than morning group, but there were no difference between groups for the number of fetuses with Down syndrome.CONCLUSION: Receiving the venous blood sample for first trimester aneuploidy screening test in the afternoon causes low PAPP-A MoM levels.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1636,"document":"33245601","golden":false,"offsetInEndSection":1743,"text":"Additionally, pNK cells from pregnant women have reduced cytotoxicity and this is possibly mediated by hCG.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":364,"document":"33245601","golden":false,"offsetInEndSection":675,"text":"Impact of pregnancy status on pNK cell cytotoxicity was characterized by two methods: (1) a three-dimensional endovascular tube formation approach and (2) a NK cell-specific K562 cell kill assay.RESULTS: A total of 35 patients were enrolled, 15 with clinical pregnancies and 20 with negative serum ?-hCG levels.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":453,"document":"26135776","golden":false,"offsetInEndSection":935,"text":"Hormonal parameters (free-beta human chorionic gonadotropin [free ?-hCG] and pregnancy-associated plasma protein-A [PAPP-A] multiples of median [MoM] levels) of first trimester (11(+0)-13(+6) weeks) combined aneuploidy screening test were compared between morning and afternoon groups.RESULTS: PAPP-A MoM levels were significantly lower in the afternoon group when compared to the morning group (p?\u003d?0.001), whereas free ?-hCG MoM levels were similar in the both groups (p?\u003d?0.392).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1272,"document":"33245601","golden":false,"offsetInEndSection":1337,"text":"Pregnancy status had no impact on VEGF-A and VEGF-C serum levels.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":676,"document":"33245601","golden":false,"offsetInEndSection":760,"text":"Overall percentage of CD45+ CD3- CD56+ pNK cell did not change during the FET cycle.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"33245601","golden":false,"offsetInEndSection":312,"text":"PROBLEM: To evaluate pregnancy-compatible phenotypic and functional changes in peripheral blood natural killer (pNK) cells during frozen embryo transfer (FET) cycles.METHOD OF STUDY: Peripheral blood was collected from patients undergoing frozen embryo transfer cycles at three separate time points in the cycle.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"1407927","golden":false,"offsetInEndSection":204,"text":"OBJECTIVE: To evaluate the antiemetic effect of acupressure at the Neiguan point.METHODS: Sixty women in early pregnancy were entered into a randomized, double-blind, cross-over, placebo-controlled trial.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":205,"document":"1407927","golden":false,"offsetInEndSection":510,"text":"During a 12-day period, organized in four steps of 3 days each, the women were divided into two homogeneous groups to test the effectiveness of unilateral and bilateral acupressure.RESULTS: Use of acupressure resulted in a significantly lower frequency of morning sickness compared with placebo treatment.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":671,"document":"1407927","golden":false,"offsetInEndSection":784,"text":"Changing from unilateral to bilateral pressure on the Neiguan point caused no significant statistical difference.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"1407927","golden":false,"offsetInEndSection":73,"text":"Morning sickness control in early pregnancy by Neiguan point acupressure.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":511,"document":"1407927","golden":false,"offsetInEndSection":670,"text":"More than a 60% positive effect was found with unilateral and bilateral acupressure, compared with an approximately 30% positive effect of placebo acupressure.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"28099781","golden":false,"offsetInEndSection":171,"text":"Thalidomide was first used for relief of morning sickness in pregnant women and then withdrawn from the market because of its dramatic effects on normal fetal development.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38206626","golden":false,"offsetInEndSection":151,"text":"Importance: Lower educational attainment is associated with increased risk of adverse pregnancy outcomes, but it is unclear which pathways mediate this","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38092039","golden":false,"offsetInEndSection":211,"text":"GDF15, a hormone acting on the brainstem, has been implicated in the nausea and vomiting of pregnancy, including its most severe form, hyperemesis gravidarum (HG), but a full mechanistic understanding is lacking","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38024132","golden":false,"offsetInEndSection":78,"text":"Background: Most pregnant women do not reach the recommendation for physical a","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"38009269","golden":false,"offsetInEndSection":172,"text":"BACKGROUND: Some gastrointestinal disorders may be associated with Helicobacter pylori infection, which not only affect maternal health, but may also lead to adverse pregna","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37929347","golden":false,"offsetInEndSection":132,"text":"As previously demonstrated, serum beta-human chorionic gonadotropin (?-hCG) is linked to identifying early gestational abnormalities","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37923683","golden":false,"offsetInEndSection":114,"text":"INTRODUCTION: AR36 is a pharmaceutical-grade plant extract used to support cardiovascular health in traditional Ch","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"37920107","golden":false,"offsetInEndSection":200,"text":"Hyperemesis gravidarum can result in life-threatening physical and psychological maternal morbidity, including severe dehydration, weight loss, electrolyte imbalance, depression, and suicidal ideation","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37779023","golden":true,"offsetInEndSection":132,"text":"[A case of very long chain acyl-CoA dehydrogenase deficiency diagnosed due to a trigger of hyperemesis gravidarum during pregnancy].","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":103,"document":"37726900","golden":false,"offsetInEndSection":280,"text":"Recent laboratory investigation of decompression sickness risk at 25,000?ft (7620?m) enabled evaluation of early pathophysiological responses to exertional decompression stress.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1703,"document":"37602934","golden":false,"offsetInEndSection":1816,"text":"Future research should investigate how to improve nutritional intake across all categories of pregnancy sickness.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":281,"document":"37584611","golden":false,"offsetInEndSection":490,"text":"This is corroborated by genetic association studies in which GDF15 and the GDF15 receptor, GDNF family receptor alpha like (GFRAL) have been linked to morning sickness and hyperemesis gravidarum (HG) in humans","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37439175","golden":false,"offsetInEndSection":116,"text":"[Aldehyde dehydrogenase 2 rs671 genetic polymorphisms are associated with chemotherapy-induced nausea and vomiting].","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":12,"document":"37226133","golden":true,"offsetInEndSection":152,"text":"Nausea and vomiting in pregnancy (NVP) affects 50-80% of pregnant women and is correlated to the level of human chorionic gonadotropin (hCG)","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":12,"document":"38331740","golden":false,"offsetInEndSection":295,"text":"Hyperemesis gravidarum (HG) is a severe form of pregnancy-related nausea and vomiting affecting 0.3-2.3% of pregnancies, which can lead to fluid, electrolyte, and acid-base imbalances, nutritional deficiencies, and weight loss, and is usually severe enough to require hospitalization","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1556,"document":"38131521","golden":false,"offsetInEndSection":1723,"text":"This study provides evidence of a potential association between maternal HG during pregnancy and increased risk of respiratory morbidity in offspring\u0027s early childhood","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2376,"document":"26657985","golden":false,"offsetInEndSection":2738,"text":"In pregnant women with elevated CRP is statistically higher incidence of psychological symptoms such as somatization, obsessive-compulsive symptoms, depression, anxiety, and nonspecific symptoms.CONCLUSION: There is a statistically significantly higher levels of cortisol and C-reactive protein in obese pregnant women and pregnant women with the criteria of MS.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1123,"document":"19280488","golden":false,"offsetInEndSection":1321,"text":"Our data suggest that avoiding iron-containing prenatal multivitamins in the first trimester is effective in improving NVP symptoms in the majority of pregnant women suffering from morning sickness.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1007,"document":"19280488","golden":false,"offsetInEndSection":1122,"text":"This is the first interventional study showing that discontinuation of iron results in improvement of NVP symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":660,"document":"19280488","golden":false,"offsetInEndSection":831,"text":"Two-thirds (63 out of 97) (p \u003c 0.001) of those women qualitatively reported an improvement in NVP symptoms after discontinuation of iron-containing prenatal multivitamins.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1653,"document":"29742676","golden":false,"offsetInEndSection":1938,"text":"Ultimately, 81.5% of dispensaries recommended discussion with a health care provider; however, only 31.8% made this recommendation without prompting.CONCLUSION: Nearly 70% of Colorado cannabis dispensaries contacted recommended cannabis products to treat nausea in the first trimester.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"19280488","golden":false,"offsetInEndSection":135,"text":"The effectiveness of discontinuing iron-containing prenatal multivitamins on reducing the severity of nausea and vomiting of pregnancy.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":142,"document":"19280488","golden":false,"offsetInEndSection":266,"text":"It has been suggested in observational studies that iron-containing prenatal multivitamins may increase the severity of NVP.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"19280488","golden":false,"offsetInEndSection":141,"text":"Nausea and vomiting of pregnancy (NVP) is experienced by the majority of pregnant women, and can negatively affect a women\u0027s quality of life.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"31489087","golden":false,"offsetInEndSection":128,"text":"INTRODUCTION: \"Calabar chalk\" is a lead-laden pica mostly consumed by pregnant women worldwide as a remedy for morning sickness.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":455,"document":"19280488","golden":false,"offsetInEndSection":659,"text":"Women (n \u003d 97) seeking advice on managing severe NVP were advised to discontinue prenatal multivitamin administration and switch to folic acid, an adult multivitamin or a children\u0027s chewable multivitamin.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":2969,"document":"26657985","golden":false,"offsetInEndSection":3157,"text":"Pregnant women with MS and elevated morning and evening levels of cortisol and CRP shows a statistically significant higher number of complications in pregnancy and psychological symptoms.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":422,"document":"26657985","golden":false,"offsetInEndSection":732,"text":"To investigate the association of psychological symptoms with the level of cortisol and CRP in women with metabolic syndrome.SUBJECTS AND METHODS: From 1646 pregnant women cross-sectional, prospective study included 180 pregnant women divided into three groups by applying the inclusion and exclusion criteria.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":331,"document":"26657985","golden":false,"offsetInEndSection":421,"text":"The values of CRP were slightly elevated in the third trimester of pregnancy (10-15 mg/L).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"18557375","golden":false,"offsetInEndSection":191,"text":"PURPOSE: One of the hypothetical reasons of the increased incidence of caries in women during the pregnancy may be the increased activity of alpha-amylase, which can be found in their saliva.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":176,"document":"26657985","golden":false,"offsetInEndSection":264,"text":"Elevated cortisol levels are reduced by linking the transport of globulin (transcortin).","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1789,"document":"26657985","golden":false,"offsetInEndSection":1850,"text":"CRP is significantly higher in women with metabolic syndrome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":780,"document":"7544304","golden":false,"offsetInEndSection":925,"text":"These findings suggest that the immunoregulatory actions of hCG are probably mediated by specific receptors in T-lymphocytes from pregnant women.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":337,"document":"36778751","golden":false,"offsetInEndSection":1530,"text":"The study attempted to establish the median concentrations of pregnancy-associated plasma protein PAPP-A and the free subunit of human chorionic gonadotropin ?-hCG in women with hypothyroidism in the 1st trimester of pregnancy.Objective: The study attempted to establish the median concentrations of pregnancy-associated plasma protein PAPP-A and the free subunit of human chorionic gonadotropin ?-hCG in women with hypothyroidism in the 1st trimester of pregnancy.Patients and methods: The study included 210 pregnant women between 11 and 13.6 weeks of pregnancy; 105 women were diagnosed with hypothyroidism before or during pregnancy, and 105 women of a similar body weight and gestational age had normal thyroid function.The measurements of the pregnancy parameters studied were performed using the DELFIA? Xpress system.Results: Differences in the multiples of the median of the PAPP-A and ?-hCG levels between women with hypothyroidism and healthy women were observed.Conclusion: Introducing correction for patients with hypothyroidism during non-invasive biochemical prenatal testing may allow obtaining more reliable results that would be the basis for referral to invasive procedures.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":94,"document":"23369067","golden":false,"offsetInEndSection":1152,"text":"The aim of this study was to investigate the efficacy of craniosacral therapy as an adjunct to standard treatment compared with standard treatment alone for PGP during pregnancy.DESIGN: Randomized, multicenter, single blind, controlled trial.SETTING: University hospital, a private clinic and 26 maternity care centers in Gothenburg, Sweden.POPULATION: A total of 123 pregnant women with PGP.METHODS: Participants were randomly assigned to standard treatment (control group, n \u003d 60) or standard treatment plus craniosacral therapy (intervention group, n \u003d 63).PRIMARY OUTCOME MEASURES: pain intensity (visual analog scale 0-100 mm) and sick leave.SECONDARY OUTCOMES: function (Oswestry Disability Index), health-related quality of life (European Quality of Life measure), unpleasantness of pain (visual analog scale), and assessment of the severity of PGP by an independent examiner.RESULTS: Between-group differences for morning pain, symptom-free women and function in the last treatment week were in favor of the intervention group. Visual analog scale me","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1351,"document":"34707571","golden":false,"offsetInEndSection":1792,"text":"Implantation rate, clinical pregnancy rate, and ongoing pregnancy rate showed an increasing trend in patients receiving 150 IU of hCG in the early phase compared with mid-late phase, even thought there was no statistically significant difference.Conclusions: Our study demonstrated that adding 150 IU of hCG in subsequent GnRH antagonist cycle in \"unpredictable\" poor responders is associated with the improvement of response to stimulation.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"7544304","golden":false,"offsetInEndSection":103,"text":"Lymphocytes from pregnant women express human chorionic gonadotropin/luteinizing hormone receptor gene.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":0,"document":"7544304","golden":false,"offsetInEndSection":150,"text":"Previous studies have indicated that human chorionic gonadotropin (hCG) has immunoregulatory properties and alters the functions of human lymphocytes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":295,"document":"7544304","golden":false,"offsetInEndSection":533,"text":"Total peripheral mononuclear lymphocytes isolated from blood samples of pregnant women by Ficoll-Paque gradient centrifugation contained mRNA transcripts encoding the hCG/LH receptors and a 50 kDa receptor protein which can bind 125I-hCG.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1121,"document":"36908009","golden":false,"offsetInEndSection":1459,"text":"In the comparison-free B-hCG, PAPP-A and NT values of both groups, no statistically significant difference was found between the two groups in terms of first-trimester test results and NT (p\u003c0.05).Conclusion: The use of dydrogesterone in first-trimester pregnancies does not affect first-trimester screening tests and nuchal translucency.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":151,"document":"7544304","golden":false,"offsetInEndSection":294,"text":"However, it has not been determined whether the gene encoding the receptors for hCG/luteinizing hormone (LH) is expressed in human lymphocytes.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1291,"document":"19665325","golden":false,"offsetInEndSection":1676,"text":"80% of the women thought that chewing would not have any effect on the fetus.DISCUSSION: Given the high use of \"pure\" betel nut among pregnant women, a significant impact on birth weight reduction and a poor knowledge about the adverse health effects of this substance, prevention programs in pregnant women should include betel nut chewing as a risk factor for poor pregnancy outcome.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":832,"document":"19280488","golden":false,"offsetInEndSection":1006,"text":"These findings were verified quantitatively using both the pregnancy-unique quantification of emesis and nausea (PUQE) (p \u003c 0.001) and well-being (p \u003c 0.001) scoring systems.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":5,"document":"37211347","golden":false,"offsetInEndSection":94,"text":"Hyperemesis gravidarum (HG) is one of the most common serious diseases in early pregnancy","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1203,"document":"36839295","golden":false,"offsetInEndSection":1344,"text":"We should pay more attention to women who experience nausea and vomiting during pregnancy and provide them with targeted nutritional support.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":220,"document":"36720519","golden":false,"offsetInEndSection":353,"text":"A total of 258 pregnant women, 137 with hyperemesis gravidarum and 121 low-risk pregnancies, were included in this case-control study","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":0,"document":"36250744","golden":false,"offsetInEndSection":181,"text":"Hyperemesis gravidarum (HG), or the severe nausea and vomiting of pregnancy, is one of the most dreaded complications of gestation, affecting between 1.5% and 3.0% of pregnant women","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":330,"document":"35839462","golden":false,"offsetInEndSection":527,"text":"We identified women with and without hyperemesis gravidarum and followed them over time to capture incident cancers, grouped by embryonic germ cell layer of origin and organ hCG receptor positivity","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":179,"document":"35725415","golden":false,"offsetInEndSection":349,"text":"In this cross-sectional study, we compared 45 HEG patients aged between 21 and 34 in terms of ADAMTS-1 levels with a control group consisting of 44 healthy pregnant women","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":939,"document":"37584611","golden":false,"offsetInEndSection":1325,"text":"These species-specific findings may help guide future studies focusing on GDF15 in pregnancy and on the evaluation of pharmacological strategies to interfere with GDF15-GFRAL signaling to treat severe nausea and HG.NEW \u0026 NOTEWORTHY In the present study pregnancy-induced changes in circulating growth differentiation factor 15 (GDF15) in rodents, rhesus macaques, and humans are mapped.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1326,"document":"37584611","golden":false,"offsetInEndSection":1460,"text":"In sum, it is demonstrated that humans and macaques exhibit a tremendous increase in placental and circulating GDF15 during pregnancy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":932,"document":"35758442","golden":false,"offsetInEndSection":1123,"text":"Furthermore, LH level at the day of IUI was higher in pregnant women than in non-pregnant (27.9 versus 20 IU/L, P?0.007).CONCLUSION: Conclusions: Pregnancy rate was equivalent in both groups.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1080,"document":"33098451","golden":false,"offsetInEndSection":1349,"text":"General proneness to nausea, maternal age, and parity were also significant independent predictors of NVP.CONCLUSIONS: Women that carried a female fetus, as opposed to a male fetus, reported significantly higher frequency of NVP during the first trimester of pregnancy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":281,"document":"37584611","golden":false,"offsetInEndSection":491,"text":"This is corroborated by genetic association studies in which GDF15 and the GDF15 receptor, GDNF family receptor alpha like (GFRAL) have been linked to morning sickness and hyperemesis gravidarum (HG) in humans.","beginSection":"abstract"},{"endSection":"title","offsetInBeginSection":0,"document":"37584611","golden":false,"offsetInEndSection":52,"text":"Cross-species comparison of pregnancy-induced GDF15.","beginSection":"title"},{"endSection":"abstract","offsetInBeginSection":708,"document":"17882157","golden":false,"offsetInEndSection":865,"text":"Marketed for use in morning sickness, thalidomide was found to be a potent teratogen capable of producing a variety of birth defects relating to development.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":71,"document":"37584611","golden":false,"offsetInEndSection":280,"text":"Although the exact physiological function of GDF15 is not yet fully comprehended, the significant elevation of circulating GDF15 levels during gestation suggests a potential role for this hormone in pregnancy.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":1461,"document":"37584611","golden":false,"offsetInEndSection":1598,"text":"In contrast, GDF15 is negligibly increased in pregnant mice and rats, questioning a physiological role for GDF15 in pregnancy in rodents.","beginSection":"abstract"},{"endSection":"abstract","offsetInBeginSection":525,"document":"10764476","golden":false,"offsetInEndSection":840,"text":"Data based on the McGill Nausea Questionnaire indicate that the nausea experienced by pregnant women is similar in character and intensity to the nausea experienced by patients undergoing cancer chemotherapy.CONCLUSIONS: Traditional teachings about nausea and vomiting of pregnancy are contradicted by our findings.","beginSection":"abstract"}],"exact_answer":[["hCG"]],"ideal_answer":["Morning sickness in pregnant women is thought to be triggered by the secretion of the hormone, human Chorionic Gonadotropin (hCG). This hormone is produced after implantation, and its rising levels during early pregnancy are believed to contribute to feelings of nausea commonly referred to as morning sickness.","Morning sickness in pregnant women is thought to be caused by the secretion of the Human Chorionic Gonadotropin (hCG) protein. It is suggested that morning sickness, which is common in early pregnancy, results from the secretion of hCG and thyroxine, further reducing maternal energy intake.","The protein that is thought to cause morning sickness in pregnant women is human chorionic gonadotropin (hCG). It is suggested that morning sickness may result from the secretion of hCG, which could potentially reduce maternal energy intake."," The hormone Human Chorionic Gonadotropin (hCG), a type of glycoprotein, is the serum marker of pregnancy. It has also been proposed to be involved in nausea and vomiting during pregnancy, but the relationship is not well understood yet.\n"," Morning sickness is a very common disorder among pregnant women, and it is suggested that it is caused by a combination of hormones released by the fetus during early development. Human chorionic gonadotropin (HCG) is thought to be one of the main drivers of morning sickness.\n"," It is suggested that morning sickness, resulting from secretion of hCG and thyroxine, reduces maternal energy intake.\n","The protein thought to cause morning sickness in pregnant women is human chorionic gonadotropin (HCG)."],"id":"659840d906a2ea257c000039","type":"factoid","body":"What protein is thought to cause morning sickness in pregnant women?"}]}